Citrus Sinensis ID: 015027

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410----
Protein Sequence
MLLLDDDVMSTVKEVNARLQDIASQIKQLDLRKKSGRKSRNVRGVISSAVRRGRGGRDPGPTIYSHPGLAFLRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLHENFWAQKKNKETEHLLGESSSYATAVIAQPDAQTVVSIDIENYYGT
Secondary Structure (PSIPRED)
ccccccccEEEHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccEEccHHHHHHHHcccccccccccccccEEEEEEEccccEEEEEEcccccccccccHHHHHHHHHccccccccEEcEEccccEEEEEEEEEcccccccccccccccccccHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccEEEEEccccccccHHHHcccccccccccccHHHHHHHHHHcccccccccccccccccHHHHHHHHHHcccccccccccccccccHHHHHHHHHHHHHHHHccccccccHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccEEEEEEcccccc
Secondary Structure Prediction (SSPRO)
cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEcHHHHHHHHccccHHccccccccccEEEEEcccccEEEEEEEccccccHHHHHHHHHHHHHHHHHHHHHEEEEEEccccEEEEEEEcccccHHHHHccccccccccHHHHHHHHHHHHHHHHHHHHcccccEEEEcccHHHEEccccccccHcHccHHEEcccccccEEEEEEEEccccccHHHHHHcEEcHHHHHHHHHHHHHHHHcccccccccccccccccHHHHHHHHHHHcccHHHHccHHHcccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccEEEccccccc
Coil and Loop (DISEMBL)
MLLLDDDVMSTVKEVNARLQDIASQIKQLDLRkksgrksrnvrGVISSavrrgrggrdpgptiyshpglafLRMKIFSKSEMIRATKnfdrsrclsqggfvsvykgvlHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFasngtlldhircESSQVLKTWKTCLRIAAETASALDYlhslasppiihgdvksanillndnytakvaDFESSVLISSDAETAMSTILIgtsgyldpvcintgkltkksdvYSFGVVLAELltgkkpgscmtlasnkkisMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLrirgterptmkQVSEELDRLRRLHENFWAQKKnketehllgesssyataviaqpdaqtvvSIDIENYYGT
Flexible Loop (DISEMBL)
MLLLDDDVMSTVKEVNarlqdiasqikqldlrkksgrksrnvrgvissavrrgrggrdpgptiyshpglAFLRMKIFSKSEMIRATKNFDRSRCLSQGGFVSvykgvlhdniqVAVKtyrradkirITERELLriisqvnhkNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGkltkksdvYSFGVVLAelltgkkpgscMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKclrirgterptmkqvsEELDRLRRLHENFWAQKKNKETEHLLGESSSYATAViaqpdaqtvvSIDIENYYGT
Low Complexity Region (SEG)
MLLLDDDVMSTVKEVNARLQDIASQIKQLDLRKKSGRKSRNVRGVISSAVrrgrggrdpgpTIYSHPGLAFLRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKiriterellriiSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLHENFWAQKKNKETEHLLGESSSYATAVIAQPDAQTVVSIDIENYYGT
Disordered region (IsUnstruct)
*************************************************************TIYSHPGLAFLRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRG******************LHENFWA****************YATAVIAQPDAQTVVSIDIENY***
Disordered Region (DISOPRED)
*******VMSTVKEVNARLQDIASQIKQLDLR*******************************************IFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVK**************LLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSC*****NK*ISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDR***************************************************
Disordered Region (DISEMBL)
MLLLDDDVMSTVKEVNARLQDIASQIKQLD***********VRGVISSAVRRGRGGRDPGPTIYSHPGLAFLRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLHENFWAQKKNKETEHLLGESSSYATAVIAQPDAQTVVSIDIENYYGT
Disordered Region (DISPRO)
******DVMST***********************************************************FLRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLR*************************************************
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MLLLDDDVMSTxxxxxxxxxxxxxxxxxxxxxKKSGRKSRNVRGVISSAVRRGRGGRDPGPTIYSHPGLAFLRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLHENFWAQKKNKETEHLLGESSSYATAVIAQPDAQTVVSIDIENYYGT
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	414	2.2.26 [Sep-21-2011]
Q9LMN7	733	Wall-associated receptor	yes	no	0.823	0.465	0.484	2e-78
Q9LMN8	741	Wall-associated receptor	no	no	0.823	0.460	0.468	3e-76
Q39191	735	Wall-associated receptor	no	no	0.823	0.463	0.460	2e-73
Q9LMN6	738	Wall-associated receptor	no	no	0.823	0.462	0.457	3e-73
Q9LMP1	732	Wall-associated receptor	no	no	0.823	0.465	0.457	5e-73
Q9LSV3	433	Putative wall-associated	no	no	0.823	0.787	0.444	2e-69
Q9S9M2	761	Wall-associated receptor	no	no	0.693	0.377	0.457	3e-66
Q9SA25	720	Wall-associated receptor	no	no	0.765	0.440	0.434	4e-66
Q8VYA3	769	Wall-associated receptor	no	no	0.731	0.394	0.432	6e-66
Q7X8C5	748	Wall-associated receptor	no	no	0.700	0.387	0.459	6e-66

>sp|Q9LMN7|WAK5_ARATH Wall-associated receptor kinase 5 OS=Arabidopsis thaliana GN=WAK5 PE=2 SV=1

 Score =  293 bits (750), Expect = 2e-78,   Method: Compositional matrix adjust.
 Identities = 170/351 (48%), Positives = 230/351 (65%), Gaps = 10/351 (2%)

Query: 65  SHPGLAFLRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADK 124
           S  G + + +KIF++  M  AT  ++ SR L QGG  +VYKG+L DN  VA+K  R  D+
Sbjct: 384 SGAGPSNVDVKIFTEEGMKEATDGYNESRILGQGGQGTVYKGILQDNSIVAIKKARLGDR 443

Query: 125 IRITE--RELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLK 182
            ++ +   E+L ++SQ+NH+NVVK+LG CLETEVPLLVYEF S+GTL DH+         
Sbjct: 444 SQVEQFINEVL-VLSQINHRNVVKLLGCCLETEVPLLVYEFISSGTLFDHLHGSMFDSSL 502

Query: 183 TWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDA 242
           TW+  LRIA E A  L YLHS AS PIIH DVK+ANILL++N TAKVADF +S LI  D 
Sbjct: 503 TWEHRLRIAIEVAGTLAYLHSYASIPIIHRDVKTANILLDENLTAKVADFGASRLIPMDQ 562

Query: 243 ETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKIS 302
           E  ++T++ GT GYLDP   NTG L +KSDVYSFGVVL ELL+G+K   C     + K  
Sbjct: 563 E-QLTTMVQGTLGYLDPEYYNTGLLNEKSDVYSFGVVLMELLSGEK-ALCFERPQSSK-H 619

Query: 303 MVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELD 362
           +V YF++++K N L +I++  V +E   +EI+  A +A +C RI G ERP+MK+V+ EL+
Sbjct: 620 LVSYFVSAMKENRLHEIIDGQVMNEYNQREIQESARIAVECTRIMGEERPSMKEVAAELE 679

Query: 363 RLR-RLHENFWAQKKNKETEHLLGE---SSSYATAVIAQPDAQTVVSIDIE 409
            LR +  ++ W+ +  KE EHLLG    S+   T+ I     Q V  +DIE
Sbjct: 680 ALRVKTTKHQWSDQYPKEVEHLLGVQILSTQGDTSSIGYDSIQNVTRLDIE 730

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: -

>sp|Q9LMN8|WAK3_ARATH Wall-associated receptor kinase 3 OS=Arabidopsis thaliana GN=WAK3 PE=2 SV=2

 Score =  285 bits (730), Expect = 3e-76,   Method: Compositional matrix adjust.
 Identities = 165/352 (46%), Positives = 226/352 (64%), Gaps = 11/352 (3%)

Query: 65  SHPGLAFLRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADK 124
           S  GL+ +  KIF++  M  AT  +D SR L QGG  +VYKG+L DN  VA+K  R AD 
Sbjct: 391 SGAGLSNIDFKIFTEEGMKEATNGYDESRILGQGGQGTVYKGILPDNTIVAIKKARLADS 450

Query: 125 IRITE--RELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLK 182
            ++ +   E+L ++SQ+NH+NVVKILG CLETEVPLLVYEF +NGTL DH+         
Sbjct: 451 RQVDQFIHEVL-VLSQINHRNVVKILGCCLETEVPLLVYEFITNGTLFDHLHGSIFDSSL 509

Query: 183 TWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDA 242
           TW+  LRIA E A  L YLHS AS PIIH D+K+ANILL++N TAKVADF +S LI  D 
Sbjct: 510 TWEHRLRIAIEVAGTLAYLHSSASIPIIHRDIKTANILLDENLTAKVADFGASKLIPMDK 569

Query: 243 ETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKIS 302
           E  ++T++ GT GYLDP    TG L +KSDVYSFGVVL ELL+G+K   C       K  
Sbjct: 570 E-QLTTMVQGTLGYLDPEYYTTGLLNEKSDVYSFGVVLMELLSGQK-ALCFERPQASK-H 626

Query: 303 MVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELD 362
           +V YF+++ + N L +I++  V +E  +KEI+  A +A++C R+ G ERP MK+V+ +L+
Sbjct: 627 LVSYFVSATEENRLHEIIDDQVLNEDNLKEIQEAARIAAECTRLMGEERPRMKEVAAKLE 686

Query: 363 RLR-RLHENFWAQKKNKETEHLLG----ESSSYATAVIAQPDAQTVVSIDIE 409
            LR    ++ W+ +  +E EHL+G     +    ++ I     + V  +DIE
Sbjct: 687 ALRVEKTKHKWSDQYPEENEHLIGGHILSAQGETSSSIGYDSIKNVAILDIE 738

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q39191|WAK1_ARATH Wall-associated receptor kinase 1 OS=Arabidopsis thaliana GN=WAK1 PE=1 SV=2

 Score =  276 bits (707), Expect = 2e-73,   Method: Compositional matrix adjust.
 Identities = 162/352 (46%), Positives = 222/352 (63%), Gaps = 11/352 (3%)

Query: 65  SHPGLAFLRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADK 124
           S  G + + +KIF++  M +AT  +  SR L QGG  +VYKG+L DN  VA+K  R  D 
Sbjct: 385 SGAGPSNVDVKIFTEDGMKKATNGYAESRILGQGGQGTVYKGILPDNSIVAIKKARLGDS 444

Query: 125 IRITE--RELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLK 182
            ++ +   E+L ++SQ+NH+NVVK+LG CLETEVPLLVYEF +NGTL DH+         
Sbjct: 445 SQVEQFINEVL-VLSQINHRNVVKLLGCCLETEVPLLVYEFITNGTLFDHLHGSMIDSSL 503

Query: 183 TWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDA 242
           TW+  L+IA E A  L YLHS AS PIIH D+K+ANILL+ N TAKVADF +S LI  D 
Sbjct: 504 TWEHRLKIAIEVAGTLAYLHSSASIPIIHRDIKTANILLDVNLTAKVADFGASRLIPMDK 563

Query: 243 ETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKIS 302
           E  + T++ GT GYLDP   NTG L +KSDVYSFGVVL ELL+G+K   C     + K  
Sbjct: 564 E-ELETMVQGTLGYLDPEYYNTGLLNEKSDVYSFGVVLMELLSGQK-ALCFKRPQSSK-H 620

Query: 303 MVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELD 362
           +V YF  + K N L +I+   V +E  +KEI+  A +A++C R+ G ERP MK+V+ +L+
Sbjct: 621 LVSYFATATKENRLDEIIGGEVMNEDNLKEIQEAARIAAECTRLMGEERPRMKEVAAKLE 680

Query: 363 RLR-RLHENFWAQKKNKETEHLLG----ESSSYATAVIAQPDAQTVVSIDIE 409
            LR    ++ W+ +  +E EHL+G     +    ++ I     + V  +DIE
Sbjct: 681 ALRVEKTKHKWSDQYPEENEHLIGGHILSAQGETSSSIGYDSIKNVAILDIE 732

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development. Required during plant's response to pathogen infection and in plant defense against heavy metal toxicity. Phosphorylates the oxygen-evolving enhancer protein 2 (OEE2) in an GRP-3-dependent manner.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LMN6|WAK4_ARATH Wall-associated receptor kinase 4 OS=Arabidopsis thaliana GN=WAK4 PE=2 SV=1

 Score =  276 bits (705), Expect = 3e-73,   Method: Compositional matrix adjust.
 Identities = 162/354 (45%), Positives = 226/354 (63%), Gaps = 13/354 (3%)

Query: 65  SHPGLAFLRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADK 124
           S  G + + +KIF++  M  AT  +D +R L QGG  +VYKG+L DN  VA+K  R  D 
Sbjct: 386 SGAGPSNVDVKIFTEEGMKEATDGYDENRILGQGGQGTVYKGILPDNSIVAIKKARLGDN 445

Query: 125 IRITE--RELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLK 182
            ++ +   E+L ++SQ+NH+NVVK+LG CLETEVPLLVYEF S+GTL DH+         
Sbjct: 446 SQVEQFINEVL-VLSQINHRNVVKLLGCCLETEVPLLVYEFISSGTLFDHLHGSMFDSSL 504

Query: 183 TWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDA 242
           TW+  LR+A E A  L YLHS AS PIIH D+K+ANILL++N TAKVADF +S LI  D 
Sbjct: 505 TWEHRLRMAVEIAGTLAYLHSSASIPIIHRDIKTANILLDENLTAKVADFGASRLIPMDK 564

Query: 243 ETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKIS 302
           E  ++T++ GT GYLDP   NTG L +KSDVYSFGVVL ELL+G+K   C       K  
Sbjct: 565 ED-LATMVQGTLGYLDPEYYNTGLLNEKSDVYSFGVVLMELLSGQK-ALCFERPQTSK-H 621

Query: 303 MVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELD 362
           +V YF ++ K N L +I++  V +E+  +EI+  A +A +C R+ G ERP MK+V+ EL+
Sbjct: 622 IVSYFASATKENRLHEIIDGQVMNENNQREIQKAARIAVECTRLTGEERPGMKEVAAELE 681

Query: 363 RLRRLH-ENFWAQK--KNKETEHLLG----ESSSYATAVIAQPDAQTVVSIDIE 409
            LR    ++ W+ +  + ++TEHL+G     +    ++ I     + V  +DIE
Sbjct: 682 ALRVTKTKHKWSDEYPEQEDTEHLVGVQKLSAQGETSSSIGYDSIRNVAILDIE 735

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LMP1|WAK2_ARATH Wall-associated receptor kinase 2 OS=Arabidopsis thaliana GN=WAK2 PE=1 SV=1

 Score =  275 bits (703), Expect = 5e-73,   Method: Compositional matrix adjust.
 Identities = 162/354 (45%), Positives = 224/354 (63%), Gaps = 13/354 (3%)

Query: 65  SHPGLAFLRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADK 124
           S  G + + +KIF++  M  AT  +  SR L QGG  +VYKG+L DN  VA+K  R  ++
Sbjct: 380 SGAGPSNVDVKIFTEKGMKEATNGYHESRILGQGGQGTVYKGILPDNSIVAIKKARLGNR 439

Query: 125 IRITE--RELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLK 182
            ++ +   E+L ++SQ+NH+NVVK+LG CLETEVPLLVYEF ++GTL DH+         
Sbjct: 440 SQVEQFINEVL-VLSQINHRNVVKVLGCCLETEVPLLVYEFINSGTLFDHLHGSLYDSSL 498

Query: 183 TWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDA 242
           TW+  LRIA E A +L YLHS AS PIIH D+K+ANILL+ N TAKVADF +S LI  D 
Sbjct: 499 TWEHRLRIATEVAGSLAYLHSSASIPIIHRDIKTANILLDKNLTAKVADFGASRLIPMDK 558

Query: 243 ETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKIS 302
           E  ++TI+ GT GYLDP   NTG L +KSDVYSFGVVL ELL+G+K   C       K +
Sbjct: 559 E-QLTTIVQGTLGYLDPEYYNTGLLNEKSDVYSFGVVLMELLSGQK-ALCFERPHCPK-N 615

Query: 303 MVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELD 362
           +V  F ++ KNN   +I++  V +E   +EI+  A +A++C R+ G ERP MK+V+ EL+
Sbjct: 616 LVSCFASATKNNRFHEIIDGQVMNEDNQREIQEAARIAAECTRLMGEERPRMKEVAAELE 675

Query: 363 RLRRLHENF-WAQ--KKNKETEHLLG----ESSSYATAVIAQPDAQTVVSIDIE 409
            LR     + W+   ++  E EHLLG     +    ++ I     + V ++DIE
Sbjct: 676 ALRVKTTKYKWSDQYRETGEIEHLLGVQILSAQGETSSSIGYDSIRNVTTLDIE 729

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LSV3|WAKLS_ARATH Putative wall-associated receptor kinase-like 16 OS=Arabidopsis thaliana GN=WAKL16 PE=3 SV=1

 Score =  263 bits (671), Expect = 2e-69,   Method: Compositional matrix adjust.
 Identities = 156/351 (44%), Positives = 216/351 (61%), Gaps = 10/351 (2%)

Query: 65  SHPGLAFLRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADK 124
           S  G + +  KIF++ +M  AT  +D SR L QGG  +VYKG+L DN  VA+K  R  D 
Sbjct: 84  SGAGSSNIDFKIFTEEDMKEATNGYDVSRILGQGGQWTVYKGILPDNSIVAIKKTRLGDN 143

Query: 125 IRITE--RELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLK 182
            ++ +   E+L ++SQ+NH+NVVK+LG CLETEVPLLVYEF + G+L DH+         
Sbjct: 144 NQVEQFINEVL-VLSQINHRNVVKLLGCCLETEVPLLVYEFITGGSLFDHLHGSMFVSSL 202

Query: 183 TWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDA 242
           TW+  L IA E A A+ YLHS AS PIIH D+K+ NILL++N TAKVADF +S L   D 
Sbjct: 203 TWEHRLEIAIEVAGAIAYLHSGASIPIIHRDIKTENILLDENLTAKVADFGASKLKPMDK 262

Query: 243 ETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKIS 302
           E  ++T++ GT GYLDP    T  L +KSDVYSFGVVL EL++G+K   C       K  
Sbjct: 263 E-QLTTMVQGTLGYLDPEYYTTWLLNEKSDVYSFGVVLMELISGQK-ALCFERPETSK-H 319

Query: 303 MVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELD 362
           +V YF+ + K N L +I++  V +E   +EI   A +A +C R++G ERP M +V+ EL+
Sbjct: 320 LVSYFVLATKENRLHEIIDDQVLNEENQREIHEAARVAVECTRLKGEERPRMIEVAAELE 379

Query: 363 RLR-RLHENFWAQKKNKETEHLLGE---SSSYATAVIAQPDAQTVVSIDIE 409
            LR +  ++ W  +  +E  HLLG    S+   T+     + + V   DIE
Sbjct: 380 TLRAKTTKHNWLDQYPEENVHLLGSNIVSAQGHTSSRGYDNNKNVARFDIE 430

Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9S9M2|WAKLD_ARATH Wall-associated receptor kinase-like 4 OS=Arabidopsis thaliana GN=WAKL4 PE=2 SV=2

 Score =  252 bits (644), Expect = 3e-66,   Method: Compositional matrix adjust.
 Identities = 134/293 (45%), Positives = 194/293 (66%), Gaps = 6/293 (2%)

Query: 75  KIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITE--REL 132
           KIFS +E+ +AT NF+ +R L QGG  +VYKG+L D   VAVK  +  D+ ++ E   E+
Sbjct: 410 KIFSSNELEKATDNFNTNRVLGQGGQGTVYKGMLVDGRIVAVKRSKAMDEDKVEEFINEV 469

Query: 133 LRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAA 192
           + +++Q+NH+N+VK+LG CLETEVP+LVYEF  NG L   +R E    + TW+  L IA 
Sbjct: 470 V-VLAQINHRNIVKLLGCCLETEVPVLVYEFVPNGDLCKRLRDECDDYIMTWEVRLHIAI 528

Query: 193 ETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIG 252
           E A AL YLHS AS PI H D+K+ NILL++ Y  KV+DF +S  ++ D +T ++T + G
Sbjct: 529 EIAGALSYLHSAASFPIYHRDIKTTNILLDEKYQVKVSDFGTSRSVTID-QTHLTTQVAG 587

Query: 253 TSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIK 312
           T GY+DP    + K T KSDVYSFGVVL EL+TGK P S +    N+  +   +F+ ++K
Sbjct: 588 TFGYVDPEYFQSSKFTDKSDVYSFGVVLVELITGKNPSSRVQSEENRGFAA--HFVAAVK 645

Query: 313 NNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLR 365
            N    I++  + DE  + ++  VA+LA +CL  +G +RP M++VS EL+R+R
Sbjct: 646 ENRFLDIVDERIKDECNLDQVMAVAKLAKRCLNRKGKKRPNMREVSVELERIR 698

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Plays a role in plant mineral nutrients response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9SA25|WAKLG_ARATH Wall-associated receptor kinase-like 8 OS=Arabidopsis thaliana GN=WAKL8 PE=2 SV=1

 Score =  252 bits (643), Expect = 4e-66,   Method: Compositional matrix adjust.
 Identities = 145/334 (43%), Positives = 209/334 (62%), Gaps = 17/334 (5%)

Query: 73  RMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITE--R 130
           R K+FS +++  AT  F+ SR L QGG  +VYKG+L D + VAVK  +   +  + E   
Sbjct: 374 RTKVFSSNDLENATDRFNASRILGQGGQGTVYKGMLEDGMIVAVKKSKALKEENLEEFIN 433

Query: 131 ELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRI 190
           E++ ++SQ+NH+NVVKILG CLETEVP+LVYEF  N  L DH+   S     +W+  L I
Sbjct: 434 EII-LLSQINHRNVVKILGCCLETEVPILVYEFIPNRNLFDHLHNPSEDFPMSWEVRLCI 492

Query: 191 AAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTIL 250
           A E A AL YLHS  S PI H DVKS NILL++ + AKV+DF  S  ++ D +T ++TI+
Sbjct: 493 ACEVADALSYLHSAVSIPIYHRDVKSTNILLDEKHRAKVSDFGISRSVAID-DTHLTTIV 551

Query: 251 IGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMV-PYFLN 309
            GT GY+DP  + +   T KSDVYSFGV+L ELLTG+KP   ++L   +++ M+  YFL 
Sbjct: 552 QGTIGYVDPEYLQSNHFTGKSDVYSFGVLLIELLTGEKP---VSLLRRQEVRMLGAYFLE 608

Query: 310 SIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLHE 369
           +++N+ L +IL+  + +E + +E+  VA+LA +CL +    RPTM+ V  ELDR+     
Sbjct: 609 AMRNDRLHEILDARIKEECDREEVLAVAKLARRCLSLNSEHRPTMRDVFIELDRM----- 663

Query: 370 NFWAQKKNKETEHLLGESSSYATAVIAQPDAQTV 403
               Q K K T+        +A   IA P++ ++
Sbjct: 664 ----QSKRKGTQSQAQNGEEHAHIQIAMPESMSL 693

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q8VYA3|WAKLJ_ARATH Wall-associated receptor kinase-like 10 OS=Arabidopsis thaliana GN=WAKL10 PE=2 SV=1

 Score =  251 bits (642), Expect = 6e-66,   Method: Compositional matrix adjust.
 Identities = 134/310 (43%), Positives = 205/310 (66%), Gaps = 7/310 (2%)

Query: 75  KIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITE--REL 132
           ++F+  E+ +AT+NF  +R L +GG  +VYKG+L D   VAVK  +  D+ ++ E   E+
Sbjct: 419 RVFNSRELEKATENFSLTRILGEGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEV 478

Query: 133 LRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQ-VLKTWKTCLRIA 191
           + I+SQ+NH+N+VK+LG CLET+VP+LVYEF  NG L +H+  +S    + TW+  LRIA
Sbjct: 479 V-ILSQINHRNIVKLLGCCLETDVPILVYEFIPNGNLFEHLHDDSDDYTMTTWEVRLRIA 537

Query: 192 AETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILI 251
            + A AL YLHS AS PI H D+KS NI+L++ + AKV+DF +S  ++ D  T ++T++ 
Sbjct: 538 VDIAGALSYLHSAASSPIYHRDIKSTNIMLDEKHRAKVSDFGTSRTVTVD-HTHLTTVVS 596

Query: 252 GTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSI 311
           GT GY+DP    + + T KSDVYSFGVVLAEL+TG+K  S   L S +  ++  YF  ++
Sbjct: 597 GTVGYMDPEYFQSSQFTDKSDVYSFGVVLAELITGEK--SVSFLRSQEYRTLATYFTLAM 654

Query: 312 KNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLHENF 371
           K N L  I++  + D  ++ ++   A++A KCL ++G +RP+M+QVS EL+++R   E+ 
Sbjct: 655 KENRLSDIIDARIRDGCKLNQVTAAAKIARKCLNMKGRKRPSMRQVSMELEKIRSYSEDM 714

Query: 372 WAQKKNKETE 381
              +   E E
Sbjct: 715 QPYEYASENE 724

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q7X8C5|WAKLB_ARATH Wall-associated receptor kinase-like 2 OS=Arabidopsis thaliana GN=WAKL2 PE=2 SV=1

 Score =  251 bits (642), Expect = 6e-66,   Method: Compositional matrix adjust.
 Identities = 136/296 (45%), Positives = 196/296 (66%), Gaps = 6/296 (2%)

Query: 75  KIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITE--REL 132
           +IFS  E+ +AT NF+++R L QGG  +VYKG+L D   VAVK  +  D+ R+ E   E+
Sbjct: 402 RIFSSHELEKATDNFNKNRVLGQGGQGTVYKGMLVDGRIVAVKRSKAVDEDRVEEFINEV 461

Query: 133 LRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAA 192
           + +++Q+NH+N+VK+LG CLETEVP+LVYEF  NG L   +  ES     TW+  L IA 
Sbjct: 462 V-VLAQINHRNIVKLLGCCLETEVPVLVYEFVPNGDLCKRLHDESDDYTMTWEVRLHIAI 520

Query: 193 ETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIG 252
           E A AL YLHS AS PI H D+K+ NILL++   AKV+DF +S  ++ D +T ++T + G
Sbjct: 521 EIAGALSYLHSAASFPIYHRDIKTTNILLDERNRAKVSDFGTSRSVTID-QTHLTTQVAG 579

Query: 253 TSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIK 312
           T GY+DP    + K T+KSDVYSFGVVL ELLTG+KP S +    N+ ++   +F+ ++K
Sbjct: 580 TFGYVDPEYFQSSKFTEKSDVYSFGVVLVELLTGEKPSSRVRSEENRGLAA--HFVEAVK 637

Query: 313 NNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLH 368
            N +  I++  + DE  M ++  VA LA +CL  +G +RP M++VS EL+ +R  H
Sbjct: 638 ENRVLDIVDDRIKDECNMDQVMSVANLARRCLNRKGKKRPNMREVSIELEMIRSSH 693

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	414
224102957	615	predicted protein [Populus trichocarpa]	0.869	0.585	0.547	1e-104
255565901	457	BRASSINOSTEROID INSENSITIVE 1-associated	0.809	0.733	0.565	1e-100
255573255	739	kinase, putative [Ricinus communis] gi|2	0.811	0.454	0.569	2e-98
255573259	771	serine-threonine protein kinase, plant-t	0.806	0.433	0.564	2e-98
224132144	646	predicted protein [Populus trichocarpa]	0.809	0.518	0.542	1e-95
224132202	721	predicted protein [Populus trichocarpa]	0.835	0.479	0.518	1e-93
224145581	584	predicted protein [Populus trichocarpa]	0.830	0.589	0.523	5e-93
224102953	633	predicted protein [Populus trichocarpa]	0.758	0.496	0.563	1e-92
224132156	667	predicted protein [Populus trichocarpa]	0.746	0.463	0.561	8e-91
224132160	667	predicted protein [Populus trichocarpa]	0.746	0.463	0.557	1e-90

>gi|224102957|ref|XP_002312869.1| predicted protein [Populus trichocarpa] gi|222849277|gb|EEE86824.1| predicted protein [Populus trichocarpa]

 Score =  385 bits (990), Expect = e-104,   Method: Compositional matrix adjust.
 Identities = 203/371 (54%), Positives = 261/371 (70%), Gaps = 11/371 (2%)

Query: 45  VISSAVRRGRGGRDPGPTIYSHPGLAFLRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVY 104
           +I S  R+ +  R+ G T+  H      R++IFS++E+ +AT N+D  + + +GGF SVY
Sbjct: 248 MILSKRRKDKNFRENGGTVLKHQ-----RVRIFSEAELTKATNNYDDDKKIGEGGFGSVY 302

Query: 105 KGVLHDNIQVAVKTYRRADKIRITE--RELLRIISQVNHKNVVKILGLCLETEVPLLVYE 162
           KG+L DN  VAVK  +  DK ++ E  +  + ++SQVNHKNVVK+LGLCLET+VPLLVYE
Sbjct: 303 KGILADNTVVAVKKSKGVDKAQMNEDFQHEICVVSQVNHKNVVKLLGLCLETKVPLLVYE 362

Query: 163 FASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLN 222
           F SNGTL  HI  + SQVL +W   LRIA+E A ALDYLHSLA PP+IHGDVKS NILL+
Sbjct: 363 FISNGTLFKHIHDKRSQVLASWSNRLRIASEAALALDYLHSLADPPVIHGDVKSVNILLD 422

Query: 223 DNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAE 282
           DNYTAKVADF +SVLIS      ++T + GT GYLDP  + TG LT+KSDVYSFGVVL E
Sbjct: 423 DNYTAKVADFGASVLISPGQTNILATKIQGTFGYLDPEYLLTGNLTEKSDVYSFGVVLVE 482

Query: 283 LLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASK 342
           LLTG+KP S     S  K + + YF ++++NN L  IL+F  ADE+EM EIE VAELA +
Sbjct: 483 LLTGEKPNS--NAKSGNKRNFIQYFNSALENNDLFGILDFQAADEAEMDEIEAVAELAKR 540

Query: 343 CLRIRGTERPTMKQVSEELDRLRRLHENFWAQKKNKETEHLLGESSSYATAVIAQP--DA 400
           CL   G  RP+MK+VSEEL +L+ L++  WAQ+ + ETEHLLGE S       + P   +
Sbjct: 541 CLNSIGVNRPSMKEVSEELAKLKALNQKSWAQQNSDETEHLLGEPSQSFRNNASPPTSQS 600

Query: 401 QTVVSIDIENY 411
           QTV+S +IENY
Sbjct: 601 QTVISFEIENY 611

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255565901|ref|XP_002523939.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223536786|gb|EEF38426.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis]

 Score =  372 bits (956), Expect = e-100,   Method: Compositional matrix adjust.
 Identities = 195/345 (56%), Positives = 259/345 (75%), Gaps = 10/345 (2%)

Query: 73  RMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITE--R 130
           R++I S++E+ +AT+N++ S+ L +GGF SVYKG+L D  QVAVK  +  D+ +I +  +
Sbjct: 112 RVRILSEAELTKATRNYETSQFLGEGGFGSVYKGILADGTQVAVKKPKDLDRTQINQEFQ 171

Query: 131 ELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRI 190
           + L I+SQVNH NVVKILGLCLET+VPLLVYEF SNG+L  HI  + SQ+L +WK  LRI
Sbjct: 172 KELAIVSQVNHINVVKILGLCLETKVPLLVYEFISNGSLYQHIHQKRSQILTSWKNRLRI 231

Query: 191 AAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTIL 250
           A ETA A+DYLHSLA+PPIIHGDVKSANILL+DNYTAKV+DF +SVLIS    T M+T +
Sbjct: 232 ATETALAIDYLHSLANPPIIHGDVKSANILLDDNYTAKVSDFGASVLISP-GYTDMATKI 290

Query: 251 IGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNS 310
            GT GYLDP  + TGKLT+KSDVYSFGVVL E+LTG+KP S     S  K +++ YFL+S
Sbjct: 291 QGTFGYLDPEYLMTGKLTEKSDVYSFGVVLVEILTGEKPNS--NARSGVKSNIIQYFLSS 348

Query: 311 IKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLHEN 370
           +++  +   L F V +E E++EI++ +ELA +CL   G +RPTMK+V+EEL RLR+L+E+
Sbjct: 349 LESKNISGTLCFMV-NEDELEEIKVFSELAKRCLSSTGIKRPTMKEVAEELGRLRKLNES 407

Query: 371 FWAQKKNKETEHLLGESS----SYATAVIAQPDAQTVVSIDIENY 411
            WAQ+ +KETEHLLG++S     + TA I+QPD   +   DI+ Y
Sbjct: 408 LWAQENSKETEHLLGDASYHCIHFQTANISQPDTHIMRRFDIDLY 452

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255573255|ref|XP_002527556.1| kinase, putative [Ricinus communis] gi|223533048|gb|EEF34808.1| kinase, putative [Ricinus communis]

 Score =  365 bits (938), Expect = 2e-98,   Method: Compositional matrix adjust.
 Identities = 197/346 (56%), Positives = 253/346 (73%), Gaps = 10/346 (2%)

Query: 69  LAFLRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRIT 128
           L   R++IFS++E+ +ATKN+D S+ L +GGF  VYKGVL DN Q+AVK  +  DK +I 
Sbjct: 393 LKHQRVRIFSEAELAKATKNYDPSQLLGEGGFGYVYKGVLADNTQIAVKKPKDIDKAQIK 452

Query: 129 E--RELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKT 186
           +  +  + I+SQVNHKNVVKILGLCLET+VPLLVYEF SNGTL  HI  + SQ+L  WK 
Sbjct: 453 QEYQHEIGIVSQVNHKNVVKILGLCLETKVPLLVYEFISNGTLFHHIHHKRSQILANWKN 512

Query: 187 CLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAM 246
            LRIAAETA A DYLHSLA PPIIHGDVKS NILL+D YTAKV+DF +SVLISS  E+ +
Sbjct: 513 RLRIAAETALAFDYLHSLADPPIIHGDVKSLNILLDDTYTAKVSDFGASVLISS-GESDI 571

Query: 247 STILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPY 306
              L GT GYLDP  + TG LT+KSDVYSFGVVL ELLTG+KP S    ++     ++ Y
Sbjct: 572 GAKLQGTFGYLDPEYLMTGILTEKSDVYSFGVVLVELLTGEKPNS----SARSGEHIIQY 627

Query: 307 FLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR 366
           FL+S++++ L QIL F+V +E+EM+EI + AELA +CLR  G +RPTMK+ +EEL RL++
Sbjct: 628 FLSSLESHNLSQILCFNVTNENEMEEIVVFAELAKQCLRSCGVKRPTMKEAAEELGRLKK 687

Query: 367 LHENFWAQKKN--KETEHLLGESS-SYATAVIAQPDAQTVVSIDIE 409
           L+EN W    +  +ET++LLGESS    TA +   +  ++ S DIE
Sbjct: 688 LNENSWNHDDHSGEETQYLLGESSIDIGTAKLNHQEILSIRSYDIE 733

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255573259|ref|XP_002527558.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223533050|gb|EEF34810.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  365 bits (937), Expect = 2e-98,   Method: Compositional matrix adjust.
 Identities = 193/342 (56%), Positives = 250/342 (73%), Gaps = 8/342 (2%)

Query: 73  RMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITE--R 130
           R++IF ++E+ +AT  +  S  L +GGF  VYKGVL D  QVAVK  +  +K+++ +  +
Sbjct: 427 RVRIFKEAELAKATNYYTTSNFLGEGGFGCVYKGVLADGTQVAVKRPKDIEKMKMNQEFQ 486

Query: 131 ELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRI 190
           + + I+SQVNH NVVK+LGLCLET VPLLVYEF SNG L  HI  + SQ+L  WK  LRI
Sbjct: 487 KEIGIVSQVNHINVVKVLGLCLETNVPLLVYEFVSNGNLYQHIHQKRSQLLTAWKNILRI 546

Query: 191 AAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTIL 250
           AAETA ALDYLHSLA+PPIIHGDVKSANILL++NYTAKV+DF +SVLISS+ +T M+T +
Sbjct: 547 AAETALALDYLHSLANPPIIHGDVKSANILLDENYTAKVSDFGASVLISSN-QTDMATKI 605

Query: 251 IGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNS 310
            GT GYLDP  + TG LT+KSDVYSFGVVL ELLTG+KP S     S +K +++ YFL+S
Sbjct: 606 QGTFGYLDPEYLMTGNLTEKSDVYSFGVVLVELLTGEKPNS--NPKSGEKNNIIQYFLSS 663

Query: 311 IKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLHEN 370
           ++N  L QI  F +  + EM+EIE+ AELA +CLR  G +RPTM +V+ EL RLR+LHE+
Sbjct: 664 LENGDLNQIPCFEITSKEEMEEIEVFAELAKQCLRSSGIKRPTMNEVAHELVRLRKLHES 723

Query: 371 FWAQKKNKETEHLLGESSSYATAVIAQPDAQTVVSI---DIE 409
            W+Q  + ETEHLL + SS     I + + Q V+S+   DIE
Sbjct: 724 SWSQHNSNETEHLLQDDSSSFFVDIGKLNLQEVLSVKANDIE 765

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224132144|ref|XP_002328196.1| predicted protein [Populus trichocarpa] gi|222837711|gb|EEE76076.1| predicted protein [Populus trichocarpa]

 Score =  356 bits (913), Expect = 1e-95,   Method: Compositional matrix adjust.
 Identities = 187/345 (54%), Positives = 247/345 (71%), Gaps = 10/345 (2%)

Query: 45  VISSAVRRGRGGRDPGPTIYSHPGLAFLRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVY 104
           VI +  RR +  R  G  +  H      R++IF ++E+ +AT N+   + L +GGF  VY
Sbjct: 310 VICTKRRRDKNFRKNGGMVLKHQ-----RVRIFREAELEKATNNYVDDQKLGEGGFGYVY 364

Query: 105 KGVLHDNIQVAVKTYRRADKIRITE--RELLRIISQVNHKNVVKILGLCLETEVPLLVYE 162
           KGVL DN  VAVK ++  DK ++ E  ++ + I+SQVNH+NVVK+LGLCLET+VPLLVYE
Sbjct: 365 KGVLADNTLVAVKKFKGVDKDQLNEEFQKEIGIVSQVNHRNVVKLLGLCLETKVPLLVYE 424

Query: 163 FASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLN 222
           F SNGTL  HI  + SQ+L +W   LRIA+E A ALDYLHSLA PP+IHGDVKS NILL+
Sbjct: 425 FISNGTLYKHIHDKRSQILASWSNRLRIASEIALALDYLHSLADPPVIHGDVKSVNILLD 484

Query: 223 DNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAE 282
           +NYTAKVADF +SVLISS  ++ ++T + GT GYLDP  + TG LT KSDV+SFGVVL E
Sbjct: 485 NNYTAKVADFGASVLISS-GQSFIATKIQGTFGYLDPEYLMTGNLTPKSDVFSFGVVLLE 543

Query: 283 LLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASK 342
           LL G+KP S     S +  +++ YF+++++NN L  IL+F  ADE EM EIE+VAE+A +
Sbjct: 544 LLIGQKPNS--HAKSGETRNIIEYFISALENNNLFGILDFQAADEGEMDEIEVVAEIAKR 601

Query: 343 CLRIRGTERPTMKQVSEELDRLRRLHENFWAQKKNKETEHLLGES 387
           C+   G  RPTMK+VS+EL + + LHE+ WAQ KN +T+HLL ES
Sbjct: 602 CVNSMGINRPTMKEVSDELAKQKALHESSWAQHKNDDTKHLLSES 646

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224132202|ref|XP_002328210.1| predicted protein [Populus trichocarpa] gi|222837725|gb|EEE76090.1| predicted protein [Populus trichocarpa]

 Score =  350 bits (897), Expect = 1e-93,   Method: Compositional matrix adjust.
 Identities = 184/355 (51%), Positives = 250/355 (70%), Gaps = 9/355 (2%)

Query: 64  YSHPGLAFL---RMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYR 120
           +   G  FL   R++IFS++E+++AT N+   R + +GGF SVY GVL DN  VAVK  +
Sbjct: 365 FQENGGKFLKNQRVRIFSEAELVKATNNYADDRKIGEGGFGSVYSGVLTDNTMVAVKKSK 424

Query: 121 RADKIRITE--RELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESS 178
             DK ++    ++ + I+SQVNHKNVVK+LGLCLET+VPLLVYEF SNGTL  HI  + S
Sbjct: 425 GVDKAQMNAEFQKEMSIVSQVNHKNVVKLLGLCLETKVPLLVYEFISNGTLSKHIHDKGS 484

Query: 179 QVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLI 238
           ++L +W   LR+A+E A ALDYLHSLA PP+IHGDVKS NILL++N+T KVADF +SVL+
Sbjct: 485 RILASWTNRLRVASEAALALDYLHSLADPPVIHGDVKSVNILLDNNHTTKVADFGASVLM 544

Query: 239 SSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASN 298
           S      ++T + GT GYLDP  + TG LT +SDVYSFGVVL ELLTG+ P S     S 
Sbjct: 545 SPGQTDILATKIQGTLGYLDPEYLMTGILTVQSDVYSFGVVLVELLTGEMPNS--ISKSG 602

Query: 299 KKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVS 358
           +K +++ +F+++++NN L +IL+F  ADE +M EIE VAELA  CL   G  RP MK+VS
Sbjct: 603 EKRNVIQHFISALENNHLFKILDFQTADEGDMDEIEAVAELAKGCLNSMGVNRPAMKEVS 662

Query: 359 EELDRLRRLHENFWAQKKNKETEHLLGESSSYATAVIAQP--DAQTVVSIDIENY 411
           +EL +L+ LH+   A +K++ET++LLGESS       + P   + TV+S+ +ENY
Sbjct: 663 DELAKLKALHQKSLAHEKSEETDYLLGESSQSFCKNASPPMNQSHTVISLQMENY 717

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224145581|ref|XP_002325694.1| predicted protein [Populus trichocarpa] gi|222862569|gb|EEF00076.1| predicted protein [Populus trichocarpa]

 Score =  347 bits (890), Expect = 5e-93,   Method: Compositional matrix adjust.
 Identities = 187/357 (52%), Positives = 254/357 (71%), Gaps = 13/357 (3%)

Query: 64  YSHPGLAFL---RMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYR 120
           +   G  FL   R++IFS++E+++AT N+   R L +G F SVYKGVL DN  VAVK  +
Sbjct: 228 FQENGGKFLKNQRVRIFSEAELVKATNNYADDRKLGEGSFGSVYKGVLTDNTVVAVKKSK 287

Query: 121 RADKIRITE--RELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESS 178
             DK ++    ++ + I+SQVNHKNVVK+LGLCLET+VPLLVYEF SNGTL  HI  + S
Sbjct: 288 GVDKAQMNAEFQKEMSIVSQVNHKNVVKLLGLCLETKVPLLVYEFISNGTLSKHIHDKGS 347

Query: 179 QVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLI 238
           ++L +W   LR+A+E A ALDYLHSLA PP+IHGDVKS NILL++N+TAKVADF +SVL+
Sbjct: 348 RILVSWTNRLRVASEAALALDYLHSLADPPVIHGDVKSVNILLDNNHTAKVADFGASVLM 407

Query: 239 SSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASN 298
           S       +T + GT GYLDP  + TG LT +SDVYSFGVVL ELLTG+ P S     S 
Sbjct: 408 SPGQTDISATKIQGTLGYLDPEYLMTGILTVQSDVYSFGVVLVELLTGEMPNS--ISKSG 465

Query: 299 KKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVS 358
           +K +++ +F+++++NN L +IL+F  ADE +M EIE VAELA +CL   G  RP MK+VS
Sbjct: 466 EKRNVIQHFISALENNHLFKILDFQTADEDDMDEIEAVAELAKRCLNSMGVNRPAMKEVS 525

Query: 359 EELDRLRRLHENFWAQKKNKETEHLLGESSSY----ATAVIAQPDAQTVVSIDIENY 411
           +EL +L+ LH+   AQ+ ++ET++LL ESS      A+ ++ Q  +QTV+S+ +ENY
Sbjct: 526 DELAKLKALHQKSLAQQNSEETDYLLDESSQSFCENASHLMNQ--SQTVISLQMENY 580

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224102953|ref|XP_002312868.1| predicted protein [Populus trichocarpa] gi|222849276|gb|EEE86823.1| predicted protein [Populus trichocarpa]

 Score =  346 bits (887), Expect = 1e-92,   Method: Compositional matrix adjust.
 Identities = 182/323 (56%), Positives = 231/323 (71%), Gaps = 9/323 (2%)

Query: 45  VISSAVRRGRGGRDPGPTIYSHPGLAFLRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVY 104
           +I S  R+ +  R+ G  +  H      R++IFS++E+ +AT N+D  + L +GGF SVY
Sbjct: 318 MILSKRRKDKNFRENGGMVLKHQ-----RVRIFSEAELTKATNNYDDDKKLGEGGFGSVY 372

Query: 105 KGVLHDNIQVAVKTYRRADKIRITE--RELLRIISQVNHKNVVKILGLCLETEVPLLVYE 162
           KGVL DN  VAVK  +  DK ++ E  +  + ++SQVNHKNVVK+LGLCLET+VPLLVYE
Sbjct: 373 KGVLADNTVVAVKKSKGVDKAQMNEDFQHEICVVSQVNHKNVVKLLGLCLETKVPLLVYE 432

Query: 163 FASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLN 222
           F SNGTL  HI  + SQVL +W   LRIA+E A ALDYLHSLA PP+IHGDVKS NILL+
Sbjct: 433 FISNGTLFKHIHDKRSQVLASWSNRLRIASEAALALDYLHSLADPPVIHGDVKSVNILLD 492

Query: 223 DNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAE 282
           DNYTAKVADF +SVLIS      ++T + GT GYLDP  + TG LT+KSDVYSFGVVL E
Sbjct: 493 DNYTAKVADFGASVLISPGQTNILATKIQGTFGYLDPEYLMTGNLTEKSDVYSFGVVLVE 552

Query: 283 LLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASK 342
           LLTG+KP S     S KK + + YF ++++NN +  IL+F  ADE+EM EIE VAELA +
Sbjct: 553 LLTGEKPNS--NAKSGKKRNFIQYFNSALENNDVFGILDFQAADEAEMDEIEAVAELAKR 610

Query: 343 CLRIRGTERPTMKQVSEELDRLR 365
           CL   G  RP+MK+VSEEL +L+
Sbjct: 611 CLNSTGVNRPSMKEVSEELAKLK 633

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224132156|ref|XP_002328199.1| predicted protein [Populus trichocarpa] gi|222837714|gb|EEE76079.1| predicted protein [Populus trichocarpa]

 Score =  340 bits (872), Expect = 8e-91,   Method: Compositional matrix adjust.
 Identities = 179/319 (56%), Positives = 237/319 (74%), Gaps = 10/319 (3%)

Query: 51  RRGRGGRDPGPTIYSHPGLAFLRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHD 110
           ++ R  R+ G  +  H      R++IFS++E+ +ATKN+D  + L +GGF SVY+GVL D
Sbjct: 357 KKDRNFRENGGMVLKHQ-----RVRIFSEAELEKATKNYDDDQKLGEGGFGSVYRGVLAD 411

Query: 111 NIQVAVKTYRRADKIRITE--RELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGT 168
           N QVAVK ++  DK ++ E  +  + ++SQVNHKNVVK+LGLCLET+VPLLVYEF SNGT
Sbjct: 412 NAQVAVKKFKGVDKAQMNEEFQNEMGVVSQVNHKNVVKLLGLCLETKVPLLVYEFISNGT 471

Query: 169 LLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAK 228
           L  HI  ++SQ+L +W + LRIA+E A AL+YLHSLA PPIIHGDVKS NILL++N TAK
Sbjct: 472 LFKHIHDKTSQLLASWSSRLRIASEIALALNYLHSLADPPIIHGDVKSVNILLDNNNTAK 531

Query: 229 VADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKK 288
           VADF +SVLISSD +T ++T + GT GYLDP  + TG LT +SDV+SFGVVL ELLTG+K
Sbjct: 532 VADFGASVLISSD-QTIIATKIQGTFGYLDPEYLMTGILTARSDVFSFGVVLVELLTGEK 590

Query: 289 PGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRG 348
           P S  T  S +K +++ +F+++++ N L +IL+F  ADE EM EIE VAELA  CL   G
Sbjct: 591 PNSSST--SGEKRNLIQHFISALETNNLFRILDFQAADEGEMDEIEAVAELAKGCLNSMG 648

Query: 349 TERPTMKQVSEELDRLRRL 367
             RPTMK+VS+EL +L+ L
Sbjct: 649 LNRPTMKEVSDELAKLKDL 667

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224132160|ref|XP_002328200.1| predicted protein [Populus trichocarpa] gi|222837715|gb|EEE76080.1| predicted protein [Populus trichocarpa]

 Score =  339 bits (870), Expect = 1e-90,   Method: Compositional matrix adjust.
 Identities = 178/319 (55%), Positives = 238/319 (74%), Gaps = 10/319 (3%)

Query: 51  RRGRGGRDPGPTIYSHPGLAFLRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHD 110
           ++ R  R+ G  +  H      R++IFS++E+ +ATKN+D  + L +GGF SVY+GVL D
Sbjct: 357 KKDRNFRENGGMVLKHQ-----RVRIFSEAELEKATKNYDDDQKLGEGGFGSVYRGVLAD 411

Query: 111 NIQVAVKTYRRADKIRITE--RELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGT 168
           N QVAVK ++  DK ++ E  +  + ++SQVNHKNVVK+LGLCLET+VPLLVYEF SNGT
Sbjct: 412 NAQVAVKKFKGVDKAQMNEEFQNEMGVVSQVNHKNVVKLLGLCLETKVPLLVYEFISNGT 471

Query: 169 LLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAK 228
           L  HI  ++SQ+L +W + LRIA+E A AL+YLHSLA PPIIHGDVKS NILL++N TAK
Sbjct: 472 LFKHIHDKTSQLLASWSSRLRIASEIALALNYLHSLADPPIIHGDVKSVNILLDNNNTAK 531

Query: 229 VADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKK 288
           VADF +SVLISSD +T ++T + GT GYLDP  + TG LT +SDV+SFGVVL ELLTG+K
Sbjct: 532 VADFGASVLISSD-QTIIATKIQGTFGYLDPEYLMTGILTARSDVFSFGVVLVELLTGEK 590

Query: 289 PGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRG 348
           P S  + +S +K +++ +F+++++ N L +IL+F  ADE EM EIE VAELA  CL   G
Sbjct: 591 PNS--SSSSGEKRNLIQHFISALETNNLFRILDFQAADEGEMDEIEAVAELAKGCLNSMG 648

Query: 349 TERPTMKQVSEELDRLRRL 367
             RPTMK+VS+EL +L+ L
Sbjct: 649 LNRPTMKEVSDELAKLKDL 667

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	414
TAIR|locus:2014962	733	WAK5 "wall associated kinase 5	0.826	0.466	0.48	5.9e-73
TAIR|locus:2014897	741	WAK3 "wall associated kinase 3	0.826	0.461	0.464	1.4e-71
TAIR|locus:2014902	735	WAK1 "cell wall-associated kin	0.826	0.465	0.455	3.8e-69
TAIR|locus:2014952	738	WAK4 "wall associated kinase 4	0.826	0.463	0.453	6.3e-69
TAIR|locus:2014912	732	WAK2 "wall-associated kinase 2	0.826	0.467	0.453	4.4e-68
TAIR|locus:2200552	730	WAKL1 "wall associated kinase-	0.734	0.416	0.451	1.4e-64
TAIR|locus:2094468	433	AT3G25490 [Arabidopsis thalian	0.826	0.789	0.44	1.8e-64
TAIR|locus:2032875	720	AT1G16260 [Arabidopsis thalian	0.736	0.423	0.448	6.9e-63
TAIR|locus:2019843	769	WAKL10 "WALL ASSOCIATED KINASE	0.801	0.431	0.406	2.3e-62
TAIR|locus:2019893	751	RFO1 "RESISTANCE TO FUSARIUM O	0.734	0.404	0.438	4.8e-62

TAIR|locus:2014962 WAK5 "wall associated kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 737 (264.5 bits), Expect = 5.9e-73, P = 5.9e-73
 Identities = 168/350 (48%), Positives = 222/350 (63%)

Query:    65 SHPGLAFLRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADK 124
             S  G + + +KIF++  M  AT  ++ SR L QGG  +VYKG+L DN  VA+K  R  D+
Sbjct:   384 SGAGPSNVDVKIFTEEGMKEATDGYNESRILGQGGQGTVYKGILQDNSIVAIKKARLGDR 443

Query:   125 XXXXXXXXXXXX-SQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKT 183
                          SQ+NH+NVVK+LG CLETEVPLLVYEF S+GTL DH+         T
Sbjct:   444 SQVEQFINEVLVLSQINHRNVVKLLGCCLETEVPLLVYEFISSGTLFDHLHGSMFDSSLT 503

Query:   184 WKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE 243
             W+  LRIA E A  L YLHS AS PIIH DVK+ANILL++N TAKVADF +S LI  D E
Sbjct:   504 WEHRLRIAIEVAGTLAYLHSYASIPIIHRDVKTANILLDENLTAKVADFGASRLIPMDQE 563

Query:   244 TAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISM 303
               ++T++ GT GYLDP   NTG L +KSDVYSFGVVL ELL+G+K   C     + K  +
Sbjct:   564 Q-LTTMVQGTLGYLDPEYYNTGLLNEKSDVYSFGVVLMELLSGEK-ALCFERPQSSK-HL 620

Query:   304 VPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDR 363
             V YF++++K N L +I++  V +E   +EI+  A +A +C RI G ERP+MK+V+ EL+ 
Sbjct:   621 VSYFVSAMKENRLHEIIDGQVMNEYNQREIQESARIAVECTRIMGEERPSMKEVAAELEA 680

Query:   364 LR-RLHENFWAQKKNKETEHLLGE---SSSYATAVIAQPDAQTVVSIDIE 409
             LR +  ++ W+ +  KE EHLLG    S+   T+ I     Q V  +DIE
Sbjct:   681 LRVKTTKHQWSDQYPKEVEHLLGVQILSTQGDTSSIGYDSIQNVTRLDIE 730

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2014897 WAK3 "wall associated kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 724 (259.9 bits), Expect = 1.4e-71, P = 1.4e-71
 Identities = 163/351 (46%), Positives = 219/351 (62%)

Query:    65 SHPGLAFLRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRAD- 123
             S  GL+ +  KIF++  M  AT  +D SR L QGG  +VYKG+L DN  VA+K  R AD 
Sbjct:   391 SGAGLSNIDFKIFTEEGMKEATNGYDESRILGQGGQGTVYKGILPDNTIVAIKKARLADS 450

Query:   124 KXXXXXXXXXXXXSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKT 183
             +            SQ+NH+NVVKILG CLETEVPLLVYEF +NGTL DH+         T
Sbjct:   451 RQVDQFIHEVLVLSQINHRNVVKILGCCLETEVPLLVYEFITNGTLFDHLHGSIFDSSLT 510

Query:   184 WKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE 243
             W+  LRIA E A  L YLHS AS PIIH D+K+ANILL++N TAKVADF +S LI  D E
Sbjct:   511 WEHRLRIAIEVAGTLAYLHSSASIPIIHRDIKTANILLDENLTAKVADFGASKLIPMDKE 570

Query:   244 TAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISM 303
               ++T++ GT GYLDP    TG L +KSDVYSFGVVL ELL+G+K   C       K  +
Sbjct:   571 Q-LTTMVQGTLGYLDPEYYTTGLLNEKSDVYSFGVVLMELLSGQK-ALCFERPQASK-HL 627

Query:   304 VPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDR 363
             V YF+++ + N L +I++  V +E  +KEI+  A +A++C R+ G ERP MK+V+ +L+ 
Sbjct:   628 VSYFVSATEENRLHEIIDDQVLNEDNLKEIQEAARIAAECTRLMGEERPRMKEVAAKLEA 687

Query:   364 LR-RLHENFWAQKKNKETEHLLG----ESSSYATAVIAQPDAQTVVSIDIE 409
             LR    ++ W+ +  +E EHL+G     +    ++ I     + V  +DIE
Sbjct:   688 LRVEKTKHKWSDQYPEENEHLIGGHILSAQGETSSSIGYDSIKNVAILDIE 738

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2014902 WAK1 "cell wall-associated kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 701 (251.8 bits), Expect = 3.8e-69, P = 3.8e-69
 Identities = 160/351 (45%), Positives = 214/351 (60%)

Query:    65 SHPGLAFLRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADK 124
             S  G + + +KIF++  M +AT  +  SR L QGG  +VYKG+L DN  VA+K  R  D 
Sbjct:   385 SGAGPSNVDVKIFTEDGMKKATNGYAESRILGQGGQGTVYKGILPDNSIVAIKKARLGDS 444

Query:   125 XXXXXXXXXXXX-SQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKT 183
                          SQ+NH+NVVK+LG CLETEVPLLVYEF +NGTL DH+         T
Sbjct:   445 SQVEQFINEVLVLSQINHRNVVKLLGCCLETEVPLLVYEFITNGTLFDHLHGSMIDSSLT 504

Query:   184 WKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE 243
             W+  L+IA E A  L YLHS AS PIIH D+K+ANILL+ N TAKVADF +S LI  D E
Sbjct:   505 WEHRLKIAIEVAGTLAYLHSSASIPIIHRDIKTANILLDVNLTAKVADFGASRLIPMDKE 564

Query:   244 TAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISM 303
               + T++ GT GYLDP   NTG L +KSDVYSFGVVL ELL+G+K   C     + K  +
Sbjct:   565 E-LETMVQGTLGYLDPEYYNTGLLNEKSDVYSFGVVLMELLSGQK-ALCFKRPQSSK-HL 621

Query:   304 VPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDR 363
             V YF  + K N L +I+   V +E  +KEI+  A +A++C R+ G ERP MK+V+ +L+ 
Sbjct:   622 VSYFATATKENRLDEIIGGEVMNEDNLKEIQEAARIAAECTRLMGEERPRMKEVAAKLEA 681

Query:   364 LR-RLHENFWAQKKNKETEHLLG----ESSSYATAVIAQPDAQTVVSIDIE 409
             LR    ++ W+ +  +E EHL+G     +    ++ I     + V  +DIE
Sbjct:   682 LRVEKTKHKWSDQYPEENEHLIGGHILSAQGETSSSIGYDSIKNVAILDIE 732

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISS;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0007166 "cell surface receptor signaling pathway" evidence=IPI

GO:0005773 "vacuole" evidence=IDA

GO:0009751 "response to salicylic acid stimulus" evidence=IEP

GO:0009615 "response to virus" evidence=IEP

GO:0050832 "defense response to fungus" evidence=RCA;IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009814 "defense response, incompatible interaction" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0009505 "plant-type cell wall" evidence=IDA

TAIR|locus:2014952 WAK4 "wall associated kinase 4" [Arabidopsis thaliana (taxid:3702)]

 Score = 699 (251.1 bits), Expect = 6.3e-69, P = 6.3e-69
 Identities = 160/353 (45%), Positives = 218/353 (61%)

Query:    65 SHPGLAFLRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADK 124
             S  G + + +KIF++  M  AT  +D +R L QGG  +VYKG+L DN  VA+K  R  D 
Sbjct:   386 SGAGPSNVDVKIFTEEGMKEATDGYDENRILGQGGQGTVYKGILPDNSIVAIKKARLGDN 445

Query:   125 XXXXXXXXXXXX-SQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKT 183
                          SQ+NH+NVVK+LG CLETEVPLLVYEF S+GTL DH+         T
Sbjct:   446 SQVEQFINEVLVLSQINHRNVVKLLGCCLETEVPLLVYEFISSGTLFDHLHGSMFDSSLT 505

Query:   184 WKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE 243
             W+  LR+A E A  L YLHS AS PIIH D+K+ANILL++N TAKVADF +S LI  D E
Sbjct:   506 WEHRLRMAVEIAGTLAYLHSSASIPIIHRDIKTANILLDENLTAKVADFGASRLIPMDKE 565

Query:   244 TAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISM 303
               ++T++ GT GYLDP   NTG L +KSDVYSFGVVL ELL+G+K   C       K  +
Sbjct:   566 D-LATMVQGTLGYLDPEYYNTGLLNEKSDVYSFGVVLMELLSGQK-ALCFERPQTSK-HI 622

Query:   304 VPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDR 363
             V YF ++ K N L +I++  V +E+  +EI+  A +A +C R+ G ERP MK+V+ EL+ 
Sbjct:   623 VSYFASATKENRLHEIIDGQVMNENNQREIQKAARIAVECTRLTGEERPGMKEVAAELEA 682

Query:   364 LRRLH-ENFWAQK--KNKETEHLLG----ESSSYATAVIAQPDAQTVVSIDIE 409
             LR    ++ W+ +  + ++TEHL+G     +    ++ I     + V  +DIE
Sbjct:   683 LRVTKTKHKWSDEYPEQEDTEHLVGVQKLSAQGETSSSIGYDSIRNVAILDIE 735

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0009826 "unidimensional cell growth" evidence=IMP

GO:0048527 "lateral root development" evidence=RCA;IMP

GO:0048589 "developmental growth" evidence=RCA

GO:0048765 "root hair cell differentiation" evidence=RCA

TAIR|locus:2014912 WAK2 "wall-associated kinase 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 691 (248.3 bits), Expect = 4.4e-68, P = 4.4e-68
 Identities = 160/353 (45%), Positives = 216/353 (61%)

Query:    65 SHPGLAFLRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADK 124
             S  G + + +KIF++  M  AT  +  SR L QGG  +VYKG+L DN  VA+K  R  ++
Sbjct:   380 SGAGPSNVDVKIFTEKGMKEATNGYHESRILGQGGQGTVYKGILPDNSIVAIKKARLGNR 439

Query:   125 XXXXXXXXXXXX-SQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKT 183
                          SQ+NH+NVVK+LG CLETEVPLLVYEF ++GTL DH+         T
Sbjct:   440 SQVEQFINEVLVLSQINHRNVVKVLGCCLETEVPLLVYEFINSGTLFDHLHGSLYDSSLT 499

Query:   184 WKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE 243
             W+  LRIA E A +L YLHS AS PIIH D+K+ANILL+ N TAKVADF +S LI  D E
Sbjct:   500 WEHRLRIATEVAGSLAYLHSSASIPIIHRDIKTANILLDKNLTAKVADFGASRLIPMDKE 559

Query:   244 TAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISM 303
               ++TI+ GT GYLDP   NTG L +KSDVYSFGVVL ELL+G+K   C       K ++
Sbjct:   560 Q-LTTIVQGTLGYLDPEYYNTGLLNEKSDVYSFGVVLMELLSGQK-ALCFERPHCPK-NL 616

Query:   304 VPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDR 363
             V  F ++ KNN   +I++  V +E   +EI+  A +A++C R+ G ERP MK+V+ EL+ 
Sbjct:   617 VSCFASATKNNRFHEIIDGQVMNEDNQREIQEAARIAAECTRLMGEERPRMKEVAAELEA 676

Query:   364 LRRLHENF-WAQ--KKNKETEHLLG----ESSSYATAVIAQPDAQTVVSIDIE 409
             LR     + W+   ++  E EHLLG     +    ++ I     + V ++DIE
Sbjct:   677 LRVKTTKYKWSDQYRETGEIEHLLGVQILSAQGETSSSIGYDSIRNVTTLDIE 729

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0009751 "response to salicylic acid stimulus" evidence=IDA

GO:0009311 "oligosaccharide metabolic process" evidence=IMP

GO:0009826 "unidimensional cell growth" evidence=IMP

GO:0009992 "cellular water homeostasis" evidence=IMP;IDA

GO:0009793 "embryo development ending in seed dormancy" evidence=RCA

GO:0010027 "thylakoid membrane organization" evidence=RCA

GO:0010228 "vegetative to reproductive phase transition of meristem" evidence=RCA

GO:0016226 "iron-sulfur cluster assembly" evidence=RCA

GO:0019761 "glucosinolate biosynthetic process" evidence=RCA

GO:0048481 "ovule development" evidence=RCA

TAIR|locus:2200552 WAKL1 "wall associated kinase-like 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 658 (236.7 bits), Expect = 1.4e-64, P = 1.4e-64
 Identities = 139/308 (45%), Positives = 197/308 (63%)

Query:    75 KIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXX 134
             KIFS  E+ +AT NF   R L QGG  +VYKG+L D   VAVK  +  D+          
Sbjct:   415 KIFSSKELRKATDNFSIDRVLGQGGQGTVYKGMLVDGSIVAVKRSKVVDEDKMEEFINEI 474

Query:   135 XX-SQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAE 193
                SQ+NH+N+VK+LG CLETEVP+LVYE+  NG L   +  ES     TW+  LRIA E
Sbjct:   475 VLLSQINHRNIVKLLGCCLETEVPILVYEYIPNGDLFKRLHDESDDYTMTWEVRLRIAIE 534

Query:   194 TASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGT 253
              A AL Y+HS AS PI H D+K+ NILL++ Y AKV+DF +S  ++ D +T ++T++ GT
Sbjct:   535 IAGALTYMHSAASFPIFHRDIKTTNILLDEKYRAKVSDFGTSRSVTLD-QTHLTTLVAGT 593

Query:   254 SGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKN 313
              GY+DP    + + T KSDVYSFGVVL EL+TG+KP S   + S +   +  +FL ++K 
Sbjct:   594 FGYMDPEYFLSSQYTHKSDVYSFGVVLVELITGEKPLS--RVRSEEGRGLATHFLEAMKE 651

Query:   314 NGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLHENFWA 373
             N +  I++  + DES+++++  VA+LA KCL  +G  RP MK+VS EL+R+R   E+   
Sbjct:   652 NRVIDIIDIRIKDESKLEQVMAVAKLARKCLNRKGKNRPNMKEVSNELERIRSSPEDLDV 711

Query:   374 QKKNKETE 381
             + +N++ E
Sbjct:   712 RTENEDEE 719

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005618 "cell wall" evidence=ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2094468 AT3G25490 [Arabidopsis thaliana (taxid:3702)]

 Score = 657 (236.3 bits), Expect = 1.8e-64, P = 1.8e-64
 Identities = 154/350 (44%), Positives = 208/350 (59%)

Query:    65 SHPGLAFLRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADK 124
             S  G + +  KIF++ +M  AT  +D SR L QGG  +VYKG+L DN  VA+K  R  D 
Sbjct:    84 SGAGSSNIDFKIFTEEDMKEATNGYDVSRILGQGGQWTVYKGILPDNSIVAIKKTRLGDN 143

Query:   125 XXXXXXXXXXXX-SQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKT 183
                          SQ+NH+NVVK+LG CLETEVPLLVYEF + G+L DH+         T
Sbjct:   144 NQVEQFINEVLVLSQINHRNVVKLLGCCLETEVPLLVYEFITGGSLFDHLHGSMFVSSLT 203

Query:   184 WKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE 243
             W+  L IA E A A+ YLHS AS PIIH D+K+ NILL++N TAKVADF +S L   D E
Sbjct:   204 WEHRLEIAIEVAGAIAYLHSGASIPIIHRDIKTENILLDENLTAKVADFGASKLKPMDKE 263

Query:   244 TAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISM 303
               ++T++ GT GYLDP    T  L +KSDVYSFGVVL EL++G+K   C       K  +
Sbjct:   264 Q-LTTMVQGTLGYLDPEYYTTWLLNEKSDVYSFGVVLMELISGQK-ALCFERPETSK-HL 320

Query:   304 VPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDR 363
             V YF+ + K N L +I++  V +E   +EI   A +A +C R++G ERP M +V+ EL+ 
Sbjct:   321 VSYFVLATKENRLHEIIDDQVLNEENQREIHEAARVAVECTRLKGEERPRMIEVAAELET 380

Query:   364 LR-RLHENFWAQKKNKETEHLLGE---SSSYATAVIAQPDAQTVVSIDIE 409
             LR +  ++ W  +  +E  HLLG    S+   T+     + + V   DIE
Sbjct:   381 LRAKTTKHNWLDQYPEENVHLLGSNIVSAQGHTSSRGYDNNKNVARFDIE 430

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2032875 AT1G16260 [Arabidopsis thaliana (taxid:3702)]

 Score = 642 (231.1 bits), Expect = 6.9e-63, P = 6.9e-63
 Identities = 140/312 (44%), Positives = 198/312 (63%)

Query:    73 RMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRA-DKXXXXXXX 131
             R K+FS +++  AT  F+ SR L QGG  +VYKG+L D + VAVK  +   ++       
Sbjct:   374 RTKVFSSNDLENATDRFNASRILGQGGQGTVYKGMLEDGMIVAVKKSKALKEENLEEFIN 433

Query:   132 XXXXXSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIA 191
                  SQ+NH+NVVKILG CLETEVP+LVYEF  N  L DH+   S     +W+  L IA
Sbjct:   434 EIILLSQINHRNVVKILGCCLETEVPILVYEFIPNRNLFDHLHNPSEDFPMSWEVRLCIA 493

Query:   192 AETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILI 251
              E A AL YLHS  S PI H DVKS NILL++ + AKV+DF  S  ++ D +T ++TI+ 
Sbjct:   494 CEVADALSYLHSAVSIPIYHRDVKSTNILLDEKHRAKVSDFGISRSVAID-DTHLTTIVQ 552

Query:   252 GTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMV-PYFLNS 310
             GT GY+DP  + +   T KSDVYSFGV+L ELLTG+KP   ++L   +++ M+  YFL +
Sbjct:   553 GTIGYVDPEYLQSNHFTGKSDVYSFGVLLIELLTGEKP---VSLLRRQEVRMLGAYFLEA 609

Query:   311 IKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLHEN 370
             ++N+ L +IL+  + +E + +E+  VA+LA +CL +    RPTM+ V  ELDR++   + 
Sbjct:   610 MRNDRLHEILDARIKEECDREEVLAVAKLARRCLSLNSEHRPTMRDVFIELDRMQSKRKG 669

Query:   371 FWAQKKNKETEH 382
               +Q +N E EH
Sbjct:   670 TQSQAQNGE-EH 680

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2019843 WAKL10 "WALL ASSOCIATED KINASE (WAK)-LIKE 10" [Arabidopsis thaliana (taxid:3702)]

 Score = 637 (229.3 bits), Expect = 2.3e-62, P = 2.3e-62
 Identities = 142/349 (40%), Positives = 214/349 (61%)

Query:    75 KIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXX 134
             ++F+  E+ +AT+NF  +R L +GG  +VYKG+L D   VAVK  +  D+          
Sbjct:   419 RVFNSRELEKATENFSLTRILGEGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEV 478

Query:   135 XX-SQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQ-VLKTWKTCLRIAA 192
                SQ+NH+N+VK+LG CLET+VP+LVYEF  NG L +H+  +S    + TW+  LRIA 
Sbjct:   479 VILSQINHRNIVKLLGCCLETDVPILVYEFIPNGNLFEHLHDDSDDYTMTTWEVRLRIAV 538

Query:   193 ETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIG 252
             + A AL YLHS AS PI H D+KS NI+L++ + AKV+DF +S  ++ D  T ++T++ G
Sbjct:   539 DIAGALSYLHSAASSPIYHRDIKSTNIMLDEKHRAKVSDFGTSRTVTVD-HTHLTTVVSG 597

Query:   253 TSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIK 312
             T GY+DP    + + T KSDVYSFGVVLAEL+TG+K  S   L S +  ++  YF  ++K
Sbjct:   598 TVGYMDPEYFQSSQFTDKSDVYSFGVVLAELITGEK--SVSFLRSQEYRTLATYFTLAMK 655

Query:   313 NNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLHENF- 371
              N L  I++  + D  ++ ++   A++A KCL ++G +RP+M+QVS EL+++R   E+  
Sbjct:   656 ENRLSDIIDARIRDGCKLNQVTAAAKIARKCLNMKGRKRPSMRQVSMELEKIRSYSEDMQ 715

Query:   372 ---WAQKKNKETEHLLG----ESSSYA--TAVIAQPDAQTVVSI--DIE 409
                +A +  +E +  L     ES +Y   TA  +Q    T  S   D+E
Sbjct:   716 PYEYASENEEEKKETLVDVNVESRNYVSVTAASSQYSIATTSSSRSDVE 764

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004383 "guanylate cyclase activity" evidence=IDA

GO:0006182 "cGMP biosynthetic process" evidence=IDA

GO:0006952 "defense response" evidence=IEP

GO:0009617 "response to bacterium" evidence=IEP

GO:0009620 "response to fungus" evidence=IEP

GO:0009751 "response to salicylic acid stimulus" evidence=IEP

GO:0009723 "response to ethylene stimulus" evidence=RCA

TAIR|locus:2019893 RFO1 "RESISTANCE TO FUSARIUM OXYSPORUM 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 634 (228.2 bits), Expect = 4.8e-62, P = 4.8e-62
 Identities = 135/308 (43%), Positives = 194/308 (62%)

Query:    75 KIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXX 134
             KIFS  E+ +AT NF+ +R L QGG  +VYKG+L D   VAVK  +  D+          
Sbjct:   407 KIFSSKELEKATDNFNMNRVLGQGGQGTVYKGMLVDGRIVAVKRSKVLDEDKVEEFINEV 466

Query:   135 XX-SQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAE 193
                SQ+NH+N+VK++G CLETEVP+LVYE   NG L   +  +S     TW   LRI+ E
Sbjct:   467 GVLSQINHRNIVKLMGCCLETEVPILVYEHIPNGDLFKRLHHDSDDYTMTWDVRLRISVE 526

Query:   194 TASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGT 253
              A AL YLHS AS P+ H DVK+ NILL++ Y AKV+DF +S  I+ D +T ++T++ GT
Sbjct:   527 IAGALAYLHSAASTPVYHRDVKTTNILLDEKYRAKVSDFGTSRSINVD-QTHLTTLVAGT 585

Query:   254 SGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKN 313
              GYLDP    T + T KSDVYSFGVVL EL+TG+KP S M    N+   +V +F  ++K 
Sbjct:   586 FGYLDPEYFQTSQFTDKSDVYSFGVVLVELITGEKPFSVMRPEENR--GLVSHFNEAMKQ 643

Query:   314 NGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLHENFWA 373
             N +  I++  + +   ++++  VA+LA +CL ++G +RP M++VS EL+R+R   E+   
Sbjct:   644 NRVLDIVDSRIKEGCTLEQVLAVAKLARRCLSLKGKKRPNMREVSVELERIRSSPEDLEL 703

Query:   374 QKKNKETE 381
               + ++ E
Sbjct:   704 HIEEEDEE 711

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005618 "cell wall" evidence=ISS

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016021 "integral to membrane" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009620 "response to fungus" evidence=IMP

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.737
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	414
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-42
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	9e-42
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-41
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-40
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-40
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	7e-39
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	3e-38
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-35
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-31
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	7e-29
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-27
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-27
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	4e-26
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-25
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-24
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	3e-24
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-23
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	6e-23
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-22
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-22
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-22
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	6e-22
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	3e-21
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	3e-21
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	4e-21
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	8e-21
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-20
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-20
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	3e-20
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-20
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	5e-20
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	5e-20
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	6e-20
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-19
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-19
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-19
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-19
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-19
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-19
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-19
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	5e-19
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-18
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-18
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	4e-18
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	4e-18
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	4e-18
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	5e-18
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	9e-18
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-17
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-17
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-17
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-17
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-17
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	9e-17
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-16
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-16
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-16
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	4e-16
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	9e-16
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	9e-16
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-15
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-15
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-15
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-15
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	2e-15
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	3e-15
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	3e-15
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-15
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	3e-15
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	4e-15
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	5e-15
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	5e-15
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	6e-15
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	6e-15
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	6e-15
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	8e-15
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-14
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-14
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-14
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-14
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-14
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-14
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-14
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-14
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-14
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	3e-14
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	3e-14
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	4e-14
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	6e-14
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	8e-14
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	9e-14
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-13
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-13
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-13
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-13
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-13
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-13
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-13
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-13
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-13
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-13
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-13
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-13
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-13
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	4e-13
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	4e-13
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	5e-13
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	5e-13
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	6e-13
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	6e-13
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	7e-13
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	7e-13
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	8e-13
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-12
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-12
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-12
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	2e-12
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-12
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-12
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	4e-12
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	7e-12
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	8e-12
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	9e-12
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-11
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-11
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	3e-11
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	3e-11
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	4e-11
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	4e-11
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	4e-11
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	5e-11
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	6e-11
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	7e-11
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	8e-11
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	9e-11
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	9e-11
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-10
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-10
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-10
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-10
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-10
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-10
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-10
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-10
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	3e-10
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	3e-10
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	3e-10
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	3e-10
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	5e-10
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	6e-10
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	6e-10
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	6e-10
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	7e-10
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	7e-10
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	8e-10
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	8e-10
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	9e-10
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-09
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-09
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-09
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-09
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-09
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-09
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-09
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-09
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-09
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-09
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-09
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-09
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	4e-09
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	5e-09
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	5e-09
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	5e-09
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	6e-09
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	7e-09
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	9e-09
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	9e-09
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	9e-09
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	9e-09
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-08
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-08
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-08
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-08
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-08
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	3e-08
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	3e-08
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-08
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-08
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	4e-08
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	4e-08
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	4e-08
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	4e-08
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	4e-08
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	4e-08
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	5e-08
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	5e-08
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	5e-08
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	6e-08
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	6e-08
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	6e-08
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	6e-08
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	7e-08
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	8e-08
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	8e-08
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	9e-08
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	9e-08
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	9e-08
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-07
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-07
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-07
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-07
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-07
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-07
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-07
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-07
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-07
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-07
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	3e-07
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	3e-07
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-07
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	4e-07
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	4e-07
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	5e-07
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	5e-07
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	5e-07
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	6e-07
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	8e-07
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	9e-07
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-06
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-06
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	1e-06
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-06
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-06
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-06
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-06
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	3e-06
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	3e-06
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	3e-06
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	4e-06
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	4e-06
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	4e-06
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	4e-06
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	5e-06
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	6e-06
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	7e-06
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	8e-06
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	8e-06
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	9e-06
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-05
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-05
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-05
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-05
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-05
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-05
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-05
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-05
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-05
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	3e-05
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-05
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	3e-05
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	3e-05
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	4e-05
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	4e-05
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	4e-05
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	5e-05
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	5e-05
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	6e-05
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	6e-05
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	8e-05
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-04
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-04
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-04
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-04
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-04
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-04
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	3e-04
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	4e-04
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	5e-04
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	7e-04
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	7e-04
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	9e-04
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	9e-04
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	0.001
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	0.001
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	0.001
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	0.002
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	0.002
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	0.003
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	0.003
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	0.003
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	0.004
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	0.004

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  148 bits (375), Expect = 2e-42
 Identities = 68/195 (34%), Positives = 107/195 (54%), Gaps = 14/195 (7%)

Query: 95  LSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRITE---RELLRIISQVNHKNVVKILGL 150
           L +GGF +VY         +VA+K  ++ D   + E   RE+  I+ ++NH N+VK+ G+
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREI-EILKKLNHPNIVKLYGV 59

Query: 151 CLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPII 210
             +     LV E+   G+L D ++    ++  +    LRI  +    L+YLHS     II
Sbjct: 60  FEDENHLYLVMEYCEGGSLKDLLKENEGKL--SEDEILRILLQILEGLEYLHSN---GII 114

Query: 211 HGDVKSANILL-NDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDP-VCINTGKLT 268
           H D+K  NILL +DN   K+ADF  S L++SD     +  ++GT  Y+ P V +  G  +
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYS 172

Query: 269 KKSDVYSFGVVLAEL 283
           +KSD++S GV+L EL
Sbjct: 173 EKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  147 bits (374), Expect = 9e-42
 Identities = 81/281 (28%), Positives = 126/281 (44%), Gaps = 39/281 (13%)

Query: 89  FDRSRCLSQGGFVSVYKGVLH-DNIQVAVKT--YRRAD--KIRITERELLRIISQVNHKN 143
           ++  R L  G F +VYK         VAVK    R     K +   RE+ RI+ +++H N
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREI-RILRRLSHPN 59

Query: 144 VVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHS 203
           +V+++    + +   LV E+   G L D++         +     +IA +    L+YLHS
Sbjct: 60  IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLS---RGGPLSEDEAKKIALQILRGLEYLHS 116

Query: 204 LASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCIN 263
                IIH D+K  NILL++N   K+ADF  +  +   + +  +   +GT  Y+ P  + 
Sbjct: 117 NG---IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT--FVGTPWYMAPEVLL 171

Query: 264 TGKL-TKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGL---RQI 319
            G     K DV+S GV+L ELLTGK                 P F      + L   R+I
Sbjct: 172 GGNGYGPKVDVWSLGVILYELLTGK-----------------PPFSGENILDQLQLIRRI 214

Query: 320 LNFHVADESEMKEIEIVAE---LASKCLRIRGTERPTMKQV 357
           L   + +  E K      E   L  KCL    ++RPT +++
Sbjct: 215 LGPPL-EFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEI 254

Length = 260

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  146 bits (371), Expect = 2e-41
 Identities = 84/283 (29%), Positives = 129/283 (45%), Gaps = 47/283 (16%)

Query: 95  LSQGGFVSVYKGVLHDN-----IQVAVKTYRRADKIRITERELLR---IISQVNHKNVVK 146
           L +G F  VYKG L        ++VAVKT +  D       E LR   I+ +++H N+VK
Sbjct: 7   LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLK-EDASEQQIEEFLREARIMRKLDHPNIVK 65

Query: 147 ILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLAS 206
           +LG+C E E  ++V E+   G LLD++R    + L +    L  A + A  ++YL S   
Sbjct: 66  LLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKEL-SLSDLLSFALQIARGMEYLESK-- 122

Query: 207 PPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV------ 260
              IH D+ + N L+ +N   K++DF  S  +  D    +        G L P+      
Sbjct: 123 -NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVK------GGKL-PIRWMAPE 174

Query: 261 CINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNG-LRQ 318
            +  GK T KSDV+SFGV+L E+ T G++P   M+ A           L  +K    L +
Sbjct: 175 SLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNA---------EVLEYLKKGYRLPK 225

Query: 319 ILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEEL 361
             N              + +L  +C      +RPT  ++ E L
Sbjct: 226 PPNCP----------PELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  144 bits (366), Expect = 1e-40
 Identities = 83/282 (29%), Positives = 126/282 (44%), Gaps = 46/282 (16%)

Query: 95  LSQGGFVSVYKGVLHDN-----IQVAVKTYRRADKIRITERELLR---IISQVNHKNVVK 146
           L +G F  VYKG L        ++VAVKT +  D       E LR   I+ +++H NVVK
Sbjct: 7   LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLK-EDASEQQIEEFLREARIMRKLDHPNVVK 65

Query: 147 ILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLAS 206
           +LG+C E E   +V E+   G LL ++R    ++  +    L  A + A  ++YL S   
Sbjct: 66  LLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKL--SLSDLLSFALQIARGMEYLESK-- 121

Query: 207 PPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG-----YLDPVC 261
              IH D+ + N L+ +N   K++DF  S  +  D             G     ++ P  
Sbjct: 122 -NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRK------RGGKLPIRWMAPES 174

Query: 262 INTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNG-LRQI 319
           +  GK T KSDV+SFGV+L E+ T G++P   M+             L  +KN   L Q 
Sbjct: 175 LKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNE---------EVLEYLKNGYRLPQP 225

Query: 320 LNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEEL 361
            N              + +L  +C      +RPT  ++ E L
Sbjct: 226 PNCP----------PELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  144 bits (366), Expect = 1e-40
 Identities = 82/285 (28%), Positives = 132/285 (46%), Gaps = 47/285 (16%)

Query: 93  RCLSQGGFVSVYKGVLHD-----NIQVAVKTYRR-ADKIRITE--RELLRIISQVNHKNV 144
           + L +G F  VYKG L         +VAVKT +  A +    E   E   I+ +++H N+
Sbjct: 5   KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEA-SIMKKLSHPNI 63

Query: 145 VKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSL 204
           V++LG+C + E   +V E+   G LLD +R +  + L   K  L++A + A  ++YL S 
Sbjct: 64  VRLLGVCTQGEPLYIVTEYMPGGDLLDFLR-KHGEKLTL-KDLLQMALQIAKGMEYLESK 121

Query: 205 ASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV---- 260
                +H D+ + N L+ +N   K++DF  S  I  D             G L P+    
Sbjct: 122 ---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRK-----RGGGKL-PIKWMA 172

Query: 261 --CINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNG-L 316
              +  GK T KSDV+SFGV+L E+ T G++P   M+             L  +++   L
Sbjct: 173 PESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE---------VLELLEDGYRL 223

Query: 317 RQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEEL 361
            +    +  DE        + EL  +C      +RPT  ++ E+L
Sbjct: 224 PR--PENCPDE--------LYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  140 bits (355), Expect = 7e-39
 Identities = 81/297 (27%), Positives = 126/297 (42%), Gaps = 62/297 (20%)

Query: 93  RCLSQGGFVSVYKGVLHDN----IQVAVKTYRRADKIRITERELL---RIISQVNHKNVV 145
           + L +G F  VYKG L        +VAVKT +  D      ++ L   R++ ++ H NVV
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLK-EDASEEERKDFLKEARVMKKLGHPNVV 59

Query: 146 KILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTC------LRIAAETASALD 199
           ++LG+C E E   LV E+   G LLD++R          K+       L  A + A  ++
Sbjct: 60  RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119

Query: 200 YLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDP 259
           YL S      +H D+ + N L+ ++   K++DF  S  +  D      T      G L P
Sbjct: 120 YLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKT-----GGKL-P 170

Query: 260 V------CINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKN 313
           +       +  G  T KSDV+SFGV+L E           TL +       PY    + N
Sbjct: 171 IRWMAPESLKDGIFTSKSDVWSFGVLLWE---------IFTLGA------TPY--PGLSN 213

Query: 314 NGLRQILN--------FHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELD 362
             + + L          +  DE        + EL   C ++   +RPT  ++ E L+
Sbjct: 214 EEVLEYLRKGYRLPKPEYCPDE--------LYELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  138 bits (349), Expect = 3e-38
 Identities = 65/281 (23%), Positives = 113/281 (40%), Gaps = 41/281 (14%)

Query: 89  FDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRI---TERELLRIISQVNHKNV 144
           ++    L +G F  VY          VA+K  ++    +      RE+ +I+ ++ H N+
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREI-KILKKLKHPNI 59

Query: 145 VKILGLCLETEVPLLVYEFASNGTLLDHIR-----CESSQVLKTWKTCLRIAAETASALD 199
           V++  +  + +   LV E+   G L D ++      E                +  SAL+
Sbjct: 60  VRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSE--------DEARFYLRQILSALE 111

Query: 200 YLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDP 259
           YLHS     I+H D+K  NILL+++   K+ADF  +  +    +    T  +GT  Y+ P
Sbjct: 112 YLHSK---GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL---TTFVGTPEYMAP 165

Query: 260 VCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQI 319
             +      K  D++S GV+L ELLTGK                 P+  +       ++I
Sbjct: 166 EVLLGKGYGKAVDIWSLGVILYELLTGK----------------PPFPGDDQLLELFKKI 209

Query: 320 LNFHVADESEMKEI-EIVAELASKCLRIRGTERPTMKQVSE 359
                       +I     +L  K L     +R T ++  +
Sbjct: 210 GKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQ 250

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  130 bits (330), Expect = 2e-35
 Identities = 69/281 (24%), Positives = 118/281 (41%), Gaps = 46/281 (16%)

Query: 88  NFDRSRCLSQGGFVSVYKGVLHDNIQ-VAVKT----YRRADKIRITERELLRIISQVNHK 142
            + R   L +G F SVY  +  D  + +AVK+        +++   ERE+ RI+S + H 
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREI-RILSSLQHP 59

Query: 143 NVVKILGLCL-ETEVPLLVY-EFASNGTLLDHIR---CESSQVLKTWKTCLRIAAETASA 197
           N+V+  G    E +  L ++ E+ S G+L   ++        V++ +        +    
Sbjct: 60  NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKY------TRQILEG 113

Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYL 257
           L YLHS     I+H D+K ANIL++ +   K+ADF  +  +        +  + GT  ++
Sbjct: 114 LAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWM 170

Query: 258 DPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLR 317
            P  I   +  + +D++S G  + E+ TGK P S +                        
Sbjct: 171 APEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP--------------------- 209

Query: 318 QILNFHVADESEMKEI-----EIVAELASKCLRIRGTERPT 353
               + +    E  EI     E   +   KCLR    +RPT
Sbjct: 210 MAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPT 250

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  120 bits (302), Expect = 2e-31
 Identities = 64/212 (30%), Positives = 97/212 (45%), Gaps = 28/212 (13%)

Query: 89  FDRSRCLSQGGFVSVYKGVLHDNIQ--VAVKT--YRRADKIRITERELLRIISQVNHKNV 144
           F+    + +GGF  VYK   H      VA+K       +K      E+ +I+ +  H N+
Sbjct: 2   FEILEKIGKGGFGEVYK-ARHKRTGKEVAIKVIKLESKEKKEKIINEI-QILKKCKHPNI 59

Query: 145 VKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLR------IAAETASAL 198
           VK  G  L+ +   +V EF S G+L D        +LK+    L       +  E    L
Sbjct: 60  VKYYGSYLKKDELWIVMEFCSGGSLKD--------LLKSTNQTLTESQIAYVCKELLKGL 111

Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTI-LIGTSGYL 257
           +YLHS     IIH D+K+ANILL  +   K+ DF     +S+      +   ++GT  ++
Sbjct: 112 EYLHSNG---IIHRDIKAANILLTSDGEVKLIDFG----LSAQLSDTKARNTMVGTPYWM 164

Query: 258 DPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
            P  IN      K+D++S G+   EL  GK P
Sbjct: 165 APEVINGKPYDYKADIWSLGITAIELAEGKPP 196

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  113 bits (286), Expect = 7e-29
 Identities = 76/306 (24%), Positives = 121/306 (39%), Gaps = 63/306 (20%)

Query: 87  KNFDRSRCLSQGGFVSVYKGVL-HDNIQVAVKTYRRADKIRIT----------ERELLRI 135
            +F   + + +G F +V        N + A+K     DK ++           E+E+L  
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKIL---DKRQLIKEKKVKYVKIEKEVLTR 57

Query: 136 ISQVNHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAET 194
           ++   H  ++K+     + E  L  V E+A NG LL +IR   S      K     AAE 
Sbjct: 58  LNG--HPGIIKLYY-TFQDEENLYFVLEYAPNGELLQYIRKYGS---LDEKCTRFYAAEI 111

Query: 195 ASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISS---------DAETA 245
             AL+YLHS     IIH D+K  NILL+ +   K+ DF ++ ++           DA   
Sbjct: 112 LLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNI 168

Query: 246 MSTI---------LIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLA 296
            S I          +GT+ Y+ P  +N     K SD+++ G ++ ++LTGK P       
Sbjct: 169 DSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN-- 226

Query: 297 SNKKISMVPYFL-NSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMK 355
                    Y     I         NF               +L  K L +   +R  + 
Sbjct: 227 --------EYLTFQKILKLEYSFPPNFP----------PDAKDLIEKLLVLDPQDRLGVN 268

Query: 356 QVSEEL 361
           +  +EL
Sbjct: 269 EGYDEL 274

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  109 bits (274), Expect = 1e-27
 Identities = 65/209 (31%), Positives = 111/209 (53%), Gaps = 20/209 (9%)

Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITEREL--LRIISQVNHKNVVKILGLCL 152
           + +G F  VYKGVL  N +VAVKT R      +  + L    I+ Q +H N+VK++G+C+
Sbjct: 3   IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62

Query: 153 ETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHG 212
           + +   +V E    G+LL  +R + +++  T K  L+++ + A+ ++YL S      IH 
Sbjct: 63  QKQPIYIVMELVPGGSLLTFLRKKKNRL--TVKKLLQMSLDAAAGMEYLESKNC---IHR 117

Query: 213 DVKSANILLNDNYTAKVADF------ESSVLISSDAETAMSTILIGTSGYLDPVCINTGK 266
           D+ + N L+ +N   K++DF      E  +   SD    +  I I    +  P  +N G+
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD---GLKQIPI---KWTAPEALNYGR 171

Query: 267 LTKKSDVYSFGVVLAELLT-GKKPGSCMT 294
            T +SDV+S+G++L E  + G  P   M+
Sbjct: 172 YTSESDVWSYGILLWETFSLGDTPYPGMS 200

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  111 bits (278), Expect = 3e-27
 Identities = 79/337 (23%), Positives = 138/337 (40%), Gaps = 26/337 (7%)

Query: 88  NFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITEREL----LRIISQVNH-K 142
           ++   R L +G F  VY     D   VA+K   +  + +  E E     ++I++ +NH  
Sbjct: 1   SYRILRKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 143 NVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLH 202
           N+VK+     +     LV E+   G+L D ++    +   +    L I A+  SAL+YLH
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Query: 203 SLASPPIIHGDVKSANILLNDNYT-AKVADFESSVLISSDAET----AMSTILIGTSGYL 257
           S     IIH D+K  NILL+ +    K+ DF  + L+     T    A+ +  +GT GY+
Sbjct: 119 SK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175

Query: 258 DP---VCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNN 314
            P   + ++    +  SD++S G+ L ELLTG  P      +S             I   
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQ------TLKIILE 229

Query: 315 GLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEE--LDRLRRLHENFW 372
                L   ++  +     +  ++L  K L      R +         L  L+    +  
Sbjct: 230 LPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLS 289

Query: 373 AQKKNKETEHLLGESSSYATAVIAQPDAQTVVSIDIE 409
              K  ++  L         A+I+  ++  +   D++
Sbjct: 290 DLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLK 326

Length = 384

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  105 bits (265), Expect = 4e-26
 Identities = 66/206 (32%), Positives = 105/206 (50%), Gaps = 12/206 (5%)

Query: 93  RCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLR---IISQVNHKNVVKILG 149
           R L  G F  V+ G  +   +VAVKT +      ++    L+   I+ ++ H  +V++  
Sbjct: 12  RKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT---MSPEAFLQEAQIMKKLRHDKLVQLYA 68

Query: 150 LCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPI 209
           +C E E   +V E+ S G+LLD ++    + L+     + +AA+ A  + YL S      
Sbjct: 69  VCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRL-PQLVDMAAQIAEGMAYLESRN---Y 124

Query: 210 IHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTK 269
           IH D+ + NIL+ +N   K+ADF  + LI  D  TA          +  P   N G+ T 
Sbjct: 125 IHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIK-WTAPEAANYGRFTI 183

Query: 270 KSDVYSFGVVLAELLT-GKKPGSCMT 294
           KSDV+SFG++L E++T G+ P   MT
Sbjct: 184 KSDVWSFGILLTEIVTYGRVPYPGMT 209

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  102 bits (258), Expect = 3e-25
 Identities = 71/289 (24%), Positives = 114/289 (39%), Gaps = 56/289 (19%)

Query: 88  NFDRSRCLSQGGFVSVYKGVLH--DNIQVAVK----TYRRADKIRITERELLRIISQVNH 141
            ++  + + +G F  VY  V    D     +K    +     +      E+ +I+ ++NH
Sbjct: 1   KYEIIKQIGKGSFGKVYL-VRRKSDGKLYVLKEIDLSNMSEKEREDALNEV-KILKKLNH 58

Query: 142 KNVVK-----ILGLCLETEVPLLVYEFASNGTLLDHI-RCESSQVLKTWKTCLRIAAETA 195
            N++K          L      +V E+A  G L   I + +        +  L    +  
Sbjct: 59  PNIIKYYESFEEKGKL-----CIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLC 113

Query: 196 SALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADF-ESSVLISSDAETAMSTILIGTS 254
            AL YLHS     I+H D+K  NI L  N   K+ DF  S VL S+     ++  ++GT 
Sbjct: 114 LALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST---VDLAKTVVGTP 167

Query: 255 GYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP--GSCM-TLASN---KKISMVPYFL 308
            YL P          KSD++S G VL EL T K P  G  +  LA      +   +P   
Sbjct: 168 YYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIP--- 224

Query: 309 NSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQV 357
            S  ++ LR +++                      L+    ERP++ Q+
Sbjct: 225 -SQYSSELRNLVS--------------------SLLQKDPEERPSIAQI 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  100 bits (251), Expect = 3e-24
 Identities = 60/215 (27%), Positives = 99/215 (46%), Gaps = 30/215 (13%)

Query: 88  NFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRITERELLRIISQV------N 140
           N+     + +G F  VYKG+ L     VA+K   +    +I E  L  I+ ++       
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIK---QISLEKIKEEALKSIMQEIDLLKNLK 57

Query: 141 HKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKT-----CLRIAAET 194
           H N+VK +G  +ET   L ++ E+A NG+L         Q++K +             + 
Sbjct: 58  HPNIVKYIG-SIETSDSLYIILEYAENGSLR--------QIIKKFGPFPESLVAVYVYQV 108

Query: 195 ASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTS 254
              L YLH      +IH D+K+ANIL   +   K+ADF  +  ++  ++      ++GT 
Sbjct: 109 LQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTP 163

Query: 255 GYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
            ++ P  I     +  SD++S G  + ELLTG  P
Sbjct: 164 YWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  100 bits (250), Expect = 3e-24
 Identities = 68/282 (24%), Positives = 130/282 (46%), Gaps = 28/282 (9%)

Query: 84  RATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITEREL-LRIISQVNHK 142
           R  + F   R L  G F  V++G+  + ++VA+K  +  D ++  + +  ++ + ++ HK
Sbjct: 3   RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHK 62

Query: 143 NVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLH 202
           +++ +  +C   E   ++ E    G+LL  +R    QVL    + + +A + A  + YL 
Sbjct: 63  HLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPV-ASLIDMACQVAEGMAYLE 121

Query: 203 SLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCI 262
                  IH D+ + NIL+ ++   KVADF  + LI  D   +    +     +  P   
Sbjct: 122 E---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAA 176

Query: 263 NTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQIL- 320
           + G  + KSDV+SFG++L E+ T G+ P   M    N ++                QI  
Sbjct: 177 SHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN---NHEV--------------YDQITA 219

Query: 321 NFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELD 362
            + +   ++    + + ++  +C      +RP+ K + EELD
Sbjct: 220 GYRMPCPAKCP--QEIYKIMLECWAAEPEDRPSFKALREELD 259

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 97.8 bits (244), Expect = 3e-23
 Identities = 64/212 (30%), Positives = 96/212 (45%), Gaps = 23/212 (10%)

Query: 91  RSRCLSQGGFVSVYKGV-LHDNIQVAVKTYR----RADKIRITERELLRIISQVNHKNVV 145
           R   +  G F  VY  V L     +AVK  R        I+    E+  ++  + H N+V
Sbjct: 4   RGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMK-VLELLKHPNLV 62

Query: 146 KILGLCLETEVPLLVYEFASNGTL---LDHIRCESSQVLKTWKTCLRIAAETASALDYLH 202
           K  G+ +  E   +  E+ S GTL   L+H R     V++          +    L YLH
Sbjct: 63  KYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIR------VYTLQLLEGLAYLH 116

Query: 203 SLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTI--LIGTSGYLDPV 260
           S     I+H D+K ANI L+ N   K+ DF  +V + ++  T    +  L GT  Y+ P 
Sbjct: 117 SHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPE 173

Query: 261 CINTGKLTKK---SDVYSFGVVLAELLTGKKP 289
            I  GK       +D++S G V+ E+ TGK+P
Sbjct: 174 VITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 96.7 bits (241), Expect = 6e-23
 Identities = 83/285 (29%), Positives = 134/285 (47%), Gaps = 49/285 (17%)

Query: 95  LSQGGFVSVYKGVL----HDNIQVAVKTYRRADKIRITERELLR---IISQVNHKNVVKI 147
           L  G F SV KGV        ++VAVKT +  + I   ++E LR   +++Q++H  +V++
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLK-QEHIAAGKKEFLREASVMAQLDHPCIVRL 61

Query: 148 LGLCLETEVPLLVYEFASNGTLLDHIRCESS-QV--LKTWKTCLRIAAETASALDYLHSL 204
           +G+C   E  +LV E A  G LL +++      V  LK        A + A  + YL S 
Sbjct: 62  IGVCKG-EPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYLESK 114

Query: 205 ASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG-----YLDP 259
                +H D+ + N+LL + + AK++DF  S  + + ++   +T    T+G     +  P
Sbjct: 115 H---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT----TAGRWPLKWYAP 167

Query: 260 VCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQ 318
            CIN GK + KSDV+S+GV L E  + G KP   M     + I+M+         +G R 
Sbjct: 168 ECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK--GAEVIAML--------ESGER- 216

Query: 319 ILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDR 363
                     E    EI + +   C + R  +RPT  ++     R
Sbjct: 217 ------LPRPEECPQEIYS-IMLSCWKYRPEDRPTFSELESTFRR 254

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 96.0 bits (239), Expect = 1e-22
 Identities = 70/211 (33%), Positives = 107/211 (50%), Gaps = 24/211 (11%)

Query: 93  RCLSQGGFVSVYKGVLHDN----IQVAVKTYRRADKIRITERELLR---IISQVNHKNVV 145
           R + +G F  VY G L D+    I  AVK+  R   +   E + L+   I+   +H NV+
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVE-QFLKEGIIMKDFSHPNVL 59

Query: 146 KILGLCLETE-VPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSL 204
            +LG+CL +E  PL+V  +  +G L + IR E+     T K  +    + A  ++YL   
Sbjct: 60  SLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHN--PTVKDLIGFGLQVAKGMEYL--- 114

Query: 205 ASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV---- 260
           AS   +H D+ + N +L++++T KVADF    L     +    ++   T   L PV    
Sbjct: 115 ASKKFVHRDLAARNCMLDESFTVKVADFG---LARDIYDKEYYSVHNHTGAKL-PVKWMA 170

Query: 261 --CINTGKLTKKSDVYSFGVVLAELLTGKKP 289
              + T K T KSDV+SFGV+L EL+T   P
Sbjct: 171 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 201

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 95.2 bits (237), Expect = 2e-22
 Identities = 59/209 (28%), Positives = 105/209 (50%), Gaps = 18/209 (8%)

Query: 93  RCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLR---IISQVNHKNVVKILG 149
           R L  G F  V++G+ ++   VAVKT +      +  ++ L    I+ ++ H  ++++  
Sbjct: 12  RKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT---MDPKDFLAEAQIMKKLRHPKLIQLYA 68

Query: 150 LCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPI 209
           +C   E   +V E    G+LL++++  + + LK     + +AA+ AS + YL +      
Sbjct: 69  VCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKL-PQLIDMAAQVASGMAYLEAQN---Y 124

Query: 210 IHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTS---GYLDPVCINTGK 266
           IH D+ + N+L+ +N   KVADF  + +I  D   A      G      +  P      +
Sbjct: 125 IHRDLAARNVLVGENNICKVADFGLARVIKEDIYEARE----GAKFPIKWTAPEAALYNR 180

Query: 267 LTKKSDVYSFGVVLAELLT-GKKPGSCMT 294
            + KSDV+SFG++L E++T G+ P   MT
Sbjct: 181 FSIKSDVWSFGILLTEIVTYGRMPYPGMT 209

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 94.9 bits (236), Expect = 3e-22
 Identities = 79/277 (28%), Positives = 131/277 (47%), Gaps = 35/277 (12%)

Query: 95  LSQGGFVSVYKGVL--HDNIQVAVKTYRRADKIRITERELLR---IISQVNHKNVVKILG 149
           L  G +  VY+GV   +    VAVKT +  D + +   E L+   ++ ++ H N+V++LG
Sbjct: 14  LGGGQYGEVYEGVWKKYSLT-VAVKTLKE-DTMEV--EEFLKEAAVMKEIKHPNLVQLLG 69

Query: 150 LCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPP 208
           +C   E P  ++ EF + G LLD++R E ++        L +A + +SA++YL       
Sbjct: 70  VCTR-EPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISSAMEYLEKKN--- 124

Query: 209 IIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLT 268
            IH D+ + N L+ +N+  KVADF  S L++ D  TA +        +  P  +   K +
Sbjct: 125 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-WTAPESLAYNKFS 183

Query: 269 KKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADE 327
            KSDV++FGV+L E+ T G  P   + L      S V   L      G R         E
Sbjct: 184 IKSDVWAFGVLLWEIATYGMSPYPGIDL------SQVYELL----EKGYRM--------E 225

Query: 328 SEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL 364
                   V EL   C +   ++RP+  ++ +  + +
Sbjct: 226 RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 94.2 bits (235), Expect = 6e-22
 Identities = 64/279 (22%), Positives = 108/279 (38%), Gaps = 38/279 (13%)

Query: 88  NFDRSRCLSQGGFVSVYKGVLH--DNIQVAVKT---YRRADKIRITERELLRIISQVNHK 142
           + +R + L QG    VYK V H       A+K        +  +   REL + +      
Sbjct: 2   DLERVKVLGQGSSGVVYK-VRHKPTGKIYALKKIHVDGDEEFRKQLLREL-KTLRSCESP 59

Query: 143 NVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWK--TCLRIAAETASALDY 200
            VVK  G   +     +V E+   G+L D ++      +          IA +    LDY
Sbjct: 60  YVVKCYGAFYKEGEISIVLEYMDGGSLADLLK-----KVGKIPEPVLAYIARQILKGLDY 114

Query: 201 LHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV 260
           LH+     IIH D+K +N+L+N     K+ADF  S ++ +  +   +   +GT  Y+ P 
Sbjct: 115 LHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT--FVGTVTYMSPE 170

Query: 261 CINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQIL 320
            I     +  +D++S G+ L E   GK P   +         +            ++ I 
Sbjct: 171 RIQGESYSYAADIWSLGLTLLECALGKFP--FLPPGQPSFFEL------------MQAIC 216

Query: 321 NFHVADESEMKEIEIVAELA---SKCLRIRGTERPTMKQ 356
           +        +   E   E     S CL+    +RP+  +
Sbjct: 217 DG---PPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAE 252

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 91.8 bits (229), Expect = 3e-21
 Identities = 61/164 (37%), Positives = 86/164 (52%), Gaps = 13/164 (7%)

Query: 127 ITERELLRIISQVNHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWK 185
           +TER    I+S++NH  +VK L    +TE  L LV E+A  G L  H+   S +   + +
Sbjct: 41  LTER---NILSRINHPFIVK-LHYAFQTEEKLYLVLEYAPGGELFSHL---SKEGRFSEE 93

Query: 186 TCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETA 245
                AAE   AL+YLHSL    II+ D+K  NILL+ +   K+ DF  +  +SS+    
Sbjct: 94  RARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRT 150

Query: 246 MSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
            +    GT  YL P  +      K  D +S GV+L E+LTGK P
Sbjct: 151 NT--FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 91.7 bits (228), Expect = 3e-21
 Identities = 67/286 (23%), Positives = 125/286 (43%), Gaps = 43/286 (15%)

Query: 87  KNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELL---RIISQVNHKN 143
           K       + +G F  V  G      +VAVK  +         +  L    +++ + H N
Sbjct: 6   KELKLGATIGKGEFGDVMLGDYRGQ-KVAVKCLKDDST---AAQAFLAEASVMTTLRHPN 61

Query: 144 VVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHS 203
           +V++LG+ L+     +V E+ + G+L+D++R     V+ T    L  A +    ++YL  
Sbjct: 62  LVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVI-TLAQQLGFALDVCEGMEYLE- 119

Query: 204 LASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCIN 263
                 +H D+ + N+L++++  AKV+DF  +   S   ++    +      +  P  + 
Sbjct: 120 --EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPV-----KWTAPEALR 172

Query: 264 TGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNF 322
             K + KSDV+SFG++L E+ + G+                VPY         L+ ++  
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYSFGR----------------VPY-----PRIPLKDVVP- 210

Query: 323 HVADESEMKEIE----IVAELASKCLRIRGTERPTMKQVSEELDRL 364
           HV     M+  E     V ++   C  +   +RPT KQ+ E+L  +
Sbjct: 211 HVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 91.6 bits (227), Expect = 4e-21
 Identities = 72/274 (26%), Positives = 127/274 (46%), Gaps = 35/274 (12%)

Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRR--ADKIRITERELLRIISQVNHKNVVKILGLCL 152
           L +G F  V+KG L D   VAVKT +     +++I      RI+ Q +H N+VK++G+C 
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62

Query: 153 ETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHG 212
           + +   +V E    G  L  +R +  + LKT K  ++ A + A+ + YL    S   IH 
Sbjct: 63  QRQPIYIVMELVPGGDFLSFLRKKKDE-LKT-KQLVKFALDAAAGMAYLE---SKNCIHR 117

Query: 213 DVKSANILLNDNYTAKVADF-----ESSVLISSDAETAMSTILIGTSGYLDPVCINTGKL 267
           D+ + N L+ +N   K++DF     E   + SS   + +  I I    +  P  +N G+ 
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSS---SGLKQIPI---KWTAPEALNYGRY 171

Query: 268 TKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADE 327
           + +SDV+S+G++L E  +               + + PY    + N   R+ +       
Sbjct: 172 SSESDVWSYGILLWETFS---------------LGVCPY--PGMTNQQAREQVEKGYRMS 214

Query: 328 SEMKEIEIVAELASKCLRIRGTERPTMKQVSEEL 361
              K  + V ++  +C   +   RP   ++ +EL
Sbjct: 215 CPQKCPDDVYKVMQRCWDYKPENRPKFSELQKEL 248

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 91.3 bits (227), Expect = 8e-21
 Identities = 75/290 (25%), Positives = 124/290 (42%), Gaps = 52/290 (17%)

Query: 95  LSQGGFVSVYKGV---LHDNIQ--VAVKTYRRADKIRITERELLR---IISQVNHKNVVK 146
           L  G F +VYKGV     + ++  VA+K  R  +      +E+L    +++ V+H +VV+
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLRE-ETSPKANKEILDEAYVMASVDHPHVVR 73

Query: 147 ILGLCLETEVPLLVYEFASNGTLLDHIRCES----SQVLKTWKTCLRIAAETASALDYLH 202
           +LG+CL +    L+ +    G LLD++R       SQ L  W  C++IA         + 
Sbjct: 74  LLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW--CVQIA-------KGMS 123

Query: 203 SLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG-----YL 257
            L    ++H D+ + N+L+      K+ DF  + L+  D             G     ++
Sbjct: 124 YLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD-----EKEYHAEGGKVPIKWM 178

Query: 258 DPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGL 316
               I     T KSDV+S+GV + EL+T G KP              +P     +   G 
Sbjct: 179 ALESILHRIYTHKSDVWSYGVTVWELMTFGAKP------YEGIPAVEIP----DLLEKGE 228

Query: 317 RQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR 366
           R         +  +  I++   L  KC  I    RPT K++  E  ++ R
Sbjct: 229 R-------LPQPPICTIDVYMVLV-KCWMIDAESRPTFKELINEFSKMAR 270

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 90.9 bits (226), Expect = 1e-20
 Identities = 78/297 (26%), Positives = 125/297 (42%), Gaps = 34/297 (11%)

Query: 87  KNFDRSRCLSQGGFVSVYKG---VLHDN--IQVAVKTYRRA---DKIRITERELLRIISQ 138
           ++    + L +G F  V       L DN   QVAVK+   +         ERE+  I+  
Sbjct: 4   RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREI-EILRT 62

Query: 139 VNHKNVVKILGLCLET--EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETAS 196
           ++H+N+VK  G+C +       L+ E+  +G+L D+++    Q+    K  L  +++   
Sbjct: 63  LDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINL--KRLLLFSSQICK 120

Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE--TAMSTILIGTS 254
            +DYL S      IH D+ + NIL+      K++DF  + ++  D +             
Sbjct: 121 GMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF 177

Query: 255 GYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKK----PGSCMTLASNKKISM-VPYFL 308
            Y  P C+ T K +  SDV+SFGV L EL T G      P   + +    +  M V   L
Sbjct: 178 WY-APECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL 236

Query: 309 NSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLR 365
             +K    R        DE        V +L   C      +RP+   +   +DRLR
Sbjct: 237 ELLKEGE-RLPRPPSCPDE--------VYDLMKLCWEAEPQDRPSFADLILIVDRLR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 89.5 bits (222), Expect = 2e-20
 Identities = 59/205 (28%), Positives = 107/205 (52%), Gaps = 15/205 (7%)

Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRAD---KIRITERELLRIISQVNHKNVVKILGLC 151
           L  G F  V+ G  + + +VA+K+ ++     +  + E  L++   Q+ H  +V++  + 
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMK---QLQHPRLVRLYAVV 70

Query: 152 LETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPII 210
             T+ P+ ++ E+  NG+L+D ++      L   K  + +AA+ A  + ++        I
Sbjct: 71  --TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKL-IDMAAQIAEGMAFIERKNY---I 124

Query: 211 HGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKK 270
           H D+++ANIL+++    K+ADF  + LI  +  TA          +  P  IN G  T K
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIK-WTAPEAINYGTFTIK 183

Query: 271 SDVYSFGVVLAELLT-GKKPGSCMT 294
           SDV+SFG++L E++T G+ P   MT
Sbjct: 184 SDVWSFGILLTEIVTYGRIPYPGMT 208

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 89.8 bits (223), Expect = 3e-20
 Identities = 62/209 (29%), Positives = 101/209 (48%), Gaps = 22/209 (10%)

Query: 92  SRCLSQGGFVSVYKGVLHD----NIQVAVKTYRRADKIRITERELLR--IISQVNHKNVV 145
            RC+ +G F  VY+GV        I VAVKT +      + E+ L    I+ Q +H ++V
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70

Query: 146 KILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRI---AAETASALDYL 201
           K++G+   TE P+ +V E A  G L  ++     QV K       +   + + ++AL YL
Sbjct: 71  KLIGVI--TENPVWIVMELAPLGELRSYL-----QVNKYSLDLASLILYSYQLSTALAYL 123

Query: 202 HSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVC 261
            S      +H D+ + N+L++     K+ DF  S  +  ++    S   +    ++ P  
Sbjct: 124 ESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIK-WMAPES 179

Query: 262 INTGKLTKKSDVYSFGVVLAELLT-GKKP 289
           IN  + T  SDV+ FGV + E+L  G KP
Sbjct: 180 INFRRFTSASDVWMFGVCMWEILMLGVKP 208

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 89.8 bits (223), Expect = 3e-20
 Identities = 68/223 (30%), Positives = 104/223 (46%), Gaps = 35/223 (15%)

Query: 93  RCLSQGGFVSVYKGVL------HDNIQVAVKTYRRA---DKIRITERELLRIISQVNHKN 143
           R L +G F  V+ G        +D   VAVKT +     D  +  ERE   +++   H+N
Sbjct: 11  RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREA-ELLTNFQHEN 69

Query: 144 VVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLK-----------TWKTCLRIAA 192
           +VK  G+C E + P++V+E+  +G L   +R                   T    L+IA 
Sbjct: 70  IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129

Query: 193 ETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLI-SSD----AETAMS 247
           + AS + Y   LAS   +H D+ + N L+  +   K+ DF  S  + ++D        M 
Sbjct: 130 QIASGMVY---LASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTML 186

Query: 248 TILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
            I      ++ P  I   K T +SDV+SFGVVL E+ T GK+P
Sbjct: 187 PIR-----WMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 89.1 bits (221), Expect = 5e-20
 Identities = 63/218 (28%), Positives = 111/218 (50%), Gaps = 27/218 (12%)

Query: 95  LSQGGFVSVYKGVL------HDNIQVAVKTYRRADKIRITE--RELLRIISQVNHKNVVK 146
           L +G F  VYKG L           VA+KT +   + ++ +  R+   ++S + H N+V 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 147 ILGLCLETEVPLLVYEFASNGTLLD-------HIRCESSQVLKTWKTCL------RIAAE 193
           +LG+C + +   +++E+ ++G L +       H    +    +T K+ L       IA +
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 194 TASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLI-SSDAETAMSTILIG 252
            A+ ++Y   L+S   +H D+ + N L+ +  T K++DF  S  I S+D     S  L+ 
Sbjct: 133 IAAGMEY---LSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189

Query: 253 TSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
              ++ P  I  GK T +SD++SFGVVL E+ + G +P
Sbjct: 190 VR-WMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 88.6 bits (219), Expect = 5e-20
 Identities = 71/262 (27%), Positives = 127/262 (48%), Gaps = 25/262 (9%)

Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLET 154
           L QG F  V+ G  +   +VA+KT +          +  +++ ++ H+ +V++  +  E 
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 73

Query: 155 EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDV 214
            +  +V E+ S G+LLD ++ E  + L+     + +AA+ AS + Y+  +     +H D+
Sbjct: 74  PI-YIVTEYMSKGSLLDFLKGEMGKYLRL-PQLVDMAAQIASGMAYVERMN---YVHRDL 128

Query: 215 KSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVY 274
           ++ANIL+ +N   KVADF  + LI  +  TA          +  P     G+ T KSDV+
Sbjct: 129 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKSDVW 187

Query: 275 SFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEI 333
           SFG++L EL T G+ P   M    N+++      L+ ++         + +    E    
Sbjct: 188 SFGILLTELTTKGRVPYPGMV---NREV------LDQVER-------GYRMPCPPECP-- 229

Query: 334 EIVAELASKCLRIRGTERPTMK 355
           E + +L  +C R    ERPT +
Sbjct: 230 ESLHDLMCQCWRKEPEERPTFE 251

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 88.5 bits (219), Expect = 6e-20
 Identities = 62/196 (31%), Positives = 102/196 (52%), Gaps = 7/196 (3%)

Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLET 154
           L  G F  V+ G  + N +VAVKT +       +  E  +I+ ++ H  +V++  +  E 
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSEE 73

Query: 155 EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDV 214
            +  +V E+ S G+LLD ++    + LK     + +AA+ A+ + Y+  +     IH D+
Sbjct: 74  PI-YIVTEYMSKGSLLDFLKDGEGRALKL-PNLVDMAAQVAAGMAYIERMN---YIHRDL 128

Query: 215 KSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVY 274
           +SANIL+ D    K+ADF  + LI  +  TA          +  P     G+ T KSDV+
Sbjct: 129 RSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKSDVW 187

Query: 275 SFGVVLAELLT-GKKP 289
           SFG++L EL+T G+ P
Sbjct: 188 SFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 91.1 bits (226), Expect = 1e-19
 Identities = 73/277 (26%), Positives = 122/277 (44%), Gaps = 26/277 (9%)

Query: 95  LSQGGFVSVYKGVLHDN-IQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLE 153
           +S+G   + YKG    N +Q  VK     + I  +E   +    ++ H N+VK++GLC  
Sbjct: 698 ISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMG---KLQHPNIVKLIGLCRS 754

Query: 154 TEVPLLVYEFASNGTLLDHIRCESSQVLK--TWKTCLRIAAETASALDYLHSLASPPIIH 211
            +   L++E+     L        S+VL+  +W+   +IA   A AL +LH   SP ++ 
Sbjct: 755 EKGAYLIHEYIEGKNL--------SEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVV 806

Query: 212 GDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKS 271
           G++    I+++          E  + +S        T    +S Y+ P    T  +T+KS
Sbjct: 807 GNLSPEKIIIDGKD-------EPHLRLSLPGLLCTDTKCFISSAYVAPETRETKDITEKS 859

Query: 272 DVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMK 331
           D+Y FG++L ELLTGK P            S+V +      +  L   ++  +  +  + 
Sbjct: 860 DIYGFGLILIELLTGKSPAD---AEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVN 916

Query: 332 EIEIV--AELASKCLRIRGTERPTMKQVSEELDRLRR 366
           + EIV    LA  C     T RP    V + L+   R
Sbjct: 917 QNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953

Length = 968

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 87.4 bits (217), Expect = 1e-19
 Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 15/204 (7%)

Query: 95  LSQGGFVSVYKGVLH----DNIQVAVKTYRRADKIRITERELLR---IISQVNHKNVVKI 147
           L  G F  V +G         I VAVK  +  DK+     + L+   I+  ++H+N++++
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKS-DKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 148 LGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASP 207
            G+ L T   ++V E A  G+LLD +R ++        T    A + A+ + YL S    
Sbjct: 62  YGVVL-THPLMMVTELAPLGSLLDRLRKDALGHF-LISTLCDYAVQIANGMRYLES---K 116

Query: 208 PIIHGDVKSANILLNDNYTAKVADFE-SSVLISSDAETAMSTILIGTSGYLDPVCINTGK 266
             IH D+ + NILL  +   K+ DF     L  ++    M   L     +  P  + T  
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRT 176

Query: 267 LTKKSDVYSFGVVLAELLT-GKKP 289
            +  SDV+ FGV L E+ T G++P
Sbjct: 177 FSHASDVWMFGVTLWEMFTYGEEP 200

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 87.7 bits (218), Expect = 1e-19
 Identities = 63/215 (29%), Positives = 97/215 (45%), Gaps = 35/215 (16%)

Query: 95  LSQGGFVSVY---KGVLHDNIQVAVKTYRRADKIR-------ITERELLRIISQVNHKNV 144
           +S+G +  V+   K    D    A+K  ++AD IR       +TER+   I+SQ     V
Sbjct: 1   ISKGAYGRVFLAKKKSTGD--IYAIKVIKKADMIRKNQVDQVLTERD---ILSQAQSPYV 55

Query: 145 VKILGLCLETEVPL-LVYEFASNG---TLLDHIRCESSQVLKTWKTCLRIAAETASALDY 200
           VK+     + +  L LV E+   G   +LL+++      V +         AE   AL+Y
Sbjct: 56  VKLY-YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARI------YIAEIVLALEY 108

Query: 201 LHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTI------LIGTS 254
           LHS     IIH D+K  NIL++ N   K+ DF  S +     +  ++        ++GT 
Sbjct: 109 LHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTP 165

Query: 255 GYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
            Y+ P  I     +K  D +S G +L E L G  P
Sbjct: 166 DYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPP 200

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 87.3 bits (217), Expect = 3e-19
 Identities = 55/203 (27%), Positives = 92/203 (45%), Gaps = 26/203 (12%)

Query: 97  QGGFVSVYKGV-LHDNIQVAVKTYRRADKIRITERELLRIISQV------NHKNVVKILG 149
           +G    VYK        +VA+K      K+R+ ++    II+++       H N+V    
Sbjct: 29  EGASGEVYKATDRATGKEVAIK------KMRLRKQNKELIINEILIMKDCKHPNIVDYYD 82

Query: 150 LCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAA---ETASALDYLHSLAS 206
             L  +   +V E+   G+L D I     Q         +IA    E    L+YLHS   
Sbjct: 83  SYLVGDELWVVMEYMDGGSLTDIIT----QNFVRMNEP-QIAYVCREVLQGLEYLHSQ-- 135

Query: 207 PPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGK 266
             +IH D+KS NILL+ + + K+ADF  +  ++   E +    ++GT  ++ P  I    
Sbjct: 136 -NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK--EKSKRNSVVGTPYWMAPEVIKRKD 192

Query: 267 LTKKSDVYSFGVVLAELLTGKKP 289
              K D++S G++  E+  G+ P
Sbjct: 193 YGPKVDIWSLGIMCIEMAEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 86.2 bits (214), Expect = 3e-19
 Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 17/206 (8%)

Query: 89  FDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKI 147
           FD    L +G + SVYK +       VA+K     + ++   +E+  I+ Q +   +VK 
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEI-SILKQCDSPYIVKY 63

Query: 148 LGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA---LDYLHSL 204
            G   +     +V E+   G++ D ++  +  +     T   IAA        L+YLHS 
Sbjct: 64  YGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTL-----TEEEIAAILYQTLKGLEYLHSN 118

Query: 205 ASPPIIHGDVKSANILLNDNYTAKVADFE-SSVLISSDAETAMSTILIGTSGYLDPVCIN 263
                IH D+K+ NILLN+   AK+ADF  S  L  + A+   +T +IGT  ++ P  I 
Sbjct: 119 K---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK--RNT-VIGTPFWMAPEVIQ 172

Query: 264 TGKLTKKSDVYSFGVVLAELLTGKKP 289
                 K+D++S G+   E+  GK P
Sbjct: 173 EIGYNNKADIWSLGITAIEMAEGKPP 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 86.2 bits (214), Expect = 3e-19
 Identities = 76/280 (27%), Positives = 128/280 (45%), Gaps = 42/280 (15%)

Query: 98  GGFVSVYKGVLH----DNIQVAVKTYRR--ADKIRITERELLR---IISQVNHKNVVKIL 148
           G F  V +G L       I VA+KT +   +DK R    + L    I+ Q +H N++++ 
Sbjct: 15  GEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQR---LDFLTEASIMGQFDHPNIIRLE 71

Query: 149 GLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPP 208
           G+  ++   +++ E+  NG+L   +R    +   T    + +    AS + YL  +    
Sbjct: 72  GVVTKSRPVMIITEYMENGSLDKFLRENDGKF--TVGQLVGMLRGIASGMKYLSEMNY-- 127

Query: 209 IIHGDVKSANILLNDNYTAKVADFE-SSVLISSDA--ETAMSTILIGTSGYLDPVCINTG 265
            +H D+ + NIL+N N   KV+DF  S  L  S+A   T    I I    +  P  I   
Sbjct: 128 -VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIR---WTAPEAIAYR 183

Query: 266 KLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHV 324
           K T  SDV+SFG+V+ E+++ G++P   M   SN+ +      + ++  +G R       
Sbjct: 184 KFTSASDVWSFGIVMWEVMSYGERPYWDM---SNQDV------IKAV-EDGYRL------ 227

Query: 325 ADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL 364
                M     + +L   C +    ERPT  Q+   LD++
Sbjct: 228 --PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 86.2 bits (213), Expect = 3e-19
 Identities = 72/272 (26%), Positives = 127/272 (46%), Gaps = 25/272 (9%)

Query: 91  RSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGL 150
             + +  G F  V+ G   +  +VA+KT R          E  +++ +++H  +V++ G+
Sbjct: 8   LVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGV 67

Query: 151 CLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPII 210
           C E     LV+EF  +G L D++R +  +  +  +T L +  +    + YL S     +I
Sbjct: 68  CTERSPICLVFEFMEHGCLSDYLRAQRGKFSQ--ETLLGMCLDVCEGMAYLESSN---VI 122

Query: 211 HGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKK 270
           H D+ + N L+ +N   KV+DF  +  +  D  T+ ST       +  P   +  K + K
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS-STGTKFPVKWSSPEVFSFSKYSSK 181

Query: 271 SDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESE 329
           SDV+SFGV++ E+ + GK P        N+  S V   +N+    G R +    +A +S 
Sbjct: 182 SDVWSFGVLMWEVFSEGKTP------YENRSNSEVVETINA----GFR-LYKPRLASQS- 229

Query: 330 MKEIEIVAELASKCLRIRGTERPTMKQVSEEL 361
                 V EL   C + R  +RP+   +  +L
Sbjct: 230 ------VYELMQHCWKERPEDRPSFSLLLHQL 255

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 85.9 bits (213), Expect = 5e-19
 Identities = 78/299 (26%), Positives = 122/299 (40%), Gaps = 61/299 (20%)

Query: 93  RCLSQGGFVSVYKGVLHD------NIQVAVKTYRRADKIRITERELLR---IISQVNHKN 143
           R L QG F  VY+G+           +VA+KT      +R    E L    ++ + N  +
Sbjct: 12  RELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMR-ERIEFLNEASVMKEFNCHH 70

Query: 144 VVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLK-------TWKTCLRIAAETAS 196
           VV++LG+    +  L+V E  + G L  ++R    +          T +  +++AAE A 
Sbjct: 71  VVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIAD 130

Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLI-SSDAETAMSTILIGTSG 255
            + YL +      +H D+ + N ++ ++ T K+ DF  +  I  +D          G  G
Sbjct: 131 GMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYR------KGGKG 181

Query: 256 YL-----DPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNS 310
            L      P  +  G  T KSDV+SFGVVL E+          TLA        PY    
Sbjct: 182 LLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMA---------TLAEQ------PY---- 222

Query: 311 IKNNGL--RQILNFHVADESEMKEIE----IVAELASKCLRIRGTERPTMKQVSEELDR 363
               GL   ++L F V D   +   E     + EL   C +     RPT  ++   L  
Sbjct: 223 ---QGLSNEEVLKF-VIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 84.7 bits (210), Expect = 1e-18
 Identities = 66/201 (32%), Positives = 94/201 (46%), Gaps = 17/201 (8%)

Query: 95  LSQGGFVSVYKGVLH--DNIQVAVKTYRRADKIRITEREL--LRIISQVNHKNVVKILGL 150
           L  G    V K VLH      +AVKT R      I ++ L  L I+ + N   +V   G 
Sbjct: 9   LGAGNSGVVSK-VLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67

Query: 151 CL-ETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPI 209
                ++ + + E+  +G  LD I  E    +   +   +IA      L YLH      I
Sbjct: 68  FYNNGDISICM-EY-MDGGSLDKILKEVQGRIPE-RILGKIAVAVLKGLTYLHEKHK--I 122

Query: 210 IHGDVKSANILLNDNYTAKVADFE-SSVLISSDAETAMSTILIGTSGYLDPVCINTGKLT 268
           IH DVK +NIL+N     K+ DF  S  L++S A+T      +GTS Y+ P  I     +
Sbjct: 123 IHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT-----FVGTSSYMAPERIQGNDYS 177

Query: 269 KKSDVYSFGVVLAELLTGKKP 289
            KSD++S G+ L EL TG+ P
Sbjct: 178 VKSDIWSLGLSLIELATGRFP 198

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 83.7 bits (207), Expect = 2e-18
 Identities = 54/199 (27%), Positives = 93/199 (46%), Gaps = 10/199 (5%)

Query: 95  LSQGGFVSVYKGVLHDNIQV-AVKTYRRADKIRITERELL---RIISQVNHKNVVKILGL 150
           + +G F  V+K V   + +V A+K    +   R    E +   R++++++   +++    
Sbjct: 8   IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67

Query: 151 CLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPII 210
            L+     +V E+A NG L   ++ +  + L       R   +    L +LHS     I+
Sbjct: 68  FLDKGKLNIVMEYAENGDLHKLLKMQRGRPL-PEDQVWRFFIQILLGLAHLHS---KKIL 123

Query: 211 HGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKK 270
           H D+KS N+ L+     K+ D   + L+S    T  +  ++GT  YL P         +K
Sbjct: 124 HRDIKSLNLFLDAYDNVKIGDLGVAKLLS--DNTNFANTIVGTPYYLSPELCEDKPYNEK 181

Query: 271 SDVYSFGVVLAELLTGKKP 289
           SDV++ GVVL E  TGK P
Sbjct: 182 SDVWALGVVLYECCTGKHP 200

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 83.2 bits (205), Expect = 4e-18
 Identities = 60/196 (30%), Positives = 100/196 (51%), Gaps = 7/196 (3%)

Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLET 154
           L QG F  V+ G  +   +VA+KT +    +     +  +I+ ++ H  +V +  +  E 
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEE 73

Query: 155 EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDV 214
            +  +V EF   G+LLD ++    + LK     + +AA+ A  + Y+  +     IH D+
Sbjct: 74  PI-YIVTEFMGKGSLLDFLKEGDGKYLKL-PQLVDMAAQIADGMAYIERMN---YIHRDL 128

Query: 215 KSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVY 274
           ++ANIL+ DN   K+ADF  + LI  +  TA          +  P     G+ T KSDV+
Sbjct: 129 RAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKSDVW 187

Query: 275 SFGVVLAELLT-GKKP 289
           SFG++L EL+T G+ P
Sbjct: 188 SFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 83.1 bits (205), Expect = 4e-18
 Identities = 55/203 (27%), Positives = 103/203 (50%), Gaps = 6/203 (2%)

Query: 93  RCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCL 152
           + L  G F  V+ G  +++ +VAVKT +          E   ++  + H  +V++  +  
Sbjct: 12  KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71

Query: 153 ETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHG 212
           + E   ++ E+ + G+LLD ++ +    +   K  +  +A+ A  + Y+        IH 
Sbjct: 72  KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKL-IDFSAQIAEGMAYIER---KNYIHR 127

Query: 213 DVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSD 272
           D+++AN+L++++   K+ADF  + +I  +  TA          +  P  IN G  T KSD
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK-WTAPEAINFGSFTIKSD 186

Query: 273 VYSFGVVLAELLT-GKKPGSCMT 294
           V+SFG++L E++T GK P   M+
Sbjct: 187 VWSFGILLYEIVTYGKIPYPGMS 209

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 83.2 bits (206), Expect = 4e-18
 Identities = 60/202 (29%), Positives = 95/202 (47%), Gaps = 11/202 (5%)

Query: 97  QGGFVSVYKGV-LHDNIQVAVKTYRRADKIRITERELLRII---SQVNHKNVVKILGLCL 152
            G    VY  + L +N +VA+K     +K + +  EL + +   SQ NH NVVK     +
Sbjct: 11  VGATAVVYAAICLPNNEKVAIKRID-LEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFV 69

Query: 153 ETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHG 212
             +   LV  + S G+LLD ++    +          +  E    L+YLHS      IH 
Sbjct: 70  VGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ---IHR 126

Query: 213 DVKSANILLNDNYTAKVADFESSVLISS--DAETAMSTILIGTSGYLDPVCINTGK-LTK 269
           D+K+ NILL ++ + K+ADF  S  ++   D    +    +GT  ++ P  +        
Sbjct: 127 DIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDF 186

Query: 270 KSDVYSFGVVLAELLTGKKPGS 291
           K+D++SFG+   EL TG  P S
Sbjct: 187 KADIWSFGITAIELATGAAPYS 208

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 82.8 bits (204), Expect = 5e-18
 Identities = 72/276 (26%), Positives = 123/276 (44%), Gaps = 37/276 (13%)

Query: 95  LSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRITERELL--RIISQVNHKNVVKILGLC 151
           + +G F  V+ G L  DN  VAVK+ R      +  + L   RI+ Q +H N+V+++G+C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 152 LETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIH 211
            + +   +V E    G  L  +R E  + LK  K  +++    A+ ++YL S      IH
Sbjct: 63  TQKQPIYIVMELVQGGDFLTFLRTEGPR-LKV-KELIQMVENAAAGMEYLESKHC---IH 117

Query: 212 GDVKSANILLNDNYTAKVADF------ESSVLISSDAETAMSTILIGTSGYLDPVCINTG 265
            D+ + N L+ +    K++DF      E  V  S+     M  I +    +  P  +N G
Sbjct: 118 RDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTG---GMKQIPV---KWTAPEALNYG 171

Query: 266 KLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVA 325
           + + +SDV+SFG++L E  +               +  VPY   ++ N   R+ +   V 
Sbjct: 172 RYSSESDVWSFGILLWEAFS---------------LGAVPY--ANLSNQQTREAIEQGVR 214

Query: 326 DESEMKEIEIVAELASKCLRIRGTERPTMKQVSEEL 361
                   + V  L  +C      +RP+   V +EL
Sbjct: 215 LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 82.9 bits (205), Expect = 9e-18
 Identities = 76/297 (25%), Positives = 125/297 (42%), Gaps = 45/297 (15%)

Query: 78  SKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHD------NIQVAVKTYRRADKIRITERE 131
            K E  R   N    + L  G F  V +   +        ++VAVK  +       +ERE
Sbjct: 28  LKWEFPR--NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLK--PTAHSSERE 83

Query: 132 LL----RIISQV-NHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKT 186
            L    +I+S + NH+N+V +LG C      L++ E+   G LL+ +R +    L     
Sbjct: 84  ALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDL 143

Query: 187 CLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAM 246
            L  + + A  + +   LAS   IH D+ + N+LL      K+ DF  +  I +D+    
Sbjct: 144 -LSFSYQVAKGMAF---LASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDS---- 195

Query: 247 STILIGTS----GYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKI 301
           + ++ G +     ++ P  I     T +SDV+S+G++L E+ + G  P   M + S    
Sbjct: 196 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK--- 252

Query: 302 SMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVS 358
                F   IK  G R     H   E        + ++   C      +RPT KQ+ 
Sbjct: 253 -----FYKLIK-EGYRMAQPEHAPAE--------IYDIMKTCWDADPLKRPTFKQIV 295

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 82.2 bits (203), Expect = 1e-17
 Identities = 73/298 (24%), Positives = 125/298 (41%), Gaps = 56/298 (18%)

Query: 93  RCLSQGGFVSVYKGVLHDN----IQVAVKTYRRADKIRITERELLRIISQ------VNHK 142
           + L +G F SV +G L  +    ++VAVKT +       T  E+   +S+       +H 
Sbjct: 5   KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDI---HTYSEIEEFLSEAACMKDFDHP 61

Query: 143 NVVKILGLCLETE------VPLLVYEFASNGTL---LDHIRCESSQVLKTWKTCLRIAAE 193
           NV+K++G+C E         P+++  F  +G L   L + R          +T L+   +
Sbjct: 62  NVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVD 121

Query: 194 TASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE------TAMS 247
            A  ++YL   ++   IH D+ + N +L ++ T  VADF  S  I S           M 
Sbjct: 122 IALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMP 178

Query: 248 TILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYF 307
              I      D V       T KSDV++FGV + E+ T                   PY 
Sbjct: 179 VKWIAIESLADRV------YTSKSDVWAFGVTMWEIAT---------------RGQTPY- 216

Query: 308 LNSIKNNGLRQIL-NFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL 364
              ++N+ +   L + +   + E   ++ + +L   C R    +RPT  ++ E L+ +
Sbjct: 217 -PGVENHEIYDYLRHGNRLKQPE-DCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 82.0 bits (203), Expect = 2e-17
 Identities = 60/197 (30%), Positives = 91/197 (46%), Gaps = 41/197 (20%)

Query: 113 QVAVKTYRR--ADKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGT-- 168
            VAVK  R   +D  R    + ++I+S+++  N+ ++LG+C       ++ E+  NG   
Sbjct: 48  LVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLN 107

Query: 169 --LLDHIRCESSQVLK----TWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLN 222
             L  H+   S         ++ T L +A + AS + YL SL     +H D+ + N L+ 
Sbjct: 108 QFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNCLVG 164

Query: 223 DNYTAKVADF-ESSVLISSDAETAMSTILIGTSGYLD-------PV------CINTGKLT 268
            NYT K+ADF  S  L SSD              Y         P+       +  GK T
Sbjct: 165 KNYTIKIADFGMSRNLYSSD--------------YYRVQGRAPLPIRWMAWESVLLGKFT 210

Query: 269 KKSDVYSFGVVLAELLT 285
            KSDV++FGV L E+LT
Sbjct: 211 TKSDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 81.3 bits (201), Expect = 2e-17
 Identities = 57/202 (28%), Positives = 104/202 (51%), Gaps = 19/202 (9%)

Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELL---RIISQVNHKNVVKILGLC 151
           L  G F  V+ G     I VA+K  R      ++E + +   +++ +++H N+V++ G+C
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGA---MSEDDFIEEAKVMMKLSHPNLVQLYGVC 68

Query: 152 LETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIH 211
            +     +V E+ +NG LL+++R E    L T +  L + ++   A++YL S      IH
Sbjct: 69  TKQRPIFIVTEYMANGCLLNYLR-ERKGKLGT-EWLLDMCSDVCEAMEYLESNG---FIH 123

Query: 212 GDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTS---GYLDPVCINTGKLT 268
            D+ + N L+ ++   KV+DF  +  +  D  T+      GT     +  P   +  + +
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ----GTKFPVKWAPPEVFDYSRFS 179

Query: 269 KKSDVYSFGVVLAELLT-GKKP 289
            KSDV+SFGV++ E+ + GK P
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKMP 201

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 81.0 bits (200), Expect = 2e-17
 Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 16/208 (7%)

Query: 88  NFDRSRCLSQGGFVSVYKGVLH----DNIQVAVKT---YRRADKIRITERELLRIISQVN 140
           ++   R L +G F       L+    D+  V  K     R ++K R      + I+S + 
Sbjct: 1   HYIPIRVLGKGAFGE---ATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQ 57

Query: 141 HKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDY 200
           H N++      ++    L+  E+A+ GTL D I       L   +  L    +  SA+ Y
Sbjct: 58  HPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKI-VRQKGQLFEEEMVLWYLFQIVSAVSY 116

Query: 201 LHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV 260
           +H      I+H D+K+ NI L      K+ DF  S ++ S  E +M+  ++GT  Y+ P 
Sbjct: 117 IHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGS--EYSMAETVVGTPYYMSPE 171

Query: 261 CINTGKLTKKSDVYSFGVVLAELLTGKK 288
                K   KSD+++ G VL ELLT K+
Sbjct: 172 LCQGVKYNFKSDIWALGCVLYELLTLKR 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 81.8 bits (202), Expect = 3e-17
 Identities = 81/244 (33%), Positives = 121/244 (49%), Gaps = 30/244 (12%)

Query: 93  RCLSQGGFVSVY---KGVLHDNIQV-AVKTYRRA-----DKIRIT-ERELLRIISQVNHK 142
           + L QG F  V+   K    D  Q+ A+K  ++A     D++R   ER+   I+++VNH 
Sbjct: 2   KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERD---ILAEVNHP 58

Query: 143 NVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYL 201
            +VK L    +TE  L L+ +F   G L   +   S +V+ T +      AE A ALD+L
Sbjct: 59  FIVK-LHYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELALALDHL 114

Query: 202 HSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVC 261
           HSL    II+ D+K  NILL++    K+ DF  S       + A S    GT  Y+ P  
Sbjct: 115 HSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPEV 169

Query: 262 INTGKLTKKSDVYSFGVVLAELLTGKKP------GSCMTLASNKKISMVPYFLNSIKNNG 315
           +N    T+ +D +SFGV++ E+LTG  P         MT+    K+ M P FL+    + 
Sbjct: 170 VNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGM-PQFLSPEAQSL 228

Query: 316 LRQI 319
           LR +
Sbjct: 229 LRAL 232

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 80.0 bits (197), Expect = 9e-17
 Identities = 81/292 (27%), Positives = 124/292 (42%), Gaps = 48/292 (16%)

Query: 95  LSQGGFVSVYK------GVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKIL 148
           + +G F  V K      G+  D     +K Y   D  R    EL  +    +H N++ +L
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74

Query: 149 GLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKT---------------WKTCLRIAAE 193
           G C       L  E+A +G LLD +R   S+VL+T                +  L  AA+
Sbjct: 75  GACEHRGYLYLAIEYAPHGNLLDFLR--KSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132

Query: 194 TASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGT 253
            A  +DY   L+    IH D+ + NIL+ +NY AK+ADF  S       +  M  + +  
Sbjct: 133 VARGMDY---LSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV-- 187

Query: 254 SGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIK 312
             ++    +N    T  SDV+S+GV+L E+++ G  P   MT A           L    
Sbjct: 188 -RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE----------LYEKL 236

Query: 313 NNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL 364
             G R     +  DE        V +L  +C R +  ERP+  Q+   L+R+
Sbjct: 237 PQGYRLEKPLNCDDE--------VYDLMRQCWREKPYERPSFAQILVSLNRM 280

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 78.4 bits (193), Expect = 2e-16
 Identities = 69/218 (31%), Positives = 107/218 (49%), Gaps = 26/218 (11%)

Query: 93  RCLSQGGFVSVYKGVLHD-------NIQVAVKTYRRADKIRITERELLR---IISQVNHK 142
             L  G F  VY+G   D        I+VAVKT R+    +  ++E L+   ++S  NH 
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQ-EKKEFLKEAHLMSNFNHP 59

Query: 143 NVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQV----LKTWKTCLRIAAETASAL 198
           N+VK+LG+CL  E   ++ E    G LL ++R    +     L T K  L I  + A   
Sbjct: 60  NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119

Query: 199 DYLHSLASPPIIHGDVKSANILLND-NYTA----KVADFE-SSVLISSDAETAMSTILIG 252
            YL  +     IH D+ + N L+++  Y A    K+ DF  +  +  SD        L+ 
Sbjct: 120 VYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176

Query: 253 TSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
              ++ P  +  GK T +SDV+SFGV++ E+LT G++P
Sbjct: 177 VR-WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 78.2 bits (193), Expect = 2e-16
 Identities = 72/233 (30%), Positives = 107/233 (45%), Gaps = 20/233 (8%)

Query: 86  TKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRAD----KIR---ITERELLRIIS 137
             NF   + + +G F  VYK + L D   VA+K  +  +    K R   + E +LL+   
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLK--- 57

Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQ-VLKTWKTCLRIAAETAS 196
           Q++H NV+K L   +E     +V E A  G L   I+    Q  L   +T  +   +  S
Sbjct: 58  QLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCS 117

Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
           AL+++HS     I+H D+K AN+ +      K+ D       SS    A S  L+GT  Y
Sbjct: 118 ALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYY 172

Query: 257 LDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP--GSCMTLAS-NKKISMVPY 306
           + P  I+      KSD++S G +L E+   + P  G  M L S  KKI    Y
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDY 225

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 78.5 bits (193), Expect = 2e-16
 Identities = 77/306 (25%), Positives = 138/306 (45%), Gaps = 51/306 (16%)

Query: 75  KIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVL-----HDNIQVAVKTYR----RADKI 125
           +I  ++E+        + + L  G F +V+KG+         I VA+KT +    R    
Sbjct: 2   RILKETEL-------RKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQ 54

Query: 126 RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCE----SSQVL 181
            IT+  L   +  ++H  +V++LG+C    + L V + +  G+LLDH+R        Q L
Sbjct: 55  EITDHML--AMGSLDHAYIVRLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDPQRL 111

Query: 182 KTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD 241
             W  C++IA         ++ L    ++H ++ + NILL  +   ++ADF  + L+  D
Sbjct: 112 LNW--CVQIAKG-------MYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162

Query: 242 AETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKK 300
            +    +       ++    I  G+ T +SDV+S+GV + E+++ G +P + M       
Sbjct: 163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE--- 219

Query: 301 ISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEE 360
              VP  L   K   L Q          ++  I++   +  KC  I    RPT K+++ E
Sbjct: 220 ---VPDLLE--KGERLAQ---------PQICTIDVYMVMV-KCWMIDENVRPTFKELANE 264

Query: 361 LDRLRR 366
             R+ R
Sbjct: 265 FTRMAR 270

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 77.8 bits (191), Expect = 4e-16
 Identities = 62/215 (28%), Positives = 101/215 (46%), Gaps = 21/215 (9%)

Query: 93  RCLSQGGFVSVYKGVLH------DNIQVAVKTYRRA-DKIRITERELLRIISQVNHKNVV 145
           R L +G F  V+    +      D I VAVKT + A D  R        +++ + H+++V
Sbjct: 11  RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIV 70

Query: 146 KILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVL----------KTWKTCLRIAAETA 195
           K  G+C+E +  ++V+E+  +G L   +R      +           T    L IA + A
Sbjct: 71  KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130

Query: 196 SALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG 255
           + + Y   LAS   +H D+ + N L+ +N   K+ DF  S  + S     +    +    
Sbjct: 131 AGMVY---LASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 187

Query: 256 YLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
           ++ P  I   K T +SDV+S GVVL E+ T GK+P
Sbjct: 188 WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 77.0 bits (189), Expect = 9e-16
 Identities = 72/257 (28%), Positives = 111/257 (43%), Gaps = 51/257 (19%)

Query: 140 NHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKT---------------W 184
           +H N++ +LG C       +  E+A  G LLD +R   S+VL+T                
Sbjct: 61  HHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLR--KSRVLETDPAFAKEHGTASTLTS 118

Query: 185 KTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET 244
           +  L+ A++ A+ + YL   +    IH D+ + N+L+ +N  +K+ADF  S       + 
Sbjct: 119 QQLLQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKK 175

Query: 245 AMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISM 303
            M  + +    ++    +N    T KSDV+SFGV+L E+++ G  P   MT A       
Sbjct: 176 TMGRLPV---RWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE------ 226

Query: 304 VPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDR 363
               L      G R     +  DE        V EL  +C R R  ERP   Q+S +L R
Sbjct: 227 ----LYEKLPQGYRMEKPRNCDDE--------VYELMRQCWRDRPYERPPFAQISVQLSR 274

Query: 364 LRR---------LHENF 371
           +           L ENF
Sbjct: 275 MLEARKAYVNMALFENF 291

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 76.6 bits (188), Expect = 9e-16
 Identities = 65/222 (29%), Positives = 110/222 (49%), Gaps = 25/222 (11%)

Query: 92  SRCLSQGGFVSVY----KGVLHDN--IQVAVKTYRRADKIRITER-ELLR---IISQVNH 141
           SR L QG F  VY    KGV+ D    +VA+KT   A  +R  ER E L    ++ + N 
Sbjct: 11  SRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMR--ERIEFLNEASVMKEFNC 68

Query: 142 KNVVKILGLCLETEVPLLVYEFASNGTLLDHIRC-------ESSQVLKTWKTCLRIAAET 194
            +VV++LG+  + +  L++ E  + G L  ++R           Q   + K  +++A E 
Sbjct: 69  HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEI 128

Query: 195 ASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLI-SSDAETAMSTILIGT 253
           A  + YL++      +H D+ + N ++ +++T K+ DF  +  I  +D        L+  
Sbjct: 129 ADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185

Query: 254 SGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMT 294
             ++ P  +  G  T  SDV+SFGVVL E+ T  ++P   M+
Sbjct: 186 R-WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS 226

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 76.2 bits (187), Expect = 1e-15
 Identities = 56/205 (27%), Positives = 109/205 (53%), Gaps = 19/205 (9%)

Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLR---IISQVNHKNVVKILGLC 151
           + +G F +V +G  +   +VAVK      K  +T +  L    ++++++HKN+V++LG+ 
Sbjct: 14  IGEGEFGAVLQGE-YTGQKVAVKNI----KCDVTAQAFLEETAVMTKLHHKNLVRLLGVI 68

Query: 152 LETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIH 211
           L   +  +V E  S G L++ +R     ++   +  L+ + + A  ++YL S     ++H
Sbjct: 69  LHNGL-YIVMELMSKGNLVNFLRTRGRALVSVIQL-LQFSLDVAEGMEYLES---KKLVH 123

Query: 212 GDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKS 271
            D+ + NIL++++  AKV+DF    L    +    ++ L     +  P  +   K + KS
Sbjct: 124 RDLAARNILVSEDGVAKVSDFG---LARVGSMGVDNSKL--PVKWTAPEALKHKKFSSKS 178

Query: 272 DVYSFGVVLAELLT-GKKPGSCMTL 295
           DV+S+GV+L E+ + G+ P   M+L
Sbjct: 179 DVWSYGVLLWEVFSYGRAPYPKMSL 203

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 76.3 bits (188), Expect = 1e-15
 Identities = 53/184 (28%), Positives = 86/184 (46%), Gaps = 22/184 (11%)

Query: 113 QVAVKTYRRADKIRITERELL----RIISQVNHKNVVKILGLCLETEVPLLVYEFASNGT 168
           QVAVK   + D  +   RELL     I+    H N+V++    L  +   +V EF   G 
Sbjct: 46  QVAVK---KMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGA 102

Query: 169 LLD---HIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNY 225
           L D   H R    Q+       L+       AL +LH+     +IH D+KS +ILL  + 
Sbjct: 103 LTDIVTHTRMNEEQIATVCLAVLK-------ALSFLHAQG---VIHRDIKSDSILLTSDG 152

Query: 226 TAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT 285
             K++DF     +S +     S  L+GT  ++ P  I+      + D++S G+++ E++ 
Sbjct: 153 RVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVD 210

Query: 286 GKKP 289
           G+ P
Sbjct: 211 GEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 76.0 bits (187), Expect = 1e-15
 Identities = 56/217 (25%), Positives = 104/217 (47%), Gaps = 28/217 (12%)

Query: 88  NFDRSRCLSQGGFVSVYKGVLHD---NIQVAVKTYRRADKIRITEREL------LRIISQ 138
           N+ R + L QG F  VY  + +D     ++AVK          T++E+      ++++  
Sbjct: 3   NWRRGKLLGQGAFGRVY--LCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKN 60

Query: 139 VNHKNVVKILGLCLETEVPLLVY-EFASNGTLLDHIR---CESSQVLKTWKTCLRIAAET 194
           + H+ +V+  G CL  +  L ++ E+   G++ D ++     +  V + +         T
Sbjct: 61  LQHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKY---------T 110

Query: 195 ASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISS--DAETAMSTILIG 252
              L+ +  L S  I+H D+K ANIL +     K+ DF +S  + +   + T M ++  G
Sbjct: 111 RQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSV-TG 169

Query: 253 TSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           T  ++ P  I+     +K+DV+S G  + E+LT K P
Sbjct: 170 TPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 75.8 bits (186), Expect = 2e-15
 Identities = 80/272 (29%), Positives = 127/272 (46%), Gaps = 27/272 (9%)

Query: 88  NFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYR---------RADKIRITERELLRIIS 137
           NF   + + +G F  VY+   L D + VA+K  +         RAD I+  E +LL+   
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIK--EIDLLK--- 57

Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIR-CESSQVLKTWKTCLRIAAETAS 196
           Q+NH NV+K     +E     +V E A  G L   I+  +  + L   KT  +   +  S
Sbjct: 58  QLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCS 117

Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
           AL+++HS     ++H D+K AN+ +      K+ D       SS    A S  L+GT  Y
Sbjct: 118 ALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYY 172

Query: 257 LDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP--GSCMTLAS-NKKISMVPY--FLNSI 311
           + P  I+      KSD++S G +L E+   + P  G  M L S  KKI    Y    +  
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDH 232

Query: 312 KNNGLRQILNFHVADESEMK-EIEIVAELASK 342
            +  LRQ++N  +  + E + +I  V ++A +
Sbjct: 233 YSEELRQLVNMCINPDPEKRPDITYVYDVAKR 264

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 75.5 bits (186), Expect = 2e-15
 Identities = 69/270 (25%), Positives = 122/270 (45%), Gaps = 46/270 (17%)

Query: 102 SVYKGVLHDNIQVAVKTYRRADK-----IRITERELLRIISQVNHKNVVKILGLCLETEV 156
           S+YKG+  +N +V ++T+++  K     I ITE E+ + + +++  N++KI G  ++   
Sbjct: 35  SIYKGI-FNNKEVIIRTFKKFHKGHKVLIDITENEI-KNLRRIDSNNILKIYGFIIDIVD 92

Query: 157 PL----LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHG 212
            L    L+ E+ + G L + +  E      ++KT L +A +    L  L+   + P  + 
Sbjct: 93  DLPRLSLILEYCTRGYLREVLDKEKDL---SFKTKLDMAIDCCKGLYNLYKYTNKP--YK 147

Query: 213 DVKSANILLNDNYTAKVADFESSVLISSDAETAMSTIL---IGTSGYLDPVCINT--GKL 267
           ++ S + L+ +NY  K        +I    E  +S+     +    Y     +N    + 
Sbjct: 148 NLTSVSFLVTENYKLK--------IICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEY 199

Query: 268 TKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADE 327
           T K D+YS GVVL E+ TGK P   +T           Y L   KNN L+  L+      
Sbjct: 200 TIKDDIYSLGVVLWEIFTGKIPFENLTTKE-------IYDLIINKNNSLKLPLDCP---- 248

Query: 328 SEMKEIEIVAELASKCLRIRGTERPTMKQV 357
               EI+ + E    C      +RP +K++
Sbjct: 249 ---LEIKCIVE---ACTSHDSIKRPNIKEI 272

Length = 283

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 75.4 bits (185), Expect = 3e-15
 Identities = 61/215 (28%), Positives = 101/215 (46%), Gaps = 23/215 (10%)

Query: 95  LSQGGFVSVYKGVLH------DNIQVAVKTYRRA-DKIRITERELLRIISQVNHKNVVKI 147
           L +G F  V+    H      D + VAVK  + A +  R   +    +++ + H+++V+ 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 148 LGLCLETEVPLLVYEFASNGTLLDHIRCE--SSQVLK----------TWKTCLRIAAETA 195
            G+C E    L+V+E+  +G L   +R     +++L           T    L IA++ A
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 196 SALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG 255
           S + YL SL     +H D+ + N L+      K+ DF  S  I S     +    +    
Sbjct: 133 SGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189

Query: 256 YLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
           ++ P  I   K T +SD++SFGVVL E+ T GK+P
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 75.2 bits (185), Expect = 3e-15
 Identities = 54/172 (31%), Positives = 82/172 (47%), Gaps = 14/172 (8%)

Query: 187 CLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFE-SSVLISSDAETA 245
             +IA      L YL+++    I+H D+K +NIL+N     K+ DF  S  LI+S A+T 
Sbjct: 105 LGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT- 161

Query: 246 MSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVP 305
                +GTS Y+ P  I  GK T KSDV+S G+ + EL  GK P +   +  + +   + 
Sbjct: 162 ----FVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMG 217

Query: 306 YFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQV 357
                   + L+QI+             E + +    CL    TERPT +Q+
Sbjct: 218 IL------DLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQL 263

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 75.1 bits (184), Expect = 3e-15
 Identities = 77/297 (25%), Positives = 130/297 (43%), Gaps = 57/297 (19%)

Query: 93  RCLSQGGFVSVYKGVLHDN---IQVAVKTYRRADKIRITERELLR---IISQVNHKNVVK 146
           + L +G F SV +G L+ +   ++VAVKT + A   R    + L     + + +H NV++
Sbjct: 5   KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64

Query: 147 ILGLCLETE------VPLLVYEFASNGTL---LDHIRCESSQVLKTWKTCLRIAAETASA 197
           ++G+CL+T        P+++  F  +G L   L + R          +  ++   + AS 
Sbjct: 65  LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124

Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE------TAMSTILI 251
           ++YL   +S   IH D+ + N +LN+N    VADF  S  I +           M    I
Sbjct: 125 MEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWI 181

Query: 252 GTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNS 310
                 D V       T KSDV+SFGV + E+ T G+ P               P   NS
Sbjct: 182 AIESLADRV------YTTKSDVWSFGVTMWEIATRGQTP--------------YPGVENS 221

Query: 311 IKNNGLRQILNFHVADESEMKE----IEIVAELASKCLRIRGTERPTMKQVSEELDR 363
              + LRQ         + +K+    ++ +  L S C  +   +RP+ + +  EL++
Sbjct: 222 EIYDYLRQ--------GNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 75.3 bits (186), Expect = 3e-15
 Identities = 54/234 (23%), Positives = 94/234 (40%), Gaps = 70/234 (29%)

Query: 89  FDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIR---------ITE-RELLRIIS 137
           +++   + +G +  VYK         VA+K      KIR         IT  RE+ +++ 
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALK------KIRMENEKEGFPITAIREI-KLLQ 53

Query: 138 QVNHKNVVKILGLCLETEVP--LLVYEFAS---NGTL--------LDHIRCESSQVLKTW 184
           ++ H N+V++  +          +V+E+      G L           I+C   Q+L+  
Sbjct: 54  KLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLE-- 111

Query: 185 KTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET 244
                        L YLHS     I+H D+K +NIL+N++   K+ADF  +   +     
Sbjct: 112 ------------GLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA 156

Query: 245 AMST-----------ILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGK 287
             +            +L+G + Y             + D++S G +LAEL  GK
Sbjct: 157 DYTNRVITLWYRPPELLLGATRY-----------GPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 74.6 bits (183), Expect = 4e-15
 Identities = 57/232 (24%), Positives = 114/232 (49%), Gaps = 29/232 (12%)

Query: 135 IISQVNHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAE 193
           +++Q+ H N+V++LG+ +E +  L +V E+ + G+L+D++R     VL      L+ + +
Sbjct: 52  VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGG-DCLLKFSLD 110

Query: 194 TASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGT 253
              A++YL +      +H D+ + N+L++++  AKV+DF  +   SS  +T    +    
Sbjct: 111 VCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV---- 163

Query: 254 SGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIK 312
             +  P  +   K + KSDV+SFG++L E+ + G+ P   + L       +VP      K
Sbjct: 164 -KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----DVVPRVEKGYK 217

Query: 313 NNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL 364
            +           D        +V ++  +C  +    RP+  Q+ E+L+ +
Sbjct: 218 MDA---------PDGCP----PVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 74.3 bits (182), Expect = 5e-15
 Identities = 75/265 (28%), Positives = 115/265 (43%), Gaps = 42/265 (15%)

Query: 116 VKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRC 175
           +K Y   D  R    EL  +    +H N++ +LG C       L  E+A +G LLD +R 
Sbjct: 30  MKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR- 88

Query: 176 ESSQVLKT---------------WKTCLRIAAETASALDYLHSLASPPIIHGDVKSANIL 220
             S+VL+T                +  L  AA+ A  +DYL   +    IH D+ + NIL
Sbjct: 89  -KSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNIL 144

Query: 221 LNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVL 280
           + +NY AK+ADF  S       +  M  + +    ++    +N    T  SDV+S+GV+L
Sbjct: 145 VGENYVAKIADFGLSRGQEVYVKKTMGRLPV---RWMAIESLNYSVYTTNSDVWSYGVLL 201

Query: 281 AELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAEL 339
            E+++ G  P   MT A           L      G R     +  DE        V +L
Sbjct: 202 WEIVSLGGTPYCGMTCAE----------LYEKLPQGYRLEKPLNCDDE--------VYDL 243

Query: 340 ASKCLRIRGTERPTMKQVSEELDRL 364
             +C R +  ERP+  Q+   L+R+
Sbjct: 244 MRQCWREKPYERPSFAQILVSLNRM 268

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 73.9 bits (182), Expect = 5e-15
 Identities = 57/209 (27%), Positives = 93/209 (44%), Gaps = 18/209 (8%)

Query: 88  NFDRSRCLSQGGFVSVYKGVLHDNIQV-AVKTYRRADKIRITE-----RELLRIISQVNH 141
           +F+  R + +G F  V      D  ++ A+K   +   +          E  RI+ ++NH
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNER-RILQELNH 59

Query: 142 KNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETASALDY 200
             +V +     + E   LV +    G L  H+    SQ +K  +  ++    E   AL+Y
Sbjct: 60  PFLVNLWYSFQDEENMYLVVDLLLGGDLRYHL----SQKVKFSEEQVKFWICEIVLALEY 115

Query: 201 LHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV 260
           LHS     IIH D+K  NILL++     + DF  +  ++ D    ++T   GT GY+ P 
Sbjct: 116 LHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGYMAPE 169

Query: 261 CINTGKLTKKSDVYSFGVVLAELLTGKKP 289
            +     +   D +S GV   E L GK+P
Sbjct: 170 VLCRQGYSVAVDWWSLGVTAYECLRGKRP 198

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 74.3 bits (182), Expect = 6e-15
 Identities = 66/229 (28%), Positives = 103/229 (44%), Gaps = 35/229 (15%)

Query: 88  NFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYR-------RADKIRITERELLRIISQV 139
           NF   + + +G F  VY+     D   VA+K  +       +A +  + E +LL+   Q+
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLK---QL 59

Query: 140 NHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETA---- 195
           NH NV+K L   +E     +V E A  G L        SQ++K +K   R+  E      
Sbjct: 60  NHPNVIKYLDSFIEDNELNIVLELADAGDL--------SQMIKYFKKQKRLIPERTVWKY 111

Query: 196 -----SALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTIL 250
                SA++++HS     ++H D+K AN+ +      K+ D       SS    A S  L
Sbjct: 112 FVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--L 166

Query: 251 IGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP--GSCMTLAS 297
           +GT  Y+ P  I+      KSD++S G +L E+   + P  G  M L S
Sbjct: 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFS 215

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 73.8 bits (181), Expect = 6e-15
 Identities = 58/207 (28%), Positives = 105/207 (50%), Gaps = 23/207 (11%)

Query: 95  LSQGGFVSVYKGVLH---DNIQVAVKTYRRADKIRITERELLR---IISQVNHKNVVKIL 148
           L  G F  V KGV       I VA+K  +  ++  + + E++R   I+ Q+++  +V+++
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRD-EMMREAEIMHQLDNPYIVRMI 61

Query: 149 GLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPP 208
           G+C E E  +LV E AS G L   +  +  ++  T    + +  + +  + YL       
Sbjct: 62  GVC-EAEALMLVMEMASGGPLNKFLSGKKDEI--TVSNVVELMHQVSMGMKYLEG---KN 115

Query: 209 IIHGDVKSANILLNDNYTAKVADFESSVLISSD-----AETAMSTILIGTSGYLDPVCIN 263
            +H D+ + N+LL + + AK++DF  S  + +D     A +A    L     +  P CIN
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPL----KWYAPECIN 171

Query: 264 TGKLTKKSDVYSFGVVLAELLT-GKKP 289
             K + +SDV+S+G+ + E  + G+KP
Sbjct: 172 FRKFSSRSDVWSYGITMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 74.6 bits (183), Expect = 6e-15
 Identities = 58/207 (28%), Positives = 99/207 (47%), Gaps = 32/207 (15%)

Query: 109 HDNIQVAVKTYRRADKIRITERELLR---IISQVNHKNVVKILGLCLETEVPLLVYEFAS 165
              + VAVK  R AD  +    + L+   I+S++ + N++++LG+C+  +   ++ E+  
Sbjct: 42  GQPVLVAVKMLR-ADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYME 100

Query: 166 NG---------------TLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPII 210
           NG               T  ++I   S   L      L +A + AS + YL SL     +
Sbjct: 101 NGDLNQFLSQREIESTFTHANNIPSVSIANL------LYMAVQIASGMKYLASLN---FV 151

Query: 211 HGDVKSANILLNDNYTAKVADF-ESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTK 269
           H D+ + N L+ ++YT K+ADF  S  L S D        ++    ++    I  GK T 
Sbjct: 152 HRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIR-WMAWESILLGKFTT 210

Query: 270 KSDVYSFGVVLAEL--LTGKKPGSCMT 294
            SDV++FGV L E+  L  ++P S ++
Sbjct: 211 ASDVWAFGVTLWEMFTLCKEQPYSLLS 237

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 74.0 bits (182), Expect = 8e-15
 Identities = 63/239 (26%), Positives = 92/239 (38%), Gaps = 45/239 (18%)

Query: 85  ATKNFDRSRCLSQGGFVSVYKG-VLHDN-----IQVAVKTYRRADKIRITERELLR---I 135
              +    R L  G F  VY+G     +     +QVAVKT          E + L    I
Sbjct: 4   PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKT-LPESCSEQDESDFLMEALI 62

Query: 136 ISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIR-CESSQV---LKTWKTCLRIA 191
           +S+ NH+N+V+++G+  E     ++ E  + G L   +R            T K  L  A
Sbjct: 63  MSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCA 122

Query: 192 AETASALDYLHSLASPPIIHGDVKSANILLND---NYTAKVADFESSVLISSDAETAMST 248
            + A    YL        IH D+ + N LL        AK+ADF             M+ 
Sbjct: 123 RDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADF------------GMAR 167

Query: 249 ILIGTSGY------------LDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMT 294
            +   S Y            + P     G  T K+DV+SFGV+L E+ + G  P    T
Sbjct: 168 DIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT 226

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 73.5 bits (180), Expect = 1e-14
 Identities = 57/215 (26%), Positives = 102/215 (47%), Gaps = 9/215 (4%)

Query: 81  EMIRATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVN 140
           E+ R +   ++   L  G F  V+    + + +VAVKT +              ++  + 
Sbjct: 2   EIPRESLKLEKK--LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQ 59

Query: 141 HKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDY 200
           H  +VK L   +  E   ++ EF + G+LLD ++ +        K  +  +A+ A  + +
Sbjct: 60  HDKLVK-LHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKL-IDFSAQIAEGMAF 117

Query: 201 LHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV 260
           +        IH D+++ANIL++ +   K+ADF  + +I  +  TA          +  P 
Sbjct: 118 IEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK-WTAPE 173

Query: 261 CINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMT 294
            IN G  T KSDV+SFG++L E++T G+ P   M+
Sbjct: 174 AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS 208

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 73.4 bits (181), Expect = 1e-14
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 14/207 (6%)

Query: 89  FDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTY---RRADKIRITERELLRIISQVNHKNV 144
           F    C+ +G F  VYK +    N  VA+K        D+I   ++E+ + +SQ     +
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEI-QFLSQCRSPYI 61

Query: 145 VKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSL 204
            K  G  L+     ++ E+   G+ LD ++      L        I  E    L+YLH  
Sbjct: 62  TKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP---GKLDETYIAF-ILREVLLGLEYLHEE 117

Query: 205 ASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINT 264
                IH D+K+ANILL++    K+ADF  S  ++S   +  +T  +GT  ++ P  I  
Sbjct: 118 GK---IHRDIKAANILLSEEGDVKLADFGVSGQLTS-TMSKRNT-FVGTPFWMAPEVIKQ 172

Query: 265 GKLTKKSDVYSFGVVLAELLTGKKPGS 291
               +K+D++S G+   EL  G+ P S
Sbjct: 173 SGYDEKADIWSLGITAIELAKGEPPLS 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 73.4 bits (180), Expect = 1e-14
 Identities = 61/212 (28%), Positives = 103/212 (48%), Gaps = 27/212 (12%)

Query: 93  RCLSQGGFVSVYKGVLH----DNIQVAVKTYR--RADKIRITERELLR---IISQVNHKN 143
           + +  G F  V  G L       I VA+KT +    +K R   R+ L    I+ Q +H N
Sbjct: 10  KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQR---RDFLSEASIMGQFDHPN 66

Query: 144 VVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHS 203
           ++ + G+  +++  ++V E+  NG+L   +R    Q   T    + +    AS + YL  
Sbjct: 67  IIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQF--TVIQLVGMLRGIASGMKYLSD 124

Query: 204 LASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG-----YLD 258
           +     +H D+ + NIL+N N   KV+DF  S ++  D E A +T      G     +  
Sbjct: 125 MGY---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTT----RGGKIPIRWTA 177

Query: 259 PVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
           P  I   K T  SDV+S+G+V+ E+++ G++P
Sbjct: 178 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 73.5 bits (180), Expect = 1e-14
 Identities = 61/212 (28%), Positives = 103/212 (48%), Gaps = 20/212 (9%)

Query: 89  FDRSRCLSQGGFVSVYKGVLHDNIQV-AVKTY---RRADKIRITERELLRIISQVNHKNV 144
           F +   + +G F  V+KG+ +   QV A+K        D+I   ++E+  ++SQ +   V
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEI-TVLSQCDSPYV 64

Query: 145 VKILGLCLETEVPLLVYEFASNGTLLDHIRC---ESSQVLKTWKTCLRIAAETASALDYL 201
            K  G  L+     ++ E+   G+ LD +R    +  Q+    K  L+        LDYL
Sbjct: 65  TKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILK-------GLDYL 117

Query: 202 HSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVC 261
           HS      IH D+K+AN+LL++    K+ADF  +  + +D +   +T  +GT  ++ P  
Sbjct: 118 HSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQL-TDTQIKRNT-FVGTPFWMAPEV 172

Query: 262 INTGKLTKKSDVYSFGVVLAELLTGKKPGSCM 293
           I       K+D++S G+   EL  G+ P S M
Sbjct: 173 IQQSAYDSKADIWSLGITAIELAKGEPPNSDM 204

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 72.7 bits (178), Expect = 2e-14
 Identities = 54/211 (25%), Positives = 104/211 (49%), Gaps = 21/211 (9%)

Query: 91  RSRCLSQGGFVSVYKGVL----HDNIQVAVKTYRRA--DKIRITERELLRIISQVNHKNV 144
           + + +  G F  V++G+L       + VA+KT +    +K R        I+ Q +H N+
Sbjct: 9   KQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNI 68

Query: 145 VKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSL 204
           +++ G+  + +  +++ E+  NG L  ++R    +   +    + +    A+ + YL  +
Sbjct: 69  IRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEF--SSYQLVGMLRGIAAGMKYLSDM 126

Query: 205 ASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG-----YLDP 259
                +H D+ + NIL+N N   KV+DF  S ++  D E   +T    + G     +  P
Sbjct: 127 N---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTT----SGGKIPIRWTAP 179

Query: 260 VCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
             I   K T  SDV+SFG+V+ E+++ G++P
Sbjct: 180 EAIAYRKFTSASDVWSFGIVMWEVMSFGERP 210

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 72.7 bits (178), Expect = 2e-14
 Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 24/211 (11%)

Query: 93  RCLSQGGFVSVYKGVLHDNIQ------VAVKTYRRADKIRITER-ELLR---IISQVNHK 142
           R L QG F  VY+G   D I+      VAVKT   +  +R  ER E L    ++      
Sbjct: 12  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR--ERIEFLNEASVMKGFTCH 69

Query: 143 NVVKILGLCLETEVPLLVYEFASNGTLLDHIRC-------ESSQVLKTWKTCLRIAAETA 195
           +VV++LG+  + +  L+V E  ++G L  ++R           +   T +  +++AAE A
Sbjct: 70  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 129

Query: 196 SALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLI-SSDAETAMSTILIGTS 254
             + YL++      +H D+ + N ++  ++T K+ DF  +  I  +D        L+   
Sbjct: 130 DGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186

Query: 255 GYLDPVCINTGKLTKKSDVYSFGVVLAELLT 285
             + P  +  G  T  SD++SFGVVL E+ +
Sbjct: 187 W-MAPESLKDGVFTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 72.1 bits (177), Expect = 2e-14
 Identities = 70/284 (24%), Positives = 119/284 (41%), Gaps = 62/284 (21%)

Query: 95  LSQGGFVSVYKGVLHDNIQ-VAVKTYRRADK-------IRITERELLRIISQVNHKNVVK 146
           L  G F SVY+G+  D+    AVK    AD        ++  E+E+  ++S++ H N+V+
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEI-ALLSKLQHPNIVQ 66

Query: 147 ILGLCLETEVPLLVY-EFASNGTLLDH-----------IRCESSQVLKTWKTCLRIAAET 194
            LG   E +  L ++ E    G+L              IR  + Q+L             
Sbjct: 67  YLGTEREED-NLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL------------ 113

Query: 195 ASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTS 254
              L+YLH       +H D+K ANIL++ N   K+ADF  +  +    E + +    G+ 
Sbjct: 114 --GLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVV---EFSFAKSFKGSP 165

Query: 255 GYLDP-VCINTGKLTKKSDVYSFGVVLAELLTGKKP-GSCMTLASNKKISMVPYFLNSIK 312
            ++ P V    G     +D++S G  + E+ TGK P      +A           +  I 
Sbjct: 166 YWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA----------AVFKIG 215

Query: 313 NNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQ 356
            +     +  H++DE++        +   KCL+   + RPT  +
Sbjct: 216 RSKELPPIPDHLSDEAK--------DFILKCLQRDPSLRPTAAE 251

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 71.8 bits (176), Expect = 3e-14
 Identities = 54/196 (27%), Positives = 94/196 (47%), Gaps = 7/196 (3%)

Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLET 154
           L  G F  V+ G     I+VA+K             E  +++ +++H  +V++ G+C + 
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ 71

Query: 155 EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDV 214
           +   +V EF  NG LL+++R    ++ K     L +  +    ++YL   +    IH D+
Sbjct: 72  KPLYIVTEFMENGCLLNYLRQRQGKLSK--DMLLSMCQDVCEGMEYLERNS---FIHRDL 126

Query: 215 KSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVY 274
            + N L++     KV+DF  +  +  D  T+ S        +  P   N  K + KSDV+
Sbjct: 127 AARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVK-WSPPEVFNFSKYSSKSDVW 185

Query: 275 SFGVVLAELLT-GKKP 289
           SFGV++ E+ T GK P
Sbjct: 186 SFGVLMWEVFTEGKMP 201

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 72.5 bits (178), Expect = 3e-14
 Identities = 64/214 (29%), Positives = 95/214 (44%), Gaps = 26/214 (12%)

Query: 87  KNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRITER-----ELLRIISQVN 140
           K F   R +  G F +VY    +  N  VA+K    + K +  E+     + +R + Q+ 
Sbjct: 15  KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQQLR 73

Query: 141 HKNVVKILGLCLETEVPLLVYEF--ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASAL 198
           H N ++  G  L      LV E+   S   +L+        V K     + IAA    AL
Sbjct: 74  HPNTIEYKGCYLREHTAWLVMEYCLGSASDILE--------VHKKPLQEVEIAAICHGAL 125

Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLD 258
             L  L S   IH D+K+ NILL +  T K+ADF S+ L+S       +   +GT  ++ 
Sbjct: 126 QGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP------ANSFVGTPYWMA 179

Query: 259 PVCI---NTGKLTKKSDVYSFGVVLAELLTGKKP 289
           P  I   + G+   K DV+S G+   EL   K P
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 71.7 bits (176), Expect = 3e-14
 Identities = 62/200 (31%), Positives = 88/200 (44%), Gaps = 12/200 (6%)

Query: 95  LSQGGFVSVYK-GVLHDNIQVAVKTYR---RADKIRITERELLRIISQVNHKNVVKILGL 150
           L +G + SVYK   L DN   A+K       + K R      +RI++ VNH N++     
Sbjct: 8   LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67

Query: 151 CLETEVPLLVYEFASNGTLLDHIRCESSQV-LKTWKTCLRIAAETASALDYLHSLASPPI 209
            L+     +V E+A  G L   I     +  L   +   RI  +    L  LH      I
Sbjct: 68  FLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---I 124

Query: 210 IHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTK 269
           +H D+KSANILL  N   K+ D      IS   +  M+   IGT  Y+ P        + 
Sbjct: 125 LHRDLKSANILLVANDLVKIGDLG----ISKVLKKNMAKTQIGTPHYMAPEVWKGRPYSY 180

Query: 270 KSDVYSFGVVLAELLTGKKP 289
           KSD++S G +L E+ T   P
Sbjct: 181 KSDIWSLGCLLYEMATFAPP 200

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 72.7 bits (178), Expect = 3e-14
 Identities = 63/227 (27%), Positives = 107/227 (47%), Gaps = 50/227 (22%)

Query: 89  FDRSRCLSQGGFVSVYKGVLHDN-----IQVAVKTYRRADKIRITERELLR---IISQVN 140
           F + + L  G F +VYKG+         I VA+K  R A   +   +E+L    +++ V+
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-KEILDEAYVMASVD 67

Query: 141 HKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCES----SQVLKTWKTCLRIAAETAS 196
           + +V ++LG+CL + V L + +    G LLD++R       SQ L  W  C++IA     
Sbjct: 68  NPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNW--CVQIA----K 120

Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET------------ 244
            ++YL       ++H D+ + N+L+      K+ DF  + L+ +D +             
Sbjct: 121 GMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKW 177

Query: 245 -AMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
            A+ +IL                 T +SDV+S+GV + EL+T G KP
Sbjct: 178 MALESILHRI-------------YTHQSDVWSYGVTVWELMTFGSKP 211

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 72.1 bits (177), Expect = 4e-14
 Identities = 69/253 (27%), Positives = 109/253 (43%), Gaps = 48/253 (18%)

Query: 95  LSQGGFVSVYK---GVLHDNIQ--VAVKTYR--RADKIRITERELLRIISQVNHKNVVKI 147
           L +G F SV       L DN    VAVK  +   A+ +R  ERE+  I+  + H N+VK 
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREI-EILKSLQHDNIVKY 70

Query: 148 LGLCLETEVP--LLVYEFASNGTLLDHI-----RCESSQVLK-TWKTCLRIAAETASALD 199
            G+C         LV E+   G+L D++     R +  ++L    + C          ++
Sbjct: 71  KGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQIC--------KGME 122

Query: 200 YLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAM------STILIGT 253
           YL    S   +H D+ + NIL+      K+ DF  + ++  D E         S I    
Sbjct: 123 YL---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIF--- 176

Query: 254 SGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKN 313
             +  P  +   K +  SDV+SFGVVL EL T           S+K  S    F+  + N
Sbjct: 177 --WYAPESLTESKFSVASDVWSFGVVLYELFT----------YSDKSCSPPAEFMRMMGN 224

Query: 314 NGLRQILNFHVAD 326
           +   Q++ +H+ +
Sbjct: 225 DKQGQMIVYHLIE 237

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 71.5 bits (175), Expect = 6e-14
 Identities = 55/183 (30%), Positives = 93/183 (50%), Gaps = 15/183 (8%)

Query: 114 VAVKTYRR-ADK-IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTL-- 169
           VAVK  R  A+K  R    + ++I+S++   N++++L +C+ ++   ++ E+  NG L  
Sbjct: 49  VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108

Query: 170 ------LDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLND 223
                       ++  V  ++ T + +A + AS + YL SL     +H D+ + N L+  
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNCLVGK 165

Query: 224 NYTAKVADF-ESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAE 282
           NYT K+ADF  S  L S D        ++    ++    I  GK T  SDV++FGV L E
Sbjct: 166 NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIR-WMSWESILLGKFTTASDVWAFGVTLWE 224

Query: 283 LLT 285
           +LT
Sbjct: 225 ILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 70.7 bits (173), Expect = 8e-14
 Identities = 54/211 (25%), Positives = 105/211 (49%), Gaps = 22/211 (10%)

Query: 88  NFDRSRCLSQGGFVSVYKGVLH------DNIQVAVK---TYRRADKIRITERELLRIISQ 138
            +++ R + +G F     G++H      D   V +K     +     R+  +   +++  
Sbjct: 1   KYEKIRVVGRGAF-----GIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKL 55

Query: 139 VNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASAL 198
           ++H N+++     LE +  ++V E+A  GTL ++I+   + +L    T L    +   AL
Sbjct: 56  LSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDE-DTILHFFVQILLAL 114

Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTA-KVADFESSVLISSDAETAMSTILIGTSGYL 257
            ++H+     I+H D+K+ NILL+ +    K+ DF  S ++SS  ++   T+ +GT  Y+
Sbjct: 115 HHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS--KSKAYTV-VGTPCYI 168

Query: 258 DPVCINTGKLTKKSDVYSFGVVLAELLTGKK 288
            P         +KSD+++ G VL EL + K+
Sbjct: 169 SPELCEGKPYNQKSDIWALGCVLYELASLKR 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 71.3 bits (174), Expect = 9e-14
 Identities = 77/305 (25%), Positives = 135/305 (44%), Gaps = 47/305 (15%)

Query: 74  MKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHD-----NIQVAVKTYRRAD--KIR 126
           ++I  ++E+        R + L  G F +VYKG+         I VA+K        K  
Sbjct: 1   LRILKETEL-------KRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKAN 53

Query: 127 ITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCES----SQVLK 182
           +   +   I++ ++H ++V++LG+CL   + L V +   +G LLD++        SQ+L 
Sbjct: 54  VEFMDEALIMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLL 112

Query: 183 TWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDA 242
            W  C++IA      + YL       ++H D+ + N+L+      K+ DF  + L+  D 
Sbjct: 113 NW--CVQIA----KGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE 163

Query: 243 ETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKI 301
           +   +        ++   CI+  K T +SDV+S+GV + EL+T G KP   +        
Sbjct: 164 KEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---- 219

Query: 302 SMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEEL 361
             +P  L   K   L Q           +  I++   +  KC  I    RP  K+++ E 
Sbjct: 220 --IPDLLE--KGERLPQ---------PPICTIDVYMVMV-KCWMIDADSRPKFKELAAEF 265

Query: 362 DRLRR 366
            R+ R
Sbjct: 266 SRMAR 270

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 70.4 bits (173), Expect = 1e-13
 Identities = 58/201 (28%), Positives = 88/201 (43%), Gaps = 20/201 (9%)

Query: 98  GGFVSVYKGV-LHDNIQVAVKTYR--RADKIRITERELLRIISQVNHKNVVKILGLCLET 154
           G +  VYK   +     VA+K  +    D   I ++E+  ++ +  H N+V   G  L  
Sbjct: 14  GTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEI-SMLKECRHPNIVAYFGSYLRR 72

Query: 155 EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIA---AETASALDYLHSLASPPIIH 211
           +   +V E+   G+L D I   +   L      L+IA    ET   L YLH       IH
Sbjct: 73  DKLWIVMEYCGGGSLQD-IYQVTRGPLSE----LQIAYVCRETLKGLAYLHETG---KIH 124

Query: 212 GDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCIN---TGKLT 268
            D+K ANILL ++   K+ADF  S  ++  A  A     IGT  ++ P        G   
Sbjct: 125 RDIKGANILLTEDGDVKLADFGVSAQLT--ATIAKRKSFIGTPYWMAPEVAAVERKGGYD 182

Query: 269 KKSDVYSFGVVLAELLTGKKP 289
            K D+++ G+   EL   + P
Sbjct: 183 GKCDIWALGITAIELAELQPP 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 70.8 bits (173), Expect = 1e-13
 Identities = 64/223 (28%), Positives = 102/223 (45%), Gaps = 34/223 (15%)

Query: 93  RCLSQGGFVSVYKGVLH------DNIQVAVKTYR------RADKIRITERELLRIISQVN 140
           R L +G F  V+    +      D + VAVK  +      R D  R  E ELL   + + 
Sbjct: 11  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQR--EAELL---TNLQ 65

Query: 141 HKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCE--------SSQVLKT-----WKTC 187
           H+++VK  G+C + +  ++V+E+  +G L   +R            Q  +          
Sbjct: 66  HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 125

Query: 188 LRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMS 247
           L IA++ AS + YL   AS   +H D+ + N L+  N   K+ DF  S  + S     + 
Sbjct: 126 LHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVG 182

Query: 248 TILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
              +    ++ P  I   K T +SDV+SFGV+L E+ T GK+P
Sbjct: 183 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 65/258 (25%), Positives = 116/258 (44%), Gaps = 37/258 (14%)

Query: 127 ITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLK---- 182
           I+E E++++I +  HKN++ +LG C +     ++ E+AS G L +++R      ++    
Sbjct: 71  ISEMEMMKMIGK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYN 128

Query: 183 ---------TWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFE 233
                    ++K  +  A + A  ++Y   LAS   IH D+ + N+L+ ++   K+ADF 
Sbjct: 129 PTQVPEEQLSFKDLVSCAYQVARGMEY---LASKKCIHRDLAARNVLVTEDNVMKIADFG 185

Query: 234 SSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSC 292
            +  I        +T       ++ P  +     T +SDV+SFGV+L E+ T G  P   
Sbjct: 186 LARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 245

Query: 293 MTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERP 352
           + +            L  +   G R     +  +E  M        +   C     ++RP
Sbjct: 246 VPVEE----------LFKLLKEGHRMDKPSNCTNELYM--------MMRDCWHAVPSQRP 287

Query: 353 TMKQVSEELDRLRRLHEN 370
           T KQ+ E+LDR+  L  N
Sbjct: 288 TFKQLVEDLDRILALTSN 305

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 70.0 bits (171), Expect = 1e-13
 Identities = 60/207 (28%), Positives = 102/207 (49%), Gaps = 23/207 (11%)

Query: 95  LSQGGFVSVYKGVLH---DNIQVAVKTYRRADKIRITERELLR---IISQVNHKNVVKIL 148
           L  G F +V KG+         VAVK  +  +     + ELLR   ++ Q+++  +V+++
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 149 GLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPP 208
           G+C E E  +LV E A  G L   ++ ++  V  T K    +  + +  + YL       
Sbjct: 63  GIC-EAESWMLVMELAELGPLNKFLQ-KNKHV--TEKNITELVHQVSMGMKYLEE---TN 115

Query: 209 IIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG-----YLDPVCIN 263
            +H D+ + N+LL   + AK++DF  S  + +D     +     T G     +  P C+N
Sbjct: 116 FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK----THGKWPVKWYAPECMN 171

Query: 264 TGKLTKKSDVYSFGVVLAELLT-GKKP 289
             K + KSDV+SFGV++ E  + G+KP
Sbjct: 172 YYKFSSKSDVWSFGVLMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 70.3 bits (172), Expect = 1e-13
 Identities = 56/207 (27%), Positives = 101/207 (48%), Gaps = 29/207 (14%)

Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELL---RIISQVNHKNVVKILGLC 151
           L  G F  V  G       VA+K  +      ++E E +   +++ +++H+ +V++ G+C
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGS---MSEDEFIEEAKVMMKLSHEKLVQLYGVC 68

Query: 152 LETEVPLLVYEFASNGTLLDHIR-----CESSQVLKTWKTCLRIAAETASALDYLHSLAS 206
            +     +V E+ SNG LL+++R      + SQ+L+  K       +    + YL    S
Sbjct: 69  TKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCK-------DVCEGMAYLE---S 118

Query: 207 PPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTS---GYLDPVCIN 263
              IH D+ + N L++D    KV+DF  S  +  D  T+     +G+     +  P  + 
Sbjct: 119 KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLL 174

Query: 264 TGKLTKKSDVYSFGVVLAELLT-GKKP 289
             K + KSDV++FGV++ E+ + GK P
Sbjct: 175 YSKFSSKSDVWAFGVLMWEVYSLGKMP 201

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 70.0 bits (172), Expect = 2e-13
 Identities = 60/283 (21%), Positives = 112/283 (39%), Gaps = 70/283 (24%)

Query: 114 VAVKTYRRA--DKI--RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTL 169
           VA+K ++ +  D+   +   RE+ +++ Q+ H+N+V +           LV+E+    TL
Sbjct: 29  VAIKKFKESEDDEDVKKTALREV-KVLRQLRHENIVNLKEAFRRKGRLYLVFEYVER-TL 86

Query: 170 LDHIRCESSQVLKTWKTCLRIAA------ETASALDYLHSLASPPIIHGDVKSANILLND 223
           L        ++L+     L   A      +   A+ Y HS     IIH D+K  NIL+++
Sbjct: 87  L--------ELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSE 135

Query: 224 NYTAKVADFESSVLISSDAETAMST-----------ILIGTSGYLDPVCINTGKLTKKSD 272
           +   K+ DF  +  + +   + ++            +L+G + Y  PV           D
Sbjct: 136 SGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPV-----------D 184

Query: 273 VYSFGVVLAELLTGKK--PGSC--------MTLASNKKISMVPYFLNSIKNNGLRQILNF 322
           V++ G ++AELL G+   PG                   S    F ++ +  G+      
Sbjct: 185 VWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVA----- 239

Query: 323 HVADESEMKEIE---------IVAELASKCLRIRGTERPTMKQ 356
              + S+ + +E            +    CLR+   ER T  +
Sbjct: 240 -FPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDE 281

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 70.2 bits (172), Expect = 2e-13
 Identities = 65/232 (28%), Positives = 109/232 (46%), Gaps = 35/232 (15%)

Query: 93  RCLSQGGFVSVYK----GVL--HDNIQVAVKTYRR---ADKIRITERELLRIISQVNHKN 143
           R + QG F  V++    G+L       VAVK  +    AD     +RE   ++++ +H N
Sbjct: 11  RDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA-LMAEFDHPN 69

Query: 144 VVKILGLCLETEVPLLVYEFASNGTLLDHIR-------CESSQVLKTWKTC--------- 187
           +VK+LG+C   +   L++E+ + G L + +R       C  S    + + C         
Sbjct: 70  IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129

Query: 188 ---LRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLI-SSDAE 243
              L IA + A+ + Y   L+    +H D+ + N L+ +N   K+ADF  S  I S+D  
Sbjct: 130 TEQLCIAKQVAAGMAY---LSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 186

Query: 244 TAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMT 294
            A     I    ++ P  I   + T +SDV+++GVVL E+ + G +P   M 
Sbjct: 187 KASENDAIPIR-WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA 237

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 70.0 bits (171), Expect = 2e-13
 Identities = 72/302 (23%), Positives = 121/302 (40%), Gaps = 55/302 (18%)

Query: 95  LSQGGFVSVYKGV------LHDNIQVAVKTYRRADKIRITERELL---RIISQVNHKNVV 145
           L +G F  V K              VAVK  +         R+LL    ++ QVNH +V+
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS-SSELRDLLSEFNLLKQVNHPHVI 66

Query: 146 KILGLCLETEVPLLVYEFASNGTLLDHIRCESSQV----------------------LKT 183
           K+ G C +    LL+ E+A  G+L   +R ES +V                        T
Sbjct: 67  KLYGACSQDGPLLLIVEYAKYGSLRSFLR-ESRKVGPSYLGSDGNRNSSYLDNPDERALT 125

Query: 184 WKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFE-SSVLISSDA 242
               +  A + +  + YL  +    ++H D+ + N+L+ +    K++DF  S  +   D+
Sbjct: 126 MGDLISFAWQISRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS 182

Query: 243 ETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKIS 302
               S   I    ++    +     T +SDV+SFGV+L E++         TL  N    
Sbjct: 183 YVKRSKGRIPVK-WMAIESLFDHIYTTQSDVWSFGVLLWEIV---------TLGGNPYPG 232

Query: 303 MVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELD 362
           + P  L ++   G R         E      E +  L   C +    +RPT   +S+EL+
Sbjct: 233 IAPERLFNLLKTGYRM--------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELE 284

Query: 363 RL 364
           ++
Sbjct: 285 KM 286

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 69.8 bits (171), Expect = 2e-13
 Identities = 64/236 (27%), Positives = 96/236 (40%), Gaps = 30/236 (12%)

Query: 130 RELLRIISQVNHKNVVKILGLCL---ETEVPLLVYEFASNGTL---LDHIRCESSQVLKT 183
           REL  I        +VK  G  L    + + + + E+   G+L      ++    ++ + 
Sbjct: 48  REL-EINKSCKSPYIVKYYGAFLDESSSSIGIAM-EYCEGGSLDSIYKKVKKRGGRIGE- 104

Query: 184 WKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFE-SSVLISSDA 242
            K   +IA      L YLHS     IIH D+K +NILL      K+ DF  S  L++S A
Sbjct: 105 -KVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA 160

Query: 243 ETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKIS 302
            T       GTS Y+ P  I     +  SDV+S G+ L E+   + P           I 
Sbjct: 161 GT-----FTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIE 215

Query: 303 MVPYFLNSIKNNGLRQILNFHVADESE--MKEIEIVAELASKCLRIRGTERPTMKQ 356
           ++ Y +N         + N  + DE    +K  E   +   +CL    T RPT   
Sbjct: 216 LLSYIVN---------MPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWD 262

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 70.1 bits (171), Expect = 2e-13
 Identities = 63/258 (24%), Positives = 116/258 (44%), Gaps = 37/258 (14%)

Query: 127 ITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLK---- 182
           ++E E++++I +  HKN++ +LG C +     ++ E+AS G L +++R      ++    
Sbjct: 68  VSEMEMMKMIGK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 125

Query: 183 ---------TWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFE 233
                    T+K  +    + A  ++Y   LAS   IH D+ + N+L+ +N   K+ADF 
Sbjct: 126 IARVPDEQMTFKDLVSCTYQVARGMEY---LASQKCIHRDLAARNVLVTENNVMKIADFG 182

Query: 234 SSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSC 292
            +  +++      +T       ++ P  +     T +SDV+SFGV++ E+ T G  P   
Sbjct: 183 LARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 242

Query: 293 MTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERP 352
           + +            L  +   G R     +  +E  M        +   C     + RP
Sbjct: 243 IPVEE----------LFKLLKEGHRMDKPANCTNELYM--------MMRDCWHAIPSHRP 284

Query: 353 TMKQVSEELDRLRRLHEN 370
           T KQ+ E+LDR+  L  N
Sbjct: 285 TFKQLVEDLDRILTLTTN 302

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 69.2 bits (169), Expect = 3e-13
 Identities = 52/205 (25%), Positives = 92/205 (44%), Gaps = 22/205 (10%)

Query: 96  SQGGFVSVYKGVLHDNIQVAV-KTYRRADKIRITERELLRIISQVNHKNVVKILGLCLET 154
           +QG  ++V +  L  +  +A  K Y +  +    E +LL+    + H N+V+ LG CL+ 
Sbjct: 22  NQGQLIAVKQVELDTSNVLAAEKEYEKLQE----EVDLLK---SLKHVNIVQYLGTCLDD 74

Query: 155 EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIA--AETASALDYLHSLASPPIIHG 212
               +  EF   G++        S +L  +           T   LD +  L +  ++H 
Sbjct: 75  NTISIFMEFVPGGSI--------SSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHR 126

Query: 213 DVKSANILLNDNYTAKVADFESSVLIS----SDAETAMSTILIGTSGYLDPVCINTGKLT 268
           D+K  N++L  N   K+ DF  +  ++        + M   + GT  ++ P  IN     
Sbjct: 127 DIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYG 186

Query: 269 KKSDVYSFGVVLAELLTGKKPGSCM 293
           +KSD++S G  + E+ TGK P + M
Sbjct: 187 RKSDIWSIGCTVFEMATGKPPLASM 211

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 69.6 bits (170), Expect = 3e-13
 Identities = 55/194 (28%), Positives = 93/194 (47%), Gaps = 31/194 (15%)

Query: 114 VAVKTYRRADKIRITERELLR---IISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLL 170
           VAVK  R  D  +    + L+   I+S++   N++++LG+C++ +   ++ E+  NG L 
Sbjct: 49  VAVKILR-PDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107

Query: 171 DHIRCESSQVLK-------------------TWKTCLRIAAETASALDYLHSLASPPIIH 211
             +   SS  L                    ++ + L +A + AS + YL SL     +H
Sbjct: 108 QFL---SSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161

Query: 212 GDVKSANILLNDNYTAKVADF-ESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKK 270
            D+ + N L+ +N T K+ADF  S  L + D        ++    ++   CI  GK T  
Sbjct: 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIR-WMAWECILMGKFTTA 220

Query: 271 SDVYSFGVVLAELL 284
           SDV++FGV L E+L
Sbjct: 221 SDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 68.7 bits (168), Expect = 3e-13
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 21/205 (10%)

Query: 98  GGFVSVYKGVL----HDNIQVAVKTYRR--ADKIRITERELL---RIISQVNHKNVVKIL 148
           G F  V +G L       I VA+KT +    +K R   R+ L    I+ Q +H N++ + 
Sbjct: 15  GEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQR---RDFLSEASIMGQFDHPNIIHLE 71

Query: 149 GLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPP 208
           G+  ++   +++ EF  NG L   +R    Q   T    + +    A+ + YL  +    
Sbjct: 72  GVVTKSRPVMIITEFMENGALDSFLRQNDGQF--TVIQLVGMLRGIAAGMKYLSEMN--- 126

Query: 209 IIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTS---GYLDPVCINTG 265
            +H D+ + NIL+N N   KV+DF  S  +  D      T  +G      +  P  I   
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR 186

Query: 266 KLTKKSDVYSFGVVLAELLT-GKKP 289
           K T  SDV+S+G+V+ E+++ G++P
Sbjct: 187 KFTSASDVWSYGIVMWEVMSYGERP 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 68.6 bits (168), Expect = 4e-13
 Identities = 71/287 (24%), Positives = 123/287 (42%), Gaps = 51/287 (17%)

Query: 95  LSQGGFVSVYKGVLHDN-----------IQVAVKTYRRADKIRITERELLRIISQVNHKN 143
           L QG F ++YKGVL              + V +K      +  +   E   ++SQ++HK+
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 144 VVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHS 203
           +VK+ G+C+  E  ++V E+   G L   +  E + V   WK  L +A + ASAL YL  
Sbjct: 63  LVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHWK--LDVAKQLASALHYLED 119

Query: 204 LASPPIIHGDVKSANILLNDNYTAKVADFESSVLIS--SDAETAMS----TILIGTSGYL 257
                ++HG+V   NIL+     A+    E  V     SD    ++       +    ++
Sbjct: 120 KK---LVHGNVCGKNILV-----ARYGLNEGYVPFIKLSDPGIPITVLSREERVERIPWI 171

Query: 258 DPVCINTG--KLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNN 314
            P CI  G   LT  +D +SFG  L E+ + G++P S ++ +                  
Sbjct: 172 APECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS------------------ 213

Query: 315 GLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEEL 361
              +   +       M +   +A L ++C     T+RP+ + +  +L
Sbjct: 214 --EKERFYQDQHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 68.4 bits (168), Expect = 4e-13
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 19/209 (9%)

Query: 94  CLSQGGFVSVYKGVLH--DNIQVAVKTYRRADKIRITERELLRIISQVN------HKNVV 145
            + +G F +V K V    D   +  K     D   +TE+E  +++S+VN      H N+V
Sbjct: 7   TIGKGSFGTVRK-VRRKSDGKILVWK---EIDYGNMTEKEKQQLVSEVNILRELKHPNIV 62

Query: 146 KILGLCL--ETEVPLLVYEFASNGTLLDHI-RCESSQVLKTWKTCLRIAAETASALDYLH 202
           +     +    +   +V E+   G L   I +C+  +     +   RI  +   AL   H
Sbjct: 63  RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECH 122

Query: 203 --SLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV 260
             S     ++H D+K ANI L+ N   K+ DF  + ++  D+  A +   +GT  Y+ P 
Sbjct: 123 NRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVGTPYYMSPE 180

Query: 261 CINTGKLTKKSDVYSFGVVLAELLTGKKP 289
            +N     +KSD++S G ++ EL     P
Sbjct: 181 QLNHMSYDEKSDIWSLGCLIYELCALSPP 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 69.3 bits (169), Expect = 5e-13
 Identities = 65/252 (25%), Positives = 118/252 (46%), Gaps = 37/252 (14%)

Query: 127 ITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIR------------ 174
           ++E E++++I +  HKN++ +LG C +     ++ E+AS G L +++R            
Sbjct: 65  VSEMEMMKMIGK--HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFD 122

Query: 175 -CESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFE 233
            C+  +   T+K  +  A + A  ++Y   LAS   IH D+ + N+L+ ++   K+ADF 
Sbjct: 123 TCKLPEEQLTFKDLVSCAYQVARGMEY---LASQKCIHRDLAARNVLVTEDNVMKIADFG 179

Query: 234 SSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCM 293
            +  + +      +T       ++ P  +     T +SDV+SFGV+L E+ T    G   
Sbjct: 180 LARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT---LGGS- 235

Query: 294 TLASNKKISMVPYFLNSIKNNGLRQILN-FHVADESEMKEIEIVAELASKCLRIRGTERP 352
                      PY    I    L ++L   H  D+      E+   +  +C     ++RP
Sbjct: 236 -----------PY--PGIPVEELFKLLKEGHRMDKPANCTHELYM-IMRECWHAVPSQRP 281

Query: 353 TMKQVSEELDRL 364
           T KQ+ E+LDR+
Sbjct: 282 TFKQLVEDLDRV 293

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 68.6 bits (168), Expect = 5e-13
 Identities = 81/314 (25%), Positives = 134/314 (42%), Gaps = 69/314 (21%)

Query: 89  FDRSRC-----LSQGGFVSVYKGVL-----HDNIQ-VAVKTYRRADKIRITERELLRIIS 137
             R R      L +G F  V K         +    VAVK      K   TE++L  ++S
Sbjct: 9   LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKML----KDDATEKDLSDLVS 64

Query: 138 QVN-------HKNVVKILGLCLETEVPLLVYEFASNGTLLDHIR-------------CES 177
           ++        HKN++ +LG+C +     +V E+A++G L D +R                
Sbjct: 65  EMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRP 124

Query: 178 SQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVL 237
            +   T K  +  A + A  +++L   AS   IH D+ + N+L+ +++  K+ADF  +  
Sbjct: 125 PEETLTQKDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARD 181

Query: 238 ISSDAETAMSTILIGTSGYLDPV------CINTGKLTKKSDVYSFGVVLAELLTGKKPGS 291
           I    +    T    T+G L PV       +     T +SDV+SFGV+L E+        
Sbjct: 182 I-HHIDYYRKT----TNGRL-PVKWMAPEALFDRVYTHQSDVWSFGVLLWEI-------- 227

Query: 292 CMTLASNKKISMVPYFLNSIKNNGLRQIL-NFHVADESEMKEIEIVAELASKCLRIRGTE 350
             TL  +      PY    I    L ++L   +  ++ +    E+   L   C     ++
Sbjct: 228 -FTLGGS------PY--PGIPVEELFKLLKEGYRMEKPQNCTQELYH-LMRDCWHEVPSQ 277

Query: 351 RPTMKQVSEELDRL 364
           RPT KQ+ E+LDR+
Sbjct: 278 RPTFKQLVEDLDRM 291

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 68.3 bits (167), Expect = 6e-13
 Identities = 47/175 (26%), Positives = 84/175 (48%), Gaps = 17/175 (9%)

Query: 130 RELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLK------T 183
           R  L +  +++HKNVV++LGLC E E   ++ E+   G L   +R   S+  K      +
Sbjct: 56  RRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLS 115

Query: 184 WKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD-- 241
            K  + +  + A  +D+L +      +H D+ + N L++     KV    S + +S D  
Sbjct: 116 TKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKV----SLLSLSKDVY 168

Query: 242 -AETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMT 294
            +E       +    +L P  +     + KSDV+SFGV++ E+ T G+ P   ++
Sbjct: 169 NSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS 223

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 68.8 bits (168), Expect = 6e-13
 Identities = 66/257 (25%), Positives = 116/257 (45%), Gaps = 47/257 (18%)

Query: 127 ITERELLRIISQVNHKNVVKILGLCLETEVPLLV-YEFASNGTLLDHIRC---------- 175
           I+E EL+++I +  HKN++ +LG+C + E PL V  E+A+ G L + +R           
Sbjct: 65  ISEMELMKLIGK--HKNIINLLGVCTQ-EGPLYVIVEYAAKGNLREFLRARRPPGPDYTF 121

Query: 176 ---ESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADF 232
              +  +   ++K  +  A + A  ++Y   L S   IH D+ + N+L+ ++   K+ADF
Sbjct: 122 DITKVPEEQLSFKDLVSCAYQVARGMEY---LESRRCIHRDLAARNVLVTEDNVMKIADF 178

Query: 233 ---ESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKK 288
                   I    +T+   + +    ++ P  +     T +SDV+SFG+++ E+ T G  
Sbjct: 179 GLARGVHDIDYYKKTSNGRLPV---KWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGS 235

Query: 289 PGSCMTLASNKKISMVPY-FLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIR 347
           P              +P   L  +   G R     +   E  M        L  +C    
Sbjct: 236 P-----------YPGIPVEELFKLLREGHRMDKPSNCTHELYM--------LMRECWHAV 276

Query: 348 GTERPTMKQVSEELDRL 364
            T+RPT KQ+ E LD++
Sbjct: 277 PTQRPTFKQLVEALDKV 293

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 68.1 bits (166), Expect = 7e-13
 Identities = 59/210 (28%), Positives = 101/210 (48%), Gaps = 20/210 (9%)

Query: 89  FDRSRCLSQGGFVSVYKGVL-HDNIQVAVKTY---RRADKIRITERELLRIISQVNHKNV 144
           F +   + +G F  VYKG+       VA+K        D+I   ++E+  ++SQ +   +
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEI-TVLSQCDSPYI 64

Query: 145 VKILGLCLETEVPLLVYEFASNGTLLDHIR---CESSQVLKTWKTCLRIAAETASALDYL 201
            +  G  L+     ++ E+   G+ LD ++    E + +     T LR   E    LDYL
Sbjct: 65  TRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYI----ATILR---EILKGLDYL 117

Query: 202 HSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVC 261
           HS      IH D+K+AN+LL++    K+ADF  +  + +D +   +T  +GT  ++ P  
Sbjct: 118 HSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQL-TDTQIKRNT-FVGTPFWMAPEV 172

Query: 262 INTGKLTKKSDVYSFGVVLAELLTGKKPGS 291
           I       K+D++S G+   EL  G+ P S
Sbjct: 173 IKQSAYDFKADIWSLGITAIELAKGEPPNS 202

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 68.0 bits (166), Expect = 7e-13
 Identities = 53/179 (29%), Positives = 89/179 (49%), Gaps = 12/179 (6%)

Query: 113 QVAVKTYR---RADKIRITERELLRIISQVNHKNVVKILGLCLET--EVPLLVYEFASNG 167
           QVAVK+ +     + I   ++E+  I+  + H+N+VK  G+C E       L+ EF  +G
Sbjct: 35  QVAVKSLKPESGGNHIADLKKEI-EILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSG 93

Query: 168 TLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTA 227
           +L +++    +++    K  L+ A +    +DYL    S   +H D+ + N+L+   +  
Sbjct: 94  SLKEYLPRNKNKI--NLKQQLKYAVQICKGMDYL---GSRQYVHRDLAARNVLVESEHQV 148

Query: 228 KVADFESSVLISSDAET-AMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT 285
           K+ DF  +  I +D E   +   L     +  P C+   K    SDV+SFGV L ELLT
Sbjct: 149 KIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 68.2 bits (166), Expect = 8e-13
 Identities = 73/276 (26%), Positives = 126/276 (45%), Gaps = 38/276 (13%)

Query: 89  FDRSRCLSQGGFVSVYKGVLHDNIQV-AVKTY---RRADKIRITERELLRIISQVNHKNV 144
           F +   + +G F  V+KG+ +   +V A+K        D+I   ++E+  ++SQ +   V
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEI-TVLSQCDSPYV 64

Query: 145 VKILGLCLETEVPLLVYEFASNGTLLDHIR---CESSQVLKTWKTCLRIAAETASALDYL 201
            K  G  L+     ++ E+   G+ LD +     + +Q+     T LR   E    LDYL
Sbjct: 65  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQI----ATILR---EILKGLDYL 117

Query: 202 HSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVC 261
           HS      IH D+K+AN+LL+++   K+ADF  +  + +D +   +   +GT  ++ P  
Sbjct: 118 HSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQL-TDTQIKRN-TFVGTPFWMAPEV 172

Query: 262 INTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILN 321
           I       K+D++S G+   EL  G+ P S   L   K + ++P      KNN      N
Sbjct: 173 IKQSAYDSKADIWSLGITAIELAKGEPPHS--ELHPMKVLFLIP------KNNPPTLEGN 224

Query: 322 FHVADESEMKEIEIVAELASKCLRIRGTERPTMKQV 357
           +           + + E    CL    + RPT K++
Sbjct: 225 YS----------KPLKEFVEACLNKEPSFRPTAKEL 250

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 67.4 bits (165), Expect = 1e-12
 Identities = 51/205 (24%), Positives = 87/205 (42%), Gaps = 27/205 (13%)

Query: 95  LSQGGFVSVYKG--VLHDNIQVAVKTYRRADKIRITERELLRIIS---QVNHKNVVKILG 149
           + +G +  VYK    L   I VA+K  +   +     +  LR I    ++NH N++K+L 
Sbjct: 7   IGEGTYGVVYKARDKLTGEI-VAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65

Query: 150 LCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCL---RIAA---ETASALDYLHS 203
           +        LV+EF      +D       +++K  +  L    I +   +    L + HS
Sbjct: 66  VFRHKGDLYLVFEF------MDTDLY---KLIKDRQRGLPESLIKSYLYQLLQGLAFCHS 116

Query: 204 LASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCI- 262
                I+H D+K  N+L+N     K+ADF  +    S       T  + T  Y  P  + 
Sbjct: 117 HG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR--PYTHYVVTRWYRAPELLL 171

Query: 263 NTGKLTKKSDVYSFGVVLAELLTGK 287
                +   D++S G + AELL+ +
Sbjct: 172 GDKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 67.1 bits (164), Expect = 2e-12
 Identities = 54/210 (25%), Positives = 101/210 (48%), Gaps = 16/210 (7%)

Query: 89  FDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYR---RADKIRITERE--LLRIISQVNHK 142
           + R   + +G + +VY+G  +     VA+K        D +   +RE  LL  + Q    
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62

Query: 143 NVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLH 202
           N+ K  G  L+     ++ E+A  G++   ++   +  +      + I  E   AL Y+H
Sbjct: 63  NITKYYGSYLKGPRLWIIMEYAEGGSVRTLMK---AGPIAEKYISV-IIREVLVALKYIH 118

Query: 203 SLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCI 262
            +    +IH D+K+ANIL+ +    K+ DF  + L++ +  ++  +  +GT  ++ P  I
Sbjct: 119 KV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN--SSKRSTFVGTPYWMAPEVI 173

Query: 263 NTGKL-TKKSDVYSFGVVLAELLTGKKPGS 291
             GK    K+D++S G+ + E+ TG  P S
Sbjct: 174 TEGKYYDTKADIWSLGITIYEMATGNPPYS 203

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 67.4 bits (164), Expect = 2e-12
 Identities = 57/185 (30%), Positives = 86/185 (46%), Gaps = 16/185 (8%)

Query: 109 HDNIQVAVKTYRRADKIRITERELL----RIISQVNHKNVVKILGLCLETEVPLLVYEFA 164
           H   QVAVK     D  +   RELL     I+    H+NVV++    L  E   ++ EF 
Sbjct: 44  HSGRQVAVKM---MDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL 100

Query: 165 SNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDN 224
             G L D +    SQ     +    +      AL YLHS     +IH D+KS +ILL  +
Sbjct: 101 QGGALTDIV----SQTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLD 153

Query: 225 YTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELL 284
              K++DF     IS D     S  L+GT  ++ P  I+      + D++S G+++ E++
Sbjct: 154 GRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMV 211

Query: 285 TGKKP 289
            G+ P
Sbjct: 212 DGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 66.4 bits (162), Expect = 2e-12
 Identities = 61/231 (26%), Positives = 106/231 (45%), Gaps = 42/231 (18%)

Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITER--------------ELLRIISQVN 140
           L QG F  ++KG+  +     V  Y    K  +  +              E   ++SQ++
Sbjct: 3   LGQGTFTKIFKGIRRE-----VGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLS 57

Query: 141 HKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDY 200
           HK++V   G+C+  +  ++V E+   G+L  +++   + +  +WK  L +A + A AL +
Sbjct: 58  HKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWK--LEVAKQLAWALHF 115

Query: 201 LHSLASPPIIHGDVKSANILL---NDNYTA-----KVADFESSVLISSDAETAMSTILIG 252
           L       + HG+V + N+LL    D  T      K++D   S+ +          IL+ 
Sbjct: 116 LEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP------KEILLE 166

Query: 253 TSGYLDPVCI-NTGKLTKKSDVYSFGVVLAELLTG-KKPGSCMTLASNKKI 301
              ++ P CI N   L+  +D +SFG  L E+ +G  KP S   L S KK+
Sbjct: 167 RIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLS--ALDSQKKL 215

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 66.6 bits (162), Expect = 2e-12
 Identities = 63/229 (27%), Positives = 108/229 (47%), Gaps = 31/229 (13%)

Query: 74  MKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDN-----IQVAVKTYRRADKIRIT 128
           M+I  ++E+        + + L  G F +VYKG+   +     I VA+K  R     +  
Sbjct: 1   MRILKETEL-------KKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPK-A 52

Query: 129 ERELLR---IISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCE----SSQVL 181
            +E+L    +++ V    V ++LG+CL + V L V +    G LLD++R       SQ L
Sbjct: 53  NKEILDEAYVMAGVGSPYVCRLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDL 111

Query: 182 KTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD 241
             W  C++IA      + YL  +    ++H D+ + N+L+      K+ DF  + L+  D
Sbjct: 112 LNW--CVQIA----KGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162

Query: 242 AETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
                +        ++    I   + T +SDV+S+GV + EL+T G KP
Sbjct: 163 ETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKP 211

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 66.6 bits (162), Expect = 3e-12
 Identities = 57/188 (30%), Positives = 88/188 (46%), Gaps = 22/188 (11%)

Query: 109 HDNIQVAVKTYRRADKIRITERELL----RIISQVNHKNVVKILGLCLETEVPLLVYEFA 164
           H   QVAVK   + D  +   RELL     I+   +H+NVV +    L  +   +V EF 
Sbjct: 45  HTGKQVAVK---KMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL 101

Query: 165 SNGTLLD---HIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILL 221
             G L D   H R    Q+     + LR       AL YLH+     +IH D+KS +ILL
Sbjct: 102 EGGALTDIVTHTRMNEEQIATVCLSVLR-------ALSYLHNQG---VIHRDIKSDSILL 151

Query: 222 NDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLA 281
             +   K++DF     +S   E      L+GT  ++ P  I+      + D++S G+++ 
Sbjct: 152 TSDGRIKLSDFGFCAQVSK--EVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVI 209

Query: 282 ELLTGKKP 289
           E++ G+ P
Sbjct: 210 EMIDGEPP 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 66.2 bits (161), Expect = 4e-12
 Identities = 58/220 (26%), Positives = 109/220 (49%), Gaps = 31/220 (14%)

Query: 95  LSQGGFVSVYKGVLH----DNIQ-VAVKT---YRRADKIRITERELLRIISQVNHKNVVK 146
           L +  F  +YKG L+    D+ Q VA+KT        +    ++E   ++++++H N+V 
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEA-SLMAELHHPNIVC 71

Query: 147 ILGLCLETEVPLLVYEFASNGTLLD---------HIRCESSQVLKTWKTCL------RIA 191
           +LG+  + +   +++E+ + G L +          + C S +   T K+ L       IA
Sbjct: 72  LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDED-GTVKSSLDHGDFLHIA 130

Query: 192 AETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFE-SSVLISSDAETAMSTIL 250
            + A+ ++YL   +S   +H D+ + NIL+ +    K++D   S  + S+D        L
Sbjct: 131 IQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187

Query: 251 IGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
           +    ++ P  I  GK +  SD++SFGVVL E+ + G +P
Sbjct: 188 LPIR-WMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 65.3 bits (160), Expect = 7e-12
 Identities = 57/213 (26%), Positives = 92/213 (43%), Gaps = 26/213 (12%)

Query: 87  KNFDRSRCLSQGGFVSVYKGVLHDNIQ--VAVKTYRRADKIRI-----TERELLRIISQV 139
            +F+  + L  G F  V   V H       A+K   +A  +++        E  RI+  +
Sbjct: 1   DDFEFIKTLGTGSFGRV-MLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEK-RILQSI 58

Query: 140 NHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIR---CESSQVLKTWKTCLRIAAETAS 196
            H  +V + G   +     LV E+   G L  H+R        V + +      AA+   
Sbjct: 59  RHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFY------AAQVVL 112

Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
           AL+YLHSL    I++ D+K  N+LL+ +   K+ DF  +  +     T     L GT  Y
Sbjct: 113 ALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYT-----LCGTPEY 164

Query: 257 LDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           L P  I +    K  D ++ G+++ E+L G  P
Sbjct: 165 LAPEIILSKGYGKAVDWWALGILIYEMLAGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 64.8 bits (159), Expect = 8e-12
 Identities = 55/232 (23%), Positives = 88/232 (37%), Gaps = 69/232 (29%)

Query: 89  FDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRI----------TERELLRIIS 137
           +++   L +G +  VYK         VA+K      KIR+            RE+  ++ 
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALK------KIRLDNEEEGIPSTALREI-SLLK 53

Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASN--GTLLDH---------IRCESSQVLKTWKT 186
           ++ H N+VK+L +        LV+E+        LD          I+    Q+L     
Sbjct: 54  ELKHPNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLL----- 108

Query: 187 CLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAM 246
                      L Y HS     I+H D+K  NIL+N +   K+ADF  +           
Sbjct: 109 ---------RGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGI-PLRTY 155

Query: 247 ST-----------ILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGK 287
           +            IL+G+  Y   V           D++S G + AE++TGK
Sbjct: 156 THEVVTLWYRAPEILLGSKHYSTAV-----------DIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 64.9 bits (158), Expect = 9e-12
 Identities = 50/185 (27%), Positives = 84/185 (45%), Gaps = 28/185 (15%)

Query: 114 VAVKTYRRADKIRITE--RELLRIISQVNHKNVVKILGLCLET--EVPLLVYEFASNGTL 169
           VAVKT +R    + T   ++ + I+  + H+N+VK  G C E   +   L+ E+   G+L
Sbjct: 36  VAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSL 95

Query: 170 LDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKV 229
            D++      + +     L  A +    + YLHS      IH D+ + N+LL+++   K+
Sbjct: 96  RDYLPKHKLNLAQL----LLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKI 148

Query: 230 ADF---------ESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVL 280
            DF              +  D ++ +         +    C+   K +  SDV+SFGV L
Sbjct: 149 GDFGLAKAVPEGHEYYRVREDGDSPVF--------WYAVECLKENKFSYASDVWSFGVTL 200

Query: 281 AELLT 285
            ELLT
Sbjct: 201 YELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 64.8 bits (158), Expect = 1e-11
 Identities = 44/106 (41%), Positives = 58/106 (54%), Gaps = 11/106 (10%)

Query: 189 RIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFE-SSVLISSDAETAMS 247
           +IA     AL+YLHS  S  +IH DVK +N+L+N N   K+ DF  S  L+ S A+    
Sbjct: 107 KIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK---- 160

Query: 248 TILIGTSGYLDPVCINTGKLTK----KSDVYSFGVVLAELLTGKKP 289
           TI  G   Y+ P  IN     K    KSDV+S G+ + EL TG+ P
Sbjct: 161 TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFP 206

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 64.1 bits (156), Expect = 2e-11
 Identities = 51/201 (25%), Positives = 90/201 (44%), Gaps = 12/201 (5%)

Query: 95  LSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRITE-RELLRIISQVNHKNVVKILGLCL 152
           L +G +  VY    L   +++A+K     D   +    E + + S + H+N+V+ LG   
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75

Query: 153 ETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHG 212
           E     +  E    G+L   +R +   +    +T +    +    L YLH      I+H 
Sbjct: 76  ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHR 132

Query: 213 DVKSANILLNDNYTA--KVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGK--LT 268
           D+K  N+L+N  Y+   K++DF +S  ++       +    GT  Y+ P  I+ G     
Sbjct: 133 DIKGDNVLVN-TYSGVVKISDFGTSKRLA--GINPCTETFTGTLQYMAPEVIDKGPRGYG 189

Query: 269 KKSDVYSFGVVLAELLTGKKP 289
             +D++S G  + E+ TGK P
Sbjct: 190 APADIWSLGCTIVEMATGKPP 210

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 63.6 bits (155), Expect = 3e-11
 Identities = 58/224 (25%), Positives = 101/224 (45%), Gaps = 38/224 (16%)

Query: 91  RSRCLSQ-GGFVSVYKGVLHDNI-----QVAVKTYR-RADKIRI----TERELLRIISQV 139
               L Q G F  ++ G+L D       +V VKT +  A +I++     E  LL     +
Sbjct: 9   TLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLY---GL 65

Query: 140 NHKNVVKILGLCLE-TEVPLLVYEFASNGTL------LDHIRCESSQVLKTWKTCLRIAA 192
           +H+N++ IL +C+E  E P ++Y + + G L             + Q L T +  + +A 
Sbjct: 66  SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQL-VHMAI 124

Query: 193 ETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFE-SSVLISSDAETAMSTILI 251
           + A  + YLH      +IH D+ + N ++++    K+ D   S  L   D         +
Sbjct: 125 QIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHC------L 175

Query: 252 GTSGY-----LDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
           G +       +    +   + +  SDV+SFGV+L EL+T G+ P
Sbjct: 176 GDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTP 219

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 63.5 bits (155), Expect = 3e-11
 Identities = 60/223 (26%), Positives = 98/223 (43%), Gaps = 29/223 (13%)

Query: 84  RATKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYR---RADKIRITERELLRIISQV 139
           R+   F++   + +G +  VY+         VA+K  R     D I I+    + ++  +
Sbjct: 4   RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNL 63

Query: 140 NHKNVVKIL----GLCLETEVPLLVYEFASN--GTLLDHIRC--ESSQVLKTWKTCLRIA 191
            H N+V++     G  L++    LV E+      +LLD++      SQV      CL + 
Sbjct: 64  RHPNIVELKEVVVGKHLDS--IFLVMEYCEQDLASLLDNMPTPFSESQV-----KCLML- 115

Query: 192 AETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILI 251
            +    L YLH      IIH D+K +N+LL D    K+ADF  +      A+     ++ 
Sbjct: 116 -QLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV- 170

Query: 252 GTSGYLDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PGS 291
            T  Y  P + +     T   D+++ G +LAELL  K   PG 
Sbjct: 171 -TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGK 212

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 63.0 bits (154), Expect = 4e-11
 Identities = 58/220 (26%), Positives = 96/220 (43%), Gaps = 58/220 (26%)

Query: 95  LSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRI----------TERE--LLRIISQVNH 141
           + +G + +VYK   L+    VA+K      K+R+          T RE  LL+ +    H
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALK------KVRVPLSEEGIPLSTLREIALLKQLESFEH 60

Query: 142 KNVVKILGLC----LETEVPL-LVYEFASN--GTLLDHIRCESSQVLKTWKTCLRIAAET 194
            N+V++L +C     + E+ L LV+E       T L   +C     L        +  + 
Sbjct: 61  PNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLS--KCPKP-GLPPETI-KDLMRQL 116

Query: 195 ASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMST------ 248
              +D+LHS     I+H D+K  NIL+  +   K+ADF  + + S   E A+++      
Sbjct: 117 LRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSF--EMALTSVVVTLW 171

Query: 249 -----ILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAEL 283
                +L+ +S Y  PV           D++S G + AEL
Sbjct: 172 YRAPEVLLQSS-YATPV-----------DMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 62.6 bits (152), Expect = 4e-11
 Identities = 55/216 (25%), Positives = 101/216 (46%), Gaps = 33/216 (15%)

Query: 95  LSQGGFVSVYKGV-LHDNIQVAVKTY-----------RRADKIRITERELLRIISQVNHK 142
           +  G F SVY G+       +AVK             R+   +    RE+  ++ ++ H+
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREI-ALLKELQHE 66

Query: 143 NVVKILGLCLETEVPLLVYEFASNG---TLLDHIRCESSQVLKTWKTCLRIAAETASALD 199
           N+V+ LG  L+ +   +  E+   G    LL++       +++ +        +    L+
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNF------VRQILKGLN 120

Query: 200 YLHSLASPPIIHGDVKSANILLNDNYTAKVADF------ESSVLISSDAETAMSTILIGT 253
           YLH+     IIH D+K ANIL+++    K++DF      E++ L +       S  L G+
Sbjct: 121 YLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPS--LQGS 175

Query: 254 SGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
             ++ P  +     T+K+D++S G ++ E+LTGK P
Sbjct: 176 VFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 63.2 bits (153), Expect = 4e-11
 Identities = 54/209 (25%), Positives = 101/209 (48%), Gaps = 19/209 (9%)

Query: 87  KNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVK--TYRRADKIRITERELLRIISQVNHKN 143
           K + R   + QG   +VY  + +    +VA+K    ++  K  +   E+L ++ +  + N
Sbjct: 19  KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEIL-VMRENKNPN 77

Query: 144 VVKILGLCLETEVPLLVYEFASNGTLLDHIR---CESSQVLKTWKTCLRIAAETASALDY 200
           +V  L   L  +   +V E+ + G+L D +     +  Q+    + CL+       ALD+
Sbjct: 78  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ-------ALDF 130

Query: 201 LHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV 260
           LHS     +IH D+KS NILL  + + K+ DF     I+   E +  + ++GT  ++ P 
Sbjct: 131 LHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMVGTPYWMAPE 185

Query: 261 CINTGKLTKKSDVYSFGVVLAELLTGKKP 289
            +       K D++S G++  E++ G+ P
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 62.6 bits (152), Expect = 5e-11
 Identities = 57/212 (26%), Positives = 101/212 (47%), Gaps = 25/212 (11%)

Query: 87  KNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRAD--KIRITERELLRIISQVNHKN 143
           K + R   + QG   +VY  + +    +VA+K        K  +   E+L ++ +  H N
Sbjct: 19  KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEIL-VMRENKHPN 77

Query: 144 VVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCL---RIAA---ETASA 197
           +V  L   L  +   +V E+ + G+L D +           +TC+   +IAA   E   A
Sbjct: 78  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVT----------ETCMDEGQIAAVCRECLQA 127

Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYL 257
           L++LHS     +IH D+KS NILL  + + K+ DF     I+   E +  + ++GT  ++
Sbjct: 128 LEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMVGTPYWM 182

Query: 258 DPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
            P  +       K D++S G++  E++ G+ P
Sbjct: 183 APEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 62.5 bits (152), Expect = 6e-11
 Identities = 52/209 (24%), Positives = 95/209 (45%), Gaps = 20/209 (9%)

Query: 88  NFDRSRCLSQGGFVSVYKGVLHDNIQ---VAVKTYRRADKIRITERELL----RIISQVN 140
           + +R + +  G F  V+   + D I     A+K     + IR+ + + +    R++ +V+
Sbjct: 2   DLERIKTVGTGTFGRVHL--VRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS 59

Query: 141 HKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDY 200
           H  ++++     +     ++ E+   G L  ++R        +  T L  A+E   AL+Y
Sbjct: 60  HPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGR---FSNSTGLFYASEIVCALEY 116

Query: 201 LHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV 260
           LHS     I++ D+K  NILL+     K+ DF  +  +     T     L GT  YL P 
Sbjct: 117 LHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWT-----LCGTPEYLAPE 168

Query: 261 CINTGKLTKKSDVYSFGVVLAELLTGKKP 289
            I +    K  D ++ G+++ E+L G  P
Sbjct: 169 VIQSKGHNKAVDWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 61.9 bits (150), Expect = 7e-11
 Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 15/209 (7%)

Query: 88  NFDRSRCLSQGGFVSVY--KGVLHDNIQVAVKTYRRADKIRITERELLR----IISQVNH 141
            ++  + + +G F  +Y  K    D+    +K      K+ + E+E  +    +++++ H
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKS-DSEHCVIKEID-LTKMPVKEKEASKKEVILLAKMKH 58

Query: 142 KNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYL 201
            N+V       E     +V E+   G L+  I  +   VL +    L    + +  L ++
Sbjct: 59  PNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRG-VLFSEDQILSWFVQISLGLKHI 117

Query: 202 HSLASPPIIHGDVKSANILLNDN-YTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV 260
           H      I+H D+KS NI L+ N   AK+ DF  +  ++   E A + +  GT  YL P 
Sbjct: 118 HDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCV--GTPYYLSPE 172

Query: 261 CINTGKLTKKSDVYSFGVVLAELLTGKKP 289
                    K+D++S G VL EL T K P
Sbjct: 173 ICQNRPYNNKTDIWSLGCVLYELCTLKHP 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 62.3 bits (151), Expect = 8e-11
 Identities = 54/183 (29%), Positives = 85/183 (46%), Gaps = 22/183 (12%)

Query: 114 VAVKTYRRADKIRITERELL----RIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTL 169
           VAVK   + D  +   RELL     I+    H+NVV++    L  +   +V EF   G L
Sbjct: 48  VAVK---KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104

Query: 170 LD---HIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYT 226
            D   H R    Q          IAA   + L  L  L +  +IH D+KS +ILL  +  
Sbjct: 105 TDIVTHTRMNEEQ----------IAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGR 154

Query: 227 AKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTG 286
            K++DF     +S +     S  L+GT  ++ P  I+      + D++S G+++ E++ G
Sbjct: 155 VKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 212

Query: 287 KKP 289
           + P
Sbjct: 213 EPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 61.8 bits (150), Expect = 9e-11
 Identities = 58/214 (27%), Positives = 86/214 (40%), Gaps = 35/214 (16%)

Query: 95  LSQGGFVSVYKGVLHDNI---QVAVKTYRRADKIR-----ITERELLRIISQVNHKNVVK 146
           +  G F  V  G  H  +   +V VK  R +         + E +  R    +NH NV++
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRE---LNHPNVLQ 59

Query: 147 ILGLCLETEVPLLVYEFASNGTLLDHIRCESSQV--LKTWKTCLRIAAETASALDYLHSL 204
            LG C+E+   LLV EF   G L +++R     V  +       R+A E AS L +LH  
Sbjct: 60  CLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA 119

Query: 205 ASPPIIHGDVKSANILLNDNYTAKVAD-------FESSVLISSDAE------TAMSTILI 251
                IH D+   N  L  + + K+ D       +     I+ D         A   + I
Sbjct: 120 D---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEI 176

Query: 252 GTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT 285
                L          TKKS+++S GV + EL T
Sbjct: 177 RGQDLL------PKDQTKKSNIWSLGVTMWELFT 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 63.0 bits (153), Expect = 9e-11
 Identities = 34/89 (38%), Positives = 50/89 (56%)

Query: 201 LHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV 260
           +H + S  +IH D+KSANILL  N   K+ DF  S + ++     +     GT  Y+ P 
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE 215

Query: 261 CINTGKLTKKSDVYSFGVVLAELLTGKKP 289
                  +KK+D++S GV+L ELLT K+P
Sbjct: 216 IWRRKPYSKKADMFSLGVLLYELLTLKRP 244

Length = 496

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 62.0 bits (150), Expect = 1e-10
 Identities = 58/222 (26%), Positives = 105/222 (47%), Gaps = 35/222 (15%)

Query: 95  LSQGGFVSVYKGVL------HDNIQVAVKTYRRADKIRITERELLR----IISQVNHKNV 144
           L +  F  VYKG L           VA+KT +  DK     RE  +    + S++ H N+
Sbjct: 13  LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLK--DKAEGPLREEFKHEAMMRSRLQHPNI 70

Query: 145 VKILGLCLETEVPLLVYEFASNGTLLD-------HIRCESSQVLKTWKTCLR------IA 191
           V +LG+  + +   +++ + S+  L +       H    S+   KT K+ L       I 
Sbjct: 71  VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130

Query: 192 AETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVAD---FESSVLISSDAETAMST 248
            + A+ +++L   +S  ++H D+ + N+L+ D    K++D   F    + ++D    M  
Sbjct: 131 TQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFRE--VYAADYYKLMGN 185

Query: 249 ILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
            L+    ++ P  I  GK +  SD++S+GVVL E+ + G +P
Sbjct: 186 SLLPIR-WMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 61.3 bits (149), Expect = 1e-10
 Identities = 56/208 (26%), Positives = 84/208 (40%), Gaps = 32/208 (15%)

Query: 95  LSQGGFVSVY---KGVLHDNIQVAVKTYRRADKI---RITERELLRII--SQVNHKNVVK 146
           +S+G F SVY   K    D    A+K  +++D I   ++T  +  R I   Q     V K
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYF--AIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAK 61

Query: 147 ILGLCLETEVPLLVYEFASNG---TLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHS 203
           +       +   LV E+ + G   +L+  +        K +       AE    ++ LH 
Sbjct: 62  LYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQY------IAEVVLGVEDLHQ 115

Query: 204 LASPPIIHGDVKSANILLNDNYTAKVADFESS--VLISSDAETAMSTILIGTSGYLDPVC 261
                IIH D+K  N+L++     K+ DF  S   L +           +GT  YL P  
Sbjct: 116 RG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK--------FVGTPDYLAPET 164

Query: 262 INTGKLTKKSDVYSFGVVLAELLTGKKP 289
           I      K SD +S G V+ E L G  P
Sbjct: 165 ILGVGDDKMSDWWSLGCVIFEFLFGYPP 192

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 61.5 bits (149), Expect = 1e-10
 Identities = 53/206 (25%), Positives = 93/206 (45%), Gaps = 17/206 (8%)

Query: 93  RCLSQGGFVSVYKGVLH----DNIQVAVKTYRR--ADKIRITERELLRIISQVNHKNVVK 146
           R L  G F  + +G L       + VA+ T R   +DK R         + Q +H N+V+
Sbjct: 11  RILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVR 70

Query: 147 ILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLAS 206
           + G+       ++V E+ SNG L   +R    Q+       + +    AS + YL  +  
Sbjct: 71  LEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQL--VAGQLMGMLPGLASGMKYLSEMG- 127

Query: 207 PPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYL--DPVCINT 264
              +H  + +  +L+N +   K++ F     +  D   A+ T + G S  L   P  I  
Sbjct: 128 --YVHKGLAAHKVLVNSDLVCKISGFRR---LQEDKSEAIYTTMSGKSPVLWAAPEAIQY 182

Query: 265 GKLTKKSDVYSFGVVLAELLT-GKKP 289
              +  SDV+SFG+V+ E+++ G++P
Sbjct: 183 HHFSSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 60/207 (28%), Positives = 94/207 (45%), Gaps = 28/207 (13%)

Query: 95  LSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRITER-----ELLRIISQVNHKNVVKIL 148
           +  G F +VY     H N  VAVK    + K +  E+     + ++ + Q+ H N ++  
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGK-QTNEKWQDIIKEVKFLQQLKHPNTIEYK 87

Query: 149 GLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLR---IAAETASALDYLHSLA 205
           G  L+     LV E+             +S +L+  K  L+   IAA T  AL  L  L 
Sbjct: 88  GCYLKEHTAWLVMEYCLG---------SASDLLEVHKKPLQEVEIAAITHGALQGLAYLH 138

Query: 206 SPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDP---VCI 262
           S  +IH D+K+ NILL +    K+ADF S+   S       +   +GT  ++ P   + +
Sbjct: 139 SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP------ANSFVGTPYWMAPEVILAM 192

Query: 263 NTGKLTKKSDVYSFGVVLAELLTGKKP 289
           + G+   K DV+S G+   EL   K P
Sbjct: 193 DEGQYDGKVDVWSLGITCIELAERKPP 219

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 57/203 (28%), Positives = 89/203 (43%), Gaps = 19/203 (9%)

Query: 95  LSQGGFVSVYKGV-LHDNIQVAVKTYR--RADKIRITERELLRIISQVNHKNVVKILGLC 151
           +  G +  VYK   LH     AVK  +    D   + ++E+  ++ +  H N+V   G  
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIF-MVKECKHCNIVAYFGSY 75

Query: 152 LETEVPLLVYEFASNGTLLD--HIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPI 209
           L  E   +  E+   G+L D  H+    S++   +     +  ET   L YLHS      
Sbjct: 76  LSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAY-----VCRETLQGLAYLHSKGK--- 127

Query: 210 IHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDP---VCINTGK 266
           +H D+K ANILL DN   K+ADF  +  I+  A  A     IGT  ++ P        G 
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVAAKIT--ATIAKRKSFIGTPYWMAPEVAAVEKNGG 185

Query: 267 LTKKSDVYSFGVVLAELLTGKKP 289
             +  D+++ G+   EL   + P
Sbjct: 186 YNQLCDIWAVGITAIELAELQPP 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 60.9 bits (148), Expect = 2e-10
 Identities = 68/266 (25%), Positives = 122/266 (45%), Gaps = 44/266 (16%)

Query: 114 VAVKTY--RRADKI--RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTL 169
           VA+K +     DK+  +I  RE+ R++ Q+ H+N+V ++ +    +   LV+EF  + T+
Sbjct: 29  VAIKKFLESEDDKMVKKIAMREI-RMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDH-TV 86

Query: 170 LDHIR-----CESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDN 224
           LD +       + S+V K     LR        +++ HS     IIH D+K  NIL++ +
Sbjct: 87  LDDLEKYPNGLDESRVRKYLFQILR-------GIEFCHS---HNIIHRDIKPENILVSQS 136

Query: 225 YTAKVADFESSVLISSDAETAMSTILIGTSGYLDP-VCINTGKLTKKSDVYSFGVVLAEL 283
              K+ DF  +  +++  E  + T  + T  Y  P + +   K  +  D+++ G ++ E+
Sbjct: 137 GVVKLCDFGFARTLAAPGE--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEM 194

Query: 284 LTGKK--PGSC--------MTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEM--- 330
           LTG+   PG          +    N    ++P      + N L   +      E E    
Sbjct: 195 LTGEPLFPGDSDIDQLYHIIKCLGN----LIPRHQEIFQKNPLFAGMRLPEVKEIEPLEK 250

Query: 331 ---KEIEIVAELASKCLRIRGTERPT 353
              K   +V +LA +CLRI   +RP+
Sbjct: 251 RFPKLSGLVLDLAKQCLRIDPDDRPS 276

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 60.6 bits (147), Expect = 2e-10
 Identities = 41/168 (24%), Positives = 82/168 (48%), Gaps = 24/168 (14%)

Query: 136 ISQVNHKNVVKILGLCLETEVPLLVY-EFASNGTLLDHIRCES---SQVLKTWKTCLRIA 191
           +  ++H N+V+ LG    TE  L ++ E+   G++   +R       Q+++ +       
Sbjct: 62  LKDLDHLNIVQYLG-FETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTE----- 115

Query: 192 AETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADF----ESSVLISSDAETAMS 247
            +    L YLHS     I+H D+K+ N+L++ +   K++DF    +S  +  +D   +M 
Sbjct: 116 -QVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ 171

Query: 248 TILIGTSGYLDPVCINTGK--LTKKSDVYSFGVVLAELLTGKKPGSCM 293
               G+  ++ P  I++     + K D++S G V+ E+  G++P S  
Sbjct: 172 ----GSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE 215

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 60.5 bits (146), Expect = 3e-10
 Identities = 47/209 (22%), Positives = 99/209 (47%), Gaps = 19/209 (9%)

Query: 87  KNFDRSRCLSQGGFVSVYKGV---LHDNIQVAVKTYRRADKIRITERELLRIISQVNHKN 143
           K + R   + QG   +V+  +       + +     ++  K  +   E+L ++ ++ + N
Sbjct: 19  KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEIL-VMKELKNPN 77

Query: 144 VVKILGLCLETEVPLLVYEFASNGTLLDHIR---CESSQVLKTWKTCLRIAAETASALDY 200
           +V  L   L  +   +V E+ + G+L D +     + +Q+    + CL+       AL++
Sbjct: 78  IVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQ-------ALEF 130

Query: 201 LHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV 260
           LH+     +IH D+KS N+LL  + + K+ DF     I+   E +  + ++GT  ++ P 
Sbjct: 131 LHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP--EQSKRSTMVGTPYWMAPE 185

Query: 261 CINTGKLTKKSDVYSFGVVLAELLTGKKP 289
            +       K D++S G++  E++ G+ P
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 60.9 bits (147), Expect = 3e-10
 Identities = 61/217 (28%), Positives = 97/217 (44%), Gaps = 32/217 (14%)

Query: 87  KNFDRSRCLSQGGFVSVYKGVLHD---NIQVAVKTYRRADKIRITER-----ELLRIISQ 138
           K F   R +  G F +VY     D   N  VA+K    + K +  E+     + ++ + +
Sbjct: 25  KLFTDLREIGHGSFGAVY--FARDVRTNEVVAIKKMSYSGK-QSNEKWQDIIKEVKFLQR 81

Query: 139 VNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLR---IAAETA 195
           + H N ++  G  L      LV E+             +S +L+  K  L+   IAA T 
Sbjct: 82  IKHPNSIEYKGCYLREHTAWLVMEYCLG---------SASDLLEVHKKPLQEVEIAAITH 132

Query: 196 SALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG 255
            AL  L  L S  +IH D+K+ NILL +    K+ADF S+ + S       +   +GT  
Sbjct: 133 GALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP------ANSFVGTPY 186

Query: 256 YLDP---VCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           ++ P   + ++ G+   K DV+S G+   EL   K P
Sbjct: 187 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 223

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 60.0 bits (145), Expect = 3e-10
 Identities = 45/163 (27%), Positives = 77/163 (47%), Gaps = 8/163 (4%)

Query: 128 TERELLRIISQVNHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKT 186
             R+   +++++ H N+V       E +  L +V E+   G L+  I+ +  + L    T
Sbjct: 44  DSRKEAVLLAKMKHPNIVA-FKESFEADGHLYIVMEYCDGGDLMQKIKLQRGK-LFPEDT 101

Query: 187 CLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAM 246
            L+   +    + ++H      ++H D+KS NI L  N   K+ DF S+ L++S    A 
Sbjct: 102 ILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG--AY 156

Query: 247 STILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           +   +GT  Y+ P          KSD++S G +L EL T K P
Sbjct: 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 60.5 bits (147), Expect = 3e-10
 Identities = 37/109 (33%), Positives = 55/109 (50%), Gaps = 17/109 (15%)

Query: 189 RIAAETASALDYL---HSLASPPIIHGDVKSANILLNDNYTAKVADFE-SSVLISSDAET 244
           ++      AL YL   H      +IH DVK +NILL+ +   K+ DF  S  L+ S A+T
Sbjct: 118 KMTVAIVKALHYLKEKHG-----VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKT 172

Query: 245 AMSTILIGTSGYLDPVCIN----TGKLTKKSDVYSFGVVLAELLTGKKP 289
             +    G + Y+ P  I+      K   ++DV+S G+ L EL TG+ P
Sbjct: 173 RSA----GCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 60.6 bits (148), Expect = 3e-10
 Identities = 56/227 (24%), Positives = 90/227 (39%), Gaps = 64/227 (28%)

Query: 95  LSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRI----TERELLRIISQVNHKNVVKILG 149
           +  G +  V   V      +VA+K         I      RE+ +++  + H+N++ +L 
Sbjct: 8   IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREI-KLLRHLRHENIIGLLD 66

Query: 150 LCLETEVPL------LVYEFA---------SNGTL-LDHIRCESSQVLKTWKTCLRIAAE 193
           + L    P       +V E           S   L  DHI+    Q+L+           
Sbjct: 67  I-LRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILR----------- 114

Query: 194 TASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADF--ESSVLISSDAETAMS---- 247
               L YLHS A+  +IH D+K +NIL+N N   K+ DF     V    D +  ++    
Sbjct: 115 ---GLKYLHS-AN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV 168

Query: 248 T-------ILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGK 287
           T       +L+ +S Y   +           D++S G + AELLT K
Sbjct: 169 TRWYRAPELLLSSSRYTKAI-----------DIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 59.7 bits (145), Expect = 5e-10
 Identities = 41/104 (39%), Positives = 54/104 (51%), Gaps = 10/104 (9%)

Query: 190 IAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFE-SSVLISSDAETAMST 248
           IA  T  AL+YL       IIH DVK +NILL+ N   K+ DF  S  L+ S A+T  + 
Sbjct: 112 IAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDA- 168

Query: 249 ILIGTSGYLDPVCINTGKLTK---KSDVYSFGVVLAELLTGKKP 289
              G   Y+ P  I+         +SDV+S G+ L E+ TGK P
Sbjct: 169 ---GCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 59.8 bits (145), Expect = 6e-10
 Identities = 42/174 (24%), Positives = 72/174 (41%), Gaps = 33/174 (18%)

Query: 209 IIHGDVKSANILLNDNYTAKVADFE-SSVLISSDAETAMSTILIGTSGYLDPVCINTGKL 267
           I+H DVK +NIL+N     K+ DF  S  LI S     M+   +GT  Y+ P  +     
Sbjct: 121 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTHY 175

Query: 268 TKKSDVYSFGVVLAELLTGKKPGSCMTLASNKK--ISMVPYFLNSIKNNGLRQILNFHVA 325
           T +SD++S G+ L E+  G+ P        + K   +M    ++  +     + ++ H  
Sbjct: 176 TVQSDIWSLGLSLVEMAIGRYP----IPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPP 231

Query: 326 DESE-MKEIEIVA--------------------ELASKCLRIRGTERPTMKQVS 358
           D    M   E++                     +   KCL+    ER  +K+++
Sbjct: 232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELT 285

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 59.1 bits (143), Expect = 6e-10
 Identities = 53/216 (24%), Positives = 98/216 (45%), Gaps = 23/216 (10%)

Query: 88  NFDRSRCLSQGGFVSVYK------GVLHDNIQVAVKTYRRADKIRITE--RELLRIISQV 139
            + + + L  G F S Y+      G L    QV       +++  + E  R+ +R+++++
Sbjct: 1   EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60

Query: 140 NHKNVVKILGLCLETEVPLLVYEFASNG---TLLDHIRCESSQVLKTWKTCLRIAAETAS 196
           NH +++++LG   E     L  E+ + G    LL         V+  +    ++      
Sbjct: 61  NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINY--TEQLL----R 114

Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDN-YTAKVADFESSVLISSDAETA--MSTILIGT 253
            L YLH      IIH DVK AN+L++      ++ADF ++  +++    A      L+GT
Sbjct: 115 GLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGT 171

Query: 254 SGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
             ++ P  +   +  +  DV+S G V+ E+ T K P
Sbjct: 172 IAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 59.8 bits (145), Expect = 6e-10
 Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 33/228 (14%)

Query: 78  SKSEMIRATKNF---DRSRCLSQGGFVSVYKGVLHDN------IQVAVKTYRRADKIRIT 128
           +      A K+    +R   +  G   +VYK V+H        ++V    +    + +I 
Sbjct: 62  ASGSAPSAAKSLSELERVNRIGSGAGGTVYK-VIHRPTGRLYALKVIYGNHEDTVRRQIC 120

Query: 129 -ERELLRIISQVNHKNVVKILGLCLET-EVPLLVYEFASNGTLLDHIRCESSQVLKTWKT 186
            E E+LR    VNH NVVK   +     E+ +L+ EF   G+L +       Q L     
Sbjct: 121 REIEILR---DVNHPNVVKCHDMFDHNGEIQVLL-EFMDGGSL-EGTHIADEQFLAD--- 172

Query: 187 CLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAM 246
              +A +  S + YLH      I+H D+K +N+L+N     K+ADF  S +++   +   
Sbjct: 173 ---VARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCN 226

Query: 247 STILIGTSGYLDPVCINT----GKLTKKS-DVYSFGVVLAELLTGKKP 289
           S+  +GT  Y+ P  INT    G     + D++S GV + E   G+ P
Sbjct: 227 SS--VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272

Length = 353

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 58.9 bits (142), Expect = 7e-10
 Identities = 53/215 (24%), Positives = 101/215 (46%), Gaps = 22/215 (10%)

Query: 88  NFDRSRCLSQGGFVSVY--------KGVLHDNIQVAVKTYRRADKIRITERELLRIISQV 139
           N+ R + L QG F  VY        + +    +Q   ++   + ++   E E+ +++  +
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEI-QLLKNL 61

Query: 140 NHKNVVKILGLCLE--TEVPLLVY-EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETAS 196
            H+ +V+  G CL    E  L ++ E+   G++ D ++   +    T     +   +   
Sbjct: 62  QHERIVQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGAL---TESVTRKYTRQILE 117

Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISS--DAETAMSTILIGTS 254
            + YLHS     I+H D+K ANIL +     K+ DF +S  + +   + T + ++  GT 
Sbjct: 118 GMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSV-TGTP 173

Query: 255 GYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
            ++ P  I+     +K+DV+S G  + E+LT K P
Sbjct: 174 YWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 59.2 bits (143), Expect = 7e-10
 Identities = 79/295 (26%), Positives = 129/295 (43%), Gaps = 40/295 (13%)

Query: 89  FDRSRCLSQGGFVSVYKGVL--HDN--IQVAVKTYRRADKIRITE-RELLR---IISQVN 140
           F   R L +G F SV +  L   D    +VAVK  + AD    ++  E LR    + + +
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLK-ADIFSSSDIEEFLREAACMKEFD 59

Query: 141 HKNVVKILGLCLETE------VPLLVYEFASNG---TLLDHIRCESSQVLKTWKTCLRIA 191
           H NV+K++G+ L +       +P+++  F  +G   T L   R          +T +R  
Sbjct: 60  HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119

Query: 192 AETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILI 251
            + AS ++YL   +S   IH D+ + N +LN+N T  VADF  S  I S           
Sbjct: 120 IDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASK 176

Query: 252 GTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNS 310
               +L    +     T  SDV++FGV + E++T G+ P      A  +   +  Y    
Sbjct: 177 LPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP-----YAGVENSEIYNYL--- 228

Query: 311 IKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLR 365
           IK N L+Q  +           +E V EL  +C       RP+ + + ++L+ + 
Sbjct: 229 IKGNRLKQPPDC----------LEDVYELMCQCWSPEPKCRPSFQHLRDQLELIW 273

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 59.4 bits (143), Expect = 8e-10
 Identities = 52/209 (24%), Positives = 101/209 (48%), Gaps = 19/209 (9%)

Query: 87  KNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVK--TYRRADKIRITERELLRIISQVNHKN 143
           K + R   + QG   +VY  + +    +VA++    ++  K  +   E+L ++ +  + N
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEIL-VMRENKNPN 78

Query: 144 VVKILGLCLETEVPLLVYEFASNGTLLDHIR---CESSQVLKTWKTCLRIAAETASALDY 200
           +V  L   L  +   +V E+ + G+L D +     +  Q+    + CL+       AL++
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ-------ALEF 131

Query: 201 LHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV 260
           LHS     +IH D+KS NILL  + + K+ DF     I+   E +  + ++GT  ++ P 
Sbjct: 132 LHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMVGTPYWMAPE 186

Query: 261 CINTGKLTKKSDVYSFGVVLAELLTGKKP 289
            +       K D++S G++  E++ G+ P
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 59.6 bits (145), Expect = 8e-10
 Identities = 59/221 (26%), Positives = 94/221 (42%), Gaps = 48/221 (21%)

Query: 95  LSQGGFVSVYKGVLHD-NIQVAVKTYRR----ADKIRITERELLRIISQVNHKNVVKILG 149
           +  G +  V          +VA+K   R    A   + T REL R++  ++H+NV+ +L 
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYREL-RLLKHMDHENVIGLLD 81

Query: 150 LCLETEVPL-------LVYEF--ASNGTLL-------DHIRCESSQVLKTWKTCLRIAAE 193
                   L       LV     A    ++       DHI+    Q+L+           
Sbjct: 82  -VFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILR----------- 129

Query: 194 TASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGT 253
               L Y+HS     IIH D+K +NI +N++   K+ DF     ++   +  M T  + T
Sbjct: 130 ---GLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFG----LARHTDDEM-TGYVAT 178

Query: 254 SGYLDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PGS 291
             Y  P + +N     +  D++S G ++AELLTGK   PGS
Sbjct: 179 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGS 219

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 59.0 bits (143), Expect = 9e-10
 Identities = 63/223 (28%), Positives = 97/223 (43%), Gaps = 37/223 (16%)

Query: 88  NFDRSRCLSQGGFVSVY----KGVLHDNIQVAVKTYRRADKIR--------ITERELLRI 135
           NF+  R L  G +  V+     G        A+K  ++A  ++         TER++L  
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60

Query: 136 ISQ----VNHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRI 190
           + +    V        L    +T+  L L+ ++ + G L  H+     Q     ++ +R+
Sbjct: 61  VRRCPFLVT-------LHYAFQTDTKLHLILDYVNGGELFTHL----YQREHFTESEVRV 109

Query: 191 -AAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFE-SSVLISSDAETAMST 248
             AE   ALD+LH L    II+ D+K  NILL+      + DF  S   ++ + E A S 
Sbjct: 110 YIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS- 165

Query: 249 ILIGTSGYLDPVCINTGKL--TKKSDVYSFGVVLAELLTGKKP 289
              GT  Y+ P  I  G     K  D +S GV+  ELLTG  P
Sbjct: 166 -FCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 59.2 bits (143), Expect = 1e-09
 Identities = 55/181 (30%), Positives = 80/181 (44%), Gaps = 10/181 (5%)

Query: 112 IQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLD 171
           +Q  +   R+  K  + ER +L  +  V H  +V +      TE    V +F + G L  
Sbjct: 28  LQKKIVLNRKEQKHIMAERNVL--LKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFF 85

Query: 172 HIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVAD 231
           H++ E S      +     AAE ASAL YLHS+    I++ D+K  NILL+      + D
Sbjct: 86  HLQRERSFPEPRARF---YAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTD 139

Query: 232 FESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGS 291
           F   +     A++  +T   GT  YL P  I         D +  G VL E+L G  P  
Sbjct: 140 F--GLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFY 197

Query: 292 C 292
           C
Sbjct: 198 C 198

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 58.7 bits (142), Expect = 1e-09
 Identities = 46/129 (35%), Positives = 64/129 (49%), Gaps = 16/129 (12%)

Query: 162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILL 221
           EF   G+L D  R     VL       RIA      L YL SL    I+H DVK +N+L+
Sbjct: 79  EFMDGGSL-DVYRKIPEHVLG------RIAVAVVKGLTYLWSLK---ILHRDVKPSNMLV 128

Query: 222 NDNYTAKVADFE-SSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVL 280
           N     K+ DF  S+ L++S A+T      +GT+ Y+ P  I+  +    SDV+S G+  
Sbjct: 129 NTRGQVKLCDFGVSTQLVNSIAKT-----YVGTNAYMAPERISGEQYGIHSDVWSLGISF 183

Query: 281 AELLTGKKP 289
            EL  G+ P
Sbjct: 184 MELALGRFP 192

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 58.7 bits (143), Expect = 1e-09
 Identities = 52/223 (23%), Positives = 95/223 (42%), Gaps = 47/223 (21%)

Query: 93  RCLSQGGFVSVYKGVLHDNIQ-VAVKTYRRA-----DKIRITERELLRIISQVNHKNVVK 146
           + L  G F SVY     +  + VA+K  ++      + + + E + LR ++   H N+VK
Sbjct: 5   KQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLN--EHPNIVK 62

Query: 147 ILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVL--KTWKTCLRIAAETASALDYLHSL 204
           +  +  E +    V+E+   G L   ++    +       ++ +    +    L ++H  
Sbjct: 63  LKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIY---QILQGLAHIHK- 117

Query: 205 ASPPIIHG----DVKSANILLNDNYTAKVADFESSVLI-SSDAETA-MST-------ILI 251
                 HG    D+K  N+L++     K+ADF  +  I S    T  +ST       IL+
Sbjct: 118 ------HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILL 171

Query: 252 GTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKK--PGSC 292
            ++ Y  PV           D+++ G ++AEL T +   PGS 
Sbjct: 172 RSTSYSSPV-----------DIWALGCIMAELYTLRPLFPGSS 203

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 59.3 bits (143), Expect = 1e-09
 Identities = 49/162 (30%), Positives = 77/162 (47%), Gaps = 6/162 (3%)

Query: 130 RELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHI--RCESSQVLKTWKTC 187
           R  L  ++  +H  +VK        +  LL+ E+ S G L   I  R +     + ++  
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG 172

Query: 188 LRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMS 247
           L +  +   ALD +HS     ++H D+KSANI L      K+ DF  S   S      ++
Sbjct: 173 L-LFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVA 228

Query: 248 TILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           +   GT  YL P      + +KK+D++S GV+L ELLT  +P
Sbjct: 229 SSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270

Length = 478

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 57.8 bits (140), Expect = 2e-09
 Identities = 57/212 (26%), Positives = 87/212 (41%), Gaps = 26/212 (12%)

Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRIT--EREL------LRIISQVNHKNVVK 146
           L  G F  VYK    +    A      A KI     E EL      + I+S+  H N+V 
Sbjct: 13  LGDGAFGKVYKAQHKETGLFA------AAKIIQIESEEELEDFMVEIDILSECKHPNIVG 66

Query: 147 ILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLAS 206
           +           ++ EF   G L D I  E  + L   +    +  +   AL++LHS   
Sbjct: 67  LYEAYFYENKLWILIEFCDGGAL-DSIMLELERGLTEPQIRY-VCRQMLEALNFLHS--- 121

Query: 207 PPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGK 266
             +IH D+K+ NILL  +   K+ADF  S    S  +   +   IGT  ++ P  +    
Sbjct: 122 HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVACET 179

Query: 267 LTK-----KSDVYSFGVVLAELLTGKKPGSCM 293
                   K+D++S G+ L EL   + P   +
Sbjct: 180 FKDNPYDYKADIWSLGITLIELAQMEPPHHEL 211

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 61/252 (24%), Positives = 112/252 (44%), Gaps = 27/252 (10%)

Query: 88  NFDRSRCLSQGGFVSVYKGVLHDN-IQVAVKTYRRADKIRITEREL------LRIISQVN 140
           N+   + L +G F  VY     D   ++AVK        + T +E+      ++++  + 
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62

Query: 141 HKNVVKILGLCLE--TEVPLLVY-EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
           H  +V+  G CL    E  L ++ E+   G++ D ++   +    T     R   +    
Sbjct: 63  HDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGAL---TENVTRRYTRQILQG 118

Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISS--DAETAMSTILIGTSG 255
           + YLHS     I+H D+K ANIL +     K+ DF +S  I +   + T + ++  GT  
Sbjct: 119 VSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSV-TGTPY 174

Query: 256 YLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP-------GSCMTLASNKKISMVPYFL 308
           ++ P  I+     +K+DV+S    + E+LT K P        +   +A+     M+P  +
Sbjct: 175 WMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGV 234

Query: 309 NSIKNNGLRQIL 320
           +    + L+QI 
Sbjct: 235 SDACRDFLKQIF 246

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 57.5 bits (139), Expect = 2e-09
 Identities = 50/176 (28%), Positives = 80/176 (45%), Gaps = 22/176 (12%)

Query: 120 RRADKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCE--- 176
           + + K R   R+ + ++S + H N+V+      E     +V ++   G L   I  +   
Sbjct: 37  KMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGV 96

Query: 177 ---SSQVLKTW--KTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVAD 231
                Q+L  W  + CL        AL ++H      I+H D+KS NI L  + T K+ D
Sbjct: 97  LFPEDQIL-DWFVQICL--------ALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGD 144

Query: 232 FESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGK 287
           F  + +++S  E A + I  GT  YL P          KSD+++ G VL E+ T K
Sbjct: 145 FGIARVLNSTVELARTCI--GTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLK 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 57.4 bits (138), Expect = 3e-09
 Identities = 48/168 (28%), Positives = 76/168 (45%), Gaps = 16/168 (9%)

Query: 127 ITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLD--HIRCESSQVLKTW 184
           + ++E++ ++    H N+V   G  L  +   +  EF   G+L D  H+    S+    +
Sbjct: 52  VVQQEII-MMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAY 110

Query: 185 KTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET 244
                ++ ET   L YLHS      +H D+K ANILL DN   K+ADF  S  I+  A  
Sbjct: 111 -----VSRETLQGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQIT--ATI 160

Query: 245 AMSTILIGTSGYLDP---VCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           A     IGT  ++ P        G   +  D+++ G+   EL   + P
Sbjct: 161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPP 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 57.8 bits (139), Expect = 3e-09
 Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 28/215 (13%)

Query: 87  KNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRITER-----ELLRIISQVN 140
           K F   R +  G F +VY    + ++  VA+K    + K +  E+     + +R + ++ 
Sbjct: 15  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQKLR 73

Query: 141 HKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLR---IAAETASA 197
           H N ++  G  L      LV E+             +S +L+  K  L+   IAA T  A
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLG---------SASDLLEVHKKPLQEVEIAAVTHGA 124

Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYL 257
           L  L  L S  +IH DVK+ NILL++    K+ DF S+ +++       +   +GT  ++
Sbjct: 125 LQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANXFVGTPYWM 178

Query: 258 DP---VCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
            P   + ++ G+   K DV+S G+   EL   K P
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 57.9 bits (140), Expect = 3e-09
 Identities = 34/102 (33%), Positives = 53/102 (51%), Gaps = 8/102 (7%)

Query: 192 AETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILI 251
           AE   ALD +HS+     IH DVK  N+LL+ +   K+ADF + + + ++      T  +
Sbjct: 149 AEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTA-V 204

Query: 252 GTSGYLDPVCINT----GKLTKKSDVYSFGVVLAELLTGKKP 289
           GT  Y+ P  + +    G   ++ D +S GV L E+L G  P
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 56.9 bits (138), Expect = 3e-09
 Identities = 33/94 (35%), Positives = 50/94 (53%), Gaps = 8/94 (8%)

Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
           A +YLH+     II+ D+K  N+LL+ N   K+ DF  +  + S  +T       GT  Y
Sbjct: 105 AFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCGTPEY 158

Query: 257 LDP-VCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           + P + +N G      D +S G++L ELLTG+ P
Sbjct: 159 VAPEIILNKGY-DFSVDYWSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 57.3 bits (139), Expect = 3e-09
 Identities = 63/215 (29%), Positives = 90/215 (41%), Gaps = 35/215 (16%)

Query: 97  QGGFVSVYKGVLHDNIQ-VAVKT--YRRADKIRI-TERELLRIISQVNHKNVVKILGLCL 152
           +G +  VYK       Q VA+K       ++  I  E  +LR  S  NH N+    G  +
Sbjct: 16  EGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYS--NHPNIATFYGAFI 73

Query: 153 ETEVPL------LVYEFASNGTLLD---HIRCESSQVLKTWKTCLRIA---AETASALDY 200
           +   P       LV E    G++ D    +R +  ++ + W     IA    ET   L Y
Sbjct: 74  KKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEW-----IAYILRETLRGLAY 128

Query: 201 LHSLASPPIIHGDVKSANILLNDNYTAKVADFE-SSVLISSDAETAMSTILIGTSGYLDP 259
           LH      +IH D+K  NILL  N   K+ DF  S+ L S+          IGT  ++ P
Sbjct: 129 LHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTF---IGTPYWMAP 182

Query: 260 VCINTGK-----LTKKSDVYSFGVVLAELLTGKKP 289
             I   +        +SDV+S G+   EL  GK P
Sbjct: 183 EVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 57.1 bits (138), Expect = 4e-09
 Identities = 42/133 (31%), Positives = 64/133 (48%), Gaps = 14/133 (10%)

Query: 160 VYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANI 219
           V E+ + G L+ HI  +SS      +     AAE    L +LH      II+ D+K  N+
Sbjct: 74  VMEYLNGGDLMFHI--QSSGRFDEARARF-YAAEIICGLQFLHKKG---IIYRDLKLDNV 127

Query: 220 LLNDNYTAKVADF---ESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSF 276
           LL+ +   K+ADF   + ++     A T       GT  Y+ P  +   K  +  D +SF
Sbjct: 128 LLDKDGHIKIADFGMCKENMNGEGKAST-----FCGTPDYIAPEILKGQKYNESVDWWSF 182

Query: 277 GVVLAELLTGKKP 289
           GV+L E+L G+ P
Sbjct: 183 GVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 56.9 bits (138), Expect = 5e-09
 Identities = 52/203 (25%), Positives = 88/203 (43%), Gaps = 24/203 (11%)

Query: 95  LSQGGFVSVYK-GVLHDNIQVAVKTY---RRADKI-RITERELLRIISQVNHKNVVKILG 149
           + +G    V+K         VA+K     R    I     RE+ + +    H  VVK+L 
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREI-KALQACQHPYVVKLLD 66

Query: 150 LCLETEVPLLVYEFASNGTLLDHIRCES-----SQVLKTWKTCLRIAAETASALDYLHSL 204
           +       +LV E+     L + +R E      +QV    K+ +R+  +    + Y+H+ 
Sbjct: 67  VFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQV----KSYMRMLLK---GVAYMHAN 118

Query: 205 ASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDP-VCIN 263
               I+H D+K AN+L++ +   K+ADF  + L S +     S   + T  Y  P +   
Sbjct: 119 G---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSH-QVATRWYRAPELLYG 174

Query: 264 TGKLTKKSDVYSFGVVLAELLTG 286
             K     D+++ G + AELL G
Sbjct: 175 ARKYDPGVDLWAVGCIFAELLNG 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 57.0 bits (138), Expect = 5e-09
 Identities = 48/184 (26%), Positives = 79/184 (42%), Gaps = 21/184 (11%)

Query: 115 AVKTYRRADKIRITERELL----RIISQVNHKNVVKILGLCLETEVPL-LVYEFASNGTL 169
           AVK  ++   ++  + E      R+++       +  L  C +T+  L  V E+ + G L
Sbjct: 24  AVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDL 83

Query: 170 LDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKV 229
           + HI  + S      +     AAE    L +LH      II+ D+K  N+LL+     K+
Sbjct: 84  MFHI--QRSGRFDEPRARF-YAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKI 137

Query: 230 ADF----ESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT 285
           ADF    E    I     T   +   GT  Y+ P  ++        D ++ GV+L E+L 
Sbjct: 138 ADFGMCKEG---ILGGVTT---STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLA 191

Query: 286 GKKP 289
           G+ P
Sbjct: 192 GQSP 195

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 56.9 bits (138), Expect = 5e-09
 Identities = 53/204 (25%), Positives = 93/204 (45%), Gaps = 47/204 (23%)

Query: 108 LHDNIQVAVKTYRRADK----IRITERELLRIISQVNHKNVVKILGL------------- 150
               ++VA+K     +      R T RE+ +I+ +  H+N++ IL +             
Sbjct: 27  KPTGVKVAIKKISPFEHQTFCQR-TLREI-KILRRFKHENIIGILDIIRPPSFESFNDVY 84

Query: 151 ---CL-ETEVPLLVY-EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLA 205
               L ET++  L+  +  SN    DHI+    Q+L+               L Y+HS  
Sbjct: 85  IVQELMETDLYKLIKTQHLSN----DHIQYFLYQILR--------------GLKYIHSAN 126

Query: 206 SPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE-TAMSTILIGTSGYLDP-VCIN 263
              ++H D+K +N+LLN N   K+ DF  + +   + + T   T  + T  Y  P + +N
Sbjct: 127 ---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLN 183

Query: 264 TGKLTKKSDVYSFGVVLAELLTGK 287
           +   TK  D++S G +LAE+L+ +
Sbjct: 184 SKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 56.7 bits (137), Expect = 6e-09
 Identities = 33/103 (32%), Positives = 54/103 (52%), Gaps = 9/103 (8%)

Query: 192 AETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILI 251
           AE   A+D +H L     +H D+K  N+LL+ N   ++ADF S + + +D  T  S + +
Sbjct: 109 AEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG-TVQSNVAV 164

Query: 252 GTSGYLDPVCIN-----TGKLTKKSDVYSFGVVLAELLTGKKP 289
           GT  Y+ P  +       G+   + D +S GV + E+L G+ P
Sbjct: 165 GTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 56.4 bits (137), Expect = 7e-09
 Identities = 52/169 (30%), Positives = 81/169 (47%), Gaps = 34/169 (20%)

Query: 140 NHKNVVKILG-LCLETEVPL-LVYEFASN--------GTLLD-HIRCESSQVLKTWKTCL 188
           +H N+VK+L  +  E +  + LV+E+             L D H R    Q+LK      
Sbjct: 65  DHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKRYIMYQLLK------ 118

Query: 189 RIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMST 248
                   AL Y+HS     +IH D+K +NILLN +   K+ADF  +  +S   E   + 
Sbjct: 119 --------ALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENP 167

Query: 249 IL---IGTSGYLDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PGS 291
           +L   + T  Y  P + + + + TK  D++S G +L E+L GK   PG+
Sbjct: 168 VLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGT 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 56.4 bits (136), Expect = 9e-09
 Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 16/204 (7%)

Query: 93  RCLSQGGFVSVYKGVLHDNIQV-AVKTYRR-----ADKIRITERELLRIISQVNHKNVVK 146
           R L +G F  V    L ++ ++ AVK  ++      D +  T  E  RI+S   +   + 
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEK-RILSLARNHPFLT 59

Query: 147 ILGLCLET-EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLA 205
            L  C +T +    V EF + G L+ HI  + S+     +     AAE  SAL +LH   
Sbjct: 60  QLYCCFQTPDRLFFVMEFVNGGDLMFHI--QKSRRFDEARARF-YAAEITSALMFLHDKG 116

Query: 206 SPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTG 265
              II+ D+K  N+LL+     K+ADF   +          ++   GT  Y+ P  +   
Sbjct: 117 ---IIYRDLKLDNVLLDHEGHCKLADF--GMCKEGIFNGKTTSTFCGTPDYIAPEILQEM 171

Query: 266 KLTKKSDVYSFGVVLAELLTGKKP 289
                 D ++ GV+L E+L G  P
Sbjct: 172 LYGPSVDWWAMGVLLYEMLCGHAP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 56.4 bits (136), Expect = 9e-09
 Identities = 47/183 (25%), Positives = 82/183 (44%), Gaps = 21/183 (11%)

Query: 114 VAVKTYRRADKIRITERELL----RIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTL 169
            A+K  ++ + +++ + + +     I+ +++H  +V ++    +      + EF   G L
Sbjct: 46  YAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGEL 105

Query: 170 LDHIRCES---SQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYT 226
             H+R      + V K +       AE   A +YLHS     II+ D+K  N+LL++   
Sbjct: 106 FTHLRKAGRFPNDVAKFY------HAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGH 156

Query: 227 AKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTG 286
            KV DF  +  +     T     L GT  YL P  I +    K  D ++ GV+L E + G
Sbjct: 157 VKVTDFGFAKKVPDRTFT-----LCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211

Query: 287 KKP 289
             P
Sbjct: 212 YPP 214

Length = 329

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 55.9 bits (134), Expect = 9e-09
 Identities = 57/215 (26%), Positives = 88/215 (40%), Gaps = 21/215 (9%)

Query: 89  FDRSRCLSQGGFVSVYKGVLHDNIQVA-VKTYR-RADKIRITERELLRIISQVNHKNVVK 146
           F+    +  G +  VYKG      Q+A +K      D+    ++E+  +    +H+N+  
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67

Query: 147 ILGLCLETEVP------LLVYEFASNGTLLDHIRCESSQVLKT-WKTCLRIAAETASALD 199
             G  ++   P       LV EF   G++ D I+      LK  W     I  E    L 
Sbjct: 68  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW--IAYICREILRGLS 125

Query: 200 YLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDP 259
           +LH      +IH D+K  N+LL +N   K+ DF  S  +  D         IGT  ++ P
Sbjct: 126 HLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMAP 180

Query: 260 ---VCINTGKLTK--KSDVYSFGVVLAELLTGKKP 289
               C      T   KSD++S G+   E+  G  P
Sbjct: 181 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 215

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 55.7 bits (134), Expect = 9e-09
 Identities = 61/237 (25%), Positives = 107/237 (45%), Gaps = 34/237 (14%)

Query: 131 ELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRI 190
           E   ++SQV+H ++  + G+C+     ++V EF  +G L   +R E  +V   WK  + +
Sbjct: 65  ETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWK--ITV 122

Query: 191 AAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTI- 249
           A + ASAL YL       ++HG+V + NILL       +A+  S  +  SD   + + + 
Sbjct: 123 AQQLASALSYLE---DKNLVHGNVCAKNILLA---RLGLAEGTSPFIKLSDPGVSFTALS 176

Query: 250 ---LIGTSGYLDPVCI-NTGKLTKKSDVYSFGVVLAEL-LTGKKPGSCMTLASNKKISMV 304
               +    ++ P C+     L+  +D +SFG  L E+   G+ P    T +  ++    
Sbjct: 177 REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYE- 235

Query: 305 PYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEEL 361
                  K + L          E   KE+   A L S+CL    T+RP+ + +  +L
Sbjct: 236 -------KKHRLP---------EPSCKEL---ATLISQCLTYEPTQRPSFRTILRDL 273

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 21/215 (9%)

Query: 88  NFDRSRCLSQGGFVSVY---KGVLHDNIQV-AVKTYRRA---DKIRITE--RELLRIISQ 138
           NF+  + L  G +  V+   K   HD+ ++ A+K  ++A    K + TE  R   +++  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 139 VNHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
           +     +  L    +T+  L L+ ++ + G L  H+   S +     +     + E   A
Sbjct: 61  IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHL---SQRERFKEQEVQIYSGEIVLA 117

Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFE-SSVLISSDAETAMSTILIGTSGY 256
           L++LH L    II+ D+K  NILL+ N    + DF  S      + E A S    GT  Y
Sbjct: 118 LEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS--FCGTIEY 172

Query: 257 LDPVCINTGKL--TKKSDVYSFGVVLAELLTGKKP 289
           + P  +  G     K  D +S GV++ ELLTG  P
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 54.8 bits (132), Expect = 2e-08
 Identities = 67/283 (23%), Positives = 107/283 (37%), Gaps = 45/283 (15%)

Query: 95  LSQGGFVSVYKGVLHDNIQVAV-------------KTYRRADK-IRITERELLRIISQVN 140
           L  G F  VYK    +N Q  +             K  R  DK I     E+  I  Q+ 
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 141 HKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRC--ESSQVL---KTWKTCLRIAAETA 195
           H N+V+     LE +   +V +      L +H     E  Q     + W   +++     
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL--- 124

Query: 196 SALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG 255
            AL YLH      I+H D+   NI+L ++    + DF    L       +  T ++GT  
Sbjct: 125 -ALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFG---LAKQKQPESKLTSVVGTIL 178

Query: 256 YLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNG 315
           Y  P  +      +K+DV++FG +L ++ T + P       S   +S+            
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP-----FYSTNMLSLA----------- 222

Query: 316 LRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVS 358
             +I+        E    E V ++ + CL      RP + QVS
Sbjct: 223 -TKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVS 264

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 54.7 bits (131), Expect = 2e-08
 Identities = 53/213 (24%), Positives = 99/213 (46%), Gaps = 18/213 (8%)

Query: 88  NFDRSRCLSQGGFVSVYKGVLHDN-IQVAVKTYRRADKIRITEREL------LRIISQVN 140
           N+   + L QG F  VY     D   ++AVK  +   +   T +E+      ++++  + 
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62

Query: 141 HKNVVKILGLCLET-EVPLLVY-EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASAL 198
           H+ +V+  G   +  E  L ++ E    G++ D ++   +    T     +   +    +
Sbjct: 63  HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGAL---TENVTRKYTRQILEGV 119

Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD--AETAMSTILIGTSGY 256
            YLHS     I+H D+K ANIL +     K+ DF +S  + +   + T M ++  GT  +
Sbjct: 120 SYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSV-TGTPYW 175

Query: 257 LDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           + P  I+     +K+D++S G  + E+LT K P
Sbjct: 176 MSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 44/143 (30%), Positives = 67/143 (46%), Gaps = 30/143 (20%)

Query: 158 LLVYEFASNGTLLDHIRCESSQVLKTWKTCLRI--------AAETASALDYLHSLASPPI 209
             V E+ + G L+ HI           ++C +         AAE    L +LHS     I
Sbjct: 72  FFVMEYLNGGDLMFHI-----------QSCHKFDLPRATFYAAEIICGLQFLHSKG---I 117

Query: 210 IHGDVKSANILLNDNYTAKVADF---ESSVLISSDAETAMSTILIGTSGYLDPVCINTGK 266
           ++ D+K  NILL+ +   K+ADF   + ++L   DA+T       GT  Y+ P  +   K
Sbjct: 118 VYRDLKLDNILLDTDGHIKIADFGMCKENML--GDAKT---CTFCGTPDYIAPEILLGQK 172

Query: 267 LTKKSDVYSFGVVLAELLTGKKP 289
                D +SFGV+L E+L G+ P
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 33/103 (32%), Positives = 54/103 (52%), Gaps = 9/103 (8%)

Query: 192 AETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILI 251
           AE   A+  +H L     +H D+K  N+LL+ N   ++ADF S + ++ D  T  S++ +
Sbjct: 109 AEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG-TVQSSVAV 164

Query: 252 GTSGYLDPVCINT-----GKLTKKSDVYSFGVVLAELLTGKKP 289
           GT  Y+ P  +       GK   + D +S GV + E+L G+ P
Sbjct: 165 GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 54.7 bits (131), Expect = 3e-08
 Identities = 34/103 (33%), Positives = 54/103 (52%), Gaps = 9/103 (8%)

Query: 192 AETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILI 251
           AE   A+D +H L     +H D+K  NIL++ N   ++ADF S + +  D  T  S++ +
Sbjct: 109 AEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-TVQSSVAV 164

Query: 252 GTSGYLDPVCINT-----GKLTKKSDVYSFGVVLAELLTGKKP 289
           GT  Y+ P  +       GK   + D +S GV + E+L G+ P
Sbjct: 165 GTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 54.2 bits (130), Expect = 3e-08
 Identities = 56/227 (24%), Positives = 99/227 (43%), Gaps = 30/227 (13%)

Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITER--------------ELLRIISQVN 140
           L +G    +Y G+L+         Y    +I++  +              E   ++ QV+
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 141 HKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDY 200
           HK++V + G+C+     ++V EF   G L   +  +S  +   WK   ++A + ASAL Y
Sbjct: 63  HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWK--FKVAKQLASALSY 120

Query: 201 LHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTIL-----IGTSG 255
           L       ++HG+V + NILL      +  D E    I         T+L     +    
Sbjct: 121 LE---DKDLVHGNVCTKNILL----AREGIDGECGPFIKLSDPGIPITVLSRQECVERIP 173

Query: 256 YLDPVCI-NTGKLTKKSDVYSFGVVLAEL-LTGKKPGSCMTLASNKK 300
           ++ P C+ ++  L+  +D +SFG  L E+   G+ P    TLA  ++
Sbjct: 174 WIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER 220

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 54.2 bits (130), Expect = 3e-08
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 22/211 (10%)

Query: 89  FDRSRCLSQGGFVSVYKGVLHDNIQVAVKTY--RRADKIRITERE-------LLRIISQV 139
           F + R L +GGF  V        ++   K Y  +R +K RI +R+         +I+ +V
Sbjct: 2   FRQYRVLGKGGFGEVCAC----QVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV 57

Query: 140 NHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASAL 198
           N + VV  L    ET+  L LV    + G L  HI    +   +  +  L  AAE    L
Sbjct: 58  NSQFVVN-LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERA-LFYAAEILCGL 115

Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLD 258
           + LH       ++ D+K  NILL+D    +++D   +V I    E       +GT GY+ 
Sbjct: 116 EDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIP---EGESIRGRVGTVGYMA 169

Query: 259 PVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           P  +N  + T   D +  G ++ E++ G+ P
Sbjct: 170 PEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 58/211 (27%), Positives = 91/211 (43%), Gaps = 26/211 (12%)

Query: 120 RRADKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHI---RCE 176
           ++ +K  ++ER +L  +  V H  +V +       +    V ++ + G L  H+   RC 
Sbjct: 36  KKEEKHIMSERNVL--LKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCF 93

Query: 177 SSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSV 236
                + +      AAE ASAL YLHSL    I++ D+K  NILL+      + DF    
Sbjct: 94  LEPRARFY------AAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFG--- 141

Query: 237 LISSDAE-TAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTL 295
           L   + E    ++   GT  YL P  ++     +  D +  G VL E+L G  P      
Sbjct: 142 LCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT 201

Query: 296 AS------NKKISMVPYFLNSIKN--NGLRQ 318
           A       NK + + P   NS ++   GL Q
Sbjct: 202 AEMYDNILNKPLQLKPNITNSARHLLEGLLQ 232

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 54.2 bits (130), Expect = 4e-08
 Identities = 59/205 (28%), Positives = 89/205 (43%), Gaps = 23/205 (11%)

Query: 95  LSQGGFVSVYKGVLHDNIQV-AVKTYRRADKIR-------ITERELLRIISQVNHKNVVK 146
           + +G F  V +    D  ++ A+KT R+A  +        + ER +L   +QVN   +V 
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVL---AQVNCPFIVP 57

Query: 147 ILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLAS 206
           +       E   LV  F + G L  H++ E        +     A E   AL+ LH    
Sbjct: 58  LKFSFQSPEKLYLVLAFINGGELFHHLQREGR--FDLSRARFYTA-ELLCALENLHKFN- 113

Query: 207 PPIIHGDVKSANILLNDNYTAKVA--DFESSVLISSDAETAMSTILIGTSGYLDPVCINT 264
             +I+ D+K  NILL+  Y   +A  DF    L   D +   +    GT  YL P  +  
Sbjct: 114 --VIYRDLKPENILLD--YQGHIALCDFGLCKLNMKDDDK--TNTFCGTPEYLAPELLLG 167

Query: 265 GKLTKKSDVYSFGVVLAELLTGKKP 289
              TK  D ++ GV+L E+LTG  P
Sbjct: 168 HGYTKAVDWWTLGVLLYEMLTGLPP 192

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 54.4 bits (131), Expect = 4e-08
 Identities = 41/130 (31%), Positives = 62/130 (47%), Gaps = 8/130 (6%)

Query: 160 VYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANI 219
           V E+A+ G L  H+  E  +V    +      AE  SAL YLHS     +++ D+K  N+
Sbjct: 73  VMEYANGGELFFHLSRE--RVFSEDRARF-YGAEIVSALGYLHSCD---VVYRDLKLENL 126

Query: 220 LLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVV 279
           +L+ +   K+ DF       SD  T M T   GT  YL P  +      +  D +  GVV
Sbjct: 127 MLDKDGHIKITDFGLCKEGISDGAT-MKT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVV 184

Query: 280 LAELLTGKKP 289
           + E++ G+ P
Sbjct: 185 MYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 54.2 bits (130), Expect = 4e-08
 Identities = 43/135 (31%), Positives = 66/135 (48%), Gaps = 14/135 (10%)

Query: 158 LLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSA 217
             V EF + G L+ HI+ +       ++     AAE    L +LHS     II+ D+K  
Sbjct: 72  FFVMEFLNGGDLMFHIQDKGR--FDLYRATF-YAAEIVCGLQFLHSKG---IIYRDLKLD 125

Query: 218 NILLNDNYTAKVADF---ESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVY 274
           N++L+ +   K+ADF   + +V   + A T       GT  Y+ P  +   K T   D +
Sbjct: 126 NVMLDRDGHIKIADFGMCKENVFGDNRAST-----FCGTPDYIAPEILQGLKYTFSVDWW 180

Query: 275 SFGVVLAELLTGKKP 289
           SFGV+L E+L G+ P
Sbjct: 181 SFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 53.9 bits (129), Expect = 4e-08
 Identities = 57/221 (25%), Positives = 90/221 (40%), Gaps = 33/221 (14%)

Query: 89  FDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKI-RITERELLRIISQVN------- 140
           F+    +  G +  VYKG      Q+A      A K+  +TE E   I  ++N       
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLA------AIKVMDVTEDEEEEIKLEINMLKKYSH 71

Query: 141 HKNVVKILGLCLETEVP------LLVYEFASNGTLLDHIRCESSQVLKTWKTCLR-IAAE 193
           H+N+    G  ++   P       LV EF   G++ D ++      LK  +  +  I  E
Sbjct: 72  HRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALK--EDWIAYICRE 129

Query: 194 TASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGT 253
               L +LH+     +IH D+K  N+LL +N   K+ DF  S  +  D         IGT
Sbjct: 130 ILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGT 184

Query: 254 SGYLDPVCINT-----GKLTKKSDVYSFGVVLAELLTGKKP 289
             ++ P  I            +SD++S G+   E+  G  P
Sbjct: 185 PYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPP 225

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 55.2 bits (133), Expect = 4e-08
 Identities = 60/241 (24%), Positives = 104/241 (43%), Gaps = 54/241 (22%)

Query: 89  FDRSRCLSQGGFVSVYKGVLHDNI---QVAVKTYRRADKIR--ITERELL--------RI 135
           +D  R + +GG   VY    +D +   +VA+K      KIR  ++E  LL        +I
Sbjct: 4   YDIIRLIGKGGMGEVYLA--YDPVCSRRVALK------KIREDLSENPLLKKRFLREAKI 55

Query: 136 ISQVNHKNVVKILGLCLETEVPLLVY------EFASNGTLLDHIR-CES-SQVLK---TW 184
            + + H  +V +  +C + +    VY      E  +  +LL  +   ES S+ L    + 
Sbjct: 56  AADLIHPGIVPVYSICSDGDP---VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSV 112

Query: 185 KTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLN--------DNYTAKVADFESSV 236
              L I  +  + ++Y+HS     ++H D+K  NILL         D   A     E   
Sbjct: 113 GAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEED 169

Query: 237 LISSDAETAMS-----TI---LIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKK 288
           L+  D +         TI   ++GT  Y+ P  +     ++ +D+Y+ GV+L ++LT   
Sbjct: 170 LLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSF 229

Query: 289 P 289
           P
Sbjct: 230 P 230

Length = 932

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 54.0 bits (130), Expect = 4e-08
 Identities = 61/224 (27%), Positives = 97/224 (43%), Gaps = 29/224 (12%)

Query: 84  RATKNFDRSRCLSQGGFVSVYKGVLHD-NIQVAVKTYR---RADKIRITERELLRIISQV 139
           R    FD    + +G +  VYK    D    VA+K  R     +   IT    ++I+ Q+
Sbjct: 4   RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQL 63

Query: 140 NHKNVVKILGLCLETEVPL----------LVYEFASNGTLLDHIR---CESSQVLKTWKT 186
           NH+N+V +  +  + +  L          LV+E+      +DH      ES  V  +   
Sbjct: 64  NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEY------MDHDLMGLLESGLVHFSEDH 117

Query: 187 CLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAM 246
                 +    L+Y H       +H D+K +NILLN+    K+ADF  + L +S+     
Sbjct: 118 IKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPY 174

Query: 247 STILIGTSGYLDP-VCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           +  +I T  Y  P + +   +     DV+S G +L EL T KKP
Sbjct: 175 TNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKP 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 53.9 bits (129), Expect = 5e-08
 Identities = 58/213 (27%), Positives = 96/213 (45%), Gaps = 26/213 (12%)

Query: 89  FDRSRCLSQGGFVSVYKGVLHDNIQVAVKTY--RRADKIRITERE-------LLRIISQV 139
           F + R L +GGF  V        ++   K Y  ++ +K RI +R+         +I+ +V
Sbjct: 2   FRQYRVLGKGGFGEVCAC----QVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV 57

Query: 140 NHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASAL 198
           N + VV  L    ET+  L LV    + G L  HI        +  +     AAE    L
Sbjct: 58  NSRFVVS-LAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVF-YAAEICCGL 115

Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTI--LIGTSGY 256
           + LH      I++ D+K  NILL+D+   +++D   +V +         TI   +GT GY
Sbjct: 116 EDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-----QTIKGRVGTVGY 167

Query: 257 LDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           + P  +   + T   D ++ G +L E++ G+ P
Sbjct: 168 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 53.4 bits (128), Expect = 5e-08
 Identities = 50/179 (27%), Positives = 84/179 (46%), Gaps = 15/179 (8%)

Query: 111 NIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEVPLL--VYEFASNGT 168
           N++ A +  R+A      E+E  +++SQ+ H N+V       E E  LL  V  F   G 
Sbjct: 34  NLRNASRRERKA-----AEQEA-QLLSQLKHPNIV-AYRESWEGEDGLLYIVMGFCEGGD 86

Query: 169 LLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAK 228
           L   ++ +  ++L      +    + A AL YLH      I+H D+K+ N+ L      K
Sbjct: 87  LYHKLKEQKGKLLPE-NQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIK 142

Query: 229 VADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGK 287
           V D   + ++ +  +  M++ LIGT  Y+ P   +      KSDV++ G  + E+ T K
Sbjct: 143 VGDLGIARVLENQCD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLK 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 53.7 bits (130), Expect = 5e-08
 Identities = 58/236 (24%), Positives = 95/236 (40%), Gaps = 60/236 (25%)

Query: 88  NFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRITERE---------LLR--- 134
            +++ + L +G +  VYK         VA+K      KI++ ER+          LR   
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIK------KIKLGERKEAKDGINFTALREIK 54

Query: 135 IISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVL-----KTWKTCLR 189
           ++ ++ H N++ +L +        LV+EF    T L+ +  + S VL     K++     
Sbjct: 55  LLQELKHPNIIGLLDVFGHKSNINLVFEFME--TDLEKVIKDKSIVLTPADIKSY----- 107

Query: 190 IAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMST- 248
               T   L+YLHS     I+H D+K  N+L+  +   K+ADF  +    S     M+  
Sbjct: 108 -MLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSP-NRKMTHQ 162

Query: 249 ----------ILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKK--PGSC 292
                     +L G   Y        G      D++S G + AELL      PG  
Sbjct: 163 VVTRWYRAPELLFGARHY------GVG-----VDMWSVGCIFAELLLRVPFLPGDS 207

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 53.3 bits (128), Expect = 6e-08
 Identities = 62/211 (29%), Positives = 95/211 (45%), Gaps = 29/211 (13%)

Query: 95  LSQGGFVSVYKGVLH--DNIQVAVKTYRRADKIRITERELLRIISQVN--HKNV----VK 146
           L +G + SVYK VLH    + +A+K  R    + + E +  +II +++  HK V    V 
Sbjct: 9   LGKGNYGSVYK-VLHRPTGVTMAMKEIR----LELDESKFNQIIMELDILHKAVSPYIVD 63

Query: 147 ILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCL-RIAAETASALDYLHSLA 205
             G         +  E+   G+L D +           +  L RI       L +L    
Sbjct: 64  FYGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH 122

Query: 206 SPPIIHGDVKSANILLNDNYTAKVADFE-SSVLISSDAETAMSTILIGTSGYLDPVCINT 264
           +  IIH DVK  N+L+N N   K+ DF  S  L++S A+T      IG   Y+ P  I +
Sbjct: 123 N--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN-----IGCQSYMAPERIKS 175

Query: 265 GKL------TKKSDVYSFGVVLAELLTGKKP 289
           G        T +SDV+S G+ + E+  G+ P
Sbjct: 176 GGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 53.6 bits (129), Expect = 6e-08
 Identities = 51/181 (28%), Positives = 72/181 (39%), Gaps = 47/181 (25%)

Query: 191 AAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMST-I 249
           AAE ASAL YLHSL    II+ D+K  NILL+      + DF    L     E + +T  
Sbjct: 102 AAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFG---LCKEGIEHSKTTST 155

Query: 250 LIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLN 309
             GT  YL P  +      +  D +  G VL E+L G  P                    
Sbjct: 156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPP-------------------- 195

Query: 310 SIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEEL---DRLRR 366
                       F+  D +EM +      + +K LR++     + + + E L   DR +R
Sbjct: 196 ------------FYSRDTAEMYD-----NILNKPLRLKPNISVSARHLLEGLLQKDRTKR 238

Query: 367 L 367
           L
Sbjct: 239 L 239

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 53.9 bits (129), Expect = 6e-08
 Identities = 43/131 (32%), Positives = 64/131 (48%), Gaps = 8/131 (6%)

Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSAN 218
            V E+ + G L  H+  E  +V    +T     AE  SALDYLHS     I++ D+K  N
Sbjct: 72  FVMEYVNGGELFFHLSRE--RVFSEDRTRF-YGAEIVSALDYLHS---GKIVYRDLKLEN 125

Query: 219 ILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGV 278
           ++L+ +   K+ DF       +DA T M T   GT  YL P  +      +  D +  GV
Sbjct: 126 LMLDKDGHIKITDFGLCKEGITDAAT-MKT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGV 183

Query: 279 VLAELLTGKKP 289
           V+ E++ G+ P
Sbjct: 184 VMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 52.9 bits (127), Expect = 6e-08
 Identities = 55/184 (29%), Positives = 83/184 (45%), Gaps = 18/184 (9%)

Query: 143 NVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCL-RIAAETASALDYL 201
           N+V +    +  +   LV + A  G L  HI    S+ L   + C+ R AAE   ALD L
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI----SKFLNIPEECVKRWAAEMVVALDAL 101

Query: 202 HSLASPPIIHGDVKSANILLNDNYTAKVADFE--SSVLISSDAETAMSTILIGTSGYLDP 259
           H      I+  D+   NILL+D    ++  F   S V  S D E A+  +      Y  P
Sbjct: 102 HREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGE-AVENM------YCAP 151

Query: 260 VCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISM-VPYFLNSIKNNGLRQ 318
                 + T+  D +S G +L ELLTGK    C     N   ++ +P +++    + L+Q
Sbjct: 152 EVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWVSEEARSLLQQ 211

Query: 319 ILNF 322
           +L F
Sbjct: 212 LLQF 215

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 53.3 bits (128), Expect = 7e-08
 Identities = 52/207 (25%), Positives = 90/207 (43%), Gaps = 26/207 (12%)

Query: 95  LSQGGFVSVYKGVLHDNIQVAV--KTY--RRADKIRITERE-----LL--RIISQVNHKN 143
           L +GGF  V         QV    K Y  ++ DK R+ +R+     L   +I+ +V+ + 
Sbjct: 1   LGKGGFGEVCA------CQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRF 54

Query: 144 VVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLH 202
           +V  L    ET+  L LV    + G L  HI           +  +  AA+    L++LH
Sbjct: 55  IVS-LAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARA-IFYAAQIICGLEHLH 112

Query: 203 SLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCI 262
                 I++ D+K  N+LL+D+   +++D   +V +    +        GT GY+ P  +
Sbjct: 113 QRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR---AGTPGYMAPEVL 166

Query: 263 NTGKLTKKSDVYSFGVVLAELLTGKKP 289
                    D ++ G  L E++ G+ P
Sbjct: 167 QGEVYDFSVDWFALGCTLYEMIAGRSP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 53.1 bits (127), Expect = 8e-08
 Identities = 61/211 (28%), Positives = 94/211 (44%), Gaps = 22/211 (10%)

Query: 89  FDRSRCLSQGGFVSVYKGVLHDNIQVAVKTY--RRADKIRITERE-------LLRIISQV 139
           F   R L +GGF  V        ++   K Y  ++ +K RI +R+         RI+ +V
Sbjct: 2   FRHYRVLGKGGFGEVCAC----QVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV 57

Query: 140 NHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASAL 198
           N + VV  L    ET+  L LV    + G L  HI    +      +     AAE    L
Sbjct: 58  NSRFVVS-LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIF-YAAELCCGL 115

Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLD 258
           + L       I++ D+K  NILL+D    +++D   +V I  + ET    +  GT GY+ 
Sbjct: 116 EDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIP-EGETVRGRV--GTVGYMA 169

Query: 259 PVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           P  IN  K T   D +  G ++ E++ G+ P
Sbjct: 170 PEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 53.1 bits (128), Expect = 8e-08
 Identities = 47/198 (23%), Positives = 84/198 (42%), Gaps = 40/198 (20%)

Query: 113 QVAVKTYRRA-DKIRITEREL--LRIISQVNHKNVVKILGLCLETEVPL-----LVYEFA 164
           +VA+K    A D   + +R L  L+I+    H N++ I  + L           +V +  
Sbjct: 32  KVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDI-LRPPGADFKDVYVVMDLM 90

Query: 165 ---------SNGTL-LDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDV 214
                    S+  L  +HIR    Q+L+               L Y+HS     +IH D+
Sbjct: 91  ESDLHHIIHSDQPLTEEHIRYFLYQLLR--------------GLKYIHSAN---VIHRDL 133

Query: 215 KSANILLNDNYTAKVADF--ESSVLISSDAETAMSTILIGTSGYLDP-VCINTGKLTKKS 271
           K +N+L+N++   ++ DF     +  S        T  + T  Y  P + ++  + T   
Sbjct: 134 KPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAI 193

Query: 272 DVYSFGVVLAELLTGKKP 289
           D++S G + AE+L G++ 
Sbjct: 194 DMWSVGCIFAEML-GRRQ 210

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 53.1 bits (128), Expect = 9e-08
 Identities = 46/208 (22%), Positives = 82/208 (39%), Gaps = 17/208 (8%)

Query: 93  RCLSQGGFVSVYKGVLHDNIQVAVKTY--RRADKIRITE--RELLRIISQVNHKNVVKIL 148
           +C      V + K    + + VAVK        K  +    +E++    Q+ H N++  +
Sbjct: 8   KCFEDLMIVHLAKHKPTNTL-VAVKKINLDSCSKEDLKLLQQEII-TSRQLQHPNILPYV 65

Query: 149 GLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPP 208
              +      +V    + G+  D ++    + L        I  +  +ALDY+HS     
Sbjct: 66  TSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAF-ILKDVLNALDYIHSKG--- 121

Query: 209 IIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG-----YLDPVCI- 262
            IH  VK+++ILL+ +    ++    SV +    +          S      +L P  + 
Sbjct: 122 FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQ 181

Query: 263 -NTGKLTKKSDVYSFGVVLAELLTGKKP 289
            N     +KSD+YS G+   EL  G  P
Sbjct: 182 QNLQGYNEKSDIYSVGITACELANGHVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 53.5 bits (128), Expect = 9e-08
 Identities = 34/102 (33%), Positives = 53/102 (51%), Gaps = 8/102 (7%)

Query: 192 AETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILI 251
           AE   ALD +HS+     IH DVK  N+LL+ +   K+ADF + + ++ +      T  +
Sbjct: 149 AEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA-V 204

Query: 252 GTSGYLDPVCINT----GKLTKKSDVYSFGVVLAELLTGKKP 289
           GT  Y+ P  + +    G   ++ D +S GV L E+L G  P
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 53.1 bits (127), Expect = 9e-08
 Identities = 62/242 (25%), Positives = 108/242 (44%), Gaps = 31/242 (12%)

Query: 87  KNFDRSRCLSQGGF----VSVYKGVLHDNIQVAVKTYRRADKIR-------ITERELLRI 135
           ++F+  R L  G F    ++ YK    D   VA+K + ++  I+        +ER   +I
Sbjct: 30  EDFNFIRTLGTGSFGRVILATYKN--EDFPPVAIKRFEKSKIIKQKQVDHVFSER---KI 84

Query: 136 ISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETA 195
           ++ +NH   V + G   +     LV EF   G     +R   ++       C   AA+  
Sbjct: 85  LNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLR--RNKRFPNDVGCF-YAAQIV 141

Query: 196 SALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG 255
              +YL SL    I++ D+K  N+LL+ +   K+ DF  + ++ +   T     L GT  
Sbjct: 142 LIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYT-----LCGTPE 193

Query: 256 YLDP-VCINTGKLTKKSDVYSFGVVLAELLTGKKP--GSCMTLASNKKISMVPYFLNSIK 312
           Y+ P + +N G   K +D ++ G+ + E+L G  P   +   L   K +  + YF   + 
Sbjct: 194 YIAPEILLNVGH-GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLD 252

Query: 313 NN 314
           NN
Sbjct: 253 NN 254

Length = 340

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 52.7 bits (127), Expect = 1e-07
 Identities = 54/233 (23%), Positives = 92/233 (39%), Gaps = 64/233 (27%)

Query: 95  LSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRI-TERELL--------RIISQVNHKNV 144
           L +G F  VYK   +     VA+K      KI +  E++          +I+ ++ H NV
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALK------KILMHNEKDGFPITALREIKILKKLKHPNV 69

Query: 145 VKILGLCLE-----TEVPLLVY------EFASNGTLLD---------HIRCESSQVLKTW 184
           V ++ + +E           VY      +   +G LL+          I+C   Q+L+  
Sbjct: 70  VPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSG-LLENPSVKLTESQIKCYMLQLLE-- 126

Query: 185 KTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET 244
                        ++YLH      I+H D+K+ANIL+++    K+ADF  +         
Sbjct: 127 ------------GINYLHE---NHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPN 171

Query: 245 AMS---------TILIGTSGYLDP-VCINTGKLTKKSDVYSFGVVLAELLTGK 287
                       T L+ T  Y  P + +   + T   D++  G V AE+ T +
Sbjct: 172 PKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 52.9 bits (127), Expect = 1e-07
 Identities = 47/146 (32%), Positives = 68/146 (46%), Gaps = 21/146 (14%)

Query: 151 CLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRI--AAETASALDYLHSLASP 207
           C +T   L  V E+ + G L+ HI     Q +  +K    +  AAE A  L +LHS    
Sbjct: 69  CFQTMDRLYFVMEYVNGGDLMYHI-----QQVGKFKEPHAVFYAAEIAIGLFFLHSKG-- 121

Query: 208 PIIHGDVKSANILLNDNYTAKVADF----ESSVLISSDAETAMSTILIGTSGYLDPVCIN 263
            II+ D+K  N++L+     K+ADF    E+   I     T       GT  Y+ P  I 
Sbjct: 122 -IIYRDLKLDNVMLDAEGHIKIADFGMCKEN---IFGGKTT---RTFCGTPDYIAPEIIA 174

Query: 264 TGKLTKKSDVYSFGVVLAELLTGKKP 289
                K  D ++FGV+L E+L G+ P
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQPP 200

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 41/131 (31%), Positives = 64/131 (48%), Gaps = 8/131 (6%)

Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSAN 218
            V E+A+ G L  H+   S + + T +      AE  SAL+YLHS     +++ D+K  N
Sbjct: 72  FVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLEN 125

Query: 219 ILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGV 278
           ++L+ +   K+ DF       SD  T M T   GT  YL P  +      +  D +  GV
Sbjct: 126 LMLDKDGHIKITDFGLCKEGISDGAT-MKT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGV 183

Query: 279 VLAELLTGKKP 289
           V+ E++ G+ P
Sbjct: 184 VMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 60/206 (29%), Positives = 92/206 (44%), Gaps = 22/206 (10%)

Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITEREL------LRIISQVNHKNVVKIL 148
           L  G F  VYK     N +       +  + + +E EL      + I++  NH  +VK+L
Sbjct: 20  LGDGAFGKVYKA---KNKETGALAAAKVIETK-SEEELEDYMVEIEILATCNHPYIVKLL 75

Query: 149 GLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPP 208
           G         ++ EF   G + D I  E  + L   +  + I  +   AL YLHS+    
Sbjct: 76  GAFYWDGKLWIMIEFCPGGAV-DAIMLELDRGLTEPQIQV-ICRQMLEALQYLHSMK--- 130

Query: 209 IIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDP--VCINTGK 266
           IIH D+K+ N+LL  +   K+ADF  S       +   S   IGT  ++ P  V   T K
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS--FIGTPYWMAPEVVMCETMK 188

Query: 267 LTK---KSDVYSFGVVLAELLTGKKP 289
            T    K+D++S G+ L E+   + P
Sbjct: 189 DTPYDYKADIWSLGITLIEMAQIEPP 214

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 51.9 bits (124), Expect = 1e-07
 Identities = 36/151 (23%), Positives = 67/151 (44%), Gaps = 7/151 (4%)

Query: 134 RIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIR-CESSQVLKTWKTCLRIAA 192
           +++S+++H  +VK     LE +   ++ E+     L   +   + +    +         
Sbjct: 54  QLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFI 113

Query: 193 ETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIG 252
           +    + Y+H      I+H D+K+ NI L +N   K+ DF  S L+    + A  T   G
Sbjct: 114 QLLLGVHYMHQRR---ILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLA--TTFTG 167

Query: 253 TSGYLDPVCINTGKLTKKSDVYSFGVVLAEL 283
           T  Y+ P  +       KSD++S G +L E+
Sbjct: 168 TPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 44/158 (27%), Positives = 74/158 (46%), Gaps = 11/158 (6%)

Query: 134 RIISQVNHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWK-TCLRIA 191
           R+++  +    +  L  C +T   L  V E+ + G L+ HI+    QV K  +   +  A
Sbjct: 52  RVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQ----QVGKFKEPQAVFYA 107

Query: 192 AETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILI 251
           AE +  L +LH      II+ D+K  N++L+     K+ADF   +      +   +    
Sbjct: 108 AEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADF--GMCKEHMVDGVTTRTFC 162

Query: 252 GTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           GT  Y+ P  I      K  D +++GV+L E+L G+ P
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPP 200

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 61/207 (29%), Positives = 94/207 (45%), Gaps = 24/207 (11%)

Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITEREL------LRIISQVNHKNVVKIL 148
           L  G F  VYK     N +  V    +    + +E EL      + I++  +H N+VK+L
Sbjct: 13  LGDGAFGKVYKA---QNKETGVLAAAKVIDTK-SEEELEDYMVEIDILASCDHPNIVKLL 68

Query: 149 -GLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASP 207
                E  + +L+ EF + G + D +  E  + L T      +  +T  AL+YLH     
Sbjct: 69  DAFYYENNLWILI-EFCAGGAV-DAVMLELERPL-TEPQIRVVCKQTLEALNYLHE---N 122

Query: 208 PIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDP--VCINTG 265
            IIH D+K+ NIL   +   K+ADF  S   +   +   S   IGT  ++ P  V   T 
Sbjct: 123 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMCETS 180

Query: 266 K---LTKKSDVYSFGVVLAELLTGKKP 289
           K      K+DV+S G+ L E+   + P
Sbjct: 181 KDRPYDYKADVWSLGITLIEMAQIEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 56/211 (26%), Positives = 100/211 (47%), Gaps = 41/211 (19%)

Query: 95  LSQGGFVSVYKGVLHDNIQ-VAVKTYRRADK---IR-ITERELLRIISQVNHKNVVKILG 149
           + +G +  V+K    +  Q VA+K +  ++    I+ I  RE+ R++ Q+ H N+V ++ 
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREI-RMLKQLKHPNLVNLIE 67

Query: 150 LCLETEVPLLVYEFASNGTLLD----HIRCESSQVLKTWKTCLRIAAETASALDYLHSLA 205
           +        LV+E+  + T+L+    + R     ++K      +I  +T  A+++ H   
Sbjct: 68  VFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIK------KIIWQTLQAVNFCHKHN 120

Query: 206 SPPIIHGDVKSANILLNDNYTAKVADFESSVLIS--SDAETA-MST-------ILIGTSG 255
               IH DVK  NIL+      K+ DF  + +++   D  T  ++T       +L+G + 
Sbjct: 121 ---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQ 177

Query: 256 YLDPVCINTGKLTKKSDVYSFGVVLAELLTG 286
           Y  PV           DV++ G V AELLTG
Sbjct: 178 YGPPV-----------DVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 55/213 (25%), Positives = 100/213 (46%), Gaps = 19/213 (8%)

Query: 87  KNFDRSRCLSQGGFVSVYKGVLHDNIQ--VAVKTYRRADKIRITER----ELLRIISQVN 140
           +++D  + + +G F  V + V H + Q   A+K   + + I+ ++     E   I++  N
Sbjct: 43  EDYDVVKVIGRGAFGEV-QLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 101

Query: 141 HKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDY 200
              VV++     + +   +V E+   G L++ +   +  V + W       AE   ALD 
Sbjct: 102 SPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM--SNYDVPEKWAKFY--TAEVVLALDA 157

Query: 201 LHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV 260
           +HS+    +IH DVK  N+LL+ +   K+ADF + + +         T  +GT  Y+ P 
Sbjct: 158 IHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTA-VGTPDYISPE 213

Query: 261 CINT----GKLTKKSDVYSFGVVLAELLTGKKP 289
            + +    G   ++ D +S GV L E+L G  P
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 52.1 bits (125), Expect = 2e-07
 Identities = 64/257 (24%), Positives = 114/257 (44%), Gaps = 40/257 (15%)

Query: 93  RCLSQGGFVSVY---KGVLHDNIQV-AVKTYRRADKIR--------ITERELLRIISQVN 140
           + L +GG+  V+   K    D  ++ A+K  ++A  +R          ER    I+  V 
Sbjct: 2   KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERN---ILEAVK 58

Query: 141 HKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALD 199
           H  +V ++    +T   L L+ E+ S G L  H+  E   +  T   C  ++ E + AL+
Sbjct: 59  HPFIVDLI-YAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDT--ACFYLS-EISLALE 114

Query: 200 YLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDP 259
           +LH      II+ D+K  NILL+     K+ DF   +   S  E  ++    GT  Y+ P
Sbjct: 115 HLHQQG---IIYRDLKPENILLDAQGHVKLTDF--GLCKESIHEGTVTHTFCGTIEYMAP 169

Query: 260 VCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNK----------KISMVPYFLN 309
             +      K  D +S G ++ ++LTG  P +    A N+          K+++ PY   
Sbjct: 170 EILMRSGHGKAVDWWSLGALMYDMLTGAPPFT----AENRKKTIDKILKGKLNLPPYLTP 225

Query: 310 SIKNNGLRQILNFHVAD 326
             ++  L+++L  + + 
Sbjct: 226 EARDL-LKKLLKRNPSS 241

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 51.6 bits (124), Expect = 3e-07
 Identities = 53/184 (28%), Positives = 79/184 (42%), Gaps = 20/184 (10%)

Query: 115 AVKTYRRADKIRITERELL----RIISQVN---HKNVVKILGLCLETEVPL-LVYEFASN 166
           A+K  ++ D I   E E L    RI    N   H  +V +   C +TE  +  V E+A+ 
Sbjct: 28  AIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFA-CFQTEDHVCFVMEYAAG 86

Query: 167 GTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYT 226
           G L+ HI    + V    +     AA     L YLH      I++ D+K  N+LL+    
Sbjct: 87  GDLMMHIH---TDVFSEPRAVF-YAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGF 139

Query: 227 AKVADFESSVLISSDAETAMST-ILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT 285
            K+ADF    L          T    GT  +L P  +     T+  D +  GV++ E+L 
Sbjct: 140 VKIADFG---LCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLV 196

Query: 286 GKKP 289
           G+ P
Sbjct: 197 GESP 200

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 51.6 bits (123), Expect = 3e-07
 Identities = 39/131 (29%), Positives = 62/131 (47%), Gaps = 7/131 (5%)

Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSAN 218
            V E+A+ G L  H+   S + + +        AE  SALDYLH  +   +++ D+K  N
Sbjct: 72  FVMEYANGGELFFHL---SRERVFSEDRARFYGAEIVSALDYLH--SEKNVVYRDLKLEN 126

Query: 219 ILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGV 278
           ++L+ +   K+ DF        D  T M T   GT  YL P  +      +  D +  GV
Sbjct: 127 LMLDKDGHIKITDFGLCKEGIKDGAT-MKT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGV 184

Query: 279 VLAELLTGKKP 289
           V+ E++ G+ P
Sbjct: 185 VMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 51.5 bits (123), Expect = 3e-07
 Identities = 45/141 (31%), Positives = 67/141 (47%), Gaps = 11/141 (7%)

Query: 151 CLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKT-CLRIAAETASALDYLHSLASPP 208
           C +T   L  V E+ + G L+  I+    QV +  +   +  AAE A  L +LHS     
Sbjct: 69  CFQTMDRLYFVMEYVNGGDLMYQIQ----QVGRFKEPHAVFYAAEIAIGLFFLHSKG--- 121

Query: 209 IIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLT 268
           II+ D+K  N++L+     K+ADF        D  T  +    GT  Y+ P  I      
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT--TKTFCGTPDYIAPEIIAYQPYG 179

Query: 269 KKSDVYSFGVVLAELLTGKKP 289
           K  D ++FGV+L E+L G+ P
Sbjct: 180 KSVDWWAFGVLLYEMLAGQAP 200

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 51.5 bits (123), Expect = 4e-07
 Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 28/218 (12%)

Query: 88  NFDRSRCLSQGGFVSVY---KGVLHDNIQV-AVKTYRRADKIRI--------TERELLRI 135
           NF+  + L  G +  V+   K   HD  ++ A+K  ++A  ++         TER +L  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 136 ISQVNHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAE 193
           + Q      +  L    +TE  L L+ ++ S G +  H+     Q     +  +R  + E
Sbjct: 61  VRQ---SPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHL----YQRDNFSEDEVRFYSGE 113

Query: 194 TASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFE-SSVLISSDAETAMSTILIG 252
              AL++LH L    I++ D+K  NILL+      + DF  S   +S + E   S    G
Sbjct: 114 IILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS--FCG 168

Query: 253 TSGYLDPVCINT-GKLTKKSDVYSFGVVLAELLTGKKP 289
           T  Y+ P  I   G   K  D +S G+++ ELLTG  P
Sbjct: 169 TIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASP 206

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 50.7 bits (121), Expect = 4e-07
 Identities = 49/161 (30%), Positives = 75/161 (46%), Gaps = 13/161 (8%)

Query: 139 VNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIR-CESSQVLKTWKTCL-RIAAETAS 196
           + H N+++ LG C E    LLV EF   G L  ++R C  ++++    T L R+A E A 
Sbjct: 52  LQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIAL 111

Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            L +LH       IH D+   N LL  + T K+ D+  S     +        L     +
Sbjct: 112 GLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRW 168

Query: 257 LDPVCINT--GKL-----TKKSDVYSFGVVLAELLT-GKKP 289
           + P  ++   G L     TK+S+V+S GV + EL   G +P
Sbjct: 169 IAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQP 209

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 51.2 bits (122), Expect = 5e-07
 Identities = 30/82 (36%), Positives = 44/82 (53%), Gaps = 6/82 (7%)

Query: 209 IIHGDVKSANILLNDNYTAKVADFE-SSVLISSDAETAMSTILIGTSGYLDPVCINTGKL 267
           I+H DVK +NIL+N     K+ DF  S  LI S     M+   +GT  Y+ P  +     
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTHY 179

Query: 268 TKKSDVYSFGVVLAELLTGKKP 289
           + +SD++S G+ L EL  G+ P
Sbjct: 180 SVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 50.6 bits (121), Expect = 5e-07
 Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 22/211 (10%)

Query: 89  FDRSRCLSQGGFVSVYKGVLHDNIQVAVKTY--RRADKIRITER--ELL-----RIISQV 139
           F   R L +GGF  V        ++   K Y  ++ +K RI +R  E +     +I+ +V
Sbjct: 2   FRHYRVLGKGGFGEVCAC----QVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV 57

Query: 140 NHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASAL 198
           N + VV  L    ET+  L LV    + G L  HI    +      +  +  AAE    L
Sbjct: 58  NSRFVVS-LAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDE-ERAVFYAAEITCGL 115

Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLD 258
           + LH      I++ D+K  NILL+D    +++D   +V I  + ET    +  GT GY+ 
Sbjct: 116 EDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIP-EGETIRGRV--GTVGYMA 169

Query: 259 PVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           P  +   + T   D +  G ++ E++ GK P
Sbjct: 170 PEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 51.0 bits (122), Expect = 5e-07
 Identities = 49/178 (27%), Positives = 80/178 (44%), Gaps = 21/178 (11%)

Query: 188 LRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMS 247
           LR +++ A  +D+L   AS   IH DV + N+LL D   AK+ DF  +  I +D+   + 
Sbjct: 215 LRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271

Query: 248 TILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPY 306
                   ++ P  I     T +SDV+S+G++L E+ + GK P   +    N K      
Sbjct: 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGI--LVNSK------ 323

Query: 307 FLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL 364
           F   +K          +     +    EI + +   C  +  TERPT  Q+S+ + R 
Sbjct: 324 FYKMVKRG--------YQMSRPDFAPPEIYSIMKM-CWNLEPTERPTFSQISQLIQRQ 372

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 51.8 bits (124), Expect = 6e-07
 Identities = 47/189 (24%), Positives = 85/189 (44%), Gaps = 21/189 (11%)

Query: 113 QVAVKTYRRADKIRITERELLR----IISQVNHKNVVKIL--GLCLETEVPLLVYEFASN 166
           +VA+K  R        +R   R    + +++ H N+V +L  G      +   V+E+   
Sbjct: 5   EVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYVPG 63

Query: 167 GTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILL---ND 223
            TL + +  +    L   +T  R+  +   AL   H+     I+H D+K  NI++     
Sbjct: 64  RTLREVLAADG--ALPAGET-GRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTGV 117

Query: 224 NYTAKVADFESSVLISSDAETAMSTI-----LIGTSGYLDPVCINTGKLTKKSDVYSFGV 278
              AKV DF    L+    +  ++T+     ++GT  Y  P  +    +T  SD+Y++G+
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGL 177

Query: 279 VLAELLTGK 287
           +  E LTG+
Sbjct: 178 IFLECLTGQ 186

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 50.4 bits (121), Expect = 8e-07
 Identities = 58/192 (30%), Positives = 91/192 (47%), Gaps = 27/192 (14%)

Query: 111 NIQVAVKTYRRADKIRI----TERELLRIISQVNHKNVVKILGLCLET-----EVPLLVY 161
           N +VA+K    A   RI    T RE+ +++  ++H+NV+ I  +             +VY
Sbjct: 30  NEKVAIKKIANAFDNRIDAKRTLREI-KLLRHLDHENVIAIKDIMPPPHREAFNDVYIVY 88

Query: 162 EFASNGTLLD---HIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSAN 218
           E      L+D   H    SSQ L +   C     +    L Y+HS     ++H D+K +N
Sbjct: 89  E------LMDTDLHQIIRSSQTL-SDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSN 138

Query: 219 ILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDP-VCINTGKLTKKSDVYSFG 277
           +LLN N   K+ DF      +S+    M+  ++ T  Y  P + +N  + T   DV+S G
Sbjct: 139 LLLNANCDLKICDF-GLARTTSEKGDFMTEYVV-TRWYRAPELLLNCSEYTTAIDVWSVG 196

Query: 278 VVLAELLTGKKP 289
            + AELL G+KP
Sbjct: 197 CIFAELL-GRKP 207

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 50.0 bits (119), Expect = 9e-07
 Identities = 29/82 (35%), Positives = 44/82 (53%), Gaps = 6/82 (7%)

Query: 209 IIHGDVKSANILLNDNYTAKVADFE-SSVLISSDAETAMSTILIGTSGYLDPVCINTGKL 267
           I+H DVK +NIL+N     K+ DF  S  LI S     M+   +GT  Y+ P  +     
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTHY 179

Query: 268 TKKSDVYSFGVVLAELLTGKKP 289
           + +SD++S G+ L E+  G+ P
Sbjct: 180 SVQSDIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 27/210 (12%)

Query: 98  GGFVSVYKGV-LHDNIQVAVKTYR---RADKIRI-TERE--LLRIISQVNHKNVVKILGL 150
           G + +VYK    H    VA+K+ R     D + + T RE  LL+ +   +H N+V+++ +
Sbjct: 11  GAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDV 70

Query: 151 CL------ETEVPLLVYEFASNG--TLLDHIRCESSQVLKTWKTCLRIAAETASALDYLH 202
           C       ET+V L V+E       T LD +        +T K  +R   +    LD+LH
Sbjct: 71  CATSRTDRETKVTL-VFEHVDQDLRTYLDKVPPPGLPA-ETIKDLMR---QFLRGLDFLH 125

Query: 203 SLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCI 262
           +     I+H D+K  NIL+      K+ADF  + + S   + A++ +++ T  Y  P  +
Sbjct: 126 ANC---IVHRDLKPENILVTSGGQVKLADFGLARIYS--CQMALTPVVV-TLWYRAPEVL 179

Query: 263 NTGKLTKKSDVYSFGVVLAELLTGKKPGSC 292
                    D++S G + AE+   +KP  C
Sbjct: 180 LQSTYATPVDMWSVGCIFAEMFR-RKPLFC 208

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 49.7 bits (119), Expect = 1e-06
 Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 27/203 (13%)

Query: 96  SQGGFVSVYKGVLHDNIQVAVKTYRR----ADKIRITERELLRIISQVNHKNVVKILGL- 150
           +QG   + Y  V      VA+K   R        +   REL+ ++  VNHKN++ +L + 
Sbjct: 28  AQGIVCAAYDTVT--GQNVAIKKLSRPFQNVTHAKRAYRELV-LMKLVNHKNIIGLLNVF 84

Query: 151 ----CLET--EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSL 204
                LE   +V  LV E      L+D   C+  Q+    +    +  +    + +LHS 
Sbjct: 85  TPQKSLEEFQDV-YLVME------LMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSA 137

Query: 205 ASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINT 264
               IIH D+K +NI++  + T K+ DF    L  +   + M T  + T  Y  P  I  
Sbjct: 138 G---IIHRDLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMTPYVVTRYYRAPEVILG 191

Query: 265 GKLTKKSDVYSFGVVLAELLTGK 287
               +  D++S G ++ E++ G 
Sbjct: 192 MGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 49.1 bits (117), Expect = 1e-06
 Identities = 43/164 (26%), Positives = 75/164 (45%), Gaps = 31/164 (18%)

Query: 139 VNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCE-----SSQVLKTWKTCLRIAAE 193
           + H N+++ LG C+E    LLV+E+   G L  ++  E     +SQ+L       R+A E
Sbjct: 52  LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ----RMACE 107

Query: 194 TASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVAD-------FESSVLISSDAETA- 245
            A+ + ++H       +H D+   N  L  + T KV D       ++   + + D +   
Sbjct: 108 IAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVP 164

Query: 246 ---MSTILIGT--SGYLDPVCINTGKLTKKSDVYSFGVVLAELL 284
              ++  L+G    G +      T + TK S+V++ GV L EL 
Sbjct: 165 LRWLAPELVGEFHGGLI------TAEQTKPSNVWALGVTLWELF 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 49.2 bits (118), Expect = 1e-06
 Identities = 32/91 (35%), Positives = 45/91 (49%), Gaps = 8/91 (8%)

Query: 196 SALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG 255
            +LD++H      I H D+K  NIL+ D+   K+ADF S   I S       T  I T  
Sbjct: 111 KSLDHMHRNG---IFHRDIKPENILIKDD-ILKLADFGSCRGIYS---KPPYTEYISTRW 163

Query: 256 YLDPVCINT-GKLTKKSDVYSFGVVLAELLT 285
           Y  P C+ T G    K D+++ G V  E+L+
Sbjct: 164 YRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 49.3 bits (117), Expect = 2e-06
 Identities = 46/194 (23%), Positives = 88/194 (45%), Gaps = 9/194 (4%)

Query: 96  SQGGFVSVYKGVLHDNIQVA--VKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLE 153
           +QG   + Y  VL  N+ +    + ++     +   REL+ ++  VNHKN++ +L +   
Sbjct: 29  AQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIISLLNVFTP 87

Query: 154 TEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGD 213
            +    + EF     +++ +     QV++      R++      L  +  L S  IIH D
Sbjct: 88  QKS---LEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRD 144

Query: 214 VKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDV 273
           +K +NI++  + T K+ DF    L  +   + M T  + T  Y  P  I      +  D+
Sbjct: 145 LKPSNIVVKSDCTLKILDFG---LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 201

Query: 274 YSFGVVLAELLTGK 287
           +S G ++ E++  K
Sbjct: 202 WSVGCIMGEMVRHK 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 49/167 (29%), Positives = 71/167 (42%), Gaps = 18/167 (10%)

Query: 127 ITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHI---RCESSQVLKT 183
           + ER +L  +  + H  +V +       E    V ++ + G L  H+   RC      + 
Sbjct: 43  MAERNVL--LKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF 100

Query: 184 WKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE 243
           +      AAE ASA+ YLHSL    II+ D+K  NILL+      + DF    L     E
Sbjct: 101 Y------AAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFG---LCKEGVE 148

Query: 244 TAMST-ILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
              +T    GT  YL P  +      +  D +  G VL E+L G  P
Sbjct: 149 PEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 48.7 bits (116), Expect = 2e-06
 Identities = 46/184 (25%), Positives = 87/184 (47%), Gaps = 22/184 (11%)

Query: 113 QVAVKTYRRADKIRI----TERELLRIISQVNHKNVVKILGLCLETEVPLLVY-EFASNG 167
           +VA+K   R  +  I      REL  ++  + H+NV+ +L    +     +   EF    
Sbjct: 42  KVAIKKLSRPFQSEIFAKRAYREL-TLLKHMQHENVIGLL----DVFTSAVSGDEFQDFY 96

Query: 168 TLLDHIRCESSQVLKTWKTCLRI---AAETASALDYLHSLASPPIIHGDVKSANILLNDN 224
            ++ +++ +  +++    +  ++     +    L Y+HS     IIH D+K  N+ +N++
Sbjct: 97  LVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNED 153

Query: 225 YTAKVADFESSVLISSDAETAMSTILIGTSGYLDP-VCINTGKLTKKSDVYSFGVVLAEL 283
              K+ DF   +   +DAE    T  + T  Y  P V +N     +  D++S G ++AE+
Sbjct: 154 CELKILDF--GLARHADAEM---TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEM 208

Query: 284 LTGK 287
           LTGK
Sbjct: 209 LTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 48.4 bits (116), Expect = 3e-06
 Identities = 45/194 (23%), Positives = 76/194 (39%), Gaps = 44/194 (22%)

Query: 128 TERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIR-----CESSQVLK 182
           TE+E   I++ ++H  +  +           LV ++   G L   ++     C S +V +
Sbjct: 50  TEQE---ILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVAR 106

Query: 183 TWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVL----- 237
            +      AAE   AL+YLH L    I++ D+K  NILL+++    ++DF+ S       
Sbjct: 107 FY------AAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157

Query: 238 -----ISSDAETAMSTILI-----------------GTSGYLDPVCINTGKLTKKSDVYS 275
                         S   I                 GT  Y+ P  I+        D ++
Sbjct: 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWT 217

Query: 276 FGVVLAELLTGKKP 289
            G++L E+L G  P
Sbjct: 218 LGILLYEMLYGTTP 231

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 48.2 bits (115), Expect = 3e-06
 Identities = 47/184 (25%), Positives = 84/184 (45%), Gaps = 33/184 (17%)

Query: 109 HDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGT 168
           HDNI   VK Y   + +  +  +L   +  +   N V I+   +ET++  ++      G 
Sbjct: 61  HDNI---VKVY---EVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVL----EQGP 110

Query: 169 LL-DHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLN-DNYT 226
           L  +H R    Q+L+               L Y+HS     ++H D+K AN+ +N ++  
Sbjct: 111 LSEEHARLFMYQLLR--------------GLKYIHS---ANVLHRDLKPANVFINTEDLV 153

Query: 227 AKVADFESSVLISSDAETA--MSTILIGTSGYLDP-VCINTGKLTKKSDVYSFGVVLAEL 283
            K+ DF  + ++         +S  L+ T  Y  P + ++    TK  D+++ G + AE+
Sbjct: 154 LKIGDFGLARIVDPHYSHKGYLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEM 212

Query: 284 LTGK 287
           LTGK
Sbjct: 213 LTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 48.2 bits (115), Expect = 3e-06
 Identities = 34/99 (34%), Positives = 50/99 (50%), Gaps = 8/99 (8%)

Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMS-TILIGTSG 255
           AL Y+H+     + H D+K  NIL N +   K+ DF  + +  +D  TA+  T  + T  
Sbjct: 115 ALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171

Query: 256 YLDPVCINT--GKLTKKSDVYSFGVVLAELLTGKK--PG 290
           Y  P    +   K T   D++S G + AE+LTGK   PG
Sbjct: 172 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 210

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 48.2 bits (115), Expect = 4e-06
 Identities = 33/111 (29%), Positives = 48/111 (43%), Gaps = 16/111 (14%)

Query: 192 AETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVL-------------I 238
           AET  AL+YLH+     I+H D+K  N+L+      K+ DF  S +             I
Sbjct: 108 AETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHI 164

Query: 239 SSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
             D    +   + GT  Y+ P  I      K  D ++ G++L E L G  P
Sbjct: 165 EKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 46.2 bits (110), Expect = 4e-06
 Identities = 29/118 (24%), Positives = 47/118 (39%), Gaps = 11/118 (9%)

Query: 118 TYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCES 177
             R     R  E  +L+++++     V K+L          L+ E+   G  LD +  E 
Sbjct: 30  PSREKGADREREVAILQLLARKGLP-VPKVLASGESDGWSYLLMEWIE-GETLDEVSEEE 87

Query: 178 SQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESS 235
                       IA + A  L  LH L    + HGD+   NIL++D     + D+E +
Sbjct: 88  K---------EDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYA 136

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 48.1 bits (114), Expect = 4e-06
 Identities = 50/195 (25%), Positives = 87/195 (44%), Gaps = 13/195 (6%)

Query: 96  SQGGFVSVYKGVLHDNIQVAVKT----YRRADKIRITERELLRIISQVNHKNVVKILGLC 151
           +QG   + +  VL   I VAVK     ++     +   REL+ ++  VNHKN++ +L + 
Sbjct: 33  AQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAYRELV-LLKCVNHKNIISLLNVF 89

Query: 152 LETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIH 211
              +    + EF     +++ +     QV+       R++      L  +  L S  IIH
Sbjct: 90  TPQKS---LEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIH 146

Query: 212 GDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKS 271
            D+K +NI++  + T K+ DF    L  +     M T  + T  Y  P  I      +  
Sbjct: 147 RDLKPSNIVVKSDCTLKILDFG---LARTACTNFMMTPYVVTRYYRAPEVILGMGYKENV 203

Query: 272 DVYSFGVVLAELLTG 286
           D++S G ++ EL+ G
Sbjct: 204 DIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 47.7 bits (113), Expect = 4e-06
 Identities = 58/220 (26%), Positives = 90/220 (40%), Gaps = 24/220 (10%)

Query: 86  TKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTY---RRADKIRITERELLRIISQVNH 141
           T  ++    + +G +  VYK     D    AVK        D+    E  +L+ +   NH
Sbjct: 21  TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLP--NH 78

Query: 142 KNVVKILGLCLETEVPL-----LVYEFASNGTLLDHIR--CESSQVLKTWKTCLRIAAET 194
            NVVK  G+  + +  +     LV E  + G++ + ++      Q L        I+   
Sbjct: 79  PNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDE----AMISYIL 134

Query: 195 ASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTS 254
             AL  L  L +  IIH DVK  NILL      K+ DF  S  ++S      ++  +GT 
Sbjct: 135 YGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTP 192

Query: 255 GYLDPVCINTGKLTKKS-----DVYSFGVVLAELLTGKKP 289
            ++ P  I   +    S     DV+S G+   EL  G  P
Sbjct: 193 FWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPP 232

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 47.7 bits (113), Expect = 5e-06
 Identities = 53/193 (27%), Positives = 94/193 (48%), Gaps = 27/193 (13%)

Query: 112 IQVAVKTYRRADKIRI----TERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNG 167
           ++VAVK   R  +  I    T REL R++  + H+NV+ +L    +   P    E  ++ 
Sbjct: 43  LRVAVKKLSRPFQSIIHAKRTYREL-RLLKHMKHENVIGLL----DVFTPARSLEEFNDV 97

Query: 168 TLLDHIR-CESSQVLKTWKTCLRIAAETASALDY-----LHSLASPPIIHGDVKSANILL 221
            L+ H+   + + ++K    C ++  +    L Y     L  + S  IIH D+K +N+ +
Sbjct: 98  YLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 153

Query: 222 NDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDP-VCINTGKLTKKSDVYSFGVVL 280
           N++   K+ DF   +   +D E    T  + T  Y  P + +N     +  D++S G ++
Sbjct: 154 NEDCELKILDF--GLARHTDDEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 208

Query: 281 AELLTGKK--PGS 291
           AELLTG+   PG+
Sbjct: 209 AELLTGRTLFPGT 221

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 47.4 bits (113), Expect = 6e-06
 Identities = 32/96 (33%), Positives = 49/96 (51%), Gaps = 7/96 (7%)

Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE--TAMSTILIGTS 254
            L Y+HS     ++H D+K  N+L+N +   K+ DF  +   S +        T  + T 
Sbjct: 117 GLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR 173

Query: 255 GYLDP-VCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
            Y  P + ++    TK  DV+S G +LAELL G+KP
Sbjct: 174 WYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKP 208

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 47.3 bits (112), Expect = 7e-06
 Identities = 45/194 (23%), Positives = 88/194 (45%), Gaps = 9/194 (4%)

Query: 96  SQGGFVSVYKGVLHDNIQVA--VKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLE 153
           +QG   + Y  +L  N+ +    + ++     +   REL+ ++  VNHKN++ +L +   
Sbjct: 36  AQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIIGLLNVFTP 94

Query: 154 TEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGD 213
            +    + EF     +++ +     QV++      R++      L  +  L S  IIH D
Sbjct: 95  QKS---LEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRD 151

Query: 214 VKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDV 273
           +K +NI++  + T K+ DF    L  +   + M T  + T  Y  P  I      +  D+
Sbjct: 152 LKPSNIVVKSDCTLKILDFG---LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDI 208

Query: 274 YSFGVVLAELLTGK 287
           +S G ++ E++ G 
Sbjct: 209 WSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 47.1 bits (112), Expect = 8e-06
 Identities = 28/104 (26%), Positives = 52/104 (50%), Gaps = 10/104 (9%)

Query: 192 AETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILI 251
           AE   A+  +H +     +H D+K  N+L++     K+ADF S+  ++++ +   S + +
Sbjct: 109 AELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN-KMVNSKLPV 164

Query: 252 GTSGYLDPVCINTGKLTKKS------DVYSFGVVLAELLTGKKP 289
           GT  Y+ P  + T     K       D +S GV+  E++ G+ P
Sbjct: 165 GTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 47.0 bits (112), Expect = 8e-06
 Identities = 54/206 (26%), Positives = 91/206 (44%), Gaps = 28/206 (13%)

Query: 95  LSQGGFVSVYKGVLHDNIQ-VAVK-----TYRRADKIR--ITERELLRIISQVNHKNVVK 146
           + QGG+  V+     D  + VA+K        + +++R  +TER+   I++    + +VK
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERD---ILTTTKSEWLVK 65

Query: 147 ILGLCLETEVPLLVYEFASNG---TLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHS 203
           +L    + E   L  E+   G   TLL+++   S    + +       AE   A+D LH 
Sbjct: 66  LLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFY------MAEMFEAVDALHE 119

Query: 204 LASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCIN 263
           L     IH D+K  N L++ +   K+ DF  S  I + A +      +G+  Y+ P  + 
Sbjct: 120 LG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSV-----VGSPDYMAPEVLR 171

Query: 264 TGKLTKKSDVYSFGVVLAELLTGKKP 289
                   D +S G +L E L G  P
Sbjct: 172 GKGYDFTVDYWSLGCMLYEFLCGFPP 197

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 46.9 bits (111), Expect = 9e-06
 Identities = 44/167 (26%), Positives = 78/167 (46%), Gaps = 25/167 (14%)

Query: 130 RELLRIISQVNHKNVVKILGLCLETEVP------LLVYEFASN--GTLLDHIRCESSQVL 181
           REL R++  + H+NV+ +L +              LV  F     G L+ H +    ++ 
Sbjct: 63  REL-RLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQ 121

Query: 182 KTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD 241
                 L+        L Y+H+     IIH D+K  N+ +N++   K+ DF     ++  
Sbjct: 122 FLVYQMLK-------GLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG----LARQ 167

Query: 242 AETAMSTILIGTSGYLDP-VCINTGKLTKKSDVYSFGVVLAELLTGK 287
            ++ M+  ++ T  Y  P V +N    T+  D++S G ++AE+LTGK
Sbjct: 168 TDSEMTGYVV-TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 46.7 bits (111), Expect = 1e-05
 Identities = 34/118 (28%), Positives = 53/118 (44%), Gaps = 19/118 (16%)

Query: 171 DHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVA 230
           DH++    Q+L+               L YLHS     I+H D+K  N+L+N N   K+ 
Sbjct: 103 DHVKVFLYQILR--------------GLKYLHSAG---ILHRDIKPGNLLVNSNCVLKIC 145

Query: 231 DFESSVLISSDAETAMSTILIGTSGYLDP-VCINTGKLTKKSDVYSFGVVLAELLTGK 287
           DF  + +   D    M T  + T  Y  P + + +   T   D++S G + AELL  +
Sbjct: 146 DFGLARVEEPDESKHM-TQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 46.4 bits (110), Expect = 1e-05
 Identities = 38/156 (24%), Positives = 61/156 (39%), Gaps = 21/156 (13%)

Query: 135 IISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAA-- 192
           ++  VNH +V+++    +   +  +V         L H   +    L      L I    
Sbjct: 110 LLQNVNHPSVIRMKDTLVSGAITCMV---------LPHYSSDLYTYLTKRSRPLPIDQAL 160

Query: 193 ----ETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMST 248
               +    L YLH+     IIH DVK+ NI +ND     + D  ++             
Sbjct: 161 IIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA---PAFL 214

Query: 249 ILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELL 284
            L GT     P  +   K   K+D++S G+VL E+L
Sbjct: 215 GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 46.2 bits (110), Expect = 2e-05
 Identities = 53/234 (22%), Positives = 95/234 (40%), Gaps = 53/234 (22%)

Query: 83  IRATKNFDRSRCLSQGGFVSVYKGVLHDNIQ--VAVKTYR---RADKIRITERELLRIIS 137
                 +++   + QG F  V+K   H   +  VA+K        +   IT    ++I+ 
Sbjct: 8   CDEVSKYEKLAKIGQGTFGEVFK-ARHKKTKQIVALKKVLMENEKEGFPITALREIKILQ 66

Query: 138 QVNHKNVVKILGLCLETEVP--------LLVYEFASN--GTLLD--HIRCESSQVLKTWK 185
            + H+NVV ++ +C     P         LV+EF  +    LL   +++   S++ K  K
Sbjct: 67  LLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMK 126

Query: 186 TCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADF---ESSVLISSDA 242
             L       + L Y+H      I+H D+K+ANIL+  +   K+ADF    +  L  +  
Sbjct: 127 MLL-------NGLYYIHR---NKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSK 176

Query: 243 ETAMST-----------ILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT 285
               +            +L+G   Y  P+           D++  G ++AE+ T
Sbjct: 177 PNRYTNRVVTLWYRPPELLLGERDYGPPI-----------DMWGAGCIMAEMWT 219

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 46.0 bits (109), Expect = 2e-05
 Identities = 29/99 (29%), Positives = 47/99 (47%), Gaps = 5/99 (5%)

Query: 191 AAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTIL 250
           AAE   AL +LH      +I+ D+K  NILL+     K+ADF   +          +T  
Sbjct: 102 AAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADF--GMCKEGILNGVTTTTF 156

Query: 251 IGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
            GT  Y+ P  +   +     D ++ GV++ E++ G+ P
Sbjct: 157 CGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 45.9 bits (109), Expect = 2e-05
 Identities = 42/181 (23%), Positives = 72/181 (39%), Gaps = 41/181 (22%)

Query: 130 RELLRIISQVNHKNVVKILGLCLETEVPLLVYE---------FASNGTLLD-HIRCESSQ 179
           REL +I++++ H+N++ ++ + +E +   LV +               L +  ++C   Q
Sbjct: 69  REL-KIMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQ 127

Query: 180 VLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESS---- 235
           +L                   L+ L     +H D+  ANI +N     K+ADF  +    
Sbjct: 128 ILNG-----------------LNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYG 170

Query: 236 ----VLISSDAETAMSTIL----IGTSGYLDP-VCINTGKLTKKSDVYSFGVVLAELLTG 286
                   S  ET          + T  Y  P + +   K     D++S G + AELLTG
Sbjct: 171 YPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG 230

Query: 287 K 287
           K
Sbjct: 231 K 231

Length = 335

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 52/206 (25%), Positives = 90/206 (43%), Gaps = 14/206 (6%)

Query: 128 TERELLRIISQVNHKNVVKILGLCLETEVPLL-VYEFASNGTLLDHIRCESSQVLKTWKT 186
           TE+ +    S  NH  +V  L  C +TE  L  V E+ + G L+ H++ +     K  + 
Sbjct: 44  TEKHVFEQAS--NHPFLVG-LHSCFQTESRLFFVIEYVNGGDLMFHMQRQR----KLPEE 96

Query: 187 CLRI-AAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETA 245
             R  +AE + AL+YLH      II+ D+K  N+LL+     K+ D+          +T 
Sbjct: 97  HARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT- 152

Query: 246 MSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVP 305
            ++   GT  Y+ P  +         D ++ GV++ E++ G+ P   +  + N   +   
Sbjct: 153 -TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTED 211

Query: 306 YFLNSIKNNGLRQILNFHVADESEMK 331
           Y    I    +R   +  V   S +K
Sbjct: 212 YLFQVILEKQIRIPRSLSVKAASVLK 237

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 46.1 bits (109), Expect = 2e-05
 Identities = 53/203 (26%), Positives = 87/203 (42%), Gaps = 27/203 (13%)

Query: 105 KGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNH----KNVVK---------ILGLC 151
           KG      QV  K  RR   +++  ++ +    +V H    +N++          I+GL 
Sbjct: 3   KGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLK 62

Query: 152 LETEVP---LLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPP 208
              +      LV ++ S G L  H++ E        K  +   AE   AL++LH      
Sbjct: 63  FSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYI---AELVLALEHLHKY---D 116

Query: 209 IIHGDVKSANILLNDNYTAKVADFE-SSVLISSDAETAMSTILIGTSGYLDP-VCINTGK 266
           I++ D+K  NILL+      + DF  S   ++ +  T       GT+ YL P V ++   
Sbjct: 117 IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTT---NTFCGTTEYLAPEVLLDEKG 173

Query: 267 LTKKSDVYSFGVVLAELLTGKKP 289
            TK  D +S GV++ E+  G  P
Sbjct: 174 YTKHVDFWSLGVLVFEMCCGWSP 196

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 45.6 bits (108), Expect = 2e-05
 Identities = 31/96 (32%), Positives = 50/96 (52%), Gaps = 11/96 (11%)

Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYL 257
           L Y+HS     ++H D+K +NIL+N+N   K+ DF     ++   +  M T  + T  Y 
Sbjct: 121 LKYVHSAG---VVHRDLKPSNILINENCDLKICDFG----LARIQDPQM-TGYVSTRYYR 172

Query: 258 DP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PG 290
            P + +   K   + D++S G + AE+L GK   PG
Sbjct: 173 APEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPG 208

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 61/237 (25%), Positives = 87/237 (36%), Gaps = 61/237 (25%)

Query: 114 VAVKTYRR---ADKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLV-YEFASNGTL 169
           VAVK  +    A + +    EL  +I   NH NVV +LG C +   PL+V  EF   G L
Sbjct: 40  VAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNL 99

Query: 170 LDHIRC---------ESSQVLKTWKTCL--------RIAAETASALDYLHSL-----ASP 207
            + +R          E S   +     +        RI A  AS L            +P
Sbjct: 100 SNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNP 159

Query: 208 P----------------------------------IIHGDVKSANILLNDNYTAKVADFE 233
           P                                   IH D+ + NILL++N   K+ DF 
Sbjct: 160 PQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFG 219

Query: 234 SSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
            +  I  D +            ++ P  I     T +SDV+SFGV+L E+ + G  P
Sbjct: 220 LARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 45.6 bits (108), Expect = 3e-05
 Identities = 53/221 (23%), Positives = 100/221 (45%), Gaps = 24/221 (10%)

Query: 112 IQVAVKTYRRADKIRITERELLRIISQVN----HKNVVK-------ILGL--CLETEVPL 158
           + V +K  RR   +++ ++EL+     ++     K+V +       ++GL  C +TE  L
Sbjct: 12  LLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRL 71

Query: 159 -LVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETASALDYLHSLASPPIIHGDVKS 216
             V EF S G L+ H++    +  K  +   R  +AE + AL++LH      II+ D+K 
Sbjct: 72  FFVIEFVSGGDLMFHMQ----RQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKL 124

Query: 217 ANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSF 276
            N+LL+     K+ D+          +T  ++   GT  Y+ P  +         D ++ 
Sbjct: 125 DNVLLDAEGHIKLTDYGMCKEGIRPGDT--TSTFCGTPNYIAPEILRGEDYGFSVDWWAL 182

Query: 277 GVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLR 317
           GV++ E++ G+ P   + ++ N   +   Y    I    +R
Sbjct: 183 GVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR 223

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 45.3 bits (107), Expect = 3e-05
 Identities = 41/168 (24%), Positives = 80/168 (47%), Gaps = 12/168 (7%)

Query: 123 DKIRITERELLRIISQVNHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVL 181
           +K+ + E+E   I+ +VN   +V  L    E++  L LV    + G L  HI     + L
Sbjct: 37  EKMALLEKE---ILEKVNSPFIVN-LAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGL 92

Query: 182 KTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD 241
           +  +  +  +A+    + +LHS+    I++ D+K  N+LL+D    +++D   +V +   
Sbjct: 93  EMERV-IHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG 148

Query: 242 AETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
                 T   GT+GY+ P  +     +   D ++ G  + E++ G+ P
Sbjct: 149 KTI---TQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 45.1 bits (107), Expect = 3e-05
 Identities = 55/222 (24%), Positives = 91/222 (40%), Gaps = 56/222 (25%)

Query: 95  LSQGGFVSVYKGVLHDNIQ-VAVKTYRRADKIRITERE------LLRIIS---QVNHKNV 144
           + +G +  VYKG      Q VA+K      KIR+   E       +R IS   ++ H N+
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMK------KIRLESEEEGVPSTAIREISLLKELQHPNI 61

Query: 145 VKILGLCLETEVPLLVYEFASNG--TLLDHIRCESSQVLKTWKTCLRIAAETASALDYLH 202
           V +  + ++     L++EF S      LD +        +  K+ L    +    + + H
Sbjct: 62  VCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLY---QILQGILFCH 118

Query: 203 SLASPPIIHGDVKSANILLNDNYTAKVADF---------------ESSVLISSDAETAMS 247
           S     ++H D+K  N+L+++    K+ADF               E   L     E    
Sbjct: 119 SRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPE---- 171

Query: 248 TILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
            +L+G+  Y  PV           D++S G + AE+ T KKP
Sbjct: 172 -VLLGSPRYSTPV-----------DIWSIGTIFAEMAT-KKP 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 45.4 bits (107), Expect = 3e-05
 Identities = 43/169 (25%), Positives = 77/169 (45%), Gaps = 13/169 (7%)

Query: 151 CLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETASALDYLHSLASPP 208
           C +T   L LV E+ + G L+ H++ +     K  +   R  AAE   AL++LH      
Sbjct: 64  CFQTTSRLFLVIEYVNGGDLMFHMQRQR----KLPEEHARFYAAEICIALNFLHERG--- 116

Query: 209 IIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLT 268
           II+ D+K  N+LL+ +   K+ D+          +T  ++   GT  Y+ P  +   +  
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT--TSTFCGTPNYIAPEILRGEEYG 174

Query: 269 KKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLR 317
              D ++ GV++ E++ G+ P   +T   N  ++   Y    I    +R
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDIIT--DNPDMNTEDYLFQVILEKPIR 221

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 44.5 bits (105), Expect = 4e-05
 Identities = 30/100 (30%), Positives = 51/100 (51%), Gaps = 8/100 (8%)

Query: 191 AAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTIL 250
           AAE    L+++H+     +++ D+K ANILL+++   +++D   +   S     A     
Sbjct: 103 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---- 155

Query: 251 IGTSGYLDPVCINTGKLTKKS-DVYSFGVVLAELLTGKKP 289
           +GT GY+ P  +  G     S D +S G +L +LL G  P
Sbjct: 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 44.6 bits (105), Expect = 4e-05
 Identities = 29/100 (29%), Positives = 50/100 (50%), Gaps = 8/100 (8%)

Query: 191 AAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTIL 250
           A E    L+++H+     +++ D+K ANILL+++   +++D   +   S     A     
Sbjct: 103 ATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---- 155

Query: 251 IGTSGYLDPVCINTGKLTKKS-DVYSFGVVLAELLTGKKP 289
           +GT GY+ P  +  G     S D +S G +L +LL G  P
Sbjct: 156 VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 45.0 bits (106), Expect = 4e-05
 Identities = 51/194 (26%), Positives = 91/194 (46%), Gaps = 31/194 (15%)

Query: 113 QVAVKTYRRADK----IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGT 168
           +VAVK   R  +     R T REL R++  + H+NV+ +L           V+  A++  
Sbjct: 42  KVAVKKLSRPFQSLIHARRTYREL-RLLKHMKHENVIGLLD----------VFTPATSIE 90

Query: 169 LLDHIRCESSQV---LKTWKTCLRIAAETASALDY-----LHSLASPPIIHGDVKSANIL 220
             + +   ++ +   L     C +++ E    L Y     L  + S  IIH D+K +N+ 
Sbjct: 91  NFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVA 150

Query: 221 LNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDP-VCINTGKLTKKSDVYSFGVV 279
           +N++   ++ DF     ++  A+  M T  + T  Y  P + +N     +  D++S G +
Sbjct: 151 VNEDCELRILDFG----LARQADDEM-TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCI 205

Query: 280 LAELLTGKK--PGS 291
           +AELL GK   PG+
Sbjct: 206 MAELLKGKALFPGN 219

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 44.6 bits (106), Expect = 5e-05
 Identities = 33/127 (25%), Positives = 49/127 (38%), Gaps = 32/127 (25%)

Query: 191 AAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETA----- 245
            AE   ALD +H L     IH D+K  NIL++ +   K+ADF     ++   +       
Sbjct: 107 IAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLND 163

Query: 246 ----------------------MSTILIGTSGYLDP-VCINTGKLTKKSDVYSFGVVLAE 282
                                  +   +GT  Y+ P V   T     + D +S GV+L E
Sbjct: 164 SHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTP-YGLECDWWSLGVILYE 222

Query: 283 LLTGKKP 289
           +L G  P
Sbjct: 223 MLYGFPP 229

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 44.4 bits (105), Expect = 5e-05
 Identities = 62/234 (26%), Positives = 98/234 (41%), Gaps = 62/234 (26%)

Query: 88  NFDRSRCLSQGGFVSVYKGVLHDNIQ-VAVKTYRRADKIRI-TERE-----LLRIIS--- 137
           NF +   + +G +  VYK       + VA+K      KIR+ TE E      +R IS   
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALK------KIRLDTETEGVPSTAIREISLLK 54

Query: 138 QVNHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAA-ETA 195
           ++NH N+VK+L + + TE  L LV+EF               Q LK +     ++     
Sbjct: 55  ELNHPNIVKLLDV-IHTENKLYLVFEFLH-------------QDLKKFMDASPLSGIPLP 100

Query: 196 SALDYLHSLA-------SPPIIHGDVKSANILLNDNYTAKVADFESS----VLISSDAET 244
               YL  L        S  ++H D+K  N+L+N     K+ADF  +    V + +    
Sbjct: 101 LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE 160

Query: 245 AMS------TILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKK--PG 290
            ++       IL+G   Y   V           D++S G + AE++T +   PG
Sbjct: 161 VVTLWYRAPEILLGCKYYSTAV-----------DIWSLGCIFAEMVTRRALFPG 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 44.6 bits (105), Expect = 6e-05
 Identities = 44/164 (26%), Positives = 71/164 (43%), Gaps = 22/164 (13%)

Query: 204 LASPPIIHGDVKSANILLNDNYTAKVADF--ESSVLISSDAETAMSTILIGTSGYLDPVC 261
           LAS   +H D+ + N+LL      K+ DF     ++  S+  +  ST L     ++ P  
Sbjct: 253 LASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFL--PVKWMAPES 310

Query: 262 INTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQIL 320
           I     T  SDV+S+G++L E+ + G  P   M + S         F N IK +G R   
Sbjct: 311 IFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST--------FYNKIK-SGYRMAK 361

Query: 321 NFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL 364
             H   E        V ++  KC      +RP+   +S+ ++ L
Sbjct: 362 PDHATQE--------VYDIMVKCWNSEPEKRPSFLHLSDIVESL 397

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 44.6 bits (105), Expect = 6e-05
 Identities = 46/164 (28%), Positives = 71/164 (43%), Gaps = 22/164 (13%)

Query: 204 LASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE--TAMSTILIGTSGYLDPVC 261
           LAS   +H D+ + N+L+ +    K+ DF  +  I  D+   +  ST L     ++ P  
Sbjct: 255 LASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL--PLKWMAPES 312

Query: 262 INTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQIL 320
           I     T  SDV+SFG++L E+ T G  P          ++ M   F N+IK  G R   
Sbjct: 313 IFNNLYTTLSDVWSFGILLWEIFTLGGTP--------YPELPMNEQFYNAIK-RGYRMAK 363

Query: 321 NFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL 364
             H +DE        + E+  KC   +   RP   Q+   +  L
Sbjct: 364 PAHASDE--------IYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 43.8 bits (104), Expect = 8e-05
 Identities = 55/236 (23%), Positives = 100/236 (42%), Gaps = 65/236 (27%)

Query: 89  FDRSRCLSQGGFVSVYKGVLHDNIQ---VAVKTYRRADKIRITE------RE--LLRIIS 137
           ++   C+ +G +  VYK    +       A+K ++  DK + T       RE  LLR   
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFK-GDKEQYTGISQSACREIALLR--- 57

Query: 138 QVNHKNVVKILGLCLETEVPL--LVYEFASN---GTLLDHIRCESSQV----LK--TWKT 186
           ++ H+NVV ++ + LE       L++++A +     +  H + +   +    +K   W+ 
Sbjct: 58  ELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQI 117

Query: 187 CLRIAAETASALDYLHSLASPPIIHGDVKSANILL----NDNYTAKVAD------FESSV 236
                      L+ +H L S  ++H D+K ANIL+     +    K+ D      F + +
Sbjct: 118 -----------LNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPL 166

Query: 237 LISSDAETAMSTI-------LIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT 285
              +D +  + TI       L+G   Y           TK  D+++ G + AELLT
Sbjct: 167 KPLADLDPVVVTIWYRAPELLLGARHY-----------TKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 43.7 bits (103), Expect = 1e-04
 Identities = 30/87 (34%), Positives = 44/87 (50%), Gaps = 1/87 (1%)

Query: 204 LASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCIN 263
           LAS   IH D+ + NILL++N   K+ DF  +  I  D +            ++ P  I 
Sbjct: 189 LASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIF 248

Query: 264 TGKLTKKSDVYSFGVVLAELLT-GKKP 289
               T +SDV+SFGV+L E+ + G  P
Sbjct: 249 DKVYTTQSDVWSFGVLLWEIFSLGASP 275

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 43.1 bits (101), Expect = 1e-04
 Identities = 47/171 (27%), Positives = 76/171 (44%), Gaps = 20/171 (11%)

Query: 127 ITERELLRIISQVNHKNVVKILGLCL------ETEVPLLVYEFASNG--TLLDHIRCESS 178
           I E  +LR +    H NVV++  +C       ET++ L V+E       T LD +  E  
Sbjct: 49  IREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTL-VFEHVDQDLTTYLDKVP-EPG 106

Query: 179 QVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLI 238
              +T K  +    +    LD+LHS     ++H D+K  NIL+  +   K+ADF  + + 
Sbjct: 107 VPTETIKDMM---FQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY 160

Query: 239 SSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           S        T ++ T  Y  P  +         D++S G + AE+   +KP
Sbjct: 161 SFQMAL---TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKP 207

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 44.0 bits (103), Expect = 1e-04
 Identities = 51/195 (26%), Positives = 82/195 (42%), Gaps = 35/195 (17%)

Query: 127 ITERELLRIISQVN------HKNVVKILGLCLE--TEVPLLVYEFASNGTLLDHI-RCES 177
           + ERE  +++ +VN      HKN+V+ +   L    +   ++ EF   G L  +I +C  
Sbjct: 51  LKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYK 110

Query: 178 SQVLKTWKTCLRIAAETASALDYLHSLASPP----IIHGDVKSANILL------------ 221
                     + I  +   AL Y H+L   P    ++H D+K  NI L            
Sbjct: 111 MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170

Query: 222 -----NDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCI--NTGKLTKKSDVY 274
                N    AK+ DF  S  I  ++   M+   +GT  Y  P  +   T     KSD++
Sbjct: 171 QANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMW 227

Query: 275 SFGVVLAELLTGKKP 289
           + G ++ EL +GK P
Sbjct: 228 ALGCIIYELCSGKTP 242

Length = 1021

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 36/121 (29%), Positives = 53/121 (43%), Gaps = 18/121 (14%)

Query: 170 LDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKV 229
           L+ + C S QV K                  +  LAS   IH D+ + NILL++N   K+
Sbjct: 178 LEDLICYSFQVAKG-----------------MEFLASRKCIHRDLAARNILLSENNVVKI 220

Query: 230 ADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKK 288
            DF  +  I  D +            ++ P  I     T +SDV+SFGV+L E+ + G  
Sbjct: 221 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 280

Query: 289 P 289
           P
Sbjct: 281 P 281

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 42.4 bits (100), Expect = 2e-04
 Identities = 54/224 (24%), Positives = 92/224 (41%), Gaps = 47/224 (20%)

Query: 88  NFDRSRCLSQGGFVSVYKGVLHDNIQ-VAVKTYRRADKIRITERELLRIIS---QVNHKN 143
            +++   + +G + +V+K    +  + VA+K  R  D         LR I    ++ HKN
Sbjct: 1   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60

Query: 144 VVKILGLCLETEVPLLVYEF----------ASNGTLLDHIRCES--SQVLKTWKTCLRIA 191
           +V++  +    +   LV+E+          + NG + D    +S   Q+LK         
Sbjct: 61  IVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDI-DPEIVKSFMFQLLK--------- 110

Query: 192 AETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESS-----VLISSDAETAM 246
                 L + HS     ++H D+K  N+L+N N   K+ADF  +      +    AE   
Sbjct: 111 -----GLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV- 161

Query: 247 STILIGTSGYLDPVCINTGKLTKKS-DVYSFGVVLAELLTGKKP 289
                 T  Y  P  +   KL   S D++S G + AEL    +P
Sbjct: 162 ------TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 49/173 (28%), Positives = 74/173 (42%), Gaps = 20/173 (11%)

Query: 129 ERELLRIISQVNHKNVVKILGLCLETEVP-----LLVYEFASNGTLLDHIRCESSQVLKT 183
           E  +L+ +S  +H NVVK  G+  + +V       LV E  + G++ D ++      LK 
Sbjct: 64  EYNILKALS--DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVK----GFLKR 117

Query: 184 WKTC--LRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD 241
            +      IA     AL  L  L     IH DVK  NILL      K+ DF  S  ++S 
Sbjct: 118 GERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST 177

Query: 242 AETAMSTILIGTSGYLDPVCINTGK-----LTKKSDVYSFGVVLAELLTGKKP 289
                ++  +GT  ++ P  I   +        + DV+S G+   EL  G  P
Sbjct: 178 RLRRNTS--VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPP 228

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 42.6 bits (100), Expect = 3e-04
 Identities = 44/161 (27%), Positives = 69/161 (42%), Gaps = 18/161 (11%)

Query: 204 LASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCIN 263
           LAS   IH D+ + NILL      K+ DF  +  I +D+   +         ++ P  I 
Sbjct: 230 LASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIF 289

Query: 264 TGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNF 322
               T +SDV+S+G++L E+ + G  P   M + S         F   IK  G R +   
Sbjct: 290 NCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK--------FYKMIK-EGYRMLSPE 340

Query: 323 HVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDR 363
                SEM +I         C      +RPT KQ+ + +++
Sbjct: 341 CAP--SEMYDI------MKSCWDADPLKRPTFKQIVQLIEQ 373

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 41.5 bits (97), Expect = 4e-04
 Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 28/210 (13%)

Query: 95  LSQGGFVSVYKG--VLHDNIQVAVKTYRR-----ADKIRITERELLRIISQVNHKNVVKI 147
           L +G + +V+KG   L +N+ VA+K  R      A    I E  LL+    + H N+V +
Sbjct: 13  LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLK---NLKHANIVTL 68

Query: 148 LGLCLETEVPL-LVYEFASNG--TLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSL 204
             + + TE  L LV+E+  +     LD+  C +   +   K  +    +    L Y H  
Sbjct: 69  HDI-IHTERCLTLVFEYLDSDLKQYLDN--CGNLMSMHNVKIFM---FQLLRGLSYCHKR 122

Query: 205 ASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDP-VCIN 263
               I+H D+K  N+L+N+    K+ADF  +   S   +T  + ++  T  Y  P V + 
Sbjct: 123 K---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLG 177

Query: 264 TGKLTKKSDVYSFGVVLAELLTGKK--PGS 291
           + + +   D++  G +L E+ TG+   PGS
Sbjct: 178 STEYSTPIDMWGVGCILYEMATGRPMFPGS 207

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 41.8 bits (98), Expect = 5e-04
 Identities = 31/100 (31%), Positives = 45/100 (45%), Gaps = 17/100 (17%)

Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
           AL YLH      IIH DVK+ NI L++   A + DF ++  + +  +T       GT   
Sbjct: 197 ALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLET 253

Query: 257 -------LDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
                  LDP C        K+D++S G+VL E+      
Sbjct: 254 NSPELLALDPYC-------AKTDIWSAGLVLFEMSVKNVT 286

Length = 392

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 41.1 bits (96), Expect = 7e-04
 Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 22/207 (10%)

Query: 95  LSQGGFVSVYKG--VLHDNIQVAVKTYRR-----ADKIRITERELLRIISQVNHKNVVKI 147
           L +G + +VYKG   L DN+ VA+K  R      A    I E  LL+    + H N+V +
Sbjct: 14  LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLK---DLKHANIVTL 69

Query: 148 LGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASP 207
             +    +   LV+E+           C +S  +   K  L    +    L+Y H     
Sbjct: 70  HDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFL---FQLLRGLNYCHR---R 123

Query: 208 PIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDP-VCINTGK 266
            ++H D+K  N+L+N+    K+ADF  +   S   +T  + ++  T  Y  P + + +  
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILLGSTD 181

Query: 267 LTKKSDVYSFGVVLAELLTGKK--PGS 291
            + + D++  G +  E+ TG+   PGS
Sbjct: 182 YSTQIDMWGVGCIFYEMSTGRPLFPGS 208

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 41.0 bits (96), Expect = 7e-04
 Identities = 39/162 (24%), Positives = 73/162 (45%), Gaps = 10/162 (6%)

Query: 134 RIISQVNHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRC--ESSQVLKTWKTCLRI 190
           RI+++V+ + +V  L    +T+  L LV    + G L  HI    E +      + C   
Sbjct: 45  RILAKVHSRFIVS-LAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACF-Y 102

Query: 191 AAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTIL 250
            A+  S L++LH      II+ D+K  N+LL+++   +++D   +V +            
Sbjct: 103 TAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKG--Y 157

Query: 251 IGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSC 292
            GT G++ P  +   +     D ++ GV L E++  + P   
Sbjct: 158 AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRA 199

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 40.4 bits (95), Expect = 9e-04
 Identities = 53/218 (24%), Positives = 85/218 (38%), Gaps = 65/218 (29%)

Query: 103 VYKGV-LHDNIQVAVKTYRRADKIRI-TERE-----LLRIIS---QVNHKNVVKILGLCL 152
           VYK         VA+K      KIR+ TE E      +R IS   ++NH N+V++L +  
Sbjct: 15  VYKARDKLTGEIVALK------KIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVH 68

Query: 153 ETEVPLLVYEFASNG--TLLDHIRCES--SQVLK--TWKTCLRIAAETASALDYLHSLAS 206
                 LV+EF        +D          ++K   ++            + Y HS   
Sbjct: 69  SENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLL--------QGIAYCHSHR- 119

Query: 207 PPIIHGDVKSANILLNDNYTAKVADF---------------ESSVLISSDAETAMSTILI 251
             ++H D+K  N+L++     K+ADF               E   L     E     IL+
Sbjct: 120 --VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPE-----ILL 172

Query: 252 GTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           G+  Y  PV           D++S G + AE++  ++P
Sbjct: 173 GSRQYSTPV-----------DIWSIGCIFAEMVN-RRP 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 40.7 bits (96), Expect = 9e-04
 Identities = 31/95 (32%), Positives = 50/95 (52%), Gaps = 7/95 (7%)

Query: 196 SALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG 255
           S + +LH      I+H D+K++N+LLN+    K+ DF  +    S  +    T L+ T  
Sbjct: 117 SGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY--TQLVVTLW 171

Query: 256 YLDP-VCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           Y  P + +   + +   D++S G + AELLT KKP
Sbjct: 172 YRAPELLLGAKEYSTAIDMWSVGCIFAELLT-KKP 205

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 40.8 bits (95), Expect = 0.001
 Identities = 45/206 (21%), Positives = 87/206 (42%), Gaps = 28/206 (13%)

Query: 105 KGVLHDNIQVAVKTYRRADKIRITER-------ELLRIISQVNHKNVVKILGLCLETEVP 157
           +GV   N          A +++   R       E+L  + ++NH+N++KI  +       
Sbjct: 180 RGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEIL-ALGRLNHENILKIEEILRSEANT 238

Query: 158 LLV---YEFASNGTLLDH-IRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGD 213
            ++   Y+F     + D     +   +L   +T   I  +   A++Y+H      +IH D
Sbjct: 239 YMITQKYDFDLYSFMYDEAFDWKDRPLL--KQT-RAIMKQLLCAVEYIHD---KKLIHRD 292

Query: 214 VKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDV 273
           +K  NI LN +    + DF +++    + E A     +GT     P  +      + +D+
Sbjct: 293 IKLENIFLNCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDI 351

Query: 274 YSFGVVLAELLT---------GKKPG 290
           +S G++L ++L+         G KPG
Sbjct: 352 WSCGLILLDMLSHDFCPIGDGGGKPG 377

Length = 501

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 40.8 bits (95), Expect = 0.001
 Identities = 61/243 (25%), Positives = 97/243 (39%), Gaps = 48/243 (19%)

Query: 87  KNFDRSRCLSQGGFVSVYKGVLHDNIQV-AVKTYRRADKIRITERELLR----IISQVNH 141
           ++F+  + + +G F  V      D   V A+K  R+AD +   +   +R    I+ + + 
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60

Query: 142 KNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYL 201
             VVK+     +     L+ EF   G ++  +       L   +T   IA ET  A+D +
Sbjct: 61  LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM--KKDTLTEEETQFYIA-ETVLAIDSI 117

Query: 202 HSLASPPIIHGDVKSANILLNDNYTAKVADF----------------ESSVLISSD---- 241
           H L     IH D+K  N+LL+     K++DF                  +  + SD    
Sbjct: 118 HQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQ 174

Query: 242 -------AET--------AMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTG 286
                  AET        A ST  +GT  Y+ P         K  D +S GV++ E+L G
Sbjct: 175 NMNSKRKAETWKRNRRQLAFST--VGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Query: 287 KKP 289
             P
Sbjct: 233 YPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 49/217 (22%), Positives = 94/217 (43%), Gaps = 40/217 (18%)

Query: 88  NFDRSRCLSQGGFVSVYKGVLHDNIQ-VAVKTYRRADK-----IRITERELLRIISQVNH 141
           ++++   L +G + +VYKG    N + VA+K  R  ++       I E  LL+    + H
Sbjct: 6   SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLK---GLKH 62

Query: 142 KNVVKILGLCLETEVPLLVYEFASN-----------GTLLDHIRCESSQVLKTWKTCLRI 190
            N+V +  +    E   LV+E+              G   ++++    Q+L+        
Sbjct: 63  ANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLR-------- 114

Query: 191 AAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTIL 250
                  L Y+H      I+H D+K  N+L++D    K+ADF  +   S  + T  + ++
Sbjct: 115 ------GLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV 165

Query: 251 IGTSGYLDP-VCINTGKLTKKSDVYSFGVVLAELLTG 286
             T  Y  P V + + + +   D++  G +  E++ G
Sbjct: 166 --TLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 39.7 bits (93), Expect = 0.002
 Identities = 40/137 (29%), Positives = 56/137 (40%), Gaps = 45/137 (32%)

Query: 192 AETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADF------------------- 232
           AET  A+D +H L     IH D+K  N+LL+     K++DF                   
Sbjct: 108 AETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILS 164

Query: 233 ESSVLISSD-----------AET--------AMSTILIGTSGYLDP-VCINTGKLTKKSD 272
            +      D           AET        A ST  +GT  Y+ P V + TG   K+ D
Sbjct: 165 HALPSNFLDFISKPMSSKRKAETWKRNRRALAYST--VGTPDYIAPEVFLQTG-YNKECD 221

Query: 273 VYSFGVVLAELLTGKKP 289
            +S GV++ E+L G  P
Sbjct: 222 WWSLGVIMYEMLVGYPP 238

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 39.2 bits (91), Expect = 0.002
 Identities = 41/188 (21%), Positives = 80/188 (42%), Gaps = 32/188 (17%)

Query: 114 VAVKTYRRAD---KIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFAS----- 165
           VA+K ++ ++   +++ T    L+++  +  +N+V++           LV+E+       
Sbjct: 29  VAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLE 88

Query: 166 ------NGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANI 219
                 NG   + +R    Q++K              A+ + H      I+H D+K  N+
Sbjct: 89  LLEEMPNGVPPEKVRSYIYQLIK--------------AIHWCHK---NDIVHRDIKPENL 131

Query: 220 LLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVV 279
           L++ N   K+ DF  +  + S+   A  T  + T  Y  P  +      K  D++S G +
Sbjct: 132 LISHNDVLKLCDFGFARNL-SEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCI 190

Query: 280 LAELLTGK 287
           L EL  G+
Sbjct: 191 LGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 39.2 bits (91), Expect = 0.003
 Identities = 63/243 (25%), Positives = 98/243 (40%), Gaps = 50/243 (20%)

Query: 88  NFDRSRCLSQGGFVSVYKGVLHDNIQV-AVKTYRRADKIRITERELLR----IISQVNHK 142
           +F+  + + +G F  V      D   + A+K  R+AD +   +   +R    I+ + +  
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGA 61

Query: 143 NVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLH 202
            VVK+     +     L+ EF   G ++  +       L    T   IA ET  A+D +H
Sbjct: 62  WVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM--KKDTLSEEATQFYIA-ETVLAIDAIH 118

Query: 203 SLASPPIIHGDVKSANILLNDNYTAKVADFESSVLIS----------------SD----- 241
            L     IH D+K  N+LL+     K++DF     +                 SD     
Sbjct: 119 QLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQN 175

Query: 242 ------AET--------AMSTILIGTSGYLDP-VCINTGKLTKKSDVYSFGVVLAELLTG 286
                 AET        A ST  +GT  Y+ P V + TG   K  D +S GV++ E+L G
Sbjct: 176 MNSKRKAETWKKNRRQLAYST--VGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEMLIG 232

Query: 287 KKP 289
             P
Sbjct: 233 YPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 39.0 bits (91), Expect = 0.003
 Identities = 54/219 (24%), Positives = 95/219 (43%), Gaps = 40/219 (18%)

Query: 88  NFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRITERELLRIIS---QVNHKN 143
           NF +   L +G + +VYKG        VA+K     D    T    +R IS   ++ H+N
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIH-LDAEEGTPSTAIREISLMKELKHEN 59

Query: 144 VVKILGLCLETEVPL-LVYEFASN------------GTL-LDHIRCESSQVLKTWKTCLR 189
           +V+ L   + TE  L LV+E+               G L  + ++  + Q+LK       
Sbjct: 60  IVR-LHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLK------- 111

Query: 190 IAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTI 249
                   + + H      ++H D+K  N+L+N     K+ADF  +        T  + +
Sbjct: 112 -------GIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEV 161

Query: 250 LIGTSGYLDP-VCINTGKLTKKSDVYSFGVVLAELLTGK 287
           +  T  Y  P V + +   +   D++S G ++AE++TG+
Sbjct: 162 V--TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 38.8 bits (90), Expect = 0.003
 Identities = 51/207 (24%), Positives = 92/207 (44%), Gaps = 22/207 (10%)

Query: 95  LSQGGFVSVYKG--VLHDNIQVAVKTYRR-----ADKIRITERELLRIISQVNHKNVVKI 147
           L +G + +V+KG   L +N+ VA+K  R      A    I E  LL+    + H N+V +
Sbjct: 14  LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLK---DLKHANIVTL 69

Query: 148 LGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASP 207
             +    +   LV+E+           C +   +   K  L    +    L Y H     
Sbjct: 70  HDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFL---YQILRGLAYCHRRK-- 124

Query: 208 PIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDP-VCINTGK 266
            ++H D+K  N+L+N+    K+ADF  +   S   +T  + ++  T  Y  P V + + +
Sbjct: 125 -VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSSE 181

Query: 267 LTKKSDVYSFGVVLAELLTGKK--PGS 291
            + + D++  G +  E+ +G+   PGS
Sbjct: 182 YSTQIDMWGVGCIFFEMASGRPLFPGS 208

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 38.8 bits (90), Expect = 0.004
 Identities = 58/247 (23%), Positives = 99/247 (40%), Gaps = 44/247 (17%)

Query: 127 ITERELLRIISQVNHKNVVKILGLCLETEVPLLV---YEFASNGTLLDHIRCESSQVLKT 183
            TE  +LR I   NH +++++ G     +   L+   Y+      L          +L  
Sbjct: 131 ATEAHILRAI---NHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAAKRNIAICDILAI 187

Query: 184 WKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESS---VLISS 240
            ++ LR       A+ YLH      IIH D+K+ NI +N      + DF ++   V I++
Sbjct: 188 ERSVLR-------AIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237

Query: 241 DAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP--------GSC 292
           +     +    GT     P  +         D++S G+VL E+ T            G C
Sbjct: 238 NKYYGWA----GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDC 293

Query: 293 MTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERP 352
               S+++I ++      I+ +G      F +  ++ + EI I   LA K  R  G+ RP
Sbjct: 294 ---DSDRQIKLI------IRRSGTHPN-EFPIDAQANLDEIYI--GLAKKSSRKPGS-RP 340

Query: 353 TMKQVSE 359
               + E
Sbjct: 341 LWTNLYE 347

Length = 391

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 38.6 bits (90), Expect = 0.004
 Identities = 35/140 (25%), Positives = 54/140 (38%), Gaps = 46/140 (32%)

Query: 192 AETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADF------------------- 232
           AE   A++ +H +     IH D+K  NIL++ +   K+ DF                   
Sbjct: 108 AELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGD 164

Query: 233 -------ESSVLISSDAETAMSTI---------------LIGTSGYLDP-VCINTGKLTK 269
                  E S   S      +  +               L+GT  Y+ P V + TG  T+
Sbjct: 165 HHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQ 223

Query: 270 KSDVYSFGVVLAELLTGKKP 289
             D +S GV+L E+L G+ P
Sbjct: 224 LCDWWSVGVILYEMLVGQPP 243

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	414
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.98
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.98
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.97
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.97
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.97
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.96
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.95
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.95
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.93
PRK09188	365	serine/threonine protein kinase; Provisional	99.92
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.91
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.91
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.91
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.91
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.89
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.88
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.88
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.87
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.87
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.86
PRK12274	218	serine/threonine protein kinase; Provisional	99.86
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.85
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.85
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.85
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.82
PRK14879	211	serine/threonine protein kinase; Provisional	99.81
PRK10345	210	hypothetical protein; Provisional	99.8
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.79
smart00090	237	RIO RIO-like kinase.	99.78
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.77
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.76
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.74
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.72
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.7
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.69
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.64
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.55
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.54
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.46
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.45
KOG1243	690	consensus Protein kinase [General function predict	99.42
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.41
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.29
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.27
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.26
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.23
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.2
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.13
COG4248	637	Uncharacterized protein with protein kinase and he	99.13
KOG3087	229	consensus Serine/threonine protein kinase [General	99.12
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.02
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.98
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.88
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.83
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.73
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.56
PRK09902	216	hypothetical protein; Provisional	98.56
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.55
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.5
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.46
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.44
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.38
PF01636	239	APH: Phosphotransferase enzyme family This family	98.34
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.32
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.25
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.19
PLN02876	822	acyl-CoA dehydrogenase	98.15
PRK10593	297	hypothetical protein; Provisional	98.14
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.06
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.05
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.01
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.88
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.82
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.8
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.75
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.69
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.67
PRK05231	319	homoserine kinase; Provisional	97.63
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.56
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.2
PLN02756	418	S-methyl-5-thioribose kinase	97.17
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.16
KOG2270	520	consensus Serine/threonine protein kinase involved	97.16
PLN02236	344	choline kinase	97.15
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.11
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.08
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.92
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.92
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.88
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.71
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.65
COG2334	331	Putative homoserine kinase type II (protein kinase	96.63
PRK11768	325	serine/threonine protein kinase; Provisional	96.42
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.39
PRK12396	409	5-methylribose kinase; Reviewed	96.32
PTZ00384	383	choline kinase; Provisional	96.17
KOG1093	725	consensus Predicted protein kinase (contains TBC a	95.9
PF04655	253	APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r	95.81
PRK06148	1013	hypothetical protein; Provisional	95.66
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.65
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.58
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.51

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-55  Score=417.55  Aligned_cols=289  Identities=42%  Similarity=0.644  Sum_probs=249.7

Q ss_pred             ccccccHHHHHHHhcCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccch-hHhHHHHHHHHHccCCCceeeeeeeE
Q 015027           73 RMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKI-RITERELLRIISQVNHKNVVKILGLC  151 (414)
Q Consensus        73 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~hpniv~l~~~~  151 (414)
                      ....|++.++..+|++|.....||+|+||.||+|.+.+|..||||++...... ..++..++.++.+++|||+|+|+|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            56779999999999999999999999999999999999999999988776654 55578888999999999999999999


Q ss_pred             ecCC-cceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEe
Q 015027          152 LETE-VPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVA  230 (414)
Q Consensus       152 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~  230 (414)
                      .+.+ ..+||||||++|+|.++|...... .++|..+++|+.++|+||+|||....++||||||||+|||+|+++++||+
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence            9988 499999999999999999876654 77999999999999999999999887899999999999999999999999


Q ss_pred             eccccccccCCccccceecc-cccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhh
Q 015027          231 DFESSVLISSDAETAMSTIL-IGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLN  309 (414)
Q Consensus       231 DfGla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~  309 (414)
                      |||+|+.....  ....... .||.+|+|||++..+..+.|+|||||||+|+||+||+.|.+...  ......+..|...
T Consensus       220 DFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~--~~~~~~l~~w~~~  295 (361)
T KOG1187|consen  220 DFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSR--PRGELSLVEWAKP  295 (361)
T ss_pred             CccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCC--CcccccHHHHHHH
Confidence            99999665431  1111122 79999999999999999999999999999999999998876322  2233346777777


Q ss_pred             hhcccccccccccccC-CcccH-HHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHH
Q 015027          310 SIKNNGLRQILNFHVA-DESEM-KEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR  366 (414)
Q Consensus       310 ~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~  366 (414)
                      .+....+..++|+.+. ..+.. .....+..++.+|++.+|..||+|.+|++.|+.+..
T Consensus       296 ~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  296 LLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             HHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence            7777788999999976 55554 677889999999999999999999999998866553

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-51  Score=372.09  Aligned_cols=250  Identities=25%  Similarity=0.325  Sum_probs=203.2

Q ss_pred             CCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecc--cchhHhHHHHHHHHHccCCCceeeeeeeEecCCc-ceEEEEe
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRA--DKIRITERELLRIISQVNHKNVVKILGLCLETEV-PLLVYEF  163 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~-~~lv~e~  163 (414)
                      +.+.+..||+|+.|+||++.++ ++..+|+|++...  .....+..+|+++++..+|||||.+||.|..+.. .+|+|||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY  159 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY  159 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence            5566788999999999999977 5888999999443  3445566778899999999999999999999985 9999999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhh-CCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCc
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHS-LASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDA  242 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  242 (414)
                      |++|||.+++...+   ..++....+|+.+|++||.|||+ .+   ||||||||+|||++..|.|||||||.+..+... 
T Consensus       160 MDgGSLd~~~k~~g---~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-  232 (364)
T KOG0581|consen  160 MDGGSLDDILKRVG---RIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-  232 (364)
T ss_pred             cCCCCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence            99999999986543   34789999999999999999996 55   999999999999999999999999999887643 


Q ss_pred             cccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccccc
Q 015027          243 ETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNF  322 (414)
Q Consensus       243 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (414)
                         ...+++||..|||||.+.+..|+.++||||||++++|+.+|+.||.......   ..+.. .        +..+++.
T Consensus       233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~---~~~~~-L--------l~~Iv~~  297 (364)
T KOG0581|consen  233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPY---LDIFE-L--------LCAIVDE  297 (364)
T ss_pred             ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCC---CCHHH-H--------HHHHhcC
Confidence               5567899999999999999999999999999999999999999986431111   01110 1        1112221


Q ss_pred             ccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          323 HVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       323 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ..+.......++++++++..||++||.+|||+.|+++
T Consensus       298 ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  298 PPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             CCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            1111111135577999999999999999999999954

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-50  Score=388.64  Aligned_cols=246  Identities=28%  Similarity=0.436  Sum_probs=208.4

Q ss_pred             cCCCCCCccccCCceEEEEEEE-cCCcEEEEEEeecc----cchhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVL-HDNIQVAVKTYRRA----DKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~  161 (414)
                      .+|...++||+|||+.||.+++ .+|..||+|++.+.    .........|+++.+.|+|||||+++++|++.+++|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5799999999999999999997 78999999999873    344445567789999999999999999999999999999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCC
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD  241 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  241 (414)
                      |+|+.++|..+++   ....+++.+++.++.||+.||.|||+++   |+|||||..|+|++++.+|||+|||+|..+..+
T Consensus        98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~  171 (592)
T KOG0575|consen   98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD  171 (592)
T ss_pred             EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence            9999999999996   3455689999999999999999999988   999999999999999999999999999988755


Q ss_pred             ccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccc
Q 015027          242 AETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILN  321 (414)
Q Consensus       242 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (414)
                      .+  ...+.+|||.|.|||++....++..+||||+|||+|.|+.|++||+......         ....++....     
T Consensus       172 ~E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke---------ty~~Ik~~~Y-----  235 (592)
T KOG0575|consen  172 GE--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE---------TYNKIKLNEY-----  235 (592)
T ss_pred             cc--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH---------HHHHHHhcCc-----
Confidence            33  3456799999999999999999999999999999999999999998543211         1222222111     


Q ss_pred             cccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          322 FHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       322 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                       ..+.    ..+.+..+||.++|+.||.+|||+++|+.
T Consensus       236 -~~P~----~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  236 -SMPS----HLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             -cccc----ccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence             1111    22355899999999999999999999954

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-50  Score=382.10  Aligned_cols=257  Identities=31%  Similarity=0.426  Sum_probs=208.5

Q ss_pred             CCCCCccccCCceEEEEEEEcCCcEEEEEEeecccch---hHhHHHHHHHHHccCCCceeeeeeeEecCC-cceEEEEeC
Q 015027           89 FDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKI---RITERELLRIISQVNHKNVVKILGLCLETE-VPLLVYEFA  164 (414)
Q Consensus        89 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~hpniv~l~~~~~~~~-~~~lv~e~~  164 (414)
                      +...+.||.|+||+||+|.+.....||||++......   ...+..|+.+|.+++|||||+++|+|.+.. ..++||||+
T Consensus        43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~  122 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM  122 (362)
T ss_pred             hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence            3445559999999999999966555999999865433   336678889999999999999999999887 789999999


Q ss_pred             CCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCC-cEEEeeccccccccCCcc
Q 015027          165 SNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNY-TAKVADFESSVLISSDAE  243 (414)
Q Consensus       165 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~DfGla~~~~~~~~  243 (414)
                      ++|+|.+++... ....+++..++.++.||++||.|||+.+ + ||||||||+|||++.++ ++||+|||+++...... 
T Consensus       123 ~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~-~-iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-  198 (362)
T KOG0192|consen  123 PGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEG-P-IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-  198 (362)
T ss_pred             CCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC-C-eeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence            999999999765 3456689999999999999999999976 3 99999999999999997 99999999998765421 


Q ss_pred             ccceecccccccccchhhcc--cCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccc
Q 015027          244 TAMSTILIGTSGYLDPVCIN--TGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILN  321 (414)
Q Consensus       244 ~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (414)
                       ...+...||+.|||||++.  ...|+.|+||||||+++|||+||+.||.......         ....+.....+..++
T Consensus       199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~---------~~~~v~~~~~Rp~~p  268 (362)
T KOG0192|consen  199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ---------VASAVVVGGLRPPIP  268 (362)
T ss_pred             -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH---------HHHHHHhcCCCCCCC
Confidence             2233368999999999999  5699999999999999999999999998554311         111111111111111


Q ss_pred             cccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHh
Q 015027          322 FHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRL  367 (414)
Q Consensus       322 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~  367 (414)
                      .        ..++.+..|+.+||+.||..||++.+++..|+.+...
T Consensus       269 ~--------~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~  306 (362)
T KOG0192|consen  269 K--------ECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH  306 (362)
T ss_pred             c--------cCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence            1        1235699999999999999999999999999988764

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4e-50  Score=367.74  Aligned_cols=252  Identities=23%  Similarity=0.310  Sum_probs=203.0

Q ss_pred             HhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchh------H--hHHHHHHHHHccCCCceeeeeeeEecCC
Q 015027           85 ATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIR------I--TERELLRIISQVNHKNVVKILGLCLETE  155 (414)
Q Consensus        85 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~------~--~~~~~~~~l~~l~hpniv~l~~~~~~~~  155 (414)
                      ..+.|.+.+.||+|+||.|-+|... +|+.||||+++......      .  ...+|+++|++|+|||||+++++|...+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            3466788999999999999999955 69999999997643221      1  1257789999999999999999999999


Q ss_pred             cceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCC---CcEEEeec
Q 015027          156 VPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDN---YTAKVADF  232 (414)
Q Consensus       156 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~---~~~kl~Df  232 (414)
                      ..|+||||++||.|.+.+..+..-   .+.....++.|++.|+.|||++|   |+||||||+|||+..+   ..+||+||
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk~l---~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF  323 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANKYL---REDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF  323 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhcccc---ccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence            999999999999999999765443   45666789999999999999998   9999999999999765   88999999


Q ss_pred             cccccccCCccccceecccccccccchhhcccCC---CCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhh
Q 015027          233 ESSVLISSDAETAMSTILIGTSGYLDPVCINTGK---LTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLN  309 (414)
Q Consensus       233 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~  309 (414)
                      |+|+...   ......+.+|||.|.|||++.+..   +..++|+||+||+||-+++|.+||+.......        ...
T Consensus       324 GlAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s--------l~e  392 (475)
T KOG0615|consen  324 GLAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS--------LKE  392 (475)
T ss_pred             chhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc--------HHH
Confidence            9999876   334567789999999999997654   33488999999999999999999974332210        111


Q ss_pred             hhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          310 SIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ++..+.+      ......+...+++..+||.+||..||++|||+.++++
T Consensus       393 QI~~G~y------~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  393 QILKGRY------AFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             HHhcCcc------cccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence            1111111      1223345566788999999999999999999999854

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-49  Score=361.76  Aligned_cols=246  Identities=28%  Similarity=0.412  Sum_probs=197.2

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch---hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI---RITERELLRIISQVNHKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~  161 (414)
                      ..+|...+.||.|+||+||+|+++ ++..||||.+......   .+....|+.+|+.++|||||.+++++..++.+||||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            467888999999999999999976 5899999999776422   222256789999999999999999999999999999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCC------CcEEEeecccc
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDN------YTAKVADFESS  235 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~------~~~kl~DfGla  235 (414)
                      |||+||+|.+|++..+   .+++.++..++.|++.||++||+++   ||||||||.||||+..      ..+||+|||+|
T Consensus        89 EyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA  162 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA  162 (429)
T ss_pred             EeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence            9999999999997655   4588999999999999999999988   9999999999999764      57899999999


Q ss_pred             ccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcc-c
Q 015027          236 VLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKN-N  314 (414)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~  314 (414)
                      +.+..   .....+.+|+|-|||||++..+.|+.|+|+||+|+|+|+|++|+.||...+..+         +...++. .
T Consensus       163 R~L~~---~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e---------L~~~~~k~~  230 (429)
T KOG0595|consen  163 RFLQP---GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKE---------LLLYIKKGN  230 (429)
T ss_pred             hhCCc---hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHH---------HHHHHhccc
Confidence            99873   345567899999999999999999999999999999999999999998544222         1111111 1


Q ss_pred             ccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHH
Q 015027          315 GLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQV  357 (414)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v  357 (414)
                      ...........        ..+.+|+...++.+|..|.++.+.
T Consensus       231 ~~~~~~~~~~s--------~~~~~Ll~~ll~~~~~~~~~~~~~  265 (429)
T KOG0595|consen  231 EIVPVLPAELS--------NPLRELLISLLQRNPKDRISFEDF  265 (429)
T ss_pred             cccCchhhhcc--------CchhhhhhHHHhcCccccCchHHh
Confidence            11111111111        225577777777777777665544

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.9e-51  Score=355.43  Aligned_cols=254  Identities=26%  Similarity=0.343  Sum_probs=201.8

Q ss_pred             cCCCCCCccccCCceEEEEEE-EcCCcEEEEEEeeccc---chhHhHHHHHHHHHccCCCceeeeee-eEecCC-cceEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRAD---KIRITERELLRIISQVNHKNVVKILG-LCLETE-VPLLV  160 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~~~~l~~l~hpniv~l~~-~~~~~~-~~~lv  160 (414)
                      .+|+++++||+|+||+||++. ..+|..||.|.+.-..   .....-..++.+|++|+|||||++++ .|.++. .++||
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            468889999999999999998 4589999999987432   22333466778999999999999998 444444 48999


Q ss_pred             EEeCCCCchhhhhhhc-CCcccCCHHHHHHHHHHHHHHHHHhhhCCC-CCeeeCCCCCCceeeCCCCcEEEeeccccccc
Q 015027          161 YEFASNGTLLDHIRCE-SSQVLKTWKTCLRIAAETASALDYLHSLAS-PPIIHGDVKSANILLNDNYTAKVADFESSVLI  238 (414)
Q Consensus       161 ~e~~~~gsL~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~  238 (414)
                      ||||.+|+|...++.- ......++.++++++.|++.||..+|+.-. .-|+||||||.||+++.+|.|||+|||+++++
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            9999999999998543 334556899999999999999999998441 23999999999999999999999999999998


Q ss_pred             cCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccc
Q 015027          239 SSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQ  318 (414)
Q Consensus       239 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (414)
                      ...  +......+|||.||+||.+.+.+|+.||||||+||++|||+.-++||.+....+         .-..+....+. 
T Consensus       179 ~s~--~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~---------L~~KI~qgd~~-  246 (375)
T KOG0591|consen  179 SSK--TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLS---------LCKKIEQGDYP-  246 (375)
T ss_pred             cch--hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHH---------HHHHHHcCCCC-
Confidence            753  445567899999999999999999999999999999999999999998653221         11112222111 


Q ss_pred             ccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          319 ILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       319 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                             .-+..-.+..+..||..|+..||+.||+.-.++.
T Consensus       247 -------~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~  280 (375)
T KOG0591|consen  247 -------PLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQ  280 (375)
T ss_pred             -------CCcHHHhhhHHHHHHHHHccCCcccCCCcchHHH
Confidence                   1111334567999999999999999998544433

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-49  Score=375.52  Aligned_cols=257  Identities=30%  Similarity=0.401  Sum_probs=213.5

Q ss_pred             CCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCCCC
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNG  167 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g  167 (414)
                      .+..++.||+|.||.||.|.++....||+|.++........+.+|+++|.+|+|+|||+++++|..++.+|||||||+.|
T Consensus       207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G  286 (468)
T KOG0197|consen  207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG  286 (468)
T ss_pred             HHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence            34567889999999999999988889999999988777778888899999999999999999999988999999999999


Q ss_pred             chhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccccce
Q 015027          168 TLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMS  247 (414)
Q Consensus       168 sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  247 (414)
                      +|.++|+... ...+...+.+.++.|||+|++||.+++   +|||||-+.||||+++..+||+|||+|+....+.. ...
T Consensus       287 sLl~yLr~~~-~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y-~~~  361 (468)
T KOG0197|consen  287 SLLDYLRTRE-GGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY-TAS  361 (468)
T ss_pred             cHHHHhhhcC-CCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCce-eec
Confidence            9999998733 234477889999999999999999988   99999999999999999999999999995544322 222


Q ss_pred             ecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhcccccccccccccCC
Q 015027          248 TILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVAD  326 (414)
Q Consensus       248 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (414)
                      ....-...|.|||.+....++.|||||||||+||||+| |+.||..++...         ++..         +.....-
T Consensus       362 ~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e---------v~~~---------le~GyRl  423 (468)
T KOG0197|consen  362 EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE---------VLEL---------LERGYRL  423 (468)
T ss_pred             CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH---------HHHH---------HhccCcC
Confidence            22223457999999999999999999999999999999 999987655322         2222         2222233


Q ss_pred             cccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHh
Q 015027          327 ESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRL  367 (414)
Q Consensus       327 ~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~  367 (414)
                      +.+...+..+.+|+..||..+|++|||++.+...|+.+...
T Consensus       424 p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~  464 (468)
T KOG0197|consen  424 PRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS  464 (468)
T ss_pred             CCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence            33344456799999999999999999999999998887653

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=4e-48  Score=351.85  Aligned_cols=242  Identities=25%  Similarity=0.312  Sum_probs=198.2

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhH----hHHHHHHHHHccCCCceeeeeeeEecCCcceEE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRI----TERELLRIISQVNHKNVVKILGLCLETEVPLLV  160 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~----~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv  160 (414)
                      .++|++++.||+|+||.||.++.+ +++.+|+|++++..-...    ....|..+|..++||+||+++..|++.+.+|+|
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            478999999999999999999965 589999999987654333    225567899999999999999999999999999


Q ss_pred             EEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccC
Q 015027          161 YEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISS  240 (414)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  240 (414)
                      +||+.||.|..+|.+++..   ++..+.-++.+|+.||.|||+.+   ||||||||+|||+|.+|+++|+|||+++....
T Consensus       104 ld~~~GGeLf~hL~~eg~F---~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~  177 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQREGRF---SEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK  177 (357)
T ss_pred             EeccCCccHHHHHHhcCCc---chhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence            9999999999999765543   67788889999999999999988   99999999999999999999999999986543


Q ss_pred             CccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccc
Q 015027          241 DAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQIL  320 (414)
Q Consensus       241 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (414)
                      .  .....+++||+.|||||++.+..|+..+|+||||+++|||++|.+||...+...         ....+....+  . 
T Consensus       178 ~--~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~---------~~~~I~~~k~--~-  243 (357)
T KOG0598|consen  178 D--GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK---------MYDKILKGKL--P-  243 (357)
T ss_pred             C--CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH---------HHHHHhcCcC--C-
Confidence            2  223455899999999999999999999999999999999999999998554322         1111111110  0 


Q ss_pred             ccccCCcccHHHHHHHHHHHHHhhccCCCCCCC
Q 015027          321 NFHVADESEMKEIEIVAELASKCLRIRGTERPT  353 (414)
Q Consensus       321 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps  353 (414)
                            ..+.-.+.+..+|+.++|..||++|..
T Consensus       244 ------~~p~~ls~~ardll~~LL~rdp~~RLg  270 (357)
T KOG0598|consen  244 ------LPPGYLSEEARDLLKKLLKRDPRQRLG  270 (357)
T ss_pred             ------CCCccCCHHHHHHHHHHhccCHHHhcC
Confidence                  011111245899999999999999964

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.2e-47  Score=338.67  Aligned_cols=265  Identities=20%  Similarity=0.286  Sum_probs=204.7

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc---hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK---IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYE  162 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  162 (414)
                      +.|+.+.++|+|+||+||+++.+ +|+.||||.+..+..   ......+++++|++++|||+|.++++|......++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            46888899999999999999977 499999999976543   34455788899999999999999999999999999999


Q ss_pred             eCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCc
Q 015027          163 FASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDA  242 (414)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  242 (414)
                      ||+..-|. -|......  .+...+.+++.|++.|+.|+|+++   +|||||||+||||+.+|.+||||||+|+.+..  
T Consensus        82 ~~dhTvL~-eLe~~p~G--~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--  153 (396)
T KOG0593|consen   82 YCDHTVLH-ELERYPNG--VPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA--  153 (396)
T ss_pred             ecchHHHH-HHHhccCC--CCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC--
Confidence            99885554 44433322  267888999999999999999988   99999999999999999999999999998875  


Q ss_pred             cccceecccccccccchhhccc-CCCCCcccchhHHHHHHHHHhCCCCCCcccccccc------ccccchhhhhhhcccc
Q 015027          243 ETAMSTILIGTSGYLDPVCINT-GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNK------KISMVPYFLNSIKNNG  315 (414)
Q Consensus       243 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~------~~~~~~~~~~~~~~~~  315 (414)
                      .....+..+.|.||+|||.+.| ..|...+||||+||++.||++|.+-|.+.+....-      ...+.+.....+..+.
T Consensus       154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~  233 (396)
T KOG0593|consen  154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP  233 (396)
T ss_pred             CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence            3345677899999999999987 68999999999999999999999988765432211      1122232222222221


Q ss_pred             -cccccccccCCccc-----HHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          316 -LRQILNFHVADESE-----MKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       316 -~~~~~~~~~~~~~~-----~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                       +..+.-+......+     ...+.-+.+|+..||+.||.+|++-++++.
T Consensus       234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence             11111111111111     112346889999999999999999999874

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-46  Score=343.66  Aligned_cols=261  Identities=25%  Similarity=0.333  Sum_probs=207.4

Q ss_pred             hcCCCCCCccccCCceEEEEEEE-cCCcEEEEEEeecccchh--HhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVL-HDNIQVAVKTYRRADKIR--ITERELLRIISQVNHKNVVKILGLCLETEVPLLVYE  162 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  162 (414)
                      .+.|++...||.|..++||+|+. ..+..||||++..+....  ...+.+++.++.++||||++++..|..+..+|+||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            57899999999999999999994 468999999998765443  334677899999999999999999999999999999


Q ss_pred             eCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCc
Q 015027          163 FASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDA  242 (414)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  242 (414)
                      ||.+||+.+++...-... +++..+..|++++++||.|||++|   .||||||+.||||+++|.|||+|||.+..+....
T Consensus       105 fMa~GS~ldIik~~~~~G-l~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G  180 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPDG-LEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG  180 (516)
T ss_pred             hhcCCcHHHHHHHHcccc-ccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence            999999999997655443 578889999999999999999988   9999999999999999999999999876554332


Q ss_pred             -cccce-ecccccccccchhhcc--cCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccc
Q 015027          243 -ETAMS-TILIGTSGYLDPVCIN--TGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQ  318 (414)
Q Consensus       243 -~~~~~-~~~~gt~~y~aPE~~~--~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (414)
                       ..... ...+||+.|||||++.  ...|+.|+||||||++..||.+|..||.......        ....... +....
T Consensus       181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk--------vLl~tLq-n~pp~  251 (516)
T KOG0582|consen  181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK--------VLLLTLQ-NDPPT  251 (516)
T ss_pred             ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH--------HHHHHhc-CCCCC
Confidence             11122 5679999999999964  4579999999999999999999999997443211        0111111 11111


Q ss_pred             ccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          319 ILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       319 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ........+........+.+++..||+.||.+|||++++++
T Consensus       252 ~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  252 LLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             cccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            11112222233344467999999999999999999999875

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-47  Score=354.22  Aligned_cols=266  Identities=22%  Similarity=0.250  Sum_probs=204.9

Q ss_pred             HhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchh--HhHHHHHHHHHccC-CCceeeeeeeEecCC-cceE
Q 015027           85 ATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIR--ITERELLRIISQVN-HKNVVKILGLCLETE-VPLL  159 (414)
Q Consensus        85 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~~~l~~l~-hpniv~l~~~~~~~~-~~~l  159 (414)
                      ..++|.++++||.|+||.||+|+.. +|..||||.++.....-  ....+|++.|++++ |||||++.+++.+.+ .+|+
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            3468999999999999999999954 68999999987654322  22366778999999 999999999999887 9999


Q ss_pred             EEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccccccc
Q 015027          160 VYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLIS  239 (414)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~  239 (414)
                      |||||+. +|+++++..  ...+++..+..|+.||++||+|+|.+|   ++|||+||+|||+..+..+||+|||+|+...
T Consensus        88 VfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~  161 (538)
T KOG0661|consen   88 VFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVR  161 (538)
T ss_pred             eHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccc
Confidence            9999975 899999776  456689999999999999999999988   9999999999999999999999999999876


Q ss_pred             CCccccceecccccccccchhhc-ccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccc-----------cccch-h
Q 015027          240 SDAETAMSTILIGTSGYLDPVCI-NTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKK-----------ISMVP-Y  306 (414)
Q Consensus       240 ~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~-----------~~~~~-~  306 (414)
                      ...   ..+..+.|.||+|||++ +..-|+.+.||||+|||++|+.+-++-|.+.+..+...           ..+.. +
T Consensus       162 Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~  238 (538)
T KOG0661|consen  162 SKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY  238 (538)
T ss_pred             cCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence            543   34567899999999998 46789999999999999999999999887544221100           00000 0


Q ss_pred             hhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHH
Q 015027          307 FLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEE  360 (414)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~  360 (414)
                      .+...-.-.+.......+....+. .+.++.+|+.+||++||.+|||+.++++.
T Consensus       239 ~La~~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  239 NLASAMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHHHHhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            000000001111111111111111 45779999999999999999999999653

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-46  Score=357.05  Aligned_cols=248  Identities=23%  Similarity=0.329  Sum_probs=205.8

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhHh-HHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeC
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRIT-ERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFA  164 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~-~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  164 (414)
                      ..|....+||+|+.|.||.|... +++.||||.+........+ ...|+.+|+..+|+|||.+++.|..++.+|+|||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            46788899999999999999954 6889999999876554433 477789999999999999999999999999999999


Q ss_pred             CCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccc
Q 015027          165 SNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET  244 (414)
Q Consensus       165 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  244 (414)
                      +||+|.|.+..    ..+++.++..|+.++++||+|||.++   |+|||||.+|||++.+|.+||+|||++..+..... 
T Consensus       353 ~ggsLTDvVt~----~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-  424 (550)
T KOG0578|consen  353 EGGSLTDVVTK----TRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-  424 (550)
T ss_pred             CCCchhhhhhc----ccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC-
Confidence            99999999843    33588999999999999999999988   99999999999999999999999999988765432 


Q ss_pred             cceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccccccc
Q 015027          245 AMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHV  324 (414)
Q Consensus       245 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (414)
                       .....+|||.|||||+.....|++|+||||||++++||+.|++||-....-       .  .+-.+..++.       .
T Consensus       425 -KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl-------r--AlyLIa~ng~-------P  487 (550)
T KOG0578|consen  425 -KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL-------R--ALYLIATNGT-------P  487 (550)
T ss_pred             -ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChH-------H--HHHHHhhcCC-------C
Confidence             446679999999999999999999999999999999999999998531110       0  0011111111       1


Q ss_pred             CCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          325 ADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       325 ~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ....+...+..|.+++.+||..|+.+|+++.++++
T Consensus       488 ~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  488 KLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             CcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence            22233344577999999999999999999999975

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-46  Score=351.11  Aligned_cols=251  Identities=27%  Similarity=0.389  Sum_probs=202.3

Q ss_pred             HHHhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhHh----HHHHHHHHHcc-CCCceeeeeeeEecCCc
Q 015027           83 IRATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRIT----ERELLRIISQV-NHKNVVKILGLCLETEV  156 (414)
Q Consensus        83 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~----~~~~~~~l~~l-~hpniv~l~~~~~~~~~  156 (414)
                      .+..++|.+.+.||+|+|++|++|+.. +++.+|||++.+.-..++.    ...|-..|.+| .||.|++|+..|.++..
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            556789999999999999999999965 5899999998654322211    12223455556 89999999999999999


Q ss_pred             ceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccc
Q 015027          157 PLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSV  236 (414)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~  236 (414)
                      +|+|+||+++|.|.++|...+.   +++...+.++.+|+.||+|||++|   ||||||||+|||+|+++++||+|||.|+
T Consensus       149 LYFvLe~A~nGdll~~i~K~Gs---fde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK  222 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYGS---FDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAK  222 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhCc---chHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccc
Confidence            9999999999999999976654   367778889999999999999988   9999999999999999999999999998


Q ss_pred             cccCCccc---------cce--ecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccch
Q 015027          237 LISSDAET---------AMS--TILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVP  305 (414)
Q Consensus       237 ~~~~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~  305 (414)
                      .+......         ...  ..++||..|.+||++..+..+..+|||+||||||+|+.|.+||.+....         
T Consensus       223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney---------  293 (604)
T KOG0592|consen  223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY---------  293 (604)
T ss_pred             cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH---------
Confidence            87653222         112  4589999999999999999999999999999999999999999744311         


Q ss_pred             hhhhhhcccccccc--cccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHH
Q 015027          306 YFLNSIKNNGLRQI--LNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEE  360 (414)
Q Consensus       306 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~  360 (414)
                       .       .++.+  ++..++...    ++.+.+|+.++|..||.+|+|.++|.+.
T Consensus       294 -l-------iFqkI~~l~y~fp~~f----p~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  294 -L-------IFQKIQALDYEFPEGF----PEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             -H-------HHHHHHHhcccCCCCC----CHHHHHHHHHHHccCccccccHHHHhhC
Confidence             0       01111  112222222    2568999999999999999999888653

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-46  Score=342.86  Aligned_cols=255  Identities=28%  Similarity=0.396  Sum_probs=198.7

Q ss_pred             hcCCCCCCccccCCceEEEEEEEcC-CcEEEEEEeecccchh-HhHHHHHHHHHccCCCceeeeeeeEecCC--cceEEE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLHD-NIQVAVKTYRRADKIR-ITERELLRIISQVNHKNVVKILGLCLETE--VPLLVY  161 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~-~~~~~~~~~l~~l~hpniv~l~~~~~~~~--~~~lv~  161 (414)
                      ..++...+.||+|+||+||++...+ |...|||.+....... ....+++++|++++|||||+++|......  .++++|
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m   95 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM   95 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence            3457778899999999999999764 8999999987763222 23466679999999999999999855444  689999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCC-CCcEEEeeccccccccC
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLND-NYTAKVADFESSVLISS  240 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~DfGla~~~~~  240 (414)
                      ||+++|+|.+++...+.  .+++..+..+..||++||.|||+++   |+||||||+|||++. ++.+||+|||++.....
T Consensus        96 Ey~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~  170 (313)
T KOG0198|consen   96 EYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES  170 (313)
T ss_pred             eccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence            99999999999987665  4688999999999999999999988   999999999999999 79999999999987664


Q ss_pred             -CccccceecccccccccchhhcccC-CCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccc
Q 015027          241 -DAETAMSTILIGTSGYLDPVCINTG-KLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQ  318 (414)
Q Consensus       241 -~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (414)
                       ...........||+.|||||++..+ ....++|||||||++.||+||.+||... .      ....+..........  
T Consensus       171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~------~~~~~~~~ig~~~~~--  241 (313)
T KOG0198|consen  171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-F------EEAEALLLIGREDSL--  241 (313)
T ss_pred             ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-c------chHHHHHHHhccCCC--
Confidence             1112223457899999999999853 3445999999999999999999999742 0      011111111111101  


Q ss_pred             ccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHH
Q 015027          319 ILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEEL  361 (414)
Q Consensus       319 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L  361 (414)
                         +.    .+...+....+++.+|+..+|++|||+.++++..
T Consensus       242 ---P~----ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp  277 (313)
T KOG0198|consen  242 ---PE----IPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP  277 (313)
T ss_pred             ---CC----CCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence               11    1222335689999999999999999999996543

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.6e-46  Score=348.37  Aligned_cols=267  Identities=22%  Similarity=0.263  Sum_probs=202.6

Q ss_pred             HhcCCCCCCccccCCceEEEEEEE-cCCcEEEEEEeecccc---hhHhHHHHHHHHHccCCCceeeeeeeEecC--Ccce
Q 015027           85 ATKNFDRSRCLSQGGFVSVYKGVL-HDNIQVAVKTYRRADK---IRITERELLRIISQVNHKNVVKILGLCLET--EVPL  158 (414)
Q Consensus        85 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~hpniv~l~~~~~~~--~~~~  158 (414)
                      ..+.|+.+++||+|+||.||+|++ .+|..||+|.+..+..   ......+|+.+|++|+||||++|.+...+.  ..+|
T Consensus       115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY  194 (560)
T KOG0600|consen  115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY  194 (560)
T ss_pred             chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence            346788899999999999999995 4699999999986542   234447778999999999999999998776  6899


Q ss_pred             EEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccc
Q 015027          159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLI  238 (414)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~  238 (414)
                      ||+|||+. +|.-++...+  ..+++.++..++.|++.||.|||+++   |+|||||.+|||||.+|.+||+|||||+++
T Consensus       195 lVFeYMdh-DL~GLl~~p~--vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y  268 (560)
T KOG0600|consen  195 LVFEYMDH-DLSGLLSSPG--VKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFY  268 (560)
T ss_pred             EEEecccc-hhhhhhcCCC--cccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeec
Confidence            99999987 7777775433  34488999999999999999999988   999999999999999999999999999988


Q ss_pred             cCCccccceecccccccccchhhcccC-CCCCcccchhHHHHHHHHHhCCCCCCcccccccccc------ccchhhhhhh
Q 015027          239 SSDAETAMSTILIGTSGYLDPVCINTG-KLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKI------SMVPYFLNSI  311 (414)
Q Consensus       239 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~------~~~~~~~~~~  311 (414)
                      ..... ...+..+-|.||.|||.+.|. .|+.++|+||.||||.||++|++.|.+.+.-.....      ...+..+...
T Consensus       269 ~~~~~-~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~  347 (560)
T KOG0600|consen  269 TPSGS-APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS  347 (560)
T ss_pred             cCCCC-cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence            76533 335667889999999999775 699999999999999999999999876442111000      0000011100


Q ss_pred             cccccccccccccC-----CcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          312 KNNGLRQILNFHVA-----DESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       312 ~~~~~~~~~~~~~~-----~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ..... ..+.+...     .+.....+....+|+..+|..||.+|.|+.+++.
T Consensus       348 kLP~~-~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  348 KLPHA-TIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             cCCcc-cccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            00000 01111000     0001112356789999999999999999998865

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=3.2e-45  Score=351.81  Aligned_cols=261  Identities=25%  Similarity=0.357  Sum_probs=200.7

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc------CCcEEEEEEeecccch--hHhHHHHHHHHHcc-CCCceeeeeeeEecC-C
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH------DNIQVAVKTYRRADKI--RITERELLRIISQV-NHKNVVKILGLCLET-E  155 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l-~hpniv~l~~~~~~~-~  155 (414)
                      .++|++.+.||+|+||.||+|.+.      ++..||||++......  ......++.++..+ +||||++++++|... .
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            467999999999999999999741      3567999998754322  23345667888888 899999999988764 4


Q ss_pred             cceEEEEeCCCCchhhhhhhcCC---------------------------------------------------------
Q 015027          156 VPLLVYEFASNGTLLDHIRCESS---------------------------------------------------------  178 (414)
Q Consensus       156 ~~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------  178 (414)
                      ..++||||+++|+|.+++.....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            57899999999999999864321                                                         


Q ss_pred             --cccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccccceecccccccc
Q 015027          179 --QVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY  256 (414)
Q Consensus       179 --~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y  256 (414)
                        ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...............+++.|
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence              123677888999999999999999987   999999999999999999999999999865433222222334567789


Q ss_pred             cchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhcccccccccccccCCcccHHHHHH
Q 015027          257 LDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEI  335 (414)
Q Consensus       257 ~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (414)
                      +|||++.+..++.++|||||||++|||++ |..||.......        .+..........     ..    +...+..
T Consensus       243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--------~~~~~~~~~~~~-----~~----~~~~~~~  305 (338)
T cd05102         243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--------EFCQRLKDGTRM-----RA----PENATPE  305 (338)
T ss_pred             cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--------HHHHHHhcCCCC-----CC----CCCCCHH
Confidence            99999999999999999999999999997 999987432111        011111111100     00    1112256


Q ss_pred             HHHHHHHhhccCCCCCCChhHHHHHHHHHHH
Q 015027          336 VAELASKCLRIRGTERPTMKQVSEELDRLRR  366 (414)
Q Consensus       336 l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~  366 (414)
                      +.+|+.+||+.||.+|||+.+|++.|+.+..
T Consensus       306 l~~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         306 IYRIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            8999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-45  Score=349.09  Aligned_cols=248  Identities=24%  Similarity=0.349  Sum_probs=200.5

Q ss_pred             HhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecc----cc--hhHhHHHHHHHHHccC-CCceeeeeeeEecCCc
Q 015027           85 ATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRA----DK--IRITERELLRIISQVN-HKNVVKILGLCLETEV  156 (414)
Q Consensus        85 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~--~~~~~~~~~~~l~~l~-hpniv~l~~~~~~~~~  156 (414)
                      ..++|.+.+.||+|+||+|+.|... ++..||+|++...    ..  ......+++.+++.++ ||||+++++++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            4578999999999999999999855 6899999977654    11  2223345678999999 9999999999999999


Q ss_pred             ceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCC-CcEEEeecccc
Q 015027          157 PLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDN-YTAKVADFESS  235 (414)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~DfGla  235 (414)
                      .|+||||+.||.|.+++...+   .+.+..+..++.|++.|++|||+++   |+||||||+|||++.+ +++||+|||++
T Consensus        95 ~~ivmEy~~gGdL~~~i~~~g---~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s  168 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVNKG---RLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLS  168 (370)
T ss_pred             EEEEEEecCCccHHHHHHHcC---CCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence            999999999999999997633   2366889999999999999999988   9999999999999999 99999999999


Q ss_pred             ccccCCccccceecccccccccchhhcccCC-CC-CcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcc
Q 015027          236 VLISSDAETAMSTILIGTSGYLDPVCINTGK-LT-KKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKN  313 (414)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  313 (414)
                      ....  .......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||.......         ....+..
T Consensus       169 ~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~---------l~~ki~~  237 (370)
T KOG0583|consen  169 AISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN---------LYRKIRK  237 (370)
T ss_pred             cccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH---------HHHHHhc
Confidence            8874  1233456679999999999999877 86 78999999999999999999998532111         1111111


Q ss_pred             cccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHH
Q 015027          314 NGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVS  358 (414)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~  358 (414)
                      ..+  .+...+.       +.++..|+.+||..+|.+|+|+.+|+
T Consensus       238 ~~~--~~p~~~~-------S~~~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  238 GEF--KIPSYLL-------SPEARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             CCc--cCCCCcC-------CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence            110  0111110       35689999999999999999999995

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-45  Score=320.47  Aligned_cols=235  Identities=27%  Similarity=0.342  Sum_probs=196.0

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhHh----HHHHHHHHHccCCCceeeeeeeEecCCcceEEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRIT----ERELLRIISQVNHKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~----~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~  161 (414)
                      ++|++++.||.|+||.|.+++.+ +|..+|+|++......+..    ...+.++|+.+.||+++++++.|.+.+.+|+||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            67899999999999999999976 5888999999876544322    245668999999999999999999999999999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCC
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD  241 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  241 (414)
                      ||++||.|..+++..++.   ++..++-++.+|+.||+|||+.+   |++|||||+|||+|.+|.+||+|||+|+.+...
T Consensus       124 eyv~GGElFS~Lrk~~rF---~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r  197 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKSGRF---SEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR  197 (355)
T ss_pred             eccCCccHHHHHHhcCCC---CchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence            999999999999765543   67888889999999999999988   999999999999999999999999999887542


Q ss_pred             ccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccc
Q 015027          242 AETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILN  321 (414)
Q Consensus       242 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (414)
                           .-+.+|||.|+|||++....|+.++|.|||||++|||+.|.+||.......         ....+....      
T Consensus       198 -----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~---------iY~KI~~~~------  257 (355)
T KOG0616|consen  198 -----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ---------IYEKILEGK------  257 (355)
T ss_pred             -----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH---------HHHHHHhCc------
Confidence                 456799999999999999999999999999999999999999997544211         111111111      


Q ss_pred             cccCCcccHHHHHHHHHHHHHhhccCCCCC
Q 015027          322 FHVADESEMKEIEIVAELASKCLRIRGTER  351 (414)
Q Consensus       322 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~R  351 (414)
                        +.  ++.-....+.+|+.++|+.|-.+|
T Consensus       258 --v~--fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  258 --VK--FPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             --cc--CCcccCHHHHHHHHHHHhhhhHhh
Confidence              11  111122558999999999999999

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-46  Score=343.82  Aligned_cols=247  Identities=23%  Similarity=0.347  Sum_probs=204.0

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchh--HhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEe
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIR--ITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  163 (414)
                      ..|...++||+|+||.||+|.+. +++.||+|++..+....  ....+++.++.+++++||.++|+.+..+..++++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            45777789999999999999965 58899999998765433  3336677899999999999999999999999999999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcc
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE  243 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  243 (414)
                      |.||++.+.+.....   +.+..+.-++++++.|+.|||..+   .+|||||+.|||+..+|.+||+|||.+.++.....
T Consensus        93 ~~gGsv~~lL~~~~~---~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~  166 (467)
T KOG0201|consen   93 CGGGSVLDLLKSGNI---LDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK  166 (467)
T ss_pred             hcCcchhhhhccCCC---CccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence            999999999965433   255666778999999999999988   99999999999999999999999999988876533


Q ss_pred             ccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccc
Q 015027          244 TAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFH  323 (414)
Q Consensus       244 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (414)
                      .  ..+++|||.|||||++.+..|+.|+||||||++.+||.+|.+|+......                  .+.-++...
T Consensus       167 r--r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm------------------rvlflIpk~  226 (467)
T KOG0201|consen  167 R--RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM------------------RVLFLIPKS  226 (467)
T ss_pred             c--cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc------------------eEEEeccCC
Confidence            3  36789999999999999999999999999999999999999998743321                  111122222


Q ss_pred             cCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          324 VADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       324 ~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      .++......++.+++++..||+.||+.|||+.++++
T Consensus       227 ~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  227 APPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             CCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            222222234466999999999999999999999876

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=8.9e-45  Score=315.26  Aligned_cols=265  Identities=20%  Similarity=0.220  Sum_probs=203.4

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeeccc---chhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRAD---KIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYE  162 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  162 (414)
                      .+|...+.||+|.||.||+|++. +|+.||||.++...   .......+|++.|+.++||||+.++++|...+...||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            46888899999999999999964 69999999998653   335666788899999999999999999999999999999


Q ss_pred             eCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCc
Q 015027          163 FASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDA  242 (414)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  242 (414)
                      ||+. +|...++...  ..++...+..++.++++|++|||.+.   |+||||||.|+|++++|.+||+|||+|+......
T Consensus        82 fm~t-dLe~vIkd~~--i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~  155 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDKN--IILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN  155 (318)
T ss_pred             eccc-cHHHHhcccc--cccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence            9976 8988886543  45678899999999999999999988   9999999999999999999999999999987654


Q ss_pred             cccceecccccccccchhhccc-CCCCCcccchhHHHHHHHHHhCCCCCCccccccccccc------cchhhhhhhcc--
Q 015027          243 ETAMSTILIGTSGYLDPVCINT-GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKIS------MVPYFLNSIKN--  313 (414)
Q Consensus       243 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~------~~~~~~~~~~~--  313 (414)
                      ..  ....+-|.+|.|||.+.| ..|+..+||||.|||+.||+-|.+-|.+.+.-+.-...      -.+..+..+..  
T Consensus       156 ~~--~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lp  233 (318)
T KOG0659|consen  156 RI--QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLP  233 (318)
T ss_pred             cc--cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccc
Confidence            33  233378999999998865 57999999999999999999998877654422110000      00000111100  


Q ss_pred             --cccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHH
Q 015027          314 --NGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEE  360 (414)
Q Consensus       314 --~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~  360 (414)
                        ..+. .++.......-..++..+.+|+.+||..||.+|+|+.|+++.
T Consensus       234 dY~~~~-~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  234 DYVKIQ-QFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             cHHHHh-cCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence              0011 111111111112234567999999999999999999998543

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.1e-45  Score=349.98  Aligned_cols=245  Identities=20%  Similarity=0.295  Sum_probs=203.5

Q ss_pred             cCCCCCCccccCCceEEEEEEE-cCCcEEEEEEeecccch----hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVL-HDNIQVAVKTYRRADKI----RITERELLRIISQVNHKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~  161 (414)
                      .-|++.+.||.|+.|.|-+|++ .+|+.+|||++......    ......|+.+|+.+.|||++++|+++++...+|+|.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            3477889999999999999995 47999999999876322    222355678999999999999999999999999999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCC
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD  241 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  241 (414)
                      ||++||.|++++...++   +++..+.+++.||+.|+.|||..+   ||||||||+|+|+|..+++||+|||+|.+-.. 
T Consensus        92 Eyv~gGELFdylv~kG~---l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~-  164 (786)
T KOG0588|consen   92 EYVPGGELFDYLVRKGP---LPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVP-  164 (786)
T ss_pred             EecCCchhHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccC-
Confidence            99999999999976554   467889999999999999999988   99999999999999999999999999987543 


Q ss_pred             ccccceecccccccccchhhcccCCCC-CcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccc
Q 015027          242 AETAMSTILIGTSGYLDPVCINTGKLT-KKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQIL  320 (414)
Q Consensus       242 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (414)
                        .....+.||+|+|++||++.|.+|. .++||||.|||||.|++|+.||++.+..         ..+..+..+.++.  
T Consensus       165 --gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir---------~LLlKV~~G~f~M--  231 (786)
T KOG0588|consen  165 --GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIR---------VLLLKVQRGVFEM--  231 (786)
T ss_pred             --CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHH---------HHHHHHHcCcccC--
Confidence              3345567999999999999999885 7899999999999999999999843321         1333333333221  


Q ss_pred             ccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          321 NFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       321 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                              +...+.+.++|+.+||..||++|.|+++|++
T Consensus       232 --------Ps~Is~eaQdLLr~ml~VDp~~RiT~~eI~k  262 (786)
T KOG0588|consen  232 --------PSNISSEAQDLLRRMLDVDPSTRITTEEILK  262 (786)
T ss_pred             --------CCcCCHHHHHHHHHHhccCccccccHHHHhh
Confidence                    1223366999999999999999999999954

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=8.5e-45  Score=343.21  Aligned_cols=250  Identities=21%  Similarity=0.303  Sum_probs=196.9

Q ss_pred             HhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhHhH----HHHHHHHHccCCCceeeeeeeEecCCcceE
Q 015027           85 ATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRITE----RELLRIISQVNHKNVVKILGLCLETEVPLL  159 (414)
Q Consensus        85 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~----~~~~~~l~~l~hpniv~l~~~~~~~~~~~l  159 (414)
                      ..++|++++.||+|+||.||+|+-+ +|..+|+|+++++.-.....    +.|-.+|...++|+||+++..|++.+.+||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            4578999999999999999999955 59999999999875443322    445567888899999999999999999999


Q ss_pred             EEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccccccc
Q 015027          160 VYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLIS  239 (414)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~  239 (414)
                      ||||++||++..+|...   ..+++..+..++.+++.|+..||+.|   +|||||||+|+|||..|++||+||||+.-+.
T Consensus       219 iMEylPGGD~mTLL~~~---~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~  292 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMRK---DTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD  292 (550)
T ss_pred             EEEecCCccHHHHHHhc---CcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence            99999999999998643   45578888889999999999999988   9999999999999999999999999985322


Q ss_pred             CC----------------------ccc-----------------------cceecccccccccchhhcccCCCCCcccch
Q 015027          240 SD----------------------AET-----------------------AMSTILIGTSGYLDPVCINTGKLTKKSDVY  274 (414)
Q Consensus       240 ~~----------------------~~~-----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~  274 (414)
                      ..                      ...                       ......+|||.|||||++.+..|+..+|+|
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW  372 (550)
T KOG0605|consen  293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW  372 (550)
T ss_pred             hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence            10                      000                       000124799999999999999999999999


Q ss_pred             hHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccc--cCCcccHHHHHHHHHHHHHhhccCCCCCC
Q 015027          275 SFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFH--VADESEMKEIEIVAELASKCLRIRGTERP  352 (414)
Q Consensus       275 SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~Li~~cl~~dP~~Rp  352 (414)
                      |||||+|||+.|.+||.+.+...         .        ...+++-.  +..+.....+.+..+||.+||. ||.+|.
T Consensus       373 SLG~ImyEmLvGyPPF~s~tp~~---------T--------~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RL  434 (550)
T KOG0605|consen  373 SLGCIMYEMLVGYPPFCSETPQE---------T--------YRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRL  434 (550)
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHH---------H--------HHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhc
Confidence            99999999999999998544321         1        11111111  1122222223668999999999 999997


Q ss_pred             C---hhHHH
Q 015027          353 T---MKQVS  358 (414)
Q Consensus       353 s---~~~v~  358 (414)
                      .   ++||.
T Consensus       435 G~~G~~EIK  443 (550)
T KOG0605|consen  435 GSKGAEEIK  443 (550)
T ss_pred             CcccHHHHh
Confidence            5   55553

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.9e-45  Score=333.10  Aligned_cols=246  Identities=24%  Similarity=0.348  Sum_probs=206.8

Q ss_pred             hcCCCCCCccccCCceEEEEEEE-cCCcEEEEEEeecccchhH----hHHHHHHHHHccCCCceeeeeeeEecCCcceEE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVL-HDNIQVAVKTYRRADKIRI----TERELLRIISQVNHKNVVKILGLCLETEVPLLV  160 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~----~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv  160 (414)
                      ..+|++.+.||+|.||.|-+|.. ..|+.||||.++++.-..+    ..++++++|+.|+||||+.++.+|++.+...||
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            46799999999999999999996 5799999999987654332    337788999999999999999999999999999


Q ss_pred             EEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccC
Q 015027          161 YEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISS  240 (414)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  240 (414)
                      |||..+|.|+||+...+   .+++..++.+++||+.|+.|+|.++   ++|||||.+|||+|.|+++||+|||++.++..
T Consensus       132 MEYaS~GeLYDYiSer~---~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~  205 (668)
T KOG0611|consen  132 MEYASGGELYDYISERG---SLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD  205 (668)
T ss_pred             EEecCCccHHHHHHHhc---cccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc
Confidence            99999999999996544   4588999999999999999999988   99999999999999999999999999988763


Q ss_pred             CccccceecccccccccchhhcccCCCC-CcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccc
Q 015027          241 DAETAMSTILIGTSGYLDPVCINTGKLT-KKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQI  319 (414)
Q Consensus       241 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (414)
                         .....+++|+|-|.+||++.|.+|. +.+|-|||||+||.|+.|..||++.+...         ...++..+.+..-
T Consensus       206 ---~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~---------lvrQIs~GaYrEP  273 (668)
T KOG0611|consen  206 ---KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR---------LVRQISRGAYREP  273 (668)
T ss_pred             ---ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH---------HHHHhhcccccCC
Confidence               3455678999999999999999885 78999999999999999999998665221         2222333322211


Q ss_pred             cccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHH
Q 015027          320 LNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEE  360 (414)
Q Consensus       320 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~  360 (414)
                             +.+    ....-||+|||..+|++|-|+++|...
T Consensus       274 -------~~P----SdA~gLIRwmLmVNP~RRATieDiAsH  303 (668)
T KOG0611|consen  274 -------ETP----SDASGLIRWMLMVNPERRATIEDIASH  303 (668)
T ss_pred             -------CCC----chHHHHHHHHHhcCcccchhHHHHhhh
Confidence                   111    236789999999999999999998544

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-45  Score=344.47  Aligned_cols=241  Identities=27%  Similarity=0.418  Sum_probs=196.8

Q ss_pred             CCCccccCCceEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCCCCchh
Q 015027           91 RSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLL  170 (414)
Q Consensus        91 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~  170 (414)
                      .++.||.|+.|.||+|++ .++.||||.++.-.      .-.++-|++|+||||+.+.|+|.....++||||||..|.|.
T Consensus       128 ELeWlGSGaQGAVF~Grl-~netVAVKKV~elk------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~  200 (904)
T KOG4721|consen  128 ELEWLGSGAQGAVFLGRL-HNETVAVKKVRELK------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY  200 (904)
T ss_pred             hhhhhccCcccceeeeec-cCceehhHHHhhhh------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence            467799999999999999 56789999775432      12357899999999999999999999999999999999999


Q ss_pred             hhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccccceecc
Q 015027          171 DHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTIL  250 (414)
Q Consensus       171 ~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~  250 (414)
                      ..|+....   .+......+..+||.|++|||.+.   |||||||.-||||..+..|||+|||.++.+... .  ....+
T Consensus       201 ~VLka~~~---itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-S--TkMSF  271 (904)
T KOG4721|consen  201 EVLKAGRP---ITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK-S--TKMSF  271 (904)
T ss_pred             HHHhccCc---cCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh-h--hhhhh
Confidence            99975443   356788899999999999999977   999999999999999999999999999877643 2  23457


Q ss_pred             cccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccccCCcccH
Q 015027          251 IGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEM  330 (414)
Q Consensus       251 ~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (414)
                      +||..|||||++.+.+.++|+||||||||||||+||..||...+...         ..-.+..+.+...++..       
T Consensus       272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA---------IIwGVGsNsL~LpvPst-------  335 (904)
T KOG4721|consen  272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA---------IIWGVGSNSLHLPVPST-------  335 (904)
T ss_pred             hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe---------eEEeccCCcccccCccc-------
Confidence            99999999999999999999999999999999999999997432111         11111222233222222       


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHH
Q 015027          331 KEIEIVAELASKCLRIRGTERPTMKQVSEELDRL  364 (414)
Q Consensus       331 ~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i  364 (414)
                       .+..|.-|+..||+..|..||++++|+..|+-.
T Consensus       336 -cP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa  368 (904)
T KOG4721|consen  336 -CPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA  368 (904)
T ss_pred             -CchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence             224588999999999999999999999988754

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1e-44  Score=360.23  Aligned_cols=260  Identities=26%  Similarity=0.395  Sum_probs=216.8

Q ss_pred             cCCCCCCccccCCceEEEEEEEcC------CcEEEEEEeecccc--hhHhHHHHHHHHHccCCCceeeeeeeEecCCcce
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLHD------NIQVAVKTYRRADK--IRITERELLRIISQVNHKNVVKILGLCLETEVPL  158 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~--~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~  158 (414)
                      .+....+.||+|.||.||+|....      .+.||||.++....  ...++++|+.++..++|||||+|+|+|.+++..+
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~  565 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC  565 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence            445667889999999999998532      46699999987654  4567788999999999999999999999999999


Q ss_pred             EEEEeCCCCchhhhhhhcCC-----------cccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcE
Q 015027          159 LVYEFASNGTLLDHIRCESS-----------QVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTA  227 (414)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~-----------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~  227 (414)
                      +|+|||..|+|.++|+...+           ..+++..+.+.|+.|||.|+.||-++.   ++||||-..|+||.++..|
T Consensus       566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~V  642 (774)
T KOG1026|consen  566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVV  642 (774)
T ss_pred             EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEE
Confidence            99999999999999975432           234778899999999999999999988   9999999999999999999


Q ss_pred             EEeeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchh
Q 015027          228 KVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPY  306 (414)
Q Consensus       228 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~  306 (414)
                      ||+|||+++.....+.......-.-..+||+||.+..+++|.+||||||||+|||+++ |..||.+.+..+         
T Consensus       643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E---------  713 (774)
T KOG1026|consen  643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE---------  713 (774)
T ss_pred             EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH---------
Confidence            9999999998776655554444455679999999999999999999999999999999 999998665433         


Q ss_pred             hhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHh
Q 015027          307 FLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRL  367 (414)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~  367 (414)
                      +...+..+.+         -+.+...+.++..|+..||+.+|.+||++++|-..|+.....
T Consensus       714 VIe~i~~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  714 VIECIRAGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             HHHHHHcCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence            2333333322         223333446799999999999999999999999999887643

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=3.4e-43  Score=329.34  Aligned_cols=245  Identities=22%  Similarity=0.333  Sum_probs=195.3

Q ss_pred             CccccCCceEEEEEEEcCCcEEEEEEeecccchh----HhHHHHHHHHHccCCCceeeeeeeEec----CCcceEEEEeC
Q 015027           93 RCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIR----ITERELLRIISQVNHKNVVKILGLCLE----TEVPLLVYEFA  164 (414)
Q Consensus        93 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l~hpniv~l~~~~~~----~~~~~lv~e~~  164 (414)
                      ..||+|++|.||+|.+ +|+.||||.+.......    ..+.+++.++.+++||||+++++++.+    ....++||||+
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            6789999999999998 78899999997654332    334577899999999999999999876    34678999999


Q ss_pred             CCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhC-CCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcc
Q 015027          165 SNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSL-ASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE  243 (414)
Q Consensus       165 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  243 (414)
                      ++|+|.+++....   .+++.....++.+++.||.|||+. +   ++||||||+|||++.++.+||+|||++....... 
T Consensus       105 ~~g~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-  177 (283)
T PHA02988        105 TRGYLREVLDKEK---DLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-  177 (283)
T ss_pred             CCCcHHHHHhhCC---CCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence            9999999996532   457888999999999999999984 5   8899999999999999999999999988654321 


Q ss_pred             ccceecccccccccchhhccc--CCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccc
Q 015027          244 TAMSTILIGTSGYLDPVCINT--GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILN  321 (414)
Q Consensus       244 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (414)
                          ....||..|+|||++.+  ..++.++|||||||++|||++|..||.......         ...........    
T Consensus       178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~---------~~~~i~~~~~~----  240 (283)
T PHA02988        178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE---------IYDLIINKNNS----  240 (283)
T ss_pred             ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH---------HHHHHHhcCCC----
Confidence                23467889999999976  689999999999999999999999997433111         11111111100    


Q ss_pred             cccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHH
Q 015027          322 FHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR  366 (414)
Q Consensus       322 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~  366 (414)
                      ...+    ...+..+.+|+.+||+.||.+|||+.++++.|+.+..
T Consensus       241 ~~~~----~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        241 LKLP----LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             CCCC----CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence            0111    1123569999999999999999999999999988753

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.7e-43  Score=344.33  Aligned_cols=258  Identities=25%  Similarity=0.384  Sum_probs=199.2

Q ss_pred             hcCCCCCCccccCCceEEEEEEE------cCCcEEEEEEeecccch--hHhHHHHHHHHHcc-CCCceeeeeeeEecCCc
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVL------HDNIQVAVKTYRRADKI--RITERELLRIISQV-NHKNVVKILGLCLETEV  156 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l-~hpniv~l~~~~~~~~~  156 (414)
                      .++|++.+.||+|+||.||+|..      .++..||||+++.....  ......+++++..+ +||||++++++|...+.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            35789999999999999999974      23568999998754322  22335667888888 89999999999999999


Q ss_pred             ceEEEEeCCCCchhhhhhhcCC----------------------------------------------------------
Q 015027          157 PLLVYEFASNGTLLDHIRCESS----------------------------------------------------------  178 (414)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~~----------------------------------------------------------  178 (414)
                      .++||||+++|+|.+++.....                                                          
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            9999999999999998854321                                                          


Q ss_pred             --------------cccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccc
Q 015027          179 --------------QVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET  244 (414)
Q Consensus       179 --------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  244 (414)
                                    ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                          124578889999999999999999987   999999999999999999999999999866443222


Q ss_pred             cceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhcccccccccccc
Q 015027          245 AMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFH  323 (414)
Q Consensus       245 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (414)
                      .......++..|+|||++.+..++.++|||||||++|||++ |..||.......        .+....... ..... + 
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--------~~~~~~~~~-~~~~~-~-  339 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--------KFYKMIKEG-YRMLS-P-  339 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--------HHHHHHHhC-ccCCC-C-
Confidence            22223345668999999999999999999999999999998 889986432111        011111111 00000 0 


Q ss_pred             cCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHH
Q 015027          324 VADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDR  363 (414)
Q Consensus       324 ~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~  363 (414)
                            ...+.++.+|+.+||+.||++|||+.+|++.|+.
T Consensus       340 ------~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         340 ------ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             ------CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence                  0112458999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2.9e-44  Score=340.02  Aligned_cols=245  Identities=26%  Similarity=0.335  Sum_probs=205.6

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhHh---HHHHHHHHHccCCCceeeeeeeEecCCcceEEEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRIT---ERELLRIISQVNHKNVVKILGLCLETEVPLLVYE  162 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~---~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  162 (414)
                      ++|.+.+.||+|+||.||+|+.+ +.+.||+|.+.+......+   ..+++++++.++|||||.++++|+...+.|+|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            57888899999999999999966 5888999999776554433   3677899999999999999999999999999999


Q ss_pred             eCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCc
Q 015027          163 FASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDA  242 (414)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  242 (414)
                      |+.| +|..++...+   .++++.+..++.+++.||.|||+++   |+|||+||.|||++.+|++|+||||+|+.+..  
T Consensus        82 ~a~g-~L~~il~~d~---~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--  152 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDG---KLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMST--  152 (808)
T ss_pred             hhhh-hHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhccc--
Confidence            9987 9999996544   3478999999999999999999988   99999999999999999999999999998765  


Q ss_pred             cccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccccc
Q 015027          243 ETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNF  322 (414)
Q Consensus       243 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (414)
                      .+...+...|||.|||||...+++|+..+|+||+|||+||+++|++||...+...            .++     .+...
T Consensus       153 ~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~------------Lv~-----~I~~d  215 (808)
T KOG0597|consen  153 NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQ------------LVK-----SILKD  215 (808)
T ss_pred             CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHH------------HHH-----HHhcC
Confidence            4455667789999999999999999999999999999999999999996433211            111     11111


Q ss_pred             ccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          323 HVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       323 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      .  ..++...+..+..++..+|.+||.+|.|..+++.
T Consensus       216 ~--v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  216 P--VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             C--CCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            1  1122255577999999999999999999998853

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=6.2e-43  Score=330.97  Aligned_cols=262  Identities=25%  Similarity=0.370  Sum_probs=197.4

Q ss_pred             cCCCCCCccccCCceEEEEEEEcC-----------------CcEEEEEEeecccc--hhHhHHHHHHHHHccCCCceeee
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLHD-----------------NIQVAVKTYRRADK--IRITERELLRIISQVNHKNVVKI  147 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~--~~~~~~~~~~~l~~l~hpniv~l  147 (414)
                      ++|.+.+.||+|+||.||+|.+.+                 +..||+|.+.....  ....+.++++++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            578889999999999999998532                 34699999876432  22345667789999999999999


Q ss_pred             eeeEecCCcceEEEEeCCCCchhhhhhhcC----------------CcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeee
Q 015027          148 LGLCLETEVPLLVYEFASNGTLLDHIRCES----------------SQVLKTWKTCLRIAAETASALDYLHSLASPPIIH  211 (414)
Q Consensus       148 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH  211 (414)
                      ++++.+.+..++||||+++|+|.+++....                ....+++..++.++.||+.||.|||+.+   |+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence            999999999999999999999999885422                1123577888999999999999999987   999


Q ss_pred             CCCCCCceeeCCCCcEEEeeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh--CCCC
Q 015027          212 GDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT--GKKP  289 (414)
Q Consensus       212 ~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t--g~~p  289 (414)
                      |||||+|||++.++.+||+|||++................++..|+|||++.+..++.++||||||+++|||++  +..|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            99999999999999999999999976543322222233456788999999998899999999999999999987  5667


Q ss_pred             CCccccccccccccchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHH
Q 015027          290 GSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELD  362 (414)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~  362 (414)
                      |.......     ............. .... .....    ..+..+.+|+.+||+.+|.+|||+.+|.+.|+
T Consensus       242 ~~~~~~~~-----~~~~~~~~~~~~~-~~~~-~~~~~----~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         242 YGELTDEQ-----VIENAGEFFRDQG-RQVY-LFRPP----PCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCcCCHHH-----HHHHHHHHhhhcc-cccc-ccCCC----CCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            76432111     0000000000000 0000 00001    11255899999999999999999999988775

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-43  Score=330.19  Aligned_cols=263  Identities=21%  Similarity=0.250  Sum_probs=205.8

Q ss_pred             HHHHHHhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchh---------------HhHHHHHHHHHccCCCc
Q 015027           80 SEMIRATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIR---------------ITERELLRIISQVNHKN  143 (414)
Q Consensus        80 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---------------~~~~~~~~~l~~l~hpn  143 (414)
                      .+-....++|.+.+.||+|.||.|-+|+.. +++.||||++.+.....               +...+++.+|++++|||
T Consensus        90 ~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~n  169 (576)
T KOG0585|consen   90 DQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPN  169 (576)
T ss_pred             cccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcC
Confidence            344455689999999999999999999965 68999999997542211               22366789999999999


Q ss_pred             eeeeeeeEec--CCcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceee
Q 015027          144 VVKILGLCLE--TEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILL  221 (414)
Q Consensus       144 iv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll  221 (414)
                      ||+|+++..+  .+.+|||+|||..|.+...=   .....+++.++++++.+++.||.|||.++   ||||||||+|+||
T Consensus       170 VV~LiEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl  243 (576)
T KOG0585|consen  170 VVKLIEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLL  243 (576)
T ss_pred             eeEEEEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEE
Confidence            9999999865  45889999999998875432   12222788999999999999999999988   9999999999999


Q ss_pred             CCCCcEEEeeccccccccCCc---cccceecccccccccchhhcccCC----CCCcccchhHHHHHHHHHhCCCCCCccc
Q 015027          222 NDNYTAKVADFESSVLISSDA---ETAMSTILIGTSGYLDPVCINTGK----LTKKSDVYSFGVVLAELLTGKKPGSCMT  294 (414)
Q Consensus       222 ~~~~~~kl~DfGla~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~SlGvil~el~tg~~p~~~~~  294 (414)
                      +++|+|||+|||.+.......   ........+|||.|+|||...++.    .+.+.||||+||+||.|+.|+.||-+..
T Consensus       244 ~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~  323 (576)
T KOG0585|consen  244 SSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF  323 (576)
T ss_pred             cCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch
Confidence            999999999999987663221   111223468999999999987633    3568899999999999999999985322


Q ss_pred             cccccccccchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHH
Q 015027          295 LASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLR  365 (414)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~  365 (414)
                                       ...-...+++..+..+...+..+.+.+||.++|.+||+.|.++.+|......-+
T Consensus       324 -----------------~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~  377 (576)
T KOG0585|consen  324 -----------------ELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR  377 (576)
T ss_pred             -----------------HHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence                             112233445555555544455678999999999999999999999866554433

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2e-43  Score=343.63  Aligned_cols=260  Identities=28%  Similarity=0.428  Sum_probs=200.3

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc------CCcEEEEEEeecccch--hHhHHHHHHHHHcc-CCCceeeeeeeEecCCc
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH------DNIQVAVKTYRRADKI--RITERELLRIISQV-NHKNVVKILGLCLETEV  156 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l-~hpniv~l~~~~~~~~~  156 (414)
                      .++|++.+.||+|+||.||+|...      ++..||+|.+......  ......++++++.+ +||||++++++|...+.
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~  116 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP  116 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence            357999999999999999999842      2357999999754322  22345667888888 89999999999999999


Q ss_pred             ceEEEEeCCCCchhhhhhhcCC----------------------------------------------------------
Q 015027          157 PLLVYEFASNGTLLDHIRCESS----------------------------------------------------------  178 (414)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~~----------------------------------------------------------  178 (414)
                      .++||||+++|+|.+++.....                                                          
T Consensus       117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (374)
T cd05106         117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD  196 (374)
T ss_pred             eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence            9999999999999998854211                                                          


Q ss_pred             ---------cccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccccceec
Q 015027          179 ---------QVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTI  249 (414)
Q Consensus       179 ---------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  249 (414)
                               ...+++..+++++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||++..............
T Consensus       197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence                     123577888999999999999999987   99999999999999999999999999976543322222223


Q ss_pred             ccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhcccccccccccccCCcc
Q 015027          250 LIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADES  328 (414)
Q Consensus       250 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (414)
                      ..++..|+|||++.+..++.++|||||||++|||++ |+.||.......        ....... .......    ..  
T Consensus       274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--------~~~~~~~-~~~~~~~----~~--  338 (374)
T cd05106         274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--------KFYKMVK-RGYQMSR----PD--  338 (374)
T ss_pred             CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--------HHHHHHH-cccCccC----CC--
Confidence            345678999999999999999999999999999997 999986432111        0000011 0000000    00  


Q ss_pred             cHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHH
Q 015027          329 EMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLR  365 (414)
Q Consensus       329 ~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~  365 (414)
                        ..+..+.+++.+||+.||.+|||+.+|++.|+++.
T Consensus       339 --~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         339 --FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             --CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence              11256999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-43  Score=353.75  Aligned_cols=262  Identities=25%  Similarity=0.307  Sum_probs=213.1

Q ss_pred             HhcCCCCCCccccCCceEEEEEEEcCC-cEEEEEEeecccchh-HhHHHHHHHHHccC-CCceeeeeee-Eec------C
Q 015027           85 ATKNFDRSRCLSQGGFVSVYKGVLHDN-IQVAVKTYRRADKIR-ITERELLRIISQVN-HKNVVKILGL-CLE------T  154 (414)
Q Consensus        85 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~-~~~~~~~~~l~~l~-hpniv~l~~~-~~~------~  154 (414)
                      ...++++.+.|.+|||+.||+|.+..+ ..+|+|++...+... ....+|+.+|++|+ |+|||.+++. ...      .
T Consensus        35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~  114 (738)
T KOG1989|consen   35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV  114 (738)
T ss_pred             CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence            345678889999999999999998765 999999887654433 33477889999997 9999999993 221      1


Q ss_pred             CcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccc
Q 015027          155 EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFES  234 (414)
Q Consensus       155 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGl  234 (414)
                      -.++|.||||.||+|-|++....... +++.++++|+.|+++|+++||... ++|||||||-+||||+.+|+.||||||.
T Consensus       115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGS  192 (738)
T KOG1989|consen  115 WEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGS  192 (738)
T ss_pred             eEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccc
Confidence            25689999999999999997654443 689999999999999999999987 8899999999999999999999999999


Q ss_pred             cccccCCccccc-------eecccccccccchhhc---ccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccc
Q 015027          235 SVLISSDAETAM-------STILIGTSGYLDPVCI---NTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMV  304 (414)
Q Consensus       235 a~~~~~~~~~~~-------~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~  304 (414)
                      |...........       .-....|+.|+|||++   .+..+++|+|||+|||+||-||....||+..           
T Consensus       193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s-----------  261 (738)
T KOG1989|consen  193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES-----------  261 (738)
T ss_pred             cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC-----------
Confidence            875443322111       1123679999999987   5789999999999999999999999999732           


Q ss_pred             hhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHhhh
Q 015027          305 PYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLHE  369 (414)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~~~  369 (414)
                                +...+++.....+.....+..|.+||+.||+.||.+||++.+|+..+.++....-
T Consensus       262 ----------g~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~  316 (738)
T KOG1989|consen  262 ----------GKLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPC  316 (738)
T ss_pred             ----------cceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCC
Confidence                      2334555555555555667889999999999999999999999999998886543

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-43  Score=339.10  Aligned_cols=267  Identities=25%  Similarity=0.396  Sum_probs=209.3

Q ss_pred             cHHHHHHHhcCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccchh---HhHHHHHHHHHccCCCceeeeeeeEecC
Q 015027           78 SKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIR---ITERELLRIISQVNHKNVVKILGLCLET  154 (414)
Q Consensus        78 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~l~~l~hpniv~l~~~~~~~  154 (414)
                      +.+++....+.+.+...||+|.||+||+|.+.+  .||||+++.+....   +.+..|+..+++-+|.||+-+.|+|..+
T Consensus       383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p  460 (678)
T KOG0193|consen  383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP  460 (678)
T ss_pred             cccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence            335666666778889999999999999999854  79999998664433   4457778899999999999999999988


Q ss_pred             CcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccc
Q 015027          155 EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFES  234 (414)
Q Consensus       155 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGl  234 (414)
                      .. .||..||+|.+|+.+|+....  .+...+.+.|+.||++|+.|||..+   |||||||..|||+.+++.|||+|||+
T Consensus       461 ~~-AIiTqwCeGsSLY~hlHv~et--kfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGL  534 (678)
T KOG0193|consen  461 PL-AIITQWCEGSSLYTHLHVQET--KFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGL  534 (678)
T ss_pred             ce-eeeehhccCchhhhhccchhh--hhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccc
Confidence            87 999999999999999976553  3466788999999999999999977   99999999999999999999999999


Q ss_pred             cccccCCccccceecccccccccchhhccc---CCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhh
Q 015027          235 SVLISSDAETAMSTILIGTSGYLDPVCINT---GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSI  311 (414)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  311 (414)
                      +................|...|||||+++.   .+|++.+||||||+|+|||+||..||.....+.-  +-       .+
T Consensus       535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqI--if-------mV  605 (678)
T KOG0193|consen  535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI--IF-------MV  605 (678)
T ss_pred             eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhhe--EE-------Ee
Confidence            976544323333344567778999999964   4789999999999999999999999973222110  00       00


Q ss_pred             cccc-cccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHh
Q 015027          312 KNNG-LRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRL  367 (414)
Q Consensus       312 ~~~~-~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~  367 (414)
                      ..+- ..+....      ....++++.+|+..||..++++||.+.+|+..|+.+...
T Consensus       606 GrG~l~pd~s~~------~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~  656 (678)
T KOG0193|consen  606 GRGYLMPDLSKI------RSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS  656 (678)
T ss_pred             cccccCccchhh------hccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence            1110 0011111      112235799999999999999999999999988887763

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-43  Score=343.53  Aligned_cols=243  Identities=23%  Similarity=0.282  Sum_probs=194.8

Q ss_pred             HHhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhHhH----HHHHHHHHcc-CCCceeeeeeeEecCCcc
Q 015027           84 RATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRITE----RELLRIISQV-NHKNVVKILGLCLETEVP  157 (414)
Q Consensus        84 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~----~~~~~~l~~l-~hpniv~l~~~~~~~~~~  157 (414)
                      ..-++|.++++||+|+||+|+++..+ +++.+|||++++..-....+    ..|.+++... +||.++.++.+|+..+++
T Consensus       365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l  444 (694)
T KOG0694|consen  365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL  444 (694)
T ss_pred             ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence            34578999999999999999999976 48899999998875433222    3333444444 599999999999999999


Q ss_pred             eEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccccc
Q 015027          158 LLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVL  237 (414)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~  237 (414)
                      |+||||+.||++..+.+    ...+++..+.-++..|+.||.|||+++   |||||||.+|||+|.+|++||+|||+++.
T Consensus       445 ~fvmey~~Ggdm~~~~~----~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe  517 (694)
T KOG0694|consen  445 FFVMEYVAGGDLMHHIH----TDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKE  517 (694)
T ss_pred             EEEEEecCCCcEEEEEe----cccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccc
Confidence            99999999999554442    233477888889999999999999988   99999999999999999999999999986


Q ss_pred             ccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccc
Q 015027          238 ISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLR  317 (414)
Q Consensus       238 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (414)
                      .-..  .....+++|||.|||||++.++.|+.++|.|||||+||||+.|+.||.+.+-+.         .        +.
T Consensus       518 ~m~~--g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee---------~--------Fd  578 (694)
T KOG0694|consen  518 GMGQ--GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE---------V--------FD  578 (694)
T ss_pred             cCCC--CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH---------H--------HH
Confidence            5432  234677899999999999999999999999999999999999999997543211         1        11


Q ss_pred             cccccccCCcccHHHHHHHHHHHHHhhccCCCCCCCh
Q 015027          318 QILNFHVADESEMKEIEIVAELASKCLRIRGTERPTM  354 (414)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~  354 (414)
                      .+++..  ..++...+.+...++.++|..+|++|..+
T Consensus       579 sI~~d~--~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  579 SIVNDE--VRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             HHhcCC--CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence            111111  11233344668999999999999999876

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=6.3e-43  Score=327.91  Aligned_cols=250  Identities=24%  Similarity=0.255  Sum_probs=195.1

Q ss_pred             CCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch----hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEE
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI----RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYE  162 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  162 (414)
                      .|+..+.||+|+||.||+|... +++.||+|.+......    .....+++.++.+++|+||+++++++.+++..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            3778899999999999999964 6899999998754321    1233567789999999999999999999999999999


Q ss_pred             eCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCc
Q 015027          163 FASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDA  242 (414)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  242 (414)
                      |+++|+|.+++..... ..+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||++.......
T Consensus        81 ~~~~g~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05631          81 IMNGGDLKFHIYNMGN-PGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE  156 (285)
T ss_pred             ecCCCcHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence            9999999888754332 23578899999999999999999987   9999999999999999999999999997654321


Q ss_pred             cccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccccc
Q 015027          243 ETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNF  322 (414)
Q Consensus       243 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (414)
                         ......||+.|+|||++.+..++.++|||||||++|||++|+.||........     ...........        
T Consensus       157 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~-----~~~~~~~~~~~--------  220 (285)
T cd05631         157 ---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK-----REEVDRRVKED--------  220 (285)
T ss_pred             ---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh-----HHHHHHHhhcc--------
Confidence               22345789999999999999999999999999999999999999974332110     00000000000        


Q ss_pred             ccCCcccHHHHHHHHHHHHHhhccCCCCCCC-----hhHHHH
Q 015027          323 HVADESEMKEIEIVAELASKCLRIRGTERPT-----MKQVSE  359 (414)
Q Consensus       323 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps-----~~~v~~  359 (414)
                        ....+...+..+.+|+.+||+.||.+||+     ++++++
T Consensus       221 --~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         221 --QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             --cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence              00111122356899999999999999997     566643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.7e-43  Score=327.97  Aligned_cols=242  Identities=23%  Similarity=0.282  Sum_probs=194.8

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc----hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK----IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~  161 (414)
                      ++|.+.+.||+|+||.||+|... +++.||+|++.....    ......+++.+++.++||||+++++++.++...++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            46889999999999999999976 589999999975432    1223456678999999999999999999999999999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCC
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD  241 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  241 (414)
                      ||+++|+|.+++....   .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  154 (291)
T cd05612          81 EYVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR  154 (291)
T ss_pred             eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence            9999999999986543   3477888999999999999999988   999999999999999999999999998765432


Q ss_pred             ccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccc
Q 015027          242 AETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILN  321 (414)
Q Consensus       242 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (414)
                           .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.......         ....+.....     
T Consensus       155 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~---------~~~~i~~~~~-----  215 (291)
T cd05612         155 -----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG---------IYEKILAGKL-----  215 (291)
T ss_pred             -----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---------HHHHHHhCCc-----
Confidence                 123478999999999999999999999999999999999999997432111         1111111100     


Q ss_pred             cccCCcccHHHHHHHHHHHHHhhccCCCCCCC-----hhHHH
Q 015027          322 FHVADESEMKEIEIVAELASKCLRIRGTERPT-----MKQVS  358 (414)
Q Consensus       322 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps-----~~~v~  358 (414)
                       .+..    .....+.+|+.+||+.||.+||+     +++++
T Consensus       216 -~~~~----~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l  252 (291)
T cd05612         216 -EFPR----HLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVK  252 (291)
T ss_pred             -CCCc----cCCHHHHHHHHHHcCCCHHHccCCccCCHHHHh
Confidence             0011    11245899999999999999995     66664

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-43  Score=303.12  Aligned_cols=263  Identities=23%  Similarity=0.274  Sum_probs=207.1

Q ss_pred             hcCCCCCCccccCCceEEEEEE-EcCCcEEEEEEeecccc-hhHhHHHHHHHHHccCCCceeeeeeeEecCC-----cce
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADK-IRITERELLRIISQVNHKNVVKILGLCLETE-----VPL  158 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~-----~~~  158 (414)
                      .++|.+.+.||+|||+-||++. ..++..+|+|++..... ......+|++.-++++|||+++++++...+.     ..|
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y   99 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY   99 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence            4789999999999999999998 55789999999987663 3344477789999999999999999876543     489


Q ss_pred             EEEEeCCCCchhhhhhhcCC-cccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccccc
Q 015027          159 LVYEFASNGTLLDHIRCESS-QVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVL  237 (414)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~  237 (414)
                      |+++|...|+|.+.+..... ....++.+++.|+.+|++||.+||+.. +++.||||||.|||+.+.+.++|.|||.+..
T Consensus       100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~  178 (302)
T KOG2345|consen  100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQ  178 (302)
T ss_pred             EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCccc
Confidence            99999999999999865433 335689999999999999999999987 6899999999999999999999999999876


Q ss_pred             ccCCccccc-------eecccccccccchhhcc---cCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhh
Q 015027          238 ISSDAETAM-------STILIGTSGYLDPVCIN---TGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYF  307 (414)
Q Consensus       238 ~~~~~~~~~-------~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~  307 (414)
                      ..-......       -.....|..|.|||.+.   +...++++|||||||+||+|+.|..||+.... .+.        
T Consensus       179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-~Gg--------  249 (302)
T KOG2345|consen  179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-QGG--------  249 (302)
T ss_pred             cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-cCC--------
Confidence            543211111       11235788999999984   55689999999999999999999999973211 100        


Q ss_pred             hhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHH
Q 015027          308 LNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL  364 (414)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i  364 (414)
                            .-.-.+.+.....+.....++.+.+|+.+||+.||.+||++.+++..++.+
T Consensus       250 ------SlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  250 ------SLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             ------eEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence                  001122222333333333557799999999999999999999998888765

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.5e-42  Score=322.09  Aligned_cols=254  Identities=22%  Similarity=0.338  Sum_probs=198.7

Q ss_pred             cCCCCCCccccCCceEEEEEEEc----CCcEEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH----DNIQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLETEVPLLV  160 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv  160 (414)
                      ++|++.+.||+|+||.||+|.+.    .+..||+|.+......  ...+.+++..+.+++||||+++++++..++..++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            56889999999999999999854    3568999998765322  23345677899999999999999999999999999


Q ss_pred             EEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccC
Q 015027          161 YEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISS  240 (414)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  240 (414)
                      |||+++|+|.+++....  ..+++..++.++.|++.||+|||+.+   ++||||||+|||++.++.++++|||.+.....
T Consensus        85 ~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~  159 (266)
T cd05064          85 TEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS  159 (266)
T ss_pred             EEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence            99999999999986543  24578999999999999999999987   99999999999999999999999998765432


Q ss_pred             CccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhcccccccc
Q 015027          241 DAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQI  319 (414)
Q Consensus       241 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (414)
                      ... .......++..|+|||.+.+..++.++|||||||++||+++ |..||.......         ......... .  
T Consensus       160 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~---------~~~~~~~~~-~--  226 (266)
T cd05064         160 EAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD---------VIKAVEDGF-R--  226 (266)
T ss_pred             cch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---------HHHHHHCCC-C--
Confidence            211 11112345678999999999999999999999999999775 999986433111         111111110 0  


Q ss_pred             cccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHH
Q 015027          320 LNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL  364 (414)
Q Consensus       320 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i  364 (414)
                        .    +.+...+..+.+++.+||+.+|.+|||+.+|.+.|+++
T Consensus       227 --~----~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         227 --L----PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             --C----CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence              0    01111235589999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.4e-42  Score=320.99  Aligned_cols=255  Identities=24%  Similarity=0.392  Sum_probs=203.3

Q ss_pred             hcCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCC
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFAS  165 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  165 (414)
                      .++|++.++||+|+||.||+|...++..||+|.+...........+++.+++.++||||+++++.+...+..++||||++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA   84 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence            36789999999999999999998888899999987655444555677889999999999999999999999999999999


Q ss_pred             CCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcccc
Q 015027          166 NGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETA  245 (414)
Q Consensus       166 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  245 (414)
                      +++|.+++..... ...++..++.++.+++.||+|||+.+   ++|+||||+||+++.++.++|+|||++......... 
T Consensus        85 ~~~L~~~l~~~~~-~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~-  159 (261)
T cd05072          85 KGSLLDFLKSDEG-GKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT-  159 (261)
T ss_pred             CCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee-
Confidence            9999999865432 23477888999999999999999977   999999999999999999999999999876432111 


Q ss_pred             ceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhccccccccccccc
Q 015027          246 MSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHV  324 (414)
Q Consensus       246 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (414)
                      ......++..|+|||++.+..++.++|||||||++|+|++ |..||.......         ........ .    ....
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---------~~~~~~~~-~----~~~~  225 (261)
T cd05072         160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---------VMSALQRG-Y----RMPR  225 (261)
T ss_pred             ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---------HHHHHHcC-C----CCCC
Confidence            1122345668999999998899999999999999999998 999986432111         11111111 0    0000


Q ss_pred             CCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHH
Q 015027          325 ADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDR  363 (414)
Q Consensus       325 ~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~  363 (414)
                      .    ...+..+.+++.+||..+|++|||++++.+.|+.
T Consensus       226 ~----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         226 M----ENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             C----CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            0    1122458999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.7e-42  Score=319.72  Aligned_cols=251  Identities=24%  Similarity=0.327  Sum_probs=199.9

Q ss_pred             cCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCCC
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASN  166 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  166 (414)
                      ++|++.+.||+|+||.||++.++++..+|+|.+............++.++++++||||+++++++...+..++||||+++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~   83 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN   83 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence            45888899999999999999988888999999876554444556678899999999999999999999999999999999


Q ss_pred             CchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccccc
Q 015027          167 GTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAM  246 (414)
Q Consensus       167 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  246 (414)
                      |+|.+++.....  .+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++......... .
T Consensus        84 ~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-~  157 (256)
T cd05114          84 GCLLNYLRQRQG--KLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-S  157 (256)
T ss_pred             CcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCcee-c
Confidence            999998865332  3578899999999999999999987   999999999999999999999999998765432111 1


Q ss_pred             eecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhcccccccccccccC
Q 015027          247 STILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVA  325 (414)
Q Consensus       247 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (414)
                      .....++..|+|||++.+..++.++||||||+++|||++ |+.||.......         ..........  ...+   
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~---------~~~~i~~~~~--~~~~---  223 (256)
T cd05114         158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE---------VVEMISRGFR--LYRP---  223 (256)
T ss_pred             cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH---------HHHHHHCCCC--CCCC---
Confidence            122234567999999998899999999999999999999 899986433111         1111111100  0001   


Q ss_pred             CcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHH
Q 015027          326 DESEMKEIEIVAELASKCLRIRGTERPTMKQVSEEL  361 (414)
Q Consensus       326 ~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L  361 (414)
                          ...+..+.+|+.+||+.+|.+|||+.++++.|
T Consensus       224 ----~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         224 ----KLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             ----CCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence                11124589999999999999999999998876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.3e-43  Score=333.91  Aligned_cols=250  Identities=22%  Similarity=0.298  Sum_probs=209.8

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc---hhHhHHHHHHHHHccCCCceeeeeeeEecCCc-ceEEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK---IRITERELLRIISQVNHKNVVKILGLCLETEV-PLLVY  161 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~-~~lv~  161 (414)
                      ++|..++++|+|+||.++..+.+ ++..+++|.+.....   .+.....++.+++++.|||||.+.+.|..++. .+|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            57899999999999999999865 578899999976543   23344677899999999999999999999888 99999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCC
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD  241 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  241 (414)
                      +||+||+|.+.+.... ...++++.++.++.|++.|+.|||++.   |+|||||+.|||++.++.|||+|||+|+.+...
T Consensus        84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            9999999999997665 345688999999999999999999877   999999999999999999999999999998765


Q ss_pred             ccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccc
Q 015027          242 AETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILN  321 (414)
Q Consensus       242 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (414)
                      .  ......+|||.||.||.+.+.+|+.|+|||||||++|||++-+++|...+...         ....+.         
T Consensus       160 ~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~---------Li~ki~---------  219 (426)
T KOG0589|consen  160 D--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE---------LILKIN---------  219 (426)
T ss_pred             h--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH---------HHHHHh---------
Confidence            3  34566899999999999999999999999999999999999999998544221         111111         


Q ss_pred             cccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHH
Q 015027          322 FHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEE  360 (414)
Q Consensus       322 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~  360 (414)
                      .....+.+...+.++..|+..||+.+|..||++.+++..
T Consensus       220 ~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  220 RGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             hccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            111222333444669999999999999999999999876

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.9e-42  Score=323.98  Aligned_cols=256  Identities=27%  Similarity=0.402  Sum_probs=202.2

Q ss_pred             cCCCCCCccccCCceEEEEEEEcC-C-----cEEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEecCCcce
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLHD-N-----IQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLETEVPL  158 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~  158 (414)
                      ++|++.+.||+|+||.||+|.... +     ..||+|.+......  .....++++.+.+++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            468889999999999999998643 2     57999998754322  233456778899999999999999999999999


Q ss_pred             EEEEeCCCCchhhhhhhcCCc-------------ccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCC
Q 015027          159 LVYEFASNGTLLDHIRCESSQ-------------VLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNY  225 (414)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~~-------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~  225 (414)
                      ++|||+++++|.+++......             ..+++..++.++.|++.||.|||+.+   ++|+||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence            999999999999998654221             34578888999999999999999987   99999999999999999


Q ss_pred             cEEEeeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccc
Q 015027          226 TAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMV  304 (414)
Q Consensus       226 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~  304 (414)
                      .+||+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||.......       
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~-------  234 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE-------  234 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------
Confidence            999999999976543322223334466889999999998899999999999999999998 999987433211       


Q ss_pred             hhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHH
Q 015027          305 PYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDR  363 (414)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~  363 (414)
                        ....+......         ..+...+..+.+|+.+||+.+|.+||++.+|++.|+.
T Consensus       235 --~~~~i~~~~~~---------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         235 --VIEMIRSRQLL---------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             --HHHHHHcCCcC---------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence              11111111110         1112233669999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.7e-42  Score=331.69  Aligned_cols=242  Identities=24%  Similarity=0.280  Sum_probs=194.4

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch----hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI----RITERELLRIISQVNHKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~  161 (414)
                      ++|.+.+.||+|+||.||+|.+. +++.||+|++......    ......++.++++++||||+++++++.+++..|+||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            67889999999999999999976 5889999999764321    223356678999999999999999999999999999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCC
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD  241 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  241 (414)
                      ||+++|+|.+++....   .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        98 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  171 (329)
T PTZ00263         98 EFVVGGELFTHLRKAG---RFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR  171 (329)
T ss_pred             cCCCCChHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence            9999999999986543   3477888889999999999999988   999999999999999999999999999865432


Q ss_pred             ccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccc
Q 015027          242 AETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILN  321 (414)
Q Consensus       242 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (414)
                           .....||+.|+|||++.+..++.++|||||||++|+|++|..||.......         ....+.....  .++
T Consensus       172 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---------~~~~i~~~~~--~~p  235 (329)
T PTZ00263        172 -----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR---------IYEKILAGRL--KFP  235 (329)
T ss_pred             -----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH---------HHHHHhcCCc--CCC
Confidence                 123578999999999999999999999999999999999999996432110         0111111110  000


Q ss_pred             cccCCcccHHHHHHHHHHHHHhhccCCCCCCC-----hhHHH
Q 015027          322 FHVADESEMKEIEIVAELASKCLRIRGTERPT-----MKQVS  358 (414)
Q Consensus       322 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps-----~~~v~  358 (414)
                      .        ..+..+.+|+.+||+.||.+||+     +++++
T Consensus       236 ~--------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll  269 (329)
T PTZ00263        236 N--------WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVK  269 (329)
T ss_pred             C--------CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence            0        11245899999999999999997     46654

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-42  Score=332.41  Aligned_cols=252  Identities=21%  Similarity=0.263  Sum_probs=198.6

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch----hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI----RITERELLRIISQVNHKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~  161 (414)
                      ++|.+.+.||+|+||.||+|.+. +++.||||++......    ......++.++..++||||+++++++..++..|+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            46889999999999999999976 4889999999764321    223355678899999999999999999999999999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCC
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD  241 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  241 (414)
                      ||+++|+|.+++....   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..... 
T Consensus        81 e~~~g~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-  153 (333)
T cd05600          81 EYVPGGDFRTLLNNLG---VLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-  153 (333)
T ss_pred             eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence            9999999999996433   3478888999999999999999988   99999999999999999999999999876543 


Q ss_pred             ccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccc
Q 015027          242 AETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILN  321 (414)
Q Consensus       242 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (414)
                          ......||+.|+|||++.+..++.++|||||||++|||++|..||.......         ....+...  ...+.
T Consensus       154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~---------~~~~i~~~--~~~~~  218 (333)
T cd05600         154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE---------TWENLKYW--KETLQ  218 (333)
T ss_pred             ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH---------HHHHHHhc--ccccc
Confidence                2234579999999999999999999999999999999999999997433211         00000000  00000


Q ss_pred             cccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHH
Q 015027          322 FHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEE  360 (414)
Q Consensus       322 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~  360 (414)
                      ...........+..+.+|+.+||..+|.+||++.++++.
T Consensus       219 ~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         219 RPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             CCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            000000001223568999999999999999999999754

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.7e-42  Score=329.47  Aligned_cols=240  Identities=22%  Similarity=0.254  Sum_probs=190.6

Q ss_pred             CccccCCceEEEEEEEc-CCcEEEEEEeecccch----hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCCCC
Q 015027           93 RCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI----RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNG  167 (414)
Q Consensus        93 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g  167 (414)
                      +.||+|+||.||+|... +|+.||+|++......    ......++.++..++||||+++++++...+..|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46899999999999965 6899999999764321    122355678899999999999999999999999999999999


Q ss_pred             chhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccccce
Q 015027          168 TLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMS  247 (414)
Q Consensus       168 sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  247 (414)
                      +|.+++....   .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....  ....
T Consensus        81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~  152 (323)
T cd05571          81 ELFFHLSRER---VFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GATM  152 (323)
T ss_pred             cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCcc
Confidence            9999886533   4578889999999999999999988   999999999999999999999999998753322  1122


Q ss_pred             ecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccccCCc
Q 015027          248 TILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADE  327 (414)
Q Consensus       248 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (414)
                      ....||+.|+|||++.+..++.++|||||||++|||++|..||.......         .........      ..++  
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~---------~~~~~~~~~------~~~p--  215 (323)
T cd05571         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---------LFELILMEE------IRFP--  215 (323)
T ss_pred             cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH---------HHHHHHcCC------CCCC--
Confidence            34579999999999999999999999999999999999999996432111         011111000      0011  


Q ss_pred             ccHHHHHHHHHHHHHhhccCCCCCC-----ChhHHHH
Q 015027          328 SEMKEIEIVAELASKCLRIRGTERP-----TMKQVSE  359 (414)
Q Consensus       328 ~~~~~~~~l~~Li~~cl~~dP~~Rp-----s~~~v~~  359 (414)
                        ...+..+.+|+.+||+.||++||     ++.++++
T Consensus       216 --~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         216 --RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             --CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence              11235689999999999999999     6888754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-42  Score=319.01  Aligned_cols=255  Identities=24%  Similarity=0.359  Sum_probs=203.3

Q ss_pred             hcCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCC
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFAS  165 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  165 (414)
                      .++|.+.+.||+|++|.||+|.+.+++.||+|.+...........+++.++++++||||+++++++...+..++||||++
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK   84 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence            45688999999999999999998778889999997655444455667789999999999999999999999999999999


Q ss_pred             CCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcccc
Q 015027          166 NGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETA  245 (414)
Q Consensus       166 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  245 (414)
                      +++|.+++.... ...+++..+..++.+++.||.|||+.+   ++|+||||+||+++.++.+||+|||++......... 
T Consensus        85 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~-  159 (261)
T cd05068          85 YGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE-  159 (261)
T ss_pred             CCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc-
Confidence            999999986544 234588999999999999999999987   999999999999999999999999999876532111 


Q ss_pred             ceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhccccccccccccc
Q 015027          246 MSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHV  324 (414)
Q Consensus       246 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (414)
                      .......+..|+|||++.+..++.++||||||+++|||++ |+.||.......         ....+... ...      
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---------~~~~~~~~-~~~------  223 (261)
T cd05068         160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE---------VLQQVDQG-YRM------  223 (261)
T ss_pred             ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH---------HHHHHHcC-CCC------
Confidence            1111123457999999999999999999999999999999 999986432111         11111111 000      


Q ss_pred             CCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHH
Q 015027          325 ADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDR  363 (414)
Q Consensus       325 ~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~  363 (414)
                        ..+...+..+.+++.+||+.+|.+||++.++.+.|+.
T Consensus       224 --~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         224 --PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             --CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence              0111123569999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=4.4e-42  Score=329.06  Aligned_cols=199  Identities=24%  Similarity=0.305  Sum_probs=171.9

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc--hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK--IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYE  162 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  162 (414)
                      .++|++.+.||+|+||.||++... ++..+|+|.+.....  ......++++++++++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            468999999999999999999976 588899999876432  22345667889999999999999999999999999999


Q ss_pred             eCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCc
Q 015027          163 FASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDA  242 (414)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  242 (414)
                      |+++++|.+++....   .+++..+..++.|++.||.|||+.+  +|+||||||+|||++.++.+||+|||++...... 
T Consensus        84 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  157 (331)
T cd06649          84 HMDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  157 (331)
T ss_pred             cCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence            999999999986533   3478889999999999999999842  3999999999999999999999999998765332 


Q ss_pred             cccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCcc
Q 015027          243 ETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCM  293 (414)
Q Consensus       243 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~  293 (414)
                         ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~  205 (331)
T cd06649         158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP  205 (331)
T ss_pred             ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence               223457899999999999999999999999999999999999999643

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.5e-42  Score=318.47  Aligned_cols=252  Identities=23%  Similarity=0.276  Sum_probs=202.1

Q ss_pred             hcCCCCCCccccCCceEEEEEEEcC-CcEEEEEEeecccchhH----hHHHHHHHHHccCCCceeeeeeeEecCCcceEE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLHD-NIQVAVKTYRRADKIRI----TERELLRIISQVNHKNVVKILGLCLETEVPLLV  160 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~----~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv  160 (414)
                      .++|++++.||+|.-|+||++.+.+ +..+|+|++.+......    ...-+-.||+.++||.++.||+.|+.++..|+|
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~  155 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV  155 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence            4678889999999999999999865 68899999977643321    123345789999999999999999999999999


Q ss_pred             EEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccC
Q 015027          161 YEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISS  240 (414)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  240 (414)
                      ||||+||+|....+.+.. ..+++..++-++.+|+-||+|||..|   ||+|||||+||||.++|++.|+||.++.....
T Consensus       156 meyCpGGdL~~LrqkQp~-~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~  231 (459)
T KOG0610|consen  156 MEYCPGGDLHSLRQKQPG-KRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPV  231 (459)
T ss_pred             EecCCCccHHHHHhhCCC-CccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence            999999999988866554 34578888889999999999999999   99999999999999999999999988754321


Q ss_pred             C--------------------------------c-c---------------------ccceecccccccccchhhcccCC
Q 015027          241 D--------------------------------A-E---------------------TAMSTILIGTSGYLDPVCINTGK  266 (414)
Q Consensus       241 ~--------------------------------~-~---------------------~~~~~~~~gt~~y~aPE~~~~~~  266 (414)
                      .                                . .                     ......++||-.|+|||++.|..
T Consensus       232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G  311 (459)
T KOG0610|consen  232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG  311 (459)
T ss_pred             CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence            0                                0 0                     01123468999999999999999


Q ss_pred             CCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhcc
Q 015027          267 LTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRI  346 (414)
Q Consensus       267 ~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~  346 (414)
                      .+.++|+|+|||++|||+.|..||.+....                 ..+..++...+..+.....+..+.+||+++|.+
T Consensus       312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~-----------------~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvK  374 (459)
T KOG0610|consen  312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNK-----------------ETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVK  374 (459)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCcCCCCch-----------------hhHHHHhcCCCcCCCCCcchhHHHHHHHHHhcc
Confidence            999999999999999999999999865432                 122223333333333334556799999999999


Q ss_pred             CCCCCCC----hhHHH
Q 015027          347 RGTERPT----MKQVS  358 (414)
Q Consensus       347 dP~~Rps----~~~v~  358 (414)
                      ||.+|..    +.||.
T Consensus       375 dP~kRlg~~rGA~eIK  390 (459)
T KOG0610|consen  375 DPSKRLGSKRGAAEIK  390 (459)
T ss_pred             ChhhhhccccchHHhh
Confidence            9999988    66663

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-43  Score=337.90  Aligned_cols=269  Identities=28%  Similarity=0.396  Sum_probs=212.1

Q ss_pred             cHHHHHHHhcCCCCCCccccCCceEEEEEEEcC--C--cE-EEEEEeeccc----chhHhHHHHHHHHHccCCCceeeee
Q 015027           78 SKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHD--N--IQ-VAVKTYRRAD----KIRITERELLRIISQVNHKNVVKIL  148 (414)
Q Consensus        78 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~--~--~~-vavK~~~~~~----~~~~~~~~~~~~l~~l~hpniv~l~  148 (414)
                      ....++...++..+.++||+|+||.||+|.+..  +  .. ||||..+.+.    .....+..|.++|++++|||||+++
T Consensus       148 ~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~y  227 (474)
T KOG0194|consen  148 PRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFY  227 (474)
T ss_pred             cccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence            344455556677778999999999999999653  2  23 8999988532    2234446778999999999999999


Q ss_pred             eeEecCCcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEE
Q 015027          149 GLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAK  228 (414)
Q Consensus       149 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~k  228 (414)
                      |++.....+++|||+|+||+|.++|.....  .++..+...++.+.+.||+|||+.+   +|||||-+.|+|++.++.+|
T Consensus       228 GVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vK  302 (474)
T KOG0194|consen  228 GVAVLEEPLMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVK  302 (474)
T ss_pred             EEEcCCCccEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEE
Confidence            999999999999999999999999987665  3478899999999999999999987   99999999999999999999


Q ss_pred             EeeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhh
Q 015027          229 VADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYF  307 (414)
Q Consensus       229 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~  307 (414)
                      |+|||+++........  .....-...|+|||.+....|+.++|||||||++||+++ |..||.+.....         .
T Consensus       303 ISDFGLs~~~~~~~~~--~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~---------v  371 (474)
T KOG0194|consen  303 ISDFGLSRAGSQYVMK--KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE---------V  371 (474)
T ss_pred             eCccccccCCcceeec--cccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH---------H
Confidence            9999998765411111  101123458999999999999999999999999999999 888988655332         1


Q ss_pred             hhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHhhhh
Q 015027          308 LNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLHEN  370 (414)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~~~~  370 (414)
                      ...+.....+...        +...+..+..++.+||..+|+.||||.++.+.|+.+.....+
T Consensus       372 ~~kI~~~~~r~~~--------~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~  426 (474)
T KOG0194|consen  372 KAKIVKNGYRMPI--------PSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA  426 (474)
T ss_pred             HHHHHhcCccCCC--------CCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence            2222122222111        113346689999999999999999999999999999876554

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2.3e-42  Score=328.89  Aligned_cols=259  Identities=24%  Similarity=0.365  Sum_probs=199.8

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCc----EEEEEEeecccc--hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNI----QVAVKTYRRADK--IRITERELLRIISQVNHKNVVKILGLCLETEVPLL  159 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~--~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~l  159 (414)
                      .+|+..+.||+|+||.||+|.+. ++.    .||+|.+.....  ......+++.+++.++||||++++++|... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            57999999999999999999864 333    489999875432  233445667899999999999999998765 5789


Q ss_pred             EEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccccccc
Q 015027          160 VYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLIS  239 (414)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~  239 (414)
                      |+||+++|+|.+++.....  .+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        86 v~e~~~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          86 ITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             eeecCCCCCHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence            9999999999999875432  3477888999999999999999987   9999999999999999999999999998765


Q ss_pred             CCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhccccccc
Q 015027          240 SDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQ  318 (414)
Q Consensus       240 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (414)
                      ............++..|+|||++.+..++.++|||||||++|||++ |..||.......         ...... .....
T Consensus       161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~---------~~~~~~-~~~~~  230 (316)
T cd05108         161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---------ISSILE-KGERL  230 (316)
T ss_pred             CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---------HHHHHh-CCCCC
Confidence            4322222222334668999999999999999999999999999998 999986432111         000001 00000


Q ss_pred             ccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHhhh
Q 015027          319 ILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLHE  369 (414)
Q Consensus       319 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~~~  369 (414)
                      ...    ..    ....+.+++.+||+.+|.+|||+.+++..|..+.+...
T Consensus       231 ~~~----~~----~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~  273 (316)
T cd05108         231 PQP----PI----CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ  273 (316)
T ss_pred             CCC----CC----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCc
Confidence            000    11    12458999999999999999999999999888765443

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=5.4e-42  Score=321.67  Aligned_cols=266  Identities=18%  Similarity=0.199  Sum_probs=196.8

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc---hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK---IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYE  162 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  162 (414)
                      ++|.+.+.||+|+||.||+|++. +++.||+|++.....   .......++.+++.++||||+++++++..++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            47899999999999999999976 588899999875432   22334567789999999999999999999999999999


Q ss_pred             eCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCc
Q 015027          163 FASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDA  242 (414)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  242 (414)
                      |++++++..+....   ..+++..+..++.||+.||.|||+.+   ++||||||+||+++.++.+||+|||++.......
T Consensus        81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  154 (287)
T cd07848          81 YVEKNMLELLEEMP---NGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS  154 (287)
T ss_pred             cCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence            99988776554321   23578889999999999999999987   9999999999999999999999999998764322


Q ss_pred             cccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccc------cccchhhhhhh-cccc
Q 015027          243 ETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKK------ISMVPYFLNSI-KNNG  315 (414)
Q Consensus       243 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~------~~~~~~~~~~~-~~~~  315 (414)
                      . .......||+.|+|||++.+..++.++|||||||++|||++|+.||..........      ........... ....
T Consensus       155 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07848         155 N-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR  233 (287)
T ss_pred             c-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence            1 12234578999999999999999999999999999999999999997533211000      00000000000 0000


Q ss_pred             cccccccccCCc------ccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          316 LRQILNFHVADE------SEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       316 ~~~~~~~~~~~~------~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ......+.....      .....+..+.+|+.+||+.||++|||++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            000000000000      00112356999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=4.2e-42  Score=336.05  Aligned_cols=260  Identities=24%  Similarity=0.361  Sum_probs=201.3

Q ss_pred             hcCCCCCCccccCCceEEEEEEEcC------CcEEEEEEeecccch--hHhHHHHHHHHHccC-CCceeeeeeeEecCCc
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLHD------NIQVAVKTYRRADKI--RITERELLRIISQVN-HKNVVKILGLCLETEV  156 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~-hpniv~l~~~~~~~~~  156 (414)
                      .++|.+.+.||+|+||.||+|++..      +..||||++......  ......++.+++++. ||||++++++|.+.+.
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            5688899999999999999998532      346999999754332  233456778999996 9999999999999999


Q ss_pred             ceEEEEeCCCCchhhhhhhcCC----------------------------------------------------------
Q 015027          157 PLLVYEFASNGTLLDHIRCESS----------------------------------------------------------  178 (414)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~~----------------------------------------------------------  178 (414)
                      .|+|||||++|+|.+++.....                                                          
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (400)
T cd05105         116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK  195 (400)
T ss_pred             eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence            9999999999999998854211                                                          


Q ss_pred             -----------------------------------cccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCC
Q 015027          179 -----------------------------------QVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLND  223 (414)
Q Consensus       179 -----------------------------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~  223 (414)
                                                         ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~  272 (400)
T cd05105         196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence                                               123567788899999999999999987   999999999999999


Q ss_pred             CCcEEEeeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccc
Q 015027          224 NYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKIS  302 (414)
Q Consensus       224 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~  302 (414)
                      ++.+||+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||.......     
T Consensus       273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~-----  347 (400)
T cd05105         273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS-----  347 (400)
T ss_pred             CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH-----
Confidence            99999999999986643322222233456788999999999999999999999999999997 999986432111     


Q ss_pred             cchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHH
Q 015027          303 MVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLR  365 (414)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~  365 (414)
                         .+....... ..        ...+...+..+.+|+.+||+.+|++|||+.+|.+.|+.+.
T Consensus       348 ---~~~~~~~~~-~~--------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         348 ---TFYNKIKSG-YR--------MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             ---HHHHHHhcC-CC--------CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence               011111111 00        0011122356899999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-42  Score=325.77  Aligned_cols=238  Identities=25%  Similarity=0.245  Sum_probs=187.6

Q ss_pred             cccCCceEEEEEEEc-CCcEEEEEEeecccc----hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCCCCch
Q 015027           95 LSQGGFVSVYKGVLH-DNIQVAVKTYRRADK----IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTL  169 (414)
Q Consensus        95 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL  169 (414)
                      ||+|+||.||+|... +++.||+|++.....    .......++.++.+++||||+++++++...+..|+||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999976 588999999975421    122335567889999999999999999999999999999999999


Q ss_pred             hhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccccceec
Q 015027          170 LDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTI  249 (414)
Q Consensus       170 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  249 (414)
                      .+++....   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.......  .....
T Consensus        81 ~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~  152 (312)
T cd05585          81 FHHLQREG---RFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNT  152 (312)
T ss_pred             HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccc
Confidence            99986543   3478888999999999999999987   9999999999999999999999999987543221  22334


Q ss_pred             ccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccccCCccc
Q 015027          250 LIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESE  329 (414)
Q Consensus       250 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (414)
                      ..||+.|+|||++.+..++.++|||||||++|+|++|..||.......         .........      ..+    +
T Consensus       153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~---------~~~~~~~~~------~~~----~  213 (312)
T cd05585         153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE---------MYRKILQEP------LRF----P  213 (312)
T ss_pred             ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH---------HHHHHHcCC------CCC----C
Confidence            579999999999999999999999999999999999999996432111         111111100      001    1


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          330 MKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       330 ~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ...+..+.+|+.+||+.||.+||++..+.+
T Consensus       214 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~e  243 (312)
T cd05585         214 DGFDRDAKDLLIGLLSRDPTRRLGYNGAQE  243 (312)
T ss_pred             CcCCHHHHHHHHHHcCCCHHHcCCCCCHHH
Confidence            112355899999999999999987544433

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2.8e-42  Score=322.22  Aligned_cols=256  Identities=27%  Similarity=0.381  Sum_probs=201.7

Q ss_pred             hcCCCCCCccccCCceEEEEEEEcC------CcEEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEecCCcc
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLHD------NIQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLETEVP  157 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~  157 (414)
                      ..+|.+.+.||+|+||.||+|...+      +..||||.+......  .....++++++..++||||+++++++......
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            3568889999999999999998643      478999998765433  34456677899999999999999999999999


Q ss_pred             eEEEEeCCCCchhhhhhhcCC-----------cccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCc
Q 015027          158 LLVYEFASNGTLLDHIRCESS-----------QVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYT  226 (414)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~-----------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~  226 (414)
                      ++||||+++++|.+++...+.           ...+++..+..++.|++.|+.|||+.+   ++||||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence            999999999999999965432           234578889999999999999999987   999999999999999999


Q ss_pred             EEEeeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccch
Q 015027          227 AKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVP  305 (414)
Q Consensus       227 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~  305 (414)
                      +||+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||.......        
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~--------  232 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE--------  232 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--------
Confidence            99999999876543222222233456788999999999999999999999999999998 999986433211        


Q ss_pred             hhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHH
Q 015027          306 YFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELD  362 (414)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~  362 (414)
                       ........... .        .+...+..+.+++.+||+.+|.+|||+.+|++.|+
T Consensus       233 -~~~~~~~~~~~-~--------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         233 -VIECITQGRLL-Q--------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             -HHHHHHcCCcC-C--------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence             11111111110 0        01112355899999999999999999999988875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=5.1e-42  Score=317.83  Aligned_cols=255  Identities=26%  Similarity=0.389  Sum_probs=202.0

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCC
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFAS  165 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  165 (414)
                      .+|.+.+.||+|+||.||+|.+. .+..||+|.+............+++++..++||||+++++++..++..++||||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT   85 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence            45778889999999999999976 48899999987654444445667789999999999999999999999999999999


Q ss_pred             CCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcccc
Q 015027          166 NGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETA  245 (414)
Q Consensus       166 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  245 (414)
                      +++|.+++..... ..+++..++.++.|++.||+|||+.+   ++||||||+||++++++.+||+|||++......... 
T Consensus        86 ~~~L~~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~-  160 (263)
T cd05052          86 YGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-  160 (263)
T ss_pred             CCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee-
Confidence            9999999865432 34578889999999999999999987   999999999999999999999999998876543211 


Q ss_pred             ceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhccccccccccccc
Q 015027          246 MSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHV  324 (414)
Q Consensus       246 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (414)
                      ......++..|+|||.+.+..++.++|||||||++|||++ |..||.......         ........ .    ..  
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---------~~~~~~~~-~----~~--  224 (263)
T cd05052         161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---------VYELLEKG-Y----RM--  224 (263)
T ss_pred             ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---------HHHHHHCC-C----CC--
Confidence            1112234568999999999999999999999999999998 999986432111         11111100 0    00  


Q ss_pred             CCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHH
Q 015027          325 ADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL  364 (414)
Q Consensus       325 ~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i  364 (414)
                        ..+...+..+.+++.+||+.+|++|||+.++.+.|+.+
T Consensus       225 --~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         225 --ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             --CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence              11111235699999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=5.4e-42  Score=322.11  Aligned_cols=265  Identities=19%  Similarity=0.220  Sum_probs=195.2

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc--hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEe
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK--IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  163 (414)
                      ++|.+.+.||.|+||.||+|... ++..||+|.+.....  .......+++++++++||||+++++++......++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            56899999999999999999975 588999999875432  223345677899999999999999999999999999999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcc
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE  243 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  243 (414)
                      +++ +|.+++.....  .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++........
T Consensus        85 ~~~-~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~  158 (288)
T cd07871          85 LDS-DLKQYLDNCGN--LMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK  158 (288)
T ss_pred             CCc-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence            975 88888864432  3477888999999999999999987   99999999999999999999999999876543211


Q ss_pred             ccceecccccccccchhhccc-CCCCCcccchhHHHHHHHHHhCCCCCCccccccccccc------cchhhhhhh-cccc
Q 015027          244 TAMSTILIGTSGYLDPVCINT-GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKIS------MVPYFLNSI-KNNG  315 (414)
Q Consensus       244 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~------~~~~~~~~~-~~~~  315 (414)
                        ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||............      ..+..+... ....
T Consensus       159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07871         159 --TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE  236 (288)
T ss_pred             --cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence              2233468899999999865 56899999999999999999999999754321110000      000000000 0000


Q ss_pred             cccccccccCCccc----HHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          316 LRQILNFHVADESE----MKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       316 ~~~~~~~~~~~~~~----~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ......+.......    .....++.+|+.+||+.||.+|||++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            01111111000000    011245889999999999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=5e-42  Score=329.30  Aligned_cols=260  Identities=24%  Similarity=0.347  Sum_probs=199.8

Q ss_pred             cCCCCCCccccCCceEEEEEEEc------CCcEEEEEEeecccchh--HhHHHHHHHHHcc-CCCceeeeeeeEec-CCc
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH------DNIQVAVKTYRRADKIR--ITERELLRIISQV-NHKNVVKILGLCLE-TEV  156 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~--~~~~~~~~~l~~l-~hpniv~l~~~~~~-~~~  156 (414)
                      ++|++.+.||+|+||.||+|...      +++.||+|++.......  .....++.++.++ +||||++++++|.. +..
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~   86 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP   86 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence            57999999999999999999742      24789999987543222  2334566788888 89999999998865 456


Q ss_pred             ceEEEEeCCCCchhhhhhhcCC----------------------------------------------------------
Q 015027          157 PLLVYEFASNGTLLDHIRCESS----------------------------------------------------------  178 (414)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~~----------------------------------------------------------  178 (414)
                      .+++|||+++++|.+++.....                                                          
T Consensus        87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (337)
T cd05054          87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY  166 (337)
T ss_pred             EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence            7899999999999998854221                                                          


Q ss_pred             cccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccccceecccccccccc
Q 015027          179 QVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLD  258 (414)
Q Consensus       179 ~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a  258 (414)
                      ...+++..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||++..+.............++..|+|
T Consensus       167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a  243 (337)
T cd05054         167 KEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA  243 (337)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence            125688899999999999999999987   99999999999999999999999999987644322222334456778999


Q ss_pred             hhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhcccccccccccccCCcccHHHHHHHH
Q 015027          259 PVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVA  337 (414)
Q Consensus       259 PE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  337 (414)
                      ||++.+..++.++|||||||++|||++ |..||.......        .+....... ....        .+...+..+.
T Consensus       244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--------~~~~~~~~~-~~~~--------~~~~~~~~~~  306 (337)
T cd05054         244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--------EFCRRLKEG-TRMR--------APEYATPEIY  306 (337)
T ss_pred             cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--------HHHHHHhcc-CCCC--------CCccCCHHHH
Confidence            999999999999999999999999998 999986422111        011111111 0000        0111225689


Q ss_pred             HHHHHhhccCCCCCCChhHHHHHHHHHHH
Q 015027          338 ELASKCLRIRGTERPTMKQVSEELDRLRR  366 (414)
Q Consensus       338 ~Li~~cl~~dP~~Rps~~~v~~~L~~i~~  366 (414)
                      +++.+||+.+|++||++.+|++.|+.+..
T Consensus       307 ~l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         307 SIMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            99999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=7.3e-42  Score=321.15  Aligned_cols=263  Identities=27%  Similarity=0.376  Sum_probs=205.7

Q ss_pred             cCCCCCCccccCCceEEEEEEEc------CCcEEEEEEeecccc-hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH------DNIQVAVKTYRRADK-IRITERELLRIISQVNHKNVVKILGLCLETEVPLL  159 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~l  159 (414)
                      ++|.+.+.||+|+||.||++...      ++..+|+|.+..... .......++.++.+++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            57889999999999999999842      245689998875432 23345667789999999999999999999999999


Q ss_pred             EEEeCCCCchhhhhhhcCC----------cccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEE
Q 015027          160 VYEFASNGTLLDHIRCESS----------QVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKV  229 (414)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~----------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl  229 (414)
                      ||||+++++|.+++.....          ...+++..++.++.|++.||+|||+.+   ++||||||+|||+++++.+||
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence            9999999999999864431          224688999999999999999999987   999999999999999999999


Q ss_pred             eeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhh
Q 015027          230 ADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFL  308 (414)
Q Consensus       230 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~  308 (414)
                      +|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||.......         ..
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~---------~~  232 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---------VI  232 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---------HH
Confidence            99999876543322222233445778999999999999999999999999999998 999986433111         11


Q ss_pred             hhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHhhhh
Q 015027          309 NSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLHEN  370 (414)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~~~~  370 (414)
                      ..........     ...    ..+..+.+|+.+||+.+|.+|||+.++.+.|+.+.+....
T Consensus       233 ~~i~~~~~~~-----~~~----~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~~~  285 (288)
T cd05093         233 ECITQGRVLQ-----RPR----TCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKASPV  285 (288)
T ss_pred             HHHHcCCcCC-----CCC----CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhccc
Confidence            1111111100     011    1124599999999999999999999999999998865433

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.6e-43  Score=299.85  Aligned_cols=247  Identities=26%  Similarity=0.329  Sum_probs=202.0

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc----hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK----IRITERELLRIISQVNHKNVVKILGLCLETEVPLLV  160 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv  160 (414)
                      .++|++.+.||+|-||.||.|+.+ ++-.||+|++.++.-    ...+..+++++-+.|+||||+++|++|.+....|++
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            478999999999999999999965 578899999987642    233446667888999999999999999999999999


Q ss_pred             EEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccC
Q 015027          161 YEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISS  240 (414)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  240 (414)
                      +||.++|+|+..|...... .+++.....++.|++.|+.|+|..+   ||||||||+|+|++..+.+|++|||.+.....
T Consensus       101 lEya~~gel~k~L~~~~~~-~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~  176 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMK-RFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS  176 (281)
T ss_pred             EEecCCchHHHHHHhcccc-cccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecCC
Confidence            9999999999999754432 3467778889999999999999876   99999999999999999999999999876542


Q ss_pred             CccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccc
Q 015027          241 DAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQIL  320 (414)
Q Consensus       241 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (414)
                          ....+.+||..|++||...+..++..+|+|++|++.||++.|.+||.......         ....+..  ..-.+
T Consensus       177 ----~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e---------tYkrI~k--~~~~~  241 (281)
T KOG0580|consen  177 ----NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE---------TYKRIRK--VDLKF  241 (281)
T ss_pred             ----CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH---------HHHHHHH--ccccC
Confidence                33456799999999999999999999999999999999999999997443111         1111111  11111


Q ss_pred             ccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          321 NFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       321 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      +        ...+....+||.+|+..+|.+|.+..++..
T Consensus       242 p--------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~  272 (281)
T KOG0580|consen  242 P--------STISGGAADLISRLLVKNPIERLALTEVMD  272 (281)
T ss_pred             C--------cccChhHHHHHHHHhccCccccccHHHHhh
Confidence            1        122355899999999999999999998854

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=5.1e-42  Score=316.63  Aligned_cols=252  Identities=24%  Similarity=0.342  Sum_probs=199.7

Q ss_pred             cCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCCC
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASN  166 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  166 (414)
                      ++|.+.+.||+|+||.||+|...++..+|+|.+...........+++.++.+++||||+++++++......++||||+++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN   83 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence            45788899999999999999987777899999876554445557778999999999999999999988899999999999


Q ss_pred             CchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccccc
Q 015027          167 GTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAM  246 (414)
Q Consensus       167 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  246 (414)
                      |+|.+++.....  .+++..++.++.||+.||+|||+.+   ++|+||||+||+++.++.+||+|||++........ ..
T Consensus        84 ~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~  157 (256)
T cd05113          84 GCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TS  157 (256)
T ss_pred             CcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCce-ee
Confidence            999999865433  4588999999999999999999987   99999999999999999999999999876543211 11


Q ss_pred             eecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhcccccccccccccC
Q 015027          247 STILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVA  325 (414)
Q Consensus       247 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (414)
                      .....++..|+|||++.+..++.++|||||||++|+|++ |..||.......         ......... ..    ...
T Consensus       158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---------~~~~~~~~~-~~----~~~  223 (256)
T cd05113         158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE---------TVEKVSQGL-RL----YRP  223 (256)
T ss_pred             cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---------HHHHHhcCC-CC----CCC
Confidence            112235567999999998899999999999999999998 999986332110         111111110 00    000


Q ss_pred             CcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHH
Q 015027          326 DESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELD  362 (414)
Q Consensus       326 ~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~  362 (414)
                      .    ..+..+.+++.+||+.+|.+|||+.++++.|+
T Consensus       224 ~----~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         224 H----LASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             C----CCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            0    11256899999999999999999999987763

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.1e-41  Score=325.47  Aligned_cols=238  Identities=22%  Similarity=0.273  Sum_probs=186.2

Q ss_pred             CCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchh----HhH---HHHHHHHHccCCCceeeeeeeEecCCcceEE
Q 015027           89 FDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIR----ITE---RELLRIISQVNHKNVVKILGLCLETEVPLLV  160 (414)
Q Consensus        89 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~---~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv  160 (414)
                      |++.+.||+|+||.||+|.+. +++.||||++.......    ...   .+++.+++.++||||+++++++...+..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            677889999999999999965 58999999997543211    111   2233455678899999999999999999999


Q ss_pred             EEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccC
Q 015027          161 YEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISS  240 (414)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  240 (414)
                      |||+++++|..++..    ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus        81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05589          81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG  153 (324)
T ss_pred             EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence            999999999888743    24588999999999999999999987   99999999999999999999999999875332


Q ss_pred             CccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccc
Q 015027          241 DAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQIL  320 (414)
Q Consensus       241 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (414)
                      .  ........||+.|+|||++.+..++.++|||||||++|||++|+.||.......         ....+.....    
T Consensus       154 ~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~---------~~~~i~~~~~----  218 (324)
T cd05589         154 F--GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE---------VFDSIVNDEV----  218 (324)
T ss_pred             C--CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH---------HHHHHHhCCC----
Confidence            2  112234679999999999999999999999999999999999999997433211         1111111100    


Q ss_pred             ccccCCcccHHHHHHHHHHHHHhhccCCCCCCCh
Q 015027          321 NFHVADESEMKEIEIVAELASKCLRIRGTERPTM  354 (414)
Q Consensus       321 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~  354 (414)
                        ..+.    ..+..+.+|+.+||+.||.+||++
T Consensus       219 --~~p~----~~~~~~~~li~~~L~~dP~~R~~~  246 (324)
T cd05589         219 --RYPR----FLSREAISIMRRLLRRNPERRLGS  246 (324)
T ss_pred             --CCCC----CCCHHHHHHHHHHhhcCHhHcCCC
Confidence              0111    112558999999999999999953

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=4.6e-42  Score=344.12  Aligned_cols=251  Identities=23%  Similarity=0.245  Sum_probs=198.9

Q ss_pred             CCCCCCccccCCceEEEEEEEc-C-CcEEEEEEeecccchh-HhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeC
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLH-D-NIQVAVKTYRRADKIR-ITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFA  164 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~-~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  164 (414)
                      .|.+.+.||+|+||.||+|... + +..||+|.+....... .....++.+++.++||||++++++|..++..|+||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            3888999999999999999854 3 6778998775543322 33456789999999999999999999999999999999


Q ss_pred             CCCchhhhhhhc-CCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcc
Q 015027          165 SNGTLLDHIRCE-SSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE  243 (414)
Q Consensus       165 ~~gsL~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  243 (414)
                      ++|+|.+++... .....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++........
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            999999988542 22345678889999999999999999987   99999999999999999999999999987654333


Q ss_pred             ccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccc
Q 015027          244 TAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFH  323 (414)
Q Consensus       244 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (414)
                      .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.......         ...........      
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~---------~~~~~~~~~~~------  289 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE---------IMQQVLYGKYD------  289 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH---------HHHHHHhCCCC------
Confidence            223445679999999999999999999999999999999999999986432110         11111111110      


Q ss_pred             cCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          324 VADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       324 ~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                         ..+...+..+.+|+.+||+.+|++|||+.+++.
T Consensus       290 ---~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        290 ---PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             ---CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence               001112255899999999999999999999865

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.9e-42  Score=314.93  Aligned_cols=251  Identities=24%  Similarity=0.360  Sum_probs=198.7

Q ss_pred             cCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCCC
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASN  166 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  166 (414)
                      .+|++.+.||+|+||.||+|.+.++..+|+|.+...........+++.+++.++||||+++++++...+..++||||+++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN   83 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence            45888999999999999999987778899999876544444556677899999999999999999999999999999999


Q ss_pred             CchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccccc
Q 015027          167 GTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAM  246 (414)
Q Consensus       167 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  246 (414)
                      ++|.+++.....  .+++..++.++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++....... ..
T Consensus        84 ~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-~~  157 (256)
T cd05059          84 GCLLNYLRERKG--KLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-TS  157 (256)
T ss_pred             CCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccc-cc
Confidence            999999865433  4588999999999999999999988   99999999999999999999999999876543211 11


Q ss_pred             eecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhcccccccccccccC
Q 015027          247 STILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVA  325 (414)
Q Consensus       247 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (414)
                      .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.......         ........ .    .....
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---------~~~~~~~~-~----~~~~~  223 (256)
T cd05059         158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---------VVESVSAG-Y----RLYRP  223 (256)
T ss_pred             cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---------HHHHHHcC-C----cCCCC
Confidence            111223457999999999999999999999999999999 899986432111         01111100 0    00001


Q ss_pred             CcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHH
Q 015027          326 DESEMKEIEIVAELASKCLRIRGTERPTMKQVSEEL  361 (414)
Q Consensus       326 ~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L  361 (414)
                          ...+..+.+|+.+||..+|++|||+.++++.|
T Consensus       224 ----~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         224 ----KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             ----CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence                11235699999999999999999999998876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=3.1e-42  Score=318.71  Aligned_cols=249  Identities=31%  Similarity=0.458  Sum_probs=189.3

Q ss_pred             CCCccccCCceEEEEEEEc-----CCcEEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEe
Q 015027           91 RSRCLSQGGFVSVYKGVLH-----DNIQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        91 ~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  163 (414)
                      +.+.||.|.||.||+|.+.     .+..|+||.++.....  ...+.++++.+++++||||++++|++...+..++||||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            3567999999999999976     2577999999664332  34557778999999999999999999988889999999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcc
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE  243 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  243 (414)
                      +++|+|.+++.... ...+++..+..++.||+.||+|||+.+   ++|+||+++|||+++++.+||+|||++........
T Consensus        83 ~~~g~L~~~L~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~  158 (259)
T PF07714_consen   83 CPGGSLDDYLKSKN-KEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK  158 (259)
T ss_dssp             -TTEBHHHHHHHTC-TTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred             cccccccccccccc-ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence            99999999997762 234588999999999999999999977   99999999999999999999999999987743322


Q ss_pred             ccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhccccccccccc
Q 015027          244 TAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNF  322 (414)
Q Consensus       244 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (414)
                      ............|+|||.+.+..++.++||||||+++|||++ |+.||.......         +......... .... 
T Consensus       159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~---------~~~~~~~~~~-~~~~-  227 (259)
T PF07714_consen  159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE---------IIEKLKQGQR-LPIP-  227 (259)
T ss_dssp             EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH---------HHHHHHTTEE-TTSB-
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccc---------cccccccccc-ceec-
Confidence            223333456778999999999999999999999999999999 788886432111         1111111111 0001 


Q ss_pred             ccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHH
Q 015027          323 HVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEEL  361 (414)
Q Consensus       323 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L  361 (414)
                             ...+..+.+++.+||+.+|.+|||+.+|++.|
T Consensus       228 -------~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  228 -------DNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             -------TTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             -------cchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                   11124589999999999999999999998876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=3.5e-42  Score=318.26  Aligned_cols=256  Identities=26%  Similarity=0.438  Sum_probs=205.2

Q ss_pred             HhcCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccc-hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEe
Q 015027           85 ATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADK-IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        85 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  163 (414)
                      ...+|.+.+.||.|+||.||+|...++..+|+|.+..... .......++.+++.++||||+++++++......++||||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL   83 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence            3467889999999999999999988899999999876654 233446677899999999999999999999999999999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcc
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE  243 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  243 (414)
                      +++++|.+++..... ..+++..+..++.+|+.||.|||+.+   ++|+||||+||++++++.+||+|||++........
T Consensus        84 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~  159 (261)
T cd05148          84 MEKGSLLAFLRSPEG-QVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY  159 (261)
T ss_pred             cccCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence            999999999976433 34588899999999999999999987   99999999999999999999999999976643221


Q ss_pred             ccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhccccccccccc
Q 015027          244 TAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNF  322 (414)
Q Consensus       244 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (414)
                      .  .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||.......         ....... ...     
T Consensus       160 ~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~---------~~~~~~~-~~~-----  222 (261)
T cd05148         160 L--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE---------VYDQITA-GYR-----  222 (261)
T ss_pred             c--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH---------HHHHHHh-CCc-----
Confidence            1  123345678999999998899999999999999999998 899986432110         1111110 000     


Q ss_pred             ccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHH
Q 015027          323 HVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL  364 (414)
Q Consensus       323 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i  364 (414)
                         ...+...+..+.+++.+||+.+|.+|||+.++++.|+.+
T Consensus       223 ---~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         223 ---MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             ---CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence               011112235689999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-41  Score=315.42  Aligned_cols=256  Identities=25%  Similarity=0.376  Sum_probs=201.3

Q ss_pred             hcCCCCCCccccCCceEEEEEEEcC----CcEEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEecCCcceE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLHD----NIQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLETEVPLL  159 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~l  159 (414)
                      .++|.+.+.||+|+||.||+|.+..    ...||||.+......  ...+..++.++.+++||||+++++++...+..++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            3578999999999999999999742    457999998754322  2334556788999999999999999999999999


Q ss_pred             EEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccccccc
Q 015027          160 VYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLIS  239 (414)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~  239 (414)
                      ||||+++++|.+++.....  .+++..++.++.|++.||+|||+++   |+|+||||+|||+++++.++|+|||++....
T Consensus        83 v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~  157 (266)
T cd05033          83 ITEYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE  157 (266)
T ss_pred             EEEcCCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence            9999999999999865433  4578999999999999999999977   9999999999999999999999999998775


Q ss_pred             CCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhccccccc
Q 015027          240 SDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQ  318 (414)
Q Consensus       240 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (414)
                      ............+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......         .........   
T Consensus       158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~---------~~~~~~~~~---  225 (266)
T cd05033         158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD---------VIKAVEDGY---  225 (266)
T ss_pred             ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH---------HHHHHHcCC---
Confidence            3222222222345678999999999999999999999999999998 999986332111         111111100   


Q ss_pred             ccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHH
Q 015027          319 ILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL  364 (414)
Q Consensus       319 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i  364 (414)
                            ..+.+...+..+.+|+.+||+.+|++||++.+|++.|+++
T Consensus       226 ------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         226 ------RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             ------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                  0001112235689999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=5.5e-42  Score=324.35  Aligned_cols=266  Identities=18%  Similarity=0.227  Sum_probs=193.4

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYE  162 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  162 (414)
                      .++|++.+.||+|+||.||+|... +++.||||++......  .....+++.+++.++||||+++++++.++...++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            478999999999999999999976 5889999998754322  2334567789999999999999999999999999999


Q ss_pred             eCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCc
Q 015027          163 FASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDA  242 (414)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  242 (414)
                      |++ ++|.+++....  ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++.......
T Consensus        84 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  157 (303)
T cd07869          84 YVH-TDLCQYMDKHP--GGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS  157 (303)
T ss_pred             CCC-cCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence            996 57777775433  23477888999999999999999988   9999999999999999999999999987543321


Q ss_pred             cccceecccccccccchhhccc-CCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccch-------hhhhh----
Q 015027          243 ETAMSTILIGTSGYLDPVCINT-GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVP-------YFLNS----  310 (414)
Q Consensus       243 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~-------~~~~~----  310 (414)
                        .......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||...............       ..+..    
T Consensus       158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (303)
T cd07869         158 --HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL  235 (303)
T ss_pred             --ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhc
Confidence              12234568999999999865 46889999999999999999999999753221100000000       00000    


Q ss_pred             --hcccccccccccccCCc-ccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          311 --IKNNGLRQILNFHVADE-SEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       311 --~~~~~~~~~~~~~~~~~-~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                        .............+... .....+..+.+|+.+||+.||++|||+.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence              00000000000000000 00001245789999999999999999999853

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-42  Score=333.62  Aligned_cols=252  Identities=23%  Similarity=0.284  Sum_probs=198.8

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc----hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK----IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~  161 (414)
                      ++|.+.+.||+|+||.||+|... +++.||||++.....    ......+++.++..++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            47889999999999999999976 589999999976432    2233456678899999999999999999999999999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCC
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD  241 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  241 (414)
                      ||+++++|.+++...   ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA  154 (350)
T ss_pred             cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence            999999999998654   34578889999999999999999977   999999999999999999999999999766543


Q ss_pred             c---------------------------cccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccc
Q 015027          242 A---------------------------ETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMT  294 (414)
Q Consensus       242 ~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~  294 (414)
                      .                           .........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~  234 (350)
T cd05573         155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT  234 (350)
T ss_pred             CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence            2                           0012234579999999999999999999999999999999999999997433


Q ss_pred             cccccccccchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCC-hhHHHHH
Q 015027          295 LASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPT-MKQVSEE  360 (414)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps-~~~v~~~  360 (414)
                      ...         ....+..  ..    .....+.....++.+.+|+.+||. +|.+||+ +.++++.
T Consensus       235 ~~~---------~~~~i~~--~~----~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         235 LQE---------TYNKIIN--WK----ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             HHH---------HHHHHhc--cC----CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            111         0000000  00    000000000023568999999997 9999999 9999753

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.8e-42  Score=307.57  Aligned_cols=266  Identities=20%  Similarity=0.217  Sum_probs=197.0

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc---hhHhHHHHHHHHHccCCCceeeeeeeEec--CCcceE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK---IRITERELLRIISQVNHKNVVKILGLCLE--TEVPLL  159 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~hpniv~l~~~~~~--~~~~~l  159 (414)
                      .++|+.+..|++|+||.||+|+++ +++.||+|+++.+..   ......+++.+|.+++|||||.+-.+...  -+..|+
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~  154 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI  154 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence            456888999999999999999976 588999999986542   33455777899999999999999888753  346899


Q ss_pred             EEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccccccc
Q 015027          160 VYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLIS  239 (414)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~  239 (414)
                      |||||+. +|...+..-.  ..+...++..++.|+++|+.|||.++   |+|||||++|+|++..|.+||+|||+|+.+.
T Consensus       155 VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg  228 (419)
T KOG0663|consen  155 VMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYG  228 (419)
T ss_pred             eHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhc
Confidence            9999976 7777775544  23466788889999999999999988   9999999999999999999999999999988


Q ss_pred             CCccccceecccccccccchhhcccC-CCCCcccchhHHHHHHHHHhCCCCCCcccccccccc----------ccchhh-
Q 015027          240 SDAETAMSTILIGTSGYLDPVCINTG-KLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKI----------SMVPYF-  307 (414)
Q Consensus       240 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~----------~~~~~~-  307 (414)
                      .+.  ...+..+-|.+|.|||.+.|. .|+..+|+||+|||+.||+++++-|.+.+-......          .+.+.+ 
T Consensus       229 sp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~  306 (419)
T KOG0663|consen  229 SPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS  306 (419)
T ss_pred             CCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence            753  334566789999999998764 699999999999999999999998875432111000          000000 


Q ss_pred             -hhhhcccccccccccccCCcccHH-HHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          308 -LNSIKNNGLRQILNFHVADESEMK-EIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       308 -~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                       ++.+....+.......+...+... ..+.-.+|+..+|..||.+|.|+.+.++
T Consensus       307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence             000000000000000011111111 2355789999999999999999999843

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=7.6e-42  Score=310.67  Aligned_cols=268  Identities=19%  Similarity=0.183  Sum_probs=199.6

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc---hhHhHHHHHHHHHccCCCc-eeeeeeeEecCC------
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK---IRITERELLRIISQVNHKN-VVKILGLCLETE------  155 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~hpn-iv~l~~~~~~~~------  155 (414)
                      ..|..+++||+|+||+||+|+.. +|+.||+|.++.+..   ......+|+-++..++|+| |+.+++++...+      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            45677788999999999999965 689999999987644   4455567779999999999 999999998877      


Q ss_pred             cceEEEEeCCCCchhhhhhhcCCc-ccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccc
Q 015027          156 VPLLVYEFASNGTLLDHIRCESSQ-VLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFES  234 (414)
Q Consensus       156 ~~~lv~e~~~~gsL~~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGl  234 (414)
                      ..++|+||++. +|..++...... ...+...+..++.||+.||+|||+++   |+||||||.||||+++|.+||+|||+
T Consensus        91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence            78999999965 899998665532 23355789999999999999999988   99999999999999999999999999


Q ss_pred             cccccCCccccceecccccccccchhhcccC-CCCCcccchhHHHHHHHHHhCCCCCCccccccccccc-----cc-hhh
Q 015027          235 SVLISSDAETAMSTILIGTSGYLDPVCINTG-KLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKIS-----MV-PYF  307 (414)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~-----~~-~~~  307 (414)
                      |+...-+..  ..+..++|.+|.|||++.+. .|+...||||+|||+.||+++++-|.+.+........     .. +..
T Consensus       167 Ara~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~  244 (323)
T KOG0594|consen  167 ARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD  244 (323)
T ss_pred             HHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence            997654322  24566889999999999876 7999999999999999999999888764431110000     00 000


Q ss_pred             hhhhccc-cccccccccc-CCcccHHH---HHHHHHHHHHhhccCCCCCCChhHHHHH
Q 015027          308 LNSIKNN-GLRQILNFHV-ADESEMKE---IEIVAELASKCLRIRGTERPTMKQVSEE  360 (414)
Q Consensus       308 ~~~~~~~-~~~~~~~~~~-~~~~~~~~---~~~l~~Li~~cl~~dP~~Rps~~~v~~~  360 (414)
                      ++..... .....+.... ........   .....+|+.+||+.+|.+|.|++.++..
T Consensus       245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            0000000 0000000000 00000000   1358899999999999999999998654

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-41  Score=330.76  Aligned_cols=251  Identities=21%  Similarity=0.260  Sum_probs=194.9

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc----hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK----IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~  161 (414)
                      ++|++.+.||+|+||.||+|... +++.||||++.....    .......++.++..++||||+++++++.++...|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47899999999999999999976 589999999976432    1223355678999999999999999999999999999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCC
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD  241 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  241 (414)
                      ||+++|+|.+++....   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 E~~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  154 (364)
T cd05599          81 EYLPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS  154 (364)
T ss_pred             CCCCCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence            9999999999986543   3578899999999999999999988   999999999999999999999999998754321


Q ss_pred             cccc------------------------------------ceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh
Q 015027          242 AETA------------------------------------MSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT  285 (414)
Q Consensus       242 ~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t  285 (414)
                      ....                                    .....+||+.|+|||++.+..++.++|||||||++|||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~  234 (364)
T cd05599         155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV  234 (364)
T ss_pred             ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence            1000                                    0112469999999999999999999999999999999999


Q ss_pred             CCCCCCccccccccccccchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCC---hhHHHH
Q 015027          286 GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPT---MKQVSE  359 (414)
Q Consensus       286 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps---~~~v~~  359 (414)
                      |..||.......         .........      ...........++.+.+|+.+|+. +|.+|++   +.++++
T Consensus       235 G~~Pf~~~~~~~---------~~~~i~~~~------~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         235 GYPPFCSDNPQE---------TYRKIINWK------ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             CCCCCCCCCHHH---------HHHHHHcCC------CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            999997433211         000000000      000000111123568899999997 8999998   787765

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.9e-41  Score=328.80  Aligned_cols=253  Identities=23%  Similarity=0.269  Sum_probs=192.1

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch----hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI----RITERELLRIISQVNHKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~  161 (414)
                      ++|++.+.||+|+||+||+|... +++.||||++......    ......+..++..++||||+++++.+.+....|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47899999999999999999965 5889999999764321    123355678899999999999999999999999999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCC
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD  241 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  241 (414)
                      ||+++|+|.+++....   .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~  154 (363)
T cd05628          81 EFLPGGDMMTLLMKKD---TLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA  154 (363)
T ss_pred             cCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence            9999999999986543   3578899999999999999999987   999999999999999999999999998754321


Q ss_pred             ccc---------------------------------cceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCC
Q 015027          242 AET---------------------------------AMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKK  288 (414)
Q Consensus       242 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~  288 (414)
                      ...                                 ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~  234 (363)
T cd05628         155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (363)
T ss_pred             ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence            100                                 01123579999999999999999999999999999999999999


Q ss_pred             CCCccccccccccccchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhc--cCCCCCCChhHHHHH
Q 015027          289 PGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLR--IRGTERPTMKQVSEE  360 (414)
Q Consensus       289 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~--~dP~~Rps~~~v~~~  360 (414)
                      ||.......         ....+........+.+..      ..+..+.+|+.+++.  .++..||++.+|++.
T Consensus       235 Pf~~~~~~~---------~~~~i~~~~~~~~~p~~~------~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         235 PFCSETPQE---------TYKKVMNWKETLIFPPEV------PISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             CCCCCCHHH---------HHHHHHcCcCcccCCCcC------CCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            997433111         011111000000111111      112457888888654  233356899998664

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.3e-41  Score=320.03  Aligned_cols=260  Identities=24%  Similarity=0.363  Sum_probs=204.9

Q ss_pred             cCCCCCCccccCCceEEEEEEEc------CCcEEEEEEeecccch-hHhHHHHHHHHHccCCCceeeeeeeEecCCcceE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH------DNIQVAVKTYRRADKI-RITERELLRIISQVNHKNVVKILGLCLETEVPLL  159 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~l  159 (414)
                      .+|.+.+.||+|+||.||+|...      ++..+++|.+...... .....+++..+++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            45788899999999999999843      2456899988655432 2344567789999999999999999999999999


Q ss_pred             EEEeCCCCchhhhhhhcCC-------------cccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCc
Q 015027          160 VYEFASNGTLLDHIRCESS-------------QVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYT  226 (414)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~  226 (414)
                      ||||+++++|.+++.....             ...+++..++.++.||+.||+|||+.+   ++||||||+|||++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence            9999999999999965432             233688999999999999999999988   999999999999999999


Q ss_pred             EEEeeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccch
Q 015027          227 AKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVP  305 (414)
Q Consensus       227 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~  305 (414)
                      ++|+|||++................++..|+|||++.+..++.++|||||||++|||++ |..||.......        
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--------  233 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE--------  233 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--------
Confidence            99999999976544322222334456788999999999999999999999999999998 999986432211        


Q ss_pred             hhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHh
Q 015027          306 YFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRL  367 (414)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~  367 (414)
                       ............         .....+..+.+|+.+||+.+|.+|||+.+|++.|+.+...
T Consensus       234 -~~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         234 -VIECITQGRVLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             -HHHHHhCCCCCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence             111111111100         0111235689999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1e-41  Score=327.31  Aligned_cols=243  Identities=23%  Similarity=0.276  Sum_probs=194.2

Q ss_pred             cCCCCCCccccCCceEEEEEEEcC--CcEEEEEEeecccc----hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLHD--NIQVAVKTYRRADK----IRITERELLRIISQVNHKNVVKILGLCLETEVPLLV  160 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~----~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv  160 (414)
                      ++|.+.+.||+|+||.||+|.+..  +..||+|.+.....    .......++.++..++||||+++++++.+.+..|+|
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv  109 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV  109 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence            578999999999999999998653  36899999875432    122334567899999999999999999999999999


Q ss_pred             EEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccC
Q 015027          161 YEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISS  240 (414)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  240 (414)
                      |||+++|+|.+++....   .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus       110 ~Ey~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~  183 (340)
T PTZ00426        110 LEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT  183 (340)
T ss_pred             EeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence            99999999999986543   3578888999999999999999988   99999999999999999999999999986543


Q ss_pred             CccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccc
Q 015027          241 DAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQIL  320 (414)
Q Consensus       241 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (414)
                      .     .....||+.|+|||++.+..++.++|||||||++|||++|..||.......         ....+.....  .+
T Consensus       184 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~---------~~~~i~~~~~--~~  247 (340)
T PTZ00426        184 R-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL---------IYQKILEGII--YF  247 (340)
T ss_pred             C-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH---------HHHHHhcCCC--CC
Confidence            2     234579999999999999999999999999999999999999997432110         0111111100  00


Q ss_pred             ccccCCcccHHHHHHHHHHHHHhhccCCCCCC-----ChhHHHH
Q 015027          321 NFHVADESEMKEIEIVAELASKCLRIRGTERP-----TMKQVSE  359 (414)
Q Consensus       321 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rp-----s~~~v~~  359 (414)
                          +.    ..+..+.+++.+||+.+|.+|+     +++++++
T Consensus       248 ----p~----~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~  283 (340)
T PTZ00426        248 ----PK----FLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE  283 (340)
T ss_pred             ----CC----CCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence                11    1124588999999999999995     7777754

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=7.4e-42  Score=319.15  Aligned_cols=257  Identities=26%  Similarity=0.405  Sum_probs=198.7

Q ss_pred             HhcCCCCCCccccCCceEEEEEEEc------CCcEEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEecCCc
Q 015027           85 ATKNFDRSRCLSQGGFVSVYKGVLH------DNIQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLETEV  156 (414)
Q Consensus        85 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~  156 (414)
                      ..++|++.+.||+|+||.||+|.+.      .+..||+|.+......  .....+++.+++.++||||+++++++..+..
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4578999999999999999999753      2467999988653322  2234566788999999999999999999999


Q ss_pred             ceEEEEeCCCCchhhhhhhcCC-------cccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEE
Q 015027          157 PLLVYEFASNGTLLDHIRCESS-------QVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKV  229 (414)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~~-------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl  229 (414)
                      .++||||+++++|.+++.....       ....++..++.++.|++.||.|||+.+   ++|+||||+||++++++.++|
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence            9999999999999999865322       123467888999999999999999977   999999999999999999999


Q ss_pred             eeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhh
Q 015027          230 ADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFL  308 (414)
Q Consensus       230 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~  308 (414)
                      +|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||.......         ..
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~---------~~  231 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ---------VL  231 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---------HH
Confidence            99999876543222222223355778999999999999999999999999999999 788886432111         11


Q ss_pred             hhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHH
Q 015027          309 NSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELD  362 (414)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~  362 (414)
                      ..........     ..    ...+..+.+++.+||+.+|.+|||+.++++.|+
T Consensus       232 ~~~~~~~~~~-----~~----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         232 RFVMEGGLLD-----KP----DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             HHHHcCCcCC-----CC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            1111111100     01    112245899999999999999999999988875

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.7e-41  Score=324.58  Aligned_cols=241  Identities=22%  Similarity=0.248  Sum_probs=190.5

Q ss_pred             CccccCCceEEEEEEEc-CCcEEEEEEeecccch----hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCCCC
Q 015027           93 RCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI----RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNG  167 (414)
Q Consensus        93 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g  167 (414)
                      +.||+|+||.||++... +++.||+|++......    ......++++++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            36899999999999965 5899999999764321    123345668899999999999999999999999999999999


Q ss_pred             chhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccccce
Q 015027          168 TLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMS  247 (414)
Q Consensus       168 sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  247 (414)
                      +|.+++....   .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++......  ....
T Consensus        81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~  152 (328)
T cd05593          81 ELFFHLSRER---VFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATM  152 (328)
T ss_pred             CHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc--cccc
Confidence            9998885433   3578899999999999999999987   999999999999999999999999998754322  1122


Q ss_pred             ecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccccCCc
Q 015027          248 TILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADE  327 (414)
Q Consensus       248 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (414)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.......         .........      ..++. 
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~---------~~~~~~~~~------~~~p~-  216 (328)
T cd05593         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---------LFELILMED------IKFPR-  216 (328)
T ss_pred             ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH---------HHHHhccCC------ccCCC-
Confidence            34579999999999999999999999999999999999999996432111         000000000      01111 


Q ss_pred             ccHHHHHHHHHHHHHhhccCCCCCC-----ChhHHHHH
Q 015027          328 SEMKEIEIVAELASKCLRIRGTERP-----TMKQVSEE  360 (414)
Q Consensus       328 ~~~~~~~~l~~Li~~cl~~dP~~Rp-----s~~~v~~~  360 (414)
                         ..+..+.+|+.+||+.||.+||     ++.++++.
T Consensus       217 ---~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         217 ---TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             ---CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence               1225589999999999999997     78888653

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.1e-41  Score=332.61  Aligned_cols=251  Identities=21%  Similarity=0.255  Sum_probs=191.4

Q ss_pred             CCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch----hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEE
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI----RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYE  162 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  162 (414)
                      .|.+++.||+|+||+||+|... +++.||||++......    ......++.++..++||||+++++++.+.+..|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5888999999999999999965 5889999999764322    2234566789999999999999999999999999999


Q ss_pred             eCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCc
Q 015027          163 FASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDA  242 (414)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  242 (414)
                      |+++|+|.+++....   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.......
T Consensus        82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~  155 (381)
T cd05626          82 YIPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH  155 (381)
T ss_pred             cCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence            999999999986543   3477888889999999999999987   9999999999999999999999999975432100


Q ss_pred             c---------------------------------------------ccceecccccccccchhhcccCCCCCcccchhHH
Q 015027          243 E---------------------------------------------TAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFG  277 (414)
Q Consensus       243 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG  277 (414)
                      .                                             ........||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (381)
T cd05626         156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG  235 (381)
T ss_pred             ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence            0                                             0011235799999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHh--hccCCCCCCChh
Q 015027          278 VVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKC--LRIRGTERPTMK  355 (414)
Q Consensus       278 vil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~c--l~~dP~~Rps~~  355 (414)
                      |++|||++|..||........        .........       ....+.....+.++.+|+.+|  +..+|..||++.
T Consensus       236 ~il~elltG~~Pf~~~~~~~~--------~~~i~~~~~-------~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~  300 (381)
T cd05626         236 VILFEMLVGQPPFLAPTPTET--------QLKVINWEN-------TLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGAD  300 (381)
T ss_pred             hHHHHHHhCCCCCcCCCHHHH--------HHHHHcccc-------ccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHH
Confidence            999999999999974332110        000000000       000000111225588999884  455666699999


Q ss_pred             HHHH
Q 015027          356 QVSE  359 (414)
Q Consensus       356 ~v~~  359 (414)
                      +++.
T Consensus       301 ~~l~  304 (381)
T cd05626         301 DIKA  304 (381)
T ss_pred             HHhc
Confidence            9965

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.6e-41  Score=323.98  Aligned_cols=240  Identities=23%  Similarity=0.271  Sum_probs=189.7

Q ss_pred             CccccCCceEEEEEEEc-CCcEEEEEEeecccch----hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCCCC
Q 015027           93 RCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI----RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNG  167 (414)
Q Consensus        93 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g  167 (414)
                      +.||+|+||.||++... +|..||+|++......    ......++++++.++||||++++++|...+..|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46899999999999965 5899999999764321    122345678999999999999999999999999999999999


Q ss_pred             chhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccccce
Q 015027          168 TLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMS  247 (414)
Q Consensus       168 sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  247 (414)
                      +|.+++....   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.......  ...
T Consensus        81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~  152 (323)
T cd05595          81 ELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATM  152 (323)
T ss_pred             cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccc
Confidence            9998886443   3478899999999999999999987   9999999999999999999999999987532221  122


Q ss_pred             ecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccccCCc
Q 015027          248 TILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADE  327 (414)
Q Consensus       248 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (414)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||...+...         ..........      .++. 
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~---------~~~~~~~~~~------~~p~-  216 (323)
T cd05595         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---------LFELILMEEI------RFPR-  216 (323)
T ss_pred             ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH---------HHHHHhcCCC------CCCC-
Confidence            34578999999999999999999999999999999999999996432111         0011100000      0111 


Q ss_pred             ccHHHHHHHHHHHHHhhccCCCCCC-----ChhHHHH
Q 015027          328 SEMKEIEIVAELASKCLRIRGTERP-----TMKQVSE  359 (414)
Q Consensus       328 ~~~~~~~~l~~Li~~cl~~dP~~Rp-----s~~~v~~  359 (414)
                         ..++.+.+|+.+||+.||.+||     ++.++++
T Consensus       217 ---~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         217 ---TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             ---CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence               1235689999999999999998     6777754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-42  Score=352.47  Aligned_cols=260  Identities=27%  Similarity=0.420  Sum_probs=206.7

Q ss_pred             cCCCCCCccccCCceEEEEEEEcC--Cc----EEEEEEeecccc--hhHhHHHHHHHHHccCCCceeeeeeeEecCCcce
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLHD--NI----QVAVKTYRRADK--IRITERELLRIISQVNHKNVVKILGLCLETEVPL  158 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~~--~~----~vavK~~~~~~~--~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~  158 (414)
                      .+....+.||+|+||.||.|...+  |.    .||||.+.....  ....+..|..+|+.++|||||+++|+|.+....+
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~  771 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL  771 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence            445667889999999999999653  43    389999887643  3345577788999999999999999999999999


Q ss_pred             EEEEeCCCCchhhhhhhcCC----cccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccc
Q 015027          159 LVYEFASNGTLLDHIRCESS----QVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFES  234 (414)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGl  234 (414)
                      |++|||++|+|..+|+....    ...++....+.++.|||+|+.||++++   +|||||...|+||+....|||+|||+
T Consensus       772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGl  848 (1025)
T KOG1095|consen  772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGL  848 (1025)
T ss_pred             EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccch
Confidence            99999999999999976521    344578889999999999999999988   99999999999999999999999999


Q ss_pred             cccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhcc
Q 015027          235 SVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKN  313 (414)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  313 (414)
                      |+.............-.-...|||||.+..+.++.|+|||||||+|||++| |..||.......         ....+..
T Consensus       849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~---------v~~~~~~  919 (1025)
T KOG1095|consen  849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE---------VLLDVLE  919 (1025)
T ss_pred             hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH---------HHHHHHh
Confidence            995544333332222122348999999999999999999999999999999 999997554322         1221222


Q ss_pred             cccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHh
Q 015027          314 NGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRL  367 (414)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~  367 (414)
                      ++       +  -+.+...+..+.+|+..||+.+|++||++..|++.+..+...
T Consensus       920 gg-------R--L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~  964 (1025)
T KOG1095|consen  920 GG-------R--LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA  964 (1025)
T ss_pred             CC-------c--cCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence            22       1  111222234588999999999999999999999988877654

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.6e-41  Score=317.90  Aligned_cols=256  Identities=23%  Similarity=0.362  Sum_probs=198.3

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-----CCcEEEEEEeecccchh--HhHHHHHHHHHccCCCceeeeeeeEecCCcceE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-----DNIQVAVKTYRRADKIR--ITERELLRIISQVNHKNVVKILGLCLETEVPLL  159 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~--~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~l  159 (414)
                      .+|++.+.||+|+||.||+|.+.     ++..||+|.+.......  .....++.+++.++||||+++++++..+...|+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            46788899999999999999842     45789999987543222  234556789999999999999999999999999


Q ss_pred             EEEeCCCCchhhhhhhcCC--------------cccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCC
Q 015027          160 VYEFASNGTLLDHIRCESS--------------QVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNY  225 (414)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~--------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~  225 (414)
                      ||||+++++|.+++.....              ...+++..++.++.|++.||.|||+.+   ++|+||||+|||+++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence            9999999999999853321              234578888999999999999999987   99999999999999999


Q ss_pred             cEEEeeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccc
Q 015027          226 TAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMV  304 (414)
Q Consensus       226 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~  304 (414)
                      .+||+|||++................++..|+|||++.+..++.++|||||||++|||++ |..||.......       
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~-------  234 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE-------  234 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-------
Confidence            999999999976543322222333455678999999998899999999999999999998 999986432110       


Q ss_pred             hhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHH
Q 015027          305 PYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDR  363 (414)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~  363 (414)
                        ............     ...    ..+..+.+++.+||+.+|.+||++.+|.+.|..
T Consensus       235 --~~~~~~~~~~~~-----~~~----~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         235 --VIEMVRKRQLLP-----CSE----DCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             --HHHHHHcCCcCC-----CCC----CCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence              111111111000     011    112458999999999999999999999888764

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=2.3e-41  Score=317.93  Aligned_cols=264  Identities=21%  Similarity=0.256  Sum_probs=188.5

Q ss_pred             cCCCCCCccccCCceEEEEEEEc--CCcEEEEEEeecccch---hHhH---HHHHHHHHccCCCceeeeeeeEe-----c
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH--DNIQVAVKTYRRADKI---RITE---RELLRIISQVNHKNVVKILGLCL-----E  153 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~---~~~~---~~~~~~l~~l~hpniv~l~~~~~-----~  153 (414)
                      ++|++.+.||+|+||.||+|.+.  ++..||+|.+......   ....   .+.++.+..++||||++++++|.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            47899999999999999999863  4678999998754321   1122   22334445567999999999985     2


Q ss_pred             CCcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecc
Q 015027          154 TEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFE  233 (414)
Q Consensus       154 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG  233 (414)
                      ....++||||++ ++|.+++..... ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG  155 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence            456899999997 588888864432 23578899999999999999999987   9999999999999999999999999


Q ss_pred             ccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhh----h
Q 015027          234 SSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFL----N  309 (414)
Q Consensus       234 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~----~  309 (414)
                      ++......   .......||+.|+|||++.+..++.++|||||||++|||++|.+||.......... .+.....    .
T Consensus       156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~-~i~~~~~~~~~~  231 (290)
T cd07862         156 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG-KILDVIGLPGEE  231 (290)
T ss_pred             ceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHH-HHHHHhCCCChh
Confidence            99765432   22334578999999999998999999999999999999999999997543211000 0000000    0


Q ss_pred             hhccc-cc-ccccccccCC---cccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          310 SIKNN-GL-RQILNFHVAD---ESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       310 ~~~~~-~~-~~~~~~~~~~---~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      .+... .. ...+......   ......+..+.+|+.+||+.||++|||+.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            00000 00 0000000000   000012355889999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.1e-41  Score=324.54  Aligned_cols=199  Identities=23%  Similarity=0.315  Sum_probs=170.9

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc--hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK--IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYE  162 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  162 (414)
                      .++|++.+.||+|+||.||++.+. ++..+|+|.+.....  .......+++++.+++||||++++++|.+++..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            478999999999999999999976 588899998876432  22344667899999999999999999999999999999


Q ss_pred             eCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCc
Q 015027          163 FASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDA  242 (414)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  242 (414)
                      |+++++|.+++....   .+++..+..++.+++.||.|||+.+  +++|+||||+|||++.++.+||+|||++...... 
T Consensus        84 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-  157 (333)
T cd06650          84 HMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  157 (333)
T ss_pred             cCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence            999999999986533   3477888899999999999999742  3999999999999999999999999998765322 


Q ss_pred             cccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCcc
Q 015027          243 ETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCM  293 (414)
Q Consensus       243 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~  293 (414)
                         ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus       158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~  205 (333)
T cd06650         158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP  205 (333)
T ss_pred             ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence               123347899999999999999999999999999999999999998643

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.6e-41  Score=312.41  Aligned_cols=253  Identities=27%  Similarity=0.390  Sum_probs=200.5

Q ss_pred             cCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCCC
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASN  166 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  166 (414)
                      ++|++.+.||+|+||.||+|...++..+|+|.+...........+++.++++++|||++++++++. ....++||||+++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~   84 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSK   84 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCC
Confidence            578899999999999999999888888999999876555555667788999999999999999875 4568999999999


Q ss_pred             CchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccccc
Q 015027          167 GTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAM  246 (414)
Q Consensus       167 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  246 (414)
                      ++|.+++..... ..+++..+..++.+++.||.|||+.+   ++|+||||+||++++++.++|+|||++......... .
T Consensus        85 ~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-~  159 (260)
T cd05070          85 GSLLDFLKDGEG-RALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-A  159 (260)
T ss_pred             CcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc-c
Confidence            999999865432 23578899999999999999999987   999999999999999999999999999765432211 1


Q ss_pred             eecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhcccccccccccccC
Q 015027          247 STILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVA  325 (414)
Q Consensus       247 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (414)
                      .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.......         ........         ..
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---------~~~~~~~~---------~~  221 (260)
T cd05070         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE---------VLEQVERG---------YR  221 (260)
T ss_pred             ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---------HHHHHHcC---------CC
Confidence            112234567999999998899999999999999999999 899986432110         11111110         00


Q ss_pred             CcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHH
Q 015027          326 DESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDR  363 (414)
Q Consensus       326 ~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~  363 (414)
                      .+.+...+..+.+|+.+||..+|.+|||+.++.+.|+.
T Consensus       222 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         222 MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            11111223569999999999999999999999888864

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=3e-41  Score=323.03  Aligned_cols=244  Identities=19%  Similarity=0.249  Sum_probs=186.1

Q ss_pred             CccccCCceEEEEEEEc-CCcEEEEEEeecccchh----HhHHHHHHHHHcc-CCCceeeeeeeEecCCcceEEEEeCCC
Q 015027           93 RCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIR----ITERELLRIISQV-NHKNVVKILGLCLETEVPLLVYEFASN  166 (414)
Q Consensus        93 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~  166 (414)
                      +.||+|+||.||+|... +++.||+|+++......    .....+..++..+ +||||++++++|.+....|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46899999999999975 58899999998643211    2234455677777 799999999999999999999999999


Q ss_pred             CchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccccc
Q 015027          167 GTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAM  246 (414)
Q Consensus       167 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  246 (414)
                      |+|.+++....   .+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++......  ...
T Consensus        81 g~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~  152 (329)
T cd05588          81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDT  152 (329)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC--CCc
Confidence            99998885432   3588999999999999999999988   999999999999999999999999998743221  112


Q ss_pred             eecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccccCC
Q 015027          247 STILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVAD  326 (414)
Q Consensus       247 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (414)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...............+..........      .++.
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~~p~  226 (329)
T cd05588         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI------RIPR  226 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC------CCCC
Confidence            2345799999999999999999999999999999999999999964322211111111111111111110      1111


Q ss_pred             cccHHHHHHHHHHHHHhhccCCCCCCCh
Q 015027          327 ESEMKEIEIVAELASKCLRIRGTERPTM  354 (414)
Q Consensus       327 ~~~~~~~~~l~~Li~~cl~~dP~~Rps~  354 (414)
                          ..+..+.+|+.+||+.||.+|||+
T Consensus       227 ----~~~~~~~~li~~~L~~dP~~R~~~  250 (329)
T cd05588         227 ----SLSVKASSVLKGFLNKDPKERLGC  250 (329)
T ss_pred             ----CCCHHHHHHHHHHhccCHHHcCCC
Confidence                112458999999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=2e-41  Score=311.62  Aligned_cols=247  Identities=25%  Similarity=0.412  Sum_probs=191.1

Q ss_pred             CccccCCceEEEEEEEc-CCcEEEEEEeecccc--hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCCCCch
Q 015027           93 RCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK--IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTL  169 (414)
Q Consensus        93 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL  169 (414)
                      +.||+|+||.||+|.+. +++.+|+|.+.....  ....+.++++++++++||||++++++|......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            36899999999999975 688999998764322  223446677899999999999999999999999999999999999


Q ss_pred             hhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccccceec
Q 015027          170 LDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTI  249 (414)
Q Consensus       170 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  249 (414)
                      .+++....  ..+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++..............
T Consensus        81 ~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  155 (252)
T cd05084          81 LTFLRTEG--PRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM  155 (252)
T ss_pred             HHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence            99986433  23478899999999999999999987   99999999999999999999999999875442211111111


Q ss_pred             ccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhcccccccccccccCCcc
Q 015027          250 LIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADES  328 (414)
Q Consensus       250 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (414)
                      ...+..|+|||.+.+..++.++||||||+++|||++ |..||.......         ........ .        ....
T Consensus       156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~---------~~~~~~~~-~--------~~~~  217 (252)
T cd05084         156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ---------TREAIEQG-V--------RLPC  217 (252)
T ss_pred             CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH---------HHHHHHcC-C--------CCCC
Confidence            123456999999999999999999999999999998 888886332110         00000000 0        0011


Q ss_pred             cHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHH
Q 015027          329 EMKEIEIVAELASKCLRIRGTERPTMKQVSEELD  362 (414)
Q Consensus       329 ~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~  362 (414)
                      +...+..+.+|+.+||+.+|++|||+.++.+.|.
T Consensus       218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            1112356899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=2.9e-41  Score=317.37  Aligned_cols=258  Identities=24%  Similarity=0.353  Sum_probs=199.9

Q ss_pred             CCCCCCccccCCceEEEEEEEc------CCcEEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEecCCcceE
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLH------DNIQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLETEVPLL  159 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~l  159 (414)
                      +|++.+.||+|+||.||+|...      ....+++|.+......  ......++.+++.++||||+++++.|..++..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4788899999999999999853      2356899988754332  2234556789999999999999999999999999


Q ss_pred             EEEeCCCCchhhhhhhcC---------------------CcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCc
Q 015027          160 VYEFASNGTLLDHIRCES---------------------SQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSAN  218 (414)
Q Consensus       160 v~e~~~~gsL~~~l~~~~---------------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~N  218 (414)
                      ||||+++++|.+++....                     ....+++..++.++.|++.||.|||+.+   ++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence            999999999999885421                     1124678889999999999999999987   9999999999


Q ss_pred             eeeCCCCcEEEeeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCcccccc
Q 015027          219 ILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLAS  297 (414)
Q Consensus       219 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~  297 (414)
                      ||+++++.+||+|||++................++..|+|||.+.+..++.++||||||+++|||++ |..||.......
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~  237 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER  237 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            9999999999999999876543322212223345678999999998999999999999999999998 999986432111


Q ss_pred             ccccccchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHH
Q 015027          298 NKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR  366 (414)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~  366 (414)
                               ........ ..        ...+...+..+.+++.+||+.+|.+||++.++++.|+.+-.
T Consensus       238 ---------~~~~~~~~-~~--------~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         238 ---------LFNLLKTG-YR--------MERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             ---------HHHHHhCC-CC--------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence                     11111111 00        00111122568999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=8.8e-42  Score=326.89  Aligned_cols=251  Identities=22%  Similarity=0.242  Sum_probs=196.2

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc----hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK----IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~  161 (414)
                      ++|.+.+.||+|+||.||++... +++.||+|++.....    ......+++.++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            46889999999999999999975 588999999986533    2223356678889999999999999999999999999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCC
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD  241 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  241 (414)
                      ||+++|+|.+++....  ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        81 e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          81 EYQPGGDLLSLLNRYE--DQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             CCCCCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            9999999999996542  23578888999999999999999988   999999999999999999999999999876533


Q ss_pred             ccccceecccccccccchhhcc------cCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccc
Q 015027          242 AETAMSTILIGTSGYLDPVCIN------TGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNG  315 (414)
Q Consensus       242 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (414)
                      .. .......||+.|+|||++.      +..++.++|||||||++|||++|..||.......         ....+... 
T Consensus       156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~---------~~~~i~~~-  224 (330)
T cd05601         156 KM-VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK---------TYNNIMNF-  224 (330)
T ss_pred             Cc-eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH---------HHHHHHcC-
Confidence            21 1233457899999999986      4567899999999999999999999996433211         00000000 


Q ss_pred             cccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          316 LRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                       .....    .+.....+..+.+|+.+||+ +|.+|||+.+++.
T Consensus       225 -~~~~~----~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         225 -QRFLK----FPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             -CCccC----CCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence             00000    00011123558999999998 9999999999864

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2.6e-41  Score=328.18  Aligned_cols=253  Identities=21%  Similarity=0.279  Sum_probs=194.8

Q ss_pred             HhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc----hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceE
Q 015027           85 ATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK----IRITERELLRIISQVNHKNVVKILGLCLETEVPLL  159 (414)
Q Consensus        85 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~l  159 (414)
                      ..++|++.+.||+|+||.||++... +++.+|+|++.....    ......+++.+++.++||||+++++++.+++..|+
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l  120 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM  120 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            3578999999999999999999976 588999999875322    12233567788999999999999999999999999


Q ss_pred             EEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccccccc
Q 015027          160 VYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLIS  239 (414)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~  239 (414)
                      ||||+++|+|.+++...    .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus       121 v~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~  193 (370)
T cd05621         121 VMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMD  193 (370)
T ss_pred             EEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecc
Confidence            99999999999998543    2477888999999999999999987   9999999999999999999999999998764


Q ss_pred             CCccccceecccccccccchhhcccCC----CCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccc
Q 015027          240 SDAETAMSTILIGTSGYLDPVCINTGK----LTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNG  315 (414)
Q Consensus       240 ~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (414)
                      ... ........||+.|+|||++.+..    ++.++|||||||++|+|++|..||.......         ....+....
T Consensus       194 ~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~---------~~~~i~~~~  263 (370)
T cd05621         194 ETG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG---------TYSKIMDHK  263 (370)
T ss_pred             cCC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH---------HHHHHHhCC
Confidence            321 11223457999999999997643    7889999999999999999999997433111         001111000


Q ss_pred             cccccccccCCcccHHHHHHHHHHHHHhhccCCCC--CCChhHHHHH
Q 015027          316 LRQILNFHVADESEMKEIEIVAELASKCLRIRGTE--RPTMKQVSEE  360 (414)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~--Rps~~~v~~~  360 (414)
                      .      ....+.....+..+.+++.+||..+|.+  |+|+.++++.
T Consensus       264 ~------~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         264 N------SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             c------ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            0      0011111122356899999999865544  8899988653

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=3.7e-41  Score=312.01  Aligned_cols=254  Identities=27%  Similarity=0.392  Sum_probs=200.7

Q ss_pred             cCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCCC
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASN  166 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  166 (414)
                      ++|.+.+.||+|+||.||+|.+.++..||+|.+............++++++.++||||+++++++. ....++||||+++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~   84 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSK   84 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCC
Confidence            568999999999999999999877778999999865544455566778999999999999999875 4567999999999


Q ss_pred             CchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccccc
Q 015027          167 GTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAM  246 (414)
Q Consensus       167 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  246 (414)
                      |+|.+++..... ..+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||.+......... .
T Consensus        85 ~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~-~  159 (262)
T cd05071          85 GSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-A  159 (262)
T ss_pred             CcHHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc-c
Confidence            999999965322 23478899999999999999999987   999999999999999999999999999766433211 1


Q ss_pred             eecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhcccccccccccccC
Q 015027          247 STILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVA  325 (414)
Q Consensus       247 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (414)
                      .....++..|+|||+..+..++.++||||||+++|+|++ |..||.......         ........ .        .
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~---------~~~~~~~~-~--------~  221 (262)
T cd05071         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERG-Y--------R  221 (262)
T ss_pred             ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH---------HHHHHhcC-C--------C
Confidence            122345678999999998999999999999999999999 888986432111         01111000 0        0


Q ss_pred             CcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHH
Q 015027          326 DESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL  364 (414)
Q Consensus       326 ~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i  364 (414)
                      .......+..+.+|+.+||+.+|.+||++.++++.|+..
T Consensus       222 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         222 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence            011122345689999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2.5e-41  Score=312.57  Aligned_cols=254  Identities=25%  Similarity=0.404  Sum_probs=201.9

Q ss_pred             hcCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCC
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFAS  165 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  165 (414)
                      .++|++.+.||+|+||.||+|...+++.||+|.+...........+++.++++++||||+++++++. .+..++||||++
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYME   83 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCC
Confidence            4678999999999999999999888999999999876554555667778999999999999999874 456899999999


Q ss_pred             CCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcccc
Q 015027          166 NGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETA  245 (414)
Q Consensus       166 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  245 (414)
                      +++|.+++..... ..+++..++.++.|++.||+|||+.+   ++|+||||+||++++++.++|+|||++........ .
T Consensus        84 ~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~  158 (260)
T cd05067          84 NGSLVDFLKTPEG-IKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-T  158 (260)
T ss_pred             CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCc-c
Confidence            9999999865433 34578889999999999999999987   99999999999999999999999999876643211 1


Q ss_pred             ceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhccccccccccccc
Q 015027          246 MSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHV  324 (414)
Q Consensus       246 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (414)
                      ......++..|+|||++.+..++.++||||||+++|||++ |+.||.......         ........ ..    .. 
T Consensus       159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---------~~~~~~~~-~~----~~-  223 (260)
T cd05067         159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE---------VIQNLERG-YR----MP-  223 (260)
T ss_pred             cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH---------HHHHHHcC-CC----CC-
Confidence            1122345678999999998999999999999999999999 999996433111         11111110 00    00 


Q ss_pred             CCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHH
Q 015027          325 ADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDR  363 (414)
Q Consensus       325 ~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~  363 (414)
                         .+...+..+.+++.+||..+|++|||++++...|+.
T Consensus       224 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         224 ---RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             ---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence               011122569999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=4.5e-41  Score=321.75  Aligned_cols=244  Identities=20%  Similarity=0.249  Sum_probs=184.6

Q ss_pred             CccccCCceEEEEEEEc-CCcEEEEEEeecccch----hHhHHHHHHHHHcc-CCCceeeeeeeEecCCcceEEEEeCCC
Q 015027           93 RCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI----RITERELLRIISQV-NHKNVVKILGLCLETEVPLLVYEFASN  166 (414)
Q Consensus        93 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~  166 (414)
                      +.||+|+||.||+|... +++.||+|++......    ......+..++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46899999999999976 5889999999864221    11223444555554 899999999999999999999999999


Q ss_pred             CchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccccc
Q 015027          167 GTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAM  246 (414)
Q Consensus       167 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  246 (414)
                      |+|..++....   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.......  ..
T Consensus        81 ~~L~~~~~~~~---~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~  152 (329)
T cd05618          81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DT  152 (329)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Cc
Confidence            99988885433   3578889999999999999999987   9999999999999999999999999987533221  12


Q ss_pred             eecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccccCC
Q 015027          247 STILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVAD  326 (414)
Q Consensus       247 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (414)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...............+..........      .++.
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------~~p~  226 (329)
T cd05618         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------RIPR  226 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC------CCCC
Confidence            2345789999999999999999999999999999999999999963222111111111111111111110      0111


Q ss_pred             cccHHHHHHHHHHHHHhhccCCCCCCCh
Q 015027          327 ESEMKEIEIVAELASKCLRIRGTERPTM  354 (414)
Q Consensus       327 ~~~~~~~~~l~~Li~~cl~~dP~~Rps~  354 (414)
                          ..+..+.+|+.+||+.||.+||++
T Consensus       227 ----~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         227 ----SLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             ----CCCHHHHHHHHHHhcCCHHHcCCC
Confidence                122458899999999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=3.3e-41  Score=315.23  Aligned_cols=257  Identities=24%  Similarity=0.354  Sum_probs=196.3

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCc----EEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEecCCcceE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNI----QVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLETEVPLL  159 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~l  159 (414)
                      .+|++.+.||+|+||.||+|.+. ++.    .+++|.+......  ...+..++..+..++||||+++++++. +...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence            56888999999999999999964 344    4778877543221  123344556788999999999999875 456789


Q ss_pred             EEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccccccc
Q 015027          160 VYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLIS  239 (414)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~  239 (414)
                      ++||+++|+|.+++.....  .+++..+..++.||+.||.|||+.+   ++||||||+|||+++++.+||+|||+++...
T Consensus        86 i~e~~~~gsL~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHRD--SLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             EEEeCCCCcHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            9999999999999965432  3578899999999999999999977   9999999999999999999999999998664


Q ss_pred             CCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhccccccc
Q 015027          240 SDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQ  318 (414)
Q Consensus       240 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (414)
                      ............++..|+|||++.+..++.++|||||||++|||++ |..||.......         ..........  
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---------~~~~~~~~~~--  229 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE---------VPDLLEKGER--  229 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---------HHHHHHCCCc--
Confidence            3322222334456778999999998899999999999999999998 999986432111         0011111110  


Q ss_pred             ccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHh
Q 015027          319 ILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRL  367 (414)
Q Consensus       319 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~  367 (414)
                      ...+.   .    ....+.+++.+||..+|.+|||+.++++.|..+.+.
T Consensus       230 ~~~~~---~----~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~  271 (279)
T cd05111         230 LAQPQ---I----CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD  271 (279)
T ss_pred             CCCCC---C----CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence            00001   0    113478899999999999999999999999887653

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=2.1e-41  Score=328.97  Aligned_cols=253  Identities=21%  Similarity=0.280  Sum_probs=196.2

Q ss_pred             HhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc----hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceE
Q 015027           85 ATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK----IRITERELLRIISQVNHKNVVKILGLCLETEVPLL  159 (414)
Q Consensus        85 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~l  159 (414)
                      ..++|.+.+.||+|+||.||+|... ++..||+|.+.....    ......+++.+++.++||||+++++++.++...|+
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            3468999999999999999999976 588999999975322    12223556788999999999999999999999999


Q ss_pred             EEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccccccc
Q 015027          160 VYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLIS  239 (414)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~  239 (414)
                      ||||+++|+|.+++...    .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus       121 v~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~  193 (370)
T cd05596         121 VMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD  193 (370)
T ss_pred             EEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence            99999999999988542    2467788889999999999999987   9999999999999999999999999997654


Q ss_pred             CCccccceecccccccccchhhcccC----CCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccc
Q 015027          240 SDAETAMSTILIGTSGYLDPVCINTG----KLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNG  315 (414)
Q Consensus       240 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (414)
                      .... .......||+.|+|||++.+.    .++.++|||||||++|||++|..||.......         ....+....
T Consensus       194 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---------~~~~i~~~~  263 (370)
T cd05596         194 ANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG---------TYSKIMDHK  263 (370)
T ss_pred             CCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH---------HHHHHHcCC
Confidence            3211 122345799999999998653    47899999999999999999999997433210         000110000


Q ss_pred             cccccccccCCcccHHHHHHHHHHHHHhhccCCCC--CCChhHHHHH
Q 015027          316 LRQILNFHVADESEMKEIEIVAELASKCLRIRGTE--RPTMKQVSEE  360 (414)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~--Rps~~~v~~~  360 (414)
                      .      .+..+.....+..+.+|+.+||+.+|.+  |||+.++++.
T Consensus       264 ~------~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         264 N------SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             C------cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            0      0001111112356899999999999988  9999998654

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.1e-41  Score=321.29  Aligned_cols=240  Identities=23%  Similarity=0.288  Sum_probs=188.7

Q ss_pred             CccccCCceEEEEEEEc----CCcEEEEEEeecccc-----hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEe
Q 015027           93 RCLSQGGFVSVYKGVLH----DNIQVAVKTYRRADK-----IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        93 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-----~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  163 (414)
                      +.||+|+||.||++...    +++.||+|++.....     .......++.+++.++||||++++++|..++..|+||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            67999999999999853    478899999975422     112234567899999999999999999999999999999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcc
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE  243 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  243 (414)
                      +++++|.+++...+   .+.+..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++......  
T Consensus        82 ~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  153 (323)
T cd05584          82 LSGGELFMHLEREG---IFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHE--  153 (323)
T ss_pred             CCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccC--
Confidence            99999999986543   3467788889999999999999988   999999999999999999999999998754322  


Q ss_pred             ccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccc
Q 015027          244 TAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFH  323 (414)
Q Consensus       244 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (414)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.||.......         ..........      .
T Consensus       154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~---------~~~~~~~~~~------~  218 (323)
T cd05584         154 GTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK---------TIDKILKGKL------N  218 (323)
T ss_pred             CCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH---------HHHHHHcCCC------C
Confidence            112234579999999999999999999999999999999999999997433111         1111111100      0


Q ss_pred             cCCcccHHHHHHHHHHHHHhhccCCCCCC-----ChhHHHH
Q 015027          324 VADESEMKEIEIVAELASKCLRIRGTERP-----TMKQVSE  359 (414)
Q Consensus       324 ~~~~~~~~~~~~l~~Li~~cl~~dP~~Rp-----s~~~v~~  359 (414)
                      ++.    ..+..+.+|+.+||+.+|++||     ++.++++
T Consensus       219 ~~~----~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         219 LPP----YLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             CCC----CCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence            111    1124589999999999999999     6777754

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2.2e-41  Score=327.08  Aligned_cols=246  Identities=24%  Similarity=0.316  Sum_probs=188.9

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc--hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEe
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK--IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  163 (414)
                      .+|+..+.||+|+||.||+|.+. +++.||||++.....  ......+++++++.++|+||+++++++...+..++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            45777889999999999999975 589999999865432  223446778999999999999999999999999999999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcc
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE  243 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  243 (414)
                      +++|+|.+..       ...+..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++........
T Consensus       154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~  223 (353)
T PLN00034        154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD  223 (353)
T ss_pred             CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence            9999986542       2256677889999999999999987   99999999999999999999999999987643211


Q ss_pred             ccceecccccccccchhhccc-----CCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccc
Q 015027          244 TAMSTILIGTSGYLDPVCINT-----GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQ  318 (414)
Q Consensus       244 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (414)
                        ......||..|+|||++..     ...+.++|||||||++|||++|+.||.......     + ...........   
T Consensus       224 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-----~-~~~~~~~~~~~---  292 (353)
T PLN00034        224 --PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD-----W-ASLMCAICMSQ---  292 (353)
T ss_pred             --cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc-----H-HHHHHHHhccC---
Confidence              1234578999999998743     234568999999999999999999996221110     0 00000000000   


Q ss_pred             ccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          319 ILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       319 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                            ........+..+.+|+.+||+.||++|||+.++++
T Consensus       293 ------~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~  327 (353)
T PLN00034        293 ------PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQ  327 (353)
T ss_pred             ------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                  00011122356999999999999999999999965

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.3e-41  Score=326.07  Aligned_cols=250  Identities=22%  Similarity=0.224  Sum_probs=191.1

Q ss_pred             CCCCCCccccCCceEEEEEEEc----CCcEEEEEEeecccc-----hhHhHHHHHHHHHcc-CCCceeeeeeeEecCCcc
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLH----DNIQVAVKTYRRADK-----IRITERELLRIISQV-NHKNVVKILGLCLETEVP  157 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-----~~~~~~~~~~~l~~l-~hpniv~l~~~~~~~~~~  157 (414)
                      +|++.+.||+|+||.||++...    +++.||+|++.....     .......++.++..+ +||||+++++++..++..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4788999999999999998853    578999999975322     112234556788888 599999999999999999


Q ss_pred             eEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccccc
Q 015027          158 LLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVL  237 (414)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~  237 (414)
                      ++||||+++|+|.+++....   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            99999999999999986433   3478889999999999999999987   99999999999999999999999999876


Q ss_pred             ccCCccccceecccccccccchhhcccC-CCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccc
Q 015027          238 ISSDAETAMSTILIGTSGYLDPVCINTG-KLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGL  316 (414)
Q Consensus       238 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (414)
                      ...... .......||+.|+|||++.+. .++.++|||||||++|||++|..||........     ...+......   
T Consensus       155 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-----~~~~~~~~~~---  225 (332)
T cd05614         155 FLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT-----QSEVSRRILK---  225 (332)
T ss_pred             ccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC-----HHHHHHHHhc---
Confidence            543221 122345799999999999865 478999999999999999999999963221110     0001110000   


Q ss_pred             ccccccccCCcccHHHHHHHHHHHHHhhccCCCCCC-----ChhHHHH
Q 015027          317 RQILNFHVADESEMKEIEIVAELASKCLRIRGTERP-----TMKQVSE  359 (414)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rp-----s~~~v~~  359 (414)
                         .++....    ..+..+.+|+.+||+.||++||     +++++++
T Consensus       226 ---~~~~~~~----~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         226 ---CDPPFPS----FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             ---CCCCCCC----CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence               0111111    1225589999999999999999     5666654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-41  Score=329.18  Aligned_cols=252  Identities=18%  Similarity=0.233  Sum_probs=191.5

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch----hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI----RITERELLRIISQVNHKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~  161 (414)
                      ++|.+.+.||+|+||.||++... +++.||||++......    ......+++++..++||||+++++++.+....|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            47889999999999999999965 6899999998754321    122345678899999999999999999999999999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCC
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD  241 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  241 (414)
                      ||+++|+|.+++....   .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 E~~~gg~L~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  154 (377)
T cd05629          81 EFLPGGDLMTMLIKYD---TFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ  154 (377)
T ss_pred             eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence            9999999999986533   3477888889999999999999988   999999999999999999999999998633210


Q ss_pred             ccc---------------------------------------------cceecccccccccchhhcccCCCCCcccchhH
Q 015027          242 AET---------------------------------------------AMSTILIGTSGYLDPVCINTGKLTKKSDVYSF  276 (414)
Q Consensus       242 ~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~Sl  276 (414)
                      ...                                             ......+||+.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  234 (377)
T cd05629         155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL  234 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence            000                                             00012469999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCC---CC
Q 015027          277 GVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTER---PT  353 (414)
Q Consensus       277 Gvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~R---ps  353 (414)
                      ||++|||++|..||.......         ....+.... .     ....+.....+..+.+|+.+||. +|.+|   +|
T Consensus       235 Gvil~elltG~~Pf~~~~~~~---------~~~~i~~~~-~-----~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~  298 (377)
T cd05629         235 GAIMFECLIGWPPFCSENSHE---------TYRKIINWR-E-----TLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGG  298 (377)
T ss_pred             chhhhhhhcCCCCCCCCCHHH---------HHHHHHccC-C-----ccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCC
Confidence            999999999999996433111         000000000 0     00000001122558999999998 66665   58


Q ss_pred             hhHHHHH
Q 015027          354 MKQVSEE  360 (414)
Q Consensus       354 ~~~v~~~  360 (414)
                      +.+++..
T Consensus       299 ~~~~l~h  305 (377)
T cd05629         299 AHEIKSH  305 (377)
T ss_pred             HHHHhcC
Confidence            8888654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.6e-41  Score=340.59  Aligned_cols=256  Identities=23%  Similarity=0.250  Sum_probs=199.9

Q ss_pred             HHhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch---hHhHHHHHHHHHccCCCceeeeeeeEecCC----
Q 015027           84 RATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI---RITERELLRIISQVNHKNVVKILGLCLETE----  155 (414)
Q Consensus        84 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~hpniv~l~~~~~~~~----  155 (414)
                      ...++|.+.+.||+|+||+||+|... +++.||||++......   ......++..+..++|+||+++++.+....    
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~  108 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP  108 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence            34579999999999999999999865 6899999998764322   223355678888999999999988775432    


Q ss_pred             ----cceEEEEeCCCCchhhhhhhcC-CcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEe
Q 015027          156 ----VPLLVYEFASNGTLLDHIRCES-SQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVA  230 (414)
Q Consensus       156 ----~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~  230 (414)
                          ..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+
T Consensus       109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~  185 (496)
T PTZ00283        109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLG  185 (496)
T ss_pred             ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEE
Confidence                3679999999999999986432 2345678889999999999999999987   9999999999999999999999


Q ss_pred             eccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhh
Q 015027          231 DFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNS  310 (414)
Q Consensus       231 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  310 (414)
                      |||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||.......         ....
T Consensus       186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~---------~~~~  256 (496)
T PTZ00283        186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE---------VMHK  256 (496)
T ss_pred             ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH---------HHHH
Confidence            9999987654333333445679999999999999999999999999999999999999996432111         1111


Q ss_pred             hcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHH
Q 015027          311 IKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEE  360 (414)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~  360 (414)
                      ....... .+.        ...++.+.+|+.+||+.+|.+||++.+++..
T Consensus       257 ~~~~~~~-~~~--------~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        257 TLAGRYD-PLP--------PSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             HhcCCCC-CCC--------CCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            1111100 011        1123569999999999999999999998753

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=4.6e-41  Score=311.85  Aligned_cols=259  Identities=24%  Similarity=0.339  Sum_probs=203.2

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc----hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK----IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~  161 (414)
                      ++|.+.+.||+|+||.||+|... +++.||||.+.....    .......++++++.++||||+++++++...+..++||
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            57899999999999999999965 689999998764321    1223455678999999999999999999999999999


Q ss_pred             EeCCCCchhhhhhhcC-CcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccC
Q 015027          162 EFASNGTLLDHIRCES-SQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISS  240 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  240 (414)
                      ||+++++|.+++.... ....+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            9999999998885422 2234578888999999999999999987   99999999999999999999999999887643


Q ss_pred             CccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccc
Q 015027          241 DAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQIL  320 (414)
Q Consensus       241 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (414)
                      ...  ......+++.|+|||.+.+..++.++||||||+++|||++|+.||.......      . ...........    
T Consensus       159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~------~-~~~~~~~~~~~----  225 (267)
T cd08228         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL------F-SLCQKIEQCDY----  225 (267)
T ss_pred             hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH------H-HHHHHHhcCCC----
Confidence            221  1223468889999999998899999999999999999999999985322110      0 01111111110    


Q ss_pred             ccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHH
Q 015027          321 NFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLR  365 (414)
Q Consensus       321 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~  365 (414)
                          ........+..+.+++.+||+.+|.+||++.+|++.|+.++
T Consensus       226 ----~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         226 ----PPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             ----CCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence                11111223356899999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.6e-41  Score=331.57  Aligned_cols=250  Identities=20%  Similarity=0.256  Sum_probs=190.3

Q ss_pred             CCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch----hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEE
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI----RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYE  162 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  162 (414)
                      +|.+++.||+|+||.||+|... +++.||+|++......    ......++.++++++||||+++++.|.+++..|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5888999999999999999965 5889999999764321    2233556789999999999999999999999999999


Q ss_pred             eCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCc
Q 015027          163 FASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDA  242 (414)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  242 (414)
                      ||++|+|.+++....   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.......
T Consensus        82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~  155 (382)
T cd05625          82 YIPGGDMMSLLIRMG---IFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (382)
T ss_pred             CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence            999999999986543   3477888889999999999999987   9999999999999999999999999975321100


Q ss_pred             ---------------------------------------------cccceecccccccccchhhcccCCCCCcccchhHH
Q 015027          243 ---------------------------------------------ETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFG  277 (414)
Q Consensus       243 ---------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG  277 (414)
                                                                   ........+||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (382)
T cd05625         156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG  235 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence                                                         00011234799999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCC---h
Q 015027          278 VVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPT---M  354 (414)
Q Consensus       278 vil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps---~  354 (414)
                      |++|||++|+.||........        .. ......      .....+.....++.+.+|+.+|+ .+|.+|++   +
T Consensus       236 vil~elltG~~Pf~~~~~~~~--------~~-~i~~~~------~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~  299 (382)
T cd05625         236 VILYEMLVGQPPFLAQTPLET--------QM-KVINWQ------TSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGA  299 (382)
T ss_pred             HHHHHHHhCCCCCCCCCHHHH--------HH-HHHccC------CCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCH
Confidence            999999999999974332110        00 000000      00001111112355788888876 59999997   6


Q ss_pred             hHHHH
Q 015027          355 KQVSE  359 (414)
Q Consensus       355 ~~v~~  359 (414)
                      .++++
T Consensus       300 ~ei~~  304 (382)
T cd05625         300 DEIKA  304 (382)
T ss_pred             HHHhc
Confidence            66643

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.2e-41  Score=315.05  Aligned_cols=268  Identities=24%  Similarity=0.283  Sum_probs=197.8

Q ss_pred             CC-CCCCccccCCceEEEEEEE-----cCCcEEEEEEeecccc--hhHhHHHHHHHHHccCCCceeeeeeeEecC--Ccc
Q 015027           88 NF-DRSRCLSQGGFVSVYKGVL-----HDNIQVAVKTYRRADK--IRITERELLRIISQVNHKNVVKILGLCLET--EVP  157 (414)
Q Consensus        88 ~~-~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~--~~~~~~~~~~~l~~l~hpniv~l~~~~~~~--~~~  157 (414)
                      +| .+.+.||+|+||+||++..     .++..||+|.+.....  ......+++++++.++||||+++++++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (283)
T cd05080           4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL   83 (283)
T ss_pred             hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence            44 8889999999999988653     2577899999876533  233445677899999999999999988653  357


Q ss_pred             eEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccccc
Q 015027          158 LLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVL  237 (414)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~  237 (414)
                      ++||||+++++|.+++...    .+++..++.++.|++.||.|||+.+   ++|+||||+|||++.++.+||+|||++..
T Consensus        84 ~lv~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~  156 (283)
T cd05080          84 QLIMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKA  156 (283)
T ss_pred             EEEecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccc
Confidence            8999999999999998543    3588999999999999999999987   99999999999999999999999999886


Q ss_pred             ccCCcccc-ceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccc
Q 015027          238 ISSDAETA-MSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGL  316 (414)
Q Consensus       238 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (414)
                      ........ ......++..|+|||++.+..++.++||||||+++|||++|..||...........   ...........+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~---~~~~~~~~~~~~  233 (283)
T cd05080         157 VPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMI---GPKQGQMTVVRL  233 (283)
T ss_pred             cCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhh---cccccccchhhh
Confidence            65332211 11223456679999999988999999999999999999999999863321100000   000000000001


Q ss_pred             ccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHH
Q 015027          317 RQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLR  365 (414)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~  365 (414)
                      ............+...+..+.+++.+||+.+|++|||+.++++.|+.+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         234 IELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            1111111111111122356999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2.5e-41  Score=318.13  Aligned_cols=260  Identities=25%  Similarity=0.369  Sum_probs=201.3

Q ss_pred             HhcCCCCCCccccCCceEEEEEEEcC------CcEEEEEEeecccchh--HhHHHHHHHHHcc-CCCceeeeeeeEecCC
Q 015027           85 ATKNFDRSRCLSQGGFVSVYKGVLHD------NIQVAVKTYRRADKIR--ITERELLRIISQV-NHKNVVKILGLCLETE  155 (414)
Q Consensus        85 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~--~~~~~~~~~l~~l-~hpniv~l~~~~~~~~  155 (414)
                      ..++|++.+.||+|+||.||++....      ...+|+|.+.......  .....++.++.++ +||||+++++++..++
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   89 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG   89 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence            34678899999999999999998642      3679999987543222  2335566788888 7999999999999999


Q ss_pred             cceEEEEeCCCCchhhhhhhc-------------CCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeC
Q 015027          156 VPLLVYEFASNGTLLDHIRCE-------------SSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLN  222 (414)
Q Consensus       156 ~~~lv~e~~~~gsL~~~l~~~-------------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~  222 (414)
                      ..+++|||+++|+|.+++...             .....+++..++.++.|++.||+|||+.+   |+||||||+|||++
T Consensus        90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~  166 (293)
T cd05053          90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT  166 (293)
T ss_pred             CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence            999999999999999998643             12335688899999999999999999977   99999999999999


Q ss_pred             CCCcEEEeeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCcccccccccc
Q 015027          223 DNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKI  301 (414)
Q Consensus       223 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~  301 (414)
                      .++.+||+|||++................++..|+|||++.+..++.++|||||||++|||++ |..||.......    
T Consensus       167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~----  242 (293)
T cd05053         167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE----  242 (293)
T ss_pred             CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH----
Confidence            999999999999987654322222222345678999999998999999999999999999998 999986432111    


Q ss_pred             ccchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHH
Q 015027          302 SMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLR  365 (414)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~  365 (414)
                           .........         ....+...+..+.+|+.+||+.+|.+|||+.++++.|+.+.
T Consensus       243 -----~~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         243 -----LFKLLKEGY---------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             -----HHHHHHcCC---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence                 111111110         00011112255899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-42  Score=309.91  Aligned_cols=269  Identities=21%  Similarity=0.256  Sum_probs=199.9

Q ss_pred             HHhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc---hhHhHHHHHHHHHccCCCceeeeeeeEec-----C
Q 015027           84 RATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK---IRITERELLRIISQVNHKNVVKILGLCLE-----T  154 (414)
Q Consensus        84 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~hpniv~l~~~~~~-----~  154 (414)
                      .....|..++.||+|+||.|..+.+. +|..||||.+.....   ......+++++|+.++|+||+.+++.+..     -
T Consensus        19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f   98 (359)
T KOG0660|consen   19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF   98 (359)
T ss_pred             eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence            34566777899999999999999976 589999999874322   22334667899999999999999999865     3


Q ss_pred             CcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccc
Q 015027          155 EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFES  234 (414)
Q Consensus       155 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGl  234 (414)
                      ..+|+|+|+| +.+|...++.+   ..++...+..++.|+++||.|+|+.+   |+||||||+|+|++.+..+||+|||+
T Consensus        99 ~DvYiV~elM-etDL~~iik~~---~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGL  171 (359)
T KOG0660|consen   99 NDVYLVFELM-ETDLHQIIKSQ---QDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGL  171 (359)
T ss_pred             ceeEEehhHH-hhHHHHHHHcC---ccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccc
Confidence            4689999999 45888888543   33578889999999999999999988   99999999999999999999999999


Q ss_pred             cccccCCccccceecccccccccchhhc-ccCCCCCcccchhHHHHHHHHHhCCCCCCcccccccccc------ccchhh
Q 015027          235 SVLISSDAETAMSTILIGTSGYLDPVCI-NTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKI------SMVPYF  307 (414)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~------~~~~~~  307 (414)
                      |+...........+..+.|.+|.|||++ ...+|+...||||.||||.||++|++-|.+.+.-..-..      ...+..
T Consensus       172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~  251 (359)
T KOG0660|consen  172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEED  251 (359)
T ss_pred             eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHH
Confidence            9988654333444667889999999987 457899999999999999999999999876442111000      001111


Q ss_pred             hhhhcccccccccc---cccCCccc---HHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          308 LNSIKNNGLRQILN---FHVADESE---MKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       308 ~~~~~~~~~~~~~~---~~~~~~~~---~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ...+........+.   .....++.   ....+...+|+.+||..||.+|+|++|++.
T Consensus       252 l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  252 LQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             HHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence            11111111111110   00000000   012256889999999999999999999864

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.2e-41  Score=328.61  Aligned_cols=261  Identities=17%  Similarity=0.167  Sum_probs=192.8

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeC
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFA  164 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  164 (414)
                      ..+|.+.+.||+|+||.||+|.+. +++.||+|.....     ...+|++++++++||||++++++|......++|||++
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~~-----~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~  165 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRG-----GTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY  165 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhhh-----hhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence            367999999999999999999975 5889999975432     2345678999999999999999999999999999999


Q ss_pred             CCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccc
Q 015027          165 SNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET  244 (414)
Q Consensus       165 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  244 (414)
                      . ++|..++....   .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++...... ..
T Consensus       166 ~-~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~-~~  237 (391)
T PHA03212        166 K-TDLYCYLAAKR---NIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDI-NA  237 (391)
T ss_pred             C-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccc-cc
Confidence            5 68888775432   3478889999999999999999987   999999999999999999999999999754322 11


Q ss_pred             cceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccc--cccchhhhhhh----------c
Q 015027          245 AMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKK--ISMVPYFLNSI----------K  312 (414)
Q Consensus       245 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~--~~~~~~~~~~~----------~  312 (414)
                      .......||+.|+|||++.+..++.++|||||||++|||++|..||..........  ...........          .
T Consensus       238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~  317 (391)
T PHA03212        238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA  317 (391)
T ss_pred             cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence            12234579999999999999999999999999999999999998864322110000  00000000000          0


Q ss_pred             cccccccc---------ccccCC--cccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          313 NNGLRQIL---------NFHVAD--ESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       313 ~~~~~~~~---------~~~~~~--~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ...+....         .+....  ......+..+.+|+.+||+.||.+|||++++++
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence            00000000         000000  001123457899999999999999999999953

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=3.6e-41  Score=329.39  Aligned_cols=260  Identities=24%  Similarity=0.389  Sum_probs=200.2

Q ss_pred             HhcCCCCCCccccCCceEEEEEEEc------CCcEEEEEEeecccch--hHhHHHHHHHHHccC-CCceeeeeeeEecCC
Q 015027           85 ATKNFDRSRCLSQGGFVSVYKGVLH------DNIQVAVKTYRRADKI--RITERELLRIISQVN-HKNVVKILGLCLETE  155 (414)
Q Consensus        85 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~-hpniv~l~~~~~~~~  155 (414)
                      ..++|.+.+.||+|+||.||+|++.      .+..||||++......  ......+++++.++. ||||++++++|...+
T Consensus        35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~  114 (401)
T cd05107          35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG  114 (401)
T ss_pred             cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence            3456888999999999999999863      2467999999765322  223456778999997 999999999999999


Q ss_pred             cceEEEEeCCCCchhhhhhhcCC---------------------------------------------------------
Q 015027          156 VPLLVYEFASNGTLLDHIRCESS---------------------------------------------------------  178 (414)
Q Consensus       156 ~~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------  178 (414)
                      ..++||||+++|+|.+++.....                                                         
T Consensus       115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (401)
T cd05107         115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD  194 (401)
T ss_pred             CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence            99999999999999999864321                                                         


Q ss_pred             --------------------------------------cccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCcee
Q 015027          179 --------------------------------------QVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANIL  220 (414)
Q Consensus       179 --------------------------------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIl  220 (414)
                                                            ...+++..++.++.||+.||.|||+.+   ++||||||+|||
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiL  271 (401)
T cd05107         195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVL  271 (401)
T ss_pred             chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEE
Confidence                                                  123566778889999999999999977   999999999999


Q ss_pred             eCCCCcEEEeeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCcccccccc
Q 015027          221 LNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNK  299 (414)
Q Consensus       221 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~  299 (414)
                      +++++.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||.......  
T Consensus       272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~--  349 (401)
T cd05107         272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE--  349 (401)
T ss_pred             EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH--
Confidence            99999999999999976543222112223456788999999998899999999999999999998 889986332111  


Q ss_pred             ccccchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHH
Q 015027          300 KISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL  364 (414)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i  364 (414)
                            ........ .....        .+...+..+.+|+.+||..+|.+||++.+|++.|+.+
T Consensus       350 ------~~~~~~~~-~~~~~--------~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         350 ------QFYNAIKR-GYRMA--------KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             ------HHHHHHHc-CCCCC--------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                  00000010 00000        0111125699999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.9e-41  Score=310.70  Aligned_cols=255  Identities=24%  Similarity=0.374  Sum_probs=195.9

Q ss_pred             CCCCCccccCCceEEEEEEEcC----CcEEEEEEeecccchh---HhHHHHHHHHHccCCCceeeeeeeEecCCc-----
Q 015027           89 FDRSRCLSQGGFVSVYKGVLHD----NIQVAVKTYRRADKIR---ITERELLRIISQVNHKNVVKILGLCLETEV-----  156 (414)
Q Consensus        89 ~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~---~~~~~~~~~l~~l~hpniv~l~~~~~~~~~-----  156 (414)
                      |.+.+.||+|+||.||+|....    +..||+|.++......   .....++..++.++||||+++++++...+.     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5678899999999999998642    3679999987643221   234556788999999999999998876554     


Q ss_pred             -ceEEEEeCCCCchhhhhhhcC---CcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeec
Q 015027          157 -PLLVYEFASNGTLLDHIRCES---SQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADF  232 (414)
Q Consensus       157 -~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df  232 (414)
                       .++||||+++|+|..++....   ....+++..++.++.|++.||.|||+.+   ++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence             799999999999998885432   2235688899999999999999999987   999999999999999999999999


Q ss_pred             cccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhh
Q 015027          233 ESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSI  311 (414)
Q Consensus       233 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  311 (414)
                      |+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.......         .....
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---------~~~~~  228 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---------IYDYL  228 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---------HHHHH
Confidence            99986644322222222345678999999998999999999999999999999 889986432111         11111


Q ss_pred             cccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHH
Q 015027          312 KNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL  364 (414)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i  364 (414)
                      ......     .    .+...+..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus       229 ~~~~~~-----~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         229 RHGNRL-----K----QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             HcCCCC-----C----CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            111100     0    1111235699999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=5.8e-41  Score=311.16  Aligned_cols=259  Identities=25%  Similarity=0.348  Sum_probs=203.8

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc----hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK----IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~  161 (414)
                      ++|.+.+.||+|+||.||+|... ++..+|||.+.....    ......+++.+++.++||||+++++++..++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            46888899999999999999964 689999998865322    2233456678999999999999999999999999999


Q ss_pred             EeCCCCchhhhhhhcC-CcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccC
Q 015027          162 EFASNGTLLDHIRCES-SQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISS  240 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  240 (414)
                      ||+++++|.+++.... ....+++..++.++.+|+.||.|||+.+   ++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            9999999999886422 2345688999999999999999999987   99999999999999999999999999876543


Q ss_pred             CccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccc
Q 015027          241 DAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQIL  320 (414)
Q Consensus       241 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (414)
                      ...  ......++..|+|||++.+..++.++||||||+++|+|++|..||.......   ..    ........      
T Consensus       159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~----~~~~~~~~------  223 (267)
T cd08229         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL---YS----LCKKIEQC------  223 (267)
T ss_pred             CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH---HH----HhhhhhcC------
Confidence            221  1233468889999999999999999999999999999999999986322110   00    00000000      


Q ss_pred             ccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHH
Q 015027          321 NFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLR  365 (414)
Q Consensus       321 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~  365 (414)
                        ..........+..+.+++.+||+.+|.+|||+.+|++.++++.
T Consensus       224 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         224 --DYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             --CCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence              0011111123356999999999999999999999999988764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=6.1e-41  Score=310.06  Aligned_cols=253  Identities=27%  Similarity=0.405  Sum_probs=200.0

Q ss_pred             cCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCCC
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASN  166 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  166 (414)
                      ++|.+.+.||+|++|.||+|.+..+..+|+|.+............+++++++++|||++++++++. .+..++||||+++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~   84 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGK   84 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCC
Confidence            568888999999999999999877778999998765554455566788999999999999999875 4568999999999


Q ss_pred             CchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccccc
Q 015027          167 GTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAM  246 (414)
Q Consensus       167 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  246 (414)
                      ++|.+++..... ...++..+..++.+++.||.|||+.+   ++|+||||+||++++++.++|+|||++......... .
T Consensus        85 ~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-~  159 (260)
T cd05069          85 GSLLDFLKEGDG-KYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-A  159 (260)
T ss_pred             CCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc-c
Confidence            999999965432 23578889999999999999999987   999999999999999999999999999765432111 1


Q ss_pred             eecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhcccccccccccccC
Q 015027          247 STILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVA  325 (414)
Q Consensus       247 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (414)
                      .....++..|+|||...+..++.++||||||+++|+|++ |..||.......         ........ ..    .   
T Consensus       160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---------~~~~~~~~-~~----~---  222 (260)
T cd05069         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---------VLEQVERG-YR----M---  222 (260)
T ss_pred             cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---------HHHHHHcC-CC----C---
Confidence            122345678999999998999999999999999999999 899986432111         11111110 00    0   


Q ss_pred             CcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHH
Q 015027          326 DESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDR  363 (414)
Q Consensus       326 ~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~  363 (414)
                       ..+...+..+.+++.+||..+|.+||+++++.+.|+.
T Consensus       223 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         223 -PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             -CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence             0111223569999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=3.1e-41  Score=322.39  Aligned_cols=241  Identities=22%  Similarity=0.255  Sum_probs=189.3

Q ss_pred             CccccCCceEEEEEEEc-CCcEEEEEEeecccch----hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCCCC
Q 015027           93 RCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI----RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNG  167 (414)
Q Consensus        93 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g  167 (414)
                      +.||+|+||.||++... ++..||+|++......    ......+++++..++||||+++++++...+..|+||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46899999999999965 6899999999764321    122345668889999999999999999999999999999999


Q ss_pred             chhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhh-CCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccccc
Q 015027          168 TLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHS-LASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAM  246 (414)
Q Consensus       168 sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  246 (414)
                      +|.+++....   .+++..+..++.||+.||.|||+ .+   |+||||||+|||++.++.+||+|||++.......  ..
T Consensus        81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~  152 (325)
T cd05594          81 ELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--AT  152 (325)
T ss_pred             cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cc
Confidence            9998885433   35788999999999999999997 56   9999999999999999999999999987543221  12


Q ss_pred             eecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccccCC
Q 015027          247 STILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVAD  326 (414)
Q Consensus       247 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (414)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||.......         .........      ..++.
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~---------~~~~i~~~~------~~~p~  217 (325)
T cd05594         153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---------LFELILMEE------IRFPR  217 (325)
T ss_pred             cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH---------HHHHHhcCC------CCCCC
Confidence            234579999999999999999999999999999999999999996432111         000000000      00111


Q ss_pred             cccHHHHHHHHHHHHHhhccCCCCCC-----ChhHHHHH
Q 015027          327 ESEMKEIEIVAELASKCLRIRGTERP-----TMKQVSEE  360 (414)
Q Consensus       327 ~~~~~~~~~l~~Li~~cl~~dP~~Rp-----s~~~v~~~  360 (414)
                          ..++.+.+|+.+||+.||.+|+     ++.++++.
T Consensus       218 ----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         218 ----TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             ----CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence                1225589999999999999997     78888643

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=2.3e-41  Score=316.74  Aligned_cols=256  Identities=21%  Similarity=0.315  Sum_probs=198.0

Q ss_pred             cCCCCCCccccCCceEEEEEEEcC------CcEEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEecCCcce
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLHD------NIQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLETEVPL  158 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~  158 (414)
                      .+|.+.+.||+|+||.||+|.+.+      +..||+|++......  .....++..++..++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            347778889999999999998642      477999999755432  233456668889999999999999999999999


Q ss_pred             EEEEeCCCCchhhhhhhcC-------------CcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCC
Q 015027          159 LVYEFASNGTLLDHIRCES-------------SQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNY  225 (414)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~  225 (414)
                      +++||+++++|.+++....             ....+++..+..++.|++.||.|||+.+   ++||||||+||++++++
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~  161 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL  161 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence            9999999999999885321             1234577888999999999999999987   99999999999999999


Q ss_pred             cEEEeeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccc
Q 015027          226 TAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMV  304 (414)
Q Consensus       226 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~  304 (414)
                      .+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||.......       
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-------  234 (283)
T cd05091         162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD-------  234 (283)
T ss_pred             ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH-------
Confidence            999999999876543322222233456789999999988899999999999999999998 888886432110       


Q ss_pred             hhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHH
Q 015027          305 PYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDR  363 (414)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~  363 (414)
                        ...........         ..+...+..+.+|+.+||+.+|.+||++.+|+..|+.
T Consensus       235 --~~~~i~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         235 --VIEMIRNRQVL---------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             --HHHHHHcCCcC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence              11111111110         0111223558999999999999999999999988864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=6.8e-41  Score=319.50  Aligned_cols=240  Identities=20%  Similarity=0.245  Sum_probs=186.4

Q ss_pred             CccccCCceEEEEEEEc-CCcEEEEEEeecccch----hHhHHHHHHHHHcc-CCCceeeeeeeEecCCcceEEEEeCCC
Q 015027           93 RCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI----RITERELLRIISQV-NHKNVVKILGLCLETEVPLLVYEFASN  166 (414)
Q Consensus        93 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~  166 (414)
                      +.||+|+||.||+|... +++.||+|++......    ......+.+++..+ +||||+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46899999999999976 4789999999764321    12223445666644 799999999999999999999999999


Q ss_pred             CchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccccc
Q 015027          167 GTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAM  246 (414)
Q Consensus       167 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  246 (414)
                      |+|.+++....   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.......  ..
T Consensus        81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~  152 (321)
T cd05591          81 GDLMFQIQRSR---KFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VT  152 (321)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC--cc
Confidence            99998886443   3478888999999999999999988   9999999999999999999999999987543221  12


Q ss_pred             eecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccccCC
Q 015027          247 STILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVAD  326 (414)
Q Consensus       247 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (414)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.......         ....+.....  ..+.    
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~---------~~~~i~~~~~--~~p~----  217 (321)
T cd05591         153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD---------LFESILHDDV--LYPV----  217 (321)
T ss_pred             ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH---------HHHHHHcCCC--CCCC----
Confidence            234578999999999999999999999999999999999999997433111         1111111100  0000    


Q ss_pred             cccHHHHHHHHHHHHHhhccCCCCCC-------ChhHHHH
Q 015027          327 ESEMKEIEIVAELASKCLRIRGTERP-------TMKQVSE  359 (414)
Q Consensus       327 ~~~~~~~~~l~~Li~~cl~~dP~~Rp-------s~~~v~~  359 (414)
                          ..+..+.+|+.+||+.||.+||       ++.++++
T Consensus       218 ----~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         218 ----WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             ----CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence                1125589999999999999999       6666654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=6.1e-41  Score=319.66  Aligned_cols=237  Identities=24%  Similarity=0.253  Sum_probs=184.5

Q ss_pred             CccccCCceEEEEEEEc-CCcEEEEEEeecccc----hhHhHHHHHHHHHcc-CCCceeeeeeeEecCCcceEEEEeCCC
Q 015027           93 RCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK----IRITERELLRIISQV-NHKNVVKILGLCLETEVPLLVYEFASN  166 (414)
Q Consensus        93 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~  166 (414)
                      +.||+|+||.||+|... +++.||||++.....    .......+..++..+ +||||+++++++...+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46899999999999976 588999999975421    112223344556554 799999999999999999999999999


Q ss_pred             CchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccccc
Q 015027          167 GTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAM  246 (414)
Q Consensus       167 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  246 (414)
                      |+|.+++....   .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++......  ...
T Consensus        81 g~L~~~i~~~~---~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--~~~  152 (320)
T cd05590          81 GDLMFHIQKSR---RFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GKT  152 (320)
T ss_pred             chHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC--CCc
Confidence            99998886543   3478889999999999999999987   999999999999999999999999998754322  112


Q ss_pred             eecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccccCC
Q 015027          247 STILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVAD  326 (414)
Q Consensus       247 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (414)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.......         ....+.....  ...     
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~---------~~~~i~~~~~--~~~-----  216 (320)
T cd05590         153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD---------LFEAILNDEV--VYP-----  216 (320)
T ss_pred             ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH---------HHHHHhcCCC--CCC-----
Confidence            334579999999999999999999999999999999999999997433111         1111111100  000     


Q ss_pred             cccHHHHHHHHHHHHHhhccCCCCCCChhH
Q 015027          327 ESEMKEIEIVAELASKCLRIRGTERPTMKQ  356 (414)
Q Consensus       327 ~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~  356 (414)
                         ...+..+.+|+.+||+.||.+||++.+
T Consensus       217 ---~~~~~~~~~li~~~L~~dP~~R~~~~~  243 (320)
T cd05590         217 ---TWLSQDAVDILKAFMTKNPTMRLGSLT  243 (320)
T ss_pred             ---CCCCHHHHHHHHHHcccCHHHCCCCCC
Confidence               012255899999999999999999843

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=3.7e-41  Score=321.60  Aligned_cols=236  Identities=26%  Similarity=0.288  Sum_probs=184.8

Q ss_pred             CccccCCceEEEEEEEc-CCcEEEEEEeecccchh----HhH-HHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCCC
Q 015027           93 RCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIR----ITE-RELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASN  166 (414)
Q Consensus        93 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~-~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  166 (414)
                      +.||+|+||+||+|... +|+.||+|++.......    ... .+...+++.++||||+++++.+...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46899999999999976 58999999997543211    111 2333356789999999999999999999999999999


Q ss_pred             CchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccccc
Q 015027          167 GTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAM  246 (414)
Q Consensus       167 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  246 (414)
                      |+|.+++....   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++......  ...
T Consensus        81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~  152 (323)
T cd05575          81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SKT  152 (323)
T ss_pred             CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CCc
Confidence            99999886533   3477888999999999999999987   999999999999999999999999998754322  122


Q ss_pred             eecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccccCC
Q 015027          247 STILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVAD  326 (414)
Q Consensus       247 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (414)
                      .....||+.|+|||++.+..++.++|||||||++|||++|..||.......         ..........  .+.+.   
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~---------~~~~i~~~~~--~~~~~---  218 (323)
T cd05575         153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE---------MYDNILNKPL--RLKPN---  218 (323)
T ss_pred             cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH---------HHHHHHcCCC--CCCCC---
Confidence            334579999999999999999999999999999999999999997433111         0111111000  00111   


Q ss_pred             cccHHHHHHHHHHHHHhhccCCCCCCChh
Q 015027          327 ESEMKEIEIVAELASKCLRIRGTERPTMK  355 (414)
Q Consensus       327 ~~~~~~~~~l~~Li~~cl~~dP~~Rps~~  355 (414)
                           .+..+.+|+.+||+.||.+||++.
T Consensus       219 -----~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         219 -----ISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             -----CCHHHHHHHHHHhhcCHHhCCCCC
Confidence                 125589999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=4.2e-41  Score=318.94  Aligned_cols=260  Identities=24%  Similarity=0.345  Sum_probs=200.7

Q ss_pred             cCCCCCCccccCCceEEEEEEEc--------CCcEEEEEEeecccc--hhHhHHHHHHHHHcc-CCCceeeeeeeEecCC
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH--------DNIQVAVKTYRRADK--IRITERELLRIISQV-NHKNVVKILGLCLETE  155 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~--~~~~~~~~~~~l~~l-~hpniv~l~~~~~~~~  155 (414)
                      ++|.+.+.||+|+||.||+|...        +...+|+|.+.....  .......++.++.++ +||||+++++++...+
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   97 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            57899999999999999999853        235699999976432  122345566788888 7999999999999999


Q ss_pred             cceEEEEeCCCCchhhhhhhcCC-------------cccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeC
Q 015027          156 VPLLVYEFASNGTLLDHIRCESS-------------QVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLN  222 (414)
Q Consensus       156 ~~~lv~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~  222 (414)
                      ..|+||||+++|+|.+++.....             ...+++..++.++.|++.||+|||+.+   ++||||||+||+++
T Consensus        98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~  174 (307)
T cd05098          98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT  174 (307)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEEc
Confidence            99999999999999999965432             124688899999999999999999987   99999999999999


Q ss_pred             CCCcEEEeeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCcccccccccc
Q 015027          223 DNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKI  301 (414)
Q Consensus       223 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~  301 (414)
                      .++.+||+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||.......    
T Consensus       175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~----  250 (307)
T cd05098         175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE----  250 (307)
T ss_pred             CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH----
Confidence            999999999999876543211111222234568999999999999999999999999999998 888886322110    


Q ss_pred             ccchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHh
Q 015027          302 SMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRL  367 (414)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~  367 (414)
                           ..........         ...+...+..+.+|+.+||..+|.+|||+.++++.|+++...
T Consensus       251 -----~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~  302 (307)
T cd05098         251 -----LFKLLKEGHR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL  302 (307)
T ss_pred             -----HHHHHHcCCC---------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence                 1111111100         011111235689999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=8.3e-41  Score=318.15  Aligned_cols=238  Identities=24%  Similarity=0.305  Sum_probs=183.9

Q ss_pred             CccccCCceEEEEEEEc-CCcEEEEEEeecccchh----HhHHHHHHHHH-ccCCCceeeeeeeEecCCcceEEEEeCCC
Q 015027           93 RCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIR----ITERELLRIIS-QVNHKNVVKILGLCLETEVPLLVYEFASN  166 (414)
Q Consensus        93 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~~l~-~l~hpniv~l~~~~~~~~~~~lv~e~~~~  166 (414)
                      +.||+|+||.||+|... +++.||+|.++......    .....+..++. ..+||||+++++++..++..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36899999999999975 58899999997643211    11122223443 45899999999999999999999999999


Q ss_pred             CchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccccc
Q 015027          167 GTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAM  246 (414)
Q Consensus       167 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  246 (414)
                      |+|.+++....   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.......  ..
T Consensus        81 g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~  152 (316)
T cd05592          81 GDLMFHIQSSG---RFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK  152 (316)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence            99999886543   3477888999999999999999987   9999999999999999999999999997643321  22


Q ss_pred             eecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccccCC
Q 015027          247 STILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVAD  326 (414)
Q Consensus       247 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (414)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......         ....+...  ...++     
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~---------~~~~i~~~--~~~~~-----  216 (316)
T cd05592         153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE---------LFDSILND--RPHFP-----  216 (316)
T ss_pred             cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH---------HHHHHHcC--CCCCC-----
Confidence            344579999999999999999999999999999999999999997433211         11111100  00011     


Q ss_pred             cccHHHHHHHHHHHHHhhccCCCCCCChh-HH
Q 015027          327 ESEMKEIEIVAELASKCLRIRGTERPTMK-QV  357 (414)
Q Consensus       327 ~~~~~~~~~l~~Li~~cl~~dP~~Rps~~-~v  357 (414)
                         ...+..+.+|+.+||+.+|.+||++. ++
T Consensus       217 ---~~~~~~~~~ll~~~l~~~P~~R~~~~~~l  245 (316)
T cd05592         217 ---RWISKEAKDCLSKLFERDPTKRLGVDGDI  245 (316)
T ss_pred             ---CCCCHHHHHHHHHHccCCHHHcCCChHHH
Confidence               11224589999999999999999975 44

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=7.9e-41  Score=319.49  Aligned_cols=240  Identities=21%  Similarity=0.226  Sum_probs=187.6

Q ss_pred             CCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc----hhHhHHHHHHHHHccCCC-ceeeeeeeEecCCcceEEE
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK----IRITERELLRIISQVNHK-NVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~~~l~~l~hp-niv~l~~~~~~~~~~~lv~  161 (414)
                      +|.+.+.||+|+||.||+|... +++.||||++.....    .......+.+++..+.|+ +|+++++++...+..|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4788999999999999999976 478999999976432    122234455777778665 6888999999999999999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCC
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD  241 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  241 (414)
                      ||+++|+|.+++....   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05587          81 EYVNGGDLMYHIQQVG---KFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG  154 (324)
T ss_pred             cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence            9999999999886543   3478889999999999999999987   999999999999999999999999998653221


Q ss_pred             ccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccc
Q 015027          242 AETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILN  321 (414)
Q Consensus       242 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (414)
                        ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.......         ....+....      
T Consensus       155 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---------~~~~i~~~~------  217 (324)
T cd05587         155 --GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---------LFQSIMEHN------  217 (324)
T ss_pred             --CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---------HHHHHHcCC------
Confidence              112334579999999999999999999999999999999999999997433111         111111100      


Q ss_pred             cccCCcccHHHHHHHHHHHHHhhccCCCCCCCh
Q 015027          322 FHVADESEMKEIEIVAELASKCLRIRGTERPTM  354 (414)
Q Consensus       322 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~  354 (414)
                      ...+    ...+..+.+|+.+||..+|.+|++.
T Consensus       218 ~~~~----~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         218 VSYP----KSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             CCCC----CCCCHHHHHHHHHHhhcCHHHcCCC
Confidence            0001    1122558999999999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=3.8e-41  Score=316.29  Aligned_cols=259  Identities=24%  Similarity=0.366  Sum_probs=199.5

Q ss_pred             HhcCCCCCCccccCCceEEEEEEEc------CCcEEEEEEeecccchh--HhHHHHHHHHHccCCCceeeeeeeEecCCc
Q 015027           85 ATKNFDRSRCLSQGGFVSVYKGVLH------DNIQVAVKTYRRADKIR--ITERELLRIISQVNHKNVVKILGLCLETEV  156 (414)
Q Consensus        85 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~--~~~~~~~~~l~~l~hpniv~l~~~~~~~~~  156 (414)
                      ..++|.+.+.||+|+||.||+|...      .+..||+|.+.......  ..+.+++..++.++||||+++++++.....
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4578999999999999999999753      24579999886544322  234566788999999999999999999999


Q ss_pred             ceEEEEeCCCCchhhhhhhcCC-------cccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEE
Q 015027          157 PLLVYEFASNGTLLDHIRCESS-------QVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKV  229 (414)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~~-------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl  229 (414)
                      .++||||+++|+|.+++.....       ....++..+..++.|++.||.|||+++   ++||||||+||++++++.++|
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence            9999999999999999965321       233466788899999999999999987   999999999999999999999


Q ss_pred             eeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhh
Q 015027          230 ADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFL  308 (414)
Q Consensus       230 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~  308 (414)
                      +|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.......         ..
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~---------~~  231 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ---------VL  231 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH---------HH
Confidence            99999876543222222223345678999999999999999999999999999998 788886432111         11


Q ss_pred             hhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHH
Q 015027          309 NSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL  364 (414)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i  364 (414)
                      ..........     ..    ...+..+.+++.+||+.+|.+|||+.++++.|+..
T Consensus       232 ~~~~~~~~~~-----~~----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         232 KFVMDGGYLD-----QP----DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             HHHHcCCCCC-----CC----CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence            1111110000     00    11125699999999999999999999998887764

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.5e-41  Score=331.19  Aligned_cols=252  Identities=21%  Similarity=0.256  Sum_probs=192.6

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc----hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK----IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~  161 (414)
                      ++|++++.||+|+||.||+|... +++.||||++.....    ......+++++++.++||||+++++.+.+++..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            36899999999999999999965 589999999865432    1223355678999999999999999999999999999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCC
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD  241 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  241 (414)
                      ||+++|+|.+++...+   .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 E~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~  154 (376)
T cd05598          81 DYIPGGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (376)
T ss_pred             eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence            9999999999986533   3477888889999999999999988   999999999999999999999999997532100


Q ss_pred             c-----------------------------------------cccceecccccccccchhhcccCCCCCcccchhHHHHH
Q 015027          242 A-----------------------------------------ETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVL  280 (414)
Q Consensus       242 ~-----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil  280 (414)
                      .                                         .........||+.|+|||++.+..++.++|||||||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil  234 (376)
T cd05598         155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL  234 (376)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence            0                                         00001234799999999999999999999999999999


Q ss_pred             HHHHhCCCCCCccccccccccccchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCC---ChhHH
Q 015027          281 AELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERP---TMKQV  357 (414)
Q Consensus       281 ~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rp---s~~~v  357 (414)
                      |||++|+.||........         .........      ..........+..+.+|+.+|+ .+|.+|+   |+.++
T Consensus       235 yell~G~~Pf~~~~~~~~---------~~~i~~~~~------~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~el  298 (376)
T cd05598         235 YEMLVGQPPFLADTPAET---------QLKVINWET------TLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEI  298 (376)
T ss_pred             eehhhCCCCCCCCCHHHH---------HHHHhccCc------cccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHH
Confidence            999999999974432110         000000000      0000001112345788999877 5999999   88888


Q ss_pred             HHH
Q 015027          358 SEE  360 (414)
Q Consensus       358 ~~~  360 (414)
                      +..
T Consensus       299 l~h  301 (376)
T cd05598         299 KAH  301 (376)
T ss_pred             hCC
Confidence            643

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=7.2e-41  Score=311.40  Aligned_cols=255  Identities=25%  Similarity=0.373  Sum_probs=192.9

Q ss_pred             CCCCCccccCCceEEEEEEEcC-Cc--EEEEEEeeccc---chhHhHHHHHHHHHccCCCceeeeeeeEecC------Cc
Q 015027           89 FDRSRCLSQGGFVSVYKGVLHD-NI--QVAVKTYRRAD---KIRITERELLRIISQVNHKNVVKILGLCLET------EV  156 (414)
Q Consensus        89 ~~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~---~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~------~~  156 (414)
                      |.+.+.||+|+||.||+|.+.. +.  .+|+|.++...   .....+..++.+++.++||||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3567889999999999999764 33  58999886542   2223345567889999999999999987532      24


Q ss_pred             ceEEEEeCCCCchhhhhhhc---CCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecc
Q 015027          157 PLLVYEFASNGTLLDHIRCE---SSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFE  233 (414)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~---~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG  233 (414)
                      .++||||+++|+|.+++...   .....+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence            68999999999999887432   12334688999999999999999999977   9999999999999999999999999


Q ss_pred             ccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhc
Q 015027          234 SSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIK  312 (414)
Q Consensus       234 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  312 (414)
                      ++................+++.|+|||++.+..++.++||||||+++|||++ |..||.......         ......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---------~~~~~~  228 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE---------IYDYLR  228 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---------HHHHHH
Confidence            9987643322112223346678999999999999999999999999999999 889986432111         111111


Q ss_pred             ccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHH
Q 015027          313 NNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL  364 (414)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i  364 (414)
                      ...... .    .    ...+..+.+++.+||+.+|.+|||+.++++.|+.+
T Consensus       229 ~~~~~~-~----~----~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         229 QGNRLK-Q----P----PDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             cCCCCC-C----C----CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            111000 0    0    11224589999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=5.6e-41  Score=316.57  Aligned_cols=262  Identities=25%  Similarity=0.395  Sum_probs=200.6

Q ss_pred             cCCCCCCccccCCceEEEEEEEcC-Cc--EEEEEEeeccc--chhHhHHHHHHHHHcc-CCCceeeeeeeEecCCcceEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLHD-NI--QVAVKTYRRAD--KIRITERELLRIISQV-NHKNVVKILGLCLETEVPLLV  160 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~--~~~~~~~~~~~~l~~l-~hpniv~l~~~~~~~~~~~lv  160 (414)
                      ++|++.+.||+|+||.||+|...+ +.  .+++|.++...  ........++.++.++ +||||+++++++......++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            578899999999999999999754 33  47888876432  2223345567888888 799999999999999999999


Q ss_pred             EEeCCCCchhhhhhhcC-------------CcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcE
Q 015027          161 YEFASNGTLLDHIRCES-------------SQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTA  227 (414)
Q Consensus       161 ~e~~~~gsL~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~  227 (414)
                      |||+++++|.+++....             ....+++..++.++.|++.||+|||+.+   ++||||||+|||+++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence            99999999999985432             1124678899999999999999999977   9999999999999999999


Q ss_pred             EEeeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchh
Q 015027          228 KVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPY  306 (414)
Q Consensus       228 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~  306 (414)
                      ||+|||++........   ......+..|+|||++.+..++.++|||||||++|||++ |..||.......         
T Consensus       159 kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~---------  226 (297)
T cd05089         159 KIADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE---------  226 (297)
T ss_pred             EECCcCCCccccceec---cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---------
Confidence            9999999864321111   111223457999999998899999999999999999997 999986433211         


Q ss_pred             hhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHhhhhhh
Q 015027          307 FLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLHENFW  372 (414)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~~~~~~  372 (414)
                      ........ .    ....    +...+..+.+|+.+||+.+|.+|||+.++++.|+.+....+.++
T Consensus       227 ~~~~~~~~-~----~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~~~  283 (297)
T cd05089         227 LYEKLPQG-Y----RMEK----PRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAYV  283 (297)
T ss_pred             HHHHHhcC-C----CCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcccc
Confidence            11111100 0    0000    11122558999999999999999999999999999887665544

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=4.7e-41  Score=313.78  Aligned_cols=256  Identities=25%  Similarity=0.345  Sum_probs=197.3

Q ss_pred             hcCCCCCCccccCCceEEEEEEEcC------CcEEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEecCCcc
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLHD------NIQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLETEVP  157 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~  157 (414)
                      .++|.+.+.||+|+||.||+|.+..      +..||+|.+......  ...+..++.+++.++||||+++++++.+....
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            4678999999999999999999753      567899988644322  23345667889999999999999999999999


Q ss_pred             eEEEEeCCCCchhhhhhhcCC----cccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCC---cEEEe
Q 015027          158 LLVYEFASNGTLLDHIRCESS----QVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNY---TAKVA  230 (414)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~---~~kl~  230 (414)
                      ++||||+++++|.+++.....    ...+++..++.++.||+.||+|||+.+   ++|+||||+||+++.++   .+||+
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence            999999999999999865432    124688999999999999999999987   99999999999998754   69999


Q ss_pred             eccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhh
Q 015027          231 DFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLN  309 (414)
Q Consensus       231 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  309 (414)
                      |||++.................+..|+|||++.+..++.++|||||||++|||++ |..||.......         ...
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~---------~~~  232 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE---------VME  232 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---------HHH
Confidence            9999987633221111122234568999999999999999999999999999997 999987433211         111


Q ss_pred             hhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHH
Q 015027          310 SIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELD  362 (414)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~  362 (414)
                      ......         ....+...+..+.+++.+||+.+|++|||+.+|++.|.
T Consensus       233 ~~~~~~---------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         233 FVTGGG---------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             HHHcCC---------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            111000         00011112356899999999999999999999988775

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=6e-41  Score=313.44  Aligned_cols=260  Identities=21%  Similarity=0.325  Sum_probs=202.4

Q ss_pred             hcCCCCCCccccCCceEEEEEEEcC-----CcEEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEec-CCcc
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLHD-----NIQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLE-TEVP  157 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~-~~~~  157 (414)
                      .++|.+.+.||+|+||.||+|.+..     +..|++|.+......  .....+++.++..++||||+++++++.. +...
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            4678899999999999999999765     688999998754322  2333556788999999999999998776 5678


Q ss_pred             eEEEEeCCCCchhhhhhhcCCc-----ccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeec
Q 015027          158 LLVYEFASNGTLLDHIRCESSQ-----VLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADF  232 (414)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df  232 (414)
                      +++++|+++++|.+++......     ..+++..++.++.+++.||+|||+.+   ++|+||||+||++++++.+||+||
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence            9999999999999998654322     45688999999999999999999977   999999999999999999999999


Q ss_pred             cccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhh
Q 015027          233 ESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSI  311 (414)
Q Consensus       233 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  311 (414)
                      |+++.+.............++..|+|||++.+..++.++|||||||++||+++ |+.||.......         .....
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---------~~~~~  232 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---------MAAYL  232 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---------HHHHH
Confidence            99986543322222223345678999999998899999999999999999999 999986432111         01111


Q ss_pred             cccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHH
Q 015027          312 KNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR  366 (414)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~  366 (414)
                      ... ..    ..    .....+..+.+++.+||..+|++|||+.++++.|+.+..
T Consensus       233 ~~~-~~----~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         233 KDG-YR----LA----QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             HcC-CC----CC----CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            111 00    00    011122568999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=5.8e-41  Score=313.47  Aligned_cols=259  Identities=24%  Similarity=0.352  Sum_probs=198.3

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCc----EEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEecCCcce
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNI----QVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLETEVPL  158 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~  158 (414)
                      .++|++.+.||+|+||+||+|.+. ++.    .||+|.+......  ......+..++..+.||||+++++++.. ...+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence            467889999999999999999854 444    4899998754322  2333556678889999999999999875 4578


Q ss_pred             EEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccc
Q 015027          159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLI  238 (414)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~  238 (414)
                      ++|||+++|+|.+++.....  .+++..++.++.||+.||.|||+.+   ++||||||+|||+++++.+||+|||+++..
T Consensus        85 l~~~~~~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~  159 (279)
T cd05109          85 LVTQLMPYGCLLDYVRENKD--RIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (279)
T ss_pred             EEEEcCCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence            99999999999999865432  3578899999999999999999987   999999999999999999999999999876


Q ss_pred             cCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhcccccc
Q 015027          239 SSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLR  317 (414)
Q Consensus       239 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (414)
                      .............+++.|+|||.+.+..++.++|||||||++|||++ |..||.......         ...........
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---------~~~~~~~~~~~  230 (279)
T cd05109         160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---------IPDLLEKGERL  230 (279)
T ss_pred             ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---------HHHHHHCCCcC
Confidence            54322211222344678999999999999999999999999999998 899986322110         00001110000


Q ss_pred             cccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHhh
Q 015027          318 QILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLH  368 (414)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~~  368 (414)
                               ..+...+..+.+++.+||+.||++||++.++++.|+.+.+..
T Consensus       231 ---------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05109         231 ---------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP  272 (279)
T ss_pred             ---------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence                     001112255899999999999999999999999988876543

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-41  Score=319.95  Aligned_cols=250  Identities=26%  Similarity=0.343  Sum_probs=208.7

Q ss_pred             HhcCCCCCCccccCCceEEEEEEEcC-CcEEEEEEeecccchh----HhHHHHHHHHHccC-CCceeeeeeeEecCCcce
Q 015027           85 ATKNFDRSRCLSQGGFVSVYKGVLHD-NIQVAVKTYRRADKIR----ITERELLRIISQVN-HKNVVKILGLCLETEVPL  158 (414)
Q Consensus        85 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~----~~~~~~~~~l~~l~-hpniv~l~~~~~~~~~~~  158 (414)
                      ....|.+.+.||+|.||.||+++.+. |+.+|+|.+.+.....    .....++++|+++. |||||.++++|++...++
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            35678889999999999999999765 9999999997764422    34567789999998 999999999999999999


Q ss_pred             EEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCC----CCcEEEeeccc
Q 015027          159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLND----NYTAKVADFES  234 (414)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~----~~~~kl~DfGl  234 (414)
                      +|||++.||.|.+.+...    .+++..+..++.||+.++.|||+.+   |+||||||+|+|+..    ++.+|++|||+
T Consensus       113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl  185 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL  185 (382)
T ss_pred             EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence            999999999999999765    1688999999999999999999988   999999999999964    35799999999


Q ss_pred             cccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccc
Q 015027          235 SVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNN  314 (414)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  314 (414)
                      +.....   .......+||+.|+|||++....|+..+||||+||++|.|++|.+||.+.+....        +. .+...
T Consensus       186 a~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~--------~~-~i~~~  253 (382)
T KOG0032|consen  186 AKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEI--------FL-AILRG  253 (382)
T ss_pred             ceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHH--------HH-HHHcC
Confidence            998765   3445678999999999999999999999999999999999999999975442211        00 11111


Q ss_pred             ccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          315 GLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      .      ..+..+.....+..+.+++..||..||.+|+|+.++++
T Consensus       254 ~------~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  254 D------FDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             C------CCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence            1      12233344444577999999999999999999999977

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=6.1e-41  Score=313.64  Aligned_cols=240  Identities=20%  Similarity=0.204  Sum_probs=186.4

Q ss_pred             cccCCceEEEEEEEc-CCcEEEEEEeecccchh----HhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCCCCch
Q 015027           95 LSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIR----ITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTL  169 (414)
Q Consensus        95 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL  169 (414)
                      ||+|+||+||++.+. +++.||+|.+.......    ..+..++++++.++||||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999965 58899999987543221    2234567889999999999999999999999999999999999


Q ss_pred             hhhhhhc-CCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcccccee
Q 015027          170 LDHIRCE-SSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMST  248 (414)
Q Consensus       170 ~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  248 (414)
                      .+++... .....+++..++.++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||++........  ...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence            8887432 22345688999999999999999999987   99999999999999999999999999876543221  223


Q ss_pred             cccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccccCCcc
Q 015027          249 ILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADES  328 (414)
Q Consensus       249 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (414)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||........     .......        ......  ..
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-----~~~~~~~--------~~~~~~--~~  220 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-----NKELKQR--------ILNDSV--TY  220 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh-----HHHHHHh--------hcccCC--CC
Confidence            45789999999999999999999999999999999999999964321110     0000000        000000  11


Q ss_pred             cHHHHHHHHHHHHHhhccCCCCCCCh
Q 015027          329 EMKEIEIVAELASKCLRIRGTERPTM  354 (414)
Q Consensus       329 ~~~~~~~l~~Li~~cl~~dP~~Rps~  354 (414)
                      +...+..+.+|+.+||+.||++||++
T Consensus       221 ~~~~~~~~~~li~~~l~~~P~~R~~~  246 (280)
T cd05608         221 PDKFSPASKSFCEALLAKDPEKRLGF  246 (280)
T ss_pred             cccCCHHHHHHHHHHhcCCHHHhcCC
Confidence            11233568999999999999999944

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=6.7e-41  Score=321.65  Aligned_cols=265  Identities=20%  Similarity=0.264  Sum_probs=190.7

Q ss_pred             CCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc---hhHhHHHHHHHHHccCCCceeeeeeeEecCC-----cce
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK---IRITERELLRIISQVNHKNVVKILGLCLETE-----VPL  158 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~-----~~~  158 (414)
                      +|++.+.||+|+||.||+|... ++..||||.+.....   .......+++++++++||||+++++++....     ..|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            5788899999999999999965 589999999874321   1223456778999999999999999886432     479


Q ss_pred             EEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccc
Q 015027          159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLI  238 (414)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~  238 (414)
                      +||||++ ++|.+++....   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 lv~e~~~-~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~  153 (338)
T cd07859          81 VVFELME-SDLHQVIKAND---DLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA  153 (338)
T ss_pred             EEEecCC-CCHHHHHHhcc---cCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence            9999995 58888875433   3578999999999999999999988   999999999999999999999999999765


Q ss_pred             cCCccc-cceecccccccccchhhccc--CCCCCcccchhHHHHHHHHHhCCCCCCccccccccc------cccchhhhh
Q 015027          239 SSDAET-AMSTILIGTSGYLDPVCINT--GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKK------ISMVPYFLN  309 (414)
Q Consensus       239 ~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~------~~~~~~~~~  309 (414)
                      ...... .......||+.|+|||++.+  ..++.++|||||||++|||++|+.||..........      ....+....
T Consensus       154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  233 (338)
T cd07859         154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS  233 (338)
T ss_pred             ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            332111 12234578999999999876  678999999999999999999999996433211000      000000000


Q ss_pred             hhccccccccc---ccccCCccc---HHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          310 SIKNNGLRQIL---NFHVADESE---MKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       310 ~~~~~~~~~~~---~~~~~~~~~---~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      .+........+   .........   ......+.+|+.+||+.||++|||+.++++
T Consensus       234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            00000000000   000000000   011245889999999999999999999854

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.8e-41  Score=313.40  Aligned_cols=256  Identities=25%  Similarity=0.388  Sum_probs=200.4

Q ss_pred             hcCCCCCCccccCCceEEEEEEEcC------CcEEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEecCCcc
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLHD------NIQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLETEVP  157 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~  157 (414)
                      .++|.+.+.||+|+||.||+|...+      +..||+|.+......  .....+++.++..++||||+++++++......
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            3578889999999999999998643      367999998654322  23345667889999999999999999999999


Q ss_pred             eEEEEeCCCCchhhhhhhcCC-------cccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEe
Q 015027          158 LLVYEFASNGTLLDHIRCESS-------QVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVA  230 (414)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~-------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~  230 (414)
                      ++||||+++|+|.+++.....       ...+++..++.++.|++.||.|||+.+   ++||||||+|||++.++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence            999999999999999865332       123578889999999999999999977   9999999999999999999999


Q ss_pred             eccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhh
Q 015027          231 DFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLN  309 (414)
Q Consensus       231 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  309 (414)
                      |||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.......         ...
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---------~~~  232 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE---------VLK  232 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH---------HHH
Confidence            9999876543322222233456788999999988899999999999999999998 999986432111         111


Q ss_pred             hhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHH
Q 015027          310 SIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELD  362 (414)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~  362 (414)
                      ........     ..+.    ..+..+.+|+.+||+.+|++|||+.++++.|+
T Consensus       233 ~~~~~~~~-----~~~~----~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         233 FVIDGGHL-----DLPE----NCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             HHhcCCCC-----CCCC----CCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            11111100     0111    11356899999999999999999999988875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.2e-40  Score=316.92  Aligned_cols=239  Identities=24%  Similarity=0.274  Sum_probs=184.9

Q ss_pred             CccccCCceEEEEEEEc-CCcEEEEEEeecccc----hhHhHHHHHHHHHc-cCCCceeeeeeeEecCCcceEEEEeCCC
Q 015027           93 RCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK----IRITERELLRIISQ-VNHKNVVKILGLCLETEVPLLVYEFASN  166 (414)
Q Consensus        93 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~~~l~~-l~hpniv~l~~~~~~~~~~~lv~e~~~~  166 (414)
                      +.||+|+||.||+|.+. +++.||||++.....    .......+..++.. ++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46899999999999976 478999999976421    11222233345554 5899999999999999999999999999


Q ss_pred             CchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccccc
Q 015027          167 GTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAM  246 (414)
Q Consensus       167 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  246 (414)
                      |+|.+++....   .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++......  ...
T Consensus        81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~  152 (316)
T cd05619          81 GDLMFHIQSCH---KFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG--DAK  152 (316)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCC--CCc
Confidence            99999986432   3478888999999999999999987   999999999999999999999999998753221  112


Q ss_pred             eecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccccCC
Q 015027          247 STILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVAD  326 (414)
Q Consensus       247 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (414)
                      .....||+.|+|||++.+..++.++|||||||++|||++|..||.......         .........  ..++.    
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---------~~~~i~~~~--~~~~~----  217 (316)
T cd05619         153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE---------LFQSIRMDN--PCYPR----  217 (316)
T ss_pred             eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH---------HHHHHHhCC--CCCCc----
Confidence            234578999999999999999999999999999999999999997433111         111111100  00111    


Q ss_pred             cccHHHHHHHHHHHHHhhccCCCCCCChh-HHH
Q 015027          327 ESEMKEIEIVAELASKCLRIRGTERPTMK-QVS  358 (414)
Q Consensus       327 ~~~~~~~~~l~~Li~~cl~~dP~~Rps~~-~v~  358 (414)
                          .....+.+|+.+||+.+|.+||++. ++.
T Consensus       218 ----~~~~~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         218 ----WLTREAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             ----cCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence                1224589999999999999999997 553

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=6.9e-41  Score=316.97  Aligned_cols=261  Identities=24%  Similarity=0.363  Sum_probs=202.3

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc--------CCcEEEEEEeecccc--hhHhHHHHHHHHHcc-CCCceeeeeeeEecC
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH--------DNIQVAVKTYRRADK--IRITERELLRIISQV-NHKNVVKILGLCLET  154 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~--~~~~~~~~~~~l~~l-~hpniv~l~~~~~~~  154 (414)
                      ..+|.+.+.||+|+||.||+|...        ++..||+|.+.....  .......++.++..+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            467888999999999999999741        245799998875422  223345667888888 899999999999999


Q ss_pred             CcceEEEEeCCCCchhhhhhhcCC-------------cccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceee
Q 015027          155 EVPLLVYEFASNGTLLDHIRCESS-------------QVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILL  221 (414)
Q Consensus       155 ~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll  221 (414)
                      ...++||||+++|+|.+++.....             ...+++..++.++.||+.||.|||+++   ++||||||+||++
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence            999999999999999999865321             234578889999999999999999987   9999999999999


Q ss_pred             CCCCcEEEeeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccc
Q 015027          222 NDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKK  300 (414)
Q Consensus       222 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~  300 (414)
                      +.++.+||+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||.......   
T Consensus       171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---  247 (304)
T cd05101         171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---  247 (304)
T ss_pred             cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH---
Confidence            9999999999999987654322222233455678999999998899999999999999999998 788875332111   


Q ss_pred             cccchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHh
Q 015027          301 ISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRL  367 (414)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~  367 (414)
                            .......... .        ..+...+..+.+|+.+||+.+|.+|||+.++++.|+++...
T Consensus       248 ------~~~~~~~~~~-~--------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~  299 (304)
T cd05101         248 ------LFKLLKEGHR-M--------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL  299 (304)
T ss_pred             ------HHHHHHcCCc-C--------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence                  1111111100 0        00111235689999999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=6.7e-41  Score=316.81  Aligned_cols=258  Identities=26%  Similarity=0.396  Sum_probs=200.8

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc------CCcEEEEEEeecccch--hHhHHHHHHHHHcc-CCCceeeeeeeEecCCc
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH------DNIQVAVKTYRRADKI--RITERELLRIISQV-NHKNVVKILGLCLETEV  156 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l-~hpniv~l~~~~~~~~~  156 (414)
                      .++|.+.+.||+|+||.||+|...      .+..||||.++.....  ......++.+++++ +||||+++++++...+.
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  113 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP  113 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence            357999999999999999999742      2457999998754322  23345677899999 79999999999999999


Q ss_pred             ceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccc
Q 015027          157 PLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSV  236 (414)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~  236 (414)
                      .++||||+++|+|.+++..... ..+++.++..++.+++.||.|||+.+   ++|+||||+|||++.++.++|+|||++.
T Consensus       114 ~~lv~e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~  189 (302)
T cd05055         114 ILVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR  189 (302)
T ss_pred             eEEEEEcCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence            9999999999999999865332 22588999999999999999999987   9999999999999999999999999998


Q ss_pred             cccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhcccc
Q 015027          237 LISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNG  315 (414)
Q Consensus       237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (414)
                      ...............+++.|+|||.+.+..++.++|||||||++|||++ |..||.......        .+...... .
T Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~--------~~~~~~~~-~  260 (302)
T cd05055         190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS--------KFYKLIKE-G  260 (302)
T ss_pred             cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH--------HHHHHHHc-C
Confidence            6644322112223356778999999999999999999999999999998 999986432111        01111110 0


Q ss_pred             cccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHH
Q 015027          316 LRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL  364 (414)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i  364 (414)
                      ...        ..+...+..+.+|+.+||+.+|++|||+.++++.|+++
T Consensus       261 ~~~--------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         261 YRM--------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             CcC--------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            000        00011125689999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=7.3e-41  Score=319.85  Aligned_cols=239  Identities=25%  Similarity=0.281  Sum_probs=185.3

Q ss_pred             CccccCCceEEEEEEEc-CCcEEEEEEeecccchh-----HhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCCC
Q 015027           93 RCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIR-----ITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASN  166 (414)
Q Consensus        93 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  166 (414)
                      +.||+|+||.||+|.+. +++.||+|++.......     ....++..+++.++||||+++++++...+..|+||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            36899999999999976 57889999997543211     1112333456788999999999999999999999999999


Q ss_pred             CchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccccc
Q 015027          167 GTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAM  246 (414)
Q Consensus       167 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  246 (414)
                      |+|.+++....   .+.+..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++......  ...
T Consensus        81 ~~L~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--~~~  152 (325)
T cd05602          81 GELFYHLQRER---CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NGT  152 (325)
T ss_pred             CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccC--CCC
Confidence            99999886533   2366778889999999999999988   999999999999999999999999998754322  112


Q ss_pred             eecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccccCC
Q 015027          247 STILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVAD  326 (414)
Q Consensus       247 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (414)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||.......         ..........  .+.+    
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---------~~~~i~~~~~--~~~~----  217 (325)
T cd05602         153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE---------MYDNILNKPL--QLKP----  217 (325)
T ss_pred             cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH---------HHHHHHhCCc--CCCC----
Confidence            334579999999999999999999999999999999999999996433111         0011100000  0111    


Q ss_pred             cccHHHHHHHHHHHHHhhccCCCCCCChhHHH
Q 015027          327 ESEMKEIEIVAELASKCLRIRGTERPTMKQVS  358 (414)
Q Consensus       327 ~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~  358 (414)
                          ..+..+.+|+.+||+.+|.+||++.+.+
T Consensus       218 ----~~~~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         218 ----NITNSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             ----CCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence                1225589999999999999999987543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.1e-41  Score=309.15  Aligned_cols=255  Identities=28%  Similarity=0.409  Sum_probs=203.8

Q ss_pred             hcCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCC
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFAS  165 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  165 (414)
                      .++|.+.+.||+|+||.||+|.++++..+|||.+...........+++.++++++||||+++++++......++||||++
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~   84 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMS   84 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccC
Confidence            46789999999999999999998888889999998765555556777889999999999999999998889999999999


Q ss_pred             CCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcccc
Q 015027          166 NGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETA  245 (414)
Q Consensus       166 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  245 (414)
                      +++|.+++..... ..+++..+..++.+++.|+.|||+++   ++|+||||+||++++++.+||+|||++........ .
T Consensus        85 ~~~L~~~i~~~~~-~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~-~  159 (261)
T cd05034          85 KGSLLDFLKSGEG-KKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY-T  159 (261)
T ss_pred             CCCHHHHHhcccc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh-h
Confidence            9999999965432 23588899999999999999999987   99999999999999999999999999876643211 1


Q ss_pred             ceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhccccccccccccc
Q 015027          246 MSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHV  324 (414)
Q Consensus       246 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (414)
                      ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||.......         ........ ....    .
T Consensus       160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---------~~~~~~~~-~~~~----~  225 (261)
T cd05034         160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE---------VLEQVERG-YRMP----R  225 (261)
T ss_pred             hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---------HHHHHHcC-CCCC----C
Confidence            1112234568999999999999999999999999999998 999986432111         11111100 0000    0


Q ss_pred             CCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHH
Q 015027          325 ADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDR  363 (414)
Q Consensus       325 ~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~  363 (414)
                      .    ...+..+.+++.+||+.+|.+||++.++.+.|+.
T Consensus       226 ~----~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         226 P----PNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             C----CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            0    1113568999999999999999999999988874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2.4e-41  Score=335.31  Aligned_cols=264  Identities=19%  Similarity=0.222  Sum_probs=188.5

Q ss_pred             HhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecC--------C
Q 015027           85 ATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLET--------E  155 (414)
Q Consensus        85 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~--------~  155 (414)
                      ...+|.+.+.||+|+||.||+|... +++.||||.+.....   ...+++.+++.++||||+++++++...        .
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ---YKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc---hHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            3467999999999999999999975 588999998865432   223466889999999999999887432        2


Q ss_pred             cceEEEEeCCCCchhhhhhhc-CCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCC-cEEEeecc
Q 015027          156 VPLLVYEFASNGTLLDHIRCE-SSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNY-TAKVADFE  233 (414)
Q Consensus       156 ~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~DfG  233 (414)
                      .+++||||+++ +|.+++... .....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++ .+||+|||
T Consensus       141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFG  216 (440)
T PTZ00036        141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFG  216 (440)
T ss_pred             EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccc
Confidence            46789999985 676666432 22345688889999999999999999988   99999999999999654 79999999


Q ss_pred             ccccccCCccccceecccccccccchhhccc-CCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchh------
Q 015027          234 SSVLISSDAETAMSTILIGTSGYLDPVCINT-GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPY------  306 (414)
Q Consensus       234 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~------  306 (414)
                      +++......   ......||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+........ .....      
T Consensus       217 la~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~-~i~~~~~~p~~  292 (440)
T PTZ00036        217 SAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLV-RIIQVLGTPTE  292 (440)
T ss_pred             cchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHHHhCCCCH
Confidence            998664322   1233578999999999865 468999999999999999999999997543211000 00000      


Q ss_pred             -hhhhh----cccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          307 -FLNSI----KNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       307 -~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                       .....    ..-.+..+....+....+...+.++.+|+.+||+.||.+|||+.+++.
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence             00000    000000000000000001112356899999999999999999999864

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2.1e-40  Score=307.15  Aligned_cols=259  Identities=25%  Similarity=0.348  Sum_probs=204.2

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc----hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK----IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~  161 (414)
                      ++|.+.+.||+|+||.||+|... +++.||+|.++....    ......++++++++++|+||+++++++..++..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57999999999999999999976 689999998864321    1233456778999999999999999999999999999


Q ss_pred             EeCCCCchhhhhhhc-CCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccC
Q 015027          162 EFASNGTLLDHIRCE-SSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISS  240 (414)
Q Consensus       162 e~~~~gsL~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  240 (414)
                      ||+++++|.+++... .....+++..+..++.+++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            999999999988643 22344688899999999999999999988   99999999999999999999999999876543


Q ss_pred             CccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccc
Q 015027          241 DAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQIL  320 (414)
Q Consensus       241 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (414)
                      ..  .......+++.|+|||.+.+..++.++|||||||++|+|++|+.||......      ... ...........   
T Consensus       159 ~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~-~~~~~~~~~~~---  226 (267)
T cd08224         159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LYS-LCKKIEKCDYP---  226 (267)
T ss_pred             CC--cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc------HHH-HHhhhhcCCCC---
Confidence            21  1123346888999999999999999999999999999999999998532210      000 00011111000   


Q ss_pred             ccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHH
Q 015027          321 NFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLR  365 (414)
Q Consensus       321 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~  365 (414)
                           .......+..+.+++.+||..+|.+|||+.+|++.|+.+.
T Consensus       227 -----~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         227 -----PLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             -----CCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence                 0001122356899999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-43  Score=310.06  Aligned_cols=248  Identities=26%  Similarity=0.352  Sum_probs=206.0

Q ss_pred             CCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCCC
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASN  166 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  166 (414)
                      -|+++.+||+|+||.||+|..+ .|+.+|||.+..+....+. ..++.+++++..|++|++||.|.....+|+|||||..
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEI-IKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA  112 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEI-IKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA  112 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHH-HHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence            3677889999999999999966 5999999999876655443 4456899999999999999999999999999999999


Q ss_pred             CchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccccc
Q 015027          167 GTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAM  246 (414)
Q Consensus       167 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  246 (414)
                      |+..|.++...  .++++..+..++...++||+|||...   -||||||+.|||++-+|++||+|||.|.++...  -..
T Consensus       113 GSiSDI~R~R~--K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT--MAK  185 (502)
T KOG0574|consen  113 GSISDIMRARR--KPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT--MAK  185 (502)
T ss_pred             CcHHHHHHHhc--CCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhh--HHh
Confidence            99999997644  45688999999999999999999977   799999999999999999999999999887642  223


Q ss_pred             eecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccccCC
Q 015027          247 STILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVAD  326 (414)
Q Consensus       247 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (414)
                      .+++.|||.|||||++..-.|+.++||||||++..||..|++||...-  +.....+++              .++..-.
T Consensus       186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIH--PMRAIFMIP--------------T~PPPTF  249 (502)
T KOG0574|consen  186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIH--PMRAIFMIP--------------TKPPPTF  249 (502)
T ss_pred             hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccc--ccceeEecc--------------CCCCCCC
Confidence            466899999999999999999999999999999999999999997322  111111111              1122222


Q ss_pred             cccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          327 ESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       327 ~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ..+...+.++.+++++||-++|++|-|+.++++
T Consensus       250 ~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  250 KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence            334556678999999999999999999998876

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.1e-40  Score=318.26  Aligned_cols=240  Identities=21%  Similarity=0.241  Sum_probs=187.4

Q ss_pred             CCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchh----HhHHHHHHHHHcc-CCCceeeeeeeEecCCcceEEE
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIR----ITERELLRIISQV-NHKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l-~hpniv~l~~~~~~~~~~~lv~  161 (414)
                      +|.+.+.||+|+||.||+|... +++.||+|++.......    .....+..++..+ .||+|+++++++...+..|+||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            5788999999999999999976 47899999997643211    1122333555555 5899999999999999999999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCC
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD  241 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  241 (414)
                      ||+++|+|.+++....   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~  154 (323)
T cd05616          81 EYVNGGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD  154 (323)
T ss_pred             cCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence            9999999998886543   3478889999999999999999987   999999999999999999999999998754322


Q ss_pred             ccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccc
Q 015027          242 AETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILN  321 (414)
Q Consensus       242 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (414)
                        ........||+.|+|||++.+..++.++|||||||++|||++|+.||.......         ....+.....     
T Consensus       155 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~---------~~~~i~~~~~-----  218 (323)
T cd05616         155 --GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---------LFQSIMEHNV-----  218 (323)
T ss_pred             --CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH---------HHHHHHhCCC-----
Confidence              112234578999999999999999999999999999999999999997433111         1111111100     


Q ss_pred             cccCCcccHHHHHHHHHHHHHhhccCCCCCCCh
Q 015027          322 FHVADESEMKEIEIVAELASKCLRIRGTERPTM  354 (414)
Q Consensus       322 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~  354 (414)
                       ..    +...+..+.+|+.+||+.+|.+|++.
T Consensus       219 -~~----p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         219 -AY----PKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             -CC----CCcCCHHHHHHHHHHcccCHHhcCCC
Confidence             00    11123568999999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=8e-42  Score=310.17  Aligned_cols=261  Identities=23%  Similarity=0.284  Sum_probs=189.1

Q ss_pred             CCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecCC-----cceEEE
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETE-----VPLLVY  161 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~-----~~~lv~  161 (414)
                      .|...+++|.|+||.||.|... ++..||||..-.+......   |+++|+.+.|||||++.-+|....     ...+||
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knr---El~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl  101 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNR---ELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL  101 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcH---HHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence            4666788999999999999965 5799999998877665443   457788999999999998886422     346899


Q ss_pred             EeCCCCchhhhhhhc-CCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCC-CcEEEeecccccccc
Q 015027          162 EFASNGTLLDHIRCE-SSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDN-YTAKVADFESSVLIS  239 (414)
Q Consensus       162 e~~~~gsL~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~DfGla~~~~  239 (414)
                      ||||. +|.+.++.. ......+...+.-+..||++||+|||+.+   |+||||||.|+|+|.+ |.+||||||.|+.+.
T Consensus       102 eymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~  177 (364)
T KOG0658|consen  102 EYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV  177 (364)
T ss_pred             HhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence            99987 898888642 11122244556678999999999999977   9999999999999965 999999999999876


Q ss_pred             CCccccceecccccccccchhhccc-CCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhh-------hhhh
Q 015027          240 SDAETAMSTILIGTSGYLDPVCINT-GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYF-------LNSI  311 (414)
Q Consensus       240 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~-------~~~~  311 (414)
                      ....   ......|..|+|||.+.| .+|+.+.||||.|||+.||+-|++-|.+.+.... ...+...+       ...+
T Consensus       178 ~~ep---niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQ-L~eIik~lG~Pt~e~I~~m  253 (364)
T KOG0658|consen  178 KGEP---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQ-LVEIIKVLGTPTREDIKSM  253 (364)
T ss_pred             cCCC---ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHH-HHHHHHHhCCCCHHHHhhc
Confidence            5432   345678899999999876 5799999999999999999999999876442111 00000000       0000


Q ss_pred             c----ccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          312 K----NNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       312 ~----~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      .    .....++....+..-......+++.+|+.++|+.+|.+|.++.+++.
T Consensus       254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence            0    00111111111101111222366899999999999999999998864

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-41  Score=314.19  Aligned_cols=250  Identities=22%  Similarity=0.247  Sum_probs=195.1

Q ss_pred             CCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch----hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEE
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI----RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYE  162 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  162 (414)
                      +|++.+.||+|+||.||++... +++.||+|.+......    .....+++.+++.++||||+++++.+..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4788899999999999999965 5899999998754321    1223456789999999999999999999999999999


Q ss_pred             eCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCc
Q 015027          163 FASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDA  242 (414)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  242 (414)
                      |+++|+|.+++..... ..+++..+..++.|++.||.|||+.+   ++||||||+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          81 LMNGGDLKFHIYNMGN-PGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             ccCCCcHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence            9999999988864332 34588899999999999999999987   9999999999999999999999999987654321


Q ss_pred             cccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccccc
Q 015027          243 ETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNF  322 (414)
Q Consensus       243 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (414)
                         ......|++.|+|||++.+..++.++|||||||++|||++|+.||.......     ............        
T Consensus       157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~-----~~~~~~~~~~~~--------  220 (285)
T cd05605         157 ---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV-----KREEVERRVKED--------  220 (285)
T ss_pred             ---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh-----HHHHHHHHhhhc--------
Confidence               1223478999999999999999999999999999999999999997432111     000000000000        


Q ss_pred             ccCCcccHHHHHHHHHHHHHhhccCCCCCC-----ChhHHHH
Q 015027          323 HVADESEMKEIEIVAELASKCLRIRGTERP-----TMKQVSE  359 (414)
Q Consensus       323 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rp-----s~~~v~~  359 (414)
                        ....+...+..+.+|+.+||+.||.+||     ++.++++
T Consensus       221 --~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         221 --QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             --ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence              0011112235689999999999999999     6667643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.1e-40  Score=315.37  Aligned_cols=261  Identities=26%  Similarity=0.393  Sum_probs=198.9

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCc--EEEEEEeecccc--hhHhHHHHHHHHHcc-CCCceeeeeeeEecCCcceE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNI--QVAVKTYRRADK--IRITERELLRIISQV-NHKNVVKILGLCLETEVPLL  159 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~--~~~~~~~~~~~l~~l-~hpniv~l~~~~~~~~~~~l  159 (414)
                      .++|++.+.||+|+||.||+|.+. ++.  .+++|.+.....  ....+.+++.++.++ +||||+++++++..++..|+
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            367888999999999999999965 354  457777654321  223345567888888 89999999999999999999


Q ss_pred             EEEeCCCCchhhhhhhcCC-------------cccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCc
Q 015027          160 VYEFASNGTLLDHIRCESS-------------QVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYT  226 (414)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~  226 (414)
                      ||||+++++|.+++.....             ...+++..++.++.|++.||+|||+.+   ++||||||+|||++.++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence            9999999999999865431             224678899999999999999999987   999999999999999999


Q ss_pred             EEEeeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccch
Q 015027          227 AKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVP  305 (414)
Q Consensus       227 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~  305 (414)
                      +||+|||++......   .......++..|+|||++.+..++.++|||||||++|||+| |..||.......        
T Consensus       163 ~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--------  231 (303)
T cd05088         163 AKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--------  231 (303)
T ss_pred             EEeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH--------
Confidence            999999998643211   11112234567999999988889999999999999999998 999986432111        


Q ss_pred             hhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHhhhh
Q 015027          306 YFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLHEN  370 (414)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~~~~  370 (414)
                       ........         .....+...+..+.+|+.+||+.+|.+||++.+++..|+.+......
T Consensus       232 -~~~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~  286 (303)
T cd05088         232 -LYEKLPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT  286 (303)
T ss_pred             -HHHHHhcC---------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhh
Confidence             01111100         00001111234589999999999999999999999999887654433

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.6e-41  Score=320.28  Aligned_cols=237  Identities=27%  Similarity=0.301  Sum_probs=188.1

Q ss_pred             CccccCCceEEEEEEE----cCCcEEEEEEeecccch---hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCC
Q 015027           93 RCLSQGGFVSVYKGVL----HDNIQVAVKTYRRADKI---RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFAS  165 (414)
Q Consensus        93 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  165 (414)
                      +.||+|+||.||++..    .+|+.||+|++......   ......+++++++++||||+++++++..++..|+||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999875    25789999999764321   2223456689999999999999999999999999999999


Q ss_pred             CCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcccc
Q 015027          166 NGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETA  245 (414)
Q Consensus       166 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  245 (414)
                      +|+|.+++...   ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.......  .
T Consensus        82 ~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~  153 (318)
T cd05582          82 GGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--K  153 (318)
T ss_pred             CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--C
Confidence            99999988543   23588999999999999999999988   9999999999999999999999999987654321  1


Q ss_pred             ceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccccC
Q 015027          246 MSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVA  325 (414)
Q Consensus       246 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (414)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......         ..........      ..+
T Consensus       154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---------~~~~i~~~~~------~~p  218 (318)
T cd05582         154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE---------TMTMILKAKL------GMP  218 (318)
T ss_pred             ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH---------HHHHHHcCCC------CCC
Confidence            2234578999999999999899999999999999999999999997433111         1111111000      001


Q ss_pred             CcccHHHHHHHHHHHHHhhccCCCCCCChhH
Q 015027          326 DESEMKEIEIVAELASKCLRIRGTERPTMKQ  356 (414)
Q Consensus       326 ~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~  356 (414)
                      .    ..+..+.+|+.+||+.||.+||++.+
T Consensus       219 ~----~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         219 Q----FLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             C----CCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            1    11255899999999999999999655

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.8e-40  Score=315.80  Aligned_cols=239  Identities=23%  Similarity=0.263  Sum_probs=184.8

Q ss_pred             CccccCCceEEEEEEEc-CCcEEEEEEeecccc----hhHhHHHHHHHHH-ccCCCceeeeeeeEecCCcceEEEEeCCC
Q 015027           93 RCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK----IRITERELLRIIS-QVNHKNVVKILGLCLETEVPLLVYEFASN  166 (414)
Q Consensus        93 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~~~l~-~l~hpniv~l~~~~~~~~~~~lv~e~~~~  166 (414)
                      +.||+|+||.||+|.+. +|..||+|.+.....    .......+..++. ..+||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46899999999999976 588999999976422    1122233335554 45899999999999999999999999999


Q ss_pred             CchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccccc
Q 015027          167 GTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAM  246 (414)
Q Consensus       167 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  246 (414)
                      |+|.+++....   .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++......  ...
T Consensus        81 g~L~~~i~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~  152 (316)
T cd05620          81 GDLMFHIQDKG---RFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DNR  152 (316)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC--CCc
Confidence            99998886533   3477888999999999999999988   999999999999999999999999998743221  122


Q ss_pred             eecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccccCC
Q 015027          247 STILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVAD  326 (414)
Q Consensus       247 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (414)
                      .....||+.|+|||++.+..++.++|||||||++|||++|..||.......         ........      .+..+.
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~---------~~~~~~~~------~~~~~~  217 (316)
T cd05620         153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE---------LFESIRVD------TPHYPR  217 (316)
T ss_pred             eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---------HHHHHHhC------CCCCCC
Confidence            344679999999999999999999999999999999999999996432111         11111100      000111


Q ss_pred             cccHHHHHHHHHHHHHhhccCCCCCCChh-HHH
Q 015027          327 ESEMKEIEIVAELASKCLRIRGTERPTMK-QVS  358 (414)
Q Consensus       327 ~~~~~~~~~l~~Li~~cl~~dP~~Rps~~-~v~  358 (414)
                          ..+..+.+|+.+||+.||.+||++. ++.
T Consensus       218 ----~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         218 ----WITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             ----CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence                1124589999999999999999984 553

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=7.9e-41  Score=312.83  Aligned_cols=255  Identities=26%  Similarity=0.382  Sum_probs=197.9

Q ss_pred             cCCCCCCccccCCceEEEEEEEc------CCcEEEEEEeecccch-hHhHHHHHHHHHccCCCceeeeeeeEecCCcceE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH------DNIQVAVKTYRRADKI-RITERELLRIISQVNHKNVVKILGLCLETEVPLL  159 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~l  159 (414)
                      .+|...++||+|+||.||++...      ++..+|+|.+...... ......++++++.++||||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            56788899999999999999742      3567899987654322 3344667789999999999999999999999999


Q ss_pred             EEEeCCCCchhhhhhhcCCc------------ccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcE
Q 015027          160 VYEFASNGTLLDHIRCESSQ------------VLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTA  227 (414)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~  227 (414)
                      ||||+++++|.+++......            ..+++..++.++.|++.|++|||+.+   ++|+||||+|||+++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence            99999999999998654321            23578899999999999999999987   9999999999999999999


Q ss_pred             EEeeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchh
Q 015027          228 KVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPY  306 (414)
Q Consensus       228 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~  306 (414)
                      ||+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |.+||.......         
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---------  232 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE---------  232 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH---------
Confidence            9999999876543222122223345678999999999999999999999999999998 999986332111         


Q ss_pred             hhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHH
Q 015027          307 FLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELD  362 (414)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~  362 (414)
                      ......... .        ...+...+..+.+|+.+||+.||.+||++.+|++.|+
T Consensus       233 ~~~~~~~~~-~--------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         233 AIECITQGR-E--------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             HHHHHHcCc-c--------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            011111000 0        0001112255899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.5e-40  Score=307.38  Aligned_cols=254  Identities=24%  Similarity=0.377  Sum_probs=201.0

Q ss_pred             hcCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCC
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFAS  165 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  165 (414)
                      .++|.+.+.||+|+||.||+|.+.++..+|+|.+...........++++++++++|+||+++++++.. ...+++|||++
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~   83 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMA   83 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCC
Confidence            46788999999999999999998778889999987655444455667789999999999999999887 77899999999


Q ss_pred             CCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcccc
Q 015027          166 NGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETA  245 (414)
Q Consensus       166 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  245 (414)
                      +++|.+++..... ...++..++.++.+++.||.|||+.+   ++|+||||+||+++.++.+||+|||++........ .
T Consensus        84 ~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~  158 (260)
T cd05073          84 KGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-T  158 (260)
T ss_pred             CCcHHHHHHhCCc-cccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCc-c
Confidence            9999999965432 33478888999999999999999977   99999999999999999999999999876543211 1


Q ss_pred             ceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhccccccccccccc
Q 015027          246 MSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHV  324 (414)
Q Consensus       246 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (414)
                      ......++..|+|||++.+..++.++|+|||||++|++++ |..||...+...         .........         
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---------~~~~~~~~~---------  220 (260)
T cd05073         159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---------VIRALERGY---------  220 (260)
T ss_pred             cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH---------HHHHHhCCC---------
Confidence            1122345667999999998899999999999999999999 999986432111         111111110         


Q ss_pred             CCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHH
Q 015027          325 ADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDR  363 (414)
Q Consensus       325 ~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~  363 (414)
                      ..+.....+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus       221 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         221 RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             CCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            000011223568999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.6e-40  Score=310.31  Aligned_cols=245  Identities=19%  Similarity=0.234  Sum_probs=189.0

Q ss_pred             cccCCceEEEEEEEc-CCcEEEEEEeecccch----hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCCCCch
Q 015027           95 LSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI----RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTL  169 (414)
Q Consensus        95 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL  169 (414)
                      ||+|+||.||++... +|+.||+|.+......    ......+++++++++||||+++++++..+...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999965 5899999998653221    12224466889999999999999999999999999999999999


Q ss_pred             hhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccccceec
Q 015027          170 LDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTI  249 (414)
Q Consensus       170 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  249 (414)
                      .+++..... ..+++..+..++.||+.||+|||+.+   ++||||||+||+++.++.++|+|||++.......   ....
T Consensus        81 ~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~  153 (277)
T cd05607          81 KYHIYNVGE-RGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQ  153 (277)
T ss_pred             HHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeec
Confidence            988854432 23578888999999999999999987   9999999999999999999999999987654321   2233


Q ss_pred             ccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccccCCccc
Q 015027          250 LIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESE  329 (414)
Q Consensus       250 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (414)
                      ..||+.|+|||++.+..++.++|||||||++|||++|..||.........     ..........    .....     .
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~-----~~~~~~~~~~----~~~~~-----~  219 (277)
T cd05607         154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK-----EELKRRTLED----EVKFE-----H  219 (277)
T ss_pred             cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH-----HHHHHHhhcc----ccccc-----c
Confidence            56899999999999889999999999999999999999998643211100     0000000000    00000     0


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCChhHHHHH
Q 015027          330 MKEIEIVAELASKCLRIRGTERPTMKQVSEE  360 (414)
Q Consensus       330 ~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~  360 (414)
                      ...+..+.+|+.+||+.||.+||+++++++.
T Consensus       220 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~  250 (277)
T cd05607         220 QNFTEESKDICRLFLAKKPEDRLGSREKNDD  250 (277)
T ss_pred             ccCCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence            1123558999999999999999999877543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=8.7e-42  Score=297.52  Aligned_cols=250  Identities=26%  Similarity=0.367  Sum_probs=200.8

Q ss_pred             HHhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch---------hHhHHHHHHHHHcc-CCCceeeeeeeEe
Q 015027           84 RATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI---------RITERELLRIISQV-NHKNVVKILGLCL  152 (414)
Q Consensus        84 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~~~~l~~l-~hpniv~l~~~~~  152 (414)
                      ..-++|...+.||.|..++|-++..+ +|..+|+|++......         .+.-..++.+|+++ .||||+++.++|+
T Consensus        14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye   93 (411)
T KOG0599|consen   14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE   93 (411)
T ss_pred             hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence            34567888889999999999998865 6889999998542211         11124556788877 6999999999999


Q ss_pred             cCCcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeec
Q 015027          153 ETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADF  232 (414)
Q Consensus       153 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df  232 (414)
                      .+...++|+|.|+.|.|.|+|..   ...++++..++|++|+..|+.|||..+   |+||||||+|||+|++-++||+||
T Consensus        94 s~sF~FlVFdl~prGELFDyLts---~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDF  167 (411)
T KOG0599|consen   94 SDAFVFLVFDLMPRGELFDYLTS---KVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDF  167 (411)
T ss_pred             CcchhhhhhhhcccchHHHHhhh---heeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEecc
Confidence            99999999999999999999953   456688999999999999999999977   999999999999999999999999


Q ss_pred             cccccccCCccccceecccccccccchhhccc------CCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchh
Q 015027          233 ESSVLISSDAETAMSTILIGTSGYLDPVCINT------GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPY  306 (414)
Q Consensus       233 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~  306 (414)
                      |+|..+...   ......+|||+|+|||.+..      ..|+..+|+|++|||+|.|+.|.+||-...            
T Consensus       168 GFa~~l~~G---ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk------------  232 (411)
T KOG0599|consen  168 GFACQLEPG---EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK------------  232 (411)
T ss_pred             ceeeccCCc---hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH------------
Confidence            999988754   33456799999999998853      468889999999999999999999974211            


Q ss_pred             hhhhhcccccccccc--cccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          307 FLNSIKNNGLRQILN--FHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       307 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                           ....++.++.  ..+..+.+.+.+...++||.+||+.||.+|.|++|++.
T Consensus       233 -----QmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  233 -----QMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             -----HHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence                 0011111111  22333444555677999999999999999999999854

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.3e-40  Score=323.38  Aligned_cols=256  Identities=20%  Similarity=0.265  Sum_probs=194.8

Q ss_pred             HHHHhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc----hhHhHHHHHHHHHccCCCceeeeeeeEecCCc
Q 015027           82 MIRATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK----IRITERELLRIISQVNHKNVVKILGLCLETEV  156 (414)
Q Consensus        82 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~  156 (414)
                      .....++|.+.+.||+|+||.||++... +++.+|+|++.....    ......++..++..++||||+++++++.++..
T Consensus        38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (371)
T cd05622          38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY  117 (371)
T ss_pred             cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence            3445689999999999999999999976 588999999875322    12223566788999999999999999999999


Q ss_pred             ceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccc
Q 015027          157 PLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSV  236 (414)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~  236 (414)
                      .|+||||+++|+|.+++...    .++...+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.
T Consensus       118 ~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~  190 (371)
T cd05622         118 LYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM  190 (371)
T ss_pred             EEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence            99999999999999988543    2467888889999999999999988   9999999999999999999999999998


Q ss_pred             cccCCccccceecccccccccchhhcccCC----CCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhc
Q 015027          237 LISSDAETAMSTILIGTSGYLDPVCINTGK----LTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIK  312 (414)
Q Consensus       237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  312 (414)
                      ...... ........||+.|+|||++.+..    ++.++|||||||++|||++|..||.......        .+.....
T Consensus       191 ~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~--------~~~~i~~  261 (371)
T cd05622         191 KMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG--------TYSKIMN  261 (371)
T ss_pred             EcCcCC-cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH--------HHHHHHc
Confidence            764321 11223457999999999987543    7899999999999999999999997433211        0100000


Q ss_pred             ccccccccccccCCcccHHHHHHHHHHHHHhhccCCCC--CCChhHHHHH
Q 015027          313 NNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTE--RPTMKQVSEE  360 (414)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~--Rps~~~v~~~  360 (414)
                      ....       ...+.....+..+.+|+.+||...+.+  ||++.++++.
T Consensus       262 ~~~~-------~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         262 HKNS-------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             CCCc-------ccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence            0000       000111122356899999999844433  6788887654

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-40  Score=304.70  Aligned_cols=251  Identities=21%  Similarity=0.311  Sum_probs=196.5

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch------hHhHHHHHHHHHccCCCceeeeeeeEecCCcceE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI------RITERELLRIISQVNHKNVVKILGLCLETEVPLL  159 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~l  159 (414)
                      ++|.+.+.||+|++|.||.|... ++..||+|.+......      .....++++++++++||||+++++++..+...++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            57999999999999999999965 5899999998754321      1233556788999999999999999999999999


Q ss_pred             EEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccccccc
Q 015027          160 VYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLIS  239 (414)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~  239 (414)
                      ||||+++++|.+++....   .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++....
T Consensus        82 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             EEEECCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            999999999999886433   3477888999999999999999987   9999999999999999999999999987654


Q ss_pred             CCccccc-eecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccc
Q 015027          240 SDAETAM-STILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQ  318 (414)
Q Consensus       240 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (414)
                      ....... .....++..|+|||++.+..++.++||||||+++|||++|+.||........        .. .........
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--------~~-~~~~~~~~~  226 (263)
T cd06625         156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA--------IF-KIATQPTNP  226 (263)
T ss_pred             ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH--------HH-HHhccCCCC
Confidence            3211111 1234678899999999999999999999999999999999999864321100        00 000000000


Q ss_pred             ccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHH
Q 015027          319 ILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEE  360 (414)
Q Consensus       319 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~  360 (414)
                          .+    +......+.+++.+||..+|.+|||+.++++.
T Consensus       227 ----~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         227 ----QL----PSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             ----CC----CccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence                11    11122458999999999999999999998653

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=4.5e-40  Score=309.92  Aligned_cols=263  Identities=26%  Similarity=0.346  Sum_probs=199.9

Q ss_pred             hcCCCCCCccccCCceEEEEEEEcC-----------------CcEEEEEEeecccch--hHhHHHHHHHHHccCCCceee
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLHD-----------------NIQVAVKTYRRADKI--RITERELLRIISQVNHKNVVK  146 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~  146 (414)
                      .++|++.+.||+|+||.||+|.+..                 +..||+|.+......  ......+++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            3578999999999999999998643                 245899998765432  233456778999999999999


Q ss_pred             eeeeEecCCcceEEEEeCCCCchhhhhhhcCC--------cccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCc
Q 015027          147 ILGLCLETEVPLLVYEFASNGTLLDHIRCESS--------QVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSAN  218 (414)
Q Consensus       147 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~N  218 (414)
                      +++++..++..++||||+++++|.+++.....        ...+++..++.++.|++.||.|||+.+   ++|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence            99999999999999999999999999865431        124588999999999999999999987   9999999999


Q ss_pred             eeeCCCCcEEEeeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh--CCCCCCccccc
Q 015027          219 ILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT--GKKPGSCMTLA  296 (414)
Q Consensus       219 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t--g~~p~~~~~~~  296 (414)
                      |+++.++.++|+|||++................+++.|+|||++.+..++.++|||||||++|||++  |..||......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ  240 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence            9999999999999999876543322222334456778999999998899999999999999999998  67787533211


Q ss_pred             cccccccchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHH
Q 015027          297 SNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELD  362 (414)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~  362 (414)
                      .     ..................      ..+...+.++.+|+.+||+.+|.+|||+.+|++.|+
T Consensus       241 ~-----~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         241 Q-----VIENAGHFFRDDGRQIYL------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             H-----HHHHHHhccccccccccC------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            1     000000000000000000      011112256999999999999999999999988875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.9e-40  Score=316.06  Aligned_cols=240  Identities=20%  Similarity=0.248  Sum_probs=186.9

Q ss_pred             CccccCCceEEEEEEEc-CCcEEEEEEeecccch----hHhHHHHHHHHHcc-CCCceeeeeeeEecCCcceEEEEeCCC
Q 015027           93 RCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI----RITERELLRIISQV-NHKNVVKILGLCLETEVPLLVYEFASN  166 (414)
Q Consensus        93 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~  166 (414)
                      +.||+|+||.||+|... +++.||||++......    ......+..++..+ +||||+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46899999999999976 4789999999864321    12223444666666 799999999999999999999999999


Q ss_pred             CchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccccc
Q 015027          167 GTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAM  246 (414)
Q Consensus       167 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  246 (414)
                      |+|.+++....   .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.......  ..
T Consensus        81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~  152 (318)
T cd05570          81 GDLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VT  152 (318)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Cc
Confidence            99998886543   3578999999999999999999987   9999999999999999999999999986532211  12


Q ss_pred             eecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccccCC
Q 015027          247 STILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVAD  326 (414)
Q Consensus       247 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (414)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.......         ..........  .+    + 
T Consensus       153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~---------~~~~i~~~~~--~~----~-  216 (318)
T cd05570         153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE---------LFQSILEDEV--RY----P-  216 (318)
T ss_pred             ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH---------HHHHHHcCCC--CC----C-
Confidence            233578999999999999999999999999999999999999996433111         1111111100  00    1 


Q ss_pred             cccHHHHHHHHHHHHHhhccCCCCCCCh-----hHHHH
Q 015027          327 ESEMKEIEIVAELASKCLRIRGTERPTM-----KQVSE  359 (414)
Q Consensus       327 ~~~~~~~~~l~~Li~~cl~~dP~~Rps~-----~~v~~  359 (414)
                         ...+..+.+|+.+||+.||.+|||+     .++++
T Consensus       217 ---~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         217 ---RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             ---CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence               1122558999999999999999999     66643

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=9.9e-41  Score=323.44  Aligned_cols=246  Identities=22%  Similarity=0.271  Sum_probs=189.1

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch----hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI----RITERELLRIISQVNHKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~  161 (414)
                      ++|+..+.||+|+||.||++... +++.||+|++......    ......++.++..++||||+++++.+.+.+..|+||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888999999999999999976 5899999999754321    223355678899999999999999999999999999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCC
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD  241 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  241 (414)
                      ||+++|+|.+++....   .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~  154 (360)
T cd05627          81 EFLPGGDMMTLLMKKD---TLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA  154 (360)
T ss_pred             eCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence            9999999999986433   3478888999999999999999988   999999999999999999999999998754321


Q ss_pred             ccc---------------------------------cceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCC
Q 015027          242 AET---------------------------------AMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKK  288 (414)
Q Consensus       242 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~  288 (414)
                      ...                                 ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~  234 (360)
T cd05627         155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (360)
T ss_pred             cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence            100                                 00123479999999999999999999999999999999999999


Q ss_pred             CCCccccccccccccchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCCh
Q 015027          289 PGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTM  354 (414)
Q Consensus       289 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~  354 (414)
                      ||.......         ....+........+++..      ..+..+.+|+.+|+. +|.+|++.
T Consensus       235 Pf~~~~~~~---------~~~~i~~~~~~~~~p~~~------~~s~~~~~li~~l~~-~p~~R~~~  284 (360)
T cd05627         235 PFCSETPQE---------TYRKVMNWKETLVFPPEV------PISEKAKDLILRFCT-DSENRIGS  284 (360)
T ss_pred             CCCCCCHHH---------HHHHHHcCCCceecCCCC------CCCHHHHHHHHHhcc-ChhhcCCC
Confidence            997433211         000000000000011111      122558899998774 99999864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.6e-40  Score=317.03  Aligned_cols=236  Identities=23%  Similarity=0.286  Sum_probs=183.4

Q ss_pred             CccccCCceEEEEEEEc-CCcEEEEEEeecccchh----Hh-HHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCCC
Q 015027           93 RCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIR----IT-ERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASN  166 (414)
Q Consensus        93 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~-~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  166 (414)
                      +.||+|+||.||+|... +++.||+|++.......    .. ..++..+++.++||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36899999999999976 58899999997543211    11 13333467889999999999999999999999999999


Q ss_pred             CchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccccc
Q 015027          167 GTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAM  246 (414)
Q Consensus       167 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  246 (414)
                      ++|..++...   ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++......  ...
T Consensus        81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~  152 (321)
T cd05603          81 GELFFHLQRE---RCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EET  152 (321)
T ss_pred             CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CCc
Confidence            9998888543   23467788889999999999999987   999999999999999999999999998753222  122


Q ss_pred             eecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccccCC
Q 015027          247 STILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVAD  326 (414)
Q Consensus       247 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (414)
                      .....||+.|+|||++.+..++.++|||||||++|||++|..||...+...         ....+....      ..+..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---------~~~~i~~~~------~~~~~  217 (321)
T cd05603         153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ---------MYDNILHKP------LQLPG  217 (321)
T ss_pred             cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH---------HHHHHhcCC------CCCCC
Confidence            344578999999999999999999999999999999999999996432111         111111100      00111


Q ss_pred             cccHHHHHHHHHHHHHhhccCCCCCCChh
Q 015027          327 ESEMKEIEIVAELASKCLRIRGTERPTMK  355 (414)
Q Consensus       327 ~~~~~~~~~l~~Li~~cl~~dP~~Rps~~  355 (414)
                          .....+.+++.+||+.+|.+||++.
T Consensus       218 ----~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         218 ----GKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             ----CCCHHHHHHHHHHccCCHhhcCCCC
Confidence                1124589999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.1e-40  Score=318.72  Aligned_cols=239  Identities=26%  Similarity=0.293  Sum_probs=185.7

Q ss_pred             CccccCCceEEEEEEEc-CCcEEEEEEeecccchh----Hh-HHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCCC
Q 015027           93 RCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIR----IT-ERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASN  166 (414)
Q Consensus        93 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~-~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  166 (414)
                      +.||+|+||.||+|... +|+.||+|++.......    .. ..+...+++.++||||+++++++..++..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46899999999999965 58999999997542211    11 12333457789999999999999999999999999999


Q ss_pred             CchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccccc
Q 015027          167 GTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAM  246 (414)
Q Consensus       167 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  246 (414)
                      |+|..++....   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++......  ...
T Consensus        81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~  152 (325)
T cd05604          81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDT  152 (325)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CCC
Confidence            99998886433   3478889999999999999999987   999999999999999999999999998754322  112


Q ss_pred             eecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccccCC
Q 015027          247 STILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVAD  326 (414)
Q Consensus       247 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (414)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||.......         ..........  .+.+    
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---------~~~~~~~~~~--~~~~----  217 (325)
T cd05604         153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE---------MYDNILHKPL--VLRP----  217 (325)
T ss_pred             cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH---------HHHHHHcCCc--cCCC----
Confidence            334579999999999999999999999999999999999999997433111         1111111100  0111    


Q ss_pred             cccHHHHHHHHHHHHHhhccCCCCCCChhHHH
Q 015027          327 ESEMKEIEIVAELASKCLRIRGTERPTMKQVS  358 (414)
Q Consensus       327 ~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~  358 (414)
                          ..+..+.+++.+||+.+|.+||++.+.+
T Consensus       218 ----~~~~~~~~ll~~ll~~~p~~R~~~~~~~  245 (325)
T cd05604         218 ----GASLTAWSILEELLEKDRQRRLGAKEDF  245 (325)
T ss_pred             ----CCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence                1124588999999999999999986433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2e-40  Score=315.25  Aligned_cols=260  Identities=22%  Similarity=0.355  Sum_probs=199.4

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc--------CCcEEEEEEeecccch--hHhHHHHHHHHHcc-CCCceeeeeeeEecC
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH--------DNIQVAVKTYRRADKI--RITERELLRIISQV-NHKNVVKILGLCLET  154 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l-~hpniv~l~~~~~~~  154 (414)
                      ..+|.+.+.||+|+||.||+|...        ....+|+|.+......  ......+++++.++ +||||+++++++...
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            357889999999999999999742        2456999998754322  22334566788888 699999999999999


Q ss_pred             CcceEEEEeCCCCchhhhhhhcCC-------------cccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceee
Q 015027          155 EVPLLVYEFASNGTLLDHIRCESS-------------QVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILL  221 (414)
Q Consensus       155 ~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll  221 (414)
                      ...++||||+++|+|.+++.....             ...+++..+..++.|++.||.|||+.+   ++||||||+|||+
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill  167 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV  167 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence            999999999999999999965321             234688889999999999999999987   9999999999999


Q ss_pred             CCCCcEEEeeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccc
Q 015027          222 NDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKK  300 (414)
Q Consensus       222 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~  300 (414)
                      +.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||.......   
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---  244 (314)
T cd05099         168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE---  244 (314)
T ss_pred             cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH---
Confidence            9999999999999976543222111222234567999999999999999999999999999999 888986432111   


Q ss_pred             cccchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHH
Q 015027          301 ISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR  366 (414)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~  366 (414)
                            ...........         ..+...+..+.+|+.+||+.+|++|||+.++++.|+.+..
T Consensus       245 ------~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~  295 (314)
T cd05099         245 ------LFKLLREGHRM---------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA  295 (314)
T ss_pred             ------HHHHHHcCCCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence                  11111111000         0011112458899999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=6e-40  Score=304.96  Aligned_cols=253  Identities=25%  Similarity=0.289  Sum_probs=187.6

Q ss_pred             CccccCCceEEEEEEEcC---CcEEEEEEeecccchh--HhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCCCC
Q 015027           93 RCLSQGGFVSVYKGVLHD---NIQVAVKTYRRADKIR--ITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNG  167 (414)
Q Consensus        93 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~--~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g  167 (414)
                      +.||+|+||.||+|...+   +..+|+|.+.......  ....+++.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            358999999999998643   4579999887654322  23455678999999999999999999999999999999999


Q ss_pred             chhhhhhhcCC--cccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcccc
Q 015027          168 TLLDHIRCESS--QVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETA  245 (414)
Q Consensus       168 sL~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  245 (414)
                      +|.+++.....  ....++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||++..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            99999865322  223466778889999999999999987   9999999999999999999999999987543322222


Q ss_pred             ceecccccccccchhhcccC-------CCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhcccccc
Q 015027          246 MSTILIGTSGYLDPVCINTG-------KLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLR  317 (414)
Q Consensus       246 ~~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (414)
                      ......++..|+|||++.+.       .++.++||||||+++|||++ |..||........         ..........
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~---------~~~~~~~~~~  228 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV---------LTYTVREQQL  228 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH---------HHHHhhcccC
Confidence            22334577889999998643       35789999999999999996 9999964322110         0000001111


Q ss_pred             cccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHH
Q 015027          318 QILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELD  362 (414)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~  362 (414)
                      ....+.....    .+..+.+++..|| .+|.+|||+.+|.+.|+
T Consensus       229 ~~~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         229 KLPKPRLKLP----LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCCCccCCC----CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            1111111111    1244888999999 68999999999987764

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.7e-40  Score=310.98  Aligned_cols=272  Identities=21%  Similarity=0.261  Sum_probs=196.4

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-----CCcEEEEEEeecccch-hHhHHHHHHHHHccCCCceeeeeeeEec--CCcc
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-----DNIQVAVKTYRRADKI-RITERELLRIISQVNHKNVVKILGLCLE--TEVP  157 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~hpniv~l~~~~~~--~~~~  157 (414)
                      ..+|++.+.||+|+||.||+|...     ++..||+|.+...... ......+++++++++||||+++++++..  ....
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   82 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   82 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence            357889999999999999999742     4788999998765432 2334567789999999999999998754  3467


Q ss_pred             eEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccccc
Q 015027          158 LLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVL  237 (414)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~  237 (414)
                      ++||||+++++|.+++....  ..+++..++.++.|++.||+|||+.+   ++||||||+||++++++.+||+|||++..
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~  157 (284)
T cd05081          83 RLVMEYLPYGSLRDYLQKHR--ERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKV  157 (284)
T ss_pred             EEEEEecCCCCHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccccc
Confidence            89999999999999986433  23578899999999999999999987   99999999999999999999999999987


Q ss_pred             ccCCccccc-eecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccc
Q 015027          238 ISSDAETAM-STILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGL  316 (414)
Q Consensus       238 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (414)
                      ......... .....++..|+|||++.+..++.++|||||||++|||++|..|+..............  .........+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  235 (284)
T cd05081         158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGND--KQGQMIVYHL  235 (284)
T ss_pred             ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccc--cccccchHHH
Confidence            654322111 1112234469999999988999999999999999999998877543221100000000  0000000000


Q ss_pred             ccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHH
Q 015027          317 RQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL  364 (414)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i  364 (414)
                      ...+............+..+.+|+.+||+.+|++|||+.+|++.|+.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         236 IELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            000000000011111235699999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.4e-40  Score=312.41  Aligned_cols=256  Identities=24%  Similarity=0.351  Sum_probs=198.8

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc------CCcEEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEecCCcc
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH------DNIQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLETEVP  157 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~  157 (414)
                      .++|++.+.||+|+||.||+|...      ++..||+|.+......  ...+..++.++++++||||+++++++..+...
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            467999999999999999999863      4678999998754322  23345677899999999999999999999999


Q ss_pred             eEEEEeCCCCchhhhhhhcC-------------------CcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCc
Q 015027          158 LLVYEFASNGTLLDHIRCES-------------------SQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSAN  218 (414)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~-------------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~N  218 (414)
                      ++||||+++|+|.+++....                   ....+++..++.++.|++.||.|||+.+   ++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence            99999999999999986432                   1223577888999999999999999987   9999999999


Q ss_pred             eeeCCCCcEEEeeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCcccccc
Q 015027          219 ILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLAS  297 (414)
Q Consensus       219 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~  297 (414)
                      |+++.++.++|+|||++.................+..|+|||.+.+..++.++|||||||++|||++ |..||.......
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~  240 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE  240 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999876543221111222344667999999998999999999999999999998 888885332111


Q ss_pred             ccccccchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHH
Q 015027          298 NKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELD  362 (414)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~  362 (414)
                               ............         .+...+..+.+|+.+||+.+|.+|||+.++++.|+
T Consensus       241 ---------~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~  287 (288)
T cd05050         241 ---------VIYYVRDGNVLS---------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ  287 (288)
T ss_pred             ---------HHHHHhcCCCCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence                     111111111100         01112356899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.4e-40  Score=320.16  Aligned_cols=261  Identities=24%  Similarity=0.341  Sum_probs=197.6

Q ss_pred             hcCCCCCCccccCCceEEEEEEE------cCCcEEEEEEeecccch--hHhHHHHHHHHHcc-CCCceeeeeeeEecC-C
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVL------HDNIQVAVKTYRRADKI--RITERELLRIISQV-NHKNVVKILGLCLET-E  155 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l-~hpniv~l~~~~~~~-~  155 (414)
                      .++|++.+.||+|+||.||+|.+      .+++.||||.++.....  ......++.++.++ +||||+++++++... .
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            35799999999999999999974      24678999999754322  22335567888888 689999999988654 4


Q ss_pred             cceEEEEeCCCCchhhhhhhcCC---------------------------------------------------------
Q 015027          156 VPLLVYEFASNGTLLDHIRCESS---------------------------------------------------------  178 (414)
Q Consensus       156 ~~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------  178 (414)
                      ..++||||+++|+|.+++.....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            67899999999999998864321                                                         


Q ss_pred             -------cccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccccceeccc
Q 015027          179 -------QVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILI  251 (414)
Q Consensus       179 -------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~  251 (414)
                             ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++................
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                   123577888899999999999999987   9999999999999999999999999987654332222222334


Q ss_pred             ccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhcccccccccccccCCcccH
Q 015027          252 GTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEM  330 (414)
Q Consensus       252 gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (414)
                      +++.|+|||++.+..++.++||||||+++|+|++ |..||.......        .+......... ...    +.    
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--------~~~~~~~~~~~-~~~----~~----  305 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--------EFCRRLKEGTR-MRA----PD----  305 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--------HHHHHHhccCC-CCC----CC----
Confidence            5678999999999999999999999999999997 999986432110        01111111100 000    00    


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHH
Q 015027          331 KEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR  366 (414)
Q Consensus       331 ~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~  366 (414)
                      ..++.+.+++.+||+.+|.+|||+.+|++.|+.+.+
T Consensus       306 ~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         306 YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            012458999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3e-40  Score=311.22  Aligned_cols=262  Identities=25%  Similarity=0.326  Sum_probs=196.1

Q ss_pred             cCCCCCCccccCCceEEEEEEEcC---------------CcEEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeee
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLHD---------------NIQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILG  149 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~  149 (414)
                      ++|++.+.||+|+||.||++....               ...||+|.+......  ......+++++.+++||||+++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            578999999999999999987542               124899998764322  233456778999999999999999


Q ss_pred             eEecCCcceEEEEeCCCCchhhhhhhcCC---------cccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCcee
Q 015027          150 LCLETEVPLLVYEFASNGTLLDHIRCESS---------QVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANIL  220 (414)
Q Consensus       150 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIl  220 (414)
                      ++...+..++||||+++++|.+++.....         ....++..++.++.|++.||+|||+.+   ++|+||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence            99999999999999999999998854321         123578889999999999999999987   999999999999


Q ss_pred             eCCCCcEEEeeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh--CCCCCCccccccc
Q 015027          221 LNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT--GKKPGSCMTLASN  298 (414)
Q Consensus       221 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t--g~~p~~~~~~~~~  298 (414)
                      +++++.+||+|||++................++..|+|||++.+..++.++|||||||++|+|++  |..||........
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~  241 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV  241 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence            99999999999999876543222222233345678999999998999999999999999999998  5677764321110


Q ss_pred             cccccchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHH
Q 015027          299 KKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELD  362 (414)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~  362 (414)
                           ............. .....     .+...+..+.+|+.+||+.+|.+|||+.+|++.|+
T Consensus       242 -----~~~~~~~~~~~~~-~~~~~-----~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         242 -----IENTGEFFRNQGR-QIYLS-----QTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             -----HHHHHHhhhhccc-cccCC-----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence                 0000000000000 00000     00011246999999999999999999999988875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2.6e-40  Score=316.28  Aligned_cols=243  Identities=19%  Similarity=0.252  Sum_probs=185.8

Q ss_pred             CccccCCceEEEEEEEc-CCcEEEEEEeecccchh----HhHHHHHHHHHcc-CCCceeeeeeeEecCCcceEEEEeCCC
Q 015027           93 RCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIR----ITERELLRIISQV-NHKNVVKILGLCLETEVPLLVYEFASN  166 (414)
Q Consensus        93 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~  166 (414)
                      +.||+|+||.||+|... +++.||+|++.......    .....+..++.++ +||||+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999975 57899999998643221    2234455666666 699999999999999999999999999


Q ss_pred             CchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccccc
Q 015027          167 GTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAM  246 (414)
Q Consensus       167 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  246 (414)
                      |+|..++....   .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++......  ...
T Consensus        81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~  152 (327)
T cd05617          81 GDLMFHMQRQR---KLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GDT  152 (327)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCC--CCc
Confidence            99998885433   3588999999999999999999987   999999999999999999999999998753221  112


Q ss_pred             eecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccccCC
Q 015027          247 STILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVAD  326 (414)
Q Consensus       247 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (414)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||........  ................      ..+.
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~------~~p~  224 (327)
T cd05617         153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPD--MNTEDYLFQVILEKPI------RIPR  224 (327)
T ss_pred             eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcc--cccHHHHHHHHHhCCC------CCCC
Confidence            3346799999999999999999999999999999999999999964322111  0111111111111100      0111


Q ss_pred             cccHHHHHHHHHHHHHhhccCCCCCCChh
Q 015027          327 ESEMKEIEIVAELASKCLRIRGTERPTMK  355 (414)
Q Consensus       327 ~~~~~~~~~l~~Li~~cl~~dP~~Rps~~  355 (414)
                          ..+..+.+++.+||+.||.+||++.
T Consensus       225 ----~~~~~~~~li~~~L~~dP~~R~~~~  249 (327)
T cd05617         225 ----FLSVKASHVLKGFLNKDPKERLGCQ  249 (327)
T ss_pred             ----CCCHHHHHHHHHHhccCHHHcCCCC
Confidence                1224589999999999999999864

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=2e-40  Score=342.89  Aligned_cols=262  Identities=19%  Similarity=0.287  Sum_probs=201.0

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc----hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK----IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~  161 (414)
                      ++|++.+.||+|+||.||+|.+. +++.||+|++.....    ......++++++++++||||+++++++.+++..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57999999999999999999976 589999999875422    2234466778999999999999999999999999999


Q ss_pred             EeCCCCchhhhhhhcCC--------cccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecc
Q 015027          162 EFASNGTLLDHIRCESS--------QVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFE  233 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~--------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG  233 (414)
                      ||++||+|.+++.....        ....++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence            99999999998854211        122356678899999999999999987   9999999999999999999999999


Q ss_pred             ccccccCCcc----------------ccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCcccccc
Q 015027          234 SSVLISSDAE----------------TAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLAS  297 (414)
Q Consensus       234 la~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~  297 (414)
                      ++........                ........||+.|+|||++.+..++.++|||||||++|||++|..||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            9986621110                011123579999999999999999999999999999999999999996422110


Q ss_pred             ccccccchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCC-ChhHHHHHHHHHHHh
Q 015027          298 NKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERP-TMKQVSEELDRLRRL  367 (414)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rp-s~~~v~~~L~~i~~~  367 (414)
                      .   .    ...        ....+. ........+..+.+++.+||+.||++|| +++++.+.|+.....
T Consensus       239 i---~----~~~--------~i~~P~-~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~  293 (932)
T PRK13184        239 I---S----YRD--------VILSPI-EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG  293 (932)
T ss_pred             h---h----hhh--------hccChh-hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence            0   0    000        000000 0000112235689999999999999996 577888888876543

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=3.5e-40  Score=302.91  Aligned_cols=246  Identities=27%  Similarity=0.423  Sum_probs=192.7

Q ss_pred             CccccCCceEEEEEEEcCCcEEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCCCCchh
Q 015027           93 RCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLL  170 (414)
Q Consensus        93 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~  170 (414)
                      +.||+|+||.||+|...++..+|+|.+......  ......++++++.++||||+++++++......++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            368999999999999878899999998754322  223456778899999999999999999999999999999999999


Q ss_pred             hhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccccceecc
Q 015027          171 DHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTIL  250 (414)
Q Consensus       171 ~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~  250 (414)
                      +++.....  .+++..++.++.+++.+|.|||+.+   ++|+||||+||+++.++.+||+|||++......... .....
T Consensus        81 ~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~  154 (250)
T cd05085          81 SFLRKKKD--ELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLK  154 (250)
T ss_pred             HHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCC
Confidence            98865432  3478899999999999999999987   999999999999999999999999998754332111 11122


Q ss_pred             cccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhcccccccccccccCCccc
Q 015027          251 IGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESE  329 (414)
Q Consensus       251 ~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (414)
                      .++..|+|||++.+..++.++||||||+++|++++ |..||.......         ........ ...    ...    
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~---------~~~~~~~~-~~~----~~~----  216 (250)
T cd05085         155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ---------AREQVEKG-YRM----SCP----  216 (250)
T ss_pred             CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH---------HHHHHHcC-CCC----CCC----
Confidence            34567999999998899999999999999999998 999986432111         00111110 000    001    


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCChhHHHHHHH
Q 015027          330 MKEIEIVAELASKCLRIRGTERPTMKQVSEELD  362 (414)
Q Consensus       330 ~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~  362 (414)
                      ...+..+.+|+.+||+.+|.+|||+.++.+.|.
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         217 QKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            112356999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=3.1e-40  Score=307.16  Aligned_cols=252  Identities=23%  Similarity=0.344  Sum_probs=194.2

Q ss_pred             HhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhHhHHHHHHHHHcc-CCCceeeeeeeEecC------Cc
Q 015027           85 ATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRITERELLRIISQV-NHKNVVKILGLCLET------EV  156 (414)
Q Consensus        85 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~l~~l-~hpniv~l~~~~~~~------~~  156 (414)
                      +++.|.+.+.||+|+||.||+|... +++.||+|.+............++.++.++ +||||+++++++...      ..
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ   83 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence            4577888999999999999999965 588999999876554444455566777777 699999999998753      45


Q ss_pred             ceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccc
Q 015027          157 PLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSV  236 (414)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~  236 (414)
                      .|+||||+++++|.+++..... ..+++..+..++.|++.||+|||+.+   |+|+||||+||++++++.++|+|||++.
T Consensus        84 ~~iv~e~~~~~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~~  159 (272)
T cd06637          84 LWLVMEFCGAGSVTDLIKNTKG-NTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSA  159 (272)
T ss_pred             EEEEEEcCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCce
Confidence            7899999999999999865332 34578889999999999999999987   9999999999999999999999999987


Q ss_pred             cccCCccccceecccccccccchhhcc-----cCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhh
Q 015027          237 LISSDAETAMSTILIGTSGYLDPVCIN-----TGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSI  311 (414)
Q Consensus       237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  311 (414)
                      ......  .......|++.|+|||++.     +..++.++|||||||++|||++|..||........       ..  ..
T Consensus       160 ~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~-------~~--~~  228 (272)
T cd06637         160 QLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA-------LF--LI  228 (272)
T ss_pred             eccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH-------HH--HH
Confidence            654321  1223457899999999986     34688899999999999999999999863321110       00  00


Q ss_pred             cccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          312 KNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ..........        ...+..+.+|+.+||..+|.+|||+.++++
T Consensus       229 ~~~~~~~~~~--------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         229 PRNPAPRLKS--------KKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             hcCCCCCCCC--------CCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            0000000100        112245899999999999999999999864

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=3.7e-40  Score=304.01  Aligned_cols=249  Identities=30%  Similarity=0.447  Sum_probs=198.7

Q ss_pred             CccccCCceEEEEEEEcC----CcEEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCCC
Q 015027           93 RCLSQGGFVSVYKGVLHD----NIQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASN  166 (414)
Q Consensus        93 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  166 (414)
                      +.||+|+||.||+|....    +..|++|.+......  ......+++.+..++|+||+++++++..+...++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            468999999999999753    788999999876543  23445677889999999999999999999999999999999


Q ss_pred             CchhhhhhhcCC------cccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccC
Q 015027          167 GTLLDHIRCESS------QVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISS  240 (414)
Q Consensus       167 gsL~~~l~~~~~------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  240 (414)
                      ++|.+++.....      ...+++..++.++.|++.||+|||+.+   ++|+||+|+||+++.++.+||+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence            999999976521      244589999999999999999999987   99999999999999999999999999987664


Q ss_pred             CccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhcccccccc
Q 015027          241 DAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQI  319 (414)
Q Consensus       241 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (414)
                      ...........+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......         ......... .  
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---------~~~~~~~~~-~--  225 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE---------VLEYLRKGY-R--  225 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH---------HHHHHHcCC-C--
Confidence            432223344567889999999988899999999999999999999 699987542111         111111110 0  


Q ss_pred             cccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHH
Q 015027          320 LNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELD  362 (414)
Q Consensus       320 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~  362 (414)
                            ...+...+..+.+++.+||+.+|.+|||+.++++.|+
T Consensus       226 ------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         226 ------LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ------CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                  0111111356999999999999999999999988763

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=4.5e-40  Score=303.07  Aligned_cols=248  Identities=24%  Similarity=0.342  Sum_probs=197.6

Q ss_pred             CCCCCCccccCCceEEEEEEEc-CCcEEEEEEeeccc---chhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEe
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRAD---KIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  163 (414)
                      +|.+.+.||+|++|.||+|... ++..|++|.+....   ........++++++.++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4778889999999999999975 58899999987532   2223345567889999999999999999999999999999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcc
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE  243 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  243 (414)
                      +++++|.+++.... ...+++..++.++.+++.||.|||+.+   ++|+||||+||+++.++.++|+|||++....... 
T Consensus        81 ~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~-  155 (256)
T cd08529          81 AENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT-  155 (256)
T ss_pred             CCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCcc-
Confidence            99999999987542 234578889999999999999999977   9999999999999999999999999988665321 


Q ss_pred             ccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccc
Q 015027          244 TAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFH  323 (414)
Q Consensus       244 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (414)
                       .......|++.|+|||++.+..++.++||||||+++|+|++|+.||.......         ...........      
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---------~~~~~~~~~~~------  219 (256)
T cd08529         156 -NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA---------LILKIIRGVFP------  219 (256)
T ss_pred             -chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---------HHHHHHcCCCC------
Confidence             12234468889999999999999999999999999999999999987433110         01111111100      


Q ss_pred             cCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          324 VADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       324 ~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                         ..+...+..+.+++.+||+.+|++||++.++++
T Consensus       220 ---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  252 (256)
T cd08529         220 ---PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR  252 (256)
T ss_pred             ---CCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence               011122356999999999999999999999865

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=2.4e-40  Score=305.15  Aligned_cols=251  Identities=26%  Similarity=0.406  Sum_probs=199.2

Q ss_pred             cCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCCC
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASN  166 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  166 (414)
                      .+|++.+.||+|+||.||+|.+.++..+|+|.+.........+..+++++++++|||++++++++......++||||+++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   83 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH   83 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence            46788899999999999999987788999999876554445566677899999999999999999999999999999999


Q ss_pred             CchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccccc
Q 015027          167 GTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAM  246 (414)
Q Consensus       167 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  246 (414)
                      ++|.+++.....  .+++..+..++.+++.|++|||+.+   ++|+||||+||+++.++.+||+|||++......... .
T Consensus        84 ~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-~  157 (256)
T cd05112          84 GCLSDYLRAQRG--KFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT-S  157 (256)
T ss_pred             CcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCccc-c
Confidence            999999865432  3478889999999999999999987   999999999999999999999999998765432111 1


Q ss_pred             eecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhcccccccccccccC
Q 015027          247 STILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVA  325 (414)
Q Consensus       247 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (414)
                      .....++..|+|||.+.+..++.++||||||+++|||++ |..||.......         ........ . ....+.. 
T Consensus       158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---------~~~~~~~~-~-~~~~~~~-  225 (256)
T cd05112         158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE---------VVETINAG-F-RLYKPRL-  225 (256)
T ss_pred             cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---------HHHHHhCC-C-CCCCCCC-
Confidence            122234568999999998899999999999999999998 999986332111         11111110 0 0011111 


Q ss_pred             CcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHH
Q 015027          326 DESEMKEIEIVAELASKCLRIRGTERPTMKQVSEEL  361 (414)
Q Consensus       326 ~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L  361 (414)
                            .+..+.+|+.+||+.+|.+|||+.++++.|
T Consensus       226 ------~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         226 ------ASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             ------CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence                  125699999999999999999999998876

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=5.7e-40  Score=306.86  Aligned_cols=250  Identities=23%  Similarity=0.306  Sum_probs=193.4

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEe
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  163 (414)
                      ++|++.+.||+|+||.||+|.+. +++.||+|.+......  ......+++++.+++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            36788899999999999999964 6889999998754322  23345677889999999999999999999999999999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcc
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE  243 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  243 (414)
                      +++++|..+.       .+++..+..++.|++.||.|||+.+   |+|+||||+|||++.++.++|+|||++......  
T Consensus        81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--  148 (279)
T cd06619          81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--  148 (279)
T ss_pred             CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence            9999996542       2367788899999999999999988   999999999999999999999999998765432  


Q ss_pred             ccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccc
Q 015027          244 TAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFH  323 (414)
Q Consensus       244 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (414)
                        ......+|..|+|||++.+..++.++||||||+++|+|++|..||..........  .............     .+.
T Consensus       149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~-----~~~  219 (279)
T cd06619         149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL--MPLQLLQCIVDED-----PPV  219 (279)
T ss_pred             --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc--chHHHHHHHhccC-----CCC
Confidence              2233578999999999999999999999999999999999999986422111000  0000000000000     000


Q ss_pred             cCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHH
Q 015027          324 VADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEE  360 (414)
Q Consensus       324 ~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~  360 (414)
                      .   .....+..+.+++.+||+.+|.+||+++++++.
T Consensus       220 ~---~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         220 L---PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             C---CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            0   011122458999999999999999999999654

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3e-40  Score=304.59  Aligned_cols=250  Identities=24%  Similarity=0.394  Sum_probs=200.7

Q ss_pred             hcCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCC
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFAS  165 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  165 (414)
                      .++|++.+.||.|+||.||+|.. .|+.||+|.+............++.+++.++|+||+++++++.+....++||||++
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   83 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA   83 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence            45788999999999999999987 47899999998765534455667789999999999999999999999999999999


Q ss_pred             CCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcccc
Q 015027          166 NGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETA  245 (414)
Q Consensus       166 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  245 (414)
                      +++|.+++..... ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||.+........  
T Consensus        84 ~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~--  157 (256)
T cd05039          84 KGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--  157 (256)
T ss_pred             CCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence            9999999865442 24588999999999999999999988   99999999999999999999999999886632211  


Q ss_pred             ceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhccccccccccccc
Q 015027          246 MSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHV  324 (414)
Q Consensus       246 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (414)
                         ....+..|+|||++.+..++.++||||||+++|+|++ |..||.......         ......... .    ...
T Consensus       158 ---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---------~~~~~~~~~-~----~~~  220 (256)
T cd05039         158 ---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---------VVPHVEKGY-R----MEA  220 (256)
T ss_pred             ---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH---------HHHHHhcCC-C----CCC
Confidence               2234567999999988899999999999999999997 999986332111         111111110 0    000


Q ss_pred             CCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHH
Q 015027          325 ADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDR  363 (414)
Q Consensus       325 ~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~  363 (414)
                          +...+..+.+++.+||..+|.+|||+.+++..|+.
T Consensus       221 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         221 ----PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             ----ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence                11123568999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=3.3e-40  Score=306.36  Aligned_cols=256  Identities=24%  Similarity=0.378  Sum_probs=198.6

Q ss_pred             hcCCCCCCccccCCceEEEEEEEcC-C---cEEEEEEeecccc--hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLHD-N---IQVAVKTYRRADK--IRITERELLRIISQVNHKNVVKILGLCLETEVPLL  159 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~--~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~l  159 (414)
                      .++|+..+.||+|+||.||+|.+.. +   ..+|+|.+.....  .......+++++.+++||||+++++++...+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            3578888999999999999999753 3   3699999865432  22334556788999999999999999999999999


Q ss_pred             EEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccccccc
Q 015027          160 VYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLIS  239 (414)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~  239 (414)
                      ||||+++++|.+++....  ..+++..+..++.|++.|++|||+.+   ++|+||||+||+++.++.+||+|||++....
T Consensus        84 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  158 (268)
T cd05063          84 ITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE  158 (268)
T ss_pred             EEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence            999999999999986543  23578889999999999999999987   9999999999999999999999999987664


Q ss_pred             CCccccce-ecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhcccccc
Q 015027          240 SDAETAMS-TILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLR  317 (414)
Q Consensus       240 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (414)
                      ........ .....++.|+|||++.+..++.++|||||||++|||++ |..||......         .....+....  
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~---------~~~~~i~~~~--  227 (268)
T cd05063         159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH---------EVMKAINDGF--  227 (268)
T ss_pred             cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH---------HHHHHHhcCC--
Confidence            33211111 11223457999999998899999999999999999997 99998633211         0111111110  


Q ss_pred             cccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHH
Q 015027          318 QILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL  364 (414)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i  364 (414)
                             ..+.....+..+.+|+.+||+.+|.+||++.+|++.|+++
T Consensus       228 -------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         228 -------RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             -------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                   0011112235689999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.9e-40  Score=303.42  Aligned_cols=247  Identities=28%  Similarity=0.399  Sum_probs=191.5

Q ss_pred             CccccCCceEEEEEEEcC----CcEEEEEEeecccc--hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCCC
Q 015027           93 RCLSQGGFVSVYKGVLHD----NIQVAVKTYRRADK--IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASN  166 (414)
Q Consensus        93 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~--~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  166 (414)
                      +.||+|+||.||+|....    +..+|+|.+.....  .......++++++.+.||||+++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            469999999999998532    26899999886654  2334456678999999999999999876 4567999999999


Q ss_pred             CchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccccc
Q 015027          167 GTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAM  246 (414)
Q Consensus       167 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  246 (414)
                      ++|.+++....   .+++..++.++.|++.||.|||..+   ++|+||||+|||++.++.+||+|||++...........
T Consensus        80 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~  153 (257)
T cd05060          80 GPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR  153 (257)
T ss_pred             CcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence            99999996544   4478999999999999999999987   99999999999999999999999999986643322111


Q ss_pred             -eecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhccccccccccccc
Q 015027          247 -STILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHV  324 (414)
Q Consensus       247 -~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (414)
                       .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.......         +.........        
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~---------~~~~~~~~~~--------  216 (257)
T cd05060         154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE---------VIAMLESGER--------  216 (257)
T ss_pred             cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH---------HHHHHHcCCc--------
Confidence             111223467999999999999999999999999999998 999986432110         1111111100        


Q ss_pred             CCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHH
Q 015027          325 ADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL  364 (414)
Q Consensus       325 ~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i  364 (414)
                       ...+...+..+.+++.+||..+|.+||++.++++.|+.+
T Consensus       217 -~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         217 -LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             -CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence             001111225589999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=3.7e-40  Score=305.87  Aligned_cols=252  Identities=22%  Similarity=0.279  Sum_probs=195.2

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch-hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeC
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI-RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFA  164 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  164 (414)
                      .+|++.+.||+|+||.||+|... ++..||+|++...... ......++.++++++||||+++++++...+..++||||+
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~   88 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC   88 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence            57999999999999999999964 6889999998754322 223455678899999999999999999999999999999


Q ss_pred             CCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccc
Q 015027          165 SNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET  244 (414)
Q Consensus       165 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  244 (414)
                      ++++|.+++....   .+++..+..++.|++.||.|||+.+   |+|+||+|+||+++.++.+||+|||++........ 
T Consensus        89 ~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-  161 (267)
T cd06646          89 GGGSLQDIYHVTG---PLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-  161 (267)
T ss_pred             CCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc-
Confidence            9999999886433   3478889999999999999999977   99999999999999999999999999986543211 


Q ss_pred             cceecccccccccchhhcc---cCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccc
Q 015027          245 AMSTILIGTSGYLDPVCIN---TGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILN  321 (414)
Q Consensus       245 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (414)
                       ......+++.|+|||.+.   ...++.++|||||||++|||++|..||..........         ......   ...
T Consensus       162 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~---------~~~~~~---~~~  228 (267)
T cd06646         162 -KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF---------LMSKSN---FQP  228 (267)
T ss_pred             -ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe---------eeecCC---CCC
Confidence             123346888999999884   4457889999999999999999999985332111000         000000   000


Q ss_pred             cccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHH
Q 015027          322 FHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEE  360 (414)
Q Consensus       322 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~  360 (414)
                      +....  ....+..+.+|+.+||+.+|++|||++++++.
T Consensus       229 ~~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  265 (267)
T cd06646         229 PKLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTH  265 (267)
T ss_pred             CCCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence            11100  11123568999999999999999999999764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=3.4e-40  Score=304.54  Aligned_cols=245  Identities=26%  Similarity=0.352  Sum_probs=189.7

Q ss_pred             ccccCCceEEEEEEEc---CCcEEEEEEeecccch---hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCCCC
Q 015027           94 CLSQGGFVSVYKGVLH---DNIQVAVKTYRRADKI---RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNG  167 (414)
Q Consensus        94 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g  167 (414)
                      .||+|+||.||+|.+.   ++..+|+|++......   ......++.+++.+.||||+++++++. .+..++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            5899999999999753   4788999998654322   233456678899999999999999875 45678999999999


Q ss_pred             chhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccccc-
Q 015027          168 TLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAM-  246 (414)
Q Consensus       168 sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~-  246 (414)
                      +|.+++....   .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++........... 
T Consensus        81 ~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  154 (257)
T cd05116          81 PLNKFLQKNK---HVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA  154 (257)
T ss_pred             cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence            9999986432   3578899999999999999999987   99999999999999999999999999987654322111 


Q ss_pred             eecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhcccccccccccccC
Q 015027          247 STILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVA  325 (414)
Q Consensus       247 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (414)
                      .....++..|+|||.+.+..++.++|||||||++|||++ |..||.......         ...........        
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---------~~~~i~~~~~~--------  217 (257)
T cd05116         155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE---------VTQMIESGERM--------  217 (257)
T ss_pred             cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---------HHHHHHCCCCC--------
Confidence            112234578999999988889999999999999999998 999987432111         11111111100        


Q ss_pred             CcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHH
Q 015027          326 DESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDR  363 (414)
Q Consensus       326 ~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~  363 (414)
                       ..+...+..+.+|+.+||+.||.+||++.+|.+.|+.
T Consensus       218 -~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         218 -ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             -CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence             0111123568999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-42  Score=324.82  Aligned_cols=243  Identities=27%  Similarity=0.350  Sum_probs=195.5

Q ss_pred             CCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchh----HhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEE
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIR----ITERELLRIISQVNHKNVVKILGLCLETEVPLLVYE  162 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  162 (414)
                      .|.-++.||.|+||.||-|++. +...||||.+..+....    .....++++|++++|||+|.+.|+|..+...|||||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            3566788999999999999965 57889999997654322    334667799999999999999999999999999999


Q ss_pred             eCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCc
Q 015027          163 FASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDA  242 (414)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  242 (414)
                      ||- ||-.|++.-..  .++.+..+..|+.+.+.||+|||+.+   .||||||+.|||+++.|.|||+|||.|.....  
T Consensus       107 YCl-GSAsDlleVhk--KplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P--  178 (948)
T KOG0577|consen  107 YCL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP--  178 (948)
T ss_pred             HHh-ccHHHHHHHHh--ccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc--
Confidence            995 47777775432  34567888999999999999999988   99999999999999999999999999876543  


Q ss_pred             cccceecccccccccchhhcc---cCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccc
Q 015027          243 ETAMSTILIGTSGYLDPVCIN---TGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQI  319 (414)
Q Consensus       243 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (414)
                          .+.++|||.|||||++.   .+.|+-++||||||+++.||...++|+-.++..+         .+-.+..+..   
T Consensus       179 ----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS---------ALYHIAQNes---  242 (948)
T KOG0577|consen  179 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---------ALYHIAQNES---  242 (948)
T ss_pred             ----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH---------HHHHHHhcCC---
Confidence                35679999999999984   5689999999999999999999999976544221         1111111111   


Q ss_pred             cccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          320 LNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       320 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                           +.....+.+..+..++..||++-|.+|||.+++++
T Consensus       243 -----PtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  243 -----PTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             -----CCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence                 11123445567999999999999999999988765

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=4.9e-40  Score=303.65  Aligned_cols=247  Identities=25%  Similarity=0.377  Sum_probs=189.9

Q ss_pred             ccccCCceEEEEEEEc---CCcEEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCCCCc
Q 015027           94 CLSQGGFVSVYKGVLH---DNIQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGT  168 (414)
Q Consensus        94 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gs  168 (414)
                      .||+|+||.||+|.+.   ++..||+|++......  .....+++.++++++||||+++++++. .+..++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            3899999999999864   3557999998765332  233456778999999999999999885 457899999999999


Q ss_pred             hhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccccc-e
Q 015027          169 LLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAM-S  247 (414)
Q Consensus       169 L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~-~  247 (414)
                      |.+++....  ..+++..++.++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++........... .
T Consensus        81 L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  155 (257)
T cd05115          81 LNKFLSGKK--DEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR  155 (257)
T ss_pred             HHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence            999986433  24588999999999999999999987   99999999999999999999999999976543322111 1


Q ss_pred             ecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhcccccccccccccCC
Q 015027          248 TILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVAD  326 (414)
Q Consensus       248 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (414)
                      ....++..|+|||++.+..++.++|||||||++|||++ |..||.......         .......... ..       
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---------~~~~~~~~~~-~~-------  218 (257)
T cd05115         156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE---------VMSFIEQGKR-LD-------  218 (257)
T ss_pred             CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH---------HHHHHHCCCC-CC-------
Confidence            11223568999999998899999999999999999996 999987433211         1111111110 00       


Q ss_pred             cccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHH
Q 015027          327 ESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL  364 (414)
Q Consensus       327 ~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i  364 (414)
                       .+...+..+.+++.+||+.+|++||++.+|.+.|+.+
T Consensus       219 -~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         219 -CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             -CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence             1111235689999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=3.2e-40  Score=304.43  Aligned_cols=249  Identities=23%  Similarity=0.404  Sum_probs=195.9

Q ss_pred             cCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEe-cCCcceEEEEeCC
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCL-ETEVPLLVYEFAS  165 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~-~~~~~~lv~e~~~  165 (414)
                      .+|.+.+.||+|+||.||++.. .|..||+|.+..... ......++.++++++|+|++++++++. .+...++||||++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~   83 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT-AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA   83 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCch-HHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence            5788899999999999999976 478899999865443 334456678999999999999999764 4567899999999


Q ss_pred             CCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcccc
Q 015027          166 NGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETA  245 (414)
Q Consensus       166 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  245 (414)
                      +++|.+++..... ...++..++.++.|++.||+|||+.+   ++||||||+||++++++.+||+|||++.......   
T Consensus        84 ~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---  156 (256)
T cd05082          84 KGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---  156 (256)
T ss_pred             CCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence            9999999865433 23578899999999999999999987   9999999999999999999999999987543321   


Q ss_pred             ceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhccccccccccccc
Q 015027          246 MSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHV  324 (414)
Q Consensus       246 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (414)
                        ....++..|+|||++.+..++.++|||||||++|+|++ |+.||.......         ........ ..    ...
T Consensus       157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~---------~~~~~~~~-~~----~~~  220 (256)
T cd05082         157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---------VVPRVEKG-YK----MDA  220 (256)
T ss_pred             --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---------HHHHHhcC-CC----CCC
Confidence              12234568999999999999999999999999999997 999986332111         11111111 00    001


Q ss_pred             CCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHH
Q 015027          325 ADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL  364 (414)
Q Consensus       325 ~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i  364 (414)
                          ....+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       221 ----~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         221 ----PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             ----CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence                111235689999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-42  Score=296.32  Aligned_cols=250  Identities=23%  Similarity=0.321  Sum_probs=198.7

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeeccc---chhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRAD---KIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~  161 (414)
                      ++.|++.+.||+|.|+.||++... +|+.+|+|++....   ...+...+++++.+.|+|||||++.+.+.+....|+|+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            467888899999999999999854 68999999886432   22334466789999999999999999999999999999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeC---CCCcEEEeeccccccc
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLN---DNYTAKVADFESSVLI  238 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~---~~~~~kl~DfGla~~~  238 (414)
                      |+|.|+.|..-+...   ...++..+-..+.||+.+|.|+|.++   |+|||+||.|+|+.   ...-+||+|||+|..+
T Consensus        90 e~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l  163 (355)
T KOG0033|consen   90 DLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  163 (355)
T ss_pred             ecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence            999999986655322   44467778889999999999999988   99999999999995   3456999999999988


Q ss_pred             cCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccc
Q 015027          239 SSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQ  318 (414)
Q Consensus       239 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (414)
                      ..   ...-...+|||+|||||++...+|+..+|||+.|||||-|+.|.+||.+.+...         ....+.....  
T Consensus       164 ~~---g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r---------lye~I~~g~y--  229 (355)
T KOG0033|consen  164 ND---GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---------LYEQIKAGAY--  229 (355)
T ss_pred             CC---ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH---------HHHHHhcccc--
Confidence            73   233455789999999999999999999999999999999999999997432111         1111111111  


Q ss_pred             ccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          319 ILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       319 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                          ....+......++..+|+++||..||.+|.|+.|.+.
T Consensus       230 ----d~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  230 ----DYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             ----CCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence                1122233334467999999999999999999998764

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=8.9e-40  Score=308.19  Aligned_cols=262  Identities=26%  Similarity=0.371  Sum_probs=196.7

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-----------------CCcEEEEEEeecccc--hhHhHHHHHHHHHccCCCceeee
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-----------------DNIQVAVKTYRRADK--IRITERELLRIISQVNHKNVVKI  147 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~--~~~~~~~~~~~l~~l~hpniv~l  147 (414)
                      ++|++.+.||+|+||.||++...                 +...+|+|.+.....  .......++.+++.++||||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            56899999999999999998532                 234689999875432  22345667789999999999999


Q ss_pred             eeeEecCCcceEEEEeCCCCchhhhhhhcCCc--------ccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCce
Q 015027          148 LGLCLETEVPLLVYEFASNGTLLDHIRCESSQ--------VLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANI  219 (414)
Q Consensus       148 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~--------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NI  219 (414)
                      ++++..++..++||||+++++|.+++......        ..+++..+..++.|++.||+|||+.+   ++|+||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence            99999999999999999999999998653321        23567889999999999999999987   99999999999


Q ss_pred             eeCCCCcEEEeeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh--CCCCCCcccccc
Q 015027          220 LLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT--GKKPGSCMTLAS  297 (414)
Q Consensus       220 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t--g~~p~~~~~~~~  297 (414)
                      |++.++.++|+|||++................+++.|+|||...++.++.++|||||||++|||++  |..||.......
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ  241 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence            999999999999999876543322122222344678999999888899999999999999999998  778886332211


Q ss_pred             ccccccchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHH
Q 015027          298 NKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELD  362 (414)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~  362 (414)
                      .     ..................      .+...+..+.+|+.+||+.||.+|||+.+|.+.|+
T Consensus       242 ~-----~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         242 V-----IENTGEFFRDQGRQVYLP------KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             H-----HHHHHHHHhhccccccCC------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            0     000000000000000000      00112256899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=3e-40  Score=306.91  Aligned_cols=255  Identities=25%  Similarity=0.385  Sum_probs=196.8

Q ss_pred             cCCCCCCccccCCceEEEEEEEcC-C---cEEEEEEeecccc--hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLHD-N---IQVAVKTYRRADK--IRITERELLRIISQVNHKNVVKILGLCLETEVPLLV  160 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~--~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv  160 (414)
                      ..|++.+.||+|+||.||+|.+.. +   ..||||.+.....  ....+..++.+++.++||||+++++++..+...++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            457888999999999999999653 3   3699999875422  223446677889999999999999999999999999


Q ss_pred             EEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccC
Q 015027          161 YEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISS  240 (414)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  240 (414)
                      |||+++++|.+++.....  .+++..++.++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||++.....
T Consensus        84 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  158 (269)
T cd05065          84 TEFMENGALDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED  158 (269)
T ss_pred             EecCCCCcHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence            999999999999865433  3478899999999999999999987   99999999999999999999999999876543


Q ss_pred             Cccccceeccc---ccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhccccc
Q 015027          241 DAETAMSTILI---GTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGL  316 (414)
Q Consensus       241 ~~~~~~~~~~~---gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (414)
                      ...........   .+..|+|||.+.+..++.++|||||||++|||++ |..||.......         ........ .
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~---------~~~~i~~~-~  228 (269)
T cd05065         159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---------VINAIEQD-Y  228 (269)
T ss_pred             CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH---------HHHHHHcC-C
Confidence            22211111111   2357999999999999999999999999999886 999986432111         11111100 0


Q ss_pred             ccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHH
Q 015027          317 RQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL  364 (414)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i  364 (414)
                          .    .+.+...+..+.+++.+||+.+|.+||++.+|+..|+.+
T Consensus       229 ----~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         229 ----R----LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             ----c----CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                0    000111235589999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=4.7e-40  Score=305.34  Aligned_cols=256  Identities=27%  Similarity=0.395  Sum_probs=198.8

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-C---CcEEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEecCCcceE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-D---NIQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLETEVPLL  159 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~l  159 (414)
                      ..+|++.+.||+|+||.||+|.+. +   +..+|+|.+......  ......++.++.+++||||+++++++..++..++
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI   82 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            357888999999999999999864 2   347999998654322  2334556788999999999999999999999999


Q ss_pred             EEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccccccc
Q 015027          160 VYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLIS  239 (414)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~  239 (414)
                      ||||+++++|.+++.....  .+++..++.++.|++.||+|||+.+   ++||||||+|||++.++.++|+|||++....
T Consensus        83 v~e~~~~~~L~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd05066          83 VTEYMENGSLDAFLRKHDG--QFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  157 (267)
T ss_pred             EEEcCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence            9999999999999965443  3478889999999999999999987   9999999999999999999999999998765


Q ss_pred             CCccccc-eecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhcccccc
Q 015027          240 SDAETAM-STILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLR  317 (414)
Q Consensus       240 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (414)
                      ....... .....++..|+|||++.+..++.++|+||||+++||+++ |..||.......         ........ ..
T Consensus       158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---------~~~~~~~~-~~  227 (267)
T cd05066         158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---------VIKAIEEG-YR  227 (267)
T ss_pred             cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---------HHHHHhCC-Cc
Confidence            4321111 111223567999999998899999999999999999886 999986433111         11111110 00


Q ss_pred             cccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHH
Q 015027          318 QILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL  364 (414)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i  364 (414)
                              .+.+...+..+.+++.+||+.+|.+||++.++++.|+++
T Consensus       228 --------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         228 --------LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             --------CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence                    001111235689999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=4.4e-40  Score=308.38  Aligned_cols=264  Identities=26%  Similarity=0.342  Sum_probs=197.4

Q ss_pred             cCCCCCCccccCCceEEEEEEE-----cCCcEEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEecC--Ccc
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVL-----HDNIQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLET--EVP  157 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~~--~~~  157 (414)
                      ..|.+.+.||+|+||.||.+..     .++..||+|.+......  ......++++++.++||||+++++++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            4578899999999999999974     24788999998754322  23346677899999999999999998775  568


Q ss_pred             eEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccccc
Q 015027          158 LLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVL  237 (414)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~  237 (414)
                      ++||||+++++|.+++.....  ..++..+..++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||++..
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNKN--KINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA  158 (284)
T ss_pred             EEEEEccCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence            899999999999999865432  3588999999999999999999987   99999999999999999999999999986


Q ss_pred             ccCCccc-cceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCcccccccccc------ccchhhhhh
Q 015027          238 ISSDAET-AMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKI------SMVPYFLNS  310 (414)
Q Consensus       238 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~------~~~~~~~~~  310 (414)
                      ....... .......++..|+|||++.+..++.++|||||||++|||+++..|+...........      .........
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05079         159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV  238 (284)
T ss_pred             cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence            6433211 112234566789999999988999999999999999999998876432111000000      000000000


Q ss_pred             hcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHH
Q 015027          311 IKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL  364 (414)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i  364 (414)
                      ....         ...+.+...+..+.+|+.+||+.+|.+|||+.++++.|+.+
T Consensus       239 ~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         239 LEEG---------KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHcC---------ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            0000         00001111235699999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-40  Score=314.24  Aligned_cols=254  Identities=20%  Similarity=0.287  Sum_probs=191.0

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch----hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI----RITERELLRIISQVNHKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~  161 (414)
                      ++|++.+.||+|+||.||++... +++.||+|++......    .....++..++..++||||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            47899999999999999999965 5899999999753221    222356667888899999999999999999999999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCC
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD  241 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  241 (414)
                      ||+++|+|.+++.....  .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        81 e~~~g~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (331)
T cd05597          81 DYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD  155 (331)
T ss_pred             ecCCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence            99999999999865332  3478888999999999999999988   999999999999999999999999998765432


Q ss_pred             ccccceecccccccccchhhccc-----CCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccc
Q 015027          242 AETAMSTILIGTSGYLDPVCINT-----GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGL  316 (414)
Q Consensus       242 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (414)
                      .. .......||+.|+|||++.+     ..++.++|||||||++|+|++|+.||.......        ...........
T Consensus       156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~--------~~~~i~~~~~~  226 (331)
T cd05597         156 GT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE--------TYGKIMNHKEH  226 (331)
T ss_pred             CC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHH--------HHHHHHcCCCc
Confidence            11 12233468999999999863     457889999999999999999999996432111        00000000000


Q ss_pred             ccccccccCCcccHHHHHHHHHHHHHhhccCCCC--CCChhHHHHH
Q 015027          317 RQILNFHVADESEMKEIEIVAELASKCLRIRGTE--RPTMKQVSEE  360 (414)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~--Rps~~~v~~~  360 (414)
                      .. +...     ....+..+.+|+.+||..++.+  ||++.++++.
T Consensus       227 ~~-~~~~-----~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         227 FQ-FPPD-----VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             cc-CCCc-----cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            00 0000     0012355899999988654433  7888888654

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.3e-40  Score=307.13  Aligned_cols=251  Identities=29%  Similarity=0.442  Sum_probs=195.8

Q ss_pred             CCCCCccccCCceEEEEEEEcC-CcEEEEEEeecccchhHhH---HHHHHHHHccCCCceeeeeeeEecCCcceEEEEeC
Q 015027           89 FDRSRCLSQGGFVSVYKGVLHD-NIQVAVKTYRRADKIRITE---RELLRIISQVNHKNVVKILGLCLETEVPLLVYEFA  164 (414)
Q Consensus        89 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~---~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  164 (414)
                      |++.+.||+|+||+||++.... ++.+|+|.+..........   ..++.++..++||||+++++++......++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            5677899999999999999765 6789999998775544332   33678889999999999999999999999999999


Q ss_pred             CCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccc
Q 015027          165 SNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET  244 (414)
Q Consensus       165 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  244 (414)
                      ++++|.+++..   ...+++..++.++.|++.||.+||+.+   ++|+||||+||+++.++.++|+|||.+.....  ..
T Consensus        81 ~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~  152 (260)
T PF00069_consen   81 PGGSLQDYLQK---NKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSE--NN  152 (260)
T ss_dssp             TTEBHHHHHHH---HSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTS--TT
T ss_pred             ccccccccccc---ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc--cc
Confidence            99999999972   233478999999999999999999987   99999999999999999999999999876421  22


Q ss_pred             cceecccccccccchhhcc-cCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccc
Q 015027          245 AMSTILIGTSGYLDPVCIN-TGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFH  323 (414)
Q Consensus       245 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (414)
                      .......+++.|+|||++. +..++.++||||||+++|+|++|..||........  ...   ..... ..   ......
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~--~~~---~~~~~-~~---~~~~~~  223 (260)
T PF00069_consen  153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQ--LEI---IEKIL-KR---PLPSSS  223 (260)
T ss_dssp             SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHH--HHH---HHHHH-HT---HHHHHT
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccchhh--hhh---hhhcc-cc---cccccc
Confidence            2344567899999999998 88999999999999999999999999874411000  000   00000 00   000000


Q ss_pred             cCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          324 VADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       324 ~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                       ..  .......+.+++.+||+.||++|||+.++++
T Consensus       224 -~~--~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  224 -QQ--SREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             -TS--HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             -cc--cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             00  0000156999999999999999999999854

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=4.6e-40  Score=315.55  Aligned_cols=261  Identities=24%  Similarity=0.354  Sum_probs=200.6

Q ss_pred             hcCCCCCCccccCCceEEEEEEEcC--------CcEEEEEEeecccch--hHhHHHHHHHHHcc-CCCceeeeeeeEecC
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLHD--------NIQVAVKTYRRADKI--RITERELLRIISQV-NHKNVVKILGLCLET  154 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~--~~~~~~~~~~l~~l-~hpniv~l~~~~~~~  154 (414)
                      ..+|.+.+.||+|+||.||+|....        +..||+|.+......  ......++.++.++ +||||++++++|..+
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   90 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence            3568899999999999999997421        236899988754322  23345667888888 799999999999999


Q ss_pred             CcceEEEEeCCCCchhhhhhhcC-------------CcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceee
Q 015027          155 EVPLLVYEFASNGTLLDHIRCES-------------SQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILL  221 (414)
Q Consensus       155 ~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll  221 (414)
                      +..+++|||+++|+|.+++....             ....+++..++.++.|++.||.|||+.+   ++||||||+|||+
T Consensus        91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill  167 (334)
T cd05100          91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLV  167 (334)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEE
Confidence            99999999999999999986532             1234678889999999999999999987   9999999999999


Q ss_pred             CCCCcEEEeeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccc
Q 015027          222 NDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKK  300 (414)
Q Consensus       222 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~  300 (414)
                      +.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.......   
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---  244 (334)
T cd05100         168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE---  244 (334)
T ss_pred             cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---
Confidence            9999999999999876543222212222344567999999999999999999999999999998 888886432111   


Q ss_pred             cccchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHh
Q 015027          301 ISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRL  367 (414)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~  367 (414)
                            ...........         ..+...+..+.+|+.+||+.+|.+|||+.++++.|+.+...
T Consensus       245 ------~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~  296 (334)
T cd05100         245 ------LFKLLKEGHRM---------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV  296 (334)
T ss_pred             ------HHHHHHcCCCC---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence                  11111111000         00111124589999999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.4e-39  Score=302.46  Aligned_cols=252  Identities=25%  Similarity=0.328  Sum_probs=184.4

Q ss_pred             CccccCCceEEEEEEEcC---CcEEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCCCC
Q 015027           93 RCLSQGGFVSVYKGVLHD---NIQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNG  167 (414)
Q Consensus        93 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g  167 (414)
                      +.||+|+||.||+|...+   ...+++|.+......  ...+.+++..++.++||||+++++.+......++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            358999999999997543   356888887644322  223356678889999999999999999999999999999999


Q ss_pred             chhhhhhhcCCc--ccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcccc
Q 015027          168 TLLDHIRCESSQ--VLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETA  245 (414)
Q Consensus       168 sL~~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  245 (414)
                      +|.+++......  ...++.....++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            999999654322  22356778899999999999999987   9999999999999999999999999986543221111


Q ss_pred             ceecccccccccchhhcc-------cCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhcccccc
Q 015027          246 MSTILIGTSGYLDPVCIN-------TGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLR  317 (414)
Q Consensus       246 ~~~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (414)
                      ......+++.|+|||++.       ...++.++|||||||++|||++ |..||.......         ...........
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---------~~~~~~~~~~~  228 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ---------VLKQVVREQDI  228 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH---------HHHHHhhccCc
Confidence            122334567899999874       3457889999999999999999 788886432110         01111111111


Q ss_pred             cccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHH
Q 015027          318 QILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEEL  361 (414)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L  361 (414)
                      ....+....    ..+..+.+++..|| .||.+|||+.+|++.|
T Consensus       229 ~~~~~~~~~----~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l  267 (269)
T cd05042         229 KLPKPQLDL----KYSDRWYEVMQFCW-LDPETRPTAEEVHELL  267 (269)
T ss_pred             cCCCCcccc----cCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence            111111111    12245788999998 5999999999998876

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=8.3e-40  Score=304.23  Aligned_cols=249  Identities=27%  Similarity=0.407  Sum_probs=190.2

Q ss_pred             CccccCCceEEEEEEEcC-Cc--EEEEEEeeccc--chhHhHHHHHHHHHcc-CCCceeeeeeeEecCCcceEEEEeCCC
Q 015027           93 RCLSQGGFVSVYKGVLHD-NI--QVAVKTYRRAD--KIRITERELLRIISQV-NHKNVVKILGLCLETEVPLLVYEFASN  166 (414)
Q Consensus        93 ~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~--~~~~~~~~~~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~  166 (414)
                      +.||+|+||.||+|.+.+ +.  .+++|.+....  ........+++++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            358999999999999754 43  46888887432  2223445667888888 799999999999999999999999999


Q ss_pred             CchhhhhhhcC-------------CcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecc
Q 015027          167 GTLLDHIRCES-------------SQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFE  233 (414)
Q Consensus       167 gsL~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG  233 (414)
                      |+|.+++....             ....+++..++.++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence            99999986432             1223578899999999999999999977   9999999999999999999999999


Q ss_pred             ccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhc
Q 015027          234 SSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIK  312 (414)
Q Consensus       234 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  312 (414)
                      ++......   ........+..|+|||++.+..++.++|||||||++|||++ |..||.......         ......
T Consensus       158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---------~~~~~~  225 (270)
T cd05047         158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---------LYEKLP  225 (270)
T ss_pred             Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH---------HHHHHh
Confidence            98532211   11111234567999999998899999999999999999997 999986432111         111111


Q ss_pred             ccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHH
Q 015027          313 NNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLR  365 (414)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~  365 (414)
                      ....         ...+...+..+.+|+.+||+.+|.+|||+.+++..|+.+.
T Consensus       226 ~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         226 QGYR---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             CCCC---------CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            1000         0001112245899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.1e-40  Score=324.26  Aligned_cols=194  Identities=22%  Similarity=0.259  Sum_probs=164.9

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeC
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFA  164 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  164 (414)
                      ...|.+.+.||+|+||.||+|.+. .++.||||.....     ....+++++++++|||||++++++..++..++|||++
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~~-----~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~  242 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYA-----SSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY  242 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccccc-----CHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence            447999999999999999999976 4788999964322     2345678999999999999999999999999999999


Q ss_pred             CCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccc
Q 015027          165 SNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET  244 (414)
Q Consensus       165 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  244 (414)
                      . ++|.+++.....  .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++........
T Consensus       243 ~-~~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~  316 (461)
T PHA03211        243 R-SDLYTYLGARLR--PLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST  316 (461)
T ss_pred             C-CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence            5 688888754322  4689999999999999999999987   999999999999999999999999999876443222


Q ss_pred             cceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCC
Q 015027          245 AMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPG  290 (414)
Q Consensus       245 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~  290 (414)
                      .......||+.|+|||++.+..++.++|||||||+||||++|..|+
T Consensus       317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l  362 (461)
T PHA03211        317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL  362 (461)
T ss_pred             ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence            2233457999999999999999999999999999999999988664

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-39  Score=300.06  Aligned_cols=247  Identities=28%  Similarity=0.421  Sum_probs=193.8

Q ss_pred             CccccCCceEEEEEEEcCCcEEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCCCCchh
Q 015027           93 RCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLL  170 (414)
Q Consensus        93 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~  170 (414)
                      +.||+|+||.||++.+.+++.||+|.+......  ......+++++++++||||+++++++......++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            468999999999999877999999998765432  334466778999999999999999999999999999999999999


Q ss_pred             hhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccccceecc
Q 015027          171 DHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTIL  250 (414)
Q Consensus       171 ~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~  250 (414)
                      +++.....  ..++..++.++.+++.||.|||+++   ++||||+|+||+++.++.+||+|||++...............
T Consensus        81 ~~l~~~~~--~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (251)
T cd05041          81 TFLRKKKN--RLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK  155 (251)
T ss_pred             HHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence            99865432  3478888999999999999999987   999999999999999999999999998765422111111222


Q ss_pred             cccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhcccccccccccccCCccc
Q 015027          251 IGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESE  329 (414)
Q Consensus       251 ~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (414)
                      ..+..|+|||.+.+..++.++||||||+++|+|++ |..||.......         ........ .        ....+
T Consensus       156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~---------~~~~~~~~-~--------~~~~~  217 (251)
T cd05041         156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ---------TRERIESG-Y--------RMPAP  217 (251)
T ss_pred             cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH---------HHHHHhcC-C--------CCCCC
Confidence            34567999999998899999999999999999999 888886433111         00001000 0        00011


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCChhHHHHHHH
Q 015027          330 MKEIEIVAELASKCLRIRGTERPTMKQVSEELD  362 (414)
Q Consensus       330 ~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~  362 (414)
                      ...+..+.+++.+||..+|.+|||+.++++.|+
T Consensus       218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            122356999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=6.7e-40  Score=309.08  Aligned_cols=248  Identities=22%  Similarity=0.330  Sum_probs=196.6

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch-hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeC
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI-RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFA  164 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  164 (414)
                      .+|.+.+.||+|+||.||+|... +++.||+|.+...... .....+++.+++.++||||+++++.+..+...++||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            57888999999999999999964 5889999998764432 233456678899999999999999999999999999999


Q ss_pred             CCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccc
Q 015027          165 SNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET  244 (414)
Q Consensus       165 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  244 (414)
                      ++++|.+++...    .+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++.......  
T Consensus       100 ~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~--  170 (296)
T cd06654         100 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--  170 (296)
T ss_pred             CCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc--
Confidence            999999988532    3478889999999999999999987   9999999999999999999999999987654321  


Q ss_pred             cceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccccccc
Q 015027          245 AMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHV  324 (414)
Q Consensus       245 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (414)
                      .......+++.|+|||.+.+..++.++|||||||++|+|++|+.||........        ...... ....     . 
T Consensus       171 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~--------~~~~~~-~~~~-----~-  235 (296)
T cd06654         171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--------LYLIAT-NGTP-----E-  235 (296)
T ss_pred             cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh--------HHHHhc-CCCC-----C-
Confidence            112334688999999999988899999999999999999999999964321110        000000 0000     0 


Q ss_pred             CCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          325 ADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       325 ~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                       ...+...+..+.+|+.+||..+|.+|||+.++++
T Consensus       236 -~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         236 -LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             -CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence             0011122355899999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=7.8e-40  Score=312.44  Aligned_cols=241  Identities=20%  Similarity=0.246  Sum_probs=187.3

Q ss_pred             CCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch----hHhHHHHHHHHHccC-CCceeeeeeeEecCCcceEEE
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI----RITERELLRIISQVN-HKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~-hpniv~l~~~~~~~~~~~lv~  161 (414)
                      +|+..+.||+|+||.||+|... +++.||+|++......    ......+..++..+. |++|+++++++...+..|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4778899999999999999965 5889999999764321    122334456666665 578888999999999999999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCC
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD  241 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  241 (414)
                      ||+++|+|.+++....   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        81 Ey~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~  154 (323)
T cd05615          81 EYVNGGDLMYHIQQVG---KFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD  154 (323)
T ss_pred             cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence            9999999999886443   3578899999999999999999987   999999999999999999999999998754322


Q ss_pred             ccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccc
Q 015027          242 AETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILN  321 (414)
Q Consensus       242 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (414)
                      .  .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......         ....+.....     
T Consensus       155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---------~~~~i~~~~~-----  218 (323)
T cd05615         155 G--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE---------LFQSIMEHNV-----  218 (323)
T ss_pred             C--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH---------HHHHHHhCCC-----
Confidence            1  12234568999999999999999999999999999999999999997433111         0111111000     


Q ss_pred             cccCCcccHHHHHHHHHHHHHhhccCCCCCCChh
Q 015027          322 FHVADESEMKEIEIVAELASKCLRIRGTERPTMK  355 (414)
Q Consensus       322 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~  355 (414)
                       ..+    ...+..+.+|+.+||+.+|.+|++..
T Consensus       219 -~~p----~~~~~~~~~li~~~l~~~p~~R~~~~  247 (323)
T cd05615         219 -SYP----KSLSKEAVSICKGLMTKHPSKRLGCG  247 (323)
T ss_pred             -CCC----ccCCHHHHHHHHHHcccCHhhCCCCC
Confidence             001    11224589999999999999999853

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=4.8e-40  Score=308.40  Aligned_cols=250  Identities=22%  Similarity=0.263  Sum_probs=193.8

Q ss_pred             CCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchh----HhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEE
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIR----ITERELLRIISQVNHKNVVKILGLCLETEVPLLVYE  162 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  162 (414)
                      .|+..+.||+|+||.||++... +++.||+|.+.......    .....++.++++++|+||+++++.+.+++..++|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            3677889999999999999976 58899999987543211    223456789999999999999999999999999999


Q ss_pred             eCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCc
Q 015027          163 FASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDA  242 (414)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  242 (414)
                      |+++++|.+++..... ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~g~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05630          81 LMNGGDLKFHIYHMGE-AGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  156 (285)
T ss_pred             ecCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence            9999999998855432 23578889999999999999999977   9999999999999999999999999987654221


Q ss_pred             cccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccccc
Q 015027          243 ETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNF  322 (414)
Q Consensus       243 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (414)
                         ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.........  ..........     .    .
T Consensus       157 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~--~~~~~~~~~~-----~----~  222 (285)
T cd05630         157 ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR--EEVERLVKEV-----Q----E  222 (285)
T ss_pred             ---cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH--HHHHhhhhhh-----h----h
Confidence               122347899999999999999999999999999999999999999743211000  0000000000     0    0


Q ss_pred             ccCCcccHHHHHHHHHHHHHhhccCCCCCCC-----hhHHHH
Q 015027          323 HVADESEMKEIEIVAELASKCLRIRGTERPT-----MKQVSE  359 (414)
Q Consensus       323 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps-----~~~v~~  359 (414)
                      ..    ....+..+.+|+.+||+.||.+|||     ++++++
T Consensus       223 ~~----~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         223 EY----SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             hc----CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence            00    1112245899999999999999999     677754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=7.2e-40  Score=307.03  Aligned_cols=260  Identities=23%  Similarity=0.289  Sum_probs=196.8

Q ss_pred             HHHHHHhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhHhHHHHHHHHHcc-CCCceeeeeeeEe-----
Q 015027           80 SEMIRATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRITERELLRIISQV-NHKNVVKILGLCL-----  152 (414)
Q Consensus        80 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~l~~l-~hpniv~l~~~~~-----  152 (414)
                      +.+..+.++|++.+.||+|+||.||+|... +++.+|+|++............++.++..+ +||||+++++++.     
T Consensus        11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   90 (286)
T cd06638          11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK   90 (286)
T ss_pred             ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence            344556789999999999999999999975 588999998876444334445566778888 6999999999884     


Q ss_pred             cCCcceEEEEeCCCCchhhhhhhc-CCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEee
Q 015027          153 ETEVPLLVYEFASNGTLLDHIRCE-SSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVAD  231 (414)
Q Consensus       153 ~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~D  231 (414)
                      .++..++||||+++++|.+++... .....+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|
T Consensus        91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~d  167 (286)
T cd06638          91 NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVD  167 (286)
T ss_pred             CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEcc
Confidence            345689999999999999887532 22234578888999999999999999977   99999999999999999999999


Q ss_pred             ccccccccCCccccceecccccccccchhhcc-----cCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchh
Q 015027          232 FESSVLISSDAETAMSTILIGTSGYLDPVCIN-----TGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPY  306 (414)
Q Consensus       232 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~  306 (414)
                      ||++.......  .......|++.|+|||++.     +..++.++|||||||++|||++|+.||.......         
T Consensus       168 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~---------  236 (286)
T cd06638         168 FGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR---------  236 (286)
T ss_pred             CCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH---------
Confidence            99987654321  1223346899999999875     3457889999999999999999999986432111         


Q ss_pred             hhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHH
Q 015027          307 FLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEE  360 (414)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~  360 (414)
                      ...............+.       .....+.+|+.+||+.+|.+|||+.++++.
T Consensus       237 ~~~~~~~~~~~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         237 ALFKIPRNPPPTLHQPE-------LWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             HHhhccccCCCcccCCC-------CcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            00000000000000000       112458999999999999999999999764

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=3.5e-40  Score=319.49  Aligned_cols=197  Identities=24%  Similarity=0.275  Sum_probs=164.0

Q ss_pred             HhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeeccc---chhHhHHHHHHHHHccCCCceeeeeeeEecCC-----
Q 015027           85 ATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRAD---KIRITERELLRIISQVNHKNVVKILGLCLETE-----  155 (414)
Q Consensus        85 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~-----  155 (414)
                      ..++|.+.+.||+|+||.||++.+. +|..||+|.+....   .......+++.+++.++||||+++++++....     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            4578999999999999999999975 58999999986532   12233456678999999999999999986543     


Q ss_pred             -cceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccc
Q 015027          156 -VPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFES  234 (414)
Q Consensus       156 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGl  234 (414)
                       ..|+||||+++ +|...+..     .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~  169 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  169 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence             46999999976 55555522     2467888899999999999999988   99999999999999999999999999


Q ss_pred             cccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCcc
Q 015027          235 SVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCM  293 (414)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~  293 (414)
                      +......   .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus       170 a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~  225 (359)
T cd07876         170 ARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT  225 (359)
T ss_pred             ccccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence            8764322   1223457899999999999999999999999999999999999999754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=7e-40  Score=301.93  Aligned_cols=249  Identities=21%  Similarity=0.303  Sum_probs=196.6

Q ss_pred             CCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc--hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeC
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK--IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFA  164 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  164 (414)
                      +|++.+.||.|+||.||++... ++..+|+|.+.....  .......+..+++.++||||+++++.+..++..|+||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4788899999999999999976 588999999864332  2233455668899999999999999999999999999999


Q ss_pred             CCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccc
Q 015027          165 SNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET  244 (414)
Q Consensus       165 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  244 (414)
                      ++++|.+++..... ..+++..++.++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||++.......  
T Consensus        81 ~~~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~--  154 (255)
T cd08219          81 DGGDLMQKIKLQRG-KLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG--  154 (255)
T ss_pred             CCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccc--
Confidence            99999998854332 23478888999999999999999987   9999999999999999999999999987654321  


Q ss_pred             cceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccccccc
Q 015027          245 AMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHV  324 (414)
Q Consensus       245 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (414)
                      .......+++.|+|||++.+..++.++|+||||+++|+|++|..||.......         ............ +    
T Consensus       155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~---------~~~~~~~~~~~~-~----  220 (255)
T cd08219         155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN---------LILKVCQGSYKP-L----  220 (255)
T ss_pred             cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH---------HHHHHhcCCCCC-C----
Confidence            12233568889999999999999999999999999999999999996432110         011111111110 0    


Q ss_pred             CCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHH
Q 015027          325 ADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEE  360 (414)
Q Consensus       325 ~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~  360 (414)
                          +...+..+.+|+.+||+.||.+|||+.+++..
T Consensus       221 ----~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         221 ----PSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             ----CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence                11122458999999999999999999999753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.3e-39  Score=299.87  Aligned_cols=249  Identities=27%  Similarity=0.340  Sum_probs=200.1

Q ss_pred             cCCCCCCccccCCceEEEEEEEcC-CcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCC
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLHD-NIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFAS  165 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  165 (414)
                      ++|.+.+.||.|+||.||+|.... +..+++|.+..... .....++++++++++||||+++++++..+...|+++||++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   81 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG   81 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence            678999999999999999999765 88999999876544 4455677789999999999999999999999999999999


Q ss_pred             CCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcccc
Q 015027          166 NGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETA  245 (414)
Q Consensus       166 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  245 (414)
                      +++|.+++....  ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........  
T Consensus        82 ~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--  154 (256)
T cd06612          82 AGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--  154 (256)
T ss_pred             CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc--
Confidence            999999986433  34588999999999999999999987   99999999999999999999999999887654321  


Q ss_pred             ceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccccC
Q 015027          246 MSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVA  325 (414)
Q Consensus       246 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (414)
                      ......++..|+|||++.+..++.++||||||+++|+|++|+.||..........         ......     ...  
T Consensus       155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~---------~~~~~~-----~~~--  218 (256)
T cd06612         155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF---------MIPNKP-----PPT--  218 (256)
T ss_pred             ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh---------hhccCC-----CCC--
Confidence            2233457889999999999999999999999999999999999986432211000         000000     000  


Q ss_pred             CcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          326 DESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       326 ~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ...+......+.+++.+||+.+|.+|||+.++++
T Consensus       219 ~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         219 LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            0011122356899999999999999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=5.9e-40  Score=307.93  Aligned_cols=263  Identities=20%  Similarity=0.241  Sum_probs=187.6

Q ss_pred             CCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch---hHh---HHHHHHHHHccCCCceeeeeeeEec-----CC
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI---RIT---ERELLRIISQVNHKNVVKILGLCLE-----TE  155 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~---~~~~~~~l~~l~hpniv~l~~~~~~-----~~  155 (414)
                      +|++.+.||+|+||.||+|... +++.||+|.+......   ...   +.+.++.+..++||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            5888999999999999999976 5889999998753211   112   2333444555689999999998864     24


Q ss_pred             cceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccc
Q 015027          156 VPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESS  235 (414)
Q Consensus       156 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla  235 (414)
                      ..++||||+++ +|.+++..... ..+++..+..++.||+.||.|||+.+   ++||||||+|||++.++.+||+|||++
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~  155 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPP-PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA  155 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence            57899999975 88888754332 23588999999999999999999988   999999999999999999999999999


Q ss_pred             ccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhh----hhhh
Q 015027          236 VLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYF----LNSI  311 (414)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~----~~~~  311 (414)
                      .......   ......+|+.|+|||++.+..++.++|||||||++|+|++|.+||.......... .+....    ...+
T Consensus       156 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~-~~~~~~~~~~~~~~  231 (288)
T cd07863         156 RIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLG-KIFDLIGLPPEDDW  231 (288)
T ss_pred             ccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHH-HHHHHhCCCChhhC
Confidence            8664321   1233568899999999999999999999999999999999999986432211000 000000    0000


Q ss_pred             ccc-c-cccccccccC---CcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          312 KNN-G-LRQILNFHVA---DESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       312 ~~~-~-~~~~~~~~~~---~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ... . ....+.+...   ..........+.+|+.+||+.||.+|||+.+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            000 0 0000000000   0000112355899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.3e-39  Score=311.96  Aligned_cols=253  Identities=21%  Similarity=0.291  Sum_probs=191.5

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc----hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK----IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~  161 (414)
                      ++|.+.+.||+|+||.||++... +++.||+|++.....    ......++..++..++|+||+++++++.+.+..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47899999999999999999976 588899999875321    1222355667888899999999999999999999999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCC
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD  241 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  241 (414)
                      ||+++|+|.+++.....  .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        81 Ey~~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          81 DYYVGGDLLTLLSKFED--RLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             eCCCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence            99999999999965332  3477888899999999999999987   999999999999999999999999999765433


Q ss_pred             ccccceecccccccccchhhccc-----CCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccc
Q 015027          242 AETAMSTILIGTSGYLDPVCINT-----GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGL  316 (414)
Q Consensus       242 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (414)
                      . ........||+.|+|||++.+     +.++.++|||||||++|+|++|+.||.......         ..........
T Consensus       156 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~---------~~~~i~~~~~  225 (331)
T cd05624         156 G-TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE---------TYGKIMNHEE  225 (331)
T ss_pred             C-ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH---------HHHHHHcCCC
Confidence            1 112234579999999999875     568899999999999999999999996432111         0000000000


Q ss_pred             ccccccccCCcccHHHHHHHHHHHHHhhccCCCC--CCChhHHHH
Q 015027          317 RQILNFHVADESEMKEIEIVAELASKCLRIRGTE--RPTMKQVSE  359 (414)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~--Rps~~~v~~  359 (414)
                      ...++...     ...+..+.+|+.+||...+.+  |++++++++
T Consensus       226 ~~~~p~~~-----~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~  265 (331)
T cd05624         226 RFQFPSHI-----TDVSEEAKDLIQRLICSRERRLGQNGIEDFKK  265 (331)
T ss_pred             cccCCCcc-----ccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence            00011110     112356899999999876544  457777754

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=8.7e-40  Score=311.24  Aligned_cols=197  Identities=23%  Similarity=0.334  Sum_probs=158.2

Q ss_pred             CCccccCCceEEEEEEEc---CCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEec--CCcceEEEEeCCC
Q 015027           92 SRCLSQGGFVSVYKGVLH---DNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLE--TEVPLLVYEFASN  166 (414)
Q Consensus        92 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~--~~~~~lv~e~~~~  166 (414)
                      .++||+|+||.||+|...   +++.||+|.+..... .....++++++++++||||+++++++..  +...++||||+++
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~   84 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH   84 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence            467999999999999964   467899999865432 2334556789999999999999999854  4567899999965


Q ss_pred             CchhhhhhhcC------CcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceee----CCCCcEEEeeccccc
Q 015027          167 GTLLDHIRCES------SQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILL----NDNYTAKVADFESSV  236 (414)
Q Consensus       167 gsL~~~l~~~~------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll----~~~~~~kl~DfGla~  236 (414)
                       +|.+++....      ....+++..+..++.||+.||.|||+.+   |+||||||+|||+    +.++.+||+|||++.
T Consensus        85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07868          85 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             -CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence             7777764321      1234678889999999999999999988   9999999999999    456899999999998


Q ss_pred             cccCCccc-cceecccccccccchhhccc-CCCCCcccchhHHHHHHHHHhCCCCCCcc
Q 015027          237 LISSDAET-AMSTILIGTSGYLDPVCINT-GKLTKKSDVYSFGVVLAELLTGKKPGSCM  293 (414)
Q Consensus       237 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~  293 (414)
                      ........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|++||...
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            76543211 12234578999999999876 46899999999999999999999999643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-41  Score=332.26  Aligned_cols=261  Identities=27%  Similarity=0.399  Sum_probs=218.0

Q ss_pred             cCCCCCCccccCCceEEEEEEEcC----CcEEEEEEeeccc--chhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLHD----NIQVAVKTYRRAD--KIRITERELLRIISQVNHKNVVKILGLCLETEVPLLV  160 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv  160 (414)
                      ....+.+.||.|.||.|++|+++-    ...||||.++...  +.+.++..+..+|.+++||||++|.|+........||
T Consensus       629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi  708 (996)
T KOG0196|consen  629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII  708 (996)
T ss_pred             hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence            344678899999999999999763    4569999998653  4455667788999999999999999999999999999


Q ss_pred             EEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccC
Q 015027          161 YEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISS  240 (414)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  240 (414)
                      .|||++|+|+.+|+.+..+.  ++.+...++++|+.|+.||-+.+   ++||||.+.|||++.+..+|++|||+++.+..
T Consensus       709 TEyMENGsLDsFLR~~DGqf--tviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvled  783 (996)
T KOG0196|consen  709 TEYMENGSLDSFLRQNDGQF--TVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED  783 (996)
T ss_pred             hhhhhCCcHHHHHhhcCCce--EeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeeccc
Confidence            99999999999999887664  78889999999999999999988   99999999999999999999999999998876


Q ss_pred             Cccccceecccc--cccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhcccccc
Q 015027          241 DAETAMSTILIG--TSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLR  317 (414)
Q Consensus       241 ~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (414)
                      +.... .+..-|  ..+|.|||.+...++|.+|||||||+++||.++ |..||=.++..                  ...
T Consensus       784 d~~~~-ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ------------------dVI  844 (996)
T KOG0196|consen  784 DPEAA-YTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ------------------DVI  844 (996)
T ss_pred             CCCcc-ccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH------------------HHH
Confidence            54222 222222  357999999999999999999999999999887 99997544422                  222


Q ss_pred             cccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHhhhhh
Q 015027          318 QILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLHENF  371 (414)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~~~~~  371 (414)
                      ..+.....-+.+++.+..|.+|+..||++|-.+||++.+|+..|+++.+.....
T Consensus       845 kaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SL  898 (996)
T KOG0196|consen  845 KAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSL  898 (996)
T ss_pred             HHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhh
Confidence            233334445556666788999999999999999999999999999998765543

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=4.4e-40  Score=312.25  Aligned_cols=265  Identities=17%  Similarity=0.225  Sum_probs=193.7

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc--hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEe
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK--IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  163 (414)
                      ++|.+.+.||+|+||.||+|... ++..||+|.+.....  ......+++.++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            57899999999999999999976 588899999875432  223345677899999999999999999999999999999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcc
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE  243 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  243 (414)
                      +++ +|.+++.....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++........
T Consensus        86 ~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  159 (309)
T cd07872          86 LDK-DLKQYMDDCGN--IMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK  159 (309)
T ss_pred             CCC-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence            975 78777754432  3477888899999999999999987   99999999999999999999999999876543211


Q ss_pred             ccceecccccccccchhhccc-CCCCCcccchhHHHHHHHHHhCCCCCCccccccccccc------cchhhhhhhccc-c
Q 015027          244 TAMSTILIGTSGYLDPVCINT-GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKIS------MVPYFLNSIKNN-G  315 (414)
Q Consensus       244 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~------~~~~~~~~~~~~-~  315 (414)
                        ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+........      ..+..+..+... .
T Consensus       160 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07872         160 --TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE  237 (309)
T ss_pred             --ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence              1233467899999998865 56899999999999999999999999754321110000      000000000000 0


Q ss_pred             cccccccccCC----cccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          316 LRQILNFHVAD----ESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       316 ~~~~~~~~~~~----~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ......+....    ......+..+.+|+.+||+.||.+|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            00000000000    000012356889999999999999999999854

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=5.7e-40  Score=304.85  Aligned_cols=249  Identities=29%  Similarity=0.448  Sum_probs=192.5

Q ss_pred             CccccCCceEEEEEEEcC-------CcEEEEEEeeccc--chhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEe
Q 015027           93 RCLSQGGFVSVYKGVLHD-------NIQVAVKTYRRAD--KIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        93 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~--~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  163 (414)
                      +.||+|+||.||+|...+       +..+|+|.+....  .....+.+++.+++.++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            358999999999998643       2579999886543  2233445677899999999999999999999999999999


Q ss_pred             CCCCchhhhhhhcC----CcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCC-----cEEEeeccc
Q 015027          164 ASNGTLLDHIRCES----SQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNY-----TAKVADFES  234 (414)
Q Consensus       164 ~~~gsL~~~l~~~~----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~-----~~kl~DfGl  234 (414)
                      +++++|.+++....    ....+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++     .++|+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence            99999999996432    1233578889999999999999999977   99999999999999877     899999999


Q ss_pred             cccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhcc
Q 015027          235 SVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKN  313 (414)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  313 (414)
                      +................++..|+|||++.+..++.++|||||||++|||++ |..||.......         .......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~---------~~~~~~~  228 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE---------VLQHVTA  228 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH---------HHHHHhc
Confidence            876543322222223355678999999999999999999999999999998 999986332110         0111111


Q ss_pred             cccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHH
Q 015027          314 NGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELD  362 (414)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~  362 (414)
                      ..         ....+...+..+.+|+.+||..+|.+||++.+|++.|+
T Consensus       229 ~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         229 GG---------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             CC---------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            00         00111123456899999999999999999999998875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=9.3e-40  Score=301.34  Aligned_cols=248  Identities=26%  Similarity=0.381  Sum_probs=193.6

Q ss_pred             CccccCCceEEEEEEEcC--C--cEEEEEEeecccc--hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCCC
Q 015027           93 RCLSQGGFVSVYKGVLHD--N--IQVAVKTYRRADK--IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASN  166 (414)
Q Consensus        93 ~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~--~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  166 (414)
                      +.||+|++|.||+|.+.+  +  ..||||.+.....  ....+..+++.+++++||||+++++.+.. ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999999643  3  3699999977654  23344667789999999999999999988 889999999999


Q ss_pred             CchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccc-c
Q 015027          167 GTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET-A  245 (414)
Q Consensus       167 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~-~  245 (414)
                      ++|.+++..... ..+++..++.++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||++......... .
T Consensus        80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence            999999976543 34588999999999999999999987   999999999999999999999999999876542211 1


Q ss_pred             ceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhccccccccccccc
Q 015027          246 MSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHV  324 (414)
Q Consensus       246 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (414)
                      ......++..|+|||++.+..++.++|||||||++|+|++ |..||.......         ..........      ..
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---------~~~~~~~~~~------~~  220 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ---------ILKKIDKEGE------RL  220 (257)
T ss_pred             cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---------HHHHHHhcCC------cC
Confidence            1223456778999999999999999999999999999998 999986332111         0000000000      00


Q ss_pred             CCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHH
Q 015027          325 ADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELD  362 (414)
Q Consensus       325 ~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~  362 (414)
                        ..+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus       221 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         221 --ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             --CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence              001112356899999999999999999999988774

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.1e-40  Score=305.37  Aligned_cols=259  Identities=25%  Similarity=0.366  Sum_probs=200.5

Q ss_pred             cCCCCCCccccCCceEEEEEEEcC-Cc----EEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEecCCcceE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLHD-NI----QVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLETEVPLL  159 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~----~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~l  159 (414)
                      .+|++.+.||+|+||.||+|.+.. +.    .+|+|.+......  .....+++.++.+++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            568889999999999999999643 33    5899988765432  2334566789999999999999999987 78899


Q ss_pred             EEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccccccc
Q 015027          160 VYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLIS  239 (414)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~  239 (414)
                      ||||+++|+|.+++......  +++..++.++.||+.||+|||+.+   ++|+||||+||++++++.+||+|||++....
T Consensus        86 v~e~~~~g~L~~~l~~~~~~--~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHKDN--IGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             EEecCCCCcHHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence            99999999999998654332  588999999999999999999977   9999999999999999999999999998765


Q ss_pred             CCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhccccccc
Q 015027          240 SDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQ  318 (414)
Q Consensus       240 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (414)
                      ............++..|+|||.+....++.++||||||+++||+++ |..||.......         +.........  
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---------~~~~~~~~~~--  229 (279)
T cd05057         161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE---------IPDLLEKGER--  229 (279)
T ss_pred             CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH---------HHHHHhCCCC--
Confidence            3322111112223567999999988899999999999999999998 999986432111         1111111100  


Q ss_pred             ccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHhhh
Q 015027          319 ILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLHE  369 (414)
Q Consensus       319 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~~~  369 (414)
                      .   ..+.    .....+.+++.+||..+|..||++.++++.|+.+.+.+.
T Consensus       230 ~---~~~~----~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~  273 (279)
T cd05057         230 L---PQPP----ICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDPQ  273 (279)
T ss_pred             C---CCCC----CCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCCc
Confidence            0   0001    111458899999999999999999999999998865433

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.4e-39  Score=311.94  Aligned_cols=254  Identities=22%  Similarity=0.290  Sum_probs=192.0

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch----hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI----RITERELLRIISQVNHKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~  161 (414)
                      ++|.+.+.||+|+||.||++... +++.+|+|++......    .....++..++..++||||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            46889999999999999999976 4788999998653221    122355667888899999999999999999999999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCC
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD  241 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  241 (414)
                      ||+++|+|.+++.....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        81 ey~~~g~L~~~l~~~~~--~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~  155 (332)
T cd05623          81 DYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  155 (332)
T ss_pred             eccCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence            99999999999965332  3477888899999999999999988   999999999999999999999999998765332


Q ss_pred             ccccceecccccccccchhhcc-----cCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccc
Q 015027          242 AETAMSTILIGTSGYLDPVCIN-----TGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGL  316 (414)
Q Consensus       242 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (414)
                      . ........||+.|+|||++.     ...++.++|||||||++|||++|+.||...+...         ....+.....
T Consensus       156 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~---------~~~~i~~~~~  225 (332)
T cd05623         156 G-TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE---------TYGKIMNHKE  225 (332)
T ss_pred             C-cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH---------HHHHHhCCCc
Confidence            1 12223457999999999986     3468899999999999999999999997433111         0001100000


Q ss_pred             ccccccccCCcccHHHHHHHHHHHHHhhccCCCC--CCChhHHHHH
Q 015027          317 RQILNFHVADESEMKEIEIVAELASKCLRIRGTE--RPTMKQVSEE  360 (414)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~--Rps~~~v~~~  360 (414)
                      ...+..     .....+..+.+|+.+||..++.+  |+++.++++.
T Consensus       226 ~~~~p~-----~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         226 RFQFPA-----QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             cccCCC-----ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            000000     00112356899999998665544  6888888654

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=3.6e-40  Score=319.75  Aligned_cols=196  Identities=29%  Similarity=0.364  Sum_probs=172.3

Q ss_pred             CCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhHhHHHHHHHHHccC-C-----CceeeeeeeEecCCcceEE
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRITERELLRIISQVN-H-----KNVVKILGLCLETEVPLLV  160 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~-h-----pniv~l~~~~~~~~~~~lv  160 (414)
                      +|.+.+.||+|+||.|-+|.+. +++.||||+++.......+...|+++|..++ |     -|+|+++++|...++.|||
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV  266 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV  266 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence            6788999999999999999965 5999999999988877777777788888886 3     4899999999999999999


Q ss_pred             EEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCC--CCcEEEeeccccccc
Q 015027          161 YEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLND--NYTAKVADFESSVLI  238 (414)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~--~~~~kl~DfGla~~~  238 (414)
                      +|.+. .+|+++++.+.-.. ++...++.|+.||+.||.+||+.+   |||+||||+||||.+  ...+||+|||.|.+.
T Consensus       267 fELL~-~NLYellK~n~f~G-lsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~  341 (586)
T KOG0667|consen  267 FELLS-TNLYELLKNNKFRG-LSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCFE  341 (586)
T ss_pred             ehhhh-hhHHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccccccc
Confidence            99995 59999998766544 588999999999999999999988   999999999999964  458999999999886


Q ss_pred             cCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCcc
Q 015027          239 SSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCM  293 (414)
Q Consensus       239 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~  293 (414)
                      ....     -..+.+..|+|||++.|.+|+.+.||||||||++||++|.+-|.+.
T Consensus       342 ~q~v-----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~  391 (586)
T KOG0667|consen  342 SQRV-----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD  391 (586)
T ss_pred             CCcc-----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence            5332     2567788999999999999999999999999999999998877653

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.6e-39  Score=304.46  Aligned_cols=266  Identities=17%  Similarity=0.180  Sum_probs=193.5

Q ss_pred             CCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch---hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEe
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI---RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  163 (414)
                      +|.+.+.||+|++|.||+|... ++..||+|.+......   ......++.+++.++||||+++++++.++...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4788899999999999999975 5899999998654221   23345667899999999999999999999999999999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcc
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE  243 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  243 (414)
                      ++ ++|.+++........+++..+..++.||+.||.|||+.+   ++|+||||+||+++.++.+||+|||++....... 
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  155 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-  155 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence            97 588888765444445688999999999999999999987   9999999999999999999999999987654321 


Q ss_pred             ccceecccccccccchhhccc-CCCCCcccchhHHHHHHHHHhCCCCCCcccccccccc------ccchhhhhhhc-ccc
Q 015027          244 TAMSTILIGTSGYLDPVCINT-GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKI------SMVPYFLNSIK-NNG  315 (414)
Q Consensus       244 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~------~~~~~~~~~~~-~~~  315 (414)
                       .......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||...........      ......+.... ...
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
T cd07861         156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD  234 (285)
T ss_pred             -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence             11223467889999998865 4578999999999999999999999974321100000      00000000000 000


Q ss_pred             cccccccccC---CcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          316 LRQILNFHVA---DESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       316 ~~~~~~~~~~---~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ..........   .......+.++.+|+.+||+.||.+|||+.+|+.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            0000000000   0000012356889999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.3e-40  Score=320.73  Aligned_cols=262  Identities=19%  Similarity=0.228  Sum_probs=195.1

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc---CCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH---DNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYE  162 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  162 (414)
                      ..+|.+.+.||+|+||.||++...   .+..||+|.+....    ....+++++++++||||+++++++......++|||
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~----~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e  166 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK----TPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP  166 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc----cHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence            457999999999999999999853   35789999886542    22356689999999999999999999999999999


Q ss_pred             eCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCc
Q 015027          163 FASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDA  242 (414)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  242 (414)
                      ++. ++|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.......
T Consensus       167 ~~~-~~l~~~l~~---~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~  239 (392)
T PHA03207        167 KYK-CDLFTYVDR---SGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP  239 (392)
T ss_pred             hcC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence            996 578888732   234588999999999999999999987   9999999999999999999999999997665433


Q ss_pred             cccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhh-------cccc
Q 015027          243 ETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSI-------KNNG  315 (414)
Q Consensus       243 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-------~~~~  315 (414)
                      .........||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..+ .......       ....
T Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~-~~l-~~i~~~~~~~~~~~~~~~  317 (392)
T PHA03207        240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSS-SQL-RSIIRCMQVHPLEFPQNG  317 (392)
T ss_pred             ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcH-HHH-HHHHHHhccCccccCCcc
Confidence            333333467999999999999999999999999999999999999998654321100 000 0000000       0000


Q ss_pred             ----------cccccccccCCcc---cHHHHHHHHHHHHHhhccCCCCCCChhHHHHH
Q 015027          316 ----------LRQILNFHVADES---EMKEIEIVAELASKCLRIRGTERPTMKQVSEE  360 (414)
Q Consensus       316 ----------~~~~~~~~~~~~~---~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~  360 (414)
                                ......+....+.   .......+.+++.+||..||.+|||+.+++..
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence                      0000000000000   00112458899999999999999999999543

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.8e-39  Score=305.31  Aligned_cols=263  Identities=24%  Similarity=0.288  Sum_probs=199.3

Q ss_pred             cccHHHHHHHhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhHhHHHHHHHHHcc-CCCceeeeeeeEec
Q 015027           76 IFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRITERELLRIISQV-NHKNVVKILGLCLE  153 (414)
Q Consensus        76 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~l~~l-~hpniv~l~~~~~~  153 (414)
                      .+....+..++++|.+.+.||+|+||.||++... +++.+|+|.+............++.++.++ +|||++++++++..
T Consensus        11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            3444555667899999999999999999999975 588999999876544334444556777777 79999999999875


Q ss_pred             C-----CcceEEEEeCCCCchhhhhhhc-CCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcE
Q 015027          154 T-----EVPLLVYEFASNGTLLDHIRCE-SSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTA  227 (414)
Q Consensus       154 ~-----~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~  227 (414)
                      .     ...++||||+++++|.+++... .....+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~  167 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV  167 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence            3     3589999999999999988532 12234578899999999999999999977   9999999999999999999


Q ss_pred             EEeeccccccccCCccccceecccccccccchhhcccC-----CCCCcccchhHHHHHHHHHhCCCCCCccccccccccc
Q 015027          228 KVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTG-----KLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKIS  302 (414)
Q Consensus       228 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~  302 (414)
                      ||+|||++........  ......++..|+|||++...     .++.++|||||||++|||++|+.||.......     
T Consensus       168 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~-----  240 (291)
T cd06639         168 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK-----  240 (291)
T ss_pred             EEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH-----
Confidence            9999999876543211  12334688899999998543     36889999999999999999999986432111     


Q ss_pred             cchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          303 MVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                          ............+.       ........+.+|+.+||+.+|.+||++.++++
T Consensus       241 ----~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         241 ----TLFKIPRNPPPTLL-------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             ----HHHHHhcCCCCCCC-------cccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence                00001111000000       01122345899999999999999999999864

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.3e-39  Score=308.79  Aligned_cols=262  Identities=22%  Similarity=0.261  Sum_probs=196.3

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEe
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  163 (414)
                      ++|++.+.||+|+||.||++... ++..+|+|.+......  ......+++++.+++||||++++++|..++..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            46889999999999999999965 5788999988754322  23345677899999999999999999999999999999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhh-CCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCc
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHS-LASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDA  242 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  242 (414)
                      +++++|.+++...   ..+++..+..++.|++.||.|||+ .+   ++|+||||+|||++.++.+||+|||++...... 
T Consensus        81 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-  153 (308)
T cd06615          81 MDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  153 (308)
T ss_pred             cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence            9999999998654   234788899999999999999997 35   999999999999999999999999998755322 


Q ss_pred             cccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccc--------
Q 015027          243 ETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNN--------  314 (414)
Q Consensus       243 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------  314 (414)
                         ......+++.|+|||++.+..++.++||||||+++|+|++|+.||.........  .............        
T Consensus       154 ---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  228 (308)
T cd06615         154 ---MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELE--AMFGRPVSEGEAKESHRPVSG  228 (308)
T ss_pred             ---ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHH--HhhcCccccccccCCcccccC
Confidence               223457889999999998888999999999999999999999998643211100  0000000000000        


Q ss_pred             -------------ccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHH
Q 015027          315 -------------GLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEE  360 (414)
Q Consensus       315 -------------~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~  360 (414)
                                   ..................+..+.+|+.+||..+|++|||+.+|++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         229 HPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             CCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                         0000000000000000123568999999999999999999998654

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=6.2e-40  Score=317.30  Aligned_cols=265  Identities=20%  Similarity=0.242  Sum_probs=192.7

Q ss_pred             HHhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc---hhHhHHHHHHHHHccCCCceeeeeeeEecC-----
Q 015027           84 RATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK---IRITERELLRIISQVNHKNVVKILGLCLET-----  154 (414)
Q Consensus        84 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~hpniv~l~~~~~~~-----  154 (414)
                      ...++|.+.+.||+|+||.||++.+. .++.||||.+.....   ......+++.+++.++||||+++++++...     
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            34578999999999999999999965 588999999875422   223335567889999999999999988643     


Q ss_pred             -CcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecc
Q 015027          155 -EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFE  233 (414)
Q Consensus       155 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG  233 (414)
                       ...|+||||+++ +|.+.+..     .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg  164 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG  164 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCc
Confidence             346999999976 56665532     2477888899999999999999987   9999999999999999999999999


Q ss_pred             ccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCcccccccccc------ccchhh
Q 015027          234 SSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKI------SMVPYF  307 (414)
Q Consensus       234 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~------~~~~~~  307 (414)
                      +++.....   .......||+.|+|||++.+..++.++|||||||++|+|++|+.||........-..      ...+.+
T Consensus       165 ~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (355)
T cd07874         165 LARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF  241 (355)
T ss_pred             ccccCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            99765432   122345789999999999999999999999999999999999999975432110000      000000


Q ss_pred             hhh--------hccc------cccccccccc---CCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHH
Q 015027          308 LNS--------IKNN------GLRQILNFHV---ADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEE  360 (414)
Q Consensus       308 ~~~--------~~~~------~~~~~~~~~~---~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~  360 (414)
                      ...        ....      ..........   ...........+.+|+.+||+.||++|||+.++++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence            000        0000      0000000000   000111123568999999999999999999999653

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.1e-39  Score=305.97  Aligned_cols=246  Identities=22%  Similarity=0.246  Sum_probs=191.2

Q ss_pred             CCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch----hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEE
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI----RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYE  162 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  162 (414)
                      .|+..+.||+|+||+||+|.+. +++.+|+|.+......    ......+++++++++|+||+++.+++..++..++|||
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            3667788999999999999975 5889999998654321    1223456789999999999999999999999999999


Q ss_pred             eCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCc
Q 015027          163 FASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDA  242 (414)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  242 (414)
                      |+++++|.+++..... ..+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||++.......
T Consensus        81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05632          81 IMNGGDLKFHIYNMGN-PGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE  156 (285)
T ss_pred             eccCccHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence            9999999988865432 24588999999999999999999987   9999999999999999999999999987653221


Q ss_pred             cccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccccc
Q 015027          243 ETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNF  322 (414)
Q Consensus       243 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (414)
                         ......|+..|+|||++.+..++.++|+|||||++|+|++|..||.........     ..........  ....  
T Consensus       157 ---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~-----~~~~~~~~~~--~~~~--  224 (285)
T cd05632         157 ---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR-----EEVDRRVLET--EEVY--  224 (285)
T ss_pred             ---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH-----HHHHHhhhcc--cccc--
Confidence               123347899999999999999999999999999999999999999743211100     0000000000  0000  


Q ss_pred             ccCCcccHHHHHHHHHHHHHhhccCCCCCCChh
Q 015027          323 HVADESEMKEIEIVAELASKCLRIRGTERPTMK  355 (414)
Q Consensus       323 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~  355 (414)
                            ....+..+.+|+.+||+.+|.+||++.
T Consensus       225 ------~~~~~~~~~~li~~~l~~~P~~R~~~~  251 (285)
T cd05632         225 ------SAKFSEEAKSICKMLLTKDPKQRLGCQ  251 (285)
T ss_pred             ------CccCCHHHHHHHHHHccCCHhHcCCCc
Confidence                  111224589999999999999999954

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=9.5e-40  Score=327.04  Aligned_cols=202  Identities=23%  Similarity=0.268  Sum_probs=161.0

Q ss_pred             HHHHHhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhHhHHHHHHHHHccC------CCceeeeeeeEec
Q 015027           81 EMIRATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRITERELLRIISQVN------HKNVVKILGLCLE  153 (414)
Q Consensus        81 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~------hpniv~l~~~~~~  153 (414)
                      ++....++|.+.+.||+|+||+||+|.+. +++.||||+++...........+++++..++      |+++++++++|..
T Consensus       123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~  202 (467)
T PTZ00284        123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN  202 (467)
T ss_pred             ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence            34445688999999999999999999975 5888999999754332222233344444443      5568999998876


Q ss_pred             C-CcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhh-CCCCCeeeCCCCCCceeeCCCC------
Q 015027          154 T-EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHS-LASPPIIHGDVKSANILLNDNY------  225 (414)
Q Consensus       154 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~iiH~Dlkp~NIll~~~~------  225 (414)
                      . ...++|||++ +++|.+++...+   .+++..+..++.||+.||.|||+ .+   |+||||||+|||++.++      
T Consensus       203 ~~~~~~iv~~~~-g~~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~  275 (467)
T PTZ00284        203 ETGHMCIVMPKY-GPCLLDWIMKHG---PFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPV  275 (467)
T ss_pred             CCceEEEEEecc-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccc
Confidence            4 5788999988 678888885432   35788999999999999999997 46   99999999999998765      


Q ss_pred             ----------cEEEeeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccc
Q 015027          226 ----------TAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMT  294 (414)
Q Consensus       226 ----------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~  294 (414)
                                .+||+|||.+.....     .....+||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       276 ~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~  349 (467)
T PTZ00284        276 TNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD  349 (467)
T ss_pred             cccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence                      499999998754321     2234689999999999999999999999999999999999999997543

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=5.6e-40  Score=318.66  Aligned_cols=263  Identities=20%  Similarity=0.235  Sum_probs=191.9

Q ss_pred             HhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc---hhHhHHHHHHHHHccCCCceeeeeeeEecC------
Q 015027           85 ATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK---IRITERELLRIISQVNHKNVVKILGLCLET------  154 (414)
Q Consensus        85 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~hpniv~l~~~~~~~------  154 (414)
                      ..++|.+.+.||+|+||.||+|... .++.||||++.....   ......+++.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            3578999999999999999999965 588999999875322   223345667889999999999999987543      


Q ss_pred             CcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccc
Q 015027          155 EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFES  234 (414)
Q Consensus       155 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGl  234 (414)
                      ...|+||||+++ +|.+.+..     .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~  172 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  172 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence            357999999976 66666632     2477888899999999999999987   99999999999999999999999999


Q ss_pred             cccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccc------cchhhh
Q 015027          235 SVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKIS------MVPYFL  308 (414)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~------~~~~~~  308 (414)
                      ++.....   .......+|+.|+|||++.+..++.++|||||||++|+|++|+.||...+........      ..+.+.
T Consensus       173 a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  249 (364)
T cd07875         173 ARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM  249 (364)
T ss_pred             ccccCCC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            9765432   1223457899999999999999999999999999999999999999754321100000      000000


Q ss_pred             hhhcc---------cc-----cccccccc---cCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          309 NSIKN---------NG-----LRQILNFH---VADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       309 ~~~~~---------~~-----~~~~~~~~---~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      .....         ..     ........   ............+.+|+.+||+.||.+|||+.++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~  317 (364)
T cd07875         250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  317 (364)
T ss_pred             HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            00000         00     00000000   000001112346899999999999999999999854

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.3e-39  Score=309.78  Aligned_cols=265  Identities=18%  Similarity=0.224  Sum_probs=189.9

Q ss_pred             CCCccccC--CceEEEEEEEc-CCcEEEEEEeecccc---hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeC
Q 015027           91 RSRCLSQG--GFVSVYKGVLH-DNIQVAVKTYRRADK---IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFA  164 (414)
Q Consensus        91 ~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  164 (414)
                      ++++||+|  +|++||++... +|+.||+|.+.....   ......+++.+++.++||||++++++|..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            45779999  78999999965 689999999976432   2233456778999999999999999999999999999999


Q ss_pred             CCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccc
Q 015027          165 SNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET  244 (414)
Q Consensus       165 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  244 (414)
                      ++|+|.+++...... .+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.++++||+.+.........
T Consensus        82 ~~~~l~~~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~  157 (327)
T cd08227          82 AYGSAKDLICTHFMD-GMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR  157 (327)
T ss_pred             CCCcHHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence            999999998653322 3578899999999999999999987   999999999999999999999999865433211110


Q ss_pred             -----cceecccccccccchhhccc--CCCCCcccchhHHHHHHHHHhCCCCCCcccccccccc---ccchhhhh-----
Q 015027          245 -----AMSTILIGTSGYLDPVCINT--GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKI---SMVPYFLN-----  309 (414)
Q Consensus       245 -----~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~---~~~~~~~~-----  309 (414)
                           .......++..|+|||++.+  ..++.++|||||||++|||++|..||...........   ...+....     
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (327)
T cd08227         158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIP  237 (327)
T ss_pred             ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchh
Confidence                 01122356778999999976  4689999999999999999999999974332110000   00000000     


Q ss_pred             --h-------------hccccc----ccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          310 --S-------------IKNNGL----RQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       310 --~-------------~~~~~~----~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                        .             ......    ...................+.+|+.+||+.||++|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence              0             000000    0000000000111223457899999999999999999999965

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=9.8e-40  Score=309.00  Aligned_cols=258  Identities=25%  Similarity=0.398  Sum_probs=196.7

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCc----EEEEEEeecccchh--HhHHHHHHHHHccCCCceeeeeeeEecCCcce
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNI----QVAVKTYRRADKIR--ITERELLRIISQVNHKNVVKILGLCLETEVPL  158 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~--~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~  158 (414)
                      .++|+..+.||+|+||.||+|.+. ++.    .||+|.+.......  .....+..+++.++||||++++++|... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~   84 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ   84 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence            356788899999999999999864 343    47899887543322  2345567889999999999999998754 467


Q ss_pred             EEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccc
Q 015027          159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLI  238 (414)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~  238 (414)
                      +++||+++|+|.+++.....  .+++..++.++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||++...
T Consensus        85 ~v~e~~~~g~l~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~  159 (303)
T cd05110          85 LVTQLMPHGCLLDYVHEHKD--NIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (303)
T ss_pred             eeehhcCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccc
Confidence            99999999999999865432  3478889999999999999999987   999999999999999999999999999876


Q ss_pred             cCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhcccccc
Q 015027          239 SSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLR  317 (414)
Q Consensus       239 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (414)
                      .............++..|+|||++.+..++.++|||||||++|||++ |..||.......         ......... .
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~---------~~~~~~~~~-~  229 (303)
T cd05110         160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---------IPDLLEKGE-R  229 (303)
T ss_pred             cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---------HHHHHHCCC-C
Confidence            54322222223345678999999999999999999999999999997 899986432111         000011000 0


Q ss_pred             cccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHh
Q 015027          318 QILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRL  367 (414)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~  367 (414)
                        ..  ...    ..+..+.+++.+||..+|++||++.++++.|+.+...
T Consensus       230 --~~--~~~----~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~  271 (303)
T cd05110         230 --LP--QPP----ICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD  271 (303)
T ss_pred             --CC--CCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence              00  000    1124589999999999999999999999998887543

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=2e-39  Score=302.30  Aligned_cols=255  Identities=23%  Similarity=0.365  Sum_probs=198.7

Q ss_pred             cCCCCCCccccCCceEEEEEEEc------CCcEEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEecCCcce
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH------DNIQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLETEVPL  158 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~  158 (414)
                      ++|.+.+.||+|+||.||+|..+      +...|++|.+......  ......+++++++++||||+++++++.+....+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            57889999999999999999964      2467999988654432  234566778999999999999999999989999


Q ss_pred             EEEEeCCCCchhhhhhhcCCc------ccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeec
Q 015027          159 LVYEFASNGTLLDHIRCESSQ------VLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADF  232 (414)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df  232 (414)
                      +||||+++|+|.+++......      ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.++++||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence            999999999999999654422      14688999999999999999999987   999999999999999999999999


Q ss_pred             cccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhh
Q 015027          233 ESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSI  311 (414)
Q Consensus       233 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  311 (414)
                      |++....... ........++..|+|||.+.+..++.++||||||+++|+|++ |..||.......         .....
T Consensus       162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---------~~~~~  231 (275)
T cd05046         162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---------VLNRL  231 (275)
T ss_pred             ccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---------HHHHH
Confidence            9987543221 112223356778999999988889999999999999999999 788885322110         11111


Q ss_pred             cccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHH
Q 015027          312 KNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELD  362 (414)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~  362 (414)
                      .........    ..    ..+..+.+++.+||+.+|.+|||+.+++..|.
T Consensus       232 ~~~~~~~~~----~~----~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         232 QAGKLELPV----PE----GCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             HcCCcCCCC----CC----CCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            111111000    11    12245999999999999999999999988774

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.2e-39  Score=304.94  Aligned_cols=270  Identities=24%  Similarity=0.331  Sum_probs=200.9

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-----CCcEEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEec--CCcc
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-----DNIQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLE--TEVP  157 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~--~~~~  157 (414)
                      .+|.+.+.||+|+||.||+|...     ++..+|||.+......  ...+..++++++.++||||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            46778899999999999999853     3678999999866553  4445667789999999999999999887  5578


Q ss_pred             eEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccccc
Q 015027          158 LLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVL  237 (414)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~  237 (414)
                      ++||||+++++|.+++.....  .+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++..
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCcc--ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence            999999999999999965443  3588899999999999999999987   99999999999999999999999999987


Q ss_pred             ccCCcccc-ceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccc
Q 015027          238 ISSDAETA-MSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGL  316 (414)
Q Consensus       238 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (414)
                      ........ ......++..|+|||.+.+..++.++||||||+++|||++|..|+................   .......
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~---~~~~~~~  235 (284)
T cd05038         159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQG---QMIVTRL  235 (284)
T ss_pred             cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccc---cccHHHH
Confidence            65322211 1112234557999999988899999999999999999999999976432211100000000   0000000


Q ss_pred             ccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHH
Q 015027          317 RQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL  364 (414)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i  364 (414)
                      ...+........+...+..+.+|+.+||+.+|.+|||+.+|++.|+.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         236 LELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            000000001111112225689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.5e-39  Score=304.37  Aligned_cols=258  Identities=22%  Similarity=0.318  Sum_probs=195.8

Q ss_pred             HHHHHHHhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhHhHHHHHHHHHcc-CCCceeeeeeeEec---
Q 015027           79 KSEMIRATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRITERELLRIISQV-NHKNVVKILGLCLE---  153 (414)
Q Consensus        79 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~l~~l-~hpniv~l~~~~~~---  153 (414)
                      ..++....+.|++.+.||.|+||.||+|.+. +++.+|+|++............++.++.++ +||||+++++++..   
T Consensus         8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~   87 (282)
T cd06636           8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSP   87 (282)
T ss_pred             hhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccc
Confidence            3344455678999999999999999999975 588999999876544444445556777777 79999999999853   


Q ss_pred             ---CCcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEe
Q 015027          154 ---TEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVA  230 (414)
Q Consensus       154 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~  230 (414)
                         ....+++|||+++|+|.+++..... ..+++..+..++.||+.||.|||+.+   ++|+||+|+||++++++.++|+
T Consensus        88 ~~~~~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~  163 (282)
T cd06636          88 PGHDDQLWLVMEFCGAGSVTDLVKNTKG-NALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLV  163 (282)
T ss_pred             cCCCCEEEEEEEeCCCCcHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEe
Confidence               4567999999999999998865432 23467888899999999999999987   9999999999999999999999


Q ss_pred             eccccccccCCccccceecccccccccchhhcc-----cCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccch
Q 015027          231 DFESSVLISSDAETAMSTILIGTSGYLDPVCIN-----TGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVP  305 (414)
Q Consensus       231 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~  305 (414)
                      |||++........  ......|++.|+|||.+.     +..++.++|||||||++|||++|..||........  .    
T Consensus       164 dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~--~----  235 (282)
T cd06636         164 DFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA--L----  235 (282)
T ss_pred             eCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh--h----
Confidence            9999876542211  123356889999999985     35688899999999999999999999863321100  0    


Q ss_pred             hhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          306 YFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                        . ......     ....   .....+..+.+|+.+||+.||.+|||+.++++
T Consensus       236 --~-~~~~~~-----~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         236 --F-LIPRNP-----PPKL---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             --h-hHhhCC-----CCCC---cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence              0 000000     0000   01112356999999999999999999999854

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=7.5e-40  Score=318.70  Aligned_cols=263  Identities=19%  Similarity=0.204  Sum_probs=191.3

Q ss_pred             CCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc---hhHhHHHHHHHHHccCCCceeeeeeeEecCC-----cce
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK---IRITERELLRIISQVNHKNVVKILGLCLETE-----VPL  158 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~-----~~~  158 (414)
                      +|++.+.||+|+||.||+|.+. +++.||||.+.....   ......+++++++.++||||+++++++....     ..|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4788999999999999999965 689999999864321   1233456778999999999999999998766     789


Q ss_pred             EEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccc
Q 015027          159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLI  238 (414)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~  238 (414)
                      +||||+. ++|.+.+...   ..+++..+..++.||+.||.|||+.+   ++||||||+|||++.++.+||+|||++...
T Consensus        81 lv~e~~~-~~l~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~  153 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSP---QPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE  153 (372)
T ss_pred             EEeeccc-cCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence            9999997 4777776432   34578899999999999999999987   999999999999999999999999999865


Q ss_pred             cCCccccceecccccccccchhhcccC-CCCCcccchhHHHHHHHHHhCCCCCCcccccccccc-----c--cchhh---
Q 015027          239 SSDAETAMSTILIGTSGYLDPVCINTG-KLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKI-----S--MVPYF---  307 (414)
Q Consensus       239 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~-----~--~~~~~---  307 (414)
                      ..... .......+|+.|+|||++.+. .++.++|||||||++|||++|+.||...........     +  ....+   
T Consensus       154 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~  232 (372)
T cd07853         154 EPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA  232 (372)
T ss_pred             ccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence            43321 122334678999999998774 579999999999999999999999975432110000     0  00000   


Q ss_pred             ----hhhhcccccc-cccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHH
Q 015027          308 ----LNSIKNNGLR-QILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEE  360 (414)
Q Consensus       308 ----~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~  360 (414)
                          .......... .......  ......++.+.+|+.+||+.||.+|||+.+++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         233 CEGARAHILRGPHKPPSLPVLY--TLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             hHHHHHHHHhCCCCCCchHHhc--ccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence                0000000000 0000000  0000113568999999999999999999998653

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=4.4e-39  Score=298.28  Aligned_cols=250  Identities=23%  Similarity=0.368  Sum_probs=195.5

Q ss_pred             CCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccch-------hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEE
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKI-------RITERELLRIISQVNHKNVVKILGLCLETEVPLLV  160 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv  160 (414)
                      +|.+.+.||+|+||.||+|...+++.+|+|.+......       .....+++.+++.++|+||+++++++.+....++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            47788999999999999999878999999998754211       12235567889999999999999999999999999


Q ss_pred             EEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccC
Q 015027          161 YEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISS  240 (414)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  240 (414)
                      |||+++++|.+++....   .+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          81 MEFVPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            99999999999986543   3477888899999999999999987   99999999999999999999999999876532


Q ss_pred             Cc----cccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccc
Q 015027          241 DA----ETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGL  316 (414)
Q Consensus       241 ~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (414)
                      ..    .........++..|+|||++.+..++.++||||||+++|+|++|..||........        ..........
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~--------~~~~~~~~~~  226 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA--------MFYIGAHRGL  226 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH--------HHHhhhccCC
Confidence            11    11122335688899999999999999999999999999999999999964321110        0000000000


Q ss_pred             ccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          317 RQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                          .+.+..    ..+..+.+++.+||+.+|.+||++.++++
T Consensus       227 ----~~~~~~----~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         227 ----MPRLPD----SFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             ----CCCCCC----CCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                011111    12255899999999999999999999864

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=2.1e-39  Score=305.85  Aligned_cols=248  Identities=22%  Similarity=0.332  Sum_probs=196.7

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch-hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeC
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI-RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFA  164 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  164 (414)
                      .+|.+.+.||+|+||.||+|... +++.||+|.+...... .....+++.+++.++||||+++++++..++..++||||+
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   98 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   98 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence            67999999999999999999964 6899999998754332 233355678899999999999999999999999999999


Q ss_pred             CCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccc
Q 015027          165 SNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET  244 (414)
Q Consensus       165 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  244 (414)
                      ++++|.+++...    .+++..+..++.+++.||.|||+.+   ++|+||||+|||++.++.++|+|||++........ 
T Consensus        99 ~~~~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-  170 (297)
T cd06656          99 AGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  170 (297)
T ss_pred             CCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc-
Confidence            999999988532    3477889999999999999999987   99999999999999999999999999876543221 


Q ss_pred             cceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccccccc
Q 015027          245 AMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHV  324 (414)
Q Consensus       245 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (414)
                       ......+++.|+|||.+.+..++.++|||||||++|+|++|..||..........         ........       
T Consensus       171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~---------~~~~~~~~-------  233 (297)
T cd06656         171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY---------LIATNGTP-------  233 (297)
T ss_pred             -CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee---------eeccCCCC-------
Confidence             1233468889999999999999999999999999999999999996432111000         00000000       


Q ss_pred             CCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          325 ADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       325 ~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ....+...+..+.+|+.+||..+|.+||++.++++
T Consensus       234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         234 ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00011122355889999999999999999999865

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-40  Score=321.70  Aligned_cols=245  Identities=24%  Similarity=0.359  Sum_probs=201.0

Q ss_pred             ccccCCceEEEEEEEcC-CcEEEEEEeeccc-chhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCCCCchhh
Q 015027           94 CLSQGGFVSVYKGVLHD-NIQVAVKTYRRAD-KIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLD  171 (414)
Q Consensus        94 ~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~  171 (414)
                      +||+|.||+||-|++.+ ...+|||.+.... ...+...|++.+-++++|.|||+++|.+.+++..-|.||-+|||||.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            58999999999999765 5669999997543 334555888899999999999999999999999999999999999999


Q ss_pred             hhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeC-CCCcEEEeeccccccccCCccccceecc
Q 015027          172 HIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLN-DNYTAKVADFESSVLISSDAETAMSTIL  250 (414)
Q Consensus       172 ~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~-~~~~~kl~DfGla~~~~~~~~~~~~~~~  250 (414)
                      +|+..-+....++.+.-.+.+||++||.|||.+.   |+|||||-+||||+ -.|.+||+|||.++.+..-  .....++
T Consensus       662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP~TETF  736 (1226)
T KOG4279|consen  662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NPCTETF  736 (1226)
T ss_pred             HHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC--Ccccccc
Confidence            9987766555578888889999999999999988   99999999999997 5899999999999877642  3345667


Q ss_pred             cccccccchhhcccC--CCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccccCCcc
Q 015027          251 IGTSGYLDPVCINTG--KLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADES  328 (414)
Q Consensus       251 ~gt~~y~aPE~~~~~--~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (414)
                      .||..|||||++..+  .|..++|||||||++.||.||++||.......          ....+-+      .....++.
T Consensus       737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq----------AAMFkVG------myKvHP~i  800 (1226)
T KOG4279|consen  737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ----------AAMFKVG------MYKVHPPI  800 (1226)
T ss_pred             ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh----------Hhhhhhc------ceecCCCC
Confidence            899999999999654  68999999999999999999999996333211          0000111      11223444


Q ss_pred             cHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          329 EMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       329 ~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      +...+.+...+|.+|+.++|..||++.+++.
T Consensus       801 Peelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  801 PEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             cHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            5566778999999999999999999999964

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2e-39  Score=300.00  Aligned_cols=250  Identities=28%  Similarity=0.398  Sum_probs=186.9

Q ss_pred             CccccCCceEEEEEEEcC----CcEEEEEEeecccc--hhHhHHHHHHHHHccCCCceeeeeeeEe-cCCcceEEEEeCC
Q 015027           93 RCLSQGGFVSVYKGVLHD----NIQVAVKTYRRADK--IRITERELLRIISQVNHKNVVKILGLCL-ETEVPLLVYEFAS  165 (414)
Q Consensus        93 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~--~~~~~~~~~~~l~~l~hpniv~l~~~~~-~~~~~~lv~e~~~  165 (414)
                      +.||+|+||.||+|.+.+    ...||+|.+.....  .......+..+++.++||||+++++++. .+...++||||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            468999999999998542    35799998854322  2233455667899999999999999876 4556899999999


Q ss_pred             CCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccc-
Q 015027          166 NGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET-  244 (414)
Q Consensus       166 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~-  244 (414)
                      +|+|.+++.....  ..++..++.++.|++.||+|||+.+   ++||||||+|||+++++.+||+|||++......... 
T Consensus        81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~  155 (262)
T cd05058          81 HGDLRNFIRSETH--NPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS  155 (262)
T ss_pred             CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence            9999999865432  2366778889999999999999977   999999999999999999999999998755432110 


Q ss_pred             -cceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhC-CCCCCccccccccccccchhhhhhhccccccccccc
Q 015027          245 -AMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTG-KKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNF  322 (414)
Q Consensus       245 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (414)
                       .......++..|+|||.+.+..++.++|||||||++|||++| .+||.......     ....    .....     ..
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~-----~~~~----~~~~~-----~~  221 (262)
T cd05058         156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD-----ITVY----LLQGR-----RL  221 (262)
T ss_pred             ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH-----HHHH----HhcCC-----CC
Confidence             111223456789999999888999999999999999999995 56665322110     0000    00000     00


Q ss_pred             ccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHH
Q 015027          323 HVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLR  365 (414)
Q Consensus       323 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~  365 (414)
                      .    .+...+..+.+++.+||+.+|++||++.+|++.|+.+.
T Consensus       222 ~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         222 L----QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             C----CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence            0    00111245899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-39  Score=300.95  Aligned_cols=247  Identities=26%  Similarity=0.370  Sum_probs=197.9

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEe
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  163 (414)
                      ++|.+.+.||.|++|.||+|.+. ++..||+|.+......  ......++++++.++||||+++++++.++...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            46888899999999999999976 5889999998755322  22345567889999999999999999999999999999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcc
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE  243 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  243 (414)
                      +++++|.+++...    .+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++....... 
T Consensus        81 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-  152 (274)
T cd06609          81 CGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-  152 (274)
T ss_pred             eCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence            9999999998643    4588999999999999999999987   9999999999999999999999999998765432 


Q ss_pred             ccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccc
Q 015027          244 TAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFH  323 (414)
Q Consensus       244 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (414)
                       .......+++.|+|||.+.+..++.++||||||+++|+|++|..||.......         .........     .+.
T Consensus       153 -~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~---------~~~~~~~~~-----~~~  217 (274)
T cd06609         153 -SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR---------VLFLIPKNN-----PPS  217 (274)
T ss_pred             -cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH---------HHHHhhhcC-----CCC
Confidence             12234568889999999998889999999999999999999999986432110         000011110     011


Q ss_pred             cCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          324 VADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       324 ~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      +...   ..+..+.+++.+||..+|.+|||++++++
T Consensus       218 ~~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         218 LEGN---KFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             Cccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            1110   02355899999999999999999999965

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-40  Score=312.58  Aligned_cols=262  Identities=24%  Similarity=0.345  Sum_probs=210.2

Q ss_pred             cCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeC
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFA  164 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  164 (414)
                      +...+.++||+|-||.|.++....+..||||.++.....  +..+..++++|.+++||||+.++|+|..++.+++|+|||
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm  617 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM  617 (807)
T ss_pred             hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence            345678899999999999999988899999999987654  356688889999999999999999999999999999999


Q ss_pred             CCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccc
Q 015027          165 SNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET  244 (414)
Q Consensus       165 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  244 (414)
                      ++|+|..++..+.... ..-....+|+.||+.|++||.+.+   ++||||.+.|+|+|.++++||+|||+++.+......
T Consensus       618 EnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy  693 (807)
T KOG1094|consen  618 ENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY  693 (807)
T ss_pred             hcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCce
Confidence            9999999997664433 344566789999999999999987   999999999999999999999999999987776666


Q ss_pred             cceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh--CCCCCCccccccccccccchhhhhhhccccccccccc
Q 015027          245 AMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT--GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNF  322 (414)
Q Consensus       245 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (414)
                      ......+-..+|||||.+..++++.++|||+||+++||+++  ...||+..........     .-...........+  
T Consensus       694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven-----~~~~~~~~~~~~~l--  766 (807)
T KOG1094|consen  694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVEN-----AGEFFRDQGRQVVL--  766 (807)
T ss_pred             eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHh-----hhhhcCCCCcceec--
Confidence            66666677789999999999999999999999999999865  7899986554331110     00000111111111  


Q ss_pred             ccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHH
Q 015027          323 HVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDR  363 (414)
Q Consensus       323 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~  363 (414)
                          ..+.-.+..+.+|+.+||..+.++|||++++...|..
T Consensus       767 ----~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~  803 (807)
T KOG1094|consen  767 ----SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE  803 (807)
T ss_pred             ----cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence                1111222458899999999999999999999877764

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.2e-39  Score=301.21  Aligned_cols=255  Identities=25%  Similarity=0.382  Sum_probs=197.9

Q ss_pred             cCCCCCCccccCCceEEEEEEEcC----CcEEEEEEeecccc--hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLHD----NIQVAVKTYRRADK--IRITERELLRIISQVNHKNVVKILGLCLETEVPLLV  160 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~--~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv  160 (414)
                      ++|.+.+.||+|+||.||+|.+.+    ...||||.......  ......+++.+++.++||||+++++++.+ +..++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            468888999999999999998643    24689998876542  23344667789999999999999998875 457899


Q ss_pred             EEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccC
Q 015027          161 YEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISS  240 (414)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  240 (414)
                      |||+++++|.+++.....  .+++..++.++.+++.||.|||+.+   ++|+||||+||+++.++.+||+|||++.....
T Consensus        85 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  159 (270)
T cd05056          85 MELAPLGELRSYLQVNKY--SLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED  159 (270)
T ss_pred             EEcCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence            999999999999965432  3588999999999999999999977   99999999999999999999999999876644


Q ss_pred             CccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhcccccccc
Q 015027          241 DAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQI  319 (414)
Q Consensus       241 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (414)
                      ... .......++..|+|||.+.+..++.++||||||+++|||++ |..||.......         ...........  
T Consensus       160 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---------~~~~~~~~~~~--  227 (270)
T cd05056         160 ESY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND---------VIGRIENGERL--  227 (270)
T ss_pred             ccc-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH---------HHHHHHcCCcC--
Confidence            311 11122234567999999988899999999999999999986 999986433211         01111111000  


Q ss_pred             cccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHH
Q 015027          320 LNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR  366 (414)
Q Consensus       320 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~  366 (414)
                         ...    ...+..+.+++.+||..+|.+|||+.++++.|+.+..
T Consensus       228 ---~~~----~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~  267 (270)
T cd05056         228 ---PMP----PNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ  267 (270)
T ss_pred             ---CCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence               001    1123569999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.2e-39  Score=300.22  Aligned_cols=238  Identities=25%  Similarity=0.407  Sum_probs=183.0

Q ss_pred             CccccCCceEEEEEEEcC-------------CcEEEEEEeecccch-hHhHHHHHHHHHccCCCceeeeeeeEecCCcce
Q 015027           93 RCLSQGGFVSVYKGVLHD-------------NIQVAVKTYRRADKI-RITERELLRIISQVNHKNVVKILGLCLETEVPL  158 (414)
Q Consensus        93 ~~lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~  158 (414)
                      +.||+|+||.||+|...+             ...|++|.+...... ...+.+++.++..++||||+++++++..+...+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            358999999999998532             235889987654322 234466678899999999999999999999999


Q ss_pred             EEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCc-------EEEee
Q 015027          159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYT-------AKVAD  231 (414)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~-------~kl~D  231 (414)
                      +||||+++++|..++....  ..+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.       ++++|
T Consensus        81 lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             EEEecccCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            9999999999988875433  23578889999999999999999987   999999999999987664       89999


Q ss_pred             ccccccccCCccccceecccccccccchhhcc-cCCCCCcccchhHHHHHHHHH-hCCCCCCccccccccccccchhhhh
Q 015027          232 FESSVLISSDAETAMSTILIGTSGYLDPVCIN-TGKLTKKSDVYSFGVVLAELL-TGKKPGSCMTLASNKKISMVPYFLN  309 (414)
Q Consensus       232 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlGvil~el~-tg~~p~~~~~~~~~~~~~~~~~~~~  309 (414)
                      ||++......      ....++..|+|||++. +..++.++|||||||++|||+ +|..||........      ..+  
T Consensus       156 ~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~------~~~--  221 (262)
T cd05077         156 PGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK------ERF--  221 (262)
T ss_pred             CCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH------HHH--
Confidence            9998654321      2235778899999886 567899999999999999998 58888763321110      000  


Q ss_pred             hhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHH
Q 015027          310 SIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEEL  361 (414)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L  361 (414)
                        ..... .     ...+    ....+.+|+.+||+.||.+||++.+|++.|
T Consensus       222 --~~~~~-~-----~~~~----~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         222 --YEGQC-M-----LVTP----SCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             --HhcCc-c-----CCCC----ChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence              00000 0     0011    124589999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.6e-39  Score=304.74  Aligned_cols=251  Identities=24%  Similarity=0.303  Sum_probs=194.4

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc--hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEe
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK--IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  163 (414)
                      ++|++.+.||+|+||.||++... ++..||+|.+.....  .......++.++.+++||||+++++.+...+..++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            36888999999999999999976 689999998875422  123445667889999999999999999999999999999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhh-CCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCc
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHS-LASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDA  242 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  242 (414)
                      +++++|..++........+++..+..++.+++.||.|||+ .+   ++|+||||+||+++.++.+||+|||++...... 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-  156 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-  156 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence            9999999888654333356889999999999999999996 35   999999999999999999999999998765322 


Q ss_pred             cccceecccccccccchhhcccC------CCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccc
Q 015027          243 ETAMSTILIGTSGYLDPVCINTG------KLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGL  316 (414)
Q Consensus       243 ~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (414)
                         ......+++.|+|||.+.+.      .++.++|||||||++|+|++|..||.......         .....     
T Consensus       157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---------~~~~~-----  219 (286)
T cd06622         157 ---LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN---------IFAQL-----  219 (286)
T ss_pred             ---ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh---------HHHHH-----
Confidence               12234678899999998554      35889999999999999999999986322100         00000     


Q ss_pred             ccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          317 RQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ..+... .....+......+.+|+.+||+.+|.+||++.+++.
T Consensus       220 ~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         220 SAIVDG-DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             HHHhhc-CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence            000000 000111123466899999999999999999999865

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=7.3e-39  Score=297.60  Aligned_cols=252  Identities=21%  Similarity=0.259  Sum_probs=183.0

Q ss_pred             CccccCCceEEEEEEEcCC---cEEEEEEeecccc--hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCCCC
Q 015027           93 RCLSQGGFVSVYKGVLHDN---IQVAVKTYRRADK--IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNG  167 (414)
Q Consensus        93 ~~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~~--~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g  167 (414)
                      +.||+|+||.||+|...++   ..+++|.+.....  ....+.++..+++.++||||+++++.|......++||||+++|
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            3589999999999985443   3466777654432  2234455667888999999999999999999999999999999


Q ss_pred             chhhhhhhcCC-cccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccccc
Q 015027          168 TLLDHIRCESS-QVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAM  246 (414)
Q Consensus       168 sL~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  246 (414)
                      +|.+++..... ....++..+..++.||+.||+|||+.+   ++||||||+|||++.++.+||+|||++...........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            99999865432 223456677889999999999999977   99999999999999999999999999864322211122


Q ss_pred             eecccccccccchhhccc-------CCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhccccccc
Q 015027          247 STILIGTSGYLDPVCINT-------GKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQ  318 (414)
Q Consensus       247 ~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (414)
                      .....++..|+|||++..       ..++.++|||||||++|||++ |..||.......         ............
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---------~~~~~~~~~~~~  228 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE---------VLNHVIKDQQVK  228 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH---------HHHHHHhhcccc
Confidence            234567889999998743       345789999999999999997 577875322110         011111111111


Q ss_pred             ccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHH
Q 015027          319 ILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEEL  361 (414)
Q Consensus       319 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L  361 (414)
                      ..++......    ...+.+++..|| .+|.+||++.+|++.|
T Consensus       229 ~~~~~~~~~~----~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l  266 (268)
T cd05086         229 LFKPQLELPY----SERWYEVLQFCW-LSPEKRATAEEVHRLL  266 (268)
T ss_pred             cCCCccCCCC----cHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence            2222222221    245788999999 6799999999998876

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.2e-39  Score=297.85  Aligned_cols=237  Identities=27%  Similarity=0.426  Sum_probs=186.5

Q ss_pred             CccccCCceEEEEEEEcCCc-----------EEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEE
Q 015027           93 RCLSQGGFVSVYKGVLHDNI-----------QVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        93 ~~lg~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~  161 (414)
                      +.||+|+||.||+|.+.+..           .+++|.+.........+.+++.+++.++||||+++++++.. ...++||
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~   79 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE   79 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence            46899999999999976432           57888877655434555677789999999999999999988 7789999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCC-------cEEEeeccc
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNY-------TAKVADFES  234 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~-------~~kl~DfGl  234 (414)
                      ||+++|+|.+++.....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++       .+||+|||+
T Consensus        80 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~  154 (259)
T cd05037          80 EYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI  154 (259)
T ss_pred             EcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCCc
Confidence            99999999999976443  4578889999999999999999977   99999999999999887       799999999


Q ss_pred             cccccCCccccceecccccccccchhhcccC--CCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhh
Q 015027          235 SVLISSDAETAMSTILIGTSGYLDPVCINTG--KLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSI  311 (414)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  311 (414)
                      +.....      .....++..|+|||++.+.  .++.++||||||+++|+|++ |..||.......         .....
T Consensus       155 a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~---------~~~~~  219 (259)
T cd05037         155 PITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE---------KERFY  219 (259)
T ss_pred             cccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh---------HHHHH
Confidence            876543      1223566789999999876  78999999999999999999 577776432111         00000


Q ss_pred             cccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHH
Q 015027          312 KNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEEL  361 (414)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L  361 (414)
                      ....       .......    ..+.+++.+||..+|.+|||+.++++.|
T Consensus       220 ~~~~-------~~~~~~~----~~~~~li~~~l~~~p~~Rpt~~~il~~l  258 (259)
T cd05037         220 QDQH-------RLPMPDC----AELANLINQCWTYDPTKRPSFRAILRDL  258 (259)
T ss_pred             hcCC-------CCCCCCc----hHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence            0000       0000001    4589999999999999999999998876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=5.5e-39  Score=299.85  Aligned_cols=247  Identities=25%  Similarity=0.342  Sum_probs=197.7

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc--hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEe
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK--IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  163 (414)
                      ..|+..+.||.|+||.||+|.+. ++..||+|.+.....  .......++.++++++||||+++++++.++...++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            45778889999999999999976 588999999875432  223345667889999999999999999999999999999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcc
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE  243 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  243 (414)
                      +++++|.+++...    .+++..+..++.+++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++....... 
T Consensus        84 ~~~~~L~~~i~~~----~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-  155 (277)
T cd06640          84 LGGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-  155 (277)
T ss_pred             CCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc-
Confidence            9999999988532    3477888899999999999999977   9999999999999999999999999997654322 


Q ss_pred             ccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccc
Q 015027          244 TAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFH  323 (414)
Q Consensus       244 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (414)
                       .......++..|+|||++.+..++.++|+|||||++|||++|..||........         ....         ...
T Consensus       156 -~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---------~~~~---------~~~  216 (277)
T cd06640         156 -IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV---------LFLI---------PKN  216 (277)
T ss_pred             -cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH---------hhhh---------hcC
Confidence             122334678899999999988999999999999999999999999864321110         0000         000


Q ss_pred             cCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHH
Q 015027          324 VADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEE  360 (414)
Q Consensus       324 ~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~  360 (414)
                      .........+..+.+++.+||+.+|.+||++.+++..
T Consensus       217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         217 NPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             CCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            1111222345669999999999999999999999765

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=3.6e-39  Score=299.46  Aligned_cols=255  Identities=20%  Similarity=0.290  Sum_probs=193.8

Q ss_pred             HHhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch-hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEE
Q 015027           84 RATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI-RITERELLRIISQVNHKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        84 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~  161 (414)
                      .+++++.....||+|+||.||+|.+. ++..||+|.+...... .....+++.+++.++||||+++++++..++..++|+
T Consensus         5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   84 (268)
T cd06624           5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM   84 (268)
T ss_pred             cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence            34566667788999999999999965 5788999988765432 234466778999999999999999999999999999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCC-CCcEEEeeccccccccC
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLND-NYTAKVADFESSVLISS  240 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~DfGla~~~~~  240 (414)
                      ||+++++|.+++.........++..+..++.||+.||+|||+.+   |+||||||+||+++. ++.++|+|||++.....
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~  161 (268)
T cd06624          85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG  161 (268)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence            99999999999865432222267778889999999999999977   999999999999976 67999999999876543


Q ss_pred             CccccceecccccccccchhhcccCC--CCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccc
Q 015027          241 DAETAMSTILIGTSGYLDPVCINTGK--LTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQ  318 (414)
Q Consensus       241 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (414)
                      ...  ......+++.|+|||++.+..  ++.++||||||+++|+|++|..||..........      +.  ......  
T Consensus       162 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~------~~--~~~~~~--  229 (268)
T cd06624         162 INP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM------FK--VGMFKI--  229 (268)
T ss_pred             CCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH------hh--hhhhcc--
Confidence            211  122345788999999986543  7899999999999999999999986322110000      00  000000  


Q ss_pred             ccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          319 ILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       319 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                        .+.    .+......+.+++.+||+.+|.+|||+.+++.
T Consensus       230 --~~~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         230 --HPE----IPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             --CCC----CCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence              000    11112355899999999999999999999864

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.5e-39  Score=307.39  Aligned_cols=265  Identities=19%  Similarity=0.235  Sum_probs=193.7

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc--hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEe
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK--IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  163 (414)
                      ++|.+.+.||+|+||.||+|... ++..||+|.+.....  ......+++.+++.++||||+++++++..+...++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            57889999999999999999975 588999999875432  223345677899999999999999999999999999999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcc
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE  243 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  243 (414)
                      ++ ++|.+++.....  .+++..+..++.||+.||.|||+.+   ++|+||||+||+++.++.+||+|||++........
T Consensus        86 ~~-~~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  159 (301)
T cd07873          86 LD-KDLKQYLDDCGN--SINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  159 (301)
T ss_pred             cc-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence            97 588888765432  3478889999999999999999987   99999999999999999999999999876443211


Q ss_pred             ccceecccccccccchhhccc-CCCCCcccchhHHHHHHHHHhCCCCCCcccccccccc-------ccchhhhhhhcccc
Q 015027          244 TAMSTILIGTSGYLDPVCINT-GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKI-------SMVPYFLNSIKNNG  315 (414)
Q Consensus       244 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~-------~~~~~~~~~~~~~~  315 (414)
                        ......+++.|+|||++.+ ..++.++|||||||++|+|++|++||...+.......       .....+........
T Consensus       160 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (301)
T cd07873         160 --TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE  237 (301)
T ss_pred             --cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence              1223457889999999865 4578899999999999999999999975432110000       00000000000000


Q ss_pred             cccccccccCCc----ccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          316 LRQILNFHVADE----SEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       316 ~~~~~~~~~~~~----~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ....-.+.....    .....+..+.+|+.+||+.||.+|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            000000000000    00112345899999999999999999999854

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=2.6e-39  Score=300.16  Aligned_cols=251  Identities=23%  Similarity=0.325  Sum_probs=194.2

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchh-HhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeC
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIR-ITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFA  164 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  164 (414)
                      ++|.+.+.||+|+||.||+|... ++..||+|.++...... ....+++.+++.++||||+++++.+...+..++||||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            47888889999999999999965 58899999987653322 23355678899999999999999999999999999999


Q ss_pred             CCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccc
Q 015027          165 SNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET  244 (414)
Q Consensus       165 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  244 (414)
                      ++++|.+++...+   .+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++......  .
T Consensus        89 ~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~--~  160 (267)
T cd06645          89 GGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITAT--I  160 (267)
T ss_pred             CCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCc--c
Confidence            9999999886443   3578899999999999999999987   999999999999999999999999998765432  1


Q ss_pred             cceecccccccccchhhcc---cCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccc
Q 015027          245 AMSTILIGTSGYLDPVCIN---TGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILN  321 (414)
Q Consensus       245 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (414)
                      .......|++.|+|||++.   ...++.++|||||||++|+|++|..||........        .. ......   ...
T Consensus       161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~--------~~-~~~~~~---~~~  228 (267)
T cd06645         161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--------LF-LMTKSN---FQP  228 (267)
T ss_pred             cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh--------HH-hhhccC---CCC
Confidence            1223457899999999974   45688999999999999999999999853221100        00 000000   000


Q ss_pred             cccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          322 FHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       322 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      +....  ....+..+.+++.+||+.+|++|||+.+|++
T Consensus       229 ~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         229 PKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             Ccccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            00000  0011245899999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=8.3e-39  Score=300.95  Aligned_cols=251  Identities=23%  Similarity=0.255  Sum_probs=194.1

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch-hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEe
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI-RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  163 (414)
                      .++|++.+.||.|+||.||+|... ++..+++|.+...... ......++.+++.++||||+++++.+..+...++||||
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF   90 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence            367899999999999999999976 4889999998765432 23345567889999999999999999999999999999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcc
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE  243 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  243 (414)
                      +++++|..++.....  .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++......  
T Consensus        91 ~~~~~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--  163 (292)
T cd06644          91 CPGGAVDAIMLELDR--GLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--  163 (292)
T ss_pred             CCCCcHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc--
Confidence            999999887754332  3578999999999999999999987   999999999999999999999999998654322  


Q ss_pred             ccceecccccccccchhhcc-----cCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccc
Q 015027          244 TAMSTILIGTSGYLDPVCIN-----TGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQ  318 (414)
Q Consensus       244 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (414)
                      ........+++.|+|||++.     ...++.++|||||||++|+|++|..||.......         ..........  
T Consensus       164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---------~~~~~~~~~~--  232 (292)
T cd06644         164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR---------VLLKIAKSEP--  232 (292)
T ss_pred             ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH---------HHHHHhcCCC--
Confidence            11223456888999999984     3457889999999999999999999986432110         0000000000  


Q ss_pred             ccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          319 ILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       319 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                         +..  ..+...+..+.+++.+||+.+|++||++.++++
T Consensus       233 ---~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         233 ---PTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             ---ccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence               000  001112245899999999999999999999854

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-40  Score=306.64  Aligned_cols=247  Identities=20%  Similarity=0.253  Sum_probs=201.2

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch---hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI---RITERELLRIISQVNHKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~  161 (414)
                      ..-|++.+.||+|.|+.|.+|+.- +|..||||++.+....   .....++++.|+.++|||||++|++......+|||+
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL   96 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL   96 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence            456888899999999999999843 7999999999765432   233456678899999999999999999999999999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceee-CCCCcEEEeeccccccccC
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILL-NDNYTAKVADFESSVLISS  240 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll-~~~~~~kl~DfGla~~~~~  240 (414)
                      |+-++|+|+||+-.....  +.+..+.++++||+.|+.|+|+.+   ++||||||+||.+ ..-|.|||+|||++..+..
T Consensus        97 ELGD~GDl~DyImKHe~G--l~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P  171 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMKHEEG--LNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP  171 (864)
T ss_pred             EecCCchHHHHHHhhhcc--ccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence            999999999999655443  378889999999999999999999   9999999999877 4579999999999977654


Q ss_pred             CccccceecccccccccchhhcccCCCC-CcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccc
Q 015027          241 DAETAMSTILIGTSGYLDPVCINTGKLT-KKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQI  319 (414)
Q Consensus       241 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (414)
                      .   ...++.+|+..|-|||++.|..|+ +++||||||||||-|++|++||+.....                 ..+..+
T Consensus       172 G---~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS-----------------ETLTmI  231 (864)
T KOG4717|consen  172 G---KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS-----------------ETLTMI  231 (864)
T ss_pred             c---chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch-----------------hhhhhh
Confidence            3   334567999999999999999887 5799999999999999999999744321                 112222


Q ss_pred             cccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          320 LNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       320 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ++=.  -.-+...+.++.+||..||..||.+|.|.++|..
T Consensus       232 mDCK--YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  232 MDCK--YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             hccc--ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence            2211  1122334567999999999999999999999853

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2e-39  Score=305.86  Aligned_cols=248  Identities=21%  Similarity=0.357  Sum_probs=196.4

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch-hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeC
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI-RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFA  164 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  164 (414)
                      .+|.+.+.||.|++|.||+|... +++.|++|.+...... .....+++..++.++||||+++++++...+..++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            46889999999999999999964 6899999998754332 233456678899999999999999999999999999999


Q ss_pred             CCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccc
Q 015027          165 SNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET  244 (414)
Q Consensus       165 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  244 (414)
                      ++++|.+++...    .+++..+..++.+++.||+|||+.+   ++|+||||+||+++.++.+||+|||++........ 
T Consensus        99 ~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-  170 (296)
T cd06655          99 AGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-  170 (296)
T ss_pred             CCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc-
Confidence            999999988532    3588999999999999999999988   99999999999999999999999999876543321 


Q ss_pred             cceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccccccc
Q 015027          245 AMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHV  324 (414)
Q Consensus       245 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (414)
                       ......+++.|+|||.+.+..++.++|||||||++|+|++|..||........        .. ..........     
T Consensus       171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~--------~~-~~~~~~~~~~-----  235 (296)
T cd06655         171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--------LY-LIATNGTPEL-----  235 (296)
T ss_pred             -cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--------HH-HHHhcCCccc-----
Confidence             12334688899999999988899999999999999999999999864332110        00 0000000000     


Q ss_pred             CCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          325 ADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       325 ~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                        ..+...+..+.+|+.+||..+|.+|||+.++++
T Consensus       236 --~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         236 --QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             --CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence              011112245889999999999999999999853

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4.7e-39  Score=298.35  Aligned_cols=248  Identities=22%  Similarity=0.342  Sum_probs=194.4

Q ss_pred             CCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchh----------HhHHHHHHHHHccCCCceeeeeeeEecCCc
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIR----------ITERELLRIISQVNHKNVVKILGLCLETEV  156 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----------~~~~~~~~~l~~l~hpniv~l~~~~~~~~~  156 (414)
                      +|.+...||+|++|.||+|... ++..+|+|.+.......          .....++.++++++||||+++++++...+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            4778889999999999999965 58899999886543211          223556788999999999999999999999


Q ss_pred             ceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccc
Q 015027          157 PLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSV  236 (414)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~  236 (414)
                      .++||||+++++|.+++....   .+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||+++
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~  154 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK  154 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence            999999999999999996542   3477888899999999999999987   9999999999999999999999999988


Q ss_pred             cccCCccc----cceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhc
Q 015027          237 LISSDAET----AMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIK  312 (414)
Q Consensus       237 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  312 (414)
                      ........    .......|+..|+|||.+.+..++.++|||||||++|+|++|..||........        . ....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--------~-~~~~  225 (267)
T cd06628         155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA--------I-FKIG  225 (267)
T ss_pred             ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH--------H-HHHh
Confidence            66532111    111234578899999999988999999999999999999999999974321100        0 0000


Q ss_pred             ccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          313 NNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      . .    ..+...    ...+..+.+++.+||+.+|.+||++.++++
T Consensus       226 ~-~----~~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         226 E-N----ASPEIP----SNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             c-c----CCCcCC----cccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            0 0    001111    112356899999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-40  Score=314.44  Aligned_cols=234  Identities=21%  Similarity=0.212  Sum_probs=177.8

Q ss_pred             cccCCceEEEEEEEc-CCcEEEEEEeecccchhH----hHHHHHHHHHcc---CCCceeeeeeeEecCCcceEEEEeCCC
Q 015027           95 LSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRI----TERELLRIISQV---NHKNVVKILGLCLETEVPLLVYEFASN  166 (414)
Q Consensus        95 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~----~~~~~~~~l~~l---~hpniv~l~~~~~~~~~~~lv~e~~~~  166 (414)
                      ||+|+||+||+|... +++.||||++........    ....+..++...   .||||+++++.+......|+||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999976 589999999875432111    112222344333   799999999999999999999999999


Q ss_pred             CchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccccc
Q 015027          167 GTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAM  246 (414)
Q Consensus       167 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  246 (414)
                      |+|.+++....   .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++.......  ..
T Consensus        81 g~L~~~l~~~~---~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~  152 (330)
T cd05586          81 GELFWHLQKEG---RFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KT  152 (330)
T ss_pred             ChHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CC
Confidence            99998886433   3478889999999999999999987   9999999999999999999999999987543221  12


Q ss_pred             eecccccccccchhhcccC-CCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccccC
Q 015027          247 STILIGTSGYLDPVCINTG-KLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVA  325 (414)
Q Consensus       247 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (414)
                      .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.......         ....+.....      .+.
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~---------~~~~i~~~~~------~~~  217 (330)
T cd05586         153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ---------MYRNIAFGKV------RFP  217 (330)
T ss_pred             ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH---------HHHHHHcCCC------CCC
Confidence            3345799999999998754 58999999999999999999999986432111         1111111110      000


Q ss_pred             CcccHHHHHHHHHHHHHhhccCCCCCCCh
Q 015027          326 DESEMKEIEIVAELASKCLRIRGTERPTM  354 (414)
Q Consensus       326 ~~~~~~~~~~l~~Li~~cl~~dP~~Rps~  354 (414)
                      .   ...+..+.+|+.+||+.||.+||++
T Consensus       218 ~---~~~~~~~~~li~~~L~~~P~~R~~~  243 (330)
T cd05586         218 K---NVLSDEGRQFVKGLLNRNPQHRLGA  243 (330)
T ss_pred             C---ccCCHHHHHHHHHHcCCCHHHCCCC
Confidence            0   0112458999999999999999954

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.6e-39  Score=303.44  Aligned_cols=246  Identities=25%  Similarity=0.352  Sum_probs=194.5

Q ss_pred             CCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc--hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeC
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK--IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFA  164 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  164 (414)
                      .|...+.||+|+||.||+|.+. ++..||+|.+.....  .......++.++++++||||+++++++..+...++||||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            3556678999999999999865 578899999874432  2233466778999999999999999999999999999999


Q ss_pred             CCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccc
Q 015027          165 SNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET  244 (414)
Q Consensus       165 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  244 (414)
                      ++++|.+++..    ..+++..+..++.+++.|+.|||+.+   ++|+||+|+||++++++.++|+|||++.......  
T Consensus        85 ~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--  155 (277)
T cd06642          85 GGGSALDLLKP----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--  155 (277)
T ss_pred             CCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc--
Confidence            99999998853    23578889999999999999999977   9999999999999999999999999987654321  


Q ss_pred             cceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccccccc
Q 015027          245 AMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHV  324 (414)
Q Consensus       245 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (414)
                      .......++..|+|||++.+..++.++|||||||++|||++|+.||.......         .........     .+..
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---------~~~~~~~~~-----~~~~  221 (277)
T cd06642         156 IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR---------VLFLIPKNS-----PPTL  221 (277)
T ss_pred             hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh---------HHhhhhcCC-----CCCC
Confidence            11223467889999999999999999999999999999999999986322111         000000000     0111


Q ss_pred             CCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHH
Q 015027          325 ADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEE  360 (414)
Q Consensus       325 ~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~  360 (414)
                          ....+..+.+++.+||+.+|.+||++.++++.
T Consensus       222 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         222 ----EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             ----CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence                11223558999999999999999999999874

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-39  Score=300.53  Aligned_cols=252  Identities=23%  Similarity=0.281  Sum_probs=196.8

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchh-HhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEe
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIR-ITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  163 (414)
                      .++|++.+.||.|+||.||+|... ++..+|+|.+....... ..+..++.++++++||||+++++.+..+...++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            457889999999999999999975 58899999987654322 3345667899999999999999999999999999999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcc
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE  243 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  243 (414)
                      +++++|.+++.....  .+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++....... 
T Consensus        84 ~~~~~L~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-  157 (280)
T cd06611          84 CDGGALDSIMLELER--GLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL-  157 (280)
T ss_pred             cCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc-
Confidence            999999999865432  3578899999999999999999988   9999999999999999999999999987654321 


Q ss_pred             ccceecccccccccchhhcc-----cCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccc
Q 015027          244 TAMSTILIGTSGYLDPVCIN-----TGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQ  318 (414)
Q Consensus       244 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (414)
                       .......+++.|+|||.+.     +..++.++||||||+++|+|++|+.||.......         ........... 
T Consensus       158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~---------~~~~~~~~~~~-  226 (280)
T cd06611         158 -QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR---------VLLKILKSEPP-  226 (280)
T ss_pred             -cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH---------HHHHHhcCCCC-
Confidence             1223456889999999974     3457789999999999999999999987432111         00011111000 


Q ss_pred             ccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHH
Q 015027          319 ILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEE  360 (414)
Q Consensus       319 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~  360 (414)
                          .+  ..+...+..+.+++.+||+.+|.+||++.++++.
T Consensus       227 ----~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         227 ----TL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             ----Cc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence                00  0011122458999999999999999999999653

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.7e-39  Score=312.88  Aligned_cols=193  Identities=23%  Similarity=0.266  Sum_probs=162.3

Q ss_pred             HHhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEE
Q 015027           84 RATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYE  162 (414)
Q Consensus        84 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  162 (414)
                      ....+|.+.+.||+|+||.||+|... ++..||+|+......     ..++.++++++||||+++++++......++|||
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~~-----~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  137 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTT-----LIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP  137 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcccc-----HHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence            34468999999999999999999976 478899997543321     335678999999999999999999999999999


Q ss_pred             eCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCc
Q 015027          163 FASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDA  242 (414)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  242 (414)
                      |+. ++|.+++....  ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++...... 
T Consensus       138 ~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-  210 (357)
T PHA03209        138 HYS-SDLYTYLTKRS--RPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-  210 (357)
T ss_pred             ccC-CcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC-
Confidence            995 58888875433  34588999999999999999999987   999999999999999999999999998754322 


Q ss_pred             cccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCC
Q 015027          243 ETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPG  290 (414)
Q Consensus       243 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~  290 (414)
                        .......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus       211 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        211 --PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             --cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence              1223356899999999999999999999999999999999865543

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=5.6e-39  Score=296.03  Aligned_cols=248  Identities=23%  Similarity=0.313  Sum_probs=195.1

Q ss_pred             CCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc---hhHhHHHHHHHHHccCCCceeeeeeeEec-CCcceEEEE
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK---IRITERELLRIISQVNHKNVVKILGLCLE-TEVPLLVYE  162 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~hpniv~l~~~~~~-~~~~~lv~e  162 (414)
                      +|++.+.||.|++|.||++... +++.||+|.+.....   .......+++++++++|||++++++.+.. +...++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4788999999999999999965 478899999875432   22334556788999999999999998764 446789999


Q ss_pred             eCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCc
Q 015027          163 FASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDA  242 (414)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  242 (414)
                      |+++++|.+++..... ..+++.++..++.+++.|+++||+.+   ++|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~l~~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~  156 (257)
T cd08223          81 FCEGGDLYHKLKEQKG-KLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC  156 (257)
T ss_pred             ccCCCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence            9999999999865332 34588999999999999999999987   9999999999999999999999999987664321


Q ss_pred             cccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccccc
Q 015027          243 ETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNF  322 (414)
Q Consensus       243 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (414)
                        .......+++.|+|||++.+..++.++||||||+++|+|++|+.||.......         ..........     +
T Consensus       157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~---------~~~~~~~~~~-----~  220 (257)
T cd08223         157 --DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS---------LVYRIIEGKL-----P  220 (257)
T ss_pred             --CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH---------HHHHHHhcCC-----C
Confidence              22334568899999999999999999999999999999999999986332111         0000101100     0


Q ss_pred             ccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          323 HVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       323 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                          ..+...+..+.+++.+||+.+|.+|||+.++++
T Consensus       221 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         221 ----PMPKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             ----CCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                011123356999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=7.9e-39  Score=296.48  Aligned_cols=256  Identities=25%  Similarity=0.356  Sum_probs=200.4

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc--hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEe
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK--IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  163 (414)
                      ++|++.+.||.|+||+||+|... ++..+++|++.....  ......+++..++.++||||+++++.+..+...++||||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            47889999999999999999965 578899999865432  223346667889999999999999999999999999999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcc
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE  243 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  243 (414)
                      +++++|.+++........+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++........
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            999999999976544345688899999999999999999987   99999999999999999999999999877654322


Q ss_pred             cc--ceecccccccccchhhcccC-CCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccc
Q 015027          244 TA--MSTILIGTSGYLDPVCINTG-KLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQIL  320 (414)
Q Consensus       244 ~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (414)
                      ..  ......|+..|+|||++... .++.++|+|||||++|+|++|+.||.......        .+...... .     
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--------~~~~~~~~-~-----  223 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--------VLMLTLQN-D-----  223 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--------hHHHHhcC-C-----
Confidence            21  22345688999999998776 78999999999999999999999986432211        00000000 0     


Q ss_pred             ccccCCc-ccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          321 NFHVADE-SEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       321 ~~~~~~~-~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      .+..... .....+..+.+++.+||..+|.+|||+.++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         224 PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            0000000 01122356899999999999999999999865

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=8.7e-39  Score=299.21  Aligned_cols=248  Identities=23%  Similarity=0.276  Sum_probs=191.1

Q ss_pred             CCCCCccccCCceEEEEEEEcC-CcEEEEEEeecccch-hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCCC
Q 015027           89 FDRSRCLSQGGFVSVYKGVLHD-NIQVAVKTYRRADKI-RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASN  166 (414)
Q Consensus        89 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  166 (414)
                      |++.+.||+|+||.||+|.... +..+++|.+...... ......++++++.++||||+++++++..+...++||||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            5678889999999999999764 778899988654322 23345567889999999999999999999999999999999


Q ss_pred             CchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccccc
Q 015027          167 GTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAM  246 (414)
Q Consensus       167 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  246 (414)
                      ++|..++....  ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.......  ..
T Consensus        87 ~~l~~~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~  159 (282)
T cd06643          87 GAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QR  159 (282)
T ss_pred             CcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--cc
Confidence            99988875432  34588899999999999999999987   9999999999999999999999999987643221  12


Q ss_pred             eecccccccccchhhcc-----cCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccc
Q 015027          247 STILIGTSGYLDPVCIN-----TGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILN  321 (414)
Q Consensus       247 ~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (414)
                      .....+++.|+|||++.     +..++.++|||||||++|+|++|.+||.......        .... ......     
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--------~~~~-~~~~~~-----  225 (282)
T cd06643         160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR--------VLLK-IAKSEP-----  225 (282)
T ss_pred             cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH--------HHHH-HhhcCC-----
Confidence            23356889999999983     4567889999999999999999999986432110        0000 000000     


Q ss_pred             cccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          322 FHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       322 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      +...  .+...+..+.+|+.+||+.+|.+||++.++++
T Consensus       226 ~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         226 PTLA--QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             CCCC--CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0000  01112255899999999999999999998843

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=4.8e-39  Score=306.02  Aligned_cols=196  Identities=22%  Similarity=0.333  Sum_probs=157.2

Q ss_pred             CccccCCceEEEEEEEc---CCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEec--CCcceEEEEeCCCC
Q 015027           93 RCLSQGGFVSVYKGVLH---DNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLE--TEVPLLVYEFASNG  167 (414)
Q Consensus        93 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~--~~~~~lv~e~~~~g  167 (414)
                      .+||+|+||.||+|...   ++..||+|.+..... .....+++.++++++||||+++++++..  +...++||||+++ 
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-   84 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-   84 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-
Confidence            57999999999999965   357899998875433 2334566789999999999999999854  5577999999975 


Q ss_pred             chhhhhhhc------CCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceee----CCCCcEEEeecccccc
Q 015027          168 TLLDHIRCE------SSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILL----NDNYTAKVADFESSVL  237 (414)
Q Consensus       168 sL~~~l~~~------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll----~~~~~~kl~DfGla~~  237 (414)
                      +|.+++...      .....+++..+..++.||+.||.|||+.+   |+||||||+|||+    +.++.+||+|||+++.
T Consensus        85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07867          85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence            676666421      11234678889999999999999999987   9999999999999    5678999999999987


Q ss_pred             ccCCccc-cceecccccccccchhhccc-CCCCCcccchhHHHHHHHHHhCCCCCCcc
Q 015027          238 ISSDAET-AMSTILIGTSGYLDPVCINT-GKLTKKSDVYSFGVVLAELLTGKKPGSCM  293 (414)
Q Consensus       238 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~  293 (414)
                      ....... .......+|+.|+|||++.+ ..++.++|||||||++|||+||.+||...
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            6543221 12234578999999999876 45899999999999999999999999643

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=5.7e-39  Score=295.91  Aligned_cols=249  Identities=25%  Similarity=0.318  Sum_probs=198.5

Q ss_pred             CCCCCCccccCCceEEEEEEEc-CCcEEEEEEeeccc---chhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEe
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRAD---KIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  163 (414)
                      +|+..+.||.|+||.||.+... ++..+++|.+....   ........++.++++++|+||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            5888999999999999999855 58899999886543   2223345667899999999999999999999999999999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcc
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE  243 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  243 (414)
                      +++++|.+++.... ...+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++........
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~  156 (256)
T cd08221          81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS  156 (256)
T ss_pred             cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence            99999999986543 234588899999999999999999987   99999999999999999999999999886644321


Q ss_pred             ccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccc
Q 015027          244 TAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFH  323 (414)
Q Consensus       244 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (414)
                        ......+++.|+|||.+.+..++.++||||||+++|+|++|..||.......         ............     
T Consensus       157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~---------~~~~~~~~~~~~-----  220 (256)
T cd08221         157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN---------LVVKIVQGNYTP-----  220 (256)
T ss_pred             --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH---------HHHHHHcCCCCC-----
Confidence              2334578999999999998889999999999999999999999986322110         111111111100     


Q ss_pred             cCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHH
Q 015027          324 VADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEE  360 (414)
Q Consensus       324 ~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~  360 (414)
                          .....+..+.+++.+||..+|.+|||+.++++.
T Consensus       221 ----~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         221 ----VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             ----CccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence                001223558999999999999999999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.8e-39  Score=335.74  Aligned_cols=254  Identities=21%  Similarity=0.279  Sum_probs=193.9

Q ss_pred             HhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc---hhHhHHHHHHHHHccCCCceeeeeeeEec--CCcce
Q 015027           85 ATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK---IRITERELLRIISQVNHKNVVKILGLCLE--TEVPL  158 (414)
Q Consensus        85 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~hpniv~l~~~~~~--~~~~~  158 (414)
                      ..++|.+++.||+|+||+||+|.+. ++..||+|.+.....   ....+..++.++.+++|||||+++++|..  ...+|
T Consensus        11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly   90 (1021)
T PTZ00266         11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY   90 (1021)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence            3468999999999999999999976 477899999875422   22334567789999999999999998864  35689


Q ss_pred             EEEEeCCCCchhhhhhhcC-CcccCCHHHHHHHHHHHHHHHHHhhhCCC----CCeeeCCCCCCceeeCC----------
Q 015027          159 LVYEFASNGTLLDHIRCES-SQVLKTWKTCLRIAAETASALDYLHSLAS----PPIIHGDVKSANILLND----------  223 (414)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~----~~iiH~Dlkp~NIll~~----------  223 (414)
                      |||||+++|+|.++|.... ....+++..++.|+.||+.||.|||+.+.    .+|+||||||+||||+.          
T Consensus        91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~  170 (1021)
T PTZ00266         91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA  170 (1021)
T ss_pred             EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence            9999999999999986432 22356889999999999999999998542    35999999999999964          


Q ss_pred             -------CCcEEEeeccccccccCCccccceecccccccccchhhccc--CCCCCcccchhHHHHHHHHHhCCCCCCccc
Q 015027          224 -------NYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINT--GKLTKKSDVYSFGVVLAELLTGKKPGSCMT  294 (414)
Q Consensus       224 -------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGvil~el~tg~~p~~~~~  294 (414)
                             .+.+||+|||++.......   ......||+.|+|||++.+  ..++.++||||||||||||++|..||....
T Consensus       171 ~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~  247 (1021)
T PTZ00266        171 QANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN  247 (1021)
T ss_pred             cccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence                   3458999999998664321   2234579999999999854  458899999999999999999999996322


Q ss_pred             cccccccccchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          295 LASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ...        .+...+....       .+..   ...+..+.+||..||+.+|.+||++.+++.
T Consensus       248 ~~~--------qli~~lk~~p-------~lpi---~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        248 NFS--------QLISELKRGP-------DLPI---KGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             cHH--------HHHHHHhcCC-------CCCc---CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            110        0111111100       0000   011256899999999999999999999974

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.7e-39  Score=302.07  Aligned_cols=255  Identities=26%  Similarity=0.320  Sum_probs=197.8

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc--hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEe
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK--IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  163 (414)
                      ++|++.+.||+|+||+||++... ++..||+|++.....  .......++++++.++||||+++++++.....+++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            56888899999999999999965 588999998875432  233446677899999999999999999999999999999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhh-CCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCc
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHS-LASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDA  242 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  242 (414)
                      +++++|.+++...+   .+++..+..++.+++.||.|||+ .+   ++|+||+|+||++++++.++|+|||++...... 
T Consensus        85 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~-  157 (284)
T cd06620          85 MDCGSLDRIYKKGG---PIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-  157 (284)
T ss_pred             CCCCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhh-
Confidence            99999998886532   35788999999999999999997 35   999999999999999999999999998654322 


Q ss_pred             cccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccc---cccchhhhhhhcccccccc
Q 015027          243 ETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKK---ISMVPYFLNSIKNNGLRQI  319 (414)
Q Consensus       243 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  319 (414)
                         ......|+..|+|||++.+..++.++|||||||++|+|++|..||..........   ...... ...        +
T Consensus       158 ---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~--------~  225 (284)
T cd06620         158 ---IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL-LQQ--------I  225 (284)
T ss_pred             ---ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHH-HHH--------H
Confidence               1223578999999999988899999999999999999999999997433211100   000000 000        1


Q ss_pred             cccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHH
Q 015027          320 LNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEE  360 (414)
Q Consensus       320 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~  360 (414)
                      .............+..+.+|+.+||+.||.+|||+.++++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~  266 (284)
T cd06620         226 VQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM  266 (284)
T ss_pred             hhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            10000111111233568999999999999999999999765

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=7.5e-39  Score=297.40  Aligned_cols=252  Identities=23%  Similarity=0.307  Sum_probs=194.3

Q ss_pred             CCCCCCccccCCceEEEEEEEcC--CcEEEEEEeecccc-----------hhHhHHHHHHHHH-ccCCCceeeeeeeEec
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLHD--NIQVAVKTYRRADK-----------IRITERELLRIIS-QVNHKNVVKILGLCLE  153 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~-----------~~~~~~~~~~~l~-~l~hpniv~l~~~~~~  153 (414)
                      +|.+.+.||+|+||.||+|.+..  +..+|+|.+.....           .......++.++. .++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47888999999999999999765  68899998864321           1112233445554 4799999999999999


Q ss_pred             CCcceEEEEeCCCCchhhhhhhc-CCcccCCHHHHHHHHHHHHHHHHHhhh-CCCCCeeeCCCCCCceeeCCCCcEEEee
Q 015027          154 TEVPLLVYEFASNGTLLDHIRCE-SSQVLKTWKTCLRIAAETASALDYLHS-LASPPIIHGDVKSANILLNDNYTAKVAD  231 (414)
Q Consensus       154 ~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~D  231 (414)
                      ++..++||||+++++|.+++... .....+++..++.++.|++.||.|||+ .+   ++|+||+|+||+++.++.+||+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence            99999999999999999887542 223346788899999999999999996 45   99999999999999999999999


Q ss_pred             ccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhh
Q 015027          232 FESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSI  311 (414)
Q Consensus       232 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  311 (414)
                      ||++.......   ......++..|+|||.+.+..++.++||||||+++|+|++|..||.......         .....
T Consensus       158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~---------~~~~~  225 (269)
T cd08528         158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS---------LATKI  225 (269)
T ss_pred             ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH---------HHHHH
Confidence            99998755432   2334568889999999998889999999999999999999999986332111         01111


Q ss_pred             cccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHH
Q 015027          312 KNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELD  362 (414)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~  362 (414)
                      ........        .....+..+.+++.+||+.||.+||++.++..+++
T Consensus       226 ~~~~~~~~--------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         226 VEAVYEPL--------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             hhccCCcC--------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            11111100        00112256899999999999999999999988764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=4.6e-39  Score=301.00  Aligned_cols=250  Identities=24%  Similarity=0.281  Sum_probs=189.0

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch--hHhH-HHHHHHHHccCCCceeeeeeeEecCCcceEEEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI--RITE-RELLRIISQVNHKNVVKILGLCLETEVPLLVYE  162 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~-~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  162 (414)
                      ++|.+.+.||+|+||.||+|.+. +|..||+|.+......  .... .+....++.++||||+++++++..++..|+|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            46889999999999999999976 5899999998764321  1122 233234667789999999999999999999999


Q ss_pred             eCCCCchhhhhhhc-CCcccCCHHHHHHHHHHHHHHHHHhhhC-CCCCeeeCCCCCCceeeCCCCcEEEeeccccccccC
Q 015027          163 FASNGTLLDHIRCE-SSQVLKTWKTCLRIAAETASALDYLHSL-ASPPIIHGDVKSANILLNDNYTAKVADFESSVLISS  240 (414)
Q Consensus       163 ~~~~gsL~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~-~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  240 (414)
                      |++ |+|.+++... .....+++..++.++.||+.||+|||++ +   ++||||||+||+++.++.+||+|||++.....
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            997 5787777542 2334568999999999999999999986 5   99999999999999999999999999876542


Q ss_pred             Cccccceecccccccccchhhccc----CCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccc
Q 015027          241 DAETAMSTILIGTSGYLDPVCINT----GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGL  316 (414)
Q Consensus       241 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (414)
                      .   .......++..|+|||.+.+    ..++.++|+|||||++|+|++|+.||.......       ....... ....
T Consensus       157 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~-~~~~  225 (283)
T cd06617         157 S---VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF-------QQLKQVV-EEPS  225 (283)
T ss_pred             c---cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH-------HHHHHHH-hcCC
Confidence            2   11233467889999998865    456889999999999999999999986321100       0000000 0000


Q ss_pred             ccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          317 RQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                           +...   ....+..+.+++.+||..+|.+|||+.++++
T Consensus       226 -----~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         226 -----PQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             -----CCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                 0110   0112356899999999999999999999865

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=3.2e-39  Score=297.40  Aligned_cols=246  Identities=26%  Similarity=0.405  Sum_probs=193.7

Q ss_pred             cCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCCC
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASN  166 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  166 (414)
                      ++|.+.+.||+|+||.||++.. +++.||+|.+..... ......++.+++.++|||++++++++..+ ..++||||+++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~~-~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~   82 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDVT-AQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSK   82 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcch-HHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCC
Confidence            5688999999999999999875 678899999865433 23445667899999999999999998765 47999999999


Q ss_pred             CchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccccc
Q 015027          167 GTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAM  246 (414)
Q Consensus       167 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  246 (414)
                      ++|.+++..... ...++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++......     
T Consensus        83 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-----  153 (254)
T cd05083          83 GNLVNFLRTRGR-ALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-----  153 (254)
T ss_pred             CCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc-----
Confidence            999999865433 23578889999999999999999977   999999999999999999999999998754321     


Q ss_pred             eecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhcccccccccccccC
Q 015027          247 STILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVA  325 (414)
Q Consensus       247 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (414)
                      ......+..|+|||.+.+..++.++||||||+++|+|++ |+.||.......         ........ ..        
T Consensus       154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---------~~~~~~~~-~~--------  215 (254)
T cd05083         154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE---------VKECVEKG-YR--------  215 (254)
T ss_pred             CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH---------HHHHHhCC-CC--------
Confidence            111234567999999998899999999999999999998 999986433211         11111111 00        


Q ss_pred             CcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHH
Q 015027          326 DESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELD  362 (414)
Q Consensus       326 ~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~  362 (414)
                      .......+..+.+++.+||+.+|.+||++.+++..|+
T Consensus       216 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  252 (254)
T cd05083         216 MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE  252 (254)
T ss_pred             CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence            0011122356899999999999999999999988775

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7e-39  Score=298.00  Aligned_cols=254  Identities=27%  Similarity=0.345  Sum_probs=197.1

Q ss_pred             HhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhHhHHHHHHHHHcc-CCCceeeeeeeEecCC------c
Q 015027           85 ATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRITERELLRIISQV-NHKNVVKILGLCLETE------V  156 (414)
Q Consensus        85 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~l~~l-~hpniv~l~~~~~~~~------~  156 (414)
                      .+++|++.+.||+|++|.||+|... +++.+++|++............++.+++++ .||||+++++++....      .
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ   83 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence            4688999999999999999999975 578999999887665545556677888888 6999999999997644      4


Q ss_pred             ceEEEEeCCCCchhhhhhhcC-CcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccc
Q 015027          157 PLLVYEFASNGTLLDHIRCES-SQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESS  235 (414)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla  235 (414)
                      .++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~~  160 (275)
T cd06608          84 LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVS  160 (275)
T ss_pred             EEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCccc
Confidence            899999999999999886432 2234578889999999999999999987   999999999999999999999999998


Q ss_pred             ccccCCccccceecccccccccchhhccc-----CCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhh
Q 015027          236 VLISSDAETAMSTILIGTSGYLDPVCINT-----GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNS  310 (414)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  310 (414)
                      .......  .......+++.|+|||++..     ..++.++|||||||++|+|++|..||.......         ....
T Consensus       161 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---------~~~~  229 (275)
T cd06608         161 AQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR---------ALFK  229 (275)
T ss_pred             eecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH---------HHHH
Confidence            7654321  12234568889999998753     347789999999999999999999986322110         0000


Q ss_pred             hcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          311 IKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ......     +..  ......+..+.+|+.+||..||++|||+.++++
T Consensus       230 ~~~~~~-----~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         230 IPRNPP-----PTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             hhccCC-----CCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            111100     000  111123356899999999999999999999864

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.2e-39  Score=295.66  Aligned_cols=252  Identities=23%  Similarity=0.310  Sum_probs=198.4

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch-hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeC
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI-RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFA  164 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  164 (414)
                      ++|.+.+.||.|+||.||+|... ++..+++|.+...... ......++.++++++||||+++++++......+++|||+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            57889999999999999999975 5788999999765432 234466678999999999999999999999999999999


Q ss_pred             CCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccc
Q 015027          165 SNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET  244 (414)
Q Consensus       165 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  244 (414)
                      ++++|.+++....  ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++.......  
T Consensus        83 ~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--  155 (262)
T cd06613          83 GGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--  155 (262)
T ss_pred             CCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh--
Confidence            9999999886542  23478889999999999999999987   9999999999999999999999999987654321  


Q ss_pred             cceecccccccccchhhcccC---CCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccc
Q 015027          245 AMSTILIGTSGYLDPVCINTG---KLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILN  321 (414)
Q Consensus       245 ~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (414)
                      .......++..|+|||.+.+.   .++.++||||||+++|+|++|..||........         ..........   .
T Consensus       156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~---------~~~~~~~~~~---~  223 (262)
T cd06613         156 AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA---------LFLISKSNFP---P  223 (262)
T ss_pred             hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH---------HHHHHhccCC---C
Confidence            122335688899999999776   889999999999999999999999864321110         0000000000   0


Q ss_pred             cccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          322 FHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       322 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ..  .......+..+.+++.+||..+|..|||+.+|+.
T Consensus       224 ~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         224 PK--LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             cc--ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            00  0112233466999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-39  Score=305.43  Aligned_cols=251  Identities=22%  Similarity=0.283  Sum_probs=195.7

Q ss_pred             cCCCCCCccccCCceEEEEEEEcC-CcEEEEEEeecccchh----HhHHHHHHHHHccCCCceeeeeeeEecCCcceEEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLHD-NIQVAVKTYRRADKIR----ITERELLRIISQVNHKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~----~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~  161 (414)
                      ++|+..+.||+|+||.||+|...+ +..||+|.+.......    ....++++++..++||||+++++.+..+...|+||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            468889999999999999999764 8999999997654321    23456678999999999999999999999999999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCC
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD  241 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  241 (414)
                      ||+.+++|.+++.... ...+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++......
T Consensus        81 e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          81 DYCPGGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             EecCCCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence            9999999999886432 234578889999999999999999987   999999999999999999999999998754322


Q ss_pred             ccc---------------------------cceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccc
Q 015027          242 AET---------------------------AMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMT  294 (414)
Q Consensus       242 ~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~  294 (414)
                      ...                           .......||..|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  236 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN  236 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            110                           01123468889999999999899999999999999999999999997443


Q ss_pred             cccccccccchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCC----hhHHH
Q 015027          295 LASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPT----MKQVS  358 (414)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps----~~~v~  358 (414)
                      ...        .+.. .        .............+..+.+++.+||..+|++|||    +.+++
T Consensus       237 ~~~--------~~~~-~--------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll  287 (316)
T cd05574         237 RDE--------TFSN-I--------LKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIK  287 (316)
T ss_pred             hHH--------HHHH-H--------hcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHH
Confidence            211        0000 0        0000001111113466999999999999999999    55553

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.5e-38  Score=295.81  Aligned_cols=253  Identities=20%  Similarity=0.325  Sum_probs=193.4

Q ss_pred             CCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch-----------hHhHHHHHHHHHccCCCceeeeeeeEecCC
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI-----------RITERELLRIISQVNHKNVVKILGLCLETE  155 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----------~~~~~~~~~~l~~l~hpniv~l~~~~~~~~  155 (414)
                      +|...+.||.|+||.||+|... +++.+|+|.+......           ......++.+++.++||||+++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            4778889999999999999865 5889999988642111           112345668899999999999999999999


Q ss_pred             cceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccc
Q 015027          156 VPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESS  235 (414)
Q Consensus       156 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla  235 (414)
                      ..++||||+++++|.+++...   ..+++..+..++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~  155 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS  155 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence            999999999999999998654   24578888999999999999999977   999999999999999999999999998


Q ss_pred             ccccCCccccceecccccccccchhhcccCC--CCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcc
Q 015027          236 VLISSDAETAMSTILIGTSGYLDPVCINTGK--LTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKN  313 (414)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  313 (414)
                      ................++..|+|||.+....  ++.++|+||||+++|+|++|..||.......       . ... ...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-------~-~~~-~~~  226 (272)
T cd06629         156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA-------A-MFK-LGN  226 (272)
T ss_pred             ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH-------H-HHH-hhc
Confidence            7654322222223446788999999987654  8899999999999999999999986322110       0 000 000


Q ss_pred             cccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          314 NGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ......+..    ......+..+.+++.+||..+|.+|||+.+|++
T Consensus       227 ~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         227 KRSAPPIPP----DVSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             cccCCcCCc----cccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            000111111    111122356999999999999999999999865

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.3e-39  Score=300.21  Aligned_cols=237  Identities=26%  Similarity=0.396  Sum_probs=181.1

Q ss_pred             ccccCCceEEEEEEEcC-------------------------CcEEEEEEeecccch-hHhHHHHHHHHHccCCCceeee
Q 015027           94 CLSQGGFVSVYKGVLHD-------------------------NIQVAVKTYRRADKI-RITERELLRIISQVNHKNVVKI  147 (414)
Q Consensus        94 ~lg~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~hpniv~l  147 (414)
                      .||+|+||.||+|....                         ...|++|++...... ...+.+++.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            58999999999997421                         135889988654332 2344666788999999999999


Q ss_pred             eeeEecCCcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCC--
Q 015027          148 LGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNY--  225 (414)
Q Consensus       148 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~--  225 (414)
                      +++|..+...++||||+++|+|..++.....  .+++..+..++.||+.||+|||+.+   |+||||||+|||++..+  
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKG--RVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence            9999999999999999999999988865333  3478889999999999999999977   99999999999997643  


Q ss_pred             -----cEEEeeccccccccCCccccceecccccccccchhhccc-CCCCCcccchhHHHHHHHHH-hCCCCCCccccccc
Q 015027          226 -----TAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINT-GKLTKKSDVYSFGVVLAELL-TGKKPGSCMTLASN  298 (414)
Q Consensus       226 -----~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~-tg~~p~~~~~~~~~  298 (414)
                           .+|++|||++......      ....++..|+|||.+.+ ..++.++|||||||++|||+ +|..||........
T Consensus       157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~  230 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK  230 (274)
T ss_pred             cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence                 4899999987644221      12356778999998865 56899999999999999995 69999864322110


Q ss_pred             cccccchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHH
Q 015027          299 KKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEEL  361 (414)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L  361 (414)
                            ..+.   ...       ......    ....+.+++.+||+.+|.+|||+.+|++.|
T Consensus       231 ------~~~~---~~~-------~~~~~~----~~~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         231 ------ERFY---EKK-------HRLPEP----SCKELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             ------HHHH---Hhc-------cCCCCC----CChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence                  0000   000       000111    113589999999999999999999998876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.3e-38  Score=345.73  Aligned_cols=263  Identities=26%  Similarity=0.418  Sum_probs=203.5

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeC
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFA  164 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  164 (414)
                      ...|.....||+|+||.||+|... ++..||||.+.......   .++++.+++++|||||+++++|.+.+..|+||||+
T Consensus       689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~  765 (968)
T PLN00113        689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP---SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI  765 (968)
T ss_pred             HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc---HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence            356778889999999999999974 68999999986544322   23367889999999999999999999999999999


Q ss_pred             CCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccc
Q 015027          165 SNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET  244 (414)
Q Consensus       165 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  244 (414)
                      ++|+|.+++..      ++|..+..++.||+.||+|||..+.++|+||||||+||+++.++..++. ||.+......   
T Consensus       766 ~~g~L~~~l~~------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~---  835 (968)
T PLN00113        766 EGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD---  835 (968)
T ss_pred             CCCcHHHHHhc------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC---
Confidence            99999999842      5889999999999999999996655669999999999999999888876 6655433211   


Q ss_pred             cceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccccccc
Q 015027          245 AMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHV  324 (414)
Q Consensus       245 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (414)
                         ....+|+.|+|||++.+..++.++|||||||++|||+||+.||.....   .......+.............+++..
T Consensus       836 ---~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~  909 (968)
T PLN00113        836 ---TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG---VHGSIVEWARYCYSDCHLDMWIDPSI  909 (968)
T ss_pred             ---CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC---CCCcHHHHHHHhcCccchhheeCccc
Confidence               223678999999999999999999999999999999999999853211   11122222221111222223333333


Q ss_pred             CC--cccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHh
Q 015027          325 AD--ESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRL  367 (414)
Q Consensus       325 ~~--~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~  367 (414)
                      ..  .........+.+++.+||+.+|++|||+.+|++.|+.+.+.
T Consensus       910 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  954 (968)
T PLN00113        910 RGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS  954 (968)
T ss_pred             cCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence            22  22344556788999999999999999999999999987654

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.3e-38  Score=295.44  Aligned_cols=249  Identities=21%  Similarity=0.313  Sum_probs=190.5

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc------hhHhHHHHHHHHHccCCCceeeeeeeEec--CCcc
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK------IRITERELLRIISQVNHKNVVKILGLCLE--TEVP  157 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~~~~l~~l~hpniv~l~~~~~~--~~~~  157 (414)
                      .+|...+.||+|+||.||+|... ++..||+|.+.....      ......+++.+++.++||||+++++++..  ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            57899999999999999999975 589999998864321      11233556789999999999999998875  3567


Q ss_pred             eEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccccc
Q 015027          158 LLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVL  237 (414)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~  237 (414)
                      +++|||+++++|.+++....   .+++...+.++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++..
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~  155 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence            89999999999999986543   2477888899999999999999977   99999999999999999999999999876


Q ss_pred             ccCCcc-ccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccc
Q 015027          238 ISSDAE-TAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGL  316 (414)
Q Consensus       238 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (414)
                      ...... ........++..|+|||++.+..++.++|||||||++|||++|+.||.......        ... ...... 
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~--------~~~-~~~~~~-  225 (266)
T cd06651         156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA--------AIF-KIATQP-  225 (266)
T ss_pred             cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH--------HHH-HHhcCC-
Confidence            532211 111223457889999999999999999999999999999999999986432110        000 000000 


Q ss_pred             ccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          317 RQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                         ..+.    .+....+.+.+++ +||..+|++||++++|++
T Consensus       226 ---~~~~----~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         226 ---TNPQ----LPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             ---CCCC----CchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence               0111    1112224577777 788899999999999954

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=8e-39  Score=294.75  Aligned_cols=250  Identities=30%  Similarity=0.429  Sum_probs=196.0

Q ss_pred             CCCCCccccCCceEEEEEEEcC-C----cEEEEEEeecccc--hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEE
Q 015027           89 FDRSRCLSQGGFVSVYKGVLHD-N----IQVAVKTYRRADK--IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        89 ~~~~~~lg~G~~g~Vy~~~~~~-~----~~vavK~~~~~~~--~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~  161 (414)
                      |.+.+.||.|+||.||++.... +    ..||+|.+.....  .......++.++..++||||+++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            4567889999999999999754 3    7899999976543  2334466778899999999999999999999999999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCC
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD  241 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  241 (414)
                      ||+++++|.+++....... +++..+..++.|++.||++||+.+   ++|+||||+||++++++.++|+|||++......
T Consensus        81 e~~~~~~l~~~~~~~~~~~-~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKE-LSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             eccCCCCHHHHHHhhhhcc-CCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence            9999999999986544321 588999999999999999999987   999999999999999999999999999776543


Q ss_pred             ccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhccccccccc
Q 015027          242 AETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQIL  320 (414)
Q Consensus       242 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (414)
                      ..... ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......         ........... ..
T Consensus       157 ~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~---------~~~~~~~~~~~-~~  225 (258)
T smart00219      157 DYYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE---------VLEYLKKGYRL-PK  225 (258)
T ss_pred             ccccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH---------HHHHHhcCCCC-CC
Confidence            21111 12336789999999988889999999999999999998 888886422111         11111111100 00


Q ss_pred             ccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHH
Q 015027          321 NFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEEL  361 (414)
Q Consensus       321 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L  361 (414)
                              ....+..+.+++.+||..+|.+|||+.++++.|
T Consensus       226 --------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      226 --------PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             --------CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                    011235689999999999999999999998754

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.4e-39  Score=308.72  Aligned_cols=263  Identities=21%  Similarity=0.284  Sum_probs=191.2

Q ss_pred             HHhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch---hHhHHHHHHHHHccCCCceeeeeeeEecC-----
Q 015027           84 RATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI---RITERELLRIISQVNHKNVVKILGLCLET-----  154 (414)
Q Consensus        84 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~hpniv~l~~~~~~~-----  154 (414)
                      ...++|.+.+.||.|+||.||+|... ++..||||.+......   .....++++++++++||||+++++++...     
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            34678999999999999999999965 5889999998754321   22334567899999999999999987543     


Q ss_pred             -CcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecc
Q 015027          155 -EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFE  233 (414)
Q Consensus       155 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG  233 (414)
                       ...|++++++ +++|.+++..    ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg  163 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVKC----QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG  163 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCc
Confidence             3468999988 7788887743    23578899999999999999999988   9999999999999999999999999


Q ss_pred             ccccccCCccccceecccccccccchhhccc-CCCCCcccchhHHHHHHHHHhCCCCCCcccccccccc------ccchh
Q 015027          234 SSVLISSDAETAMSTILIGTSGYLDPVCINT-GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKI------SMVPY  306 (414)
Q Consensus       234 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~------~~~~~  306 (414)
                      ++......     .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........      ...+.
T Consensus       164 ~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  238 (343)
T cd07878         164 LARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPE  238 (343)
T ss_pred             cceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            99865432     233478999999999876 5789999999999999999999999964321110000      00000


Q ss_pred             hhhhhcccccccccc--cccCCcc----cHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          307 FLNSIKNNGLRQILN--FHVADES----EMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       307 ~~~~~~~~~~~~~~~--~~~~~~~----~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ...............  +......    .....+.+.+|+.+||+.||.+|||+.+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         239 VLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             HHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            000000000000000  0000000    0001245789999999999999999999964

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.7e-40  Score=317.05  Aligned_cols=242  Identities=25%  Similarity=0.379  Sum_probs=191.5

Q ss_pred             CCccccCCceEEEEEEEc-CCcEEEEEEeecc-----cchhHhHHHHHHHHHccCCCceeeeeeeEecCCc--ceEEEEe
Q 015027           92 SRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRA-----DKIRITERELLRIISQVNHKNVVKILGLCLETEV--PLLVYEF  163 (414)
Q Consensus        92 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~--~~lv~e~  163 (414)
                      ...||+|+|-+||+|.+. +|..||--.++..     ......+.+++.+|+.|+||||++++..|.+...  ..+|+|.
T Consensus        45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL  124 (632)
T KOG0584|consen   45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL  124 (632)
T ss_pred             hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence            456999999999999976 4878875443322     2223556788899999999999999999987665  7789999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCC-CCcEEEeeccccccccCCc
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLND-NYTAKVADFESSVLISSDA  242 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~DfGla~~~~~~~  242 (414)
                      +..|+|..|++..+.-   +.+.+..|++||++||.|||++. |+|||||||-+||||+. -|.|||+|+|+|...... 
T Consensus       125 ~TSGtLr~Y~kk~~~v---n~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s-  199 (632)
T KOG0584|consen  125 FTSGTLREYRKKHRRV---NIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS-  199 (632)
T ss_pred             ccCCcHHHHHHHhccC---CHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhcc-
Confidence            9999999999765543   66788999999999999999988 89999999999999986 599999999999987543 


Q ss_pred             cccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccccc
Q 015027          243 ETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNF  322 (414)
Q Consensus       243 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (414)
                         .....+|||.|||||+.. ..|++.+||||||+.++||+|+..||..-...    ..+...+...++...+..+-+ 
T Consensus       200 ---~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~----AQIYKKV~SGiKP~sl~kV~d-  270 (632)
T KOG0584|consen  200 ---HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP----AQIYKKVTSGIKPAALSKVKD-  270 (632)
T ss_pred             ---ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCH----HHHHHHHHcCCCHHHhhccCC-
Confidence               334479999999999987 89999999999999999999999998632211    112222222222222222222 


Q ss_pred             ccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          323 HVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       323 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                                 +++.++|.+||.. .++|||+.|++.
T Consensus       271 -----------Pevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  271 -----------PEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             -----------HHHHHHHHHHhcC-chhccCHHHHhh
Confidence                       4589999999999 999999999954

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.4e-38  Score=293.22  Aligned_cols=246  Identities=24%  Similarity=0.319  Sum_probs=194.9

Q ss_pred             CCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc------hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEE
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK------IRITERELLRIISQVNHKNVVKILGLCLETEVPLLV  160 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv  160 (414)
                      +|+..+.||+|+||.||+|... ++..|++|.+.....      .......++.+++.++||||+++++++..+...++|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4777889999999999999976 689999999875431      223345667889999999999999999999999999


Q ss_pred             EEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccC
Q 015027          161 YEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISS  240 (414)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  240 (414)
                      |||+++++|.+++....   .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++.....
T Consensus        81 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          81 LELVPGGSLAKLLKKYG---SFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             EEecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            99999999999986543   3478888999999999999999987   99999999999999999999999999876543


Q ss_pred             CccccceecccccccccchhhcccCC-CCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccc
Q 015027          241 DAETAMSTILIGTSGYLDPVCINTGK-LTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQI  319 (414)
Q Consensus       241 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (414)
                      ..   ......+++.|+|||.+.... ++.++|+||||+++|+|++|+.||.......         .............
T Consensus       155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~---------~~~~~~~~~~~~~  222 (258)
T cd06632         155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA---------AVFKIGRSKELPP  222 (258)
T ss_pred             cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH---------HHHHHHhcccCCC
Confidence            32   223456888999999987766 8999999999999999999999986432100         0000000000001


Q ss_pred             cccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          320 LNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       320 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      +.        ......+.+++.+||+.+|.+||++.+++.
T Consensus       223 ~~--------~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         223 IP--------DHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             cC--------CCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence            11        112255899999999999999999999864

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-40  Score=313.85  Aligned_cols=259  Identities=26%  Similarity=0.373  Sum_probs=214.0

Q ss_pred             hcCCCCCCccccCCceEEEEEEEcC-CcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeC
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLHD-NIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFA  164 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  164 (414)
                      ..+.....+||.|-||.||.|.|+. .-.||||.++.+.-.-+++..+..+|+.+.|||+|+++|+|..+...|||.|||
T Consensus       266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM  345 (1157)
T KOG4278|consen  266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM  345 (1157)
T ss_pred             chheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence            3455567889999999999999986 678999999988777777788889999999999999999999999999999999


Q ss_pred             CCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccc
Q 015027          165 SNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET  244 (414)
Q Consensus       165 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  244 (414)
                      ..|+|.+||+...... .+....+.++.||..|+.||...+   +|||||-+.|+|+.++..||++|||+++++..+..+
T Consensus       346 ~yGNLLdYLRecnr~e-v~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYT  421 (1157)
T KOG4278|consen  346 CYGNLLDYLRECNRSE-VPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYT  421 (1157)
T ss_pred             cCccHHHHHHHhchhh-cchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCcee
Confidence            9999999998766543 366777899999999999999877   999999999999999999999999999999877554


Q ss_pred             cceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhcccccccccccc
Q 015027          245 AMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFH  323 (414)
Q Consensus       245 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (414)
                      ..... .-...|.|||.+..+.++.|+|||+|||+|||+.| |-.||.+.+...                  +-.++...
T Consensus       422 AHAGA-KFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq------------------VY~LLEkg  482 (1157)
T KOG4278|consen  422 AHAGA-KFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------------------VYGLLEKG  482 (1157)
T ss_pred             cccCc-cCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH------------------HHHHHhcc
Confidence            43221 22457999999999999999999999999999998 888887544222                  11111112


Q ss_pred             cCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHh
Q 015027          324 VADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRL  367 (414)
Q Consensus       324 ~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~  367 (414)
                      ..-..+...++.+.+|++.||+++|..||++.++-+.++.+-..
T Consensus       483 yRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~  526 (1157)
T KOG4278|consen  483 YRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS  526 (1157)
T ss_pred             ccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence            22223333446699999999999999999999999999988653

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=8.8e-39  Score=297.49  Aligned_cols=255  Identities=25%  Similarity=0.358  Sum_probs=193.4

Q ss_pred             CCCCCccccCCceEEEEEEEc----CCcEEEEEEeecccch---hHhHHHHHHHHHccCCCceeeeeeeEecCC------
Q 015027           89 FDRSRCLSQGGFVSVYKGVLH----DNIQVAVKTYRRADKI---RITERELLRIISQVNHKNVVKILGLCLETE------  155 (414)
Q Consensus        89 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~hpniv~l~~~~~~~~------  155 (414)
                      |.+.+.||+|+||.||+|.+.    ++..||||++......   ......++++++.++||||+++++++...+      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567788999999999999853    3688999998764322   223455678999999999999999886532      


Q ss_pred             cceEEEEeCCCCchhhhhhhcC---CcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeec
Q 015027          156 VPLLVYEFASNGTLLDHIRCES---SQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADF  232 (414)
Q Consensus       156 ~~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df  232 (414)
                      ..+++++|+++|+|.+++....   ....+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence            2478999999999988874321   2234578889999999999999999977   999999999999999999999999


Q ss_pred             cccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhh
Q 015027          233 ESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSI  311 (414)
Q Consensus       233 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  311 (414)
                      |+++...............+++.|++||.+.+..++.++|||||||++|+|++ |..||.......         .....
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~---------~~~~~  228 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---------IYNYL  228 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH---------HHHHH
Confidence            99886643322222223345678999999998899999999999999999999 889986432110         00011


Q ss_pred             cccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHH
Q 015027          312 KNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL  364 (414)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i  364 (414)
                      .....     .....    ..+..+.+++.+||+.+|.+|||+.++++.|+.+
T Consensus       229 ~~~~~-----~~~~~----~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         229 IKGNR-----LKQPP----DCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             HcCCc-----CCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            10000     00001    1225699999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.5e-39  Score=300.50  Aligned_cols=239  Identities=25%  Similarity=0.423  Sum_probs=183.4

Q ss_pred             CccccCCceEEEEEEEcC-C-------cEEEEEEeecccch-hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEe
Q 015027           93 RCLSQGGFVSVYKGVLHD-N-------IQVAVKTYRRADKI-RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        93 ~~lg~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~-~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  163 (414)
                      +.||+|+||.||+|.... +       ..+|+|.+...... .....++..+++.++||||+++++++..+...++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            368999999999998642 2       34888887654322 23446667889999999999999999999999999999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCc--------EEEeecccc
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYT--------AKVADFESS  235 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~--------~kl~DfGla  235 (414)
                      +++|+|.+++.....  .+++..++.++.||+.||+|||+.+   |+||||||+||+++.++.        ++++|||++
T Consensus        81 ~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          81 VKFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             CCCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence            999999999875443  3478888999999999999999987   999999999999987665        699999988


Q ss_pred             ccccCCccccceecccccccccchhhccc-CCCCCcccchhHHHHHHHHHhCC-CCCCccccccccccccchhhhhhhcc
Q 015027          236 VLISSDAETAMSTILIGTSGYLDPVCINT-GKLTKKSDVYSFGVVLAELLTGK-KPGSCMTLASNKKISMVPYFLNSIKN  313 (414)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~~  313 (414)
                      .....      .....+++.|+|||++.+ ..++.++||||||+++|+|++|. .||.......         ...... 
T Consensus       156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~---------~~~~~~-  219 (258)
T cd05078         156 ITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK---------KLQFYE-  219 (258)
T ss_pred             cccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH---------HHHHHH-
Confidence            65432      123467889999999976 45899999999999999999984 6654322110         000000 


Q ss_pred             cccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHH
Q 015027          314 NGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELD  362 (414)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~  362 (414)
                      ..      ..++..    ....+.+|+.+||+.+|.+|||++++++.|+
T Consensus       220 ~~------~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         220 DR------HQLPAP----KWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             cc------ccCCCC----CcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            00      001111    1245899999999999999999999988763

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.7e-38  Score=300.74  Aligned_cols=255  Identities=21%  Similarity=0.220  Sum_probs=195.2

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch----hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI----RITERELLRIISQVNHKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~  161 (414)
                      ++|++.+.||+|+||.||++... +++.|++|.+......    .....+++++++.++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            46889999999999999999976 4789999998765321    123345678899999999999999999999999999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCC
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD  241 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  241 (414)
                      ||+++++|.+++...+   .+++..+..++.+++.||.|||+.+   ++||||||+||+++.++.+||+|||+++.....
T Consensus        81 e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~  154 (305)
T cd05609          81 EYVEGGDCATLLKNIG---ALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS  154 (305)
T ss_pred             ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence            9999999999996543   3578888999999999999999987   999999999999999999999999998642111


Q ss_pred             cc-------------ccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhh
Q 015027          242 AE-------------TAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFL  308 (414)
Q Consensus       242 ~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~  308 (414)
                      ..             ........++..|+|||.+.+..++.++|||||||++|||++|..||.+.....         ..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~---------~~  225 (305)
T cd05609         155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE---------LF  225 (305)
T ss_pred             ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---------HH
Confidence            00             001112457889999999988899999999999999999999999986332110         11


Q ss_pred             hhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHH
Q 015027          309 NSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDR  363 (414)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~  363 (414)
                      .........   .+...    ...+..+.+++.+||+.+|.+||+...+.+.|+.
T Consensus       226 ~~~~~~~~~---~~~~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         226 GQVISDDIE---WPEGD----EALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             HHHHhcccC---CCCcc----ccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            111111000   00000    0123558999999999999999997666555543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=3.1e-38  Score=295.77  Aligned_cols=265  Identities=20%  Similarity=0.286  Sum_probs=195.3

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc---hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK---IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYE  162 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  162 (414)
                      ++|++.+.||+|+||.||+|.+. +++.||+|++.....   ......+++.++++++||||+++++++..+...++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46889999999999999999976 589999999865432   22334567789999999999999999999999999999


Q ss_pred             eCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCc
Q 015027          163 FASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDA  242 (414)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  242 (414)
                      |+++++|..++...   ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07847          81 YCDHTVLNELEKNP---RGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG  154 (286)
T ss_pred             ccCccHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence            99998888776432   23588999999999999999999987   9999999999999999999999999998765432


Q ss_pred             cccceecccccccccchhhccc-CCCCCcccchhHHHHHHHHHhCCCCCCcccccccccc------ccchhhhhhhcccc
Q 015027          243 ETAMSTILIGTSGYLDPVCINT-GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKI------SMVPYFLNSIKNNG  315 (414)
Q Consensus       243 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~------~~~~~~~~~~~~~~  315 (414)
                      .  ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||...........      ...+..........
T Consensus       155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07847         155 D--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ  232 (286)
T ss_pred             c--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence            1  1223457889999999876 5688999999999999999999999974432111000      00000000000000


Q ss_pred             c-ccccccccCCccc-----HHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          316 L-RQILNFHVADESE-----MKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       316 ~-~~~~~~~~~~~~~-----~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      . .....+......+     ...+..+.+|+.+||+.+|++|||+.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            0 0000000000000     012356899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=7.2e-39  Score=296.69  Aligned_cols=252  Identities=26%  Similarity=0.299  Sum_probs=196.6

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc--hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEe
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK--IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  163 (414)
                      ++|+..+.||.|+||.||++.+. +++.+|+|.+.....  .......++.+++.++||||+++++++..+...++|+||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            36778889999999999999976 588999999876532  223345667889999999999999999999999999999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhh-CCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCc
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHS-LASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDA  242 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  242 (414)
                      +++++|.+++....  ..+++..+..++.|++.||.|||+ .+   ++|+||||+||++++++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~  155 (265)
T cd06605          81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL  155 (265)
T ss_pred             cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence            99999999986543  345778889999999999999999 77   9999999999999999999999999987654321


Q ss_pred             cccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccccc
Q 015027          243 ETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNF  322 (414)
Q Consensus       243 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (414)
                      .    ....++..|+|||.+.+..++.++||||||+++|+|++|..||..........   .. .........     .+
T Consensus       156 ~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~---~~-~~~~~~~~~-----~~  222 (265)
T cd06605         156 A----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGI---FE-LLQYIVNEP-----PP  222 (265)
T ss_pred             h----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccH---HH-HHHHHhcCC-----CC
Confidence            1    12578889999999999999999999999999999999999986432111000   00 000000000     00


Q ss_pred             ccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          323 HVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       323 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      .+.   ....+..+.+++.+||..+|.+|||+.+++.
T Consensus       223 ~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         223 RLP---SGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             CCC---hhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            000   1113356899999999999999999999853

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.5e-38  Score=293.05  Aligned_cols=248  Identities=23%  Similarity=0.322  Sum_probs=196.4

Q ss_pred             CCCCCCccccCCceEEEEEEEc-CCcEEEEEEeeccc---chhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEe
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRAD---KIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  163 (414)
                      +|++.+.||+|+||.||++... +++.||+|.+....   .......++++++++++||||+++++++...+..++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            5888999999999999999965 58899999987532   2223446667899999999999999999999999999999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcc
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE  243 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  243 (414)
                      +++++|.+++..... ..+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~  156 (256)
T cd08218          81 CEGGDLYKKINAQRG-VLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE  156 (256)
T ss_pred             CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence            999999998865332 23478888999999999999999987   99999999999999999999999999876543211


Q ss_pred             ccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccc
Q 015027          244 TAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFH  323 (414)
Q Consensus       244 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (414)
                        ......|++.|+|||++.+..++.++|+|||||++|+|++|..||.......         ...........     .
T Consensus       157 --~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~---------~~~~~~~~~~~-----~  220 (256)
T cd08218         157 --LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN---------LVLKIIRGSYP-----P  220 (256)
T ss_pred             --hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH---------HHHHHhcCCCC-----C
Confidence              1223467889999999999999999999999999999999999986322110         11111111000     0


Q ss_pred             cCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          324 VADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       324 ~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                          .+...+..+.+++.+||+.+|.+||++.+|++
T Consensus       221 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         221 ----VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             ----CcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence                11112355899999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.8e-38  Score=293.01  Aligned_cols=249  Identities=20%  Similarity=0.275  Sum_probs=191.4

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch------hHhHHHHHHHHHccCCCceeeeeeeEecC--Ccc
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI------RITERELLRIISQVNHKNVVKILGLCLET--EVP  157 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~~~~l~~l~hpniv~l~~~~~~~--~~~  157 (414)
                      ++|.+.+.||+|+||.||.|... ++..||||.+......      ......++.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            57889999999999999999975 5899999988643211      12335567899999999999999988764  467


Q ss_pred             eEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccccc
Q 015027          158 LLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVL  237 (414)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~  237 (414)
                      ++||||+++++|.+++....   .+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++..
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~  155 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR  155 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence            89999999999999986432   2477888999999999999999988   99999999999999999999999999876


Q ss_pred             ccCCccc-cceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccc
Q 015027          238 ISSDAET-AMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGL  316 (414)
Q Consensus       238 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (414)
                      ....... .......++..|+|||++.+..++.++|||||||++|+|++|+.||.......        ... .....  
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--------~~~-~~~~~--  224 (265)
T cd06652         156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA--------AIF-KIATQ--  224 (265)
T ss_pred             cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH--------HHH-HHhcC--
Confidence            5432111 11223468889999999998899999999999999999999999986322110        000 00000  


Q ss_pred             ccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          317 RQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                            ......+......+.+++.+||. +|++||++++|++
T Consensus       225 ------~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         225 ------PTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             ------CCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence                  00111122333568899999995 8999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=7e-39  Score=300.00  Aligned_cols=264  Identities=17%  Similarity=0.191  Sum_probs=190.2

Q ss_pred             CCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch---hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEe
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI---RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  163 (414)
                      +|.+.+.||+|+||.||+|... +|..||+|.+......   ......++.++++++||||+++++++.+....++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4788899999999999999976 5889999998754221   22334567899999999999999999999999999999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcc
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE  243 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  243 (414)
                      +++ +|.+++....  ..+++..++.++.||++||.|||+.+   ++|+||||+||+++.++.+||+|||++....... 
T Consensus        81 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-  153 (284)
T cd07839          81 CDQ-DLKKYFDSCN--GDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-  153 (284)
T ss_pred             CCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC-
Confidence            975 7777765433  23588999999999999999999987   9999999999999999999999999987654321 


Q ss_pred             ccceecccccccccchhhcccC-CCCCcccchhHHHHHHHHHhCCCCCCccccccccccccc-------hhhhhhhcc-c
Q 015027          244 TAMSTILIGTSGYLDPVCINTG-KLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMV-------PYFLNSIKN-N  314 (414)
Q Consensus       244 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~-------~~~~~~~~~-~  314 (414)
                       .......+++.|+|||++.+. .++.++|||||||++|+|++|..|+............+.       ......... .
T Consensus       154 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07839         154 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLP  232 (284)
T ss_pred             -CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcc
Confidence             112334678899999998764 478999999999999999999988642211100000000       000000000 0


Q ss_pred             ccc--cccccccC-CcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          315 GLR--QILNFHVA-DESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       315 ~~~--~~~~~~~~-~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ...  ........ .......+..+.+|+.+||+.||.+|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            000  00000000 0000112356889999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.4e-38  Score=296.05  Aligned_cols=259  Identities=25%  Similarity=0.258  Sum_probs=195.7

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc--hhHhHHHHHHHHHccCCCceeeeeeeEecC--CcceEEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK--IRITERELLRIISQVNHKNVVKILGLCLET--EVPLLVY  161 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~~l~~l~hpniv~l~~~~~~~--~~~~lv~  161 (414)
                      ++|...+.||.|++|.||+|.+. +++.+|+|.+.....  ......++++++++++||||++++++|...  +..++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            36788899999999999999975 588999999875433  223346677899999999999999998653  4689999


Q ss_pred             EeCCCCchhhhhhhcC-CcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccC
Q 015027          162 EFASNGTLLDHIRCES-SQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISS  240 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  240 (414)
                      ||+++++|.+++.... ....+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            9999999998875322 2334577889999999999999999987   99999999999999999999999999875532


Q ss_pred             CccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccc
Q 015027          241 DAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQIL  320 (414)
Q Consensus       241 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (414)
                      ..    .....++..|+|||.+.+..++.++|||||||++|+|++|..||...............+.    ..... ..+
T Consensus       158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----~~~~~-~~~  228 (287)
T cd06621         158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYI----VNMPN-PEL  228 (287)
T ss_pred             cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHH----hcCCc-hhh
Confidence            21    1234578899999999999999999999999999999999999874422100001111110    00000 000


Q ss_pred             ccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          321 NFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       321 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ....  ......++.+.+++.+||+.+|.+|||+.++++
T Consensus       229 ~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         229 KDEP--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             ccCC--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            0000  001123456899999999999999999999966

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2e-38  Score=298.11  Aligned_cols=242  Identities=24%  Similarity=0.289  Sum_probs=193.9

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc----hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK----IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~  161 (414)
                      ++|.+.+.||+|+||.||++.+. +++.+|+|.+.....    .......+++++++++||||+++++++.++...++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            46888999999999999999976 589999999876432    1223355678999999999999999999999999999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCC
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD  241 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  241 (414)
                      ||+++++|.+++....   .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++......
T Consensus        81 e~~~~~~L~~~~~~~~---~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  154 (290)
T cd05580          81 EYVPGGELFSHLRKSG---RFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR  154 (290)
T ss_pred             ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence            9999999999986543   3578889999999999999999987   999999999999999999999999998876543


Q ss_pred             ccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccc
Q 015027          242 AETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILN  321 (414)
Q Consensus       242 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (414)
                           .....+++.|+|||.+.+..++.++||||||+++|+|++|..||.......         .........      
T Consensus       155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---------~~~~~~~~~------  214 (290)
T cd05580         155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ---------IYEKILEGK------  214 (290)
T ss_pred             -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH---------HHHHHhcCC------
Confidence                 233468899999999988889999999999999999999999986433110         011111100      


Q ss_pred             cccCCcccHHHHHHHHHHHHHhhccCCCCCC-----ChhHHH
Q 015027          322 FHVADESEMKEIEIVAELASKCLRIRGTERP-----TMKQVS  358 (414)
Q Consensus       322 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rp-----s~~~v~  358 (414)
                      ..++..    ....+.+++.+||..+|.+||     ++++++
T Consensus       215 ~~~~~~----~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~  252 (290)
T cd05580         215 VRFPSF----FSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK  252 (290)
T ss_pred             ccCCcc----CCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence            001111    125589999999999999998     556654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-39  Score=306.25  Aligned_cols=258  Identities=26%  Similarity=0.342  Sum_probs=206.0

Q ss_pred             CCCCCccccCCceEEEEEEEcC---C--cEEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEE
Q 015027           89 FDRSRCLSQGGFVSVYKGVLHD---N--IQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        89 ~~~~~~lg~G~~g~Vy~~~~~~---~--~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~  161 (414)
                      ....++||.|-||.||+|+..+   |  -.||||..+.+...  .+.+..+.-+|++++|||||+++|+|.+. ..||||
T Consensus       391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wivm  469 (974)
T KOG4257|consen  391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVM  469 (974)
T ss_pred             ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEE
Confidence            3456789999999999999532   3  34899999876443  34457777899999999999999999865 569999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCC
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD  241 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  241 (414)
                      |.++-|.|..||..+...  ++......++.||+.+|+|||+..   ++||||-..|||+...--|||+|||+++.+..+
T Consensus       470 EL~~~GELr~yLq~nk~s--L~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~  544 (974)
T KOG4257|consen  470 ELAPLGELREYLQQNKDS--LPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLEDD  544 (974)
T ss_pred             ecccchhHHHHHHhcccc--chHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence            999999999999765543  466788889999999999999976   999999999999999999999999999998766


Q ss_pred             ccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhccccccccc
Q 015027          242 AETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQIL  320 (414)
Q Consensus       242 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (414)
                      ...... ...-...|||||.+.-..++.+||||-|||.+||++. |..||.+.....                  ....+
T Consensus       545 ~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD------------------VI~~i  605 (974)
T KOG4257|consen  545 AYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD------------------VIGHI  605 (974)
T ss_pred             chhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc------------------eEEEe
Confidence            444332 3344568999999999999999999999999999987 999997544322                  11111


Q ss_pred             ccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHhhhhh
Q 015027          321 NFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLHENF  371 (414)
Q Consensus       321 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~~~~~  371 (414)
                      ...-..+.+...++.|..|+.+||+.+|.+||.+.++...|+.+....+..
T Consensus       606 EnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek~~  656 (974)
T KOG4257|consen  606 ENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEKIN  656 (974)
T ss_pred             cCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhhhh
Confidence            111122223333466999999999999999999999999999988754443

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.1e-38  Score=292.95  Aligned_cols=252  Identities=21%  Similarity=0.364  Sum_probs=195.5

Q ss_pred             CCCCCCccccCCceEEEEEEE-cCCcEEEEEEeecccc-------hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceE
Q 015027           88 NFDRSRCLSQGGFVSVYKGVL-HDNIQVAVKTYRRADK-------IRITERELLRIISQVNHKNVVKILGLCLETEVPLL  159 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-------~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~l  159 (414)
                      +|+..+.||+|++|.||+|.. .+++.||+|.+.....       .......+++.+++++||||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            478889999999999999996 4689999999875431       12334567789999999999999999999999999


Q ss_pred             EEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCC-cEEEeeccccccc
Q 015027          160 VYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNY-TAKVADFESSVLI  238 (414)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~DfGla~~~  238 (414)
                      ||||+++++|.+++....   .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++ .+||+|||++...
T Consensus        81 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             EEeccCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence            999999999999986533   3478889999999999999999987   99999999999998775 6999999998776


Q ss_pred             cCCccc--cceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccc
Q 015027          239 SSDAET--AMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGL  316 (414)
Q Consensus       239 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (414)
                      ......  .......++..|+|||.+.+..++.++||||||+++|+|++|..||........     .. .......   
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-----~~-~~~~~~~---  225 (268)
T cd06630         155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH-----LA-LIFKIAS---  225 (268)
T ss_pred             ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch-----HH-HHHHHhc---
Confidence            543111  112234678899999999888999999999999999999999999863221100     00 0000000   


Q ss_pred             ccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          317 RQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                           .......+......+.+++.+||..+|.+|||+.+++.
T Consensus       226 -----~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         226 -----ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             -----cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence                 00011122223366899999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-38  Score=296.77  Aligned_cols=265  Identities=18%  Similarity=0.234  Sum_probs=192.6

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEe
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  163 (414)
                      ++|.+.+.||+|++|.||+|... +++.||+|.+......  .....+++.++++++||||+++++++.+++..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            67899999999999999999976 5889999998754322  23345677899999999999999999999999999999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcc
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE  243 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  243 (414)
                      +++ +|.+++.....  .+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++........
T Consensus        85 ~~~-~L~~~~~~~~~--~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  158 (291)
T cd07844          85 LDT-DLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK  158 (291)
T ss_pred             CCC-CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence            985 89888865433  4478889999999999999999987   99999999999999999999999999875432211


Q ss_pred             ccceecccccccccchhhccc-CCCCCcccchhHHHHHHHHHhCCCCCCcccccccccc-------ccchhhhhhhccc-
Q 015027          244 TAMSTILIGTSGYLDPVCINT-GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKI-------SMVPYFLNSIKNN-  314 (414)
Q Consensus       244 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~-------~~~~~~~~~~~~~-  314 (414)
                        ......++..|+|||++.+ ..++.++||||||+++|+|++|+.||...........       ...+......... 
T Consensus       159 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (291)
T cd07844         159 --TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNP  236 (291)
T ss_pred             --cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcc
Confidence              1122356788999999865 5688999999999999999999999964331100000       0000000000000 


Q ss_pred             ccc----ccc-ccccCCc-ccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          315 GLR----QIL-NFHVADE-SEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       315 ~~~----~~~-~~~~~~~-~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ...    ... ....... ........+.+++.+||+.+|.+|||+.+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence            000    000 0000000 00001145789999999999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=3.5e-38  Score=296.51  Aligned_cols=267  Identities=17%  Similarity=0.190  Sum_probs=191.4

Q ss_pred             HhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEE
Q 015027           85 ATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        85 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~  161 (414)
                      ++++|.+.+.||+|+||.||+|... ++..||+|.+......  .....+++.+++.++|+||+++++++..+...++||
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            4578999999999999999999965 5889999998654322  223456678899999999999999999999999999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCC
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD  241 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  241 (414)
                      ||++ ++|.+++....  ..+++..+..++.||+.||.|||+.+   ++|+||||+||+++.++.+||+|||++......
T Consensus        83 e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  156 (291)
T cd07870          83 EYMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP  156 (291)
T ss_pred             eccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence            9996 56766664332  23467788889999999999999987   999999999999999999999999998764332


Q ss_pred             ccccceecccccccccchhhcccC-CCCCcccchhHHHHHHHHHhCCCCCCcccccccccccc-------chhhhhhhcc
Q 015027          242 AETAMSTILIGTSGYLDPVCINTG-KLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISM-------VPYFLNSIKN  313 (414)
Q Consensus       242 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~-------~~~~~~~~~~  313 (414)
                      ..  ......+++.|+|||++.+. .++.++|||||||++|+|++|..||.............       .+........
T Consensus       157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (291)
T cd07870         157 SQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSK  234 (291)
T ss_pred             CC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhh
Confidence            11  12234578899999998754 57889999999999999999999997433211000000       0000000000


Q ss_pred             -ccc-ccccccccCCc-----ccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          314 -NGL-RQILNFHVADE-----SEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       314 -~~~-~~~~~~~~~~~-----~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                       ... ...........     ........+.+++.+||..||++|||+.+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence             000 00000000000     00001256889999999999999999999853

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-39  Score=299.53  Aligned_cols=272  Identities=25%  Similarity=0.374  Sum_probs=199.3

Q ss_pred             CCCCCccccCCceEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecCC----cceEEEEeC
Q 015027           89 FDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETE----VPLLVYEFA  164 (414)
Q Consensus        89 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~----~~~lv~e~~  164 (414)
                      ....+.+|+|.||.||+|.+ +++.||||++.............+--+-.+.|+||+++++.-....    .++||++|.
T Consensus       212 l~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh  290 (534)
T KOG3653|consen  212 LQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFH  290 (534)
T ss_pred             hhhHHHhhcCccceeehhhc-cCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeec
Confidence            44567799999999999998 5589999999876554433322223344678999999999876554    789999999


Q ss_pred             CCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhC------CCCCeeeCCCCCCceeeCCCCcEEEeeccccccc
Q 015027          165 SNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSL------ASPPIIHGDVKSANILLNDNYTAKVADFESSVLI  238 (414)
Q Consensus       165 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~------~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~  238 (414)
                      +.|+|.++|..    ...+|....+|+..+++||+|||+.      .+++|+|||||+.||||..+++..|+|||+|..+
T Consensus       291 ~kGsL~dyL~~----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~  366 (534)
T KOG3653|consen  291 PKGSLCDYLKA----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRL  366 (534)
T ss_pred             cCCcHHHHHHh----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEe
Confidence            99999999954    4458999999999999999999963      3478999999999999999999999999999888


Q ss_pred             cCCccccceecccccccccchhhcccCC-CC-----CcccchhHHHHHHHHHhCCCCCCc--cc---cccccccccchh-
Q 015027          239 SSDAETAMSTILIGTSGYLDPVCINTGK-LT-----KKSDVYSFGVVLAELLTGKKPGSC--MT---LASNKKISMVPY-  306 (414)
Q Consensus       239 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~Dv~SlGvil~el~tg~~p~~~--~~---~~~~~~~~~~~~-  306 (414)
                      ............+||.+|||||++.+.- +.     .+.||||+|.|||||++.-.-+..  ..   ..-..+.+..|. 
T Consensus       367 ~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~  446 (534)
T KOG3653|consen  367 EPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTL  446 (534)
T ss_pred             cCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCH
Confidence            7654444445589999999999997642 22     368999999999999987543321  00   000111111111 


Q ss_pred             --hhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHhh
Q 015027          307 --FLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLH  368 (414)
Q Consensus       307 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~~  368 (414)
                        ....+.....+..+...+...   ..+..+.+.+..||+.||+.|.|+.=+.+.+..+....
T Consensus       447 e~mq~~VV~kK~RP~~p~~W~~h---~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~  507 (534)
T KOG3653|consen  447 EEMQELVVRKKQRPKIPDAWRKH---AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW  507 (534)
T ss_pred             HHHHHHHHhhccCCCChhhhhcC---ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence              112222222222222222222   22356899999999999999999999988888777553

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-38  Score=294.42  Aligned_cols=246  Identities=23%  Similarity=0.363  Sum_probs=192.2

Q ss_pred             CCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch--hHhHHHHHHHHHccC---CCceeeeeeeEecCCcceEEE
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI--RITERELLRIISQVN---HKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~---hpniv~l~~~~~~~~~~~lv~  161 (414)
                      .|+..+.||+|+||.||+|.+. ++..||+|.+......  ......++.+++.++   |||++++++++..+...++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            5778899999999999999964 6899999998654221  223344556777775   999999999999999999999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCC
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD  241 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  241 (414)
                      ||+++++|.+++...    .+++..++.++.+++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++......
T Consensus        82 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06917          82 EYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN  154 (277)
T ss_pred             ecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence            999999999988542    4578999999999999999999988   999999999999999999999999998876543


Q ss_pred             ccccceecccccccccchhhccc-CCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccc
Q 015027          242 AETAMSTILIGTSGYLDPVCINT-GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQIL  320 (414)
Q Consensus       242 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (414)
                      .  .......|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||........         .......     .
T Consensus       155 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~---------~~~~~~~-----~  218 (277)
T cd06917         155 S--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA---------MMLIPKS-----K  218 (277)
T ss_pred             c--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh---------hhccccC-----C
Confidence            2  12233468889999998865 4578999999999999999999999974332110         0000000     0


Q ss_pred             ccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          321 NFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       321 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      .+.+...   ..+..+.+++.+||+.+|.+||++.+++.
T Consensus       219 ~~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         219 PPRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             CCCCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            0111110   12356899999999999999999999965

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=3.1e-38  Score=292.09  Aligned_cols=251  Identities=26%  Similarity=0.397  Sum_probs=196.0

Q ss_pred             CCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch---hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEe
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI---RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  163 (414)
                      +|.+.+.||+|+||.||+|... +++.|++|.+......   ......++.+++.++|+||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            5788899999999999999965 6899999998765442   33446677899999999999999999999999999999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcc
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE  243 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  243 (414)
                      +++++|.+++....   ..++..+..++.+++.||.|||+.+   ++|+||+|+||++++++.+||+|||++........
T Consensus        81 ~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~  154 (264)
T cd06626          81 CSGGTLEELLEHGR---ILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT  154 (264)
T ss_pred             CCCCcHHHHHhhcC---CCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence            99999999986532   2477888999999999999999988   99999999999999999999999999877654322


Q ss_pred             ccc--eecccccccccchhhcccCC---CCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccc
Q 015027          244 TAM--STILIGTSGYLDPVCINTGK---LTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQ  318 (414)
Q Consensus       244 ~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (414)
                      ...  .....+++.|+|||++.+..   ++.++||||||+++|+|++|+.||.......       . ....... ....
T Consensus       155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~-------~-~~~~~~~-~~~~  225 (264)
T cd06626         155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-------Q-IMFHVGA-GHKP  225 (264)
T ss_pred             cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH-------H-HHHHHhc-CCCC
Confidence            111  12346788999999998766   8999999999999999999999996332100       0 0000000 0000


Q ss_pred             ccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          319 ILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       319 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      .+.      .....+..+.+++.+||+.+|.+|||+.+++.
T Consensus       226 ~~~------~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         226 PIP------DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             CCC------cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            111      11112355889999999999999999999853

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.7e-38  Score=299.00  Aligned_cols=246  Identities=23%  Similarity=0.297  Sum_probs=192.0

Q ss_pred             CCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch-hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCCC
Q 015027           89 FDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI-RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASN  166 (414)
Q Consensus        89 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  166 (414)
                      |.....||+|+||.||++... ++..||||.+...... .....+++..++.++||||+++++.+..++..++||||+++
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~  103 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG  103 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence            444566999999999999965 5889999998654322 23345667889999999999999999999999999999999


Q ss_pred             CchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccccc
Q 015027          167 GTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAM  246 (414)
Q Consensus       167 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  246 (414)
                      ++|.+++...    .+++..+..++.||+.||.|||+.+   ++||||||+||+++.++.++|+|||++........  .
T Consensus       104 ~~L~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~  174 (292)
T cd06658         104 GALTDIVTHT----RMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--K  174 (292)
T ss_pred             CcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--c
Confidence            9999987432    3578889999999999999999987   99999999999999999999999999876543221  2


Q ss_pred             eecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccccCC
Q 015027          247 STILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVAD  326 (414)
Q Consensus       247 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (414)
                      .....++..|+|||.+.+..++.++||||||+++|||++|..||.......         ......     ..+...+..
T Consensus       175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---------~~~~~~-----~~~~~~~~~  240 (292)
T cd06658         175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ---------AMRRIR-----DNLPPRVKD  240 (292)
T ss_pred             CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---------HHHHHH-----hcCCCcccc
Confidence            233568899999999998899999999999999999999999986322110         000000     001111111


Q ss_pred             cccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          327 ESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       327 ~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                        ....+..+.+++.+||..+|.+|||++++++
T Consensus       241 --~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  271 (292)
T cd06658         241 --SHKVSSVLRGFLDLMLVREPSQRATAQELLQ  271 (292)
T ss_pred             --ccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence              0112245899999999999999999999965

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=4.3e-38  Score=289.83  Aligned_cols=247  Identities=24%  Similarity=0.368  Sum_probs=195.1

Q ss_pred             CCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc---hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEe
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK---IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  163 (414)
                      +|+..+.||+|+||.||++... ++..+|+|.+.....   .......++++++.++||||+++++.+..++..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            5888899999999999999965 588999999875432   223345667899999999999999999999999999999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCC-CcEEEeeccccccccCCc
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDN-YTAKVADFESSVLISSDA  242 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~DfGla~~~~~~~  242 (414)
                      +++++|.+++..... ..+++..+..++.+++.||.|||+++   ++|+||+|+||+++.+ +.+||+|||++.......
T Consensus        81 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          81 APGGTLAEYIQKRCN-SLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             CCCCCHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence            999999999965432 23578889999999999999999987   9999999999999854 568999999998764331


Q ss_pred             cccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccccc
Q 015027          243 ETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNF  322 (414)
Q Consensus       243 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (414)
                         ......++..|+|||.+.+..++.++||||||+++|+|++|..||.......         ............+   
T Consensus       157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---------~~~~~~~~~~~~~---  221 (256)
T cd08220         157 ---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA---------LVLKIMSGTFAPI---  221 (256)
T ss_pred             ---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH---------HHHHHHhcCCCCC---
Confidence               1223468889999999998889999999999999999999999986432111         1111111111000   


Q ss_pred             ccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          323 HVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       323 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                            +...+..+.+++.+||+.+|.+|||+.+++.
T Consensus       222 ------~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         222 ------SDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             ------CCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                  0112355899999999999999999999965

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=3.5e-38  Score=291.68  Aligned_cols=251  Identities=24%  Similarity=0.315  Sum_probs=199.8

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc--hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEe
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK--IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  163 (414)
                      ++|++.+.||+|++|.||+|... +++.|++|++.....  .......++..+..++||||+++++++......++||||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            46888999999999999999976 489999999876643  233446667889999999999999999999999999999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhh-CCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCc
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHS-LASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDA  242 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  242 (414)
                      +++++|.+++...   ..+++..++.++.|++.|+.|||+ .+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~  154 (264)
T cd06623          81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL  154 (264)
T ss_pred             cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence            9999999999654   345788999999999999999999 88   9999999999999999999999999988765432


Q ss_pred             cccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccccc
Q 015027          243 ETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNF  322 (414)
Q Consensus       243 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (414)
                      ..  .....++..|+|||.+.+..++.++|+||||+++|+|++|..||.......  .    .............     
T Consensus       155 ~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~----~~~~~~~~~~~~~-----  221 (264)
T cd06623         155 DQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS--F----FELMQAICDGPPP-----  221 (264)
T ss_pred             Cc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccC--H----HHHHHHHhcCCCC-----
Confidence            21  123467889999999999999999999999999999999999986443100  0    0011111111000     


Q ss_pred             ccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          323 HVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       323 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      .....   ..+..+.+++.+||..+|++|||+.++++
T Consensus       222 ~~~~~---~~~~~l~~li~~~l~~~p~~R~~~~~ll~  255 (264)
T cd06623         222 SLPAE---EFSPEFRDFISACLQKDPKKRPSAAELLQ  255 (264)
T ss_pred             CCCcc---cCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            00000   02356999999999999999999999965

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=3.1e-38  Score=297.90  Aligned_cols=247  Identities=23%  Similarity=0.301  Sum_probs=192.1

Q ss_pred             CCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch-hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCCC
Q 015027           89 FDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI-RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASN  166 (414)
Q Consensus        89 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  166 (414)
                      |.....||+|+||.||+|... +++.||+|.+...... .....+++.++..++||||+++++++..++..++||||+++
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~  102 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG  102 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence            334457999999999999965 6899999998654322 23345567889999999999999999999999999999999


Q ss_pred             CchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccccc
Q 015027          167 GTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAM  246 (414)
Q Consensus       167 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  246 (414)
                      ++|..++..    ..+++..++.++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||++........  .
T Consensus       103 ~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~  173 (297)
T cd06659         103 GALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--K  173 (297)
T ss_pred             CCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc--c
Confidence            999987743    23578899999999999999999987   99999999999999999999999999875543211  1


Q ss_pred             eecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccccCC
Q 015027          247 STILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVAD  326 (414)
Q Consensus       247 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (414)
                      .....++..|+|||++.+..++.++|||||||++|||++|..||.......         .............     . 
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---------~~~~~~~~~~~~~-----~-  238 (297)
T cd06659         174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ---------AMKRLRDSPPPKL-----K-  238 (297)
T ss_pred             ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---------HHHHHhccCCCCc-----c-
Confidence            233568899999999998899999999999999999999999986332111         0000100000000     0 


Q ss_pred             cccHHHHHHHHHHHHHhhccCCCCCCChhHHHHH
Q 015027          327 ESEMKEIEIVAELASKCLRIRGTERPTMKQVSEE  360 (414)
Q Consensus       327 ~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~  360 (414)
                       .....+..+.+++.+||+.+|.+||++.++++.
T Consensus       239 -~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         239 -NAHKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             -ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence             000112458999999999999999999999764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=4.3e-38  Score=293.83  Aligned_cols=246  Identities=25%  Similarity=0.352  Sum_probs=194.8

Q ss_pred             CCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeC
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFA  164 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  164 (414)
                      -|+..+.||.|+||.||+|... ++..||+|.+......  ...+.+++..+++++||||+++++++..+...++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            4778889999999999999865 5889999988654322  233456678899999999999999999999999999999


Q ss_pred             CCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccc
Q 015027          165 SNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET  244 (414)
Q Consensus       165 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  244 (414)
                      ++++|.+++..    ..+++..+..++.+++.|+.+||+.+   ++|+||+|+||+++.++.++|+|||++.......  
T Consensus        85 ~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~--  155 (277)
T cd06641          85 GGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--  155 (277)
T ss_pred             CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch--
Confidence            99999998853    23578899999999999999999977   9999999999999999999999999987654321  


Q ss_pred             cceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccccccc
Q 015027          245 AMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHV  324 (414)
Q Consensus       245 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (414)
                      .......++..|+|||.+.+..++.++|+|||||++|+|++|..||.......         ..........     +.+
T Consensus       156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---------~~~~~~~~~~-----~~~  221 (277)
T cd06641         156 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK---------VLFLIPKNNP-----PTL  221 (277)
T ss_pred             hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH---------HHHHHhcCCC-----CCC
Confidence            11233467889999999988889999999999999999999999986322110         0000100100     011


Q ss_pred             CCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHH
Q 015027          325 ADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEE  360 (414)
Q Consensus       325 ~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~  360 (414)
                      .    ...+..+.+++.+||+.+|.+||++.++++.
T Consensus       222 ~----~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         222 E----GNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             C----cccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            1    1122558999999999999999999999774

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3e-39  Score=305.72  Aligned_cols=251  Identities=20%  Similarity=0.271  Sum_probs=197.8

Q ss_pred             hcCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccch---hHhHHHHHHHHHcc-CCCceeeeeeeEecCCcceEEE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKI---RITERELLRIISQV-NHKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l-~hpniv~l~~~~~~~~~~~lv~  161 (414)
                      ...|+++++||+||.+.||++...+.+.+|+|.+......   ...+..|+.+|.+| .|.+||+++++-..++.+|+||
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm  439 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM  439 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence            4568999999999999999999888888998877654332   33447778888888 4999999999999999999999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCC
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD  241 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  241 (414)
                      ||-+ .+|..+|.......+ .| .+..+..|++.++.++|.+|   |||.||||.|+|+- .|.+||+|||+|..+..+
T Consensus       440 E~Gd-~DL~kiL~k~~~~~~-~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~D  512 (677)
T KOG0596|consen  440 ECGD-IDLNKILKKKKSIDP-DW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQPD  512 (677)
T ss_pred             eccc-ccHHHHHHhccCCCc-hH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccCcc
Confidence            9864 489988876655432 34 66778899999999999988   99999999999997 569999999999998877


Q ss_pred             ccccceecccccccccchhhcccCC-----------CCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhh
Q 015027          242 AETAMSTILIGTSGYLDPVCINTGK-----------LTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNS  310 (414)
Q Consensus       242 ~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  310 (414)
                      ...-.....+||+.||+||.+....           .++++||||||||||+|+.|+.||.....           +   
T Consensus       513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-----------~---  578 (677)
T KOG0596|consen  513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-----------Q---  578 (677)
T ss_pred             ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-----------H---
Confidence            6666667789999999999985432           56789999999999999999999862210           1   


Q ss_pred             hcccccccccccccCCcccH-HHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          311 IKNNGLRQILNFHVADESEM-KEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~-~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                        ...+..+.++....+++. ....++.+++..||+.||.+|||+.++++
T Consensus       579 --~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  579 --IAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             --HHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence              122333444432211111 01123899999999999999999999975

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=3.6e-38  Score=291.44  Aligned_cols=252  Identities=21%  Similarity=0.322  Sum_probs=195.3

Q ss_pred             CCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch---hHhHHHHHHHHHccCCCceeeeeeeEec--CCcceEEE
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI---RITERELLRIISQVNHKNVVKILGLCLE--TEVPLLVY  161 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~hpniv~l~~~~~~--~~~~~lv~  161 (414)
                      +|++.+.||.|+||.||++... ++..+|+|.+......   ......++++++.++||||+++++++..  +...+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            4788899999999999999965 6889999998754322   2233556788999999999999998764  44678999


Q ss_pred             EeCCCCchhhhhhhc-CCcccCCHHHHHHHHHHHHHHHHHhhhCC--CCCeeeCCCCCCceeeCCCCcEEEeeccccccc
Q 015027          162 EFASNGTLLDHIRCE-SSQVLKTWKTCLRIAAETASALDYLHSLA--SPPIIHGDVKSANILLNDNYTAKVADFESSVLI  238 (414)
Q Consensus       162 e~~~~gsL~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~--~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~  238 (414)
                      ||+++++|.+++... .....+++..++.++.+++.||.|||..+  ..+++|+||+|+||+++.++.+||+|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999998653 22345688999999999999999999332  234999999999999999999999999999876


Q ss_pred             cCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccc
Q 015027          239 SSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQ  318 (414)
Q Consensus       239 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (414)
                      .....  ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||.......         ........... 
T Consensus       161 ~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---------~~~~~~~~~~~-  228 (265)
T cd08217         161 GHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ---------LASKIKEGKFR-  228 (265)
T ss_pred             cCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH---------HHHHHhcCCCC-
Confidence            54321  1233468999999999998889999999999999999999999987433110         11111111110 


Q ss_pred             ccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          319 ILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       319 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                          .    .+...+..+.+++.+||+.+|.+|||+.+|++
T Consensus       229 ----~----~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~  261 (265)
T cd08217         229 ----R----IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ  261 (265)
T ss_pred             ----C----CccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence                1    11122356899999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=5.7e-38  Score=294.31  Aligned_cols=252  Identities=23%  Similarity=0.336  Sum_probs=200.5

Q ss_pred             HhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEe
Q 015027           85 ATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        85 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  163 (414)
                      .++.|...+.||+|++|.||+|.+. ++..+++|.+............++++++.++|+|++++++.+......++|+||
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   96 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY   96 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence            4567888899999999999999976 588999999986654334445667899999999999999999999999999999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcc
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE  243 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  243 (414)
                      +++++|.+++....  ..+++..+..++.+++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        97 ~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  171 (286)
T cd06614          97 MDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS  171 (286)
T ss_pred             cCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence            99999999997644  34588899999999999999999977   99999999999999999999999998875543211


Q ss_pred             ccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccc
Q 015027          244 TAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFH  323 (414)
Q Consensus       244 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (414)
                        ......+++.|++||.+.+..++.++||||||+++|+|++|..||.......         .............    
T Consensus       172 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~---------~~~~~~~~~~~~~----  236 (286)
T cd06614         172 --KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR---------ALFLITTKGIPPL----  236 (286)
T ss_pred             --hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH---------HHHHHHhcCCCCC----
Confidence              1233457889999999998899999999999999999999999986322110         0000000100000    


Q ss_pred             cCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          324 VADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       324 ~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                         ......+..+.+++.+||+.+|.+|||+.++++
T Consensus       237 ---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         237 ---KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             ---cchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence               001112356899999999999999999999965

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=4.4e-38  Score=296.26  Aligned_cols=248  Identities=23%  Similarity=0.347  Sum_probs=195.7

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch-hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeC
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI-RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFA  164 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  164 (414)
                      .+|.+.+.||+|+||.||++... ++..||+|.+...... ......++.+++.++||||+++++.+...+..|+|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            67899999999999999999864 6889999998644322 233456678899999999999999999999999999999


Q ss_pred             CCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccc
Q 015027          165 SNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET  244 (414)
Q Consensus       165 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  244 (414)
                      ++++|.+++...    .+++..+..++.+++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........ 
T Consensus        99 ~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-  170 (293)
T cd06647          99 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  170 (293)
T ss_pred             CCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc-
Confidence            999999998542    3477888999999999999999988   99999999999999999999999998876543221 


Q ss_pred             cceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccccccc
Q 015027          245 AMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHV  324 (414)
Q Consensus       245 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (414)
                       ......+++.|+|||.+.+..++.++||||||+++|++++|+.||........    ..     ......       ..
T Consensus       171 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~----~~-----~~~~~~-------~~  233 (293)
T cd06647         171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA----LY-----LIATNG-------TP  233 (293)
T ss_pred             -ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh----ee-----ehhcCC-------CC
Confidence             22334688899999999888899999999999999999999999964321110    00     000000       00


Q ss_pred             CCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          325 ADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       325 ~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ........+..+.+++.+||..+|.+||++.+++.
T Consensus       234 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  268 (293)
T cd06647         234 ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  268 (293)
T ss_pred             CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            01111122356899999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.4e-38  Score=298.22  Aligned_cols=265  Identities=21%  Similarity=0.304  Sum_probs=194.3

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch---hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI---RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYE  162 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  162 (414)
                      ++|++.+.||+|+||.||+|.+. +++.||+|.+......   .....+++++++.++||||+++++++..+...++|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            46888999999999999999976 5899999988654322   2334567789999999999999999999999999999


Q ss_pred             eCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCc
Q 015027          163 FASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDA  242 (414)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  242 (414)
                      |+++++|.++.....   .+++..+..++.||+.||.|||+.+   ++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07846          81 FVDHTVLDDLEKYPN---GLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  154 (286)
T ss_pred             cCCccHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence            999998887764322   2588999999999999999999987   9999999999999999999999999987654432


Q ss_pred             cccceecccccccccchhhccc-CCCCCcccchhHHHHHHHHHhCCCCCCcccccccccc------ccchhhhhhhcccc
Q 015027          243 ETAMSTILIGTSGYLDPVCINT-GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKI------SMVPYFLNSIKNNG  315 (414)
Q Consensus       243 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~------~~~~~~~~~~~~~~  315 (414)
                        .......++..|+|||++.+ ..++.++||||||+++|||++|.+||...........      .+.+..........
T Consensus       155 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07846         155 --EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP  232 (286)
T ss_pred             --cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccch
Confidence              12233467889999999865 4578899999999999999999999864321100000      00000000000000


Q ss_pred             c-ccccccccCCcc-----cHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          316 L-RQILNFHVADES-----EMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       316 ~-~~~~~~~~~~~~-----~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      . .....+......     ....+..+.+|+.+||+.+|.+||++.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            0 000000000000     0112356999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=4.2e-38  Score=296.92  Aligned_cols=263  Identities=21%  Similarity=0.250  Sum_probs=194.1

Q ss_pred             CCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch------hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEE
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI------RITERELLRIISQVNHKNVVKILGLCLETEVPLLV  160 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv  160 (414)
                      +|.+.+.||+|+||.||+|... +++.||||.+......      ......++.++++++||||+++++++.+....++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4788899999999999999975 5899999999765432      22334567889999999999999999999999999


Q ss_pred             EEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccC
Q 015027          161 YEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISS  240 (414)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  240 (414)
                      |||+ +++|.+++....  ..+++..+..++.||++||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            9999 889999986543  24688999999999999999999988   99999999999999999999999999987654


Q ss_pred             Cccccceecccccccccchhhccc-CCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhh----hh-ccc
Q 015027          241 DAETAMSTILIGTSGYLDPVCINT-GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLN----SI-KNN  314 (414)
Q Consensus       241 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~----~~-~~~  314 (414)
                      ...  ......+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||.......... .....+..    .+ ...
T Consensus       155 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  231 (298)
T cd07841         155 PNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLG-KIFEALGTPTEENWPGVT  231 (298)
T ss_pred             CCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHH-HHHHHcCCCchhhhhhcc
Confidence            321  1223356788999998854 467899999999999999999988876433211000 00000000    00 000


Q ss_pred             ccccccccccCCcc-----cHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          315 GLRQILNFHVADES-----EMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       315 ~~~~~~~~~~~~~~-----~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ..............     ....+..+.+++.+||+.+|++|||+.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~  281 (298)
T cd07841         232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE  281 (298)
T ss_pred             cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            00000000000000     0112356899999999999999999999955

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-38  Score=300.90  Aligned_cols=203  Identities=23%  Similarity=0.352  Sum_probs=165.0

Q ss_pred             CCCCCCccccCCceEEEEEEEc---CCcEEEEEEeeccc----chhHhHHHHHHHHHccCCCceeeeeeeEecC--Ccce
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLH---DNIQVAVKTYRRAD----KIRITERELLRIISQVNHKNVVKILGLCLET--EVPL  158 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~----~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~--~~~~  158 (414)
                      +|.+.+.||+|+||.||+|...   ++..||+|.+....    .......+++.++.+++||||+++++++.+.  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4788899999999999999965   47899999998632    2223345567899999999999999999988  7899


Q ss_pred             EEEEeCCCCchhhhhhhcC--CcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCC----CCcEEEeec
Q 015027          159 LVYEFASNGTLLDHIRCES--SQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLND----NYTAKVADF  232 (414)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~----~~~~kl~Df  232 (414)
                      +||||+++ +|.+.+....  ....+++..+..++.||+.||+|||+.+   ++||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999976 6666553322  1224578889999999999999999987   999999999999999    999999999


Q ss_pred             cccccccCCcc-ccceecccccccccchhhccc-CCCCCcccchhHHHHHHHHHhCCCCCCccc
Q 015027          233 ESSVLISSDAE-TAMSTILIGTSGYLDPVCINT-GKLTKKSDVYSFGVVLAELLTGKKPGSCMT  294 (414)
Q Consensus       233 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~  294 (414)
                      |++........ ........+++.|+|||++.+ ..++.++|||||||++|+|++|++||....
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~  220 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE  220 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence            99886643322 112234567889999998866 458899999999999999999999997544

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=8.6e-38  Score=296.24  Aligned_cols=245  Identities=28%  Similarity=0.343  Sum_probs=191.1

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch----hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI----RITERELLRIISQVNHKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~  161 (414)
                      +.|...+.||+|+||.||+|... +++.||+|.+......    ......++.+++.++||||++++++|..++..++||
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            56888999999999999999975 5899999998644321    123456678899999999999999999999999999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCC
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD  241 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  241 (414)
                      ||+++ +|.+++....  ..+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++......
T Consensus        95 e~~~g-~l~~~~~~~~--~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~  168 (307)
T cd06607          95 EYCLG-SASDILEVHK--KPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA  168 (307)
T ss_pred             HhhCC-CHHHHHHHcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence            99974 6666664332  23588999999999999999999987   999999999999999999999999998765322


Q ss_pred             ccccceecccccccccchhhcc---cCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccc
Q 015027          242 AETAMSTILIGTSGYLDPVCIN---TGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQ  318 (414)
Q Consensus       242 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (414)
                            ....+++.|+|||++.   ...++.++||||||+++|||++|..||.......         ..........  
T Consensus       169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~---------~~~~~~~~~~--  231 (307)
T cd06607         169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---------ALYHIAQNDS--  231 (307)
T ss_pred             ------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH---------HHHHHhcCCC--
Confidence                  2346788999999874   4568899999999999999999999986432111         0000000000  


Q ss_pred             ccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHH
Q 015027          319 ILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEE  360 (414)
Q Consensus       319 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~  360 (414)
                         +   .......+..+.+++.+||+.+|.+||++.+|+..
T Consensus       232 ---~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         232 ---P---TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             ---C---CCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence               0   00111233568999999999999999999999764

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.6e-38  Score=293.43  Aligned_cols=245  Identities=23%  Similarity=0.265  Sum_probs=195.3

Q ss_pred             CCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc----hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEE
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK----IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYE  162 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  162 (414)
                      +|++.+.||.|+||.||+|.+. ++..||+|.+.....    ......++++++++++||||+++++++..+...++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            5788899999999999999976 589999999976432    22334566789999999999999999999999999999


Q ss_pred             eCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCc
Q 015027          163 FASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDA  242 (414)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  242 (414)
                      |+++++|.+++...   ..+++..+..++.|++.||.|||+++   ++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  154 (258)
T cd05578          81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT  154 (258)
T ss_pred             CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence            99999999998654   34578889999999999999999987   9999999999999999999999999987654331


Q ss_pred             cccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccccc
Q 015027          243 ETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNF  322 (414)
Q Consensus       243 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (414)
                         ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||.......      ...+......  ...... 
T Consensus       155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~~~~--~~~~~~-  222 (258)
T cd05578         155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI------RDQIRAKQET--ADVLYP-  222 (258)
T ss_pred             ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH------HHHHHHHhcc--ccccCc-
Confidence               2234568889999999998889999999999999999999999987443210      0001111010  001111 


Q ss_pred             ccCCcccHHHHHHHHHHHHHhhccCCCCCCCh--hHH
Q 015027          323 HVADESEMKEIEIVAELASKCLRIRGTERPTM--KQV  357 (414)
Q Consensus       323 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~--~~v  357 (414)
                             ...+..+.+++.+||+.+|.+||++  +++
T Consensus       223 -------~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l  252 (258)
T cd05578         223 -------ATWSTEAIDAINKLLERDPQKRLGDNLKDL  252 (258)
T ss_pred             -------ccCcHHHHHHHHHHccCChhHcCCccHHHH
Confidence                   1122568999999999999999999  554

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.6e-38  Score=319.91  Aligned_cols=200  Identities=20%  Similarity=0.268  Sum_probs=156.0

Q ss_pred             HhcCCCCCCccccCCceEEEEEEEcC--CcEEEEE------------------EeecccchhHhHHHHHHHHHccCCCce
Q 015027           85 ATKNFDRSRCLSQGGFVSVYKGVLHD--NIQVAVK------------------TYRRADKIRITERELLRIISQVNHKNV  144 (414)
Q Consensus        85 ~~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK------------------~~~~~~~~~~~~~~~~~~l~~l~hpni  144 (414)
                      ..++|++++.||+|+||+||++..+.  +...++|                  .+............++.++++++||||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            45789999999999999999987542  2222222                  111111222334566789999999999


Q ss_pred             eeeeeeEecCCcceEEEEeCCCCchhhhhhhcCC--cccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeC
Q 015027          145 VKILGLCLETEVPLLVYEFASNGTLLDHIRCESS--QVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLN  222 (414)
Q Consensus       145 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~  222 (414)
                      +++++++...+..|+|++++. ++|.+++.....  ........+..++.||+.||.|||+.+   |+||||||+|||++
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~  301 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLN  301 (501)
T ss_pred             CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC
Confidence            999999999999999999995 467666643221  111235667789999999999999987   99999999999999


Q ss_pred             CCCcEEEeeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCC
Q 015027          223 DNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP  289 (414)
Q Consensus       223 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p  289 (414)
                      .++.+||+|||++..+..... .......||+.|+|||++.+..++.++|||||||++|||++|..+
T Consensus       302 ~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~  367 (501)
T PHA03210        302 CDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFC  367 (501)
T ss_pred             CCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence            999999999999987653311 222345799999999999999999999999999999999998754

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-40  Score=312.44  Aligned_cols=250  Identities=22%  Similarity=0.306  Sum_probs=194.4

Q ss_pred             cCCCCCCccccCCceEEEEEEEcC-CcEEEEEEeecccchh-HhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeC
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLHD-NIQVAVKTYRRADKIR-ITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFA  164 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~-~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  164 (414)
                      +.|.++..||.|+||.||+|..++ +-..|-|++....... ....-++.+|..+.||+||++++.|+.++.+||+.|||
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC  111 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC  111 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence            456778889999999999999775 4445677775443322 23345578999999999999999999999999999999


Q ss_pred             CCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccc
Q 015027          165 SNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET  244 (414)
Q Consensus       165 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  244 (414)
                      .||-....+..-+.  .+++.++..++++++.||.|||++.   |||||||+.|||++-+|.++|+|||.+-....  ..
T Consensus       112 ~GGAVDaimlEL~r--~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~  184 (1187)
T KOG0579|consen  112 GGGAVDAIMLELGR--VLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TR  184 (1187)
T ss_pred             CCchHhHHHHHhcc--ccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchh--HH
Confidence            99998887765443  3478899999999999999999977   99999999999999999999999998754332  12


Q ss_pred             cceecccccccccchhhc-----ccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccc
Q 015027          245 AMSTILIGTSGYLDPVCI-----NTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQI  319 (414)
Q Consensus       245 ~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (414)
                      .....++|||.|||||+.     ...+|+.++||||||++|.||..+.+|-...+...         ++-.+....-..+
T Consensus       185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR---------VllKiaKSePPTL  255 (1187)
T KOG0579|consen  185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR---------VLLKIAKSEPPTL  255 (1187)
T ss_pred             hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH---------HHHHHhhcCCCcc
Confidence            234567999999999986     45689999999999999999999999965322111         1111111111111


Q ss_pred             cccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          320 LNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       320 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      +       .+...+..+.+++.+||..||..||++.++++
T Consensus       256 l-------qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  256 L-------QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             c-------CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence            1       22334466999999999999999999999875

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=5.1e-38  Score=294.10  Aligned_cols=266  Identities=17%  Similarity=0.210  Sum_probs=195.6

Q ss_pred             CCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeC
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFA  164 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  164 (414)
                      +|++.+.||.|++|.||+|.+. +|..||||.+......  .....+++.++++++||||+++++++...+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            5888999999999999999976 5889999998765322  233455678999999999999999999999999999999


Q ss_pred             CCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccc
Q 015027          165 SNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET  244 (414)
Q Consensus       165 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  244 (414)
                      ++ +|.+++........+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||++........ 
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-  155 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-  155 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence            85 88888866554455688999999999999999999987   99999999999999999999999999876543211 


Q ss_pred             cceecccccccccchhhccc-CCCCCcccchhHHHHHHHHHhCCCCCCcccccccccccc------chhhhhhhcc-ccc
Q 015027          245 AMSTILIGTSGYLDPVCINT-GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISM------VPYFLNSIKN-NGL  316 (414)
Q Consensus       245 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~------~~~~~~~~~~-~~~  316 (414)
                       ......+++.|++||++.+ ..++.++|||||||++|+|++|..||.............      .......+.. ...
T Consensus       156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07836         156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY  234 (284)
T ss_pred             -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence             1233467889999998865 457889999999999999999999997543211000000      0000000000 000


Q ss_pred             cccccccc---CCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          317 RQILNFHV---ADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       317 ~~~~~~~~---~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ........   ........+..+.+++.+||+.+|.+||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00000000   00000112356889999999999999999999864

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-39  Score=286.08  Aligned_cols=241  Identities=23%  Similarity=0.249  Sum_probs=195.2

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhHhH----HHHHHHHHccCCCceeeeeeeEecCCcceEE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRITE----RELLRIISQVNHKNVVKILGLCLETEVPLLV  160 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~----~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv  160 (414)
                      -++|+.+++||+|.||.|.+++-+ +++.+|+|+++++......+    .-+-+.|...+||.+..+.-.|+..+++|+|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            478999999999999999999966 58999999998875544433    3345789999999999999999999999999


Q ss_pred             EEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccC
Q 015027          161 YEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISS  240 (414)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  240 (414)
                      |||..||.|.-+|.+..   ..++...+-+...|+.||.|||+.+   |+.||||.+|.|+|.+|++||+|||+++.--.
T Consensus       247 MeyanGGeLf~HLsrer---~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~  320 (516)
T KOG0690|consen  247 MEYANGGELFFHLSRER---VFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIK  320 (516)
T ss_pred             EEEccCceEeeehhhhh---cccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhccc
Confidence            99999999999986533   3366667778899999999999977   99999999999999999999999999875433


Q ss_pred             CccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccc
Q 015027          241 DAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQIL  320 (414)
Q Consensus       241 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (414)
                        .......++|||.|+|||++....|...+|.|.+||++|||+||+.||...+...     +.    ..        ++
T Consensus       321 --~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k-----LF----eL--------Il  381 (516)
T KOG0690|consen  321 --YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK-----LF----EL--------IL  381 (516)
T ss_pred             --ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH-----HH----HH--------HH
Confidence              2334567899999999999999999999999999999999999999997443221     00    00        11


Q ss_pred             ccccCCcccHHHHHHHHHHHHHhhccCCCCCCC
Q 015027          321 NFHVADESEMKEIEIVAELASKCLRIRGTERPT  353 (414)
Q Consensus       321 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps  353 (414)
                      ...+  .++...+++...|+..+|.+||.+|..
T Consensus       382 ~ed~--kFPr~ls~eAktLLsGLL~kdP~kRLG  412 (516)
T KOG0690|consen  382 MEDL--KFPRTLSPEAKTLLSGLLKKDPKKRLG  412 (516)
T ss_pred             hhhc--cCCccCCHHHHHHHHHHhhcChHhhcC
Confidence            0000  111222355889999999999999964

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=2.1e-39  Score=287.29  Aligned_cols=208  Identities=22%  Similarity=0.313  Sum_probs=173.8

Q ss_pred             HHhcCCCCCCccccCCceEEEEEEEcC-----CcEEEEEEeeccc---chhHhHHHHHHHHHccCCCceeeeeeeEec-C
Q 015027           84 RATKNFDRSRCLSQGGFVSVYKGVLHD-----NIQVAVKTYRRAD---KIRITERELLRIISQVNHKNVVKILGLCLE-T  154 (414)
Q Consensus        84 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~---~~~~~~~~~~~~l~~l~hpniv~l~~~~~~-~  154 (414)
                      .-...|+.+..||+|+||.||+|...+     ...+|||.++...   .......+|+.+++.++||||+.+..+|.. +
T Consensus        21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d  100 (438)
T KOG0666|consen   21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD  100 (438)
T ss_pred             HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence            445679999999999999999997432     2368999997653   445666778899999999999999999987 7


Q ss_pred             CcceEEEEeCCCCchhhhhhhcC--CcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCC----CcEE
Q 015027          155 EVPLLVYEFASNGTLLDHIRCES--SQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDN----YTAK  228 (414)
Q Consensus       155 ~~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~----~~~k  228 (414)
                      ..+++++||.+. +|...++...  ....++...+.+|+.||+.|++|||++.   |+||||||.|||+..+    |.||
T Consensus       101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VK  176 (438)
T KOG0666|consen  101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVK  176 (438)
T ss_pred             ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeE
Confidence            889999999977 7777774332  2345677889999999999999999998   9999999999999876    9999


Q ss_pred             EeeccccccccCCcccc-ceecccccccccchhhcccC-CCCCcccchhHHHHHHHHHhCCCCCCcccc
Q 015027          229 VADFESSVLISSDAETA-MSTILIGTSGYLDPVCINTG-KLTKKSDVYSFGVVLAELLTGKKPGSCMTL  295 (414)
Q Consensus       229 l~DfGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~  295 (414)
                      |+|||+++.+....... ....++-|.+|.|||.+.|. .||.+.||||+|||+.||+|-.+-|.+.+.
T Consensus       177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~  245 (438)
T KOG0666|consen  177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREE  245 (438)
T ss_pred             eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhh
Confidence            99999999987765443 34456789999999998764 699999999999999999999988876443

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-38  Score=296.36  Aligned_cols=266  Identities=20%  Similarity=0.236  Sum_probs=196.1

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc---hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK---IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYE  162 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  162 (414)
                      ++|++.+.||+|+||.||+|.+. +++.||+|.+.....   .......+++++++++||||+++++++..++..++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36889999999999999999976 588999998865422   22344667789999999999999999999999999999


Q ss_pred             eCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCc
Q 015027          163 FASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDA  242 (414)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  242 (414)
                      |++++.+..+....   ..+++..+..++.+|+.||.|||+.+   ++|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~  154 (288)
T cd07833          81 YVERTLLELLEASP---GGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP  154 (288)
T ss_pred             cCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence            99987776655432   22478899999999999999999987   9999999999999999999999999988765442


Q ss_pred             cccceecccccccccchhhcccC-CCCCcccchhHHHHHHHHHhCCCCCCccccccccc------cccchhhhhhhccc-
Q 015027          243 ETAMSTILIGTSGYLDPVCINTG-KLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKK------ISMVPYFLNSIKNN-  314 (414)
Q Consensus       243 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~------~~~~~~~~~~~~~~-  314 (414)
                      . .......++..|+|||++.+. .++.++||||||+++|+|++|+.||..........      ..+.+......... 
T Consensus       155 ~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07833         155 A-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP  233 (288)
T ss_pred             c-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence            2 122345678899999999888 88999999999999999999999986432110000      00000000000000 


Q ss_pred             -----cccccccc-ccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          315 -----GLRQILNF-HVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       315 -----~~~~~~~~-~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                           ........ ......+...+..+.+|+.+||..+|++|||++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence                 00000000 0000011112466999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=5.4e-38  Score=294.08  Aligned_cols=265  Identities=19%  Similarity=0.186  Sum_probs=195.2

Q ss_pred             CCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc---hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEe
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK---IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  163 (414)
                      +|.+.+.||+|+||.||+|.+. +|..||+|++.....   .......++.++++++||||+++++++..+...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4788899999999999999975 589999999876542   223445667899999999999999999999999999999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcc
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE  243 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  243 (414)
                      + +++|.+++....  ..+++..++.++.||+.||.|||+.+   ++|+||||+||+++.++.++|+|||++........
T Consensus        81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (286)
T cd07832          81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP  154 (286)
T ss_pred             c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence            9 999999886543  34588999999999999999999987   99999999999999999999999999887654322


Q ss_pred             ccceecccccccccchhhcccC-CCCCcccchhHHHHHHHHHhCCCCCCcccccccccccc------chhhhhhhcc-cc
Q 015027          244 TAMSTILIGTSGYLDPVCINTG-KLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISM------VPYFLNSIKN-NG  315 (414)
Q Consensus       244 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~------~~~~~~~~~~-~~  315 (414)
                       .......++..|+|||.+.+. .++.++||||||+++|+|++|.+||............+      .+..+..... ..
T Consensus       155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07832         155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPD  233 (286)
T ss_pred             -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcch
Confidence             122345788999999998654 46899999999999999999988876432111000000      0000000000 00


Q ss_pred             cccccccccCC----cccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          316 LRQILNFHVAD----ESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       316 ~~~~~~~~~~~----~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ......+....    .........+.+|+.+||+.+|.+|||+++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            00000000000    000012366899999999999999999999865

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-38  Score=309.77  Aligned_cols=272  Identities=25%  Similarity=0.334  Sum_probs=201.8

Q ss_pred             CCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhHhH--HHHHHHHHccCCCceeeeeeeEecCC------cceE
Q 015027           89 FDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRITE--RELLRIISQVNHKNVVKILGLCLETE------VPLL  159 (414)
Q Consensus        89 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~--~~~~~~l~~l~hpniv~l~~~~~~~~------~~~l  159 (414)
                      +...+.||+|+||.||+|+.+ +|+.||||.++........+  ..|++++++++|||||++++.-++..      ...+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            344567999999999999955 69999999998755444333  56779999999999999999865433      5689


Q ss_pred             EEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeC----CCCcEEEeecccc
Q 015027          160 VYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLN----DNYTAKVADFESS  235 (414)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~----~~~~~kl~DfGla  235 (414)
                      |||||.||+|...+..-.....+++.+.+.++.+++.||.|||+++   |+||||||.||++-    ..-..||+|||.|
T Consensus        95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            9999999999999988877788899999999999999999999987   99999999999984    2335799999999


Q ss_pred             ccccCCccccceecccccccccchhhccc-CCCCCcccchhHHHHHHHHHhCCCCCCccccccc-cccccchh-------
Q 015027          236 VLISSDAETAMSTILIGTSGYLDPVCINT-GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASN-KKISMVPY-------  306 (414)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~-~~~~~~~~-------  306 (414)
                      +.+..+   ......+||+.|++||.... +.|+.-+|.|||||++|+++||..||........ .+..+...       
T Consensus       172 rel~d~---s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v  248 (732)
T KOG4250|consen  172 RELDDN---SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGV  248 (732)
T ss_pred             ccCCCC---CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCce
Confidence            988754   35677899999999999984 8899999999999999999999999863222111 00000000       


Q ss_pred             --hhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCC--ChhHHHHHHHHHHH
Q 015027          307 --FLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERP--TMKQVSEELDRLRR  366 (414)
Q Consensus       307 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rp--s~~~v~~~L~~i~~  366 (414)
                        .......+.+..-..-..+..-.......+-..+..+|..+|.+|.  ...+....+..|..
T Consensus       249 ~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~  312 (732)
T KOG4250|consen  249 AIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN  312 (732)
T ss_pred             eEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence              0000000000000000011111223335577888889999999998  67776666666554

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=7.9e-38  Score=292.44  Aligned_cols=240  Identities=20%  Similarity=0.251  Sum_probs=182.3

Q ss_pred             ccccCCceEEEEEEEc-CCcEEEEEEeecccch----hHhH---HHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCC
Q 015027           94 CLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI----RITE---RELLRIISQVNHKNVVKILGLCLETEVPLLVYEFAS  165 (414)
Q Consensus        94 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~---~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  165 (414)
                      .||+|+||.||++... +++.+|+|.+......    ....   ...++++...+||||+.+++++..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999975 5889999988654221    1111   222345555689999999999999999999999999


Q ss_pred             CCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcccc
Q 015027          166 NGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETA  245 (414)
Q Consensus       166 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  245 (414)
                      +++|.+++....   .+++..+..++.|++.||.|||+.+   ++|+||||+|||+++++.++|+|||++......    
T Consensus        81 ~~~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~----  150 (279)
T cd05633          81 GGDLHYHLSQHG---VFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK----  150 (279)
T ss_pred             CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceecccc----
Confidence            999998886433   3588999999999999999999988   999999999999999999999999998755322    


Q ss_pred             ceecccccccccchhhcc-cCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccccccc
Q 015027          246 MSTILIGTSGYLDPVCIN-TGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHV  324 (414)
Q Consensus       246 ~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (414)
                      ......||+.|+|||.+. +..++.++|||||||++|+|++|..||........      ... ....     ...+..+
T Consensus       151 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~------~~~-~~~~-----~~~~~~~  218 (279)
T cd05633         151 KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK------HEI-DRMT-----LTVNVEL  218 (279)
T ss_pred             CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH------HHH-HHHh-----hcCCcCC
Confidence            112346899999999986 45689999999999999999999999964321110      000 0000     0001111


Q ss_pred             CCcccHHHHHHHHHHHHHhhccCCCCCC-----ChhHHHH
Q 015027          325 ADESEMKEIEIVAELASKCLRIRGTERP-----TMKQVSE  359 (414)
Q Consensus       325 ~~~~~~~~~~~l~~Li~~cl~~dP~~Rp-----s~~~v~~  359 (414)
                          +...+..+.+++.+||+.||.+||     |++++++
T Consensus       219 ----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~  254 (279)
T cd05633         219 ----PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE  254 (279)
T ss_pred             ----ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence                111235689999999999999999     5777754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.4e-37  Score=286.12  Aligned_cols=250  Identities=25%  Similarity=0.346  Sum_probs=199.4

Q ss_pred             CCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc---hhHhHHHHHHHHHccCCCceeeeeeeEecC--CcceEEE
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK---IRITERELLRIISQVNHKNVVKILGLCLET--EVPLLVY  161 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~hpniv~l~~~~~~~--~~~~lv~  161 (414)
                      +|...+.||+|++|.||+|... ++..|++|.+.....   ......+++..+++++||||+++++.+...  ...++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4778899999999999999976 689999999876652   233446677899999999999999999988  8899999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCC
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD  241 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  241 (414)
                      ||+++++|.+++....   .+++..+..++.+++.||+|||+.+   ++|+||+|+||+++.++.++|+|||.+......
T Consensus        81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  154 (260)
T cd06606          81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI  154 (260)
T ss_pred             EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence            9999999999986544   5588999999999999999999977   999999999999999999999999998877654


Q ss_pred             ccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccc
Q 015027          242 AETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILN  321 (414)
Q Consensus       242 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (414)
                      ..........++..|+|||.+.+...+.++||||||+++|+|++|..||.......       . ..........     
T Consensus       155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~-~~~~~~~~~~-----  221 (260)
T cd06606         155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM-------A-ALYKIGSSGE-----  221 (260)
T ss_pred             cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-------H-HHHhccccCC-----
Confidence            32112334578889999999998889999999999999999999999987433000       0 0000000000     


Q ss_pred             cccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          322 FHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       322 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                         ....+...+..+.+++.+||+.+|.+||++.+++.
T Consensus       222 ---~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         222 ---PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             ---CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence               00111112356999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=5.7e-38  Score=295.32  Aligned_cols=265  Identities=18%  Similarity=0.199  Sum_probs=193.8

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch---hHhHHHHHHHHHccCCCceeeeeeeEecC--CcceEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI---RITERELLRIISQVNHKNVVKILGLCLET--EVPLLV  160 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~hpniv~l~~~~~~~--~~~~lv  160 (414)
                      ++|.+.+.||+|+||.||+|... +++.+|+|.++.....   .....+++.++.+++||||+++++++...  ...|+|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            57889999999999999999976 5889999999754322   12334567889999999999999998877  889999


Q ss_pred             EEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccC
Q 015027          161 YEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISS  240 (414)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  240 (414)
                      |||+++ +|.+++.....  .+++..++.++.||+.||.|||+.+   ++|+||||+||+++.++.+||+|||++.....
T Consensus        85 ~e~~~~-~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843          85 MEYVEH-DLKSLMETMKQ--PFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS  158 (293)
T ss_pred             ehhcCc-CHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence            999975 88888865432  4588999999999999999999987   99999999999999999999999999886654


Q ss_pred             CccccceecccccccccchhhcccC-CCCCcccchhHHHHHHHHHhCCCCCCccccccccccccc------hhhhh----
Q 015027          241 DAETAMSTILIGTSGYLDPVCINTG-KLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMV------PYFLN----  309 (414)
Q Consensus       241 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~------~~~~~----  309 (414)
                      ..  .......+++.|+|||.+.+. .++.++||||||+++|+|++|..||..............      +..+.    
T Consensus       159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (293)
T cd07843         159 PL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE  236 (293)
T ss_pred             Cc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence            32  112334578899999998654 468999999999999999999999974432110000000      00000    


Q ss_pred             --hhcccccccccccccCCcccHH-HHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          310 --SIKNNGLRQILNFHVADESEMK-EIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       310 --~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                        ..............+....+.. .++.+.+|+.+||+.+|++|||+.+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence              0000000000000000001111 2355899999999999999999999864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=3.1e-37  Score=282.61  Aligned_cols=248  Identities=30%  Similarity=0.429  Sum_probs=198.5

Q ss_pred             CCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc-hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCC
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK-IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFAS  165 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  165 (414)
                      +|...+.||+|++|.||++... ++..+++|++..... ......++++.+++++|||++++++++..+...++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            4778889999999999999976 688999999977654 33445667789999999999999999999999999999999


Q ss_pred             CCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcccc
Q 015027          166 NGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETA  245 (414)
Q Consensus       166 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  245 (414)
                      +++|.+++....  ..+++..+..++.+++.||.+||..+   ++|+||+|+||++++++.++|+|||.+........  
T Consensus        81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--  153 (253)
T cd05122          81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--  153 (253)
T ss_pred             CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence            999999886543  34588999999999999999999977   99999999999999999999999999877654321  


Q ss_pred             ceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccccC
Q 015027          246 MSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVA  325 (414)
Q Consensus       246 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (414)
                       .....++..|++||.+.+..++.++||||||+++|+|++|+.||........        . .............    
T Consensus       154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--------~-~~~~~~~~~~~~~----  219 (253)
T cd05122         154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA--------L-FKIATNGPPGLRN----  219 (253)
T ss_pred             -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH--------H-HHHHhcCCCCcCc----
Confidence             2345788899999999988899999999999999999999999864321110        0 0000000000000    


Q ss_pred             CcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          326 DESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       326 ~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                         ....+..+.+++.+||+.+|++|||+.++++
T Consensus       220 ---~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         220 ---PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             ---ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence               0111255899999999999999999999864

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=2.5e-37  Score=289.98  Aligned_cols=247  Identities=21%  Similarity=0.271  Sum_probs=193.0

Q ss_pred             CCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch-hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCC
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI-RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFAS  165 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  165 (414)
                      .|...+.||+|++|.||++... +++.+++|.+...... .....+++.+++.++||||+++++++...+..++|+||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            3555678999999999999964 6889999988654322 2234566788999999999999999999999999999999


Q ss_pred             CCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcccc
Q 015027          166 NGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETA  245 (414)
Q Consensus       166 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  245 (414)
                      +++|.+++..    ..+++..+..++.|++.||+|||+++   ++||||+|+||+++.++.++|+|||++........  
T Consensus       100 ~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--  170 (285)
T cd06648         100 GGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--  170 (285)
T ss_pred             CCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc--
Confidence            9999999865    23478889999999999999999988   99999999999999999999999998876543221  


Q ss_pred             ceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccccC
Q 015027          246 MSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVA  325 (414)
Q Consensus       246 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (414)
                      ......|++.|+|||.+.+..++.++||||||+++|+|++|..||.......         .........     .+...
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~---------~~~~~~~~~-----~~~~~  236 (285)
T cd06648         171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQ---------AMKRIRDNL-----PPKLK  236 (285)
T ss_pred             ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHH---------HHHHHHhcC-----CCCCc
Confidence            1233568899999999998889999999999999999999999986322110         000011000     00000


Q ss_pred             CcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          326 DESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       326 ~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      .  ....+..+.+++.+||+.+|.+|||+.++++
T Consensus       237 ~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         237 N--LHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             c--cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            0  0012245999999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.2e-37  Score=288.27  Aligned_cols=240  Identities=25%  Similarity=0.258  Sum_probs=188.5

Q ss_pred             cccCCceEEEEEEEc-CCcEEEEEEeecccc----hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCCCCch
Q 015027           95 LSQGGFVSVYKGVLH-DNIQVAVKTYRRADK----IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTL  169 (414)
Q Consensus        95 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL  169 (414)
                      ||.|++|.||+|.+. +++.+|+|++.....    .......++++++.++||||+++++++.++...++||||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999976 489999999876432    223345667889999999999999999999999999999999999


Q ss_pred             hhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccccceec
Q 015027          170 LDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTI  249 (414)
Q Consensus       170 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  249 (414)
                      .+++....   .+++..+..++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......   ....
T Consensus        81 ~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~  151 (262)
T cd05572          81 WTILRDRG---LFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT  151 (262)
T ss_pred             HHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence            99996532   3578889999999999999999977   9999999999999999999999999998765432   2233


Q ss_pred             ccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccccCCccc
Q 015027          250 LIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESE  329 (414)
Q Consensus       250 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (414)
                      ..+++.|++||.+.+..++.++|+||||+++|+|++|..||.......       ............        ....+
T Consensus       152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~--------~~~~~  216 (262)
T cd05572         152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP-------MEIYNDILKGNG--------KLEFP  216 (262)
T ss_pred             ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH-------HHHHHHHhccCC--------CCCCC
Confidence            468889999999988889999999999999999999999997443100       000000000000        00111


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCC-----hhHHH
Q 015027          330 MKEIEIVAELASKCLRIRGTERPT-----MKQVS  358 (414)
Q Consensus       330 ~~~~~~l~~Li~~cl~~dP~~Rps-----~~~v~  358 (414)
                      ...+..+.+++.+||+.+|.+||+     +.+++
T Consensus       217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~  250 (262)
T cd05572         217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIK  250 (262)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCCcccCHHHHh
Confidence            111356999999999999999999     55553

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.2e-38  Score=303.38  Aligned_cols=248  Identities=25%  Similarity=0.325  Sum_probs=204.5

Q ss_pred             HHhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchh---HhHHHHHHHHHccCCCceeeeeeeEecCCcceE
Q 015027           84 RATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIR---ITERELLRIISQVNHKNVVKILGLCLETEVPLL  159 (414)
Q Consensus        84 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~l  159 (414)
                      .....|.+.+.||+|.|+.|.+|+.. ++..||||++.+.....   ....+++++|..++|||||+++.+......+|+
T Consensus        53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl  132 (596)
T KOG0586|consen   53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL  132 (596)
T ss_pred             ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence            34578999999999999999999965 69999999997754322   335667799999999999999999999999999


Q ss_pred             EEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccccccc
Q 015027          160 VYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLIS  239 (414)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~  239 (414)
                      ||||+.+|.+++++...+...   +..+..++.|++.+++|||+.+   |+|||||++||||+.+-++||+|||++..+.
T Consensus       133 V~eya~~ge~~~yl~~~gr~~---e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~  206 (596)
T KOG0586|consen  133 VMEYASGGELFDYLVKHGRMK---EKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD  206 (596)
T ss_pred             EEEeccCchhHHHHHhcccch---hhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec
Confidence            999999999999998877664   3778889999999999999987   9999999999999999999999999999886


Q ss_pred             CCccccceecccccccccchhhcccCCC-CCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccc
Q 015027          240 SDAETAMSTILIGTSGYLDPVCINTGKL-TKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQ  318 (414)
Q Consensus       240 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (414)
                      .   .......+|++.|+|||++.+..| ++.+|+||+|++||.|++|..||++..........+.         .    
T Consensus       207 ~---~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~---------g----  270 (596)
T KOG0586|consen  207 Y---GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLR---------G----  270 (596)
T ss_pred             c---cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhee---------e----
Confidence            3   344566799999999999998776 5789999999999999999999986553331111110         0    


Q ss_pred             ccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          319 ILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       319 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                        ..+++..-.    .++.+|++++|-.+|.+|++++++.+
T Consensus       271 --k~rIp~~ms----~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  271 --KYRIPFYMS----CDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             --eecccceee----chhHHHHHHhhccCccccCCHHHhhh
Confidence              011111111    33789999999999999999999854

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=9.4e-38  Score=294.16  Aligned_cols=258  Identities=17%  Similarity=0.225  Sum_probs=181.8

Q ss_pred             hcCCCCCCccccCCceEEEEEEEcC----CcEEEEEEeecccchhHh------------HHHHHHHHHccCCCceeeeee
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLHD----NIQVAVKTYRRADKIRIT------------ERELLRIISQVNHKNVVKILG  149 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~------------~~~~~~~l~~l~hpniv~l~~  149 (414)
                      .++|.+.+.||+|+||.||+|...+    +..+|+|...........            ....+..+..+.|+|++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            3679999999999999999999654    345677764332221111            112223456678999999999


Q ss_pred             eEecCC----cceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCC
Q 015027          150 LCLETE----VPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNY  225 (414)
Q Consensus       150 ~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~  225 (414)
                      ++....    ..+++++++.. ++.+.+....   ..++..+..++.|++.||+|||+.+   |+||||||+|||++.++
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~  163 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRIK---CKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN  163 (294)
T ss_pred             eeeEecCCceEEEEEEehhcc-CHHHHHHhhc---cCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence            766543    33677887743 5655554322   2367788899999999999999987   99999999999999999


Q ss_pred             cEEEeeccccccccCCccc-----cceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccc
Q 015027          226 TAKVADFESSVLISSDAET-----AMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKK  300 (414)
Q Consensus       226 ~~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~  300 (414)
                      .++|+|||+|+........     .......||+.|+|||++.+..++.++|||||||++|||++|..||..........
T Consensus       164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~  243 (294)
T PHA02882        164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI  243 (294)
T ss_pred             cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence            9999999999866432111     11223469999999999999999999999999999999999999997543211100


Q ss_pred             cccchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHH
Q 015027          301 ISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEEL  361 (414)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L  361 (414)
                      ......+.......        .....   ..++.+.+++..||..+|.+||++.++.+.|
T Consensus       244 ~~~~~~~~~~~~~~--------~~~~~---~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        244 HAAKCDFIKRLHEG--------KIKIK---NANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HHhHHHHHHHhhhh--------hhccC---CCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            00000011111111        00000   0125689999999999999999999998876

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=5e-38  Score=294.25  Aligned_cols=264  Identities=20%  Similarity=0.215  Sum_probs=191.7

Q ss_pred             CCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch---hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEe
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI---RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  163 (414)
                      +|+..+.||.|++|.||+|... ++..||||.+......   ......+++++++++||||+++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            5888999999999999999975 5889999988754322   23445677999999999999999999999999999999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcc
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE  243 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  243 (414)
                      +. ++|.+++..... ..+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.+||+|||++....... 
T Consensus        81 ~~-~~l~~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~-  154 (284)
T cd07860          81 LH-QDLKKFMDASPL-SGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-  154 (284)
T ss_pred             cc-cCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc-
Confidence            96 588888755432 34578899999999999999999987   9999999999999999999999999987654321 


Q ss_pred             ccceecccccccccchhhcccCC-CCCcccchhHHHHHHHHHhCCCCCCccccccccccccchh-------hhhhhc-cc
Q 015027          244 TAMSTILIGTSGYLDPVCINTGK-LTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPY-------FLNSIK-NN  314 (414)
Q Consensus       244 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~-------~~~~~~-~~  314 (414)
                       .......+++.|+|||++.+.. ++.++||||||+++|+|+||+.||...+..... ......       ...... ..
T Consensus       155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07860         155 -RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL-FRIFRTLGTPDEVVWPGVTSLP  232 (284)
T ss_pred             -cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH-HHHHHHhCCCChhhhhhhhHHH
Confidence             1123335688999999886644 688999999999999999999998643211100 000000       000000 00


Q ss_pred             ccccccccccCCc---ccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          315 GLRQILNFHVADE---SEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       315 ~~~~~~~~~~~~~---~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      .....+.......   ........+.+++.+||+.||.+|||+.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         233 DYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence            0000000000000   00011245889999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=9.9e-38  Score=301.64  Aligned_cols=263  Identities=20%  Similarity=0.243  Sum_probs=192.8

Q ss_pred             HhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc---hhHhHHHHHHHHHccCCCceeeeeeeEecC------
Q 015027           85 ATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK---IRITERELLRIISQVNHKNVVKILGLCLET------  154 (414)
Q Consensus        85 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~hpniv~l~~~~~~~------  154 (414)
                      ..++|+..+.||+|+||.||+|... +++.||+|.+.....   .......++.++++++||||++++++|...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            4578999999999999999999965 689999999864321   122334567899999999999999988643      


Q ss_pred             CcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccc
Q 015027          155 EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFES  234 (414)
Q Consensus       155 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGl  234 (414)
                      ...|+||||+++ +|.+.+...     ++...+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+
T Consensus        94 ~~~~lv~e~~~~-~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~  164 (353)
T cd07850          94 QDVYLVMELMDA-NLCQVIQMD-----LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  164 (353)
T ss_pred             CcEEEEEeccCC-CHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence            356999999965 787777432     577888899999999999999987   99999999999999999999999999


Q ss_pred             cccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCcccccccccc------ccchhhh
Q 015027          235 SVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKI------SMVPYFL  308 (414)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~------~~~~~~~  308 (414)
                      +.......   ......+++.|+|||++.+..++.++|||||||++|+|++|+.||...+....-..      ...+.+.
T Consensus       165 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
T cd07850         165 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM  241 (353)
T ss_pred             ceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            98654321   12334678899999999999999999999999999999999999964331100000      0000000


Q ss_pred             hh--------hcc------cccccccc----cccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          309 NS--------IKN------NGLRQILN----FHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       309 ~~--------~~~------~~~~~~~~----~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ..        ...      ..+...+.    +..........+..+.+|+.+||+.||++|||+.+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            00        000      00000100    00011111223456899999999999999999999965

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.2e-37  Score=290.73  Aligned_cols=240  Identities=20%  Similarity=0.224  Sum_probs=185.9

Q ss_pred             cccCCceEEEEEEEc-CCcEEEEEEeecccc----hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCCCCch
Q 015027           95 LSQGGFVSVYKGVLH-DNIQVAVKTYRRADK----IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTL  169 (414)
Q Consensus        95 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL  169 (414)
                      ||+|+||+||++... +|+.||+|.+.....    .......++++++.++||||+++++.+...+..|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999865 588999999875321    122234567889999999999999999999999999999999999


Q ss_pred             hhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccccceec
Q 015027          170 LDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTI  249 (414)
Q Consensus       170 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  249 (414)
                      .+++..... ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++......   .....
T Consensus        81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~  153 (277)
T cd05577          81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIKG  153 (277)
T ss_pred             HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC---Ccccc
Confidence            999865443 34578889999999999999999987   999999999999999999999999998765432   12233


Q ss_pred             ccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccccCCccc
Q 015027          250 LIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESE  329 (414)
Q Consensus       250 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (414)
                      ..++..|+|||++.+..++.++||||||+++|+|++|+.||.........     ...    ......  ...    ..+
T Consensus       154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-----~~~----~~~~~~--~~~----~~~  218 (277)
T cd05577         154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK-----EEL----KRRTLE--MAV----EYP  218 (277)
T ss_pred             ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH-----HHH----Hhcccc--ccc----cCC
Confidence            46788999999998888999999999999999999999999643321100     000    000000  000    011


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCChhH
Q 015027          330 MKEIEIVAELASKCLRIRGTERPTMKQ  356 (414)
Q Consensus       330 ~~~~~~l~~Li~~cl~~dP~~Rps~~~  356 (414)
                      ...+..+.+++.+||+.+|.+||++++
T Consensus       219 ~~~~~~~~~li~~~l~~~p~~R~~~~~  245 (277)
T cd05577         219 DKFSPEAKDLCEALLQKDPEKRLGCRG  245 (277)
T ss_pred             ccCCHHHHHHHHHHccCChhHccCCCc
Confidence            112356899999999999999995555

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-37  Score=288.28  Aligned_cols=241  Identities=24%  Similarity=0.250  Sum_probs=184.2

Q ss_pred             CccccCCceEEEEEEEc-CCcEEEEEEeecccchh----Hh-HHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCCC
Q 015027           93 RCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIR----IT-ERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASN  166 (414)
Q Consensus        93 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~-~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  166 (414)
                      +.||.|+||.||+|... +++.||+|.+.......    .. ..+...+....+|||++++++++..++..|+||||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            56899999999999975 58899999986543211    11 12222344556899999999999999999999999999


Q ss_pred             CchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccccc
Q 015027          167 GTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAM  246 (414)
Q Consensus       167 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  246 (414)
                      ++|.+++....   .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++.....      
T Consensus        82 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------  149 (260)
T cd05611          82 GDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------  149 (260)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence            99999986533   3578889999999999999999987   99999999999999999999999999875432      


Q ss_pred             eecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccccCC
Q 015027          247 STILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVAD  326 (414)
Q Consensus       247 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (414)
                      .....+++.|+|||.+.+..++.++||||||+++|+|++|..||.......         ...........      ...
T Consensus       150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---------~~~~~~~~~~~------~~~  214 (260)
T cd05611         150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA---------VFDNILSRRIN------WPE  214 (260)
T ss_pred             cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH---------HHHHHHhcccC------CCC
Confidence            223467889999999988889999999999999999999999986432111         11111111000      000


Q ss_pred             cccHHHHHHHHHHHHHhhccCCCCCCChhHHHHH
Q 015027          327 ESEMKEIEIVAELASKCLRIRGTERPTMKQVSEE  360 (414)
Q Consensus       327 ~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~  360 (414)
                      ......+..+.+++.+||+.+|.+||++..+.+.
T Consensus       215 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~  248 (260)
T cd05611         215 EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEI  248 (260)
T ss_pred             cccccCCHHHHHHHHHHccCCHHHccCCCcHHHH
Confidence            0011123568999999999999999988766444

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=9.8e-38  Score=287.63  Aligned_cols=248  Identities=23%  Similarity=0.359  Sum_probs=195.1

Q ss_pred             CCCCCCccccCCceEEEEEEEc-CCcEEEEEEeeccc---chhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEe
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRAD---KIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  163 (414)
                      +|.+.+.||+|+||.||+|... +|..+|+|.+....   ........++.+++.++||||+++++.+..+...++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            5778899999999999999976 48899999987642   1223345667899999999999999999999999999999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCC-cEEEeeccccccccCCc
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNY-TAKVADFESSVLISSDA  242 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~DfGla~~~~~~~  242 (414)
                      +++++|.+++..... ..+++..+..++.+++.||.|||+.+   ++|+||||+||++++++ .+||+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          81 CDGGDLMKRINRQRG-VLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM  156 (257)
T ss_pred             CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence            999999999865433 23578899999999999999999987   99999999999999875 56999999987664322


Q ss_pred             cccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccccc
Q 015027          243 ETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNF  322 (414)
Q Consensus       243 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (414)
                        .......|++.|+|||++.+..++.++|+||||+++|+|++|..||.......        ... ..........   
T Consensus       157 --~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--------~~~-~~~~~~~~~~---  222 (257)
T cd08225         157 --ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ--------LVL-KICQGYFAPI---  222 (257)
T ss_pred             --ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH--------HHH-HHhcccCCCC---
Confidence              12233468889999999988889999999999999999999999986432111        010 0111111000   


Q ss_pred             ccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          323 HVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       323 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                        .    ...+..+.+++.+||..+|++|||+.++++
T Consensus       223 --~----~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         223 --S----PNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             --C----CCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence              0    112245999999999999999999999965

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.2e-37  Score=293.30  Aligned_cols=266  Identities=17%  Similarity=0.138  Sum_probs=189.7

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch---hHhHHHHHHHHHccC-CCceeeeeeeEecCCc-----
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI---RITERELLRIISQVN-HKNVVKILGLCLETEV-----  156 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~-hpniv~l~~~~~~~~~-----  156 (414)
                      ++|++.+.||+|+||.||+|.+. +++.||+|.+......   .....+++.+++.++ ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46889999999999999999975 5899999988654322   233455668888885 6999999999887665     


Q ss_pred             ceEEEEeCCCCchhhhhhhcCC--cccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCC-CCcEEEeecc
Q 015027          157 PLLVYEFASNGTLLDHIRCESS--QVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLND-NYTAKVADFE  233 (414)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~DfG  233 (414)
                      .|+||||+++ +|.+++.....  ...+++..++.++.||+.||.|||+.+   ++||||+|+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence            7999999986 78887754322  235688999999999999999999987   999999999999998 8999999999


Q ss_pred             ccccccCCccccceecccccccccchhhccc-CCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchh------
Q 015027          234 SSVLISSDAETAMSTILIGTSGYLDPVCINT-GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPY------  306 (414)
Q Consensus       234 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~------  306 (414)
                      ++........  ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||...+...... .+...      
T Consensus       157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~-~~~~~~~~~~~  233 (295)
T cd07837         157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLL-HIFKLLGTPTE  233 (295)
T ss_pred             cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHH-HHHHHhCCCCh
Confidence            9876543211  1223356889999998865 457999999999999999999999986432211000 00000      


Q ss_pred             -hhhhhccccc---ccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          307 -FLNSIKNNGL---RQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       307 -~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                       ..........   .....+..........+..+.++|.+||+.+|.+|||+.+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence             0000000000   0000000000000112356899999999999999999999854

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-39  Score=333.52  Aligned_cols=253  Identities=25%  Similarity=0.323  Sum_probs=199.3

Q ss_pred             HHhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchh---HhHHHHHHHHHccCCCceeeeeeeEecCCcceE
Q 015027           84 RATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIR---ITERELLRIISQVNHKNVVKILGLCLETEVPLL  159 (414)
Q Consensus        84 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~l  159 (414)
                      ..+-++.....||.|.||.||.|... +|...|+|.+.......   ....+++.++..++|||+|+++|+-.+.+..+|
T Consensus      1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred             cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence            34557788899999999999999954 68889999886543332   334778899999999999999999999999999


Q ss_pred             EEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccccccc
Q 015027          160 VYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLIS  239 (414)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~  239 (414)
                      .||||++|+|.+.+...+..   ++.....+..|++.|++|||+.|   |+||||||.|||++.+|.+|++|||.|..+.
T Consensus      1312 FMEyC~~GsLa~ll~~gri~---dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGRIE---DEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred             HHHHhccCcHHHHHHhcchh---hhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEec
Confidence            99999999999999765432   45556678899999999999988   9999999999999999999999999998876


Q ss_pred             CCcccc--ceecccccccccchhhcccC---CCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccc
Q 015027          240 SDAETA--MSTILIGTSGYLDPVCINTG---KLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNN  314 (414)
Q Consensus       240 ~~~~~~--~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  314 (414)
                      ....+.  ......||+-|||||++.+.   ....++||||||||..||+||+.||...+...         ........
T Consensus      1386 ~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~---------aIMy~V~~ 1456 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW---------AIMYHVAA 1456 (1509)
T ss_pred             CchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh---------HHHhHHhc
Confidence            653221  22356899999999999764   46678999999999999999999997444221         11111111


Q ss_pred             ccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          315 GLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      +-        .+..+...+.+-.+++.+||..||++|.++.|+++
T Consensus      1457 gh--------~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1457 GH--------KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred             cC--------CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence            11        11122224456789999999999999999887744

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.7e-37  Score=290.05  Aligned_cols=261  Identities=21%  Similarity=0.232  Sum_probs=187.0

Q ss_pred             CCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch--hHhHHHHHHHHHccC-CCceeeeeeeEecC--CcceEEEE
Q 015027           89 FDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI--RITERELLRIISQVN-HKNVVKILGLCLET--EVPLLVYE  162 (414)
Q Consensus        89 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~-hpniv~l~~~~~~~--~~~~lv~e  162 (414)
                      |++.+.||+|+||.||+|... ++..||+|.+......  ......++..+.++. ||||+++++++.+.  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            567889999999999999965 5889999998754221  122234556677774 99999999999987  88999999


Q ss_pred             eCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCc
Q 015027          163 FASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDA  242 (414)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  242 (414)
                      |+++ +|.+.+....  ..+++..++.++.|++.||.|||+.+   ++||||+|+||+++. +.+||+|||++.......
T Consensus        81 ~~~~-~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~  153 (282)
T cd07831          81 LMDM-NLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP  153 (282)
T ss_pred             cCCc-cHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence            9975 7777775433  34588999999999999999999987   999999999999999 999999999998664321


Q ss_pred             cccceecccccccccchhhcc-cCCCCCcccchhHHHHHHHHHhCCCCCCccccccccc-----cc-cchhhhhhhcccc
Q 015027          243 ETAMSTILIGTSGYLDPVCIN-TGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKK-----IS-MVPYFLNSIKNNG  315 (414)
Q Consensus       243 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~-----~~-~~~~~~~~~~~~~  315 (414)
                      .   .....++..|+|||++. +..++.++|||||||++|||++|..||...+......     .+ ..+..........
T Consensus       154 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
T cd07831         154 P---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR  230 (282)
T ss_pred             C---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc
Confidence            1   12346788999999764 4567889999999999999999999997533211000     00 0000000000000


Q ss_pred             cccc-cccccCC---cccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          316 LRQI-LNFHVAD---ESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       316 ~~~~-~~~~~~~---~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      .... +......   ......+..+.+|+.+||+.+|.+|||+.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            0000 0000000   000123467999999999999999999999865

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1e-37  Score=288.41  Aligned_cols=245  Identities=26%  Similarity=0.273  Sum_probs=190.8

Q ss_pred             cccCCceEEEEEEEcC-CcEEEEEEeecccc----hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCCCCch
Q 015027           95 LSQGGFVSVYKGVLHD-NIQVAVKTYRRADK----IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTL  169 (414)
Q Consensus        95 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL  169 (414)
                      ||.|+||.||++.... ++.+++|.+.....    ......++++++++++||||+++++.+..+...|+||||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999999764 89999999876543    223345567889999999999999999999999999999999999


Q ss_pred             hhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcc------
Q 015027          170 LDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE------  243 (414)
Q Consensus       170 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~------  243 (414)
                      .+++....   .+++..+..++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++........      
T Consensus        81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  154 (265)
T cd05579          81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD  154 (265)
T ss_pred             HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence            99986543   4588899999999999999999987   99999999999999999999999999876543311      


Q ss_pred             ccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccc
Q 015027          244 TAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFH  323 (414)
Q Consensus       244 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (414)
                      ........++..|+|||...+..++.++||||||+++|+|++|..||.......         ..........       
T Consensus       155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---------~~~~~~~~~~-------  218 (265)
T cd05579         155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE---------IFQNILNGKI-------  218 (265)
T ss_pred             cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH---------HHHHHhcCCc-------
Confidence            112234567889999999988889999999999999999999999986432111         0011110000       


Q ss_pred             cCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHH
Q 015027          324 VADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELD  362 (414)
Q Consensus       324 ~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~  362 (414)
                       ........+..+.+++.+||+.+|.+|||+..+.+.|+
T Consensus       219 -~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         219 -EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             -CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence             00000011356899999999999999999966655443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2.7e-37  Score=288.68  Aligned_cols=240  Identities=20%  Similarity=0.257  Sum_probs=183.9

Q ss_pred             ccccCCceEEEEEEEc-CCcEEEEEEeecccch-------hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCC
Q 015027           94 CLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI-------RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFAS  165 (414)
Q Consensus        94 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  165 (414)
                      .||+|+||.||+|... +++.||+|.+......       ...+...++.++...||||+++++++...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999965 5889999998754211       1112233455666789999999999999999999999999


Q ss_pred             CCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcccc
Q 015027          166 NGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETA  245 (414)
Q Consensus       166 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  245 (414)
                      |++|.+++...   ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++......    
T Consensus        81 g~~L~~~l~~~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~----  150 (278)
T cd05606          81 GGDLHYHLSQH---GVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK----  150 (278)
T ss_pred             CCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCcc----
Confidence            99999888543   34688999999999999999999987   999999999999999999999999998755322    


Q ss_pred             ceecccccccccchhhcccC-CCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccccccc
Q 015027          246 MSTILIGTSGYLDPVCINTG-KLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHV  324 (414)
Q Consensus       246 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (414)
                      ......|+..|+|||++.++ .++.++|||||||++|+|++|+.||.........      .......      .....+
T Consensus       151 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~------~~~~~~~------~~~~~~  218 (278)
T cd05606         151 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH------EIDRMTL------TMAVEL  218 (278)
T ss_pred             CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH------HHHHHhh------ccCCCC
Confidence            12234789999999998754 6899999999999999999999999643211100      0000000      001111


Q ss_pred             CCcccHHHHHHHHHHHHHhhccCCCCCC-----ChhHHHH
Q 015027          325 ADESEMKEIEIVAELASKCLRIRGTERP-----TMKQVSE  359 (414)
Q Consensus       325 ~~~~~~~~~~~l~~Li~~cl~~dP~~Rp-----s~~~v~~  359 (414)
                      ..    ..+..+.+++.+||..+|.+||     ++.++++
T Consensus       219 ~~----~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         219 PD----SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             CC----cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence            11    1135699999999999999999     8888854

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=2.1e-37  Score=293.88  Aligned_cols=265  Identities=20%  Similarity=0.206  Sum_probs=191.7

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch---hHhHHHHHHHHHccCCCceeeeeeeEecC--CcceE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI---RITERELLRIISQVNHKNVVKILGLCLET--EVPLL  159 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~hpniv~l~~~~~~~--~~~~l  159 (414)
                      .++|++.+.||+|+||.||+|.+. +|..||+|.+......   ......++.++++++|+||+++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            467999999999999999999975 5899999998754322   12234567899999999999999998755  46899


Q ss_pred             EEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccccccc
Q 015027          160 VYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLIS  239 (414)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~  239 (414)
                      ||||+++ +|.+++....  ..+++..+..++.||+.||.|||+.+   ++||||||+||+++.++.+||+|||++....
T Consensus        86 v~e~~~~-~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~  159 (309)
T cd07845          86 VMEYCEQ-DLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG  159 (309)
T ss_pred             EEecCCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence            9999975 7877775432  34588999999999999999999988   9999999999999999999999999998765


Q ss_pred             CCccccceecccccccccchhhccc-CCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccch-------hhhhhh
Q 015027          240 SDAETAMSTILIGTSGYLDPVCINT-GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVP-------YFLNSI  311 (414)
Q Consensus       240 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~-------~~~~~~  311 (414)
                      ....  ......+++.|+|||.+.+ ..++.++|||||||++|+|++|..||...+...... ....       ......
T Consensus       160 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~-~~~~~~~~~~~~~~~~~  236 (309)
T cd07845         160 LPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLD-LIIQLLGTPNESIWPGF  236 (309)
T ss_pred             CccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHhcCCCChhhchhh
Confidence            4321  1222345788999999865 568999999999999999999999997443211000 0000       000000


Q ss_pred             cccccccccc-cccCCcc----cHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          312 KNNGLRQILN-FHVADES----EMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       312 ~~~~~~~~~~-~~~~~~~----~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ........+. .......    ....++.+.+|+.+||+.||++|||+.+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            0000000000 0000000    0012356889999999999999999999854

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-39  Score=295.69  Aligned_cols=248  Identities=22%  Similarity=0.228  Sum_probs=199.0

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc----hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK----IRITERELLRIISQVNHKNVVKILGLCLETEVPLLV  160 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv  160 (414)
                      .+.|..-++||+|+||.||-+... +|+.+|.|.+.+...    .......+-++|.+++.+.||.+--.|+..+.+++|
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV  263 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV  263 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence            467888999999999999999854 699999998754322    112224556789999999999999999999999999


Q ss_pred             EEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccC
Q 015027          161 YEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISS  240 (414)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  240 (414)
                      +..|.||+|.-+|...+. ..+++..++-++.+|+.||.+||..+   |++|||||+|||+|+.|++.|+|+|+|..+..
T Consensus       264 LtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~  339 (591)
T KOG0986|consen  264 LTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPE  339 (591)
T ss_pred             EEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCC
Confidence            999999999999976664 44588888999999999999999988   99999999999999999999999999988764


Q ss_pred             CccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccc
Q 015027          241 DAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQIL  320 (414)
Q Consensus       241 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (414)
                      .   ......+||.+|||||++.+..|+...|.|||||++|||+.|+.||.......              +...+...+
T Consensus       340 g---~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv--------------k~eEvdrr~  402 (591)
T KOG0986|consen  340 G---KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV--------------KREEVDRRT  402 (591)
T ss_pred             C---CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh--------------hHHHHHHHH
Confidence            3   22344589999999999999999999999999999999999999996332111              000000000


Q ss_pred             ccccCCcccHHHHHHHHHHHHHhhccCCCCCCChh
Q 015027          321 NFHVADESEMKEIEIVAELASKCLRIRGTERPTMK  355 (414)
Q Consensus       321 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~  355 (414)
                       ......++...++++.+|...+|+.||++|...+
T Consensus       403 -~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  403 -LEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             -hcchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence             0112233445567799999999999999997654

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.3e-37  Score=292.02  Aligned_cols=253  Identities=23%  Similarity=0.263  Sum_probs=187.3

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch--hHhHHHHHHHHHccC-CCceeeeeeeEecCCcceEEEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI--RITERELLRIISQVN-HKNVVKILGLCLETEVPLLVYE  162 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e  162 (414)
                      ++|...+.||+|+||.||++... +++.+|+|.+......  ......++.++.++. ||||+++++++..+...+++||
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e   83 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME   83 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence            35666788999999999999965 5899999998754322  223345567777775 9999999999999999999999


Q ss_pred             eCCCCchhhhh---hhcCCcccCCHHHHHHHHHHHHHHHHHhhhC-CCCCeeeCCCCCCceeeCCCCcEEEeeccccccc
Q 015027          163 FASNGTLLDHI---RCESSQVLKTWKTCLRIAAETASALDYLHSL-ASPPIIHGDVKSANILLNDNYTAKVADFESSVLI  238 (414)
Q Consensus       163 ~~~~gsL~~~l---~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~  238 (414)
                      |++. +|.++.   ... ....+++..+..++.+++.||+|||+. +   ++||||||+||+++.++.+||+|||++...
T Consensus        84 ~~~~-~l~~l~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  158 (288)
T cd06616          84 LMDI-SLDKFYKYVYEV-LKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQL  158 (288)
T ss_pred             cccC-CHHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHh
Confidence            9864 554433   221 123458889999999999999999974 5   999999999999999999999999998765


Q ss_pred             cCCccccceecccccccccchhhcccC---CCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccc
Q 015027          239 SSDAETAMSTILIGTSGYLDPVCINTG---KLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNG  315 (414)
Q Consensus       239 ~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (414)
                      ....   ......|++.|+|||++.+.   .++.++|||||||++|+|++|+.||.....       ...... ......
T Consensus       159 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~~-~~~~~~  227 (288)
T cd06616         159 VDSI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-------VFDQLT-QVVKGD  227 (288)
T ss_pred             ccCC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-------HHHHHh-hhcCCC
Confidence            4321   11233678899999999766   689999999999999999999999863320       000000 000000


Q ss_pred             cccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHH
Q 015027          316 LRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEE  360 (414)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~  360 (414)
                           .+..........+..+.+|+.+||+.+|.+|||+.+|+..
T Consensus       228 -----~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         228 -----PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             -----CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 0111111111233569999999999999999999998653

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2.2e-37  Score=284.96  Aligned_cols=247  Identities=26%  Similarity=0.321  Sum_probs=197.8

Q ss_pred             CCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc---hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEe
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK---IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  163 (414)
                      +|++.+.||+|+||.||++... ++..+++|.+.....   .......++++++.++||||+++++++......++||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            5788899999999999999865 588999999876432   222335567889999999999999999999999999999


Q ss_pred             CCCCchhhhhhhcC-CcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCc
Q 015027          164 ASNGTLLDHIRCES-SQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDA  242 (414)
Q Consensus       164 ~~~gsL~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  242 (414)
                      +++++|.+++.... ....+++..+..++.+++.||+|||+.+   ++|+||+|+||++++++.+||+|||++...... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            99999999885522 2234578889999999999999999987   999999999999999999999999999876543 


Q ss_pred             cccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccccc
Q 015027          243 ETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNF  322 (414)
Q Consensus       243 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (414)
                         ......+++.|++||.+.+..++.++|+||||+++|+|++|+.||...+...         ...........     
T Consensus       157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---------~~~~~~~~~~~-----  219 (256)
T cd08530         157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD---------LRYKVQRGKYP-----  219 (256)
T ss_pred             ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---------HHHHHhcCCCC-----
Confidence               2223467889999999999999999999999999999999999987433211         11111111111     


Q ss_pred             ccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          323 HVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       323 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                          ..+......+.+++.+||+.+|.+|||+.++++
T Consensus       220 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         220 ----PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             ----CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                111133466999999999999999999999865

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=7e-37  Score=284.19  Aligned_cols=249  Identities=20%  Similarity=0.244  Sum_probs=189.9

Q ss_pred             HHHHHHhcCCCCCCcc--ccCCceEEEEEEEc-CCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecCCc
Q 015027           80 SEMIRATKNFDRSRCL--SQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEV  156 (414)
Q Consensus        80 ~~~~~~~~~~~~~~~l--g~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~  156 (414)
                      .+.....++|.+.+.+  |+|+||.||++... ++..+|+|.+........ +.....++  .+||||+++++.|...+.
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-e~~~~~~~--~~h~~iv~~~~~~~~~~~   83 (267)
T PHA03390          7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-EPMVHQLM--KDNPNFIKLYYSVTTLKG   83 (267)
T ss_pred             HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-hHHHHHHh--hcCCCEEEEEEEEecCCe
Confidence            3444556778887777  99999999999965 588899999876432211 11111222  269999999999999999


Q ss_pred             ceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCC-cEEEeecccc
Q 015027          157 PLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNY-TAKVADFESS  235 (414)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~DfGla  235 (414)
                      .++||||+++++|.+++....   .+++..+..++.||+.||.|||+.+   ++||||||+||+++.++ .++|+|||++
T Consensus        84 ~~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~  157 (267)
T PHA03390         84 HVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLC  157 (267)
T ss_pred             eEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence            999999999999999986543   5588999999999999999999988   99999999999999988 9999999998


Q ss_pred             ccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccc
Q 015027          236 VLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNG  315 (414)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (414)
                      ......      ....++..|+|||++.+..++.++||||||+++|+|++|..||.......   ... ..+.... .  
T Consensus       158 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~---~~~-~~~~~~~-~--  224 (267)
T PHA03390        158 KIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE---LDL-ESLLKRQ-Q--  224 (267)
T ss_pred             eecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch---hhH-HHHHHhh-c--
Confidence            765422      22367889999999999999999999999999999999999997332111   000 0000000 0  


Q ss_pred             cccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCC-hhHHH
Q 015027          316 LRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPT-MKQVS  358 (414)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps-~~~v~  358 (414)
                            ...  ......+..+.+++.+||+.+|.+||+ +++++
T Consensus       225 ------~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l  260 (267)
T PHA03390        225 ------KKL--PFIKNVSKNANDFVQSMLKYNINYRLTNYNEII  260 (267)
T ss_pred             ------ccC--CcccccCHHHHHHHHHHhccChhhCCchHHHHh
Confidence                  000  001123356999999999999999996 58875

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-38  Score=277.44  Aligned_cols=248  Identities=22%  Similarity=0.271  Sum_probs=185.6

Q ss_pred             CCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhHhH--HHHHHHHHc-cCCCceeeeeeeEecCCcceEEEEeC
Q 015027           89 FDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRITE--RELLRIISQ-VNHKNVVKILGLCLETEVPLLVYEFA  164 (414)
Q Consensus        89 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~--~~~~~~l~~-l~hpniv~l~~~~~~~~~~~lv~e~~  164 (414)
                      .+.+..||.|+.|+|++++.. +|..+|||.+.......+..  ...+.++.+ ...|+||+.+|+|..+..+++.||.|
T Consensus        94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM  173 (391)
T KOG0983|consen   94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM  173 (391)
T ss_pred             hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence            345677999999999999966 58899999998765443222  222233333 34899999999999999999999998


Q ss_pred             CCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccc
Q 015027          165 SNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET  244 (414)
Q Consensus       165 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  244 (414)
                      . ..+..++....  .+.++..+-++...+++||.||...+  +|+|||+||+|||+|+.|++||||||++..+...   
T Consensus       174 s-~C~ekLlkrik--~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS---  245 (391)
T KOG0983|consen  174 S-TCAEKLLKRIK--GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS---  245 (391)
T ss_pred             H-HHHHHHHHHhc--CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc---
Confidence            3 35555554332  33577778889999999999998854  5999999999999999999999999999766532   


Q ss_pred             cceecccccccccchhhccc---CCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccc
Q 015027          245 AMSTILIGTSGYLDPVCINT---GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILN  321 (414)
Q Consensus       245 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (414)
                      ...+...|-+.|||||.+.-   ..|+-++||||||++++||.||+.||.+-..+-.        .+..+.. ...    
T Consensus       246 kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe--------~ltkvln-~eP----  312 (391)
T KOG0983|consen  246 KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE--------VLTKVLN-EEP----  312 (391)
T ss_pred             cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH--------HHHHHHh-cCC----
Confidence            33455678899999999853   4689999999999999999999999975332210        1111111 111    


Q ss_pred             cccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          322 FHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       322 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      +.++.  ....++.+.+++..||.+|+.+||...++++
T Consensus       313 P~L~~--~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  313 PLLPG--HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             CCCCc--ccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence            11111  1124577999999999999999999999875

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=3.5e-37  Score=293.45  Aligned_cols=249  Identities=26%  Similarity=0.339  Sum_probs=192.4

Q ss_pred             CCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch----hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEE
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI----RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYE  162 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  162 (414)
                      .|...+.||+|+||.||+|... ++..||+|.+......    ......+++++++++|||++++++++.++...++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            3777889999999999999965 5889999998754222    1234556789999999999999999999999999999


Q ss_pred             eCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCc
Q 015027          163 FASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDA  242 (414)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  242 (414)
                      |+++ +|.+.+....  ..+++..+..++.+++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++.....  
T Consensus       106 ~~~g-~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~--  177 (317)
T cd06635         106 YCLG-SASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP--  177 (317)
T ss_pred             CCCC-CHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC--
Confidence            9975 7777664432  23588999999999999999999987   99999999999999999999999999865432  


Q ss_pred             cccceecccccccccchhhcc---cCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccc
Q 015027          243 ETAMSTILIGTSGYLDPVCIN---TGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQI  319 (414)
Q Consensus       243 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (414)
                          .....+++.|+|||++.   ++.++.++|||||||++|+|++|..||.......         ..........   
T Consensus       178 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---------~~~~~~~~~~---  241 (317)
T cd06635         178 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---------ALYHIAQNES---  241 (317)
T ss_pred             ----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH---------HHHHHHhccC---
Confidence                22346888999999973   4568899999999999999999999986322110         0000101100   


Q ss_pred             cccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHH
Q 015027          320 LNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLR  365 (414)
Q Consensus       320 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~  365 (414)
                           ........+..+.+|+.+||+.+|.+||++.++++.+..+.
T Consensus       242 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  282 (317)
T cd06635         242 -----PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR  282 (317)
T ss_pred             -----CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence                 00111122355899999999999999999999988655444

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-37  Score=287.05  Aligned_cols=252  Identities=28%  Similarity=0.381  Sum_probs=193.4

Q ss_pred             CCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhH--------hHHHHHHHHHccCCCceeeeeeeEe-cCCcc
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRI--------TERELLRIISQVNHKNVVKILGLCL-ETEVP  157 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~--------~~~~~~~~l~~l~hpniv~l~~~~~-~~~~~  157 (414)
                      +|-.+.+||+|||+.||+|.+- ..+.||||+-........        ...++.++-+.|.||.||++|++|. +.+.+
T Consensus       464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsF  543 (775)
T KOG1151|consen  464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSF  543 (775)
T ss_pred             HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccc
Confidence            5667888999999999999954 588899998765443332        2255668899999999999999996 55678


Q ss_pred             eEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeC---CCCcEEEeeccc
Q 015027          158 LLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLN---DNYTAKVADFES  234 (414)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~---~~~~~kl~DfGl  234 (414)
                      |-|+|||+|.+|.-||....   ..+++.++.|+.||+.||.||.... ++|||-||||.|||+-   ..|.+||+|||+
T Consensus       544 CTVLEYceGNDLDFYLKQhk---lmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFGL  619 (775)
T KOG1151|consen  544 CTVLEYCEGNDLDFYLKQHK---LMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFGL  619 (775)
T ss_pred             eeeeeecCCCchhHHHHhhh---hhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecch
Confidence            89999999999999996543   3478999999999999999999887 8899999999999995   468999999999


Q ss_pred             cccccCCccc-----cceecccccccccchhhccc----CCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccch
Q 015027          235 SVLISSDAET-----AMSTILIGTSGYLDPVCINT----GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVP  305 (414)
Q Consensus       235 a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~  305 (414)
                      ++.+..+...     .......||.||++||++.-    .+++.|+||||+|||+|.++.|+.||........       
T Consensus       620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd-------  692 (775)
T KOG1151|consen  620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD-------  692 (775)
T ss_pred             hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH-------
Confidence            9988765433     22345689999999999853    3588999999999999999999999974322110       


Q ss_pred             hhhhhhccccccccccc-ccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHH
Q 015027          306 YFLNSIKNNGLRQILNF-HVADESEMKEIEIVAELASKCLRIRGTERPTMKQV  357 (414)
Q Consensus       306 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v  357 (414)
                       .   ...+.   +++. .+..+.-...+.+..++|++||+.--+.|....++
T Consensus       693 -I---LqeNT---IlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qL  738 (775)
T KOG1151|consen  693 -I---LQENT---ILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQL  738 (775)
T ss_pred             -H---Hhhhc---hhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHH
Confidence             0   01111   1110 11111111223568999999999999999877766

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-37  Score=288.18  Aligned_cols=263  Identities=18%  Similarity=0.179  Sum_probs=191.7

Q ss_pred             CCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch---hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeC
Q 015027           89 FDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI---RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFA  164 (414)
Q Consensus        89 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  164 (414)
                      |++.+.||.|++|.||+|.+. +|..||+|++......   ......++.+++.++|||++++++++.+++..++||||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            677889999999999999975 6999999998754322   233455678999999999999999999999999999999


Q ss_pred             CCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccc
Q 015027          165 SNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET  244 (414)
Q Consensus       165 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  244 (414)
                      + ++|.+++..... ..+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........ 
T Consensus        81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-  154 (283)
T cd07835          81 D-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-  154 (283)
T ss_pred             C-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence            5 589888865432 34588999999999999999999977   99999999999999999999999999876543211 


Q ss_pred             cceecccccccccchhhcccC-CCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchh-------hhhhh-cccc
Q 015027          245 AMSTILIGTSGYLDPVCINTG-KLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPY-------FLNSI-KNNG  315 (414)
Q Consensus       245 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~-------~~~~~-~~~~  315 (414)
                       ......+++.|+|||++.+. .++.++||||||+++|+|++|..||...+....... ....       .+... ....
T Consensus       155 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07835         155 -TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFR-IFRTLGTPDEDVWPGVTSLPD  232 (283)
T ss_pred             -ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHHhCCCChHHhhhhhhchh
Confidence             12233568899999988654 578999999999999999999999964432110000 0000       00000 0000


Q ss_pred             cccccccc---cCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          316 LRQILNFH---VADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       316 ~~~~~~~~---~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ....+...   .........+..+.+++.+||+.+|.+|||++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         233 YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            00000000   000000111255889999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=2.3e-37  Score=291.32  Aligned_cols=265  Identities=18%  Similarity=0.227  Sum_probs=190.6

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc---hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK---IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYE  162 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  162 (414)
                      ++|++.+.||+|++|.||+|.+. +++.||+|.+.....   .......+++++++++||||+++++++..+...++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            57889999999999999999976 588999999865432   12334566789999999999999999999999999999


Q ss_pred             eCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCC-CCcEEEeeccccccccCC
Q 015027          163 FASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLND-NYTAKVADFESSVLISSD  241 (414)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~DfGla~~~~~~  241 (414)
                      |++ ++|.+++..... ...++..+..++.||+.||+|||+.+   ++|+||+|+||+++. ++.+||+|||++......
T Consensus        82 ~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         82 YLD-LDLKKHMDSSPD-FAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP  156 (294)
T ss_pred             ccc-ccHHHHHHhCCC-CCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence            996 478777754332 23467888899999999999999977   999999999999985 567999999999765432


Q ss_pred             ccccceecccccccccchhhccc-CCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccch-------hhhhhh-c
Q 015027          242 AETAMSTILIGTSGYLDPVCINT-GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVP-------YFLNSI-K  312 (414)
Q Consensus       242 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~-------~~~~~~-~  312 (414)
                      .  .......+++.|+|||++.+ ..++.++|||||||++|+|++|..||.......... ....       ..+... .
T Consensus       157 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  233 (294)
T PLN00009        157 V--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELF-KIFRILGTPNEETWPGVTS  233 (294)
T ss_pred             c--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHHhCCCChhhcccccc
Confidence            1  12233467889999998866 457899999999999999999999997433211000 0000       000000 0


Q ss_pred             ccccccccccccCC---cccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          313 NNGLRQILNFHVAD---ESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       313 ~~~~~~~~~~~~~~---~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ..............   ......+..+.+++.+||+.+|++||++.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00000000000000   000112245899999999999999999999975

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-37  Score=284.32  Aligned_cols=249  Identities=21%  Similarity=0.267  Sum_probs=191.3

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeeccc------chhHhHHHHHHHHHccCCCceeeeeeeEecC--Ccc
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRAD------KIRITERELLRIISQVNHKNVVKILGLCLET--EVP  157 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~--~~~  157 (414)
                      .+|.+.+.||+|+||.||+|.+. ++..||+|.+....      ........++.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            57899999999999999999965 58999999875421      1112335567899999999999999998764  457


Q ss_pred             eEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccccc
Q 015027          158 LLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVL  237 (414)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~  237 (414)
                      ++||||+++++|.+++....   .+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++..
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence            89999999999999986433   2477888999999999999999988   99999999999999999999999999876


Q ss_pred             ccCCcc-ccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccc
Q 015027          238 ISSDAE-TAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGL  316 (414)
Q Consensus       238 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (414)
                      ...... ........++..|+|||++.+..++.++|||||||++|+|++|+.||.......        .... ......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------~~~~-~~~~~~  226 (264)
T cd06653         156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA--------AIFK-IATQPT  226 (264)
T ss_pred             cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH--------HHHH-HHcCCC
Confidence            533111 111123468889999999998889999999999999999999999986322110        0000 000000


Q ss_pred             ccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          317 RQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                              ....+......+.+++.+||+ +|..||++.+++.
T Consensus       227 --------~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         227 --------KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             --------CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence                    111122233569999999999 5799999998754

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=4e-37  Score=291.55  Aligned_cols=265  Identities=21%  Similarity=0.263  Sum_probs=189.4

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch---hHhHHHHHHHHHccCCCceeeeeeeEecCC------
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI---RITERELLRIISQVNHKNVVKILGLCLETE------  155 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~hpniv~l~~~~~~~~------  155 (414)
                      .++|.+.+.||+|+||.||+|... +++.||||.+......   ......+++++++++||||+++++++...+      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            457999999999999999999975 5889999998654322   223345678999999999999999987654      


Q ss_pred             --cceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecc
Q 015027          156 --VPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFE  233 (414)
Q Consensus       156 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG  233 (414)
                        ..++||||+.+ +|.+.+....  ..+++..++.++.||+.||+|||+.+   ++|+||||+||+++.++.+||+|||
T Consensus        91 ~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg  164 (310)
T cd07865          91 KGSFYLVFEFCEH-DLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFG  164 (310)
T ss_pred             CceEEEEEcCCCc-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCC
Confidence              34999999965 7777775432  23588999999999999999999987   9999999999999999999999999


Q ss_pred             ccccccCCccc--cceecccccccccchhhcccC-CCCCcccchhHHHHHHHHHhCCCCCCccccccccc------cccc
Q 015027          234 SSVLISSDAET--AMSTILIGTSGYLDPVCINTG-KLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKK------ISMV  304 (414)
Q Consensus       234 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~------~~~~  304 (414)
                      ++.........  .......++..|+|||.+.+. .++.++||||||+++|||++|+.||..........      ....
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~  244 (310)
T cd07865         165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT  244 (310)
T ss_pred             CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            99765432211  112234678889999988654 47889999999999999999999986433210000      0000


Q ss_pred             hhhhhhhcc----------cccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          305 PYFLNSIKN----------NGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       305 ~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      +........          ..........+..   ......+.+|+.+||..||.+|||+.++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~---~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKP---YVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             hhhcccccchhhhhhccCCCccchhhHHhccc---ccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            000000000          0000000000000   001245789999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-38  Score=277.04  Aligned_cols=254  Identities=24%  Similarity=0.294  Sum_probs=200.0

Q ss_pred             HHhcCCCCC-CccccCCceEEEEEEEc-CCcEEEEEEeecccchhHhHHHHHHH-HHccCCCceeeeeeeEec----CCc
Q 015027           84 RATKNFDRS-RCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRITERELLRI-ISQVNHKNVVKILGLCLE----TEV  156 (414)
Q Consensus        84 ~~~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~-l~~l~hpniv~l~~~~~~----~~~  156 (414)
                      ..+++|.+. ++||-|-.|.|-.+..+ +++.+|+|++......+    +++++ ...-.|||||.++++|.+    ...
T Consensus        58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~KAR----rEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSPKAR----REVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCHHHH----hHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            356778765 67999999999999866 68899999987654432    22232 222369999999999864    356


Q ss_pred             ceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeC---CCCcEEEeecc
Q 015027          157 PLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLN---DNYTAKVADFE  233 (414)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~---~~~~~kl~DfG  233 (414)
                      +.+|||.|+||.|+..+...+. ..+++.++..|+.||+.|+.|||+.+   |.||||||+|+|..   .|..+||+|||
T Consensus       134 LLiVmE~meGGeLfsriq~~g~-~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG  209 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDRGD-QAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG  209 (400)
T ss_pred             eEeeeecccchHHHHHHHHccc-ccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence            7899999999999999977665 34589999999999999999999988   99999999999996   46789999999


Q ss_pred             ccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcc
Q 015027          234 SSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKN  313 (414)
Q Consensus       234 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  313 (414)
                      +|+....   .....+.+.||.|.|||++...+|+...|+||+||++|-|++|.+||....-     ..+.+.....+..
T Consensus       210 FAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg-----~aispgMk~rI~~  281 (400)
T KOG0604|consen  210 FAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-----LAISPGMKRRIRT  281 (400)
T ss_pred             cccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC-----ccCChhHHhHhhc
Confidence            9986543   2233456889999999999999999999999999999999999999973321     1222222222222


Q ss_pred             cccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          314 NGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      +.      ..++.+.+.+.++..+++|+.+|..+|++|.|+.++..
T Consensus       282 gq------y~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  282 GQ------YEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             cC------ccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            21      23455556777899999999999999999999999854

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-38  Score=321.58  Aligned_cols=252  Identities=24%  Similarity=0.296  Sum_probs=203.8

Q ss_pred             HHHHHhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecc----cchhHhHHHHHHHHHccCCCceeeeeeeEecCC
Q 015027           81 EMIRATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRA----DKIRITERELLRIISQVNHKNVVKILGLCLETE  155 (414)
Q Consensus        81 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~  155 (414)
                      ++....++|.+++.||+|+||.|..++.+ +++.||.|++++-    ......+.++-.+|..-+.+-|+.++-.|.++.
T Consensus        69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~  148 (1317)
T KOG0612|consen   69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER  148 (1317)
T ss_pred             HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence            44455689999999999999999999976 5888999999873    233445677778888888999999999999999


Q ss_pred             cceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccc
Q 015027          156 VPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESS  235 (414)
Q Consensus       156 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla  235 (414)
                      ++|+|||||+||+|..++...+   .+++..++-++..|+-||..||+.|   +|||||||+|||||.+|++||+|||.+
T Consensus       149 ~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsC  222 (1317)
T KOG0612|consen  149 YLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSC  222 (1317)
T ss_pred             ceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhH
Confidence            9999999999999999996554   3477888889999999999999999   999999999999999999999999998


Q ss_pred             ccccCCccccceecccccccccchhhcc----c-CCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhh
Q 015027          236 VLISSDAETAMSTILIGTSGYLDPVCIN----T-GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNS  310 (414)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  310 (414)
                      ..+..+ ........+|||.|.+||++.    + +.|++.+|+||+||++|||+.|..||...+..        ..+   
T Consensus       223 lkm~~d-G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslv--------eTY---  290 (1317)
T KOG0612|consen  223 LKMDAD-GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLV--------ETY---  290 (1317)
T ss_pred             HhcCCC-CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHH--------HHH---
Confidence            777654 445566779999999999984    3 57899999999999999999999999743311        111   


Q ss_pred             hcccccccccc--cccCCcccHHHHHHHHHHHHHhhccCCCCCCC---hhHH
Q 015027          311 IKNNGLRQILN--FHVADESEMKEIEIVAELASKCLRIRGTERPT---MKQV  357 (414)
Q Consensus       311 ~~~~~~~~~~~--~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps---~~~v  357 (414)
                            ..+++  ..+..+.....++...+||.+.+.. |+.|..   ++++
T Consensus       291 ------~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~~-~e~RLgrngiedi  335 (1317)
T KOG0612|consen  291 ------GKIMNHKESLSFPDETDVSEEAKDLIEALLCD-REVRLGRNGIEDI  335 (1317)
T ss_pred             ------HHHhchhhhcCCCcccccCHHHHHHHHHHhcC-hhhhcccccHHHH
Confidence                  11111  1222223334567899999998875 778877   6666

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=4.6e-38  Score=320.82  Aligned_cols=254  Identities=26%  Similarity=0.345  Sum_probs=188.0

Q ss_pred             HHHhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeeccc--chhHhHHHHHHHHHccCCCceeeeeeeEec------
Q 015027           83 IRATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRAD--KIRITERELLRIISQVNHKNVVKILGLCLE------  153 (414)
Q Consensus        83 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~~~l~~l~hpniv~l~~~~~~------  153 (414)
                      .+-.++|+.++.||+||||.||+++.+ ||+.+|||++....  .......+|+..+++|+|||||+++..|.+      
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence            455678999999999999999999977 89999999997653  222334667799999999999998854100      


Q ss_pred             ------------------------------------------------------------------------C-------
Q 015027          154 ------------------------------------------------------------------------T-------  154 (414)
Q Consensus       154 ------------------------------------------------------------------------~-------  154 (414)
                                                                                              +       
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                                                    0       


Q ss_pred             ----------------------------------CcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHH
Q 015027          155 ----------------------------------EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDY  200 (414)
Q Consensus       155 ----------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~  200 (414)
                                                        ..+||=||||+..+|.+++..+....  .....++++++|++||.|
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaY  712 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAY  712 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHH
Confidence                                              12478899999988888886554432  246678999999999999


Q ss_pred             hhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccC----------------Cccccceecccccccccchhhccc
Q 015027          201 LHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISS----------------DAETAMSTILIGTSGYLDPVCINT  264 (414)
Q Consensus       201 LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~----------------~~~~~~~~~~~gt~~y~aPE~~~~  264 (414)
                      +|+.|   +|||||||.|||+|++..|||+|||+|.....                .......+..+||.-|+|||++.+
T Consensus       713 IH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~  789 (1351)
T KOG1035|consen  713 IHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD  789 (1351)
T ss_pred             HHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence            99988   99999999999999999999999999987220                111113456789999999999976


Q ss_pred             CC---CCCcccchhHHHHHHHHHhCCCCCCc-cccccccccccchhhhhhhcccccccccccccCCcccHHHHHHHHHHH
Q 015027          265 GK---LTKKSDVYSFGVVLAELLTGKKPGSC-MTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELA  340 (414)
Q Consensus       265 ~~---~~~~~Dv~SlGvil~el~tg~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li  340 (414)
                      ..   |+.|+|+|||||||+||+.   ||.. +++.         ..+...+...+...      ........+.-..+|
T Consensus       790 ~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa---------~iL~~LR~g~iP~~------~~f~~~~~~~e~slI  851 (1351)
T KOG1035|consen  790 TSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERA---------SILTNLRKGSIPEP------ADFFDPEHPEEASLI  851 (1351)
T ss_pred             cccccccchhhhHHHHHHHHHHhc---cCCchHHHH---------HHHHhcccCCCCCC------cccccccchHHHHHH
Confidence            54   9999999999999999985   4531 1111         11222222111111      111122224457899


Q ss_pred             HHhhccCCCCCCChhHHHH
Q 015027          341 SKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       341 ~~cl~~dP~~Rps~~~v~~  359 (414)
                      ++|++.||.+|||+.|++.
T Consensus       852 ~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  852 RWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             HHHhcCCCccCCCHHHHhh
Confidence            9999999999999999875

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-37  Score=287.00  Aligned_cols=269  Identities=23%  Similarity=0.319  Sum_probs=199.5

Q ss_pred             hcCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecCC----cceEEE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETE----VPLLVY  161 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~----~~~lv~  161 (414)
                      .....+.+.||+|.||.||+|.+ .|..||||++...+........++-.-..|+|+||+.+++.-..+.    .+|||.
T Consensus       210 arqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvT  288 (513)
T KOG2052|consen  210 ARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVT  288 (513)
T ss_pred             hheeEEEEEecCccccceeeccc-cCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEee
Confidence            45677889999999999999999 6789999999865544332222233344578999999998765443    579999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhh-----CCCCCeeeCCCCCCceeeCCCCcEEEeeccccc
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHS-----LASPPIIHGDVKSANILLNDNYTAKVADFESSV  236 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-----~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~  236 (414)
                      +|.+.|||+|||..    ..++....++++..++.||++||.     +|.|.|.|||||+.||||..++.+.|+|+|+|.
T Consensus       289 dYHe~GSL~DyL~r----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv  364 (513)
T KOG2052|consen  289 DYHEHGSLYDYLNR----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  364 (513)
T ss_pred             ecccCCcHHHHHhh----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeE
Confidence            99999999999954    455788899999999999999994     677889999999999999999999999999998


Q ss_pred             cccCCccc--cceecccccccccchhhcccCC----C--CCcccchhHHHHHHHHHhCC----------CCCCccccccc
Q 015027          237 LISSDAET--AMSTILIGTSGYLDPVCINTGK----L--TKKSDVYSFGVVLAELLTGK----------KPGSCMTLASN  298 (414)
Q Consensus       237 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~----~--~~~~Dv~SlGvil~el~tg~----------~p~~~~~~~~~  298 (414)
                      ........  ...+..+||.+|||||++...-    +  -..+||||||.|+||+...-          +||...-....
T Consensus       365 ~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DP  444 (513)
T KOG2052|consen  365 RHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDP  444 (513)
T ss_pred             EecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCC
Confidence            76554222  2345679999999999986431    1  23589999999999997632          45442221110


Q ss_pred             cccccchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHH
Q 015027          299 KKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR  366 (414)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~  366 (414)
                      .    .+....-+....++..++.++.   +.+....+.+|++.||..+|..|.|+-.|.+.|.++..
T Consensus       445 s----~eeMrkVVCv~~~RP~ipnrW~---s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  445 S----FEEMRKVVCVQKLRPNIPNRWK---SDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             C----HHHHhcceeecccCCCCCcccc---cCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            0    0111111222223333333332   23556779999999999999999999999999888775

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=7.6e-37  Score=292.50  Aligned_cols=263  Identities=16%  Similarity=0.191  Sum_probs=187.0

Q ss_pred             CccccC--CceEEEEEEEc-CCcEEEEEEeecccch---hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCCC
Q 015027           93 RCLSQG--GFVSVYKGVLH-DNIQVAVKTYRRADKI---RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASN  166 (414)
Q Consensus        93 ~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  166 (414)
                      ..||+|  +||+||++.+. +++.||+|++......   .....+++.+++.++||||++++++|..++..++||||+++
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            346666  99999999975 6999999998754322   23345666788889999999999999999999999999999


Q ss_pred             CchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcccc-
Q 015027          167 GTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETA-  245 (414)
Q Consensus       167 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~-  245 (414)
                      ++|.+++...... .+++..+..++.|++.||+|||+.+   ++||||||+|||++.++.++++||+.+.......... 
T Consensus        84 ~~l~~~l~~~~~~-~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~  159 (328)
T cd08226          84 GSANSLLKTYFPE-GMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK  159 (328)
T ss_pred             CCHHHHHHhhccc-CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence            9999988654332 3578888899999999999999987   9999999999999999999999998654332111110 


Q ss_pred             ----ceecccccccccchhhcccC--CCCCcccchhHHHHHHHHHhCCCCCCcccccccccc-----ccchhh---h---
Q 015027          246 ----MSTILIGTSGYLDPVCINTG--KLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKI-----SMVPYF---L---  308 (414)
Q Consensus       246 ----~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~-----~~~~~~---~---  308 (414)
                          ......++..|+|||++.+.  .++.++|||||||++|+|++|..||...........     ...++.   .   
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (328)
T cd08226         160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE  239 (328)
T ss_pred             ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence                00112345679999999763  578999999999999999999999974332110000     000000   0   


Q ss_pred             -hhh----------------cccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          309 -NSI----------------KNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       309 -~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                       ...                ............+........+..+.+|+.+||+.||++|||+.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence             000                000000011111222223344567999999999999999999999964

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-36  Score=278.91  Aligned_cols=246  Identities=24%  Similarity=0.343  Sum_probs=197.2

Q ss_pred             CCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc---hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEe
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK---IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  163 (414)
                      +|.+.+.||+|++|.||++... ++..|++|.+.....   ......++++++++++|||++++++++.++...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4788899999999999999876 578999999977653   233446677889999999999999999999999999999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcc
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE  243 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  243 (414)
                      +++++|.+++...   ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (254)
T cd06627          81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK  154 (254)
T ss_pred             CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence            9999999998654   34588999999999999999999987   99999999999999999999999999987654322


Q ss_pred             ccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccc
Q 015027          244 TAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFH  323 (414)
Q Consensus       244 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (414)
                      .  .....++..|+|||.+.+..++.++||||||+++|+|++|..||.......        .... ...... ..+.. 
T Consensus       155 ~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~--------~~~~-~~~~~~-~~~~~-  221 (254)
T cd06627         155 D--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA--------ALFR-IVQDDH-PPLPE-  221 (254)
T ss_pred             c--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH--------HHHH-HhccCC-CCCCC-
Confidence            1  233467889999999988889999999999999999999999986332100        0000 000000 00111 


Q ss_pred             cCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          324 VADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       324 ~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                             ..+..+.+++.+||..+|++|||+.+++.
T Consensus       222 -------~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         222 -------GISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             -------CCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence                   11255899999999999999999999864

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=6.3e-37  Score=286.77  Aligned_cols=263  Identities=21%  Similarity=0.243  Sum_probs=191.9

Q ss_pred             CCCCCccccCCceEEEEEEEc-CCcEEEEEEeeccc---chhHhHHHHHHHHHccCCCceeeeeeeEecC--CcceEEEE
Q 015027           89 FDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRAD---KIRITERELLRIISQVNHKNVVKILGLCLET--EVPLLVYE  162 (414)
Q Consensus        89 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~--~~~~lv~e  162 (414)
                      |++.+.||.|+||.||+|... ++..+|+|.+....   ........++.+++.++|||++++++++...  +..++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            667889999999999999976 48899999998763   2223345567889999999999999999888  88999999


Q ss_pred             eCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCc
Q 015027          163 FASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDA  242 (414)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  242 (414)
                      |+++ +|.+++....  ...++..++.++.||+.||+|||+.+   ++|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~  154 (287)
T cd07840          81 YMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN  154 (287)
T ss_pred             cccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence            9975 8888875442  34578899999999999999999987   9999999999999999999999999998765432


Q ss_pred             cccceecccccccccchhhccc-CCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchh-------hhhhhccc
Q 015027          243 ETAMSTILIGTSGYLDPVCINT-GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPY-------FLNSIKNN  314 (414)
Q Consensus       243 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~-------~~~~~~~~  314 (414)
                      . .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||........ .......       ........
T Consensus       155 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07840         155 S-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ-LEKIFELCGSPTDENWPGVSKL  232 (287)
T ss_pred             c-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCchhhccccccc
Confidence            1 12233456788999998764 4678999999999999999999999874332110 0000000       00000000


Q ss_pred             ------ccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          315 ------GLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       315 ------~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                            .........+........+..+.+++.+||+.+|.+||++.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                  000000000000000001466899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-37  Score=298.87  Aligned_cols=267  Identities=20%  Similarity=0.259  Sum_probs=190.3

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc--hhHhHHHHHHHHHccCCCceeeeeeeEecCC-----cc
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK--IRITERELLRIISQVNHKNVVKILGLCLETE-----VP  157 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~-----~~  157 (414)
                      +++|.+.+.||+|+||.||+|.+. +|+.||+|.+.....  .......++.++++++||||+++++++....     ..
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            578999999999999999999965 689999999864322  2233455678999999999999999876543     57


Q ss_pred             eEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccccc
Q 015027          158 LLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVL  237 (414)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~  237 (414)
                      ++|+||+++ +|.+++..    ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++..
T Consensus        84 ~lv~e~~~~-~l~~~~~~----~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~  155 (336)
T cd07849          84 YIVQELMET-DLYKLIKT----QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI  155 (336)
T ss_pred             EEEehhccc-CHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence            999999975 77777643    24578889999999999999999988   99999999999999999999999999876


Q ss_pred             ccCCccc-cceecccccccccchhhccc-CCCCCcccchhHHHHHHHHHhCCCCCCcccccccccc-----c-cchhhhh
Q 015027          238 ISSDAET-AMSTILIGTSGYLDPVCINT-GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKI-----S-MVPYFLN  309 (414)
Q Consensus       238 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~-----~-~~~~~~~  309 (414)
                      ....... .......||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||...........     . ..+....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  235 (336)
T cd07849         156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLN  235 (336)
T ss_pred             ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence            5432111 11233578899999998754 5689999999999999999999999964321100000     0 0000000


Q ss_pred             hhcccccccc---cccccCCcc---cHHHHHHHHHHHHHhhccCCCCCCChhHHHHH
Q 015027          310 SIKNNGLRQI---LNFHVADES---EMKEIEIVAELASKCLRIRGTERPTMKQVSEE  360 (414)
Q Consensus       310 ~~~~~~~~~~---~~~~~~~~~---~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~  360 (414)
                      ..........   .........   ....+..+.+|+.+||+.+|++|||+.++++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            0000000000   000000000   00113558999999999999999999998654

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=4.8e-37  Score=289.56  Aligned_cols=251  Identities=22%  Similarity=0.268  Sum_probs=186.9

Q ss_pred             hcCCCCCCccccCCceEEEEEEEcC-CcEEEEEEeecccch--hHhHHHHHHHHHcc-CCCceeeeeeeEecCCcceEEE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLHD-NIQVAVKTYRRADKI--RITERELLRIISQV-NHKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~~~~~l~~l-~hpniv~l~~~~~~~~~~~lv~  161 (414)
                      .++|.+.+.||+|+||.||+|.+.+ ++.||||.+......  ......++.++.+. .||||+++++++.++...|+||
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            4678899999999999999999865 899999999754322  12223333444444 5999999999999999999999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhh-CCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccC
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHS-LASPPIIHGDVKSANILLNDNYTAKVADFESSVLISS  240 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  240 (414)
                      ||+++ +|.+++.....  .+++..+..++.+++.||+|||+ .+   ++||||+|+||++++++.+||+|||++.....
T Consensus        94 e~~~~-~l~~l~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~  167 (296)
T cd06618          94 ELMST-CLDKLLKRIQG--PIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVD  167 (296)
T ss_pred             eccCc-CHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence            99854 67666644322  45888899999999999999997 35   99999999999999999999999999876543


Q ss_pred             CccccceecccccccccchhhcccCC----CCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccc
Q 015027          241 DAETAMSTILIGTSGYLDPVCINTGK----LTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGL  316 (414)
Q Consensus       241 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (414)
                      ..   ......++..|+|||.+.+..    ++.++||||||+++|+|++|+.||.......       . ..........
T Consensus       168 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-------~-~~~~~~~~~~  236 (296)
T cd06618         168 SK---AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-------E-VLTKILQEEP  236 (296)
T ss_pred             CC---cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH-------H-HHHHHhcCCC
Confidence            21   112335788999999987554    8889999999999999999999986321110       0 0000000000


Q ss_pred             ccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHH
Q 015027          317 RQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEE  360 (414)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~  360 (414)
                      . ....      ....+..+.+|+.+||+.+|.+||++.++++.
T Consensus       237 ~-~~~~------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         237 P-SLPP------NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             C-CCCC------CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            0 0000      00122558999999999999999999999765

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=5.5e-37  Score=289.77  Aligned_cols=268  Identities=23%  Similarity=0.273  Sum_probs=192.3

Q ss_pred             HHhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc---hhHhHHHHHHHHHccCCCceeeeeeeEecCC----
Q 015027           84 RATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK---IRITERELLRIISQVNHKNVVKILGLCLETE----  155 (414)
Q Consensus        84 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~----  155 (414)
                      ...++|++.+.||+|+||.||+|... +++.||+|.+.....   .......++++++.++||||+++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            35678999999999999999999976 588999999975432   2233355678999999999999999987654    


Q ss_pred             ------cceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEE
Q 015027          156 ------VPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKV  229 (414)
Q Consensus       156 ------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl  229 (414)
                            ..++|+||+++ +|.+.+...  ...+++..++.++.||+.||+|||+.+   |+|+||||+||++++++.+||
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl  157 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL  157 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence                  78999999986 666666443  224588999999999999999999987   999999999999999999999


Q ss_pred             eeccccccccCCccccceecccccccccchhhccc-CCCCCcccchhHHHHHHHHHhCCCCCCcccccccccc------c
Q 015027          230 ADFESSVLISSDAETAMSTILIGTSGYLDPVCINT-GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKI------S  302 (414)
Q Consensus       230 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~------~  302 (414)
                      +|||++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++|++||...........      .
T Consensus       158 ~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~  236 (302)
T cd07864         158 ADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGS  236 (302)
T ss_pred             CcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence            99999986654321 11222356778999998864 4578999999999999999999999974321110000      0


Q ss_pred             cchhhhhhhcccccc------cccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          303 MVPYFLNSIKNNGLR------QILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       303 ~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ..+.....+......      ........... ...+..+.+++.+||+.+|.+|||+.+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             CChhhcccccccccccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            000000000000000      00000000000 011356899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.4e-36  Score=288.72  Aligned_cols=262  Identities=20%  Similarity=0.217  Sum_probs=185.0

Q ss_pred             CccccCCceEEEEEEEcCCcEEEEEEeeccc---chhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCCCCch
Q 015027           93 RCLSQGGFVSVYKGVLHDNIQVAVKTYRRAD---KIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTL  169 (414)
Q Consensus        93 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL  169 (414)
                      +.+|.|+++.||++.. ++..||||++....   ........++.+++.++||||+++++++...+..+++|||+++++|
T Consensus         8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l   86 (314)
T cd08216           8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC   86 (314)
T ss_pred             HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence            3445555555555544 68999999987652   1223346667899999999999999999999999999999999999


Q ss_pred             hhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccc-----
Q 015027          170 LDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET-----  244 (414)
Q Consensus       170 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~-----  244 (414)
                      .+++..... ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||.+.........     
T Consensus        87 ~~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~  162 (314)
T cd08216          87 EDLLKTHFP-EGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH  162 (314)
T ss_pred             HHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence            999865432 23577888899999999999999987   999999999999999999999999988655322111     


Q ss_pred             cceecccccccccchhhccc--CCCCCcccchhHHHHHHHHHhCCCCCCccccccccc---cccchhh-----hhhhccc
Q 015027          245 AMSTILIGTSGYLDPVCINT--GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKK---ISMVPYF-----LNSIKNN  314 (414)
Q Consensus       245 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~---~~~~~~~-----~~~~~~~  314 (414)
                      .......++..|+|||++.+  ..++.++|||||||++|||++|..||..........   .+..+..     .......
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
T cd08216         163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDS  242 (314)
T ss_pred             cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCC
Confidence            11223456778999999865  458899999999999999999999997432111000   0000000     0000000


Q ss_pred             -------ccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          315 -------GLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       315 -------~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                             .....................+.+|+.+||+.||++|||+.++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         243 MSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             cCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence                   000000001111222233467899999999999999999999965

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.2e-36  Score=288.59  Aligned_cols=246  Identities=26%  Similarity=0.340  Sum_probs=189.5

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc----hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK----IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~  161 (414)
                      +.|...+.||+|+||.||+|... ++..+|+|.+.....    ......+++++++.++|||++++++++......++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            34777888999999999999975 578899999864321    1123355678999999999999999999999999999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCC
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD  241 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  241 (414)
                      ||+. |+|.+.+.....  .+++..+..++.+++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++......
T Consensus        95 e~~~-~~l~~~~~~~~~--~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  168 (308)
T cd06634          95 EYCL-GSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  168 (308)
T ss_pred             EccC-CCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence            9997 577777644332  3478889999999999999999987   999999999999999999999999998765422


Q ss_pred             ccccceecccccccccchhhcc---cCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccc
Q 015027          242 AETAMSTILIGTSGYLDPVCIN---TGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQ  318 (414)
Q Consensus       242 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (414)
                            ....+++.|+|||.+.   ...++.++|||||||++|+|++|..||.......         ........... 
T Consensus       169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---------~~~~~~~~~~~-  232 (308)
T cd06634         169 ------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---------ALYHIAQNESP-  232 (308)
T ss_pred             ------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH---------HHHHHhhcCCC-
Confidence                  2346788999999974   3567889999999999999999999985322110         00001111100 


Q ss_pred             ccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHH
Q 015027          319 ILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEEL  361 (414)
Q Consensus       319 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L  361 (414)
                             .......+..+.+|+.+||+.+|.+||++.+++..-
T Consensus       233 -------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~  268 (308)
T cd06634         233 -------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  268 (308)
T ss_pred             -------CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence                   001112235589999999999999999999997653

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=9.8e-37  Score=280.52  Aligned_cols=249  Identities=27%  Similarity=0.342  Sum_probs=198.9

Q ss_pred             CCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc---hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEe
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK---IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  163 (414)
                      +|.+.+.||.|+||.||++.+. ++..+++|.+.....   ......++++.++.++|||++++++.+..+...++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            5788899999999999999975 588999999876532   223345667889999999999999999999999999999


Q ss_pred             CCCCchhhhhhhcC-CcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCc
Q 015027          164 ASNGTLLDHIRCES-SQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDA  242 (414)
Q Consensus       164 ~~~gsL~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  242 (414)
                      +++++|.+++.... ....+++..+..++.+++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999999986542 1245588999999999999999999987   9999999999999999999999999998765432


Q ss_pred             cccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccccc
Q 015027          243 ETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNF  322 (414)
Q Consensus       243 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (414)
                        .......|++.|+|||.+.+..++.++|+||||+++|+|++|..||.......         ............    
T Consensus       158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---------~~~~~~~~~~~~----  222 (258)
T cd08215         158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE---------LALKILKGQYPP----  222 (258)
T ss_pred             --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH---------HHHHHhcCCCCC----
Confidence              12334578889999999998899999999999999999999999986433111         111111111100    


Q ss_pred             ccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          323 HVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       323 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                       +..    ..+..+.+++.+||..+|.+|||+.++++
T Consensus       223 -~~~----~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         223 -IPS----QYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             -CCC----CCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence             111    11245899999999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.1e-36  Score=286.64  Aligned_cols=243  Identities=21%  Similarity=0.265  Sum_probs=189.5

Q ss_pred             CCccccCCceEEEEEEEc-CCcEEEEEEeecccc-hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCCCCch
Q 015027           92 SRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK-IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTL  169 (414)
Q Consensus        92 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL  169 (414)
                      ...||+|+||.||++... ++..||||.+..... .......++.+++.++||||+++++.+...+..++||||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            356999999999999875 689999998854332 223345567889999999999999999999999999999999999


Q ss_pred             hhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccccceec
Q 015027          170 LDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTI  249 (414)
Q Consensus       170 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  249 (414)
                      .+++...    .+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.......  .....
T Consensus       105 ~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~  175 (292)
T cd06657         105 TDIVTHT----RMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKS  175 (292)
T ss_pred             HHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc--ccccc
Confidence            9887432    3478889999999999999999987   9999999999999999999999999987654322  12233


Q ss_pred             ccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccccCCccc
Q 015027          250 LIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESE  329 (414)
Q Consensus       250 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (414)
                      ..+++.|+|||.+.+..++.++|+||||+++|+|++|..||.......         ....... .    ....+..  .
T Consensus       176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~---------~~~~~~~-~----~~~~~~~--~  239 (292)
T cd06657         176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---------AMKMIRD-N----LPPKLKN--L  239 (292)
T ss_pred             cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---------HHHHHHh-h----CCcccCC--c
Confidence            568899999999988889999999999999999999999986322110         0000000 0    0000000  0


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          330 MKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       330 ~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ...+..+.+++.+||+.+|.+||++.++++
T Consensus       240 ~~~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         240 HKVSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             ccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            011245889999999999999999999855

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=2.7e-37  Score=288.17  Aligned_cols=247  Identities=26%  Similarity=0.354  Sum_probs=195.9

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc----hhHhHHHHHHHHHccC-CCceeeeeeeEecCCcceEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK----IRITERELLRIISQVN-HKNVVKILGLCLETEVPLLV  160 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~~~l~~l~-hpniv~l~~~~~~~~~~~lv  160 (414)
                      ++|.+.+.||+|+||.||+|... ++..||+|++.....    ......++..++++++ ||||+++++++..++..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            46888999999999999999976 689999999876322    1223355567888898 99999999999999999999


Q ss_pred             EEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccC
Q 015027          161 YEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISS  240 (414)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  240 (414)
                      |||+++++|.+++...+   .+++..++.++.|++.||.+||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~  154 (280)
T cd05581          81 LEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP  154 (280)
T ss_pred             EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence            99999999999996543   4688999999999999999999987   99999999999999999999999999876654


Q ss_pred             Cccc------------------cceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccc
Q 015027          241 DAET------------------AMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKIS  302 (414)
Q Consensus       241 ~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~  302 (414)
                      ....                  .......++..|+|||+..+..++.++||||||++++++++|+.||.......     
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----  229 (280)
T cd05581         155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL-----  229 (280)
T ss_pred             ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH-----
Confidence            3211                  22234567889999999988889999999999999999999999987443110     


Q ss_pred             cchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCCh----hHHH
Q 015027          303 MVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTM----KQVS  358 (414)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~----~~v~  358 (414)
                         .+ .....  ....+        +...++.+.+|+.+||+.+|.+|||+    ++++
T Consensus       230 ---~~-~~~~~--~~~~~--------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll  275 (280)
T cd05581         230 ---TF-QKILK--LEYSF--------PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELK  275 (280)
T ss_pred             ---HH-HHHHh--cCCCC--------CCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHh
Confidence               00 00000  00001        11113568999999999999999999    6664

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-36  Score=283.42  Aligned_cols=262  Identities=21%  Similarity=0.234  Sum_probs=188.7

Q ss_pred             CCCCCccccCCceEEEEEEEcC-CcEEEEEEeecccch---hHhH---HHHHHHHHccCCCceeeeeeeEecCCc-----
Q 015027           89 FDRSRCLSQGGFVSVYKGVLHD-NIQVAVKTYRRADKI---RITE---RELLRIISQVNHKNVVKILGLCLETEV-----  156 (414)
Q Consensus        89 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~---~~~~~~l~~l~hpniv~l~~~~~~~~~-----  156 (414)
                      |++.+.||+|+||.||+|.... +..||+|.+......   ....   .+.++.++.++||||+++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            5678899999999999999864 899999999743221   1122   223344555679999999999988776     


Q ss_pred             ceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccc
Q 015027          157 PLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSV  236 (414)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~  236 (414)
                      .+++|||+++ +|.+++..... ..+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++.
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~  155 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR  155 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence            8999999975 78888765332 24588999999999999999999987   9999999999999999999999999987


Q ss_pred             cccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhh----hhhc
Q 015027          237 LISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFL----NSIK  312 (414)
Q Consensus       237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~----~~~~  312 (414)
                      .......   .....++..|+|||++.+..++.++|||||||++|+|++|.+||........... ......    ..+.
T Consensus       156 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  231 (287)
T cd07838         156 IYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDK-IFDVIGLPSEEEWP  231 (287)
T ss_pred             eccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHH-HHHHcCCCChHhcC
Confidence            7643311   1223578899999999999999999999999999999999999874332110000 000000    0000


Q ss_pred             cccc--ccccccccC---CcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          313 NNGL--RQILNFHVA---DESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       313 ~~~~--~~~~~~~~~---~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ....  .........   .......+..+.+++.+||+.||.+||++.+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             CCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            0000  000000000   0111123466889999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=4.4e-37  Score=294.85  Aligned_cols=267  Identities=20%  Similarity=0.252  Sum_probs=192.7

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc---hhHhHHHHHHHHHccCCCceeeeeeeEec----CCcc
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK---IRITERELLRIISQVNHKNVVKILGLCLE----TEVP  157 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~hpniv~l~~~~~~----~~~~  157 (414)
                      ..+|.+.+.||+|+||.||+|... ++..||+|.+.....   .......++.++++++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            478999999999999999999965 589999999876432   22233456789999999999999998763    3467


Q ss_pred             eEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccccc
Q 015027          158 LLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVL  237 (414)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~  237 (414)
                      ++||||+. ++|.+++....   .+++..+..++.||+.||.|||+.+   ++||||||+||+++.++.+||+|||++..
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~  156 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSDQ---PLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG  156 (334)
T ss_pred             EEEEehhh-hhHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence            99999996 58888875433   3588999999999999999999987   99999999999999999999999999876


Q ss_pred             ccCCccc--cceecccccccccchhhccc-CCCCCcccchhHHHHHHHHHhCCCCCCccccccccc-----cc-cchhhh
Q 015027          238 ISSDAET--AMSTILIGTSGYLDPVCINT-GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKK-----IS-MVPYFL  308 (414)
Q Consensus       238 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~-----~~-~~~~~~  308 (414)
                      .......  .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||..........     .+ ......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~  236 (334)
T cd07855         157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL  236 (334)
T ss_pred             ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence            5432211  11223478889999998865 568999999999999999999999996533211000     00 000000


Q ss_pred             hhhccccccccc---ccccCCc---ccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          309 NSIKNNGLRQIL---NFHVADE---SEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       309 ~~~~~~~~~~~~---~~~~~~~---~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ............   .......   .....+..+.+++.+||+.+|.+|||+.+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            000000000000   0000000   00112466999999999999999999998854

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=6.9e-37  Score=293.88  Aligned_cols=267  Identities=25%  Similarity=0.268  Sum_probs=191.0

Q ss_pred             HhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeeccc---chhHhHHHHHHHHHcc-CCCceeeeeeeEecC--Ccc
Q 015027           85 ATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRAD---KIRITERELLRIISQV-NHKNVVKILGLCLET--EVP  157 (414)
Q Consensus        85 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~~~l~~l-~hpniv~l~~~~~~~--~~~  157 (414)
                      ..++|.+.+.||+|+||.||+|.+. ++..+|+|.+....   ........++.+++++ +||||++++++|...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            3578999999999999999999976 58899999885421   1122234567889999 999999999998653  367


Q ss_pred             eEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccccc
Q 015027          158 LLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVL  237 (414)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~  237 (414)
                      ++||||++ ++|..++...    .+++..+..++.||+.||.|||+.+   |+|+||||+||+++.++.+||+|||++..
T Consensus        85 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~  156 (337)
T cd07852          85 YLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS  156 (337)
T ss_pred             EEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence            99999997 4888887543    4477888899999999999999987   99999999999999999999999999986


Q ss_pred             ccCCccc---cceecccccccccchhhccc-CCCCCcccchhHHHHHHHHHhCCCCCCcccccccccc-----cc-chhh
Q 015027          238 ISSDAET---AMSTILIGTSGYLDPVCINT-GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKI-----SM-VPYF  307 (414)
Q Consensus       238 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~-----~~-~~~~  307 (414)
                      .......   .......||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||...........     +. ....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
T cd07852         157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED  236 (337)
T ss_pred             cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            6443221   12234568999999998754 5678999999999999999999999864332110000     00 0000


Q ss_pred             hhhhcccccccccc----cccC--CcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          308 LNSIKNNGLRQILN----FHVA--DESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       308 ~~~~~~~~~~~~~~----~~~~--~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ...+.......+++    ....  .......+..+.+++.+||+.+|.+|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~  294 (337)
T cd07852         237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE  294 (337)
T ss_pred             HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhh
Confidence            00000000000000    0000  0000012356899999999999999999999965

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-37  Score=286.36  Aligned_cols=263  Identities=20%  Similarity=0.191  Sum_probs=194.3

Q ss_pred             CCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch---hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeC
Q 015027           89 FDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI---RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFA  164 (414)
Q Consensus        89 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  164 (414)
                      |.+.+.||.|++|.||+|... ++..+++|.+......   ......++++++.++||||+++++++..+...++||||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            567788999999999999975 6889999998755332   233455678899999999999999999999999999999


Q ss_pred             CCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccc
Q 015027          165 SNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET  244 (414)
Q Consensus       165 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  244 (414)
                      ++ +|.+++....  ..+++..+..++.+++.||.|||+.+   ++|+||||+||+++.++.++|+|||.+.......  
T Consensus        81 ~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--  152 (283)
T cd05118          81 DT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--  152 (283)
T ss_pred             CC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--
Confidence            75 8887776533  34588899999999999999999987   9999999999999999999999999987765432  


Q ss_pred             cceecccccccccchhhcccC-CCCCcccchhHHHHHHHHHhCCCCCCcccccccccc------ccchhhhhhhcc---c
Q 015027          245 AMSTILIGTSGYLDPVCINTG-KLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKI------SMVPYFLNSIKN---N  314 (414)
Q Consensus       245 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~------~~~~~~~~~~~~---~  314 (414)
                      .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||...+.......      ...+..+.....   .
T Consensus       153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd05118         153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARN  232 (283)
T ss_pred             ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhh
Confidence            122334678899999998876 789999999999999999999999864332110000      000000000000   0


Q ss_pred             ccccccccc--cCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          315 GLRQILNFH--VADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       315 ~~~~~~~~~--~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      .........  .........+..+.+++.+||+.||.+||++.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence            000000000  000011123467999999999999999999999864

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=9.3e-37  Score=286.66  Aligned_cols=249  Identities=21%  Similarity=0.250  Sum_probs=188.2

Q ss_pred             CCCCCCccccCCceEEEEEEEc----CCcEEEEEEeecccc-----hhHhHHHHHHHHHcc-CCCceeeeeeeEecCCcc
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLH----DNIQVAVKTYRRADK-----IRITERELLRIISQV-NHKNVVKILGLCLETEVP  157 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-----~~~~~~~~~~~l~~l-~hpniv~l~~~~~~~~~~  157 (414)
                      +|++.+.||+|+||.||++...    +|..||+|++.....     .......+++++.++ +||||+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4788899999999999999863    688999999875322     123335567888888 599999999999999999


Q ss_pred             eEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccccc
Q 015027          158 LLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVL  237 (414)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~  237 (414)
                      ++||||+++++|.+++....   .+++..+..++.|++.||.|||+.+   ++||||+|+|||++.++.+||+|||++..
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~  154 (290)
T cd05613          81 HLILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE  154 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence            99999999999999986543   3477888889999999999999987   99999999999999999999999999876


Q ss_pred             ccCCccccceecccccccccchhhcccC--CCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccc
Q 015027          238 ISSDAETAMSTILIGTSGYLDPVCINTG--KLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNG  315 (414)
Q Consensus       238 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (414)
                      ...... .......|+..|+|||.+.+.  .++.++||||||+++|+|++|..||.......     ............ 
T Consensus       155 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-----~~~~~~~~~~~~-  227 (290)
T cd05613         155 FHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN-----SQAEISRRILKS-  227 (290)
T ss_pred             cccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc-----cHHHHHHHhhcc-
Confidence            543211 122235688999999998753  47889999999999999999999986321110     000000000000 


Q ss_pred             cccccccccCCcccHHHHHHHHHHHHHhhccCCCCCC-----ChhHHH
Q 015027          316 LRQILNFHVADESEMKEIEIVAELASKCLRIRGTERP-----TMKQVS  358 (414)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rp-----s~~~v~  358 (414)
                           .+..    +......+.+++.+||+.+|.+||     ++.+++
T Consensus       228 -----~~~~----~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~  266 (290)
T cd05613         228 -----EPPY----PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIK  266 (290)
T ss_pred             -----CCCC----CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHH
Confidence                 0001    111225589999999999999997     455553

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.2e-37  Score=296.17  Aligned_cols=266  Identities=22%  Similarity=0.267  Sum_probs=191.8

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeeccc---chhHhHHHHHHHHHccCCCceeeeeeeEecC-----Cc
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRAD---KIRITERELLRIISQVNHKNVVKILGLCLET-----EV  156 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~-----~~  156 (414)
                      .++|.+.+.||+|+||+||+|... ++..||||.+....   ........++.+++.++||||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            467999999999999999999965 58999999986532   1122334567889999999999999988654     34


Q ss_pred             ceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccc
Q 015027          157 PLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSV  236 (414)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~  236 (414)
                      .|+||||+. ++|.+++...   ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++.
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~  156 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSS---QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR  156 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence            799999996 5888887543   23578899999999999999999987   9999999999999999999999999998


Q ss_pred             cccCCccccceecccccccccchhhccc-CCCCCcccchhHHHHHHHHHhCCCCCCcccccccccc------ccchhhhh
Q 015027          237 LISSDAETAMSTILIGTSGYLDPVCINT-GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKI------SMVPYFLN  309 (414)
Q Consensus       237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~------~~~~~~~~  309 (414)
                      ......  .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.......      ...+....
T Consensus       157 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  234 (337)
T cd07858         157 TTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG  234 (337)
T ss_pred             ccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence            664321  22234467889999998864 5689999999999999999999999964321100000      00000000


Q ss_pred             hhccccccccc---ccccCC---cccHHHHHHHHHHHHHhhccCCCCCCChhHHHHH
Q 015027          310 SIKNNGLRQIL---NFHVAD---ESEMKEIEIVAELASKCLRIRGTERPTMKQVSEE  360 (414)
Q Consensus       310 ~~~~~~~~~~~---~~~~~~---~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~  360 (414)
                      ..........+   ......   ......+..+.+|+.+||+.+|++|||+.++++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         235 FIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             hcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence            00000000000   000000   0001234568999999999999999999999655

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-37  Score=301.15  Aligned_cols=248  Identities=22%  Similarity=0.340  Sum_probs=198.1

Q ss_pred             CCCCccccCCceEEEEEEEcC--Cc--EEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEe
Q 015027           90 DRSRCLSQGGFVSVYKGVLHD--NI--QVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        90 ~~~~~lg~G~~g~Vy~~~~~~--~~--~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  163 (414)
                      .+.++||+|+||.|++|.|..  |.  .||||.++.+...  ...+.+|..+|.+|+|||+++|||+..+ ....+|||+
T Consensus       113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL  191 (1039)
T KOG0199|consen  113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL  191 (1039)
T ss_pred             HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence            345789999999999999763  43  4899999876543  4556777889999999999999999887 677899999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcc
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE  243 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  243 (414)
                      ++.|||.+.|+. ..+..+-......++.||+.||.||.+.+   +|||||-..|+|+-..-.|||+|||+.+.+.....
T Consensus       192 aplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned  267 (1039)
T KOG0199|consen  192 APLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENED  267 (1039)
T ss_pred             cccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence            999999999987 44555567888899999999999999987   99999999999999999999999999998765433


Q ss_pred             c-cceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhcccccccccc
Q 015027          244 T-AMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILN  321 (414)
Q Consensus       244 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (414)
                      . .+.....-...|+|||.+....++.++|||+|||++|||++ |+.||-+.....         .+..         ++
T Consensus       268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q---------IL~~---------iD  329 (1039)
T KOG0199|consen  268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ---------ILKN---------ID  329 (1039)
T ss_pred             ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH---------HHHh---------cc
Confidence            2 22233334557999999999999999999999999999999 788986433211         1111         11


Q ss_pred             cccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHH
Q 015027          322 FHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEE  360 (414)
Q Consensus       322 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~  360 (414)
                      ..-.-+.+...++.+.+++..||..+|.+|||+..|.+.
T Consensus       330 ~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~  368 (1039)
T KOG0199|consen  330 AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED  368 (1039)
T ss_pred             ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence            222222333445779999999999999999999999643

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.5e-36  Score=285.03  Aligned_cols=254  Identities=23%  Similarity=0.236  Sum_probs=192.8

Q ss_pred             CCCCCCccccCCceEEEEEEEc----CCcEEEEEEeecccc-----hhHhHHHHHHHHHcc-CCCceeeeeeeEecCCcc
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLH----DNIQVAVKTYRRADK-----IRITERELLRIISQV-NHKNVVKILGLCLETEVP  157 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-----~~~~~~~~~~~l~~l-~hpniv~l~~~~~~~~~~  157 (414)
                      +|.+.+.||+|++|.||++...    ++..||||.+.....     .......+++++.++ +||||+++++.+..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4778899999999999999843    468899999875422     112234566888888 599999999999999999


Q ss_pred             eEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccccc
Q 015027          158 LLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVL  237 (414)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~  237 (414)
                      ++||||+++++|.+++....   .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++..
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          81 HLILDYVNGGELFTHLYQRE---HFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcC---CcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence            99999999999999886432   3477888999999999999999977   99999999999999999999999999876


Q ss_pred             ccCCccccceecccccccccchhhcccCC--CCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccc
Q 015027          238 ISSDAETAMSTILIGTSGYLDPVCINTGK--LTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNG  315 (414)
Q Consensus       238 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (414)
                      ...... .......|+..|+|||.+.+..  .+.++||||||+++|+|++|..||.......     ............ 
T Consensus       155 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-----~~~~~~~~~~~~-  227 (288)
T cd05583         155 FLAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN-----SQSEISRRILKS-  227 (288)
T ss_pred             cccccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc-----hHHHHHHHHHcc-
Confidence            543311 1122346888999999987655  7889999999999999999999985321100     000111100000 


Q ss_pred             cccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHH
Q 015027          316 LRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDR  363 (414)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~  363 (414)
                           .+..+    ......+.+++.+||+.+|++|||+.++.+.|+.
T Consensus       228 -----~~~~~----~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         228 -----KPPFP----KTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             -----CCCCC----cccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence                 00011    1122458999999999999999999888776654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-36  Score=284.34  Aligned_cols=263  Identities=20%  Similarity=0.224  Sum_probs=190.7

Q ss_pred             CCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch--hHhHHHHHHHHHccC-CCceeeeeeeEecCCcceEEEEeC
Q 015027           89 FDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI--RITERELLRIISQVN-HKNVVKILGLCLETEVPLLVYEFA  164 (414)
Q Consensus        89 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~  164 (414)
                      |.+.+.||+|++|.||+|... +++.|+||.+......  ......++..+.+++ ||||+++++++..++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            567889999999999999976 4788999998654331  112234567788888 999999999999999999999999


Q ss_pred             CCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccc
Q 015027          165 SNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET  244 (414)
Q Consensus       165 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  244 (414)
                       +|+|.+++..... ..+++..+..++.|++.+|.|||+++   ++|+||+|+||++++++.++|+|||++.......  
T Consensus        81 -~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~--  153 (283)
T cd07830          81 -EGNLYQLMKDRKG-KPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP--  153 (283)
T ss_pred             -CCCHHHHHHhccc-ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC--
Confidence             7799888865442 34588999999999999999999987   9999999999999999999999999987664321  


Q ss_pred             cceecccccccccchhhcc-cCCCCCcccchhHHHHHHHHHhCCCCCCcccccccccc--c-----cchhhhhhhc-ccc
Q 015027          245 AMSTILIGTSGYLDPVCIN-TGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKI--S-----MVPYFLNSIK-NNG  315 (414)
Q Consensus       245 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~--~-----~~~~~~~~~~-~~~  315 (414)
                       ......++..|+|||++. +..++.++|+||||+++|+|++|+.||...........  .     ....+..... ...
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07830         154 -PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK  232 (283)
T ss_pred             -CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence             122346788999999874 45688999999999999999999999864332110000  0     0000000000 000


Q ss_pred             cccccccccCC---cccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          316 LRQILNFHVAD---ESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       316 ~~~~~~~~~~~---~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ....+......   ......+..+.+++.+||+.+|.+|||+++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            00000000000   000011356899999999999999999999864

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=3.3e-36  Score=286.20  Aligned_cols=242  Identities=27%  Similarity=0.343  Sum_probs=187.0

Q ss_pred             CCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch----hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEe
Q 015027           89 FDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI----RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        89 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  163 (414)
                      |...+.||+|+||.||+|... ++..|++|.+......    ......++++++.++|||++++++++.+....|+||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            666778999999999999965 5889999998754321    12335567899999999999999999999999999999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcc
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE  243 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  243 (414)
                      +. |+|.+++....  ..+++..+..++.||+.||.|||+.+   ++|+||+|+||+++.++.+||+|||++.....   
T Consensus       103 ~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---  173 (313)
T cd06633         103 CL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP---  173 (313)
T ss_pred             CC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence            96 47777765433  23578899999999999999999987   99999999999999999999999998864321   


Q ss_pred             ccceecccccccccchhhcc---cCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccc
Q 015027          244 TAMSTILIGTSGYLDPVCIN---TGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQIL  320 (414)
Q Consensus       244 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (414)
                         .....|+..|+|||++.   +..++.++|||||||++|+|++|..||........         .............
T Consensus       174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~---------~~~~~~~~~~~~~  241 (313)
T cd06633         174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---------LYHIAQNDSPTLQ  241 (313)
T ss_pred             ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH---------HHHHHhcCCCCCC
Confidence               22356888999999984   45688899999999999999999999864321110         0000001111110


Q ss_pred             ccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          321 NFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       321 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      .        ...+..+.+|+.+||+.+|.+||++.+++.
T Consensus       242 ~--------~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         242 S--------NEWTDSFRGFVDYCLQKIPQERPASAELLR  272 (313)
T ss_pred             c--------cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0        111245899999999999999999999875

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1e-36  Score=293.23  Aligned_cols=260  Identities=20%  Similarity=0.269  Sum_probs=187.3

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc---hhHhHHHHHHHHHccCCCceeeeeeeEecCC------
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK---IRITERELLRIISQVNHKNVVKILGLCLETE------  155 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~------  155 (414)
                      .++|.+.+.||+|+||.||+|... +|..||||.+.....   .......++.+++.++||||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            478999999999999999999965 689999999865321   2233456678999999999999999987543      


Q ss_pred             cceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccc
Q 015027          156 VPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESS  235 (414)
Q Consensus       156 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla  235 (414)
                      ..++|+||+.. +|..++.     ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++
T Consensus        94 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~  164 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA  164 (342)
T ss_pred             eEEEEeccccc-CHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence            45899999964 6665541     23478889999999999999999987   999999999999999999999999998


Q ss_pred             ccccCCccccceecccccccccchhhccc-CCCCCcccchhHHHHHHHHHhCCCCCCcccccccccc------ccchhhh
Q 015027          236 VLISSDAETAMSTILIGTSGYLDPVCINT-GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKI------SMVPYFL  308 (414)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~------~~~~~~~  308 (414)
                      ......     .....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||...........      ...+.+.
T Consensus       165 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  239 (342)
T cd07879         165 RHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFV  239 (342)
T ss_pred             cCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            764321     123467889999999876 4688999999999999999999999974331110000      0000000


Q ss_pred             hhhcccccccccc--cccCCc-cc---HHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          309 NSIKNNGLRQILN--FHVADE-SE---MKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       309 ~~~~~~~~~~~~~--~~~~~~-~~---~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      .............  +..... ..   ......+.+|+.+||+.||.+||++.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~  296 (342)
T cd07879         240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE  296 (342)
T ss_pred             HHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            0000000000000  000000 00   012245889999999999999999999964

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=2.1e-36  Score=279.61  Aligned_cols=248  Identities=18%  Similarity=0.249  Sum_probs=189.3

Q ss_pred             CCCCCCccccCCceEEEEEEEcC-CcEEEEEEeeccc------chhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEE
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLHD-NIQVAVKTYRRAD------KIRITERELLRIISQVNHKNVVKILGLCLETEVPLLV  160 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~------~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv  160 (414)
                      +|.+.+.||+|+||.||++.+.. +..+++|.++...      ........+..+++.++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            57888999999999999998654 4556666654321      1122234456788999999999999999999999999


Q ss_pred             EEeCCCCchhhhhhhc-CCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccccccc
Q 015027          161 YEFASNGTLLDHIRCE-SSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLIS  239 (414)
Q Consensus       161 ~e~~~~gsL~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~  239 (414)
                      |||+++++|.+++... .....+++..+..++.|++.||.|||+.+   ++|+||+|+||++++ +.++|+|||++....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence            9999999999888542 22345688999999999999999999987   999999999999985 579999999987664


Q ss_pred             CCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccc
Q 015027          240 SDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQI  319 (414)
Q Consensus       240 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (414)
                      ...  .......+++.|+|||.+.+..++.++|+||||+++|+|++|..||.......         .........    
T Consensus       157 ~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~---------~~~~~~~~~----  221 (260)
T cd08222         157 GSC--DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS---------VVLRIVEGP----  221 (260)
T ss_pred             CCc--ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---------HHHHHHcCC----
Confidence            322  12234567889999999988889999999999999999999999986322110         000000000    


Q ss_pred             cccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          320 LNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       320 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                       .+    ..+...+..+.+++.+||..+|.+||++.++++
T Consensus       222 -~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         222 -TP----SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             -CC----CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence             00    111223356899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=2.1e-36  Score=286.81  Aligned_cols=268  Identities=22%  Similarity=0.216  Sum_probs=189.1

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch---hHhHHHHHHHHHccCCCceeeeeeeEecCC------
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI---RITERELLRIISQVNHKNVVKILGLCLETE------  155 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~hpniv~l~~~~~~~~------  155 (414)
                      .++|.+.+.||.|+||.||+|... +++.+|+|.+......   .....+++++++.++||||+++++++....      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            478999999999999999999976 5889999998654321   223456678999999999999999875433      


Q ss_pred             --cceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecc
Q 015027          156 --VPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFE  233 (414)
Q Consensus       156 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG  233 (414)
                        ..++||||+.+ +|...+....  ..+++..+..++.|+++||.|||+.+   ++|+||||+||++++++.++|+|||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg  160 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPS--VKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG  160 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence              46999999975 5666654322  24588999999999999999999988   9999999999999999999999999


Q ss_pred             ccccccCCccc---------cceecccccccccchhhccc-CCCCCcccchhHHHHHHHHHhCCCCCCccccccccccc-
Q 015027          234 SSVLISSDAET---------AMSTILIGTSGYLDPVCINT-GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKIS-  302 (414)
Q Consensus       234 la~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~-  302 (414)
                      ++.........         .......+++.|+|||.+.+ ..++.++|||||||++|||++|++||............ 
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~  240 (311)
T cd07866         161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF  240 (311)
T ss_pred             cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            99765432211         11123467888999998765 45889999999999999999999998643321100000 


Q ss_pred             -----cchhhhhhhcc-ccccc-ccccccCCcc---cHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          303 -----MVPYFLNSIKN-NGLRQ-ILNFHVADES---EMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       303 -----~~~~~~~~~~~-~~~~~-~~~~~~~~~~---~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                           ..+.....+.. ..... ..........   .....+.+.+++.+||+.+|.+|||+.+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence                 00000000000 00000 0000000000   0011256889999999999999999999854

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-36  Score=290.97  Aligned_cols=265  Identities=21%  Similarity=0.236  Sum_probs=194.9

Q ss_pred             CCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc---hhHhHHHHHHHHHccCCCceeeeeeeEecCC-----cce
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK---IRITERELLRIISQVNHKNVVKILGLCLETE-----VPL  158 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~-----~~~  158 (414)
                      +|.+.+.||.|++|.||+|... ++..||||.+.....   ......+++.+++.++||||+++++++....     ..|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5888999999999999999976 489999999876432   2234456678999999999999999988765     789


Q ss_pred             EEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccc
Q 015027          159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLI  238 (414)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~  238 (414)
                      +||||+++ +|.+++....   .+++..+..++.+++.||.|||+.+   ++|+||||+|||++.++.++|+|||++...
T Consensus        81 lv~e~~~~-~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~  153 (330)
T cd07834          81 IVTELMET-DLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV  153 (330)
T ss_pred             EEecchhh-hHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence            99999974 7888875433   5588999999999999999999988   999999999999999999999999999876


Q ss_pred             cCCccc-cceecccccccccchhhcccC-CCCCcccchhHHHHHHHHHhCCCCCCcccccccccc------ccchhhhhh
Q 015027          239 SSDAET-AMSTILIGTSGYLDPVCINTG-KLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKI------SMVPYFLNS  310 (414)
Q Consensus       239 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~------~~~~~~~~~  310 (414)
                      ...... .......+++.|+|||++.+. .++.++||||||+++|+|++|..||...........      ...+.....
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  233 (330)
T cd07834         154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF  233 (330)
T ss_pred             cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence            543210 112334678899999999887 899999999999999999999999975432110000      000000000


Q ss_pred             hcccccccccc---cccC---CcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          311 IKNNGLRQILN---FHVA---DESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       311 ~~~~~~~~~~~---~~~~---~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      .........+.   ....   .......+..+.+|+.+||+.+|.+|||+.+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  288 (330)
T cd07834         234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA  288 (330)
T ss_pred             ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            00000000000   0000   0000112356899999999999999999999864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=3.7e-36  Score=288.56  Aligned_cols=265  Identities=19%  Similarity=0.210  Sum_probs=190.1

Q ss_pred             hcCCCC-CCccccCCceEEEEEEEc-CCcEEEEEEeecccchh---------------HhHHHHHHHHHccCCCceeeee
Q 015027           86 TKNFDR-SRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIR---------------ITERELLRIISQVNHKNVVKIL  148 (414)
Q Consensus        86 ~~~~~~-~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---------------~~~~~~~~~l~~l~hpniv~l~  148 (414)
                      .++|.. .+.||.|+||.||+|.+. +++.||||.+.......               ....+++.+++.++||||++++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV   86 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence            356654 467999999999999976 58999999986543221               1234567889999999999999


Q ss_pred             eeEecCCcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEE
Q 015027          149 GLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAK  228 (414)
Q Consensus       149 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~k  228 (414)
                      +++..++..++||||++ |+|.+++...   ..+++.....++.|++.||+|||+.+   ++|+||+|+||+++.++.++
T Consensus        87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~k  159 (335)
T PTZ00024         87 DVYVEGDFINLVMDIMA-SDLKKVVDRK---IRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICK  159 (335)
T ss_pred             EEEecCCcEEEEEeccc-cCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEE
Confidence            99999999999999997 5888888543   23578889999999999999999987   99999999999999999999


Q ss_pred             EeeccccccccCCc------------cccceecccccccccchhhcccC-CCCCcccchhHHHHHHHHHhCCCCCCcccc
Q 015027          229 VADFESSVLISSDA------------ETAMSTILIGTSGYLDPVCINTG-KLTKKSDVYSFGVVLAELLTGKKPGSCMTL  295 (414)
Q Consensus       229 l~DfGla~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~  295 (414)
                      |+|||++.......            .........+++.|+|||.+.+. .++.++|||||||++|+|++|..||.....
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~  239 (335)
T PTZ00024        160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE  239 (335)
T ss_pred             ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            99999987654110            01111233568889999998764 478999999999999999999999974432


Q ss_pred             ccccccccchhhhhh----hccc-------ccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          296 ASNKKISMVPYFLNS----IKNN-------GLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       296 ~~~~~~~~~~~~~~~----~~~~-------~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ..... .........    +...       ............ .....+..+.+++.+||+.+|++|||+.+++.
T Consensus       240 ~~~~~-~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        240 IDQLG-RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKT-IFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             HHHHH-HHHHHhCCCchhhCcchhhcccccccCcCCcccHHH-hCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            11000 000000000    0000       000000000000 00011355889999999999999999999953

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-36  Score=279.63  Aligned_cols=263  Identities=21%  Similarity=0.211  Sum_probs=193.0

Q ss_pred             CCCCCccccCCceEEEEEEEc-CCcEEEEEEeeccc---chhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeC
Q 015027           89 FDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRAD---KIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFA  164 (414)
Q Consensus        89 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  164 (414)
                      |+..+.||+|++|.||+|... +++.+|+|.+....   ........++.+++.++||||+++++++.+.+..++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            566788999999999999976 48999999998653   22233455678899999999999999999999999999999


Q ss_pred             CCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccc
Q 015027          165 SNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET  244 (414)
Q Consensus       165 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  244 (414)
                      + ++|.+++....  ..+++..+..++.+++.||.|||+.+   ++|+||+|+||++++++.++|+|||++........ 
T Consensus        81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-  153 (282)
T cd07829          81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-  153 (282)
T ss_pred             C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence            8 58999986543  24588999999999999999999987   99999999999999999999999999877644321 


Q ss_pred             cceecccccccccchhhcccC-CCCCcccchhHHHHHHHHHhCCCCCCcccccccccc------ccchhhhhhhcccc-c
Q 015027          245 AMSTILIGTSGYLDPVCINTG-KLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKI------SMVPYFLNSIKNNG-L  316 (414)
Q Consensus       245 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~------~~~~~~~~~~~~~~-~  316 (414)
                       ......++..|+|||.+.+. .++.++|||||||++|||++|..||...........      ...+..+....... .
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
T cd07829         154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY  232 (282)
T ss_pred             -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccc
Confidence             22234567789999998766 889999999999999999999999865331110000      00000000000000 0


Q ss_pred             ccccccccCC---cccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          317 RQILNFHVAD---ESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       317 ~~~~~~~~~~---~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ...+......   .........+.+++.+||..+|++||++.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            0000000000   000011356999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=7.2e-36  Score=285.68  Aligned_cols=264  Identities=19%  Similarity=0.216  Sum_probs=190.8

Q ss_pred             HHHhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeeccc---chhHhHHHHHHHHHccCCCceeeeeeeEec-CCcc
Q 015027           83 IRATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRAD---KIRITERELLRIISQVNHKNVVKILGLCLE-TEVP  157 (414)
Q Consensus        83 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~~~l~~l~hpniv~l~~~~~~-~~~~  157 (414)
                      ...+++|.+.+.||.|+||.||+|... ++..||+|.+....   ........++.+++.++||||++++++|.. ....
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   85 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI   85 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence            446789999999999999999999965 68999999875432   122334566789999999999999999875 5678


Q ss_pred             eEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccccc
Q 015027          158 LLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVL  237 (414)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~  237 (414)
                      ++||||+ +++|..++..    ..+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++..
T Consensus        86 ~lv~e~~-~~~L~~~~~~----~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~  157 (328)
T cd07856          86 YFVTELL-GTDLHRLLTS----RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI  157 (328)
T ss_pred             EEEeehh-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence            9999999 5588887743    23467778889999999999999987   99999999999999999999999999875


Q ss_pred             ccCCccccceecccccccccchhhccc-CCCCCcccchhHHHHHHHHHhCCCCCCccccccccc------cccchhhhhh
Q 015027          238 ISSDAETAMSTILIGTSGYLDPVCINT-GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKK------ISMVPYFLNS  310 (414)
Q Consensus       238 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~------~~~~~~~~~~  310 (414)
                      ....     .....+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||..........      ....+.+...
T Consensus       158 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (328)
T cd07856         158 QDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT  232 (328)
T ss_pred             cCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            4321     123457889999998765 578999999999999999999999996433210000      0000000000


Q ss_pred             hccccccccccc-ccCCccc-----HHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          311 IKNNGLRQILNF-HVADESE-----MKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       311 ~~~~~~~~~~~~-~~~~~~~-----~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ........++.. ......+     ...+..+.+++.+||+.+|++|||+.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~  287 (328)
T cd07856         233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA  287 (328)
T ss_pred             ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            000000000000 0000000     011256899999999999999999999843

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-37  Score=301.05  Aligned_cols=259  Identities=25%  Similarity=0.389  Sum_probs=208.4

Q ss_pred             CCCCccccCCceEEEEEEEc-C----CcEEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEE
Q 015027           90 DRSRCLSQGGFVSVYKGVLH-D----NIQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYE  162 (414)
Q Consensus        90 ~~~~~lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  162 (414)
                      ...++||+|+||+||+|.+- .    ..+||+|++......  ..+..+++-.|..++|||+++++++|..+. +-||++
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq  777 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ  777 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence            44688999999999999953 3    356999999776544  455677888999999999999999998776 779999


Q ss_pred             eCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCc
Q 015027          163 FASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDA  242 (414)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  242 (414)
                      ||+.|+|.||++.+....  ..+..+.|+.||++||.|||.+.   ++||||-..||||..-..+|+.|||+++.+..+.
T Consensus       778 ~mP~G~LlDyvr~hr~~i--gsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~  852 (1177)
T KOG1025|consen  778 LMPLGCLLDYVREHRDNI--GSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE  852 (1177)
T ss_pred             hcccchHHHHHHHhhccc--cHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence            999999999998755443  56788999999999999999877   9999999999999999999999999999988765


Q ss_pred             cccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhcccccccccc
Q 015027          243 ETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILN  321 (414)
Q Consensus       243 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (414)
                      .........-.+.|||=|.+....|+.++|||||||++||++| |..|+.+....+                  +..++.
T Consensus       853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e------------------I~dlle  914 (1177)
T KOG1025|consen  853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE------------------IPDLLE  914 (1177)
T ss_pred             ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH------------------hhHHHh
Confidence            5544444445668999999999999999999999999999999 999987654322                  111111


Q ss_pred             cccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHhhhhhh
Q 015027          322 FHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLHENFW  372 (414)
Q Consensus       322 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~~~~~~  372 (414)
                      ...+-..+.-...++.-++.+||..|+..||+++++...+.++.+..+.+.
T Consensus       915 ~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpqryl  965 (1177)
T KOG1025|consen  915 KGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQRYL  965 (1177)
T ss_pred             ccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcceEe
Confidence            111111122222458899999999999999999999999998887655543

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.1e-36  Score=286.98  Aligned_cols=269  Identities=21%  Similarity=0.282  Sum_probs=193.3

Q ss_pred             HHHHHHHhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch---hHhHHHHHHHHHccCCCceeeeeeeEecC
Q 015027           79 KSEMIRATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI---RITERELLRIISQVNHKNVVKILGLCLET  154 (414)
Q Consensus        79 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~hpniv~l~~~~~~~  154 (414)
                      ..++...+++|.+.+.||+|+||.||+|... +++.||+|.+......   .....+++.++.+++||||+++++++...
T Consensus         9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~   88 (345)
T cd07877           9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA   88 (345)
T ss_pred             HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence            3455667899999999999999999999864 6889999998754221   22335567899999999999999988643


Q ss_pred             ------CcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEE
Q 015027          155 ------EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAK  228 (414)
Q Consensus       155 ------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~k  228 (414)
                            ...+++++++ +++|.+++...    .+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+|
T Consensus        89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~k  160 (345)
T cd07877          89 RSLEEFNDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK  160 (345)
T ss_pred             ccccccccEEEEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEE
Confidence                  3467888877 77898877532    3578889999999999999999988   99999999999999999999


Q ss_pred             EeeccccccccCCccccceecccccccccchhhccc-CCCCCcccchhHHHHHHHHHhCCCCCCcccccccccc------
Q 015027          229 VADFESSVLISSDAETAMSTILIGTSGYLDPVCINT-GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKI------  301 (414)
Q Consensus       229 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~------  301 (414)
                      |+|||++......     .....+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||...........      
T Consensus       161 l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  235 (345)
T cd07877         161 ILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG  235 (345)
T ss_pred             Eeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            9999998764321     223467889999999866 5688999999999999999999999864321110000      


Q ss_pred             ccchhhhhhhcccccccc---cccccCCcc---cHHHHHHHHHHHHHhhccCCCCCCChhHHHHH
Q 015027          302 SMVPYFLNSIKNNGLRQI---LNFHVADES---EMKEIEIVAELASKCLRIRGTERPTMKQVSEE  360 (414)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~---~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~  360 (414)
                      ...+.....+........   +........   ....+..+.+|+.+||+.||.+|||+.+++..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         236 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             CCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            000000000000000000   000000000   00113558999999999999999999998543

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.1e-36  Score=288.53  Aligned_cols=263  Identities=19%  Similarity=0.242  Sum_probs=191.3

Q ss_pred             HHhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc---hhHhHHHHHHHHHccCCCceeeeeeeEecCC----
Q 015027           84 RATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK---IRITERELLRIISQVNHKNVVKILGLCLETE----  155 (414)
Q Consensus        84 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~----  155 (414)
                      ...++|.+.+.||+|+||.||+|... ++..||||.+.....   .......++.+++.++||||+++++++..+.    
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07880          12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR   91 (343)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence            35678999999999999999999965 689999999864322   1233456778999999999999999987654    


Q ss_pred             --cceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecc
Q 015027          156 --VPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFE  233 (414)
Q Consensus       156 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG  233 (414)
                        ..++||||+ +++|.+++..    ..+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.++|+|||
T Consensus        92 ~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg  163 (343)
T cd07880          92 FHDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG  163 (343)
T ss_pred             cceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecc
Confidence              358999999 6788887743    23578899999999999999999988   9999999999999999999999999


Q ss_pred             ccccccCCccccceecccccccccchhhccc-CCCCCcccchhHHHHHHHHHhCCCCCCccccccccc------cccchh
Q 015027          234 SSVLISSDAETAMSTILIGTSGYLDPVCINT-GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKK------ISMVPY  306 (414)
Q Consensus       234 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~------~~~~~~  306 (414)
                      ++......     .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||..........      ......
T Consensus       164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  238 (343)
T cd07880         164 LARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE  238 (343)
T ss_pred             cccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence            98765432     123467889999999876 458899999999999999999999997433110000      000000


Q ss_pred             hhhhhccccccccccc--ccCC----cccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          307 FLNSIKNNGLRQILNF--HVAD----ESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       307 ~~~~~~~~~~~~~~~~--~~~~----~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      +...+...........  ....    .........+.+++.+||+.||.+|||+.+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         239 FVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             HHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            1111100000000000  0000    000111245889999999999999999999864

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-37  Score=280.72  Aligned_cols=264  Identities=19%  Similarity=0.249  Sum_probs=201.3

Q ss_pred             HHhcCCCCCCccccCCceEEEEEEEcC-CcEEEEEEeecccchhHhHHHHHHHHHccCC--C----ceeeeeeeEecCCc
Q 015027           84 RATKNFDRSRCLSQGGFVSVYKGVLHD-NIQVAVKTYRRADKIRITERELLRIISQVNH--K----NVVKILGLCLETEV  156 (414)
Q Consensus        84 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h--p----niv~l~~~~~~~~~  156 (414)
                      ..+++|.+...+|+|+||.|-.+.+.. +..||||+++.-....+...-+++.+.++.+  |    -+|.+.++|...++
T Consensus        86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh  165 (415)
T KOG0671|consen   86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH  165 (415)
T ss_pred             ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence            347899999999999999999998764 7899999998877777776667788888732  2    37888899999999


Q ss_pred             ceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeC--------------
Q 015027          157 PLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLN--------------  222 (414)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~--------------  222 (414)
                      .+||+|.+ |-|+.+++..+.. .+.+...+..++.|++++++|||+++   ++|-||||+|||+.              
T Consensus       166 iCivfell-G~S~~dFlk~N~y-~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~  240 (415)
T KOG0671|consen  166 ICIVFELL-GLSTFDFLKENNY-IPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKV  240 (415)
T ss_pred             eEEEEecc-ChhHHHHhccCCc-cccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCcc
Confidence            99999998 5599999976554 34578899999999999999999988   99999999999983              


Q ss_pred             ------CCCcEEEeeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccc
Q 015027          223 ------DNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLA  296 (414)
Q Consensus       223 ------~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~  296 (414)
                            .+..++|+|||.|+.-...     .+..+.|..|.|||++.+-.++..+||||+||||+|+.+|..-|...+..
T Consensus       241 ~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~  315 (415)
T KOG0671|consen  241 CFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL  315 (415)
T ss_pred             ceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence                  1346899999999875433     35568899999999999999999999999999999999999998865522


Q ss_pred             cccccccchhhhhhhcccccccc-------------------------cccc----cCCcccHHHHHHHHHHHHHhhccC
Q 015027          297 SNKKISMVPYFLNSIKNNGLRQI-------------------------LNFH----VADESEMKEIEIVAELASKCLRIR  347 (414)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~----~~~~~~~~~~~~l~~Li~~cl~~d  347 (414)
                      +  ...+.+..+.+.........                         .+..    ..-.....+...|.+|+.+||..|
T Consensus       316 E--HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fD  393 (415)
T KOG0671|consen  316 E--HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFD  393 (415)
T ss_pred             H--HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccC
Confidence            2  11122221111111110000                         0000    000111223356999999999999


Q ss_pred             CCCCCChhHHHH
Q 015027          348 GTERPTMKQVSE  359 (414)
Q Consensus       348 P~~Rps~~~v~~  359 (414)
                      |.+|+|+.|+++
T Consensus       394 P~~RiTl~EAL~  405 (415)
T KOG0671|consen  394 PARRITLREALS  405 (415)
T ss_pred             ccccccHHHHhc
Confidence            999999999853

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-36  Score=298.25  Aligned_cols=256  Identities=22%  Similarity=0.296  Sum_probs=207.0

Q ss_pred             HHHHhcCCCCCCccccCCceEEEEEEE-cCCcEEEEEEeecccchhHhHHHHHHHHHcc-CCCceeeeeeeEec-----C
Q 015027           82 MIRATKNFDRSRCLSQGGFVSVYKGVL-HDNIQVAVKTYRRADKIRITERELLRIISQV-NHKNVVKILGLCLE-----T  154 (414)
Q Consensus        82 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l-~hpniv~l~~~~~~-----~  154 (414)
                      +...+..|++...||.|.+|.||+++. ++++..|+|+.........++..+.+++..+ .|||++.++|+|..     +
T Consensus        14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~   93 (953)
T KOG0587|consen   14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG   93 (953)
T ss_pred             CCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence            334467799999999999999999994 4689999999988877766666666777766 69999999999863     5


Q ss_pred             CcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccc
Q 015027          155 EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFES  234 (414)
Q Consensus       155 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGl  234 (414)
                      +.+|||||||.+||..|+++... ...+.|..+..|++.++.|+.+||.+.   ++|||||-.|||++.++.|||+|||.
T Consensus        94 DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGv  169 (953)
T KOG0587|consen   94 DQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGV  169 (953)
T ss_pred             CeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeee
Confidence            68999999999999999997655 444588999999999999999999977   99999999999999999999999999


Q ss_pred             cccccCCccccceecccccccccchhhccc-----CCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhh
Q 015027          235 SVLISSDAETAMSTILIGTSGYLDPVCINT-----GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLN  309 (414)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~  309 (414)
                      +.++....  ....+.+|||.|||||++..     ..|+.++|+||||++..||.-|.+|+..+-...         ++ 
T Consensus       170 SaQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr---------aL-  237 (953)
T KOG0587|consen  170 SAQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR---------AL-  237 (953)
T ss_pred             eeeeeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh---------hh-
Confidence            98876532  33456799999999999854     357889999999999999999999986433211         00 


Q ss_pred             hhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          310 SIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                            +...-+|......+...++.+.++|..||.+|-.+||++.++++
T Consensus       238 ------F~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  238 ------FLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             ------ccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence                  00011122222335566788999999999999999999988864

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-36  Score=267.42  Aligned_cols=257  Identities=25%  Similarity=0.309  Sum_probs=194.0

Q ss_pred             CccccCCceEEEEEE-EcCCcEEEEEEeecccc-hhHhHHHHHHHHHcc-CCCceeeeeeeEecCCcceEEEEeCCCCch
Q 015027           93 RCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADK-IRITERELLRIISQV-NHKNVVKILGLCLETEVPLLVYEFASNGTL  169 (414)
Q Consensus        93 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~gsL  169 (414)
                      +.||+|+|+.|-.++ ..+|..+|||++.+... .+....++++++.+. .|+||+++++||+++...|||||-|.||+|
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl  163 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL  163 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence            459999999999988 66899999999976533 233445556777776 599999999999999999999999999999


Q ss_pred             hhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCC---CcEEEeeccccccccC-----C
Q 015027          170 LDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDN---YTAKVADFESSVLISS-----D  241 (414)
Q Consensus       170 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~---~~~kl~DfGla~~~~~-----~  241 (414)
                      ..++....   -.++.++.++..+|+.||.|||..|   |.||||||+|||..+.   .-+||+||.+..-...     .
T Consensus       164 LshI~~~~---~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp  237 (463)
T KOG0607|consen  164 LSHIQKRK---HFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP  237 (463)
T ss_pred             HHHHHHhh---hccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence            99986543   3478889999999999999999988   9999999999999654   3489999987643221     1


Q ss_pred             ccccceecccccccccchhhcc-----cCCCCCcccchhHHHHHHHHHhCCCCCCcccccccccc--ccchhhhhhhccc
Q 015027          242 AETAMSTILIGTSGYLDPVCIN-----TGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKI--SMVPYFLNSIKNN  314 (414)
Q Consensus       242 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~--~~~~~~~~~~~~~  314 (414)
                      ..+....+.+|+..|||||+..     ...|+.+.|.||||||||-|++|.+||.++.....+..  ...+...+.    
T Consensus       238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~----  313 (463)
T KOG0607|consen  238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNK----  313 (463)
T ss_pred             CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHH----
Confidence            1222334568899999999862     34689999999999999999999999987654321110  111111111    


Q ss_pred             ccccccc--cccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          315 GLRQILN--FHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       315 ~~~~~~~--~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      -+..+-.  ..++...+...+.+..+|+..+|..++..|.++.+++.
T Consensus       314 LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  314 LFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             HHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            0111111  23344455666788999999999999999999888754

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=8.1e-36  Score=287.04  Aligned_cols=266  Identities=19%  Similarity=0.199  Sum_probs=187.2

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch-hHhHHHHHHHHHccCCCceeeeeeeEecC---------
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI-RITERELLRIISQVNHKNVVKILGLCLET---------  154 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~hpniv~l~~~~~~~---------  154 (414)
                      ..+|.+.+.||.|+||.||+|... ++..||+|.+...... .....++++++++++||||+++++++...         
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            368999999999999999999975 5889999998665432 23345667899999999999999876543         


Q ss_pred             -----CcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeC-CCCcEE
Q 015027          155 -----EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLN-DNYTAK  228 (414)
Q Consensus       155 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~-~~~~~k  228 (414)
                           ...++||||++ ++|.+++..    ..+++..+..++.||+.||.|||+.+   ++||||||+||+++ +++.+|
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k  155 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK  155 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence                 34789999997 488887743    23578899999999999999999988   99999999999997 466789


Q ss_pred             EeeccccccccCCccc-cceecccccccccchhhccc-CCCCCcccchhHHHHHHHHHhCCCCCCcccccccccccc---
Q 015027          229 VADFESSVLISSDAET-AMSTILIGTSGYLDPVCINT-GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISM---  303 (414)
Q Consensus       229 l~DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~---  303 (414)
                      |+|||++......... .......++..|+|||++.+ ..++.++|||||||++|+|++|+.||.............   
T Consensus       156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~  235 (342)
T cd07854         156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV  235 (342)
T ss_pred             ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            9999998765432111 11123357889999998654 568899999999999999999999996433211000000   


Q ss_pred             -------chhhhhhhcccccccccccccC-CcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          304 -------VPYFLNSIKNNGLRQILNFHVA-DESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       304 -------~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                             ...+.................. ..........+.+|+.+||+.||.+|||+.+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence                   0000000000000000000000 0000012255889999999999999999999853

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-37  Score=280.14  Aligned_cols=242  Identities=22%  Similarity=0.264  Sum_probs=190.7

Q ss_pred             hcCCCCCCccccCCceEEEEEEEcC-CcEEEEEEeecccchhHhH----HHHHHHHHcc-CCCceeeeeeeEecCCcceE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLHD-NIQVAVKTYRRADKIRITE----RELLRIISQV-NHKNVVKILGLCLETEVPLL  159 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~----~~~~~~l~~l-~hpniv~l~~~~~~~~~~~l  159 (414)
                      ..+|..+.+||+|+||.|-+|..++ ...+|||+++++.......    ..+-++|... +-|.+++++.+|+.-+.+|+
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF  427 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF  427 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence            3679999999999999999998764 6779999998764333222    2222455444 47899999999999999999


Q ss_pred             EEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccccccc
Q 015027          160 VYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLIS  239 (414)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~  239 (414)
                      ||||+.||+|..++..-+..   .+..+.-++..|+-||-|||+.+   ||+||||.+|||+|.+|++||+|||+++.--
T Consensus       428 VMEyvnGGDLMyhiQQ~GkF---KEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni  501 (683)
T KOG0696|consen  428 VMEYVNGGDLMYHIQQVGKF---KEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI  501 (683)
T ss_pred             EEEEecCchhhhHHHHhccc---CCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccc
Confidence            99999999999999766554   34567778999999999999988   9999999999999999999999999987543


Q ss_pred             CCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccc
Q 015027          240 SDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQI  319 (414)
Q Consensus       240 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (414)
                      .+  .....+.+|||.|+|||++..++|+.++|.|||||+||||+.|++||++.+...         ..+.+        
T Consensus       502 ~~--~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e---------lF~aI--------  562 (683)
T KOG0696|consen  502 FD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---------LFQAI--------  562 (683)
T ss_pred             cC--CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH---------HHHHH--------
Confidence            22  234567899999999999999999999999999999999999999998544211         11111        


Q ss_pred             cccccCCcccHHHHHHHHHHHHHhhccCCCCCCCh
Q 015027          320 LNFHVADESEMKEIEIVAELASKCLRIRGTERPTM  354 (414)
Q Consensus       320 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~  354 (414)
                      .+-.+  .++...+.+..++....|.+.|.+|...
T Consensus       563 ~ehnv--syPKslSkEAv~ickg~ltK~P~kRLGc  595 (683)
T KOG0696|consen  563 MEHNV--SYPKSLSKEAVAICKGLLTKHPGKRLGC  595 (683)
T ss_pred             HHccC--cCcccccHHHHHHHHHHhhcCCccccCC
Confidence            11111  1222233568899999999999999653

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-35  Score=270.37  Aligned_cols=235  Identities=29%  Similarity=0.323  Sum_probs=187.1

Q ss_pred             cccCCceEEEEEEEc-CCcEEEEEEeecccch----hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCCCCch
Q 015027           95 LSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI----RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTL  169 (414)
Q Consensus        95 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL  169 (414)
                      ||.|+||.||++... +++.+|+|.+......    ......++.++++++||||+++++.+..+...++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999976 4889999998765432    22345566889999999999999999999999999999999999


Q ss_pred             hhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccccceec
Q 015027          170 LDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTI  249 (414)
Q Consensus       170 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  249 (414)
                      .+++....   .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......  .....
T Consensus        81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~  152 (250)
T cd05123          81 FSHLSKEG---RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNT  152 (250)
T ss_pred             HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccC
Confidence            99996543   3578899999999999999999977   9999999999999999999999999987764331  12334


Q ss_pred             ccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccccCCccc
Q 015027          250 LIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESE  329 (414)
Q Consensus       250 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (414)
                      ..++..|+|||.+.+...+.++|+||||+++|+|++|..||.......         .........      ...+.   
T Consensus       153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---------~~~~~~~~~------~~~~~---  214 (250)
T cd05123         153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE---------IYEKILKDP------LRFPE---  214 (250)
T ss_pred             CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---------HHHHHhcCC------CCCCC---
Confidence            567889999999998889999999999999999999999986433100         111111100      00111   


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCChhH
Q 015027          330 MKEIEIVAELASKCLRIRGTERPTMKQ  356 (414)
Q Consensus       330 ~~~~~~l~~Li~~cl~~dP~~Rps~~~  356 (414)
                       ..+..+.+++.+||..||.+||++.+
T Consensus       215 -~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         215 -FLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             -CCCHHHHHHHHHHhcCCHhhCCCccc
Confidence             11255899999999999999999944

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-36  Score=288.43  Aligned_cols=240  Identities=23%  Similarity=0.267  Sum_probs=189.9

Q ss_pred             HhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEe
Q 015027           85 ATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        85 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  163 (414)
                      .+..|.+...+|.|+|+.|-.+... +++..++|++.........+..  -.+..-+||||+++.+.+.++...|+|||+
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~--~~~~~~~h~niv~~~~v~~~~~~~~~v~e~  397 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIP--ISLLVRDHPNIVKSHDVYEDGKEIYLVMEL  397 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccccccccccc--hhhhhcCCCcceeecceecCCceeeeeehh
Confidence            3678888899999999999999865 5888999999876322222221  223334799999999999999999999999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceee-CCCCcEEEeeccccccccCCc
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILL-NDNYTAKVADFESSVLISSDA  242 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll-~~~~~~kl~DfGla~~~~~~~  242 (414)
                      +.|+-|.+.+.....    ....+..|+++|+.++.|||++|   ++||||||+|||+ ++.++++|+|||.+...... 
T Consensus       398 l~g~ell~ri~~~~~----~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-  469 (612)
T KOG0603|consen  398 LDGGELLRRIRSKPE----FCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-  469 (612)
T ss_pred             ccccHHHHHHHhcch----hHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence            999988887754332    22566779999999999999988   9999999999999 68999999999999887654 


Q ss_pred             cccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccccc
Q 015027          243 ETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNF  322 (414)
Q Consensus       243 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (414)
                          ....+-|..|.|||++...+|++++||||||++||+|++|+.||.......    .    ....+.          
T Consensus       470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~----e----i~~~i~----------  527 (612)
T KOG0603|consen  470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI----E----IHTRIQ----------  527 (612)
T ss_pred             ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH----H----HHHhhc----------
Confidence                223466889999999999999999999999999999999999997443220    0    001111          


Q ss_pred             ccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHH
Q 015027          323 HVADESEMKEIEIVAELASKCLRIRGTERPTMKQVS  358 (414)
Q Consensus       323 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~  358 (414)
                        ........+...++|+.+||+.||.+||++.++.
T Consensus       528 --~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~  561 (612)
T KOG0603|consen  528 --MPKFSECVSDEAKDLLQQLLQVDPALRLGADEIG  561 (612)
T ss_pred             --CCccccccCHHHHHHHHHhccCChhhCcChhhhc
Confidence              1111133446699999999999999999999983

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.8e-36  Score=287.26  Aligned_cols=262  Identities=21%  Similarity=0.265  Sum_probs=190.9

Q ss_pred             HhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc---hhHhHHHHHHHHHccCCCceeeeeeeEecCCc----
Q 015027           85 ATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK---IRITERELLRIISQVNHKNVVKILGLCLETEV----  156 (414)
Q Consensus        85 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~----  156 (414)
                      ..++|.+.+.||+|++|.||+|... ++..||+|.+.....   .......++.++++++||||+++++++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            4678999999999999999999976 588999999865321   11223456788999999999999998876554    


Q ss_pred             --ceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccc
Q 015027          157 --PLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFES  234 (414)
Q Consensus       157 --~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGl  234 (414)
                        .++|+||+ +++|.+++..    ..+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||+
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~  164 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL  164 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence              89999999 5699888853    34588899999999999999999987   99999999999999999999999999


Q ss_pred             cccccCCccccceecccccccccchhhccc-CCCCCcccchhHHHHHHHHHhCCCCCCcccccccccc------ccchhh
Q 015027          235 SVLISSDAETAMSTILIGTSGYLDPVCINT-GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKI------SMVPYF  307 (414)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~------~~~~~~  307 (414)
                      +......     .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...........      ...+.+
T Consensus       165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  239 (343)
T cd07851         165 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEEL  239 (343)
T ss_pred             ccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Confidence            8765432     223467889999999865 4678999999999999999999999964332110000      000000


Q ss_pred             hhhhcccccccccc---cccCCcc---cHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          308 LNSIKNNGLRQILN---FHVADES---EMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       308 ~~~~~~~~~~~~~~---~~~~~~~---~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ...+.......++.   .......   ....+..+.+|+.+||+.+|.+|||+.+|+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            00010000000000   0000000   0011356899999999999999999999853

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=3.9e-35  Score=304.24  Aligned_cols=144  Identities=26%  Similarity=0.316  Sum_probs=126.0

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch----hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI----RITERELLRIISQVNHKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~  161 (414)
                      ++|.+.+.||+|+||.||+|.+. +++.||||++......    ......++.++..++||||+++++++......|+||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            67899999999999999999976 5899999999764322    133455667888999999999999999999999999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccc
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSV  236 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~  236 (414)
                      ||+++++|.+++....   .+++..++.++.||+.||.|||..+   |+||||||+|||++.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999999986433   3477888999999999999999977   9999999999999999999999999886

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=2.4e-35  Score=268.98  Aligned_cols=220  Identities=23%  Similarity=0.203  Sum_probs=173.0

Q ss_pred             CCceEEEEEEEc-CCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCCCCchhhhhhhc
Q 015027           98 GGFVSVYKGVLH-DNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCE  176 (414)
Q Consensus        98 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~  176 (414)
                      |.+|.||++.+. +++.+|+|.+.......    .+...+....||||+++++++...+..++||||+++|+|.+++...
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~~~----~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   79 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSEYS----RERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF   79 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhhhh----hHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence            899999999975 58899999997654222    1223344457999999999999999999999999999999998654


Q ss_pred             CCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccccceecccccccc
Q 015027          177 SSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY  256 (414)
Q Consensus       177 ~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y  256 (414)
                      .   .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++++|||.+......     .....++..|
T Consensus        80 ~---~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y  148 (237)
T cd05576          80 L---NIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMY  148 (237)
T ss_pred             c---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCccc
Confidence            3   3578899999999999999999987   999999999999999999999999987655432     1223456789


Q ss_pred             cchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccccCCcccHHHHHHH
Q 015027          257 LDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIV  336 (414)
Q Consensus       257 ~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  336 (414)
                      +|||.+.+..++.++||||+|+++|||++|..|+.......              .. ..    ...++    ...+..+
T Consensus       149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~--------------~~-~~----~~~~~----~~~~~~~  205 (237)
T cd05576         149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI--------------NT-HT----TLNIP----EWVSEEA  205 (237)
T ss_pred             cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc--------------cc-cc----ccCCc----ccCCHHH
Confidence            99999988889999999999999999999998865221100              00 00    00001    1122458


Q ss_pred             HHHHHHhhccCCCCCCChh
Q 015027          337 AELASKCLRIRGTERPTMK  355 (414)
Q Consensus       337 ~~Li~~cl~~dP~~Rps~~  355 (414)
                      .+|+.+||+.||.+||++.
T Consensus       206 ~~li~~~l~~dp~~R~~~~  224 (237)
T cd05576         206 RSLLQQLLQFNPTERLGAG  224 (237)
T ss_pred             HHHHHHHccCCHHHhcCCC
Confidence            9999999999999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=3.3e-35  Score=281.63  Aligned_cols=264  Identities=21%  Similarity=0.215  Sum_probs=184.4

Q ss_pred             CCCCCCccccCCceEEEEEEEc-C--CcEEEEEEeecccch---hHhHHHHHHHHHcc-CCCceeeeeeeEecC----Cc
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLH-D--NIQVAVKTYRRADKI---RITERELLRIISQV-NHKNVVKILGLCLET----EV  156 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~-~--~~~vavK~~~~~~~~---~~~~~~~~~~l~~l-~hpniv~l~~~~~~~----~~  156 (414)
                      +|.+.+.||+|+||.||++... .  +..||+|.+......   ......++.++.++ .||||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4778899999999999999965 3  678999998643211   22334556778877 599999999875432    45


Q ss_pred             ceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccc
Q 015027          157 PLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSV  236 (414)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~  236 (414)
                      .+++++|+. ++|.+.+...   ..+++..+..++.||+.||.|||+.+   ++||||||+|||++.++.+||+|||++.
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~  153 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSG---QPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR  153 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence            688899886 5888887532   33578899999999999999999988   9999999999999999999999999997


Q ss_pred             cccCCccc--cceecccccccccchhhccc-CCCCCcccchhHHHHHHHHHhCCCCCCcccccccccc------ccchhh
Q 015027          237 LISSDAET--AMSTILIGTSGYLDPVCINT-GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKI------SMVPYF  307 (414)
Q Consensus       237 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~------~~~~~~  307 (414)
                      ........  .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........      ...+..
T Consensus       154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  233 (332)
T cd07857         154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET  233 (332)
T ss_pred             ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            65432111  11233578999999998765 5689999999999999999999999874331100000      000000


Q ss_pred             hhhhcccccccc---cc--cccC-CcccHHHHHHHHHHHHHhhccCCCCCCChhHHH
Q 015027          308 LNSIKNNGLRQI---LN--FHVA-DESEMKEIEIVAELASKCLRIRGTERPTMKQVS  358 (414)
Q Consensus       308 ~~~~~~~~~~~~---~~--~~~~-~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~  358 (414)
                      ...+........   ..  +... ..........+.+|+.+||+.+|.+|||+.+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll  290 (332)
T cd07857         234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEAL  290 (332)
T ss_pred             HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence            000000000000   00  0000 000000125689999999999999999999985

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-37  Score=268.33  Aligned_cols=252  Identities=23%  Similarity=0.237  Sum_probs=184.5

Q ss_pred             CCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhHh--H-HHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCC
Q 015027           90 DRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRIT--E-RELLRIISQVNHKNVVKILGLCLETEVPLLVYEFAS  165 (414)
Q Consensus        90 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~--~-~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  165 (414)
                      +-+..||.|+||+|++-..+ .|+..|||.++.......+  . .+.-..++.-+.||||++||.+..++..|+.||+|+
T Consensus        67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd  146 (361)
T KOG1006|consen   67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD  146 (361)
T ss_pred             HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh
Confidence            34567999999999999876 5999999999876542222  1 222234556679999999999999999999999996


Q ss_pred             CCchhhhhhh--cCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcc
Q 015027          166 NGTLLDHIRC--ESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE  243 (414)
Q Consensus       166 ~gsL~~~l~~--~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  243 (414)
                      - ||..+...  ...+..+++...-.|....+.||.||...  .+|||||+||+|||++..|.+||||||++..+...  
T Consensus       147 ~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S--  221 (361)
T KOG1006|consen  147 I-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS--  221 (361)
T ss_pred             h-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHHH--
Confidence            4 65443321  11233457777778888899999999873  45999999999999999999999999999876533  


Q ss_pred             ccceecccccccccchhhccc--CCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccc
Q 015027          244 TAMSTILIGTSGYLDPVCINT--GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILN  321 (414)
Q Consensus       244 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (414)
                       -..+.-.|-..|||||.+..  ..|+-+|||||||++|||+.||..||.....--        ..+..+..+....+..
T Consensus       222 -iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svf--------eql~~Vv~gdpp~l~~  292 (361)
T KOG1006|consen  222 -IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVF--------EQLCQVVIGDPPILLF  292 (361)
T ss_pred             -HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHH--------HHHHHHHcCCCCeecC
Confidence             22344577888999999853  358999999999999999999999987443210        0111122222222211


Q ss_pred             cccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          322 FHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       322 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ..    .....+..+..++.-||.+|-+.||+..++.+
T Consensus       293 ~~----~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  293 DK----ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             cc----cccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence            11    11234466999999999999999999998854

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-35  Score=243.00  Aligned_cols=262  Identities=19%  Similarity=0.249  Sum_probs=191.6

Q ss_pred             CCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc---hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEe
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK---IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  163 (414)
                      +|...++||+|.||+||+|+.. ++..||+|.++.++.   ......+++-+++.+.|.|||++++....++..-+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            5667788999999999999955 588899999986543   334557777899999999999999999999999999999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcc
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE  243 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  243 (414)
                      |+. .|..+......  .++.+.+.+++.|+++||.|+|+++   +.|||+||.|.||+.+|.+||+|||+++.+.-+. 
T Consensus        83 cdq-dlkkyfdslng--~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipv-  155 (292)
T KOG0662|consen   83 CDQ-DLKKYFDSLNG--DLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPV-  155 (292)
T ss_pred             hhH-HHHHHHHhcCC--cCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCce-
Confidence            965 77776654333  3377888999999999999999988   9999999999999999999999999999876542 


Q ss_pred             ccceecccccccccchhhcccCC-CCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhccccccc---
Q 015027          244 TAMSTILIGTSGYLDPVCINTGK-LTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQ---  318 (414)
Q Consensus       244 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  318 (414)
                       ...+..+-|.+|.+|.++.|.+ |+...|+||-|||+.|+.. |++-|.+.+....-...  -+.+.....+.+..   
T Consensus       156 -rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkri--f~~lg~p~ed~wps~t~  232 (292)
T KOG0662|consen  156 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRI--FRLLGTPTEDQWPSMTK  232 (292)
T ss_pred             -EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHH--HHHhCCCccccCCcccc
Confidence             2234456789999999987754 8899999999999999988 66656543322110000  00000111111111   


Q ss_pred             cccccc-----CCcccHHHHH----HHHHHHHHhhccCCCCCCChhHHHH
Q 015027          319 ILNFHV-----ADESEMKEIE----IVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       319 ~~~~~~-----~~~~~~~~~~----~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      +-+...     ......+..+    .=.+|+.+.|.-+|.+|.+++..++
T Consensus       233 lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  233 LPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             CCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            111110     1111112222    2358999999999999999988754

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-35  Score=297.17  Aligned_cols=260  Identities=25%  Similarity=0.379  Sum_probs=199.2

Q ss_pred             HhcCCCCCCccccCCceEEEEEEEcC--------CcEEEEEEeecccch--hHhHHHHHHHHHcc-CCCceeeeeeeEec
Q 015027           85 ATKNFDRSRCLSQGGFVSVYKGVLHD--------NIQVAVKTYRRADKI--RITERELLRIISQV-NHKNVVKILGLCLE  153 (414)
Q Consensus        85 ~~~~~~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~--~~~~~~~~~~l~~l-~hpniv~l~~~~~~  153 (414)
                      ..++..+.+.||+|.||.|++|....        ...||||.++.....  ......++.+|+.+ .||||+.++|+|..
T Consensus       294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~  373 (609)
T KOG0200|consen  294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ  373 (609)
T ss_pred             chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence            34455666799999999999998531        346999999865443  33346667778777 59999999999999


Q ss_pred             CCcceEEEEeCCCCchhhhhhhcC------Cc-------ccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCcee
Q 015027          154 TEVPLLVYEFASNGTLLDHIRCES------SQ-------VLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANIL  220 (414)
Q Consensus       154 ~~~~~lv~e~~~~gsL~~~l~~~~------~~-------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIl  220 (414)
                      .+..++|+||+..|+|.++++...      ..       ..++....+.++.||+.|++||++..   ++||||-+.|||
T Consensus       374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVL  450 (609)
T KOG0200|consen  374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVL  450 (609)
T ss_pred             CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEE
Confidence            999999999999999999997655      00       13678889999999999999999977   999999999999


Q ss_pred             eCCCCcEEEeeccccccccCCccccce-ecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccc
Q 015027          221 LNDNYTAKVADFESSVLISSDAETAMS-TILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASN  298 (414)
Q Consensus       221 l~~~~~~kl~DfGla~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~  298 (414)
                      +..+..+||+|||+|+........... +...-...|||||.+....|+.++|||||||+||||++ |..||.+....  
T Consensus       451 i~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~--  528 (609)
T KOG0200|consen  451 ITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT--  528 (609)
T ss_pred             ecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH--
Confidence            999999999999999865543332211 11012346999999999999999999999999999999 88998642100  


Q ss_pred             cccccchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHH
Q 015027          299 KKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL  364 (414)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i  364 (414)
                            +.+......+         .....+.....++.+++..||+.+|++||++.++.+.++..
T Consensus       529 ------~~l~~~l~~G---------~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  529 ------EELLEFLKEG---------NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             ------HHHHHHHhcC---------CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence                  1111111111         11111112235688999999999999999999999999984

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=9e-36  Score=280.26  Aligned_cols=249  Identities=21%  Similarity=0.279  Sum_probs=196.9

Q ss_pred             hcCCCC--CCccccCCceEEEEEEEc-CCcEEEEEEeecccc---hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceE
Q 015027           86 TKNFDR--SRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK---IRITERELLRIISQVNHKNVVKILGLCLETEVPLL  159 (414)
Q Consensus        86 ~~~~~~--~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~l  159 (414)
                      ..-|++  .+.||.|-||+||-|... +|+.||||++.+..-   .....+.++.+|+++.||.||.+...|+..+..++
T Consensus       561 stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFV  640 (888)
T KOG4236|consen  561 STVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFV  640 (888)
T ss_pred             HHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEE
Confidence            344544  478999999999999954 799999999976543   23344777899999999999999999999999999


Q ss_pred             EEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCC---CCcEEEeeccccc
Q 015027          160 VYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLND---NYTAKVADFESSV  236 (414)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~DfGla~  236 (414)
                      |||-+.|.-|.-.|....+  .+++..-.-++.||+.||.|||..+   |+|+||||+|||+.+   -..+||||||+|+
T Consensus       641 VMEKl~GDMLEMILSsEkg--RL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfAR  715 (888)
T KOG4236|consen  641 VMEKLHGDMLEMILSSEKG--RLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFAR  715 (888)
T ss_pred             EehhhcchHHHHHHHhhcc--cchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeecccccee
Confidence            9999976555544443333  3366666678899999999999977   999999999999964   4689999999999


Q ss_pred             cccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccc
Q 015027          237 LISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGL  316 (414)
Q Consensus       237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (414)
                      .....   .....++|||.|+|||+++.+.|+..-|+||.|||+|--++|..||...+..           ..++.... 
T Consensus       716 iIgEk---sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI-----------ndQIQNAa-  780 (888)
T KOG4236|consen  716 IIGEK---SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI-----------NDQIQNAA-  780 (888)
T ss_pred             ecchh---hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccch-----------hHHhhccc-
Confidence            98743   3456679999999999999999999999999999999999999999632211           11111111 


Q ss_pred             ccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          317 RQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                           ...+...+.+.+....+||..+|+..-.+|-|..+.+.
T Consensus       781 -----FMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls  818 (888)
T KOG4236|consen  781 -----FMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS  818 (888)
T ss_pred             -----cccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence                 12334455566678999999999999999999877643

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=7.8e-35  Score=295.09  Aligned_cols=263  Identities=19%  Similarity=0.234  Sum_probs=168.8

Q ss_pred             HhcCCCCCCccccCCceEEEEEEEc-C----CcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeee------Eec
Q 015027           85 ATKNFDRSRCLSQGGFVSVYKGVLH-D----NIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGL------CLE  153 (414)
Q Consensus        85 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~------~~~  153 (414)
                      ..++|.+.+.||+|+||.||+|.+. +    +..||||.+...........   ..+....+.++..++..      +..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~---e~l~~~~~~~~~~~~~~~~~~~~~~~  206 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMN---ERVRRACPNSCADFVYGFLEPVSSKK  206 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHH---HHHHhhchhhHHHHHHhhhccccccc
Confidence            4678999999999999999999975 4    68899998764332211111   12222223333333222      235


Q ss_pred             CCcceEEEEeCCCCchhhhhhhcCCcc-----------------cCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCC
Q 015027          154 TEVPLLVYEFASNGTLLDHIRCESSQV-----------------LKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKS  216 (414)
Q Consensus       154 ~~~~~lv~e~~~~gsL~~~l~~~~~~~-----------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp  216 (414)
                      +...++||||+++++|.+++.......                 ......+..++.||+.||.|||+.+   |+||||||
T Consensus       207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLKP  283 (566)
T PLN03225        207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKP  283 (566)
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCCH
Confidence            567899999999999999886432110                 1112345679999999999999987   99999999


Q ss_pred             CceeeCC-CCcEEEeeccccccccCCccccceecccccccccchhhcccC----------------------CCCCcccc
Q 015027          217 ANILLND-NYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTG----------------------KLTKKSDV  273 (414)
Q Consensus       217 ~NIll~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~Dv  273 (414)
                      +|||++. ++.+||+|||+|..+.... ........+|+.|+|||.+...                      .++.++||
T Consensus       284 ~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV  362 (566)
T PLN03225        284 QNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI  362 (566)
T ss_pred             HHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence            9999985 6899999999998654332 1223456789999999965322                      24456799


Q ss_pred             hhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccccCCc------ccHHHHHHHHHHHHHhhccC
Q 015027          274 YSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADE------SEMKEIEIVAELASKCLRIR  347 (414)
Q Consensus       274 ~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~Li~~cl~~d  347 (414)
                      |||||+||||+++..|+......-.........-...     +.....+.....      ..........+|+.+||+.|
T Consensus       363 wSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d  437 (566)
T PLN03225        363 YSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVA-----WRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFK  437 (566)
T ss_pred             HHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHH-----HHHhhccccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence            9999999999998776542110000000000000000     000000000000      00000123568999999999


Q ss_pred             CCCCCChhHHHH
Q 015027          348 GTERPTMKQVSE  359 (414)
Q Consensus       348 P~~Rps~~~v~~  359 (414)
                      |++|||+.++++
T Consensus       438 P~kR~ta~e~L~  449 (566)
T PLN03225        438 GRQRISAKAALA  449 (566)
T ss_pred             cccCCCHHHHhC
Confidence            999999999965

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-36  Score=280.29  Aligned_cols=241  Identities=24%  Similarity=0.270  Sum_probs=194.3

Q ss_pred             cCCCCCCccccCCceEEEEEEEcCCc-EEEEEEeecccch----hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLHDNI-QVAVKTYRRADKI----RITERELLRIISQVNHKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~~~~-~vavK~~~~~~~~----~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~  161 (414)
                      .+++++..||-|+||.|-++..+... .+|+|++++..-.    ......+-++|..++.|.||++|..|.+++.+|++|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            45677888999999999999876543 4899988765322    222245567888899999999999999999999999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCC
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD  241 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  241 (414)
                      |-|-||.|...++..+..   +..+..-++..+++|+.|||+.+   ||+|||||+|.++|.+|-+||.|||+|+.+...
T Consensus       500 EaClGGElWTiLrdRg~F---dd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g  573 (732)
T KOG0614|consen  500 EACLGGELWTILRDRGSF---DDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG  573 (732)
T ss_pred             HhhcCchhhhhhhhcCCc---ccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence            999999999999876654   55667778899999999999988   999999999999999999999999999998755


Q ss_pred             ccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccc
Q 015027          242 AETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILN  321 (414)
Q Consensus       242 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (414)
                      .   ...+++|||.|.|||++.+...+.++|.||||+++|||++|.+||++.+...       -  .+.+-. ++.    
T Consensus       574 ~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmk-------t--Yn~ILk-Gid----  636 (732)
T KOG0614|consen  574 R---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMK-------T--YNLILK-GID----  636 (732)
T ss_pred             C---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHH-------H--HHHHHh-hhh----
Confidence            3   3467899999999999999999999999999999999999999998654221       0  111111 111    


Q ss_pred             cccCCcccHHHHHHHHHHHHHhhccCCCCCCC
Q 015027          322 FHVADESEMKEIEIVAELASKCLRIRGTERPT  353 (414)
Q Consensus       322 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps  353 (414)
                         ....+....+...+|+.+++..+|.+|..
T Consensus       637 ---~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  637 ---KIEFPRRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             ---hhhcccccchhHHHHHHHHHhcCcHhhhc
Confidence               11122233355889999999999999976

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-34  Score=258.59  Aligned_cols=250  Identities=19%  Similarity=0.269  Sum_probs=189.5

Q ss_pred             HhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc-----hhHhHHHHHHHHHccCCCceeeeeeeEecCCcce
Q 015027           85 ATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK-----IRITERELLRIISQVNHKNVVKILGLCLETEVPL  158 (414)
Q Consensus        85 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~  158 (414)
                      ..++|+++++||+|+|+.|..+++. +.+.+|+|+++++-.     .....-+--..-+.-+||.+|-++.+|..+..++
T Consensus       248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf  327 (593)
T KOG0695|consen  248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF  327 (593)
T ss_pred             ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence            3468999999999999999999965 578899999876421     1111111111223457999999999999999999


Q ss_pred             EEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccc
Q 015027          159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLI  238 (414)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~  238 (414)
                      +|.||++||+|.-++..+   ..++++.++-+...|+-||.|||+.|   ||.||||.+|+|+|..|++||+|||+++.-
T Consensus       328 fvieyv~ggdlmfhmqrq---rklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~  401 (593)
T KOG0695|consen  328 FVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG  401 (593)
T ss_pred             EEEEEecCcceeeehhhh---hcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcC
Confidence            999999999998887543   34478888889999999999999988   999999999999999999999999998754


Q ss_pred             cCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccc
Q 015027          239 SSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQ  318 (414)
Q Consensus       239 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (414)
                      -.+  ....++++|||.|.|||+++|..|...+|.|+|||+++||+.|+.||+...... ...+--.+..+.+-....+ 
T Consensus       402 l~~--gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n-~d~ntedylfqvilekqir-  477 (593)
T KOG0695|consen  402 LGP--GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDN-PDMNTEDYLFQVILEKQIR-  477 (593)
T ss_pred             CCC--CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCC-cccchhHHHHHHHhhhccc-
Confidence            332  234567899999999999999999999999999999999999999997543221 1112222222222111111 


Q ss_pred             ccccccCCcccHHHHHHHHHHHHHhhccCCCCCCC
Q 015027          319 ILNFHVADESEMKEIEIVAELASKCLRIRGTERPT  353 (414)
Q Consensus       319 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps  353 (414)
                           ++...+    -....++...|.+||.+|..
T Consensus       478 -----iprsls----vkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  478 -----IPRSLS----VKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             -----ccceee----hhhHHHHHHhhcCCcHHhcC
Confidence                 111111    12567888999999999965

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.9e-34  Score=274.33  Aligned_cols=203  Identities=22%  Similarity=0.314  Sum_probs=168.4

Q ss_pred             CCCCCCccccCCceEEEEEEE-cCCcEEEEEEeecccchhHh----HHHHHHHHHccCCCceeeeeeeEecCCcceEEEE
Q 015027           88 NFDRSRCLSQGGFVSVYKGVL-HDNIQVAVKTYRRADKIRIT----ERELLRIISQVNHKNVVKILGLCLETEVPLLVYE  162 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~----~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  162 (414)
                      -|..++.||-|+||.|.+++- ++...+|.|.+.+.+.....    ...|..||..-+.+-||+||-.|.+++.+|+|||
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd  709 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD  709 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence            467788899999999999984 45677999999876543222    2445578999999999999999999999999999


Q ss_pred             eCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccC--
Q 015027          163 FASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISS--  240 (414)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~--  240 (414)
                      |++||++..+|...+   .+.+..++-++.+++.|+++.|..|   +|||||||+|||||.+|++||+||||+.-+.-  
T Consensus       710 YIPGGDmMSLLIrmg---IFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH  783 (1034)
T KOG0608|consen  710 YIPGGDMMSLLIRMG---IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  783 (1034)
T ss_pred             ccCCccHHHHHHHhc---cCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceecc
Confidence            999999999886544   3467788888999999999999999   99999999999999999999999999863221  


Q ss_pred             -------Ccc-------------------------------ccceecccccccccchhhcccCCCCCcccchhHHHHHHH
Q 015027          241 -------DAE-------------------------------TAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAE  282 (414)
Q Consensus       241 -------~~~-------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~e  282 (414)
                             ...                               .......+||+.|+|||++....|+..+|+||.||||||
T Consensus       784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e  863 (1034)
T KOG0608|consen  784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE  863 (1034)
T ss_pred             ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence                   000                               000123579999999999999999999999999999999


Q ss_pred             HHhCCCCCCccccc
Q 015027          283 LLTGKKPGSCMTLA  296 (414)
Q Consensus       283 l~tg~~p~~~~~~~  296 (414)
                      |+.|++||-..+..
T Consensus       864 m~~g~~pf~~~tp~  877 (1034)
T KOG0608|consen  864 MLVGQPPFLADTPG  877 (1034)
T ss_pred             HhhCCCCccCCCCC
Confidence            99999999755443

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=2.3e-33  Score=255.17  Aligned_cols=237  Identities=27%  Similarity=0.344  Sum_probs=187.5

Q ss_pred             CceEEEEEEEcC-CcEEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCCCCchhhhhhh
Q 015027           99 GFVSVYKGVLHD-NIQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRC  175 (414)
Q Consensus        99 ~~g~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~  175 (414)
                      +||.||+|.... +..+++|++......  ......+++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            589999999764 899999999765443  34556677889999999999999999999999999999999999999865


Q ss_pred             cCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccccceeccccccc
Q 015027          176 ESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG  255 (414)
Q Consensus       176 ~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~  255 (414)
                      ...   .++..++.++.+++.++.+||+.+   ++|+||+|+||+++.++.++|+|||.+.......   ......++..
T Consensus        81 ~~~---~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~  151 (244)
T smart00220       81 RGR---LSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE  151 (244)
T ss_pred             ccC---CCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence            433   578899999999999999999987   9999999999999999999999999998765432   2334567889


Q ss_pred             ccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccccCCcccHHHHHH
Q 015027          256 YLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEI  335 (414)
Q Consensus       256 y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (414)
                      |++||.+.+..++.++||||||+++|+|++|..||.......        ............ .....      ...+..
T Consensus       152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~--------~~~~~~~~~~~~-~~~~~------~~~~~~  216 (244)
T smart00220      152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL--------ELFKKIGKPKPP-FPPPE------WKISPE  216 (244)
T ss_pred             CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH--------HHHHHHhccCCC-Ccccc------ccCCHH
Confidence            999999998889999999999999999999999986421110        001111110000 00000      002245


Q ss_pred             HHHHHHHhhccCCCCCCChhHHHH
Q 015027          336 VAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       336 l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      +.+++.+||..+|.+||++.++++
T Consensus       217 ~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      217 AKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHHHHccCCchhccCHHHHhh
Confidence            899999999999999999999965

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-35  Score=255.72  Aligned_cols=268  Identities=21%  Similarity=0.264  Sum_probs=192.0

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeec---ccchhHhHHHHHHHHHccCCCceeeeeeeEecC-------
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRR---ADKIRITERELLRIISQVNHKNVVKILGLCLET-------  154 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~-------  154 (414)
                      .+.|....++|+|.||.||+|+.+ +|+.||+|++-.   .......+.+++++|..+.|+|++.+++.|...       
T Consensus        16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~   95 (376)
T KOG0669|consen   16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD   95 (376)
T ss_pred             chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence            345677788999999999999965 588899987644   334456677888999999999999999988532       


Q ss_pred             -CcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecc
Q 015027          155 -EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFE  233 (414)
Q Consensus       155 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG  233 (414)
                       ...|+||++|+. +|.-+|....  ..++..++.+++.++..||.|+|.+.   |+|||+||.|+||+.+|.+||+|||
T Consensus        96 r~t~ylVf~~ceh-DLaGlLsn~~--vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFG  169 (376)
T KOG0669|consen   96 RATFYLVFDFCEH-DLAGLLSNRK--VRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFG  169 (376)
T ss_pred             cceeeeeHHHhhh-hHHHHhcCcc--ccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccc
Confidence             347999999976 7777774332  33467889999999999999999977   9999999999999999999999999


Q ss_pred             ccccccCCccc--cceecccccccccchhhccc-CCCCCcccchhHHHHHHHHHhCCCCCCcccccccc------ccccc
Q 015027          234 SSVLISSDAET--AMSTILIGTSGYLDPVCINT-GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNK------KISMV  304 (414)
Q Consensus       234 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~------~~~~~  304 (414)
                      +++.+......  ...++.+-|.+|++||.+.| ..|+++.|||.-|||+.||.||.+-+++.+....-      -.+..
T Consensus       170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t  249 (376)
T KOG0669|consen  170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT  249 (376)
T ss_pred             cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence            99766543221  22345667999999999876 57999999999999999999999887653311100      00111


Q ss_pred             hhhhhhhcccccccccc-cccCCcccH---HH------HHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          305 PYFLNSIKNNGLRQILN-FHVADESEM---KE------IEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       305 ~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~------~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      +..++.+..-.+.+.+. +.++...-.   ..      -....+|+.++|..||.+||.+.+++.
T Consensus       250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln  314 (376)
T KOG0669|consen  250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN  314 (376)
T ss_pred             cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence            11111111111111110 000000000   00      035789999999999999999998864

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=4.1e-33  Score=276.14  Aligned_cols=265  Identities=18%  Similarity=0.204  Sum_probs=176.7

Q ss_pred             HhcCCCCCCccccCCceEEEEEEE-----------------cCCcEEEEEEeecccchh---------------HhHHHH
Q 015027           85 ATKNFDRSRCLSQGGFVSVYKGVL-----------------HDNIQVAVKTYRRADKIR---------------ITEREL  132 (414)
Q Consensus        85 ~~~~~~~~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~---------------~~~~~~  132 (414)
                      ..++|.+.++||+|+||.||+|.+                 ..++.||||.+.......               +....+
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            467899999999999999999964                 235679999986543211               111223


Q ss_pred             HHHHHccCCCce-----eeeeeeEec--------CCcceEEEEeCCCCchhhhhhhcCC---------------------
Q 015027          133 LRIISQVNHKNV-----VKILGLCLE--------TEVPLLVYEFASNGTLLDHIRCESS---------------------  178 (414)
Q Consensus       133 ~~~l~~l~hpni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~---------------------  178 (414)
                      +.++.+++|.++     ++++++|..        .+..++||||+++++|.+++.....                     
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            355666666554     667777653        3467999999999999998864211                     


Q ss_pred             cccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccccceecccccccccc
Q 015027          179 QVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLD  258 (414)
Q Consensus       179 ~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a  258 (414)
                      ....++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++......... ......+|+.|+|
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~a  378 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSP  378 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeC
Confidence            112356778899999999999999987   999999999999999999999999999765432111 1122345789999


Q ss_pred             hhhcccCCC----------------------CCcccchhHHHHHHHHHhCCC-CCCccccccccccccchhhhhhhcccc
Q 015027          259 PVCINTGKL----------------------TKKSDVYSFGVVLAELLTGKK-PGSCMTLASNKKISMVPYFLNSIKNNG  315 (414)
Q Consensus       259 PE~~~~~~~----------------------~~~~Dv~SlGvil~el~tg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (414)
                      ||.+.....                      ..+.||||+||++|+|++|.. ||.......... .........+..  
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~-~~~~~~~~~~r~--  455 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTEL-RQYDNDLNRWRM--  455 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHH-hhccchHHHHHh--
Confidence            998754321                      134799999999999999875 665322111100 000000011100  


Q ss_pred             cccccccccCCcccHHHHHHHHHHHHHhhccCC---CCCCChhHHHH
Q 015027          316 LRQILNFHVADESEMKEIEIVAELASKCLRIRG---TERPTMKQVSE  359 (414)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP---~~Rps~~~v~~  359 (414)
                         ...................+|+.+||..+|   .+|+|+.++++
T Consensus       456 ---~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        456 ---YKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             ---hcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence               000000111111223568999999999866   68999999854

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-33  Score=255.26  Aligned_cols=265  Identities=22%  Similarity=0.306  Sum_probs=203.5

Q ss_pred             HHHHHhcCCCCCCccccCCceEEEEEEEc------CCcEEEEEEeecccchhH--hHHHHHHHHHccCCCceeeeeeeEe
Q 015027           81 EMIRATKNFDRSRCLSQGGFVSVYKGVLH------DNIQVAVKTYRRADKIRI--TERELLRIISQVNHKNVVKILGLCL  152 (414)
Q Consensus        81 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~--~~~~~~~~l~~l~hpniv~l~~~~~  152 (414)
                      ++.....+++....+-+|.||.||.|.+.      +.+.|.+|.++.....-+  ....+.-++..+.|||+..+.+++.
T Consensus       278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~i  357 (563)
T KOG1024|consen  278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSI  357 (563)
T ss_pred             hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence            33344567888888999999999999654      345577777765432211  1233334566678999999999885


Q ss_pred             c-CCcceEEEEeCCCCchhhhhh-----hcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCc
Q 015027          153 E-TEVPLLVYEFASNGTLLDHIR-----CESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYT  226 (414)
Q Consensus       153 ~-~~~~~lv~e~~~~gsL~~~l~-----~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~  226 (414)
                      + ...+++++.++.-|+|..++.     ........+-.+...++.|++.|++|||.++   |||.||...|++||+...
T Consensus       358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~Lq  434 (563)
T KOG1024|consen  358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQ  434 (563)
T ss_pred             eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhhee
Confidence            4 567899999999999999997     2223334456677889999999999999988   999999999999999999


Q ss_pred             EEEeeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccch
Q 015027          227 AKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVP  305 (414)
Q Consensus       227 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~  305 (414)
                      +||+|=.+++.+.................||+||.+....|+..+|||||||+||||+| |+.||...+..+        
T Consensus       435 VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE--------  506 (563)
T KOG1024|consen  435 VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE--------  506 (563)
T ss_pred             EEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH--------
Confidence            99999999998776656555555666778999999999999999999999999999999 999987443222        


Q ss_pred             hhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHH
Q 015027          306 YFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR  366 (414)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~  366 (414)
                        ...+-.++.+..-        +...+.+|..++.-||...|++||+++|+...|.++..
T Consensus       507 --m~~ylkdGyRlaQ--------P~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~  557 (563)
T KOG1024|consen  507 --MEHYLKDGYRLAQ--------PFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHT  557 (563)
T ss_pred             --HHHHHhccceecC--------CCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence              1112222222222        22233559999999999999999999999999988753

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.98  E-value=5.1e-33  Score=233.66  Aligned_cols=205  Identities=24%  Similarity=0.261  Sum_probs=159.5

Q ss_pred             HHHHhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhHhH--HHHHH-HHHccCCCceeeeeeeEecCCcc
Q 015027           82 MIRATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRITE--RELLR-IISQVNHKNVVKILGLCLETEVP  157 (414)
Q Consensus        82 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~--~~~~~-~l~~l~hpniv~l~~~~~~~~~~  157 (414)
                      +....+....+..||+|++|.|-+-++. +|+..|+|.+...-......  ..++. .++...+|++|.+||.+......
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv  120 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV  120 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence            3344455566788999999999888854 69999999987654333222  22222 34455799999999999999999


Q ss_pred             eEEEEeCCCCchhhhhhh-cCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccc
Q 015027          158 LLVYEFASNGTLLDHIRC-ESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSV  236 (414)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~  236 (414)
                      ++.||.|+- ||..+-.. -......++..+-+|+..|..||.|||+.-  .+||||+||+||||+.+|+||+||||++.
T Consensus       121 wIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG  197 (282)
T KOG0984|consen  121 WICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISG  197 (282)
T ss_pred             EEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccce
Confidence            999999964 77654422 122334477888899999999999999854  59999999999999999999999999998


Q ss_pred             cccCCccccceecccccccccchhhccc----CCCCCcccchhHHHHHHHHHhCCCCCCc
Q 015027          237 LISSDAETAMSTILIGTSGYLDPVCINT----GKLTKKSDVYSFGVVLAELLTGKKPGSC  292 (414)
Q Consensus       237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~SlGvil~el~tg~~p~~~  292 (414)
                      .+....   ..+...|-..|||||.+..    ..|+-++||||||+++.||.+++.||..
T Consensus       198 ~L~dSi---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~  254 (282)
T KOG0984|consen  198 YLVDSI---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES  254 (282)
T ss_pred             eehhhh---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence            775432   2233467778999998843    3789999999999999999999999874

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.98  E-value=4.6e-33  Score=275.11  Aligned_cols=243  Identities=24%  Similarity=0.309  Sum_probs=179.9

Q ss_pred             CCccccCCceE-EEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHcc-CCCceeeeeeeEecCCcceEEEEeCCCCch
Q 015027           92 SRCLSQGGFVS-VYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQV-NHKNVVKILGLCLETEVPLLVYEFASNGTL  169 (414)
Q Consensus        92 ~~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~gsL  169 (414)
                      .+.+|.|+.|+ ||+|.. +|+.||||++-.+..  ....+|+..|+.- .|||||++++.-.+....||..|.|. .+|
T Consensus       514 ~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~~--~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~sL  589 (903)
T KOG1027|consen  514 KEILGYGSNGTVVFRGVY-EGREVAVKRLLEEFF--DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-CSL  589 (903)
T ss_pred             HHHcccCCCCcEEEEEee-CCceehHHHHhhHhH--HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-hhH
Confidence            45578898876 699998 788999998755432  1224445655554 69999999999999999999999995 499


Q ss_pred             hhhhhhcCCcc-cCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCC-----CCcEEEeeccccccccCCcc
Q 015027          170 LDHIRCESSQV-LKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLND-----NYTAKVADFESSVLISSDAE  243 (414)
Q Consensus       170 ~~~l~~~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~-----~~~~kl~DfGla~~~~~~~~  243 (414)
                      .|++....... .......+.++.|+++||++||+.+   |+||||||.||||+.     ...++|+|||+++.+..+..
T Consensus       590 ~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~s  666 (903)
T KOG1027|consen  590 QDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKS  666 (903)
T ss_pred             HHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccCCCcc
Confidence            99997631111 1111334678999999999999987   999999999999975     35789999999998876533


Q ss_pred             cc-ceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhC-CCCCCccccccccccccchhhhhhhcccccccccc
Q 015027          244 TA-MSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTG-KKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILN  321 (414)
Q Consensus       244 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (414)
                      .- ......||.+|+|||++....-+.++||||||||+|+.++| ..||......+          .+.........   
T Consensus       667 S~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~----------~NIl~~~~~L~---  733 (903)
T KOG1027|consen  667 SFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ----------ANILTGNYTLV---  733 (903)
T ss_pred             hhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh----------hhhhcCcccee---
Confidence            22 23456899999999999998889999999999999999996 89997432111          01111110000   


Q ss_pred             cccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          322 FHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       322 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                       .+......    +..+||.+|++++|..||++.+|+.
T Consensus       734 -~L~~~~d~----eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  734 -HLEPLPDC----EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             -eeccCchH----HHHHHHHHhcCCCcccCCCHHHHhC
Confidence             00111100    5899999999999999999999963

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.97  E-value=2.7e-32  Score=256.57  Aligned_cols=204  Identities=23%  Similarity=0.241  Sum_probs=177.0

Q ss_pred             HHHhcCCCCCCccccCCceEEEEEEEcC-CcEEEEEEeecccchhHhHHHHHHHHHccCC------CceeeeeeeEecCC
Q 015027           83 IRATKNFDRSRCLSQGGFVSVYKGVLHD-NIQVAVKTYRRADKIRITERELLRIISQVNH------KNVVKILGLCLETE  155 (414)
Q Consensus        83 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h------pniv~l~~~~~~~~  155 (414)
                      +....+|.+....|+|-|++|..|.+.. |+.||||++........+-..++++|.+|+.      -|+++++-.|...+
T Consensus       428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn  507 (752)
T KOG0670|consen  428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN  507 (752)
T ss_pred             hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence            3456789999999999999999999764 8899999999888777777777888888852      48999999999999


Q ss_pred             cceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCC-CcEEEeeccc
Q 015027          156 VPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDN-YTAKVADFES  234 (414)
Q Consensus       156 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~DfGl  234 (414)
                      ++|||+|-+ ..+|.+.|...+....+....+..++.|+.-||..|...+   |+|.||||+|||++++ ..+||||||.
T Consensus       508 HLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGS  583 (752)
T KOG0670|consen  508 HLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGS  583 (752)
T ss_pred             eeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCcc
Confidence            999999988 4589999988888888888999999999999999999988   9999999999999864 6789999999


Q ss_pred             cccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccc
Q 015027          235 SVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMT  294 (414)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~  294 (414)
                      |.......    .+.+.-+..|.|||++.|-+|+...|+||.||+||||.||+..|.+.+
T Consensus       584 A~~~~ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~T  639 (752)
T KOG0670|consen  584 ASFASENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRT  639 (752)
T ss_pred             cccccccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCC
Confidence            98775432    233445667999999999999999999999999999999999887644

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=1.6e-32  Score=265.06  Aligned_cols=252  Identities=24%  Similarity=0.340  Sum_probs=196.7

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhH-hHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEe
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRI-TERELLRIISQVNHKNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  163 (414)
                      ..+|+.+..+|.|+||.||++++. .+...|+|+++....... ....++-+++..+|||||.++|.+......+++|||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            367899999999999999999976 589999999987644332 224455678889999999999999999999999999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcc
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE  243 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  243 (414)
                      |.+|+|.+.-+.   ..++++-++..+++..++|+.|||+.+   -+|||||-.|||+++.|.+|++|||.+-.+...  
T Consensus        94 cgggslQdiy~~---TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat--  165 (829)
T KOG0576|consen   94 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT--  165 (829)
T ss_pred             cCCCcccceeee---cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh--
Confidence            999999987653   344578889999999999999999988   799999999999999999999999998776543  


Q ss_pred             ccceecccccccccchhhc---ccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccc
Q 015027          244 TAMSTILIGTSGYLDPVCI---NTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQIL  320 (414)
Q Consensus       244 ~~~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (414)
                      -.....+.||+.|||||+.   ..+.|...+|||++|++..|+-.-++|.-..-       .+...++  +....++   
T Consensus       166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlh-------pmr~l~L--mTkS~~q---  233 (829)
T KOG0576|consen  166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLH-------PMRALFL--MTKSGFQ---  233 (829)
T ss_pred             hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccc-------hHHHHHH--hhccCCC---
Confidence            2234567999999999986   46789999999999999999988777732110       0111111  1111111   


Q ss_pred             ccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          321 NFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       321 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      .+.+.  ......+.+.+|++.||.++|++|||++.++.
T Consensus       234 pp~lk--Dk~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  234 PPTLK--DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             CCccc--CCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            11111  12233466999999999999999999987754

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=6.2e-30  Score=226.91  Aligned_cols=209  Identities=33%  Similarity=0.504  Sum_probs=179.2

Q ss_pred             cccCCceEEEEEEEcC-CcEEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCCCCchhh
Q 015027           95 LSQGGFVSVYKGVLHD-NIQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLD  171 (414)
Q Consensus        95 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~  171 (414)
                      ||+|++|.||++.... +..+++|++......  ......+++.++.+.|++++++++++......+++|||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999764 899999999876542  3445666789999999999999999999899999999999999999


Q ss_pred             hhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCC-CCcEEEeeccccccccCCccccceecc
Q 015027          172 HIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLND-NYTAKVADFESSVLISSDAETAMSTIL  250 (414)
Q Consensus       172 ~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~DfGla~~~~~~~~~~~~~~~  250 (414)
                      ++....  ...++..+..++.+++.++.+||+.+   ++|+||+|.||+++. ++.++|+|||.+........  .....
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~  153 (215)
T cd00180          81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI  153 (215)
T ss_pred             HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence            986542  23578899999999999999999987   999999999999999 89999999999876654321  12334


Q ss_pred             cccccccchhhcccC-CCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccccCCccc
Q 015027          251 IGTSGYLDPVCINTG-KLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESE  329 (414)
Q Consensus       251 ~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (414)
                      .+...|++||.+... .++.++|+|++|+++++|                                              
T Consensus       154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------  187 (215)
T cd00180         154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------  187 (215)
T ss_pred             cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence            577889999999877 888999999999999999                                              


Q ss_pred             HHHHHHHHHHHHHhhccCCCCCCChhHHHHH
Q 015027          330 MKEIEIVAELASKCLRIRGTERPTMKQVSEE  360 (414)
Q Consensus       330 ~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~  360 (414)
                          ..+.+++.+|++.+|.+||++.++++.
T Consensus       188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 ----PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             ----HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence                228899999999999999999998754

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.3e-30  Score=242.26  Aligned_cols=131  Identities=26%  Similarity=0.359  Sum_probs=111.3

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhHhHHHHHHHHHccC-----C---CceeeeeeeEec----
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRITERELLRIISQVN-----H---KNVVKILGLCLE----  153 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~-----h---pniv~l~~~~~~----  153 (414)
                      .+|.+.++||-|.|++||++.+. +.+.||+|+.+......+....++++|++++     |   .+||+|++.|..    
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpN  157 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPN  157 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCC
Confidence            67889999999999999999975 5788999999988877777777888888763     3   369999999964    


Q ss_pred             CCcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceee
Q 015027          154 TEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILL  221 (414)
Q Consensus       154 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll  221 (414)
                      +.++++|+|++ |.+|..+|.....+. ++...+..|+.||+.||.|||..+  +|||-||||+|||+
T Consensus       158 G~HVCMVfEvL-GdnLLklI~~s~YrG-lpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  158 GQHVCMVFEVL-GDNLLKLIKYSNYRG-LPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL  221 (590)
T ss_pred             CcEEEEEehhh-hhHHHHHHHHhCCCC-CcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence            56899999999 668888886655544 377889999999999999999865  59999999999996

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.1e-32  Score=237.87  Aligned_cols=263  Identities=21%  Similarity=0.229  Sum_probs=186.2

Q ss_pred             CCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc---hhHhHHHHHHHHHccCCCceeeeeeeEecCC-----cce
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK---IRITERELLRIISQVNHKNVVKILGLCLETE-----VPL  158 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~-----~~~  158 (414)
                      +.+..+.||-|+||.||.+++. +|+.||+|.+..-..   ......+++++|+.++|.|++..++......     ..|
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            4456788999999999999965 699999998864322   2234466679999999999999998876443     457


Q ss_pred             EEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccc
Q 015027          159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLI  238 (414)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~  238 (414)
                      ++.|.|.. +|...+.   +...++...+.-++.||++||.|||+.+   |.||||||.|.|++.|..+||||||+++..
T Consensus       134 V~TELmQS-DLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARve  206 (449)
T KOG0664|consen  134 VLTELMQS-DLHKIIV---SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTW  206 (449)
T ss_pred             HHHHHHHh-hhhheec---cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEeccccccccc
Confidence            88888854 6776663   3334455666778999999999999988   999999999999999999999999999987


Q ss_pred             cCCccccceecccccccccchhhccc-CCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhh----------
Q 015027          239 SSDAETAMSTILIGTSGYLDPVCINT-GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYF----------  307 (414)
Q Consensus       239 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~----------  307 (414)
                      ..+... ..+..+-|..|.|||.+.| ..|+.++||||.|||+.||+..+.-|........  ..++-..          
T Consensus       207 e~d~~~-hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQ--L~lItdLLGTPs~EaMr  283 (449)
T KOG0664|consen  207 DQRDRL-NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQ--LQMIIDLLGTPSQEAMK  283 (449)
T ss_pred             chhhhh-hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHH--HHHHHHHhCCCcHHHHH
Confidence            665433 3344567889999999976 4799999999999999999999888764332211  1111000          


Q ss_pred             ------hhhhcccccccccccccCCc-ccHHHHHHHHHHHHHhhccCCCCCCChhHHHHH
Q 015027          308 ------LNSIKNNGLRQILNFHVADE-SEMKEIEIVAELASKCLRIRGTERPTMKQVSEE  360 (414)
Q Consensus       308 ------~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~  360 (414)
                            ...+-....+.-..+.+..- .+...-.+...+...++..||.+|.+..+.+..
T Consensus       284 ~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~  343 (449)
T KOG0664|consen  284 YACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQH  343 (449)
T ss_pred             HHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence                  00010111010000111000 001111346788899999999999998877543

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=3.2e-31  Score=252.25  Aligned_cols=197  Identities=21%  Similarity=0.352  Sum_probs=165.3

Q ss_pred             HhcCCCCCCccccCCceEEEEEEEcC-CcEEEEEEeecccchhHh---------HHHHHHHHHccC---CCceeeeeeeE
Q 015027           85 ATKNFDRSRCLSQGGFVSVYKGVLHD-NIQVAVKTYRRADKIRIT---------ERELLRIISQVN---HKNVVKILGLC  151 (414)
Q Consensus        85 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~---------~~~~~~~l~~l~---hpniv~l~~~~  151 (414)
                      ...+|..++.+|.|+||.|++|.++. ...|+||.+.+++-....         .--++++|..++   |+||++++++|
T Consensus       559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF  638 (772)
T KOG1152|consen  559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF  638 (772)
T ss_pred             ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence            34568899999999999999999875 677999998775422111         122346666665   99999999999


Q ss_pred             ecCCcceEEEEeC-CCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEe
Q 015027          152 LETEVPLLVYEFA-SNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVA  230 (414)
Q Consensus       152 ~~~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~  230 (414)
                      ++++.+||+||-- ++-+|++++.....   +++..+..|+.||+.|+++||+.+   |+|||||-+|+.++.+|-+||+
T Consensus       639 Eddd~yyl~te~hg~gIDLFd~IE~kp~---m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~kli  712 (772)
T KOG1152|consen  639 EDDDYYYLETEVHGEGIDLFDFIEFKPR---MDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLI  712 (772)
T ss_pred             ecCCeeEEEecCCCCCcchhhhhhccCc---cchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEe
Confidence            9999999999976 45589999965443   478889999999999999999998   9999999999999999999999


Q ss_pred             eccccccccCCccccceecccccccccchhhcccCCCC-CcccchhHHHHHHHHHhCCCCCC
Q 015027          231 DFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLT-KKSDVYSFGVVLAELLTGKKPGS  291 (414)
Q Consensus       231 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~SlGvil~el~tg~~p~~  291 (414)
                      |||.|......    ....++||..|.|||++.|.+|- ..-|||++|++||.++....||.
T Consensus       713 dfgsaa~~ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  713 DFGSAAYTKSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             eccchhhhcCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            99998776433    35567999999999999998874 56899999999999999999975

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.97  E-value=3.7e-31  Score=236.09  Aligned_cols=261  Identities=23%  Similarity=0.262  Sum_probs=188.8

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch---hHhHHHHHHHHHccCCCceeeeeeeEecCC------
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI---RITERELLRIISQVNHKNVVKILGLCLETE------  155 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~hpniv~l~~~~~~~~------  155 (414)
                      ..+|.-++.+|.|.- .|-.+.+. .+++||+|........   .....+++..+..+.|+||++++.+|....      
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            356777788899988 56666544 5899999988654221   233356678889999999999999996543      


Q ss_pred             cceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccc
Q 015027          156 VPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESS  235 (414)
Q Consensus       156 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla  235 (414)
                      ..|+|||||.. +|...+.     ..++.+++..++.|++.|+.|||+.+   |+||||||+||++..++.+||.|||+|
T Consensus        95 e~y~v~e~m~~-nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~a  165 (369)
T KOG0665|consen   95 EVYLVMELMDA-NLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLA  165 (369)
T ss_pred             hHHHHHHhhhh-HHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhh
Confidence            57999999965 7877764     33467888999999999999999988   999999999999999999999999999


Q ss_pred             ccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCcccccccc------ccccchhhhh
Q 015027          236 VLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNK------KISMVPYFLN  309 (414)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~------~~~~~~~~~~  309 (414)
                      +.....   -..+..+.|..|.|||++.+..+.+.+||||+||++.||++|..-|.+......=      .....+.|..
T Consensus       166 r~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~  242 (369)
T KOG0665|consen  166 RTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMK  242 (369)
T ss_pred             cccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHH
Confidence            865432   2456678899999999999988999999999999999999999887653321100      0001111111


Q ss_pred             hh--------ccc------cccccc-ccccC--CcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          310 SI--------KNN------GLRQIL-NFHVA--DESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       310 ~~--------~~~------~~~~~~-~~~~~--~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      .+        ...      .+...+ |..+.  .+.+.-.+..+.+|+.+||..+|++|.|++++++
T Consensus       243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             HhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence            11        000      000011 10111  1111122355889999999999999999999865

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=3.1e-31  Score=226.22  Aligned_cols=255  Identities=20%  Similarity=0.320  Sum_probs=188.0

Q ss_pred             hcCCCCCCccccCCceEEEEEE-EcCCcEEEEEEeecccchhHhHHHHHHHHHccC-CCceeeeeeeEecC--CcceEEE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRITERELLRIISQVN-HKNVVKILGLCLET--EVPLLVY  161 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~-hpniv~l~~~~~~~--~~~~lv~  161 (414)
                      .++|++.+++|+|-++.||.|. ..++..++||++++-..  ....+++++|..|. ||||+++++...+.  ..+.+|+
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk--kKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiF  114 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK--KKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIF  114 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH--HHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHh
Confidence            4689999999999999999999 45688899999987543  33456678999987 99999999998764  5678999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCC-CCcEEEeeccccccccC
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLND-NYTAKVADFESSVLISS  240 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~DfGla~~~~~  240 (414)
                      ||+++.+...+.      ..++...+..++.++++||.|||+.|   |.|||+||.|++||. .-.++|+|+|+|.+...
T Consensus       115 E~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp  185 (338)
T KOG0668|consen  115 EYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  185 (338)
T ss_pred             hhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCC
Confidence            999887665443      23355677889999999999999999   999999999999995 56799999999998865


Q ss_pred             Cccccceecccccccccchhhcc-cCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccc-----------------
Q 015027          241 DAETAMSTILIGTSGYLDPVCIN-TGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKIS-----------------  302 (414)
Q Consensus       241 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~-----------------  302 (414)
                      ...   .+..+.+..|--||.+. -+.|+.+-|+|||||+|..|+..+.||-......+....                 
T Consensus       186 ~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY  262 (338)
T KOG0668|consen  186 GKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKY  262 (338)
T ss_pred             Cce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHH
Confidence            432   34456677888999885 467889999999999999999999998532211111000                 


Q ss_pred             ---cchhhhhhh---cccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHH
Q 015027          303 ---MVPYFLNSI---KNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVS  358 (414)
Q Consensus       303 ---~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~  358 (414)
                         +.+.+...+   ....+..++++.    ...-..++..+|+.++|..|-.+|||++|..
T Consensus       263 ~i~Ldp~~~~i~~~~~rk~w~~Fi~~~----n~hl~~peaiDlldklLrYDHqeRlTakEam  320 (338)
T KOG0668|consen  263 QIDLDPQFEDILGRHSRKPWSRFINSE----NQHLVSPEAIDLLDKLLRYDHQERLTAKEAM  320 (338)
T ss_pred             ccCCChhHhhHhhccccccHHHhCCcc----ccccCChHHHHHHHHHHhhccccccchHHHh
Confidence               011111100   001111111111    1111236689999999999999999999984

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.1e-30  Score=226.29  Aligned_cols=254  Identities=19%  Similarity=0.269  Sum_probs=184.3

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhHhHHHHHHHHHcc-CCCceeeeeee-EecCCcceEEEE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRITERELLRIISQV-NHKNVVKILGL-CLETEVPLLVYE  162 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~l~~l-~hpniv~l~~~-~~~~~~~~lv~e  162 (414)
                      .+.|.+.+.||+|.||.+-++.++ +.+.+++|.+.........+.++...--.| .|.||+.-|+. |+..+.+++++|
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE  102 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE  102 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence            467999999999999999999976 478899999988776666665554432223 48999987764 667778889999


Q ss_pred             eCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeC--CCCcEEEeeccccccccC
Q 015027          163 FASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLN--DNYTAKVADFESSVLISS  240 (414)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~--~~~~~kl~DfGla~~~~~  240 (414)
                      |+|.|+|..-+...+    +.+....+++.|++.|+.|+|+.+   ++|||||.+||||-  +...+||||||+.+..+.
T Consensus       103 ~aP~gdL~snv~~~G----igE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~  175 (378)
T KOG1345|consen  103 FAPRGDLRSNVEAAG----IGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT  175 (378)
T ss_pred             cCccchhhhhcCccc----ccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCc
Confidence            999999998885433    356777889999999999999977   99999999999993  455899999999876543


Q ss_pred             CccccceecccccccccchhhcccC-----CCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccc
Q 015027          241 DAETAMSTILIGTSGYLDPVCINTG-----KLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNG  315 (414)
Q Consensus       241 ~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (414)
                      ..     .....+..|.+||.....     ...+.+|||.||+++|.++||..||+...........+..|.....  ..
T Consensus       176 tV-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~--~~  248 (378)
T KOG1345|consen  176 TV-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKN--PA  248 (378)
T ss_pred             ee-----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccC--cc
Confidence            22     222345578999876432     3467899999999999999999999854443333322222221111  11


Q ss_pred             cccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHH
Q 015027          316 LRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELD  362 (414)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~  362 (414)
                      +...++         ..++.+..+..+-|..+|++|-.+.++.+.-.
T Consensus       249 ~P~~F~---------~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk  286 (378)
T KOG1345|consen  249 LPKKFN---------PFSEKALRLFKKSLTPRFKDRCKIWTAKKMRK  286 (378)
T ss_pred             Cchhhc---------ccCHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence            111111         11255888999999999999966666554433

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.96  E-value=6.6e-29  Score=223.55  Aligned_cols=198  Identities=32%  Similarity=0.457  Sum_probs=168.3

Q ss_pred             CCCCCccccCCceEEEEEEEcC-CcEEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCC
Q 015027           89 FDRSRCLSQGGFVSVYKGVLHD-NIQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFAS  165 (414)
Q Consensus        89 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  165 (414)
                      |.+.+.||.|++|.||++...+ +..+++|.+......  ......+++.+..++|+|++++++++......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            5667889999999999999765 889999999865432  3444566788899999999999999999999999999999


Q ss_pred             CCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcccc
Q 015027          166 NGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETA  245 (414)
Q Consensus       166 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  245 (414)
                      +++|.+++......  .++..+..++.+++.++.+||+.+   ++|+||+|+||+++.++.++|+|||.+........ .
T Consensus        81 ~~~L~~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~  154 (225)
T smart00221       81 GGDLFDYLRKKGGK--LSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-A  154 (225)
T ss_pred             CCCHHHHHHhcccC--CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-c
Confidence            99999998654332  478889999999999999999987   99999999999999999999999999887654321 1


Q ss_pred             ceecccccccccchhhc-ccCCCCCcccchhHHHHHHHHHhCCCCCCc
Q 015027          246 MSTILIGTSGYLDPVCI-NTGKLTKKSDVYSFGVVLAELLTGKKPGSC  292 (414)
Q Consensus       246 ~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~SlGvil~el~tg~~p~~~  292 (414)
                      ......++..|++||.+ ....++.++|||+||+++++|++|+.||..
T Consensus       155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            22345678889999998 777888899999999999999999999963

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.3e-29  Score=221.53  Aligned_cols=297  Identities=18%  Similarity=0.287  Sum_probs=215.1

Q ss_pred             HHHHHHHHHHHHHHhhhhhcccCCCCCCcccccchheecCCCCCCCCCCccCCCCccccccccccHHHHHHHhcCCCCCC
Q 015027           14 EVNARLQDIASQIKQLDLRKKSGRKSRNVRGVISSAVRRGRGGRDPGPTIYSHPGLAFLRMKIFSKSEMIRATKNFDRSR   93 (414)
Q Consensus        14 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   93 (414)
                      -.+.+++++.++.+| .+.+-+.+.+.+.          |...++...+.....|.+...+               .++.
T Consensus       143 ~l~~~l~e~aek~gq-~~nripfkdt~wk----------gtktr~rdatlsr~~gid~~~l---------------nl~t  196 (448)
T KOG0195|consen  143 MLKNTLLEIAEKHGQ-SPNRIPFKDTTWK----------GTKTRTRDATLSRYTGIDVSSL---------------NLIT  196 (448)
T ss_pred             HHHHHHHHHHHHhCC-CCCcccccccccc----------cccccccccccccccCcchhhh---------------hhhh
Confidence            356778888888888 4445555666553          3334444455555555544332               3345


Q ss_pred             ccccCCceEEEEEEEcCCcEEEEEEeeccc---chhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCCCCchh
Q 015027           94 CLSQGGFVSVYKGVLHDNIQVAVKTYRRAD---KIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLL  170 (414)
Q Consensus        94 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~  170 (414)
                      +|.+...|..|+|+++. ..++.|++....   .....+.++.-.|+-+.||||+.++|.|....++.++..||+.|||+
T Consensus       197 kl~e~hsgelwrgrwqg-ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsly  275 (448)
T KOG0195|consen  197 KLAESHSGELWRGRWQG-NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLY  275 (448)
T ss_pred             hhccCCCcccccccccC-cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHH
Confidence            68889999999999954 456667665332   23344566666777788999999999999999999999999999999


Q ss_pred             hhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEe--eccccccccCCcccccee
Q 015027          171 DHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVA--DFESSVLISSDAETAMST  248 (414)
Q Consensus       171 ~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~--DfGla~~~~~~~~~~~~~  248 (414)
                      ..+....+ ...+..++.+++.+|++|++|||+.. +-|.--.|.+..++||++.+++|+  |--++.+.         .
T Consensus       276 nvlhe~t~-vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsfqe---------~  344 (448)
T KOG0195|consen  276 NVLHEQTS-VVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE---------V  344 (448)
T ss_pred             HHHhcCcc-EEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeeeec---------c
Confidence            99976554 33466889999999999999999976 434445689999999999888875  32222211         1


Q ss_pred             cccccccccchhhcccCCCC---CcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccccC
Q 015027          249 ILIGTSGYLDPVCINTGKLT---KKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVA  325 (414)
Q Consensus       249 ~~~gt~~y~aPE~~~~~~~~---~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (414)
                      .....|.||+||.++..+-+   .++|+|||++++|||.|...||.........         ..+...+++..+++...
T Consensus       345 gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg---------mkialeglrv~ippgis  415 (448)
T KOG0195|consen  345 GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG---------MKIALEGLRVHIPPGIS  415 (448)
T ss_pred             ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh---------hhhhhccccccCCCCcc
Confidence            22457899999999766543   4799999999999999999999865433311         12233444444444433


Q ss_pred             CcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHH
Q 015027          326 DESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLR  365 (414)
Q Consensus       326 ~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~  365 (414)
                              ..+.+|+.-|+..||.+||.+..|+-.|+++.
T Consensus       416 --------~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  416 --------RHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             --------HHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence                    45899999999999999999999999999874

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.95  E-value=2.9e-29  Score=266.21  Aligned_cols=196  Identities=19%  Similarity=0.216  Sum_probs=137.8

Q ss_pred             ccCC-CceeeeeeeE-------ecCCcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCe
Q 015027          138 QVNH-KNVVKILGLC-------LETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPI  209 (414)
Q Consensus       138 ~l~h-pniv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i  209 (414)
                      .++| +||++++++|       ......++++||+ +++|.+++....  ..+++..++.++.||+.||.|||+++   |
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~g---I  101 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD--RSVDAFECFHVFRQIVEIVNAAHSQG---I  101 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc--ccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            4456 6888888877       2334667888988 559999996432  33588999999999999999999988   9


Q ss_pred             eeCCCCCCceeeCCC-------------------CcEEEeeccccccccCCcc--------------ccceecccccccc
Q 015027          210 IHGDVKSANILLNDN-------------------YTAKVADFESSVLISSDAE--------------TAMSTILIGTSGY  256 (414)
Q Consensus       210 iH~Dlkp~NIll~~~-------------------~~~kl~DfGla~~~~~~~~--------------~~~~~~~~gt~~y  256 (414)
                      +||||||+||||+..                   +.+|++|||+++.......              ........||+.|
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  181 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY  181 (793)
T ss_pred             eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence            999999999999654                   4455666666543211000              0001124689999


Q ss_pred             cchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccccCCcccHHHHHHH
Q 015027          257 LDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIV  336 (414)
Q Consensus       257 ~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  336 (414)
                      ||||++.+..++.++|||||||+||||++|.+|+.....           ........    .+++..     .......
T Consensus       182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-----------~~~~~~~~----~~~~~~-----~~~~~~~  241 (793)
T PLN00181        182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-----------TMSSLRHR----VLPPQI-----LLNWPKE  241 (793)
T ss_pred             EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-----------HHHHHHHh----hcChhh-----hhcCHHH
Confidence            999999999999999999999999999999888642110           00000000    011110     0112346


Q ss_pred             HHHHHHhhccCCCCCCChhHHHH
Q 015027          337 AELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       337 ~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ..++.+||+++|.+|||+.++++
T Consensus       242 ~~~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        242 ASFCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHHHHHhCCCChhhCcChHHHhh
Confidence            78899999999999999999975

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.95  E-value=2.7e-28  Score=225.37  Aligned_cols=201  Identities=21%  Similarity=0.269  Sum_probs=160.9

Q ss_pred             HHHHhcCCCCCCccccCCceEEEEEEEc----CCcEEEEEEeecccchhHhHHHHHHHHHcc-CCCceeeeeeeEecCCc
Q 015027           82 MIRATKNFDRSRCLSQGGFVSVYKGVLH----DNIQVAVKTYRRADKIRITERELLRIISQV-NHKNVVKILGLCLETEV  156 (414)
Q Consensus        82 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~l~~l-~hpniv~l~~~~~~~~~  156 (414)
                      +....+.|..+.+||.|+|++||++.+.    ..+.||+|.+........ ...++++|..+ .+.||+++.+++..++.
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~r-i~~El~~L~~~gG~~ni~~~~~~~rnnd~  109 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSR-ILNELEMLYRLGGSDNIIKLNGCFRNNDQ  109 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchH-HHHHHHHHHHhccchhhhcchhhhccCCe
Confidence            3445578999999999999999999954    367799999876554333 34445777776 58999999999999999


Q ss_pred             ceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCC-CCcEEEeecccc
Q 015027          157 PLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLND-NYTAKVADFESS  235 (414)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~DfGla  235 (414)
                      ..+|+||++.....++...      ++...+..++..++.||.++|.+|   ||||||||+|+|.+. .+.-.|.|||+|
T Consensus       110 v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA  180 (418)
T KOG1167|consen  110 VAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLA  180 (418)
T ss_pred             eEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhH
Confidence            9999999999888877742      246778889999999999999988   999999999999984 577899999998


Q ss_pred             ccccCCc------------------------------------------cccceecccccccccchhhccc-CCCCCccc
Q 015027          236 VLISSDA------------------------------------------ETAMSTILIGTSGYLDPVCINT-GKLTKKSD  272 (414)
Q Consensus       236 ~~~~~~~------------------------------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~D  272 (414)
                      .......                                          .....-...||++|.|||++.. ..-+.++|
T Consensus       181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD  260 (418)
T KOG1167|consen  181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID  260 (418)
T ss_pred             HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence            7211100                                          0000113479999999999854 56788999


Q ss_pred             chhHHHHHHHHHhCCCCCCc
Q 015027          273 VYSFGVVLAELLTGKKPGSC  292 (414)
Q Consensus       273 v~SlGvil~el~tg~~p~~~  292 (414)
                      |||.|||++.+++++.||-.
T Consensus       261 iws~GVI~Lslls~~~PFf~  280 (418)
T KOG1167|consen  261 IWSAGVILLSLLSRRYPFFK  280 (418)
T ss_pred             eeeccceeehhhcccccccc
Confidence            99999999999999999854

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=3.2e-27  Score=205.15  Aligned_cols=169  Identities=20%  Similarity=0.152  Sum_probs=125.0

Q ss_pred             CchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccccc
Q 015027          167 GTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAM  246 (414)
Q Consensus       167 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  246 (414)
                      |+|.+++...+  ..+++..++.++.||+.||.|||+.+         ||+|||++.++.+|+  ||++......     
T Consensus         1 GsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~-----   62 (176)
T smart00750        1 VSLADILEVRG--RPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE-----   62 (176)
T ss_pred             CcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc-----
Confidence            68899886543  34589999999999999999999854         999999999999999  9998775432     


Q ss_pred             eecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccccCC
Q 015027          247 STILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVAD  326 (414)
Q Consensus       247 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (414)
                        ...||+.|||||++.+..++.++|||||||++|||++|+.||.......    ............     ....  ..
T Consensus        63 --~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~----~~~~~~~~~~~~-----~~~~--~~  129 (176)
T smart00750       63 --QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS----AILEILLNGMPA-----DDPR--DR  129 (176)
T ss_pred             --cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc----HHHHHHHHHhcc-----CCcc--cc
Confidence              1268899999999999999999999999999999999999986332111    000000000000     0000  00


Q ss_pred             cccHHHHH--HHHHHHHHhhccCCCCCCChhHHHHHHHHHHH
Q 015027          327 ESEMKEIE--IVAELASKCLRIRGTERPTMKQVSEELDRLRR  366 (414)
Q Consensus       327 ~~~~~~~~--~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~  366 (414)
                      ........  .+.+++.+||+.+|.+|||+.++++.+..+..
T Consensus       130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~  171 (176)
T smart00750      130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA  171 (176)
T ss_pred             ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence            01112222  59999999999999999999999998877643

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=1.9e-24  Score=205.81  Aligned_cols=261  Identities=18%  Similarity=0.207  Sum_probs=189.5

Q ss_pred             CCCCCCccccCCceEEEEEEEcCC--cEEEEEEeecccchhH-hHHHHHHHHHccC----CCceeeeeeeE-ecCCcceE
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLHDN--IQVAVKTYRRADKIRI-TERELLRIISQVN----HKNVVKILGLC-LETEVPLL  159 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~-~~~~~~~~l~~l~----hpniv~l~~~~-~~~~~~~l  159 (414)
                      +|.+.+.||+|+||.||++.....  ..+|+|.......... ...-+..++..+.    -+++..+++.. ..+...|+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            799999999999999999997653  5789998876532221 2222234444443    36889999988 47778899


Q ss_pred             EEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCC-----CcEEEeeccc
Q 015027          160 VYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDN-----YTAKVADFES  234 (414)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~-----~~~kl~DfGl  234 (414)
                      ||+.+ |.+|.++..... ...++..+++.|+.|++.+|.+||+.|   ++||||||+|+++...     -.+.|.|||+
T Consensus        99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl  173 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL  173 (322)
T ss_pred             EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence            99988 779999876555 445588999999999999999999988   9999999999999854     4699999999


Q ss_pred             cc--cccCCccc----c-c-eecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchh
Q 015027          235 SV--LISSDAET----A-M-STILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPY  306 (414)
Q Consensus       235 a~--~~~~~~~~----~-~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~  306 (414)
                      ++  ........    . . .....||..|+++.++.+.+.+++.|+||++.++.+++.|..||........        
T Consensus       174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~--------  245 (322)
T KOG1164|consen  174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL--------  245 (322)
T ss_pred             CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch--------
Confidence            98  32222111    1 1 2345699999999999999999999999999999999999999975443221        


Q ss_pred             hhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHh
Q 015027          307 FLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRL  367 (414)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~  367 (414)
                       ...............     .....+..+.++...+-..+...+|....+...|......
T Consensus       246 -~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~  300 (322)
T KOG1164|consen  246 -KSKFEKDPRKLLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS  300 (322)
T ss_pred             -HHHHHHHhhhhcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence             000111111111110     0011124467777777778999999999999887776544

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.92  E-value=5e-25  Score=209.86  Aligned_cols=164  Identities=20%  Similarity=0.170  Sum_probs=125.9

Q ss_pred             HHhcCCCCCCccccCCceEEEEEEEc--CCcEEEEEEeeccc------chhHhHHHHHHHHHccCCCceee-eeeeEecC
Q 015027           84 RATKNFDRSRCLSQGGFVSVYKGVLH--DNIQVAVKTYRRAD------KIRITERELLRIISQVNHKNVVK-ILGLCLET  154 (414)
Q Consensus        84 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~------~~~~~~~~~~~~l~~l~hpniv~-l~~~~~~~  154 (414)
                      ....+|.+.+.||+|+||+||+|.+.  +++.||||++....      .....+..|++++++++|+|+++ ++++    
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----   90 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----   90 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence            34578999999999999999999865  47778999875321      12334567789999999999985 4432    


Q ss_pred             CcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCC-CCCceeeCCCCcEEEeecc
Q 015027          155 EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDV-KSANILLNDNYTAKVADFE  233 (414)
Q Consensus       155 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dl-kp~NIll~~~~~~kl~DfG  233 (414)
                      +..|+||||++|++|....    ..   .   ...++.+++++|.|||+.+   |+|||| ||+|||++.++.+||+|||
T Consensus        91 ~~~~LVmE~~~G~~L~~~~----~~---~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFG  157 (365)
T PRK09188         91 GKDGLVRGWTEGVPLHLAR----PH---G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQ  157 (365)
T ss_pred             CCcEEEEEccCCCCHHHhC----cc---c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECc
Confidence            4579999999999996321    11   1   1457889999999999988   999999 9999999999999999999


Q ss_pred             ccccccCCccccc------eecccccccccchhhccc
Q 015027          234 SSVLISSDAETAM------STILIGTSGYLDPVCINT  264 (414)
Q Consensus       234 la~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~  264 (414)
                      +|+..........      .....+++.|+|||.+..
T Consensus       158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             cceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            9987654321111      135578888999998854

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.91  E-value=1.9e-25  Score=226.22  Aligned_cols=252  Identities=21%  Similarity=0.255  Sum_probs=181.9

Q ss_pred             CCCCccccCCceEEEEEEEc-CCcEEEEEEee----cccchhHh---HHHHHHHHHccCCCceeeeeeeEecCCcceEEE
Q 015027           90 DRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYR----RADKIRIT---ERELLRIISQVNHKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        90 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~----~~~~~~~~---~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~  161 (414)
                      .....+|.|++|.|+..... .....+.|.+.    ........   ...++.+-..+.|||++..+..+.+....+-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            35677999999988877643 34444444433    11111111   123344566789999999888887777666679


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCC
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD  241 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  241 (414)
                      |||++ +|...+....   .++...+..++.|++.|+.|+|+.|   |.|||+|++|+++..+|.+||+|||.+.....+
T Consensus       401 E~~~~-Dlf~~~~~~~---~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~  473 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNG---KLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP  473 (601)
T ss_pred             hcccH-HHHHHHhccc---ccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence            99999 9999886542   2355677889999999999999998   999999999999999999999999999876655


Q ss_pred             ccc--cceecccccccccchhhcccCCCCCc-ccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccc
Q 015027          242 AET--AMSTILIGTSGYLDPVCINTGKLTKK-SDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQ  318 (414)
Q Consensus       242 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (414)
                      .+.  ......+|+..|+|||++.+..|++. .||||.|+++..|++|+.||...........          .......
T Consensus       474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~----------~~~~~~~  543 (601)
T KOG0590|consen  474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK----------TNNYSDQ  543 (601)
T ss_pred             cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh----------hhccccc
Confidence            444  55667789999999999999999874 8999999999999999999975543322110          0000000


Q ss_pred             ccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHH
Q 015027          319 ILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVS  358 (414)
Q Consensus       319 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~  358 (414)
                      .-...-........+.....++.+||+.+|.+|.|+++|+
T Consensus       544 ~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~  583 (601)
T KOG0590|consen  544 RNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQIL  583 (601)
T ss_pred             cccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHh
Confidence            0000001111223345688999999999999999999994

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.91  E-value=6e-23  Score=194.22  Aligned_cols=261  Identities=26%  Similarity=0.319  Sum_probs=192.1

Q ss_pred             CCCCCccccCCceEEEEEEEcCCcEEEEEEeecccch----hHhHHHHHHHHHccCCC-ceeeeeeeEecCCcceEEEEe
Q 015027           89 FDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKI----RITERELLRIISQVNHK-NVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        89 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~hp-niv~l~~~~~~~~~~~lv~e~  163 (414)
                      |...+.||.|+||.||++...  ..+++|.+......    ......+..++..+.|+ +++++.+++......+++++|
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            667788999999999999986  78999998765443    33445666789999988 799999999777778999999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCC-cEEEeeccccccccCCc
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNY-TAKVADFESSVLISSDA  242 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~DfGla~~~~~~~  242 (414)
                      +.++++.+++................++.+++.++.|+|+.+   ++|||+||+||+++..+ .++++|||++.......
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            999999966654331124577888999999999999999988   99999999999999988 79999999998655432


Q ss_pred             ccc----ceecccccccccchhhccc---CCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccc
Q 015027          243 ETA----MSTILIGTSGYLDPVCINT---GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNG  315 (414)
Q Consensus       243 ~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (414)
                      ...    ......||..|+|||.+.+   ..+....|+||+|++++++++|..||......     .........+....
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~-----~~~~~~~~~~~~~~  231 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS-----SATSQTLKIILELP  231 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc-----ccHHHHHHHHHhcC
Confidence            221    2456789999999999987   57889999999999999999999997643321     00000111111110


Q ss_pred             cccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHH
Q 015027          316 LRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEE  360 (414)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~  360 (414)
                      .. .................+.+++..|+..+|..|.+.......
T Consensus       232 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         232 TP-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             Cc-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            00 000000000001122458899999999999999998776554

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=1.4e-23  Score=188.65  Aligned_cols=262  Identities=18%  Similarity=0.219  Sum_probs=192.5

Q ss_pred             hcCCCCCCccccCCceEEEEEE-EcCCcEEEEEEeecccchhHhHHHHHHHHHcc-CCCceeeeeeeEecCCcceEEEEe
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRITERELLRIISQV-NHKNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~  163 (414)
                      .-+|.+.++||+|+||.++.|. +-++++||||.-........- +.|.+..+.| ..++|..++-|...+.+-.||+|+
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQL-rdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL  105 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQL-RDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL  105 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEeccccCCcchH-HHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence            4579999999999999999999 558999999987655443322 2223444433 478999999998888888999999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCC-----CCcEEEeeccccccc
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLND-----NYTAKVADFESSVLI  238 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~-----~~~~kl~DfGla~~~  238 (414)
                      + |-||.|+..-.+...  +.++++.++.|++.-++|+|+..   +|.|||||+|+||..     ...+.++|||+|+.+
T Consensus       106 L-GPSLEDLFD~CgR~F--SvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y  179 (449)
T KOG1165|consen  106 L-GPSLEDLFDLCGRRF--SVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY  179 (449)
T ss_pred             h-CcCHHHHHHHhcCcc--cHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence            8 779999886666554  77999999999999999999988   999999999999963     346899999999988


Q ss_pred             cCCcccc-----ceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcc
Q 015027          239 SSDAETA-----MSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKN  313 (414)
Q Consensus       239 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  313 (414)
                      ..+....     ......||.+||+=..+.|.+-+.+.|+=|||-++++++-|..||.+......++.      ..  +.
T Consensus       180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~k------Ye--KI  251 (449)
T KOG1165|consen  180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEK------YE--KI  251 (449)
T ss_pred             cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHH------HH--Hh
Confidence            7643221     23456899999999999999999999999999999999999999997665442211      00  00


Q ss_pred             cccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHH
Q 015027          314 NGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLR  365 (414)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~  365 (414)
                      +......+..   ..-...+.++..-+.-.-..+-.+-|..+-+...+..+.
T Consensus       252 Ge~Kr~T~i~---~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvl  300 (449)
T KOG1165|consen  252 GETKRSTPIE---VLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVL  300 (449)
T ss_pred             ccccccCCHH---HHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence            1111110000   000112345666666666667777788776666555544

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=6.7e-24  Score=182.80  Aligned_cols=265  Identities=20%  Similarity=0.213  Sum_probs=192.3

Q ss_pred             HhcCCCCCCccccCCceEEEEEE-EcCCcEEEEEEeecccchhHhHHHHHHHHHccC-CCceeeeeeeEecCCcceEEEE
Q 015027           85 ATKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRITERELLRIISQVN-HKNVVKILGLCLETEVPLLVYE  162 (414)
Q Consensus        85 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e  162 (414)
                      ...+|.++++||.|+||.+|.|. ..+|..||||+-+.......-. .+.++...|+ -..|..+..+..+...-.+||+
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~-yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLL-YESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchh-HHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            35789999999999999999999 5579999999876654333222 2234444454 4678888888888888899999


Q ss_pred             eCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeC---CCCcEEEeecccccccc
Q 015027          163 FASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLN---DNYTAKVADFESSVLIS  239 (414)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~---~~~~~kl~DfGla~~~~  239 (414)
                      .+ |-||.++..-.....  +.++++-++-|++.-++|+|..+   +|||||||+|.|..   ....+.|+|||+|+.+.
T Consensus        92 LL-GPsLEdLfnfC~R~f--tmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   92 LL-GPSLEDLFNFCSRRF--TMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             cc-CccHHHHHHHHhhhh--hHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence            98 779999886655544  67889999999999999999988   99999999999986   34578999999998765


Q ss_pred             CCccc-----cceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccc
Q 015027          240 SDAET-----AMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNN  314 (414)
Q Consensus       240 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  314 (414)
                      .....     .......||..|++=..+.+.+-+.+.|+=|+|.+|..+.-|..||++.........      ...+.+.
T Consensus       166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QK------yEkI~Ek  239 (341)
T KOG1163|consen  166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQK------YEKISEK  239 (341)
T ss_pred             cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHH------HHHHHHh
Confidence            43221     123456899999998888888889999999999999999999999987654332110      0000000


Q ss_pred             ccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHh
Q 015027          315 GLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRL  367 (414)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~  367 (414)
                      .....+ ..+..-+    +.++.-.+.-|-..--++-|...-+.+...-+.+.
T Consensus       240 K~s~~i-e~LC~G~----P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~  287 (341)
T KOG1163|consen  240 KMSTPI-EVLCKGF----PAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRT  287 (341)
T ss_pred             hcCCCH-HHHhCCC----cHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhh
Confidence            000000 0111111    24577788888888888889877766666555443

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.89  E-value=2.1e-23  Score=185.26  Aligned_cols=170  Identities=13%  Similarity=0.124  Sum_probs=131.2

Q ss_pred             HhcCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccchhHh----------HHHHHHHHHccCCCceeeeeeeEecC
Q 015027           85 ATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRIT----------ERELLRIISQVNHKNVVKILGLCLET  154 (414)
Q Consensus        85 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~----------~~~~~~~l~~l~hpniv~l~~~~~~~  154 (414)
                      ..++|+..+.||.|+||.||++.. ++..+|||++.........          ...+++.+.++.||+|..+.+++...
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            368999999999999999999655 5778999999765433322          24566788899999999999886533


Q ss_pred             --------CcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCc
Q 015027          155 --------EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYT  226 (414)
Q Consensus       155 --------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~  226 (414)
                              ...++||||++|.+|.++..       .+.    ....+++.++..+|..+   ++|||+||+||+++.+| 
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-  172 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-  172 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence                    35789999999999987631       122    24569999999999988   99999999999999988 


Q ss_pred             EEEeeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHH
Q 015027          227 AKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELL  284 (414)
Q Consensus       227 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~  284 (414)
                      ++|+|||.......+...              ..+.....+..++|+||||+++.-+.
T Consensus       173 i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence            999999987654321110              11334455678999999999987654

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.88  E-value=3.7e-22  Score=174.97  Aligned_cols=139  Identities=16%  Similarity=0.201  Sum_probs=105.2

Q ss_pred             CCccccCCceEEEEEEEcCCcEEEEEEeecccchh---------------------------HhHHHHHHHHHccCCCce
Q 015027           92 SRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIR---------------------------ITERELLRIISQVNHKNV  144 (414)
Q Consensus        92 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---------------------------~~~~~~~~~l~~l~hpni  144 (414)
                      ...||+|+||.||+|...+|+.||||+++......                           .....|.+.+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            46799999999999998789999999997642210                           011235677888877776


Q ss_pred             eeeeeeEecCCcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHh-hhCCCCCeeeCCCCCCceeeCC
Q 015027          145 VKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYL-HSLASPPIIHGDVKSANILLND  223 (414)
Q Consensus       145 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~L-H~~~~~~iiH~Dlkp~NIll~~  223 (414)
                      ........  ...+|||||++++++.......   ..++...+..++.|++.+|.++ |+.+   |+||||||+|||++ 
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~---~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-  152 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD---APLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-  152 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence            44333222  2238999999998776543222   2357788999999999999999 6777   99999999999998 


Q ss_pred             CCcEEEeecccccccc
Q 015027          224 NYTAKVADFESSVLIS  239 (414)
Q Consensus       224 ~~~~kl~DfGla~~~~  239 (414)
                      ++.++|+|||+|....
T Consensus       153 ~~~v~LiDFG~a~~~~  168 (190)
T cd05147         153 DGKLYIIDVSQSVEHD  168 (190)
T ss_pred             CCcEEEEEccccccCC
Confidence            4789999999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.88  E-value=1.7e-22  Score=195.96  Aligned_cols=219  Identities=23%  Similarity=0.365  Sum_probs=161.7

Q ss_pred             HccCCCceeeeeeeEecCCcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCC
Q 015027          137 SQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKS  216 (414)
Q Consensus       137 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp  216 (414)
                      +.+.|.|+.+++|.+.++...++|.+||..|+|.|.+....  ..+++.....++++|+.||.|||.-.  -.+|+.+++
T Consensus         2 ~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~--~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~s   77 (484)
T KOG1023|consen    2 RQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED--IKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALKS   77 (484)
T ss_pred             cccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc--cCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeecc
Confidence            46789999999999999999999999999999999997633  34488889999999999999999843  239999999


Q ss_pred             CceeeCCCCcEEEeeccccccccCCccccceecccccccccchhhcccCC-------CCCcccchhHHHHHHHHHhCCCC
Q 015027          217 ANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGK-------LTKKSDVYSFGVVLAELLTGKKP  289 (414)
Q Consensus       217 ~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~Dv~SlGvil~el~tg~~p  289 (414)
                      .|+++|....+||+|||+.................-..-|.|||.+.+..       .+.+.||||||++++|+++...|
T Consensus        78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~  157 (484)
T KOG1023|consen   78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP  157 (484)
T ss_pred             ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence            99999999999999999987764311111122222344699999997642       46789999999999999999999


Q ss_pred             CCccccccccccccchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHh
Q 015027          290 GSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRL  367 (414)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~  367 (414)
                      |......... .    .....+.. .-...+.+.+....  +..+.+..++..||..+|..||++.+|...++.+...
T Consensus       158 ~~~~~~~~~~-~----eii~~~~~-~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~  227 (484)
T KOG1023|consen  158 FDLRNLVEDP-D----EIILRVKK-GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG  227 (484)
T ss_pred             cccccccCCh-H----HHHHHHHh-cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence            9753332221 0    11111111 11111111111111  2234689999999999999999999998888877653

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.87  E-value=1.8e-21  Score=171.14  Aligned_cols=140  Identities=19%  Similarity=0.237  Sum_probs=107.1

Q ss_pred             CCccccCCceEEEEEEEcCCcEEEEEEeecccch---------------------------hHhHHHHHHHHHccCCCce
Q 015027           92 SRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKI---------------------------RITERELLRIISQVNHKNV  144 (414)
Q Consensus        92 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~l~~l~hpni  144 (414)
                      .+.||+|+||.||+|.+.+|+.||||+++.....                           ......+.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            5679999999999999878999999999865211                           0011344577888889887


Q ss_pred             eeeeeeEecCCcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhh-CCCCCeeeCCCCCCceeeCC
Q 015027          145 VKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHS-LASPPIIHGDVKSANILLND  223 (414)
Q Consensus       145 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~iiH~Dlkp~NIll~~  223 (414)
                      .....+...  ..++||||++|+++.......   ..++......++.+++.++.++|+ .+   |+||||||+|||++ 
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-  152 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-  152 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence            544443332  248999999988654332111   234667888999999999999999 87   99999999999999 


Q ss_pred             CCcEEEeeccccccccC
Q 015027          224 NYTAKVADFESSVLISS  240 (414)
Q Consensus       224 ~~~~kl~DfGla~~~~~  240 (414)
                      ++.++|+|||++.....
T Consensus       153 ~~~~~liDFG~a~~~~~  169 (190)
T cd05145         153 DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             CCCEEEEEcccceecCC
Confidence            88999999999986643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.87  E-value=3.9e-22  Score=183.21  Aligned_cols=225  Identities=19%  Similarity=0.155  Sum_probs=150.2

Q ss_pred             CCCceeeeeeeEecC---------------------------CcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHH
Q 015027          140 NHKNVVKILGLCLET---------------------------EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAA  192 (414)
Q Consensus       140 ~hpniv~l~~~~~~~---------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~  192 (414)
                      +|||||+++++|.+.                           ...|+||..++. +|..++..+..    +.....-++.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~~----s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRHR----SYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCCC----chHHHHHHHH
Confidence            699999999887542                           245899988855 89999865443    4456667899


Q ss_pred             HHHHHHHHhhhCCCCCeeeCCCCCCceee--CC--CCcEEEeeccccccccCC----ccccceecccccccccchhhccc
Q 015027          193 ETASALDYLHSLASPPIIHGDVKSANILL--ND--NYTAKVADFESSVLISSD----AETAMSTILIGTSGYLDPVCINT  264 (414)
Q Consensus       193 ~i~~~l~~LH~~~~~~iiH~Dlkp~NIll--~~--~~~~kl~DfGla~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~  264 (414)
                      |+++|+.|||.++   |.|||+|++|||+  |+  -..+.|+|||.+..-...    .........-|...-||||+...
T Consensus       349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta  425 (598)
T KOG4158|consen  349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA  425 (598)
T ss_pred             HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence            9999999999988   9999999999999  33  356789999987533221    01111223457778999999854


Q ss_pred             CC------CCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccccCCcccHHHHHHHHH
Q 015027          265 GK------LTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAE  338 (414)
Q Consensus       265 ~~------~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  338 (414)
                      .+      .-.|+|.|+.|.+.||+++...||......   .....     ...+..+.. +..        ..++.+.+
T Consensus       426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem---~L~~r-----~Yqe~qLPa-lp~--------~vpp~~rq  488 (598)
T KOG4158|consen  426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM---LLDTR-----TYQESQLPA-LPS--------RVPPVARQ  488 (598)
T ss_pred             CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh---eechh-----hhhhhhCCC-Ccc--------cCChHHHH
Confidence            32      235899999999999999999999741100   00000     011111111 111        12245899


Q ss_pred             HHHHhhccCCCCCCChhHHHHHHHHHHHhhhhhhhhhccccccccccCCCC
Q 015027          339 LASKCLRIRGTERPTMKQVSEELDRLRRLHENFWAQKKNKETEHLLGESSS  389 (414)
Q Consensus       339 Li~~cl~~dP~~Rps~~~v~~~L~~i~~~~~~~~~~~~~~~~~~~~~~~~~  389 (414)
                      |+...|+.||++|++..-....|.-......++..+-......+++.+--+
T Consensus       489 lV~~lL~r~pskRvsp~iAANvl~LsLw~~~~~vka~~~~~~~~~~~wLL~  539 (598)
T KOG4158|consen  489 LVFDLLKRDPSKRVSPNIAANVLNLSLWRMGEDVKAMMEKCGISQMTWLLA  539 (598)
T ss_pred             HHHHHhcCCccccCCccHHHhHHHHHHhcCchHHHHhcccccHHHHHHHHH
Confidence            999999999999999877777766544434444444444444444444333

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.86  E-value=2.7e-22  Score=204.07  Aligned_cols=245  Identities=21%  Similarity=0.262  Sum_probs=175.3

Q ss_pred             CCCCCCccccCCceEEEEEEEcCCcEEEEEEeeccc-chh----HhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEE
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRAD-KIR----ITERELLRIISQVNHKNVVKILGLCLETEVPLLVYE  162 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~----~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  162 (414)
                      +|...+.||.+.|=.|.+|.+..|. |+||++.+.. ...    .+..++++ ...++|||.+++.-+...+...|||-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            6778899999999999999987776 9999987654 222    22233334 566789999999888888888899999


Q ss_pred             eCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCc
Q 015027          163 FASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDA  242 (414)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  242 (414)
                      |... +|+|.+.   .++.+...+...|+.|++.||.-+|..+   |+|+|||.+||||+.=..+.|+||-.-+...-+.
T Consensus       102 yvkh-nLyDRlS---TRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe  174 (1431)
T KOG1240|consen  102 YVKH-NLYDRLS---TRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPE  174 (1431)
T ss_pred             HHhh-hhhhhhc---cchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCC
Confidence            9855 8998884   3344456667789999999999999988   9999999999999998899999997544322111


Q ss_pred             -cccceecc----cccccccchhhcccC----------C-CCCcccchhHHHHHHHHHh-CCCCCCccccccccccccch
Q 015027          243 -ETAMSTIL----IGTSGYLDPVCINTG----------K-LTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVP  305 (414)
Q Consensus       243 -~~~~~~~~----~gt~~y~aPE~~~~~----------~-~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~  305 (414)
                       .....+.+    ..-..|+|||.+...          . .+++-||||+||+++||++ |++||.....        ..
T Consensus       175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL--------~a  246 (1431)
T KOG1240|consen  175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQL--------LA  246 (1431)
T ss_pred             CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHH--------Hh
Confidence             11111111    222369999987431          2 5788999999999999998 7888863221        11


Q ss_pred             hhhh-h-hcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHH
Q 015027          306 YFLN-S-IKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEEL  361 (414)
Q Consensus       306 ~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L  361 (414)
                      |-.. . ..+..+..+-+            ..+..|+..|++.||.+|.++++.++.-
T Consensus       247 Yr~~~~~~~e~~Le~Ied------------~~~Rnlil~Mi~rdPs~RlSAedyL~~y  292 (1431)
T KOG1240|consen  247 YRSGNADDPEQLLEKIED------------VSLRNLILSMIQRDPSKRLSAEDYLQKY  292 (1431)
T ss_pred             HhccCccCHHHHHHhCcC------------ccHHHHHHHHHccCchhccCHHHHHHhh
Confidence            1000 0 00001111111            2389999999999999999999998763

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.86  E-value=3.8e-21  Score=167.28  Aligned_cols=184  Identities=15%  Similarity=0.098  Sum_probs=137.5

Q ss_pred             CCCCccccCCceEEEEEEEcCCcEEEEEEeecccchhH-----hHHHHHHHHHccC-CCceeeeeeeEecCCcceEEEEe
Q 015027           90 DRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRI-----TERELLRIISQVN-HKNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        90 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~  163 (414)
                      .+...|++|+||+||.+.. .+.+++.+.+........     .+..|+++|.++. |+++++++++    ...+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            4567799999999997766 788888887766544222     3466789999995 5889999886    346899999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCC-CCCceeeCCCCcEEEeeccccccccCCc
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDV-KSANILLNDNYTAKVADFESSVLISSDA  242 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dl-kp~NIll~~~~~~kl~DfGla~~~~~~~  242 (414)
                      ++|.+|...+..         . ...++.+++.+|.++|+.|   |+|||| ||+|||++.++.++|+|||+|.......
T Consensus        80 I~G~~L~~~~~~---------~-~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~  146 (218)
T PRK12274         80 LAGAAMYQRPPR---------G-DLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA  146 (218)
T ss_pred             ecCccHHhhhhh---------h-hHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence            999998654311         1 1346789999999999988   999999 7999999999999999999998554322


Q ss_pred             cc----c-------ceecccccccccchhhcccC-CCC-CcccchhHHHHHHHHHhCCCCCC
Q 015027          243 ET----A-------MSTILIGTSGYLDPVCINTG-KLT-KKSDVYSFGVVLAELLTGKKPGS  291 (414)
Q Consensus       243 ~~----~-------~~~~~~gt~~y~aPE~~~~~-~~~-~~~Dv~SlGvil~el~tg~~p~~  291 (414)
                      ..    .       .......++.|++|+...-- ..+ ...+.++.|+-+|.++|+..|+-
T Consensus       147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~  208 (218)
T PRK12274        147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW  208 (218)
T ss_pred             hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence            10    0       01122468889999654321 222 46788999999999999998853

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.85  E-value=6.7e-21  Score=197.18  Aligned_cols=260  Identities=19%  Similarity=0.225  Sum_probs=188.6

Q ss_pred             HHHHHhcCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHccC---CCceeeeeeeEecCCcc
Q 015027           81 EMIRATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVN---HKNVVKILGLCLETEVP  157 (414)
Q Consensus        81 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~---hpniv~l~~~~~~~~~~  157 (414)
                      +.......|.+.+.||+|+||+||+|...+|+.||||+-++........  ..+++.+|+   -+-|..+..++.-.+..
T Consensus       692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI--~~q~~~RLk~~~~~~~~~~~~a~~~~~~S  769 (974)
T KOG1166|consen  692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYI--CLQVMERLKPQMLPSIMHISSAHVFQNAS  769 (974)
T ss_pred             eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeee--hHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence            3445567888999999999999999998789999999987766543322  124455555   23445555555566677


Q ss_pred             eEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeC-------CCCcEEEe
Q 015027          158 LLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLN-------DNYTAKVA  230 (414)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~-------~~~~~kl~  230 (414)
                      ++|+||.+.|+|.+++..   ....+|..+..++.|++..+..||..+   |||+||||+|.||.       ++..++|+
T Consensus       770 ~lv~ey~~~Gtlld~~N~---~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lI  843 (974)
T KOG1166|consen  770 VLVSEYSPYGTLLDLINT---NKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLI  843 (974)
T ss_pred             eeeeeccccccHHHhhcc---CCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEE
Confidence            899999999999999973   333478889999999999999999988   99999999999994       35679999


Q ss_pred             eccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhh
Q 015027          231 DFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNS  310 (414)
Q Consensus       231 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  310 (414)
                      |||-+..+..-.........++|-.+--+|+..|..++..+|.|.|+.+++.|+.|+.--.                   
T Consensus       844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q~-------------------  904 (974)
T KOG1166|consen  844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYMEV-------------------  904 (974)
T ss_pred             ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHHh-------------------
Confidence            9999977665555556677788999999999999999999999999999999999975410                   


Q ss_pred             hcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHhhhhhh
Q 015027          311 IKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLHENFW  372 (414)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~~~~~~  372 (414)
                       ..+. ...++..++.....   ...-+++..+|..|-..=|...++...++.....+...+
T Consensus       905 -~~g~-~~~~~~~~~Ry~~~---~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~~~~~  961 (974)
T KOG1166|consen  905 -KNGS-SWMVKTNFPRYWKR---DMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAEHFTGL  961 (974)
T ss_pred             -cCCc-ceeccccchhhhhH---HHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHHHHHHH
Confidence             0000 00011111111111   114466777777443334777777777777665544433

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.85  E-value=2.2e-22  Score=195.45  Aligned_cols=224  Identities=26%  Similarity=0.225  Sum_probs=171.9

Q ss_pred             ccccCCceEEEEEEE----cCCcEEEEEEeecccchh---HhHHHHHHHHHccC-CCceeeeeeeEecCCcceEEEEeCC
Q 015027           94 CLSQGGFVSVYKGVL----HDNIQVAVKTYRRADKIR---ITERELLRIISQVN-HKNVVKILGLCLETEVPLLVYEFAS  165 (414)
Q Consensus        94 ~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~---~~~~~~~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~~  165 (414)
                      .+|+|+||.|+++.-    +.|..+|+|++++.....   .....+..++...+ ||.++++.-.++.+...+++++|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            379999999998662    246778998886542211   12223335666666 9999999999999999999999999


Q ss_pred             CCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcccc
Q 015027          166 NGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETA  245 (414)
Q Consensus       166 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  245 (414)
                      ||.|...+......   ++.....+...++-++.++|+.+   ++|||+|++||+++.+|++++.|||+++..-....  
T Consensus        81 gg~lft~l~~~~~f---~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~--  152 (612)
T KOG0603|consen   81 GGDLFTRLSKEVMF---DELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI--  152 (612)
T ss_pred             cchhhhccccCCch---HHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh--
Confidence            99998877543332   45555667788999999999988   99999999999999999999999999987543221  


Q ss_pred             ceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccccC
Q 015027          246 MSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVA  325 (414)
Q Consensus       246 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (414)
                          .+||..|||||++.  .....+|.||||++++||+||..||....                     ...++.  ..
T Consensus       153 ----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~~---------------------~~~Il~--~~  203 (612)
T KOG0603|consen  153 ----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGDT---------------------MKRILK--AE  203 (612)
T ss_pred             ----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchHH---------------------HHHHhh--hc
Confidence                28999999999998  67889999999999999999999997400                     011111  01


Q ss_pred             CcccHHHHHHHHHHHHHhhccCCCCCCCh
Q 015027          326 DESEMKEIEIVAELASKCLRIRGTERPTM  354 (414)
Q Consensus       326 ~~~~~~~~~~l~~Li~~cl~~dP~~Rps~  354 (414)
                      ...+......+.+++..++..+|.+|.-.
T Consensus       204 ~~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  204 LEMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             cCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            12334445668999999999999999754

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.85  E-value=2e-20  Score=171.14  Aligned_cols=231  Identities=21%  Similarity=0.259  Sum_probs=140.2

Q ss_pred             CCCCCccccCCceEEEEEEEcC-CcEEEEEEeecccchhHhH----HHHHHHHHccC----------CCceeeeeeeE--
Q 015027           89 FDRSRCLSQGGFVSVYKGVLHD-NIQVAVKTYRRADKIRITE----RELLRIISQVN----------HKNVVKILGLC--  151 (414)
Q Consensus        89 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~----~~~~~~l~~l~----------hpniv~l~~~~--  151 (414)
                      +...+.||.|+++.||.+++.. ++.+|||++..........    .++.-....+.          |-.++..++..  
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            4456789999999999999864 8999999987554322211    22211111111          11222222221  


Q ss_pred             -------ecC---C-----cceEEEEeCCCCchhhhhhh---cCCc-ccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeC
Q 015027          152 -------LET---E-----VPLLVYEFASNGTLLDHIRC---ESSQ-VLKTWKTCLRIAAETASALDYLHSLASPPIIHG  212 (414)
Q Consensus       152 -------~~~---~-----~~~lv~e~~~~gsL~~~l~~---~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~  212 (414)
                             ...   .     +.+++|+-+. ++|.+.+..   .... ..+.....+.+..|+++.+++||+.|   ++|+
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHg  169 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHG  169 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEES
T ss_pred             cCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEec
Confidence                   111   1     2367888774 588777532   1111 22233445667799999999999988   9999


Q ss_pred             CCCCCceeeCCCCcEEEeeccccccccCCccccceecccccccccchhhccc--------CCCCCcccchhHHHHHHHHH
Q 015027          213 DVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINT--------GKLTKKSDVYSFGVVLAELL  284 (414)
Q Consensus       213 Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~SlGvil~el~  284 (414)
                      ||+|+|+|++.+|.++|+||+........     ......+..|.+||....        -.++.+.|.|+||+++|.|.
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~-----~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW  244 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAGTR-----YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW  244 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETTEE-----EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecCce-----eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence            99999999999999999999876654321     111234567999997643        25788999999999999999


Q ss_pred             hCCCCCCccccccccccccchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCC
Q 015027          285 TGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTER  351 (414)
Q Consensus       285 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~R  351 (414)
                      ||..||...........                     .+ ..+. ..++.+..||..+|+.+|.+|
T Consensus       245 C~~lPf~~~~~~~~~~~---------------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  245 CGRLPFGLSSPEADPEW---------------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HSS-STCCCGGGSTSGG---------------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HccCCCCCCCccccccc---------------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence            99999985443221110                     00 0122 445679999999999999987

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.82  E-value=4.2e-21  Score=183.17  Aligned_cols=172  Identities=25%  Similarity=0.338  Sum_probs=130.8

Q ss_pred             cceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccc
Q 015027          156 VPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESS  235 (414)
Q Consensus       156 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla  235 (414)
                      ..||.|++|...+|.+++.+.......++...+.++.|++.|+.|   .+   .+|+|+||.||+...+..+||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence            578999999999999999766666666888899999999999999   55   899999999999999999999999998


Q ss_pred             ccccCCc----cccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhh
Q 015027          236 VLISSDA----ETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNS  310 (414)
Q Consensus       236 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~  310 (414)
                      .......    .....+...||.+||+||.+.++.|+.++||||||++|+||+. =..++....            ....
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~------------t~~d  471 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA------------TLTD  471 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH------------hhhh
Confidence            7766543    2223455689999999999999999999999999999999997 233322111            0111


Q ss_pred             hcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCCh
Q 015027          311 IKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTM  354 (414)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~  354 (414)
                      +..+.    +++.....+     +.-..|+.+++.+.|.+||++
T Consensus       472 ~r~g~----ip~~~~~d~-----p~e~~ll~~lls~~p~~RP~~  506 (516)
T KOG1033|consen  472 IRDGI----IPPEFLQDY-----PEEYTLLQQLLSPSPEERPSA  506 (516)
T ss_pred             hhcCC----CChHHhhcC-----cHHHHHHHHhcCCCcccCchH
Confidence            11111    111111111     224689999999999999943

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.81  E-value=1.2e-18  Score=155.75  Aligned_cols=133  Identities=23%  Similarity=0.310  Sum_probs=108.7

Q ss_pred             CccccCCceEEEEEEEcCCcEEEEEEeecccch---------hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEe
Q 015027           93 RCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKI---------RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        93 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  163 (414)
                      +.||+|++|.||+|.. .|..+++|........         ......+..++..+.|++++....++......++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5789999999999987 6778999986543211         11224456788888999988777777777888999999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccccc
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVL  237 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~  237 (414)
                      ++|++|.+.+....      . ....++.+++.+|.++|+.+   ++|+|++|.|||++ ++.++|+|||++..
T Consensus        81 ~~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSNG------M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999884321      2 67789999999999999988   99999999999999 78999999998754

>PRK10345 hypothetical protein; Provisional

Probab=99.80  E-value=4.6e-19  Score=156.98  Aligned_cols=135  Identities=16%  Similarity=0.143  Sum_probs=100.4

Q ss_pred             CCCCccccCCceEEEEEEEcCCcEEEEEEeecccc-hhHhHHHHHHHHHcc-----CCCceeeeeeeEecCC---cce-E
Q 015027           90 DRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADK-IRITERELLRIISQV-----NHKNVVKILGLCLETE---VPL-L  159 (414)
Q Consensus        90 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l-----~hpniv~l~~~~~~~~---~~~-l  159 (414)
                      .-...||+|+||.||.  .......+||++..... ......+|+.+++.+     .||||++++|++.++.   ..+ +
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            3457799999999995  33333347998875422 233446677888888     6799999999998864   333 7


Q ss_pred             EEEe--CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHH-HHhhhCCCCCeeeCCCCCCceeeCC----CCcEEEeec
Q 015027          160 VYEF--ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASAL-DYLHSLASPPIIHGDVKSANILLND----NYTAKVADF  232 (414)
Q Consensus       160 v~e~--~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l-~~LH~~~~~~iiH~Dlkp~NIll~~----~~~~kl~Df  232 (414)
                      |+||  +++++|.+++....    +++.  ..++.+++.++ .|||+++   |+||||||+|||++.    ++.++|+||
T Consensus        83 I~e~~G~~~~tL~~~l~~~~----~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg  153 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQCR----YEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN  153 (210)
T ss_pred             EecCCCCcchhHHHHHHccc----ccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence            8999  56799999995421    2333  35678888887 9999988   999999999999974    348999994


Q ss_pred             ccc
Q 015027          233 ESS  235 (414)
Q Consensus       233 Gla  235 (414)
                      +.+
T Consensus       154 ~G~  156 (210)
T PRK10345        154 IGE  156 (210)
T ss_pred             CCC
Confidence            433

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.79  E-value=1.1e-18  Score=154.53  Aligned_cols=146  Identities=18%  Similarity=0.176  Sum_probs=110.7

Q ss_pred             HHHHHHHhcCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccch-----------------------hHhHHHHHHH
Q 015027           79 KSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKI-----------------------RITERELLRI  135 (414)
Q Consensus        79 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------------~~~~~~~~~~  135 (414)
                      ..++......|.+.+.||+|+||.||++...+|+.||||++......                       ......+..+
T Consensus         7 ~~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~   86 (198)
T cd05144           7 LHTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAA   86 (198)
T ss_pred             HHHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHH
Confidence            34555555568889999999999999999878999999987653210                       0112344566


Q ss_pred             HHccCCC--ceeeeeeeEecCCcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCC
Q 015027          136 ISQVNHK--NVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGD  213 (414)
Q Consensus       136 l~~l~hp--niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~D  213 (414)
                      +..+.|+  .++..++.    ...++||||++|++|......         .....++.+++.++.++|+.+   ++|+|
T Consensus        87 l~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g---i~H~D  150 (198)
T cd05144          87 LKALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG---IIHGD  150 (198)
T ss_pred             HHHHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC---CCcCC
Confidence            7777776  34444432    345899999999998765421         234567899999999999977   99999


Q ss_pred             CCCCceeeCCCCcEEEeeccccccccC
Q 015027          214 VKSANILLNDNYTAKVADFESSVLISS  240 (414)
Q Consensus       214 lkp~NIll~~~~~~kl~DfGla~~~~~  240 (414)
                      |||+||+++.++.++|+|||++.....
T Consensus       151 l~p~Nill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         151 LSEFNILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             CCcccEEEcCCCcEEEEECCccccCCC
Confidence            999999999999999999999865543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>smart00090 RIO RIO-like kinase

Probab=99.78  E-value=2.1e-18  Score=156.39  Aligned_cols=148  Identities=20%  Similarity=0.235  Sum_probs=108.9

Q ss_pred             HHHHhcCCCCCCccccCCceEEEEEE--EcCCcEEEEEEeecccch-------------------------hHhHHHHHH
Q 015027           82 MIRATKNFDRSRCLSQGGFVSVYKGV--LHDNIQVAVKTYRRADKI-------------------------RITERELLR  134 (414)
Q Consensus        82 ~~~~~~~~~~~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~-------------------------~~~~~~~~~  134 (414)
                      +......|.+.+.||+|+||.||+|.  ..+|+.||+|++......                         ......++.
T Consensus        23 ~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~  102 (237)
T smart00090       23 LLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFR  102 (237)
T ss_pred             HHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHH
Confidence            33444468889999999999999998  457999999998754210                         011234557


Q ss_pred             HHHccCCC--ceeeeeeeEecCCcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeC
Q 015027          135 IISQVNHK--NVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHG  212 (414)
Q Consensus       135 ~l~~l~hp--niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~  212 (414)
                      .+.++.+.  .+++++++    ...++||||++|++|........   .........++.||+.++.+||+.+  +++||
T Consensus       103 ~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~  173 (237)
T smart00090      103 NLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV---EPEEEEEFELYDDILEEMRKLYKEG--ELVHG  173 (237)
T ss_pred             HHHHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccccC---CcchHHHHHHHHHHHHHHHHHHhcC--CEEeC
Confidence            77777653  33444443    23589999999988876542221   2244566789999999999999854  29999


Q ss_pred             CCCCCceeeCCCCcEEEeecccccccc
Q 015027          213 DVKSANILLNDNYTAKVADFESSVLIS  239 (414)
Q Consensus       213 Dlkp~NIll~~~~~~kl~DfGla~~~~  239 (414)
                      ||||+||+++ ++.++|+|||.+....
T Consensus       174 Dikp~NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      174 DLSEYNILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             CCChhhEEEE-CCCEEEEEChhhhccC
Confidence            9999999999 8899999999987544

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.77  E-value=2.5e-19  Score=182.49  Aligned_cols=209  Identities=22%  Similarity=0.302  Sum_probs=141.1

Q ss_pred             hcCCCCCCccccCCceEEEEEEEcC-CcEEEEEEeecccchhHhHHHHHH-HHHccCCCceeeeeeeEecCCcceEEEEe
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLHD-NIQVAVKTYRRADKIRITERELLR-IISQVNHKNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~-~l~~l~hpniv~l~~~~~~~~~~~lv~e~  163 (414)
                      ..+|+.++.+..|+||.||..+++. .+.+|+|+- +....       ++ ++.....|.+|                  
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiN-kq~li-------lRnilt~a~npfvv------------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKIN-KQNLI-------LRNILTFAGNPFVV------------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhccc-ccchh-------hhccccccCCccee------------------
Confidence            4679999999999999999999764 667888532 22110       11 23333334333                  


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcc
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE  243 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  243 (414)
                         |+-...+..-+..   +        .+++.+++|||+.+   |+|||+||+|.+|..-|++|++|||+++.-.....
T Consensus       136 ---gDc~tllk~~g~l---P--------vdmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a  198 (1205)
T KOG0606|consen  136 ---GDCATLLKNIGPL---P--------VDMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA  198 (1205)
T ss_pred             ---chhhhhcccCCCC---c--------chhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence               2323333221221   2        12378899999988   99999999999999999999999998864322111


Q ss_pred             -------------ccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhh
Q 015027          244 -------------TAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNS  310 (414)
Q Consensus       244 -------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  310 (414)
                                   .-....++|||.|.|||++..+.|...+|+|++|+|+||++-|..||.+.+.+.         .+..
T Consensus       199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee---------lfg~  269 (1205)
T KOG0606|consen  199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE---------LFGQ  269 (1205)
T ss_pred             chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH---------HHhh
Confidence                         111234689999999999999999999999999999999999999997554322         1111


Q ss_pred             hcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCC
Q 015027          311 IKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPT  353 (414)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps  353 (414)
                      +.....      .+.. .....+.++++++.++|+.+|..|--
T Consensus       270 visd~i------~wpE-~dea~p~Ea~dli~~LL~qnp~~Rlg  305 (1205)
T KOG0606|consen  270 VISDDI------EWPE-EDEALPPEAQDLIEQLLRQNPLCRLG  305 (1205)
T ss_pred             hhhhhc------cccc-cCcCCCHHHHHHHHHHHHhChHhhcc
Confidence            100000      0000 01112256899999999999999953

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.76  E-value=8.1e-18  Score=149.06  Aligned_cols=129  Identities=19%  Similarity=0.292  Sum_probs=101.9

Q ss_pred             ccccCCceEEEEEEEcCCcEEEEEEeecccch---------hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeC
Q 015027           94 CLSQGGFVSVYKGVLHDNIQVAVKTYRRADKI---------RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFA  164 (414)
Q Consensus        94 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  164 (414)
                      .||+|+||.||+|.. ++..+++|........         ......+++++..+.|+++.....++......++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            389999999999985 6788999986543210         122245667888888887665555555666789999999


Q ss_pred             CCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccccc
Q 015027          165 SNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVL  237 (414)
Q Consensus       165 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~  237 (414)
                      +|++|.+.+.....          .++.+++.+|.+||+.+   ++|+|++|.||+++ ++.++++|||++..
T Consensus        80 ~g~~l~~~~~~~~~----------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGND----------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcHH----------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            99999988743211          67899999999999988   99999999999999 88999999998765

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.74  E-value=1.5e-17  Score=168.93  Aligned_cols=138  Identities=16%  Similarity=0.230  Sum_probs=108.8

Q ss_pred             HhcCCCCCCccccCCceEEEEEEEcCCcEEEEEEee-cccc--------hhHhHHHHHHHHHccCCCceeeeeeeEecCC
Q 015027           85 ATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYR-RADK--------IRITERELLRIISQVNHKNVVKILGLCLETE  155 (414)
Q Consensus        85 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~-~~~~--------~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~  155 (414)
                      ....|...+.||+|+||+||+|.+.+. .+++|... ....        .......|++++..++|++++....++....
T Consensus       331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~  409 (535)
T PRK09605        331 VKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE  409 (535)
T ss_pred             cccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence            345567789999999999999987544 34444322 1111        1122356678999999999998887777777


Q ss_pred             cceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccc
Q 015027          156 VPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESS  235 (414)
Q Consensus       156 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla  235 (414)
                      ..++||||+++++|.+++.           ....++.+++.+|.+||+.+   ++||||||+|||+ .++.++|+|||++
T Consensus       410 ~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla  474 (535)
T PRK09605        410 EKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLG  474 (535)
T ss_pred             CCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccc
Confidence            8899999999999998874           34568999999999999988   9999999999999 5779999999998


Q ss_pred             ccc
Q 015027          236 VLI  238 (414)
Q Consensus       236 ~~~  238 (414)
                      +..
T Consensus       475 ~~~  477 (535)
T PRK09605        475 KYS  477 (535)
T ss_pred             ccC
Confidence            653

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.72  E-value=2e-17  Score=145.06  Aligned_cols=136  Identities=21%  Similarity=0.247  Sum_probs=94.9

Q ss_pred             CCccccCCceEEEEEEEcCCcEEEEEEeecccchhHhH-------------------------HHHHHHHHccCCC--ce
Q 015027           92 SRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITE-------------------------RELLRIISQVNHK--NV  144 (414)
Q Consensus        92 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~-------------------------~~~~~~l~~l~hp--ni  144 (414)
                      .+.||+|+||+||+|.+.+++.||||++..........                         ..+...+..+.+.  .+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            46799999999999998789999999987643211111                         1122333333322  23


Q ss_pred             eeeeeeEecCCcceEEEEeCCCCchhhh-hhhcCCcccCCHHHHHHHHHHHHHHHHHhhh-CCCCCeeeCCCCCCceeeC
Q 015027          145 VKILGLCLETEVPLLVYEFASNGTLLDH-IRCESSQVLKTWKTCLRIAAETASALDYLHS-LASPPIIHGDVKSANILLN  222 (414)
Q Consensus       145 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~iiH~Dlkp~NIll~  222 (414)
                      .+.+++    ...++||||++++.+... +.....    . ..+..++.+++.++.++|. .+   ++|+||||+||+++
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~----~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRL----L-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhhh----c-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE
Confidence            344433    246899999999644321 111100    1 4567789999999999998 77   99999999999999


Q ss_pred             CCCcEEEeeccccccccC
Q 015027          223 DNYTAKVADFESSVLISS  240 (414)
Q Consensus       223 ~~~~~kl~DfGla~~~~~  240 (414)
                       ++.++|+|||.+.....
T Consensus       150 -~~~~~liDfg~a~~~~~  166 (187)
T cd05119         150 -DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             -CCcEEEEECcccccccC
Confidence             89999999999876543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.70  E-value=3.8e-18  Score=173.20  Aligned_cols=253  Identities=21%  Similarity=0.253  Sum_probs=182.4

Q ss_pred             cCCCCCCccccCCceEEEEEEEcC--CcEEEEEEeecccchh---HhHHHHHHHHHccC-CCceeeeeeeEecCCcceEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLHD--NIQVAVKTYRRADKIR---ITERELLRIISQVN-HKNVVKILGLCLETEVPLLV  160 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~---~~~~~~~~~l~~l~-hpniv~l~~~~~~~~~~~lv  160 (414)
                      ..|.+.+.||+|+|+.|-......  ...+|+|.+.......   .....+..+-..+. |+|++.+++...+.+..+++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            457777889999999998887543  4557777665443111   11122233444454 99999999999999999999


Q ss_pred             EEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhh-hCCCCCeeeCCCCCCceeeCCCC-cEEEeeccccccc
Q 015027          161 YEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLH-SLASPPIIHGDVKSANILLNDNY-TAKVADFESSVLI  238 (414)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH-~~~~~~iiH~Dlkp~NIll~~~~-~~kl~DfGla~~~  238 (414)
                      ++|..|+++.+.+...... ..+....-.++.|+..++.|+| ..+   +.|+||||+|.+++.++ ..+++|||+|...
T Consensus       100 ~~~s~g~~~f~~i~~~~~~-~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~  175 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHPDST-GTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY  175 (601)
T ss_pred             cCcccccccccccccCCcc-CCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence            9999999999888322210 1133445567899999999999 766   99999999999999999 9999999999887


Q ss_pred             cC-Cccccceecccc-cccccchhhcccC-CCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccc
Q 015027          239 SS-DAETAMSTILIG-TSGYLDPVCINTG-KLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNG  315 (414)
Q Consensus       239 ~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (414)
                      .. ..........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+............+..        ..
T Consensus       176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~--------~~  247 (601)
T KOG0590|consen  176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKS--------NK  247 (601)
T ss_pred             cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecc--------cc
Confidence            76 444445556688 9999999999884 5567899999999999999999998754433321111111        00


Q ss_pred             cccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHH
Q 015027          316 LRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQV  357 (414)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v  357 (414)
                      ......      ..........+++.+++..+|..|.+.+++
T Consensus       248 ~~~~~~------~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~  283 (601)
T KOG0590|consen  248 GRFTQL------PWNSISDQAHDLLHKILKENPSNRLSIEEL  283 (601)
T ss_pred             cccccC------ccccCChhhhhcccccccCCchhccccccc
Confidence            000000      011111347889999999999999999887

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.69  E-value=3.8e-16  Score=131.27  Aligned_cols=135  Identities=23%  Similarity=0.220  Sum_probs=109.2

Q ss_pred             CCCccccCCceEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHccCC--CceeeeeeeEecCCcceEEEEeCCCCc
Q 015027           91 RSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNH--KNVVKILGLCLETEVPLLVYEFASNGT  168 (414)
Q Consensus        91 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h--pniv~l~~~~~~~~~~~lv~e~~~~gs  168 (414)
                      +.+.||+|+++.||++...+ ..+++|....... ......+...+..++|  .+++++++++...+..+++|||++++.
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~   79 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET   79 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence            35679999999999999854 7899999876543 2334455566777765  588999998888888999999999987


Q ss_pred             hhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccccc
Q 015027          169 LLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVL  237 (414)
Q Consensus       169 L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~  237 (414)
                      +..+          +......++.+++.++.++|.....+++|+|++|.||+++..+.+++.|||.+..
T Consensus        80 ~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          80 LDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             cccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            7654          3355567889999999999986445599999999999999989999999998764

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.64  E-value=3.1e-15  Score=135.92  Aligned_cols=134  Identities=15%  Similarity=0.197  Sum_probs=99.8

Q ss_pred             Cccc-cCCceEEEEEEEcCCcEEEEEEeecccc--------------hhHhHHHHHHHHHccCCCce--eeeeeeEecCC
Q 015027           93 RCLS-QGGFVSVYKGVLHDNIQVAVKTYRRADK--------------IRITERELLRIISQVNHKNV--VKILGLCLETE  155 (414)
Q Consensus        93 ~~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------~~~~~~~~~~~l~~l~hpni--v~l~~~~~~~~  155 (414)
                      ..|| .|+.|+||.+.. .+..++||.+.....              .......+++++..+.|++|  +..+++.....
T Consensus        37 ~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            4577 789999998877 477899998854211              11223456788888988875  66776644322


Q ss_pred             -c---ceEEEEeCCC-CchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEe
Q 015027          156 -V---PLLVYEFASN-GTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVA  230 (414)
Q Consensus       156 -~---~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~  230 (414)
                       .   .++||||++| .+|.+++...    .++..    .+.+|+.+|.+||+.|   |+|+||||.|||++.++.++|+
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI  184 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI  184 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence             2   2599999997 6888887432    22332    3578999999999988   9999999999999998999999


Q ss_pred             eccccccc
Q 015027          231 DFESSVLI  238 (414)
Q Consensus       231 DfGla~~~  238 (414)
                      |||.+...
T Consensus       185 Dfg~~~~~  192 (239)
T PRK01723        185 DFDRGELR  192 (239)
T ss_pred             ECCCcccC
Confidence            99988753

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.55  E-value=5.7e-15  Score=133.42  Aligned_cols=203  Identities=23%  Similarity=0.284  Sum_probs=138.8

Q ss_pred             HHHccCCCceeeeeeeEecC-----CcceEEEEeCCCCchhhhhhhc-CCcccCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 015027          135 IISQVNHKNVVKILGLCLET-----EVPLLVYEFASNGTLLDHIRCE-SSQVLKTWKTCLRIAAETASALDYLHSLASPP  208 (414)
Q Consensus       135 ~l~~l~hpniv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~  208 (414)
                      -+-++.|.|||+++.++.+.     ....++.|||..|+|..+|+.. ..+..+......+++.||+.||.|||+.. ++
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-Pp  198 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-PP  198 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-Cc
Confidence            44556799999999998654     3568899999999999999653 23344456666789999999999999987 89


Q ss_pred             eeeCCCCCCceeeCCCCcEEEeecccccccc--CCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhC
Q 015027          209 IIHGDVKSANILLNDNYTAKVADFESSVLIS--SDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTG  286 (414)
Q Consensus       209 iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~--~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg  286 (414)
                      |+|+++..+.|++..+|-+|++----...-.  ............+.++|.|||.-...+.+-.+|||+||+...||..+
T Consensus       199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail  278 (458)
T KOG1266|consen  199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL  278 (458)
T ss_pred             cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence            9999999999999999999986321110000  00011112233567899999987777788899999999999999888


Q ss_pred             CCCCCccccccccccccchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          287 KKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       287 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ..--......-     ..+....    +.....-+..            =.+++.+|++..|..||+|++++.
T Consensus       279 Eiq~tnseS~~-----~~ee~ia----~~i~~len~l------------qr~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  279 EIQSTNSESKV-----EVEENIA----NVIIGLENGL------------QRGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             eeccCCCccee-----ehhhhhh----hheeeccCcc------------ccCcCcccccCCCCCCcchhhhhc
Confidence            65321111000     0000000    0000000110            246889999999999999998764

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.54  E-value=5.1e-14  Score=138.85  Aligned_cols=141  Identities=20%  Similarity=0.168  Sum_probs=94.6

Q ss_pred             CCccccCCceEEEEEEEcCCcEEEEEEeecccchhH-----------------------------------------hHH
Q 015027           92 SRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRI-----------------------------------------TER  130 (414)
Q Consensus        92 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-----------------------------------------~~~  130 (414)
                      .+.||.|++|.||+|++.+|+.||||+.++.-....                                         .+.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            367999999999999999999999999865421100                                         001


Q ss_pred             HHHHHHHc----cCCCceeeeeeeE-ecCCcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHH-HHHHhhhC
Q 015027          131 ELLRIISQ----VNHKNVVKILGLC-LETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETAS-ALDYLHSL  204 (414)
Q Consensus       131 ~~~~~l~~----l~hpniv~l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~-~l~~LH~~  204 (414)
                      .|.+.+.+    +.|.+-+.+-..+ ......++||||++|++|.+.........  .   ...++..++. .+..+|..
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~--~---~~~ia~~~~~~~l~ql~~~  276 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL--D---RKALAENLARSFLNQVLRD  276 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC--C---HHHHHHHHHHHHHHHHHhC
Confidence            11122222    2232223322222 22345789999999999988764321111  1   2345555555 46788887


Q ss_pred             CCCCeeeCCCCCCceeeCCCCcEEEeeccccccccC
Q 015027          205 ASPPIIHGDVKSANILLNDNYTAKVADFESSVLISS  240 (414)
Q Consensus       205 ~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  240 (414)
                      |   ++|+|+||.||+++.++.++++|||++..+..
T Consensus       277 g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       277 G---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             C---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            7   99999999999999999999999999877653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.46  E-value=3.9e-13  Score=115.69  Aligned_cols=131  Identities=19%  Similarity=0.161  Sum_probs=92.5

Q ss_pred             CCccccCCceEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHccCCCce-eeeeeeEecCCcceEEEEeCCCCchh
Q 015027           92 SRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNV-VKILGLCLETEVPLLVYEFASNGTLL  170 (414)
Q Consensus        92 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpni-v~l~~~~~~~~~~~lv~e~~~~gsL~  170 (414)
                      ++.|+.|.++.||++.. .+..+++|..............+...+..+.+.++ ++++.+.  ....++||||++|.++.
T Consensus         3 ~~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~   79 (170)
T cd05151           3 ISPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL   79 (170)
T ss_pred             eeecCCcccCceEEEEE-CCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence            35688999999999987 47789999986654222223344455665544443 4455543  33458999999998876


Q ss_pred             hhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCC--CCCeeeCCCCCCceeeCCCCcEEEeecccccc
Q 015027          171 DHIRCESSQVLKTWKTCLRIAAETASALDYLHSLA--SPPIIHGDVKSANILLNDNYTAKVADFESSVL  237 (414)
Q Consensus       171 ~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~--~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~  237 (414)
                      +.-      .     ....++.+++.+|+.||..+  ...++|+|++|.||+++ ++.++++|||.+..
T Consensus        80 ~~~------~-----~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          80 TED------F-----SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             ccc------c-----cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            430      0     01235678999999999876  23359999999999999 66899999998753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.45  E-value=1.5e-13  Score=137.11  Aligned_cols=144  Identities=17%  Similarity=0.119  Sum_probs=90.1

Q ss_pred             hcCCCCCCccccCCceEEEEEEEcC-CcEEEEEEeecccchh-----------------------------------Hh-
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLHD-NIQVAVKTYRRADKIR-----------------------------------IT-  128 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~-----------------------------------~~-  128 (414)
                      -..|+. +.||.|++|.||+|++++ |+.||||+.++.-...                                   .. 
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            345776 789999999999999887 9999999997542100                                   00 


Q ss_pred             -----HHHHHHHHHc----cCCCceeeeeeeEec-CCcceEEEEeCCCCchhhhh--hhcCC-cccCCHHHHHHHHHHHH
Q 015027          129 -----ERELLRIISQ----VNHKNVVKILGLCLE-TEVPLLVYEFASNGTLLDHI--RCESS-QVLKTWKTCLRIAAETA  195 (414)
Q Consensus       129 -----~~~~~~~l~~----l~hpniv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l--~~~~~-~~~~~~~~~~~i~~~i~  195 (414)
                           ...++..+.+    +.+.+.+.+-.++.+ ....+|||||++|+.+.+..  ...+. ...+....+..++.|+ 
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-  276 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-  276 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence                 0111111111    223333333333322 34567999999999997743  22111 0111222222333333 


Q ss_pred             HHHHHhhhCCCCCeeeCCCCCCceeeCCCC----cEEEeeccccccccC
Q 015027          196 SALDYLHSLASPPIIHGDVKSANILLNDNY----TAKVADFESSVLISS  240 (414)
Q Consensus       196 ~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~----~~kl~DfGla~~~~~  240 (414)
                            ...|   ++|+|+||.||+++.++    .+++.|||++..+..
T Consensus       277 ------f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        277 ------FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             ------HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                  3445   99999999999999887    999999999887654

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.42  E-value=4.3e-12  Score=125.28  Aligned_cols=166  Identities=19%  Similarity=0.234  Sum_probs=123.4

Q ss_pred             EcCCcEEEEEEeecccch-hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCCCCchhhhhhhcCCcccCCHHH
Q 015027          108 LHDNIQVAVKTYRRADKI-RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKT  186 (414)
Q Consensus       108 ~~~~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~  186 (414)
                      ..++.+|.|...+..... .....+.++.|+.++||||+++++.+..++..|||+|-+  ..|..++...+      ...
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~------~~~  105 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG------KEE  105 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH------HHH
Confidence            336888888888766551 112345568899999999999999999999999999988  45666665433      344


Q ss_pred             HHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccccceecccccccccchhhcccCC
Q 015027          187 CLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGK  266 (414)
Q Consensus       187 ~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  266 (414)
                      ...-+.||+.||.|||+.+  +++|++|..+.|+++..|..||++|.++.....-..  ......--..|..|+.+....
T Consensus       106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~  181 (690)
T KOG1243|consen  106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE  181 (690)
T ss_pred             HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc
Confidence            5567899999999999744  499999999999999999999999988755433211  111122233467776554333


Q ss_pred             CCCcccchhHHHHHHHHHhCC
Q 015027          267 LTKKSDVYSFGVVLAELLTGK  287 (414)
Q Consensus       267 ~~~~~Dv~SlGvil~el~tg~  287 (414)
                        -..|.|-|||+++|++.|.
T Consensus       182 --~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  182 --WSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             --cchhhhhHHHHHHHHhCcc
Confidence              4579999999999999993

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.41  E-value=3.4e-13  Score=131.60  Aligned_cols=247  Identities=21%  Similarity=0.161  Sum_probs=170.1

Q ss_pred             cCCCCCCcccc--CCceEEEEEEE--c-CCcEEEEEEeecccc---hhHhHHHHHHHHHcc-CCCceeeeeeeEecCCcc
Q 015027           87 KNFDRSRCLSQ--GGFVSVYKGVL--H-DNIQVAVKTYRRADK---IRITERELLRIISQV-NHKNVVKILGLCLETEVP  157 (414)
Q Consensus        87 ~~~~~~~~lg~--G~~g~Vy~~~~--~-~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l-~hpniv~l~~~~~~~~~~  157 (414)
                      ..|.+...+|.  |.+|.||.+..  . ++..+|+|.-+....   ....-..++....++ .|+|.++.+..+...+..
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l  193 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL  193 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence            45777888999  99999999986  3 578899987332211   111111222222222 599999999999999999


Q ss_pred             eEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHH----HHHHhhhCCCCCeeeCCCCCCceeeCCC-CcEEEeec
Q 015027          158 LLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETAS----ALDYLHSLASPPIIHGDVKSANILLNDN-YTAKVADF  232 (414)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~----~l~~LH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~Df  232 (414)
                      |+-+|+|. .+|..+.......  ++...++..+.+...    ||.++|+..   ++|-|+||.||+...+ ...+++||
T Consensus       194 fiqtE~~~-~sl~~~~~~~~~~--~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df  267 (524)
T KOG0601|consen  194 FIQTELCG-ESLQSYCHTPCNF--LPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDF  267 (524)
T ss_pred             eeeecccc-chhHHhhhccccc--CCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCc
Confidence            99999995 5777766543332  355677778888888    999999977   9999999999999998 89999999


Q ss_pred             cccccccCCccccc---eecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhh
Q 015027          233 ESSVLISSDAETAM---STILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLN  309 (414)
Q Consensus       233 Gla~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~  309 (414)
                      |+...+....-...   .....|...|++||... .-++..+|+|++|.++.+-.+|..+......     .+     +.
T Consensus       268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~-----~~-----W~  336 (524)
T KOG0601|consen  268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKN-----SS-----WS  336 (524)
T ss_pred             ceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCC-----CC-----cc
Confidence            99987765432211   12225677899999875 5678899999999999999998766432110     00     00


Q ss_pred             hhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHH
Q 015027          310 SIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVS  358 (414)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~  358 (414)
                      ......        +..++-......+..++..+++.+|..|++.+.+.
T Consensus       337 ~~r~~~--------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~  377 (524)
T KOG0601|consen  337 QLRQGY--------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT  377 (524)
T ss_pred             cccccc--------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence            000000        11111111123366699999999999999876653

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.29  E-value=3.8e-12  Score=124.36  Aligned_cols=256  Identities=18%  Similarity=0.189  Sum_probs=172.3

Q ss_pred             cccHHH-HHHHhcCCCCCCccccCCceEEEEEEEc--CCcEEEEEEeecccchhHhH---HHHHHHHH-ccCCCceeeee
Q 015027           76 IFSKSE-MIRATKNFDRSRCLSQGGFVSVYKGVLH--DNIQVAVKTYRRADKIRITE---RELLRIIS-QVNHKNVVKIL  148 (414)
Q Consensus        76 ~~~~~~-~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~---~~~~~~l~-~l~hpniv~l~  148 (414)
                      .|...+ ......+|..+..||.|.|+.|+.....  ++..+++|.+...-......   ..+..+.. ...|.+++.++
T Consensus       253 i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~  332 (524)
T KOG0601|consen  253 IFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKN  332 (524)
T ss_pred             eecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCC
Confidence            333334 3444568899999999999999988743  57889999876543322211   11212222 23588999988


Q ss_pred             eeEecCCcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCC-CcE
Q 015027          149 GLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDN-YTA  227 (414)
Q Consensus       149 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~-~~~  227 (414)
                      ..|......|+=-|||+++++.....   ....+.....+++..+++.++.++|+..   ++|+|+||+||++..+ +..
T Consensus       333 ~~W~~~r~~~ip~e~~~~~s~~l~~~---~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~  406 (524)
T KOG0601|consen  333 SSWSQLRQGYIPLEFCEGGSSSLRSV---TSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFS  406 (524)
T ss_pred             CCccccccccCchhhhcCcchhhhhH---HHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhh
Confidence            88888788889999999998866552   2223355677889999999999999877   9999999999999876 888


Q ss_pred             EEeeccccccccCCccccceeccccccccc--chhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccch
Q 015027          228 KVADFESSVLISSDAETAMSTILIGTSGYL--DPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVP  305 (414)
Q Consensus       228 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~  305 (414)
                      +++|||.+.-+...     ......+-+++  +|+......+..+.|+||||..+.+.++|.+--....           
T Consensus       407 ~~~~~~~~t~~~~~-----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~-----------  470 (524)
T KOG0601|consen  407 KLGDFGCWTRLAFS-----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV-----------  470 (524)
T ss_pred             hcccccccccccee-----cccccccccccccchhhccccccccccccccccccccccccCcccCcccc-----------
Confidence            99999988642211     11112222344  5666667788899999999999999999875321000           


Q ss_pred             hhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHH
Q 015027          306 YFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL  364 (414)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i  364 (414)
                               ....+.........  .....+..+...++..++..||.+.++....+..
T Consensus       471 ---------~~~~i~~~~~p~~~--~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  471 ---------QSLTIRSGDTPNLP--GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             ---------cceeeecccccCCC--chHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence                     00000000000000  1114478889999999999999988876554443

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.27  E-value=1.2e-10  Score=101.52  Aligned_cols=136  Identities=15%  Similarity=0.180  Sum_probs=94.4

Q ss_pred             CCccccCCceEEEEEEEcC-------CcEEEEEEeeccc--------------c---------hhHhH----HHHHHHHH
Q 015027           92 SRCLSQGGFVSVYKGVLHD-------NIQVAVKTYRRAD--------------K---------IRITE----RELLRIIS  137 (414)
Q Consensus        92 ~~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~--------------~---------~~~~~----~~~~~~l~  137 (414)
                      ...||.|--+.||.|...+       +..+|||+.+...              .         .....    ..|.+.|.
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3568999999999998543       4789999975321              0         00011    24556666


Q ss_pred             ccCC--CceeeeeeeEecCCcceEEEEeCCCCchhh-hhhhcCCcccCCHHHHHHHHHHHHHHHHHh-hhCCCCCeeeCC
Q 015027          138 QVNH--KNVVKILGLCLETEVPLLVYEFASNGTLLD-HIRCESSQVLKTWKTCLRIAAETASALDYL-HSLASPPIIHGD  213 (414)
Q Consensus       138 ~l~h--pniv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~~~~i~~~i~~~l~~L-H~~~~~~iiH~D  213 (414)
                      ++..  -++++.+++    ..-+|||||+.+..+.. .+..    ..++......+..+++.+|..+ |..+   ++|+|
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd----~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGD  150 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD----AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHAD  150 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc----cccCHHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence            6643  456666654    45689999997754422 2211    1223445667789999999999 7877   99999


Q ss_pred             CCCCceeeCCCCcEEEeecccccccc
Q 015027          214 VKSANILLNDNYTAKVADFESSVLIS  239 (414)
Q Consensus       214 lkp~NIll~~~~~~kl~DfGla~~~~  239 (414)
                      |++.||+++ ++.+.|+|||.+....
T Consensus       151 Ls~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         151 LSEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             CCHHHEEEE-CCcEEEEECCCceeCC
Confidence            999999997 4689999999887654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.26  E-value=8.8e-11  Score=105.49  Aligned_cols=141  Identities=23%  Similarity=0.267  Sum_probs=102.1

Q ss_pred             CccccCCceEEEEEEEcCCcEEEEEEeecccc--hhHhHHHHHHHHHccCC--CceeeeeeeEecC---CcceEEEEeCC
Q 015027           93 RCLSQGGFVSVYKGVLHDNIQVAVKTYRRADK--IRITERELLRIISQVNH--KNVVKILGLCLET---EVPLLVYEFAS  165 (414)
Q Consensus        93 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~l~~l~h--pniv~l~~~~~~~---~~~~lv~e~~~  165 (414)
                      +.|+.|.++.||++...+|..+++|.......  .......+.+++..+.+  .++.+++.+....   +..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            56899999999999886678999999765433  22233445566666654  4457777776654   36789999999


Q ss_pred             CCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCC----------------------------------------
Q 015027          166 NGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLA----------------------------------------  205 (414)
Q Consensus       166 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~----------------------------------------  205 (414)
                      |.++.+.+..    ..++......++.+++++|..||+..                                        
T Consensus        84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            9988775521    12355566677778888888777421                                        


Q ss_pred             -------------CCCeeeCCCCCCceeeCC--CCcEEEeecccccc
Q 015027          206 -------------SPPIIHGDVKSANILLND--NYTAKVADFESSVL  237 (414)
Q Consensus       206 -------------~~~iiH~Dlkp~NIll~~--~~~~kl~DfGla~~  237 (414)
                                   ...++|+|++|.||+++.  ++.+.|+||+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                         245799999999999998  67789999997754

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.23  E-value=2.5e-12  Score=132.11  Aligned_cols=247  Identities=21%  Similarity=0.203  Sum_probs=166.4

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhHhH----HHHHHHHHccCCCceeeeeeeEecCCcceEE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRITE----RELLRIISQVNHKNVVKILGLCLETEVPLLV  160 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~----~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv  160 (414)
                      .+.|.+.+-+-.|+++.++.+.-. .|...++|............    ...-.++-...||.++...-.+.-....+||
T Consensus       803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~  882 (1205)
T KOG0606|consen  803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV  882 (1205)
T ss_pred             CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence            356667778889999999987743 35445555544333222111    1111112223456666655555556778999


Q ss_pred             EEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccC
Q 015027          161 YEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISS  240 (414)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  240 (414)
                      ++|+.+++|...++..+.   .+.......+..+..++++||...   +.|+|++|.|+|+..+++.+++|||.......
T Consensus       883 ~~~~~~~~~~Skl~~~~~---~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~  956 (1205)
T KOG0606|consen  883 GHYLNGGDLPSKLHNSGC---LSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL  956 (1205)
T ss_pred             hHHhccCCchhhhhcCCC---cccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccccc
Confidence            999999999988865552   244455667788899999999865   89999999999999999999999984322110


Q ss_pred             C-----------------------------ccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCC
Q 015027          241 D-----------------------------AETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGS  291 (414)
Q Consensus       241 ~-----------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~  291 (414)
                      -                             ..........+|+.|.+||.+.+......+|+|++|++++|.++|.+||.
T Consensus       957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen  957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred             ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence            0                             00011234578999999999999999999999999999999999999987


Q ss_pred             ccccccccccccchhhhhhhcccccccccccccCCc-ccHHHHHHHHHHHHHhhccCCCCCCChh
Q 015027          292 CMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADE-SEMKEIEIVAELASKCLRIRGTERPTMK  355 (414)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~Li~~cl~~dP~~Rps~~  355 (414)
                      .......                 +..+.+...... -+...+....+++...+..+|.+|..+.
T Consensus      1037 a~tpq~~-----------------f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1037 AETPQQI-----------------FENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             Ccchhhh-----------------hhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            4432221                 111111111111 1112235588999999999999998765

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.20  E-value=2.3e-10  Score=96.64  Aligned_cols=130  Identities=20%  Similarity=0.276  Sum_probs=93.6

Q ss_pred             CccccCCceEEEEEEEcCCcEEEEEEeeccc----chh-----HhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEe
Q 015027           93 RCLSQGGFVSVYKGVLHDNIQVAVKTYRRAD----KIR-----ITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        93 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~-----~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  163 (414)
                      ..+++|+-+.+|.+.+. |.++++|.-.+..    ...     ..-..+.+++.++.--.|..-.=+..+.....|+|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            35789999999999763 4456666533221    111     1124456777777655555444455566777899999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccccc
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVL  237 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~  237 (414)
                      ++|-.|.+.+...          ...++..|-.-+.-||..+   |+|+||.++||++.... +.++|||++..
T Consensus        81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999999888544          1345677777788899988   99999999999998764 99999999864

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.13  E-value=1.3e-09  Score=104.85  Aligned_cols=167  Identities=18%  Similarity=0.285  Sum_probs=125.7

Q ss_pred             ceEEEEEEEc-CCcEEEEEEeecccchhH-hHHHHHHHHHccCCCceeeeeeeEe----cCCcceEEEEeCCCC-chhhh
Q 015027          100 FVSVYKGVLH-DNIQVAVKTYRRADKIRI-TERELLRIISQVNHKNVVKILGLCL----ETEVPLLVYEFASNG-TLLDH  172 (414)
Q Consensus       100 ~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~~~l~~l~hpniv~l~~~~~----~~~~~~lv~e~~~~g-sL~~~  172 (414)
                      -.+.|++... +|..|++|+++.+..... ......++.+++.|+|+|++.++|.    .+..+++||+|.|+. +|.++
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            4678999854 799999999954432221 2233457788999999999999886    345678999999874 78776


Q ss_pred             hhhcCC------------cccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccC
Q 015027          173 IRCESS------------QVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISS  240 (414)
Q Consensus       173 l~~~~~------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  240 (414)
                      ......            ....++..+|.++.|++.||.++|+.|   +..+-|.|.+|+++.+.+++|+..|+...+..
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            543221            223467889999999999999999988   88899999999999999999999988776654


Q ss_pred             CccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCC
Q 015027          241 DAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKK  288 (414)
Q Consensus       241 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~  288 (414)
                      +.              .+|  +.   --.+-|.=.||.+++.|.||..
T Consensus       446 d~--------------~~~--le---~~Qq~D~~~lG~ll~aLAt~~~  474 (655)
T KOG3741|consen  446 DP--------------TEP--LE---SQQQNDLRDLGLLLLALATGTE  474 (655)
T ss_pred             CC--------------Ccc--hh---HHhhhhHHHHHHHHHHHhhccc
Confidence            42              111  11   1235688899999999999954

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.13  E-value=6.5e-09  Score=97.82  Aligned_cols=266  Identities=20%  Similarity=0.180  Sum_probs=160.0

Q ss_pred             CCCccccCCceEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHH-ccCCCceeeeeeeE-------ecCCcceEEEE
Q 015027           91 RSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIIS-QVNHKNVVKILGLC-------LETEVPLLVYE  162 (414)
Q Consensus        91 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~-~l~hpniv~l~~~~-------~~~~~~~lv~e  162 (414)
                      ..+.||+|+-+.+|-.-.  -...+-|+............  ...|. .-.||-+-.=+.|-       ..+...-++|.
T Consensus        15 ~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~aqk--~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP   90 (637)
T COG4248          15 PGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQAQK--VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP   90 (637)
T ss_pred             CCccccCCccceeeecch--hhchhheeecCCCchHHHHH--HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence            356799999999994321  11223466654433222211  12232 33566443312221       11223567888


Q ss_pred             eCCCC-chhhhhh---hcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccc
Q 015027          163 FASNG-TLLDHIR---CESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLI  238 (414)
Q Consensus       163 ~~~~g-sL~~~l~---~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~  238 (414)
                      .+++. ...+++.   +..+-....|...+++++.++.+.+.||..|   ..-+|+.++|+|+++++.|.|.|=..-...
T Consensus        91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi~  167 (637)
T COG4248          91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQIN  167 (637)
T ss_pred             cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceeec
Confidence            88765 2333332   2223345679999999999999999999988   899999999999999999999974322221


Q ss_pred             cCCccccceecccccccccchhhcc-----cCCCCCcccchhHHHHHHHHHhC-CCCCCccccccccccccchhhhh---
Q 015027          239 SSDAETAMSTILIGTSGYLDPVCIN-----TGKLTKKSDVYSFGVVLAELLTG-KKPGSCMTLASNKKISMVPYFLN---  309 (414)
Q Consensus       239 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~el~tg-~~p~~~~~~~~~~~~~~~~~~~~---  309 (414)
                      .   .....-..+|.+.|.+||...     +-.-+...|.|.||+++++++.| +.||++...........-.....   
T Consensus       168 ~---ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f  244 (637)
T COG4248         168 A---NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRF  244 (637)
T ss_pred             c---CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhccee
Confidence            1   222334568899999999764     44567789999999999999886 99998654332211111100000   


Q ss_pred             hhcccccccccccccCCcccHHHHHHHHHHHHHhhccC--CCCCCChhHHHHHHHHHHHh
Q 015027          310 SIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIR--GTERPTMKQVSEELDRLRRL  367 (414)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~d--P~~Rps~~~v~~~L~~i~~~  367 (414)
                      ......-........ .....-.++.+..|..+|+...  +.-|||++-.+..|..+...
T Consensus       245 ~ya~~~~~g~~p~P~-~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~  303 (637)
T COG4248         245 AYASDQRRGLKPPPR-SIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ  303 (637)
T ss_pred             eechhccCCCCCCCC-CCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence            000000000000000 0111122366889999999764  56899999988888877754

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.12  E-value=1.1e-09  Score=92.20  Aligned_cols=142  Identities=20%  Similarity=0.227  Sum_probs=99.3

Q ss_pred             CCCccccCCceEEEEEEEcCCcEEEEEEeeccc---------chhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEE
Q 015027           91 RSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRAD---------KIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        91 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---------~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~  161 (414)
                      .+..+-||+-+.|+++.+ .|+...||.-....         .....-..+.+.+.++.--.|.--.=++.+...-.|+|
T Consensus        11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            566788999999999988 66777777532211         11122245567777765545554444555666677999


Q ss_pred             EeCCC-CchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCC---cEEEeecccccc
Q 015027          162 EFASN-GTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNY---TAKVADFESSVL  237 (414)
Q Consensus       162 e~~~~-gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~---~~kl~DfGla~~  237 (414)
                      ||++| .++.+++........ .......++..|-..+.-||.++   |||+||..+||++..++   .+.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~-~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDES-EDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCcc-cchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence            99987 477888765443332 22233678889999999999988   99999999999996543   458999999754

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.02  E-value=3.1e-09  Score=92.33  Aligned_cols=125  Identities=26%  Similarity=0.329  Sum_probs=79.0

Q ss_pred             EEEEEEEcCCcEEEEEEeeccc--------------c-------------hhHhHHHHHHHHHccCCC--ceeeeeeeEe
Q 015027          102 SVYKGVLHDNIQVAVKTYRRAD--------------K-------------IRITERELLRIISQVNHK--NVVKILGLCL  152 (414)
Q Consensus       102 ~Vy~~~~~~~~~vavK~~~~~~--------------~-------------~~~~~~~~~~~l~~l~hp--niv~l~~~~~  152 (414)
                      .||.|...+|..+|||+.+...              .             .......|.+.|.++..-  ++++++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            4899999899999999975320              0             001124566788888765  466666552 


Q ss_pred             cCCcceEEEEeCC--CCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHH-hhhCCCCCeeeCCCCCCceeeCCCCcEEE
Q 015027          153 ETEVPLLVYEFAS--NGTLLDHIRCESSQVLKTWKTCLRIAAETASALDY-LHSLASPPIIHGDVKSANILLNDNYTAKV  229 (414)
Q Consensus       153 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~-LH~~~~~~iiH~Dlkp~NIll~~~~~~kl  229 (414)
                         .-+|||||++  |..+..+......     ......++.+++..+.. +|..|   ++|+||.+.||+++++ .+.+
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~~~-----~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i  147 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVDLS-----PEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI  147 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCGGG-----GSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred             ---CCEEEEEecCCCccchhhHHhcccc-----chhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence               3479999998  6555443321111     12234567777775555 56777   9999999999999987 9999


Q ss_pred             eecccccccc
Q 015027          230 ADFESSVLIS  239 (414)
Q Consensus       230 ~DfGla~~~~  239 (414)
                      +|||.+....
T Consensus       148 IDf~qav~~~  157 (188)
T PF01163_consen  148 IDFGQAVDSS  157 (188)
T ss_dssp             --GTTEEETT
T ss_pred             EecCcceecC
Confidence            9999887654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.98  E-value=1e-08  Score=94.40  Aligned_cols=138  Identities=13%  Similarity=0.042  Sum_probs=90.5

Q ss_pred             cccCCceEEEEEEEcCCcEEEEEEeecccch------------hHhHHHHHHHHHccCCCc--eeeeeeeEec-----CC
Q 015027           95 LSQGGFVSVYKGVLHDNIQVAVKTYRRADKI------------RITERELLRIISQVNHKN--VVKILGLCLE-----TE  155 (414)
Q Consensus        95 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------------~~~~~~~~~~l~~l~hpn--iv~l~~~~~~-----~~  155 (414)
                      +-......|+++.. +|+.+.||........            ......|.+.+.++..-+  .+..+++...     ..
T Consensus        30 v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~  108 (268)
T PRK15123         30 FRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR  108 (268)
T ss_pred             EecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence            34344445667655 6778999976433211            001333444444442222  2233444432     23


Q ss_pred             cceEEEEeCCCC-chhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCC-------CCcE
Q 015027          156 VPLLVYEFASNG-TLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLND-------NYTA  227 (414)
Q Consensus       156 ~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~-------~~~~  227 (414)
                      ..+||+|++++. +|.+++..... ...+......++.+++..+.-||..|   |+|+|++++|||++.       ++.+
T Consensus       109 ~s~LVte~l~~~~sL~~~~~~~~~-~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~  184 (268)
T PRK15123        109 TSFIITEDLAPTISLEDYCADWAT-NPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKL  184 (268)
T ss_pred             eeEEEEeeCCCCccHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceE
Confidence            468999999886 88888753221 22245666789999999999999988   999999999999975       5789


Q ss_pred             EEeecccccc
Q 015027          228 KVADFESSVL  237 (414)
Q Consensus       228 kl~DfGla~~  237 (414)
                      .|+||+.+..
T Consensus       185 ~LIDl~r~~~  194 (268)
T PRK15123        185 SVIDLHRAQI  194 (268)
T ss_pred             EEEECCcccc
Confidence            9999998754

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.88  E-value=5.8e-10  Score=110.82  Aligned_cols=152  Identities=25%  Similarity=0.311  Sum_probs=102.0

Q ss_pred             HHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccc-------cceecccccccccchhhcc
Q 015027          191 AAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET-------AMSTILIGTSGYLDPVCIN  263 (414)
Q Consensus       191 ~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~  263 (414)
                      +.+++.|+.|+|.  +.++||++|.|++|.++.++..||+.|+.+.........       ...........|.|||++.
T Consensus       105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            4456699999998  456999999999999999999999999987655442111       1111223455799999999


Q ss_pred             cCCCCCcccchhHHHHHHHHHhCCCC-CCccccccccccccchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHH
Q 015027          264 TGKLTKKSDVYSFGVVLAELLTGKKP-GSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASK  342 (414)
Q Consensus       264 ~~~~~~~~Dv~SlGvil~el~tg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~  342 (414)
                      +...+.++|+||+||++|-+..|..+ +......       ..+-.       .....+ .-....+...+.++.+=+.+
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~-------~~~~~-------~~~~~~-~~~~~~s~~~p~el~~~l~k  247 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGL-------LSYSF-------SRNLLN-AGAFGYSNNLPSELRESLKK  247 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccCCc-------chhhh-------hhcccc-cccccccccCcHHHHHHHHH
Confidence            98899999999999999999955544 3211100       00000       000000 00011112334668999999


Q ss_pred             hhccCCCCCCChhHHHH
Q 015027          343 CLRIRGTERPTMKQVSE  359 (414)
Q Consensus       343 cl~~dP~~Rps~~~v~~  359 (414)
                      ++..++.-||++..+..
T Consensus       248 ~l~~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  248 LLNGDSAVRPTLDLLLS  264 (700)
T ss_pred             HhcCCcccCcchhhhhc
Confidence            99999999998776643

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.83  E-value=3.9e-08  Score=88.19  Aligned_cols=137  Identities=19%  Similarity=0.174  Sum_probs=96.1

Q ss_pred             cCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccc-----------------------hhHhHHHHHHHHHccCCC-
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADK-----------------------IRITERELLRIISQVNHK-  142 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------------------~~~~~~~~~~~l~~l~hp-  142 (414)
                      .-..+...||-|--+.||.|....|.++|||.-+....                       .......+.+.|.+|... 
T Consensus        91 ~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G  170 (304)
T COG0478          91 IVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG  170 (304)
T ss_pred             hHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence            33456788999999999999999999999998642210                       112224455777777544 


Q ss_pred             -ceeeeeeeEecCCcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceee
Q 015027          143 -NVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILL  221 (414)
Q Consensus       143 -niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll  221 (414)
                       .+++.+++    +.-.+||||++|-.|...--        +.+..-.++..|+.-+.-+-..|   |+|+|+++-||++
T Consensus       171 ~~VP~P~~~----nRHaVvMe~ieG~eL~~~r~--------~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV  235 (304)
T COG0478         171 VKVPKPIAW----NRHAVVMEYIEGVELYRLRL--------DVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILV  235 (304)
T ss_pred             CCCCCcccc----ccceeeeehcccceeecccC--------cccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEE
Confidence             56666554    34579999999977654321        12223345555666555555666   9999999999999


Q ss_pred             CCCCcEEEeeccccccc
Q 015027          222 NDNYTAKVADFESSVLI  238 (414)
Q Consensus       222 ~~~~~~kl~DfGla~~~  238 (414)
                      +++|.+.++||--+...
T Consensus       236 ~~dg~~~vIDwPQ~v~~  252 (304)
T COG0478         236 TEDGDIVVIDWPQAVPI  252 (304)
T ss_pred             ecCCCEEEEeCcccccC
Confidence            99999999999866543

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.73  E-value=9.6e-08  Score=95.23  Aligned_cols=141  Identities=19%  Similarity=0.147  Sum_probs=86.8

Q ss_pred             CccccCCceEEEEEEEcCCcEEEEEEeecccchhHh-----------------------------------------HHH
Q 015027           93 RCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRIT-----------------------------------------ERE  131 (414)
Q Consensus        93 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~-----------------------------------------~~~  131 (414)
                      ..|+.++-|.||+|++++|+.||||+.++.-.....                                         ...
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            678999999999999999999999998653211100                                         001


Q ss_pred             HHHHHHc----c-CCCceeeeeeeEecCCcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCC
Q 015027          132 LLRIISQ----V-NHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLAS  206 (414)
Q Consensus       132 ~~~~l~~----l-~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~  206 (414)
                      |...+.+    + +.|++.--.=++.-.+...|+|||++|-.+.+........  .+.+.+.....++.  +.-+-..| 
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g--~d~k~ia~~~~~~f--~~q~~~dg-  285 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAG--IDRKELAELLVRAF--LRQLLRDG-  285 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcC--CCHHHHHHHHHHHH--HHHHHhcC-
Confidence            1111111    1 1233221111222345668999999999998875322211  13223222222221  22222234 


Q ss_pred             CCeeeCCCCCCceeeCCCCcEEEeeccccccccC
Q 015027          207 PPIIHGDVKSANILLNDNYTAKVADFESSVLISS  240 (414)
Q Consensus       207 ~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  240 (414)
                        ++|.|.+|.||+++.+|.+.+.|||+...+..
T Consensus       286 --ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         286 --FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             --ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence              99999999999999999999999999877654

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.56  E-value=1.1e-06  Score=78.00  Aligned_cols=89  Identities=17%  Similarity=0.168  Sum_probs=69.3

Q ss_pred             eeeeeeeEecCC----cceEEEEeCCCC-chhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCc
Q 015027          144 VVKILGLCLETE----VPLLVYEFASNG-TLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSAN  218 (414)
Q Consensus       144 iv~l~~~~~~~~----~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~N  218 (414)
                      .++.+++.....    ..++|+|++++. +|.+++.....   .+......++.+++..+.-||..|   |+|+|+++.|
T Consensus        75 tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i~~lH~~g---i~H~Dl~~~N  148 (206)
T PF06293_consen   75 TPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLIAKLHDAG---IYHGDLNPSN  148 (206)
T ss_pred             CCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHHHHHHHCc---CCCCCCCccc
Confidence            444555554422    348999999885 79888865322   244566788999999999999988   9999999999


Q ss_pred             eeeCCCC---cEEEeeccccccc
Q 015027          219 ILLNDNY---TAKVADFESSVLI  238 (414)
Q Consensus       219 Ill~~~~---~~kl~DfGla~~~  238 (414)
                      ||++.++   .+.++||+-+...
T Consensus       149 ILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  149 ILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             EEEeCCCCceeEEEEcchhceeC
Confidence            9999887   8999999987653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.56  E-value=1.3e-06  Score=76.65  Aligned_cols=136  Identities=19%  Similarity=0.103  Sum_probs=93.5

Q ss_pred             ccCCceEEEEEEEcCCcEEEEEEeecc-------cchhHhHHHHHHHHHccCCCc--eeeeeeeEec-----CCcceEEE
Q 015027           96 SQGGFVSVYKGVLHDNIQVAVKTYRRA-------DKIRITERELLRIISQVNHKN--VVKILGLCLE-----TEVPLLVY  161 (414)
Q Consensus        96 g~G~~g~Vy~~~~~~~~~vavK~~~~~-------~~~~~~~~~~~~~l~~l~hpn--iv~l~~~~~~-----~~~~~lv~  161 (414)
                      |+||.+.|+.... +|..+-+|.-...       .....++..|+..+.++..-+  +++.. ++..     .-..+||+
T Consensus        27 ~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         27 RRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT  104 (216)
T ss_pred             CCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence            6689999998776 4447888875411       113345555556555554222  44444 3321     12357999


Q ss_pred             EeCCC-CchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCc--EEEeecccccc
Q 015027          162 EFASN-GTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYT--AKVADFESSVL  237 (414)
Q Consensus       162 e~~~~-gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~--~kl~DfGla~~  237 (414)
                      |-++| -+|.+++...... ..+......++.+|+..+.-||+.|   +.|+|+.+.|||++.++.  ++++||.-++.
T Consensus       105 e~L~g~~~L~~~l~~~~~~-~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        105 EDMAGFISIADWYAQHAVS-PYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EeCCCCccHHHHHhcCCcC-CcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            98864 4888887543222 2355667789999999999999988   999999999999986667  99999987654

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.55  E-value=9.5e-09  Score=101.34  Aligned_cols=189  Identities=20%  Similarity=0.192  Sum_probs=136.8

Q ss_pred             hcCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHccCCCc-eeeeeeeEecCCcceEEEEeC
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHKN-VVKILGLCLETEVPLLVYEFA  164 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpn-iv~l~~~~~~~~~~~lv~e~~  164 (414)
                      +..+....-+++|+++.+||.+....+...++.+...    ...+-++++|.+++||| .+..++-+..+...+++++++
T Consensus       241 ~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~  316 (829)
T KOG0576|consen  241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRIC  316 (829)
T ss_pred             ccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhh
Confidence            3334444557899999999998655555556666554    23334468899999999 777777777788889999999


Q ss_pred             CCC-chhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcc
Q 015027          165 SNG-TLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE  243 (414)
Q Consensus       165 ~~g-sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  243 (414)
                      .++ +-.+....  ....+..-+...+++.-+++++++|+..   -+|+|    ||+..+ +..+.+||+....+.... 
T Consensus       317 s~~rs~~~~~~~--se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-  385 (829)
T KOG0576|consen  317 STGRSSALEMTV--SEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-  385 (829)
T ss_pred             cCCccccccCCh--hhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc-
Confidence            887 32222211  1111122334456677788999999853   48888    777775 689999999987765432 


Q ss_pred             ccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCC
Q 015027          244 TAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGS  291 (414)
Q Consensus       244 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~  291 (414)
                        ......+|+.++|||+.....+....|+|++|+-..++.-|.+|-.
T Consensus       386 --~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  386 --KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             --ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence              3455689999999999999999999999999988888888887744

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.50  E-value=2e-06  Score=77.47  Aligned_cols=138  Identities=14%  Similarity=0.144  Sum_probs=80.4

Q ss_pred             CccccCCceEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHccCCCc--eeeeeeeEecCCcceEEEEeCCCCc-h
Q 015027           93 RCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHKN--VVKILGLCLETEVPLLVYEFASNGT-L  169 (414)
Q Consensus        93 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpn--iv~l~~~~~~~~~~~lv~e~~~~gs-L  169 (414)
                      ..||+|..+.||+.   .+..+++|........ ....+|.+.++.+..-.  +.+.+++....+...+|||+++|.. +
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~~~-~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~   82 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGFDK-ETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF   82 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCCCH-HHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence            46899999999984   3556788987653322 22344556666664333  4667778777777889999999963 1


Q ss_pred             hhhh---------------------hhcCCcccCCHHHH-HHHHH----------HHHH-HHHHhhh-CCCCCeeeCCCC
Q 015027          170 LDHI---------------------RCESSQVLKTWKTC-LRIAA----------ETAS-ALDYLHS-LASPPIIHGDVK  215 (414)
Q Consensus       170 ~~~l---------------------~~~~~~~~~~~~~~-~~i~~----------~i~~-~l~~LH~-~~~~~iiH~Dlk  215 (414)
                      ...+                     +..... ....... ..+..          .+.. ...+|.. .....++|+|+.
T Consensus        83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~-~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~  161 (226)
T TIGR02172        83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKCD-TSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ  161 (226)
T ss_pred             hhhhcCCHHHHHHHHHHHHHHHHHHhCCCCC-CCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence            1111                     000000 0010100 00000          0111 1122221 112457999999


Q ss_pred             CCceeeCCCCcEEEeeccccc
Q 015027          216 SANILLNDNYTAKVADFESSV  236 (414)
Q Consensus       216 p~NIll~~~~~~kl~DfGla~  236 (414)
                      |.||++++++ +.++||+.+.
T Consensus       162 ~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       162 IGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCcEEEcCCC-cEEEechhcC
Confidence            9999999888 9999999764

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.46  E-value=2.1e-06  Score=75.63  Aligned_cols=136  Identities=16%  Similarity=0.175  Sum_probs=87.3

Q ss_pred             hcCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccchhHhH----------HHHHHHHHccC---CCceeeeeeeE-
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITE----------RELLRIISQVN---HKNVVKILGLC-  151 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~----------~~~~~~l~~l~---hpniv~l~~~~-  151 (414)
                      .++|...+.+-......|.+-.. +|..+++|..+......+..          ...+..+..+.   -.....++.+. 
T Consensus        30 ~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e  108 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE  108 (229)
T ss_pred             hCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence            46777778887777666766555 67889999876644322211          11112222222   22222222222 


Q ss_pred             ----ecCCcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcE
Q 015027          152 ----LETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTA  227 (414)
Q Consensus       152 ----~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~  227 (414)
                          .-....++||||++|..|.++..-       +.    .+...+.+++.-||..|   ++|+|++|.|++++++ .+
T Consensus       109 kk~~~~~~~~~ll~EYIeG~~l~d~~~i-------~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~i  173 (229)
T PF06176_consen  109 KKIFRYTSSYVLLMEYIEGVELNDIEDI-------DE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-GI  173 (229)
T ss_pred             eeeccceeEEEEEEEEecCeecccchhc-------CH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-cE
Confidence                222345689999999988765421       11    24466778899999988   9999999999999965 49


Q ss_pred             EEeecccccc
Q 015027          228 KVADFESSVL  237 (414)
Q Consensus       228 kl~DfGla~~  237 (414)
                      ++.||+..+.
T Consensus       174 ~iID~~~k~~  183 (229)
T PF06176_consen  174 RIIDTQGKRM  183 (229)
T ss_pred             EEEECccccc
Confidence            9999987553

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.44  E-value=1.6e-06  Score=86.42  Aligned_cols=139  Identities=17%  Similarity=0.147  Sum_probs=84.6

Q ss_pred             CccccCCceEEEEEEEcCCcEEEEEEeecccchh--H------------------------------------hHHHH--
Q 015027           93 RCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIR--I------------------------------------TEREL--  132 (414)
Q Consensus        93 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~------------------------------------~~~~~--  132 (414)
                      +.||.-+.|.||+|++++|+.||||+-++.-...  .                                    .+..|  
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            6689999999999999999999999975431110  0                                    00000  


Q ss_pred             --HHHHHccCCCc------eeeeeeeEecCCcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhC
Q 015027          133 --LRIISQVNHKN------VVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSL  204 (414)
Q Consensus       133 --~~~l~~l~hpn------iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~  204 (414)
                        -+....+.|-+      |++++-.+  .....|+||||+|..+.|.-.-.....  +...   ++..+.++.  +++.
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~gi--~~~~---i~~~l~~~~--~~qI  317 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRGI--SPHD---ILNKLVEAY--LEQI  317 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcCC--CHHH---HHHHHHHHH--HHHH
Confidence              01222233433      44443332  345689999999998877542222111  2233   333333321  1111


Q ss_pred             CCCCeeeCCCCCCceeeCC----CCcEEEeeccccccccC
Q 015027          205 ASPPIIHGDVKSANILLND----NYTAKVADFESSVLISS  240 (414)
Q Consensus       205 ~~~~iiH~Dlkp~NIll~~----~~~~kl~DfGla~~~~~  240 (414)
                      -..+++|+|-+|.||++..    ++.+.+-|||+......
T Consensus       318 f~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  318 FKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             HhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            1123999999999999983    67899999999876654

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.38  E-value=5.8e-06  Score=75.51  Aligned_cols=74  Identities=9%  Similarity=0.020  Sum_probs=47.0

Q ss_pred             cccCCc-eEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHccC-CCceeeeeeeEecCCcceEEEEeCCCCchhh
Q 015027           95 LSQGGF-VSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVN-HKNVVKILGLCLETEVPLLVYEFASNGTLLD  171 (414)
Q Consensus        95 lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~  171 (414)
                      |..|.+ ..||+.... +..+.||+.....  ......|++++..+. +--+.+++++...++..++|||+++|.+|..
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~   81 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA   81 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence            334444 789998764 4788999876542  111222334444332 3446677887776677899999999987754

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.34  E-value=3.5e-06  Score=76.00  Aligned_cols=143  Identities=23%  Similarity=0.249  Sum_probs=77.3

Q ss_pred             CCccccCCceEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHccCCC--ceeeeeeeEec---CCcceEEEEeCCC
Q 015027           92 SRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHK--NVVKILGLCLE---TEVPLLVYEFASN  166 (414)
Q Consensus        92 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hp--niv~l~~~~~~---~~~~~lv~e~~~~  166 (414)
                      ++.|+.|..+.||+....+ ..+++|..... ........+..++..+...  .+.+++.+...   ....+++|++++|
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g   79 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG   79 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred             CccCCCCCeeeEEEEEECC-cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence            3568999999999999866 69999997665 2222223333444444322  35566664432   3346899999999


Q ss_pred             Cchhh----------------hhh---hc-CCcccCCHHH---------HHHH------------HHHHHH-HHHHhhh-
Q 015027          167 GTLLD----------------HIR---CE-SSQVLKTWKT---------CLRI------------AAETAS-ALDYLHS-  203 (414)
Q Consensus       167 gsL~~----------------~l~---~~-~~~~~~~~~~---------~~~i------------~~~i~~-~l~~LH~-  203 (414)
                      ..+..                .+.   .. ..........         ....            ...+.. .+..++. 
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (239)
T PF01636_consen   80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL  159 (239)
T ss_dssp             EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence            87776                111   11 0000001100         0000            111222 2333332 


Q ss_pred             ---CCCCCeeeCCCCCCceeeC-CCCcEEEeeccccc
Q 015027          204 ---LASPPIIHGDVKSANILLN-DNYTAKVADFESSV  236 (414)
Q Consensus       204 ---~~~~~iiH~Dlkp~NIll~-~~~~~kl~DfGla~  236 (414)
                         .....++|+|+.|.|||++ +++.+.|+||+.+.
T Consensus       160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             hccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence               1235699999999999999 66667899998764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.32  E-value=1e-05  Score=72.09  Aligned_cols=151  Identities=21%  Similarity=0.255  Sum_probs=95.0

Q ss_pred             cHHHHHHHhcCCCCCC---ccccCCceEEEEEEEcCCcEEEEEEeecccchhHhH-------------------------
Q 015027           78 SKSEMIRATKNFDRSR---CLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITE-------------------------  129 (414)
Q Consensus        78 ~~~~~~~~~~~~~~~~---~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~-------------------------  129 (414)
                      +.+.+....++..+..   .|+.|--+.||+|...++..+|||+++.........                         
T Consensus        36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~  115 (268)
T COG1718          36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA  115 (268)
T ss_pred             HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence            3444555555555444   455677778999998889999999986542211110                         


Q ss_pred             HHHHHHHHccC--CCceeeeeeeEecCCcceEEEEeCCCCch-hhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhh-CC
Q 015027          130 RELLRIISQVN--HKNVVKILGLCLETEVPLLVYEFASNGTL-LDHIRCESSQVLKTWKTCLRIAAETASALDYLHS-LA  205 (414)
Q Consensus       130 ~~~~~~l~~l~--hpniv~l~~~~~~~~~~~lv~e~~~~gsL-~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~  205 (414)
                      ..+.+-|.++.  +-.+.+-+++.    .-.|||||+....+ .-.|..    ..+.......+..++++.+.-|-. .+
T Consensus       116 ~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD----v~~e~~e~~~~~~~~v~~~~~l~~~a~  187 (268)
T COG1718         116 RKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD----VPLELEEAEGLYEDVVEYMRRLYKEAG  187 (268)
T ss_pred             HHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc----CCcCchhHHHHHHHHHHHHHHHHHhcC
Confidence            12223333332  23334444432    23699999965411 112211    111223566778888888888877 55


Q ss_pred             CCCeeeCCCCCCceeeCCCCcEEEeeccccccccC
Q 015027          206 SPPIIHGDVKSANILLNDNYTAKVADFESSVLISS  240 (414)
Q Consensus       206 ~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  240 (414)
                         ++|+||+.=|||+. ++.+.++|||-|.....
T Consensus       188 ---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~h  218 (268)
T COG1718         188 ---LVHGDLSEYNILVH-DGEPYIIDVSQAVTIDH  218 (268)
T ss_pred             ---cccccchhhheEEE-CCeEEEEECccccccCC
Confidence               99999999999999 78999999998876543

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.25  E-value=4.9e-05  Score=66.23  Aligned_cols=124  Identities=25%  Similarity=0.307  Sum_probs=86.3

Q ss_pred             cCCCCCCccccCCc-eEEEEEEEcCCcEEEEEEeec---ccc-------------------hhHhHHHHHHH---HHccC
Q 015027           87 KNFDRSRCLSQGGF-VSVYKGVLHDNIQVAVKTYRR---ADK-------------------IRITERELLRI---ISQVN  140 (414)
Q Consensus        87 ~~~~~~~~lg~G~~-g~Vy~~~~~~~~~vavK~~~~---~~~-------------------~~~~~~~~~~~---l~~l~  140 (414)
                      .+++.++.||.|.- |.||++.. +|+.+|+|++..   ...                   ....+..|.+.   |+...
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            78899999999999 99999998 677999999432   000                   00112333344   44445


Q ss_pred             CCce--eeeeeeEecC------------------CcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHH
Q 015027          141 HKNV--VKILGLCLET------------------EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDY  200 (414)
Q Consensus       141 hpni--v~l~~~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~  200 (414)
                      +.++  |+++|+..-.                  ....||.||++...            ...    .+-+.+|.+-+..
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~----~~~~~~~~~dl~~  179 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQ----IRDIPQMLRDLKI  179 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccc----hhHHHHHHHHHHH
Confidence            6666  9999987422                  12357888776543            111    1235677888899


Q ss_pred             hhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccc
Q 015027          201 LHSLASPPIIHGDVKSANILLNDNYTAKVADFESS  235 (414)
Q Consensus       201 LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla  235 (414)
                      +|..|   |+-+|+++.|..     .-||+|||.+
T Consensus       180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence            99988   999999999987     5589999864

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.19  E-value=9.6e-06  Score=70.73  Aligned_cols=103  Identities=21%  Similarity=0.254  Sum_probs=78.3

Q ss_pred             HHHHHHccCC-CceeeeeeeEecCCcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCee
Q 015027          132 LLRIISQVNH-KNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPII  210 (414)
Q Consensus       132 ~~~~l~~l~h-pniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ii  210 (414)
                      |.-+++.+.+ +++++++|+|-    .++|.||.+.+++...-..-..-...+|..+.+|+.++++.+.++++.....+.
T Consensus         9 E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~   84 (188)
T PF12260_consen    9 EPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFY   84 (188)
T ss_pred             HHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEE
Confidence            3456666655 59999999994    367899998776643210000112338999999999999999999985545588


Q ss_pred             eCCCCCCceeeCCCCcEEEeeccccccc
Q 015027          211 HGDVKSANILLNDNYTAKVADFESSVLI  238 (414)
Q Consensus       211 H~Dlkp~NIll~~~~~~kl~DfGla~~~  238 (414)
                      -.|++++|+-++++|.+|++|...+...
T Consensus        85 lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   85 LCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EeecchHHeEEeCCCcEEEEechhcchh
Confidence            8999999999999999999999876544

Proteins in this uncharacterised family are described as transmembrane proteins.

>PLN02876 acyl-CoA dehydrogenase

Probab=98.15  E-value=3.2e-05  Score=82.99  Aligned_cols=78  Identities=9%  Similarity=0.192  Sum_probs=54.0

Q ss_pred             CCccccCCceEEEEEEEcCC---cEEEEEEeecccc--hhHhHHHHHHHHHccC-CCce--eeeeeeEecC---CcceEE
Q 015027           92 SRCLSQGGFVSVYKGVLHDN---IQVAVKTYRRADK--IRITERELLRIISQVN-HKNV--VKILGLCLET---EVPLLV  160 (414)
Q Consensus        92 ~~~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~~--~~~~~~~~~~~l~~l~-hpni--v~l~~~~~~~---~~~~lv  160 (414)
                      .+.++.|.++.+|+....++   ..+++|+......  ......+|.++++.+. |+++  ++++.+|.+.   +..|+|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            56789999999999876553   4678887654321  1223455567777774 6654  7788887664   467999


Q ss_pred             EEeCCCCch
Q 015027          161 YEFASNGTL  169 (414)
Q Consensus       161 ~e~~~~gsL  169 (414)
                      |||++|..+
T Consensus       123 ME~v~G~~~  131 (822)
T PLN02876        123 MEYLEGRIF  131 (822)
T ss_pred             EEecCCccc
Confidence            999998654

>PRK10593 hypothetical protein; Provisional

Probab=98.14  E-value=6.8e-05  Score=70.55  Aligned_cols=77  Identities=10%  Similarity=0.106  Sum_probs=49.7

Q ss_pred             CCCccccCCceEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHccC---CCceeeeeeeEec---CCcceEEEEeC
Q 015027           91 RSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVN---HKNVVKILGLCLE---TEVPLLVYEFA  164 (414)
Q Consensus        91 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~---hpniv~l~~~~~~---~~~~~lv~e~~  164 (414)
                      ..+.||.|..+.||.....++ .+.+|..+... .......|...++.+.   -..++++++++..   .+..++|||++
T Consensus        18 ~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~~-~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i   95 (297)
T PRK10593         18 RVECISEQPYAALWALYDSQG-NPMPLMARSFS-TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL   95 (297)
T ss_pred             eeeecCCccceeEEEEEcCCC-CEEEEEecccc-cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence            356799999999999876555 47777754321 1112233334444442   2467788887754   36689999999


Q ss_pred             CCCch
Q 015027          165 SNGTL  169 (414)
Q Consensus       165 ~~gsL  169 (414)
                      +++++
T Consensus        96 ~G~~~  100 (297)
T PRK10593         96 RGVSV  100 (297)
T ss_pred             CCEec
Confidence            98765

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.06  E-value=4.9e-05  Score=68.87  Aligned_cols=73  Identities=22%  Similarity=0.244  Sum_probs=44.9

Q ss_pred             CccccCCceEEEEEEEcC--CcEEEEEEeecccchhHhHHHHHHHHHccCCC-ceeeeeeeEecCCcceEEEEeCCCCch
Q 015027           93 RCLSQGGFVSVYKGVLHD--NIQVAVKTYRRADKIRITERELLRIISQVNHK-NVVKILGLCLETEVPLLVYEFASNGTL  169 (414)
Q Consensus        93 ~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hp-niv~l~~~~~~~~~~~lv~e~~~~gsL  169 (414)
                      +.|..|-...+|+....+  +..+++|+.............++.++..+... -.+++++.+.    -.+||||++|.++
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~l   79 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRTL   79 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCcC
Confidence            457788889999988654  67899997765432212222334555555332 2344554432    2489999998765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.05  E-value=4.2e-05  Score=69.44  Aligned_cols=31  Identities=32%  Similarity=0.543  Sum_probs=26.2

Q ss_pred             CCeeeCCCCCCceeeCCCCcEEEeecccccc
Q 015027          207 PPIIHGDVKSANILLNDNYTAKVADFESSVL  237 (414)
Q Consensus       207 ~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~  237 (414)
                      +.++|+|+.+.||++++++..-|+||+.+..
T Consensus       164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            4489999999999999776677999997643

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.01  E-value=0.00016  Score=63.36  Aligned_cols=131  Identities=22%  Similarity=0.249  Sum_probs=86.1

Q ss_pred             CCccccCCceEEEEEEEcCCcEEEEEEeeccc-----------------chhHhHHHHHHH---HH---ccCCCceeeee
Q 015027           92 SRCLSQGGFVSVYKGVLHDNIQVAVKTYRRAD-----------------KIRITERELLRI---IS---QVNHKNVVKIL  148 (414)
Q Consensus        92 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-----------------~~~~~~~~~~~~---l~---~l~hpniv~l~  148 (414)
                      ...||+|+.-.||.  +.+.....||+.....                 .......+|+..   +.   ...+.+|.+++
T Consensus         6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            45689999999994  4556678899887665                 111222222222   22   23488999999


Q ss_pred             eeEecCCcceEEEEeCCC--C----chhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeC
Q 015027          149 GLCLETEVPLLVYEFASN--G----TLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLN  222 (414)
Q Consensus       149 ~~~~~~~~~~lv~e~~~~--g----sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~  222 (414)
                      |+.+++...-+|+|.+-.  |    +|.+++....    ++. ..   ...+-+-..||-.++   |+.+|++|.||++.
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~----~~~-~~---~~~L~~f~~~l~~~~---Iv~~dl~~~NIv~~  152 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG----LTE-EL---RQALDEFKRYLLDHH---IVIRDLNPHNIVVQ  152 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC----ccH-HH---HHHHHHHHHHHHHcC---CeecCCCcccEEEE
Confidence            999999888999998743  2    6777774322    233 22   233334456666666   99999999999995


Q ss_pred             CC--C--cEEEee-cccc
Q 015027          223 DN--Y--TAKVAD-FESS  235 (414)
Q Consensus       223 ~~--~--~~kl~D-fGla  235 (414)
                      .+  +  .+.|+| ||-.
T Consensus       153 ~~~~~~~~lvlIDG~G~~  170 (199)
T PF10707_consen  153 RRDSGEFRLVLIDGLGEK  170 (199)
T ss_pred             ecCCCceEEEEEeCCCCc
Confidence            32  2  567776 5543

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.88  E-value=0.0001  Score=62.28  Aligned_cols=129  Identities=22%  Similarity=0.244  Sum_probs=82.7

Q ss_pred             CCCCccccCCceEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHccCCCceee-eeeeEecCCcceEEEEeCCCCc
Q 015027           90 DRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVK-ILGLCLETEVPLLVYEFASNGT  168 (414)
Q Consensus        90 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~-l~~~~~~~~~~~lv~e~~~~gs  168 (414)
                      ...+.|++|++|.||+|.+ .|..+|+|+-+.++....- ..+.+++..+.-.++.+ ++.+..    .++.|||+.|-+
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~ds~r~~l-~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~~   98 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEW-RGGEVALKVRRRDSPRRNL-EKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGRP   98 (201)
T ss_pred             hhhhhhhcccccEEEEeec-cCceEEEEEecCCcchhhH-HHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCcc
Confidence            3467799999999999998 5558999987766543332 33346666665544433 444322    346699999988


Q ss_pred             hhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCC-C-CceeeCCCCcEEEeeccccccc
Q 015027          169 LLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVK-S-ANILLNDNYTAKVADFESSVLI  238 (414)
Q Consensus       169 L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlk-p-~NIll~~~~~~kl~DfGla~~~  238 (414)
                      |.+.-...      +...    ...+++.---|-..|   |-|..|. | .||++.++ .+.|+||..|+..
T Consensus        99 L~~~~~~~------~rk~----l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~-~~~iIDFd~At~k  156 (201)
T COG2112          99 LGKLEIGG------DRKH----LLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDR-DVYIIDFDSATFK  156 (201)
T ss_pred             hhhhhhcc------cHHH----HHHHHHHHHHHHHhc---cchhhhcCCceeEEecCC-cEEEEEccchhhc
Confidence            87655321      1222    234444434445555   8888887 4 45555544 9999999988753

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.82  E-value=0.00015  Score=66.72  Aligned_cols=138  Identities=13%  Similarity=0.073  Sum_probs=72.7

Q ss_pred             ccccCCceEEEEEEEcCCcEEEEEEeecccchh-HhHHHHHHHHHccCCCce-eeeeeeEecCCcceEEEEeCCCCchhh
Q 015027           94 CLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIR-ITERELLRIISQVNHKNV-VKILGLCLETEVPLLVYEFASNGTLLD  171 (414)
Q Consensus        94 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~l~~l~hpni-v~l~~~~~~~~~~~lv~e~~~~gsL~~  171 (414)
                      .+..|-.+.+|+... ++..+++|......... .....|.++++.+....+ .+++..+.    .++||||++|..+..
T Consensus         3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~   77 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL   77 (256)
T ss_pred             cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence            356688889998874 56788899765432221 112233345554433222 33444432    369999999876542


Q ss_pred             h--------------h---hhcCC-cccCCHH-HHHHHHHH---------HHHHHHHhhhC-----CCCCeeeCCCCCCc
Q 015027          172 H--------------I---RCESS-QVLKTWK-TCLRIAAE---------TASALDYLHSL-----ASPPIIHGDVKSAN  218 (414)
Q Consensus       172 ~--------------l---~~~~~-~~~~~~~-~~~~i~~~---------i~~~l~~LH~~-----~~~~iiH~Dlkp~N  218 (414)
                      .              +   +.... ....+.. .+..+..+         +...+..+-..     ....++|+|+.|.|
T Consensus        78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N  157 (256)
T TIGR02721        78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN  157 (256)
T ss_pred             ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence            1              1   11110 1111111 11111111         11112222111     12358999999999


Q ss_pred             eeeCCCCcEEEeecccccc
Q 015027          219 ILLNDNYTAKVADFESSVL  237 (414)
Q Consensus       219 Ill~~~~~~kl~DfGla~~  237 (414)
                      |++++++ +.|+||..+..
T Consensus       158 il~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       158 LVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             EEEeCCC-CEEEeccccCc
Confidence            9999877 78999987653

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.80  E-value=5.9e-05  Score=79.96  Aligned_cols=191  Identities=18%  Similarity=0.203  Sum_probs=131.3

Q ss_pred             HHHHHccCCCceeeeeeeEecCCc----ceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCC
Q 015027          133 LRIISQVNHKNVVKILGLCLETEV----PLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPP  208 (414)
Q Consensus       133 ~~~l~~l~hpniv~l~~~~~~~~~----~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~  208 (414)
                      +..+.+..|+|++.++.+......    ..+..+++...++...+...+.   .+..+.+.+..+..+||.++|+..   
T Consensus       233 ~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~---i~~~~~r~~~~~~~~GL~~~h~~~---  306 (1351)
T KOG1035|consen  233 LESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGS---IPLETLRILHQKLLEGLAYLHSLS---  306 (1351)
T ss_pred             HHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccc---cCHHHHHHHHHHHhhhHHHHHHhc---
Confidence            467888899999999998765433    2345578888888887765443   366788888999999999999875   


Q ss_pred             eeeCCCCCC---ceeeCCCCcEEEe--eccccccccCCccccceecccccccccchhhcccCCCCCc--ccchhHHHHHH
Q 015027          209 IIHGDVKSA---NILLNDNYTAKVA--DFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKK--SDVYSFGVVLA  281 (414)
Q Consensus       209 iiH~Dlkp~---NIll~~~~~~kl~--DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--~Dv~SlGvil~  281 (414)
                      ..|.-+..+   +.-.+..+.+.++  ||+.+.......   .......+..+-+||......++.+  .|+|.+|..+.
T Consensus       307 l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~---~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~  383 (1351)
T KOG1035|consen  307 LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNE---KSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLL  383 (1351)
T ss_pred             cceeEEecccccccccCccceeecchhhhcccccCCCcc---cchhhcCccccccccccccccchhhhhhHHHHHHHHHh
Confidence            566555555   5555667777777  888877654321   1222344556788887776665554  79999999999


Q ss_pred             HHHhCCCCCCccccccccccccchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHH
Q 015027          282 ELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEE  360 (414)
Q Consensus       282 el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~  360 (414)
                      .+..|..+-....                    ....+++....        ..+.+...+|+..++++|+++.+++..
T Consensus       384 ~~~~~~~i~~~~~--------------------~~~~~l~~~~~--------~~~~d~~~~~~~~~~~~Rl~~~~ll~~  434 (1351)
T KOG1035|consen  384 QLSQGEDISEKSA--------------------VPVSLLDVLST--------SELLDALPKCLDEDSEERLSALELLTH  434 (1351)
T ss_pred             hhhhcCccccccc--------------------chhhhhccccc--------hhhhhhhhhhcchhhhhccchhhhhhc
Confidence            9999876522100                    00001110000        136788999999999999999998654

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.75  E-value=0.00071  Score=63.61  Aligned_cols=142  Identities=16%  Similarity=0.146  Sum_probs=78.0

Q ss_pred             CCccccCCceEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHccCCC--ceeeeeee------EecCCcceEEEEe
Q 015027           92 SRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHK--NVVKILGL------CLETEVPLLVYEF  163 (414)
Q Consensus        92 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hp--niv~l~~~------~~~~~~~~lv~e~  163 (414)
                      .+.+..|....+|+.... +..+++|+.....  ......+.+++..+.+.  .+++++..      ...++..++|++|
T Consensus        19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~~~--~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~   95 (296)
T cd05153          19 FEGISAGIENTNYFVTTD-SGRYVLTLFEKVS--AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEF   95 (296)
T ss_pred             eecccCccccceEEEEeC-CCcEEEEEcCCCC--hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEe
Confidence            556778888899988753 4578889876521  12222233444444222  24444432      1234566899999


Q ss_pred             CCCCchhh----hh----------hhcCCc--------ccCCHHHHH----------HHHHHHHHHHHHhhh----CCCC
Q 015027          164 ASNGTLLD----HI----------RCESSQ--------VLKTWKTCL----------RIAAETASALDYLHS----LASP  207 (414)
Q Consensus       164 ~~~gsL~~----~l----------~~~~~~--------~~~~~~~~~----------~i~~~i~~~l~~LH~----~~~~  207 (414)
                      ++|..+..    ..          +.....        ....|....          .....+...+.++..    .-..
T Consensus        96 i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~  175 (296)
T cd05153          96 LAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPR  175 (296)
T ss_pred             CCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence            99876532    00          000000        011111110          011112233444442    1124


Q ss_pred             CeeeCCCCCCceeeCCCCcEEEeeccccc
Q 015027          208 PIIHGDVKSANILLNDNYTAKVADFESSV  236 (414)
Q Consensus       208 ~iiH~Dlkp~NIll~~~~~~kl~DfGla~  236 (414)
                      .+||+|+.|.||++++++.+.|.||+.+.
T Consensus       176 ~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         176 GVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             cCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            59999999999999998778999998764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.69  E-value=0.00028  Score=66.62  Aligned_cols=74  Identities=24%  Similarity=0.311  Sum_probs=44.1

Q ss_pred             CccccCCceEEEEEEEcC-------CcEEEEEEeecccchhHhHHHHHHHHHccCCCc-eeeeeeeEecCCcceEEEEeC
Q 015027           93 RCLSQGGFVSVYKGVLHD-------NIQVAVKTYRRADKIRITERELLRIISQVNHKN-VVKILGLCLETEVPLLVYEFA  164 (414)
Q Consensus        93 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpn-iv~l~~~~~~~~~~~lv~e~~  164 (414)
                      +.+..|-...+|+....+       +..+++|+.............|.+++..+.... ..++++++..    .+|+||+
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i   79 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFI   79 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhee
Confidence            456677778999988654       578999997654322222233334444443222 3455655532    3689999


Q ss_pred             CCCchh
Q 015027          165 SNGTLL  170 (414)
Q Consensus       165 ~~gsL~  170 (414)
                      +|.++.
T Consensus        80 ~G~~l~   85 (302)
T cd05156          80 PSRTLT   85 (302)
T ss_pred             CCCcCC
Confidence            987664

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.67  E-value=0.0013  Score=64.04  Aligned_cols=74  Identities=22%  Similarity=0.165  Sum_probs=48.5

Q ss_pred             CccccCCceEEEEEEEcCC-cEEEEEEeeccc-------c-hh---HhHHHHHHHHHccCCCceeeeeeeEecCCcceEE
Q 015027           93 RCLSQGGFVSVYKGVLHDN-IQVAVKTYRRAD-------K-IR---ITERELLRIISQVNHKNVVKILGLCLETEVPLLV  160 (414)
Q Consensus        93 ~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~-------~-~~---~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv  160 (414)
                      +.||.|.+..||++...+| +.|+||.-.+..       . ..   ..+.+.++.+......++++++.+  +.+..++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence            5689999999999998776 589999854211       0 11   112233334443334567778777  44567899


Q ss_pred             EEeCCCCc
Q 015027          161 YEFASNGT  168 (414)
Q Consensus       161 ~e~~~~gs  168 (414)
                      |||+++..
T Consensus       110 ME~L~~~~  117 (401)
T PRK09550        110 MEDLSDHK  117 (401)
T ss_pred             EecCCCcc
Confidence            99998743

>PRK05231 homoserine kinase; Provisional

Probab=97.63  E-value=0.0016  Score=61.90  Aligned_cols=158  Identities=15%  Similarity=0.131  Sum_probs=80.1

Q ss_pred             cHHHHHHHhcCCCC-----CCccccCCceEEEEEEEcCCcEEEEEEeecccchh-HhHHHHHHHHHcc--CCCceeeee-
Q 015027           78 SKSEMIRATKNFDR-----SRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIR-ITERELLRIISQV--NHKNVVKIL-  148 (414)
Q Consensus        78 ~~~~~~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~l~~l--~hpniv~l~-  148 (414)
                      +.+++......|.+     .+.++.|....+|+....+| .+++|++....... ..+.+.++.|...  .-|.+++-. 
T Consensus         8 s~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~   86 (319)
T PRK05231          8 SDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFERLTAEDLPFFLGLMQHLAARGVPVPAPVARRD   86 (319)
T ss_pred             CHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEeccCChHHhHHHHHHHHHHHHCCCCCCcceeCCC
Confidence            44455444455644     35566777789999876555 68899875211111 1122233333322  223333211 


Q ss_pred             e--eEecCCcceEEEEeCCCCchhh-----------hh---hhcCCc--------ccC-CHHHHHH------------HH
Q 015027          149 G--LCLETEVPLLVYEFASNGTLLD-----------HI---RCESSQ--------VLK-TWKTCLR------------IA  191 (414)
Q Consensus       149 ~--~~~~~~~~~lv~e~~~~gsL~~-----------~l---~~~~~~--------~~~-~~~~~~~------------i~  191 (414)
                      |  +....+..+++++|++|..+..           .+   +.....        ..+ .|.....            .+
T Consensus        87 G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  166 (319)
T PRK05231         87 GAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALL  166 (319)
T ss_pred             CCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHH
Confidence            1  1123456789999999975421           11   000000        001 1111111            11


Q ss_pred             HH-HHHHHHHhhhC----CCCCeeeCCCCCCceeeCCCCcEEEeeccccc
Q 015027          192 AE-TASALDYLHSL----ASPPIIHGDVKSANILLNDNYTAKVADFESSV  236 (414)
Q Consensus       192 ~~-i~~~l~~LH~~----~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~  236 (414)
                      .+ +...+..+...    -+.++||+|+.|.||+++.+...-|+||+.+.
T Consensus       167 ~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        167 EAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             HHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            11 11122222211    23469999999999999977666899999764

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.56  E-value=0.003  Score=59.71  Aligned_cols=143  Identities=19%  Similarity=0.229  Sum_probs=77.4

Q ss_pred             CCccccCCceEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHccCCC--ceeeeeeeE------ecCCcceEEEEe
Q 015027           92 SRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHK--NVVKILGLC------LETEVPLLVYEF  163 (414)
Q Consensus        92 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hp--niv~l~~~~------~~~~~~~lv~e~  163 (414)
                      ++.++.|....+|+....++ .+++|+........ ....+.+++..|...  .+++++...      ...+..+++++|
T Consensus        27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~~~-~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~  104 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRVKAE-ELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEF  104 (307)
T ss_pred             ccccCCccccceEEEEeCCC-cEEEEEecCCCCHH-HHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEe
Confidence            55677787789998875444 67889875532211 112223444443221  133443321      224567899999


Q ss_pred             CCCCchhh-----------h---hhhcCCc---------ccCCHHHHH------------HHHHHHHHHHHHhhh----C
Q 015027          164 ASNGTLLD-----------H---IRCESSQ---------VLKTWKTCL------------RIAAETASALDYLHS----L  204 (414)
Q Consensus       164 ~~~gsL~~-----------~---l~~~~~~---------~~~~~~~~~------------~i~~~i~~~l~~LH~----~  204 (414)
                      ++|..+..           .   ++.....         ....|....            .....+...++++..    .
T Consensus       105 i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~  184 (307)
T TIGR00938       105 LQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRD  184 (307)
T ss_pred             CCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhc
Confidence            99865421           0   1110000         001121110            001123334555532    1


Q ss_pred             CCCCeeeCCCCCCceeeCCCCcEEEeeccccc
Q 015027          205 ASPPIIHGDVKSANILLNDNYTAKVADFESSV  236 (414)
Q Consensus       205 ~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~  236 (414)
                      ....+||+|+.+.||+++.++.+.|+||+.+.
T Consensus       185 ~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       185 LPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             CCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            23569999999999999988877899999764

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.20  E-value=0.0052  Score=57.81  Aligned_cols=32  Identities=28%  Similarity=0.584  Sum_probs=28.6

Q ss_pred             CCeeeCCCCCCceeeCCCCcEEEeeccccccc
Q 015027          207 PPIIHGDVKSANILLNDNYTAKVADFESSVLI  238 (414)
Q Consensus       207 ~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~  238 (414)
                      ..++|+|+.+.|++++.++-+-+.||+++..-
T Consensus       198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             ceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence            56999999999999999888999999998653

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.17  E-value=0.0095  Score=57.94  Aligned_cols=72  Identities=13%  Similarity=0.097  Sum_probs=46.5

Q ss_pred             CCccccCCceEEEEEEEcCCcEEEEEEeecccc--------hhHhH---HHHHHHHHccCCCceeeeeeeEecCCcceEE
Q 015027           92 SRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADK--------IRITE---RELLRIISQVNHKNVVKILGLCLETEVPLLV  160 (414)
Q Consensus        92 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~---~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv  160 (414)
                      .+.||.|....||+... ++..++||.-.....        .....   .+.++.+..+...++++++.++.  +..+++
T Consensus        37 ~~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence            46689999999999887 455799997652111        11111   22233333333457888988877  446789


Q ss_pred             EEeCCC
Q 015027          161 YEFASN  166 (414)
Q Consensus       161 ~e~~~~  166 (414)
                      |||+++
T Consensus       114 ME~L~~  119 (418)
T PLN02756        114 MRYLEP  119 (418)
T ss_pred             EeecCC
Confidence            999977

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.16  E-value=0.0043  Score=57.87  Aligned_cols=76  Identities=21%  Similarity=0.206  Sum_probs=46.3

Q ss_pred             CCCccccCCceEEEEEEEcCCcEEEEEEeeccc-chhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCCCC
Q 015027           91 RSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRAD-KIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNG  167 (414)
Q Consensus        91 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g  167 (414)
                      ..+.++.|....+|+.. .+++.+.||+-.... ..-..+.+-++.|.+..--.+++++++....+..||||||++.+
T Consensus        21 ~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~   97 (288)
T PF03881_consen   21 SIEPVSGGDINEAYRLD-TDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG   97 (288)
T ss_dssp             EEEEE--SSSSEEEEEE-TTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred             eeEecCCCChhheEEEE-CCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence            34668889999999877 578899999887332 22233444456665555667888999888777789999999877

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.16  E-value=0.005  Score=58.26  Aligned_cols=142  Identities=17%  Similarity=0.248  Sum_probs=91.1

Q ss_pred             CCCCccccCCceEEEEEEEcCCcEEEEEEeecccch---------------------------hHhHHHHHHHHHccCCC
Q 015027           90 DRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKI---------------------------RITERELLRIISQVNHK  142 (414)
Q Consensus        90 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~l~~l~hp  142 (414)
                      .+..+|..|--+.||.|+-.+|..+|||+++.+-..                           ......+++-|.+++..
T Consensus       147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            456778889999999999989999999998542100                           01112234555555544


Q ss_pred             ceeeeeeeEecCCcceEEEEeCCCCch-hhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceee
Q 015027          143 NVVKILGLCLETEVPLLVYEFASNGTL-LDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILL  221 (414)
Q Consensus       143 niv~l~~~~~~~~~~~lv~e~~~~gsL-~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll  221 (414)
                      .|.----...  ..-.|||+|+..... .-.|    ....++...+..+-.+++.-+.-|.+.+  +++|.||+-=|+|+
T Consensus       227 GIP~PePIlL--k~hVLVM~FlGrdgw~aPkL----Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly  298 (520)
T KOG2270|consen  227 GIPCPEPILL--KNHVLVMEFLGRDGWAAPKL----KDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY  298 (520)
T ss_pred             CCCCCCceee--ecceEeeeeccCCCCcCccc----ccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE
Confidence            4332111111  123689999953221 1112    1223344566777788888888887654  39999999999998


Q ss_pred             CCCCcEEEeeccccccccC
Q 015027          222 NDNYTAKVADFESSVLISS  240 (414)
Q Consensus       222 ~~~~~~kl~DfGla~~~~~  240 (414)
                      - +|.+.++|.+-+.....
T Consensus       299 h-dG~lyiIDVSQSVE~DH  316 (520)
T KOG2270|consen  299 H-DGKLYIIDVSQSVEHDH  316 (520)
T ss_pred             E-CCEEEEEEccccccCCC
Confidence            7 56999999987765443

>PLN02236 choline kinase

Probab=97.15  E-value=0.0037  Score=60.13  Aligned_cols=140  Identities=16%  Similarity=0.211  Sum_probs=76.1

Q ss_pred             CccccCCceEEEEEEEcC-----CcEEEEEEeecccchhHhHHHHHHHHHccCCCce-eeeeeeEecCCcceEEEEeCCC
Q 015027           93 RCLSQGGFVSVYKGVLHD-----NIQVAVKTYRRADKIRITERELLRIISQVNHKNV-VKILGLCLETEVPLLVYEFASN  166 (414)
Q Consensus        93 ~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpni-v~l~~~~~~~~~~~lv~e~~~~  166 (414)
                      ..|..|-...+|+....+     +..|++|+.............|..++..+..-++ .++++++..+    .|.+|+++
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g  117 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA  117 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence            445568888999987532     3679999886543222122333344444433333 3456665433    58999988


Q ss_pred             Cchhhh-----------------hhhcC---CcccCCHHHHHHHHHHH-----------------HHHHHHh----hh-C
Q 015027          167 GTLLDH-----------------IRCES---SQVLKTWKTCLRIAAET-----------------ASALDYL----HS-L  204 (414)
Q Consensus       167 gsL~~~-----------------l~~~~---~~~~~~~~~~~~i~~~i-----------------~~~l~~L----H~-~  204 (414)
                      .+|...                 ++...   ......+..+.++..++                 ...+..|    .. .
T Consensus       118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~  197 (344)
T PLN02236        118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD  197 (344)
T ss_pred             CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence            766321                 01111   01111233332332111                 1111112    21 1


Q ss_pred             CCCCeeeCCCCCCceeeCC-CCcEEEeeccccc
Q 015027          205 ASPPIIHGDVKSANILLND-NYTAKVADFESSV  236 (414)
Q Consensus       205 ~~~~iiH~Dlkp~NIll~~-~~~~kl~DfGla~  236 (414)
                      ....++|+|+++.|||+++ ++.+.++||..+.
T Consensus       198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             CCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            1235899999999999986 4789999998765

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.11  E-value=5.3e-05  Score=82.19  Aligned_cols=155  Identities=12%  Similarity=-0.011  Sum_probs=112.5

Q ss_pred             HHHccCCCceeeeeeeEec--CCcceEEEEeCCCCchhhhhhhcCC-cccCCHHHHHHHHHHHHHHHHHhhhC--CCCCe
Q 015027          135 IISQVNHKNVVKILGLCLE--TEVPLLVYEFASNGTLLDHIRCESS-QVLKTWKTCLRIAAETASALDYLHSL--ASPPI  209 (414)
Q Consensus       135 ~l~~l~hpniv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~--~~~~i  209 (414)
                      .++...|+++.....-...  ....|.+++|+.+|.+.+.+-.+.. ...+....+.....+.+.+..-+|+.  ++.-.
T Consensus      1282 e~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~ 1361 (2724)
T KOG1826|consen 1282 ELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTN 1361 (2724)
T ss_pred             hhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccc
Confidence            3445679888876655433  3456899999999999998854332 22233333333333335555555532  23457


Q ss_pred             eeCCCCCCceeeCCCCcEEEeeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCC
Q 015027          210 IHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP  289 (414)
Q Consensus       210 iH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p  289 (414)
                      +|+++|+.|.+|..+..+|++++|+.+....  .....+...+++.|++|+....-.++.++|+|..|+-+|+...|..+
T Consensus      1362 v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~ 1439 (2724)
T KOG1826|consen 1362 VSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAY 1439 (2724)
T ss_pred             hhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHH
Confidence            9999999999999999999999999984332  23344556788899999999888999999999999999999999888


Q ss_pred             CC
Q 015027          290 GS  291 (414)
Q Consensus       290 ~~  291 (414)
                      |.
T Consensus      1440 fi 1441 (2724)
T KOG1826|consen 1440 FI 1441 (2724)
T ss_pred             HH
Confidence            63

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.08  E-value=0.00075  Score=62.62  Aligned_cols=135  Identities=18%  Similarity=0.170  Sum_probs=88.6

Q ss_pred             CCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccch-----------------------hHhHHHHHHHHHccCC-C-
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKI-----------------------RITERELLRIISQVNH-K-  142 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------------~~~~~~~~~~l~~l~h-p-  142 (414)
                      -+.+.++||-|--+.||.+.+..|++.++|.-+.....                       +.....+...|+.|.. - 
T Consensus        93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            45678899999999999999999999999975322110                       0111223344444422 1 


Q ss_pred             ceeeeeeeEecCCcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeC
Q 015027          143 NVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLN  222 (414)
Q Consensus       143 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~  222 (414)
                      -+++.+++    +.-++|||++.|-.|...-.-.      +..+   +...+..-+--|..+|   +||+|+.-=||+++
T Consensus       173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~------d~~~---ly~~lm~~Iv~la~~G---lIHgDFNEFNimv~  236 (465)
T KOG2268|consen  173 PVPKPIDH----NRHCVVMELVDGYPLRQVRHVE------DPPT---LYDDLMGLIVRLANHG---LIHGDFNEFNIMVK  236 (465)
T ss_pred             CCCCcccc----cceeeHHHhhcccceeeeeecC------ChHH---HHHHHHHHHHHHHHcC---ceecccchheeEEe
Confidence            13333333    3457999999998876433111      2222   3344444455666666   99999999999999


Q ss_pred             CCCcEEEeeccccccc
Q 015027          223 DNYTAKVADFESSVLI  238 (414)
Q Consensus       223 ~~~~~kl~DfGla~~~  238 (414)
                      +++.++++||.-....
T Consensus       237 dd~~i~vIDFPQmvS~  252 (465)
T KOG2268|consen  237 DDDKIVVIDFPQMVST  252 (465)
T ss_pred             cCCCEEEeechHhhcc
Confidence            9999999999755433

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.92  E-value=0.0092  Score=55.47  Aligned_cols=31  Identities=19%  Similarity=0.556  Sum_probs=25.6

Q ss_pred             CCeeeCCCCCCceeeCCCCc-EEEeecccccc
Q 015027          207 PPIIHGDVKSANILLNDNYT-AKVADFESSVL  237 (414)
Q Consensus       207 ~~iiH~Dlkp~NIll~~~~~-~kl~DfGla~~  237 (414)
                      +.++|+|++|.|||+++++. .-|.||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            45899999999999997554 56999998754

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.92  E-value=0.017  Score=54.54  Aligned_cols=29  Identities=34%  Similarity=0.414  Sum_probs=25.0

Q ss_pred             CCeeeCCCCCCceeeCCCCcEEEeeccccc
Q 015027          207 PPIIHGDVKSANILLNDNYTAKVADFESSV  236 (414)
Q Consensus       207 ~~iiH~Dlkp~NIll~~~~~~kl~DfGla~  236 (414)
                      .++||+|+.+.||+++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            45899999999999997 578899999654

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.88  E-value=0.012  Score=56.14  Aligned_cols=72  Identities=18%  Similarity=0.115  Sum_probs=43.5

Q ss_pred             ccccCCceEEEEEEEcCC-cEEEEEEeecccc-------hh----HhHHHHHHHHHccCCCceeeeeeeEecCCcceEEE
Q 015027           94 CLSQGGFVSVYKGVLHDN-IQVAVKTYRRADK-------IR----ITERELLRIISQVNHKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        94 ~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~-------~~----~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~  161 (414)
                      .||.|....||++...+| +.|+||.-.....       ..    ..+.+.++....+--..+++++.+  +.+...+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            579999999999997654 6899997532111       00    112223333333322355666554  556667999


Q ss_pred             EeCCCC
Q 015027          162 EFASNG  167 (414)
Q Consensus       162 e~~~~g  167 (414)
                      |+++..
T Consensus        80 EdL~~~   85 (370)
T TIGR01767        80 EDLSHH   85 (370)
T ss_pred             hhCccc
Confidence            999654

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.71  E-value=0.018  Score=54.59  Aligned_cols=31  Identities=16%  Similarity=0.427  Sum_probs=27.6

Q ss_pred             CCeeeCCCCCCceeeCCCCcEEEeecccccc
Q 015027          207 PPIIHGDVKSANILLNDNYTAKVADFESSVL  237 (414)
Q Consensus       207 ~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~  237 (414)
                      ..+||+|+.++|+|++.++.+.++||..+..
T Consensus       196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       196 TVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            4599999999999999999999999987654

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.65  E-value=0.015  Score=55.62  Aligned_cols=30  Identities=30%  Similarity=0.419  Sum_probs=25.5

Q ss_pred             CeeeCCCCCCceeeCC-CCcEEEeecccccc
Q 015027          208 PIIHGDVKSANILLND-NYTAKVADFESSVL  237 (414)
Q Consensus       208 ~iiH~Dlkp~NIll~~-~~~~kl~DfGla~~  237 (414)
                      -.+|.|+.+.|||+++ ++.++++||..|..
T Consensus       183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             EEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            4799999999999974 57899999987643

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.63  E-value=0.027  Score=53.53  Aligned_cols=136  Identities=20%  Similarity=0.236  Sum_probs=75.8

Q ss_pred             CceEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHccC---CCceee---eeee----EecCCcceEEEEeCCCCc
Q 015027           99 GFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVN---HKNVVK---ILGL----CLETEVPLLVYEFASNGT  168 (414)
Q Consensus        99 ~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~---hpniv~---l~~~----~~~~~~~~lv~e~~~~gs  168 (414)
                      .-..+|+....+|+. ++|+.... ........++..+..+.   .|=.++   +=|-    .......+-|++|++|..
T Consensus        37 ~eN~~f~~~~~~g~~-iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~~  114 (331)
T COG2334          37 EENSNFRVQTEDGRY-ILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGRP  114 (331)
T ss_pred             ccCceEEEEecCCCe-EEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCcC
Confidence            456789988877766 99998886 34444444445554442   222222   2221    111236788999999988


Q ss_pred             hhh-h-----------h---hh--cC------C-cccCCHHH-------------HHHHHHHHHHHHHHhhh----CCCC
Q 015027          169 LLD-H-----------I---RC--ES------S-QVLKTWKT-------------CLRIAAETASALDYLHS----LASP  207 (414)
Q Consensus       169 L~~-~-----------l---~~--~~------~-~~~~~~~~-------------~~~i~~~i~~~l~~LH~----~~~~  207 (414)
                      +.. -           +   +.  .+      . .....|..             ......++...+..+.+    .-+.
T Consensus       115 ~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp~  194 (331)
T COG2334         115 LERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLPA  194 (331)
T ss_pred             cCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCCc
Confidence            772 1           0   00  00      0 11123320             01122233334444432    1112


Q ss_pred             C---eeeCCCCCCceeeCCCCc-EEEeeccccc
Q 015027          208 P---IIHGDVKSANILLNDNYT-AKVADFESSV  236 (414)
Q Consensus       208 ~---iiH~Dlkp~NIll~~~~~-~kl~DfGla~  236 (414)
                      .   +||+|+.|.||+++.+.. +.+.||+-+.
T Consensus       195 ~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         195 LGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             ccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence            2   899999999999998874 8999999764

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.42  E-value=0.094  Score=50.01  Aligned_cols=93  Identities=16%  Similarity=0.076  Sum_probs=50.1

Q ss_pred             cccHHHHHHHhcCCCCC---C-ccccCCceEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHcc---CCCceeeee
Q 015027           76 IFSKSEMIRATKNFDRS---R-CLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQV---NHKNVVKIL  148 (414)
Q Consensus        76 ~~~~~~~~~~~~~~~~~---~-~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l---~hpniv~l~  148 (414)
                      .++...+..+...+.+.   + ..-.+.-..||+....++..+++|+.+..........++.+.+..|   .-| ++...
T Consensus        10 ~l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gip-v~~p~   88 (325)
T PRK11768         10 TLTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDEDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIP-VVAPL   88 (325)
T ss_pred             CCChHHHHHHHHHcCCCCccceEeeccccceEEEEecCCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCC-CCCCc
Confidence            34555556555555331   1 1123445679999887888999998865432232323333433333   222 22211


Q ss_pred             ---e--eEecCCcceEEEEeCCCCch
Q 015027          149 ---G--LCLETEVPLLVYEFASNGTL  169 (414)
Q Consensus       149 ---~--~~~~~~~~~lv~e~~~~gsL  169 (414)
                         |  ....++..+.|+++++|...
T Consensus        89 ~~~G~~~~~~~g~~~~l~~~~~G~~~  114 (325)
T PRK11768         89 AFNGQTLHEHQGFRFALFPRRGGRAP  114 (325)
T ss_pred             cCCCCEEEEECCEEEEEEeeeCCCCC
Confidence               1  12234567889999988643

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.39  E-value=0.013  Score=52.00  Aligned_cols=30  Identities=33%  Similarity=0.503  Sum_probs=21.2

Q ss_pred             CeeeCCCCCCceee-CCCCcEEEeecccccc
Q 015027          208 PIIHGDVKSANILL-NDNYTAKVADFESSVL  237 (414)
Q Consensus       208 ~iiH~Dlkp~NIll-~~~~~~kl~DfGla~~  237 (414)
                      .++|+|+.|.|||+ +.++.++++||..|..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            48999999999999 8899999999987653

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.32  E-value=0.028  Score=54.47  Aligned_cols=73  Identities=21%  Similarity=0.237  Sum_probs=45.9

Q ss_pred             CCccccCCceEEEEEEEcC-CcEEEEEEeecccch------h----HhHHHHHHHHHccCCCceeeeeeeEecCCcceEE
Q 015027           92 SRCLSQGGFVSVYKGVLHD-NIQVAVKTYRRADKI------R----ITERELLRIISQVNHKNVVKILGLCLETEVPLLV  160 (414)
Q Consensus        92 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~------~----~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv  160 (414)
                      .+.||.|.-..||++.+.+ ++.|+||.-...-..      .    ..+.+.++....+--.++++++.+  +.+...+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            4578999999999999753 668999975321110      0    112333444555433456667655  55566789


Q ss_pred             EEeCCC
Q 015027          161 YEFASN  166 (414)
Q Consensus       161 ~e~~~~  166 (414)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            998865

>PTZ00384 choline kinase; Provisional

Probab=96.17  E-value=0.056  Score=52.67  Aligned_cols=75  Identities=20%  Similarity=0.260  Sum_probs=42.9

Q ss_pred             CCccccCCceEEEEEEEcCC--cE-----EEEEEeecccchhHhHHHHHHHHHccCCCce-eeeeeeEecCCcceEEEEe
Q 015027           92 SRCLSQGGFVSVYKGVLHDN--IQ-----VAVKTYRRADKIRITERELLRIISQVNHKNV-VKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        92 ~~~lg~G~~g~Vy~~~~~~~--~~-----vavK~~~~~~~~~~~~~~~~~~l~~l~hpni-v~l~~~~~~~~~~~lv~e~  163 (414)
                      ++.|..|-...+|++...++  ..     |.++..............|.+++..+...++ .++++.+..    ++|+||
T Consensus        55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~ef  130 (383)
T PTZ00384         55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEW  130 (383)
T ss_pred             EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEE
Confidence            44566788899999975432  22     4444432222111122334566666654444 445666542    599999


Q ss_pred             CCCCchh
Q 015027          164 ASNGTLL  170 (414)
Q Consensus       164 ~~~gsL~  170 (414)
                      ++|.+|.
T Consensus       131 IeGr~l~  137 (383)
T PTZ00384        131 VEGNTMG  137 (383)
T ss_pred             eccccCC
Confidence            9998763

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=95.90  E-value=0.0073  Score=59.48  Aligned_cols=43  Identities=19%  Similarity=0.311  Sum_probs=33.8

Q ss_pred             HHHHHccCCCceeeeeeeEecC-CcceEEEEeCCCCchhhhhhhc
Q 015027          133 LRIISQVNHKNVVKILGLCLET-EVPLLVYEFASNGTLLDHIRCE  176 (414)
Q Consensus       133 ~~~l~~l~hpniv~l~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~  176 (414)
                      .++++.+.|+|+..++++-... ....+|||++ +.||+|.+..+
T Consensus        33 ~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~   76 (725)
T KOG1093|consen   33 FQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTG   76 (725)
T ss_pred             hHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhc
Confidence            4788889999999999987543 3567899998 56999888543

>PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties []

Probab=95.81  E-value=0.065  Score=48.93  Aligned_cols=78  Identities=15%  Similarity=0.035  Sum_probs=55.5

Q ss_pred             CccccCCceEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeC-CCCchhh
Q 015027           93 RCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFA-SNGTLLD  171 (414)
Q Consensus        93 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~-~~gsL~~  171 (414)
                      ..+..|+.+.|+.++..+|.++++|+.........+...+ ..|+..+-...|++++.-  ...-.+++|.+ ++.+|.+
T Consensus         8 ~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~~~E~~g~-~~L~~w~G~GaVrll~~d--~~~~AlLLErl~~g~~L~~   84 (253)
T PF04655_consen    8 GPPAHGSSSLVVPVRRADGTPAVLKLAPPHAEAEHEARGE-AALRWWNGRGAVRLLAAD--PERGALLLERLDPGRSLAS   84 (253)
T ss_pred             CCCCCCcceEEEEEEcCCCCeEEEEecCCcccchhhhhHH-hHhheeCCCCceeeeccc--cccchhhhhhccCCCchhh
Confidence            4466799999999999899999999987655433332222 447777777889998874  33456888999 4457765


Q ss_pred             hh
Q 015027          172 HI  173 (414)
Q Consensus       172 ~l  173 (414)
                      ..
T Consensus        85 ~~   86 (253)
T PF04655_consen   85 LP   86 (253)
T ss_pred             cc
Confidence            44

Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process

>PRK06148 hypothetical protein; Provisional

Probab=95.66  E-value=0.17  Score=55.85  Aligned_cols=31  Identities=29%  Similarity=0.501  Sum_probs=25.5

Q ss_pred             CCeeeCCCCCCceeeCCCC--cEE-Eeecccccc
Q 015027          207 PPIIHGDVKSANILLNDNY--TAK-VADFESSVL  237 (414)
Q Consensus       207 ~~iiH~Dlkp~NIll~~~~--~~k-l~DfGla~~  237 (414)
                      ..+||+|+.+.|||++.++  .+. |+|||.+..
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            4599999999999999775  454 999997653

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.65  E-value=0.049  Score=51.71  Aligned_cols=73  Identities=22%  Similarity=0.172  Sum_probs=54.9

Q ss_pred             cceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccc
Q 015027          156 VPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESS  235 (414)
Q Consensus       156 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla  235 (414)
                      ..|++|++- |+++.- +      ....++++..++.+.+..+.-+...  -+.=|||+...||||+ +|++-|+||-++
T Consensus       300 y~yl~~kdh-gt~is~-i------k~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDfkls  368 (488)
T COG5072         300 YLYLHFKDH-GTPISI-I------KADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDFKLS  368 (488)
T ss_pred             EEEEEEecC-Cceeee-e------ecccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEeeee
Confidence            346677765 444432 1      2226788899999888877777663  4589999999999999 999999999999


Q ss_pred             cccc
Q 015027          236 VLIS  239 (414)
Q Consensus       236 ~~~~  239 (414)
                      +.-.
T Consensus       369 Rl~~  372 (488)
T COG5072         369 RLSY  372 (488)
T ss_pred             eccc
Confidence            8543

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.58  E-value=0.2  Score=44.73  Aligned_cols=77  Identities=19%  Similarity=0.236  Sum_probs=51.9

Q ss_pred             CccccCCceEEEEEEEcCCcEEEEEEeecccc-hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCCCCchh
Q 015027           93 RCLSQGGFVSVYKGVLHDNIQVAVKTYRRADK-IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLL  170 (414)
Q Consensus        93 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~  170 (414)
                      +.+..|..-..|...+ +..++.||+-..... ....+..-++.|.+-+.-++.+++.+..+....|+||||++-+.+.
T Consensus        22 ~~v~gG~inea~~v~d-g~~~~FvK~n~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d   99 (286)
T COG3001          22 EEVSGGDINEAWRLRD-GTDPFFVKCNQREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD   99 (286)
T ss_pred             cccCCccccceeEeec-CCcceEEEecchhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence            3445555555565444 567889997544321 1222334456677767778889999999999999999999987664

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.51  E-value=0.076  Score=46.98  Aligned_cols=137  Identities=15%  Similarity=0.120  Sum_probs=79.7

Q ss_pred             EEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHH
Q 015027          113 QVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRI  190 (414)
Q Consensus       113 ~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i  190 (414)
                      +..+|.++.....  ..-+....+++.++.  .|+++..-  +.-.+-++.|+|..-...            .    ..+
T Consensus        87 ~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i~------------~----~N~  146 (308)
T PF07387_consen   87 PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKIN------------F----SNF  146 (308)
T ss_pred             hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcccc------------h----hHH
Confidence            4455555443221  122234456666653  67777632  333556889998442110            1    112


Q ss_pred             HHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccccceecccccccccchhhcccCCCCCc
Q 015027          191 AAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKK  270 (414)
Q Consensus       191 ~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  270 (414)
                      +.-=+++|.-.|+.. ...+|+|-.|+||+-|..|.+||.|-+.-..  .            +-.|.-   ......|++
T Consensus       147 i~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~--~------------~V~~vN---~~Y~~lT~~  208 (308)
T PF07387_consen  147 ITAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE--N------------QVNMVN---IEYESLTQE  208 (308)
T ss_pred             HHHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhhhh--h------------eeeEEe---eeccccChH
Confidence            222246677888654 5699999999999999999999999774211  0            001111   012345677


Q ss_pred             ccchhHHHHHHHHHhCC
Q 015027          271 SDVYSFGVVLAELLTGK  287 (414)
Q Consensus       271 ~Dv~SlGvil~el~tg~  287 (414)
                      +.+-+|=.-+++++...
T Consensus       209 aE~~~fv~s~l~~v~~~  225 (308)
T PF07387_consen  209 AEVKVFVKSCLKLVEKQ  225 (308)
T ss_pred             HHHHHHHHHHHHHHHHH
Confidence            77777777777777654

The function of this family is unknown.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	414
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-37
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		3e-37
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		9e-37
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		5e-36
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-29
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		4e-29
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-28
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		7e-27
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-20
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-20
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-19
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-19
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-19
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-19
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-19
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-19
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-19
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-19
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-19
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-19
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-19
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-19
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-19
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-19
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-19
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-19
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-19
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-19
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-19
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-19
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-19
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-19
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-19
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-19
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-19
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-19
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-19
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-19
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		3e-19
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		3e-19
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		3e-19
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		3e-19
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		3e-19
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		4e-19
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		5e-19
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		5e-19
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		6e-19
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		6e-19
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		6e-19
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		7e-19
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		7e-19
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		8e-19
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		8e-19
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		8e-19
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		8e-19
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		9e-19
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		9e-19
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-18
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-18
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-18
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-18
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-18
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-18
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-18
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		5e-18
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-17
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-17
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-17
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-17
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		6e-17
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		7e-17
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-16
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-16
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-16
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		3e-16
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-16
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-16
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		3e-16
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		3e-16
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-16
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		4e-16
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		4e-16
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		4e-16
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		4e-16
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		5e-16
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		5e-16
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		5e-16
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		5e-16
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		5e-16
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		5e-16
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		5e-16
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		5e-16
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		5e-16
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-16
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		5e-16
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		5e-16
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-16
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		5e-16
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		5e-16
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-16
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		5e-16
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		5e-16
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		5e-16
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		5e-16
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		5e-16
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		6e-16
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		6e-16
3a4o_X	286	Lyn Kinase Domain Length = 286		8e-16
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		8e-16
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		9e-16
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-15
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-15
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-15
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-15
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-15
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-15
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-15
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-15
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-15
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-15
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-15
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-15
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-15
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-15
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-15
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-15
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-15
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-15
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-15
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-15
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		4e-15
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		4e-15
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		4e-15
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		4e-15
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		4e-15
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		4e-15
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		5e-15
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		5e-15
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		5e-15
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		5e-15
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		5e-15
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		5e-15
4h58_A	275	Braf In Complex With Compound 3 Length = 275		5e-15
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		5e-15
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		5e-15
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		5e-15
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		5e-15
3g51_A	325	Structural Diversity Of The Active Conformation Of		5e-15
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		5e-15
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		5e-15
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		5e-15
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		6e-15
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		6e-15
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		6e-15
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		7e-15
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		7e-15
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		8e-15
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		8e-15
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		8e-15
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		9e-15
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		9e-15
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		9e-15
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		9e-15
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		9e-15
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		9e-15
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-14
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-14
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-14
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-14
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-14
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-14
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-14
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-14
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-14
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-14
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-14
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-14
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-14
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-14
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-14
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-14
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-14
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-14
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		3e-14
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		3e-14
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-14
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		4e-14
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		4e-14
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-14
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		5e-14
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		6e-14
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		6e-14
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		7e-14
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		7e-14
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		7e-14
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		7e-14
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		8e-14
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		8e-14
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		8e-14
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		8e-14
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		8e-14
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-14
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		8e-14
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		8e-14
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		9e-14
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		9e-14
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-13
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-13
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-13
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-13
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-13
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-13
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-13
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		3e-13
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-13
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		3e-13
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		3e-13
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		4e-13
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		6e-13
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		7e-13
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-12
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-12
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-12
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-12
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-12
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-12
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-12
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-12
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-12
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-12
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-12
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-12
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-12
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-12
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-12
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-12
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-12
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-12
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-12
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-12
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-12
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-12
1oec_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-12
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-12
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-12
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		3e-12
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-12
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		3e-12
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		4e-12
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		4e-12
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		4e-12
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-12
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		4e-12
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		5e-12
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		5e-12
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-12
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		5e-12
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		5e-12
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		6e-12
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		6e-12
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		6e-12
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		7e-12
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		7e-12
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		7e-12
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		7e-12
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		8e-12
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		8e-12
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-12
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		8e-12
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		9e-12
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		9e-12
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		9e-12
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-11
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-11
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-11
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-11
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-11
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-11
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-11
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-11
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-11
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		1e-11
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-11
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-11
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-11
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-11
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-11
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-11
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		1e-11
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-11
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-11
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-11
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-11
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-11
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-11
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-11
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-11
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-11
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-11
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		3e-11
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-11
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-11
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-11
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-11
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		3e-11
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		4e-11
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		4e-11
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		4e-11
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-11
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		4e-11
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		5e-11
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		5e-11
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		5e-11
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		5e-11
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		5e-11
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		5e-11
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		5e-11
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		5e-11
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		5e-11
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		5e-11
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		5e-11
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		5e-11
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		5e-11
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		5e-11
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		5e-11
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-11
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		5e-11
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		5e-11
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		6e-11
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		6e-11
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		6e-11
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		6e-11
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		7e-11
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-11
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		7e-11
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		7e-11
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-11
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		8e-11
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		8e-11
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		8e-11
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		8e-11
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		8e-11
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		9e-11
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		9e-11
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		9e-11
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-10
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-10
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-10
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-10
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-10
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-10
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-10
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-10
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-10
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-10
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-10
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-10
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-10
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-10
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-10
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-10
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-10
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-10
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-10
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-10
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-10
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-10
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-10
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-10
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-10
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-10
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-10
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-10
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-10
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-10
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-10
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-10
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-10
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		3e-10
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		3e-10
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		3e-10
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-10
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		3e-10
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-10
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		3e-10
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		4e-10
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-10
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-10
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		5e-10
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		5e-10
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		5e-10
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		5e-10
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		5e-10
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		6e-10
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		6e-10
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		6e-10
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-10
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		7e-10
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-10
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		7e-10
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		7e-10
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		7e-10
4fie_A	423	Full-Length Human Pak4 Length = 423		7e-10
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		8e-10
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		8e-10
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		8e-10
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		9e-10
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		9e-10
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		9e-10
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		9e-10
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-09
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-09
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-09
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-09
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-09
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-09
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-09
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-09
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-09
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-09
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-09
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-09
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-09
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-09
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		2e-09
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-09
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-09
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-09
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-09
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-09
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-09
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-09
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-09
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-09
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-09
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-09
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-09
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-09
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-09
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-09
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		3e-09
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		3e-09
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		3e-09
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-09
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		3e-09
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-09
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		3e-09
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		3e-09
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-09
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		3e-09
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-09
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-09
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-09
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		3e-09
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		3e-09
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		3e-09
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		3e-09
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		3e-09
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		3e-09
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		3e-09
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		3e-09
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		4e-09
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		4e-09
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		4e-09
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		4e-09
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		5e-09
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		5e-09
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		5e-09
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		6e-09
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		6e-09
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		6e-09
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		7e-09
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		7e-09
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		7e-09
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		7e-09
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		8e-09
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		8e-09
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		8e-09
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		8e-09
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		8e-09
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		8e-09
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		9e-09
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		9e-09
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		9e-09
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		9e-09
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-08
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-08
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-08
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-08
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-08
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-08
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-08
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-08
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-08
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-08
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-08
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-08
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-08
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-08
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-08
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-08
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-08
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-08
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-08
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-08
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-08
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-08
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-08
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-08
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-08
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-08
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-08
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-08
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		3e-08
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		3e-08
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-08
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		3e-08
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		3e-08
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-08
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		3e-08
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		3e-08
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-08
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		3e-08
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-08
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-08
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-08
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		4e-08
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-08
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		4e-08
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		4e-08
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		4e-08
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		4e-08
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		5e-08
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-08
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		5e-08
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-08
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		5e-08
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-08
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		6e-08
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		6e-08
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		7e-08
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		7e-08
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		8e-08
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		8e-08
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-07
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-07
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-07
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-07
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-07
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-07
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-07
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-07
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-07
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-07
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-07
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-07
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-07
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-07
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-07
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-07
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-07
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-07
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-07
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-07
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-07
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-07
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-07
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-07
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-07
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		3e-07
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		4e-07
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		4e-07
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		5e-07
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		5e-07
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		5e-07
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		6e-07
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		6e-07
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		6e-07
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		6e-07
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		6e-07
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		7e-07
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		7e-07
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		7e-07
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		7e-07
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		7e-07
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		7e-07
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		7e-07
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		7e-07
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		8e-07
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		8e-07
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		8e-07
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		8e-07
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		8e-07
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		8e-07
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		8e-07
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		8e-07
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		8e-07
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		8e-07
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		8e-07
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		9e-07
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		9e-07
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		9e-07
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		9e-07
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-06
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-06
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		1e-06
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-06
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-06
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-06
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-06
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-06
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-06
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-06
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-06
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-06
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-06
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-06
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-06
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-06
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-06
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-06
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-06
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		1e-06
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-06
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-06
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-06
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-06
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-06
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-06
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-06
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-06
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-06
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-06
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-06
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-06
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-06
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		2e-06
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-06
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-06
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-06
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-06
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-06
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-06
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-06
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-06
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-06
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-06
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-06
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-06
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-06
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-06
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-06
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-06
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		3e-06
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-06
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		3e-06
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-06
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		3e-06
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		3e-06
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-06
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-06
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-06
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-06
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		3e-06
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		3e-06
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		3e-06
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-06
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		3e-06
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-06
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		3e-06
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-06
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		3e-06
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		3e-06
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-06
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-06
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-06
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		4e-06
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		4e-06
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		4e-06
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		4e-06
4ae9_A	343	Structure And Function Of The Human Sperm-specific		4e-06
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		4e-06
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		4e-06
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		4e-06
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		4e-06
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		4e-06
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		4e-06
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		4e-06
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		4e-06
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		4e-06
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		4e-06
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		4e-06
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		4e-06
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-06
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		4e-06
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		5e-06
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		5e-06
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		5e-06
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-06
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		5e-06
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		5e-06
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-06
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		5e-06
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		5e-06
4ae6_A	343	Structure And Function Of The Human Sperm-specific		5e-06
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		5e-06
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		5e-06
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		5e-06
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		5e-06
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		5e-06
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		6e-06
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		6e-06
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		6e-06
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		6e-06
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		6e-06
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		6e-06
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		6e-06
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		6e-06
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		6e-06
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		6e-06
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		7e-06
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		7e-06
3soa_A	444	Full-Length Human Camkii Length = 444		7e-06
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		7e-06
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		7e-06
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		7e-06
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		8e-06
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		9e-06
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		9e-06
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		9e-06
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		9e-06
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		9e-06
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		9e-06
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-05
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-05
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		1e-05
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-05
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-05
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-05
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-05
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-05
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-05
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-05
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-05
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-05
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-05
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-05
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-05
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-05
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-05
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-05
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-05
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-05
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-05
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-05
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-05
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-05
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-05
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-05
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-05
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-05
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-05
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-05
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-05
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		3e-05
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		3e-05
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		3e-05
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-05
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		3e-05
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		3e-05
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		3e-05
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-05
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-05
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		3e-05
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		3e-05
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		3e-05
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		3e-05
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		3e-05
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		3e-05
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		3e-05
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		3e-05
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		3e-05
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		3e-05
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		3e-05
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-05
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		3e-05
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		3e-05
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		3e-05
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		3e-05
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		3e-05
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-05
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-05
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		3e-05
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		3e-05
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		3e-05
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		3e-05
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		3e-05
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		3e-05
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		3e-05
3hec_A	348	P38 In Complex With Imatinib Length = 348		3e-05
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-05
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		3e-05
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		3e-05
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		3e-05
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		4e-05
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-05
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		4e-05
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-05
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		4e-05
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		4e-05
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		5e-05
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		5e-05
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		5e-05
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		5e-05
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		5e-05
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		5e-05
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-05
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		6e-05
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		6e-05
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		7e-05
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		7e-05
4exu_A	371	Mapk13, Inactive Form Length = 371		7e-05
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-05
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		8e-05
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		8e-05
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		8e-05
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		8e-05
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		8e-05
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		8e-05
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		8e-05
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		9e-05
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		9e-05
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		9e-05
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		9e-05
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		9e-05
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		9e-05
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		9e-05
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		9e-05
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		9e-05
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		9e-05
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		9e-05
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		9e-05
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-04
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-04
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-04
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		1e-04
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-04
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-04
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-04
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		1e-04
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		1e-04
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-04
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-04
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-04
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-04
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-04
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-04
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-04
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-04
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-04
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-04
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-04
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-04
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-04
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-04
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-04
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-04
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-04
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-04
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-04
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-04
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		3e-04
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		4e-04
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		5e-04
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		5e-04
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		5e-04
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		5e-04
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-04
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		5e-04
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		5e-04
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		6e-04
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		6e-04
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		6e-04
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		7e-04
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		8e-04

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  154 bits (388), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 98/290 (33%), Positives = 152/290 (52%), Gaps = 11/290 (3%)
Query: 85  ATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRR---ADKXXXXXXXXXXXXSQVNH 141
           AT NFD    +  G F  VYKGVL D  +VA+K  RR   + +            S   H
Sbjct: 37  ATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALK--RRTPESSQGIEEFETEIETLSFCRH 94
Query: 142 KNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLK-TWKTCLRIAAETASALDY 200
            ++V ++G C E    +L+Y++  NG L  H+       +  +W+  L I    A  L Y
Sbjct: 95  PHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHY 154
Query: 201 LHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV 260
           LH+ A   IIH DVKS NILL++N+  K+ DF  S   +   +T +  ++ GT GY+DP 
Sbjct: 155 LHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYIDPE 211
Query: 261 CINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQIL 320
               G+LT+KSDVYSFGVVL E+L  +   + +     + +++  + + S  N  L QI+
Sbjct: 212 YFIKGRLTEKSDVYSFGVVLFEVLCARS--AIVQSLPREMVNLAEWAVESHNNGQLEQIV 269
Query: 321 NFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLHEN 370
           + ++AD+   + +    + A KCL +   +RP+M  V  +L+   RL E+
Sbjct: 270 DPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQES 319

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  152 bits (385), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 98/290 (33%), Positives = 152/290 (52%), Gaps = 11/290 (3%)
Query: 85  ATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRR---ADKXXXXXXXXXXXXSQVNH 141
           AT NFD    +  G F  VYKGVL D  +VA+K  RR   + +            S   H
Sbjct: 37  ATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALK--RRTPESSQGIEEFETEIETLSFCRH 94
Query: 142 KNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLK-TWKTCLRIAAETASALDY 200
            ++V ++G C E    +L+Y++  NG L  H+       +  +W+  L I    A  L Y
Sbjct: 95  PHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHY 154
Query: 201 LHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV 260
           LH+ A   IIH DVKS NILL++N+  K+ DF  S   +   +T +  ++ GT GY+DP 
Sbjct: 155 LHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYIDPE 211
Query: 261 CINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQIL 320
               G+LT+KSDVYSFGVVL E+L  +   + +     + +++  + + S  N  L QI+
Sbjct: 212 YFIKGRLTEKSDVYSFGVVLFEVLCARS--AIVQSLPREMVNLAEWAVESHNNGQLEQIV 269
Query: 321 NFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLHEN 370
           + ++AD+   + +    + A KCL +   +RP+M  V  +L+   RL E+
Sbjct: 270 DPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQES 319

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  150 bits (380), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 93/294 (31%), Positives = 153/294 (52%), Gaps = 4/294 (1%)
Query: 67  PGLAFLRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYR--RADK 124
           P +   ++K FS  E+  A+ NF     L +GGF  VYKG L D   VAVK  +  R   
Sbjct: 18  PEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQG 77
Query: 125 XXXXXXXXXXXXSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCE-SSQVLKT 183
                       S   H+N++++ G C+     LLVY + +NG++   +R    SQ    
Sbjct: 78  GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLD 137
Query: 184 WKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE 243
           W    RIA  +A  L YLH    P IIH DVK+ANILL++ + A V DF  + L+    +
Sbjct: 138 WPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY-KD 196
Query: 244 TAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISM 303
             +   + GT G++ P  ++TGK ++K+DV+ +GV+L EL+TG++      LA++  + +
Sbjct: 197 XHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 256
Query: 304 VPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQV 357
           + +    +K   L  +++  +    + +E+E + ++A  C +    ERP M +V
Sbjct: 257 LDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEV 310

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  148 bits (374), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 92/294 (31%), Positives = 152/294 (51%), Gaps = 4/294 (1%)
Query: 67  PGLAFLRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYR--RADK 124
           P +   ++K FS  E+  A+ NF     L +GGF  VYKG L D   VAVK  +  R   
Sbjct: 10  PEVHLGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQG 69
Query: 125 XXXXXXXXXXXXSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCE-SSQVLKT 183
                       S   H+N++++ G C+     LLVY + +NG++   +R    SQ    
Sbjct: 70  GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLD 129
Query: 184 WKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE 243
           W    RIA  +A  L YLH    P IIH DVK+ANILL++ + A V DF  + L+    +
Sbjct: 130 WPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY-KD 188
Query: 244 TAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISM 303
             +   + G  G++ P  ++TGK ++K+DV+ +GV+L EL+TG++      LA++  + +
Sbjct: 189 XHVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 248
Query: 304 VPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQV 357
           + +    +K   L  +++  +    + +E+E + ++A  C +    ERP M +V
Sbjct: 249 LDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEV 302

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 89/310 (28%), Positives = 154/310 (49%), Gaps = 34/310 (10%)
Query: 73  RMKIFSKSEMIRATKNFDR------SRCLSQGGFVSVYKGVLHDNIQVAVKTYR-----R 121
           R   FS  E+   T NFD          + +GGF  VYKG + +N  VAVK         
Sbjct: 11  RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDIT 69
Query: 122 ADKXXXXXXXXXXXXSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVL 181
            ++            ++  H+N+V++LG   + +   LVY +  NG+LLD + C      
Sbjct: 70  TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP 129
Query: 182 KTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD 241
            +W    +IA   A+ +++LH       IH D+KSANILL++ +TAK++DF  +      
Sbjct: 130 LSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKF 186
Query: 242 AETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTG-------KKPGSCMT 294
           A+T M + ++GT+ Y+ P  +  G++T KSD+YSFGVVL E++TG       ++P   + 
Sbjct: 187 AQTVMXSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD 245
Query: 295 LASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTM 354
           +    +             + + + +N     +++   +E +  +AS+CL  +  +RP +
Sbjct: 246 IKEEIEDEE------KTIEDYIDKKMN-----DADSTSVEAMYSVASQCLHEKKNKRPDI 294
Query: 355 KQVSEELDRL 364
           K+V + L  +
Sbjct: 295 KKVQQLLQEM 304

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  125 bits (314), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 89/310 (28%), Positives = 153/310 (49%), Gaps = 34/310 (10%)
Query: 73  RMKIFSKSEMIRATKNFDR------SRCLSQGGFVSVYKGVLHDNIQVAVKTYR-----R 121
           R   FS  E+   T NFD          + +GGF  VYKG + +N  VAVK         
Sbjct: 11  RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDIT 69
Query: 122 ADKXXXXXXXXXXXXSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVL 181
            ++            ++  H+N+V++LG   + +   LVY +  NG+LLD + C      
Sbjct: 70  TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP 129
Query: 182 KTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD 241
            +W    +IA   A+ +++LH       IH D+KSANILL++ +TAK++DF  +      
Sbjct: 130 LSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKF 186
Query: 242 AETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTG-------KKPGSCMT 294
           A+T M   ++GT+ Y+ P  +  G++T KSD+YSFGVVL E++TG       ++P   + 
Sbjct: 187 AQTVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD 245
Query: 295 LASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTM 354
           +    +             + + + +N     +++   +E +  +AS+CL  +  +RP +
Sbjct: 246 IKEEIEDEE------KTIEDYIDKKMN-----DADSTSVEAMYSVASQCLHEKKNKRPDI 294
Query: 355 KQVSEELDRL 364
           K+V + L  +
Sbjct: 295 KKVQQLLQEM 304

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 88/310 (28%), Positives = 152/310 (49%), Gaps = 34/310 (10%)
Query: 73  RMKIFSKSEMIRATKNFDR------SRCLSQGGFVSVYKGVLHDNIQVAVKTYR-----R 121
           R   FS  E+   T NFD          + +GGF  VYKG + +N  VAVK         
Sbjct: 5   RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDIT 63
Query: 122 ADKXXXXXXXXXXXXSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVL 181
            ++            ++  H+N+V++LG   + +   LVY +  NG+LLD + C      
Sbjct: 64  TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP 123
Query: 182 KTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD 241
            +W    +IA   A+ +++LH       IH D+KSANILL++ +TAK++DF  +      
Sbjct: 124 LSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKF 180
Query: 242 AETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTG-------KKPGSCMT 294
           A+  M   ++GT+ Y+ P  +  G++T KSD+YSFGVVL E++TG       ++P   + 
Sbjct: 181 AQXVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD 239
Query: 295 LASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTM 354
           +    +             + + + +N     +++   +E +  +AS+CL  +  +RP +
Sbjct: 240 IKEEIEDEE------KTIEDYIDKKMN-----DADSTSVEAMYSVASQCLHEKKNKRPDI 288
Query: 355 KQVSEELDRL 364
           K+V + L  +
Sbjct: 289 KKVQQLLQEM 298

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  118 bits (295), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 90/310 (29%), Positives = 151/310 (48%), Gaps = 40/310 (12%)
Query: 73  RMKIFSKSEMIRATKNFDRSRCLS-------QGGFVSVYKGVLHDNIQVAVKTYR----- 120
           R   FS  E+   T NFD  R +S       +GGF  VYKG + +N  VAVK        
Sbjct: 2   RFHSFSFYELKNVTNNFDE-RPISVGGNKXGEGGFGVVYKGYV-NNTTVAVKKLAAMVDI 59
Query: 121 RADKXXXXXXXXXXXXSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQV 180
             ++            ++  H+N+V++LG   + +   LVY +  NG+LLD + C     
Sbjct: 60  TTEELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTP 119
Query: 181 LKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISS 240
             +W    +IA   A+ +++LH       IH D+KSANILL++ +TAK++DF  +     
Sbjct: 120 PLSWHXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEK 176
Query: 241 DAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTG-------KKPGSCM 293
            A+    + ++GT+ Y  P  +  G++T KSD+YSFGVVL E++TG       ++P   +
Sbjct: 177 FAQXVXXSRIVGTTAYXAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL 235
Query: 294 TLASNKKISMVPY--FLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTER 351
            +    +        +++   N             +++   +E    +AS+CL  +  +R
Sbjct: 236 DIKEEIEDEEKTIEDYIDKKXN-------------DADSTSVEAXYSVASQCLHEKKNKR 282
Query: 352 PTMKQVSEEL 361
           P +K+V + L
Sbjct: 283 PDIKKVQQLL 292

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 74/272 (27%), Positives = 123/272 (45%), Gaps = 25/272 (9%)
Query: 95  LSQGGFVSVYKGVLHD-NIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLE 153
           L  G F  VY+GV    ++ VAVKT +                 ++ H N+V++LG+C  
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 78
Query: 154 TEVPLLVYEFASNGTLLDHIR-CESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHG 212
                ++ EF + G LLD++R C   +V       L +A + +SA++YL        IH 
Sbjct: 79  EPPFYIITEFMTYGNLLDYLRECNRQEVSAV--VLLYMATQISSAMEYLEKKN---FIHR 133
Query: 213 DVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSD 272
           D+ + N L+ +N+  KVADF  S L++ D  TA +        +  P  +   K + KSD
Sbjct: 134 DLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK-WTAPESLAYNKFSIKSD 192
Query: 273 VYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKE 332
           V++FGV+L E+ T                 M PY    I  + + ++L      E     
Sbjct: 193 VWAFGVLLWEIAT---------------YGMSPY--PGIDPSQVYELLEKDYRMERPEGC 235
Query: 333 IEIVAELASKCLRIRGTERPTMKQVSEELDRL 364
            E V EL   C +   ++RP+  ++ +  + +
Sbjct: 236 PEKVYELMRACWQWNPSDRPSFAEIHQAFETM 267

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 123/272 (45%), Gaps = 25/272 (9%)
Query: 95  LSQGGFVSVYKGVLHD-NIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLE 153
           L  G +  VY+GV    ++ VAVKT +                 ++ H N+V++LG+C  
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 78
Query: 154 TEVPLLVYEFASNGTLLDHIR-CESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHG 212
                ++ EF + G LLD++R C   +V       L +A + +SA++YL        IH 
Sbjct: 79  EPPFYIIIEFMTYGNLLDYLRECNRQEVSAV--VLLYMATQISSAMEYLEKKN---FIHR 133
Query: 213 DVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSD 272
           D+ + N L+ +N+  KVADF  S L++ D  TA +        +  P  +   K + KSD
Sbjct: 134 DLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK-WTAPESLAYNKFSIKSD 192
Query: 273 VYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKE 332
           V++FGV+L E+ T                 M PY    I  + + ++L      E     
Sbjct: 193 VWAFGVLLWEIAT---------------YGMSPY--PGIDPSQVYELLEKDYRMERPEGC 235
Query: 333 IEIVAELASKCLRIRGTERPTMKQVSEELDRL 364
            E V EL   C +   ++RP+  ++ +  + +
Sbjct: 236 PEKVYELMRACWQWNPSDRPSFAEIHQAFETM 267

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 129/290 (44%), Gaps = 27/290 (9%)
Query: 77  FSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHD-NIQVAVKTYRRADKXXXXXXXXXXX 135
           + K EM R   +      L  G +  VY+GV    ++ VAVKT +               
Sbjct: 6   YDKWEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAV 63
Query: 136 XSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIR-CESSQVLKTWKTCLRIAAET 194
             ++ H N+V++LG+C       ++ EF + G LLD++R C   +V       L +A + 
Sbjct: 64  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAV--VLLYMATQI 121
Query: 195 ASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTS 254
           +SA++YL        IH D+ + N L+ +N+  KVADF  S L++ D  TA +       
Sbjct: 122 SSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK 178
Query: 255 GYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNN 314
            +  P  +   K + KSDV++FGV+L E+ T                 M PY    I  +
Sbjct: 179 -WTAPESLAYNKFSIKSDVWAFGVLLWEIAT---------------YGMSPY--PGIDLS 220
Query: 315 GLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL 364
            + ++L      E      E V EL   C +   ++RP+  ++ +  + +
Sbjct: 221 QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 270

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 129/290 (44%), Gaps = 27/290 (9%)
Query: 77  FSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHD-NIQVAVKTYRRADKXXXXXXXXXXX 135
           + K EM R   +      L  G +  VY+GV    ++ VAVKT +               
Sbjct: 10  YDKWEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAV 67
Query: 136 XSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIR-CESSQVLKTWKTCLRIAAET 194
             ++ H N+V++LG+C       ++ EF + G LLD++R C   +V       L +A + 
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV--VLLYMATQI 125
Query: 195 ASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTS 254
           +SA++YL        IH D+ + N L+ +N+  KVADF  S L++ D  TA +       
Sbjct: 126 SSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK 182
Query: 255 GYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNN 314
            +  P  +   K + KSDV++FGV+L E+ T                 M PY    I  +
Sbjct: 183 -WTAPESLAYNKFSIKSDVWAFGVLLWEIAT---------------YGMSPY--PGIDLS 224
Query: 315 GLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL 364
            + ++L      E      E V EL   C +   ++RP+  ++ +  + +
Sbjct: 225 QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 76/280 (27%), Positives = 131/280 (46%), Gaps = 36/280 (12%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLET 154
           L  G F  V+ G  + + +VAVK+ ++                Q+ H+ +V++  +  + 
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 89
Query: 155 EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDV 214
            +  ++ E+  NG+L+D ++  S   L T    L +AA+ A  + ++        IH D+
Sbjct: 90  PI-YIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEERN---YIHRDL 144
Query: 215 KSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVY 274
           ++ANIL++D  + K+ADF  + LI  +  TA          +  P  IN G  T KSDV+
Sbjct: 145 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK-WTAPEAINYGTFTIKSDVW 203
Query: 275 SFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKN--NGLRQILNFHVADESEMK 331
           SFG++L E++T G+ P   MT   N ++         I+N   G R +   +  +E    
Sbjct: 204 SFGILLTEIVTHGRIPYPGMT---NPEV---------IQNLERGYRMVRPDNCPEE---- 247
Query: 332 EIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLHENF 371
               + +L   C + R  +RPT        D LR + E+F
Sbjct: 248 ----LYQLMRLCWKERPEDRPT-------FDYLRSVLEDF 276

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 76/280 (27%), Positives = 131/280 (46%), Gaps = 36/280 (12%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLET 154
           L  G F  V+ G  + + +VAVK+ ++                Q+ H+ +V++  +  + 
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 86
Query: 155 EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDV 214
            +  ++ E+  NG+L+D ++  S   L T    L +AA+ A  + ++        IH D+
Sbjct: 87  PI-YIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEERN---YIHRDL 141
Query: 215 KSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVY 274
           ++ANIL++D  + K+ADF  + LI  +  TA          +  P  IN G  T KSDV+
Sbjct: 142 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK-WTAPEAINYGTFTIKSDVW 200
Query: 275 SFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKN--NGLRQILNFHVADESEMK 331
           SFG++L E++T G+ P   MT   N ++         I+N   G R +   +  +E    
Sbjct: 201 SFGILLTEIVTHGRIPYPGMT---NPEV---------IQNLERGYRMVRPDNCPEE---- 244
Query: 332 EIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLHENF 371
               + +L   C + R  +RPT        D LR + E+F
Sbjct: 245 ----LYQLMRLCWKERPEDRPT-------FDYLRSVLEDF 273

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 76/280 (27%), Positives = 131/280 (46%), Gaps = 36/280 (12%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLET 154
           L  G F  V+ G  + + +VAVK+ ++                Q+ H+ +V++  +  + 
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 88
Query: 155 EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDV 214
            +  ++ E+  NG+L+D ++  S   L T    L +AA+ A  + ++        IH D+
Sbjct: 89  PI-YIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEERN---YIHRDL 143
Query: 215 KSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVY 274
           ++ANIL++D  + K+ADF  + LI  +  TA          +  P  IN G  T KSDV+
Sbjct: 144 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK-WTAPEAINYGTFTIKSDVW 202
Query: 275 SFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKN--NGLRQILNFHVADESEMK 331
           SFG++L E++T G+ P   MT   N ++         I+N   G R +   +  +E    
Sbjct: 203 SFGILLTEIVTHGRIPYPGMT---NPEV---------IQNLERGYRMVRPDNCPEE---- 246
Query: 332 EIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLHENF 371
               + +L   C + R  +RPT        D LR + E+F
Sbjct: 247 ----LYQLMRLCWKERPEDRPT-------FDYLRSVLEDF 275

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 129/290 (44%), Gaps = 27/290 (9%)
Query: 77  FSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHD-NIQVAVKTYRRADKXXXXXXXXXXX 135
           + K EM R   +      L  G +  VY+GV    ++ VAVKT +               
Sbjct: 10  YDKWEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAV 67
Query: 136 XSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIR-CESSQVLKTWKTCLRIAAET 194
             ++ H N+V++LG+C       ++ EF + G LLD++R C   +V       L +A + 
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAV--VLLYMATQI 125
Query: 195 ASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTS 254
           +SA++YL        IH D+ + N L+ +N+  KVADF  S L++ D  TA +       
Sbjct: 126 SSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 182
Query: 255 GYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNN 314
            +  P  +   K + KSDV++FGV+L E+ T                 M PY    I  +
Sbjct: 183 -WTAPESLAYNKFSIKSDVWAFGVLLWEIAT---------------YGMSPY--PGIDLS 224
Query: 315 GLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL 364
            + ++L      E      E V EL   C +   ++RP+  ++ +  + +
Sbjct: 225 QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 129/290 (44%), Gaps = 27/290 (9%)
Query: 77  FSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHD-NIQVAVKTYRRADKXXXXXXXXXXX 135
           + K EM R   +      L  G +  VY+GV    ++ VAVKT +               
Sbjct: 5   YDKWEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAV 62
Query: 136 XSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIR-CESSQVLKTWKTCLRIAAET 194
             ++ H N+V++LG+C       ++ EF + G LLD++R C   +V       L +A + 
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAV--VLLYMATQI 120
Query: 195 ASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTS 254
           +SA++YL        IH D+ + N L+ +N+  KVADF  S L++ D  TA +       
Sbjct: 121 SSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 177
Query: 255 GYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNN 314
            +  P  +   K + KSDV++FGV+L E+ T                 M PY    I  +
Sbjct: 178 -WTAPESLAYNKFSIKSDVWAFGVLLWEIAT---------------YGMSPY--PGIDLS 219
Query: 315 GLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL 364
            + ++L      E      E V EL   C +   ++RP+  ++ +  + +
Sbjct: 220 QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 123/272 (45%), Gaps = 25/272 (9%)
Query: 95  LSQGGFVSVYKGVLHD-NIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLE 153
           L  G +  VY+GV    ++ VAVKT +                 ++ H N+V++LG+C  
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 78
Query: 154 TEVPLLVYEFASNGTLLDHIR-CESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHG 212
                ++ EF + G LLD++R C   +V       L +A + +SA++YL        IH 
Sbjct: 79  EPPFYIITEFMTYGNLLDYLRECNRQEVSAV--VLLYMATQISSAMEYLEKKN---FIHR 133
Query: 213 DVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSD 272
           D+ + N L+ +N+  KVADF  S L++ D  TA +        +  P  +   K + KSD
Sbjct: 134 DLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIK-WTAPESLAYNKFSIKSD 192
Query: 273 VYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKE 332
           V++FGV+L E+ T                 M PY    I  + + ++L      E     
Sbjct: 193 VWAFGVLLWEIAT---------------YGMSPY--PGIDPSQVYELLEKDYRMERPEGC 235
Query: 333 IEIVAELASKCLRIRGTERPTMKQVSEELDRL 364
            E V EL   C +   ++RP+  ++ +  + +
Sbjct: 236 PEKVYELMRACWQWNPSDRPSFAEIHQAFETM 267

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 129/290 (44%), Gaps = 27/290 (9%)
Query: 77  FSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHD-NIQVAVKTYRRADKXXXXXXXXXXX 135
           + K EM R   +      L  G +  VY+GV    ++ VAVKT +               
Sbjct: 5   YDKWEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAV 62
Query: 136 XSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIR-CESSQVLKTWKTCLRIAAET 194
             ++ H N+V++LG+C       ++ EF + G LLD++R C   +V       L +A + 
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAV--VLLYMATQI 120
Query: 195 ASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTS 254
           +SA++YL        IH D+ + N L+ +N+  KVADF  S L++ D  TA +       
Sbjct: 121 SSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 177
Query: 255 GYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNN 314
            +  P  +   K + KSDV++FGV+L E+ T                 M PY    I  +
Sbjct: 178 -WTAPESLAYNKFSIKSDVWAFGVLLWEIAT---------------YGMSPY--PGIDLS 219
Query: 315 GLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL 364
            + ++L      E      E V EL   C +   ++RP+  ++ +  + +
Sbjct: 220 QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 72/269 (26%), Positives = 127/269 (47%), Gaps = 25/269 (9%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLET 154
           L QG F  V+ G  +   +VA+KT +                 ++ H+ +V++  +  E 
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 75
Query: 155 EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDV 214
            +  +V E+ S G+LLD ++ E+ + L+     + +AA+ AS + Y+  +     +H D+
Sbjct: 76  PI-XIVTEYMSKGSLLDFLKGETGKYLRL-PQLVDMAAQIASGMAYVERMN---YVHRDL 130
Query: 215 KSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVY 274
           ++ANIL+ +N   KVADF  + LI  +  TA          +  P     G+ T KSDV+
Sbjct: 131 RAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIK-WTAPEAALYGRFTIKSDVW 189
Query: 275 SFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEI 333
           SFG++L EL T G+ P   M    N+++      L+ ++         + +    E    
Sbjct: 190 SFGILLTELTTKGRVPYPGMV---NREV------LDQVER-------GYRMPCPPECP-- 231
Query: 334 EIVAELASKCLRIRGTERPTMKQVSEELD 362
           E + +L  +C R    ERPT + +   L+
Sbjct: 232 ESLHDLMCQCWRKEPEERPTFEYLQAFLE 260

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 129/290 (44%), Gaps = 27/290 (9%)
Query: 77  FSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHD-NIQVAVKTYRRADKXXXXXXXXXXX 135
           + K EM R   +      L  G +  VY+GV    ++ VAVKT +               
Sbjct: 5   YDKWEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAV 62
Query: 136 XSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIR-CESSQVLKTWKTCLRIAAET 194
             ++ H N+V++LG+C       ++ EF + G LLD++R C   +V       L +A + 
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAV--VLLYMATQI 120
Query: 195 ASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTS 254
           +SA++YL        IH D+ + N L+ +N+  KVADF  S L++ D  TA +       
Sbjct: 121 SSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 177
Query: 255 GYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNN 314
            +  P  +   K + KSDV++FGV+L E+ T                 M PY    I  +
Sbjct: 178 -WTAPESLAYNKFSIKSDVWAFGVLLWEIAT---------------YGMSPY--PGIDLS 219
Query: 315 GLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL 364
            + ++L      E      E V EL   C +   ++RP+  ++ +  + +
Sbjct: 220 QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 129/290 (44%), Gaps = 27/290 (9%)
Query: 77  FSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHD-NIQVAVKTYRRADKXXXXXXXXXXX 135
           + K EM R   +      L  G +  VY+GV    ++ VAVKT +               
Sbjct: 10  YDKWEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAV 67
Query: 136 XSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIR-CESSQVLKTWKTCLRIAAET 194
             ++ H N+V++LG+C       ++ EF + G LLD++R C   +V       L +A + 
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV--VLLYMATQI 125
Query: 195 ASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTS 254
           +SA++YL        IH D+ + N L+ +N+  KVADF  S L++ D  TA +       
Sbjct: 126 SSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 182
Query: 255 GYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNN 314
            +  P  +   K + KSDV++FGV+L E+ T                 M PY    I  +
Sbjct: 183 -WTAPESLAYNKFSIKSDVWAFGVLLWEIAT---------------YGMSPY--PGIDLS 224
Query: 315 GLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL 364
            + ++L      E      E V EL   C +   ++RP+  ++ +  + +
Sbjct: 225 QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 129/290 (44%), Gaps = 27/290 (9%)
Query: 77  FSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHD-NIQVAVKTYRRADKXXXXXXXXXXX 135
           + K EM R   +      L  G +  VY+GV    ++ VAVKT +               
Sbjct: 5   YDKWEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAV 62
Query: 136 XSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIR-CESSQVLKTWKTCLRIAAET 194
             ++ H N+V++LG+C       ++ EF + G LLD++R C   +V       L +A + 
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAV--VLLYMATQI 120
Query: 195 ASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTS 254
           +SA++YL        IH D+ + N L+ +N+  KVADF  S L++ D  TA +       
Sbjct: 121 SSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 177
Query: 255 GYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNN 314
            +  P  +   K + KSDV++FGV+L E+ T                 M PY    I  +
Sbjct: 178 -WTAPESLAYNKFSIKSDVWAFGVLLWEIAT---------------YGMSPY--PGIDLS 219
Query: 315 GLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL 364
            + ++L      E      E V EL   C +   ++RP+  ++ +  + +
Sbjct: 220 QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 129/290 (44%), Gaps = 27/290 (9%)
Query: 77  FSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHD-NIQVAVKTYRRADKXXXXXXXXXXX 135
           + K EM R   +      L  G +  VY+GV    ++ VAVKT +               
Sbjct: 10  YDKWEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAV 67
Query: 136 XSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIR-CESSQVLKTWKTCLRIAAET 194
             ++ H N+V++LG+C       ++ EF + G LLD++R C   +V       L +A + 
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAV--VLLYMATQI 125
Query: 195 ASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTS 254
           +SA++YL        IH D+ + N L+ +N+  KVADF  S L++ D  TA +       
Sbjct: 126 SSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 182
Query: 255 GYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNN 314
            +  P  +   K + KSDV++FGV+L E+ T                 M PY    I  +
Sbjct: 183 -WTAPESLAYNKFSIKSDVWAFGVLLWEIAT---------------YGMSPY--PGIDLS 224
Query: 315 GLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL 364
            + ++L      E      E V EL   C +   ++RP+  ++ +  + +
Sbjct: 225 QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 129/290 (44%), Gaps = 27/290 (9%)
Query: 77  FSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHD-NIQVAVKTYRRADKXXXXXXXXXXX 135
           + K EM R   +      L  G +  VY+GV    ++ VAVKT +               
Sbjct: 9   YDKWEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAV 66
Query: 136 XSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIR-CESSQVLKTWKTCLRIAAET 194
             ++ H N+V++LG+C       ++ EF + G LLD++R C   +V       L +A + 
Sbjct: 67  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV--VLLYMATQI 124
Query: 195 ASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTS 254
           +SA++YL        IH D+ + N L+ +N+  KVADF  S L++ D  TA +       
Sbjct: 125 SSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 181
Query: 255 GYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNN 314
            +  P  +   K + KSDV++FGV+L E+ T                 M PY    I  +
Sbjct: 182 -WTAPESLAYNKFSIKSDVWAFGVLLWEIAT---------------YGMSPY--PGIDLS 223
Query: 315 GLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL 364
            + ++L      E      E V EL   C +   ++RP+  ++ +  + +
Sbjct: 224 QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/280 (27%), Positives = 131/280 (46%), Gaps = 36/280 (12%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLET 154
           L  G F  V+ G  + + +VAVK+ ++                Q+ H+ +V++  +  + 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 80
Query: 155 EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDV 214
            +  ++ E+  NG+L+D ++  S   L T    L +AA+ A  + ++        IH D+
Sbjct: 81  PI-YIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEERN---YIHRDL 135
Query: 215 KSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVY 274
           ++ANIL++D  + K+ADF  + LI  +  TA          +  P  IN G  T KSDV+
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK-WTAPEAINYGTFTIKSDVW 194
Query: 275 SFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKN--NGLRQILNFHVADESEMK 331
           SFG++L E++T G+ P   MT   N ++         I+N   G R +   +  +E    
Sbjct: 195 SFGILLTEIVTHGRIPYPGMT---NPEV---------IQNLERGYRMVRPDNCPEE---- 238
Query: 332 EIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLHENF 371
               + +L   C + R  +RPT        D LR + E+F
Sbjct: 239 ----LYQLMRLCWKERPEDRPT-------FDYLRSVLEDF 267

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 129/290 (44%), Gaps = 27/290 (9%)
Query: 77  FSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHD-NIQVAVKTYRRADKXXXXXXXXXXX 135
           + K EM R   +      L  G +  VY+GV    ++ VAVKT +               
Sbjct: 10  YDKWEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAV 67
Query: 136 XSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIR-CESSQVLKTWKTCLRIAAET 194
             ++ H N+V++LG+C       ++ EF + G LLD++R C   +V       L +A + 
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV--VLLYMATQI 125
Query: 195 ASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTS 254
           +SA++YL        IH D+ + N L+ +N+  KVADF  S L++ D  TA +       
Sbjct: 126 SSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 182
Query: 255 GYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNN 314
            +  P  +   K + KSDV++FGV+L E+ T                 M PY    I  +
Sbjct: 183 -WTAPESLAYNKFSIKSDVWAFGVLLWEIAT---------------YGMSPY--PGIDLS 224
Query: 315 GLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL 364
            + ++L      E      E V EL   C +   ++RP+  ++ +  + +
Sbjct: 225 QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 133/281 (47%), Gaps = 38/281 (13%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLET 154
           L  G F  V+ G  + + +VAVK+ ++                Q+ H+ +V++  +   T
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV--T 80
Query: 155 EVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGD 213
           + P+ ++ E+  NG+L+D ++  S   L T    L +AA+ A  + ++        IH D
Sbjct: 81  QEPIYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEERN---YIHRD 136
Query: 214 VKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDV 273
           +++ANIL++D  + K+ADF  + LI  +  TA          +  P  IN G  T KSDV
Sbjct: 137 LRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK-WTAPEAINYGTFTIKSDV 195
Query: 274 YSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKN--NGLRQILNFHVADESEM 330
           +SFG++L E++T G+ P   MT   N ++         I+N   G R +   +  +E   
Sbjct: 196 WSFGILLTEIVTHGRIPYPGMT---NPEV---------IQNLERGYRMVRPDNCPEE--- 240
Query: 331 KEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLHENF 371
                + +L   C + R  +RPT        D LR + E+F
Sbjct: 241 -----LYQLMRLCWKERPEDRPT-------FDYLRSVLEDF 269

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 129/290 (44%), Gaps = 27/290 (9%)
Query: 77  FSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHD-NIQVAVKTYRRADKXXXXXXXXXXX 135
           + K EM R   +      L  G +  VY+GV    ++ VAVKT +               
Sbjct: 5   YDKWEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAV 62
Query: 136 XSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIR-CESSQVLKTWKTCLRIAAET 194
             ++ H N+V++LG+C       ++ EF + G LLD++R C   +V       L +A + 
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV--VLLYMATQI 120
Query: 195 ASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTS 254
           +SA++YL        IH D+ + N L+ +N+  KVADF  S L++ D  TA +       
Sbjct: 121 SSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 177
Query: 255 GYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNN 314
            +  P  +   K + KSDV++FGV+L E+ T                 M PY    I  +
Sbjct: 178 -WTAPESLAYNKFSIKSDVWAFGVLLWEIAT---------------YGMSPY--PGIDLS 219
Query: 315 GLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL 364
            + ++L      E      E V EL   C +   ++RP+  ++ +  + +
Sbjct: 220 QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 129/290 (44%), Gaps = 27/290 (9%)
Query: 77  FSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHD-NIQVAVKTYRRADKXXXXXXXXXXX 135
           + K EM R   +      L  G +  VY+GV    ++ VAVKT +               
Sbjct: 7   YDKWEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAV 64
Query: 136 XSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIR-CESSQVLKTWKTCLRIAAET 194
             ++ H N+V++LG+C       ++ EF + G LLD++R C   +V       L +A + 
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV--VLLYMATQI 122
Query: 195 ASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTS 254
           +SA++YL        IH D+ + N L+ +N+  KVADF  S L++ D  TA +       
Sbjct: 123 SSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 179
Query: 255 GYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNN 314
            +  P  +   K + KSDV++FGV+L E+ T                 M PY    I  +
Sbjct: 180 -WTAPESLAYNKFSIKSDVWAFGVLLWEIAT---------------YGMSPY--PGIDLS 221
Query: 315 GLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL 364
            + ++L      E      E V EL   C +   ++RP+  ++ +  + +
Sbjct: 222 QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 271

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 129/290 (44%), Gaps = 27/290 (9%)
Query: 77  FSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHD-NIQVAVKTYRRADKXXXXXXXXXXX 135
           + K EM R   +      L  G +  VY+GV    ++ VAVKT +               
Sbjct: 7   YDKWEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAV 64
Query: 136 XSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIR-CESSQVLKTWKTCLRIAAET 194
             ++ H N+V++LG+C       ++ EF + G LLD++R C   +V       L +A + 
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV--VLLYMATQI 122
Query: 195 ASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTS 254
           +SA++YL        IH D+ + N L+ +N+  KVADF  S L++ D  TA +       
Sbjct: 123 SSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 179
Query: 255 GYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNN 314
            +  P  +   K + KSDV++FGV+L E+ T                 M PY    I  +
Sbjct: 180 -WTAPESLAYNKFSIKSDVWAFGVLLWEIAT---------------YGMSPY--PGIDLS 221
Query: 315 GLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL 364
            + ++L      E      E V EL   C +   ++RP+  ++ +  + +
Sbjct: 222 QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 271

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 129/290 (44%), Gaps = 27/290 (9%)
Query: 77  FSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHD-NIQVAVKTYRRADKXXXXXXXXXXX 135
           + K EM R   +      L  G +  VY+GV    ++ VAVKT +               
Sbjct: 18  YDKWEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAV 75
Query: 136 XSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIR-CESSQVLKTWKTCLRIAAET 194
             ++ H N+V++LG+C       ++ EF + G LLD++R C   +V       L +A + 
Sbjct: 76  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV--VLLYMATQI 133
Query: 195 ASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTS 254
           +SA++YL        IH D+ + N L+ +N+  KVADF  S L++ D  TA +       
Sbjct: 134 SSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 190
Query: 255 GYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNN 314
            +  P  +   K + KSDV++FGV+L E+ T                 M PY    I  +
Sbjct: 191 -WTAPESLAYNKFSIKSDVWAFGVLLWEIAT---------------YGMSPY--PGIDLS 232
Query: 315 GLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL 364
            + ++L      E      E V EL   C +   ++RP+  ++ +  + +
Sbjct: 233 QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 282

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 129/290 (44%), Gaps = 27/290 (9%)
Query: 77  FSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHD-NIQVAVKTYRRADKXXXXXXXXXXX 135
           + K EM R   +      L  G +  VY+GV    ++ VAVKT +               
Sbjct: 5   YDKWEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAV 62
Query: 136 XSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIR-CESSQVLKTWKTCLRIAAET 194
             ++ H N+V++LG+C       ++ EF + G LLD++R C   +V       L +A + 
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV--VLLYMATQI 120
Query: 195 ASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTS 254
           +SA++YL        IH D+ + N L+ +N+  KVADF  S L++ D  TA +       
Sbjct: 121 SSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 177
Query: 255 GYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNN 314
            +  P  +   K + KSDV++FGV+L E+ T                 M PY    I  +
Sbjct: 178 -WTAPESLAYNKFSIKSDVWAFGVLLWEIAT---------------YGMSPY--PGIDLS 219
Query: 315 GLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL 364
            + ++L      E      E V EL   C +   ++RP+  ++ +  + +
Sbjct: 220 QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/280 (27%), Positives = 131/280 (46%), Gaps = 36/280 (12%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLET 154
           L  G F  V+ G  + + +VAVK+ ++                Q+ H+ +V++  +  + 
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 90
Query: 155 EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDV 214
            +  ++ E+  NG+L+D ++  S   L T    L +AA+ A  + ++        IH D+
Sbjct: 91  PI-YIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEERN---YIHRDL 145
Query: 215 KSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVY 274
           ++ANIL++D  + K+ADF  + LI  +  TA          +  P  IN G  T KSDV+
Sbjct: 146 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK-WTAPEAINYGTFTIKSDVW 204
Query: 275 SFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKN--NGLRQILNFHVADESEMK 331
           SFG++L E++T G+ P   MT   N ++         I+N   G R +   +  +E    
Sbjct: 205 SFGILLTEIVTHGRIPYPGMT---NPEV---------IQNLERGYRMVRPDNCPEE---- 248
Query: 332 EIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLHENF 371
               + +L   C + R  +RPT        D LR + E+F
Sbjct: 249 ----LYQLMRLCWKERPEDRPT-------FDYLRSVLEDF 277

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 129/290 (44%), Gaps = 27/290 (9%)
Query: 77  FSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHD-NIQVAVKTYRRADKXXXXXXXXXXX 135
           + K EM R   +      L  G +  VY+GV    ++ VAVKT +               
Sbjct: 7   YDKWEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAV 64
Query: 136 XSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIR-CESSQVLKTWKTCLRIAAET 194
             ++ H N+V++LG+C       ++ EF + G LLD++R C   +V       L +A + 
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV--VLLYMATQI 122
Query: 195 ASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTS 254
           +SA++YL        IH D+ + N L+ +N+  KVADF  S L++ D  TA +       
Sbjct: 123 SSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIK 179
Query: 255 GYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNN 314
            +  P  +   K + KSDV++FGV+L E+ T                 M PY    I  +
Sbjct: 180 -WTAPESLAYNKFSIKSDVWAFGVLLWEIAT---------------YGMSPY--PGIDLS 221
Query: 315 GLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL 364
            + ++L      E      E V EL   C +   ++RP+  ++ +  + +
Sbjct: 222 QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 271

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 129/290 (44%), Gaps = 27/290 (9%)
Query: 77  FSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHD-NIQVAVKTYRRADKXXXXXXXXXXX 135
           + K EM R   +      L  G +  VY+GV    ++ VAVKT +               
Sbjct: 6   YDKWEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAV 63
Query: 136 XSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIR-CESSQVLKTWKTCLRIAAET 194
             ++ H N+V++LG+C       ++ EF + G LLD++R C   +V       L +A + 
Sbjct: 64  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV--VLLYMATQI 121
Query: 195 ASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTS 254
           +SA++YL        IH D+ + N L+ +N+  KVADF  S L++ D  TA +       
Sbjct: 122 SSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIK 178
Query: 255 GYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNN 314
            +  P  +   K + KSDV++FGV+L E+ T                 M PY    I  +
Sbjct: 179 -WTAPESLAYNKFSIKSDVWAFGVLLWEIAT---------------YGMSPY--PGIDLS 220
Query: 315 GLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL 364
            + ++L      E      E V EL   C +   ++RP+  ++ +  + +
Sbjct: 221 QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 270

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 133/281 (47%), Gaps = 38/281 (13%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLET 154
           L  G F  V+ G  + + +VAVK+ ++                Q+ H+ +V++  +   T
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV--T 79
Query: 155 EVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGD 213
           + P+ ++ E+  NG+L+D ++  S   L T    L +AA+ A  + ++        IH D
Sbjct: 80  QEPIYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEERN---YIHRD 135
Query: 214 VKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDV 273
           +++ANIL++D  + K+ADF  + LI  +  TA          +  P  IN G  T KSDV
Sbjct: 136 LRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK-WTAPEAINYGTFTIKSDV 194
Query: 274 YSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKN--NGLRQILNFHVADESEM 330
           +SFG++L E++T G+ P   MT   N ++         I+N   G R +   +  +E   
Sbjct: 195 WSFGILLTEIVTHGRIPYPGMT---NPEV---------IQNLERGYRMVRPDNCPEE--- 239
Query: 331 KEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLHENF 371
                + +L   C + R  +RPT        D LR + E+F
Sbjct: 240 -----LYQLMRLCWKERPEDRPT-------FDYLRSVLEDF 268

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 72/269 (26%), Positives = 127/269 (47%), Gaps = 25/269 (9%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLET 154
           L QG F  V+ G  +   +VA+KT +                 ++ H+ +V++  +  E 
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 78
Query: 155 EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDV 214
            +  +V E+ S G+LLD ++ E+ + L+     + +AA+ AS + Y+  +     +H D+
Sbjct: 79  PI-YIVTEYMSKGSLLDFLKGETGKYLRL-PQLVDMAAQIASGMAYVERMN---YVHRDL 133
Query: 215 KSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVY 274
           ++ANIL+ +N   KVADF  + LI  +  TA          +  P     G+ T KSDV+
Sbjct: 134 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKSDVW 192
Query: 275 SFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEI 333
           SFG++L EL T G+ P   M    N+++      L+ ++         + +    E    
Sbjct: 193 SFGILLTELTTKGRVPYPGMV---NREV------LDQVER-------GYRMPCPPECP-- 234
Query: 334 EIVAELASKCLRIRGTERPTMKQVSEELD 362
           E + +L  +C R    ERPT + +   L+
Sbjct: 235 ESLHDLMCQCWRKEPEERPTFEYLQAFLE 263

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 133/281 (47%), Gaps = 38/281 (13%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLET 154
           L  G F  V+ G  + + +VAVK+ ++                Q+ H+ +V++  +   T
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV--T 78
Query: 155 EVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGD 213
           + P+ ++ E+  NG+L+D ++  S   L T    L +AA+ A  + ++        IH D
Sbjct: 79  QEPIYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEERN---YIHRD 134
Query: 214 VKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDV 273
           +++ANIL++D  + K+ADF  + LI  +  TA          +  P  IN G  T KSDV
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK-WTAPEAINYGTFTIKSDV 193
Query: 274 YSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKN--NGLRQILNFHVADESEM 330
           +SFG++L E++T G+ P   MT   N ++         I+N   G R +   +  +E   
Sbjct: 194 WSFGILLTEIVTHGRIPYPGMT---NPEV---------IQNLERGYRMVRPDNCPEE--- 238
Query: 331 KEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLHENF 371
                + +L   C + R  +RPT        D LR + E+F
Sbjct: 239 -----LYQLMRLCWKERPEDRPT-------FDYLRSVLEDF 267

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 133/281 (47%), Gaps = 38/281 (13%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLET 154
           L  G F  V+ G  + + +VAVK+ ++                Q+ H+ +V++  +   T
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV--T 83
Query: 155 EVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGD 213
           + P+ ++ E+  NG+L+D ++  S   L T    L +AA+ A  + ++        IH D
Sbjct: 84  QEPIYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEERN---YIHRD 139
Query: 214 VKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDV 273
           +++ANIL++D  + K+ADF  + LI  +  TA          +  P  IN G  T KSDV
Sbjct: 140 LRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK-WTAPEAINYGTFTIKSDV 198
Query: 274 YSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKN--NGLRQILNFHVADESEM 330
           +SFG++L E++T G+ P   MT   N ++         I+N   G R +   +  +E   
Sbjct: 199 WSFGILLTEIVTHGRIPYPGMT---NPEV---------IQNLERGYRMVRPDNCPEE--- 243
Query: 331 KEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLHENF 371
                + +L   C + R  +RPT        D LR + E+F
Sbjct: 244 -----LYQLMRLCWKERPEDRPT-------FDYLRSVLEDF 272

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 133/281 (47%), Gaps = 38/281 (13%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLET 154
           L  G F  V+ G  + + +VAVK+ ++                Q+ H+ +V++  +   T
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV--T 84
Query: 155 EVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGD 213
           + P+ ++ E+  NG+L+D ++  S   L T    L +AA+ A  + ++        IH D
Sbjct: 85  QEPIYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEERN---YIHRD 140
Query: 214 VKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDV 273
           +++ANIL++D  + K+ADF  + LI  +  TA          +  P  IN G  T KSDV
Sbjct: 141 LRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK-WTAPEAINYGTFTIKSDV 199
Query: 274 YSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKN--NGLRQILNFHVADESEM 330
           +SFG++L E++T G+ P   MT   N ++         I+N   G R +   +  +E   
Sbjct: 200 WSFGILLTEIVTHGRIPYPGMT---NPEV---------IQNLERGYRMVRPDNCPEE--- 244
Query: 331 KEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLHENF 371
                + +L   C + R  +RPT        D LR + E+F
Sbjct: 245 -----LYQLMRLCWKERPEDRPT-------FDYLRSVLEDF 273

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 133/281 (47%), Gaps = 38/281 (13%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLET 154
           L  G F  V+ G  + + +VAVK+ ++                Q+ H+ +V++  +   T
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV--T 78
Query: 155 EVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGD 213
           + P+ ++ E+  NG+L+D ++  S   L T    L +AA+ A  + ++        IH D
Sbjct: 79  QEPIYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEERN---YIHRD 134
Query: 214 VKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDV 273
           +++ANIL++D  + K+ADF  + LI  +  TA          +  P  IN G  T KSDV
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK-WTAPEAINYGTFTIKSDV 193
Query: 274 YSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKN--NGLRQILNFHVADESEM 330
           +SFG++L E++T G+ P   MT   N ++         I+N   G R +   +  +E   
Sbjct: 194 WSFGILLTEIVTHGRIPYPGMT---NPEV---------IQNLERGYRMVRPDNCPEE--- 238
Query: 331 KEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLHENF 371
                + +L   C + R  +RPT        D LR + E+F
Sbjct: 239 -----LYQLMRLCWKERPEDRPT-------FDYLRSVLEDF 267

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 133/281 (47%), Gaps = 38/281 (13%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLET 154
           L  G F  V+ G  + + +VAVK+ ++                Q+ H+ +V++  +   T
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV--T 73
Query: 155 EVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGD 213
           + P+ ++ E+  NG+L+D ++  S   L T    L +AA+ A  + ++        IH D
Sbjct: 74  QEPIYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEERN---YIHRD 129
Query: 214 VKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDV 273
           +++ANIL++D  + K+ADF  + LI  +  TA          +  P  IN G  T KSDV
Sbjct: 130 LRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK-WTAPEAINYGTFTIKSDV 188
Query: 274 YSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKN--NGLRQILNFHVADESEM 330
           +SFG++L E++T G+ P   MT   N ++         I+N   G R +   +  +E   
Sbjct: 189 WSFGILLTEIVTHGRIPYPGMT---NPEV---------IQNLERGYRMVRPDNCPEE--- 233
Query: 331 KEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLHENF 371
                + +L   C + R  +RPT        D LR + E+F
Sbjct: 234 -----LYQLMRLCWKERPEDRPT-------FDYLRSVLEDF 262

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 72/269 (26%), Positives = 126/269 (46%), Gaps = 25/269 (9%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLET 154
           L QG F  V+ G  +   +VA+KT +                 ++ H+ +V++  +  E 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKIRHEKLVQLYAVVSEE 85
Query: 155 EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDV 214
            +  +V E+ S G+LLD ++ E  + L+     + +AA+ AS + Y+  +     +H D+
Sbjct: 86  PI-YIVTEYMSKGSLLDFLKGEMGKYLRL-PQLVDMAAQIASGMAYVERMN---YVHRDL 140
Query: 215 KSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVY 274
           ++ANIL+ +N   KVADF  + LI  +  TA          +  P     G+ T KSDV+
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKSDVW 199
Query: 275 SFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEI 333
           SFG++L EL T G+ P   M    N+++      L+ ++         + +    E    
Sbjct: 200 SFGILLTELTTKGRVPYPGMV---NREV------LDQVER-------GYRMPCPPECP-- 241
Query: 334 EIVAELASKCLRIRGTERPTMKQVSEELD 362
           E + +L  +C R    ERPT + +   L+
Sbjct: 242 ESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 72/269 (26%), Positives = 127/269 (47%), Gaps = 25/269 (9%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLET 154
           L QG F  V+ G  +   +VA+KT +                 ++ H+ +V++  +  E 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 251
Query: 155 EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDV 214
            +  +V E+ S G+LLD ++ E+ + L+     + +AA+ AS + Y+  +     +H D+
Sbjct: 252 PI-YIVTEYMSKGSLLDFLKGETGKYLRL-PQLVDMAAQIASGMAYVERMN---YVHRDL 306
Query: 215 KSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVY 274
           ++ANIL+ +N   KVADF  + LI  +  TA          +  P     G+ T KSDV+
Sbjct: 307 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKSDVW 365
Query: 275 SFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEI 333
           SFG++L EL T G+ P   M    N+++      L+ ++         + +    E    
Sbjct: 366 SFGILLTELTTKGRVPYPGMV---NREV------LDQVER-------GYRMPCPPECP-- 407
Query: 334 EIVAELASKCLRIRGTERPTMKQVSEELD 362
           E + +L  +C R    ERPT + +   L+
Sbjct: 408 ESLHDLMCQCWRKEPEERPTFEYLQAFLE 436

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 72/269 (26%), Positives = 126/269 (46%), Gaps = 25/269 (9%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLET 154
           L QG F  V+ G  +   +VA+KT +                 ++ H+ +V++  +  E 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 85
Query: 155 EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDV 214
            +  +V E+ S G+LLD ++ E  + L+     + +AA+ AS + Y+  +     +H D+
Sbjct: 86  PI-YIVIEYMSKGSLLDFLKGEMGKYLRL-PQLVDMAAQIASGMAYVERMN---YVHRDL 140
Query: 215 KSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVY 274
           ++ANIL+ +N   KVADF  + LI  +  TA          +  P     G+ T KSDV+
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIK-WTAPEAALYGRFTIKSDVW 199
Query: 275 SFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEI 333
           SFG++L EL T G+ P   M    N+++      L+ ++         + +    E    
Sbjct: 200 SFGILLTELTTKGRVPYPGMV---NREV------LDQVER-------GYRMPCPPECP-- 241
Query: 334 EIVAELASKCLRIRGTERPTMKQVSEELD 362
           E + +L  +C R    ERPT + +   L+
Sbjct: 242 ESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 72/269 (26%), Positives = 126/269 (46%), Gaps = 25/269 (9%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLET 154
           L QG F  V+ G  +   +VA+KT +                 ++ H+ +V++  +  E 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 85
Query: 155 EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDV 214
            +  +V E+ S G+LLD ++ E  + L+     + +AA+ AS + Y+  +     +H D+
Sbjct: 86  PI-YIVIEYMSKGSLLDFLKGEMGKYLRL-PQLVDMAAQIASGMAYVERMN---YVHRDL 140
Query: 215 KSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVY 274
           ++ANIL+ +N   KVADF  + LI  +  TA          +  P     G+ T KSDV+
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKSDVW 199
Query: 275 SFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEI 333
           SFG++L EL T G+ P   M    N+++      L+ ++         + +    E    
Sbjct: 200 SFGILLTELTTKGRVPYPGMV---NREV------LDQVER-------GYRMPCPPECP-- 241
Query: 334 EIVAELASKCLRIRGTERPTMKQVSEELD 362
           E + +L  +C R    ERPT + +   L+
Sbjct: 242 ESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 72/269 (26%), Positives = 127/269 (47%), Gaps = 25/269 (9%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLET 154
           L QG F  V+ G  +   +VA+KT +                 ++ H+ +V++  +  E 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 251
Query: 155 EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDV 214
            +  +V E+ S G+LLD ++ E+ + L+     + +AA+ AS + Y+  +     +H D+
Sbjct: 252 PI-YIVTEYMSKGSLLDFLKGETGKYLRL-PQLVDMAAQIASGMAYVERMN---YVHRDL 306
Query: 215 KSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVY 274
           ++ANIL+ +N   KVADF  + LI  +  TA          +  P     G+ T KSDV+
Sbjct: 307 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKSDVW 365
Query: 275 SFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEI 333
           SFG++L EL T G+ P   M    N+++      L+ ++         + +    E    
Sbjct: 366 SFGILLTELTTKGRVPYPGMV---NREV------LDQVER-------GYRMPCPPECP-- 407
Query: 334 EIVAELASKCLRIRGTERPTMKQVSEELD 362
           E + +L  +C R    ERPT + +   L+
Sbjct: 408 ESLHDLMCQCWRKEPEERPTFEYLQAFLE 436

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 72/269 (26%), Positives = 127/269 (47%), Gaps = 25/269 (9%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLET 154
           L QG F  V+ G  +   +VA+KT +                 ++ H+ +V++  +  E 
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 334
Query: 155 EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDV 214
            +  +V E+ S G+LLD ++ E+ + L+     + +AA+ AS + Y+  +     +H D+
Sbjct: 335 PI-YIVTEYMSKGSLLDFLKGETGKYLRL-PQLVDMAAQIASGMAYVERMN---YVHRDL 389
Query: 215 KSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVY 274
           ++ANIL+ +N   KVADF  + LI  +  TA          +  P     G+ T KSDV+
Sbjct: 390 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKSDVW 448
Query: 275 SFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEI 333
           SFG++L EL T G+ P   M    N+++      L+ ++         + +    E    
Sbjct: 449 SFGILLTELTTKGRVPYPGMV---NREV------LDQVER-------GYRMPCPPECP-- 490
Query: 334 EIVAELASKCLRIRGTERPTMKQVSEELD 362
           E + +L  +C R    ERPT + +   L+
Sbjct: 491 ESLHDLMCQCWRKEPEERPTFEYLQAFLE 519

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 72/269 (26%), Positives = 127/269 (47%), Gaps = 25/269 (9%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLET 154
           L QG F  V+ G  +   +VA+KT +                 ++ H+ +V++  +  E 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 251
Query: 155 EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDV 214
            +  +V E+ S G+LLD ++ E+ + L+     + +AA+ AS + Y+  +     +H D+
Sbjct: 252 PI-YIVGEYMSKGSLLDFLKGETGKYLRL-PQLVDMAAQIASGMAYVERMN---YVHRDL 306
Query: 215 KSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVY 274
           ++ANIL+ +N   KVADF  + LI  +  TA          +  P     G+ T KSDV+
Sbjct: 307 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKSDVW 365
Query: 275 SFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEI 333
           SFG++L EL T G+ P   M    N+++      L+ ++         + +    E    
Sbjct: 366 SFGILLTELTTKGRVPYPGMV---NREV------LDQVER-------GYRMPCPPECP-- 407
Query: 334 EIVAELASKCLRIRGTERPTMKQVSEELD 362
           E + +L  +C R    ERPT + +   L+
Sbjct: 408 ESLHDLMCQCWRKEPEERPTFEYLQAFLE 436

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 72/269 (26%), Positives = 126/269 (46%), Gaps = 25/269 (9%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLET 154
           L QG F  V+ G  +   +VA+KT +                 ++ H+ +V++  +  E 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 85
Query: 155 EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDV 214
            +  +V E+ S G+LLD ++ E  + L+     + +AA+ AS + Y+  +     +H D+
Sbjct: 86  PI-YIVTEYMSKGSLLDFLKGEMGKYLRL-PQLVDMAAQIASGMAYVERMN---YVHRDL 140
Query: 215 KSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVY 274
           ++ANIL+ +N   KVADF  + LI  +  TA          +  P     G+ T KSDV+
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKSDVW 199
Query: 275 SFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEI 333
           SFG++L EL T G+ P   M    N+++      L+ ++         + +    E    
Sbjct: 200 SFGILLTELTTKGRVPYPGMV---NREV------LDQVER-------GYRMPCPPECP-- 241
Query: 334 EIVAELASKCLRIRGTERPTMKQVSEELD 362
           E + +L  +C R    ERPT + +   L+
Sbjct: 242 ESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 72/269 (26%), Positives = 126/269 (46%), Gaps = 25/269 (9%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLET 154
           L QG F  V+ G  +   +VA+KT +                 ++ H+ +V++  +  E 
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 74
Query: 155 EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDV 214
            +  +V E+ S G+LLD ++ E  + L+     + +AA+ AS + Y+  +     +H D+
Sbjct: 75  PI-YIVTEYMSKGSLLDFLKGEMGKYLRL-PQLVDMAAQIASGMAYVERMN---YVHRDL 129
Query: 215 KSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVY 274
           ++ANIL+ +N   KVADF  + LI  +  TA          +  P     G+ T KSDV+
Sbjct: 130 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKSDVW 188
Query: 275 SFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEI 333
           SFG++L EL T G+ P   M    N+++      L+ ++         + +    E    
Sbjct: 189 SFGILLTELTTKGRVPYPGMV---NREV------LDQVER-------GYRMPCPPECP-- 230
Query: 334 EIVAELASKCLRIRGTERPTMKQVSEELD 362
           E + +L  +C R    ERPT + +   L+
Sbjct: 231 ESLHDLMCQCWRKDPEERPTFEYLQAFLE 259

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 129/290 (44%), Gaps = 27/290 (9%)
Query: 77  FSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHD-NIQVAVKTYRRADKXXXXXXXXXXX 135
           + K EM R   +      L  G +  VY+GV    ++ VAVKT +               
Sbjct: 212 YDKWEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAV 269
Query: 136 XSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIR-CESSQVLKTWKTCLRIAAET 194
             ++ H N+V++LG+C       ++ EF + G LLD++R C   +V       L +A + 
Sbjct: 270 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAV--VLLYMATQI 327
Query: 195 ASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTS 254
           +SA++YL        IH ++ + N L+ +N+  KVADF  S L++ D  TA +       
Sbjct: 328 SSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 384
Query: 255 GYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNN 314
            +  P  +   K + KSDV++FGV+L E+ T                 M PY    I  +
Sbjct: 385 -WTAPESLAYNKFSIKSDVWAFGVLLWEIAT---------------YGMSPY--PGIDLS 426
Query: 315 GLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL 364
            + ++L      E      E V EL   C +   ++RP+  ++ +  + +
Sbjct: 427 QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 72/269 (26%), Positives = 126/269 (46%), Gaps = 25/269 (9%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLET 154
           L QG F  V+ G  +   +VA+KT +                 ++ H+ +V++  +  E 
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 76
Query: 155 EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDV 214
            +  +V E+ S G+LLD ++ E  + L+     + +AA+ AS + Y+  +     +H D+
Sbjct: 77  PI-YIVTEYMSKGSLLDFLKGEMGKYLRL-PQLVDMAAQIASGMAYVERMN---YVHRDL 131
Query: 215 KSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVY 274
           ++ANIL+ +N   KVADF  + LI  +  TA          +  P     G+ T KSDV+
Sbjct: 132 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKSDVW 190
Query: 275 SFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEI 333
           SFG++L EL T G+ P   M    N+++      L+ ++         + +    E    
Sbjct: 191 SFGILLTELTTKGRVPYPGMV---NREV------LDQVER-------GYRMPCPPECP-- 232
Query: 334 EIVAELASKCLRIRGTERPTMKQVSEELD 362
           E + +L  +C R    ERPT + +   L+
Sbjct: 233 ESLHDLMCQCWRKDPEERPTFEYLQAFLE 261

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 72/269 (26%), Positives = 126/269 (46%), Gaps = 25/269 (9%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLET 154
           L QG F  V+ G  +   +VA+KT +                 ++ H+ +V++  +  E 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 85
Query: 155 EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDV 214
            +  +V E+ S G+LLD ++ E  + L+     + +AA+ AS + Y+  +     +H D+
Sbjct: 86  PI-YIVCEYMSKGSLLDFLKGEMGKYLRL-PQLVDMAAQIASGMAYVERMN---YVHRDL 140
Query: 215 KSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVY 274
           ++ANIL+ +N   KVADF  + LI  +  TA          +  P     G+ T KSDV+
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKSDVW 199
Query: 275 SFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEI 333
           SFG++L EL T G+ P   M    N+++      L+ ++         + +    E    
Sbjct: 200 SFGILLTELTTKGRVPYPGMV---NREV------LDQVER-------GYRMPCPPECP-- 241
Query: 334 EIVAELASKCLRIRGTERPTMKQVSEELD 362
           E + +L  +C R    ERPT + +   L+
Sbjct: 242 ESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 72/269 (26%), Positives = 125/269 (46%), Gaps = 25/269 (9%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLET 154
           L QG F  V+ G  +   +VA+KT +                 ++ H+ +V++  +  E 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 85
Query: 155 EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDV 214
            +  +V E+ S G LLD ++ E  + L+     + +AA+ AS + Y+  +     +H D+
Sbjct: 86  PI-YIVMEYMSKGCLLDFLKGEMGKYLRL-PQLVDMAAQIASGMAYVERMN---YVHRDL 140
Query: 215 KSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVY 274
           ++ANIL+ +N   KVADF  + LI  +  TA          +  P     G+ T KSDV+
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKSDVW 199
Query: 275 SFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEI 333
           SFG++L EL T G+ P   M    N+++      L+ ++         + +    E    
Sbjct: 200 SFGILLTELTTKGRVPYPGMV---NREV------LDQVER-------GYRMPCPPECP-- 241
Query: 334 EIVAELASKCLRIRGTERPTMKQVSEELD 362
           E + +L  +C R    ERPT + +   L+
Sbjct: 242 ESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 129/290 (44%), Gaps = 27/290 (9%)
Query: 77  FSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHD-NIQVAVKTYRRADKXXXXXXXXXXX 135
           + K EM R   +      L  G +  VY+GV    ++ VAVKT +               
Sbjct: 251 YDKWEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAV 308
Query: 136 XSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIR-CESSQVLKTWKTCLRIAAET 194
             ++ H N+V++LG+C       ++ EF + G LLD++R C   +V       L +A + 
Sbjct: 309 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV--VLLYMATQI 366
Query: 195 ASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTS 254
           +SA++YL        IH ++ + N L+ +N+  KVADF  S L++ D  TA +       
Sbjct: 367 SSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 423
Query: 255 GYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNN 314
            +  P  +   K + KSDV++FGV+L E+ T                 M PY    I  +
Sbjct: 424 -WTAPESLAYNKFSIKSDVWAFGVLLWEIAT---------------YGMSPY--PGIDLS 465
Query: 315 GLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL 364
            + ++L      E      E V EL   C +   ++RP+  ++ +  + +
Sbjct: 466 QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 515

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 127/269 (47%), Gaps = 25/269 (9%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLET 154
           L QG F  V+ G  +   +VA+KT +                 ++ H+ +V++  +  E 
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 82
Query: 155 EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDV 214
            +  +V E+ + G+LLD ++ E+ + L+     + ++A+ AS + Y+  +     +H D+
Sbjct: 83  PI-YIVTEYMNKGSLLDFLKGETGKYLRL-PQLVDMSAQIASGMAYVERMN---YVHRDL 137
Query: 215 KSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVY 274
           ++ANIL+ +N   KVADF  + LI  +  TA          +  P     G+ T KSDV+
Sbjct: 138 RAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIK-WTAPEAALYGRFTIKSDVW 196
Query: 275 SFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEI 333
           SFG++L EL T G+ P   M    N+++      L+ ++         + +    E    
Sbjct: 197 SFGILLTELTTKGRVPYPGMV---NREV------LDQVER-------GYRMPCPPECP-- 238
Query: 334 EIVAELASKCLRIRGTERPTMKQVSEELD 362
           E + +L  +C R    ERPT + +   L+
Sbjct: 239 ESLHDLMCQCWRKEPEERPTFEYLQAFLE 267

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 72/269 (26%), Positives = 125/269 (46%), Gaps = 25/269 (9%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLET 154
           L QG F  V+ G  +   +VA+KT +                 ++ H+ +V++  +  E 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 85
Query: 155 EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDV 214
            +  +V E+ S G LLD ++ E  + L+     + +AA+ AS + Y+  +     +H D+
Sbjct: 86  PI-YIVTEYMSKGCLLDFLKGEMGKYLRL-PQLVDMAAQIASGMAYVERMN---YVHRDL 140
Query: 215 KSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVY 274
           ++ANIL+ +N   KVADF  + LI  +  TA          +  P     G+ T KSDV+
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKSDVW 199
Query: 275 SFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEI 333
           SFG++L EL T G+ P   M    N+++      L+ ++         + +    E    
Sbjct: 200 SFGILLTELTTKGRVPYPGMV---NREV------LDQVER-------GYRMPCPPECP-- 241
Query: 334 EIVAELASKCLRIRGTERPTMKQVSEELD 362
           E + +L  +C R    ERPT + +   L+
Sbjct: 242 ESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 72/269 (26%), Positives = 126/269 (46%), Gaps = 25/269 (9%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLET 154
           L QG F  V+ G  +   +VA+KT +  +              ++ H+ +V++  +  E 
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 252
Query: 155 EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDV 214
            +  +V E+ S G+LLD ++ E  + L+     + +AA+ AS + Y+  +     +H D+
Sbjct: 253 PI-YIVTEYMSKGSLLDFLKGEMGKYLRL-PQLVDMAAQIASGMAYVERMN---YVHRDL 307
Query: 215 KSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVY 274
           ++ANIL+ +N   KVADF    LI  +  TA          +  P     G+ T KSDV+
Sbjct: 308 RAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKSDVW 366
Query: 275 SFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEI 333
           SFG++L EL T G+ P   M    N+++      L+ ++         + +    E    
Sbjct: 367 SFGILLTELTTKGRVPYPGMV---NREV------LDQVER-------GYRMPCPPECP-- 408
Query: 334 EIVAELASKCLRIRGTERPTMKQVSEELD 362
           E + +L  +C R    ERPT + +   L+
Sbjct: 409 ESLHDLMCQCWRKDPEERPTFEYLQAFLE 437

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 127/269 (47%), Gaps = 25/269 (9%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLET 154
           L QG F  V+ G  +   +VA+KT +                 ++ H+ +V++  +  E 
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 82
Query: 155 EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDV 214
            +  +V E+ + G+LLD ++ E+ + L+     + ++A+ AS + Y+  +     +H D+
Sbjct: 83  PI-YIVTEYMNKGSLLDFLKGETGKYLRL-PQLVDMSAQIASGMAYVERMN---YVHRDL 137
Query: 215 KSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVY 274
           ++ANIL+ +N   KVADF  + LI  +  TA          +  P     G+ T KSDV+
Sbjct: 138 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKSDVW 196
Query: 275 SFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEI 333
           SFG++L EL T G+ P   M    N+++      L+ ++         + +    E    
Sbjct: 197 SFGILLTELTTKGRVPYPGMV---NREV------LDQVER-------GYRMPCPPECP-- 238
Query: 334 EIVAELASKCLRIRGTERPTMKQVSEELD 362
           E + +L  +C R    ERPT + +   L+
Sbjct: 239 ESLHDLMCQCWRKEPEERPTFEYLQAFLE 267

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/281 (27%), Positives = 133/281 (47%), Gaps = 38/281 (13%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLET 154
           L  G F  V+ G  + + +VAVK+ ++                Q+ H+ +V++  +   T
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV--T 74
Query: 155 EVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGD 213
           + P+ ++ E+  NG+L+D ++  S   L T    L +AA+ A  + ++        IH +
Sbjct: 75  QEPIYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEERN---YIHRN 130
Query: 214 VKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDV 273
           +++ANIL++D  + K+ADF  + LI  +  TA          +  P  IN G  T KSDV
Sbjct: 131 LRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK-WTAPEAINYGTFTIKSDV 189
Query: 274 YSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKN--NGLRQILNFHVADESEM 330
           +SFG++L E++T G+ P   MT   N ++         I+N   G R +   +  +E   
Sbjct: 190 WSFGILLTEIVTHGRIPYPGMT---NPEV---------IQNLERGYRMVRPDNCPEE--- 234
Query: 331 KEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLHENF 371
                + +L   C + R  +RPT        D LR + E+F
Sbjct: 235 -----LYQLMRLCWKERPEDRPT-------FDYLRSVLEDF 263

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 72/269 (26%), Positives = 125/269 (46%), Gaps = 25/269 (9%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLET 154
           L QG F  V+ G  +   +VA+KT +                 ++ H+ +V++  +  E 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 85
Query: 155 EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDV 214
            +  +V E+ S G+LLD ++ E  + L+     + +AA+ AS + Y+  +     +H D+
Sbjct: 86  PI-YIVTEYMSKGSLLDFLKGEMGKYLRL-PQLVDMAAQIASGMAYVERMN---YVHRDL 140
Query: 215 KSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVY 274
            +ANIL+ +N   KVADF  + LI  +  TA          +  P     G+ T KSDV+
Sbjct: 141 AAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKSDVW 199
Query: 275 SFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEI 333
           SFG++L EL T G+ P   M    N+++      L+ ++         + +    E    
Sbjct: 200 SFGILLTELTTKGRVPYPGMV---NREV------LDQVER-------GYRMPCPPECP-- 241
Query: 334 EIVAELASKCLRIRGTERPTMKQVSEELD 362
           E + +L  +C R    ERPT + +   L+
Sbjct: 242 ESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 76/280 (27%), Positives = 130/280 (46%), Gaps = 36/280 (12%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLET 154
           L  G    V+ G  + + +VAVK+ ++                Q+ H+ +V++  +  + 
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE 80
Query: 155 EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDV 214
            +  ++ E+  NG+L+D ++  S   L T    L +AA+ A  + ++        IH D+
Sbjct: 81  PI-YIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEERN---YIHRDL 135
Query: 215 KSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVY 274
           ++ANIL++D  + K+ADF  + LI  DAE            +  P  IN G  T KSDV+
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIE-DAEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 194
Query: 275 SFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKN--NGLRQILNFHVADESEMK 331
           SFG++L E++T G+ P   MT   N ++         I+N   G R +   +  +E    
Sbjct: 195 SFGILLTEIVTHGRIPYPGMT---NPEV---------IQNLERGYRMVRPDNCPEE---- 238
Query: 332 EIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLHENF 371
               + +L   C + R  +RPT        D LR + E+F
Sbjct: 239 ----LYQLMRLCWKERPEDRPT-------FDYLRSVLEDF 267

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 86/305 (28%), Positives = 136/305 (44%), Gaps = 42/305 (13%)
Query: 77  FSKSEMIRATKN-FDRSRCLSQGGFVSVYKG-VLHDNIQVAVKTYRRAD--------KXX 126
           F KS +     N  +  + + +GGF  V+KG ++ D   VA+K+    D        +  
Sbjct: 8   FPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKF 67
Query: 127 XXXXXXXXXXSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKT 186
                     S +NH N+VK+ GL      P +V EF   G L  H   + +  +K W  
Sbjct: 68  QEFQREVFIMSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLY-HRLLDKAHPIK-WSV 123
Query: 187 CLRIAAETASALDYLHSLASPPIIHGDVKSANILL-----NDNYTAKVADFESSVLISSD 241
            LR+  + A  ++Y+ +  +PPI+H D++S NI L     N    AKVADF     +S  
Sbjct: 124 KLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFS----LSQQ 178
Query: 242 AETAMSTILIGTSGYLDPVCINTGK--LTKKSDVYSFGVVLAELLTGKKPGSCMTLASNK 299
           +  ++S +L G   ++ P  I   +   T+K+D YSF ++L  +LTG+ P    +    K
Sbjct: 179 SVHSVSGLL-GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK 237
Query: 300 KISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE 359
                  F+N I+  GLR  +      E     +  V EL   C      +RP    + +
Sbjct: 238 -------FINMIREEGLRPTI-----PEDCPPRLRNVIEL---CWSGDPKKRPHFSYIVK 282
Query: 360 ELDRL 364
           EL  L
Sbjct: 283 ELSEL 287

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 85/307 (27%), Positives = 137/307 (44%), Gaps = 46/307 (14%)
Query: 77  FSKSEMIRATKN-FDRSRCLSQGGFVSVYKG-VLHDNIQVAVKTYRRAD--------KXX 126
           F KS +     N  +  + + +GGF  V+KG ++ D   VA+K+    D        +  
Sbjct: 8   FPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKF 67
Query: 127 XXXXXXXXXXSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKT 186
                     S +NH N+VK+ GL      P +V EF   G L  H   + +  +K W  
Sbjct: 68  QEFQREVFIMSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLY-HRLLDKAHPIK-WSV 123
Query: 187 CLRIAAETASALDYLHSLASPPIIHGDVKSANILL-----NDNYTAKVADFESSVLISSD 241
            LR+  + A  ++Y+ +  +PPI+H D++S NI L     N    AKVADF +S      
Sbjct: 124 KLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTS------ 176
Query: 242 AETAMSTI--LIGTSGYLDPVCINTGK--LTKKSDVYSFGVVLAELLTGKKPGSCMTLAS 297
            + ++ ++  L+G   ++ P  I   +   T+K+D YSF ++L  +LTG+ P    +   
Sbjct: 177 -QQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK 235
Query: 298 NKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQV 357
            K       F+N I+  GLR  +      E     +  V EL   C      +RP    +
Sbjct: 236 IK-------FINMIREEGLRPTI-----PEDCPPRLRNVIEL---CWSGDPKKRPHFSYI 280
Query: 358 SEELDRL 364
            +EL  L
Sbjct: 281 VKELSEL 287

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 98/200 (49%), Gaps = 7/200 (3%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLET 154
           L  G F  V+ G  + N +VA+KT +                 ++ H  +V++  +  E 
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPESFLEEAQIMKKLKHDKLVQLYAVVSEE 76
Query: 155 EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDV 214
            +  +V E+ + G+LLD ++    + LK     + +AA+ A+ + Y+  +     IH D+
Sbjct: 77  PI-YIVTEYMNKGSLLDFLKDGEGRALKL-PNLVDMAAQVAAGMAYIERMN---YIHRDL 131
Query: 215 KSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVY 274
           +SANIL+ +    K+ADF  + LI  +  TA          +  P     G+ T KSDV+
Sbjct: 132 RSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIK-WTAPEAALYGRFTIKSDVW 190
Query: 275 SFGVVLAELLT-GKKPGSCM 293
           SFG++L EL+T G+ P   M
Sbjct: 191 SFGILLTELVTKGRVPYPGM 210

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 86/305 (28%), Positives = 136/305 (44%), Gaps = 42/305 (13%)
Query: 77  FSKSEMIRATKN-FDRSRCLSQGGFVSVYKG-VLHDNIQVAVKTYRRAD--------KXX 126
           F KS +     N  +  + + +GGF  V+KG ++ D   VA+K+    D        +  
Sbjct: 8   FPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKF 67
Query: 127 XXXXXXXXXXSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKT 186
                     S +NH N+VK+ GL      P +V EF   G L  H   + +  +K W  
Sbjct: 68  QEFQREVFIMSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLY-HRLLDKAHPIK-WSV 123
Query: 187 CLRIAAETASALDYLHSLASPPIIHGDVKSANILL-----NDNYTAKVADFESSVLISSD 241
            LR+  + A  ++Y+ +  +PPI+H D++S NI L     N    AKVADF     +S  
Sbjct: 124 KLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG----LSQQ 178
Query: 242 AETAMSTILIGTSGYLDPVCINTGK--LTKKSDVYSFGVVLAELLTGKKPGSCMTLASNK 299
           +  ++S +L G   ++ P  I   +   T+K+D YSF ++L  +LTG+ P    +    K
Sbjct: 179 SVHSVSGLL-GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK 237
Query: 300 KISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE 359
                  F+N I+  GLR  +      E     +  V EL   C      +RP    + +
Sbjct: 238 -------FINMIREEGLRPTI-----PEDCPPRLRNVIEL---CWSGDPKKRPHFSYIVK 282
Query: 360 ELDRL 364
           EL  L
Sbjct: 283 ELSEL 287

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 69/281 (24%), Positives = 133/281 (47%), Gaps = 33/281 (11%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAV-KTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLE 153
           +  G F +VYKG  H ++ V +        +             +  H N++  +G   +
Sbjct: 20  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 79
Query: 154 TEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGD 213
            ++ + V ++    +L  H+    ++     K  + IA +TA  +DYLH+ +   IIH D
Sbjct: 80  PQLAI-VTQWCEGSSLYHHLHASETKF--EMKKLIDIARQTARGMDYLHAKS---IIHRD 133
Query: 214 VKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCI---NTGKLTKK 270
           +KS NI L+++ T K+ DF  + + S  + +     L G+  ++ P  I   ++   + +
Sbjct: 134 LKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 193
Query: 271 SDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYF-----LNSIKNNGLRQILNFHVA 325
           SDVY+FG+VL EL+TG+ P S +    ++ I MV        L+ +++N  +++      
Sbjct: 194 SDVYAFGIVLYELMTGQLPYSNIN-NRDQIIEMVGRGSLSPDLSKVRSNCPKRM------ 246
Query: 326 DESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR 366
                        L ++CL+ +  ERP+  ++  E++ L R
Sbjct: 247 -----------KRLMAECLKKKRDERPSFPRILAEIEELAR 276

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 7/205 (3%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRAD---KXXXXXXXXXXXXSQVNHKNVVKILGLC 151
           +  G F +V++   H +  VAVK     D   +             ++ H N+V  +G  
Sbjct: 45  IGAGSFGTVHRAEWHGS-DVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 152 LETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIH 211
            +     +V E+ S G+L   +    ++     +  L +A + A  ++YLH+  +PPI+H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVH 162
Query: 212 GDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKS 271
            D+KS N+L++  YT KV DF  S L +S      S    GT  ++ P  +      +KS
Sbjct: 163 RDLKSPNLLVDKKYTVKVCDFGLSRLKAS--XFLXSKXAAGTPEWMAPEVLRDEPSNEKS 220
Query: 272 DVYSFGVVLAELLTGKKPGSCMTLA 296
           DVYSFGV+L EL T ++P   +  A
Sbjct: 221 DVYSFGVILWELATLQQPWGNLNPA 245

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 96/198 (48%), Gaps = 9/198 (4%)
Query: 95  LSQGGFVSVYKGVLHD-NIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLE 153
           L  G +  VY GV    ++ VAVKT +                 ++ H N+V++LG+C  
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTL 99
Query: 154 TEVPLLVYEFASNGTLLDHIR-CESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHG 212
                +V E+   G LLD++R C   +V       L +A + +SA++YL        IH 
Sbjct: 100 EPPFYIVTEYMPYGNLLDYLRECNREEVTAV--VLLYMATQISSAMEYLEKKN---FIHR 154
Query: 213 DVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSD 272
           D+ + N L+ +N+  KVADF  S L++ D  TA +        +  P  +     + KSD
Sbjct: 155 DLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIK-WTAPESLAYNTFSIKSD 213
Query: 273 VYSFGVVLAELLT-GKKP 289
           V++FGV+L E+ T G  P
Sbjct: 214 VWAFGVLLWEIATYGMSP 231

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 101/205 (49%), Gaps = 7/205 (3%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRAD---KXXXXXXXXXXXXSQVNHKNVVKILGLC 151
           +  G F +V++   H +  VAVK     D   +             ++ H N+V  +G  
Sbjct: 45  IGAGSFGTVHRAEWHGS-DVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 152 LETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIH 211
            +     +V E+ S G+L   +    ++     +  L +A + A  ++YLH+  +PPI+H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVH 162
Query: 212 GDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKS 271
            ++KS N+L++  YT KV DF  S L +S   ++ S    GT  ++ P  +      +KS
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSA--AGTPEWMAPEVLRDEPSNEKS 220
Query: 272 DVYSFGVVLAELLTGKKPGSCMTLA 296
           DVYSFGV+L EL T ++P   +  A
Sbjct: 221 DVYSFGVILWELATLQQPWGNLNPA 245

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/281 (24%), Positives = 132/281 (46%), Gaps = 33/281 (11%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAV-KTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLE 153
           +  G F +VYKG  H ++ V +        +             +  H N++  +G   +
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 91
Query: 154 TEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGD 213
            ++ + V ++    +L  H+    ++     K  + IA +TA  +DYLH+ +   IIH D
Sbjct: 92  PQLAI-VTQWCEGSSLYHHLHASETKF--EMKKLIDIARQTARGMDYLHAKS---IIHRD 145
Query: 214 VKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCI---NTGKLTKK 270
           +KS NI L+++ T K+ DF  +   S  + +     L G+  ++ P  I   ++   + +
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205
Query: 271 SDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYF-----LNSIKNNGLRQILNFHVA 325
           SDVY+FG+VL EL+TG+ P S +    ++ I MV        L+ +++N  +++      
Sbjct: 206 SDVYAFGIVLYELMTGQLPYSNIN-NRDQIIEMVGRGSLSPDLSKVRSNCPKRM------ 258
Query: 326 DESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR 366
                        L ++CL+ +  ERP+  ++  E++ L R
Sbjct: 259 -----------KRLMAECLKKKRDERPSFPRILAEIEELAR 288

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/277 (23%), Positives = 118/277 (42%), Gaps = 25/277 (9%)
Query: 95  LSQGGFVSVYKGVLH-DNIQVAVKTYRR--ADKXXXXXXXXXXXXSQVNHKNVVKILGLC 151
           + +G F  V+ G L  DN  VAVK+ R                   Q +H N+V+++G+C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 152 LETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIH 211
            + +   +V E    G  L  +R E +++    KT L++  + A+ ++YL S      IH
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRV--KTLLQMVGDAAAGMEYLESKCC---IH 236
Query: 212 GDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKS 271
            D+ + N L+ +    K++DF  S   +     A   +      +  P  +N G+ + +S
Sbjct: 237 RDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYSSES 296
Query: 272 DVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMK 331
           DV+SFG++L E  +               +   PY   ++ N   R+ +           
Sbjct: 297 DVWSFGILLWETFS---------------LGASPY--PNLSNQQTREFVEKGGRLPCPEL 339
Query: 332 EIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLH 368
             + V  L  +C      +RP+   + +EL  +R+ H
Sbjct: 340 CPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH 376

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 97/208 (46%), Gaps = 22/208 (10%)
Query: 95  LSQGGFVSVYKGVLHDN----IQVAVKTYRRADKXXXXXXXXXX--XXSQVNHKNVVKIL 148
           + +G F  VY G L DN    I  AVK+  R                    +H NV+ +L
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 149 GLCLETE-VPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASP 207
           G+CL +E  PL+V  +  +G L + IR E+     T K  +    + A  + YL   AS 
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKYL---ASK 151
Query: 208 PIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV------C 261
             +H D+ + N +L++ +T KVADF     ++ D        +   +G   PV       
Sbjct: 152 KFVHRDLAARNCMLDEKFTVKVADFG----LARDMYDKEXXSVHNKTGAKLPVKWMALES 207
Query: 262 INTGKLTKKSDVYSFGVVLAELLTGKKP 289
           + T K T KSDV+SFGV+L EL+T   P
Sbjct: 208 LQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/281 (24%), Positives = 131/281 (46%), Gaps = 33/281 (11%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAV-KTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLE 153
           +  G F +VYKG  H ++ V +        +             +  H N++  +G    
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA 91
Query: 154 TEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGD 213
            ++ + V ++    +L  H+    ++     K  + IA +TA  +DYLH+ +   IIH D
Sbjct: 92  PQLAI-VTQWCEGSSLYHHLHASETKF--EMKKLIDIARQTARGMDYLHAKS---IIHRD 145
Query: 214 VKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCI---NTGKLTKK 270
           +KS NI L+++ T K+ DF  +   S  + +     L G+  ++ P  I   ++   + +
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205
Query: 271 SDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYF-----LNSIKNNGLRQILNFHVA 325
           SDVY+FG+VL EL+TG+ P S +    ++ I MV        L+ +++N  +++      
Sbjct: 206 SDVYAFGIVLYELMTGQLPYSNIN-NRDQIIEMVGRGSLSPDLSKVRSNCPKRM------ 258
Query: 326 DESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR 366
                        L ++CL+ +  ERP+  ++  E++ L R
Sbjct: 259 -----------KRLMAECLKKKRDERPSFPRILAEIEELAR 288

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 85/155 (54%), Gaps = 10/155 (6%)
Query: 137 SQVNHKNVVKILGLCLETEVPLLV-YEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAET 194
           S+++H   VK L  C + +  L     +A NG LL +IR    ++    +TC R   AE 
Sbjct: 92  SRLDHPFFVK-LYFCFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEI 146
Query: 195 ASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTS 254
            SAL+YLH      IIH D+K  NILLN++   ++ DF ++ ++S +++ A +   +GT+
Sbjct: 147 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 203
Query: 255 GYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
            Y+ P  +      K SD+++ G ++ +L+ G  P
Sbjct: 204 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 238

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/277 (23%), Positives = 118/277 (42%), Gaps = 25/277 (9%)
Query: 95  LSQGGFVSVYKGVLH-DNIQVAVKTYRR--ADKXXXXXXXXXXXXSQVNHKNVVKILGLC 151
           + +G F  V+ G L  DN  VAVK+ R                   Q +H N+V+++G+C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 152 LETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIH 211
            + +   +V E    G  L  +R E +++    KT L++  + A+ ++YL S      IH
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRV--KTLLQMVGDAAAGMEYLESKCC---IH 236
Query: 212 GDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKS 271
            D+ + N L+ +    K++DF  S   +     A   +      +  P  +N G+ + +S
Sbjct: 237 RDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSES 296
Query: 272 DVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMK 331
           DV+SFG++L E  +               +   PY   ++ N   R+ +           
Sbjct: 297 DVWSFGILLWETFS---------------LGASPY--PNLSNQQTREFVEKGGRLPCPEL 339
Query: 332 EIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLH 368
             + V  L  +C      +RP+   + +EL  +R+ H
Sbjct: 340 CPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH 376

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 83/154 (53%), Gaps = 8/154 (5%)
Query: 137 SQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETA 195
           S+++H   VK+     + E       +A NG LL +IR    ++    +TC R   AE  
Sbjct: 64  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIV 119
Query: 196 SALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG 255
           SAL+YLH      IIH D+K  NILLN++   ++ DF ++ ++S +++ A +   +GT+ 
Sbjct: 120 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 176
Query: 256 YLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           Y+ P  +      K SD+++ G ++ +L+ G  P
Sbjct: 177 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 210

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 83/154 (53%), Gaps = 8/154 (5%)
Query: 137 SQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETA 195
           S+++H   VK+     + E       +A NG LL +IR    ++    +TC R   AE  
Sbjct: 63  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIV 118
Query: 196 SALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG 255
           SAL+YLH      IIH D+K  NILLN++   ++ DF ++ ++S +++ A +   +GT+ 
Sbjct: 119 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 175
Query: 256 YLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           Y+ P  +      K SD+++ G ++ +L+ G  P
Sbjct: 176 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 209

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 83/154 (53%), Gaps = 8/154 (5%)
Query: 137 SQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETA 195
           S+++H   VK+     + E       +A NG LL +IR    ++    +TC R   AE  
Sbjct: 65  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIV 120
Query: 196 SALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG 255
           SAL+YLH      IIH D+K  NILLN++   ++ DF ++ ++S +++ A +   +GT+ 
Sbjct: 121 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 177
Query: 256 YLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           Y+ P  +      K SD+++ G ++ +L+ G  P
Sbjct: 178 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 211

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 83/154 (53%), Gaps = 8/154 (5%)
Query: 137 SQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETA 195
           S+++H   VK+     + E       +A NG LL +IR    ++    +TC R   AE  
Sbjct: 62  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIV 117
Query: 196 SALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG 255
           SAL+YLH      IIH D+K  NILLN++   ++ DF ++ ++S +++ A +   +GT+ 
Sbjct: 118 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 174
Query: 256 YLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           Y+ P  +      K SD+++ G ++ +L+ G  P
Sbjct: 175 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 208

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 125/283 (44%), Gaps = 26/283 (9%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLET 154
           L  G F  V+ G  +++ +VAVKT +                  + H  +V++  +  + 
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE 79
Query: 155 EVPLLVYEFASNGTLLDHIRC-ESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGD 213
           E   ++ EF + G+LLD ++  E  +VL      +  +A+ A  + Y+        IH D
Sbjct: 80  EPIYIITEFMAKGSLLDFLKSDEGGKVLLP--KLIDFSAQIAEGMAYIERKN---YIHRD 134
Query: 214 VKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDV 273
           +++AN+L++++   K+ADF  + +I  +  TA          +  P  IN G  T KS+V
Sbjct: 135 LRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK-WTAPEAINFGCFTIKSNV 193
Query: 274 YSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKE 332
           +SFG++L E++T GK P    T A           + S  + G R     +  DE     
Sbjct: 194 WSFGILLYEIVTYGKIPYPGRTNAD----------VMSALSQGYRMPRMENCPDE----- 238
Query: 333 IEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLHENFWAQK 375
              + ++   C + +  ERPT   +   LD      E  + Q+
Sbjct: 239 ---LYDIMKMCWKEKAEERPTFDYLQSVLDDFYTATEGQYQQQ 278

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 84/154 (54%), Gaps = 8/154 (5%)
Query: 137 SQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETA 195
           S+++H   VK+     + E       +A NG LL +IR    ++    +TC R   AE  
Sbjct: 87  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIR----KIGSFDETCTRFYTAEIV 142
Query: 196 SALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG 255
           SAL+YLH      IIH D+K  NILLN++   ++ DF ++ ++S +++ A +   +GT+ 
Sbjct: 143 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 199
Query: 256 YLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           Y+ P  +     +K SD+++ G ++ +L+ G  P
Sbjct: 200 YVSPELLTEKSASKSSDLWALGCIIYQLVAGLPP 233

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 97/208 (46%), Gaps = 22/208 (10%)
Query: 95  LSQGGFVSVYKGVLHDN----IQVAVKTYRRADKXXXXXXXXXX--XXSQVNHKNVVKIL 148
           + +G F  VY G L DN    I  AVK+  R                    +H NV+ +L
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 149 GLCLETE-VPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASP 207
           G+CL +E  PL+V  +  +G L + IR E+     T K  +    + A  + YL   AS 
Sbjct: 93  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKYL---ASK 147
Query: 208 PIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV------C 261
             +H D+ + N +L++ +T KVADF     ++ D        +   +G   PV       
Sbjct: 148 KFVHRDLAARNCMLDEKFTVKVADFG----LARDMYDKEYYSVHNKTGAKLPVKWMALES 203
Query: 262 INTGKLTKKSDVYSFGVVLAELLTGKKP 289
           + T K T KSDV+SFGV+L EL+T   P
Sbjct: 204 LQTQKFTTKSDVWSFGVLLWELMTRGAP 231

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 97/208 (46%), Gaps = 22/208 (10%)
Query: 95  LSQGGFVSVYKGVLHDN----IQVAVKTYRRADKXXXXXXXXXX--XXSQVNHKNVVKIL 148
           + +G F  VY G L DN    I  AVK+  R                    +H NV+ +L
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 149 GLCLETE-VPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASP 207
           G+CL +E  PL+V  +  +G L + IR E+     T K  +    + A  + YL   AS 
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKYL---ASK 151
Query: 208 PIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV------C 261
             +H D+ + N +L++ +T KVADF     ++ D        +   +G   PV       
Sbjct: 152 KFVHRDLAARNCMLDEKFTVKVADFG----LARDMYDKEYYSVHNKTGAKLPVKWMALES 207
Query: 262 INTGKLTKKSDVYSFGVVLAELLTGKKP 289
           + T K T KSDV+SFGV+L EL+T   P
Sbjct: 208 LQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 97/208 (46%), Gaps = 22/208 (10%)
Query: 95  LSQGGFVSVYKGVLHDN----IQVAVKTYRRADKXXXXXXXXXX--XXSQVNHKNVVKIL 148
           + +G F  VY G L DN    I  AVK+  R                    +H NV+ +L
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 149 GLCLETE-VPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASP 207
           G+CL +E  PL+V  +  +G L + IR E+     T K  +    + A  + YL   AS 
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKYL---ASK 152
Query: 208 PIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV------C 261
             +H D+ + N +L++ +T KVADF     ++ D        +   +G   PV       
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFG----LARDMYDKEYYSVHNKTGAKLPVKWMALES 208
Query: 262 INTGKLTKKSDVYSFGVVLAELLTGKKP 289
           + T K T KSDV+SFGV+L EL+T   P
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 97/208 (46%), Gaps = 22/208 (10%)
Query: 95  LSQGGFVSVYKGVLHDN----IQVAVKTYRRADKXXXXXXXXXX--XXSQVNHKNVVKIL 148
           + +G F  VY G L DN    I  AVK+  R                    +H NV+ +L
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 149 GLCLETE-VPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASP 207
           G+CL +E  PL+V  +  +G L + IR E+     T K  +    + A  + YL   AS 
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKYL---ASK 150
Query: 208 PIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV------C 261
             +H D+ + N +L++ +T KVADF     ++ D        +   +G   PV       
Sbjct: 151 KFVHRDLAARNCMLDEKFTVKVADFG----LARDMYDKEYYSVHNKTGAKLPVKWMALES 206
Query: 262 INTGKLTKKSDVYSFGVVLAELLTGKKP 289
           + T K T KSDV+SFGV+L EL+T   P
Sbjct: 207 LQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 83/154 (53%), Gaps = 8/154 (5%)
Query: 137 SQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETA 195
           S+++H   VK+     + E       +A NG LL +IR    ++    +TC R   AE  
Sbjct: 87  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIV 142
Query: 196 SALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG 255
           SAL+YLH      IIH D+K  NILLN++   ++ DF ++ ++S +++ A +   +GT+ 
Sbjct: 143 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 256 YLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           Y+ P  +      K SD+++ G ++ +L+ G  P
Sbjct: 200 YVSPELLTEKSAXKSSDLWALGCIIYQLVAGLPP 233

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 97/208 (46%), Gaps = 22/208 (10%)
Query: 95  LSQGGFVSVYKGVLHDN----IQVAVKTYRRADKXXXXXXXXXX--XXSQVNHKNVVKIL 148
           + +G F  VY G L DN    I  AVK+  R                    +H NV+ +L
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 149 GLCLETE-VPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASP 207
           G+CL +E  PL+V  +  +G L + IR E+     T K  +    + A  + YL   AS 
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKYL---ASK 152
Query: 208 PIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV------C 261
             +H D+ + N +L++ +T KVADF     ++ D        +   +G   PV       
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFG----LARDMYDKEYYSVHNKTGAKLPVKWMALES 208
Query: 262 INTGKLTKKSDVYSFGVVLAELLTGKKP 289
           + T K T KSDV+SFGV+L EL+T   P
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 83/154 (53%), Gaps = 8/154 (5%)
Query: 137 SQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETA 195
           S+++H   VK+     + E       +A NG LL +IR    ++    +TC R   AE  
Sbjct: 87  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIV 142
Query: 196 SALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG 255
           SAL+YLH      IIH D+K  NILLN++   ++ DF ++ ++S +++ A +   +GT+ 
Sbjct: 143 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 256 YLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           Y+ P  +      K SD+++ G ++ +L+ G  P
Sbjct: 200 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 97/208 (46%), Gaps = 22/208 (10%)
Query: 95  LSQGGFVSVYKGVLHDN----IQVAVKTYRRADKXXXXXXXXXX--XXSQVNHKNVVKIL 148
           + +G F  VY G L DN    I  AVK+  R                    +H NV+ +L
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 115
Query: 149 GLCLETE-VPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASP 207
           G+CL +E  PL+V  +  +G L + IR E+     T K  +    + A  + YL   AS 
Sbjct: 116 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKYL---ASK 170
Query: 208 PIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV------C 261
             +H D+ + N +L++ +T KVADF     ++ D        +   +G   PV       
Sbjct: 171 KFVHRDLAARNCMLDEKFTVKVADFG----LARDMYDKEYYSVHNKTGAKLPVKWMALES 226
Query: 262 INTGKLTKKSDVYSFGVVLAELLTGKKP 289
           + T K T KSDV+SFGV+L EL+T   P
Sbjct: 227 LQTQKFTTKSDVWSFGVLLWELMTRGAP 254

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 83/154 (53%), Gaps = 8/154 (5%)
Query: 137 SQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETA 195
           S+++H   VK+     + E       +A NG LL +IR    ++    +TC R   AE  
Sbjct: 85  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIV 140
Query: 196 SALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG 255
           SAL+YLH      IIH D+K  NILLN++   ++ DF ++ ++S +++ A +   +GT+ 
Sbjct: 141 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 197
Query: 256 YLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           Y+ P  +      K SD+++ G ++ +L+ G  P
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 83/154 (53%), Gaps = 8/154 (5%)
Query: 137 SQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETA 195
           S+++H   VK+     + E       +A NG LL +IR    ++    +TC R   AE  
Sbjct: 85  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIV 140
Query: 196 SALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG 255
           SAL+YLH      IIH D+K  NILLN++   ++ DF ++ ++S +++ A +   +GT+ 
Sbjct: 141 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQ 197
Query: 256 YLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           Y+ P  +      K SD+++ G ++ +L+ G  P
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 97/208 (46%), Gaps = 22/208 (10%)
Query: 95  LSQGGFVSVYKGVLHDN----IQVAVKTYRRADKXXXXXXXXXX--XXSQVNHKNVVKIL 148
           + +G F  VY G L DN    I  AVK+  R                    +H NV+ +L
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 116
Query: 149 GLCLETE-VPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASP 207
           G+CL +E  PL+V  +  +G L + IR E+     T K  +    + A  + YL   AS 
Sbjct: 117 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKYL---ASK 171
Query: 208 PIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV------C 261
             +H D+ + N +L++ +T KVADF     ++ D        +   +G   PV       
Sbjct: 172 KFVHRDLAARNCMLDEKFTVKVADFG----LARDMYDKEYYSVHNKTGAKLPVKWMALES 227
Query: 262 INTGKLTKKSDVYSFGVVLAELLTGKKP 289
           + T K T KSDV+SFGV+L EL+T   P
Sbjct: 228 LQTQKFTTKSDVWSFGVLLWELMTRGAP 255

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 83/154 (53%), Gaps = 8/154 (5%)
Query: 137 SQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETA 195
           S+++H   VK+     + E       +A NG LL +IR    ++    +TC R   AE  
Sbjct: 85  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIV 140
Query: 196 SALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG 255
           SAL+YLH      IIH D+K  NILLN++   ++ DF ++ ++S +++ A +   +GT+ 
Sbjct: 141 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 197
Query: 256 YLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           Y+ P  +      K SD+++ G ++ +L+ G  P
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 83/154 (53%), Gaps = 8/154 (5%)
Query: 137 SQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETA 195
           S+++H   VK+     + E       +A NG LL +IR    ++    +TC R   AE  
Sbjct: 88  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIV 143
Query: 196 SALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG 255
           SAL+YLH      IIH D+K  NILLN++   ++ DF ++ ++S +++ A +   +GT+ 
Sbjct: 144 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 200
Query: 256 YLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           Y+ P  +      K SD+++ G ++ +L+ G  P
Sbjct: 201 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 234

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 97/208 (46%), Gaps = 22/208 (10%)
Query: 95  LSQGGFVSVYKGVLHDN----IQVAVKTYRRADKXXXXXXXXXX--XXSQVNHKNVVKIL 148
           + +G F  VY G L DN    I  AVK+  R                    +H NV+ +L
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 149 GLCLETE-VPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASP 207
           G+CL +E  PL+V  +  +G L + IR E+     T K  +    + A  + YL   AS 
Sbjct: 95  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKYL---ASK 149
Query: 208 PIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV------C 261
             +H D+ + N +L++ +T KVADF     ++ D        +   +G   PV       
Sbjct: 150 KFVHRDLAARNCMLDEKFTVKVADFG----LARDMYDKEYYSVHNKTGAKLPVKWMALES 205
Query: 262 INTGKLTKKSDVYSFGVVLAELLTGKKP 289
           + T K T KSDV+SFGV+L EL+T   P
Sbjct: 206 LQTQKFTTKSDVWSFGVLLWELMTRGAP 233

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 83/154 (53%), Gaps = 8/154 (5%)
Query: 137 SQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETA 195
           S+++H   VK+     + E       +A NG LL +IR    ++    +TC R   AE  
Sbjct: 85  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIV 140
Query: 196 SALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG 255
           SAL+YLH      IIH D+K  NILLN++   ++ DF ++ ++S +++ A +   +GT+ 
Sbjct: 141 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 197
Query: 256 YLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           Y+ P  +      K SD+++ G ++ +L+ G  P
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 83/154 (53%), Gaps = 8/154 (5%)
Query: 137 SQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETA 195
           S+++H   VK+     + E       +A NG LL +IR    ++    +TC R   AE  
Sbjct: 87  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIV 142
Query: 196 SALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG 255
           SAL+YLH      IIH D+K  NILLN++   ++ DF ++ ++S +++ A +   +GT+ 
Sbjct: 143 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 256 YLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           Y+ P  +      K SD+++ G ++ +L+ G  P
Sbjct: 200 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 97/208 (46%), Gaps = 22/208 (10%)
Query: 95  LSQGGFVSVYKGVLHDN----IQVAVKTYRRADKXXXXXXXXXX--XXSQVNHKNVVKIL 148
           + +G F  VY G L DN    I  AVK+  R                    +H NV+ +L
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 89
Query: 149 GLCLETE-VPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASP 207
           G+CL +E  PL+V  +  +G L + IR E+     T K  +    + A  + YL   AS 
Sbjct: 90  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKYL---ASK 144
Query: 208 PIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV------C 261
             +H D+ + N +L++ +T KVADF     ++ D        +   +G   PV       
Sbjct: 145 KFVHRDLAARNCMLDEKFTVKVADFG----LARDMYDKEYYSVHNKTGAKLPVKWMALES 200
Query: 262 INTGKLTKKSDVYSFGVVLAELLTGKKP 289
           + T K T KSDV+SFGV+L EL+T   P
Sbjct: 201 LQTQKFTTKSDVWSFGVLLWELMTRGAP 228

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 83/154 (53%), Gaps = 8/154 (5%)
Query: 137 SQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETA 195
           S+++H   VK+     + E       +A NG LL +IR    ++    +TC R   AE  
Sbjct: 87  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIV 142
Query: 196 SALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG 255
           SAL+YLH      IIH D+K  NILLN++   ++ DF ++ ++S +++ A +   +GT+ 
Sbjct: 143 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 256 YLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           Y+ P  +      K SD+++ G ++ +L+ G  P
Sbjct: 200 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 83/154 (53%), Gaps = 8/154 (5%)
Query: 137 SQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETA 195
           S+++H   VK+     + E       +A NG LL +IR    ++    +TC R   AE  
Sbjct: 69  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIV 124
Query: 196 SALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG 255
           SAL+YLH      IIH D+K  NILLN++   ++ DF ++ ++S +++ A +   +GT+ 
Sbjct: 125 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 181
Query: 256 YLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           Y+ P  +      K SD+++ G ++ +L+ G  P
Sbjct: 182 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 215

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 83/154 (53%), Gaps = 8/154 (5%)
Query: 137 SQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETA 195
           S+++H   VK+     + E       +A NG LL +IR    ++    +TC R   AE  
Sbjct: 84  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIV 139
Query: 196 SALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG 255
           SAL+YLH      IIH D+K  NILLN++   ++ DF ++ ++S +++ A +   +GT+ 
Sbjct: 140 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 196
Query: 256 YLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           Y+ P  +      K SD+++ G ++ +L+ G  P
Sbjct: 197 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 230

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 83/154 (53%), Gaps = 8/154 (5%)
Query: 137 SQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETA 195
           S+++H   VK+     + E       +A NG LL +IR    ++    +TC R   AE  
Sbjct: 87  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIV 142
Query: 196 SALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG 255
           SAL+YLH      IIH D+K  NILLN++   ++ DF ++ ++S +++ A +   +GT+ 
Sbjct: 143 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 256 YLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           Y+ P  +      K SD+++ G ++ +L+ G  P
Sbjct: 200 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 83/154 (53%), Gaps = 8/154 (5%)
Query: 137 SQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETA 195
           S+++H   VK+     + E       +A NG LL +IR    ++    +TC R   AE  
Sbjct: 90  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIV 145
Query: 196 SALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG 255
           SAL+YLH      IIH D+K  NILLN++   ++ DF ++ ++S +++ A +   +GT+ 
Sbjct: 146 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 202
Query: 256 YLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           Y+ P  +      K SD+++ G ++ +L+ G  P
Sbjct: 203 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 236

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 124/283 (43%), Gaps = 26/283 (9%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLET 154
           L  G F  V+ G  +++ +VAVKT +                  + H  +V++  +    
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTRE 80
Query: 155 EVPLLVYEFASNGTLLDHIRC-ESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGD 213
           E   ++ E+ + G+LLD ++  E  +VL      +  +A+ A  + Y+        IH D
Sbjct: 81  EPIYIITEYMAKGSLLDFLKSDEGGKVLLP--KLIDFSAQIAEGMAYIERKN---YIHRD 135
Query: 214 VKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDV 273
           +++AN+L++++   K+ADF  + +I  +  TA          +  P  IN G  T KSDV
Sbjct: 136 LRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK-WTAPEAINFGCFTIKSDV 194
Query: 274 YSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKE 332
           +SFG++L E++T GK P    T A           + +  + G R     +  DE     
Sbjct: 195 WSFGILLYEIVTYGKIPYPGRTNAD----------VMTALSQGYRMPRVENCPDE----- 239
Query: 333 IEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLHENFWAQK 375
              + ++   C + +  ERPT   +   LD      E  + Q+
Sbjct: 240 ---LYDIMKMCWKEKAEERPTFDYLQSVLDDFYTATEGQYQQQ 279

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 83/154 (53%), Gaps = 8/154 (5%)
Query: 137 SQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETA 195
           S+++H   VK+     + E       +A NG LL +IR    ++    +TC R   AE  
Sbjct: 88  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIV 143
Query: 196 SALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG 255
           SAL+YLH      IIH D+K  NILLN++   ++ DF ++ ++S +++ A +   +GT+ 
Sbjct: 144 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 200
Query: 256 YLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           Y+ P  +      K SD+++ G ++ +L+ G  P
Sbjct: 201 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 234

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 83/154 (53%), Gaps = 8/154 (5%)
Query: 137 SQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETA 195
           S+++H   VK+     + E       +A NG LL +IR    ++    +TC R   AE  
Sbjct: 84  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIV 139
Query: 196 SALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG 255
           SAL+YLH      IIH D+K  NILLN++   ++ DF ++ ++S +++ A +   +GT+ 
Sbjct: 140 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 196
Query: 256 YLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           Y+ P  +      K SD+++ G ++ +L+ G  P
Sbjct: 197 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 230

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 111/231 (48%), Gaps = 24/231 (10%)
Query: 137 SQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETAS 196
           S+VNH N+VK+ G CL      LV E+A  G+L + +         T    +    + + 
Sbjct: 57  SRVNHPNIVKLYGACLNPVC--LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQ 114
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTA-KVADFESSVLISSDAETAMSTILIGTSG 255
            + YLHS+    +IH D+K  N+LL    T  K+ DF ++     D +T M+    G++ 
Sbjct: 115 GVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNK-GSAA 169
Query: 256 YLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNG 315
           ++ P        ++K DV+S+G++L E++T +KP          +I    + +    +NG
Sbjct: 170 WMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKP--------FDEIGGPAFRIMWAVHNG 221
Query: 316 LRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR 366
            R  L  ++      K IE    L ++C     ++RP+M+++ + +  L R
Sbjct: 222 TRPPLIKNLP-----KPIE---SLMTRCWSKDPSQRPSMEEIVKIMTHLMR 264

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 111/231 (48%), Gaps = 24/231 (10%)
Query: 137 SQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETAS 196
           S+VNH N+VK+ G CL      LV E+A  G+L + +         T    +    + + 
Sbjct: 56  SRVNHPNIVKLYGACLNPVC--LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQ 113
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTA-KVADFESSVLISSDAETAMSTILIGTSG 255
            + YLHS+    +IH D+K  N+LL    T  K+ DF ++     D +T M+    G++ 
Sbjct: 114 GVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNK-GSAA 168
Query: 256 YLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNG 315
           ++ P        ++K DV+S+G++L E++T +KP          +I    + +    +NG
Sbjct: 169 WMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKP--------FDEIGGPAFRIMWAVHNG 220
Query: 316 LRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR 366
            R  L  ++      K IE    L ++C     ++RP+M+++ + +  L R
Sbjct: 221 TRPPLIKNLP-----KPIE---SLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 97/208 (46%), Gaps = 22/208 (10%)
Query: 95  LSQGGFVSVYKGVLHDN----IQVAVKTYRRADKXXXXXXXXXX--XXSQVNHKNVVKIL 148
           + +G F  VY G L DN    I  AVK+  R                    +H NV+ +L
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 149 GLCLETE-VPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASP 207
           G+CL +E  PL+V  +  +G L + IR E+     T K  +    + A  + +L   AS 
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKFL---ASK 150
Query: 208 PIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV------C 261
             +H D+ + N +L++ +T KVADF     ++ D        +   +G   PV       
Sbjct: 151 KFVHRDLAARNCMLDEKFTVKVADFG----LARDMYDKEFDSVHNKTGAKLPVKWMALES 206
Query: 262 INTGKLTKKSDVYSFGVVLAELLTGKKP 289
           + T K T KSDV+SFGV+L EL+T   P
Sbjct: 207 LQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 97/208 (46%), Gaps = 22/208 (10%)
Query: 95  LSQGGFVSVYKGVLHDN----IQVAVKTYRRADKXXXXXXXXXX--XXSQVNHKNVVKIL 148
           + +G F  VY G L DN    I  AVK+  R                    +H NV+ +L
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 149 GLCLETE-VPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASP 207
           G+CL +E  PL+V  +  +G L + IR E+     T K  +    + A  + +L   AS 
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKFL---ASK 152
Query: 208 PIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV------C 261
             +H D+ + N +L++ +T KVADF     ++ D        +   +G   PV       
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFG----LARDMYDKEFDSVHNKTGAKLPVKWMALES 208
Query: 262 INTGKLTKKSDVYSFGVVLAELLTGKKP 289
           + T K T KSDV+SFGV+L EL+T   P
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 97/208 (46%), Gaps = 22/208 (10%)
Query: 95  LSQGGFVSVYKGVLHDN----IQVAVKTYRRADKXXXXXXXXXX--XXSQVNHKNVVKIL 148
           + +G F  VY G L DN    I  AVK+  R                    +H NV+ +L
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 102
Query: 149 GLCLETE-VPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASP 207
           G+CL +E  PL+V  +  +G L + IR E+     T K  +    + A  + +L   AS 
Sbjct: 103 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKFL---ASK 157
Query: 208 PIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV------C 261
             +H D+ + N +L++ +T KVADF     ++ D        +   +G   PV       
Sbjct: 158 KFVHRDLAARNCMLDEKFTVKVADFG----LARDMYDKEFDSVHNKTGAKLPVKWMALES 213
Query: 262 INTGKLTKKSDVYSFGVVLAELLTGKKP 289
           + T K T KSDV+SFGV+L EL+T   P
Sbjct: 214 LQTQKFTTKSDVWSFGVLLWELMTRGAP 241

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 132/292 (45%), Gaps = 46/292 (15%)
Query: 91  RSRCLSQGGFVSVYKGVLHDN-----IQVAVKTYRRA--DKXXXXXXXXXXXXSQVNHKN 143
           R + +  G F  VYKG+L  +     + VA+KT +    +K             Q +H N
Sbjct: 48  RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107
Query: 144 VVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQ--VLKTWKTCLRIAAETASALDYL 201
           ++++ G+  + +  +++ E+  NG L   +R +  +  VL+       IAA     + YL
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAA----GMKYL 163
Query: 202 HSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG------ 255
            ++     +H D+ + NIL+N N   KV+DF  S ++  D E   +     TSG      
Sbjct: 164 ANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT-----TSGGKIPIR 215
Query: 256 YLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNN 314
           +  P  I+  K T  SDV+SFG+V+ E++T G++P     L++++ +  +        N+
Sbjct: 216 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP--YWELSNHEVMKAI--------ND 265
Query: 315 GLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR 366
           G R          + M     + +L  +C +     RP    +   LD+L R
Sbjct: 266 GFRL--------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 309

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 97/208 (46%), Gaps = 22/208 (10%)
Query: 95  LSQGGFVSVYKGVLHDN----IQVAVKTYRRADKXXXXXXXXXX--XXSQVNHKNVVKIL 148
           + +G F  VY G L DN    I  AVK+  R                    +H NV+ +L
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 149 GLCLETE-VPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASP 207
           G+CL +E  PL+V  +  +G L + IR E+     T K  +    + A  + +L   AS 
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKFL---ASK 153
Query: 208 PIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV------C 261
             +H D+ + N +L++ +T KVADF     ++ D        +   +G   PV       
Sbjct: 154 KFVHRDLAARNCMLDEKFTVKVADFG----LARDMYDKEFDSVHNKTGAKLPVKWMALES 209
Query: 262 INTGKLTKKSDVYSFGVVLAELLTGKKP 289
           + T K T KSDV+SFGV+L EL+T   P
Sbjct: 210 LQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 97/208 (46%), Gaps = 22/208 (10%)
Query: 95  LSQGGFVSVYKGVLHDN----IQVAVKTYRRADKXXXXXXXXXX--XXSQVNHKNVVKIL 148
           + +G F  VY G L DN    I  AVK+  R                    +H NV+ +L
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 149 GLCLETE-VPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASP 207
           G+CL +E  PL+V  +  +G L + IR E+     T K  +    + A  + +L   AS 
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKFL---ASK 152
Query: 208 PIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV------C 261
             +H D+ + N +L++ +T KVADF     ++ D        +   +G   PV       
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFG----LARDMYDKEFDSVHNKTGAKLPVKWMALES 208
Query: 262 INTGKLTKKSDVYSFGVVLAELLTGKKP 289
           + T K T KSDV+SFGV+L EL+T   P
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 95/196 (48%), Gaps = 7/196 (3%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLET 154
           +  G F  V+ G   +  +VA+KT R                 +++H  +V++ G+CLE 
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 77
Query: 155 EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDV 214
               LV+EF  +G L D++R  + + L   +T L +  +    + YL       +IH D+
Sbjct: 78  APICLVFEFMEHGCLSDYLR--TQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDL 132
Query: 215 KSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVY 274
            + N L+ +N   KV+DF  +  +  D  T+ ST       +  P   +  + + KSDV+
Sbjct: 133 AARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYSSKSDVW 191
Query: 275 SFGVVLAELLT-GKKP 289
           SFGV++ E+ + GK P
Sbjct: 192 SFGVLMWEVFSEGKIP 207

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 95/196 (48%), Gaps = 7/196 (3%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLET 154
           +  G F  V+ G   +  +VA+KT R                 +++H  +V++ G+CLE 
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 72
Query: 155 EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDV 214
               LV+EF  +G L D++R  + + L   +T L +  +    + YL       +IH D+
Sbjct: 73  APICLVFEFMEHGCLSDYLR--TQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDL 127
Query: 215 KSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVY 274
            + N L+ +N   KV+DF  +  +  D  T+ ST       +  P   +  + + KSDV+
Sbjct: 128 AARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYSSKSDVW 186
Query: 275 SFGVVLAELLT-GKKP 289
           SFGV++ E+ + GK P
Sbjct: 187 SFGVLMWEVFSEGKIP 202

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 97/208 (46%), Gaps = 22/208 (10%)
Query: 95  LSQGGFVSVYKGVLHDN----IQVAVKTYRRADKXXXXXXXXXX--XXSQVNHKNVVKIL 148
           + +G F  VY G L DN    I  AVK+  R                    +H NV+ +L
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 149 GLCLETE-VPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASP 207
           G+CL +E  PL+V  +  +G L + IR E+     T K  +    + A  + +L   AS 
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKFL---ASK 153
Query: 208 PIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV------C 261
             +H D+ + N +L++ +T KVADF     ++ D        +   +G   PV       
Sbjct: 154 KFVHRDLAARNCMLDEKFTVKVADFG----LARDMLDKEFDSVHNKTGAKLPVKWMALES 209
Query: 262 INTGKLTKKSDVYSFGVVLAELLTGKKP 289
           + T K T KSDV+SFGV+L EL+T   P
Sbjct: 210 LQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/243 (28%), Positives = 107/243 (44%), Gaps = 20/243 (8%)
Query: 87  KNFDRSRCLSQGGFVSVY-------KGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQV 139
           ++FD  R L +G F +VY       K +L   ++V  KT                  S +
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFIL--ALKVLFKTQLEKAGVEHQLRREVEIQSHL 69
Query: 140 NHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALD 199
            H N++++ G   +     L+ E+A  GT+   ++  S       +T   I  E A+AL 
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSR--FDEQRTATYIT-ELANALS 126
Query: 200 YLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDP 259
           Y HS     +IH D+K  N+LL  N   K+ADF  SV     A ++  T L GT  YL P
Sbjct: 127 YCHSKR---VIHRDIKPENLLLGSNGELKIADFGWSV----HAPSSRRTTLCGTLDYLPP 179
Query: 260 VCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLA-SNKKISMVPYFLNSIKNNGLRQ 318
             I      +K D++S GV+  E L G  P    T   + ++IS V +        G R 
Sbjct: 180 EMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTEGARD 239
Query: 319 ILN 321
           +++
Sbjct: 240 LIS 242

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 95/196 (48%), Gaps = 7/196 (3%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLET 154
           +  G F  V+ G   +  +VA+KT R                 +++H  +V++ G+CLE 
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 74
Query: 155 EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDV 214
               LV+EF  +G L D++R +    L   +T L +  +    + YL   +   +IH D+
Sbjct: 75  APICLVFEFMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEAS---VIHRDL 129
Query: 215 KSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVY 274
            + N L+ +N   KV+DF  +  +  D  T+ ST       +  P   +  + + KSDV+
Sbjct: 130 AARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYSSKSDVW 188
Query: 275 SFGVVLAELLT-GKKP 289
           SFGV++ E+ + GK P
Sbjct: 189 SFGVLMWEVFSEGKIP 204

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/241 (28%), Positives = 107/241 (44%), Gaps = 42/241 (17%)
Query: 140 NHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKT---------------W 184
           +H N++ +LG C       L  E+A +G LLD +R   S+VL+T                
Sbjct: 84  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR--KSRVLETDPAFAIANSTASTLSS 141
Query: 185 KTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET 244
           +  L  AA+ A  +DYL   +    IH D+ + NIL+ +NY AK+ADF  S       + 
Sbjct: 142 QQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 198
Query: 245 AMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISM 303
            M  + +    ++    +N    T  SDV+S+GV+L E+++ G  P   MT A       
Sbjct: 199 TMGRLPV---RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------ 249
Query: 304 VPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDR 363
               L      G R     +  DE        V +L  +C R +  ERP+  Q+   L+R
Sbjct: 250 ----LYEKLPQGYRLEKPLNCDDE--------VYDLMRQCWREKPYERPSFAQILVSLNR 297
Query: 364 L 364
           +
Sbjct: 298 M 298

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 97/208 (46%), Gaps = 22/208 (10%)
Query: 95  LSQGGFVSVYKGVLHDN----IQVAVKTYRRADKXXXXXXXXXX--XXSQVNHKNVVKIL 148
           + +G F  VY G L DN    I  AVK+  R                    +H NV+ +L
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 149 GLCLETE-VPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASP 207
           G+CL +E  PL+V  +  +G L + IR E+     T K  +    + A  + +L   AS 
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKFL---ASK 211
Query: 208 PIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV------C 261
             +H D+ + N +L++ +T KVADF     ++ D        +   +G   PV       
Sbjct: 212 KFVHRDLAARNCMLDEKFTVKVADFG----LARDMYDKEFDSVHNKTGAKLPVKWMALES 267
Query: 262 INTGKLTKKSDVYSFGVVLAELLTGKKP 289
           + T K T KSDV+SFGV+L EL+T   P
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWELMTRGAP 295

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 95/196 (48%), Gaps = 7/196 (3%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLET 154
           +  G F  V+ G   +  +VA+KT R                 +++H  +V++ G+CLE 
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 74
Query: 155 EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDV 214
               LV+EF  +G L D++R  + + L   +T L +  +    + YL       +IH D+
Sbjct: 75  APICLVFEFMEHGCLSDYLR--TQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDL 129
Query: 215 KSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVY 274
            + N L+ +N   KV+DF  +  +  D  T+ ST       +  P   +  + + KSDV+
Sbjct: 130 AARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYSSKSDVW 188
Query: 275 SFGVVLAELLT-GKKP 289
           SFGV++ E+ + GK P
Sbjct: 189 SFGVLMWEVFSEGKIP 204

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 93/208 (44%), Gaps = 28/208 (13%)
Query: 98  GGFVSVYKGVLHDNIQVAVKTYRR-----ADKXXXXXXXXXXXXSQVNHKNVVKILGLCL 152
           GGF  VY+     + +VAVK  R        +            + + H N++ + G+CL
Sbjct: 18  GGFGKVYRAFWIGD-EVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCL 76
Query: 153 ETEVPLLVYEFASNGTL---LDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPI 209
           +     LV EFA  G L   L   R     +L  W      A + A  ++YLH  A  PI
Sbjct: 77  KEPNLCLVMEFARGGPLNRVLSGKRI-PPDILVNW------AVQIARGMNYLHDEAIVPI 129
Query: 210 IHGDVKSANILLND--------NYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVC 261
           IH D+KS+NIL+          N   K+ DF   +       T MS    G   ++ P  
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDF--GLAREWHRTTKMSAA--GAYAWMAPEV 185
Query: 262 INTGKLTKKSDVYSFGVVLAELLTGKKP 289
           I     +K SDV+S+GV+L ELLTG+ P
Sbjct: 186 IRASMFSKGSDVWSYGVLLWELLTGEVP 213

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/241 (28%), Positives = 107/241 (44%), Gaps = 42/241 (17%)
Query: 140 NHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKT---------------W 184
           +H N++ +LG C       L  E+A +G LLD +R   S+VL+T                
Sbjct: 74  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR--KSRVLETDPAFAIANSTASTLSS 131
Query: 185 KTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET 244
           +  L  AA+ A  +DYL   +    IH D+ + NIL+ +NY AK+ADF  S       + 
Sbjct: 132 QQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 188
Query: 245 AMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISM 303
            M  + +    ++    +N    T  SDV+S+GV+L E+++ G  P   MT A       
Sbjct: 189 TMGRLPV---RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------ 239
Query: 304 VPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDR 363
               L      G R     +  DE        V +L  +C R +  ERP+  Q+   L+R
Sbjct: 240 ----LYEKLPQGYRLEKPLNCDDE--------VYDLMRQCWREKPYERPSFAQILVSLNR 287
Query: 364 L 364
           +
Sbjct: 288 M 288

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 118/283 (41%), Gaps = 40/283 (14%)
Query: 85  ATKNFDRSRCLSQGGFVSVY-------KGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXS 137
           A ++F+  R L +G F +VY       K +L   ++V  K                   S
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFIL--ALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
            + H N++++ G   +     L+ E+A  GT+   ++  S       +T   I  E A+A
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYIT-ELANA 123
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYL 257
           L Y HS     +IH D+K  N+LL      K+ADF  SV     A ++  T L GT  YL
Sbjct: 124 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYL 176
Query: 258 DPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASN-KKISMVPYFLNSIKNNGL 316
            P  I      +K D++S GV+  E L GK P    T     K+IS V +        G 
Sbjct: 177 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 236
Query: 317 RQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE 359
           R                    +L S+ L+   ++RP +++V E
Sbjct: 237 R--------------------DLISRLLKHNPSQRPMLREVLE 259

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 118/283 (41%), Gaps = 40/283 (14%)
Query: 85  ATKNFDRSRCLSQGGFVSVY-------KGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXS 137
           A ++F+  R L +G F +VY       K +L   ++V  K                   S
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFIL--ALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
            + H N++++ G   +     L+ E+A  GT+   ++  S       +T   I  E A+A
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYIT-ELANA 120
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYL 257
           L Y HS     +IH D+K  N+LL      K+ADF  SV     A ++  T L GT  YL
Sbjct: 121 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTXLCGTLDYL 173
Query: 258 DPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASN-KKISMVPYFLNSIKNNGL 316
            P  I      +K D++S GV+  E L GK P    T     K+IS V +        G 
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 233
Query: 317 RQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE 359
           R                    +L S+ L+   ++RP +++V E
Sbjct: 234 R--------------------DLISRLLKHNPSQRPMLREVLE 256

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 118/283 (41%), Gaps = 40/283 (14%)
Query: 85  ATKNFDRSRCLSQGGFVSVY-------KGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXS 137
           A ++F+  R L +G F +VY       K +L   ++V  K                   S
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFIL--ALKVLFKAQLEKAGVEHQLRREVEIQS 62
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
            + H N++++ G   +     L+ E+A  GT+   ++  S       +T   I  E A+A
Sbjct: 63  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYIT-ELANA 119
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYL 257
           L Y HS     +IH D+K  N+LL      K+ADF  SV     A ++  T L GT  YL
Sbjct: 120 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYL 172
Query: 258 DPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASN-KKISMVPYFLNSIKNNGL 316
            P  I      +K D++S GV+  E L GK P    T     K+IS V +        G 
Sbjct: 173 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 232
Query: 317 RQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE 359
           R                    +L S+ L+   ++RP +++V E
Sbjct: 233 R--------------------DLISRLLKHNPSQRPMLREVLE 255

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 118/283 (41%), Gaps = 40/283 (14%)
Query: 85  ATKNFDRSRCLSQGGFVSVY-------KGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXS 137
           A ++F+  R L +G F +VY       K +L   ++V  K                   S
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFIL--ALKVLFKAQLEKAGVEHQLRREVEIQS 60
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
            + H N++++ G   +     L+ E+A  GT+   ++  S       +T   I  E A+A
Sbjct: 61  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYIT-ELANA 117
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYL 257
           L Y HS     +IH D+K  N+LL      K+ADF  SV     A ++  T L GT  YL
Sbjct: 118 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYL 170
Query: 258 DPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASN-KKISMVPYFLNSIKNNGL 316
            P  I      +K D++S GV+  E L GK P    T     K+IS V +        G 
Sbjct: 171 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 230
Query: 317 RQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE 359
           R                    +L S+ L+   ++RP +++V E
Sbjct: 231 R--------------------DLISRLLKHNPSQRPMLREVLE 253

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 77/304 (25%), Positives = 133/304 (43%), Gaps = 47/304 (15%)
Query: 75  KIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVL---HDNIQVAVKTYRRADKXXXXXXX 131
           +IF ++E+        + + L  G F +V+KGV     ++I++ V      DK       
Sbjct: 26  RIFKETEL-------RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQ 78
Query: 132 XXX----XXSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCE----SSQVLKT 183
                      ++H ++V++LGLC  + +  LV ++   G+LLDH+R        Q+L  
Sbjct: 79  AVTDHMLAIGSLDHAHIVRLLGLCPGSSL-QLVTQYLPLGSLLDHVRQHRGALGPQLLLN 137
Query: 184 WKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE 243
           W        + A  + YL       ++H ++ + N+LL      +VADF  + L+  D +
Sbjct: 138 W------GVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK 188
Query: 244 TAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKIS 302
             + +       ++    I+ GK T +SDV+S+GV + EL+T G +P + + LA      
Sbjct: 189 QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE----- 243
Query: 303 MVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELD 362
            VP  L   +     QI                V  +  KC  I    RPT K+++ E  
Sbjct: 244 -VPDLLEKGERLAQPQICTID------------VYMVMVKCWMIDENIRPTFKELANEFT 290
Query: 363 RLRR 366
           R+ R
Sbjct: 291 RMAR 294

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXS---QVNHKNVVKILGLC 151
           +  G F +VYKG  H +  VAVK  +  D             +   +  H N++  +G  
Sbjct: 44  IGSGSFGTVYKGKWHGD--VAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYM 101
Query: 152 LETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIH 211
            +  + + V ++    +L  H+  + ++        + IA +TA  +DYLH+     IIH
Sbjct: 102 TKDNLAI-VTQWCEGSSLYKHLHVQETKFQMF--QLIDIARQTAQGMDYLHAKN---IIH 155
Query: 212 GDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCI---NTGKLT 268
            D+KS NI L++  T K+ DF  + + S  + +       G+  ++ P  I   +    +
Sbjct: 156 RDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFS 215
Query: 269 KKSDVYSFGVVLAELLTGKKPGS 291
            +SDVYS+G+VL EL+TG+ P S
Sbjct: 216 FQSDVYSYGIVLYELMTGELPYS 238

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 118/283 (41%), Gaps = 40/283 (14%)
Query: 85  ATKNFDRSRCLSQGGFVSVY-------KGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXS 137
           A ++F+  R L +G F +VY       K +L   ++V  K                   S
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFIL--ALKVLFKAQLEKAGVEHQLRREVEIQS 67
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
            + H N++++ G   +     L+ E+A  GT+   ++  S       +T   I  E A+A
Sbjct: 68  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYIT-ELANA 124
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYL 257
           L Y HS     +IH D+K  N+LL      K+ADF  SV     A ++  T L GT  YL
Sbjct: 125 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYL 177
Query: 258 DPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASN-KKISMVPYFLNSIKNNGL 316
            P  I      +K D++S GV+  E L GK P    T     K+IS V +        G 
Sbjct: 178 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 237
Query: 317 RQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE 359
           R                    +L S+ L+   ++RP +++V E
Sbjct: 238 R--------------------DLISRLLKHNPSQRPMLREVLE 260

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 118/283 (41%), Gaps = 40/283 (14%)
Query: 85  ATKNFDRSRCLSQGGFVSVY-------KGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXS 137
           A ++F+  R L +G F +VY       K +L   ++V  K                   S
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFIL--ALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
            + H N++++ G   +     L+ E+A  GT+   ++  S       +T   I  E A+A
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYIT-ELANA 125
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYL 257
           L Y HS     +IH D+K  N+LL      K+ADF  SV     A ++  T L GT  YL
Sbjct: 126 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYL 178
Query: 258 DPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASN-KKISMVPYFLNSIKNNGL 316
            P  I      +K D++S GV+  E L GK P    T     K+IS V +        G 
Sbjct: 179 PPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 238
Query: 317 RQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE 359
           R                    +L S+ L+   ++RP +++V E
Sbjct: 239 R--------------------DLISRLLKHNPSQRPXLREVLE 261

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 118/283 (41%), Gaps = 40/283 (14%)
Query: 85  ATKNFDRSRCLSQGGFVSVY-------KGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXS 137
           A ++F+  R L +G F +VY       K +L   ++V  K                   S
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFIL--ALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
            + H N++++ G   +     L+ E+A  GT+   ++  S       +T   I  E A+A
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYIT-ELANA 123
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYL 257
           L Y HS     +IH D+K  N+LL      K+ADF  SV     A ++  T L GT  YL
Sbjct: 124 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYL 176
Query: 258 DPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASN-KKISMVPYFLNSIKNNGL 316
            P  I      +K D++S GV+  E L GK P    T     K+IS V +        G 
Sbjct: 177 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 236
Query: 317 RQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE 359
           R                    +L S+ L+   ++RP +++V E
Sbjct: 237 R--------------------DLISRLLKHNPSQRPMLREVLE 259

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 70/278 (25%), Positives = 130/278 (46%), Gaps = 27/278 (9%)
Query: 95  LSQGGFVSVYKGVLHDNIQV-AVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLE 153
           +  G F +VYKG  H ++ V  +       +             +  H N++  +G   +
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 80
Query: 154 TEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGD 213
            ++ + V ++    +L  H+    ++        + IA +TA  +DYLH+ +   IIH D
Sbjct: 81  PQLAI-VTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHAKS---IIHRD 134
Query: 214 VKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCI---NTGKLTKK 270
           +KS NI L+++ T K+ DF  + + S  + +     L G+  ++ P  I   +    + +
Sbjct: 135 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 194
Query: 271 SDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEM 330
           SDVY+FG+VL EL+TG+ P S +    ++ I MV            R  L+    D S++
Sbjct: 195 SDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVG-----------RGYLS---PDLSKV 239
Query: 331 KE--IEIVAELASKCLRIRGTERPTMKQVSEELDRLRR 366
           +    + +  L ++CL+ +  ERP   Q+   ++ L R
Sbjct: 240 RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 277

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 118/283 (41%), Gaps = 40/283 (14%)
Query: 85  ATKNFDRSRCLSQGGFVSVY-------KGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXS 137
           A ++F+  R L +G F +VY       K +L   ++V  K                   S
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFIL--ALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
            + H N++++ G   +     L+ E+A  GT+   ++  S       +T   I  E A+A
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYIT-ELANA 125
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYL 257
           L Y HS     +IH D+K  N+LL      K+ADF  SV     A ++  T L GT  YL
Sbjct: 126 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYL 178
Query: 258 DPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASN-KKISMVPYFLNSIKNNGL 316
            P  I      +K D++S GV+  E L GK P    T     K+IS V +        G 
Sbjct: 179 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 238
Query: 317 RQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE 359
           R                    +L S+ L+   ++RP +++V E
Sbjct: 239 R--------------------DLISRLLKHNPSQRPMLREVLE 261

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 70/278 (25%), Positives = 130/278 (46%), Gaps = 27/278 (9%)
Query: 95  LSQGGFVSVYKGVLHDNIQV-AVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLE 153
           +  G F +VYKG  H ++ V  +       +             +  H N++  +G   +
Sbjct: 18  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 77
Query: 154 TEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGD 213
            ++ + V ++    +L  H+    ++        + IA +TA  +DYLH+ +   IIH D
Sbjct: 78  PQLAI-VTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHAKS---IIHRD 131
Query: 214 VKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCI---NTGKLTKK 270
           +KS NI L+++ T K+ DF  + + S  + +     L G+  ++ P  I   +    + +
Sbjct: 132 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 191
Query: 271 SDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEM 330
           SDVY+FG+VL EL+TG+ P S +    ++ I MV            R  L+    D S++
Sbjct: 192 SDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVG-----------RGYLS---PDLSKV 236
Query: 331 KE--IEIVAELASKCLRIRGTERPTMKQVSEELDRLRR 366
           +    + +  L ++CL+ +  ERP   Q+   ++ L R
Sbjct: 237 RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 274

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 118/283 (41%), Gaps = 40/283 (14%)
Query: 85  ATKNFDRSRCLSQGGFVSVY-------KGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXS 137
           A ++F+  R L +G F +VY       K +L   ++V  K                   S
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFIL--ALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
            + H N++++ G   +     L+ E+A  GT+   ++  S       +T   I  E A+A
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYIT-ELANA 120
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYL 257
           L Y HS     +IH D+K  N+LL      K+ADF  SV     A ++  T L GT  YL
Sbjct: 121 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYL 173
Query: 258 DPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASN-KKISMVPYFLNSIKNNGL 316
            P  I      +K D++S GV+  E L GK P    T     K+IS V +        G 
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 233
Query: 317 RQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE 359
           R                    +L S+ L+   ++RP +++V E
Sbjct: 234 R--------------------DLISRLLKHNPSQRPMLREVLE 256

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 70/278 (25%), Positives = 130/278 (46%), Gaps = 27/278 (9%)
Query: 95  LSQGGFVSVYKGVLHDNIQV-AVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLE 153
           +  G F +VYKG  H ++ V  +       +             +  H N++  +G   +
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 80
Query: 154 TEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGD 213
            ++ + V ++    +L  H+    ++        + IA +TA  +DYLH+ +   IIH D
Sbjct: 81  PQLAI-VTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHAKS---IIHRD 134
Query: 214 VKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCI---NTGKLTKK 270
           +KS NI L+++ T K+ DF  + + S  + +     L G+  ++ P  I   +    + +
Sbjct: 135 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 194
Query: 271 SDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEM 330
           SDVY+FG+VL EL+TG+ P S +    ++ I MV            R  L+    D S++
Sbjct: 195 SDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVG-----------RGYLS---PDLSKV 239
Query: 331 KE--IEIVAELASKCLRIRGTERPTMKQVSEELDRLRR 366
           +    + +  L ++CL+ +  ERP   Q+   ++ L R
Sbjct: 240 RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 277

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 70/278 (25%), Positives = 130/278 (46%), Gaps = 27/278 (9%)
Query: 95  LSQGGFVSVYKGVLHDNIQV-AVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLE 153
           +  G F +VYKG  H ++ V  +       +             +  H N++  +G   +
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 75
Query: 154 TEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGD 213
            ++ + V ++    +L  H+    ++        + IA +TA  +DYLH+ +   IIH D
Sbjct: 76  PQLAI-VTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHAKS---IIHRD 129
Query: 214 VKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCI---NTGKLTKK 270
           +KS NI L+++ T K+ DF  + + S  + +     L G+  ++ P  I   +    + +
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189
Query: 271 SDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEM 330
           SDVY+FG+VL EL+TG+ P S +    ++ I MV            R  L+    D S++
Sbjct: 190 SDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVG-----------RGYLS---PDLSKV 234
Query: 331 KE--IEIVAELASKCLRIRGTERPTMKQVSEELDRLRR 366
           +    + +  L ++CL+ +  ERP   Q+   ++ L R
Sbjct: 235 RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 118/283 (41%), Gaps = 40/283 (14%)
Query: 85  ATKNFDRSRCLSQGGFVSVY-------KGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXS 137
           A ++F+  R L +G F +VY       K +L   ++V  K                   S
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFIL--ALKVLFKAQLEKAGVEHQLRREVEIQS 80
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
            + H N++++ G   +     L+ E+A  GT+   ++  S       +T   I  E A+A
Sbjct: 81  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYIT-ELANA 137
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYL 257
           L Y HS     +IH D+K  N+LL      K+ADF  SV     A ++  T L GT  YL
Sbjct: 138 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYL 190
Query: 258 DPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASN-KKISMVPYFLNSIKNNGL 316
            P  I      +K D++S GV+  E L GK P    T     K+IS V +        G 
Sbjct: 191 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 250
Query: 317 RQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE 359
           R                    +L S+ L+   ++RP +++V E
Sbjct: 251 R--------------------DLISRLLKHNPSQRPMLREVLE 273

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 77/304 (25%), Positives = 133/304 (43%), Gaps = 47/304 (15%)
Query: 75  KIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVL---HDNIQVAVKTYRRADKXXXXXXX 131
           +IF ++E+        + + L  G F +V+KGV     ++I++ V      DK       
Sbjct: 8   RIFKETEL-------RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQ 60
Query: 132 XXX----XXSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCE----SSQVLKT 183
                      ++H ++V++LGLC  + +  LV ++   G+LLDH+R        Q+L  
Sbjct: 61  AVTDHMLAIGSLDHAHIVRLLGLCPGSSL-QLVTQYLPLGSLLDHVRQHRGALGPQLLLN 119
Query: 184 WKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE 243
           W        + A  + YL       ++H ++ + N+LL      +VADF  + L+  D +
Sbjct: 120 W------GVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK 170
Query: 244 TAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKIS 302
             + +       ++    I+ GK T +SDV+S+GV + EL+T G +P + + LA      
Sbjct: 171 QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE----- 225
Query: 303 MVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELD 362
            VP  L   +     QI                V  +  KC  I    RPT K+++ E  
Sbjct: 226 -VPDLLEKGERLAQPQICTID------------VYMVMVKCWMIDENIRPTFKELANEFT 272
Query: 363 RLRR 366
           R+ R
Sbjct: 273 RMAR 276

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 118/283 (41%), Gaps = 40/283 (14%)
Query: 85  ATKNFDRSRCLSQGGFVSVY-------KGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXS 137
           A ++F+  R L +G F +VY       K +L   ++V  K                   S
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFIL--ALKVLFKAQLEKAGVEHQLRREVEIQS 89
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
            + H N++++ G   +     L+ E+A  GT+   ++  S       +T   I  E A+A
Sbjct: 90  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYIT-ELANA 146
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYL 257
           L Y HS     +IH D+K  N+LL      K+ADF  SV     A ++  T L GT  YL
Sbjct: 147 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYL 199
Query: 258 DPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASN-KKISMVPYFLNSIKNNGL 316
            P  I      +K D++S GV+  E L GK P    T     K+IS V +        G 
Sbjct: 200 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 259
Query: 317 RQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE 359
           R                    +L S+ L+   ++RP +++V E
Sbjct: 260 R--------------------DLISRLLKHNPSQRPMLREVLE 282

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 70/278 (25%), Positives = 130/278 (46%), Gaps = 27/278 (9%)
Query: 95  LSQGGFVSVYKGVLHDNIQVA-VKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLE 153
           +  G F +VYKG  H ++ V  +       +             +  H N++  +G   +
Sbjct: 43  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 102
Query: 154 TEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGD 213
            ++ + V ++    +L  H+    ++        + IA +TA  +DYLH+ +   IIH D
Sbjct: 103 PQLAI-VTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHAKS---IIHRD 156
Query: 214 VKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCI---NTGKLTKK 270
           +KS NI L+++ T K+ DF  + + S  + +     L G+  ++ P  I   +    + +
Sbjct: 157 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 216
Query: 271 SDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEM 330
           SDVY+FG+VL EL+TG+ P S +    ++ I MV            R  L+    D S++
Sbjct: 217 SDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVG-----------RGYLS---PDLSKV 261
Query: 331 KE--IEIVAELASKCLRIRGTERPTMKQVSEELDRLRR 366
           +    + +  L ++CL+ +  ERP   Q+   ++ L R
Sbjct: 262 RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 299

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/191 (34%), Positives = 94/191 (49%), Gaps = 17/191 (8%)
Query: 138 QVNHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETAS 196
           +VNH  +VK L    +TE  L L+ +F   G L   +   S +V+ T +      AE A 
Sbjct: 82  EVNHPFIVK-LHYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELAL 137
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
           ALD+LHSL    II+ D+K  NILL++    K+ DF  S       + A S    GT  Y
Sbjct: 138 ALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEY 192
Query: 257 LDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP------GSCMTLASNKKISMVPYFLNS 310
           + P  +N    T+ +D +SFGV++ E+LTG  P         MT+    K+ M P FL+ 
Sbjct: 193 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGM-PQFLSP 251
Query: 311 IKNNGLRQILN 321
              + LR +  
Sbjct: 252 EAQSLLRMLFK 262

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 122/271 (45%), Gaps = 29/271 (10%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLET 154
           L  G F  V+    + + +VAVKT +                  + H  +VK+  +  + 
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKE 82
Query: 155 EVPLLVYEFASNGTLLDHIRCE--SSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHG 212
            +  ++ EF + G+LLD ++ +  S Q L      +  +A+ A  + ++        IH 
Sbjct: 83  PI-YIITEFMAKGSLLDFLKSDEGSKQPLPK---LIDFSAQIAEGMAFIEQRN---YIHR 135
Query: 213 DVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSD 272
           D+++ANIL++ +   K+ADF  + +I  +  TA          +  P  IN G  T KSD
Sbjct: 136 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK-WTAPEAINFGSFTIKSD 194
Query: 273 VYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMK 331
           V+SFG++L E++T G+ P   M   SN      P  + +++  G R     +  +E    
Sbjct: 195 VWSFGILLMEIVTYGRIPYPGM---SN------PEVIRALE-RGYRMPRPENCPEE---- 240
Query: 332 EIEIVAELASKCLRIRGTERPTMKQVSEELD 362
               +  +  +C + R  ERPT + +   LD
Sbjct: 241 ----LYNIMMRCWKNRPEERPTFEYIQSVLD 267

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 95/196 (48%), Gaps = 7/196 (3%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLET 154
           +  G F  V+ G   +  +VA+KT +                 +++H  +V++ G+CLE 
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCLEQ 94
Query: 155 EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDV 214
               LV+EF  +G L D++R  + + L   +T L +  +    + YL       +IH D+
Sbjct: 95  APICLVFEFMEHGCLSDYLR--TQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDL 149
Query: 215 KSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVY 274
            + N L+ +N   KV+DF  +  +  D  T+ ST       +  P   +  + + KSDV+
Sbjct: 150 AARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYSSKSDVW 208
Query: 275 SFGVVLAELLT-GKKP 289
           SFGV++ E+ + GK P
Sbjct: 209 SFGVLMWEVFSEGKIP 224

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 70/278 (25%), Positives = 130/278 (46%), Gaps = 27/278 (9%)
Query: 95  LSQGGFVSVYKGVLHDNIQVA-VKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLE 153
           +  G F +VYKG  H ++ V  +       +             +  H N++  +G   +
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 103
Query: 154 TEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGD 213
            ++ + V ++    +L  H+    ++        + IA +TA  +DYLH+ +   IIH D
Sbjct: 104 PQLAI-VTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHAKS---IIHRD 157
Query: 214 VKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCI---NTGKLTKK 270
           +KS NI L+++ T K+ DF  + + S  + +     L G+  ++ P  I   +    + +
Sbjct: 158 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 217
Query: 271 SDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEM 330
           SDVY+FG+VL EL+TG+ P S +    ++ I MV            R  L+    D S++
Sbjct: 218 SDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVG-----------RGYLS---PDLSKV 262
Query: 331 KE--IEIVAELASKCLRIRGTERPTMKQVSEELDRLRR 366
           +    + +  L ++CL+ +  ERP   Q+   ++ L R
Sbjct: 263 RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 300

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/191 (34%), Positives = 94/191 (49%), Gaps = 17/191 (8%)
Query: 138 QVNHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETAS 196
           +VNH  +VK L    +TE  L L+ +F   G L   +   S +V+ T +      AE A 
Sbjct: 83  EVNHPFIVK-LHYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELAL 138
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
           ALD+LHSL    II+ D+K  NILL++    K+ DF  S       + A S    GT  Y
Sbjct: 139 ALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEY 193
Query: 257 LDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP------GSCMTLASNKKISMVPYFLNS 310
           + P  +N    T+ +D +SFGV++ E+LTG  P         MT+    K+ M P FL+ 
Sbjct: 194 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGM-PQFLSP 252
Query: 311 IKNNGLRQILN 321
              + LR +  
Sbjct: 253 EAQSLLRMLFK 263

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 125/294 (42%), Gaps = 24/294 (8%)
Query: 86  TKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYR----RADKXXXXXXXXXXXXSQVN 140
           +  ++    L  GG   V+    L D+  VAVK  R    R               + +N
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 141 HKNVVKILGLC-LETE---VPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETAS 196
           H  +V +      ET    +P +V E+    TL D +  E      T K  + + A+   
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM---TPKRAIEVIADACQ 127
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTI-LIGTSG 255
           AL++ H      IIH DVK ANIL++     KV DF  +  I+    +   T  +IGT+ 
Sbjct: 128 ALNFSHQNG---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQ 184
Query: 256 YLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP--GSCMTLASNKKISMVPYFLNSIKN 313
           YL P       +  +SDVYS G VL E+LTG+ P  G      + + +   P    S ++
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP-IPPSARH 243
Query: 314 NGLRQILNFHV----ADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDR 363
            GL   L+  V    A   E +  +  AE+ +  +R+   E P   +V  + +R
Sbjct: 244 EGLSADLDAVVLKALAKNPENR-YQTAAEMRADLVRVHNGEPPEAPKVLTDAER 296

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/191 (34%), Positives = 94/191 (49%), Gaps = 17/191 (8%)
Query: 138 QVNHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETAS 196
           +VNH  +VK L    +TE  L L+ +F   G L   +   S +V+ T +      AE A 
Sbjct: 82  EVNHPFIVK-LHYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELAL 137
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
           ALD+LHSL    II+ D+K  NILL++    K+ DF  S       + A S    GT  Y
Sbjct: 138 ALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEY 192
Query: 257 LDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP------GSCMTLASNKKISMVPYFLNS 310
           + P  +N    T+ +D +SFGV++ E+LTG  P         MT+    K+ M P FL+ 
Sbjct: 193 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGM-PQFLSP 251
Query: 311 IKNNGLRQILN 321
              + LR +  
Sbjct: 252 EAQSLLRMLFK 262

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 76/283 (26%), Positives = 117/283 (41%), Gaps = 40/283 (14%)
Query: 85  ATKNFDRSRCLSQGGFVSVY-------KGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXS 137
           A ++F+  R L +G F +VY       K +L   ++V  K                   S
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFIL--ALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
            + H N++++ G   +     L+ E+A  G +   ++  S       +T   I  E A+A
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK--FDEQRTATYIT-ELANA 125
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYL 257
           L Y HS     +IH D+K  N+LL      K+ADF  SV     A ++  T L GT  YL
Sbjct: 126 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYL 178
Query: 258 DPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASN-KKISMVPYFLNSIKNNGL 316
            P  I      +K D++S GV+  E L GK P    T     K+IS V +        G 
Sbjct: 179 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 238
Query: 317 RQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE 359
           R                    +L S+ L+   ++RP +++V E
Sbjct: 239 R--------------------DLISRLLKHNPSQRPMLREVLE 261

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 118/283 (41%), Gaps = 40/283 (14%)
Query: 85  ATKNFDRSRCLSQGGFVSVY-------KGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXS 137
           A ++F+  R L +G F +VY       K +L   ++V  K                   S
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFIL--ALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
            + H N++++ G   +     L+ E+A  GT+   ++  S       +T   I  E A+A
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYIT-ELANA 120
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYL 257
           L Y HS     +IH D+K  N+LL      K+ADF  SV     A ++  T L GT  YL
Sbjct: 121 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTDLCGTLDYL 173
Query: 258 DPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASN-KKISMVPYFLNSIKNNGL 316
            P  I      +K D++S GV+  E L GK P    T     K+IS V +        G 
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 233
Query: 317 RQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE 359
           R                    +L S+ L+   ++RP +++V E
Sbjct: 234 R--------------------DLISRLLKHNPSQRPMLREVLE 256

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 118/283 (41%), Gaps = 40/283 (14%)
Query: 85  ATKNFDRSRCLSQGGFVSVY-------KGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXS 137
           A ++F+  R L +G F +VY       K +L   ++V  K                   S
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFIL--ALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
            + H N++++ G   +     L+ E+A  GT+   ++  S       +T   I  E A+A
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYIT-ELANA 121
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYL 257
           L Y HS     +IH D+K  N+LL      K+ADF  SV     A ++  T L GT  YL
Sbjct: 122 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTDLCGTLDYL 174
Query: 258 DPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASN-KKISMVPYFLNSIKNNGL 316
            P  I      +K D++S GV+  E L GK P    T     K+IS V +        G 
Sbjct: 175 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 234
Query: 317 RQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE 359
           R                    +L S+ L+   ++RP +++V E
Sbjct: 235 R--------------------DLISRLLKHNPSQRPMLREVLE 257

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 70/278 (25%), Positives = 129/278 (46%), Gaps = 27/278 (9%)
Query: 95  LSQGGFVSVYKGVLHDNIQV-AVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLE 153
           +  G F +VYKG  H ++ V  +       +             +  H N++  +G    
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA 75
Query: 154 TEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGD 213
            ++ + V ++    +L  H+    ++        + IA +TA  +DYLH+ +   IIH D
Sbjct: 76  PQLAI-VTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHAKS---IIHRD 129
Query: 214 VKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCI---NTGKLTKK 270
           +KS NI L+++ T K+ DF  + + S  + +     L G+  ++ P  I   +    + +
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189
Query: 271 SDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEM 330
           SDVY+FG+VL EL+TG+ P S +    ++ I MV            R  L+    D S++
Sbjct: 190 SDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVG-----------RGYLS---PDLSKV 234
Query: 331 KE--IEIVAELASKCLRIRGTERPTMKQVSEELDRLRR 366
           +    + +  L ++CL+ +  ERP   Q+   ++ L R
Sbjct: 235 RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 122/271 (45%), Gaps = 29/271 (10%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLET 154
           L  G F  V+    + + +VAVKT +                  + H  +VK+  +  + 
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKE 255
Query: 155 EVPLLVYEFASNGTLLDHIRCE--SSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHG 212
            +  ++ EF + G+LLD ++ +  S Q L      +  +A+ A  + ++        IH 
Sbjct: 256 PI-YIITEFMAKGSLLDFLKSDEGSKQPLPK---LIDFSAQIAEGMAFIEQRN---YIHR 308
Query: 213 DVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSD 272
           D+++ANIL++ +   K+ADF  + +I  +  TA          +  P  IN G  T KSD
Sbjct: 309 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK-WTAPEAINFGSFTIKSD 367
Query: 273 VYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMK 331
           V+SFG++L E++T G+ P   M   SN      P  + +++  G R     +  +E    
Sbjct: 368 VWSFGILLMEIVTYGRIPYPGM---SN------PEVIRALE-RGYRMPRPENCPEE---- 413
Query: 332 EIEIVAELASKCLRIRGTERPTMKQVSEELD 362
               +  +  +C + R  ERPT + +   LD
Sbjct: 414 ----LYNIMMRCWKNRPEERPTFEYIQSVLD 440

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 118/283 (41%), Gaps = 40/283 (14%)
Query: 85  ATKNFDRSRCLSQGGFVSVY-------KGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXS 137
           A ++F+  R L +G F +VY       K +L   ++V  K                   S
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFIL--ALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
            + H N++++ G   +     L+ E+A  GT+   ++  S       +T   I  E A+A
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYIT-ELANA 120
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYL 257
           L Y HS     +IH D+K  N+LL      K+ADF  SV     A ++  T L GT  YL
Sbjct: 121 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTELCGTLDYL 173
Query: 258 DPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASN-KKISMVPYFLNSIKNNGL 316
            P  I      +K D++S GV+  E L GK P    T     K+IS V +        G 
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 233
Query: 317 RQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE 359
           R                    +L S+ L+   ++RP +++V E
Sbjct: 234 R--------------------DLISRLLKHNPSQRPMLREVLE 256

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 68/241 (28%), Positives = 107/241 (44%), Gaps = 42/241 (17%)
Query: 140 NHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKT---------------W 184
           +H N++ +LG C       L  E+A +G LLD +R   S+VL+T                
Sbjct: 81  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR--KSRVLETDPAFAIANSTASTLSS 138
Query: 185 KTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET 244
           +  L  AA+ A  +DYL   +    IH ++ + NIL+ +NY AK+ADF  S       + 
Sbjct: 139 QQLLHFAADVARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKK 195
Query: 245 AMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISM 303
            M  + +    ++    +N    T  SDV+S+GV+L E+++ G  P   MT A       
Sbjct: 196 TMGRLPV---RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------ 246
Query: 304 VPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDR 363
               L      G R     +  DE        V +L  +C R +  ERP+  Q+   L+R
Sbjct: 247 ----LYEKLPQGYRLEKPLNCDDE--------VYDLMRQCWREKPYERPSFAQILVSLNR 294
Query: 364 L 364
           +
Sbjct: 295 M 295

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 118/283 (41%), Gaps = 40/283 (14%)
Query: 85  ATKNFDRSRCLSQGGFVSVY-------KGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXS 137
           A ++F+  R L +G F +VY       K +L   ++V  K                   S
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFIL--ALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
            + H N++++ G   +     L+ E+A  GT+   ++  S       +T   I  E A+A
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYIT-ELANA 120
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYL 257
           L Y HS     +IH D+K  N+LL      K+ADF  SV     A ++  T L GT  YL
Sbjct: 121 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTDLCGTLDYL 173
Query: 258 DPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASN-KKISMVPYFLNSIKNNGL 316
            P  I      +K D++S GV+  E L GK P    T     K+IS V +        G 
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 233
Query: 317 RQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE 359
           R                    +L S+ L+   ++RP +++V E
Sbjct: 234 R--------------------DLISRLLKHNPSQRPMLREVLE 256

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 118/283 (41%), Gaps = 40/283 (14%)
Query: 85  ATKNFDRSRCLSQGGFVSVY-------KGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXS 137
           A ++F+  R L +G F +VY       K +L   ++V  K                   S
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFIL--ALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
            + H N++++ G   +     L+ E+A  GT+   ++  S       +T   I  E A+A
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYIT-ELANA 125
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYL 257
           L Y HS     +IH D+K  N+LL      K+ADF  SV     A ++  T L GT  YL
Sbjct: 126 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTDLCGTLDYL 178
Query: 258 DPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASN-KKISMVPYFLNSIKNNGL 316
            P  I      +K D++S GV+  E L GK P    T     K+IS V +        G 
Sbjct: 179 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 238
Query: 317 RQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE 359
           R                    +L S+ L+   ++RP +++V E
Sbjct: 239 R--------------------DLISRLLKHNPSQRPMLREVLE 261

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 105/243 (43%), Gaps = 20/243 (8%)
Query: 87  KNFDRSRCLSQGGFVSVY-------KGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQV 139
           ++FD  R L +G F +VY       K +L   ++V  KT                  S +
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFIL--ALKVLFKTQLEKAGVEHQLRREVEIQSHL 69
Query: 140 NHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALD 199
            H N++++ G   +     L+ E+A  GT+   ++  S       +T   I  E A+AL 
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSR--FDEQRTATYIT-ELANALS 126
Query: 200 YLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDP 259
           Y HS     +IH D+K  N+LL  N   K+ADF  SV     A ++    L GT  YL P
Sbjct: 127 YCHSKR---VIHRDIKPENLLLGSNGELKIADFGWSV----HAPSSRRDTLCGTLDYLPP 179
Query: 260 VCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASN-KKISMVPYFLNSIKNNGLRQ 318
             I      +K D++S GV+  E L G  P    T     ++IS V +        G R 
Sbjct: 180 EMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTEGARD 239
Query: 319 ILN 321
           +++
Sbjct: 240 LIS 242

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 94/196 (47%), Gaps = 7/196 (3%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLET 154
           +  G F  V+ G   +  +VA+KT R                 +++H  +V++ G+CLE 
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 75
Query: 155 EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDV 214
               LV EF  +G L D++R  + + L   +T L +  +    + YL       +IH D+
Sbjct: 76  APICLVTEFMEHGCLSDYLR--TQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDL 130
Query: 215 KSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVY 274
            + N L+ +N   KV+DF  +  +  D  T+ ST       +  P   +  + + KSDV+
Sbjct: 131 AARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYSSKSDVW 189
Query: 275 SFGVVLAELLT-GKKP 289
           SFGV++ E+ + GK P
Sbjct: 190 SFGVLMWEVFSEGKIP 205

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 105/230 (45%), Gaps = 23/230 (10%)
Query: 93  RCLSQGGFVSVYKGVLH------DNIQVAVKTYRRA-DKXXXXXXXXXXXXSQVNHKNVV 145
           R L +G F  V+    +      D I VAVKT + A D             + + H+++V
Sbjct: 19  RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIV 78
Query: 146 KILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVL----------KTWKTCLRIAAETA 195
           K  G+C+E +  ++V+E+  +G L   +R      +           T    L IA + A
Sbjct: 79  KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIA 138
Query: 196 SALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG 255
           + + Y   LAS   +H D+ + N L+ +N   K+ DF  S  + S     +    +    
Sbjct: 139 AGMVY---LASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 195
Query: 256 YLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMV 304
           ++ P  I   K T +SDV+S GVVL E+ T GK+P     L++N+ I  +
Sbjct: 196 WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP--WYQLSNNEVIECI 243

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 76/283 (26%), Positives = 119/283 (42%), Gaps = 40/283 (14%)
Query: 85  ATKNFDRSRCLSQGGFVSVY-------KGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXS 137
           A ++F+  R L +G F +VY       K +L   ++V  K                   S
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFIL--ALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
            + H N++++ G   ++    L+ E+A  GT+   ++  S       +T   I  E A+A
Sbjct: 64  HLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYIT-ELANA 120
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYL 257
           L Y HS     +IH D+K  N+LL      K+ADF  SV     A ++    L GT  YL
Sbjct: 121 LSYCHSKK---VIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRAALCGTLDYL 173
Query: 258 DPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLA-SNKKISMVPYFLNSIKNNGL 316
            P  I      +K D++S GV+  E L GK P    T   + K+IS V +        G 
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFTFPDFVTEGA 233
Query: 317 RQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE 359
           R                    +L S+ L+   ++RP +++V E
Sbjct: 234 R--------------------DLISRLLKHNPSQRPMLREVLE 256

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/278 (25%), Positives = 129/278 (46%), Gaps = 27/278 (9%)
Query: 95  LSQGGFVSVYKGVLHDNIQV-AVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLE 153
           +  G F +VYKG  H ++ V  +       +             +  H N++  +G   +
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 75
Query: 154 TEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGD 213
            ++ + V ++    +L  H+    ++        + IA +TA  +DYLH+ +   IIH D
Sbjct: 76  PQLAI-VTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHAKS---IIHRD 129
Query: 214 VKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCI---NTGKLTKK 270
           +KS NI L+++ T K+ DF  +   S  + +     L G+  ++ P  I   +    + +
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189
Query: 271 SDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEM 330
           SDVY+FG+VL EL+TG+ P S +    ++ I MV            R  L+    D S++
Sbjct: 190 SDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVG-----------RGYLS---PDLSKV 234
Query: 331 KE--IEIVAELASKCLRIRGTERPTMKQVSEELDRLRR 366
           +    + +  L ++CL+ +  ERP   Q+   ++ L R
Sbjct: 235 RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 76/283 (26%), Positives = 117/283 (41%), Gaps = 40/283 (14%)
Query: 85  ATKNFDRSRCLSQGGFVSVY-------KGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXS 137
           A ++F+  R L +G F +VY       K +L   ++V  K                   S
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFIL--ALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
            + H N++++ G   +     L+ E+A  GT+   ++  S       +T   I  E A+A
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYIT-ELANA 123
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYL 257
           L Y HS     +IH D+K  N+LL      K+ADF  SV     A ++    L GT  YL
Sbjct: 124 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRXXLCGTLDYL 176
Query: 258 DPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASN-KKISMVPYFLNSIKNNGL 316
            P  I      +K D++S GV+  E L GK P    T     K+IS V +        G 
Sbjct: 177 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 236
Query: 317 RQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE 359
           R                    +L S+ L+   ++RP +++V E
Sbjct: 237 R--------------------DLISRLLKHNPSQRPMLREVLE 259

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/278 (25%), Positives = 129/278 (46%), Gaps = 27/278 (9%)
Query: 95  LSQGGFVSVYKGVLHDNIQVA-VKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLE 153
           +  G F +VYKG  H ++ V  +       +             +  H N++  +G   +
Sbjct: 36  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 95
Query: 154 TEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGD 213
            ++ + V ++    +L  H+    ++        + IA +TA  +DYLH+ +   IIH D
Sbjct: 96  PQLAI-VTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHAKS---IIHRD 149
Query: 214 VKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCI---NTGKLTKK 270
           +KS NI L+++ T K+ DF  +   S  + +     L G+  ++ P  I   +    + +
Sbjct: 150 LKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 209
Query: 271 SDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEM 330
           SDVY+FG+VL EL+TG+ P S +    ++ I MV            R  L+    D S++
Sbjct: 210 SDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVG-----------RGYLS---PDLSKV 254
Query: 331 KE--IEIVAELASKCLRIRGTERPTMKQVSEELDRLRR 366
           +    + +  L ++CL+ +  ERP   Q+   ++ L R
Sbjct: 255 RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 292

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/269 (24%), Positives = 114/269 (42%), Gaps = 39/269 (14%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLET 154
           L  G F  V  G       VA+K  +                  ++H+ +V++ G+C + 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 91
Query: 155 EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDV 214
               ++ E+ +NG LL+++R E     +T +  L +  +   A++YL    S   +H D+
Sbjct: 92  RPIFIITEYMANGCLLNYLR-EMRHRFQT-QQLLEMCKDVCEAMEYLE---SKQFLHRDL 146
Query: 215 KSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTS---GYLDPVCINTGKLTKKS 271
            + N L+ND    KV+DF  S  +  D ET+     +G+     +  P  +   K + KS
Sbjct: 147 AARNCLVNDQGVVKVSDFGLSRYVLDDEETSS----VGSKFPVRWSPPEVLMYSKFSSKS 202
Query: 272 DVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPY--FLNSIKNNGLRQILNF---HVAD 326
           D+++FGV++ E+ +               +  +PY  F NS     + Q L     H+A 
Sbjct: 203 DIWAFGVLMWEIYS---------------LGKMPYERFTNSETAEHIAQGLRLYRPHLAS 247
Query: 327 ESEMKEIEIVAELASKCLRIRGTERPTMK 355
           E        V  +   C   +  ERPT K
Sbjct: 248 EK-------VYTIMYSCWHEKADERPTFK 269

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 80/294 (27%), Positives = 125/294 (42%), Gaps = 24/294 (8%)
Query: 86  TKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYR----RADKXXXXXXXXXXXXSQVN 140
           +  ++    L  GG   V+    L D+  VAVK  R    R               + +N
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 141 HKNVVKILGLC-LETE---VPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETAS 196
           H  +V +      ET    +P +V E+    TL D +  E      T K  + + A+   
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM---TPKRAIEVIADACQ 127
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTI-LIGTSG 255
           AL++ H      IIH DVK ANI+++     KV DF  +  I+    +   T  +IGT+ 
Sbjct: 128 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 256 YLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP--GSCMTLASNKKISMVPYFLNSIKN 313
           YL P       +  +SDVYS G VL E+LTG+ P  G      + + +   P    S ++
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP-IPPSARH 243
Query: 314 NGLRQILNFHV----ADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDR 363
            GL   L+  V    A   E +  +  AE+ +  +R+   E P   +V  + +R
Sbjct: 244 EGLSADLDAVVLKALAKNPENR-YQTAAEMRADLVRVHNGEPPEAPKVLTDAER 296

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 76/283 (26%), Positives = 117/283 (41%), Gaps = 40/283 (14%)
Query: 85  ATKNFDRSRCLSQGGFVSVY-------KGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXS 137
           A ++F+  R L +G F +VY       K +L   ++V  K                   S
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFIL--ALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
            + H N++++ G   +     L+ E+A  GT+   ++  S       +T   I  E A+A
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYIT-ELANA 120
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYL 257
           L Y HS     +IH D+K  N+LL      K+ADF  SV     A ++    L GT  YL
Sbjct: 121 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRAALCGTLDYL 173
Query: 258 DPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASN-KKISMVPYFLNSIKNNGL 316
            P  I      +K D++S GV+  E L GK P    T     K+IS V +        G 
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 233
Query: 317 RQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE 359
           R                    +L S+ L+   ++RP +++V E
Sbjct: 234 R--------------------DLISRLLKHNPSQRPMLREVLE 256

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 76/283 (26%), Positives = 117/283 (41%), Gaps = 40/283 (14%)
Query: 85  ATKNFDRSRCLSQGGFVSVY-------KGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXS 137
           A ++F+  R L +G F +VY       K +L   ++V  K                   S
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFIL--ALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
            + H N++++ G   +     L+ E+A  GT+   ++  S       +T   I  E A+A
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYIT-ELANA 120
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYL 257
           L Y HS     +IH D+K  N+LL      K+ADF  SV     A ++    L GT  YL
Sbjct: 121 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRXXLCGTLDYL 173
Query: 258 DPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASN-KKISMVPYFLNSIKNNGL 316
            P  I      +K D++S GV+  E L GK P    T     K+IS V +        G 
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 233
Query: 317 RQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE 359
           R                    +L S+ L+   ++RP +++V E
Sbjct: 234 R--------------------DLISRLLKHNPSQRPMLREVLE 256

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/283 (26%), Positives = 118/283 (41%), Gaps = 40/283 (14%)
Query: 85  ATKNFDRSRCLSQGGFVSVY-------KGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXS 137
           A ++F+  R L +G F +VY       K +L   ++V  K                   S
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFIL--ALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
            + H N++++ G   +     L+ E+A  GT+   ++  S       +T   I  E A+A
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYIT-ELANA 123
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYL 257
           L Y HS     +IH D+K  N+LL      K+A+F  SV     A ++  T L GT  YL
Sbjct: 124 LSYCHSKR---VIHRDIKPENLLLGSAGELKIANFGWSV----HAPSSRRTTLCGTLDYL 176
Query: 258 DPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASN-KKISMVPYFLNSIKNNGL 316
            P  I      +K D++S GV+  E L GK P    T     K+IS V +        G 
Sbjct: 177 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 236
Query: 317 RQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE 359
           R                    +L S+ L+   ++RP +++V E
Sbjct: 237 R--------------------DLISRLLKHNPSQRPMLREVLE 259

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 80/294 (27%), Positives = 125/294 (42%), Gaps = 24/294 (8%)
Query: 86  TKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYR----RADKXXXXXXXXXXXXSQVN 140
           +  ++    L  GG   V+    L D+  VAVK  R    R               + +N
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 141 HKNVVKILGLC-LETE---VPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETAS 196
           H  +V +      ET    +P +V E+    TL D +  E      T K  + + A+   
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM---TPKRAIEVIADACQ 127
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTI-LIGTSG 255
           AL++ H      IIH DVK ANI+++     KV DF  +  I+    +   T  +IGT+ 
Sbjct: 128 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 256 YLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP--GSCMTLASNKKISMVPYFLNSIKN 313
           YL P       +  +SDVYS G VL E+LTG+ P  G      + + +   P    S ++
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPDSVAYQHVREDP-IPPSARH 243
Query: 314 NGLRQILNFHV----ADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDR 363
            GL   L+  V    A   E +  +  AE+ +  +R+   E P   +V  + +R
Sbjct: 244 EGLSADLDAVVLKALAKNPENR-YQTAAEMRADLVRVHNGEPPEAPKVLTDAER 296

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/278 (25%), Positives = 129/278 (46%), Gaps = 27/278 (9%)
Query: 95  LSQGGFVSVYKGVLHDNIQVA-VKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLE 153
           +  G F +VYKG  H ++ V  +       +             +  H N++  +G   +
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 103
Query: 154 TEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGD 213
            ++ + V ++    +L  H+    ++        + IA +TA  +DYLH+ +   IIH D
Sbjct: 104 PQLAI-VTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHAKS---IIHRD 157
Query: 214 VKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCI---NTGKLTKK 270
           +KS NI L+++ T K+ DF  +   S  + +     L G+  ++ P  I   +    + +
Sbjct: 158 LKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 217
Query: 271 SDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEM 330
           SDVY+FG+VL EL+TG+ P S +    ++ I MV            R  L+    D S++
Sbjct: 218 SDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVG-----------RGYLS---PDLSKV 262
Query: 331 KE--IEIVAELASKCLRIRGTERPTMKQVSEELDRLRR 366
           +    + +  L ++CL+ +  ERP   Q+   ++ L R
Sbjct: 263 RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 300

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/283 (26%), Positives = 117/283 (41%), Gaps = 40/283 (14%)
Query: 85  ATKNFDRSRCLSQGGFVSVY-------KGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXS 137
           A ++F+  R L +G F +VY       K +L   ++V  K                   S
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFIL--ALKVLFKAQLEKAGVEHQLRREVEIQS 65
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
            + H N++++ G   +     L+ E+A  GT+   ++  S       +T   I  E A+A
Sbjct: 66  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYIT-ELANA 122
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYL 257
           L Y HS     +IH D+K  N+LL      K+ADF  SV     A ++    L GT  YL
Sbjct: 123 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRXXLCGTLDYL 175
Query: 258 DPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASN-KKISMVPYFLNSIKNNGL 316
            P  I      +K D++S GV+  E L GK P    T     K+IS V +        G 
Sbjct: 176 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 235
Query: 317 RQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE 359
           R                    +L S+ L+   ++RP +++V E
Sbjct: 236 R--------------------DLISRLLKHNPSQRPMLREVLE 258

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/283 (26%), Positives = 118/283 (41%), Gaps = 40/283 (14%)
Query: 85  ATKNFDRSRCLSQGGFVSVY-------KGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXS 137
           A ++F+  R L +G F +VY       K +L   ++V  K                   S
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFIL--ALKVLFKAQLEKAGVEHQLRREVEIQS 65
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
            + H N++++ G   +     L+ E+A  GT+   ++  S       +T   I  E A+A
Sbjct: 66  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYIT-ELANA 122
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYL 257
           L Y HS     +IH D+K  N+LL      K+A+F  SV     A ++  T L GT  YL
Sbjct: 123 LSYCHSKR---VIHRDIKPENLLLGSAGELKIANFGWSV----HAPSSRRTTLCGTLDYL 175
Query: 258 DPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASN-KKISMVPYFLNSIKNNGL 316
            P  I      +K D++S GV+  E L GK P    T     K+IS V +        G 
Sbjct: 176 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 235
Query: 317 RQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE 359
           R                    +L S+ L+   ++RP +++V E
Sbjct: 236 R--------------------DLISRLLKHNPSQRPMLREVLE 258

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/283 (26%), Positives = 117/283 (41%), Gaps = 40/283 (14%)
Query: 85  ATKNFDRSRCLSQGGFVSVY-------KGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXS 137
           A ++F+  R L +G F +VY       K +L   ++V  K                   S
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFIL--ALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
            + H N++++ G   +     L+ E+A  GT+   ++  S       +T   I  E A+A
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYIT-ELANA 121
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYL 257
           L Y HS     +IH D+K  N+LL      K+ADF  SV     A ++    L GT  YL
Sbjct: 122 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRDTLCGTLDYL 174
Query: 258 DPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASN-KKISMVPYFLNSIKNNGL 316
            P  I      +K D++S GV+  E L GK P    T     K+IS V +        G 
Sbjct: 175 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 234
Query: 317 RQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE 359
           R                    +L S+ L+   ++RP +++V E
Sbjct: 235 R--------------------DLISRLLKHNPSQRPMLREVLE 257

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/283 (26%), Positives = 117/283 (41%), Gaps = 40/283 (14%)
Query: 85  ATKNFDRSRCLSQGGFVSVY-------KGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXS 137
           A ++F+  R L +G F +VY       K +L   ++V  K                   S
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFIL--ALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
            + H N++++ G   +     L+ E+A  GT+   ++  S       +T   I  E A+A
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYIT-ELANA 123
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYL 257
           L Y HS     +IH D+K  N+LL      K+ADF  SV     A ++    L GT  YL
Sbjct: 124 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRAALCGTLDYL 176
Query: 258 DPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASN-KKISMVPYFLNSIKNNGL 316
            P  I      +K D++S GV+  E L GK P    T     K+IS V +        G 
Sbjct: 177 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 236
Query: 317 RQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE 359
           R                    +L S+ L+   ++RP +++V E
Sbjct: 237 R--------------------DLISRLLKHNPSQRPMLREVLE 259

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 116/283 (40%), Gaps = 40/283 (14%)
Query: 85  ATKNFDRSRCLSQGGFVSVY-------KGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXS 137
           A ++F+  R L +G F +VY       K +L   ++V  K                   S
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFIL--ALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
            + H N++++ G   +     L+ E+A  G +   ++  S       +T   I  E A+A
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK--FDEQRTATYIT-ELANA 125
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYL 257
           L Y HS     +IH D+K  N+LL      K+ADF  SV     A ++    L GT  YL
Sbjct: 126 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRXXLXGTLDYL 178
Query: 258 DPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASN-KKISMVPYFLNSIKNNGL 316
            P  I      +K D++S GV+  E L GK P    T     K+IS V +        G 
Sbjct: 179 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 238
Query: 317 RQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE 359
           R                    +L S+ L+   ++RP +++V E
Sbjct: 239 R--------------------DLISRLLKHNPSQRPMLREVLE 261

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/283 (26%), Positives = 117/283 (41%), Gaps = 40/283 (14%)
Query: 85  ATKNFDRSRCLSQGGFVSVY-------KGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXS 137
           A ++F+  R L +G F +VY       K +L   ++V  K                   S
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFIL--ALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
            + H N++++ G   +     L+ E+A  GT+   ++  S       +T   I  E A+A
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYIT-ELANA 121
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYL 257
           L Y HS     +IH D+K  N+LL      K+ADF      S  A ++  T L GT  YL
Sbjct: 122 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFG----WSCHAPSSRRTTLSGTLDYL 174
Query: 258 DPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASN-KKISMVPYFLNSIKNNGL 316
            P  I      +K D++S GV+  E L GK P    T     K+IS V +        G 
Sbjct: 175 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 234
Query: 317 RQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE 359
           R                    +L S+ L+   ++RP +++V E
Sbjct: 235 R--------------------DLISRLLKHNPSQRPMLREVLE 257

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 108/238 (45%), Gaps = 19/238 (7%)
Query: 137 SQVNHKNVVKILGLC-LETE---VPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAA 192
           + +NH  +V +      ET    +P +V E+    TL D +  E      T K  + + A
Sbjct: 67  AALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM---TPKRAIEVIA 123
Query: 193 ETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTI-LI 251
           +   AL++ H      IIH DVK ANI+++     KV DF  +  I+    +   T  +I
Sbjct: 124 DACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 180
Query: 252 GTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP--GSCMTLASNKKISMVPYFLN 309
           GT+ YL P       +  +SDVYS G VL E+LTG+ P  G      + + +   P    
Sbjct: 181 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP-IPP 239
Query: 310 SIKNNGLRQILNFHV----ADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDR 363
           S ++ GL   L+  V    A   E +  +  AE+ +  +R+   E P   +V  + +R
Sbjct: 240 SARHEGLSADLDAVVLKALAKNPENR-YQTAAEMRADLVRVHNGEPPEAPKVLTDAER 296

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/290 (24%), Positives = 129/290 (44%), Gaps = 29/290 (10%)
Query: 77  FSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXX 136
           F +S      K     + + +G F  V  G    N +VAVK  +  D             
Sbjct: 183 FYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGN-KVAVKCIKN-DATAQAFLAEASVM 240
Query: 137 SQVNHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETA 195
           +Q+ H N+V++LG+ +E +  L +V E+ + G+L+D++R     VL      L+ + +  
Sbjct: 241 TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGG-DCLLKFSLDVC 299
Query: 196 SALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG 255
            A++YL        +H D+ + N+L++++  AKV+DF  +   SS  +T    +      
Sbjct: 300 EAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-----K 351
Query: 256 YLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNG 315
           +  P  +   K + KSDV+SFG++L E+ +                  VPY    +K+  
Sbjct: 352 WTAPEALREKKFSTKSDVWSFGILLWEIYS---------------FGRVPYPRIPLKDVV 396
Query: 316 LRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLR 365
            R    + +  ++       V ++   C  +    RPT  Q+ E+L+ +R
Sbjct: 397 PRVEKGYKM--DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 76/283 (26%), Positives = 117/283 (41%), Gaps = 40/283 (14%)
Query: 85  ATKNFDRSRCLSQGGFVSVY-------KGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXS 137
           A ++F+  R L +G F +VY       K +L   ++V  K                   S
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFIL--ALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
            + H N++++ G   +     L+ E+A  GT+   ++  S       +T   I  E A+A
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYIT-ELANA 123
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYL 257
           L Y HS     +IH D+K  N+LL      K+ADF  SV     A ++    L GT  YL
Sbjct: 124 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRDDLCGTLDYL 176
Query: 258 DPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASN-KKISMVPYFLNSIKNNGL 316
            P  I      +K D++S GV+  E L GK P    T     K+IS V +        G 
Sbjct: 177 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 236
Query: 317 RQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE 359
           R                    +L S+ L+   ++RP +++V E
Sbjct: 237 R--------------------DLISRLLKHNPSQRPMLREVLE 259

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 76/283 (26%), Positives = 117/283 (41%), Gaps = 40/283 (14%)
Query: 85  ATKNFDRSRCLSQGGFVSVY-------KGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXS 137
           A ++F+  R L +G F +VY       K +L   ++V  K                   S
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFIL--ALKVLFKAQLEKAGVEHQLRREVEIQS 89
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
            + H N++++ G   +     L+ E+A  GT+   ++  S       +T   I  E A+A
Sbjct: 90  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYIT-ELANA 146
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYL 257
           L Y HS     +IH D+K  N+LL      K+ADF  SV     A ++    L GT  YL
Sbjct: 147 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRDDLCGTLDYL 199
Query: 258 DPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASN-KKISMVPYFLNSIKNNGL 316
            P  I      +K D++S GV+  E L GK P    T     K+IS V +        G 
Sbjct: 200 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 259
Query: 317 RQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE 359
           R                    +L S+ L+   ++RP +++V E
Sbjct: 260 R--------------------DLISRLLKHNPSQRPMLREVLE 282

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 108/238 (45%), Gaps = 19/238 (7%)
Query: 137 SQVNHKNVVKILGLC-LETE---VPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAA 192
           + +NH  +V +      ET    +P +V E+    TL D +  E      T K  + + A
Sbjct: 67  AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM---TPKRAIEVIA 123
Query: 193 ETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTI-LI 251
           +   AL++ H      IIH DVK ANI+++     KV DF  +  I+    +   T  +I
Sbjct: 124 DACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 180
Query: 252 GTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP--GSCMTLASNKKISMVPYFLN 309
           GT+ YL P       +  +SDVYS G VL E+LTG+ P  G      + + +   P    
Sbjct: 181 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP-IPP 239
Query: 310 SIKNNGLRQILNFHV----ADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDR 363
           S ++ GL   L+  V    A   E +  +  AE+ +  +R+   E P   +V  + +R
Sbjct: 240 SARHEGLSADLDAVVLKALAKNPENR-YQTAAEMRADLVRVHNGEPPEAPKVLTDAER 296

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 102/216 (47%), Gaps = 25/216 (11%)
Query: 88  NFDRSRCLSQGGFVSVYKGVLH----DNIQVAVKTYR--RADKXXXXXXXXXXXXSQVNH 141
           N    + +  G F  V  G L       I VA+KT +    +K             Q +H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 142 KNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAA---ETASAL 198
            N++++ G+  +++  ++V E+  NG+L   +R   +Q      T +++       AS +
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF-----TVIQLVGMLRGIASGM 160
Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMST----ILIGTS 254
            YL  +     +H D+ + NIL+N N   KV+DF  S ++  D E A +T    I I   
Sbjct: 161 KYLSDMG---FVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI--- 214
Query: 255 GYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
            +  P  I   K T  SDV+S+G+VL E+++ G++P
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/192 (33%), Positives = 93/192 (48%), Gaps = 17/192 (8%)
Query: 137 SQVNHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETA 195
           + VNH  VVK L    +TE  L L+ +F   G L   +   S +V+ T +      AE A
Sbjct: 85  ADVNHPFVVK-LHYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELA 140
Query: 196 SALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG 255
             LD+LHSL    II+ D+K  NILL++    K+ DF  S       + A S    GT  
Sbjct: 141 LGLDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYS--FCGTVE 195
Query: 256 YLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP------GSCMTLASNKKISMVPYFLN 309
           Y+ P  +N    +  +D +S+GV++ E+LTG  P         MTL    K+ M P FL+
Sbjct: 196 YMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGM-PQFLS 254
Query: 310 SIKNNGLRQILN 321
           +   + LR +  
Sbjct: 255 TEAQSLLRALFK 266

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 119/267 (44%), Gaps = 17/267 (6%)
Query: 88  NFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRAD----KXXXXXXXXXXXXSQVNHK 142
           NF   + + +G F  VY+   L D + VA+K  +  D    K             Q+NH 
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 143 NVVKILGLCLETEVPLLVYEFASNGTLLDHIR-CESSQVLKTWKTCLRIAAETASALDYL 201
           NV+K     +E     +V E A  G L   I+  +  + L   +T  +   +  SAL+++
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM 152
Query: 202 HSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVC 261
           HS     ++H D+K AN+ +      K+ D       SS    A S  L+GT  Y+ P  
Sbjct: 153 HSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPER 207
Query: 262 INTGKLTKKSDVYSFGVVLAELLTGKKP--GSCMTLAS-NKKISMV--PYFLNSIKNNGL 316
           I+      KSD++S G +L E+   + P  G  M L S  KKI     P   +   +  L
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL 267
Query: 317 RQILNFHVADESEMK-EIEIVAELASK 342
           RQ++N  +  + E + ++  V ++A +
Sbjct: 268 RQLVNMCINPDPEKRPDVTYVYDVAKR 294

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/269 (24%), Positives = 113/269 (42%), Gaps = 39/269 (14%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLET 154
           L  G F  V  G       VA+K  +                  ++H+ +V++ G+C + 
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 75
Query: 155 EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDV 214
               ++ E+ +NG LL+++R E     +T +  L +  +   A++YL    S   +H D+
Sbjct: 76  RPIFIITEYMANGCLLNYLR-EMRHRFQT-QQLLEMCKDVCEAMEYLE---SKQFLHRDL 130
Query: 215 KSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTS---GYLDPVCINTGKLTKKS 271
            + N L+ND    KV+DF  S  +  D  T+     +G+     +  P  +   K + KS
Sbjct: 131 AARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLMYSKFSSKS 186
Query: 272 DVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPY--FLNSIKNNGLRQILNF---HVAD 326
           D+++FGV++ E+ +               +  +PY  F NS     + Q L     H+A 
Sbjct: 187 DIWAFGVLMWEIYS---------------LGKMPYERFTNSETAEHIAQGLRLYRPHLAS 231
Query: 327 ESEMKEIEIVAELASKCLRIRGTERPTMK 355
           E        V  +   C   +  ERPT K
Sbjct: 232 EK-------VYTIMYSCWHEKADERPTFK 253

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 69/290 (23%), Positives = 129/290 (44%), Gaps = 29/290 (10%)
Query: 77  FSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXX 136
           F +S      K     + + +G F  V  G    N +VAVK  +  D             
Sbjct: 11  FYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGN-KVAVKCIKN-DATAQAFLAEASVM 68
Query: 137 SQVNHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETA 195
           +Q+ H N+V++LG+ +E +  L +V E+ + G+L+D++R     VL      L+ + +  
Sbjct: 69  TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGG-DCLLKFSLDVC 127
Query: 196 SALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG 255
            A++YL        +H D+ + N+L++++  AKV+DF  +   SS  +T    +      
Sbjct: 128 EAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-----K 179
Query: 256 YLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNG 315
           +  P  +   K + KSDV+SFG++L E+ +                  VPY    +K+  
Sbjct: 180 WTAPEALREKKFSTKSDVWSFGILLWEIYS---------------FGRVPYPRIPLKDVV 224
Query: 316 LRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLR 365
            R    + +  ++       V E+   C  +    RP+  Q+ E+L+ ++
Sbjct: 225 PRVEKGYKM--DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 64/266 (24%), Positives = 110/266 (41%), Gaps = 33/266 (12%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLET 154
           L  G F  V  G       VA+K  +                  ++H+ +V++ G+C + 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 76
Query: 155 EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDV 214
               ++ E+ +NG LL+++R E     +T +  L +  +   A++YL    S   +H D+
Sbjct: 77  RPIFIITEYMANGCLLNYLR-EMRHRFQT-QQLLEMCKDVCEAMEYLE---SKQFLHRDL 131
Query: 215 KSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVY 274
            + N L+ND    KV+DF  S  +  D  T+          +  P  +   K + KSD++
Sbjct: 132 AARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVR-WSPPEVLMYSKFSSKSDIW 190
Query: 275 SFGVVLAELLTGKKPGSCMTLASNKKISMVPY--FLNSIKNNGLRQILNF---HVADESE 329
           +FGV++ E+ +               +  +PY  F NS     + Q L     H+A E  
Sbjct: 191 AFGVLMWEIYS---------------LGKMPYERFTNSETAEHIAQGLRLYRPHLASEK- 234
Query: 330 MKEIEIVAELASKCLRIRGTERPTMK 355
                 V  +   C   +  ERPT K
Sbjct: 235 ------VYTIMYSCWHEKADERPTFK 254

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 65/269 (24%), Positives = 113/269 (42%), Gaps = 39/269 (14%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLET 154
           L  G F  V  G       VA+K  +                  ++H+ +V++ G+C + 
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 82
Query: 155 EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDV 214
               ++ E+ +NG LL+++R E     +T +  L +  +   A++YL    S   +H D+
Sbjct: 83  RPIFIITEYMANGCLLNYLR-EMRHRFQT-QQLLEMCKDVCEAMEYLE---SKQFLHRDL 137
Query: 215 KSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTS---GYLDPVCINTGKLTKKS 271
            + N L+ND    KV+DF  S  +  D  T+     +G+     +  P  +   K + KS
Sbjct: 138 AARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLMYSKFSSKS 193
Query: 272 DVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPY--FLNSIKNNGLRQILNF---HVAD 326
           D+++FGV++ E+ +               +  +PY  F NS     + Q L     H+A 
Sbjct: 194 DIWAFGVLMWEIYS---------------LGKMPYERFTNSETAEHIAQGLRLYRPHLAS 238
Query: 327 ESEMKEIEIVAELASKCLRIRGTERPTMK 355
           E        V  +   C   +  ERPT K
Sbjct: 239 EK-------VYTIMYSCWHEKADERPTFK 260

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 65/269 (24%), Positives = 113/269 (42%), Gaps = 39/269 (14%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLET 154
           L  G F  V  G       VA+K  +                  ++H+ +V++ G+C + 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 76
Query: 155 EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDV 214
               ++ E+ +NG LL+++R E     +T +  L +  +   A++YL    S   +H D+
Sbjct: 77  RPIFIITEYMANGCLLNYLR-EMRHRFQT-QQLLEMCKDVCEAMEYLE---SKQFLHRDL 131
Query: 215 KSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG---YLDPVCINTGKLTKKS 271
            + N L+ND    KV+DF  S  +  D  T+     +G+     +  P  +   K + KS
Sbjct: 132 AARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLMYSKFSSKS 187
Query: 272 DVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPY--FLNSIKNNGLRQILNF---HVAD 326
           D+++FGV++ E+ +               +  +PY  F NS     + Q L     H+A 
Sbjct: 188 DIWAFGVLMWEIYS---------------LGKMPYERFTNSETAEHIAQGLRLYRPHLAS 232
Query: 327 ESEMKEIEIVAELASKCLRIRGTERPTMK 355
           E        V  +   C   +  ERPT K
Sbjct: 233 EK-------VYTIMYSCWHEKADERPTFK 254

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 122/286 (42%), Gaps = 39/286 (13%)
Query: 93  RCLSQGGFVSVYKGVLH----DNIQVAVKTYR--RADKXXXXXXXXXXXXSQVNHKNVVK 146
           R +  G F  V  G L      ++ VA+KT +    +K             Q +H NVV 
Sbjct: 49  RVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVH 108
Query: 147 ILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLAS 206
           + G+    +  ++V EF  NG L   +R    Q      T +++          +  LA 
Sbjct: 109 LEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQF-----TVIQLVGMLRGIAAGMRYLAD 163
Query: 207 PPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG-----YLDPVC 261
              +H D+ + NIL+N N   KV+DF  S +I  D E   +T    T G     +  P  
Sbjct: 164 MGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTT----TGGKIPVRWTAPEA 219
Query: 262 INTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQIL 320
           I   K T  SDV+S+G+V+ E+++ G++P   M   SN+ +      + +I+  G R   
Sbjct: 220 IQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM---SNQDV------IKAIE-EGYRL-- 267
Query: 321 NFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR 366
                  + M     + +L   C +    ERP  +Q+   LD++ R
Sbjct: 268 ------PAPMDCPAGLHQLMLDCWQKERAERPKFEQIVGILDKMIR 307

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 102/216 (47%), Gaps = 25/216 (11%)
Query: 88  NFDRSRCLSQGGFVSVYKGVLH----DNIQVAVKTYR--RADKXXXXXXXXXXXXSQVNH 141
           N    + +  G F  V  G L       I VA+KT +    +K             Q +H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 142 KNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAA---ETASAL 198
            N++++ G+  +++  ++V E+  NG+L   +R   +Q      T +++       AS +
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF-----TVIQLVGMLRGIASGM 160
Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMST----ILIGTS 254
            YL  +     +H D+ + NIL+N N   KV+DF  S ++  D E A +T    I I   
Sbjct: 161 KYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI--- 214
Query: 255 GYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
            +  P  I   K T  SDV+S+G+VL E+++ G++P
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 102/216 (47%), Gaps = 25/216 (11%)
Query: 88  NFDRSRCLSQGGFVSVYKGVLH----DNIQVAVKTYR--RADKXXXXXXXXXXXXSQVNH 141
           N    + +  G F  V  G L       I VA+KT +    +K             Q +H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 142 KNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAA---ETASAL 198
            N++++ G+  +++  ++V E+  NG+L   +R   +Q      T +++       AS +
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF-----TVIQLVGMLRGIASGM 160
Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMST----ILIGTS 254
            YL  +     +H D+ + NIL+N N   KV+DF  S ++  D E A +T    I I   
Sbjct: 161 KYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI--- 214
Query: 255 GYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
            +  P  I   K T  SDV+S+G+VL E+++ G++P
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 65/269 (24%), Positives = 113/269 (42%), Gaps = 39/269 (14%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLET 154
           L  G F  V  G       VA+K  +                  ++H+ +V++ G+C + 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 71
Query: 155 EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDV 214
               ++ E+ +NG LL+++R E     +T +  L +  +   A++YL    S   +H D+
Sbjct: 72  RPIFIITEYMANGCLLNYLR-EMRHRFQT-QQLLEMCKDVCEAMEYLE---SKQFLHRDL 126
Query: 215 KSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTS---GYLDPVCINTGKLTKKS 271
            + N L+ND    KV+DF  S  +  D  T+     +G+     +  P  +   K + KS
Sbjct: 127 AARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLMYSKFSSKS 182
Query: 272 DVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPY--FLNSIKNNGLRQILNF---HVAD 326
           D+++FGV++ E+ +               +  +PY  F NS     + Q L     H+A 
Sbjct: 183 DIWAFGVLMWEIYS---------------LGKMPYERFTNSETAEHIAQGLRLYRPHLAS 227
Query: 327 ESEMKEIEIVAELASKCLRIRGTERPTMK 355
           E        V  +   C   +  ERPT K
Sbjct: 228 EK-------VYTIMYSCWHEKADERPTFK 249

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 102/216 (47%), Gaps = 25/216 (11%)
Query: 88  NFDRSRCLSQGGFVSVYKGVLH----DNIQVAVKTYR--RADKXXXXXXXXXXXXSQVNH 141
           N    + +  G F  V  G L       I VA+KT +    +K             Q +H
Sbjct: 44  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 103
Query: 142 KNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAA---ETASAL 198
            N++++ G+  +++  ++V E+  NG+L   +R   +Q      T +++       AS +
Sbjct: 104 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF-----TVIQLVGMLRGIASGM 158
Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMST----ILIGTS 254
            YL  +     +H D+ + NIL+N N   KV+DF  S ++  D E A +T    I I   
Sbjct: 159 KYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI--- 212
Query: 255 GYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
            +  P  I   K T  SDV+S+G+VL E+++ G++P
Sbjct: 213 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 248

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 102/216 (47%), Gaps = 25/216 (11%)
Query: 88  NFDRSRCLSQGGFVSVYKGVLH----DNIQVAVKTYR--RADKXXXXXXXXXXXXSQVNH 141
           N    + +  G F  V  G L       I VA+KT +    +K             Q +H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 142 KNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAA---ETASAL 198
            N++++ G+  +++  ++V E+  NG+L   +R   +Q      T +++       AS +
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF-----TVIQLVGMLRGIASGM 160
Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMST----ILIGTS 254
            YL  +     +H D+ + NIL+N N   KV+DF  S ++  D E A +T    I I   
Sbjct: 161 KYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI--- 214
Query: 255 GYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
            +  P  I   K T  SDV+S+G+VL E+++ G++P
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 102/216 (47%), Gaps = 25/216 (11%)
Query: 88  NFDRSRCLSQGGFVSVYKGVLH----DNIQVAVKTYR--RADKXXXXXXXXXXXXSQVNH 141
           N    + +  G F  V  G L       I VA+KT +    +K             Q +H
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 76
Query: 142 KNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAA---ETASAL 198
            N++++ G+  +++  ++V E+  NG+L   +R   +Q      T +++       AS +
Sbjct: 77  PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF-----TVIQLVGMLRGIASGM 131
Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMST----ILIGTS 254
            YL  +     +H D+ + NIL+N N   KV+DF  S ++  D E A +T    I I   
Sbjct: 132 KYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI--- 185
Query: 255 GYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
            +  P  I   K T  SDV+S+G+VL E+++ G++P
Sbjct: 186 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 221

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 102/216 (47%), Gaps = 25/216 (11%)
Query: 88  NFDRSRCLSQGGFVSVYKGVLH----DNIQVAVKTYR--RADKXXXXXXXXXXXXSQVNH 141
           N    + +  G F  V  G L       I VA+KT +    +K             Q +H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 142 KNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAA---ETASAL 198
            N++++ G+  +++  ++V E+  NG+L   +R   +Q      T +++       AS +
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF-----TVIQLVGMLRGIASGM 160
Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMST----ILIGTS 254
            YL  +     +H D+ + NIL+N N   KV+DF  S ++  D E A +T    I I   
Sbjct: 161 KYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI--- 214
Query: 255 GYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
            +  P  I   K T  SDV+S+G+VL E+++ G++P
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 102/216 (47%), Gaps = 25/216 (11%)
Query: 88  NFDRSRCLSQGGFVSVYKGVLH----DNIQVAVKTYR--RADKXXXXXXXXXXXXSQVNH 141
           N    + +  G F  V  G L       I VA+KT +    +K             Q +H
Sbjct: 34  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 93
Query: 142 KNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAA---ETASAL 198
            N++++ G+  +++  ++V E+  NG+L   +R   +Q      T +++       AS +
Sbjct: 94  PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF-----TVIQLVGMLRGIASGM 148
Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMST----ILIGTS 254
            YL  +     +H D+ + NIL+N N   KV+DF  S ++  D E A +T    I I   
Sbjct: 149 KYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI--- 202
Query: 255 GYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
            +  P  I   K T  SDV+S+G+VL E+++ G++P
Sbjct: 203 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 238

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 65/269 (24%), Positives = 113/269 (42%), Gaps = 39/269 (14%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLET 154
           L  G F  V  G       VA+K  +                  ++H+ +V++ G+C + 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 91
Query: 155 EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDV 214
               ++ E+ +NG LL+++R E     +T +  L +  +   A++YL    S   +H D+
Sbjct: 92  RPIFIITEYMANGCLLNYLR-EMRHRFQT-QQLLEMCKDVCEAMEYLE---SKQFLHRDL 146
Query: 215 KSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTS---GYLDPVCINTGKLTKKS 271
            + N L+ND    KV+DF  S  +  D  T+     +G+     +  P  +   K + KS
Sbjct: 147 AARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLMYSKFSSKS 202
Query: 272 DVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPY--FLNSIKNNGLRQILNF---HVAD 326
           D+++FGV++ E+ +               +  +PY  F NS     + Q L     H+A 
Sbjct: 203 DIWAFGVLMWEIYS---------------LGKMPYERFTNSETAEHIAQGLRLYRPHLAS 247
Query: 327 ESEMKEIEIVAELASKCLRIRGTERPTMK 355
           E        V  +   C   +  ERPT K
Sbjct: 248 EK-------VYTIMYSCWHEKADERPTFK 269

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 124/288 (43%), Gaps = 40/288 (13%)
Query: 91  RSRCLSQGGFVSVYKGVLHDN-----IQVAVKTYRR--ADKXXXXXXXXXXXXSQVNHKN 143
           R + L  G F +VYKG+         I VA+K        K            + ++H +
Sbjct: 19  RVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPH 78
Query: 144 VVKILGLCLETEVPLLVYEFASNGTLLDHIRCE----SSQVLKTWKTCLRIAAETASALD 199
           +V++LG+CL   +  LV +   +G LL+++        SQ+L  W  C++IA      + 
Sbjct: 79  LVRLLGVCLSPTI-QLVTQLMPHGCLLEYVHEHKDNIGSQLLLNW--CVQIA----KGMM 131
Query: 200 YLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDP 259
           YL       ++H D+ + N+L+      K+ DF  + L+  D +   +        ++  
Sbjct: 132 YLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMAL 188
Query: 260 VCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQ 318
            CI+  K T +SDV+S+GV + EL+T G KP   +          +P  L   K   L Q
Sbjct: 189 ECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE------IPDLLE--KGERLPQ 240
Query: 319 ILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR 366
                      +  I++   +  KC  I    RP  K+++ E  R+ R
Sbjct: 241 ---------PPICTIDVYMVMV-KCWMIDADSRPKFKELAAEFSRMAR 278

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 124/272 (45%), Gaps = 29/272 (10%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLET 154
           + +G F  V  G    N +VAVK  +  D             +Q+ H N+V++LG+ +E 
Sbjct: 14  IGKGEFGDVMLGDYRGN-KVAVKCIKN-DATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 71
Query: 155 EVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGD 213
           +  L +V E+ + G+L+D++R     VL      L+ + +   A++YL        +H D
Sbjct: 72  KGGLYIVTEYMAKGSLVDYLRSRGRSVLGG-DCLLKFSLDVCEAMEYLEG---NNFVHRD 127
Query: 214 VKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDV 273
           + + N+L++++  AKV+DF  +   SS  +T    +      +  P  +   K + KSDV
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-----KWTAPEALREKKFSTKSDV 182
Query: 274 YSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEI 333
           +SFG++L E+ +                  VPY    +K+   R    + +  ++     
Sbjct: 183 WSFGILLWEIYS---------------FGRVPYPRIPLKDVVPRVEKGYKM--DAPDGCP 225
Query: 334 EIVAELASKCLRIRGTERPTMKQVSEELDRLR 365
             V E+   C  +    RP+  Q+ E+L+ ++
Sbjct: 226 PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 257

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 124/288 (43%), Gaps = 40/288 (13%)
Query: 91  RSRCLSQGGFVSVYKGVLHDN-----IQVAVKTYRR--ADKXXXXXXXXXXXXSQVNHKN 143
           R + L  G F +VYKG+         I VA+K        K            + ++H +
Sbjct: 42  RVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPH 101
Query: 144 VVKILGLCLETEVPLLVYEFASNGTLLDHIRCE----SSQVLKTWKTCLRIAAETASALD 199
           +V++LG+CL   +  LV +   +G LL+++        SQ+L  W  C++IA      + 
Sbjct: 102 LVRLLGVCLSPTI-QLVTQLMPHGCLLEYVHEHKDNIGSQLLLNW--CVQIA----KGMM 154
Query: 200 YLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDP 259
           YL       ++H D+ + N+L+      K+ DF  + L+  D +   +        ++  
Sbjct: 155 YLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMAL 211
Query: 260 VCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQ 318
            CI+  K T +SDV+S+GV + EL+T G KP   +          +P  L   K   L Q
Sbjct: 212 ECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE------IPDLLE--KGERLPQ 263
Query: 319 ILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR 366
                      +  I++   +  KC  I    RP  K+++ E  R+ R
Sbjct: 264 ---------PPICTIDVYMVMV-KCWMIDADSRPKFKELAAEFSRMAR 301

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 102/216 (47%), Gaps = 25/216 (11%)
Query: 88  NFDRSRCLSQGGFVSVYKGVLH----DNIQVAVKTYR--RADKXXXXXXXXXXXXSQVNH 141
           N    + +  G F  V  G L       I VA+KT +    +K             Q +H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 142 KNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAA---ETASAL 198
            N++++ G+  +++  ++V E   NG+L   +R   +Q      T +++       AS +
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQF-----TVIQLVGMLRGIASGM 160
Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMST----ILIGTS 254
            YL  + +   +H D+ + NIL+N N   KV+DF  S ++  D E A +T    I I   
Sbjct: 161 KYLSDMGA---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI--- 214
Query: 255 GYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
            +  P  I   K T  SDV+S+G+VL E+++ G++P
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 102/216 (47%), Gaps = 25/216 (11%)
Query: 88  NFDRSRCLSQGGFVSVYKGVLH----DNIQVAVKTYR--RADKXXXXXXXXXXXXSQVNH 141
           N    + +  G F  V  G L       I VA+KT +    +K             Q +H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 142 KNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAA---ETASAL 198
            N++++ G+  +++  ++V E+  NG+L   +R   +Q      T +++       AS +
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF-----TVIQLVGMLRGIASGM 160
Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMST----ILIGTS 254
            YL  +     +H D+ + NIL+N N   KV+DF  + ++  D E A +T    I I   
Sbjct: 161 KYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPI--- 214
Query: 255 GYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
            +  P  I   K T  SDV+S+G+VL E+++ G++P
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 25/216 (11%)
Query: 88  NFDRSRCLSQGGFVSVYKGVLH----DNIQVAVKTYR--RADKXXXXXXXXXXXXSQVNH 141
           N    + +  G F  V  G L       I VA+KT +    +K             Q +H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 142 KNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAA---ETASAL 198
            N++++ G+  +++  ++V E+  NG+L   +R   +Q      T +++       AS +
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF-----TVIQLVGMLRGIASGM 160
Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMST----ILIGTS 254
            YL  +     +H D+ + NIL+N N   KV+DF    ++  D E A +T    I I   
Sbjct: 161 KYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPI--- 214
Query: 255 GYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
            +  P  I   K T  SDV+S+G+VL E+++ G++P
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 77/159 (48%), Gaps = 13/159 (8%)
Query: 137 SQVNHKNVVKILGLCLETE-----VPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIA 191
           + +NH  +V +     E E     +P +V E+    TL D +  E      T K  + + 
Sbjct: 84  AALNHPAIVAVYDTG-EAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM---TPKRAIEVI 139
Query: 192 AETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTI-L 250
           A+   AL++ H      IIH DVK ANI+++     KV DF  +  I+    +   T  +
Sbjct: 140 ADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 196
Query: 251 IGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           IGT+ YL P       +  +SDVYS G VL E+LTG+ P
Sbjct: 197 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 235

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 101/216 (46%), Gaps = 25/216 (11%)
Query: 88  NFDRSRCLSQGGFVSVYKGVLH----DNIQVAVKTYR--RADKXXXXXXXXXXXXSQVNH 141
           N    + +  G F  V  G L       I VA+KT +    +K             Q +H
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 76
Query: 142 KNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAA---ETASAL 198
            N++++ G+  +++  ++V E   NG+L   +R   +Q      T +++       AS +
Sbjct: 77  PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQF-----TVIQLVGMLRGIASGM 131
Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMST----ILIGTS 254
            YL  +     +H D+ + NIL+N N   KV+DF  S ++  D E A +T    I I   
Sbjct: 132 KYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI--- 185
Query: 255 GYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
            +  P  I   K T  SDV+S+G+VL E+++ G++P
Sbjct: 186 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 221

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 101/216 (46%), Gaps = 25/216 (11%)
Query: 88  NFDRSRCLSQGGFVSVYKGVLH----DNIQVAVKTYR--RADKXXXXXXXXXXXXSQVNH 141
           N    + +  G F  V  G L       I VA+KT +    +K             Q +H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 142 KNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAA---ETASAL 198
            N++++ G+  +++  ++V E   NG+L   +R   +Q      T +++       AS +
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQF-----TVIQLVGMLRGIASGM 160
Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMST----ILIGTS 254
            YL  +     +H D+ + NIL+N N   KV+DF  S ++  D E A +T    I I   
Sbjct: 161 KYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI--- 214
Query: 255 GYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
            +  P  I   K T  SDV+S+G+VL E+++ G++P
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 96/214 (44%), Gaps = 30/214 (14%)
Query: 93  RCLSQGGFVSVYKGVLHDN----IQVAVKTYRRADKXXXXXXXXXX--XXSQVNHKNVVK 146
           R + +G F  VY G   D     IQ A+K+  R  +                +NH NV+ 
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 147 ILGLCLETE-VPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLA 205
           ++G+ L  E +P ++  +  +G LL  IR  S Q   T K  +    + A  ++YL   A
Sbjct: 87  LIGIMLPPEGLPHVLLPYMCHGDLLQFIR--SPQRNPTVKDLISFGLQVARGMEYL---A 141
Query: 206 SPPIIHGDVKSANILLNDNYTAKVADF----------ESSVLISSDAETAMSTILIGTSG 255
               +H D+ + N +L++++T KVADF            SV     A   +    + +  
Sbjct: 142 EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALES-- 199
Query: 256 YLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
                 + T + T KSDV+SFGV+L ELLT   P
Sbjct: 200 ------LQTYRFTTKSDVWSFGVLLWELLTRGAP 227

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/278 (24%), Positives = 126/278 (45%), Gaps = 30/278 (10%)
Query: 93  RCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCL 152
           + + +G F  V  G    N +VAVK  +  D             +Q+ H N+V++LG+ +
Sbjct: 18  QTIGKGEFGDVMLGDYRGN-KVAVKCIKN-DATAQAFLAEASVMTQLRHSNLVQLLGVIV 75
Query: 153 ETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIH 211
           E +  L +V E+ + G+L+D++R     VL      L+ + +   A++YL        +H
Sbjct: 76  EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGG-DCLLKFSLDVCEAMEYLEG---NNFVH 131
Query: 212 GDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKS 271
            D+ + N+L++++  AKV+DF  +   SS  +T    +      +  P  +     + KS
Sbjct: 132 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-----KWTAPEALREAAFSTKS 186
Query: 272 DVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMK 331
           DV+SFG++L E+ +                  VPY    +K+   R    + +  ++   
Sbjct: 187 DVWSFGILLWEIYS---------------FGRVPYPRIPLKDVVPRVEKGYKM--DAPDG 229
Query: 332 EIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLHE 369
               V E+   C  +    RP+  Q+ E+L+ ++  HE
Sbjct: 230 CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT-HE 266

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 104/235 (44%), Gaps = 36/235 (15%)
Query: 141 HKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDY 200
           H+N+V +LG C      L++ E+   G LL+ +R   S+VL+T      IA  TAS  D 
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLR-RKSRVLET-DPAFAIANSTASTRDL 166
Query: 201 LHS----------LASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTIL 250
           LH           LAS   IH DV + N+LL + + AK+ DF  +  I +D+   +    
Sbjct: 167 LHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 226
Query: 251 IGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNS 310
                ++ P  I     T +SDV+S+G++L E+ +               + + PY    
Sbjct: 227 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS---------------LGLNPY-PGI 270
Query: 311 IKNNGLRQILNFHVADESEMKEIEI----VAELASKCLRIRGTERPTMKQVSEEL 361
           + N+   ++    V D  +M +       +  +   C  +  T RPT +Q+   L
Sbjct: 271 LVNSKFYKL----VKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL 321

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 16/210 (7%)
Query: 95  LSQGGFVSVY---KGVLHDNIQVAVKTY----RRADKXXXXXXXXXXXXSQVNHKNVVKI 147
           L  GG  +VY     +L  NI+VA+K      R  ++            SQ++H+N+V +
Sbjct: 19  LGGGGMSTVYLAEDTIL--NIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 148 LGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASP 207
           + +  E +   LV E+    TL ++I  ES   L +  T +    +    + + H +   
Sbjct: 77  IDVDEEDDCYYLVMEYIEGPTLSEYI--ESHGPL-SVDTAINFTNQILDGIKHAHDMR-- 131
Query: 208 PIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKL 267
            I+H D+K  NIL++ N T K+ DF  +  +S  + T  + +L GT  Y  P        
Sbjct: 132 -IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVL-GTVQYFSPEQAKGEAT 189
Query: 268 TKKSDVYSFGVVLAELLTGKKPGSCMTLAS 297
            + +D+YS G+VL E+L G+ P +  T  S
Sbjct: 190 DECTDIYSIGIVLYEMLVGEPPFNGETAVS 219

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 120/271 (44%), Gaps = 39/271 (14%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLET 154
           L  G F  V+    + + +VAVKT +                  + H  +VK+  +  + 
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKE 249
Query: 155 EVPLLVYEFASNGTLLDHIRCE--SSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHG 212
            +  ++ EF + G+LLD ++ +  S Q L      +  +A+ A  + ++        IH 
Sbjct: 250 PI-YIITEFMAKGSLLDFLKSDEGSKQPLPK---LIDFSAQIAEGMAFIEQRN---YIHR 302
Query: 213 DVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSD 272
           D+++ANIL++ +   K+ADF    L    A+  +         +  P  IN G  T KSD
Sbjct: 303 DLRAANILVSASLVCKIADFG---LARVGAKFPIK--------WTAPEAINFGSFTIKSD 351
Query: 273 VYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMK 331
           V+SFG++L E++T G+ P   M   SN      P  + +++  G R     +  +E    
Sbjct: 352 VWSFGILLMEIVTYGRIPYPGM---SN------PEVIRALE-RGYRMPRPENCPEE---- 397
Query: 332 EIEIVAELASKCLRIRGTERPTMKQVSEELD 362
               +  +  +C + R  ERPT + +   LD
Sbjct: 398 ----LYNIMMRCWKNRPEERPTFEYIQSVLD 424

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 106/226 (46%), Gaps = 20/226 (8%)
Query: 76  IFSKSEMIRATKNFDRSRCLSQGGFVSVY----KGVLHDN--IQVAVKTYRRAD--KXXX 127
           +F   E   A +    SR L QG F  VY    KGV+ D    +VA+KT   A   +   
Sbjct: 5   VFVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 64
Query: 128 XXXXXXXXXSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRC-----ESSQVL- 181
                     + N  +VV++LG+  + +  L++ E  + G L  ++R      E++ VL 
Sbjct: 65  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 124
Query: 182 -KTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFE-SSVLIS 239
             +    +++A E A  + YL++      +H D+ + N ++ +++T K+ DF  +  +  
Sbjct: 125 PPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 181
Query: 240 SDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT 285
           +D        L+    ++ P  +  G  T  SDV+SFGVVL E+ T
Sbjct: 182 TDYYRKGGKGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/261 (24%), Positives = 112/261 (42%), Gaps = 29/261 (11%)
Query: 112 IQVAVKTYRRA--DKXXXXXXXXXXXXSQVNHKNVVKILGLCLETEVPLLVYEFASNGTL 169
           I VA+KT +    +K             Q +H NV+ + G+  ++   +++ EF  NG+L
Sbjct: 62  IFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL 121
Query: 170 LDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKV 229
              +R    Q      T +++          +  LA    +H D+ + NIL+N N   KV
Sbjct: 122 DSFLRQNDGQF-----TVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKV 176
Query: 230 ADFESSVLISSDAETAMSTILIGTS---GYLDPVCINTGKLTKKSDVYSFGVVLAELLT- 285
           +DF  S  +  D      T  +G      +  P  I   K T  SDV+S+G+V+ E+++ 
Sbjct: 177 SDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSY 236
Query: 286 GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLR 345
           G++P   MT   N+ +      +N+I+        ++ +     M     + +L   C +
Sbjct: 237 GERPYWDMT---NQDV------INAIEQ-------DYRLP--PPMDCPSALHQLMLDCWQ 278
Query: 346 IRGTERPTMKQVSEELDRLRR 366
                RP   Q+   LD++ R
Sbjct: 279 KDRNHRPKFGQIVNTLDKMIR 299

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 108/232 (46%), Gaps = 20/232 (8%)
Query: 70  AFLRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVY----KGVLHDNIQ--VAVKTYRRAD 123
           +F    ++   E   A +    SR L QG F  VY    KGV+ D  +  VA+KT   A 
Sbjct: 2   SFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA 61
Query: 124 --KXXXXXXXXXXXXSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRC-----E 176
             +             + N  +VV++LG+  + +  L++ E  + G L  ++R      E
Sbjct: 62  SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEME 121
Query: 177 SSQVL--KTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFES 234
           ++ VL   +    +++A E A  + YL++      +H D+ + N ++ +++T K+ DF  
Sbjct: 122 NNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGM 178
Query: 235 SVLI-SSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT 285
           +  I  +D        L+    ++ P  +  G  T  SDV+SFGVVL E+ T
Sbjct: 179 TRDIXETDXXRKGGKGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 107/244 (43%), Gaps = 35/244 (14%)
Query: 141 HKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLK-------------TWKTC 187
           HKN++ +LG C +     ++ E+AS G L +++R      ++             T+K  
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 188 LRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMS 247
           +    + A  ++YL   AS   IH D+ + N+L+ +N   K+ADF  +  I++      +
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKT 216
Query: 248 TILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPY 306
           T       ++ P  +     T +SDV+SFGV++ E+ T G  P   + +           
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--------- 267
Query: 307 FLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR 366
            L  +   G R     +  +E  M        +   C     ++RPT KQ+ E+LDR+  
Sbjct: 268 -LFKLLKEGHRMDKPANCTNELYM--------MMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 367 LHEN 370
           L  N
Sbjct: 319 LTTN 322

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 107/244 (43%), Gaps = 35/244 (14%)
Query: 141 HKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLK-------------TWKTC 187
           HKN++ +LG C +     ++ E+AS G L +++R      ++             T+K  
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDL 159
Query: 188 LRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMS 247
           +    + A  ++YL   AS   IH D+ + N+L+ +N   K+ADF  +  I++      +
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKT 216
Query: 248 TILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPY 306
           T       ++ P  +     T +SDV+SFGV++ E+ T G  P   + +           
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--------- 267
Query: 307 FLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR 366
            L  +   G R     +  +E  M        +   C     ++RPT KQ+ E+LDR+  
Sbjct: 268 -LFKLLKEGHRMDKPANCTNELYM--------MMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 367 LHEN 370
           L  N
Sbjct: 319 LTTN 322

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 117/272 (43%), Gaps = 30/272 (11%)
Query: 89  FDRSRCLSQGGFVSVYKGVLHDNIQV-AVKT--YRRADKXXXXXXXXXXXXSQVNHKNVV 145
           F +   + +G F  V+KG+ +   QV A+K      A+             SQ +   V 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 146 KILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLA 205
           K  G  L+     ++ E+   G+ LD +R       +   T L+   E    LDYLHS  
Sbjct: 85  KYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQI-ATMLK---EILKGLDYLHSEK 140
Query: 206 SPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTG 265
               IH D+K+AN+LL++    K+ADF  +  + +D +   +T  +GT  ++ P  I   
Sbjct: 141 K---IHRDIKAANVLLSEQGDVKLADFGVAGQL-TDTQIKRNT-FVGTPFWMAPEVIQQS 195
Query: 266 KLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVA 325
               K+D++S G+   EL  G+ P S M     + + ++P      KNN    + +F   
Sbjct: 196 AYDSKADIWSLGITAIELAKGEPPNSDM--HPMRVLFLIP------KNNPPTLVGDF--- 244
Query: 326 DESEMKEIEIVAELASKCLRIRGTERPTMKQV 357
                   +   E    CL    + RPT K++
Sbjct: 245 -------TKSFKEFIDACLNKDPSFRPTAKEL 269

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 77/311 (24%), Positives = 135/311 (43%), Gaps = 57/311 (18%)
Query: 76  IFSKSEMIRATKNFDRSRCLSQGGFVSVY----KGVLHDNIQ--VAVKTYRRAD--KXXX 127
           ++   E   A +    SR L QG F  VY    KGV+ D  +  VA+KT   A   +   
Sbjct: 14  VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 73
Query: 128 XXXXXXXXXSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRC-----ESSQVL- 181
                     + N  +VV++LG+  + +  L++ E  + G L  ++R      E++ VL 
Sbjct: 74  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 133
Query: 182 -KTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFE-SSVLIS 239
             +    +++A E A  + YL++      +H D+ + N ++ +++T K+ DF  +  +  
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 190
Query: 240 SDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-------------- 285
           +D        L+    ++ P  +  G  T  SDV+SFGVVL E+ T              
Sbjct: 191 TDYYRKGGKGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV 249
Query: 286 ---------GKKPGSC-------MTLASNKKISMVPYFL---NSIKNN---GLRQILNFH 323
                      KP +C       M +       M P FL   +SIK     G R++ +F+
Sbjct: 250 LRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV-SFY 308
Query: 324 VADESEMKEIE 334
            ++E+++ E E
Sbjct: 309 YSEENKLPEPE 319

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 80/164 (48%), Gaps = 15/164 (9%)
Query: 137 SQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETAS 196
            Q +H N++++ G+     + ++V E+  NG+L   +R    Q   T    + +     +
Sbjct: 105 GQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQF--TIMQLVGMLRGVGA 162
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG- 255
            + YL  L     +H D+ + N+L++ N   KV+DF  S ++  D + A +T    T G 
Sbjct: 163 GMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTT----TGGK 215
Query: 256 ----YLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMT 294
               +  P  I     +  SDV+SFGVV+ E+L  G++P   MT
Sbjct: 216 IPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT 259

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 80/164 (48%), Gaps = 15/164 (9%)
Query: 137 SQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETAS 196
            Q +H N++++ G+     + ++V E+  NG+L   +R    Q   T    + +     +
Sbjct: 105 GQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQF--TIMQLVGMLRGVGA 162
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG- 255
            + YL  L     +H D+ + N+L++ N   KV+DF  S ++  D + A +T    T G 
Sbjct: 163 GMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTT----TGGK 215
Query: 256 ----YLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMT 294
               +  P  I     +  SDV+SFGVV+ E+L  G++P   MT
Sbjct: 216 IPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT 259

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 20/217 (9%)
Query: 85  ATKNFDRSRCLSQGGFVSVY----KGVLHDN--IQVAVKTYRRAD--KXXXXXXXXXXXX 136
           A +    SR L QG F  VY    KGV+ D    +VA+KT   A   +            
Sbjct: 8   AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 67
Query: 137 SQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRC-----ESSQVL--KTWKTCLR 189
            + N  +VV++LG+  + +  L++ E  + G L  ++R      E++ VL   +    ++
Sbjct: 68  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 127
Query: 190 IAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLI-SSDAETAMST 248
           +A E A  + YL++      +H D+ + N ++ +++T K+ DF  +  I  +D       
Sbjct: 128 MAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGK 184
Query: 249 ILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT 285
            L+    ++ P  +  G  T  SDV+SFGVVL E+ T
Sbjct: 185 GLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 107/244 (43%), Gaps = 35/244 (14%)
Query: 141 HKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLK-------------TWKTC 187
           HKN++ +LG C +     ++ E+AS G L +++R      ++             T+K  
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 188 LRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMS 247
           +    + A  ++YL   AS   IH D+ + N+L+ +N   K+ADF  +  I++      +
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 248 TILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPY 306
           T       ++ P  +     T +SDV+SFGV++ E+ T G  P   + +           
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--------- 267
Query: 307 FLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR 366
            L  +   G R     +  +E  M        +   C     ++RPT KQ+ E+LDR+  
Sbjct: 268 -LFKLLKEGHRMDKPANCTNELYM--------MMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 367 LHEN 370
           L  N
Sbjct: 319 LTTN 322

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 103/235 (43%), Gaps = 36/235 (15%)
Query: 141 HKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDY 200
           H+N+V +LG C      L++ E+   G LL+ +R   S+VL+T      IA  T S  D 
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLR-RKSRVLET-DPAFAIANSTLSTRDL 166
Query: 201 LHS----------LASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTIL 250
           LH           LAS   IH DV + N+LL + + AK+ DF  +  I +D+   +    
Sbjct: 167 LHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 226
Query: 251 IGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNS 310
                ++ P  I     T +SDV+S+G++L E+ +               + + PY    
Sbjct: 227 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS---------------LGLNPY-PGI 270
Query: 311 IKNNGLRQILNFHVADESEMKEIEI----VAELASKCLRIRGTERPTMKQVSEEL 361
           + N+   ++    V D  +M +       +  +   C  +  T RPT +Q+   L
Sbjct: 271 LVNSKFYKL----VKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL 321

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 107/244 (43%), Gaps = 35/244 (14%)
Query: 141 HKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLK-------------TWKTC 187
           HKN++ +LG C +     ++ E+AS G L +++R      ++             T+K  
Sbjct: 87  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 146
Query: 188 LRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMS 247
           +    + A  ++YL   AS   IH D+ + N+L+ +N   K+ADF  +  I++      +
Sbjct: 147 VSCTYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKT 203
Query: 248 TILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPY 306
           T       ++ P  +     T +SDV+SFGV++ E+ T G  P   + +           
Sbjct: 204 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--------- 254
Query: 307 FLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR 366
            L  +   G R     +  +E  M        +   C     ++RPT KQ+ E+LDR+  
Sbjct: 255 -LFKLLKEGHRMDKPANCTNELYM--------MMRDCWHAVPSQRPTFKQLVEDLDRILT 305
Query: 367 LHEN 370
           L  N
Sbjct: 306 LTTN 309

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 107/244 (43%), Gaps = 35/244 (14%)
Query: 141 HKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLK-------------TWKTC 187
           HKN++ +LG C +     ++ E+AS G L +++R      ++             T+K  
Sbjct: 100 HKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 188 LRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMS 247
           +    + A  ++YL   AS   IH D+ + N+L+ +N   K+ADF  +  I++      +
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 248 TILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPY 306
           T       ++ P  +     T +SDV+SFGV++ E+ T G  P   + +           
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--------- 267
Query: 307 FLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR 366
            L  +   G R     +  +E  M        +   C     ++RPT KQ+ E+LDR+  
Sbjct: 268 -LFKLLKEGHRMDKPANCTNELYM--------MMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 367 LHEN 370
           L  N
Sbjct: 319 LTTN 322

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 107/244 (43%), Gaps = 35/244 (14%)
Query: 141 HKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLK-------------TWKTC 187
           HKN++ +LG C +     ++ E+AS G L +++R      ++             T+K  
Sbjct: 89  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 148
Query: 188 LRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMS 247
           +    + A  ++YL   AS   IH D+ + N+L+ +N   K+ADF  +  I++      +
Sbjct: 149 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 205
Query: 248 TILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPY 306
           T       ++ P  +     T +SDV+SFGV++ E+ T G  P   + +           
Sbjct: 206 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--------- 256
Query: 307 FLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR 366
            L  +   G R     +  +E  M        +   C     ++RPT KQ+ E+LDR+  
Sbjct: 257 -LFKLLKEGHRMDKPANCTNELYM--------MMRDCWHAVPSQRPTFKQLVEDLDRILT 307
Query: 367 LHEN 370
           L  N
Sbjct: 308 LTTN 311

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 96/215 (44%), Gaps = 23/215 (10%)
Query: 95  LSQGGFVSVYKGVLH------DNIQVAVKTYRRA-DKXXXXXXXXXXXXSQVNHKNVVKI 147
           L +G F  V+    H      D + VAVK  + A +             + + H+++V+ 
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 148 LGLCLETEVPLLVYEFASNGTLLDHIRCES--SQVLKTWK----------TCLRIAAETA 195
            G+C E    L+V+E+  +G L   +R     +++L   +            L +A++ A
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 196 SALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG 255
           + + YL  L     +H D+ + N L+      K+ DF  S  I S     +    +    
Sbjct: 146 AGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 202
Query: 256 YLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
           ++ P  I   K T +SDV+SFGVVL E+ T GK+P
Sbjct: 203 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 237

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 77/314 (24%), Positives = 137/314 (43%), Gaps = 57/314 (18%)
Query: 76  IFSKSEMIRATKNFDRSRCLSQGGFVSVY----KGVLHDNIQ--VAVKTYRRAD--KXXX 127
           ++   E   A +    SR L QG F  VY    KGV+ D  +  VA+KT   A   +   
Sbjct: 7   VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 66
Query: 128 XXXXXXXXXSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRC-----ESSQVL- 181
                     + N  +VV++LG+  + +  L++ E  + G L  ++R      E++ VL 
Sbjct: 67  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 126
Query: 182 -KTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFE-SSVLIS 239
             +    +++A E A  + YL++      +H D+ + N ++ +++T K+ DF  +  +  
Sbjct: 127 PPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 183
Query: 240 SDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-------------- 285
           +D        L+    ++ P  +  G  T  SDV+SFGVVL E+ T              
Sbjct: 184 TDYYRKGGKGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV 242
Query: 286 ---------GKKPGSC-------MTLASNKKISMVPYFL---NSIKNN---GLRQILNFH 323
                      KP +C       M +       M P FL   +SIK     G R++ +F+
Sbjct: 243 LRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV-SFY 301
Query: 324 VADESEMKEIEIVA 337
            ++E++M+   ++A
Sbjct: 302 YSEENKMENNPVLA 315

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 107/244 (43%), Gaps = 35/244 (14%)
Query: 141 HKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLK-------------TWKTC 187
           HKN++ +LG C +     ++ E+AS G L +++R      ++             T+K  
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 188 LRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMS 247
           +    + A  ++YL   AS   IH D+ + N+L+ +N   K+ADF  +  I++      +
Sbjct: 206 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 262
Query: 248 TILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPY 306
           T       ++ P  +     T +SDV+SFGV++ E+ T G  P   + +           
Sbjct: 263 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--------- 313
Query: 307 FLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR 366
            L  +   G R     +  +E  M        +   C     ++RPT KQ+ E+LDR+  
Sbjct: 314 -LFKLLKEGHRMDKPANCTNELYM--------MMRDCWHAVPSQRPTFKQLVEDLDRILT 364
Query: 367 LHEN 370
           L  N
Sbjct: 365 LTTN 368

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 96/215 (44%), Gaps = 23/215 (10%)
Query: 95  LSQGGFVSVYKGVLH------DNIQVAVKTYRRA-DKXXXXXXXXXXXXSQVNHKNVVKI 147
           L +G F  V+    H      D + VAVK  + A +             + + H+++V+ 
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 148 LGLCLETEVPLLVYEFASNGTLLDHIRCES--SQVLKTWK----------TCLRIAAETA 195
            G+C E    L+V+E+  +G L   +R     +++L   +            L +A++ A
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 196 SALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG 255
           + + YL  L     +H D+ + N L+      K+ DF  S  I S     +    +    
Sbjct: 140 AGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 196
Query: 256 YLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
           ++ P  I   K T +SDV+SFGVVL E+ T GK+P
Sbjct: 197 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 231

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 107/244 (43%), Gaps = 35/244 (14%)
Query: 141 HKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLK-------------TWKTC 187
           HKN++ +LG C +     ++ E+AS G L +++R      ++             T+K  
Sbjct: 100 HKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 188 LRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMS 247
           +    + A  ++YL   AS   IH D+ + N+L+ +N   K+ADF  +  I++      +
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 248 TILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPY 306
           T       ++ P  +     T +SDV+SFGV++ E+ T G  P   + +           
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--------- 267
Query: 307 FLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR 366
            L  +   G R     +  +E  M        +   C     ++RPT KQ+ E+LDR+  
Sbjct: 268 -LFKLLKEGHRMDKPANCTNELYM--------MMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 367 LHEN 370
           L  N
Sbjct: 319 LTTN 322

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 107/244 (43%), Gaps = 35/244 (14%)
Query: 141 HKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLK-------------TWKTC 187
           HKN++ +LG C +     ++ E+AS G L +++R      ++             T+K  
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 188 LRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMS 247
           +    + A  ++YL   AS   IH D+ + N+L+ +N   K+ADF  +  I++      +
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNT 216
Query: 248 TILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPY 306
           T       ++ P  +     T +SDV+SFGV++ E+ T G  P   + +           
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--------- 267
Query: 307 FLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR 366
            L  +   G R     +  +E  M        +   C     ++RPT KQ+ E+LDR+  
Sbjct: 268 -LFKLLKEGHRMDKPANCTNELYM--------MMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 367 LHEN 370
           L  N
Sbjct: 319 LTTN 322

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 92/217 (42%), Gaps = 9/217 (4%)
Query: 89  FDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKIL 148
           FD    L +G + SVYK +  +  Q+        +              Q +  +VVK  
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYY 90
Query: 149 GLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPP 208
           G   +     +V E+   G++ D IR  +  +  T      I   T   L+YLH +    
Sbjct: 91  GSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTL--TEDEIATILQSTLKGLEYLHFMRK-- 146
Query: 209 IIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLT 268
            IH D+K+ NILLN    AK+ADF  +  ++     A    +IGT  ++ P  I      
Sbjct: 147 -IHRDIKAGNILLNTEGHAKLADFGVAGQLTD--XMAKRNXVIGTPFWMAPEVIQEIGYN 203
Query: 269 KKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVP 305
             +D++S G+   E+  GK P +   +   + I M+P
Sbjct: 204 CVADIWSLGITAIEMAEGKPPYA--DIHPMRAIFMIP 238

>pdb|1OEC|A Chain A, Fgfr2 Kinase Domain Length = 316

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 107/244 (43%), Gaps = 35/244 (14%)
Query: 141 HKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLK-------------TWKTC 187
           HKN++ +LG C +     ++ E+AS G L +++R      ++             T+K  
Sbjct: 92  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 151
Query: 188 LRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMS 247
           +    + A  ++YL   AS   IH D+ + N+L+ +N   K+ADF  +  I++      +
Sbjct: 152 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 208
Query: 248 TILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPY 306
           T       ++ P  +     T +SDV+SFGV++ E+ T G  P   + +           
Sbjct: 209 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--------- 259
Query: 307 FLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR 366
            L  +   G R     +  +E  M        +   C     ++RPT KQ+ E+LDR+  
Sbjct: 260 -LFKLLKEGHRMDKPANCTNELYM--------MMRDCWHAVPSQRPTFKQLVEDLDRILT 310
Query: 367 LHEN 370
           L  N
Sbjct: 311 LTTN 314

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 108/232 (46%), Gaps = 20/232 (8%)
Query: 70  AFLRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVY----KGVLHDN--IQVAVKTYRRAD 123
           +F    ++   E   A +    SR L QG F  VY    KGV+ D    +VA+KT   A 
Sbjct: 2   SFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA 61
Query: 124 --KXXXXXXXXXXXXSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRC-----E 176
             +             + N  +VV++LG+  + +  L++ E  + G L  ++R      E
Sbjct: 62  SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEME 121
Query: 177 SSQVL--KTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFE- 233
           ++ VL   +    +++A E A  + YL++      +H D+ + N ++ +++T K+ DF  
Sbjct: 122 NNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGM 178
Query: 234 SSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT 285
           +  +  +D        L+    ++ P  +  G  T  SDV+SFGVVL E+ T
Sbjct: 179 TRDIYETDYYRKGGKGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 96/215 (44%), Gaps = 23/215 (10%)
Query: 95  LSQGGFVSVYKGVLH------DNIQVAVKTYRRA-DKXXXXXXXXXXXXSQVNHKNVVKI 147
           L +G F  V+    H      D + VAVK  + A +             + + H+++V+ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 148 LGLCLETEVPLLVYEFASNGTLLDHIRCES--SQVLKTWK----------TCLRIAAETA 195
            G+C E    L+V+E+  +G L   +R     +++L   +            L +A++ A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 196 SALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG 255
           + + YL  L     +H D+ + N L+      K+ DF  S  I S     +    +    
Sbjct: 169 AGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225
Query: 256 YLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
           ++ P  I   K T +SDV+SFGVVL E+ T GK+P
Sbjct: 226 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/270 (23%), Positives = 109/270 (40%), Gaps = 51/270 (18%)
Query: 139 VNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASAL 198
           + H NV+K +G+  + +    + E+   GTL   I+   SQ    W   +  A + AS +
Sbjct: 64  LEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQY--PWSQRVSFAKDIASGM 121
Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD------------AETAM 246
            YLHS+    IIH D+ S N L+ +N    VADF  + L+  +             +   
Sbjct: 122 AYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKK 178
Query: 247 STILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPY 306
              ++G   ++ P  IN     +K DV+SFG+VL E++               +++  P 
Sbjct: 179 RYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIG--------------RVNADPD 224
Query: 307 FLNSIKNNGL--RQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL 364
           +L    + GL  R  L+ +           I      +C  +   +RP+  ++   L+ L
Sbjct: 225 YLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITV----RCCDLDPEKRPSFVKLEHWLETL 280
Query: 365 R--------------RLHENFWAQKKNKET 380
           R              +L   FW   +  E+
Sbjct: 281 RMHLAGHLPLGPQLEQLDRGFWETYRRGES 310

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 91/185 (49%), Gaps = 15/185 (8%)
Query: 112 IQVAVKTYRRA--DKXXXXXXXXXXXXSQVNHKNVVKILGLCLETEVPLLVYEFASNGTL 169
           I VA+KT +    DK             Q +H N++ + G+  + +  +++ E+  NG+L
Sbjct: 58  ICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSL 117
Query: 170 LDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKV 229
              +R    +   T    + +     S + YL  +++   +H D+ + NIL+N N   KV
Sbjct: 118 DAFLRKNDGRF--TVIQLVGMLRGIGSGMKYLSDMSA---VHRDLAARNILVNSNLVCKV 172
Query: 230 ADFESSVLISSDAETAMST----ILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT 285
           +DF  S ++  D E A +T    I I    +  P  I   K T  SDV+S+G+V+ E+++
Sbjct: 173 SDFGMSRVLEDDPEAAYTTRGGKIPI---RWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 229
Query: 286 -GKKP 289
            G++P
Sbjct: 230 YGERP 234

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 106/226 (46%), Gaps = 20/226 (8%)
Query: 76  IFSKSEMIRATKNFDRSRCLSQGGFVSVY----KGVLHDN--IQVAVKTYRRAD--KXXX 127
           ++   E   A +    SR L QG F  VY    KGV+ D    +VA+KT   A   +   
Sbjct: 7   VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 66
Query: 128 XXXXXXXXXSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRC-----ESSQVL- 181
                     + N  +VV++LG+  + +  L++ E  + G L  ++R      E++ VL 
Sbjct: 67  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 126
Query: 182 -KTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSV-LIS 239
             +    +++A E A  + YL++      +H D+ + N ++ +++T K+ DF  +  +  
Sbjct: 127 PPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 183
Query: 240 SDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT 285
           +D        L+    ++ P  +  G  T  SDV+SFGVVL E+ T
Sbjct: 184 TDYYRKGGKGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 22/214 (10%)
Query: 88  NFDRSRCLSQGGFVSVYKGVLHDN-----IQVAVKTYRRA--DKXXXXXXXXXXXXSQVN 140
            F + + LS G F +VYKG+         I VA+K  R A   K            + V+
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 141 HKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCE----SSQVLKTWKTCLRIAAETAS 196
           + +V ++LG+CL + V L++ +    G LLD++R       SQ L  W  C++IA     
Sbjct: 83  NPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW--CVQIA----K 135
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            ++YL       ++H D+ + N+L+      K+ DF  + L+ ++ +   +        +
Sbjct: 136 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 192
Query: 257 LDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
           +    I     T +SDV+S+GV + EL+T G KP
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 226

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 106/226 (46%), Gaps = 20/226 (8%)
Query: 76  IFSKSEMIRATKNFDRSRCLSQGGFVSVY----KGVLHDN--IQVAVKTYRRAD--KXXX 127
           ++   E   A +    SR L QG F  VY    KGV+ D    +VA+KT   A   +   
Sbjct: 36  VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 95
Query: 128 XXXXXXXXXSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRC-----ESSQVL- 181
                     + N  +VV++LG+  + +  L++ E  + G L  ++R      E++ VL 
Sbjct: 96  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 155
Query: 182 -KTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSV-LIS 239
             +    +++A E A  + YL++      +H D+ + N ++ +++T K+ DF  +  +  
Sbjct: 156 PPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 212
Query: 240 SDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT 285
           +D        L+    ++ P  +  G  T  SDV+SFGVVL E+ T
Sbjct: 213 TDYYRKGGKGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 85/183 (46%), Gaps = 17/183 (9%)
Query: 137 SQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETAS 196
           S V H  ++++ G   + +   ++ ++   G L   +R   SQ           AAE   
Sbjct: 61  SIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR--KSQRFPN-PVAKFYAAEVCL 117
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
           AL+YLHS     II+ D+K  NILL+ N   K+ DF  +  +       ++  L GT  Y
Sbjct: 118 ALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYXLCGTPDY 169
Query: 257 LDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPG-SCMTLASNKKI-----SMVPYFLNS 310
           + P  ++T    K  D +SFG+++ E+L G  P     T+ + +KI        P+F   
Sbjct: 170 IAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNED 229
Query: 311 IKN 313
           +K+
Sbjct: 230 VKD 232

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/244 (24%), Positives = 107/244 (43%), Gaps = 35/244 (14%)
Query: 141 HKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLK-------------TWKTC 187
           HKN++ +LG C +     ++ E+AS G L +++R      ++             T+K  
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 188 LRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMS 247
           +    + A  ++YL   AS   IH D+ + N+L+ +N   ++ADF  +  I++      +
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKT 216
Query: 248 TILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPY 306
           T       ++ P  +     T +SDV+SFGV++ E+ T G  P   + +           
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--------- 267
Query: 307 FLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR 366
            L  +   G R     +  +E  M        +   C     ++RPT KQ+ E+LDR+  
Sbjct: 268 -LFKLLKEGHRMDKPANCTNELYM--------MMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 367 LHEN 370
           L  N
Sbjct: 319 LTTN 322

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 103/217 (47%), Gaps = 20/217 (9%)
Query: 85  ATKNFDRSRCLSQGGFVSVY----KGVLHDN--IQVAVKTYRRAD--KXXXXXXXXXXXX 136
           A +    SR L QG F  VY    KGV+ D    +VA+KT   A   +            
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 69
Query: 137 SQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRC-----ESSQVL--KTWKTCLR 189
            + N  +VV++LG+  + +  L++ E  + G L  ++R      E++ VL   +    ++
Sbjct: 70  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 129
Query: 190 IAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFE-SSVLISSDAETAMST 248
           +A E A  + YL++      +H D+ + N ++ +++T K+ DF  +  +  +D       
Sbjct: 130 MAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 186
Query: 249 ILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT 285
            L+    ++ P  +  G  T  SDV+SFGVVL E+ T
Sbjct: 187 GLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 77/312 (24%), Positives = 135/312 (43%), Gaps = 49/312 (15%)
Query: 67  PGLAFLRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDN-----IQVAVKTYRR 121
           P  A LR  I  ++E       F + + L  G F +VYKG+         I VA+K  R 
Sbjct: 6   PNQALLR--ILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE 56
Query: 122 A--DKXXXXXXXXXXXXSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCE--- 176
           A   K            + V++ +V ++LG+CL + V L++ +    G LLD++R     
Sbjct: 57  ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDN 115
Query: 177 -SSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESS 235
             SQ L  W  C++IA      ++YL       ++H D+ + N+L+      K+ DF  +
Sbjct: 116 IGSQYLLNW--CVQIA----KGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRA 166
Query: 236 VLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMT 294
            L+ ++ +   +        ++    I     T +SDV+S+GV + EL+T G KP   + 
Sbjct: 167 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 226
Query: 295 LASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTM 354
            +           ++SI   G R         +  +  I++   +  KC  I    RP  
Sbjct: 227 ASE----------ISSILEKGER-------LPQPPICTIDVYM-IMRKCWMIDADSRPKF 268
Query: 355 KQVSEELDRLRR 366
           +++  E  ++ R
Sbjct: 269 RELIIEFSKMAR 280

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/235 (28%), Positives = 109/235 (46%), Gaps = 31/235 (13%)
Query: 67  PGLAFLRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDN-----IQVAVKTYRR 121
           P  A LR  I  ++E       F + + LS G F +VYKG+         I VA+K  R 
Sbjct: 4   PNQALLR--ILKETE-------FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELRE 54
Query: 122 A--DKXXXXXXXXXXXXSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCE--- 176
           A   K            + V++ +V ++LG+CL + V L+  +    G LLD++R     
Sbjct: 55  ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDN 113
Query: 177 -SSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESS 235
             SQ L  W  C++IA      ++YL       ++H D+ + N+L+      K+ DF  +
Sbjct: 114 IGSQYLLNW--CVQIA----KGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLA 164
Query: 236 VLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
            L+ ++ +   +        ++    I     T +SDV+S+GV + EL+T G KP
Sbjct: 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 71/277 (25%), Positives = 119/277 (42%), Gaps = 40/277 (14%)
Query: 89  FDRSRCLSQGGFVSVYKGVLHDN-----IQVAVKTYRRADKXXXXXXXXXXXXSQVNHKN 143
           F +   + +G F  V+KG+  DN     + + +     A+             SQ +   
Sbjct: 9   FTKLEKIGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 66
Query: 144 VVKILGLCLETEVPLLVYEFASNGTLLDHIR---CESSQVLKTWKTCLRIAAETASALDY 200
           V K  G  L+     ++ E+   G+ LD +     + +Q+     T LR   E    LDY
Sbjct: 67  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQI----ATILR---EILKGLDY 119
Query: 201 LHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV 260
           LHS      IH D+K+AN+LL+++   K+ADF  +  + +D +   +T  +GT  ++ P 
Sbjct: 120 LHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQL-TDTQIKRNT-FVGTPFWMAPE 174
Query: 261 CINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQIL 320
            I       K+D++S G+   EL  G+ P S   L   K + ++P      KNN      
Sbjct: 175 VIKQSAYDSKADIWSLGITAIELARGEPPHS--ELHPMKVLFLIP------KNNPPTLEG 226
Query: 321 NFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQV 357
           N+           + + E    CL    + RPT K++
Sbjct: 227 NYS----------KPLKEFVEACLNKEPSFRPTAKEL 253

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 22/214 (10%)
Query: 88  NFDRSRCLSQGGFVSVYKGVLHDN-----IQVAVKTYRRA--DKXXXXXXXXXXXXSQVN 140
            F + + LS G F +VYKG+         I VA+K  R A   K            + V+
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 141 HKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCE----SSQVLKTWKTCLRIAAETAS 196
           + +V ++LG+CL + V L+  +    G LLD++R       SQ L  W  C++IA     
Sbjct: 83  NPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW--CVQIA----K 135
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            ++YL       ++H D+ + N+L+      K+ DF  + L+ ++ +   +        +
Sbjct: 136 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 192
Query: 257 LDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
           +    I     T +SDV+S+GV + EL+T G KP
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 226

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 109/235 (46%), Gaps = 31/235 (13%)
Query: 67  PGLAFLRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDN-----IQVAVKTYRR 121
           P  A LR  I  ++E       F + + L  G F +VYKG+         I VA+K  R 
Sbjct: 6   PNQALLR--ILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE 56
Query: 122 A--DKXXXXXXXXXXXXSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCE--- 176
           A   K            + V++ +V ++LG+CL + V L++ +    G LLD++R     
Sbjct: 57  ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDN 115
Query: 177 -SSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESS 235
             SQ L  W  C++IA      ++YL       ++H D+ + N+L+      K+ DF  +
Sbjct: 116 IGSQYLLNW--CVQIA----KGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRA 166
Query: 236 VLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
            L+ ++ +   +        ++    I     T +SDV+S+GV + EL+T G KP
Sbjct: 167 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 109/235 (46%), Gaps = 31/235 (13%)
Query: 67  PGLAFLRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDN-----IQVAVKTYRR 121
           P  A LR  I  ++E       F + + L  G F +VYKG+         I VA+K  R 
Sbjct: 8   PNQALLR--ILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE 58
Query: 122 A--DKXXXXXXXXXXXXSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCE--- 176
           A   K            + V++ +V ++LG+CL + V L++ +    G LLD++R     
Sbjct: 59  ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDN 117
Query: 177 -SSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESS 235
             SQ L  W  C++IA      ++YL       ++H D+ + N+L+      K+ DF  +
Sbjct: 118 IGSQYLLNW--CVQIA----KGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRA 168
Query: 236 VLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
            L+ ++ +   +        ++    I     T +SDV+S+GV + EL+T G KP
Sbjct: 169 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 223

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 90/185 (48%), Gaps = 15/185 (8%)
Query: 112 IQVAVKTYRRA--DKXXXXXXXXXXXXSQVNHKNVVKILGLCLETEVPLLVYEFASNGTL 169
           I VA+KT +    DK             Q +H N++ + G+  + +  +++ E+  NG+L
Sbjct: 43  ICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSL 102
Query: 170 LDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKV 229
              +R    +   T    + +     S + YL  ++    +H D+ + NIL+N N   KV
Sbjct: 103 DAFLRKNDGRF--TVIQLVGMLRGIGSGMKYLSDMS---YVHRDLAARNILVNSNLVCKV 157
Query: 230 ADFESSVLISSDAETAMST----ILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT 285
           +DF  S ++  D E A +T    I I    +  P  I   K T  SDV+S+G+V+ E+++
Sbjct: 158 SDFGMSRVLEDDPEAAYTTRGGKIPI---RWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 214
Query: 286 -GKKP 289
            G++P
Sbjct: 215 YGERP 219

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 90/185 (48%), Gaps = 15/185 (8%)
Query: 112 IQVAVKTYRRA--DKXXXXXXXXXXXXSQVNHKNVVKILGLCLETEVPLLVYEFASNGTL 169
           I VA+KT +    DK             Q +H N++ + G+  + +  +++ E+  NG+L
Sbjct: 37  ICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSL 96
Query: 170 LDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKV 229
              +R    +   T    + +     S + YL  ++    +H D+ + NIL+N N   KV
Sbjct: 97  DAFLRKNDGRF--TVIQLVGMLRGIGSGMKYLSDMS---YVHRDLAARNILVNSNLVCKV 151
Query: 230 ADFESSVLISSDAETAMST----ILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT 285
           +DF  S ++  D E A +T    I I    +  P  I   K T  SDV+S+G+V+ E+++
Sbjct: 152 SDFGMSRVLEDDPEAAYTTRGGKIPI---RWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 208
Query: 286 -GKKP 289
            G++P
Sbjct: 209 YGERP 213

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 100/213 (46%), Gaps = 19/213 (8%)
Query: 93  RCLSQGGFVSVYKGVLH----DNIQVAVKTYR--RADKXXXXXXXXXXXXSQVNHKNVVK 146
           R +  G F  V  G L       + VA+KT +    +K             Q +H N++ 
Sbjct: 28  RVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIH 87
Query: 147 ILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLAS 206
           + G+  +++  ++V E+  NG+L   ++    Q   T    + +    ++ + YL  +  
Sbjct: 88  LEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQF--TVIQLVGMLRGISAGMKYLSDMG- 144
Query: 207 PPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMST----ILIGTSGYLDPVCI 262
              +H D+ + NIL+N N   KV+DF  S ++  D E A +T    I I  +    P  I
Sbjct: 145 --YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTA---PEAI 199
Query: 263 NTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMT 294
              K T  SDV+S+G+V+ E+++ G++P   MT
Sbjct: 200 AFRKFTSASDVWSYGIVMWEVVSYGERPYWEMT 232

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 77/312 (24%), Positives = 134/312 (42%), Gaps = 49/312 (15%)
Query: 67  PGLAFLRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDN-----IQVAVKTYRR 121
           P  A LR  I  ++E       F + + L  G F +VYKG+         I VA+K  R 
Sbjct: 6   PNQALLR--ILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE 56
Query: 122 A--DKXXXXXXXXXXXXSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCE--- 176
           A   K            + V++ +V ++LG+CL + V L+  +    G LLD++R     
Sbjct: 57  ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDN 115
Query: 177 -SSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESS 235
             SQ L  W  C++IA      ++YL       ++H D+ + N+L+      K+ DF  +
Sbjct: 116 IGSQYLLNW--CVQIA----KGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRA 166
Query: 236 VLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMT 294
            L+ ++ +   +        ++    I     T +SDV+S+GV + EL+T G KP   + 
Sbjct: 167 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 226
Query: 295 LASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTM 354
            +           ++SI   G R         +  +  I++   +  KC  I    RP  
Sbjct: 227 ASE----------ISSILEKGER-------LPQPPICTIDVYM-IMRKCWMIDADSRPKF 268
Query: 355 KQVSEELDRLRR 366
           +++  E  ++ R
Sbjct: 269 RELIIEFSKMAR 280

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 71/277 (25%), Positives = 119/277 (42%), Gaps = 40/277 (14%)
Query: 89  FDRSRCLSQGGFVSVYKGVLHDN-----IQVAVKTYRRADKXXXXXXXXXXXXSQVNHKN 143
           F +   + +G F  V+KG+  DN     + + +     A+             SQ +   
Sbjct: 29  FTKLEKIGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 86
Query: 144 VVKILGLCLETEVPLLVYEFASNGTLLDHIR---CESSQVLKTWKTCLRIAAETASALDY 200
           V K  G  L+     ++ E+   G+ LD +     + +Q+     T LR   E    LDY
Sbjct: 87  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQI----ATILR---EILKGLDY 139
Query: 201 LHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV 260
           LHS      IH D+K+AN+LL+++   K+ADF  +  + +D +   +T  +GT  ++ P 
Sbjct: 140 LHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQL-TDTQIKRNT-FVGTPFWMAPE 194
Query: 261 CINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQIL 320
            I       K+D++S G+   EL  G+ P S   L   K + ++P      KNN      
Sbjct: 195 VIKQSAYDSKADIWSLGITAIELARGEPPHS--ELHPMKVLFLIP------KNNPPTLEG 246
Query: 321 NFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQV 357
           N+           + + E    CL    + RPT K++
Sbjct: 247 NYS----------KPLKEFVEACLNKEPSFRPTAKEL 273

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 108/235 (45%), Gaps = 31/235 (13%)
Query: 67  PGLAFLRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDN-----IQVAVKTYRR 121
           P  A LR  I  ++E       F + + L  G F +VYKG+         I VA+K  R 
Sbjct: 4   PNQALLR--ILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE 54
Query: 122 A--DKXXXXXXXXXXXXSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCE--- 176
           A   K            + V++ +V ++LG+CL + V L+  +    G LLD++R     
Sbjct: 55  ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDN 113
Query: 177 -SSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESS 235
             SQ L  W  C++IA      ++YL       ++H D+ + N+L+      K+ DF  +
Sbjct: 114 IGSQYLLNW--CVQIA----KGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRA 164
Query: 236 VLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
            L+ ++ +   +        ++    I     T +SDV+S+GV + EL+T G KP
Sbjct: 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 79/167 (47%), Gaps = 17/167 (10%)
Query: 137 SQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVL-------------KT 183
           + + H+++VK  G+C + +  ++V+E+  +G L   +R      +               
Sbjct: 72  TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 131
Query: 184 WKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE 243
               L IA++ AS + YL   AS   +H D+ + N L+  N   K+ DF  S  + S   
Sbjct: 132 LSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY 188
Query: 244 TAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
             +    +    ++ P  I   K T +SDV+SFGV+L E+ T GK+P
Sbjct: 189 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 20/226 (8%)
Query: 76  IFSKSEMIRATKNFDRSRCLSQGGFVSVY----KGVLHDN--IQVAVKTYRRAD--KXXX 127
           ++   E   A +    SR L QG F  VY    KGV+ D    +VA+KT   A   +   
Sbjct: 1   VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 60
Query: 128 XXXXXXXXXSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRC-----ESSQVL- 181
                     + N  +VV++LG+  + +  L++ E  + G L  ++R      E++ VL 
Sbjct: 61  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 120
Query: 182 -KTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFE-SSVLIS 239
             +    +++A E A  + YL++      +H D+ + N  + +++T K+ DF  +  +  
Sbjct: 121 PPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCXVAEDFTVKIGDFGMTRDIYE 177
Query: 240 SDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT 285
           +D        L+    ++ P  +  G  T  SDV+SFGVVL E+ T
Sbjct: 178 TDYYRKGGKGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 109/235 (46%), Gaps = 31/235 (13%)
Query: 67  PGLAFLRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDN-----IQVAVKTYRR 121
           P  A LR  I  ++E       F + + L  G F +VYKG+         I VA+K  R 
Sbjct: 5   PNQALLR--ILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE 55
Query: 122 A--DKXXXXXXXXXXXXSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCE--- 176
           A   K            + V++ +V ++LG+CL + V L++ +    G LLD++R     
Sbjct: 56  ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGXLLDYVREHKDN 114
Query: 177 -SSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESS 235
             SQ L  W  C++IA      ++YL       ++H D+ + N+L+      K+ DF  +
Sbjct: 115 IGSQYLLNW--CVQIA----KGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLA 165
Query: 236 VLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
            L+ ++ +   +        ++    I     T +SDV+S+GV + EL+T G KP
Sbjct: 166 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 220

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 108/235 (45%), Gaps = 31/235 (13%)
Query: 67  PGLAFLRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDN-----IQVAVKTYRR 121
           P  A LR  I  ++E       F + + L  G F +VYKG+         I VA+K  R 
Sbjct: 11  PNQALLR--ILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE 61
Query: 122 A--DKXXXXXXXXXXXXSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCE--- 176
           A   K            + V++ +V ++LG+CL + V L+  +    G LLD++R     
Sbjct: 62  ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDN 120
Query: 177 -SSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESS 235
             SQ L  W  C++IA      ++YL       ++H D+ + N+L+      K+ DF  +
Sbjct: 121 IGSQYLLNW--CVQIA----KGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRA 171
Query: 236 VLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
            L+ ++ +   +        ++    I     T +SDV+S+GV + EL+T G KP
Sbjct: 172 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 226

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 109/235 (46%), Gaps = 31/235 (13%)
Query: 67  PGLAFLRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDN-----IQVAVKTYRR 121
           P  A LR  I  ++E       F + + L  G F +VYKG+         I VA+K  R 
Sbjct: 4   PNQALLR--ILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE 54
Query: 122 A--DKXXXXXXXXXXXXSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCE--- 176
           A   K            + V++ +V ++LG+CL + V L++ +    G LLD++R     
Sbjct: 55  ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDN 113
Query: 177 -SSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESS 235
             SQ L  W  C++IA      ++YL       ++H D+ + N+L+      K+ DF  +
Sbjct: 114 IGSQYLLNW--CVQIA----KGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLA 164
Query: 236 VLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
            L+ ++ +   +        ++    I     T +SDV+S+GV + EL+T G KP
Sbjct: 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 77/312 (24%), Positives = 134/312 (42%), Gaps = 49/312 (15%)
Query: 67  PGLAFLRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDN-----IQVAVKTYRR 121
           P  A LR  I  ++E       F + + L  G F +VYKG+         I VA+K  R 
Sbjct: 14  PNQALLR--ILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE 64
Query: 122 A--DKXXXXXXXXXXXXSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCE--- 176
           A   K            + V++ +V ++LG+CL + V L+  +    G LLD++R     
Sbjct: 65  ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDN 123
Query: 177 -SSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESS 235
             SQ L  W  C++IA      ++YL       ++H D+ + N+L+      K+ DF  +
Sbjct: 124 IGSQYLLNW--CVQIA----KGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLA 174
Query: 236 VLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMT 294
            L+ ++ +   +        ++    I     T +SDV+S+GV + EL+T G KP   + 
Sbjct: 175 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 234
Query: 295 LASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTM 354
            +           ++SI   G R         +  +  I++   +  KC  I    RP  
Sbjct: 235 ASE----------ISSILEKGER-------LPQPPICTIDVYM-IMRKCWMIDADSRPKF 276
Query: 355 KQVSEELDRLRR 366
           +++  E  ++ R
Sbjct: 277 RELIIEFSKMAR 288

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 109/235 (46%), Gaps = 31/235 (13%)
Query: 67  PGLAFLRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDN-----IQVAVKTYRR 121
           P  A LR  I  ++E       F + + L  G F +VYKG+         I VA+K  R 
Sbjct: 7   PNQALLR--ILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE 57
Query: 122 A--DKXXXXXXXXXXXXSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCE--- 176
           A   K            + V++ +V ++LG+CL + V L++ +    G LLD++R     
Sbjct: 58  ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDN 116
Query: 177 -SSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESS 235
             SQ L  W  C++IA      ++YL       ++H D+ + N+L+      K+ DF  +
Sbjct: 117 IGSQYLLNW--CVQIA----KGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLA 167
Query: 236 VLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
            L+ ++ +   +        ++    I     T +SDV+S+GV + EL+T G KP
Sbjct: 168 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 222

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 109/235 (46%), Gaps = 31/235 (13%)
Query: 67  PGLAFLRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDN-----IQVAVKTYRR 121
           P  A LR  I  ++E       F + + L  G F +VYKG+         I VA+K  R 
Sbjct: 5   PNQALLR--ILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE 55
Query: 122 A--DKXXXXXXXXXXXXSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCE--- 176
           A   K            + V++ +V ++LG+CL + V L++ +    G LLD++R     
Sbjct: 56  ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDN 114
Query: 177 -SSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESS 235
             SQ L  W  C++IA      ++YL       ++H D+ + N+L+      K+ DF  +
Sbjct: 115 IGSQYLLNW--CVQIA----KGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLA 165
Query: 236 VLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
            L+ ++ +   +        ++    I     T +SDV+S+GV + EL+T G KP
Sbjct: 166 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 220

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 77/312 (24%), Positives = 134/312 (42%), Gaps = 49/312 (15%)
Query: 67  PGLAFLRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDN-----IQVAVKTYRR 121
           P  A LR  I  ++E       F + + L  G F +VYKG+         I VA+K  R 
Sbjct: 4   PNQALLR--ILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE 54
Query: 122 A--DKXXXXXXXXXXXXSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCE--- 176
           A   K            + V++ +V ++LG+CL + V L+  +    G LLD++R     
Sbjct: 55  ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGXLLDYVREHKDN 113
Query: 177 -SSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESS 235
             SQ L  W  C++IA      ++YL       ++H D+ + N+L+      K+ DF  +
Sbjct: 114 IGSQYLLNW--CVQIA----KGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLA 164
Query: 236 VLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMT 294
            L+ ++ +   +        ++    I     T +SDV+S+GV + EL+T G KP   + 
Sbjct: 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 224
Query: 295 LASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTM 354
            +           ++SI   G R         +  +  I++   +  KC  I    RP  
Sbjct: 225 ASE----------ISSILEKGER-------LPQPPICTIDVYM-IMVKCWMIDADSRPKF 266
Query: 355 KQVSEELDRLRR 366
           +++  E  ++ R
Sbjct: 267 RELIIEFSKMAR 278

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 109/235 (46%), Gaps = 31/235 (13%)
Query: 67  PGLAFLRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDN-----IQVAVKTYRR 121
           P  A LR  I  ++E       F + + L  G F +VYKG+         I VA+K  R 
Sbjct: 6   PNQALLR--ILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE 56
Query: 122 A--DKXXXXXXXXXXXXSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCE--- 176
           A   K            + V++ +V ++LG+CL + V L++ +    G LLD++R     
Sbjct: 57  ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDN 115
Query: 177 -SSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESS 235
             SQ L  W  C++IA      ++YL       ++H D+ + N+L+      K+ DF  +
Sbjct: 116 IGSQYLLNW--CVQIA----KGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLA 166
Query: 236 VLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
            L+ ++ +   +        ++    I     T +SDV+S+GV + EL+T G KP
Sbjct: 167 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 101/214 (47%), Gaps = 22/214 (10%)
Query: 88  NFDRSRCLSQGGFVSVYKGVLHDN-----IQVAVKTYRRA--DKXXXXXXXXXXXXSQVN 140
            F + + L  G F +VYKG+         I VA+K  R A   K            + V+
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 141 HKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCE----SSQVLKTWKTCLRIAAETAS 196
           + +V ++LG+CL + V L++ +    G LLD++R       SQ L  W  C++IA     
Sbjct: 80  NPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW--CVQIA----K 132
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            ++YL       ++H D+ + N+L+      K+ DF  + L+ ++ +   +        +
Sbjct: 133 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 189
Query: 257 LDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
           +    I     T +SDV+S+GV + EL+T G KP
Sbjct: 190 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 223

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 76/311 (24%), Positives = 134/311 (43%), Gaps = 57/311 (18%)
Query: 76  IFSKSEMIRATKNFDRSRCLSQGGFVSVY----KGVLHDNIQ--VAVKTYRRAD--KXXX 127
           ++   E   A +    SR L QG F  VY    KGV+ D  +  VA+KT   A   +   
Sbjct: 14  VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 73
Query: 128 XXXXXXXXXSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRC-----ESSQVL- 181
                     + N  +VV++LG+  + +  L++ E  + G L  ++R       ++ VL 
Sbjct: 74  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 133
Query: 182 -KTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFE-SSVLIS 239
             +    +++A E A  + YL++      +H D+ + N ++ +++T K+ DF  +  +  
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 190
Query: 240 SDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-------------- 285
           +D        L+    ++ P  +  G  T  SDV+SFGVVL E+ T              
Sbjct: 191 TDYYRKGGKGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV 249
Query: 286 ---------GKKPGSC-------MTLASNKKISMVPYFL---NSIKNN---GLRQILNFH 323
                      KP +C       M +       M P FL   +SIK     G R++ +F+
Sbjct: 250 LRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV-SFY 308
Query: 324 VADESEMKEIE 334
            ++E+++ E E
Sbjct: 309 YSEENKLPEPE 319

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/244 (24%), Positives = 106/244 (43%), Gaps = 35/244 (14%)
Query: 141 HKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLK-------------TWKTC 187
           HKN++ +LG C +     ++  +AS G L +++R      ++             T+K  
Sbjct: 100 HKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 188 LRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMS 247
           +    + A  ++YL   AS   IH D+ + N+L+ +N   K+ADF  +  I++      +
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 248 TILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPY 306
           T       ++ P  +     T +SDV+SFGV++ E+ T G  P   + +           
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--------- 267
Query: 307 FLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR 366
            L  +   G R     +  +E  M        +   C     ++RPT KQ+ E+LDR+  
Sbjct: 268 -LFKLLKEGHRMDKPANCTNELYM--------MMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 367 LHEN 370
           L  N
Sbjct: 319 LTTN 322

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 77/312 (24%), Positives = 134/312 (42%), Gaps = 49/312 (15%)
Query: 67  PGLAFLRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDN-----IQVAVKTYRR 121
           P  A LR  I  ++E       F + + L  G F +VYKG+         I VA+K  R 
Sbjct: 7   PNQALLR--ILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE 57
Query: 122 A--DKXXXXXXXXXXXXSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCE--- 176
           A   K            + V++ +V ++LG+CL + V L+  +    G LLD++R     
Sbjct: 58  ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDN 116
Query: 177 -SSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESS 235
             SQ L  W  C++IA      ++YL       ++H D+ + N+L+      K+ DF  +
Sbjct: 117 IGSQYLLNW--CVQIA----KGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLA 167
Query: 236 VLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMT 294
            L+ ++ +   +        ++    I     T +SDV+S+GV + EL+T G KP   + 
Sbjct: 168 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 227
Query: 295 LASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTM 354
            +           ++SI   G R         +  +  I++   +  KC  I    RP  
Sbjct: 228 ASE----------ISSILEKGER-------LPQPPICTIDVYM-IMRKCWMIDADSRPKF 269
Query: 355 KQVSEELDRLRR 366
           +++  E  ++ R
Sbjct: 270 RELIIEFSKMAR 281

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 108/235 (45%), Gaps = 31/235 (13%)
Query: 67  PGLAFLRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDN-----IQVAVKTYRR 121
           P  A LR  I  ++E       F + + L  G F +VYKG+         I VA+K  R 
Sbjct: 4   PNQALLR--ILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE 54
Query: 122 A--DKXXXXXXXXXXXXSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCE--- 176
           A   K            + V++ +V ++LG+CL + V L+  +    G LLD++R     
Sbjct: 55  ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDN 113
Query: 177 -SSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESS 235
             SQ L  W  C++IA      ++YL       ++H D+ + N+L+      K+ DF  +
Sbjct: 114 IGSQYLLNW--CVQIA----KGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLA 164
Query: 236 VLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
            L+ ++ +   +        ++    I     T +SDV+S+GV + EL+T G KP
Sbjct: 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/281 (24%), Positives = 121/281 (43%), Gaps = 43/281 (15%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLET 154
           L  G F  V  G       VAVK  +                 +++H  +VK  G+C   
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC-SK 74
Query: 155 EVPL-LVYEFASNGTLLDHIR-----CESSQVLKTWKTCLRIAAETASALDYLHSLASPP 208
           E P+ +V E+ SNG LL+++R      E SQ+L   + C  +    A        L S  
Sbjct: 75  EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLL---EMCYDVCEGMA-------FLESHQ 124
Query: 209 IIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTS---GYLDPVCINTG 265
            IH D+ + N L++ +   KV+DF  +  +  D   +     +GT     +  P   +  
Sbjct: 125 FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS----VGTKFPVKWSAPEVFHYF 180
Query: 266 KLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHV 324
           K + KSDV++FG+++ E+ + GK P     L +N ++         +K +   ++   H+
Sbjct: 181 KYSSKSDVWAFGILMWEVFSLGKMP---YDLYTNSEV--------VLKVSQGHRLYRPHL 229
Query: 325 ADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLR 365
           A ++       + ++   C      +RPT +Q+   ++ LR
Sbjct: 230 ASDT-------IYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 91/208 (43%), Gaps = 24/208 (11%)
Query: 96  SQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKIL-----GL 150
           ++G F  V+K  L ++  VAVK +   DK              + H+N+++ +     G 
Sbjct: 24  ARGRFGCVWKAQLMNDF-VAVKIFPLQDKQSWQSEREIFSTPGMKHENLLQFIAAEKRGS 82
Query: 151 CLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLAS---- 206
            LE E+  L+  F   G+L D+++      + TW     +A   +  L YLH        
Sbjct: 83  NLEVEL-WLITAFHDKGSLTDYLKGN----IITWNELCHVAETMSRGLSYLHEDVPWCRG 137
Query: 207 ----PPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCI 262
               P I H D KS N+LL  + TA +ADF  +V          +   +GT  Y+ P  +
Sbjct: 138 EGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEVL 197
Query: 263 NTGKLTKKS-----DVYSFGVVLAELLT 285
                 ++      D+Y+ G+VL EL++
Sbjct: 198 EGAINFQRDAFLRIDMYAMGLVLWELVS 225

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 108/235 (45%), Gaps = 31/235 (13%)
Query: 67  PGLAFLRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDN-----IQVAVKTYRR 121
           P  A LR  I  ++E       F + + L  G F +VYKG+         I VA+K  R 
Sbjct: 7   PNQALLR--ILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE 57
Query: 122 A--DKXXXXXXXXXXXXSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCE--- 176
           A   K            + V++ +V ++LG+CL + V L+  +    G LLD++R     
Sbjct: 58  ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDN 116
Query: 177 -SSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESS 235
             SQ L  W  C++IA      ++YL       ++H D+ + N+L+      K+ DF  +
Sbjct: 117 IGSQYLLNW--CVQIA----KGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLA 167
Query: 236 VLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
            L+ ++ +   +        ++    I     T +SDV+S+GV + EL+T G KP
Sbjct: 168 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 222

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/261 (23%), Positives = 111/261 (42%), Gaps = 29/261 (11%)
Query: 112 IQVAVKTYRRA--DKXXXXXXXXXXXXSQVNHKNVVKILGLCLETEVPLLVYEFASNGTL 169
           I VA+KT +    +K             Q +H NV+ + G+  ++   +++ EF  NG+L
Sbjct: 36  IFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL 95
Query: 170 LDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKV 229
              +R    Q      T +++          +  LA    +H  + + NIL+N N   KV
Sbjct: 96  DSFLRQNDGQF-----TVIQLVGMLRGIAAGMKYLADMNYVHRALAARNILVNSNLVCKV 150
Query: 230 ADFESSVLISSDAETAMSTILIGTS---GYLDPVCINTGKLTKKSDVYSFGVVLAELLT- 285
           +DF  S  +  D      T  +G      +  P  I   K T  SDV+S+G+V+ E+++ 
Sbjct: 151 SDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSY 210
Query: 286 GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLR 345
           G++P   MT   N+ +      +N+I+        ++ +     M     + +L   C +
Sbjct: 211 GERPYWDMT---NQDV------INAIEQ-------DYRLP--PPMDCPSALHQLMLDCWQ 252
Query: 346 IRGTERPTMKQVSEELDRLRR 366
                RP   Q+   LD++ R
Sbjct: 253 KDRNHRPKFGQIVNTLDKMIR 273

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 108/235 (45%), Gaps = 31/235 (13%)
Query: 67  PGLAFLRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDN-----IQVAVKTYRR 121
           P  A LR  I  ++E       F + + L  G F +VYKG+         I VA+K  R 
Sbjct: 7   PNQALLR--ILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE 57
Query: 122 A--DKXXXXXXXXXXXXSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCE--- 176
           A   K            + V++ +V ++LG+CL + V L+  +    G LLD++R     
Sbjct: 58  ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDN 116
Query: 177 -SSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESS 235
             SQ L  W  C++IA      ++YL       ++H D+ + N+L+      K+ DF  +
Sbjct: 117 IGSQYLLNW--CVQIA----KGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLA 167
Query: 236 VLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
            L+ ++ +   +        ++    I     T +SDV+S+GV + EL+T G KP
Sbjct: 168 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 222

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 77/312 (24%), Positives = 134/312 (42%), Gaps = 49/312 (15%)
Query: 67  PGLAFLRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDN-----IQVAVKTYRR 121
           P  A LR  I  ++E       F + + L  G F +VYKG+         I VA+K  R 
Sbjct: 4   PNQALLR--ILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE 54
Query: 122 A--DKXXXXXXXXXXXXSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCE--- 176
           A   K            + V++ +V ++LG+CL + V L+  +    G LLD++R     
Sbjct: 55  ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDN 113
Query: 177 -SSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESS 235
             SQ L  W  C++IA      ++YL       ++H D+ + N+L+      K+ DF  +
Sbjct: 114 IGSQYLLNW--CVQIA----KGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLA 164
Query: 236 VLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMT 294
            L+ ++ +   +        ++    I     T +SDV+S+GV + EL+T G KP   + 
Sbjct: 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 224
Query: 295 LASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTM 354
            +           ++SI   G R         +  +  I++   +  KC  I    RP  
Sbjct: 225 ASE----------ISSILEKGER-------LPQPPICTIDVYM-IMRKCWMIDADSRPKF 266
Query: 355 KQVSEELDRLRR 366
           +++  E  ++ R
Sbjct: 267 RELIIEFSKMAR 278

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 108/235 (45%), Gaps = 31/235 (13%)
Query: 67  PGLAFLRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDN-----IQVAVKTYRR 121
           P  A LR  I  ++E       F + + L  G F +VYKG+         I VA+K  R 
Sbjct: 6   PNQALLR--ILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE 56
Query: 122 A--DKXXXXXXXXXXXXSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCE--- 176
           A   K            + V++ +V ++LG+CL + V L+  +    G LLD++R     
Sbjct: 57  ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDN 115
Query: 177 -SSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESS 235
             SQ L  W  C++IA      ++YL       ++H D+ + N+L+      K+ DF  +
Sbjct: 116 IGSQYLLNW--CVQIA----KGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLA 166
Query: 236 VLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
            L+ ++ +   +        ++    I     T +SDV+S+GV + EL+T G KP
Sbjct: 167 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 77/312 (24%), Positives = 134/312 (42%), Gaps = 49/312 (15%)
Query: 67  PGLAFLRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDN-----IQVAVKTYRR 121
           P  A LR  I  ++E       F + + L  G F +VYKG+         I VA+K  R 
Sbjct: 29  PNQALLR--ILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE 79
Query: 122 A--DKXXXXXXXXXXXXSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCE--- 176
           A   K            + V++ +V ++LG+CL + V L+  +    G LLD++R     
Sbjct: 80  ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDN 138
Query: 177 -SSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESS 235
             SQ L  W  C++IA      ++YL       ++H D+ + N+L+      K+ DF  +
Sbjct: 139 IGSQYLLNW--CVQIA----KGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLA 189
Query: 236 VLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMT 294
            L+ ++ +   +        ++    I     T +SDV+S+GV + EL+T G KP   + 
Sbjct: 190 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 249
Query: 295 LASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTM 354
            +           ++SI   G R         +  +  I++   +  KC  I    RP  
Sbjct: 250 ASE----------ISSILEKGER-------LPQPPICTIDVYM-IMVKCWMIDADSRPKF 291
Query: 355 KQVSEELDRLRR 366
           +++  E  ++ R
Sbjct: 292 RELIIEFSKMAR 303

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/235 (28%), Positives = 105/235 (44%), Gaps = 31/235 (13%)
Query: 67  PGLAFLRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDN-----IQVAVKTYRR 121
           P  A LR  I  ++E+ +        + L  G F +VYKG+   +     I VA+K  R 
Sbjct: 6   PNQALLR--ILKETELRKV-------KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRE 56
Query: 122 --ADKXXXXXXXXXXXXSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCE--- 176
             + K            + V    V ++LG+CL + V  LV +    G LLDH+R     
Sbjct: 57  NTSPKANKEILDEAYVMAGVGSPYVSRLLGICLTSTV-QLVTQLMPYGCLLDHVRENRGR 115
Query: 177 -SSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESS 235
             SQ L  W  C++IA      + YL  +    ++H D+ + N+L+      K+ DF  +
Sbjct: 116 LGSQDLLNW--CMQIA----KGMSYLEDVR---LVHRDLAARNVLVKSPNHVKITDFGLA 166
Query: 236 VLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
            L+  D     +        ++    I   + T +SDV+S+GV + EL+T G KP
Sbjct: 167 RLLDIDETEYHADGGKVPIKWMALESILRRRFTHQSDVWSYGVTVWELMTFGAKP 221

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 22/214 (10%)
Query: 88  NFDRSRCLSQGGFVSVYKGVLHDN-----IQVAVKTYRRA--DKXXXXXXXXXXXXSQVN 140
            F + + L  G F +VYKG+         I VA+K  R A   K            + V+
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 141 HKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCE----SSQVLKTWKTCLRIAAETAS 196
           + +V ++LG+CL + V L+  +    G LLD++R       SQ L  W  C++IA     
Sbjct: 83  NPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW--CVQIA----K 135
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            ++YL       ++H D+ + N+L+      K+ DF  + L+ ++ +   +        +
Sbjct: 136 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 192
Query: 257 LDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
           +    I     T +SDV+S+GV + EL+T G KP
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 226

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/244 (24%), Positives = 106/244 (43%), Gaps = 35/244 (14%)
Query: 141 HKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLK-------------TWKTC 187
           HKN++ +LG C +     ++  +AS G L +++R      ++             T+K  
Sbjct: 100 HKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 188 LRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMS 247
           +    + A  ++YL   AS   IH D+ + N+L+ +N   K+ADF  +  I++      +
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 248 TILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPY 306
           T       ++ P  +     T +SDV+SFGV++ E+ T G  P   + +           
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--------- 267
Query: 307 FLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR 366
            L  +   G R     +  +E  M        +   C     ++RPT KQ+ E+LDR+  
Sbjct: 268 -LFKLLKEGHRMDKPANCTNELYM--------MMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 367 LHEN 370
           L  N
Sbjct: 319 LTTN 322

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/291 (24%), Positives = 126/291 (43%), Gaps = 40/291 (13%)
Query: 88  NFDRSRCLSQGGFVSVYKGVLHDN-----IQVAVKTYRRA--DKXXXXXXXXXXXXSQVN 140
            F + + L  G F +VYKG+         I VA+K  R A   K            + V+
Sbjct: 13  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 72
Query: 141 HKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCE----SSQVLKTWKTCLRIAAETAS 196
           + +V ++LG+CL + V L+  +    G LLD++R       SQ L  W  C++IA     
Sbjct: 73  NPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW--CVQIA----E 125
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            ++YL       ++H D+ + N+L+      K+ DF  + L+ ++ +   +        +
Sbjct: 126 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 182
Query: 257 LDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNG 315
           +    I     T +SDV+S+GV + EL+T G KP   +  +           ++SI   G
Sbjct: 183 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----------ISSILEKG 232
Query: 316 LRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR 366
            R         +  +  I++   +  KC  I    RP  +++  E  ++ R
Sbjct: 233 ER-------LPQPPICTIDVYM-IMVKCWMIDADSRPKFRELIIEFSKMAR 275

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 108/235 (45%), Gaps = 31/235 (13%)
Query: 67  PGLAFLRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDN-----IQVAVKTYRR 121
           P  A LR  I  ++E       F + + L  G F +VYKG+         I VA+K  R 
Sbjct: 10  PNQALLR--ILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE 60
Query: 122 A--DKXXXXXXXXXXXXSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCE--- 176
           A   K            + V++ +V ++LG+CL + V L+  +    G LLD++R     
Sbjct: 61  ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDN 119
Query: 177 -SSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESS 235
             SQ L  W  C++IA      ++YL       ++H D+ + N+L+      K+ DF  +
Sbjct: 120 IGSQYLLNW--CVQIA----KGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLA 170
Query: 236 VLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
            L+ ++ +   +        ++    I     T +SDV+S+GV + EL+T G KP
Sbjct: 171 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 225

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/291 (24%), Positives = 126/291 (43%), Gaps = 40/291 (13%)
Query: 88  NFDRSRCLSQGGFVSVYKGVLHDN-----IQVAVKTYRRA--DKXXXXXXXXXXXXSQVN 140
            F + + L  G F +VYKG+         I VA+K  R A   K            + V+
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 141 HKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCE----SSQVLKTWKTCLRIAAETAS 196
           + +V ++LG+CL + V L+  +    G LLD++R       SQ L  W  C++IA     
Sbjct: 70  NPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW--CVQIA----K 122
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            ++YL       ++H D+ + N+L+      K+ DF  + L+ ++ +   +        +
Sbjct: 123 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179
Query: 257 LDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNG 315
           +    I     T +SDV+S+GV + EL+T G KP   +  +           ++SI   G
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----------ISSILEKG 229
Query: 316 LRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR 366
            R         +  +  I++   +  KC  I    RP  +++  E  ++ R
Sbjct: 230 ER-------LPQPPICTIDVYM-IMVKCWMIDADSRPKFRELIIEFSKMAR 272

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/277 (25%), Positives = 118/277 (42%), Gaps = 40/277 (14%)
Query: 89  FDRSRCLSQGGFVSVYKGVLHDN-----IQVAVKTYRRADKXXXXXXXXXXXXSQVNHKN 143
           F +   + +G F  V+KG+  DN     + + +     A+             SQ +   
Sbjct: 24  FTKLEKIGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 81
Query: 144 VVKILGLCLETEVPLLVYEFASNGTLLDHIR---CESSQVLKTWKTCLRIAAETASALDY 200
           V K  G  L+     ++ E+   G+ LD +     + +Q+     T LR   E    LDY
Sbjct: 82  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQI----ATILR---EILKGLDY 134
Query: 201 LHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV 260
           LHS      IH D+K+AN+LL+++   K+ADF  +  + +D +   +   +GT  ++ P 
Sbjct: 135 LHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQL-TDTQIKRNX-FVGTPFWMAPE 189
Query: 261 CINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQIL 320
            I       K+D++S G+   EL  G+ P S   L   K + ++P      KNN      
Sbjct: 190 VIKQSAYDSKADIWSLGITAIELARGEPPHS--ELHPMKVLFLIP------KNNPPTLEG 241
Query: 321 NFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQV 357
           N+           + + E    CL    + RPT K++
Sbjct: 242 NYS----------KPLKEFVEACLNKEPSFRPTAKEL 268

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 20/226 (8%)
Query: 76  IFSKSEMIRATKNFDRSRCLSQGGFVSVY----KGVLHDN--IQVAVKTYRRAD--KXXX 127
           ++   E   A +    SR L QG F  VY    KGV+ D    +VA+KT   A   +   
Sbjct: 4   VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 63
Query: 128 XXXXXXXXXSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRC-----ESSQVL- 181
                     + N  +VV++LG+  + +  L++ E  + G L  ++R       ++ VL 
Sbjct: 64  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 123
Query: 182 -KTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSV-LIS 239
             +    +++A E A  + YL++      +H D+ + N ++ +++T K+ DF  +  +  
Sbjct: 124 PPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 180
Query: 240 SDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT 285
           +D        L+    ++ P  +  G  T  SDV+SFGVVL E+ T
Sbjct: 181 TDYYRKGGKGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 114/254 (44%), Gaps = 34/254 (13%)
Query: 137 SQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRC------ESSQVLKTWKTCLRI 190
           SQ +H N+V      +  +   LV +  S G++LD I+         S VL    T   I
Sbjct: 68  SQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDE-STIATI 126
Query: 191 AAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTI- 249
             E    L+YLH       IH DVK+ NILL ++ + ++ADF  S  +++  +   + + 
Sbjct: 127 LREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVR 183
Query: 250 --LIGTSGYLDPVCINTGK-LTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPY 306
              +GT  ++ P  +   +    K+D++SFG+   EL TG  P          K   +  
Sbjct: 184 KTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP--------YHKYPPMKV 235
Query: 307 FLNSIKNNGLRQILNFHVADESEMKEI-EIVAELASKCLRIRGTERPTMKQVSEELDRLR 365
            + +++N+     L   V D+  +K+  +   ++ S CL+    +RPT  ++        
Sbjct: 236 LMLTLQNDPPS--LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAEL-------- 285
Query: 366 RLHENFWAQKKNKE 379
            L   F+ + KNKE
Sbjct: 286 -LRHKFFQKAKNKE 298

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/277 (25%), Positives = 118/277 (42%), Gaps = 40/277 (14%)
Query: 89  FDRSRCLSQGGFVSVYKGVLHDN-----IQVAVKTYRRADKXXXXXXXXXXXXSQVNHKN 143
           F +   + +G F  V+KG+  DN     + + +     A+             SQ +   
Sbjct: 9   FTKLEKIGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 66
Query: 144 VVKILGLCLETEVPLLVYEFASNGTLLDHIR---CESSQVLKTWKTCLRIAAETASALDY 200
           V K  G  L+     ++ E+   G+ LD +     + +Q+     T LR   E    LDY
Sbjct: 67  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQI----ATILR---EILKGLDY 119
Query: 201 LHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV 260
           LHS      IH D+K+AN+LL+++   K+ADF  +  + +D +   +   +GT  ++ P 
Sbjct: 120 LHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQL-TDTQIKRNX-FVGTPFWMAPE 174
Query: 261 CINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQIL 320
            I       K+D++S G+   EL  G+ P S   L   K + ++P      KNN      
Sbjct: 175 VIKQSAYDSKADIWSLGITAIELARGEPPHS--ELHPMKVLFLIP------KNNPPTLEG 226
Query: 321 NFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQV 357
           N+           + + E    CL    + RPT K++
Sbjct: 227 NYS----------KPLKEFVEACLNKEPSFRPTAKEL 253

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/289 (24%), Positives = 125/289 (43%), Gaps = 37/289 (12%)
Query: 92  SRCLSQGGFVSVYKGVLHD----NIQVAVKTYR---RADKXXXXXXXXXXXXSQVNHKNV 144
            + L +G F SV +G L      +++VAVKT +    + +               +H NV
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 145 VKILGLCLETEV-----PLLVYEFASNG---TLLDHIRCESSQVLKTWKTCLRIAAETAS 196
           +++LG+C+E        P+++  F   G   T L + R E+       +T L+   + A 
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            ++YL   ++   +H D+ + N +L D+ T  VADF  S  I S        I      +
Sbjct: 159 GMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 215
Query: 257 LDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGL 316
           +    +     T KSDV++FGV + E+ T                 M PY    ++N+ +
Sbjct: 216 IAIESLADRVYTSKSDVWAFGVTMWEIATR---------------GMTPY--PGVQNHEM 258
Query: 317 RQ-ILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL 364
              +L+ H   + E   ++ + E+   C R    +RPT   +  +L++L
Sbjct: 259 YDYLLHGHRLKQPE-DCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/256 (24%), Positives = 105/256 (41%), Gaps = 20/256 (7%)
Query: 88  NFDRSRCLSQGGFVSVYKGVLHDN-----IQVAVKTYRRADKXXXXXXXXXXXXSQVNHK 142
           +FD  R L +G F +VY      N     ++V  K+    +             S + H 
Sbjct: 16  DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHP 75
Query: 143 NVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLH 202
           N++++     + +   L+ EFA  G L   ++       +   T +    E A AL Y H
Sbjct: 76  NILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFM---EELADALHYCH 132
Query: 203 SLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCI 262
                 +IH D+K  N+L+      K+ADF  SV     A +     + GT  YL P  I
Sbjct: 133 ERK---VIHRDIKPENLLMGYKGELKIADFGWSV----HAPSLRRRXMCGTLDYLPPEMI 185
Query: 263 NTGKLTKKSDVYSFGVVLAELLTGKKP-GSCMTLASNKKISMV----PYFLNSIKNNGLR 317
                 +K D++  GV+  E L G  P  S     ++++I  V    P FL+    + + 
Sbjct: 186 EGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLIS 245
Query: 318 QILNFHVADESEMKEI 333
           ++L +H      +K +
Sbjct: 246 KLLRYHPPQRLPLKGV 261

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 96/203 (47%), Gaps = 15/203 (7%)
Query: 95  LSQGGFVSVYKGVLH---DNIQVAVKTYRRADKXX--XXXXXXXXXXSQVNHKNVVKILG 149
           L  G F SV +GV       I VA+K  ++  +               Q+++  +V+++G
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 150 LCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPI 209
           +C + E  +LV E A  G L   +  +  ++  +      +  + +  + YL        
Sbjct: 78  VC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVS--NVAELLHQVSMGMKYLEEKN---F 131
Query: 210 IHGDVKSANILLNDNYTAKVADFESSVLISSDAE--TAMSTILIGTSGYLDPVCINTGKL 267
           +H D+ + N+LL + + AK++DF  S  + +D    TA S        Y  P CIN  K 
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA-PECINFRKF 190
Query: 268 TKKSDVYSFGVVLAELLT-GKKP 289
           + +SDV+S+GV + E L+ G+KP
Sbjct: 191 SSRSDVWSYGVTMWEALSYGQKP 213

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 97/232 (41%), Gaps = 17/232 (7%)
Query: 86  TKNFDRSRCLSQGGFVSVYKGV---LHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHK 142
            +++D  + L +G +  V   V     + + V +   +RA                +NH+
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 65
Query: 143 NVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLH 202
           NVVK  G   E  +  L  E+ S G L D I      +        R   +  + + YLH
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 203 SLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCI 262
            +    I H D+K  N+LL++    K++DF  + +   +    +   + GT  Y+ P  +
Sbjct: 123 GIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 179
Query: 263 NTGKL-TKKSDVYSFGVVLAELLTGKKPG-----SCMTLAS--NKKISMVPY 306
              +   +  DV+S G+VL  +L G+ P      SC   +    KK  + P+
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 231

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 97/232 (41%), Gaps = 17/232 (7%)
Query: 86  TKNFDRSRCLSQGGFVSVYKGV---LHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHK 142
            +++D  + L +G +  V   V     + + V +   +RA                +NH+
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 143 NVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLH 202
           NVVK  G   E  +  L  E+ S G L D I      +        R   +  + + YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 203 SLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCI 262
            +    I H D+K  N+LL++    K++DF  + +   +    +   + GT  Y+ P  +
Sbjct: 122 GIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 263 NTGKL-TKKSDVYSFGVVLAELLTGKKPG-----SCMTLAS--NKKISMVPY 306
              +   +  DV+S G+VL  +L G+ P      SC   +    KK  + P+
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 230

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 10/208 (4%)
Query: 86  TKNFDRSRCLSQGGFVSVYKGV---LHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHK 142
            +++D  + L +G +  V   V     + + V +   +RA              + +NH+
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHE 65
Query: 143 NVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLH 202
           NVVK  G   E  +  L  E+ S G L D I      +        R   +  + + YLH
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 203 SLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCI 262
            +    I H D+K  N+LL++    K++DF  + +   +    +   + GT  Y+ P  +
Sbjct: 123 GIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 263 NTGKL-TKKSDVYSFGVVLAELLTGKKP 289
              +   +  DV+S G+VL  +L G+ P
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 97/232 (41%), Gaps = 17/232 (7%)
Query: 86  TKNFDRSRCLSQGGFVSVYKGV---LHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHK 142
            +++D  + L +G +  V   V     + + V +   +RA                +NH+
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 143 NVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLH 202
           NVVK  G   E  +  L  E+ S G L D I      +        R   +  + + YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 203 SLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCI 262
            +    I H D+K  N+LL++    K++DF  + +   +    +   + GT  Y+ P  +
Sbjct: 122 GIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 263 NTGKL-TKKSDVYSFGVVLAELLTGKKPG-----SCMTLAS--NKKISMVPY 306
              +   +  DV+S G+VL  +L G+ P      SC   +    KK  + P+
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 230

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 10/208 (4%)
Query: 86  TKNFDRSRCLSQGGFVSVYKGV---LHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHK 142
            +++D  + L +G +  V   V     + + V +   +RA                +NH+
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 143 NVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLH 202
           NVVK  G   E  +  L  E+ S G L D I      +        R   +  + + YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 203 SLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCI 262
            +    I H D+K  N+LL++    K++DF  + +   +    +   + GT  Y+ P  +
Sbjct: 122 GIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 263 NTGKL-TKKSDVYSFGVVLAELLTGKKP 289
              +   +  DV+S G+VL  +L G+ P
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 96/232 (41%), Gaps = 17/232 (7%)
Query: 86  TKNFDRSRCLSQGGFVSVYKGV---LHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHK 142
            +++D  + L +G +  V   V     + + V +   +RA                +NH+
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 143 NVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLH 202
           NVVK  G   E  +  L  E+ S G L D I      +        R   +  + + YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 203 SLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCI 262
            +    I H D+K  N+LL++    K++DF  + +   +    +   + GT  Y+ P  +
Sbjct: 122 GIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 263 NTGKL-TKKSDVYSFGVVLAELLTGKKPG-----SCMTLAS--NKKISMVPY 306
              +   +  DV+S G+VL  +L G+ P      SC   +    KK  + P+
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 230

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 10/208 (4%)
Query: 86  TKNFDRSRCLSQGGFVSVYKGV---LHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHK 142
            +++D  + L +G +  V   V     + + V +   +RA                +NH+
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 63
Query: 143 NVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLH 202
           NVVK  G   E  +  L  E+ S G L D I      +        R   +  + + YLH
Sbjct: 64  NVVKFYGHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLH 120
Query: 203 SLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCI 262
            +    I H D+K  N+LL++    K++DF  + +   +    +   + GT  Y+ P  +
Sbjct: 121 GIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 263 NTGKL-TKKSDVYSFGVVLAELLTGKKP 289
              +   +  DV+S G+VL  +L G+ P
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELP 205

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 105/244 (43%), Gaps = 35/244 (14%)
Query: 141 HKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLK-------------TWKTC 187
           HKN++ +LG C +     ++ E+AS G L ++++      L+             + K  
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDL 152
Query: 188 LRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMS 247
           +  A + A  ++YL   AS   IH D+ + N+L+ ++   K+ADF  +  I        +
Sbjct: 153 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKT 209
Query: 248 TILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPY 306
           T       ++ P  +     T +SDV+SFGV+L E+ T G  P   + +           
Sbjct: 210 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--------- 260
Query: 307 FLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR 366
            L  +   G R     +  +E  M        +   C     ++RPT KQ+ E+LDR+  
Sbjct: 261 -LFKLLKEGHRMDKPSNCTNELYM--------MMRDCWHAVPSQRPTFKQLVEDLDRIVA 311
Query: 367 LHEN 370
           L  N
Sbjct: 312 LTSN 315

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 10/208 (4%)
Query: 86  TKNFDRSRCLSQGGFVSVYKGV---LHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHK 142
            +++D  + L +G +  V   V     + + V +   +RA                +NH+
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 143 NVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLH 202
           NVVK  G   E  +  L  E+ S G L D I      +        R   +  + + YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 203 SLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCI 262
            +    I H D+K  N+LL++    K++DF  + +   +    +   + GT  Y+ P  +
Sbjct: 122 GIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 263 NTGKL-TKKSDVYSFGVVLAELLTGKKP 289
              +   +  DV+S G+VL  +L G+ P
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 10/208 (4%)
Query: 86  TKNFDRSRCLSQGGFVSVYKGV---LHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHK 142
            +++D  + L +G +  V   V     + + V +   +RA                +NH+
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 143 NVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLH 202
           NVVK  G   E  +  L  E+ S G L D I      +        R   +  + + YLH
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 203 SLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCI 262
            +    I H D+K  N+LL++    K++DF  + +   +    +   + GT  Y+ P  +
Sbjct: 123 GIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 263 NTGKL-TKKSDVYSFGVVLAELLTGKKP 289
              +   +  DV+S G+VL  +L G+ P
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 10/208 (4%)
Query: 86  TKNFDRSRCLSQGGFVSVYKGV---LHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHK 142
            +++D  + L +G +  V   V     + + V +   +RA                +NH+
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 143 NVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLH 202
           NVVK  G   E  +  L  E+ S G L D I      +        R   +  + + YLH
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 203 SLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCI 262
            +    I H D+K  N+LL++    K++DF  + +   +    +   + GT  Y+ P  +
Sbjct: 123 GIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 263 NTGKL-TKKSDVYSFGVVLAELLTGKKP 289
              +   +  DV+S G+VL  +L G+ P
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 10/208 (4%)
Query: 86  TKNFDRSRCLSQGGFVSVYKGV---LHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHK 142
            +++D  + L +G +  V   V     + + V +   +RA                +NH+
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 143 NVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLH 202
           NVVK  G   E  +  L  E+ S G L D I      +        R   +  + + YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 203 SLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCI 262
            +    I H D+K  N+LL++    K++DF  + +   +    +   + GT  Y+ P  +
Sbjct: 122 GIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 263 NTGKL-TKKSDVYSFGVVLAELLTGKKP 289
              +   +  DV+S G+VL  +L G+ P
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 10/208 (4%)
Query: 86  TKNFDRSRCLSQGGFVSVYKGV---LHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHK 142
            +++D  + L +G +  V   V     + + V +   +RA                +NH+
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 143 NVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLH 202
           NVVK  G   E  +  L  E+ S G L D I      +        R   +  + + YLH
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 203 SLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCI 262
            +    I H D+K  N+LL++    K++DF  + +   +    +   + GT  Y+ P  +
Sbjct: 123 GIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 263 NTGKL-TKKSDVYSFGVVLAELLTGKKP 289
              +   +  DV+S G+VL  +L G+ P
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 10/208 (4%)
Query: 86  TKNFDRSRCLSQGGFVSVYKGV---LHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHK 142
            +++D  + L +G +  V   V     + + V +   +RA                +NH+
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 143 NVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLH 202
           NVVK  G   E  +  L  E+ S G L D I      +        R   +  + + YLH
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 203 SLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCI 262
            +    I H D+K  N+LL++    K++DF  + +   +    +   + GT  Y+ P  +
Sbjct: 123 GIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 263 NTGKL-TKKSDVYSFGVVLAELLTGKKP 289
              +   +  DV+S G+VL  +L G+ P
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 10/208 (4%)
Query: 86  TKNFDRSRCLSQGGFVSVYKGV---LHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHK 142
            +++D  + L +G +  V   V     + + V +   +RA                +NH+
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 143 NVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLH 202
           NVVK  G   E  +  L  E+ S G L D I      +        R   +  + + YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 203 SLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCI 262
            +    I H D+K  N+LL++    K++DF  + +   +    +   + GT  Y+ P  +
Sbjct: 122 GIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 263 NTGKL-TKKSDVYSFGVVLAELLTGKKP 289
              +   +  DV+S G+VL  +L G+ P
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 105/244 (43%), Gaps = 35/244 (14%)
Query: 141 HKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLK-------------TWKTC 187
           HKN++ +LG C +     ++ E+AS G L ++++      L+             + K  
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDL 152
Query: 188 LRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMS 247
           +  A + A  ++YL   AS   IH D+ + N+L+ ++   K+ADF  +  I        +
Sbjct: 153 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 209
Query: 248 TILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPY 306
           T       ++ P  +     T +SDV+SFGV+L E+ T G  P   + +           
Sbjct: 210 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--------- 260
Query: 307 FLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR 366
            L  +   G R     +  +E  M        +   C     ++RPT KQ+ E+LDR+  
Sbjct: 261 -LFKLLKEGHRMDKPSNCTNELYM--------MMRDCWHAVPSQRPTFKQLVEDLDRIVA 311
Query: 367 LHEN 370
           L  N
Sbjct: 312 LTSN 315

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 107/235 (45%), Gaps = 31/235 (13%)
Query: 67  PGLAFLRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDN-----IQVAVKTYRR 121
           P  A LR  I  ++E       F + + L  G F +VYKG+         I VA+   R 
Sbjct: 38  PNQALLR--ILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELRE 88
Query: 122 A--DKXXXXXXXXXXXXSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCE--- 176
           A   K            + V++ +V ++LG+CL + V L+  +    G LLD++R     
Sbjct: 89  ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDN 147
Query: 177 -SSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESS 235
             SQ L  W  C++IA      ++YL       ++H D+ + N+L+      K+ DF  +
Sbjct: 148 IGSQYLLNW--CVQIA----KGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLA 198
Query: 236 VLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
            L+ ++ +   +        ++    I     T +SDV+S+GV + EL+T G KP
Sbjct: 199 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 253

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/256 (24%), Positives = 105/256 (41%), Gaps = 20/256 (7%)
Query: 88  NFDRSRCLSQGGFVSVYKGVLHDN-----IQVAVKTYRRADKXXXXXXXXXXXXSQVNHK 142
           +FD  R L +G F +VY      N     ++V  K+    +             S + H 
Sbjct: 15  DFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHP 74
Query: 143 NVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLH 202
           N++++     + +   L+ EFA  G L   ++       +   T +    E A AL Y H
Sbjct: 75  NILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFM---EELADALHYCH 131
Query: 203 SLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCI 262
                 +IH D+K  N+L+      K+ADF  SV     A +     + GT  YL P  I
Sbjct: 132 ERK---VIHRDIKPENLLMGYKGELKIADFGWSV----HAPSLRRRXMCGTLDYLPPEMI 184
Query: 263 NTGKLTKKSDVYSFGVVLAELLTGKKP-GSCMTLASNKKISMV----PYFLNSIKNNGLR 317
                 +K D++  GV+  E L G  P  S     ++++I  V    P FL+    + + 
Sbjct: 185 EGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLIS 244
Query: 318 QILNFHVADESEMKEI 333
           ++L +H      +K +
Sbjct: 245 KLLRYHPPQRLPLKGV 260

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 10/208 (4%)
Query: 86  TKNFDRSRCLSQGGFVSVYKGV---LHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHK 142
            +++D  + L +G +  V   V     + + V +   +RA                +NH+
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 143 NVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLH 202
           NVVK  G   E  +  L  E+ S G L D I      +        R   +  + + YLH
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 203 SLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCI 262
            +    I H D+K  N+LL++    K++DF  + +   +    +   + GT  Y+ P  +
Sbjct: 123 GIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 263 NTGKL-TKKSDVYSFGVVLAELLTGKKP 289
              +   +  DV+S G+VL  +L G+ P
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/232 (23%), Positives = 96/232 (41%), Gaps = 17/232 (7%)
Query: 86  TKNFDRSRCLSQGGFVSVYKGV---LHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHK 142
            +++D  + L +G +  V   V     + + V +   +RA                +NH+
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 143 NVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLH 202
           NVVK  G   E  +  L  E+ S G L D I      +        R   +  + + YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 203 SLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCI 262
            +    I H D+K  N+LL++    K++DF  + +   +    +   + GT  Y+ P  +
Sbjct: 122 GIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 263 NTGKL-TKKSDVYSFGVVLAELLTGKKPG-----SCMTLAS--NKKISMVPY 306
              +   +  DV+S G+VL  +L G+ P      SC   +    KK  + P+
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 230

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 10/208 (4%)
Query: 86  TKNFDRSRCLSQGGFVSVYKGV---LHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHK 142
            +++D  + L +G +  V   V     + + V +   +RA                +NH+
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 143 NVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLH 202
           NVVK  G   E  +  L  E+ S G L D I      +        R   +  + + YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 203 SLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCI 262
            +    I H D+K  N+LL++    K++DF  + +   +    +   + GT  Y+ P  +
Sbjct: 122 GIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 263 NTGKL-TKKSDVYSFGVVLAELLTGKKP 289
              +   +  DV+S G+VL  +L G+ P
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 105/244 (43%), Gaps = 35/244 (14%)
Query: 141 HKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLK-------------TWKTC 187
           HKN++ +LG C +     ++ E+AS G L ++++      L+             + K  
Sbjct: 85  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 144
Query: 188 LRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMS 247
           +  A + A  ++YL   AS   IH D+ + N+L+ ++   K+ADF  +  I        +
Sbjct: 145 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 201
Query: 248 TILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPY 306
           T       ++ P  +     T +SDV+SFGV+L E+ T G  P   + +           
Sbjct: 202 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--------- 252
Query: 307 FLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR 366
            L  +   G R     +  +E  M        +   C     ++RPT KQ+ E+LDR+  
Sbjct: 253 -LFKLLKEGHRMDKPSNCTNELYM--------MMRDCWHAVPSQRPTFKQLVEDLDRIVA 303
Query: 367 LHEN 370
           L  N
Sbjct: 304 LTSN 307

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 105/244 (43%), Gaps = 35/244 (14%)
Query: 141 HKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLK-------------TWKTC 187
           HKN++ +LG C +     ++ E+AS G L ++++      L+             + K  
Sbjct: 82  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 141
Query: 188 LRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMS 247
           +  A + A  ++YL   AS   IH D+ + N+L+ ++   K+ADF  +  I        +
Sbjct: 142 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 198
Query: 248 TILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPY 306
           T       ++ P  +     T +SDV+SFGV+L E+ T G  P   + +           
Sbjct: 199 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--------- 249
Query: 307 FLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR 366
            L  +   G R     +  +E  M        +   C     ++RPT KQ+ E+LDR+  
Sbjct: 250 -LFKLLKEGHRMDKPSNCTNELYM--------MMRDCWHAVPSQRPTFKQLVEDLDRIVA 300
Query: 367 LHEN 370
           L  N
Sbjct: 301 LTSN 304

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/226 (23%), Positives = 93/226 (41%), Gaps = 28/226 (12%)
Query: 84  RATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK--XXXXXXXXXXXXSQVN 140
           R   +F+  +CL +GGF  V++     D+   A+K  R  ++              +++ 
Sbjct: 2   RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61
Query: 141 HKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTW------------KTCL 188
           H  +V+     LE      +   +    L   ++    + LK W              CL
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 189 RIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADF----------ESSVLI 238
            I  + A A+++LHS     ++H D+K +NI    +   KV DF          E   ++
Sbjct: 122 HIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 239 SSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELL 284
           +     A  T  +GT  Y+ P  I+    + K D++S G++L ELL
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 105/244 (43%), Gaps = 35/244 (14%)
Query: 141 HKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLK-------------TWKTC 187
           HKN++ +LG C +     ++ E+AS G L ++++      L+             + K  
Sbjct: 86  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 145
Query: 188 LRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMS 247
           +  A + A  ++YL   AS   IH D+ + N+L+ ++   K+ADF  +  I        +
Sbjct: 146 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 202
Query: 248 TILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPY 306
           T       ++ P  +     T +SDV+SFGV+L E+ T G  P   + +           
Sbjct: 203 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--------- 253
Query: 307 FLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR 366
            L  +   G R     +  +E  M        +   C     ++RPT KQ+ E+LDR+  
Sbjct: 254 -LFKLLKEGHRMDKPSNCTNELYM--------MMRDCWHAVPSQRPTFKQLVEDLDRIVA 304
Query: 367 LHEN 370
           L  N
Sbjct: 305 LTSN 308

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 10/208 (4%)
Query: 86  TKNFDRSRCLSQGGFVSVYKGV---LHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHK 142
            +++D  + L +G +  V   V     + + V +   +RA                +NH+
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 143 NVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLH 202
           NVVK  G   E  +  L  E+ S G L D I      +        R   +  + + YLH
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 203 SLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCI 262
            +    I H D+K  N+LL++    K++DF  + +   +    +   + GT  Y+ P  +
Sbjct: 122 GIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 263 NTGKL-TKKSDVYSFGVVLAELLTGKKP 289
              +   +  DV+S G+VL  +L G+ P
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 105/244 (43%), Gaps = 35/244 (14%)
Query: 141 HKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLK-------------TWKTC 187
           HKN++ +LG C +     ++ E+AS G L ++++      L+             + K  
Sbjct: 78  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDL 137
Query: 188 LRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMS 247
           +  A + A  ++YL   AS   IH D+ + N+L+ ++   K+ADF  +  I        +
Sbjct: 138 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 194
Query: 248 TILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPY 306
           T       ++ P  +     T +SDV+SFGV+L E+ T G  P   + +           
Sbjct: 195 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--------- 245
Query: 307 FLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR 366
            L  +   G R     +  +E  M        +   C     ++RPT KQ+ E+LDR+  
Sbjct: 246 -LFKLLKEGHRMDKPSNCTNELYM--------MMRDCWHAVPSQRPTFKQLVEDLDRIVA 296
Query: 367 LHEN 370
           L  N
Sbjct: 297 LTSN 300

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 105/244 (43%), Gaps = 35/244 (14%)
Query: 141 HKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLK-------------TWKTC 187
           HKN++ +LG C +     ++ E+AS G L ++++      L+             + K  
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 152
Query: 188 LRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMS 247
           +  A + A  ++YL   AS   IH D+ + N+L+ ++   K+ADF  +  I        +
Sbjct: 153 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 209
Query: 248 TILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPY 306
           T       ++ P  +     T +SDV+SFGV+L E+ T G  P   + +           
Sbjct: 210 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--------- 260
Query: 307 FLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR 366
            L  +   G R     +  +E  M        +   C     ++RPT KQ+ E+LDR+  
Sbjct: 261 -LFKLLKEGHRMDKPSNCTNELYM--------MMRDCWHAVPSQRPTFKQLVEDLDRIVA 311
Query: 367 LHEN 370
           L  N
Sbjct: 312 LTSN 315

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/248 (24%), Positives = 104/248 (41%), Gaps = 18/248 (7%)
Query: 84  RATKNFDRSRCLSQGGFVSVYKGVLHDNIQV-----AVKTYRRADKXXXXXXXXXXXXSQ 138
           R  K + R R L +GGF   Y+    D  +V       K+                    
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 139 VNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASAL 198
           +++ +VV   G   + +   +V E     +LL+  +   +      +  +R   +T   +
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMR---QTIQGV 155
Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLD 258
            YLH+     +IH D+K  N+ LND+   K+ DF  +  I  D E   +  L GT  Y+ 
Sbjct: 156 QYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT--LCGTPNYIA 210
Query: 259 PVCINTGKLTKKSDVYSFGVVLAELLTGKKP--GSCMT---LASNKKISMVPYFLNSIKN 313
           P  +     + + D++S G +L  LL GK P   SC+    +   K    VP  +N + +
Sbjct: 211 PEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVAS 270
Query: 314 NGLRQILN 321
             +R++L+
Sbjct: 271 ALIRRMLH 278

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 88/207 (42%), Gaps = 10/207 (4%)
Query: 87  KNFDRSRCLSQGGFVSVYKGV---LHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKN 143
           +++D  + L +G +  V   V     + + V +   +RA                +NH+N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 144 VVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHS 203
           VVK  G   E  +  L  E+ S G L D I      +        R   +  + + YLH 
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 204 LASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCIN 263
           +    I H D+K  N+LL++    K++DF  + +   +    +   + GT  Y+ P  + 
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 264 TGKL-TKKSDVYSFGVVLAELLTGKKP 289
             +   +  DV+S G+VL  +L G+ P
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 88/207 (42%), Gaps = 10/207 (4%)
Query: 87  KNFDRSRCLSQGGFVSVYKGV---LHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKN 143
           +++D  + L +G +  V   V     + + V +   +RA                +NH+N
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 144 VVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHS 203
           VVK  G   E  +  L  E+ S G L D I      +        R   +  + + YLH 
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 204 LASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCIN 263
           +    I H D+K  N+LL++    K++DF  + +   +    +   + GT  Y+ P  + 
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 264 TGKL-TKKSDVYSFGVVLAELLTGKKP 289
             +   +  DV+S G+VL  +L G+ P
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 105/244 (43%), Gaps = 35/244 (14%)
Query: 141 HKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLK-------------TWKTC 187
           HKN++ +LG C +     ++ E+AS G L ++++      L+             + K  
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDL 152
Query: 188 LRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMS 247
           +  A + A  ++YL   AS   IH D+ + N+L+ ++   K+ADF  +  I        +
Sbjct: 153 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 209
Query: 248 TILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPY 306
           T       ++ P  +     T +SDV+SFGV+L E+ T G  P   + +           
Sbjct: 210 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--------- 260
Query: 307 FLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR 366
            L  +   G R     +  +E  M        +   C     ++RPT KQ+ E+LDR+  
Sbjct: 261 -LFKLLKEGHRMDKPSNCTNELYM--------MMRDCWHAVPSQRPTFKQLVEDLDRIVA 311
Query: 367 LHEN 370
           L  N
Sbjct: 312 LTSN 315

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/248 (24%), Positives = 103/248 (41%), Gaps = 18/248 (7%)
Query: 84  RATKNFDRSRCLSQGGFVSVYKGVLHDNIQV-----AVKTYRRADKXXXXXXXXXXXXSQ 138
           R  K + R R L +GGF   Y+    D  +V       K+                    
Sbjct: 23  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 82
Query: 139 VNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASAL 198
           +++ +VV   G   + +   +V E     +LL+  +   +      +  +R   +T   +
Sbjct: 83  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMR---QTIQGV 139
Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLD 258
            YLH+     +IH D+K  N+ LND+   K+ DF  +  I  D E      L GT  Y+ 
Sbjct: 140 QYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKD--LCGTPNYIA 194
Query: 259 PVCINTGKLTKKSDVYSFGVVLAELLTGKKP--GSCMT---LASNKKISMVPYFLNSIKN 313
           P  +     + + D++S G +L  LL GK P   SC+    +   K    VP  +N + +
Sbjct: 195 PEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVAS 254
Query: 314 NGLRQILN 321
             +R++L+
Sbjct: 255 ALIRRMLH 262

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 105/244 (43%), Gaps = 35/244 (14%)
Query: 141 HKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLK-------------TWKTC 187
           HKN++ +LG C +     ++ E+AS G L ++++      L+             + K  
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 188 LRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMS 247
           +  A + A  ++YL   AS   IH D+ + N+L+ ++   K+ADF  +  I        +
Sbjct: 194 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250
Query: 248 TILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPY 306
           T       ++ P  +     T +SDV+SFGV+L E+ T G  P   + +           
Sbjct: 251 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--------- 301
Query: 307 FLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR 366
            L  +   G R     +  +E  M        +   C     ++RPT KQ+ E+LDR+  
Sbjct: 302 -LFKLLKEGHRMDKPSNCTNELYM--------MMRDCWHAVPSQRPTFKQLVEDLDRIVA 352
Query: 367 LHEN 370
           L  N
Sbjct: 353 LTSN 356

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 76/157 (48%), Gaps = 9/157 (5%)
Query: 137 SQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETAS 196
            Q  H N++++ G+   +   +++ EF  NG L   +R    Q   T    + +    AS
Sbjct: 72  GQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQF--TVIQLVGMLRGIAS 129
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTS-- 254
            + YL  ++    +H D+ + NIL+N N   KV+DF  S  +  ++     T  +G    
Sbjct: 130 GMRYLAEMS---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIP 186
Query: 255 -GYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
             +  P  I   K T  SD +S+G+V+ E+++ G++P
Sbjct: 187 IRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERP 223

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/248 (24%), Positives = 103/248 (41%), Gaps = 18/248 (7%)
Query: 84  RATKNFDRSRCLSQGGFVSVYKGVLHDNIQV-----AVKTYRRADKXXXXXXXXXXXXSQ 138
           R  K + R R L +GGF   Y+    D  +V       K+                    
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 139 VNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASAL 198
           +++ +VV   G   + +   +V E     +LL+  +   +      +  +R   +T   +
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMR---QTIQGV 155
Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLD 258
            YLH+     +IH D+K  N+ LND+   K+ DF  +  I  D E      L GT  Y+ 
Sbjct: 156 QYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKD--LCGTPNYIA 210
Query: 259 PVCINTGKLTKKSDVYSFGVVLAELLTGKKP--GSCMT---LASNKKISMVPYFLNSIKN 313
           P  +     + + D++S G +L  LL GK P   SC+    +   K    VP  +N + +
Sbjct: 211 PEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVAS 270
Query: 314 NGLRQILN 321
             +R++L+
Sbjct: 271 ALIRRMLH 278

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 89/204 (43%), Gaps = 21/204 (10%)
Query: 96  SQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGL---CL 152
           ++G F  V+K  L  N  VAVK +   DK              + H+N+++ +G      
Sbjct: 33  ARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGT 91
Query: 153 ETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHS-------L 204
             +V L L+  F   G+L D ++      + +W     IA   A  L YLH         
Sbjct: 92  SVDVDLWLITAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDG 147
Query: 205 ASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINT 264
             P I H D+KS N+LL +N TA +ADF  ++   +      +   +GT  Y+ P  +  
Sbjct: 148 HKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEG 207
Query: 265 GKLTKKS-----DVYSFGVVLAEL 283
               ++      D+Y+ G+VL EL
Sbjct: 208 AINFQRDAFLRIDMYAMGLVLWEL 231

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 105/242 (43%), Gaps = 34/242 (14%)
Query: 139 VNHKNVVKILGLCLET--EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETAS 196
           + H N+VK  G+C         L+ E+   G+L D+++  + ++       L+  ++   
Sbjct: 71  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHI--KLLQYTSQICK 128
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE------TAMSTIL 250
            ++YL    +   IH D+ + NIL+ +    K+ DF  + ++  D E         S I 
Sbjct: 129 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 185
Query: 251 IGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-----GKKPGSCMTLASNKKIS--M 303
                +  P  +   K +  SDV+SFGVVL EL T        P   M +  N K    +
Sbjct: 186 -----WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 240
Query: 304 VPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDR 363
           V + +  +KNNG R        DE  M        + ++C      +RP+ + ++  +D+
Sbjct: 241 VFHLIELLKNNG-RLPRPDGCPDEIYM--------IMTECWNNNVNQRPSFRDLALRVDQ 291
Query: 364 LR 365
           +R
Sbjct: 292 IR 293

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/248 (24%), Positives = 103/248 (41%), Gaps = 18/248 (7%)
Query: 84  RATKNFDRSRCLSQGGFVSVYKGVLHDNIQV-----AVKTYRRADKXXXXXXXXXXXXSQ 138
           R  K + R R L +GGF   Y+    D  +V       K+                    
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 139 VNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASAL 198
           +++ +VV   G   + +   +V E     +LL+  +   +      +  +R   +T   +
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMR---QTIQGV 155
Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLD 258
            YLH+     +IH D+K  N+ LND+   K+ DF  +  I  D E      L GT  Y+ 
Sbjct: 156 QYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KKXLCGTPNYIA 210
Query: 259 PVCINTGKLTKKSDVYSFGVVLAELLTGKKP--GSCMT---LASNKKISMVPYFLNSIKN 313
           P  +     + + D++S G +L  LL GK P   SC+    +   K    VP  +N + +
Sbjct: 211 PEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVAS 270
Query: 314 NGLRQILN 321
             +R++L+
Sbjct: 271 ALIRRMLH 278

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 70/152 (46%), Gaps = 7/152 (4%)
Query: 139 VNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASAL 198
           +NH+NVVK  G   E  +  L  E+ S G L D I      +        R   +  + +
Sbjct: 61  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGV 117
Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLD 258
            YLH +    I H D+K  N+LL++    K++DF  + +   +    +   + GT  Y+ 
Sbjct: 118 VYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 174
Query: 259 PVCINTGKL-TKKSDVYSFGVVLAELLTGKKP 289
           P  +   +   +  DV+S G+VL  +L G+ P
Sbjct: 175 PELLKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 94/204 (46%), Gaps = 14/204 (6%)
Query: 93  RCLSQGGFVSVYKGVL----HDNIQVAVKTYRR--ADKXXXXXXXXXXXXSQVNHKNVVK 146
           RC+ +G F  V++G+     +  + VA+KT +   +D              Q +H ++VK
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 147 ILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLAS 206
           ++G+  E  V  ++ E  + G L   ++     +     + +  A + ++AL YL S   
Sbjct: 76  LIGVITENPV-WIIMELCTLGELRSFLQVRKFSL--DLASLILYAYQLSTALAYLESKR- 131
Query: 207 PPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGK 266
              +H D+ + N+L++ N   K+ DF  S  +        S   +    ++ P  IN  +
Sbjct: 132 --FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIK-WMAPESINFRR 188
Query: 267 LTKKSDVYSFGVVLAELLT-GKKP 289
            T  SDV+ FGV + E+L  G KP
Sbjct: 189 FTSASDVWMFGVCMWEILMHGVKP 212

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 79/163 (48%), Gaps = 14/163 (8%)
Query: 137 SQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLD---HIRCES---SQVLKTWKTCLRI 190
           SQ +H N+V      +  +   LV +  S G++LD   HI  +    S VL    T   I
Sbjct: 63  SQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDE-STIATI 121
Query: 191 AAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTI- 249
             E    L+YLH       IH DVK+ NILL ++ + ++ADF  S  +++  +   + + 
Sbjct: 122 LREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVR 178
Query: 250 --LIGTSGYLDPVCINTGK-LTKKSDVYSFGVVLAELLTGKKP 289
              +GT  ++ P  +   +    K+D++SFG+   EL TG  P
Sbjct: 179 KTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 221

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 96/210 (45%), Gaps = 24/210 (11%)
Query: 92  SRCLSQGGFVSVYKGVL----HDNIQVAVKTYRR--ADKXXXXXXXXXXXXSQVNHKNVV 145
            RC+ +G F  V++G+     +  + VA+KT +   +D              Q +H ++V
Sbjct: 12  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 71
Query: 146 KILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLA 205
           K++G+  E  V  ++ E  + G L   ++     +     + +  A + ++AL YL S  
Sbjct: 72  KLIGVITENPV-WIIMELCTLGELRSFLQVRKYSL--DLASLILYAYQLSTALAYLESKR 128
Query: 206 SPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG-----YLDPV 260
               +H D+ + N+L++ N   K+ DF  S  +        ST    + G     ++ P 
Sbjct: 129 ---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED------STYYKASKGKLPIKWMAPE 179
Query: 261 CINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
            IN  + T  SDV+ FGV + E+L  G KP
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKP 209

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 77/160 (48%), Gaps = 15/160 (9%)
Query: 137 SQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAA---E 193
            Q  H N++++ G+   +   +++ EF  NG L   +R    Q      T +++      
Sbjct: 70  GQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQF-----TVIQLVGMLRG 124
Query: 194 TASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGT 253
            AS + YL  ++    +H D+ + NIL+N N   KV+DF  S  +  ++     T  +G 
Sbjct: 125 IASGMRYLAEMS---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGG 181
Query: 254 S---GYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
                +  P  I   K T  SD +S+G+V+ E+++ G++P
Sbjct: 182 KIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERP 221

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 83/159 (52%), Gaps = 17/159 (10%)
Query: 137 SQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETAS 196
            Q+++  +V+++G+C E E  +LV E A  G L  ++  + ++ +K  K  + +  + + 
Sbjct: 73  QQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSM 128
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG- 255
            + YL        +H D+ + N+LL   + AK++DF  S  + +D     +     T G 
Sbjct: 129 GMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----THGK 181
Query: 256 ----YLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
               +  P CIN  K + KSDV+SFGV++ E  + G+KP
Sbjct: 182 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 96/210 (45%), Gaps = 24/210 (11%)
Query: 92  SRCLSQGGFVSVYKGVL----HDNIQVAVKTYRR--ADKXXXXXXXXXXXXSQVNHKNVV 145
            RC+ +G F  V++G+     +  + VA+KT +   +D              Q +H ++V
Sbjct: 18  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 77
Query: 146 KILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLA 205
           K++G+  E  V  ++ E  + G L   ++     +     + +  A + ++AL YL S  
Sbjct: 78  KLIGVITENPV-WIIMELCTLGELRSFLQVRKYSL--DLASLILYAYQLSTALAYLESKR 134
Query: 206 SPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG-----YLDPV 260
               +H D+ + N+L++ N   K+ DF  S  +        ST    + G     ++ P 
Sbjct: 135 ---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED------STYYKASKGKLPIKWMAPE 185
Query: 261 CINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
            IN  + T  SDV+ FGV + E+L  G KP
Sbjct: 186 SINFRRFTSASDVWMFGVCMWEILMHGVKP 215

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 96/210 (45%), Gaps = 24/210 (11%)
Query: 92  SRCLSQGGFVSVYKGVL----HDNIQVAVKTYRR--ADKXXXXXXXXXXXXSQVNHKNVV 145
            RC+ +G F  V++G+     +  + VA+KT +   +D              Q +H ++V
Sbjct: 17  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 76
Query: 146 KILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLA 205
           K++G+  E  V  ++ E  + G L   ++     +     + +  A + ++AL YL S  
Sbjct: 77  KLIGVITENPV-WIIMELCTLGELRSFLQVRKYSL--DLASLILYAYQLSTALAYLESKR 133
Query: 206 SPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG-----YLDPV 260
               +H D+ + N+L++ N   K+ DF  S  +        ST    + G     ++ P 
Sbjct: 134 ---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED------STYYKASKGKLPIKWMAPE 184
Query: 261 CINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
            IN  + T  SDV+ FGV + E+L  G KP
Sbjct: 185 SINFRRFTSASDVWMFGVCMWEILMHGVKP 214

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 93  RCLSQGGFVSVYKGVL----HDNIQVAVKTYRR--ADKXXXXXXXXXXXXSQVNHKNVVK 146
           RC+ +G F  V++G+     +  + VA+KT +   +D              Q +H ++VK
Sbjct: 44  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 103
Query: 147 ILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLAS 206
           ++G+  E  V  ++ E  + G L   ++     +     + +  A + ++AL YL S   
Sbjct: 104 LIGVITENPV-WIIMELCTLGELRSFLQVRKYSL--DLASLILYAYQLSTALAYLESKR- 159
Query: 207 PPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG-----YLDPVC 261
              +H D+ + N+L++ N   K+ DF  S  +        ST    + G     ++ P  
Sbjct: 160 --FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED------STYYKASKGKLPIKWMAPES 211
Query: 262 INTGKLTKKSDVYSFGVVLAELLT-GKKP 289
           IN  + T  SDV+ FGV + E+L  G KP
Sbjct: 212 INFRRFTSASDVWMFGVCMWEILMHGVKP 240

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 93  RCLSQGGFVSVYKGVL----HDNIQVAVKTYRR--ADKXXXXXXXXXXXXSQVNHKNVVK 146
           RC+ +G F  V++G+     +  + VA+KT +   +D              Q +H ++VK
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 147 ILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLAS 206
           ++G+  E  V  ++ E  + G L   ++     +     + +  A + ++AL YL S   
Sbjct: 76  LIGVITENPV-WIIMELCTLGELRSFLQVRKYSL--DLASLILYAYQLSTALAYLESKR- 131
Query: 207 PPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG-----YLDPVC 261
              +H D+ + N+L++ N   K+ DF  S  +        ST    + G     ++ P  
Sbjct: 132 --FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED------STYYKASKGKLPIKWMAPES 183
Query: 262 INTGKLTKKSDVYSFGVVLAELLT-GKKP 289
           IN  + T  SDV+ FGV + E+L  G KP
Sbjct: 184 INFRRFTSASDVWMFGVCMWEILMHGVKP 212

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 93  RCLSQGGFVSVYKGVL----HDNIQVAVKTYRR--ADKXXXXXXXXXXXXSQVNHKNVVK 146
           RC+ +G F  V++G+     +  + VA+KT +   +D              Q +H ++VK
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 147 ILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLAS 206
           ++G+  E  V  ++ E  + G L   ++     +     + +  A + ++AL YL S   
Sbjct: 76  LIGVITENPV-WIIMELCTLGELRSFLQVRKYSL--DLASLILYAYQLSTALAYLESKR- 131
Query: 207 PPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG-----YLDPVC 261
              +H D+ + N+L++ N   K+ DF  S  +        ST    + G     ++ P  
Sbjct: 132 --FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED------STYYKASKGKLPIKWMAPES 183
Query: 262 INTGKLTKKSDVYSFGVVLAELLT-GKKP 289
           IN  + T  SDV+ FGV + E+L  G KP
Sbjct: 184 INFRRFTSASDVWMFGVCMWEILMHGVKP 212

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 96/210 (45%), Gaps = 24/210 (11%)
Query: 92  SRCLSQGGFVSVYKGVL----HDNIQVAVKTYRR--ADKXXXXXXXXXXXXSQVNHKNVV 145
            RC+ +G F  V++G+     +  + VA+KT +   +D              Q +H ++V
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 146 KILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLA 205
           K++G+  E  V  ++ E  + G L   ++     +     + +  A + ++AL YL S  
Sbjct: 455 KLIGVITENPV-WIIMELCTLGELRSFLQVRKFSL--DLASLILYAYQLSTALAYLESKR 511
Query: 206 SPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG-----YLDPV 260
               +H D+ + N+L++ N   K+ DF  S  +        ST    + G     ++ P 
Sbjct: 512 ---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED------STYYKASKGKLPIKWMAPE 562
Query: 261 CINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
            IN  + T  SDV+ FGV + E+L  G KP
Sbjct: 563 SINFRRFTSASDVWMFGVCMWEILMHGVKP 592

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 83/159 (52%), Gaps = 17/159 (10%)
Query: 137 SQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETAS 196
            Q+++  +V+++G+C E E  +LV E A  G L  ++  + ++ +K  K  + +  + + 
Sbjct: 61  QQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSM 116
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG- 255
            + YL        +H D+ + N+LL   + AK++DF  S  + +D     +     T G 
Sbjct: 117 GMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----THGK 169
Query: 256 ----YLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
               +  P CIN  K + KSDV+SFGV++ E  + G+KP
Sbjct: 170 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 208

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 96/210 (45%), Gaps = 24/210 (11%)
Query: 92  SRCLSQGGFVSVYKGVL----HDNIQVAVKTYRR--ADKXXXXXXXXXXXXSQVNHKNVV 145
            RC+ +G F  V++G+     +  + VA+KT +   +D              Q +H ++V
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 146 KILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLA 205
           K++G+  E  V  ++ E  + G L   ++     +     + +  A + ++AL YL S  
Sbjct: 80  KLIGVITENPV-WIIMELCTLGELRSFLQVRKYSL--DLASLILYAYQLSTALAYLESKR 136
Query: 206 SPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG-----YLDPV 260
               +H D+ + N+L++ N   K+ DF  S  +        ST    + G     ++ P 
Sbjct: 137 ---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED------STYYKASKGKLPIKWMAPE 187
Query: 261 CINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
            IN  + T  SDV+ FGV + E+L  G KP
Sbjct: 188 SINFRRFTSASDVWMFGVCMWEILMHGVKP 217

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 83/159 (52%), Gaps = 17/159 (10%)
Query: 137 SQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETAS 196
            Q+++  +V+++G+C E E  +LV E A  G L  ++  + ++ +K  K  + +  + + 
Sbjct: 67  QQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSM 122
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG- 255
            + YL        +H D+ + N+LL   + AK++DF  S  + +D     +     T G 
Sbjct: 123 GMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQ----THGK 175
Query: 256 ----YLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
               +  P CIN  K + KSDV+SFGV++ E  + G+KP
Sbjct: 176 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 83/159 (52%), Gaps = 17/159 (10%)
Query: 137 SQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETAS 196
            Q+++  +V+++G+C E E  +LV E A  G L  ++  + ++ +K  K  + +  + + 
Sbjct: 63  QQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSM 118
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG- 255
            + YL        +H D+ + N+LL   + AK++DF  S  + +D     +     T G 
Sbjct: 119 GMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----THGK 171
Query: 256 ----YLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
               +  P CIN  K + KSDV+SFGV++ E  + G+KP
Sbjct: 172 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 210

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 83/159 (52%), Gaps = 17/159 (10%)
Query: 137 SQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETAS 196
            Q+++  +V+++G+C E E  +LV E A  G L  ++  + ++ +K  K  + +  + + 
Sbjct: 67  QQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSM 122
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG- 255
            + YL        +H D+ + N+LL   + AK++DF  S  + +D     +     T G 
Sbjct: 123 GMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----THGK 175
Query: 256 ----YLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
               +  P CIN  K + KSDV+SFGV++ E  + G+KP
Sbjct: 176 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 84/163 (51%), Gaps = 17/163 (10%)
Query: 137 SQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETAS 196
            Q+++  +V+++G+C E E  +LV E A  G L  ++  + ++ +K  K  + +  + + 
Sbjct: 83  QQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSM 138
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG- 255
            + YL        +H D+ + N+LL   + AK++DF  S  + +D     +     T G 
Sbjct: 139 GMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----THGK 191
Query: 256 ----YLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCM 293
               +  P CIN  K + KSDV+SFGV++ E  + G+KP   M
Sbjct: 192 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 234

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 84/163 (51%), Gaps = 17/163 (10%)
Query: 137 SQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETAS 196
            Q+++  +V+++G+C E E  +LV E A  G L  ++  + ++ +K  K  + +  + + 
Sbjct: 83  QQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSM 138
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG- 255
            + YL        +H D+ + N+LL   + AK++DF  S  + +D     +     T G 
Sbjct: 139 GMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----THGK 191
Query: 256 ----YLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCM 293
               +  P CIN  K + KSDV+SFGV++ E  + G+KP   M
Sbjct: 192 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 234

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 84/163 (51%), Gaps = 17/163 (10%)
Query: 137 SQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETAS 196
            Q+++  +V+++G+C E E  +LV E A  G L  ++  + ++ +K  K  + +  + + 
Sbjct: 81  QQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSM 136
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG- 255
            + YL        +H D+ + N+LL   + AK++DF  S  + +D     +     T G 
Sbjct: 137 GMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----THGK 189
Query: 256 ----YLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCM 293
               +  P CIN  K + KSDV+SFGV++ E  + G+KP   M
Sbjct: 190 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 232

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 96/207 (46%), Gaps = 14/207 (6%)
Query: 89  FDRSRCLSQGGFVSVYKGVL-HDNIQVAVKT--YRRADKXXXXXXXXXXXXSQVNHKNVV 145
           F +   + +G F  VYKG+  H    VA+K      A+             SQ +   + 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 146 KILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTW-KTCLRIAAETASALDYLHSL 204
           +  G  L++    ++ E+   G+ LD ++     + +T+  T LR   E    LDYLHS 
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGSALDLLK--PGPLEETYIATILR---EILKGLDYLHSE 135
Query: 205 ASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINT 264
                IH D+K+AN+LL++    K+ADF  +  + +D +   +   +GT  ++ P  I  
Sbjct: 136 RK---IHRDIKAANVLLSEQGDVKLADFGVAGQL-TDTQIKRNX-FVGTPFWMAPEVIKQ 190
Query: 265 GKLTKKSDVYSFGVVLAELLTGKKPGS 291
                K+D++S G+   EL  G+ P S
Sbjct: 191 SAYDFKADIWSLGITAIELAKGEPPNS 217

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 73/153 (47%), Gaps = 18/153 (11%)
Query: 141 HKNVVKILGLCLET--EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASAL 198
           H+N+VK  G+C E       L+ EF  +G+L +++    +++    K  L+ A +    +
Sbjct: 82  HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKI--NLKQQLKYAVQICKGM 139
Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAM------STILIG 252
           DYL    S   +H D+ + N+L+   +  K+ DF  +  I +D E         S +   
Sbjct: 140 DYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVF-- 194
Query: 253 TSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT 285
              +  P C+   K    SDV+SFGV L ELLT
Sbjct: 195 ---WYAPECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 73/153 (47%), Gaps = 18/153 (11%)
Query: 141 HKNVVKILGLCLET--EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASAL 198
           H+N+VK  G+C E       L+ EF  +G+L +++    +++    K  L+ A +    +
Sbjct: 70  HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKI--NLKQQLKYAVQICKGM 127
Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAM------STILIG 252
           DYL    S   +H D+ + N+L+   +  K+ DF  +  I +D E         S +   
Sbjct: 128 DYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVF-- 182
Query: 253 TSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT 285
              +  P C+   K    SDV+SFGV L ELLT
Sbjct: 183 ---WYAPECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 80/185 (43%), Gaps = 16/185 (8%)
Query: 109 HDNIQVAVKTYR-RADKXXXXXXXXXXXXSQVNHKNVVKILGLCLETEVPLLVYEFASNG 167
           H   QVAVK    R  +               +H NVV +    L  +   +V EF   G
Sbjct: 68  HTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGG 127
Query: 168 TLLD---HIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDN 224
            L D   H R    Q+     + LR       AL YLH+     +IH D+KS +ILL  +
Sbjct: 128 ALTDIVTHTRMNEEQIATVCLSVLR-------ALSYLHNQG---VIHRDIKSDSILLTSD 177
Query: 225 YTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELL 284
              K++DF     +S   E      L+GT  ++ P  I+      + D++S G+++ E++
Sbjct: 178 GRIKLSDFGFCAQVSK--EVPKRKXLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMI 235
Query: 285 TGKKP 289
            G+ P
Sbjct: 236 DGEPP 240

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 98/231 (42%), Gaps = 36/231 (15%)
Query: 83  IRATKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNH 141
           +R   +F+    L QG F  V K     D+   A+K  R  ++            + +NH
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNH 61
Query: 142 KNVVKILGLCLE--------TEVP-----LLVYEFASNGTLLDHIRCES--SQVLKTWKT 186
           + VV+     LE        T V       +  E+  NGTL D I  E+   Q  + W  
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW-- 119
Query: 187 CLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADF-------ESSVLIS 239
             R+  +   AL Y+HS     IIH D+K  NI ++++   K+ DF        S  ++ 
Sbjct: 120 --RLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 240 SDAETAMS-----TILIGTSGYL-DPVCINTGKLTKKSDVYSFGVVLAELL 284
            D++         T  IGT+ Y+   V   TG   +K D+YS G++  E++
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 84/162 (51%), Gaps = 17/162 (10%)
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
           Q+++  +V+++G+C E E  +LV E A  G L  ++  + ++ +K  K  + +  + +  
Sbjct: 426 QLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMG 481
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG-- 255
           + YL        +H D+ + N+LL   + AK++DF  S  + +D     +     T G  
Sbjct: 482 MKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----THGKW 534
Query: 256 ---YLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCM 293
              +  P CIN  K + KSDV+SFGV++ E  + G+KP   M
Sbjct: 535 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 576

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 84/162 (51%), Gaps = 17/162 (10%)
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
           Q+++  +V+++G+C E E  +LV E A  G L  ++  + ++ +K  K  + +  + +  
Sbjct: 427 QLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMG 482
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG-- 255
           + YL        +H D+ + N+LL   + AK++DF  S  + +D     +     T G  
Sbjct: 483 MKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ----THGKW 535
Query: 256 ---YLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCM 293
              +  P CIN  K + KSDV+SFGV++ E  + G+KP   M
Sbjct: 536 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 577

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 104/242 (42%), Gaps = 34/242 (14%)
Query: 139 VNHKNVVKILGLCLET--EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETAS 196
           + H N+VK  G+C         L+ E+   G+L D+++    ++       L+  ++   
Sbjct: 74  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--KLLQYTSQICK 131
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE------TAMSTIL 250
            ++YL    +   IH D+ + NIL+ +    K+ DF  + ++  D E         S I 
Sbjct: 132 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 188
Query: 251 IGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-----GKKPGSCMTLASNKKIS--M 303
                +  P  +   K +  SDV+SFGVVL EL T        P   M +  N K    +
Sbjct: 189 -----WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 243
Query: 304 VPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDR 363
           V + +  +KNNG R        DE  M        + ++C      +RP+ + ++  +D+
Sbjct: 244 VFHLIELLKNNG-RLPRPDGCPDEIYM--------IMTECWNNNVNQRPSFRDLALRVDQ 294
Query: 364 LR 365
           +R
Sbjct: 295 IR 296

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 104/242 (42%), Gaps = 34/242 (14%)
Query: 139 VNHKNVVKILGLCLET--EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETAS 196
           + H N+VK  G+C         L+ E+   G+L D+++    ++       L+  ++   
Sbjct: 75  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--KLLQYTSQICK 132
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE------TAMSTIL 250
            ++YL    +   IH D+ + NIL+ +    K+ DF  + ++  D E         S I 
Sbjct: 133 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 189
Query: 251 IGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-----GKKPGSCMTLASNKKIS--M 303
                +  P  +   K +  SDV+SFGVVL EL T        P   M +  N K    +
Sbjct: 190 -----WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 244
Query: 304 VPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDR 363
           V + +  +KNNG R        DE  M        + ++C      +RP+ + ++  +D+
Sbjct: 245 VFHLIELLKNNG-RLPRPDGCPDEIYM--------IMTECWNNNVNQRPSFRDLALRVDQ 295
Query: 364 LR 365
           +R
Sbjct: 296 IR 297

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 104/242 (42%), Gaps = 34/242 (14%)
Query: 139 VNHKNVVKILGLCLET--EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETAS 196
           + H N+VK  G+C         L+ E+   G+L D+++    ++       L+  ++   
Sbjct: 68  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--KLLQYTSQICK 125
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE------TAMSTIL 250
            ++YL    +   IH D+ + NIL+ +    K+ DF  + ++  D E         S I 
Sbjct: 126 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF 182
Query: 251 IGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-----GKKPGSCMTLASNKKIS--M 303
                +  P  +   K +  SDV+SFGVVL EL T        P   M +  N K    +
Sbjct: 183 -----WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 237
Query: 304 VPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDR 363
           V + +  +KNNG R        DE  M        + ++C      +RP+ + ++  +D+
Sbjct: 238 VFHLIELLKNNG-RLPRPDGCPDEIYM--------IMTECWNNNVNQRPSFRDLALRVDQ 288
Query: 364 LR 365
           +R
Sbjct: 289 IR 290

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 104/242 (42%), Gaps = 34/242 (14%)
Query: 139 VNHKNVVKILGLCLET--EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETAS 196
           + H N+VK  G+C         L+ E+   G+L D+++    ++       L+  ++   
Sbjct: 68  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--KLLQYTSQICK 125
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE------TAMSTIL 250
            ++YL    +   IH D+ + NIL+ +    K+ DF  + ++  D E         S I 
Sbjct: 126 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 182
Query: 251 IGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-----GKKPGSCMTLASNKKIS--M 303
                +  P  +   K +  SDV+SFGVVL EL T        P   M +  N K    +
Sbjct: 183 -----WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 237
Query: 304 VPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDR 363
           V + +  +KNNG R        DE  M        + ++C      +RP+ + ++  +D+
Sbjct: 238 VFHLIELLKNNG-RLPRPDGCPDEIYM--------IMTECWNNNVNQRPSFRDLALRVDQ 288
Query: 364 LR 365
           +R
Sbjct: 289 IR 290

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 104/242 (42%), Gaps = 34/242 (14%)
Query: 139 VNHKNVVKILGLCLET--EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETAS 196
           + H N+VK  G+C         L+ E+   G+L D+++    ++       L+  ++   
Sbjct: 86  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--KLLQYTSQICK 143
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE------TAMSTIL 250
            ++YL    +   IH D+ + NIL+ +    K+ DF  + ++  D E         S I 
Sbjct: 144 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 200
Query: 251 IGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-----GKKPGSCMTLASNKKIS--M 303
                +  P  +   K +  SDV+SFGVVL EL T        P   M +  N K    +
Sbjct: 201 -----WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 255
Query: 304 VPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDR 363
           V + +  +KNNG R        DE  M        + ++C      +RP+ + ++  +D+
Sbjct: 256 VFHLIELLKNNG-RLPRPDGCPDEIYM--------IMTECWNNNVNQRPSFRDLALRVDQ 306
Query: 364 LR 365
           +R
Sbjct: 307 IR 308

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 104/242 (42%), Gaps = 34/242 (14%)
Query: 139 VNHKNVVKILGLCLET--EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETAS 196
           + H N+VK  G+C         L+ E+   G+L D+++    ++       L+  ++   
Sbjct: 86  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--KLLQYTSQICK 143
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE------TAMSTIL 250
            ++YL    +   IH D+ + NIL+ +    K+ DF  + ++  D E         S I 
Sbjct: 144 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 200
Query: 251 IGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-----GKKPGSCMTLASNKKIS--M 303
                +  P  +   K +  SDV+SFGVVL EL T        P   M +  N K    +
Sbjct: 201 -----WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 255
Query: 304 VPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDR 363
           V + +  +KNNG R        DE  M        + ++C      +RP+ + ++  +D+
Sbjct: 256 VFHLIELLKNNG-RLPRPDGCPDEIYM--------IMTECWNNNVNQRPSFRDLALRVDQ 306
Query: 364 LR 365
           +R
Sbjct: 307 IR 308

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 104/242 (42%), Gaps = 34/242 (14%)
Query: 139 VNHKNVVKILGLCLET--EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETAS 196
           + H N+VK  G+C         L+ E+   G+L D+++    ++       L+  ++   
Sbjct: 66  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--KLLQYTSQICK 123
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE------TAMSTIL 250
            ++YL    +   IH D+ + NIL+ +    K+ DF  + ++  D E         S I 
Sbjct: 124 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 180
Query: 251 IGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-----GKKPGSCMTLASNKKIS--M 303
                +  P  +   K +  SDV+SFGVVL EL T        P   M +  N K    +
Sbjct: 181 -----WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 235
Query: 304 VPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDR 363
           V + +  +KNNG R        DE  M        + ++C      +RP+ + ++  +D+
Sbjct: 236 VFHLIELLKNNG-RLPRPDGCPDEIYM--------IMTECWNNNVNQRPSFRDLALRVDQ 286
Query: 364 LR 365
           +R
Sbjct: 287 IR 288

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 104/242 (42%), Gaps = 34/242 (14%)
Query: 139 VNHKNVVKILGLCLET--EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETAS 196
           + H N+VK  G+C         L+ E+   G+L D+++    ++       L+  ++   
Sbjct: 73  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--KLLQYTSQICK 130
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE------TAMSTIL 250
            ++YL    +   IH D+ + NIL+ +    K+ DF  + ++  D E         S I 
Sbjct: 131 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 187
Query: 251 IGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-----GKKPGSCMTLASNKKIS--M 303
                +  P  +   K +  SDV+SFGVVL EL T        P   M +  N K    +
Sbjct: 188 -----WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 242
Query: 304 VPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDR 363
           V + +  +KNNG R        DE  M        + ++C      +RP+ + ++  +D+
Sbjct: 243 VFHLIELLKNNG-RLPRPDGCPDEIYM--------IMTECWNNNVNQRPSFRDLALRVDQ 293
Query: 364 LR 365
           +R
Sbjct: 294 IR 295

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 104/242 (42%), Gaps = 34/242 (14%)
Query: 139 VNHKNVVKILGLCLET--EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETAS 196
           + H N+VK  G+C         L+ E+   G+L D+++    ++       L+  ++   
Sbjct: 72  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--KLLQYTSQICK 129
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE------TAMSTIL 250
            ++YL    +   IH D+ + NIL+ +    K+ DF  + ++  D E         S I 
Sbjct: 130 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 186
Query: 251 IGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-----GKKPGSCMTLASNKKIS--M 303
                +  P  +   K +  SDV+SFGVVL EL T        P   M +  N K    +
Sbjct: 187 -----WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 241
Query: 304 VPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDR 363
           V + +  +KNNG R        DE  M        + ++C      +RP+ + ++  +D+
Sbjct: 242 VFHLIELLKNNG-RLPRPDGCPDEIYM--------IMTECWNNNVNQRPSFRDLALRVDQ 292
Query: 364 LR 365
           +R
Sbjct: 293 IR 294

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 104/242 (42%), Gaps = 34/242 (14%)
Query: 139 VNHKNVVKILGLCLET--EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETAS 196
           + H N+VK  G+C         L+ E+   G+L D+++    ++       L+  ++   
Sbjct: 99  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--KLLQYTSQICK 156
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE------TAMSTIL 250
            ++YL    +   IH D+ + NIL+ +    K+ DF  + ++  D E         S I 
Sbjct: 157 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 213
Query: 251 IGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-----GKKPGSCMTLASNKKIS--M 303
                +  P  +   K +  SDV+SFGVVL EL T        P   M +  N K    +
Sbjct: 214 -----WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 268
Query: 304 VPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDR 363
           V + +  +KNNG R        DE  M        + ++C      +RP+ + ++  +D+
Sbjct: 269 VFHLIELLKNNG-RLPRPDGCPDEIYM--------IMTECWNNNVNQRPSFRDLALRVDQ 319
Query: 364 LR 365
           +R
Sbjct: 320 IR 321

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 104/242 (42%), Gaps = 34/242 (14%)
Query: 139 VNHKNVVKILGLCLET--EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETAS 196
           + H N+VK  G+C         L+ E+   G+L D+++    ++       L+  ++   
Sbjct: 67  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--KLLQYTSQICK 124
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE------TAMSTIL 250
            ++YL    +   IH D+ + NIL+ +    K+ DF  + ++  D E         S I 
Sbjct: 125 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 181
Query: 251 IGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-----GKKPGSCMTLASNKKIS--M 303
                +  P  +   K +  SDV+SFGVVL EL T        P   M +  N K    +
Sbjct: 182 -----WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 236
Query: 304 VPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDR 363
           V + +  +KNNG R        DE  M        + ++C      +RP+ + ++  +D+
Sbjct: 237 VFHLIELLKNNG-RLPRPDGCPDEIYM--------IMTECWNNNVNQRPSFRDLALRVDQ 287
Query: 364 LR 365
           +R
Sbjct: 288 IR 289

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 104/242 (42%), Gaps = 34/242 (14%)
Query: 139 VNHKNVVKILGLCLET--EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETAS 196
           + H N+VK  G+C         L+ E+   G+L D+++    ++       L+  ++   
Sbjct: 71  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--KLLQYTSQICK 128
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE------TAMSTIL 250
            ++YL    +   IH D+ + NIL+ +    K+ DF  + ++  D E         S I 
Sbjct: 129 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 185
Query: 251 IGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-----GKKPGSCMTLASNKKIS--M 303
                +  P  +   K +  SDV+SFGVVL EL T        P   M +  N K    +
Sbjct: 186 -----WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 240
Query: 304 VPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDR 363
           V + +  +KNNG R        DE  M        + ++C      +RP+ + ++  +D+
Sbjct: 241 VFHLIELLKNNG-RLPRPDGCPDEIYM--------IMTECWNNNVNQRPSFRDLALRVDQ 291
Query: 364 LR 365
           +R
Sbjct: 292 IR 293

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 104/242 (42%), Gaps = 34/242 (14%)
Query: 139 VNHKNVVKILGLCLET--EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETAS 196
           + H N+VK  G+C         L+ E+   G+L D+++    ++       L+  ++   
Sbjct: 68  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--KLLQYTSQICK 125
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE------TAMSTIL 250
            ++YL    +   IH D+ + NIL+ +    K+ DF  + ++  D E         S I 
Sbjct: 126 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 182
Query: 251 IGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-----GKKPGSCMTLASNKKIS--M 303
                +  P  +   K +  SDV+SFGVVL EL T        P   M +  N K    +
Sbjct: 183 -----WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 237
Query: 304 VPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDR 363
           V + +  +KNNG R        DE  M        + ++C      +RP+ + ++  +D+
Sbjct: 238 VFHLIELLKNNG-RLPRPDGCPDEIYM--------IMTECWNNNVNQRPSFRDLALRVDQ 288
Query: 364 LR 365
           +R
Sbjct: 289 IR 290

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/231 (24%), Positives = 98/231 (42%), Gaps = 34/231 (14%)
Query: 141 HKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDY 200
           H+N+V +LG C      L++ E+   G LL+ +R +    L+          E  S+ D 
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDL 168
Query: 201 LHS----------LASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTIL 250
           LH           LAS   IH DV + N+LL + + AK+ DF  +  I +D+   +    
Sbjct: 169 LHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 228
Query: 251 IGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNS 310
                ++ P  I     T +SDV+S+G++L E+ +               + + PY    
Sbjct: 229 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS---------------LGLNPY-PGI 272
Query: 311 IKNNGLRQILNFHVADESEMKEIEI----VAELASKCLRIRGTERPTMKQV 357
           + N+   ++    V D  +M +       +  +   C  +  T RPT +Q+
Sbjct: 273 LVNSKFYKL----VKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQI 319

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/189 (26%), Positives = 91/189 (48%), Gaps = 17/189 (8%)
Query: 139 VNHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
           +NH N+VK+  + +ETE  L L+ E+AS G + D++        K  ++  R   +  SA
Sbjct: 68  LNHPNIVKLFEV-IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR---QIVSA 123
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYL 257
           + Y H      I+H D+K+ N+LL+ +   K+ADF  S   +   +        G+  Y 
Sbjct: 124 VQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL---DTFCGSPPYA 177
Query: 258 DPVCINTGKLT-KKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISM-----VPYFLNSI 311
            P      K    + DV+S GV+L  L++G  P     L   ++  +     +P+++++ 
Sbjct: 178 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTD 237
Query: 312 KNNGLRQIL 320
             N L++ L
Sbjct: 238 CENLLKRFL 246

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 96/203 (47%), Gaps = 15/203 (7%)
Query: 95  LSQGGFVSVYKGVLH---DNIQVAVKTYRRADKXXXXXXXXXXXX--SQVNHKNVVKILG 149
           L  G F SV +GV       I VA+K  ++  +               Q+++  +V+++G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 150 LCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPI 209
           +C + E  +LV E A  G L   +  +  ++  +      +  + +  + YL        
Sbjct: 404 VC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVS--NVAELLHQVSMGMKYLEEKN---F 457
Query: 210 IHGDVKSANILLNDNYTAKVADFESSVLISSDAE--TAMSTILIGTSGYLDPVCINTGKL 267
           +H ++ + N+LL + + AK++DF  S  + +D    TA S        Y  P CIN  K 
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA-PECINFRKF 516
Query: 268 TKKSDVYSFGVVLAELLT-GKKP 289
           + +SDV+S+GV + E L+ G+KP
Sbjct: 517 SSRSDVWSYGVTMWEALSYGQKP 539

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 104/242 (42%), Gaps = 34/242 (14%)
Query: 139 VNHKNVVKILGLCLET--EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETAS 196
           + H N+VK  G+C         L+ EF   G+L ++++    ++       L+  ++   
Sbjct: 71  LQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHI--KLLQYTSQICK 128
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE------TAMSTIL 250
            ++YL    +   IH D+ + NIL+ +    K+ DF  + ++  D E         S I 
Sbjct: 129 GMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 185
Query: 251 IGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-----GKKPGSCMTLASNKKIS--M 303
                +  P  +   K +  SDV+SFGVVL EL T        P   M +  N K    +
Sbjct: 186 -----WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 240
Query: 304 VPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDR 363
           V + +  +KNNG R        DE  M        + ++C      +RP+ + ++  +D+
Sbjct: 241 VFHLIELLKNNG-RLPRPDGCPDEIYM--------IMTECWNNNVNQRPSFRDLALRVDQ 291
Query: 364 LR 365
           +R
Sbjct: 292 IR 293

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/284 (23%), Positives = 118/284 (41%), Gaps = 43/284 (15%)
Query: 93  RCLSQGGFVSVYKGVLHDNIQ------VAVKTYRRAD--KXXXXXXXXXXXXSQVNHKNV 144
           R L QG F  VY+G   D I+      VAVKT   +   +                  +V
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 145 VKILGLCLETEVPLLVYEFASNGTLLDHIRC-------ESSQVLKTWKTCLRIAAETASA 197
           V++LG+  + +  L+V E  ++G L  ++R           +   T +  +++AAE A  
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYL 257
           + YL++      +H D+ + N ++  ++T K+ DF  +  I   A        +    ++
Sbjct: 143 MAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWM 199
Query: 258 DPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLR 317
            P  +  G  T  SD++SFGVVL E+ +               ++  PY    + N    
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPY--QGLSNE--- 239
Query: 318 QILNFHVADESEMKE----IEIVAELASKCLRIRGTERPTMKQV 357
           Q+L F V D   + +     E V +L   C +     RPT  ++
Sbjct: 240 QVLKF-VMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEI 282

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 79/151 (52%), Gaps = 12/151 (7%)
Query: 141 HKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDY 200
           H +++K+  +        +V E+ S G L D+I C+  +V +      R+  +  SA+DY
Sbjct: 70  HPHIIKLYQVISTPTDFFMVMEYVSGGELFDYI-CKHGRVEEM--EARRLFQQILSAVDY 126
Query: 201 LHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV 260
            H      ++H D+K  N+LL+ +  AK+ADF  S ++ SD E   ++   G+  Y  P 
Sbjct: 127 CHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRTS--CGSPNYAAPE 180
Query: 261 CINTGKL--TKKSDVYSFGVVLAELLTGKKP 289
            I +G+L    + D++S GV+L  LL G  P
Sbjct: 181 VI-SGRLYAGPEVDIWSCGVILYALLCGTLP 210

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 97/204 (47%), Gaps = 21/204 (10%)
Query: 139 VNHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
           +NH N+VK+  + +ETE  L LV E+AS G + D++        K  +   R   +  SA
Sbjct: 70  LNHPNIVKLFEV-IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR---QIVSA 125
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESS--VLISSDAETAMSTILIGTSG 255
           + Y H      I+H D+K+ N+LL+ +   K+ADF  S      +  +T       G+  
Sbjct: 126 VQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT-----FCGSPP 177
Query: 256 YLDPVCINTGKLT-KKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISM-----VPYFLN 309
           Y  P      K    + DV+S GV+L  L++G  P     L   ++  +     +P++++
Sbjct: 178 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMS 237
Query: 310 SIKNNGLRQILNFHVADESEMKEI 333
           +   N L++ L  + +    +++I
Sbjct: 238 TDCENLLKKFLILNPSKRGTLEQI 261

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 97/204 (47%), Gaps = 21/204 (10%)
Query: 139 VNHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
           +NH N+VK+  + +ETE  L LV E+AS G + D++        K  +   R   +  SA
Sbjct: 70  LNHPNIVKLFEV-IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR---QIVSA 125
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESS--VLISSDAETAMSTILIGTSG 255
           + Y H      I+H D+K+ N+LL+ +   K+ADF  S      +  +T       G+  
Sbjct: 126 VQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT-----FCGSPP 177
Query: 256 YLDPVCINTGKLT-KKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISM-----VPYFLN 309
           Y  P      K    + DV+S GV+L  L++G  P     L   ++  +     +P++++
Sbjct: 178 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMS 237
Query: 310 SIKNNGLRQILNFHVADESEMKEI 333
           +   N L++ L  + +    +++I
Sbjct: 238 TDCENLLKKFLILNPSKRGTLEQI 261

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 97/204 (47%), Gaps = 21/204 (10%)
Query: 139 VNHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
           +NH N+VK+  + +ETE  L LV E+AS G + D++        K  +   R   +  SA
Sbjct: 70  LNHPNIVKLFEV-IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR---QIVSA 125
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESS--VLISSDAETAMSTILIGTSG 255
           + Y H      I+H D+K+ N+LL+ +   K+ADF  S      +  +T       G+  
Sbjct: 126 VQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT-----FCGSPP 177
Query: 256 YLDPVCINTGKLT-KKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISM-----VPYFLN 309
           Y  P      K    + DV+S GV+L  L++G  P     L   ++  +     +P++++
Sbjct: 178 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMS 237
Query: 310 SIKNNGLRQILNFHVADESEMKEI 333
           +   N L++ L  + +    +++I
Sbjct: 238 TDCENLLKKFLILNPSKRGTLEQI 261

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 92/193 (47%), Gaps = 25/193 (12%)
Query: 139 VNHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
           +NH N+VK+  + +ETE  L L+ E+AS G + D++        K  ++  R   +  SA
Sbjct: 71  LNHPNIVKLFEV-IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR---QIVSA 126
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADF----ESSVLISSDAETAMSTILIGT 253
           + Y H      I+H D+K+ N+LL+ +   K+ADF    E +V    DA         G 
Sbjct: 127 VQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA-------FCGA 176
Query: 254 SGYLDPVCINTGKLT-KKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISM-----VPYF 307
             Y  P      K    + DV+S GV+L  L++G  P     L   ++  +     +P++
Sbjct: 177 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFY 236
Query: 308 LNSIKNNGLRQIL 320
           +++   N L++ L
Sbjct: 237 MSTDCENLLKRFL 249

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/228 (23%), Positives = 100/228 (43%), Gaps = 34/228 (14%)
Query: 141 HKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKT-------WKTCLRIAAE 193
           H+N+V +LG C      L++ E+   G LL+ +R ++   L          +  L  +++
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQ 168
Query: 194 TASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGT 253
            A  + +L   AS   IH DV + N+LL + + AK+ DF  +  I +D+   +       
Sbjct: 169 VAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP 225
Query: 254 SGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKN 313
             ++ P  I     T +SDV+S+G++L E+ +               + + PY    + N
Sbjct: 226 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFS---------------LGLNPY-PGILVN 269
Query: 314 NGLRQILNFHVADESEMKEIEI----VAELASKCLRIRGTERPTMKQV 357
           +   ++    V D  +M +       +  +   C  +  T RPT +Q+
Sbjct: 270 SKFYKL----VKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQI 313

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 72/286 (25%), Positives = 124/286 (43%), Gaps = 44/286 (15%)
Query: 95  LSQGGFVSVYKGV---------LHDNIQVAVKTYRRADKX-XXXXXXXXXXXSQVNHKNV 144
           L QG F  ++KGV         LH+  +V +K   +A +             S+++HK++
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHET-EVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 145 VKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSL 204
           V   G+C+  +  +LV EF   G+L  +++   + +   WK  L +A + A+A   +H L
Sbjct: 75  VLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWK--LEVAKQLAAA---MHFL 129
Query: 205 ASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMST----ILIGTSGYLDPV 260
               +IHG+V + NILL      K  +     +  SD   +++     IL     ++ P 
Sbjct: 130 EENTLIHGNVCAKNILLIREEDRKTGN--PPFIKLSDPGISITVLPKDILQERIPWVPPE 187
Query: 261 CI-NTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQ 318
           CI N   L   +D +SFG  L E+ + G KP S   L S +K+                 
Sbjct: 188 CIENPKNLNLATDKWSFGTTLWEICSGGDKPLS--ALDSQRKLQFYE------------- 232
Query: 319 ILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL 364
             + H     +  E+   A L + C+      RP+ + +  +L+ L
Sbjct: 233 --DRHQLPAPKAAEL---ANLINNCMDYEPDHRPSFRAIIRDLNSL 273

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/232 (23%), Positives = 101/232 (43%), Gaps = 34/232 (14%)
Query: 141 HKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKT-------WKTCLRIAAE 193
           H+N+V +LG C      L++ E+   G LL+ +R ++   L          +  L  +++
Sbjct: 101 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQ 160
Query: 194 TASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGT 253
            A  + +L   AS   IH DV + N+LL + + AK+ DF  +  I +D+   +       
Sbjct: 161 VAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP 217
Query: 254 SGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKN 313
             ++ P  I     T +SDV+S+G++L E+ +               + + PY    + N
Sbjct: 218 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFS---------------LGLNPY-PGILVN 261
Query: 314 NGLRQILNFHVADESEMKEIEI----VAELASKCLRIRGTERPTMKQVSEEL 361
           +   ++    V D  +M +       +  +   C  +  T RPT +Q+   L
Sbjct: 262 SKFYKL----VKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL 309

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 78/151 (51%), Gaps = 12/151 (7%)
Query: 141 HKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDY 200
           H +++K+  +        +V E+ S G L D+I C+  +V +      R+  +  SA+DY
Sbjct: 70  HPHIIKLYQVISTPTDFFMVMEYVSGGELFDYI-CKHGRVEEM--EARRLFQQILSAVDY 126
Query: 201 LHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV 260
            H      ++H D+K  N+LL+ +  AK+ADF  S ++ SD E    +   G+  Y  P 
Sbjct: 127 CHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRDS--CGSPNYAAPE 180
Query: 261 CINTGKL--TKKSDVYSFGVVLAELLTGKKP 289
            I +G+L    + D++S GV+L  LL G  P
Sbjct: 181 VI-SGRLYAGPEVDIWSCGVILYALLCGTLP 210

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 79/151 (52%), Gaps = 12/151 (7%)
Query: 141 HKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDY 200
           H +++K+  +        +V E+ S G L D+I C++ ++ +  K   R+  +  S +DY
Sbjct: 75  HPHIIKLYQVISTPSDIFMVMEYVSGGELFDYI-CKNGRLDE--KESRRLFQQILSGVDY 131
Query: 201 LHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV 260
            H      ++H D+K  N+LL+ +  AK+ADF  S ++ SD E    +   G+  Y  P 
Sbjct: 132 CHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRXS--CGSPNYAAPE 185
Query: 261 CINTGKLT--KKSDVYSFGVVLAELLTGKKP 289
            I +G+L    + D++S GV+L  LL G  P
Sbjct: 186 VI-SGRLYAGPEVDIWSSGVILYALLCGTLP 215

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 69/285 (24%), Positives = 120/285 (42%), Gaps = 45/285 (15%)
Query: 93  RCLSQGGFVSVYKGVLHDNIQ------VAVKTYRRAD--KXXXXXXXXXXXXSQVNHKNV 144
           R L QG F  VY+G   D I+      VAVKT   +   +                  +V
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 145 VKILGLCLETEVPLLVYEFASNGTLLDHIRC-------ESSQVLKTWKTCLRIAAETASA 197
           V++LG+  + +  L+V E  ++G L  ++R           +   T +  +++AAE A  
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLI-SSDAETAMSTILIGTSGY 256
           + YL++      +H D+ + N ++  ++T K+ DF  +  I  +D        L+    +
Sbjct: 143 MAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR-W 198
Query: 257 LDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGL 316
           + P  +  G  T  SD++SFGVVL E+ +               ++  PY    + N   
Sbjct: 199 MAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPY--QGLSN--- 238
Query: 317 RQILNFHVADESEMKE----IEIVAELASKCLRIRGTERPTMKQV 357
            Q+L F V D   + +     E V +L   C +     RPT  ++
Sbjct: 239 EQVLKF-VMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEI 282

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 20/207 (9%)
Query: 93  RCLSQGGFVSVYKGVLHDNIQ------VAVKTYRRAD--KXXXXXXXXXXXXSQVNHKNV 144
           R L QG F  VY+G   D I+      VAVKT   +   +                  +V
Sbjct: 20  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 79
Query: 145 VKILGLCLETEVPLLVYEFASNGTLLDHIRC-------ESSQVLKTWKTCLRIAAETASA 197
           V++LG+  + +  L+V E  ++G L  ++R           +   T +  +++AAE A  
Sbjct: 80  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 139
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLI-SSDAETAMSTILIGTSGY 256
           + YL++      +H D+ + N ++  ++T K+ DF  +  I  +D        L+    +
Sbjct: 140 MAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR-W 195
Query: 257 LDPVCINTGKLTKKSDVYSFGVVLAEL 283
           + P  +  G  T  SD++SFGVVL E+
Sbjct: 196 MAPESLKDGVFTTSSDMWSFGVVLWEI 222

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 97/204 (47%), Gaps = 21/204 (10%)
Query: 139 VNHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
           +NH N+VK+  + +ETE  L LV E+AS G + D++        K  +   R   +  SA
Sbjct: 63  LNHPNIVKLFEV-IETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFR---QIVSA 118
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESS--VLISSDAETAMSTILIGTSG 255
           + Y H      I+H D+K+ N+LL+ +   K+ADF  S      +  +T       G+  
Sbjct: 119 VQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT-----FCGSPP 170
Query: 256 YLDPVCINTGKLT-KKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISM-----VPYFLN 309
           Y  P      K    + DV+S GV+L  L++G  P     L   ++  +     +P++++
Sbjct: 171 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMS 230
Query: 310 SIKNNGLRQILNFHVADESEMKEI 333
           +   N L++ L  + +    +++I
Sbjct: 231 TDCENLLKKFLILNPSKRGTLEQI 254

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 95/202 (47%), Gaps = 17/202 (8%)
Query: 139 VNHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
           +NH N+VK+  + +ETE  L LV E+AS G + D++        K  +   R   +  SA
Sbjct: 70  LNHPNIVKLFEV-IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR---QIVSA 125
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYL 257
           + Y H      I+H D+K+ N+LL+ +   K+ADF  S   +   +        G   Y 
Sbjct: 126 VQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKL---DAFCGAPPYA 179
Query: 258 DPVCINTGKLT-KKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISM-----VPYFLNSI 311
            P      K    + DV+S GV+L  L++G  P     L   ++  +     +P+++++ 
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTD 239
Query: 312 KNNGLRQILNFHVADESEMKEI 333
             N L++ L  + +    +++I
Sbjct: 240 CENLLKKFLILNPSKRGTLEQI 261

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 79/182 (43%), Gaps = 10/182 (5%)
Query: 109 HDNIQVAVKTYR-RADKXXXXXXXXXXXXSQVNHKNVVKILGLCLETEVPLLVYEFASNG 167
           H   QVAVK    R  +                H NVV++    L  E   ++ EF   G
Sbjct: 68  HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGG 127
Query: 168 TLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTA 227
            L D +    SQV    +    +      AL YLH+     +IH D+KS +ILL  +   
Sbjct: 128 ALTDIV----SQVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRV 180
Query: 228 KVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGK 287
           K++DF     IS D        L+GT  ++ P  I+      + D++S G+++ E++ G+
Sbjct: 181 KLSDFGFCAQISKDVPK--RKXLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238
Query: 288 KP 289
            P
Sbjct: 239 PP 240

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 20/207 (9%)
Query: 93  RCLSQGGFVSVYKGVLHDNIQ------VAVKTYRRAD--KXXXXXXXXXXXXSQVNHKNV 144
           R L QG F  VY+G   D I+      VAVKT   +   +                  +V
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 145 VKILGLCLETEVPLLVYEFASNGTLLDHIRC-------ESSQVLKTWKTCLRIAAETASA 197
           V++LG+  + +  L+V E  ++G L  ++R           +   T +  +++AAE A  
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLI-SSDAETAMSTILIGTSGY 256
           + YL++      +H D+ + N ++  ++T K+ DF  +  I  +D        L+    +
Sbjct: 143 MAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR-W 198
Query: 257 LDPVCINTGKLTKKSDVYSFGVVLAEL 283
           + P  +  G  T  SD++SFGVVL E+
Sbjct: 199 MAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 92/207 (44%), Gaps = 22/207 (10%)
Query: 94  CLSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLE 153
           C+ +G +  V++G+ H    VAVK +   D+              + H N++  +   + 
Sbjct: 15  CVGKGRYGEVWRGLWHGE-SVAVKIFSSRDEQSWFRETEIYNTVLLRHDNILGFIASDMT 73
Query: 154 TEVP----LLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLH-----SL 204
           +        L+  +  +G+L D ++    Q L+     LR+A   A  L +LH     + 
Sbjct: 74  SRNSSTQLWLITHYHEHGSLYDFLQ---RQTLEP-HLALRLAVSAACGLAHLHVEIFGTQ 129
Query: 205 ASPPIIHGDVKSANILLNDNYTAKVADFESSVLIS--SDAETAMSTILIGTSGYLDPVCI 262
             P I H D KS N+L+  N    +AD   +V+ S  SD     +   +GT  Y+ P  +
Sbjct: 130 GKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEVL 189
Query: 263 NTGKLT------KKSDVYSFGVVLAEL 283
           +    T      K +D+++FG+VL E+
Sbjct: 190 DEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 72/153 (47%), Gaps = 15/153 (9%)
Query: 140 NHKNVVKILGLCLETEVPLLVYEFASNGTLLD---HIRCESSQVLKTWKTCLRIAAETAS 196
            H+NVV++    L  +   +V EF   G L D   H R    Q+      CL +      
Sbjct: 206 QHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAV---CLAVL----Q 258
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
           AL  LH+     +IH D+KS +ILL  +   K++DF     +S   E      L+GT  +
Sbjct: 259 ALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRRKXLVGTPYW 313
Query: 257 LDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           + P  I+      + D++S G+++ E++ G+ P
Sbjct: 314 MAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 346

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 96/202 (47%), Gaps = 17/202 (8%)
Query: 139 VNHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
           +NH N+VK+  + +ETE  L LV E+AS G + D++        K  +   R   +  SA
Sbjct: 70  LNHPNIVKLFEV-IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR---QIVSA 125
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYL 257
           + Y H      I+H D+K+ N+LL+ +   K+ADF  S   +   +        G+  Y 
Sbjct: 126 VQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDE---FCGSPPYA 179
Query: 258 DPVCINTGKLT-KKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISM-----VPYFLNSI 311
            P      K    + DV+S GV+L  L++G  P     L   ++  +     +P+++++ 
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTD 239
Query: 312 KNNGLRQILNFHVADESEMKEI 333
             N L++ L  + +    +++I
Sbjct: 240 CENLLKKFLILNPSKRGTLEQI 261

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/242 (23%), Positives = 104/242 (42%), Gaps = 34/242 (14%)
Query: 139 VNHKNVVKILGLCLET--EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETAS 196
           + H N+VK  G+C         L+ E+   G+L D+++    ++       L+  ++   
Sbjct: 69  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--KLLQYTSQICK 126
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE------TAMSTIL 250
            ++YL    +   IH ++ + NIL+ +    K+ DF  + ++  D E         S I 
Sbjct: 127 GMEYL---GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIF 183
Query: 251 IGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-----GKKPGSCMTLASNKKIS--M 303
                +  P  +   K +  SDV+SFGVVL EL T        P   M +  N K    +
Sbjct: 184 -----WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 238
Query: 304 VPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDR 363
           V + +  +KNNG R        DE  M        + ++C      +RP+ + ++  +D+
Sbjct: 239 VFHLIELLKNNG-RLPRPDGCPDEIYM--------IMTECWNNNVNQRPSFRDLALRVDQ 289
Query: 364 LR 365
           +R
Sbjct: 290 IR 291

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 72/153 (47%), Gaps = 15/153 (9%)
Query: 140 NHKNVVKILGLCLETEVPLLVYEFASNGTLLD---HIRCESSQVLKTWKTCLRIAAETAS 196
            H+NVV++    L  +   +V EF   G L D   H R    Q+      CL +      
Sbjct: 129 QHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAV---CLAVL----Q 181
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
           AL  LH+     +IH D+KS +ILL  +   K++DF     +S   E      L+GT  +
Sbjct: 182 ALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRRKXLVGTPYW 236
Query: 257 LDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           + P  I+      + D++S G+++ E++ G+ P
Sbjct: 237 MAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 269

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 72/286 (25%), Positives = 122/286 (42%), Gaps = 44/286 (15%)
Query: 95  LSQGGFVSVYKGV---------LHDNIQVAVKTYRRADKX-XXXXXXXXXXXSQVNHKNV 144
           L QG F  ++KGV         LH+  +V +K   +A +             S+++HK++
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHET-EVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 145 VKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSL 204
           V   G+C   +  +LV EF   G+L  +++   + +   WK  L +A + A A   +H L
Sbjct: 75  VLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILWK--LEVAKQLAWA---MHFL 129
Query: 205 ASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMST----ILIGTSGYLDPV 260
               +IHG+V + NILL      K  +     +  SD   +++     IL     ++ P 
Sbjct: 130 EENTLIHGNVCAKNILLIREEDRKTGN--PPFIKLSDPGISITVLPKDILQERIPWVPPE 187
Query: 261 CI-NTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQ 318
           CI N   L   +D +SFG  L E+ + G KP S   L S +K+                 
Sbjct: 188 CIENPKNLNLATDKWSFGTTLWEICSGGDKPLS--ALDSQRKLQFYE------------- 232
Query: 319 ILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL 364
             + H     +  E+   A L + C+      RP+ + +  +L+ L
Sbjct: 233 --DRHQLPAPKAAEL---ANLINNCMDYEPDHRPSFRAIIRDLNSL 273

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 95/210 (45%), Gaps = 24/210 (11%)
Query: 92  SRCLSQGGFVSVYKGVL----HDNIQVAVKTYRR--ADKXXXXXXXXXXXXSQVNHKNVV 145
            RC+ +G F  V++G+     +  + VA+KT +   +D              Q +H ++V
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 146 KILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLA 205
           K++G+  E  V  ++ E  + G L   ++     +     + +  A + ++AL YL S  
Sbjct: 455 KLIGVITENPV-WIIMELCTLGELRSFLQVRKFSL--DLASLILYAYQLSTALAYLESKR 511
Query: 206 SPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG-----YLDPV 260
               +H D+ + N+L++     K+ DF  S  +        ST    + G     ++ P 
Sbjct: 512 ---FVHRDIAARNVLVSATDCVKLGDFGLSRYMED------STYYKASKGKLPIKWMAPE 562
Query: 261 CINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
            IN  + T  SDV+ FGV + E+L  G KP
Sbjct: 563 SINFRRFTSASDVWMFGVCMWEILMHGVKP 592

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 91/207 (43%), Gaps = 22/207 (10%)
Query: 94  CLSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLE 153
           C+ +G +  V++G       VAVK +   D+              + H+N++  +   + 
Sbjct: 15  CVGKGRYGEVWRGSWQGE-NVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMT 73
Query: 154 TEVP----LLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLH-----SL 204
           +        L+  +   G+L D+++  +   +    +CLRI    AS L +LH     + 
Sbjct: 74  SRHSSTQLWLITHYHEMGSLYDYLQLTTLDTV----SCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 205 ASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET--AMSTILIGTSGYLDP--- 259
             P I H D+KS NIL+  N    +AD   +V+ S         +   +GT  Y+ P   
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189
Query: 260 ---VCINTGKLTKKSDVYSFGVVLAEL 283
              + ++     K+ D+++FG+VL E+
Sbjct: 190 DETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 105/228 (46%), Gaps = 27/228 (11%)
Query: 138 QVNHKNVVKILGLCLE-TEVPL-LVYEFASNGTLLDHIR--CESSQVLKTWKTCLRIAAE 193
           ++ H N+V+     ++ T   L +V E+   G L   I    +  Q L   +  LR+  +
Sbjct: 61  ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDE-EFVLRVMTQ 119
Query: 194 TASALDYLH--SLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILI 251
              AL   H  S     ++H D+K AN+ L+     K+ DF  + +++ D  T+ +   +
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD--TSFAKTFV 177
Query: 252 GTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSI 311
           GT  Y+ P  +N     +KSD++S G +L EL     P    T  S K+++        I
Sbjct: 178 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP---FTAFSQKELA------GKI 228
Query: 312 KNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE 359
           +    R+I  +  +DE        + E+ ++ L ++   RP+++++ E
Sbjct: 229 REGKFRRI-PYRYSDE--------LNEIITRMLNLKDYHRPSVEEILE 267

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 95/210 (45%), Gaps = 24/210 (11%)
Query: 92  SRCLSQGGFVSVYKGVL----HDNIQVAVKTYRR--ADKXXXXXXXXXXXXSQVNHKNVV 145
            RC+ +G F  V++G+     +  + VA+KT +   +D              Q +H ++V
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 146 KILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLA 205
           K++G+  E  V  ++ E  + G L   ++     +     + +  A + ++AL YL S  
Sbjct: 75  KLIGVITENPV-WIIMELCTLGELRSFLQVRKFSL--DLASLILYAYQLSTALAYLESKR 131
Query: 206 SPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG-----YLDPV 260
               +H D+ + N+L++     K+ DF  S  +        ST    + G     ++ P 
Sbjct: 132 ---FVHRDIAARNVLVSATDCVKLGDFGLSRYMED------STYYKASKGKLPIKWMAPE 182
Query: 261 CINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
            IN  + T  SDV+ FGV + E+L  G KP
Sbjct: 183 SINFRRFTSASDVWMFGVCMWEILMHGVKP 212

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 91/207 (43%), Gaps = 22/207 (10%)
Query: 94  CLSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLE 153
           C+ +G +  V++G       VAVK +   D+              + H+N++  +   + 
Sbjct: 15  CVGKGRYGEVWRGSWQGE-NVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMT 73
Query: 154 TEVP----LLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLH-----SL 204
           +        L+  +   G+L D+++  +   +    +CLRI    AS L +LH     + 
Sbjct: 74  SRHSSTQLWLITHYHEMGSLYDYLQLTTLDTV----SCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 205 ASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET--AMSTILIGTSGYLDP--- 259
             P I H D+KS NIL+  N    +AD   +V+ S         +   +GT  Y+ P   
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189
Query: 260 ---VCINTGKLTKKSDVYSFGVVLAEL 283
              + ++     K+ D+++FG+VL E+
Sbjct: 190 DETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 68/285 (23%), Positives = 120/285 (42%), Gaps = 45/285 (15%)
Query: 93  RCLSQGGFVSVYKGVLHDNIQ------VAVKTYRRAD--KXXXXXXXXXXXXSQVNHKNV 144
           R L QG F  VY+G   D I+      VAVKT   +   +                  +V
Sbjct: 22  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 81
Query: 145 VKILGLCLETEVPLLVYEFASNGTLLDHIRC-------ESSQVLKTWKTCLRIAAETASA 197
           V++LG+  + +  L+V E  ++G L  ++R           +   T +  +++AAE A  
Sbjct: 82  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 141
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFE-SSVLISSDAETAMSTILIGTSGY 256
           + YL++      +H D+ + N ++  ++T K+ DF  +  +  +D        L+    +
Sbjct: 142 MAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-W 197
Query: 257 LDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGL 316
           + P  +  G  T  SD++SFGVVL E+ +               ++  PY    + N   
Sbjct: 198 MAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPY--QGLSNE-- 238
Query: 317 RQILNFHVADESEMKE----IEIVAELASKCLRIRGTERPTMKQV 357
            Q+L F V D   + +     E V +L   C +     RPT  ++
Sbjct: 239 -QVLKF-VMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEI 281

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 92/209 (44%), Gaps = 13/209 (6%)
Query: 87  KNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTY-RRADKXXXXXXXXXXXXSQVNHKNV 144
           +N DR   L +G +  VY G  L + +++A+K    R  +              + HKN+
Sbjct: 23  ENGDRV-VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNI 81
Query: 145 VKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSL 204
           V+ LG   E     +  E    G+L   +R +   +    +T      +    L YLH  
Sbjct: 82  VQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN 141
Query: 205 ASPPIIHGDVKSANILLNDNYTA--KVADFESSVLISSDAETAMSTILIGTSGYLDPVCI 262
               I+H D+K  N+L+N  Y+   K++DF +S  ++       +    GT  Y+ P  I
Sbjct: 142 Q---IVHRDIKGDNVLIN-TYSGVLKISDFGTSKRLA--GINPCTETFTGTLQYMAPEII 195
Query: 263 NTGK--LTKKSDVYSFGVVLAELLTGKKP 289
           + G     K +D++S G  + E+ TGK P
Sbjct: 196 DKGPRGYGKAADIWSLGCTIIEMATGKPP 224

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 72/153 (47%), Gaps = 15/153 (9%)
Query: 140 NHKNVVKILGLCLETEVPLLVYEFASNGTLLD---HIRCESSQVLKTWKTCLRIAAETAS 196
            H+NVV++    L  +   +V EF   G L D   H R    Q+      CL +      
Sbjct: 86  QHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAV---CLAVL----Q 138
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
           AL  LH+     +IH D+KS +ILL  +   K++DF     +S   E      L+GT  +
Sbjct: 139 ALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRRKXLVGTPYW 193
Query: 257 LDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           + P  I+      + D++S G+++ E++ G+ P
Sbjct: 194 MAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 226

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 87/181 (48%), Gaps = 21/181 (11%)
Query: 139 VNHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
           +NH N+VK+  + +ETE  L LV E+AS G + D++        K  +   R   +  SA
Sbjct: 71  LNHPNIVKLFEV-IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR---QIVSA 126
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESS--VLISSDAETAMSTILIGTSG 255
           + Y H      I+H D+K+ N+LL+ +   K+ADF  S    + +  +T       G+  
Sbjct: 127 VQYCHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDT-----FCGSPP 178
Query: 256 YLDPVCINTGKLT-KKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISM-----VPYFLN 309
           Y  P      K    + DV+S GV+L  L++G  P     L   ++  +     +P++++
Sbjct: 179 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMS 238
Query: 310 S 310
           +
Sbjct: 239 T 239

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 72/153 (47%), Gaps = 15/153 (9%)
Query: 140 NHKNVVKILGLCLETEVPLLVYEFASNGTLLD---HIRCESSQVLKTWKTCLRIAAETAS 196
            H+NVV++    L  +   +V EF   G L D   H R    Q+      CL +      
Sbjct: 84  QHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAV---CLAVL----Q 136
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
           AL  LH+     +IH D+KS +ILL  +   K++DF     +S   E      L+GT  +
Sbjct: 137 ALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRRKXLVGTPYW 191
Query: 257 LDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           + P  I+      + D++S G+++ E++ G+ P
Sbjct: 192 MAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 224

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 105/228 (46%), Gaps = 27/228 (11%)
Query: 138 QVNHKNVVKILGLCLE-TEVPL-LVYEFASNGTLLDHIR--CESSQVLKTWKTCLRIAAE 193
           ++ H N+V+     ++ T   L +V E+   G L   I    +  Q L   +  LR+  +
Sbjct: 61  ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDE-EFVLRVMTQ 119
Query: 194 TASALDYLH--SLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILI 251
              AL   H  S     ++H D+K AN+ L+     K+ DF  + +++ D  T+ +   +
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD--TSFAKAFV 177
Query: 252 GTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSI 311
           GT  Y+ P  +N     +KSD++S G +L EL     P    T  S K+++        I
Sbjct: 178 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP---FTAFSQKELA------GKI 228
Query: 312 KNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE 359
           +    R+I  +  +DE        + E+ ++ L ++   RP+++++ E
Sbjct: 229 REGKFRRI-PYRYSDE--------LNEIITRMLNLKDYHRPSVEEILE 267

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 68/285 (23%), Positives = 120/285 (42%), Gaps = 45/285 (15%)
Query: 93  RCLSQGGFVSVYKGVLHDNIQ------VAVKTYRRAD--KXXXXXXXXXXXXSQVNHKNV 144
           R L QG F  VY+G   D I+      VAVKT   +   +                  +V
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 145 VKILGLCLETEVPLLVYEFASNGTLLDHIRC-------ESSQVLKTWKTCLRIAAETASA 197
           V++LG+  + +  L+V E  ++G L  ++R           +   T +  +++AAE A  
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFE-SSVLISSDAETAMSTILIGTSGY 256
           + YL++      +H D+ + N ++  ++T K+ DF  +  +  +D        L+    +
Sbjct: 143 MAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-W 198
Query: 257 LDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGL 316
           + P  +  G  T  SD++SFGVVL E+ +               ++  PY    + N   
Sbjct: 199 MAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPY--QGLSNE-- 239
Query: 317 RQILNFHVADESEMKE----IEIVAELASKCLRIRGTERPTMKQV 357
            Q+L F V D   + +     E V +L   C +     RPT  ++
Sbjct: 240 -QVLKF-VMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEI 282

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 92/209 (44%), Gaps = 13/209 (6%)
Query: 87  KNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTY-RRADKXXXXXXXXXXXXSQVNHKNV 144
           +N DR   L +G +  VY G  L + +++A+K    R  +              + HKN+
Sbjct: 9   ENGDRV-VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNI 67
Query: 145 VKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSL 204
           V+ LG   E     +  E    G+L   +R +   +    +T      +    L YLH  
Sbjct: 68  VQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN 127
Query: 205 ASPPIIHGDVKSANILLNDNYTA--KVADFESSVLISSDAETAMSTILIGTSGYLDPVCI 262
               I+H D+K  N+L+N  Y+   K++DF +S  ++       +    GT  Y+ P  I
Sbjct: 128 Q---IVHRDIKGDNVLIN-TYSGVLKISDFGTSKRLA--GINPCTETFTGTLQYMAPEII 181
Query: 263 NTGK--LTKKSDVYSFGVVLAELLTGKKP 289
           + G     K +D++S G  + E+ TGK P
Sbjct: 182 DKGPRGYGKAADIWSLGCTIIEMATGKPP 210

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 76/152 (50%), Gaps = 15/152 (9%)
Query: 141 HKNVVKILGLCLETEVPLLVYEFASNGTLLDHIR--C-ESSQVLKTWKTCLRIAAETASA 197
           + N+V  L   L  +   +V E+ + G+L D +   C +  Q+    + CL+       A
Sbjct: 76  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ-------A 128
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYL 257
           L++LHS     +IH D+KS NILL  + + K+ DF     I+   E +  + ++GT  ++
Sbjct: 129 LEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT--PEQSKRSTMVGTPYWM 183
Query: 258 DPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
            P  +       K D++S G++  E++ G+ P
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 76/152 (50%), Gaps = 15/152 (9%)
Query: 141 HKNVVKILGLCLETEVPLLVYEFASNGTLLDHIR--C-ESSQVLKTWKTCLRIAAETASA 197
           + N+V  L   L  +   +V E+ + G+L D +   C +  Q+    + CL+       A
Sbjct: 77  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ-------A 129
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYL 257
           L++LHS     +IH D+KS NILL  + + K+ DF     I+   E +  + ++GT  ++
Sbjct: 130 LEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSXMVGTPYWM 184
Query: 258 DPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
            P  +       K D++S G++  E++ G+ P
Sbjct: 185 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 72/153 (47%), Gaps = 15/153 (9%)
Query: 140 NHKNVVKILGLCLETEVPLLVYEFASNGTLLD---HIRCESSQVLKTWKTCLRIAAETAS 196
            H+NVV++    L  +   +V EF   G L D   H R    Q+      CL +      
Sbjct: 75  QHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAV---CLAVL----Q 127
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
           AL  LH+     +IH D+KS +ILL  +   K++DF     +S   E      L+GT  +
Sbjct: 128 ALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRRKXLVGTPYW 182
Query: 257 LDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           + P  I+      + D++S G+++ E++ G+ P
Sbjct: 183 MAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 215

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 76/152 (50%), Gaps = 15/152 (9%)
Query: 141 HKNVVKILGLCLETEVPLLVYEFASNGTLLDHIR--C-ESSQVLKTWKTCLRIAAETASA 197
           + N+V  L   L  +   +V E+ + G+L D +   C +  Q+    + CL+       A
Sbjct: 76  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ-------A 128
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYL 257
           L++LHS     +IH D+KS NILL  + + K+ DF     I+   E +  + ++GT  ++
Sbjct: 129 LEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSXMVGTPYWM 183
Query: 258 DPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
            P  +       K D++S G++  E++ G+ P
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 91/207 (43%), Gaps = 22/207 (10%)
Query: 94  CLSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLE 153
           C+ +G +  V++G       VAVK +   D+              + H+N++  +   + 
Sbjct: 44  CVGKGRYGEVWRGSWQGE-NVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMT 102
Query: 154 TEVP----LLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLH-----SL 204
           +        L+  +   G+L D+++  +   +    +CLRI    AS L +LH     + 
Sbjct: 103 SRHSSTQLWLITHYHEMGSLYDYLQLTTLDTV----SCLRIVLSIASGLAHLHIEIFGTQ 158
Query: 205 ASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET--AMSTILIGTSGYLDP--- 259
             P I H D+KS NIL+  N    +AD   +V+ S         +   +GT  Y+ P   
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 218
Query: 260 ---VCINTGKLTKKSDVYSFGVVLAEL 283
              + ++     K+ D+++FG+VL E+
Sbjct: 219 DETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 97/215 (45%), Gaps = 28/215 (13%)
Query: 87  KNFDRSRCLSQGGFVSVY--KGVLHDNIQVAVK----TYRRADKXXXXXXXXXXXXSQVN 140
           K F   R +  G F +VY  + V +  + VA+K    + +++++             ++ 
Sbjct: 15  KLFSDLREIGHGSFGAVYFARDVRNSEV-VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 141 HKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLR---IAAETASA 197
           H N ++  G  L      LV E+             +S +L+  K  L+   IAA T  A
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGS---------ASDLLEVHKKPLQEVEIAAVTHGA 124
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYL 257
           L  L  L S  +IH DVK+ NILL++    K+ DF S+ ++      A +   +GT  ++
Sbjct: 125 LQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWM 178
Query: 258 DP---VCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
            P   + ++ G+   K DV+S G+   EL   K P
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 72/153 (47%), Gaps = 15/153 (9%)
Query: 140 NHKNVVKILGLCLETEVPLLVYEFASNGTLLD---HIRCESSQVLKTWKTCLRIAAETAS 196
            H+NVV++    L  +   +V EF   G L D   H R    Q+      CL +      
Sbjct: 79  QHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAV---CLAVL----Q 131
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
           AL  LH+     +IH D+KS +ILL  +   K++DF     +S   E      L+GT  +
Sbjct: 132 ALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRRKXLVGTPYW 186
Query: 257 LDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           + P  I+      + D++S G+++ E++ G+ P
Sbjct: 187 MAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 219

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 97/215 (45%), Gaps = 28/215 (13%)
Query: 87  KNFDRSRCLSQGGFVSVY--KGVLHDNIQVAVK----TYRRADKXXXXXXXXXXXXSQVN 140
           K F   R +  G F +VY  + V +  + VA+K    + +++++             ++ 
Sbjct: 54  KLFSDLREIGHGSFGAVYFARDVRNSEV-VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 141 HKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLR---IAAETASA 197
           H N ++  G  L      LV E+             +S +L+  K  L+   IAA T  A
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGS---------ASDLLEVHKKPLQEVEIAAVTHGA 163
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYL 257
           L  L  L S  +IH DVK+ NILL++    K+ DF S+ ++      A +   +GT  ++
Sbjct: 164 LQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWM 217
Query: 258 DP---VCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
            P   + ++ G+   K DV+S G+   EL   K P
Sbjct: 218 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 95/205 (46%), Gaps = 14/205 (6%)
Query: 92  SRCLSQGGFVSVYKGVLHDN----IQVAVKTYRR--ADKXXXXXXXXXXXXSQVNHKNVV 145
           +R L +G F  VY+GV  ++    I VAVKT ++                   ++H ++V
Sbjct: 13  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 72
Query: 146 KILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLA 205
           K++G+ +E E   ++ E    G L  H    +   LK   T +  + +   A+ YL S+ 
Sbjct: 73  KLIGI-IEEEPTWIIMELYPYGEL-GHYLERNKNSLKV-LTLVLYSLQICKAMAYLESIN 129
Query: 206 SPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTG 265
               +H D+   NIL+      K+ DF  S  I  D +   +++      ++ P  IN  
Sbjct: 130 C---VHRDIAVRNILVASPECVKLGDFGLSRYIE-DEDYYKASVTRLPIKWMSPESINFR 185
Query: 266 KLTKKSDVYSFGVVLAELLT-GKKP 289
           + T  SDV+ F V + E+L+ GK+P
Sbjct: 186 RFTTASDVWMFAVCMWEILSFGKQP 210

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 139 VNHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
           +NH N+VK+  + +ETE  L LV E+AS G + D++        K  +   R   +  SA
Sbjct: 70  LNHPNIVKLFEV-IETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFR---QIVSA 125
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYL 257
           + Y H      I+H D+K+ N+LL+ +   K+ADF  S   +   +        G   Y 
Sbjct: 126 VQYCHQKF---IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKL---DAFCGAPPYA 179
Query: 258 DPVCINTGKLT-KKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISM-----VPYFLNSI 311
            P      K    + DV+S GV+L  L++G  P     L   ++  +     +P++ ++ 
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYXSTD 239
Query: 312 KNNGLRQILNFHVADESEMKEI 333
             N L++ L  + +    +++I
Sbjct: 240 CENLLKKFLILNPSKRGTLEQI 261

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/302 (21%), Positives = 125/302 (41%), Gaps = 50/302 (16%)
Query: 87  KNFDRSRCLSQGGFVSVYKGVLHD------NIQVAVKTYR-RADKXXXXXXXXX-XXXSQ 138
           +N +  + L  G F  V     +       +IQVAVK  + +AD              +Q
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 139 V-NHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQV----------------- 180
           + +H+N+V +LG C  +    L++E+   G LL+++R +  +                  
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 181 ---LKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVL 237
              + T++  L  A + A  +++L   +    +H D+ + N+L+      K+ DF  +  
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFKSC---VHRDLAARNVLVTHGKVVKICDFGLARD 221
Query: 238 ISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLA 296
           I SD+   +         ++ P  +  G  T KSDV+S+G++L E+ + G  P   + + 
Sbjct: 222 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 281
Query: 297 SNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQ 356
           +N            +  NG +    F+  +     EI I+ +    C      +RP+   
Sbjct: 282 AN---------FYKLIQNGFKMDQPFYATE-----EIYIIMQ---SCWAFDSRKRPSFPN 324
Query: 357 VS 358
           ++
Sbjct: 325 LT 326

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 95/205 (46%), Gaps = 14/205 (6%)
Query: 92  SRCLSQGGFVSVYKGVLHDN----IQVAVKTYRR--ADKXXXXXXXXXXXXSQVNHKNVV 145
           +R L +G F  VY+GV  ++    I VAVKT ++                   ++H ++V
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 146 KILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLA 205
           K++G+ +E E   ++ E    G L  H    +   LK   T +  + +   A+ YL S+ 
Sbjct: 77  KLIGI-IEEEPTWIIMELYPYGEL-GHYLERNKNSLKV-LTLVLYSLQICKAMAYLESIN 133
Query: 206 SPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTG 265
               +H D+   NIL+      K+ DF  S  I  D +   +++      ++ P  IN  
Sbjct: 134 C---VHRDIAVRNILVASPECVKLGDFGLSRYIE-DEDYYKASVTRLPIKWMSPESINFR 189
Query: 266 KLTKKSDVYSFGVVLAELLT-GKKP 289
           + T  SDV+ F V + E+L+ GK+P
Sbjct: 190 RFTTASDVWMFAVCMWEILSFGKQP 214

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 97/231 (41%), Gaps = 36/231 (15%)
Query: 83  IRATKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNH 141
           +R   +F+    L QG F  V K     D+   A+K  R  ++            + +NH
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNH 61
Query: 142 KNVVKILGLCLE--------TEVP-----LLVYEFASNGTLLDHIRCES--SQVLKTWKT 186
           + VV+     LE        T V       +  E+  N TL D I  E+   Q  + W  
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYW-- 119
Query: 187 CLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADF-------ESSVLIS 239
             R+  +   AL Y+HS     IIH D+K  NI ++++   K+ DF        S  ++ 
Sbjct: 120 --RLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 240 SDAETAMS-----TILIGTSGYL-DPVCINTGKLTKKSDVYSFGVVLAELL 284
            D++         T  IGT+ Y+   V   TG   +K D+YS G++  E++
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 95/205 (46%), Gaps = 14/205 (6%)
Query: 92  SRCLSQGGFVSVYKGVLHDN----IQVAVKTYRR--ADKXXXXXXXXXXXXSQVNHKNVV 145
           +R L +G F  VY+GV  ++    I VAVKT ++                   ++H ++V
Sbjct: 29  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 88
Query: 146 KILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLA 205
           K++G+ +E E   ++ E    G L  H    +   LK   T +  + +   A+ YL S+ 
Sbjct: 89  KLIGI-IEEEPTWIIMELYPYGEL-GHYLERNKNSLKV-LTLVLYSLQICKAMAYLESIN 145
Query: 206 SPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTG 265
               +H D+   NIL+      K+ DF  S  I  D +   +++      ++ P  IN  
Sbjct: 146 C---VHRDIAVRNILVASPECVKLGDFGLSRYIE-DEDYYKASVTRLPIKWMSPESINFR 201
Query: 266 KLTKKSDVYSFGVVLAELLT-GKKP 289
           + T  SDV+ F V + E+L+ GK+P
Sbjct: 202 RFTTASDVWMFAVCMWEILSFGKQP 226

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 88/214 (41%), Gaps = 18/214 (8%)
Query: 87  KNFDRSRCLSQGGFVSVYKGVL------HDNIQVAVKTYRR--ADKXXXXXXXXXXXXSQ 138
           KN    R L  G F  VY+G +         +QVAVKT     +++            S+
Sbjct: 57  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 116
Query: 139 VNHKNVVKILGLCLETEVPLLVYEFASNGTL---LDHIRCESSQVLK-TWKTCLRIAAET 194
            NH+N+V+ +G+ L++    ++ E  + G L   L   R   SQ         L +A + 
Sbjct: 117 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 176
Query: 195 ASALDYLHSLASPPIIHGDVKSANILL---NDNYTAKVADFESSVLISSDAETAMSTILI 251
           A    YL        IH D+ + N LL        AK+ DF  +  I   +        +
Sbjct: 177 ACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 233
Query: 252 GTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT 285
               ++ P     G  T K+D +SFGV+L E+ +
Sbjct: 234 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 70/153 (45%), Gaps = 8/153 (5%)
Query: 139 VNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASAL 198
           ++H+N++++ G+ L   + + V E A  G+LLD +R      L    T  R A + A  +
Sbjct: 78  LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLG--TLSRYAVQVAEGM 134
Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTAKVADFE-SSVLISSDAETAMSTILIGTSGYL 257
            YL S      IH D+ + N+LL      K+ DF     L  +D    M         + 
Sbjct: 135 GYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWC 191
Query: 258 DPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
            P  + T   +  SD + FGV L E+ T G++P
Sbjct: 192 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 89/214 (41%), Gaps = 18/214 (8%)
Query: 87  KNFDRSRCLSQGGFVSVYKGVL------HDNIQVAVKTYRR--ADKXXXXXXXXXXXXSQ 138
           KN    R L  G F  VY+G +         +QVAVKT     +++            S+
Sbjct: 31  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 90
Query: 139 VNHKNVVKILGLCLETEVPLLVYEFASNGTL---LDHIRCESSQVLK-TWKTCLRIAAET 194
           +NH+N+V+ +G+ L++    ++ E  + G L   L   R   SQ         L +A + 
Sbjct: 91  LNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 150
Query: 195 ASALDYLHSLASPPIIHGDVKSANILL---NDNYTAKVADFESSVLISSDAETAMSTILI 251
           A    YL        IH D+ + N LL        AK+ DF  +  I   +        +
Sbjct: 151 ACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 207
Query: 252 GTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT 285
               ++ P     G  T K+D +SFGV+L E+ +
Sbjct: 208 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 88/214 (41%), Gaps = 18/214 (8%)
Query: 87  KNFDRSRCLSQGGFVSVYKGVL------HDNIQVAVKTYRR--ADKXXXXXXXXXXXXSQ 138
           KN    R L  G F  VY+G +         +QVAVKT     +++            S+
Sbjct: 31  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 90
Query: 139 VNHKNVVKILGLCLETEVPLLVYEFASNGTL---LDHIRCESSQVLK-TWKTCLRIAAET 194
            NH+N+V+ +G+ L++    ++ E  + G L   L   R   SQ         L +A + 
Sbjct: 91  FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 150
Query: 195 ASALDYLHSLASPPIIHGDVKSANILL---NDNYTAKVADFESSVLISSDAETAMSTILI 251
           A    YL        IH D+ + N LL        AK+ DF  +  I   +        +
Sbjct: 151 ACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAM 207
Query: 252 GTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT 285
               ++ P     G  T K+D +SFGV+L E+ +
Sbjct: 208 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 89/214 (41%), Gaps = 18/214 (8%)
Query: 87  KNFDRSRCLSQGGFVSVYKGVL------HDNIQVAVKTYRR--ADKXXXXXXXXXXXXSQ 138
           KN    R L  G F  VY+G +         +QVAVKT     +++            S+
Sbjct: 45  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 104
Query: 139 VNHKNVVKILGLCLETEVPLLVYEFASNGTL---LDHIRCESSQVLK-TWKTCLRIAAET 194
           +NH+N+V+ +G+ L++    ++ E  + G L   L   R   SQ         L +A + 
Sbjct: 105 LNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 164
Query: 195 ASALDYLHSLASPPIIHGDVKSANILL---NDNYTAKVADFESSVLISSDAETAMSTILI 251
           A    YL        IH D+ + N LL        AK+ DF  +  I   +        +
Sbjct: 165 ACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 221
Query: 252 GTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT 285
               ++ P     G  T K+D +SFGV+L E+ +
Sbjct: 222 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 104/228 (45%), Gaps = 27/228 (11%)
Query: 138 QVNHKNVVKILGLCLE-TEVPL-LVYEFASNGTLLDHIR--CESSQVLKTWKTCLRIAAE 193
           ++ H N+V+     ++ T   L +V E+   G L   I    +  Q L   +  LR+  +
Sbjct: 61  ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDE-EFVLRVMTQ 119
Query: 194 TASALDYLH--SLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILI 251
              AL   H  S     ++H D+K AN+ L+     K+ DF  + +++ D + A     +
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKE--FV 177
Query: 252 GTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSI 311
           GT  Y+ P  +N     +KSD++S G +L EL     P    T  S K+++        I
Sbjct: 178 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP---FTAFSQKELA------GKI 228
Query: 312 KNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE 359
           +    R+I  +  +DE        + E+ ++ L ++   RP+++++ E
Sbjct: 229 REGKFRRI-PYRYSDE--------LNEIITRMLNLKDYHRPSVEEILE 267

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 70/153 (45%), Gaps = 8/153 (5%)
Query: 139 VNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASAL 198
           ++H+N++++ G+ L   + + V E A  G+LLD +R      L    T  R A + A  +
Sbjct: 68  LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLG--TLSRYAVQVAEGM 124
Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTAKVADFE-SSVLISSDAETAMSTILIGTSGYL 257
            YL S      IH D+ + N+LL      K+ DF     L  +D    M         + 
Sbjct: 125 GYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWC 181
Query: 258 DPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
            P  + T   +  SD + FGV L E+ T G++P
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 96/237 (40%), Gaps = 30/237 (12%)
Query: 140 NHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIR-------CESSQVLKTWKTCLRIAA 192
           NH N+V +LG C      L++ E+   G LL+ +R       C  +         L +  
Sbjct: 108 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 167
Query: 193 ETASALDY-----LHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMS 247
           E   +  Y     +  LAS   IH D+ + NILL      K+ DF  +  I +D+   + 
Sbjct: 168 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVK 227
Query: 248 TILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPY 306
                   ++ P  I     T +SDV+S+G+ L EL + G  P   M + S         
Sbjct: 228 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-------- 279
Query: 307 FLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDR 363
           F   IK  G R +   H   E        + ++   C      +RPT KQ+ + +++
Sbjct: 280 FYKMIK-EGFRMLSPEHAPAE--------MYDIMKTCWDADPLKRPTFKQIVQLIEK 327

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 88/214 (41%), Gaps = 18/214 (8%)
Query: 87  KNFDRSRCLSQGGFVSVYKGVL------HDNIQVAVKTYRR--ADKXXXXXXXXXXXXSQ 138
           KN    R L  G F  VY+G +         +QVAVKT     +++            S+
Sbjct: 47  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 106
Query: 139 VNHKNVVKILGLCLETEVPLLVYEFASNGTL---LDHIRCESSQVLK-TWKTCLRIAAET 194
            NH+N+V+ +G+ L++    ++ E  + G L   L   R   SQ         L +A + 
Sbjct: 107 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 166
Query: 195 ASALDYLHSLASPPIIHGDVKSANILL---NDNYTAKVADFESSVLISSDAETAMSTILI 251
           A    YL        IH D+ + N LL        AK+ DF  +  I   +        +
Sbjct: 167 ACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 223
Query: 252 GTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT 285
               ++ P     G  T K+D +SFGV+L E+ +
Sbjct: 224 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 88/214 (41%), Gaps = 18/214 (8%)
Query: 87  KNFDRSRCLSQGGFVSVYKGVL------HDNIQVAVKTYRR--ADKXXXXXXXXXXXXSQ 138
           KN    R L  G F  VY+G +         +QVAVKT     +++            S+
Sbjct: 30  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 139 VNHKNVVKILGLCLETEVPLLVYEFASNGTL---LDHIRCESSQVLK-TWKTCLRIAAET 194
            NH+N+V+ +G+ L++    ++ E  + G L   L   R   SQ         L +A + 
Sbjct: 90  FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 195 ASALDYLHSLASPPIIHGDVKSANILL---NDNYTAKVADFESSVLISSDAETAMSTILI 251
           A    YL        IH D+ + N LL        AK+ DF  +  I   +        +
Sbjct: 150 ACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 206
Query: 252 GTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT 285
               ++ P     G  T K+D +SFGV+L E+ +
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 76/152 (50%), Gaps = 15/152 (9%)
Query: 141 HKNVVKILGLCLETEVPLLVYEFASNGTLLDHIR--C-ESSQVLKTWKTCLRIAAETASA 197
           + N+V  L   L  +   +V E+ + G+L D +   C +  Q+    + CL+       A
Sbjct: 76  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ-------A 128
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYL 257
           L++LHS     +IH D+KS NILL  + + K+ DF     I+   E +  + ++GT  ++
Sbjct: 129 LEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSEMVGTPYWM 183
Query: 258 DPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
            P  +       K D++S G++  E++ G+ P
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 88/214 (41%), Gaps = 18/214 (8%)
Query: 87  KNFDRSRCLSQGGFVSVYKGVL------HDNIQVAVKTYRR--ADKXXXXXXXXXXXXSQ 138
           KN    R L  G F  VY+G +         +QVAVKT     +++            S+
Sbjct: 31  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 90
Query: 139 VNHKNVVKILGLCLETEVPLLVYEFASNGTL---LDHIRCESSQVLK-TWKTCLRIAAET 194
            NH+N+V+ +G+ L++    ++ E  + G L   L   R   SQ         L +A + 
Sbjct: 91  FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 150
Query: 195 ASALDYLHSLASPPIIHGDVKSANILL---NDNYTAKVADFESSVLISSDAETAMSTILI 251
           A    YL        IH D+ + N LL        AK+ DF  +  I   +        +
Sbjct: 151 ACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 207
Query: 252 GTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT 285
               ++ P     G  T K+D +SFGV+L E+ +
Sbjct: 208 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 70/153 (45%), Gaps = 8/153 (5%)
Query: 139 VNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASAL 198
           ++H+N++++ G+ L   + + V E A  G+LLD +R      L    T  R A + A  +
Sbjct: 72  LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLG--TLSRYAVQVAEGM 128
Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTAKVADFE-SSVLISSDAETAMSTILIGTSGYL 257
            YL S      IH D+ + N+LL      K+ DF     L  +D    M         + 
Sbjct: 129 GYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 185
Query: 258 DPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
            P  + T   +  SD + FGV L E+ T G++P
Sbjct: 186 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 70/153 (45%), Gaps = 8/153 (5%)
Query: 139 VNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASAL 198
           ++H+N++++ G+ L   + + V E A  G+LLD +R      L    T  R A + A  +
Sbjct: 78  LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLG--TLSRYAVQVAEGM 134
Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTAKVADFE-SSVLISSDAETAMSTILIGTSGYL 257
            YL S      IH D+ + N+LL      K+ DF     L  +D    M         + 
Sbjct: 135 GYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 191
Query: 258 DPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
            P  + T   +  SD + FGV L E+ T G++P
Sbjct: 192 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 87/214 (40%), Gaps = 18/214 (8%)
Query: 87  KNFDRSRCLSQGGFVSVYKGVL------HDNIQVAVKTYRR--ADKXXXXXXXXXXXXSQ 138
           KN    R L  G F  VY+G +         +QVAVKT     +++            S+
Sbjct: 71  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130
Query: 139 VNHKNVVKILGLCLETEVPLLVYEFASNGTL---LDHIRCESSQVLK-TWKTCLRIAAET 194
            NH+N+V+ +G+ L++    ++ E  + G L   L   R   SQ         L +A + 
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 195 ASALDYLHSLASPPIIHGDVKSANILL---NDNYTAKVADFESSVLISSDAETAMSTILI 251
           A    YL        IH D+ + N LL        AK+ DF  +  I            +
Sbjct: 191 ACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAM 247
Query: 252 GTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT 285
               ++ P     G  T K+D +SFGV+L E+ +
Sbjct: 248 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 88/214 (41%), Gaps = 18/214 (8%)
Query: 87  KNFDRSRCLSQGGFVSVYKGVL------HDNIQVAVKTYRR--ADKXXXXXXXXXXXXSQ 138
           KN    R L  G F  VY+G +         +QVAVKT     +++            S+
Sbjct: 30  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 139 VNHKNVVKILGLCLETEVPLLVYEFASNGTL---LDHIRCESSQVLK-TWKTCLRIAAET 194
            NH+N+V+ +G+ L++    ++ E  + G L   L   R   SQ         L +A + 
Sbjct: 90  FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 195 ASALDYLHSLASPPIIHGDVKSANILL---NDNYTAKVADFESSVLISSDAETAMSTILI 251
           A    YL        IH D+ + N LL        AK+ DF  +  I   +        +
Sbjct: 150 ACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 206
Query: 252 GTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT 285
               ++ P     G  T K+D +SFGV+L E+ +
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 88/214 (41%), Gaps = 18/214 (8%)
Query: 87  KNFDRSRCLSQGGFVSVYKGVL------HDNIQVAVKTYRR--ADKXXXXXXXXXXXXSQ 138
           KN    R L  G F  VY+G +         +QVAVKT     +++            S+
Sbjct: 37  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 96
Query: 139 VNHKNVVKILGLCLETEVPLLVYEFASNGTL---LDHIRCESSQVLK-TWKTCLRIAAET 194
            NH+N+V+ +G+ L++    ++ E  + G L   L   R   SQ         L +A + 
Sbjct: 97  FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 156
Query: 195 ASALDYLHSLASPPIIHGDVKSANILL---NDNYTAKVADFESSVLISSDAETAMSTILI 251
           A    YL        IH D+ + N LL        AK+ DF  +  I   +        +
Sbjct: 157 ACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 213
Query: 252 GTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT 285
               ++ P     G  T K+D +SFGV+L E+ +
Sbjct: 214 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 87/214 (40%), Gaps = 18/214 (8%)
Query: 87  KNFDRSRCLSQGGFVSVYKGVL------HDNIQVAVKTYRR--ADKXXXXXXXXXXXXSQ 138
           KN    R L  G F  VY+G +         +QVAVKT     +++            S+
Sbjct: 48  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 107
Query: 139 VNHKNVVKILGLCLETEVPLLVYEFASNGTL---LDHIRCESSQVLK-TWKTCLRIAAET 194
            NH+N+V+ +G+ L++    ++ E  + G L   L   R   SQ         L +A + 
Sbjct: 108 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 167
Query: 195 ASALDYLHSLASPPIIHGDVKSANILL---NDNYTAKVADFESSVLISSDAETAMSTILI 251
           A    YL        IH D+ + N LL        AK+ DF  +  I            +
Sbjct: 168 ACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAM 224
Query: 252 GTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT 285
               ++ P     G  T K+D +SFGV+L E+ +
Sbjct: 225 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 88/214 (41%), Gaps = 18/214 (8%)
Query: 87  KNFDRSRCLSQGGFVSVYKGVL------HDNIQVAVKTYRR--ADKXXXXXXXXXXXXSQ 138
           KN    R L  G F  VY+G +         +QVAVKT     +++            S+
Sbjct: 45  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 104
Query: 139 VNHKNVVKILGLCLETEVPLLVYEFASNGTL---LDHIRCESSQVLK-TWKTCLRIAAET 194
            NH+N+V+ +G+ L++    ++ E  + G L   L   R   SQ         L +A + 
Sbjct: 105 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 164
Query: 195 ASALDYLHSLASPPIIHGDVKSANILL---NDNYTAKVADFESSVLISSDAETAMSTILI 251
           A    YL        IH D+ + N LL        AK+ DF  +  I   +        +
Sbjct: 165 ACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 221
Query: 252 GTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT 285
               ++ P     G  T K+D +SFGV+L E+ +
Sbjct: 222 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 90/208 (43%), Gaps = 20/208 (9%)
Query: 95  LSQGGFVSVYKGVLHD-NIQVAVKTYRR--ADKXXXXXXXXXXXXSQVNHKNVVKI---- 147
           L  GGF  V + +  D   QVA+K  R+  + K             ++NH NVV      
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 148 --LGLCLETEVPLLVYEFASNGTLLDHI-RCESSQVLKTWKTCLRIAAETASALDYLHSL 204
             L      ++PLL  E+   G L  ++ + E+   LK       + ++ +SAL YLH  
Sbjct: 82  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKE-GPIRTLLSDISSALRYLHEN 140
Query: 205 ASPPIIHGDVKSANILLN---DNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVC 261
               IIH D+K  NI+L         K+ D   +  +    +  + T  +GT  YL P  
Sbjct: 141 R---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD---QGELCTEFVGTLQYLAPEL 194
Query: 262 INTGKLTKKSDVYSFGVVLAELLTGKKP 289
           +   K T   D +SFG +  E +TG +P
Sbjct: 195 LEQKKYTVTVDYWSFGTLAFECITGFRP 222

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 70/153 (45%), Gaps = 8/153 (5%)
Query: 139 VNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASAL 198
           ++H+N++++ G+ L   + + V E A  G+LLD +R      L    T  R A + A  +
Sbjct: 72  LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLG--TLSRYAVQVAEGM 128
Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTAKVADFE-SSVLISSDAETAMSTILIGTSGYL 257
            YL S      IH D+ + N+LL      K+ DF     L  +D    M         + 
Sbjct: 129 GYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 185
Query: 258 DPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
            P  + T   +  SD + FGV L E+ T G++P
Sbjct: 186 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 88/214 (41%), Gaps = 18/214 (8%)
Query: 87  KNFDRSRCLSQGGFVSVYKGVL------HDNIQVAVKTYRR--ADKXXXXXXXXXXXXSQ 138
           KN    R L  G F  VY+G +         +QVAVKT     +++            S+
Sbjct: 45  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISK 104
Query: 139 VNHKNVVKILGLCLETEVPLLVYEFASNGTL---LDHIRCESSQVLK-TWKTCLRIAAET 194
            NH+N+V+ +G+ L++    ++ E  + G L   L   R   SQ         L +A + 
Sbjct: 105 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 164
Query: 195 ASALDYLHSLASPPIIHGDVKSANILL---NDNYTAKVADFESSVLISSDAETAMSTILI 251
           A    YL        IH D+ + N LL        AK+ DF  +  I   +        +
Sbjct: 165 ACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 221
Query: 252 GTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT 285
               ++ P     G  T K+D +SFGV+L E+ +
Sbjct: 222 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 96/237 (40%), Gaps = 30/237 (12%)
Query: 140 NHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIR-------CESSQVLKTWKTCLRIAA 192
           NH N+V +LG C      L++ E+   G LL+ +R       C  +         L +  
Sbjct: 103 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 162
Query: 193 ETASALDY-----LHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMS 247
           E   +  Y     +  LAS   IH D+ + NILL      K+ DF  +  I +D+   + 
Sbjct: 163 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 222
Query: 248 TILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPY 306
                   ++ P  I     T +SDV+S+G+ L EL + G  P   M + S         
Sbjct: 223 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-------- 274
Query: 307 FLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDR 363
           F   IK  G R +   H   E        + ++   C      +RPT KQ+ + +++
Sbjct: 275 FYKMIK-EGFRMLSPEHAPAE--------MYDIMKTCWDADPLKRPTFKQIVQLIEK 322

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 90/208 (43%), Gaps = 20/208 (9%)
Query: 95  LSQGGFVSVYKGVLHD-NIQVAVKTYRR--ADKXXXXXXXXXXXXSQVNHKNVVKI---- 147
           L  GGF  V + +  D   QVA+K  R+  + K             ++NH NVV      
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 82
Query: 148 --LGLCLETEVPLLVYEFASNGTLLDHI-RCESSQVLKTWKTCLRIAAETASALDYLHSL 204
             L      ++PLL  E+   G L  ++ + E+   LK       + ++ +SAL YLH  
Sbjct: 83  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKE-GPIRTLLSDISSALRYLHEN 141
Query: 205 ASPPIIHGDVKSANILLN---DNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVC 261
               IIH D+K  NI+L         K+ D   +  +    +  + T  +GT  YL P  
Sbjct: 142 R---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD---QGELCTEFVGTLQYLAPEL 195
Query: 262 INTGKLTKKSDVYSFGVVLAELLTGKKP 289
           +   K T   D +SFG +  E +TG +P
Sbjct: 196 LEQKKYTVTVDYWSFGTLAFECITGFRP 223

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 88/214 (41%), Gaps = 18/214 (8%)
Query: 87  KNFDRSRCLSQGGFVSVYKGVL------HDNIQVAVKTYRR--ADKXXXXXXXXXXXXSQ 138
           KN    R L  G F  VY+G +         +QVAVKT     +++            S+
Sbjct: 22  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 81
Query: 139 VNHKNVVKILGLCLETEVPLLVYEFASNGTL---LDHIRCESSQVLK-TWKTCLRIAAET 194
            NH+N+V+ +G+ L++    ++ E  + G L   L   R   SQ         L +A + 
Sbjct: 82  FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 141
Query: 195 ASALDYLHSLASPPIIHGDVKSANILL---NDNYTAKVADFESSVLISSDAETAMSTILI 251
           A    YL        IH D+ + N LL        AK+ DF  +  I   +        +
Sbjct: 142 ACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 198
Query: 252 GTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT 285
               ++ P     G  T K+D +SFGV+L E+ +
Sbjct: 199 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 70/153 (45%), Gaps = 8/153 (5%)
Query: 139 VNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASAL 198
           ++H+N++++ G+ L   + + V E A  G+LLD +R      L    T  R A + A  +
Sbjct: 68  LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLG--TLSRYAVQVAEGM 124
Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTAKVADFE-SSVLISSDAETAMSTILIGTSGYL 257
            YL S      IH D+ + N+LL      K+ DF     L  +D    M         + 
Sbjct: 125 GYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 258 DPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
            P  + T   +  SD + FGV L E+ T G++P
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 70/153 (45%), Gaps = 8/153 (5%)
Query: 139 VNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASAL 198
           ++H+N++++ G+ L   + + V E A  G+LLD +R      L    T  R A + A  +
Sbjct: 68  LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLG--TLSRYAVQVAEGM 124
Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTAKVADFE-SSVLISSDAETAMSTILIGTSGYL 257
            YL S      IH D+ + N+LL      K+ DF     L  +D    M         + 
Sbjct: 125 GYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 258 DPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
            P  + T   +  SD + FGV L E+ T G++P
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 96/237 (40%), Gaps = 30/237 (12%)
Query: 140 NHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIR-------CESSQVLKTWKTCLRIAA 192
           NH N+V +LG C      L++ E+   G LL+ +R       C  +         L +  
Sbjct: 108 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 167
Query: 193 ETASALDY-----LHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMS 247
           E   +  Y     +  LAS   IH D+ + NILL      K+ DF  +  I +D+   + 
Sbjct: 168 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 227
Query: 248 TILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPY 306
                   ++ P  I     T +SDV+S+G+ L EL + G  P   M + S         
Sbjct: 228 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-------- 279
Query: 307 FLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDR 363
           F   IK  G R +   H   E        + ++   C      +RPT KQ+ + +++
Sbjct: 280 FYKMIK-EGFRMLSPEHAPAE--------MYDIMKTCWDADPLKRPTFKQIVQLIEK 327

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 96/237 (40%), Gaps = 30/237 (12%)
Query: 140 NHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIR-------CESSQVLKTWKTCLRIAA 192
           NH N+V +LG C      L++ E+   G LL+ +R       C  +         L +  
Sbjct: 101 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 160
Query: 193 ETASALDY-----LHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMS 247
           E   +  Y     +  LAS   IH D+ + NILL      K+ DF  +  I +D+   + 
Sbjct: 161 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 220
Query: 248 TILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPY 306
                   ++ P  I     T +SDV+S+G+ L EL + G  P   M + S         
Sbjct: 221 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-------- 272
Query: 307 FLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDR 363
           F   IK  G R +   H   E        + ++   C      +RPT KQ+ + +++
Sbjct: 273 FYKMIK-EGFRMLSPEHAPAE--------MYDIMKTCWDADPLKRPTFKQIVQLIEK 320

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 67/285 (23%), Positives = 120/285 (42%), Gaps = 45/285 (15%)
Query: 93  RCLSQGGFVSVYKGVLHDNIQ------VAVKTYRRAD--KXXXXXXXXXXXXSQVNHKNV 144
           R L QG F  VY+G   D I+      VAVKT   +   +                  +V
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 145 VKILGLCLETEVPLLVYEFASNGTLLDHIRC-------ESSQVLKTWKTCLRIAAETASA 197
           V++LG+  + +  L+V E  ++G L  ++R           +   T +  +++AAE A  
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFE-SSVLISSDAETAMSTILIGTSGY 256
           + YL++      +H ++ + N ++  ++T K+ DF  +  +  +D        L+    +
Sbjct: 143 MAYLNAKK---FVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-W 198
Query: 257 LDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGL 316
           + P  +  G  T  SD++SFGVVL E+ +               ++  PY    + N   
Sbjct: 199 MAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPY--QGLSN--- 238
Query: 317 RQILNFHVADESEMKE----IEIVAELASKCLRIRGTERPTMKQV 357
            Q+L F V D   + +     E V +L   C +     RPT  ++
Sbjct: 239 EQVLKF-VMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEI 282

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 96/237 (40%), Gaps = 30/237 (12%)
Query: 140 NHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIR-------CESSQVLKTWKTCLRIAA 192
           NH N+V +LG C      L++ E+   G LL+ +R       C  +         L +  
Sbjct: 85  NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 193 ETASALDY-----LHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMS 247
           E   +  Y     +  LAS   IH D+ + NILL      K+ DF  +  I +D+   + 
Sbjct: 145 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204
Query: 248 TILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPY 306
                   ++ P  I     T +SDV+S+G+ L EL + G  P   M + S         
Sbjct: 205 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-------- 256
Query: 307 FLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDR 363
           F   IK  G R +   H   E        + ++   C      +RPT KQ+ + +++
Sbjct: 257 FYKMIK-EGFRMLSPEHAPAE--------MYDIMKTCWDADPLKRPTFKQIVQLIEK 304

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 67/285 (23%), Positives = 120/285 (42%), Gaps = 45/285 (15%)
Query: 93  RCLSQGGFVSVYKGVLHDNIQ------VAVKTYRRAD--KXXXXXXXXXXXXSQVNHKNV 144
           R L QG F  VY+G   D I+      VAVKT   +   +                  +V
Sbjct: 24  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 83
Query: 145 VKILGLCLETEVPLLVYEFASNGTLLDHIRC-------ESSQVLKTWKTCLRIAAETASA 197
           V++LG+  + +  L+V E  ++G L  ++R           +   T +  +++AAE A  
Sbjct: 84  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 143
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFE-SSVLISSDAETAMSTILIGTSGY 256
           + YL++      +H ++ + N ++  ++T K+ DF  +  +  +D        L+    +
Sbjct: 144 MAYLNAKK---FVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-W 199
Query: 257 LDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGL 316
           + P  +  G  T  SD++SFGVVL E+ +               ++  PY    + N   
Sbjct: 200 MAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPY--QGLSN--- 239
Query: 317 RQILNFHVADESEMKE----IEIVAELASKCLRIRGTERPTMKQV 357
            Q+L F V D   + +     E V +L   C +     RPT  ++
Sbjct: 240 EQVLKF-VMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEI 283

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 66/145 (45%), Gaps = 12/145 (8%)
Query: 140 NHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALD 199
           N KN  +    CL      +  EF   GTL   I     + L      L +  +    +D
Sbjct: 97  NSKNSSRSKTKCL-----FIQMEFCDKGTLEQWIEKRRGEKLDK-VLALELFEQITKGVD 150
Query: 200 YLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDP 259
           Y+HS     +IH D+K +NI L D    K+ DF     + +D +   S    GT  Y+ P
Sbjct: 151 YIHS---KKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK---GTLRYMSP 204
Query: 260 VCINTGKLTKKSDVYSFGVVLAELL 284
             I++    K+ D+Y+ G++LAELL
Sbjct: 205 EQISSQDYGKEVDLYALGLILAELL 229

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 68/151 (45%), Gaps = 6/151 (3%)
Query: 137 SQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETAS 196
           + + H N+V+      E     +V ++   G L   I  +   VL      L    +   
Sbjct: 78  ANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKG-VLFQEDQILDWFVQICL 136
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
           AL ++H      I+H D+KS NI L  + T ++ DF  + +++S  E A +   IGT  Y
Sbjct: 137 ALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARAC--IGTPYY 191
Query: 257 LDPVCINTGKLTKKSDVYSFGVVLAELLTGK 287
           L P          KSD+++ G VL EL T K
Sbjct: 192 LSPEICENKPYNNKSDIWALGCVLYELCTLK 222

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 67/161 (41%), Gaps = 17/161 (10%)
Query: 140 NHKNVVKILGLCLETEVP------LLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAE 193
           +H+N+    G  ++   P       LV EF   G++ D I+      LK  +    I  E
Sbjct: 79  HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKE-EWIAYICRE 137
Query: 194 TASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGT 253
               L +LH      +IH D+K  N+LL +N   K+ DF  S  +  D         IGT
Sbjct: 138 ILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGT 192
Query: 254 SGYLDP---VCINTGKLTK--KSDVYSFGVVLAELLTGKKP 289
             ++ P    C      T   KSD++S G+   E+  G  P
Sbjct: 193 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 74/161 (45%), Gaps = 27/161 (16%)
Query: 139 VNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHI-------RCESSQVLKTWKTCLRIA 191
           ++H N++K+  +  + +   LV EF   G L + I        C+++ ++K         
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMK--------- 153
Query: 192 AETASALDYLHSLASPPIIHGDVKSANILL---NDNYTAKVADFESSVLISSDAETAMST 248
            +  S + YLH      I+H D+K  NILL   N     K+ DF  S   S D +     
Sbjct: 154 -QILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDR- 208
Query: 249 ILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
             +GT+ Y+ P  +   K  +K DV+S GV++  LL G  P
Sbjct: 209 --LGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPP 246

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 76/152 (50%), Gaps = 15/152 (9%)
Query: 141 HKNVVKILGLCLETEVPLLVYEFASNGTLLDHIR--C-ESSQVLKTWKTCLRIAAETASA 197
           + N+V  L   L  +   +V E+ + G+L D +   C +  Q+    + CL+       A
Sbjct: 77  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ-------A 129
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYL 257
           L++LHS     +IH ++KS NILL  + + K+ DF     I+   E +  + ++GT  ++
Sbjct: 130 LEFLHSNQ---VIHRNIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMVGTPYWM 184
Query: 258 DPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
            P  +       K D++S G++  E++ G+ P
Sbjct: 185 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/241 (21%), Positives = 101/241 (41%), Gaps = 47/241 (19%)
Query: 141 HKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKT----------------- 183
           H+N+V +LG C      L++ E+   G LL+ +R ++  +L                   
Sbjct: 94  HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGR 153
Query: 184 ---WKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISS 240
               +  L  +++ A  + +L   AS   IH DV + N+LL + + AK+ DF  +  I +
Sbjct: 154 PLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN 210
Query: 241 DAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKK 300
           D+   +         ++ P  I     T +SDV+S+G++L E+ +               
Sbjct: 211 DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS--------------- 255
Query: 301 ISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEI----VAELASKCLRIRGTERPTMKQ 356
           + + PY    + N+   ++    V D  +M +       +  +   C  +  T RPT +Q
Sbjct: 256 LGLNPY-PGILVNSKFYKL----VKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQ 310
Query: 357 V 357
           +
Sbjct: 311 I 311

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 90/220 (40%), Gaps = 31/220 (14%)
Query: 84  RATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTY--RRADKXXXXXXXXXXXXSQVNH 141
           R   +F     +  GGF  V+K       ++  KTY  +R               ++++H
Sbjct: 8   RFGMDFKEIELIGSGGFGQVFKA----KHRIDGKTYVIKRVKYNNEKAEREVKALAKLDH 63
Query: 142 KNVVKILGLCLE-----------------TEVPLLVYEFASNGTLLDHIRCESSQVLKTW 184
            N+V   G C +                 T+   +  EF   GTL   I     + L   
Sbjct: 64  VNIVHYNG-CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDK- 121
Query: 185 KTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET 244
              L +  +    +DY+HS     +I+ D+K +NI L D    K+ DF     + +D + 
Sbjct: 122 VLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR 178
Query: 245 AMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELL 284
             S    GT  Y+ P  I++    K+ D+Y+ G++LAELL
Sbjct: 179 XRSK---GTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 65/143 (45%), Gaps = 18/143 (12%)
Query: 192 AETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILI 251
            E   A+D +H L     +H D+K  N+LL+ N   ++ADF S + ++ D  T  S++ +
Sbjct: 182 GEMVLAIDSIHQLH---YVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDG-TVQSSVAV 237
Query: 252 GTSGYLDPVCINT-----GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPY 306
           GT  Y+ P  +       GK   + D +S GV + E+L G+ P    +L           
Sbjct: 238 GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET-------- 289
Query: 307 FLNSIKNNGLRQILNFHVADESE 329
               I N+  R     HV D SE
Sbjct: 290 -YGKIMNHEERFQFPSHVTDVSE 311

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 95/195 (48%), Gaps = 21/195 (10%)
Query: 139 VNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASAL 198
           + H +++K+  +       ++V E+A  G L D+I  E  ++  T     R   +   A+
Sbjct: 66  LRHPHIIKLYDVITTPTDIVMVIEYAG-GELFDYI-VEKKRM--TEDEGRRFFQQIICAI 121
Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLD 258
           +Y H      I+H D+K  N+LL+DN   K+ADF  S +++       S    G+  Y  
Sbjct: 122 EYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAA 175
Query: 259 PVCINTGKLT--KKSDVYSFGVVLAELLTGKKPGSCMTLAS-----NKKISMVPYFLNSI 311
           P  IN GKL    + DV+S G+VL  +L G+ P     + +     N  + ++P FL+  
Sbjct: 176 PEVIN-GKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPG 234
Query: 312 KNNGLRQILNFHVAD 326
             + +R+++   VAD
Sbjct: 235 AQSLIRRMI---VAD 246

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 65/143 (45%), Gaps = 18/143 (12%)
Query: 192 AETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILI 251
            E   A+D +H L     +H D+K  N+LL+ N   ++ADF S + ++ D  T  S++ +
Sbjct: 198 GEMVLAIDSIHQLH---YVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDG-TVQSSVAV 253
Query: 252 GTSGYLDPVCINT-----GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPY 306
           GT  Y+ P  +       GK   + D +S GV + E+L G+ P    +L           
Sbjct: 254 GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET-------- 305
Query: 307 FLNSIKNNGLRQILNFHVADESE 329
               I N+  R     HV D SE
Sbjct: 306 -YGKIMNHEERFQFPSHVTDVSE 327

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 75/160 (46%), Gaps = 16/160 (10%)
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
           ++NH  ++KI     + E   +V E    G L D +    ++ LK   TC     +   A
Sbjct: 196 KLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVV--GNKRLKE-ATCKLYFYQMLLA 251
Query: 198 LDYLHSLASPPIIHGDVKSANILLN---DNYTAKVADFESSVLISSDAETAMSTILIGTS 254
           + YLH      IIH D+K  N+LL+   ++   K+ DF  S ++    ET++   L GT 
Sbjct: 252 VQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSLMRTLCGTP 305
Query: 255 GYLDP---VCINTGKLTKKSDVYSFGVVLAELLTGKKPGS 291
            YL P   V + T    +  D +S GV+L   L+G  P S
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 345

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 77/161 (47%), Gaps = 14/161 (8%)
Query: 140 NHKNVVKILGLCLETEVPLLV-YEFASNGTLLDHIRCESSQVLK---------TWKTCLR 189
           +H NVV +LG C +   PL+V  EF   G L  ++R + ++ +          T +  + 
Sbjct: 89  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIX 148
Query: 190 IAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTI 249
            + + A  +++L   AS   IH D+ + NILL++    K+ DF  +  I  D +      
Sbjct: 149 YSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGD 205
Query: 250 LIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
                 ++ P  I     T +SDV+SFGV+L E+ + G  P
Sbjct: 206 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 246

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 75/160 (46%), Gaps = 16/160 (10%)
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
           ++NH  ++KI     + E   +V E    G L D +    ++ LK   TC     +   A
Sbjct: 210 KLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVV--GNKRLKE-ATCKLYFYQMLLA 265
Query: 198 LDYLHSLASPPIIHGDVKSANILLN---DNYTAKVADFESSVLISSDAETAMSTILIGTS 254
           + YLH      IIH D+K  N+LL+   ++   K+ DF  S ++    ET++   L GT 
Sbjct: 266 VQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSLMRTLCGTP 319
Query: 255 GYLDP---VCINTGKLTKKSDVYSFGVVLAELLTGKKPGS 291
            YL P   V + T    +  D +S GV+L   L+G  P S
Sbjct: 320 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 359

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 64/131 (48%), Gaps = 8/131 (6%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSAN 218
            V E+A+ G L  H+   S + + T +      AE  SAL+YLHS     +++ D+K  N
Sbjct: 85  FVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLEN 138
Query: 219 ILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGV 278
           ++L+ +   K+ DF       SD  T M T   GT  YL P  +      +  D +  GV
Sbjct: 139 LMLDKDGHIKITDFGLCKEGISDGAT-MKT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGV 196
Query: 279 VLAELLTGKKP 289
           V+ E++ G+ P
Sbjct: 197 VMYEMMCGRLP 207

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 110/276 (39%), Gaps = 34/276 (12%)
Query: 88  NFDRSRCLSQGGFVSVY-----KGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHK 142
           +F+  R L +G F +VY     K      ++V  K+    +             + ++H 
Sbjct: 24  DFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHP 83
Query: 143 NVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLH 202
           N++++     +     L+ E+A  G L   +  + S      +T   I  E A AL Y H
Sbjct: 84  NILRLYNYFYDRRRIYLILEYAPRGELYKEL--QKSCTFDEQRTAT-IMEELADALMYCH 140
Query: 203 SLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCI 262
                 +IH D+K  N+LL      K+ADF  SV     A +     + GT  YL P  I
Sbjct: 141 GKK---VIHRDIKPENLLLGLKGELKIADFGWSV----HAPSLRRKTMCGTLDYLPPEMI 193
Query: 263 NTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNF 322
                 +K D++  GV+  ELL G  P                 F ++  N   R+I+  
Sbjct: 194 EGRMHNEKVDLWCIGVLCYELLVGNPP-----------------FESASHNETYRRIVKV 236
Query: 323 HVADESEMKEIEIVAELASKCLRIRGTERPTMKQVS 358
            +   + +       +L SK LR   +ER  + QVS
Sbjct: 237 DLKFPASVP--TGAQDLISKLLRHNPSERLPLAQVS 270

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 64/131 (48%), Gaps = 8/131 (6%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSAN 218
            V E+A+ G L  H+   S + + T +      AE  SAL+YLHS     +++ D+K  N
Sbjct: 82  FVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLEN 135
Query: 219 ILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGV 278
           ++L+ +   K+ DF       SD  T M T   GT  YL P  +      +  D +  GV
Sbjct: 136 LMLDKDGHIKITDFGLCKEGISDGAT-MKT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGV 193
Query: 279 VLAELLTGKKP 289
           V+ E++ G+ P
Sbjct: 194 VMYEMMCGRLP 204

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 77/163 (47%), Gaps = 16/163 (9%)
Query: 140 NHKNVVKILGLCLETEVPLLV-YEFASNGTLLDHIRCESSQVLK-----------TWKTC 187
           +H NVV +LG C +   PL+V  EF   G L  ++R + ++ +            T +  
Sbjct: 91  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHL 150
Query: 188 LRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMS 247
           +  + + A  +++L   AS   IH D+ + NILL++    K+ DF  +  I  D +    
Sbjct: 151 IXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRK 207
Query: 248 TILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
                   ++ P  I     T +SDV+SFGV+L E+ + G  P
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 95/214 (44%), Gaps = 29/214 (13%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVK-ILG---L 150
           + +G + +VYKG L D   VAVK +  A++              + H N+ + I+G   +
Sbjct: 21  IGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERV 79
Query: 151 CLETEVP-LLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLAS--- 206
             +  +  LLV E+  NG+L  ++   +S     W +  R+A      L YLH+      
Sbjct: 80  TADGRMEYLLVMEYYPNGSLXKYLSLHTSD----WVSSCRLAHSVTRGLAYLHTELPRGD 135
Query: 207 ---PPIIHGDVKSANILLNDNYTAKVADFESSV------LISSDAETAMSTILIGTSGYL 257
              P I H D+ S N+L+ ++ T  ++DF  S+      L+    E   +   +GT  Y+
Sbjct: 136 HYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYM 195
Query: 258 DPVCI-------NTGKLTKKSDVYSFGVVLAELL 284
            P  +       +     K+ D+Y+ G++  E+ 
Sbjct: 196 APEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 64/131 (48%), Gaps = 8/131 (6%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSAN 218
            V E+A+ G L  H+   S + + T +      AE  SAL+YLHS     +++ D+K  N
Sbjct: 82  FVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLEN 135
Query: 219 ILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGV 278
           ++L+ +   K+ DF       SD  T M T   GT  YL P  +      +  D +  GV
Sbjct: 136 LMLDKDGHIKITDFGLCKEGISDGAT-MKT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGV 193
Query: 279 VLAELLTGKKP 289
           V+ E++ G+ P
Sbjct: 194 VMYEMMCGRLP 204

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 75/160 (46%), Gaps = 16/160 (10%)
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
           ++NH  ++KI     + E   +V E    G L D +    ++ LK   TC     +   A
Sbjct: 71  KLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVV--GNKRLKE-ATCKLYFYQMLLA 126
Query: 198 LDYLHSLASPPIIHGDVKSANILLN---DNYTAKVADFESSVLISSDAETAMSTILIGTS 254
           + YLH      IIH D+K  N+LL+   ++   K+ DF  S ++    ET++   L GT 
Sbjct: 127 VQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSLMRTLCGTP 180
Query: 255 GYLDP---VCINTGKLTKKSDVYSFGVVLAELLTGKKPGS 291
            YL P   V + T    +  D +S GV+L   L+G  P S
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 220

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 75/160 (46%), Gaps = 16/160 (10%)
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
           ++NH  ++KI     + E   +V E    G L D +    ++ LK   TC     +   A
Sbjct: 71  KLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVV--GNKRLKE-ATCKLYFYQMLLA 126
Query: 198 LDYLHSLASPPIIHGDVKSANILLN---DNYTAKVADFESSVLISSDAETAMSTILIGTS 254
           + YLH      IIH D+K  N+LL+   ++   K+ DF  S ++    ET++   L GT 
Sbjct: 127 VQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSLMRTLCGTP 180
Query: 255 GYLDP---VCINTGKLTKKSDVYSFGVVLAELLTGKKPGS 291
            YL P   V + T    +  D +S GV+L   L+G  P S
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 220

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 67/136 (49%), Gaps = 16/136 (11%)
Query: 158 LLVYEFASNGTLLDHIR-CESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKS 216
             V E+ + G L+ HI+ C    + +        AAE    L +LHS     I++ D+K 
Sbjct: 94  FFVMEYLNGGDLMYHIQSCHKFDLSRA----TFYAAEIILGLQFLHSKG---IVYRDLKL 146
Query: 217 ANILLNDNYTAKVADF---ESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDV 273
            NILL+ +   K+ADF   + ++L   DA+T       GT  Y+ P  +   K     D 
Sbjct: 147 DNILLDKDGHIKIADFGMCKENML--GDAKT---NXFCGTPDYIAPEILLGQKYNHSVDW 201
Query: 274 YSFGVVLAELLTGKKP 289
           +SFGV+L E+L G+ P
Sbjct: 202 WSFGVLLYEMLIGQSP 217

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 75/160 (46%), Gaps = 16/160 (10%)
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
           ++NH  ++KI     + E   +V E    G L D +    ++ LK   TC     +   A
Sbjct: 71  KLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVV--GNKRLKE-ATCKLYFYQMLLA 126
Query: 198 LDYLHSLASPPIIHGDVKSANILLN---DNYTAKVADFESSVLISSDAETAMSTILIGTS 254
           + YLH      IIH D+K  N+LL+   ++   K+ DF  S ++    ET++   L GT 
Sbjct: 127 VQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSLMRTLCGTP 180
Query: 255 GYLDP---VCINTGKLTKKSDVYSFGVVLAELLTGKKPGS 291
            YL P   V + T    +  D +S GV+L   L+G  P S
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 220

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 75/160 (46%), Gaps = 16/160 (10%)
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
           ++NH  ++KI     + E   +V E    G L D +    ++ LK   TC     +   A
Sbjct: 70  KLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVV--GNKRLKE-ATCKLYFYQMLLA 125
Query: 198 LDYLHSLASPPIIHGDVKSANILLN---DNYTAKVADFESSVLISSDAETAMSTILIGTS 254
           + YLH      IIH D+K  N+LL+   ++   K+ DF  S ++    ET++   L GT 
Sbjct: 126 VQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSLMRTLCGTP 179
Query: 255 GYLDP---VCINTGKLTKKSDVYSFGVVLAELLTGKKPGS 291
            YL P   V + T    +  D +S GV+L   L+G  P S
Sbjct: 180 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 219

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/131 (28%), Positives = 63/131 (48%), Gaps = 8/131 (6%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSAN 218
            V E+A+ G L  H+   S + + T +      AE  SAL+YLHS     +++ D+K  N
Sbjct: 82  FVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLEN 135
Query: 219 ILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGV 278
           ++L+ +   K+ DF   +     ++ A      GT  YL P  +      +  D +  GV
Sbjct: 136 LMLDKDGHIKITDF--GLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGV 193
Query: 279 VLAELLTGKKP 289
           V+ E++ G+ P
Sbjct: 194 VMYEMMCGRLP 204

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/131 (28%), Positives = 63/131 (48%), Gaps = 8/131 (6%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSAN 218
            V E+A+ G L  H+   S + + T +      AE  SAL+YLHS     +++ D+K  N
Sbjct: 82  FVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLEN 135
Query: 219 ILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGV 278
           ++L+ +   K+ DF   +     ++ A      GT  YL P  +      +  D +  GV
Sbjct: 136 LMLDKDGHIKITDF--GLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGV 193
Query: 279 VLAELLTGKKP 289
           V+ E++ G+ P
Sbjct: 194 VMYEMMCGRLP 204

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/131 (28%), Positives = 63/131 (48%), Gaps = 8/131 (6%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSAN 218
            V E+A+ G L  H+   S + + T +      AE  SAL+YLHS     +++ D+K  N
Sbjct: 87  FVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLEN 140
Query: 219 ILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGV 278
           ++L+ +   K+ DF   +     ++ A      GT  YL P  +      +  D +  GV
Sbjct: 141 LMLDKDGHIKITDF--GLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGV 198
Query: 279 VLAELLTGKKP 289
           V+ E++ G+ P
Sbjct: 199 VMYEMMCGRLP 209

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 75/160 (46%), Gaps = 16/160 (10%)
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
           ++NH  ++KI     + E   +V E    G L D +    ++ LK   TC     +   A
Sbjct: 77  KLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVV--GNKRLKE-ATCKLYFYQMLLA 132
Query: 198 LDYLHSLASPPIIHGDVKSANILLN---DNYTAKVADFESSVLISSDAETAMSTILIGTS 254
           + YLH      IIH D+K  N+LL+   ++   K+ DF  S ++    ET++   L GT 
Sbjct: 133 VQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GETSLMRTLCGTP 186
Query: 255 GYLDP---VCINTGKLTKKSDVYSFGVVLAELLTGKKPGS 291
            YL P   V + T    +  D +S GV+L   L+G  P S
Sbjct: 187 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 226

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/131 (28%), Positives = 62/131 (47%), Gaps = 7/131 (5%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSAN 218
            V E+A+ G L  H+   S + + +        AE  SALDYLHS  +  +++ D+K  N
Sbjct: 228 FVMEYANGGELFFHL---SRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLEN 282
Query: 219 ILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGV 278
           ++L+ +   K+ DF   +      + A      GT  YL P  +      +  D +  GV
Sbjct: 283 LMLDKDGHIKITDF--GLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGV 340
Query: 279 VLAELLTGKKP 289
           V+ E++ G+ P
Sbjct: 341 VMYEMMCGRLP 351

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/131 (28%), Positives = 63/131 (48%), Gaps = 8/131 (6%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSAN 218
            V E+A+ G L  H+   S + + T +      AE  SAL+YLHS     +++ D+K  N
Sbjct: 82  FVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLEN 135
Query: 219 ILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGV 278
           ++L+ +   K+ DF   +     ++ A      GT  YL P  +      +  D +  GV
Sbjct: 136 LMLDKDGHIKITDF--GLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGV 193
Query: 279 VLAELLTGKKP 289
           V+ E++ G+ P
Sbjct: 194 VMYEMMCGRLP 204

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 54/103 (52%), Gaps = 9/103 (8%)
Query: 192 AETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILI 251
           AE   A+D +H L     +H D+K  NIL++ N   ++ADF S + +  D  T  S++ +
Sbjct: 182 AEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-TVQSSVAV 237
Query: 252 GTSGYLDPVCINT-----GKLTKKSDVYSFGVVLAELLTGKKP 289
           GT  Y+ P  +       G+   + D +S GV + E+L G+ P
Sbjct: 238 GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/131 (28%), Positives = 62/131 (47%), Gaps = 7/131 (5%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSAN 218
            V E+A+ G L  H+   S + + +        AE  SALDYLHS  +  +++ D+K  N
Sbjct: 225 FVMEYANGGELFFHL---SRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLEN 279
Query: 219 ILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGV 278
           ++L+ +   K+ DF   +      + A      GT  YL P  +      +  D +  GV
Sbjct: 280 LMLDKDGHIKITDF--GLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGV 337
Query: 279 VLAELLTGKKP 289
           V+ E++ G+ P
Sbjct: 338 VMYEMMCGRLP 348

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/257 (22%), Positives = 107/257 (41%), Gaps = 59/257 (22%)
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLK--------------- 182
           QVNH +V+K+ G C +    LL+ E+A  G+L   +R ES +V                 
Sbjct: 82  QVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLR-ESRKVGPGYLGSGGSRNSSSLD 140
Query: 183 -------TWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADF--- 232
                  T    +  A + +  + YL  ++   ++H D+ + NIL+ +    K++DF   
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLAEMS---LVHRDLAARNILVAEGRKMKISDFGLS 197
Query: 233 -----ESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGK 287
                E S +  S     +  + I      D +       T +SDV+SFGV+L E++   
Sbjct: 198 RDVYEEDSXVKRSQGRIPVKWMAI--ESLFDHI------YTTQSDVWSFGVLLWEIV--- 246
Query: 288 KPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIR 347
                 TL  N    + P  L ++   G R     + ++E        +  L  +C +  
Sbjct: 247 ------TLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEE--------MYRLMLQCWKQE 292
Query: 348 GTERPTMKQVSEELDRL 364
             +RP    +S++L+++
Sbjct: 293 PDKRPVFADISKDLEKM 309

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 74/158 (46%), Gaps = 8/158 (5%)
Query: 140 NHKNVVKILGLCLETEVPLLV-YEFASNGTLLDHIRCESSQVL------KTWKTCLRIAA 192
           +H NVV +LG C +   PL+V  EF   G L  ++R + ++ +      K + T   +  
Sbjct: 89  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIC 148
Query: 193 ETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIG 252
            +      +  LAS   IH D+ + NILL++    K+ DF  +  I  D +         
Sbjct: 149 YSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 208
Query: 253 TSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
              ++ P  I     T +SDV+SFGV+L E+ + G  P
Sbjct: 209 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 246

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/186 (24%), Positives = 83/186 (44%), Gaps = 13/186 (6%)
Query: 141 HKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDY 200
           H++VV   G   + +   +V E     +LL+  +   +      +  LR   +      Y
Sbjct: 74  HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR---QIVLGCQY 130
Query: 201 LHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV 260
           LH      +IH D+K  N+ LN++   K+ DF  +  +  D E     +L GT  Y+ P 
Sbjct: 131 LHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPE 185
Query: 261 CINTGKLTKKSDVYSFGVVLAELLTGKKP--GSCMT---LASNKKISMVPYFLNSIKNNG 315
            ++    + + DV+S G ++  LL GK P   SC+    L   K    +P  +N +  + 
Sbjct: 186 VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASL 245
Query: 316 LRQILN 321
           ++++L 
Sbjct: 246 IQKMLQ 251

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/250 (22%), Positives = 104/250 (41%), Gaps = 17/250 (6%)
Query: 87  KNFDRSRCLSQGGFVSVYKG-VLHDNIQVAVKTYRRADKXXXXXXXXXXX----XSQVNH 141
           ++F     L +G F  VY+   +H  ++VA+K   +                    Q+ H
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 142 KNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYL 201
            +++++     ++    LV E   NG +  +++        +         +  + + YL
Sbjct: 71  PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPF--SENEARHFMHQIITGMLYL 128
Query: 202 HSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVC 261
           HS     I+H D+  +N+LL  N   K+ADF  +  +    E   +  L GT  Y+ P  
Sbjct: 129 HSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYISPEI 183
Query: 262 INTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLAS--NKKI---SMVPYFLNSIKNNGL 316
                   +SDV+S G +   LL G+ P    T+ +  NK +     +P FL+    + +
Sbjct: 184 ATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLI 243
Query: 317 RQILNFHVAD 326
            Q+L  + AD
Sbjct: 244 HQLLRRNPAD 253

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/252 (23%), Positives = 110/252 (43%), Gaps = 38/252 (15%)
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
           Q+ H+N+V +L +C + +   LV+EF  + T+LD +    + +   ++   +   +  + 
Sbjct: 80  QLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGL--DYQVVQKYLFQIING 136
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYL 257
           + + HS     IIH D+K  NIL++ +   K+ DF  +  +++  E       + T  Y 
Sbjct: 137 IGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE--VATRWYR 191
Query: 258 DP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PGS--------CMTLASNKKISMVPY 306
            P + +   K  K  DV++ G ++ E+  G+   PG          M    N    ++P 
Sbjct: 192 APELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGN----LIPR 247
Query: 307 FLNSIKNN----GLR--QILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEE 360
                  N    G+R  +I      +    K  E+V +LA KCL I   +RP   ++   
Sbjct: 248 HQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAEL--- 304
Query: 361 LDRLRRLHENFW 372
                 LH +F+
Sbjct: 305 ------LHHDFF 310

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 67/136 (49%), Gaps = 16/136 (11%)
Query: 158 LLVYEFASNGTLLDHIR-CESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKS 216
             V E+ + G L+ HI+ C    + +        AAE    L +LHS     I++ D+K 
Sbjct: 95  FFVMEYLNGGDLMYHIQSCHKFDLSRA----TFYAAEIILGLQFLHSKG---IVYRDLKL 147
Query: 217 ANILLNDNYTAKVADF---ESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDV 273
            NILL+ +   K+ADF   + ++L   DA+T       GT  Y+ P  +   K     D 
Sbjct: 148 DNILLDKDGHIKIADFGMCKENML--GDAKT---NEFCGTPDYIAPEILLGQKYNHSVDW 202
Query: 274 YSFGVVLAELLTGKKP 289
           +SFGV+L E+L G+ P
Sbjct: 203 WSFGVLLYEMLIGQSP 218

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 93/207 (44%), Gaps = 24/207 (11%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKIL-----G 149
           + +G +  V+ G      +VAVK +   ++              + H+N++  +     G
Sbjct: 45  IGKGRYGEVWMGKWRGE-KVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKG 103
Query: 150 LCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHS-----L 204
               T++  L+ ++  NG+L D+++  +       K+ L++A  + S L +LH+      
Sbjct: 104 TGSWTQL-YLITDYHENGSLYDYLKSTTLDA----KSMLKLAYSSVSGLCHLHTEIFSTQ 158
Query: 205 ASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETA--MSTILIGTSGYLDPVCI 262
             P I H D+KS NIL+  N T  +AD   +V   SD           +GT  Y+ P  +
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVL 218
Query: 263 ------NTGKLTKKSDVYSFGVVLAEL 283
                 N  +    +D+YSFG++L E+
Sbjct: 219 DESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 74/162 (45%), Gaps = 12/162 (7%)
Query: 140 NHKNVVKILGLCLETEVPLLV-YEFASNGTLLDHIRCESSQVL----------KTWKTCL 188
           +H NVV +LG C +   PL+V  EF   G L  ++R + ++ +          K + T  
Sbjct: 80  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 139
Query: 189 RIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMST 248
            +   +      +  LAS   IH D+ + NILL++    K+ DF  +  I  D +     
Sbjct: 140 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 199
Query: 249 ILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
                  ++ P  I     T +SDV+SFGV+L E+ + G  P
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 241

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/131 (28%), Positives = 62/131 (47%), Gaps = 7/131 (5%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSAN 218
            V E+A+ G L  H+   S + + +        AE  SALDYLHS  +  +++ D+K  N
Sbjct: 85  FVMEYANGGELFFHL---SRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLEN 139
Query: 219 ILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGV 278
           ++L+ +   K+ DF   +      + A      GT  YL P  +      +  D +  GV
Sbjct: 140 LMLDKDGHIKITDF--GLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGV 197
Query: 279 VLAELLTGKKP 289
           V+ E++ G+ P
Sbjct: 198 VMYEMMCGRLP 208

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/131 (28%), Positives = 62/131 (47%), Gaps = 7/131 (5%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSAN 218
            V E+A+ G L  H+   S + + +        AE  SALDYLHS  +  +++ D+K  N
Sbjct: 87  FVMEYANGGELFFHL---SRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLEN 141
Query: 219 ILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGV 278
           ++L+ +   K+ DF   +      + A      GT  YL P  +      +  D +  GV
Sbjct: 142 LMLDKDGHIKITDF--GLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGV 199
Query: 279 VLAELLTGKKP 289
           V+ E++ G+ P
Sbjct: 200 VMYEMMCGRLP 210

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 74/162 (45%), Gaps = 12/162 (7%)
Query: 140 NHKNVVKILGLCLETEVPLLVY-EFASNGTLLDHIRCESSQVL----------KTWKTCL 188
           +H NVV +LG C +   PL+V  EF   G L  ++R + ++ +          K + T  
Sbjct: 80  HHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 139
Query: 189 RIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMST 248
            +   +      +  LAS   IH D+ + NILL++    K+ DF  +  I  D +     
Sbjct: 140 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 199
Query: 249 ILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
                  ++ P  I     T +SDV+SFGV+L E+ + G  P
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 241

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/186 (24%), Positives = 83/186 (44%), Gaps = 13/186 (6%)
Query: 141 HKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDY 200
           H++VV   G   + +   +V E     +LL+  +   +      +  LR   +      Y
Sbjct: 98  HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR---QIVLGCQY 154
Query: 201 LHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV 260
           LH      +IH D+K  N+ LN++   K+ DF  +  +  D E     +L GT  Y+ P 
Sbjct: 155 LHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPE 209
Query: 261 CINTGKLTKKSDVYSFGVVLAELLTGKKP--GSCMT---LASNKKISMVPYFLNSIKNNG 315
            ++    + + DV+S G ++  LL GK P   SC+    L   K    +P  +N +  + 
Sbjct: 210 VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASL 269
Query: 316 LRQILN 321
           ++++L 
Sbjct: 270 IQKMLQ 275

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 74/161 (45%), Gaps = 11/161 (6%)
Query: 140 NHKNVVKILGLCLETEVPLLV-YEFASNGTLLDHIRCESSQVL---------KTWKTCLR 189
           +H NVV +LG C +   PL+V  EF   G L  ++R + ++ +         K + T   
Sbjct: 90  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEH 149
Query: 190 IAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTI 249
           +   +      +  LAS   IH D+ + NILL++    K+ DF  +  I  D +      
Sbjct: 150 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 209
Query: 250 LIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
                 ++ P  I     T +SDV+SFGV+L E+ + G  P
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/131 (28%), Positives = 62/131 (47%), Gaps = 7/131 (5%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSAN 218
            V E+A+ G L  H+   S + + +        AE  SALDYLHS  +  +++ D+K  N
Sbjct: 86  FVMEYANGGELFFHL---SRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLEN 140
Query: 219 ILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGV 278
           ++L+ +   K+ DF   +      + A      GT  YL P  +      +  D +  GV
Sbjct: 141 LMLDKDGHIKITDF--GLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGV 198
Query: 279 VLAELLTGKKP 289
           V+ E++ G+ P
Sbjct: 199 VMYEMMCGRLP 209

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/257 (22%), Positives = 106/257 (41%), Gaps = 59/257 (22%)
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLK--------------- 182
           QVNH +V+K+ G C +    LL+ E+A  G+L   +R ES +V                 
Sbjct: 82  QVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLR-ESRKVGPGYLGSGGSRNSSSLD 140
Query: 183 -------TWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADF--- 232
                  T    +  A + +  + YL  +    ++H D+ + NIL+ +    K++DF   
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLS 197
Query: 233 -----ESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGK 287
                E S +  S     +  + I      D +       T +SDV+SFGV+L E++   
Sbjct: 198 RDVYEEDSYVKRSQGRIPVKWMAI--ESLFDHI------YTTQSDVWSFGVLLWEIV--- 246
Query: 288 KPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIR 347
                 TL  N    + P  L ++   G R     + ++E        +  L  +C +  
Sbjct: 247 ------TLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEE--------MYRLMLQCWKQE 292
Query: 348 GTERPTMKQVSEELDRL 364
             +RP    +S++L+++
Sbjct: 293 PDKRPVFADISKDLEKM 309

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/257 (22%), Positives = 106/257 (41%), Gaps = 59/257 (22%)
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLK--------------- 182
           QVNH +V+K+ G C +    LL+ E+A  G+L   +R ES +V                 
Sbjct: 82  QVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLR-ESRKVGPGYLGSGGSRNSSSLD 140
Query: 183 -------TWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADF--- 232
                  T    +  A + +  + YL  +    ++H D+ + NIL+ +    K++DF   
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLS 197
Query: 233 -----ESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGK 287
                E S +  S     +  + I      D +       T +SDV+SFGV+L E++   
Sbjct: 198 RDVYEEDSXVKRSQGRIPVKWMAI--ESLFDHI------YTTQSDVWSFGVLLWEIV--- 246
Query: 288 KPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIR 347
                 TL  N    + P  L ++   G R     + ++E        +  L  +C +  
Sbjct: 247 ------TLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEE--------MYRLMLQCWKQE 292
Query: 348 GTERPTMKQVSEELDRL 364
             +RP    +S++L+++
Sbjct: 293 PDKRPVFADISKDLEKM 309

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/186 (24%), Positives = 83/186 (44%), Gaps = 13/186 (6%)
Query: 141 HKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDY 200
           H++VV   G   + +   +V E     +LL+  +   +      +  LR   +      Y
Sbjct: 100 HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR---QIVLGCQY 156
Query: 201 LHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV 260
           LH      +IH D+K  N+ LN++   K+ DF  +  +  D E     +L GT  Y+ P 
Sbjct: 157 LHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPE 211
Query: 261 CINTGKLTKKSDVYSFGVVLAELLTGKKP--GSCMT---LASNKKISMVPYFLNSIKNNG 315
            ++    + + DV+S G ++  LL GK P   SC+    L   K    +P  +N +  + 
Sbjct: 212 VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASL 271
Query: 316 LRQILN 321
           ++++L 
Sbjct: 272 IQKMLQ 277

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 94/207 (45%), Gaps = 24/207 (11%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGL---- 150
           + +G F  V++G      +VAVK +   ++              + H+N++  +      
Sbjct: 11  IGKGRFGEVWRGKWRGE-EVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 69
Query: 151 -CLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLH-----SL 204
               T++  LV ++  +G+L D++   +  V    +  +++A  TAS L +LH     + 
Sbjct: 70  NGTWTQL-WLVSDYHEHGSLFDYLNRYTVTV----EGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 205 ASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET--AMSTILIGTSGYLDPVCI 262
             P I H D+KS NIL+  N T  +AD   +V   S  +T        +GT  Y+ P  +
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184
Query: 263 NTG------KLTKKSDVYSFGVVLAEL 283
           +        +  K++D+Y+ G+V  E+
Sbjct: 185 DDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 94/207 (45%), Gaps = 24/207 (11%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGL---- 150
           + +G F  V++G      +VAVK +   ++              + H+N++  +      
Sbjct: 17  IGKGRFGEVWRGKWRGE-EVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 75
Query: 151 -CLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLH-----SL 204
               T++  LV ++  +G+L D++   +  V    +  +++A  TAS L +LH     + 
Sbjct: 76  NGTWTQL-WLVSDYHEHGSLFDYLNRYTVTV----EGMIKLALSTASGLAHLHMEIVGTQ 130
Query: 205 ASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET--AMSTILIGTSGYLDPVCI 262
             P I H D+KS NIL+  N T  +AD   +V   S  +T        +GT  Y+ P  +
Sbjct: 131 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 190
Query: 263 NTG------KLTKKSDVYSFGVVLAEL 283
           +        +  K++D+Y+ G+V  E+
Sbjct: 191 DDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 94/207 (45%), Gaps = 24/207 (11%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGL---- 150
           + +G F  V++G      +VAVK +   ++              + H+N++  +      
Sbjct: 12  IGKGRFGEVWRGKWRGE-EVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 70
Query: 151 -CLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLH-----SL 204
               T++  LV ++  +G+L D++   +  V    +  +++A  TAS L +LH     + 
Sbjct: 71  NGTWTQL-WLVSDYHEHGSLFDYLNRYTVTV----EGMIKLALSTASGLAHLHMEIVGTQ 125
Query: 205 ASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET--AMSTILIGTSGYLDPVCI 262
             P I H D+KS NIL+  N T  +AD   +V   S  +T        +GT  Y+ P  +
Sbjct: 126 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 185
Query: 263 NTG------KLTKKSDVYSFGVVLAEL 283
           +        +  K++D+Y+ G+V  E+
Sbjct: 186 DDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 74/162 (45%), Gaps = 12/162 (7%)
Query: 140 NHKNVVKILGLCLETEVPLLV-YEFASNGTLLDHIRCESSQVL----------KTWKTCL 188
           +H NVV +LG C +   PL+V  EF   G L  ++R + ++ +          K + T  
Sbjct: 89  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148
Query: 189 RIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMST 248
            +   +      +  LAS   IH D+ + NILL++    K+ DF  +  I  D +     
Sbjct: 149 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 208
Query: 249 ILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
                  ++ P  I     T +SDV+SFGV+L E+ + G  P
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 94/207 (45%), Gaps = 24/207 (11%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGL---- 150
           + +G F  V++G      +VAVK +   ++              + H+N++  +      
Sbjct: 14  IGKGRFGEVWRGKWRGE-EVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 72
Query: 151 -CLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLH-----SL 204
               T++  LV ++  +G+L D++   +  V    +  +++A  TAS L +LH     + 
Sbjct: 73  NGTWTQL-WLVSDYHEHGSLFDYLNRYTVTV----EGMIKLALSTASGLAHLHMEIVGTQ 127
Query: 205 ASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET--AMSTILIGTSGYLDPVCI 262
             P I H D+KS NIL+  N T  +AD   +V   S  +T        +GT  Y+ P  +
Sbjct: 128 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 187
Query: 263 NTG------KLTKKSDVYSFGVVLAEL 283
           +        +  K++D+Y+ G+V  E+
Sbjct: 188 DDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 96/231 (41%), Gaps = 36/231 (15%)
Query: 83  IRATKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNH 141
           +R   +F+    L QG F  V K     D+   A+K  R  ++            + +NH
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVXLLASLNH 61
Query: 142 KNVVKILGLCLE--------TEVP-----LLVYEFASNGTLLDHIRCES--SQVLKTWKT 186
           + VV+     LE        T V       +  E+  N TL D I  E+   Q  + W  
Sbjct: 62  QYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYW-- 119
Query: 187 CLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADF-------ESSVLIS 239
             R+  +   AL Y+HS     IIH ++K  NI ++++   K+ DF        S  ++ 
Sbjct: 120 --RLFRQILEALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 240 SDAETAMS-----TILIGTSGYL-DPVCINTGKLTKKSDVYSFGVVLAELL 284
            D++         T  IGT+ Y+   V   TG   +K D YS G++  E +
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 84/176 (47%), Gaps = 27/176 (15%)
Query: 137 SQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWK----------- 185
           ++ ++ N+VK+LG+C   +   L++E+ + G L + +R  S   + +             
Sbjct: 105 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 164
Query: 186 -------TC---LRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFE-S 234
                  +C   L IA + A+ + YL        +H D+ + N L+ +N   K+ADF  S
Sbjct: 165 SPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLS 221
Query: 235 SVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
             + S+D   A     I    ++ P  I   + T +SDV+++GVVL E+ + G +P
Sbjct: 222 RNIYSADYYKADGNDAIPIR-WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 94/207 (45%), Gaps = 24/207 (11%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGL---- 150
           + +G F  V++G      +VAVK +   ++              + H+N++  +      
Sbjct: 50  IGKGRFGEVWRGKWRGE-EVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 108
Query: 151 -CLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLH-----SL 204
               T++  LV ++  +G+L D++   +  V    +  +++A  TAS L +LH     + 
Sbjct: 109 NGTWTQL-WLVSDYHEHGSLFDYLNRYTVTV----EGMIKLALSTASGLAHLHMEIVGTQ 163
Query: 205 ASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET--AMSTILIGTSGYLDPVCI 262
             P I H D+KS NIL+  N T  +AD   +V   S  +T        +GT  Y+ P  +
Sbjct: 164 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 223
Query: 263 NTG------KLTKKSDVYSFGVVLAEL 283
           +        +  K++D+Y+ G+V  E+
Sbjct: 224 DDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 71/157 (45%), Gaps = 15/157 (9%)
Query: 139 VNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASAL 198
             H +++ ++     +    LV++    G L D++   + +V  + K    I      A+
Sbjct: 157 AGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL---TEKVALSEKETRSIMRSLLEAV 213
Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLD 258
            +LH+     I+H D+K  NILL+DN   +++DF  S  +    +      L GT GYL 
Sbjct: 214 SFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE---LCGTPGYLA 267
Query: 259 PVCINTG------KLTKKSDVYSFGVVLAELLTGKKP 289
           P  +            K+ D+++ GV+L  LL G  P
Sbjct: 268 PEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 55/110 (50%), Gaps = 17/110 (15%)
Query: 187 CLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAM 246
           CL I  + A A+++LHS     ++H D+K +NI    +   KV DF   ++ + D +   
Sbjct: 166 CLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDF--GLVTAMDQDEEE 220
Query: 247 STIL------------IGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELL 284
            T+L            +GT  Y+ P  I+    + K D++S G++L ELL
Sbjct: 221 QTVLTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 74/162 (45%), Gaps = 12/162 (7%)
Query: 140 NHKNVVKILGLCLETEVPLLVY-EFASNGTLLDHIRCESSQVL----------KTWKTCL 188
           +H NVV +LG C +   PL+V  EF   G L  ++R + ++ +          K + T  
Sbjct: 80  HHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 139
Query: 189 RIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMST 248
            +   +      +  LAS   IH D+ + NILL++    K+ DF  +  I  D +     
Sbjct: 140 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 199
Query: 249 ILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
                  ++ P  I     T +SDV+SFGV+L E+ + G  P
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 241

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 94/207 (45%), Gaps = 24/207 (11%)
Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGL---- 150
           + +G F  V++G      +VAVK +   ++              + H+N++  +      
Sbjct: 37  IGKGRFGEVWRGKWRGE-EVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 95
Query: 151 -CLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLH-----SL 204
               T++  LV ++  +G+L D++   +  V    +  +++A  TAS L +LH     + 
Sbjct: 96  NGTWTQL-WLVSDYHEHGSLFDYLNRYTVTV----EGMIKLALSTASGLAHLHMEIVGTQ 150
Query: 205 ASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET--AMSTILIGTSGYLDPVCI 262
             P I H D+KS NIL+  N T  +AD   +V   S  +T        +GT  Y+ P  +
Sbjct: 151 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 210
Query: 263 NTG------KLTKKSDVYSFGVVLAEL 283
           +        +  K++D+Y+ G+V  E+
Sbjct: 211 DDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 72/154 (46%), Gaps = 12/154 (7%)
Query: 140 NHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALD 199
           N   VV++     +     +V E+   G L++ +   +  V + W       AE   ALD
Sbjct: 127 NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARFY--TAEVVLALD 182
Query: 200 YLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDP 259
            +HS+     IH DVK  N+LL+ +   K+ADF + + ++ +      T  +GT  Y+ P
Sbjct: 183 AIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA-VGTPDYISP 238
Query: 260 VCINT----GKLTKKSDVYSFGVVLAELLTGKKP 289
             + +    G   ++ D +S GV L E+L G  P
Sbjct: 239 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 74/156 (47%), Gaps = 16/156 (10%)
Query: 140 NHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALD 199
           N   VV++     + +   +V E+   G L++ +   +  V + W       AE   ALD
Sbjct: 133 NSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM--SNYDVPEKWAKFY--TAEVVLALD 188
Query: 200 YLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAM--STILIGTSGYL 257
            +HS+    +IH DVK  N+LL+ +   K+ADF + + +    ET M      +GT  Y+
Sbjct: 189 AIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMD---ETGMVHCDTAVGTPDYI 242
Query: 258 DPVCINT----GKLTKKSDVYSFGVVLAELLTGKKP 289
            P  + +    G   ++ D +S GV L E+L G  P
Sbjct: 243 SPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 278

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 74/162 (45%), Gaps = 12/162 (7%)
Query: 140 NHKNVVKILGLCLETEVPLLVY-EFASNGTLLDHIRCESSQVL----------KTWKTCL 188
           +H NVV +LG C +   PL+V  EF   G L  ++R + ++ +          K + T  
Sbjct: 80  HHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 139
Query: 189 RIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMST 248
            +   +      +  LAS   IH D+ + NILL++    K+ DF  +  I  D +     
Sbjct: 140 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 199
Query: 249 ILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
                  ++ P  I     T +SDV+SFGV+L E+ + G  P
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 241

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 74/162 (45%), Gaps = 12/162 (7%)
Query: 140 NHKNVVKILGLCLETEVPLLV-YEFASNGTLLDHIRCESSQVL----------KTWKTCL 188
           +H NVV +LG C +   PL+V  EF   G L  ++R + ++ +          K + T  
Sbjct: 89  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148
Query: 189 RIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMST 248
            +   +      +  LAS   IH D+ + NILL++    K+ DF  +  I  D +     
Sbjct: 149 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKG 208
Query: 249 ILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
                  ++ P  I     T +SDV+SFGV+L E+ + G  P
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 72/154 (46%), Gaps = 12/154 (7%)
Query: 140 NHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALD 199
           N   VV++     +     +V E+   G L++ +   +  V + W       AE   ALD
Sbjct: 132 NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARFY--TAEVVLALD 187
Query: 200 YLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDP 259
            +HS+     IH DVK  N+LL+ +   K+ADF + + ++ +      T  +GT  Y+ P
Sbjct: 188 AIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA-VGTPDYISP 243
Query: 260 VCINT----GKLTKKSDVYSFGVVLAELLTGKKP 289
             + +    G   ++ D +S GV L E+L G  P
Sbjct: 244 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 72/154 (46%), Gaps = 12/154 (7%)
Query: 140 NHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALD 199
           N   VV++     +     +V E+   G L++ +   +  V + W       AE   ALD
Sbjct: 132 NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARFY--TAEVVLALD 187
Query: 200 YLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDP 259
            +HS+     IH DVK  N+LL+ +   K+ADF + + ++ +      T  +GT  Y+ P
Sbjct: 188 AIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA-VGTPDYISP 243
Query: 260 VCINT----GKLTKKSDVYSFGVVLAELLTGKKP 289
             + +    G   ++ D +S GV L E+L G  P
Sbjct: 244 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 74/162 (45%), Gaps = 12/162 (7%)
Query: 140 NHKNVVKILGLCLETEVPLLV-YEFASNGTLLDHIRCESSQVL----------KTWKTCL 188
           +H NVV +LG C +   PL+V  EF   G L  ++R + ++ +          K + T  
Sbjct: 126 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 185
Query: 189 RIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMST 248
            +   +      +  LAS   IH D+ + NILL++    K+ DF  +  I  D +     
Sbjct: 186 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 245
Query: 249 ILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
                  ++ P  I     T +SDV+SFGV+L E+ + G  P
Sbjct: 246 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 287

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 74/162 (45%), Gaps = 12/162 (7%)
Query: 140 NHKNVVKILGLCLETEVPLLV-YEFASNGTLLDHIRCESSQVL----------KTWKTCL 188
           +H NVV +LG C +   PL+V  EF   G L  ++R + ++ +          K + T  
Sbjct: 91  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLE 150
Query: 189 RIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMST 248
            +   +      +  LAS   IH D+ + NILL++    K+ DF  +  I  D +     
Sbjct: 151 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 210
Query: 249 ILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
                  ++ P  I     T +SDV+SFGV+L E+ + G  P
Sbjct: 211 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 252

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 74/162 (45%), Gaps = 12/162 (7%)
Query: 140 NHKNVVKILGLCLETEVPLLV-YEFASNGTLLDHIRCESSQVL----------KTWKTCL 188
           +H NVV +LG C +   PL+V  EF   G L  ++R + ++ +          K + T  
Sbjct: 89  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148
Query: 189 RIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMST 248
            +   +      +  LAS   IH D+ + NILL++    K+ DF  +  I  D +     
Sbjct: 149 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 208
Query: 249 ILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
                  ++ P  I     T +SDV+SFGV+L E+ + G  P
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 21/216 (9%)
Query: 87  KNFDRSRCLSQGGFVSVY---KGVLHDNIQV-AVKTYRRAD-----KXXXXXXXXXXXXS 137
           +NF+  + L  G +  V+   K   HD  ++ A+K  ++A      K             
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 138 QVNHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETA 195
            +     +  L    +TE  L L+ ++ + G L  H+    SQ  +  +  ++I   E  
Sbjct: 114 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL----SQRERFTEHEVQIYVGEIV 169
Query: 196 SALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG 255
            AL++LH L    II+ D+K  NILL+ N    + DF  S    +D ET  +    GT  
Sbjct: 170 LALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD-ETERAYDFCGTIE 225
Query: 256 YLDPVCINTGK--LTKKSDVYSFGVVLAELLTGKKP 289
           Y+ P  +  G     K  D +S GV++ ELLTG  P
Sbjct: 226 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/186 (24%), Positives = 83/186 (44%), Gaps = 13/186 (6%)
Query: 141 HKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDY 200
           H++VV   G   + +   +V E     +LL+  +   +      +  LR   +      Y
Sbjct: 76  HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR---QIVLGCQY 132
Query: 201 LHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV 260
           LH      +IH D+K  N+ LN++   K+ DF  +  +  D E   +  L GT  Y+ P 
Sbjct: 133 LHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPE 187
Query: 261 CINTGKLTKKSDVYSFGVVLAELLTGKKP--GSCMT---LASNKKISMVPYFLNSIKNNG 315
            ++    + + DV+S G ++  LL GK P   SC+    L   K    +P  +N +  + 
Sbjct: 188 VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASL 247
Query: 316 LRQILN 321
           ++++L 
Sbjct: 248 IQKMLQ 253

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/186 (24%), Positives = 83/186 (44%), Gaps = 13/186 (6%)
Query: 141 HKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDY 200
           H++VV   G   + +   +V E     +LL+  +   +      +  LR   +      Y
Sbjct: 80  HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR---QIVLGCQY 136
Query: 201 LHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV 260
           LH      +IH D+K  N+ LN++   K+ DF  +  +  D E   +  L GT  Y+ P 
Sbjct: 137 LHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPE 191
Query: 261 CINTGKLTKKSDVYSFGVVLAELLTGKKP--GSCMT---LASNKKISMVPYFLNSIKNNG 315
            ++    + + DV+S G ++  LL GK P   SC+    L   K    +P  +N +  + 
Sbjct: 192 VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASL 251
Query: 316 LRQILN 321
           ++++L 
Sbjct: 252 IQKMLQ 257

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/186 (24%), Positives = 83/186 (44%), Gaps = 13/186 (6%)
Query: 141 HKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDY 200
           H++VV   G   + +   +V E     +LL+  +   +      +  LR   +      Y
Sbjct: 76  HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR---QIVLGCQY 132
Query: 201 LHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV 260
           LH      +IH D+K  N+ LN++   K+ DF  +  +  D E   +  L GT  Y+ P 
Sbjct: 133 LHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPE 187
Query: 261 CINTGKLTKKSDVYSFGVVLAELLTGKKP--GSCMT---LASNKKISMVPYFLNSIKNNG 315
            ++    + + DV+S G ++  LL GK P   SC+    L   K    +P  +N +  + 
Sbjct: 188 VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASL 247
Query: 316 LRQILN 321
           ++++L 
Sbjct: 248 IQKMLQ 253

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 86/171 (50%), Gaps = 25/171 (14%)
Query: 137 SQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLD-------HIRCESSQVLKTWKTCL- 188
           +++ H NVV +LG+  + +   +++ + S+G L +       H    S+   +T K+ L 
Sbjct: 84  ARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALE 143
Query: 189 -----RIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE 243
                 + A+ A+ ++YL   +S  ++H D+ + N+L+ D    K++D      +  +  
Sbjct: 144 PPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLG----LFREVY 196
Query: 244 TAMSTILIGTS----GYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
            A    L+G S     ++ P  I  GK +  SD++S+GVVL E+ + G +P
Sbjct: 197 AADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 247

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 74/171 (43%), Gaps = 22/171 (12%)
Query: 159 LVYEFASNGTLLDHI---RCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVK 215
            V ++ + G L  H+   RC      + +      AAE ASAL YLHSL    I++ D+K
Sbjct: 116 FVLDYINGGELFYHLQRERCFLEPRARFY------AAEIASALGYLHSLN---IVYRDLK 166
Query: 216 SANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYS 275
             NILL+      + DF   +   +    + ++   GT  YL P  ++     +  D + 
Sbjct: 167 PENILLDSQGHIVLTDF--GLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWC 224
Query: 276 FGVVLAELLTGKKPGSCMTLAS------NKKISMVPYFLNSIKN--NGLRQ 318
            G VL E+L G  P      A       NK + + P   NS ++   GL Q
Sbjct: 225 LGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQ 275

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 70/156 (44%), Gaps = 15/156 (9%)
Query: 140 NHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALD 199
            H N++++           LV++    G L D++  + +   K  +  +R   E   AL 
Sbjct: 82  GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH 141
Query: 200 YLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDP 259
            L+      I+H D+K  NILL+D+   K+ DF  S  +  D    + ++  GT  YL P
Sbjct: 142 KLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLRSV-CGTPSYLAP 192
Query: 260 VCI------NTGKLTKKSDVYSFGVVLAELLTGKKP 289
             I      N     K+ D++S GV++  LL G  P
Sbjct: 193 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 86/171 (50%), Gaps = 25/171 (14%)
Query: 137 SQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLD-------HIRCESSQVLKTWKTCL- 188
           +++ H NVV +LG+  + +   +++ + S+G L +       H    S+   +T K+ L 
Sbjct: 67  ARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALE 126
Query: 189 -----RIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE 243
                 + A+ A+ ++YL   +S  ++H D+ + N+L+ D    K++D      +  +  
Sbjct: 127 PPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLG----LFREVY 179
Query: 244 TAMSTILIGTS----GYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
            A    L+G S     ++ P  I  GK +  SD++S+GVVL E+ + G +P
Sbjct: 180 AADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 36/113 (31%), Positives = 57/113 (50%), Gaps = 9/113 (7%)
Query: 192 AETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILI 251
            E   ALDYL +     IIH D+K  NILL+++    + DF  + ++  + +    T + 
Sbjct: 122 CELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI---TTMA 175
Query: 252 GTSGYLDPVCINTGKLTKKS---DVYSFGVVLAELLTGKKPGSCMTLASNKKI 301
           GT  Y+ P   ++ K    S   D +S GV   ELL G++P    +  S+K+I
Sbjct: 176 GTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEI 228

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 75/161 (46%), Gaps = 11/161 (6%)
Query: 139 VNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHI-RCESSQVLKTWKTCLRIAAETASA 197
           ++H N++KI  +  +     +V E    G LL+ I   ++     +      +  +  +A
Sbjct: 77  LDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNA 136
Query: 198 LDYLHSLASPPIIHGDVKSANILLND---NYTAKVADFESSVLISSDAETAMSTILIGTS 254
           L Y HS     ++H D+K  NIL  D   +   K+ DF  + L  SD     ST   GT+
Sbjct: 137 LAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH---STNAAGTA 190
Query: 255 GYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTL 295
            Y+ P       +T K D++S GVV+  LLTG  P +  +L
Sbjct: 191 LYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSL 230

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 69/156 (44%), Gaps = 15/156 (9%)
Query: 140 NHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALD 199
            H N++++           LV++    G L D++  + +   K  +  +R   E   AL 
Sbjct: 82  GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH 141
Query: 200 YLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDP 259
            L+      I+H D+K  NILL+D+   K+ DF  S  +  D    +  +  GT  YL P
Sbjct: 142 KLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREV-CGTPSYLAP 192
Query: 260 VCI------NTGKLTKKSDVYSFGVVLAELLTGKKP 289
             I      N     K+ D++S GV++  LL G  P
Sbjct: 193 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 74/157 (47%), Gaps = 17/157 (10%)
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHI--RCESSQVLKTWKTCLRIAAETA 195
           +++H N++K+  +  ++    +V E  + G L D I  R   S+         RI  +  
Sbjct: 77  KLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE-----HDAARIIKQVF 131
Query: 196 SALDYLHSLASPPIIHGDVKSANILLND---NYTAKVADFESSVLISSDAETAMSTILIG 252
           S + Y+H      I+H D+K  NILL     +   K+ DF  S     +  T M    IG
Sbjct: 132 SGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKD-RIG 185
Query: 253 TSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           T+ Y+ P  +  G   +K DV+S GV+L  LL+G  P
Sbjct: 186 TAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 69/156 (44%), Gaps = 15/156 (9%)
Query: 140 NHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALD 199
            H N++++           LV++    G L D++  + +   K  +  +R   E   AL 
Sbjct: 69  GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH 128
Query: 200 YLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDP 259
            L+      I+H D+K  NILL+D+   K+ DF  S  +  D    +  +  GT  YL P
Sbjct: 129 KLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREV-CGTPSYLAP 179
Query: 260 VCI------NTGKLTKKSDVYSFGVVLAELLTGKKP 289
             I      N     K+ D++S GV++  LL G  P
Sbjct: 180 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 215

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 71/155 (45%), Gaps = 12/155 (7%)
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
           ++ H N+V +  +        L+ +  S G L D I     +   T +   R+  +   A
Sbjct: 72  KIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVLDA 128
Query: 198 LDYLHSLASPPIIHGDVKSANIL---LNDNYTAKVADFESSVLISSDAETAMSTILIGTS 254
           + YLH L    I+H D+K  N+L   L+++    ++DF  S +   D  + +ST   GT 
Sbjct: 129 VKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTA-CGTP 182
Query: 255 GYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           GY+ P  +     +K  D +S GV+   LL G  P
Sbjct: 183 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 71/155 (45%), Gaps = 12/155 (7%)
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
           ++ H N+V +  +        L+ +  S G L D I     +   T +   R+  +   A
Sbjct: 72  KIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVLDA 128
Query: 198 LDYLHSLASPPIIHGDVKSANIL---LNDNYTAKVADFESSVLISSDAETAMSTILIGTS 254
           + YLH L    I+H D+K  N+L   L+++    ++DF  S +   D  + +ST   GT 
Sbjct: 129 VKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTA-CGTP 182
Query: 255 GYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           GY+ P  +     +K  D +S GV+   LL G  P
Sbjct: 183 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 74/157 (47%), Gaps = 17/157 (10%)
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHI--RCESSQVLKTWKTCLRIAAETA 195
           Q++H N++K+     +     LV E  + G L D I  R   S+V        RI  +  
Sbjct: 88  QLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-----DAARIIRQVL 142
Query: 196 SALDYLHSLASPPIIHGDVKSANILL---NDNYTAKVADFESSVLISSDAETAMSTILIG 252
           S + Y+H      I+H D+K  N+LL   + +   ++ DF  S    +  +       IG
Sbjct: 143 SGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK---IG 196
Query: 253 TSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           T+ Y+ P  ++ G   +K DV+S GV+L  LL+G  P
Sbjct: 197 TAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPP 232

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/247 (23%), Positives = 98/247 (39%), Gaps = 36/247 (14%)
Query: 141 HKNVVKILGLCLETEVP--LLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASAL 198
           H++++K  G C +       LV E+   G+L D++   S  + +     L  A +    +
Sbjct: 92  HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL----LLFAQQICEGM 147
Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET------AMSTILIG 252
            YLH+      IH D+ + N+LL+++   K+ DF  +  +    E         S +   
Sbjct: 148 AYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVF-- 202
Query: 253 TSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTG-----KKPGSCMTLASNKKISMVPYF 307
              +  P C+   K    SDV+SFGV L ELLT        P   + L    +  M    
Sbjct: 203 ---WYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR 259
Query: 308 LNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRL 367
           L  +   G R        D+   +    V  L   C     + RPT + +   +  L+ +
Sbjct: 260 LTELLERGER----LPRPDKCPAE----VYHLMKNCWETEASFRPTFENL---IPILKTV 308
Query: 368 HENFWAQ 374
           HE +  Q
Sbjct: 309 HEKYQGQ 315

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 74/157 (47%), Gaps = 17/157 (10%)
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHI--RCESSQVLKTWKTCLRIAAETA 195
           +++H N++K+  +  ++    +V E  + G L D I  R   S+         RI  +  
Sbjct: 77  KLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE-----HDAARIIKQVF 131
Query: 196 SALDYLHSLASPPIIHGDVKSANILLND---NYTAKVADFESSVLISSDAETAMSTILIG 252
           S + Y+H      I+H D+K  NILL     +   K+ DF  S     +  T M    IG
Sbjct: 132 SGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKD-RIG 185
Query: 253 TSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           T+ Y+ P  +  G   +K DV+S GV+L  LL+G  P
Sbjct: 186 TAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 79/187 (42%), Gaps = 29/187 (15%)
Query: 189 RIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFE-SSVLISSDAETAMS 247
           +IA     AL++LHS  S  +IH DVK +N+L+N     K+ DF  S  L+ S A+    
Sbjct: 157 KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAK---- 210
Query: 248 TILIGTSGYLDPVCINTGKLTK----KSDVYSFGVVLAELLTGKKPGSCMTLASNKKISM 303
           TI  G   Y+ P  IN     K    KSD++S G+ + EL                 I  
Sbjct: 211 TIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL----------------AILR 254
Query: 304 VPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDR 363
            PY         L+Q++          K      +  S+CL+    ERPT  ++ +    
Sbjct: 255 FPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH--P 312
Query: 364 LRRLHEN 370
              LHE+
Sbjct: 313 FFTLHES 319

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 71/155 (45%), Gaps = 12/155 (7%)
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
           ++ H N+V +  +        L+ +  S G L D I     +   T +   R+  +   A
Sbjct: 72  KIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVLDA 128
Query: 198 LDYLHSLASPPIIHGDVKSANIL---LNDNYTAKVADFESSVLISSDAETAMSTILIGTS 254
           + YLH L    I+H D+K  N+L   L+++    ++DF  S +   D  + +ST   GT 
Sbjct: 129 VKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTAC-GTP 182
Query: 255 GYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           GY+ P  +     +K  D +S GV+   LL G  P
Sbjct: 183 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 38/132 (28%), Positives = 63/132 (47%), Gaps = 13/132 (9%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETASALDYLHSLASPPIIHGDVKSA 217
           +V E+A  G +  H+R    ++ +  +   R  AA+     +YLHSL    +I+ D+K  
Sbjct: 119 MVLEYAPGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPE 171
Query: 218 NILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFG 277
           N+L++     KVADF  +  +        +  L GT  YL P  I +    K  D ++ G
Sbjct: 172 NLLIDQQGYIKVADFGFAKRVK-----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALG 226
Query: 278 VVLAELLTGKKP 289
           V++ E+  G  P
Sbjct: 227 VLIYEMAAGYPP 238

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 71/155 (45%), Gaps = 12/155 (7%)
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
           ++ H N+V +  +        L+ +  S G L D I     +   T +   R+  +   A
Sbjct: 72  KIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVLDA 128
Query: 198 LDYLHSLASPPIIHGDVKSANIL---LNDNYTAKVADFESSVLISSDAETAMSTILIGTS 254
           + YLH L    I+H D+K  N+L   L+++    ++DF  S +   D  + +ST   GT 
Sbjct: 129 VKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTA-CGTP 182
Query: 255 GYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           GY+ P  +     +K  D +S GV+   LL G  P
Sbjct: 183 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 74/157 (47%), Gaps = 17/157 (10%)
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHI--RCESSQVLKTWKTCLRIAAETA 195
           +++H N++K+  +  ++    +V E  + G L D I  R   S+         RI  +  
Sbjct: 77  KLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE-----HDAARIIKQVF 131
Query: 196 SALDYLHSLASPPIIHGDVKSANILLND---NYTAKVADFESSVLISSDAETAMSTILIG 252
           S + Y+H      I+H D+K  NILL     +   K+ DF  S     +  T M    IG
Sbjct: 132 SGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKD-RIG 185
Query: 253 TSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           T+ Y+ P  +  G   +K DV+S GV+L  LL+G  P
Sbjct: 186 TAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/230 (23%), Positives = 96/230 (41%), Gaps = 18/230 (7%)
Query: 68  GLAFLRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHD--NIQVAVK---TYRRA 122
           G    R   F  +   + + N+D    L +G F SV +  +H    ++ A K   T + +
Sbjct: 10  GQQMGRGSEFMMNASTKFSDNYDVKEELGKGAF-SVVRRCVHKTTGLEFAAKIINTKKLS 68
Query: 123 DKXXXXXXXXXXXXSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLK 182
            +             ++ H N+V++     E     LV++  + G L + I         
Sbjct: 69  ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEA 128
Query: 183 TWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLND---NYTAKVADFESSVLIS 239
               C++   E+   + Y HS     I+H ++K  N+LL         K+ADF  ++ ++
Sbjct: 129 DASHCIQQILES---IAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182
Query: 240 SDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
            D+E        GT GYL P  +     +K  D+++ GV+L  LL G  P
Sbjct: 183 -DSEAWHG--FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 74/157 (47%), Gaps = 17/157 (10%)
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHI--RCESSQVLKTWKTCLRIAAETA 195
           Q++H N++K+     +     LV E  + G L D I  R   S+V        RI  +  
Sbjct: 82  QLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-----DAARIIRQVL 136
Query: 196 SALDYLHSLASPPIIHGDVKSANILL---NDNYTAKVADFESSVLISSDAETAMSTILIG 252
           S + Y+H      I+H D+K  N+LL   + +   ++ DF  S    +  +       IG
Sbjct: 137 SGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK---IG 190
Query: 253 TSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           T+ Y+ P  ++ G   +K DV+S GV+L  LL+G  P
Sbjct: 191 TAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPP 226

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/141 (30%), Positives = 68/141 (48%), Gaps = 11/141 (7%)
Query: 151 CLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKT-CLRIAAETASALDYLHSLASPP 208
           C +T   L  V E+ + G L+ HI+    QV +  +   +  AAE A  L +L S     
Sbjct: 89  CFQTMDRLYFVMEYVNGGDLMYHIQ----QVGRFKEPHAVFYAAEIAIGLFFLQSKG--- 141
Query: 209 IIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLT 268
           II+ D+K  N++L+     K+ADF   +   +  +   +    GT  Y+ P  I      
Sbjct: 142 IIYRDLKLDNVMLDSEGHIKIADF--GMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYG 199
Query: 269 KKSDVYSFGVVLAELLTGKKP 289
           K  D ++FGV+L E+L G+ P
Sbjct: 200 KSVDWWAFGVLLYEMLAGQAP 220

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 92/214 (42%), Gaps = 18/214 (8%)
Query: 84  RATKNFDRSRCLSQGGFVSVYKGVLHD--NIQVAVK---TYRRADKXXXXXXXXXXXXSQ 138
           + + N+D    L +G F SV +  +H    ++ A K   T + + +             +
Sbjct: 3   KFSDNYDVKEELGKGAF-SVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 61
Query: 139 VNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASAL 198
           + H N+V++     E     LV++  + G L + I             C++   E+   +
Sbjct: 62  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILES---I 118
Query: 199 DYLHSLASPPIIHGDVKSANILLND---NYTAKVADFESSVLISSDAETAMSTILIGTSG 255
            Y HS     I+H ++K  N+LL         K+ADF  ++ ++ D+E        GT G
Sbjct: 119 AYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHG--FAGTPG 172
Query: 256 YLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           YL P  +     +K  D+++ GV+L  LL G  P
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/141 (30%), Positives = 68/141 (48%), Gaps = 11/141 (7%)
Query: 151 CLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKT-CLRIAAETASALDYLHSLASPP 208
           C +T   L  V E+ + G L+ HI+    QV +  +   +  AAE A  L +L S     
Sbjct: 410 CFQTMDRLYFVMEYVNGGDLMYHIQ----QVGRFKEPHAVFYAAEIAIGLFFLQSKG--- 462
Query: 209 IIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLT 268
           II+ D+K  N++L+     K+ADF   +   +  +   +    GT  Y+ P  I      
Sbjct: 463 IIYRDLKLDNVMLDSEGHIKIADF--GMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYG 520
Query: 269 KKSDVYSFGVVLAELLTGKKP 289
           K  D ++FGV+L E+L G+ P
Sbjct: 521 KSVDWWAFGVLLYEMLAGQAP 541

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 75/157 (47%), Gaps = 17/157 (10%)
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHI--RCESSQVLKTWKTCLRIAAETA 195
           Q++H N++K+     +     LV E  + G L D I  R   S+V        RI  +  
Sbjct: 105 QLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-----DAARIIRQVL 159
Query: 196 SALDYLHSLASPPIIHGDVKSANILL---NDNYTAKVADFESSVLISSDAETAMSTILIG 252
           S + Y+H      I+H D+K  N+LL   + +   ++ DF  S     +A   M    IG
Sbjct: 160 SGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKKMKD-KIG 213
Query: 253 TSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           T+ Y+ P  ++ G   +K DV+S GV+L  LL+G  P
Sbjct: 214 TAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPP 249

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 66/154 (42%), Gaps = 11/154 (7%)
Query: 139 VNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASAL 198
           + H N+V++     E     LV++  + G L + I             C++   +   A+
Sbjct: 60  LKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQ---QILEAV 116
Query: 199 DYLHSLASPPIIHGDVKSANILLND---NYTAKVADFESSVLISSDAETAMSTILIGTSG 255
            + H +    ++H D+K  N+LL         K+ADF  ++ +  D +        GT G
Sbjct: 117 LHCHQMG---VVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFG--FAGTPG 171
Query: 256 YLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           YL P  +      K  D+++ GV+L  LL G  P
Sbjct: 172 YLSPEVLRKEAYGKPVDIWACGVILYILLVGYPP 205

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 92/214 (42%), Gaps = 18/214 (8%)
Query: 84  RATKNFDRSRCLSQGGFVSVYKGVLHD--NIQVAVK---TYRRADKXXXXXXXXXXXXSQ 138
           + + N+D    L +G F SV +  +H    ++ A K   T + + +             +
Sbjct: 2   KFSDNYDVKEELGKGAF-SVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 60
Query: 139 VNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASAL 198
           + H N+V++     E     LV++  + G L + I             C++   E+ +  
Sbjct: 61  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIA-- 118
Query: 199 DYLHSLASPPIIHGDVKSANILLND---NYTAKVADFESSVLISSDAETAMSTILIGTSG 255
            Y HS     I+H ++K  N+LL         K+ADF  ++ ++ D+E        GT G
Sbjct: 119 -YCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHG--FAGTPG 171
Query: 256 YLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           YL P  +     +K  D+++ GV+L  LL G  P
Sbjct: 172 YLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 205

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 92/214 (42%), Gaps = 18/214 (8%)
Query: 84  RATKNFDRSRCLSQGGFVSVYKGVLHD--NIQVAVK---TYRRADKXXXXXXXXXXXXSQ 138
           + + N+D    L +G F SV +  +H    ++ A K   T + + +             +
Sbjct: 3   KFSDNYDVKEELGKGAF-SVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 61
Query: 139 VNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASAL 198
           + H N+V++     E     LV++  + G L + I             C++   E+ +  
Sbjct: 62  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIA-- 119
Query: 199 DYLHSLASPPIIHGDVKSANILLND---NYTAKVADFESSVLISSDAETAMSTILIGTSG 255
            Y HS     I+H ++K  N+LL         K+ADF  ++ ++ D+E        GT G
Sbjct: 120 -YCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHG--FAGTPG 172
Query: 256 YLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           YL P  +     +K  D+++ GV+L  LL G  P
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 74/298 (24%), Positives = 118/298 (39%), Gaps = 44/298 (14%)
Query: 95  LSQGGFVSVYKGVLHDNIQVA-VKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLE 153
           + +G F  VY G  H  + +  +   R  +              Q  H+NVV  +G C+ 
Sbjct: 41  IGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS 100
Query: 154 TEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGD 213
                ++       TL   +R ++  VL   KT  +IA E    + YLH+     I+H D
Sbjct: 101 PPHLAIITSLCKGRTLYSVVR-DAKIVLDVNKT-RQIAQEIVKGMGYLHAKG---ILHKD 155
Query: 214 VKSANILLNDNYTAKVADFE----SSVLISSDAETAMSTILIGTSGYLDPVCI------- 262
           +KS N+   DN    + DF     S VL +   E  +  I  G   +L P  I       
Sbjct: 156 LKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLR-IQNGWLCHLAPEIIRQLSPDT 213
Query: 263 --NTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQIL 320
             +    +K SDV++ G +  EL   + P       +    +++      +K N L QI 
Sbjct: 214 EEDKLPFSKHSDVFALGTIWYELHAREWP-----FKTQPAEAIIWQMGTGMKPN-LSQI- 266
Query: 321 NFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL----RRLHE--NFW 372
                     KEI   +++   C      ERPT  ++ + L++L    RRL    +FW
Sbjct: 267 -------GMGKEI---SDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFW 314

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 75/157 (47%), Gaps = 17/157 (10%)
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHI--RCESSQVLKTWKTCLRIAAETA 195
           Q++H N++K+     +     LV E  + G L D I  R   S+V        RI  +  
Sbjct: 106 QLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-----DAARIIRQVL 160
Query: 196 SALDYLHSLASPPIIHGDVKSANILL---NDNYTAKVADFESSVLISSDAETAMSTILIG 252
           S + Y+H      I+H D+K  N+LL   + +   ++ DF  S     +A   M    IG
Sbjct: 161 SGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKKMKD-KIG 214
Query: 253 TSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           T+ Y+ P  ++ G   +K DV+S GV+L  LL+G  P
Sbjct: 215 TAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPP 250

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 62/132 (46%), Gaps = 10/132 (7%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKT-CLRIAAETASALDYLHSLASPPIIHGDVKSA 217
            V E+ + G L+ HI+    QV K  +   +  AAE +  L +LH      II+ D+K  
Sbjct: 97  FVMEYVNGGDLMYHIQ----QVGKFKEPQAVFYAAEISIGLFFLHKRG---IIYRDLKLD 149
Query: 218 NILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFG 277
           N++L+     K+ADF        D  T       GT  Y+ P  I      K  D +++G
Sbjct: 150 NVMLDSEGHIKIADFGMCKEHMMDGVTTRE--FCGTPDYIAPEIIAYQPYGKSVDWWAYG 207
Query: 278 VVLAELLTGKKP 289
           V+L E+L G+ P
Sbjct: 208 VLLYEMLAGQPP 219

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 92/215 (42%), Gaps = 25/215 (11%)
Query: 95  LSQGGFVSVYKGV-LHDNIQVA---VKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGL 150
           + +G F +VYKG+     ++VA   ++  +                  + H N+V+    
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYDS 93
Query: 151 CLET----EVPLLVYEFASNGTL---LDHIRCESSQVLKTWKTCLRIAAETASALDYLHS 203
              T    +  +LV E  ++GTL   L   +    +VL++W  C +I       L +LH+
Sbjct: 94  WESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSW--CRQIL----KGLQFLHT 147
Query: 204 LASPPIIHGDVKSANILL-NDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCI 262
             +PPIIH D+K  NI +     + K+ D   + L       + +  +IGT  +  P   
Sbjct: 148 -RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEFXAPEXY 202
Query: 263 NTGKLTKKSDVYSFGVVLAELLTGKKPGS-CMTLA 296
              K  +  DVY+FG    E  T + P S C   A
Sbjct: 203 EE-KYDESVDVYAFGXCXLEXATSEYPYSECQNAA 236

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 71/153 (46%), Gaps = 20/153 (13%)
Query: 141 HKNVVKILGLCLET-EVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASAL 198
           H++++K  G C +  E  L LV E+   G+L D++   S  + +     L  A +    +
Sbjct: 75  HEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQL----LLFAQQICEGM 130
Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE------TAMSTILIG 252
            YLHS      IH ++ + N+LL+++   K+ DF  +  +    E         S +   
Sbjct: 131 AYLHSQH---YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF-- 185
Query: 253 TSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT 285
              +  P C+   K    SDV+SFGV L ELLT
Sbjct: 186 ---WYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 97/226 (42%), Gaps = 17/226 (7%)
Query: 96  SQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXX---XSQVNHKNVVKILGLCL 152
           +QG  V+ Y  +L  N  VA+K   R  +                 VNHKN++ +L +  
Sbjct: 36  AQGIVVAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFT 93
Query: 153 ETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHG 212
             +    + EF     +++ +    SQV++      R++      L  +  L S  IIH 
Sbjct: 94  PQKS---LEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLHSAGIIHR 150
Query: 213 DVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSD 272
           D+K +NI++  + T K+ DF    L  +   + M T  + T  Y  P  I      +  D
Sbjct: 151 DLKPSNIVVKSDATLKILDFG---LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVD 207
Query: 273 VYSFGVVLAELLTGKK--PGSCMTLASNKKISMV----PYFLNSIK 312
           ++S GV++ E++ G    PG+      NK I  +    P F+  ++
Sbjct: 208 IWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQ 253

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 67/154 (43%), Gaps = 11/154 (7%)
Query: 139 VNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASAL 198
           + H N+V++     E     LV++  + G L + I             C++   E+   +
Sbjct: 60  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILES---V 116
Query: 199 DYLHSLASPPIIHGDVKSANILL---NDNYTAKVADFESSVLISSDAETAMSTILIGTSG 255
           ++ H      I+H D+K  N+LL   +     K+ADF  ++ +  D +        GT G
Sbjct: 117 NHCHLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFG--FAGTPG 171
Query: 256 YLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           YL P  +      K  D+++ GV+L  LL G  P
Sbjct: 172 YLSPEVLRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 71/163 (43%), Gaps = 27/163 (16%)
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHI-------RCESSQVLKTWKTCLRI 190
           ++ H N++ +  +       +L+ E  S G L D +         E++Q LK        
Sbjct: 64  EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLK-------- 115
Query: 191 AAETASALDYLHSLASPPIIHGDVKSANILLND----NYTAKVADFESSVLISSDAETAM 246
                  LD +H L S  I H D+K  NI+L D    N   K+ DF  +  I +  E   
Sbjct: 116 -----QILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN 170
Query: 247 STILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
              + GT  ++ P  +N   L  ++D++S GV+   LL+G  P
Sbjct: 171 ---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 67/154 (43%), Gaps = 11/154 (7%)
Query: 139 VNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASAL 198
           + H N+V++     E     LV++  + G L + I             C++   E+   +
Sbjct: 60  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILES---V 116
Query: 199 DYLHSLASPPIIHGDVKSANILL---NDNYTAKVADFESSVLISSDAETAMSTILIGTSG 255
           ++ H      I+H D+K  N+LL   +     K+ADF  ++ +  D +        GT G
Sbjct: 117 NHCHLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFG--FAGTPG 171
Query: 256 YLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           YL P  +      K  D+++ GV+L  LL G  P
Sbjct: 172 YLSPEVLRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 62/132 (46%), Gaps = 13/132 (9%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETASALDYLHSLASPPIIHGDVKSA 217
           +V E+   G +  H+R    ++ +  +   R  AA+     +YLHSL    +I+ D+K  
Sbjct: 118 MVMEYVPGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPE 170
Query: 218 NILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFG 277
           N+L++     KVADF  +  +        +  L GT  YL P  I +    K  D ++ G
Sbjct: 171 NLLIDQQGYIKVADFGFAKRVK-----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALG 225
Query: 278 VVLAELLTGKKP 289
           V++ E+  G  P
Sbjct: 226 VLIYEMAAGYPP 237

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 67/151 (44%), Gaps = 10/151 (6%)
Query: 140 NHKNVVKILGLCLETEVPLL-VYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASAL 198
           NH  + ++   C +T   L  V EF + G L+ HI  + S+     +     AAE  SAL
Sbjct: 82  NHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHI--QKSRRFDEARARF-YAAEIISAL 137
Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLD 258
            +LH      II+ D+K  N+LL+     K+ADF   +          +    GT  Y+ 
Sbjct: 138 MFLHDKG---IIYRDLKLDNVLLDHEGHCKLADF--GMCKEGICNGVTTATFCGTPDYIA 192
Query: 259 PVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           P  +         D ++ GV+L E+L G  P
Sbjct: 193 PEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 71/163 (43%), Gaps = 27/163 (16%)
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHI-------RCESSQVLKTWKTCLRI 190
           ++ H N++ +  +       +L+ E  S G L D +         E++Q LK        
Sbjct: 71  EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLK-------- 122
Query: 191 AAETASALDYLHSLASPPIIHGDVKSANILLND----NYTAKVADFESSVLISSDAETAM 246
                  LD +H L S  I H D+K  NI+L D    N   K+ DF  +  I +  E   
Sbjct: 123 -----QILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN 177
Query: 247 STILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
              + GT  ++ P  +N   L  ++D++S GV+   LL+G  P
Sbjct: 178 ---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 72/159 (45%), Gaps = 25/159 (15%)
Query: 141 HKNVVKILGLCLETEVPLLVYEFASNGTLLDHIR-------CESSQVLKTWKTCLRIAAE 193
           H N+VK+  +  +     LV E  + G L + I+        E+S +++          +
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMR----------K 114
Query: 194 TASALDYLHSLASPPIIHGDVKSANILL---NDNYTAKVADFESSVLISSDAETAMSTIL 250
             SA+ ++H +    ++H D+K  N+L    NDN   K+ DF  + L   D +   +   
Sbjct: 115 LVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF 171
Query: 251 IGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
             T  Y  P  +N     +  D++S GV+L  +L+G+ P
Sbjct: 172 --TLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVP 208

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 71/163 (43%), Gaps = 27/163 (16%)
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHI-------RCESSQVLKTWKTCLRI 190
           ++ H N++ +  +       +L+ E  S G L D +         E++Q LK        
Sbjct: 85  EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLK-------- 136
Query: 191 AAETASALDYLHSLASPPIIHGDVKSANILLND----NYTAKVADFESSVLISSDAETAM 246
                  LD +H L S  I H D+K  NI+L D    N   K+ DF  +  I +  E   
Sbjct: 137 -----QILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN 191
Query: 247 STILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
              + GT  ++ P  +N   L  ++D++S GV+   LL+G  P
Sbjct: 192 ---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 231

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 62/132 (46%), Gaps = 13/132 (9%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETASALDYLHSLASPPIIHGDVKSA 217
           +V E+A  G +  H+R    ++ +  +   R  AA+     +YLHSL    +I+ D+K  
Sbjct: 118 MVMEYAPGGEMFSHLR----RIGRFXEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPE 170
Query: 218 NILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFG 277
           N++++     KV DF  +  +        +  L GT  YL P  I +    K  D ++ G
Sbjct: 171 NLMIDQQGYIKVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALG 225
Query: 278 VVLAELLTGKKP 289
           V++ E+  G  P
Sbjct: 226 VLIYEMAAGYPP 237

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 62/132 (46%), Gaps = 13/132 (9%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETASALDYLHSLASPPIIHGDVKSA 217
           +V E+A  G +  H+R    ++ +  +   R  AA+     +YLHSL    +I+ D+K  
Sbjct: 119 MVMEYAPGGEMFSHLR----RIGRFXEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPE 171
Query: 218 NILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFG 277
           N++++     KV DF  +  +        +  L GT  YL P  I +    K  D ++ G
Sbjct: 172 NLMIDQQGYIKVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALG 226
Query: 278 VVLAELLTGKKP 289
           V++ E+  G  P
Sbjct: 227 VLIYEMAAGYPP 238

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 68/155 (43%), Gaps = 13/155 (8%)
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
           ++ H+N+V +  +   T    LV +  S G L D I     + + T K    +  +  SA
Sbjct: 62  KIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRIL---ERGVYTEKDASLVIQQVLSA 118
Query: 198 LDYLHSLASPPIIHGDVKSANILL---NDNYTAKVADFESSVLISSDAETAMSTILIGTS 254
           + YLH      I+H D+K  N+L     +N    + DF     +S   +  + +   GT 
Sbjct: 119 VKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFG----LSKMEQNGIMSTACGTP 171
Query: 255 GYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           GY+ P  +     +K  D +S GV+   LL G  P
Sbjct: 172 GYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 62/132 (46%), Gaps = 13/132 (9%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETASALDYLHSLASPPIIHGDVKSA 217
           +V E+   G +  H+R    ++ +  +   R  AA+     +YLHSL    +I+ D+K  
Sbjct: 118 MVMEYMPGGDMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPE 170
Query: 218 NILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFG 277
           N+L++     KVADF  +  +        +  L GT  YL P  I +    K  D ++ G
Sbjct: 171 NLLIDQQGYIKVADFGFAKRVK-----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALG 225
Query: 278 VVLAELLTGKKP 289
           V++ E+  G  P
Sbjct: 226 VLIYEMAAGYPP 237

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 71/153 (46%), Gaps = 20/153 (13%)
Query: 141 HKNVVKILGLCLET-EVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASAL 198
           H++++K  G C +  E  L LV E+   G+L D++   S  + +     L  A +    +
Sbjct: 75  HEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQL----LLFAQQICEGM 130
Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE------TAMSTILIG 252
            YLH+      IH ++ + N+LL+++   K+ DF  +  +    E         S +   
Sbjct: 131 AYLHAQH---YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF-- 185
Query: 253 TSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT 285
              +  P C+   K    SDV+SFGV L ELLT
Sbjct: 186 ---WYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE-TAMSTILIGTSG 255
            L Y+HS     ++H D+K +N+LLN     K+ DF  + +   D + T   T  + T  
Sbjct: 140 GLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 256 YLDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PG 290
           Y  P + +N+   TK  D++S G +LAE+L+ +   PG
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 234

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE-TAMSTILIGTSG 255
            L Y+HS     ++H D+K +N+LLN     K+ DF  + +   D + T   T  + T  
Sbjct: 136 GLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 256 YLDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PG 290
           Y  P + +N+   TK  D++S G +LAE+L+ +   PG
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 230

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 62/132 (46%), Gaps = 13/132 (9%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETASALDYLHSLASPPIIHGDVKSA 217
           +V E+   G +  H+R    ++ +  +   R  AA+     +YLHSL    +I+ D+K  
Sbjct: 118 MVMEYMPGGDMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPE 170
Query: 218 NILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFG 277
           N+L++     KVADF  +  +        +  L GT  YL P  I +    K  D ++ G
Sbjct: 171 NLLIDQQGYIKVADFGFAKRVK-----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALG 225
Query: 278 VVLAELLTGKKP 289
           V++ E+  G  P
Sbjct: 226 VLIYEMAAGYPP 237

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE-TAMSTILIGTSG 255
            L Y+HS     ++H D+K +N+LLN     K+ DF  + +   D + T   T  + T  
Sbjct: 136 GLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 256 YLDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PG 290
           Y  P + +N+   TK  D++S G +LAE+L+ +   PG
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 230

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 90/212 (42%), Gaps = 21/212 (9%)
Query: 89  FDRSRCLSQGGFVSVYK-----GVLHDNIQVAVKTYRRA-----DKXXXXXXXXXXXXSQ 138
           F+  R L +GG+  V++     G     I  A+K  ++A      K             +
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKI-FAMKVLKKAMIVRNAKDTAHTKAERNILEE 77
Query: 139 VNHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
           V H  +V ++    +T   L L+ E+ S G L   ++ E   +      C  +A E + A
Sbjct: 78  VKHPFIVDLI-YAFQTGGKLYLILEYLSGGELF--MQLEREGIFMEDTACFYLA-EISMA 133
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYL 257
           L +LH      II+ D+K  NI+LN     K+ DF   +   S  +  ++    GT  Y+
Sbjct: 134 LGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDF--GLCKESIHDGTVTHTFCGTIEYM 188
Query: 258 DPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
            P  +      +  D +S G ++ ++LTG  P
Sbjct: 189 APEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE-TAMSTILIGTSG 255
            L Y+HS     ++H D+K +N+LLN     K+ DF  + +   D + T   T  + T  
Sbjct: 140 GLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 256 YLDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PG 290
           Y  P + +N+   TK  D++S G +LAE+L+ +   PG
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 234

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 70/158 (44%), Gaps = 18/158 (11%)
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
           ++ H+N+V +  +        LV +  S G L D I  +     K   T +R   +   A
Sbjct: 76  KIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIR---QVLDA 132
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMS------TILI 251
           + YLH +    I+H D+K  N+L    Y ++  D ES ++IS    + M       +   
Sbjct: 133 VYYLHRMG---IVHRDLKPENLL----YYSQ--DEESKIMISDFGLSKMEGKGDVMSTAC 183
Query: 252 GTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           GT GY+ P  +     +K  D +S GV+   LL G  P
Sbjct: 184 GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 221

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 37/149 (24%), Positives = 62/149 (41%), Gaps = 21/149 (14%)
Query: 209 IIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLT 268
           I+H DVK +NIL+N     K+ DF     +S      M+   +GT  Y+ P  +     +
Sbjct: 129 IMHRDVKPSNILVNSRGEIKLCDFG----VSGQLIDEMANEFVGTRSYMSPERLQGTHYS 184
Query: 269 KKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADES 328
            +SD++S G+ L E+  G+ P   M +       ++ Y +N         + +    D  
Sbjct: 185 VQSDIWSMGLSLVEMAVGRYPRPPMAI-----FELLDYIVNEPPPKLPSAVFSLEFQD-- 237
Query: 329 EMKEIEIVAELASKCLRIRGTERPTMKQV 357
                       +KCL     ER  +KQ+
Sbjct: 238 ----------FVNKCLIKNPAERADLKQL 256

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 75/186 (40%), Gaps = 27/186 (14%)
Query: 189 RIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMST 248
           +IA     AL++LHS  S  +IH DVK +N+L+N     K+ DF  S  +  D    +  
Sbjct: 113 KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA 170
Query: 249 ILIGTSGYLDPVCINTGKLTK----KSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMV 304
              G   Y+ P  IN     K    KSD++S G+ + EL                 I   
Sbjct: 171 ---GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL----------------AILRF 211
Query: 305 PYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL 364
           PY         L+Q++          K      +  S+CL+    ERPT  ++ +     
Sbjct: 212 PYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH--PF 269
Query: 365 RRLHEN 370
             LHE+
Sbjct: 270 FTLHES 275

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE-TAMSTILIGTSG 255
            L Y+HS     ++H D+K +N+LLN     K+ DF  + +   D + T   T  + T  
Sbjct: 136 GLKYIHSAN---VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 256 YLDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PG 290
           Y  P + +N+   TK  D++S G +LAE+L+ +   PG
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 230

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 90/212 (42%), Gaps = 21/212 (9%)
Query: 89  FDRSRCLSQGGFVSVYK-----GVLHDNIQVAVKTYRRA-----DKXXXXXXXXXXXXSQ 138
           F+  R L +GG+  V++     G     I  A+K  ++A      K             +
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKI-FAMKVLKKAMIVRNAKDTAHTKAERNILEE 77
Query: 139 VNHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
           V H  +V ++    +T   L L+ E+ S G L   ++ E   +      C  +A E + A
Sbjct: 78  VKHPFIVDLI-YAFQTGGKLYLILEYLSGGELF--MQLEREGIFMEDTACFYLA-EISMA 133
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYL 257
           L +LH      II+ D+K  NI+LN     K+ DF   +   S  +  ++    GT  Y+
Sbjct: 134 LGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDF--GLCKESIHDGTVTHXFCGTIEYM 188
Query: 258 DPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
            P  +      +  D +S G ++ ++LTG  P
Sbjct: 189 APEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE-TAMSTILIGTSG 255
            L Y+HS     ++H D+K +N+LLN     K+ DF  + +   D + T   T  + T  
Sbjct: 156 GLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 212
Query: 256 YLDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PG 290
           Y  P + +N+   TK  D++S G +LAE+L+ +   PG
Sbjct: 213 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 250

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 66/154 (42%), Gaps = 11/154 (7%)
Query: 139 VNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASAL 198
           + H N+V++     E     LV++  + G L + I             C+    E+   +
Sbjct: 87  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILES---V 143
Query: 199 DYLHSLASPPIIHGDVKSANILLND---NYTAKVADFESSVLISSDAETAMSTILIGTSG 255
           +++H      I+H D+K  N+LL         K+ADF  ++ +  + +        GT G
Sbjct: 144 NHIHQHD---IVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFG--FAGTPG 198
Query: 256 YLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           YL P  +      K  D+++ GV+L  LL G  P
Sbjct: 199 YLSPEVLRKDPYGKPVDIWACGVILYILLVGYPP 232

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 72/157 (45%), Gaps = 17/157 (10%)
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHI--RCESSQVLKTWKTCLRIAAETA 195
           Q++H N+ K+     +     LV E  + G L D I  R   S+V        RI  +  
Sbjct: 82  QLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-----DAARIIRQVL 136
Query: 196 SALDYLHSLASPPIIHGDVKSANILL---NDNYTAKVADFESSVLISSDAETAMSTILIG 252
           S + Y H      I+H D+K  N+LL   + +   ++ DF  S    +  +       IG
Sbjct: 137 SGITYXHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDK---IG 190
Query: 253 TSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           T+ Y+ P  ++ G   +K DV+S GV+L  LL+G  P
Sbjct: 191 TAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPP 226

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 78/182 (42%), Gaps = 18/182 (9%)
Query: 114 VAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHI 173
           VAVK   R +K              + H N+V+   + L      +V E+AS G L + I
Sbjct: 47  VAVKYIERGEKIAANVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI 106
Query: 174 RCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTA--KVAD 231
            C + +   +         +  S + Y H++    + H D+K  N LL+ +     K+ D
Sbjct: 107 -CNAGRF--SEDEARFFFQQLISGVSYCHAMQ---VCHRDLKLENTLLDGSPAPRLKICD 160
Query: 232 F---ESSVLISSDAETAMSTILIGTSGYLDP-VCINTGKLTKKSDVYSFGVVLAELLTGK 287
           F   +SSVL S    T      +GT  Y+ P V +      K +DV+S GV L  +L G 
Sbjct: 161 FGYSKSSVLHSQPKST------VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGA 214
Query: 288 KP 289
            P
Sbjct: 215 YP 216

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 96/222 (43%), Gaps = 24/222 (10%)
Query: 87  KNFDRSRCLSQGGFVSVYKGVLHDN----IQVAVKTYRR---ADKXXXXXXXXXXXXSQV 139
           + F   R L +G F SV +  L       ++VAVK  +    A               + 
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 140 NHKNVVKILGLCLETE------VPLLVYEFASNGTLLDHIRCESSQVLKT-----WKTCL 188
           +H +V K++G+ L +       +P+++  F  +G L  H    +S++ +       +T +
Sbjct: 83  DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDL--HAFLLASRIGENPFNLPLQTLV 140
Query: 189 RIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMST 248
           R   + A  ++YL   +S   IH D+ + N +L ++ T  VADF  S  I S        
Sbjct: 141 RFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGC 197
Query: 249 ILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
                  +L    +     T  SDV++FGV + E++T G+ P
Sbjct: 198 ASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE-TAMSTILIGTSG 255
            L Y+HS     ++H D+K +N+LLN     K+ DF  + +   D + T   T  + T  
Sbjct: 140 GLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 256 YLDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PG 290
           Y  P + +N+   TK  D++S G +LAE+L+ +   PG
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 234

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 62/132 (46%), Gaps = 13/132 (9%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETASALDYLHSLASPPIIHGDVKSA 217
           +V E+A  G +  H+R    ++ +  +   R  AA+     +YLHSL    +I+ D+K  
Sbjct: 119 MVMEYAPGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPE 171
Query: 218 NILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFG 277
           N++++     KV DF  +  +        +  L GT  YL P  I +    K  D ++ G
Sbjct: 172 NLMIDQQGYIKVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALG 226
Query: 278 VVLAELLTGKKP 289
           V++ E+  G  P
Sbjct: 227 VLIYEMAAGYPP 238

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE-TAMSTILIGTSG 255
            L Y+HS     ++H D+K +N+LLN     K+ DF  + +   D + T   T  + T  
Sbjct: 136 GLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 256 YLDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PG 290
           Y  P + +N+   TK  D++S G +LAE+L+ +   PG
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 230

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE-TAMSTILIGTSG 255
            L Y+HS     ++H D+K +N+LLN     K+ DF  + +   D + T   T  + T  
Sbjct: 134 GLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 190
Query: 256 YLDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PG 290
           Y  P + +N+   TK  D++S G +LAE+L+ +   PG
Sbjct: 191 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 228

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 62/132 (46%), Gaps = 13/132 (9%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETASALDYLHSLASPPIIHGDVKSA 217
           +V E+A  G +  H+R    ++ +  +   R  AA+     +YLHSL    +I+ D+K  
Sbjct: 119 MVMEYAPGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPE 171
Query: 218 NILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFG 277
           N++++     KV DF  +  +        +  L GT  YL P  I +    K  D ++ G
Sbjct: 172 NLMIDQQGYIKVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALG 226
Query: 278 VVLAELLTGKKP 289
           V++ E+  G  P
Sbjct: 227 VLIYEMAAGYPP 238

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE-TAMSTILIGTSG 255
            L Y+HS     ++H D+K +N+LLN     K+ DF  + +   D + T   T  + T  
Sbjct: 140 GLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 256 YLDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PG 290
           Y  P + +N+   TK  D++S G +LAE+L+ +   PG
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 234

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 62/132 (46%), Gaps = 13/132 (9%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETASALDYLHSLASPPIIHGDVKSA 217
           +V E+A  G +  H+R    ++ +  +   R  AA+     +YLHSL    +I+ D+K  
Sbjct: 118 MVMEYAPGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPE 170
Query: 218 NILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFG 277
           N++++     KV DF  +  +        +  L GT  YL P  I +    K  D ++ G
Sbjct: 171 NLMIDQQGYIKVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALG 225
Query: 278 VVLAELLTGKKP 289
           V++ E+  G  P
Sbjct: 226 VLIYEMAAGYPP 237

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE-TAMSTILIGTSG 255
            L Y+HS     ++H D+K +N+LLN     K+ DF  + +   D + T   T  + T  
Sbjct: 141 GLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 197
Query: 256 YLDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PG 290
           Y  P + +N+   TK  D++S G +LAE+L+ +   PG
Sbjct: 198 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 235

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE-TAMSTILIGTSG 255
            L Y+HS     ++H D+K +N+LLN     K+ DF  + +   D + T   T  + T  
Sbjct: 142 GLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 198
Query: 256 YLDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PG 290
           Y  P + +N+   TK  D++S G +LAE+L+ +   PG
Sbjct: 199 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 236

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE-TAMSTILIGTSG 255
            L Y+HS     ++H D+K +N+LLN     K+ DF  + +   D + T   T  + T  
Sbjct: 133 GLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 189
Query: 256 YLDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PG 290
           Y  P + +N+   TK  D++S G +LAE+L+ +   PG
Sbjct: 190 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 227

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 62/132 (46%), Gaps = 13/132 (9%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETASALDYLHSLASPPIIHGDVKSA 217
           +V E+A  G +  H+R    ++ +  +   R  AA+     +YLHSL    +I+ D+K  
Sbjct: 119 MVMEYAPGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPE 171
Query: 218 NILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFG 277
           N++++     KV DF  +  +        +  L GT  YL P  I +    K  D ++ G
Sbjct: 172 NLMIDQQGYIKVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALG 226
Query: 278 VVLAELLTGKKP 289
           V++ E+  G  P
Sbjct: 227 VLIYEMAAGYPP 238

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE-TAMSTILIGTSG 255
            L Y+HS     ++H D+K +N+LLN     K+ DF  + +   D + T   T  + T  
Sbjct: 140 GLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 256 YLDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PG 290
           Y  P + +N+   TK  D++S G +LAE+L+ +   PG
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 234

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE-TAMSTILIGTSG 255
            L Y+HS     ++H D+K +N+LLN     K+ DF  + +   D + T   T  + T  
Sbjct: 134 GLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 190
Query: 256 YLDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PG 290
           Y  P + +N+   TK  D++S G +LAE+L+ +   PG
Sbjct: 191 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 228

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE-TAMSTILIGTSG 255
            L Y+HS     ++H D+K +N+LLN     K+ DF  + +   D + T   T  + T  
Sbjct: 138 GLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 194
Query: 256 YLDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PG 290
           Y  P + +N+   TK  D++S G +LAE+L+ +   PG
Sbjct: 195 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 232

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE-TAMSTILIGTSG 255
            L Y+HS     ++H D+K +N+LLN     K+ DF  + +   D + T   T  + T  
Sbjct: 144 GLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 200
Query: 256 YLDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PG 290
           Y  P + +N+   TK  D++S G +LAE+L+ +   PG
Sbjct: 201 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 238

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE-TAMSTILIGTSG 255
            L Y+HS     ++H D+K +N+LLN     K+ DF  + +   D + T   T  + T  
Sbjct: 136 GLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 256 YLDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PG 290
           Y  P + +N+   TK  D++S G +LAE+L+ +   PG
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 230

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 78/182 (42%), Gaps = 18/182 (9%)
Query: 114 VAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHI 173
           VAVK   R +K              + H N+V+   + L      +V E+AS G L + I
Sbjct: 46  VAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI 105
Query: 174 RCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTA--KVAD 231
            C + +   +         +  S + Y H++    + H D+K  N LL+ +     K+ D
Sbjct: 106 -CNAGRF--SEDEARFFFQQLISGVSYCHAMQ---VCHRDLKLENTLLDGSPAPRLKICD 159
Query: 232 F---ESSVLISSDAETAMSTILIGTSGYLDP-VCINTGKLTKKSDVYSFGVVLAELLTGK 287
           F   +SSVL S    T      +GT  Y+ P V +      K +DV+S GV L  +L G 
Sbjct: 160 FGYSKSSVLHSQPKST------VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGA 213
Query: 288 KP 289
            P
Sbjct: 214 YP 215

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE-TAMSTILIGTSG 255
            L Y+HS     ++H D+K +N+LLN     K+ DF  + +   D + T   T  + T  
Sbjct: 156 GLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 212
Query: 256 YLDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PG 290
           Y  P + +N+   TK  D++S G +LAE+L+ +   PG
Sbjct: 213 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 250

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE-TAMSTILIGTSG 255
            L Y+HS     ++H D+K +N+LLN     K+ DF  + +   D + T   T  + T  
Sbjct: 138 GLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 194
Query: 256 YLDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PG 290
           Y  P + +N+   TK  D++S G +LAE+L+ +   PG
Sbjct: 195 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 232

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE-TAMSTILIGTSG 255
            L Y+HS     ++H D+K +N+LLN     K+ DF  + +   D + T   T  + T  
Sbjct: 138 GLKYIHSAN---VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRW 194
Query: 256 YLDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PG 290
           Y  P + +N+   TK  D++S G +LAE+L+ +   PG
Sbjct: 195 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 232

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 62/132 (46%), Gaps = 13/132 (9%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETASALDYLHSLASPPIIHGDVKSA 217
           +V E+A  G +  H+R    ++ +  +   R  AA+     +YLHSL    +I+ D+K  
Sbjct: 118 MVMEYAPGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPE 170
Query: 218 NILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFG 277
           N++++     KV DF  +  +        +  L GT  YL P  I +    K  D ++ G
Sbjct: 171 NLMIDQQGYIKVTDFGLAKRVK-----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALG 225
Query: 278 VVLAELLTGKKP 289
           V++ E+  G  P
Sbjct: 226 VLIYEMAAGYPP 237

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 85/168 (50%), Gaps = 21/168 (12%)
Query: 140 NHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALD 199
            +KN+++++    +     LV+E    G++L HI+    Q     +   R+  + A+ALD
Sbjct: 69  GNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQ---KQKHFNEREASRVVRDVAAALD 125
Query: 200 YLHSLASPPIIHGDVKSANILLNDNY---TAKVADFE-SSVLISSDAETAMSTILI---- 251
           +LH+     I H D+K  NIL          K+ DF+  S +  +++ T ++T  +    
Sbjct: 126 FLHTKG---IAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPC 182
Query: 252 GTSGYLDP--VCINTGKLT---KKSDVYSFGVVLAELLTGKKP--GSC 292
           G++ Y+ P  V + T + T   K+ D++S GVVL  +L+G  P  G C
Sbjct: 183 GSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHC 230

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/137 (31%), Positives = 65/137 (47%), Gaps = 17/137 (12%)
Query: 163 FASNGTL---LDHIRCES-SQVLKTWKTCL-----RIAAETASALDYLHSLASPPIIHGD 213
           F S+G +   ++H+   S  QVLK  K        +++      L YL       I+H D
Sbjct: 83  FYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQ--IMHRD 140
Query: 214 VKSANILLNDNYTAKVADFE-SSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSD 272
           VK +NIL+N     K+ DF  S  LI S     M+   +GT  Y+ P  +     + +SD
Sbjct: 141 VKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMAPERLQGTHYSVQSD 195
Query: 273 VYSFGVVLAELLTGKKP 289
           ++S G+ L EL  G+ P
Sbjct: 196 IWSMGLSLVELAVGRYP 212

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/247 (25%), Positives = 101/247 (40%), Gaps = 49/247 (19%)
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTL--LD-HIRCESSQVLKTWKTCLRIAAET 194
           Q+ H N+V +L +        LV+E+  +  L  LD + R     ++K+      I  +T
Sbjct: 58  QLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKS------ITWQT 111
Query: 195 ASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISS-----DAETAM--- 246
             A+++ H       IH DVK  NIL+  +   K+ DF  + L++      D E A    
Sbjct: 112 LQAVNFCHKHNC---IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWY 168
Query: 247 --STILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKK--PGSC----MTLASN 298
               +L+G + Y  PV           DV++ G V AELL+G    PG      + L   
Sbjct: 169 RSPELLVGDTQYGPPV-----------DVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRK 217
Query: 299 KKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEI--------VAELASKCLRIRGTE 350
               ++P        N  +      + D  +M+ +E+           L   CL +  TE
Sbjct: 218 TLGDLIPRHQQVFSTN--QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTE 275
Query: 351 RPTMKQV 357
           R T +Q+
Sbjct: 276 RLTCEQL 282

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/99 (29%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 191 AAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTIL 250
           AAE    L+ LH      I++ D+K  NILL+D+   +++D   +V +  + +T    + 
Sbjct: 292 AAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP-EGQTIKGRV- 346
Query: 251 IGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
            GT GY+ P  +   + T   D ++ G +L E++ G+ P
Sbjct: 347 -GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 82/180 (45%), Gaps = 12/180 (6%)
Query: 139 VNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASAL 198
           VNHKN++ +L +    +    + EF     +++ +    SQV++      R++      L
Sbjct: 80  VNHKNIIGLLNVFTPQKS---LEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQML 136
Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLD 258
             +  L S  IIH D+K +NI++  + T K+ DF    L  +   + M T  + T  Y  
Sbjct: 137 VGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFG---LARTAGTSFMMTPYVVTRYYRA 193
Query: 259 PVCINTGKLTKKSDVYSFGVVLAELLTGKK--PGSCMTLASNKKISMV----PYFLNSIK 312
           P  I      +  D++S GV++ E++ G    PG+      NK I  +    P F+  ++
Sbjct: 194 PEVILGMGYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQ 253

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/99 (29%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 191 AAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTIL 250
           AAE    L+ LH      I++ D+K  NILL+D+   +++D   +V +  + +T    + 
Sbjct: 292 AAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP-EGQTIKGRV- 346
Query: 251 IGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
            GT GY+ P  +   + T   D ++ G +L E++ G+ P
Sbjct: 347 -GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 80/180 (44%), Gaps = 12/180 (6%)
Query: 140 NHKNVVKILGLCLETEVPLL-VYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETASA 197
           NH  +V  L  C +TE  L  V E+ + G L+ H++ +     K  +   R  +AE + A
Sbjct: 79  NHPFLVG-LHSCFQTESRLFFVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLA 133
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYL 257
           L+YLH      II+ D+K  N+LL+     K+ D+          +T  ++   GT  Y+
Sbjct: 134 LNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXFCGTPNYI 188
Query: 258 DPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLR 317
            P  +         D ++ GV++ E++ G+ P   +  + N   +   Y    I    +R
Sbjct: 189 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR 248

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/154 (23%), Positives = 66/154 (42%), Gaps = 11/154 (7%)
Query: 139 VNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASAL 198
           + H N+V++     E     L+++  + G L + I             C++   +   A+
Sbjct: 78  LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQ---QILEAV 134
Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTA---KVADFESSVLISSDAETAMSTILIGTSG 255
            + H +    ++H D+K  N+LL         K+ADF  ++ +  + +        GT G
Sbjct: 135 LHCHQMG---VVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--FAGTPG 189
Query: 256 YLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           YL P  +      K  D+++ GV+L  LL G  P
Sbjct: 190 YLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 223

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 80/180 (44%), Gaps = 12/180 (6%)
Query: 140 NHKNVVKILGLCLETEVPLL-VYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETASA 197
           NH  +V  L  C +TE  L  V E+ + G L+ H++ +     K  +   R  +AE + A
Sbjct: 111 NHPFLVG-LHSCFQTESRLFFVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLA 165
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYL 257
           L+YLH      II+ D+K  N+LL+     K+ D+          +T  ++   GT  Y+
Sbjct: 166 LNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNYI 220
Query: 258 DPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLR 317
            P  +         D ++ GV++ E++ G+ P   +  + N   +   Y    I    +R
Sbjct: 221 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR 280

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 78/182 (42%), Gaps = 18/182 (9%)
Query: 114 VAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHI 173
           VAVK   R +K              + H N+V+   + L      +V E+AS G L + I
Sbjct: 47  VAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI 106
Query: 174 RCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTA--KVAD 231
            C + +   +         +  S + Y H++    + H D+K  N LL+ +     K+AD
Sbjct: 107 -CNAGRF--SEDEARFFFQQLISGVSYAHAMQ---VAHRDLKLENTLLDGSPAPRLKIAD 160
Query: 232 F---ESSVLISSDAETAMSTILIGTSGYLDP-VCINTGKLTKKSDVYSFGVVLAELLTGK 287
           F   ++SVL S           +GT  Y+ P V +      K +DV+S GV L  +L G 
Sbjct: 161 FGYSKASVLHSQPKSA------VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGA 214
Query: 288 KP 289
            P
Sbjct: 215 YP 216

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 80/180 (44%), Gaps = 12/180 (6%)
Query: 140 NHKNVVKILGLCLETEVPLL-VYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETASA 197
           NH  +V  L  C +TE  L  V E+ + G L+ H++ +     K  +   R  +AE + A
Sbjct: 64  NHPFLVG-LHSCFQTESRLFFVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLA 118
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYL 257
           L+YLH      II+ D+K  N+LL+     K+ D+          +T  ++   GT  Y+
Sbjct: 119 LNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXFCGTPNYI 173
Query: 258 DPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLR 317
            P  +         D ++ GV++ E++ G+ P   +  + N   +   Y    I    +R
Sbjct: 174 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR 233

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 43/81 (53%), Gaps = 4/81 (4%)
Query: 209 IIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLT 268
           I+H DVK +NIL+N     K+ DF     +S     +M+   +GT  Y+ P  +     +
Sbjct: 145 IMHRDVKPSNILVNSRGEIKLCDFG----VSGQLIDSMANSFVGTRSYMSPERLQGTHYS 200
Query: 269 KKSDVYSFGVVLAELLTGKKP 289
            +SD++S G+ L E+  G+ P
Sbjct: 201 VQSDIWSMGLSLVEMAVGRYP 221

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 80/180 (44%), Gaps = 12/180 (6%)
Query: 140 NHKNVVKILGLCLETEVPLL-VYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETASA 197
           NH  +V  L  C +TE  L  V E+ + G L+ H++ +     K  +   R  +AE + A
Sbjct: 68  NHPFLVG-LHSCFQTESRLFFVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLA 122
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYL 257
           L+YLH      II+ D+K  N+LL+     K+ D+          +T  ++   GT  Y+
Sbjct: 123 LNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXFCGTPNYI 177
Query: 258 DPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLR 317
            P  +         D ++ GV++ E++ G+ P   +  + N   +   Y    I    +R
Sbjct: 178 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR 237

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/82 (35%), Positives = 44/82 (53%), Gaps = 6/82 (7%)
Query: 209 IIHGDVKSANILLNDNYTAKVADFE-SSVLISSDAETAMSTILIGTSGYLDPVCINTGKL 267
           I+H DVK +NIL+N     K+ DF  S  LI S     M+   +GT  Y+ P  +     
Sbjct: 153 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTHY 207
Query: 268 TKKSDVYSFGVVLAELLTGKKP 289
           + +SD++S G+ L E+  G+ P
Sbjct: 208 SVQSDIWSMGLSLVEMAVGRYP 229

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 82/175 (46%), Gaps = 35/175 (20%)
Query: 140 NHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIR-------CESSQVLKTWKTCLRIAA 192
            H+NV++++    E +   LV+E    G++L HI         E+S V++          
Sbjct: 69  GHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQ---------- 118
Query: 193 ETASALDYLHSLASPPIIHGDVKSANILL---NDNYTAKVADFE--SSVLISSDAETAMS 247
           + ASALD+LH+     I H D+K  NIL    N     K+ DF+  S + ++ D     +
Sbjct: 119 DVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIST 175
Query: 248 TILI---GTSGYLDPVCINTGK-----LTKKSDVYSFGVVLAELLTGKKP--GSC 292
             L+   G++ Y+ P  +           K+ D++S GV+L  LL+G  P  G C
Sbjct: 176 PELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRC 230

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 62/132 (46%), Gaps = 13/132 (9%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETASALDYLHSLASPPIIHGDVKSA 217
           +V E+ + G +  H+R    ++ +  +   R  AA+     +YLHSL    +I+ D+K  
Sbjct: 118 MVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPE 170
Query: 218 NILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFG 277
           N+L++     +V DF  +  +        +  L GT  YL P  I +    K  D ++ G
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLAPAIILSKGYNKAVDWWALG 225
Query: 278 VVLAELLTGKKP 289
           V++ E+  G  P
Sbjct: 226 VLIYEMAAGYPP 237

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 62/132 (46%), Gaps = 13/132 (9%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETASALDYLHSLASPPIIHGDVKSA 217
           +V E+ + G +  H+R    ++ +  +   R  AA+     +YLHSL    +I+ D+K  
Sbjct: 139 MVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPE 191
Query: 218 NILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFG 277
           N+L++     +V DF  +  +     T     L GT  YL P  I +    K  D ++ G
Sbjct: 192 NLLIDQQGYIQVTDFGFAKRVKGATWT-----LCGTPEYLAPEIILSKGYNKAVDWWALG 246
Query: 278 VVLAELLTGKKP 289
           V++ E+  G  P
Sbjct: 247 VLIYEMAAGYPP 258

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 75/156 (48%), Gaps = 14/156 (8%)
Query: 140 NHKNVVKIL-GLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASAL 198
           +H N+VK+L     E  + +L+ EF + G + D +  E  + L T      +  +T  AL
Sbjct: 92  DHPNIVKLLDAFYYENNLWILI-EFCAGGAV-DAVMLELERPL-TESQIQVVCKQTLDAL 148
Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLD 258
           +YLH      IIH D+K+ NIL   +   K+ADF  S   +   +   S   IGT  ++ 
Sbjct: 149 NYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDS--FIGTPYWMA 203
Query: 259 P--VCINTGK---LTKKSDVYSFGVVLAELLTGKKP 289
           P  V   T K      K+DV+S G+ L E+   + P
Sbjct: 204 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 96/232 (41%), Gaps = 34/232 (14%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSAN 218
           LV E+  +G L D ++   +++  +    L  +++    ++YL S      +H D+ + N
Sbjct: 91  LVMEYLPSGCLRDFLQRHRARLDAS--RLLLYSSQICKGMEYLGSRR---CVHRDLAARN 145
Query: 219 ILLNDNYTAKVADFESSVLISSDA------ETAMSTILIGTSGYLDPVCINTGKLTKKSD 272
           IL+      K+ADF  + L+  D       E   S I      +  P  ++    +++SD
Sbjct: 146 ILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF-----WYAPESLSDNIFSRQSD 200
Query: 273 VYSFGVVLAELLTGKKPGSCMTLASNKKISM----VPYFLNSIKNNGLRQILNFHVADES 328
           V+SFGVVL EL T     SC   A   ++      VP     ++     Q L    A  +
Sbjct: 201 VWSFGVVLYELFTYCD-KSCSPSAEFLRMMGCERDVPALCRLLELLEEGQRLPAPPACPA 259
Query: 329 EMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLHENFWAQKKNKET 380
           E      V EL   C      +RP+   +  +LD L       W+  +  ET
Sbjct: 260 E------VHELMKLCWAPSPQDRPSFSALGPQLDML-------WSGSRGCET 298

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 78/155 (50%), Gaps = 17/155 (10%)
Query: 139 VNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHI--RCESSQVLKTWKTCLRIAAETAS 196
           + H +++K+  +    +  ++V E+A N  L D+I  R + S+     +   R   +  S
Sbjct: 61  LRHPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSE-----QEARRFFQQIIS 114
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
           A++Y H      I+H D+K  N+LL+++   K+ADF  S +++       S    G+  Y
Sbjct: 115 AVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPNY 168
Query: 257 LDPVCINTGKLT--KKSDVYSFGVVLAELLTGKKP 289
             P  I +GKL    + DV+S GV+L  +L  + P
Sbjct: 169 AAPEVI-SGKLYAGPEVDVWSCGVILYVMLCRRLP 202

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/82 (35%), Positives = 44/82 (53%), Gaps = 6/82 (7%)
Query: 209 IIHGDVKSANILLNDNYTAKVADFE-SSVLISSDAETAMSTILIGTSGYLDPVCINTGKL 267
           I+H DVK +NIL+N     K+ DF  S  LI S     M+   +GT  Y+ P  +     
Sbjct: 188 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTHY 242
Query: 268 TKKSDVYSFGVVLAELLTGKKP 289
           + +SD++S G+ L E+  G+ P
Sbjct: 243 SVQSDIWSMGLSLVEMAVGRYP 264

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 63/132 (47%), Gaps = 13/132 (9%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETASALDYLHSLASPPIIHGDVKSA 217
           +V E+ + G +  H+R    ++ +  +   R  AA+     +YLHSL    +I+ D+K  
Sbjct: 105 MVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPE 157
Query: 218 NILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFG 277
           N+L+++    +V DF  +  +        +  L GT  YL P  I +    K  D ++ G
Sbjct: 158 NLLIDEQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALG 212
Query: 278 VVLAELLTGKKP 289
           V++ E+  G  P
Sbjct: 213 VLIYEMAAGYPP 224

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 62/132 (46%), Gaps = 13/132 (9%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETASALDYLHSLASPPIIHGDVKSA 217
           +V E+ + G +  H+R    ++ +  +   R  AA+     +YLHSL    +I+ D+K  
Sbjct: 118 MVMEYVAGGEMFSHLR----RIGRFXEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPE 170
Query: 218 NILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFG 277
           N+L++     +V DF  +  +        +  L GT  YL P  I +    K  D ++ G
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALG 225
Query: 278 VVLAELLTGKKP 289
           V++ E+  G  P
Sbjct: 226 VLIYEMAAGYPP 237

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 43/81 (53%), Gaps = 4/81 (4%)
Query: 209 IIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLT 268
           I+H DVK +NIL+N     K+ DF     +S     +M+   +GT  Y+ P  +     +
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFG----VSGQLIDSMANSFVGTRSYMSPERLQGTHYS 181
Query: 269 KKSDVYSFGVVLAELLTGKKP 289
            +SD++S G+ L E+  G+ P
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYP 202

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 62/132 (46%), Gaps = 13/132 (9%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETASALDYLHSLASPPIIHGDVKSA 217
           +V E+ + G +  H+R    ++ +  +   R  AA+     +YLHSL    +I+ D+K  
Sbjct: 113 MVMEYVAGGEMFSHLR----RIGRFXEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPE 165
Query: 218 NILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFG 277
           N+L++     +V DF  +  +        +  L GT  YL P  I +    K  D ++ G
Sbjct: 166 NLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALG 220
Query: 278 VVLAELLTGKKP 289
           V++ E+  G  P
Sbjct: 221 VLIYEMAAGYPP 232

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 62/132 (46%), Gaps = 13/132 (9%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETASALDYLHSLASPPIIHGDVKSA 217
           +V E+A  G +  H+R    ++ +  +   R  AA+     +YLHSL    +I+ D+K  
Sbjct: 118 MVMEYAPGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPE 170
Query: 218 NILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFG 277
           N++++     +V DF  +  +        +  L GT  YL P  I +    K  D ++ G
Sbjct: 171 NLMIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALG 225
Query: 278 VVLAELLTGKKP 289
           V++ E+  G  P
Sbjct: 226 VLIYEMAAGYPP 237

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 43/81 (53%), Gaps = 4/81 (4%)
Query: 209 IIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLT 268
           I+H DVK +NIL+N     K+ DF     +S     +M+   +GT  Y+ P  +     +
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFG----VSGQLIDSMANSFVGTRSYMSPERLQGTHYS 181
Query: 269 KKSDVYSFGVVLAELLTGKKP 289
            +SD++S G+ L E+  G+ P
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYP 202

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 61/132 (46%), Gaps = 13/132 (9%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETASALDYLHSLASPPIIHGDVKSA 217
           +V E+   G +  H+R    ++ +  +   R  AA+     +YLHSL    +I+ D+K  
Sbjct: 119 MVMEYVPGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPE 171
Query: 218 NILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFG 277
           N+L++     +V DF  +  +     T     L GT  YL P  I +    K  D ++ G
Sbjct: 172 NLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEYLAPEIILSKGYNKAVDWWALG 226
Query: 278 VVLAELLTGKKP 289
           V++ E+  G  P
Sbjct: 227 VLIYEMAAGYPP 238

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 62/132 (46%), Gaps = 13/132 (9%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETASALDYLHSLASPPIIHGDVKSA 217
           +V E+ + G +  H+R    ++ +  +   R  AA+     +YLHSL    +I+ D+K  
Sbjct: 118 MVMEYVAGGEMFSHLR----RIGRFXEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPE 170
Query: 218 NILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFG 277
           N+L++     +V DF  +  +        +  L GT  YL P  I +    K  D ++ G
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALG 225
Query: 278 VVLAELLTGKKP 289
           V++ E+  G  P
Sbjct: 226 VLIYEMAAGYPP 237

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 78/155 (50%), Gaps = 17/155 (10%)
Query: 139 VNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHI--RCESSQVLKTWKTCLRIAAETAS 196
           + H +++K+  +    +  ++V E+A N  L D+I  R + S+     +   R   +  S
Sbjct: 71  LRHPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSE-----QEARRFFQQIIS 124
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
           A++Y H      I+H D+K  N+LL+++   K+ADF  S +++       S    G+  Y
Sbjct: 125 AVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPNY 178
Query: 257 LDPVCINTGKL--TKKSDVYSFGVVLAELLTGKKP 289
             P  I +GKL    + DV+S GV+L  +L  + P
Sbjct: 179 AAPEVI-SGKLYAGPEVDVWSCGVILYVMLCRRLP 212

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 73/156 (46%), Gaps = 14/156 (8%)
Query: 140 NHKNVVKIL-GLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASAL 198
           +H N+VK+L     E  + +L+ EF + G + D +  E  + L T      +  +T  AL
Sbjct: 92  DHPNIVKLLDAFYYENNLWILI-EFCAGGAV-DAVMLELERPL-TESQIQVVCKQTLDAL 148
Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLD 258
           +YLH      IIH D+K+ NIL   +   K+ADF   V   +          IGT  ++ 
Sbjct: 149 NYLHDNK---IIHRDLKAGNILFTLDGDIKLADF--GVSAKNTRXIQRRDXFIGTPYWMA 203
Query: 259 P--VCINTGK---LTKKSDVYSFGVVLAELLTGKKP 289
           P  V   T K      K+DV+S G+ L E+   + P
Sbjct: 204 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 62/132 (46%), Gaps = 13/132 (9%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETASALDYLHSLASPPIIHGDVKSA 217
           +V E+ + G +  H+R    ++ +  +   R  AA+     +YLHSL    +I+ D+K  
Sbjct: 118 MVMEYVAGGEMFSHLR----RIGRFXEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPE 170
Query: 218 NILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFG 277
           N+L++     +V DF  +  +        +  L GT  YL P  I +    K  D ++ G
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALG 225
Query: 278 VVLAELLTGKKP 289
           V++ E+  G  P
Sbjct: 226 VLIYEMAAGYPP 237

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 78/155 (50%), Gaps = 17/155 (10%)
Query: 139 VNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHI--RCESSQVLKTWKTCLRIAAETAS 196
           + H +++K+  +    +  ++V E+A N  L D+I  R + S+     +   R   +  S
Sbjct: 65  LRHPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSE-----QEARRFFQQIIS 118
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
           A++Y H      I+H D+K  N+LL+++   K+ADF  S +++       S    G+  Y
Sbjct: 119 AVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPNY 172
Query: 257 LDPVCINTGKL--TKKSDVYSFGVVLAELLTGKKP 289
             P  I +GKL    + DV+S GV+L  +L  + P
Sbjct: 173 AAPEVI-SGKLYAGPEVDVWSCGVILYVMLCRRLP 206

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 62/132 (46%), Gaps = 13/132 (9%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETASALDYLHSLASPPIIHGDVKSA 217
           +V E+ + G +  H+R    ++ +  +   R  AA+     +YLHSL    +I+ D+K  
Sbjct: 139 MVMEYVAGGEMFSHLR----RIGRFXEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPE 191
Query: 218 NILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFG 277
           N+L++     +V DF  +  +        +  L GT  YL P  I +    K  D ++ G
Sbjct: 192 NLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALG 246
Query: 278 VVLAELLTGKKP 289
           V++ E+  G  P
Sbjct: 247 VLIYEMAAGYPP 258

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 75/156 (48%), Gaps = 14/156 (8%)
Query: 140 NHKNVVKIL-GLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASAL 198
           +H N+VK+L     E  + +L+ EF + G + D +  E  + L T      +  +T  AL
Sbjct: 92  DHPNIVKLLDAFYYENNLWILI-EFCAGGAV-DAVMLELERPL-TESQIQVVCKQTLDAL 148
Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLD 258
           +YLH      IIH D+K+ NIL   +   K+ADF  S   +   +   S   IGT  ++ 
Sbjct: 149 NYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMA 203
Query: 259 P--VCINTGK---LTKKSDVYSFGVVLAELLTGKKP 289
           P  V   T K      K+DV+S G+ L E+   + P
Sbjct: 204 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 43/81 (53%), Gaps = 4/81 (4%)
Query: 209 IIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLT 268
           I+H DVK +NIL+N     K+ DF     +S     +M+   +GT  Y+ P  +     +
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFG----VSGQLIDSMANSFVGTRSYMSPERLQGTHYS 181
Query: 269 KKSDVYSFGVVLAELLTGKKP 289
            +SD++S G+ L E+  G+ P
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYP 202

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 43/81 (53%), Gaps = 4/81 (4%)
Query: 209 IIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLT 268
           I+H DVK +NIL+N     K+ DF     +S     +M+   +GT  Y+ P  +     +
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFG----VSGQLIDSMANSFVGTRSYMSPERLQGTHYS 181
Query: 269 KKSDVYSFGVVLAELLTGKKP 289
            +SD++S G+ L E+  G+ P
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYP 202

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 43/81 (53%), Gaps = 4/81 (4%)
Query: 209 IIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLT 268
           I+H DVK +NIL+N     K+ DF     +S     +M+   +GT  Y+ P  +     +
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFG----VSGQLIDSMANSFVGTRSYMSPERLQGTHYS 181
Query: 269 KKSDVYSFGVVLAELLTGKKP 289
            +SD++S G+ L E+  G+ P
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYP 202

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 68/155 (43%), Gaps = 24/155 (15%)
Query: 141 HKNVVKILGLCLET--EVPLLVYEFASNGTLLDHI--RCESSQVLKTWKTCLRIAAETAS 196
           H+++VK  G C +   +   LV E+   G+L D++   C     L      L  A +   
Sbjct: 70  HEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQL------LLFAQQICE 123
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET------AMSTIL 250
            + YLH+      IH  + + N+LL+++   K+ DF  +  +    E         S + 
Sbjct: 124 GMAYLHAQH---YIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF 180
Query: 251 IGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT 285
                +  P C+   K    SDV+SFGV L ELLT
Sbjct: 181 -----WYAPECLKECKFYYASDVWSFGVTLYELLT 210

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 78/155 (50%), Gaps = 17/155 (10%)
Query: 139 VNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHI--RCESSQVLKTWKTCLRIAAETAS 196
           + H +++K+  +    +  ++V E+A N  L D+I  R + S+     +   R   +  S
Sbjct: 70  LRHPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSE-----QEARRFFQQIIS 123
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
           A++Y H      I+H D+K  N+LL+++   K+ADF  S +++       S    G+  Y
Sbjct: 124 AVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPNY 177
Query: 257 LDPVCINTGKL--TKKSDVYSFGVVLAELLTGKKP 289
             P  I +GKL    + DV+S GV+L  +L  + P
Sbjct: 178 AAPEVI-SGKLYAGPEVDVWSCGVILYVMLCRRLP 211

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 68/153 (44%), Gaps = 20/153 (13%)
Query: 141 HKNVVKILGLCLET--EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASAL 198
           H+++VK  G C +   +   LV E+   G+L D++      + +     L  A +    +
Sbjct: 69  HEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQL----LLFAQQICEGM 124
Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET------AMSTILIG 252
            YLH+      IH  + + N+LL+++   K+ DF  +  +    E         S +   
Sbjct: 125 AYLHAQH---YIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF-- 179
Query: 253 TSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT 285
              +  P C+   K    SDV+SFGV L ELLT
Sbjct: 180 ---WYAPECLKECKFYYASDVWSFGVTLYELLT 209

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 61/132 (46%), Gaps = 13/132 (9%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETASALDYLHSLASPPIIHGDVKSA 217
           +V E+   G +  H+R    ++ +  +   R  AA+     +YLHSL    +I+ D+K  
Sbjct: 104 MVMEYVPGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPE 156
Query: 218 NILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFG 277
           N+L++     +V DF  +  +     T     L GT  YL P  I +    K  D ++ G
Sbjct: 157 NLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEYLAPEIILSKGYNKAVDWWALG 211
Query: 278 VVLAELLTGKKP 289
           V++ E+  G  P
Sbjct: 212 VLIYEMAAGYPP 223

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 80/165 (48%), Gaps = 19/165 (11%)
Query: 158 LLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSA 217
           LL+ E    G L++ ++   S+   +  T L+I  +T  A+ ++H    PPIIH D+K  
Sbjct: 110 LLLTELC-KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR-QKPPIIHRDLKVE 167
Query: 218 NILLNDNYTAKVADFESSVLISSDAE---TAMSTILI-------GTSGYLDPVCIN---T 264
           N+LL++  T K+ DF S+  IS   +   +A    L+        T  Y  P  I+    
Sbjct: 168 NLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSN 227
Query: 265 GKLTKKSDVYSFGVVLAELLTGKKP---GSCMTLASNKKISMVPY 306
             + +K D+++ G +L  L   + P   G+ + +  N K S+ P+
Sbjct: 228 FPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIV-NGKYSIPPH 271

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 62/132 (46%), Gaps = 13/132 (9%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETASALDYLHSLASPPIIHGDVKSA 217
           +V E+A  G +  H+R    ++ +  +   R  AA+     +YLHSL    +I+ D+K  
Sbjct: 118 MVMEYAPGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPE 170
Query: 218 NILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFG 277
           N++++     +V DF  +  +        +  L GT  YL P  I +    K  D ++ G
Sbjct: 171 NLMIDQQGYIQVTDFGLAKRVK-----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALG 225
Query: 278 VVLAELLTGKKP 289
           V++ E+  G  P
Sbjct: 226 VLIYEMAAGYPP 237

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 62/132 (46%), Gaps = 13/132 (9%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETASALDYLHSLASPPIIHGDVKSA 217
           +V E+ + G +  H+R    ++ +  +   R  AA+     +YLHSL    +I+ D+K  
Sbjct: 118 MVMEYVAGGEMFSHLR----RIGRFAEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPE 170
Query: 218 NILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFG 277
           N+L++     +V DF  +  +        +  L GT  YL P  I +    K  D ++ G
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALG 225
Query: 278 VVLAELLTGKKP 289
           V++ E+  G  P
Sbjct: 226 VLIYEMAAGYPP 237

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 71/161 (44%), Gaps = 17/161 (10%)
Query: 139 VNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHI--RCESSQVLKTWKTCLRIAAETAS 196
           ++H N++K+     +     LV E    G L D I  R + ++V         I  +  S
Sbjct: 93  LDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEV-----DAAVIIKQVLS 147
Query: 197 ALDYLHSLASPPIIHGDVKSANILLND---NYTAKVADFESSVLISSDAETAMSTILIGT 253
            + YLH      I+H D+K  N+LL     +   K+ DF  S +  +  +       +GT
Sbjct: 148 GVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKER---LGT 201
Query: 254 SGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMT 294
           + Y+ P  +   K  +K DV+S GV+L  LL G  P    T
Sbjct: 202 AYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQT 241

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 61/132 (46%), Gaps = 13/132 (9%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETASALDYLHSLASPPIIHGDVKSA 217
           +V E+   G +  H+R    ++ +  +   R  AA+     +YLHSL    +I+ D+K  
Sbjct: 119 MVMEYVPGGEMFSHLR----RIGRFXEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPE 171
Query: 218 NILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFG 277
           N+L++     +V DF  +  +        +  L GT  YL P  I +    K  D ++ G
Sbjct: 172 NLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALG 226
Query: 278 VVLAELLTGKKP 289
           V++ E+  G  P
Sbjct: 227 VLIYEMAAGYPP 238

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 69/156 (44%), Gaps = 13/156 (8%)
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
           ++ H NV+ +  +       +L+ E  + G L D +  + S    T +       +  + 
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESL---TEEEATEFLKQILNG 126
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAK----VADFESSVLISSDAETAMSTILIGT 253
           + YLHSL    I H D+K  NI+L D    K    + DF  +  I    E      + GT
Sbjct: 127 VYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGT 180
Query: 254 SGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
             ++ P  +N   L  ++D++S GV+   LL+G  P
Sbjct: 181 PAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 61/132 (46%), Gaps = 13/132 (9%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETASALDYLHSLASPPIIHGDVKSA 217
           +V E+   G +  H+R    ++ +  +   R  AA+     +YLHSL    +I+ D+K  
Sbjct: 118 MVMEYVPGGEMFSHLR----RIGRFXEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPE 170
Query: 218 NILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFG 277
           N+L++     +V DF  +  +        +  L GT  YL P  I +    K  D ++ G
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALG 225
Query: 278 VVLAELLTGKKP 289
           V++ E+  G  P
Sbjct: 226 VLIYEMAAGYPP 237

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 62/132 (46%), Gaps = 13/132 (9%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETASALDYLHSLASPPIIHGDVKSA 217
           +V E+ + G +  H+R    ++ +  +   R  AA+     +YLHSL    +I+ D+K  
Sbjct: 118 MVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPE 170
Query: 218 NILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFG 277
           N+L++     +V DF  +  +        +  L GT  YL P  I +    K  D ++ G
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVK-----GRTWXLXGTPEYLAPEIILSKGYNKAVDWWALG 225
Query: 278 VVLAELLTGKKP 289
           V++ E+  G  P
Sbjct: 226 VLIYEMAAGYPP 237

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 64/135 (47%), Gaps = 10/135 (7%)
Query: 158 LLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSA 217
           +L+ E+A+ G +      E ++++      +R+  +    + YLH      I+H D+K  
Sbjct: 105 ILILEYAAGGEIFSLCLPELAEMVSE-NDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQ 160
Query: 218 NILLNDNYT---AKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVY 274
           NILL+  Y     K+ DF  S  I    E      ++GT  YL P  +N   +T  +D++
Sbjct: 161 NILLSSIYPLGDIKIVDFGMSRKIGHACELRE---IMGTPEYLAPEILNYDPITTATDMW 217
Query: 275 SFGVVLAELLTGKKP 289
           + G++   LLT   P
Sbjct: 218 NIGIIAYMLLTHTSP 232

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 61/132 (46%), Gaps = 13/132 (9%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETASALDYLHSLASPPIIHGDVKSA 217
           +V E+   G +  H+R    ++ +  +   R  AA+     +YLHSL    +I+ D+K  
Sbjct: 118 MVMEYVPGGEMFSHLR----RIGRFXEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPE 170
Query: 218 NILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFG 277
           N+L++     +V DF  +  +        +  L GT  YL P  I +    K  D ++ G
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALG 225
Query: 278 VVLAELLTGKKP 289
           V++ E+  G  P
Sbjct: 226 VLIYEMAAGYPP 237

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 62/132 (46%), Gaps = 13/132 (9%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETASALDYLHSLASPPIIHGDVKSA 217
           +V E+ + G +  H+R    ++ +  +   R  AA+     +YLHSL    +I+ D+K  
Sbjct: 118 MVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPE 170
Query: 218 NILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFG 277
           N+L++     +V DF  +  +        +  L GT  YL P  I +    K  D ++ G
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALG 225
Query: 278 VVLAELLTGKKP 289
           V++ E+  G  P
Sbjct: 226 VLIYEMAAGYPP 237

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 62/132 (46%), Gaps = 13/132 (9%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETASALDYLHSLASPPIIHGDVKSA 217
           +V E+ + G +  H+R    ++ +  +   R  AA+     +YLHSL    +I+ D+K  
Sbjct: 118 MVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPE 170
Query: 218 NILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFG 277
           N+L++     +V DF  +  +        +  L GT  YL P  I +    K  D ++ G
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALG 225
Query: 278 VVLAELLTGKKP 289
           V++ E+  G  P
Sbjct: 226 VLIYEMAAGYPP 237

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 62/132 (46%), Gaps = 13/132 (9%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETASALDYLHSLASPPIIHGDVKSA 217
           +V E+ + G +  H+R    ++ +  +   R  AA+     +YLHSL    +I+ D+K  
Sbjct: 119 MVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPE 171
Query: 218 NILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFG 277
           N+L++     +V DF  +  +        +  L GT  YL P  I +    K  D ++ G
Sbjct: 172 NLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALG 226
Query: 278 VVLAELLTGKKP 289
           V++ E+  G  P
Sbjct: 227 VLIYEMAAGYPP 238

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 62/132 (46%), Gaps = 13/132 (9%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETASALDYLHSLASPPIIHGDVKSA 217
           +V E+ + G +  H+R    ++ +  +   R  AA+     +YLHSL    +I+ D+K  
Sbjct: 118 MVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPE 170
Query: 218 NILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFG 277
           N+L++     +V DF  +  +        +  L GT  YL P  I +    K  D ++ G
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALG 225
Query: 278 VVLAELLTGKKP 289
           V++ E+  G  P
Sbjct: 226 VLIYEMAAGYPP 237

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 62/132 (46%), Gaps = 13/132 (9%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETASALDYLHSLASPPIIHGDVKSA 217
           +V E+ + G +  H+R    ++ +  +   R  AA+     +YLHSL    +I+ D+K  
Sbjct: 118 MVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPE 170
Query: 218 NILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFG 277
           N+L++     +V DF  +  +        +  L GT  YL P  I +    K  D ++ G
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVK-----GRTWXLAGTPEYLAPEIILSKGYNKAVDWWALG 225
Query: 278 VVLAELLTGKKP 289
           V++ E+  G  P
Sbjct: 226 VLIYEMAAGYPP 237

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 61/132 (46%), Gaps = 13/132 (9%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETASALDYLHSLASPPIIHGDVKSA 217
           +V E+   G +  H+R    ++ +  +   R  AA+     +YLHSL    +I+ D+K  
Sbjct: 111 MVMEYVPGGEMFSHLR----RIGRFXEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPE 163
Query: 218 NILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFG 277
           N+L++     +V DF  +  +        +  L GT  YL P  I +    K  D ++ G
Sbjct: 164 NLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALG 218
Query: 278 VVLAELLTGKKP 289
           V++ E+  G  P
Sbjct: 219 VLIYEMAAGYPP 230

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 62/132 (46%), Gaps = 13/132 (9%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETASALDYLHSLASPPIIHGDVKSA 217
           +V E+ + G +  H+R    ++ +  +   R  AA+     +YLHSL    +I+ D+K  
Sbjct: 118 MVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPE 170
Query: 218 NILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFG 277
           N+L++     +V DF  +  +        +  L GT  YL P  I +    K  D ++ G
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALG 225
Query: 278 VVLAELLTGKKP 289
           V++ E+  G  P
Sbjct: 226 VLIYEMAAGYPP 237

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 62/132 (46%), Gaps = 13/132 (9%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETASALDYLHSLASPPIIHGDVKSA 217
           +V E+ + G +  H+R    ++ +  +   R  AA+     +YLHSL    +I+ D+K  
Sbjct: 118 MVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPE 170
Query: 218 NILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFG 277
           N+L++     +V DF  +  +        +  L GT  YL P  I +    K  D ++ G
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALG 225
Query: 278 VVLAELLTGKKP 289
           V++ E+  G  P
Sbjct: 226 VLIYEMAAGYPP 237

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 11/98 (11%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            L Y+HS     IIH D+K +N+ +N++   ++ DF     ++  A+  M T  + T  Y
Sbjct: 143 GLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFG----LARQADEEM-TGYVATRWY 194
Query: 257 LDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PGS 291
             P + +N     +  D++S G ++AELL GK   PGS
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGS 232

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 52/92 (56%), Gaps = 9/92 (9%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            L Y+H+     IIH D+K  N+ +N++   K+ DF     ++  A++ M   ++ T  Y
Sbjct: 140 GLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG----LARQADSEMXGXVV-TRWY 191
Query: 257 LDP-VCINTGKLTKKSDVYSFGVVLAELLTGK 287
             P V +N  + T+  D++S G ++AE++TGK
Sbjct: 192 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 11/98 (11%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            L Y+HS     IIH D+K +N+ +N++   ++ DF     ++  A+  M T  + T  Y
Sbjct: 143 GLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFG----LARQADEEM-TGYVATRWY 194
Query: 257 LDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PGS 291
             P + +N     +  D++S G ++AELL GK   PGS
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGS 232

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 62/132 (46%), Gaps = 13/132 (9%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETASALDYLHSLASPPIIHGDVKSA 217
           +V E+ + G +  H+R    ++ +  +   R  AA+     +YLHSL    +I+ D+K  
Sbjct: 118 MVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPE 170
Query: 218 NILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFG 277
           N+L++     +V DF  +  +        +  L GT  YL P  I +    K  D ++ G
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALG 225
Query: 278 VVLAELLTGKKP 289
           V++ E+  G  P
Sbjct: 226 VLIYEMAAGYPP 237

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 11/98 (11%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            L Y+HS     IIH D+K +N+ +N++   ++ DF     ++  A+  M T  + T  Y
Sbjct: 135 GLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG----LARQADEEM-TGYVATRWY 186
Query: 257 LDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PGS 291
             P + +N     +  D++S G ++AELL GK   PGS
Sbjct: 187 RAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGS 224

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 91/216 (42%), Gaps = 27/216 (12%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSAN 218
           LV E+  +G L D ++   +++  +    L  +++    ++YL S      +H D+ + N
Sbjct: 87  LVMEYLPSGCLRDFLQRHRARLDAS--RLLLYSSQICKGMEYLGSRR---CVHRDLAARN 141
Query: 219 ILLNDNYTAKVADFESSVLISSDA------ETAMSTILIGTSGYLDPVCINTGKLTKKSD 272
           IL+      K+ADF  + L+  D       E   S I      +  P  ++    +++SD
Sbjct: 142 ILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIF-----WYAPESLSDNIFSRQSD 196
Query: 273 VYSFGVVLAELLTGKKPGSCMTLASNKKISM----VPYFLNSIKNNGLRQILNFHVADES 328
           V+SFGVVL EL T     SC   A   ++      VP     ++     Q L    A  +
Sbjct: 197 VWSFGVVLYELFTYCD-KSCSPSAEFLRMMGCERDVPALCRLLELLEEGQRLPAPPACPA 255
Query: 329 EMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL 364
           E      V EL   C      +RP+   +  +LD L
Sbjct: 256 E------VHELMKLCWAPSPQDRPSFSALGPQLDML 285

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 96/232 (41%), Gaps = 34/232 (14%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSAN 218
           LV E+  +G L D ++   +++  +    L  +++    ++YL S      +H D+ + N
Sbjct: 90  LVMEYLPSGCLRDFLQRHRARLDAS--RLLLYSSQICKGMEYLGSRR---CVHRDLAARN 144
Query: 219 ILLNDNYTAKVADFESSVLISSDA------ETAMSTILIGTSGYLDPVCINTGKLTKKSD 272
           IL+      K+ADF  + L+  D       E   S I      +  P  ++    +++SD
Sbjct: 145 ILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF-----WYAPESLSDNIFSRQSD 199
Query: 273 VYSFGVVLAELLTGKKPGSCMTLASNKKISM----VPYFLNSIKNNGLRQILNFHVADES 328
           V+SFGVVL EL T     SC   A   ++      VP     ++     Q L    A  +
Sbjct: 200 VWSFGVVLYELFTYCD-KSCSPSAEFLRMMGSERDVPALSRLLELLEEGQRLPAPPACPA 258
Query: 329 EMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLHENFWAQKKNKET 380
           E      V EL   C      +RP+   +  +LD L       W+  +  ET
Sbjct: 259 E------VHELMKLCWAPSPQDRPSFSALGPQLDML-------WSGSRGCET 297

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 51/98 (52%), Gaps = 7/98 (7%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE-TAMSTILIGTSG 255
            L Y+HS     ++H D+K +N+LLN     K+ DF  + +   D + T      + T  
Sbjct: 140 GLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRW 196
Query: 256 YLDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PG 290
           Y  P + +N+   TK  D++S G +LAE+L+ +   PG
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 234

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 61/132 (46%), Gaps = 13/132 (9%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETASALDYLHSLASPPIIHGDVKSA 217
           +V E+   G +  H+R    ++ +  +   R  AA+     +YLHSL    +I+ D+K  
Sbjct: 139 MVMEYVPGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPE 191
Query: 218 NILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFG 277
           N+L++     +V DF  +  +        +  L GT  YL P  I +    K  D ++ G
Sbjct: 192 NLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALG 246
Query: 278 VVLAELLTGKKP 289
           V++ E+  G  P
Sbjct: 247 VLIYEMAAGYPP 258

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 51/98 (52%), Gaps = 7/98 (7%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE-TAMSTILIGTSG 255
            L Y+HS     ++H D+K +N+LLN     K+ DF  + +   D + T      + T  
Sbjct: 141 GLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRW 197
Query: 256 YLDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PG 290
           Y  P + +N+   TK  D++S G +LAE+L+ +   PG
Sbjct: 198 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 235

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 61/132 (46%), Gaps = 13/132 (9%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETASALDYLHSLASPPIIHGDVKSA 217
           +V E+   G +  H+R    ++ +  +   R  AA+     +YLHSL    +I+ D+K  
Sbjct: 119 MVMEYVPGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPE 171
Query: 218 NILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFG 277
           N+L++     +V DF  +  +        +  L GT  YL P  I +    K  D ++ G
Sbjct: 172 NLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALG 226
Query: 278 VVLAELLTGKKP 289
           V++ E+  G  P
Sbjct: 227 VLIYEMAAGYPP 238

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 96/233 (41%), Gaps = 34/233 (14%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSAN 218
           LV E+  +G L D ++   +++  +    L  +++    ++YL S      +H D+ + N
Sbjct: 103 LVMEYLPSGCLRDFLQRHRARLDAS--RLLLYSSQICKGMEYLGSRR---CVHRDLAARN 157
Query: 219 ILLNDNYTAKVADFESSVLISSDA------ETAMSTILIGTSGYLDPVCINTGKLTKKSD 272
           IL+      K+ADF  + L+  D       E   S I      +  P  ++    +++SD
Sbjct: 158 ILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF-----WYAPESLSDNIFSRQSD 212
Query: 273 VYSFGVVLAELLTGKKPGSCMTLASNKKISM----VPYFLNSIKNNGLRQILNFHVADES 328
           V+SFGVVL EL T     SC   A   ++      VP     ++     Q L    A  +
Sbjct: 213 VWSFGVVLYELFTYCD-KSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPA 271
Query: 329 EMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLHENFWAQKKNKETE 381
           E      V EL   C      +RP+   +  +LD L       W+  +  ET 
Sbjct: 272 E------VHELMKLCWAPSPQDRPSFSALGPQLDML-------WSGSRGCETH 311

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 61/132 (46%), Gaps = 13/132 (9%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETASALDYLHSLASPPIIHGDVKSA 217
           +V E+   G +  H+R    ++ +  +   R  AA+     +YLHSL    +I+ D+K  
Sbjct: 118 MVMEYVPGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPE 170
Query: 218 NILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFG 277
           N+L++     +V DF  +  +        +  L GT  YL P  I +    K  D ++ G
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALG 225
Query: 278 VVLAELLTGKKP 289
           V++ E+  G  P
Sbjct: 226 VLIYEMAAGYPP 237

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 61/132 (46%), Gaps = 13/132 (9%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETASALDYLHSLASPPIIHGDVKSA 217
           +V E+   G +  H+R    ++ +  +   R  AA+     +YLHSL    +I+ D+K  
Sbjct: 118 MVMEYVPGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPE 170
Query: 218 NILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFG 277
           N+L++     +V DF  +  +        +  L GT  YL P  I +    K  D ++ G
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALG 225
Query: 278 VVLAELLTGKKP 289
           V++ E+  G  P
Sbjct: 226 VLIYEMAAGYPP 237

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 61/132 (46%), Gaps = 13/132 (9%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETASALDYLHSLASPPIIHGDVKSA 217
           +V E+   G +  H+R    ++ +  +   R  AA+     +YLHSL    +I+ D+K  
Sbjct: 118 MVMEYVPGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPE 170
Query: 218 NILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFG 277
           N+L++     +V DF  +  +        +  L GT  YL P  I +    K  D ++ G
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALG 225
Query: 278 VVLAELLTGKKP 289
           V++ E+  G  P
Sbjct: 226 VLIYEMAAGYPP 237

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 61/132 (46%), Gaps = 13/132 (9%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETASALDYLHSLASPPIIHGDVKSA 217
           +V E+   G +  H+R    ++ +  +   R  AA+     +YLHSL    +I+ D+K  
Sbjct: 119 MVMEYVPGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPE 171
Query: 218 NILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFG 277
           N+L++     +V DF  +  +        +  L GT  YL P  I +    K  D ++ G
Sbjct: 172 NLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALG 226
Query: 278 VVLAELLTGKKP 289
           V++ E+  G  P
Sbjct: 227 VLIYEMAAGYPP 238

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 61/132 (46%), Gaps = 13/132 (9%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETASALDYLHSLASPPIIHGDVKSA 217
           +V E+   G +  H+R    ++ +  +   R  AA+     +YLHSL    +I+ D+K  
Sbjct: 119 MVMEYVPGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPE 171
Query: 218 NILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFG 277
           N+L++     +V DF  +  +        +  L GT  YL P  I +    K  D ++ G
Sbjct: 172 NLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALG 226
Query: 278 VVLAELLTGKKP 289
           V++ E+  G  P
Sbjct: 227 VLIYEMAAGYPP 238

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 61/132 (46%), Gaps = 13/132 (9%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETASALDYLHSLASPPIIHGDVKSA 217
           +V E+   G +  H+R    ++ +  +   R  AA+     +YLHSL    +I+ D+K  
Sbjct: 118 MVMEYVPGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPE 170
Query: 218 NILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFG 277
           N+L++     +V DF  +  +        +  L GT  YL P  I +    K  D ++ G
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALG 225
Query: 278 VVLAELLTGKKP 289
           V++ E+  G  P
Sbjct: 226 VLIYEMAAGYPP 237

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 61/132 (46%), Gaps = 13/132 (9%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETASALDYLHSLASPPIIHGDVKSA 217
           +V E+   G +  H+R    ++ +  +   R  AA+     +YLHSL    +I+ D+K  
Sbjct: 119 MVMEYVPGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPE 171
Query: 218 NILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFG 277
           N+L++     +V DF  +  +        +  L GT  YL P  I +    K  D ++ G
Sbjct: 172 NLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALG 226
Query: 278 VVLAELLTGKKP 289
           V++ E+  G  P
Sbjct: 227 VLIYEMAAGYPP 238

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 61/132 (46%), Gaps = 13/132 (9%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETASALDYLHSLASPPIIHGDVKSA 217
           +V E+   G +  H+R    ++ +  +   R  AA+     +YLHSL    +I+ D+K  
Sbjct: 118 MVMEYVPGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPE 170
Query: 218 NILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFG 277
           N+L++     +V DF  +  +        +  L GT  YL P  I +    K  D ++ G
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALG 225
Query: 278 VVLAELLTGKKP 289
           V++ E+  G  P
Sbjct: 226 VLIYEMAAGYPP 237

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 61/132 (46%), Gaps = 13/132 (9%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETASALDYLHSLASPPIIHGDVKSA 217
           +V E+   G +  H+R    ++ +  +   R  AA+     +YLHSL    +I+ D+K  
Sbjct: 118 MVMEYVPGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPE 170
Query: 218 NILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFG 277
           N+L++     +V DF  +  +        +  L GT  YL P  I +    K  D ++ G
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALG 225
Query: 278 VVLAELLTGKKP 289
           V++ E+  G  P
Sbjct: 226 VLIYEMAAGYPP 237

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 61/132 (46%), Gaps = 13/132 (9%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETASALDYLHSLASPPIIHGDVKSA 217
           +V E+   G +  H+R    ++ +  +   R  AA+     +YLHSL    +I+ D+K  
Sbjct: 111 MVMEYVPGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPE 163
Query: 218 NILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFG 277
           N+L++     +V DF  +  +        +  L GT  YL P  I +    K  D ++ G
Sbjct: 164 NLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALG 218
Query: 278 VVLAELLTGKKP 289
           V++ E+  G  P
Sbjct: 219 VLIYEMAAGYPP 230

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 78/182 (42%), Gaps = 18/182 (9%)
Query: 114 VAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHI 173
           VAVK   R +K              + H N+V+   + L      +V E+AS G L + I
Sbjct: 47  VAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI 106
Query: 174 RCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTA--KVAD 231
            C + +   +         +  S + Y H++    + H D+K  N LL+ +     K+  
Sbjct: 107 -CNAGRF--SEDEARFFFQQLISGVSYCHAMQ---VCHRDLKLENTLLDGSPAPRLKICA 160
Query: 232 F---ESSVLISSDAETAMSTILIGTSGYLDP-VCINTGKLTKKSDVYSFGVVLAELLTGK 287
           F   +SSVL S   +T      +GT  Y+ P V +      K +DV+S GV L  +L G 
Sbjct: 161 FGYSKSSVLHSQPKDT------VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGA 214
Query: 288 KP 289
            P
Sbjct: 215 YP 216

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 72/186 (38%), Gaps = 27/186 (14%)
Query: 189 RIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMST 248
           +IA     AL++LHS  S  +IH DVK +N+L+N     K  DF  S  +  D    +  
Sbjct: 140 KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDA 197
Query: 249 ILIGTSGYLDPVCINTGKLTK----KSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMV 304
              G   Y  P  IN     K    KSD++S G+   EL                 I   
Sbjct: 198 ---GCKPYXAPERINPELNQKGYSVKSDIWSLGITXIEL----------------AILRF 238
Query: 305 PYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL 364
           PY         L+Q++          K      +  S+CL+    ERPT  ++ +     
Sbjct: 239 PYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELXQH--PF 296
Query: 365 RRLHEN 370
             LHE+
Sbjct: 297 FTLHES 302

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 81/175 (46%), Gaps = 35/175 (20%)
Query: 140 NHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIR-------CESSQVLKTWKTCLRIAA 192
            H+NV++++    E +   LV+E    G++L HI         E+S V++          
Sbjct: 69  GHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQ---------- 118
Query: 193 ETASALDYLHSLASPPIIHGDVKSANILL---NDNYTAKVADF--ESSVLISSDAETAMS 247
           + ASALD+LH+     I H D+K  NIL    N     K+ DF   S + ++ D     +
Sbjct: 119 DVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPIST 175
Query: 248 TILI---GTSGYLDPVCINTGK-----LTKKSDVYSFGVVLAELLTGKKP--GSC 292
             L+   G++ Y+ P  +           K+ D++S GV+L  LL+G  P  G C
Sbjct: 176 PELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRC 230

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 69/156 (44%), Gaps = 13/156 (8%)
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
           ++ H NV+ +  +       +L+ E  + G L D +  + S    T +       +  + 
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESL---TEEEATEFLKQILNG 126
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAK----VADFESSVLISSDAETAMSTILIGT 253
           + YLHSL    I H D+K  NI+L D    K    + DF  +  I    E      + GT
Sbjct: 127 VYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGT 180
Query: 254 SGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
             ++ P  +N   L  ++D++S GV+   LL+G  P
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE-TAMSTILIGTSG 255
            L Y+HS     ++H D+K +N+L+N     K+ DF  + +   + + T   T  + T  
Sbjct: 156 GLKYIHSAN---VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRW 212
Query: 256 YLDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PG 290
           Y  P + +N+   TK  D++S G +LAE+L+ +   PG
Sbjct: 213 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 250

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 69/156 (44%), Gaps = 13/156 (8%)
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
           ++ H NV+ +  +       +L+ E  + G L D +  + S    T +       +  + 
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESL---TEEEATEFLKQILNG 126
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAK----VADFESSVLISSDAETAMSTILIGT 253
           + YLHSL    I H D+K  NI+L D    K    + DF  +  I    E      + GT
Sbjct: 127 VYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGT 180
Query: 254 SGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
             ++ P  +N   L  ++D++S GV+   LL+G  P
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 69/156 (44%), Gaps = 13/156 (8%)
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
           ++ H NV+ +  +       +L+ E  + G L D +  + S    T +       +  + 
Sbjct: 69  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESL---TEEEATEFLKQILNG 125
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAK----VADFESSVLISSDAETAMSTILIGT 253
           + YLHSL    I H D+K  NI+L D    K    + DF  +  I    E      + GT
Sbjct: 126 VYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGT 179
Query: 254 SGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
             ++ P  +N   L  ++D++S GV+   LL+G  P
Sbjct: 180 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 31/86 (36%), Positives = 45/86 (52%), Gaps = 8/86 (9%)
Query: 209 IIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLT 268
           +IH DVK +NILL++    K+ DF  S  +  D     S    G + Y+ P  I+    T
Sbjct: 146 VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA---GCAAYMAPERIDPPDPT 202
Query: 269 K-----KSDVYSFGVVLAELLTGKKP 289
           K     ++DV+S G+ L EL TG+ P
Sbjct: 203 KPDYDIRADVWSLGISLVELATGQFP 228

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 69/156 (44%), Gaps = 13/156 (8%)
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
           ++ H NV+ +  +       +L+ E  + G L D +  + S    T +       +  + 
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESL---TEEEATEFLKQILNG 126
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAK----VADFESSVLISSDAETAMSTILIGT 253
           + YLHSL    I H D+K  NI+L D    K    + DF  +  I    E      + GT
Sbjct: 127 VYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGT 180
Query: 254 SGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
             ++ P  +N   L  ++D++S GV+   LL+G  P
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 69/156 (44%), Gaps = 13/156 (8%)
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
           ++ H NV+ +  +       +L+ E  + G L D +  + S    T +       +  + 
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESL---TEEEATEFLKQILNG 126
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAK----VADFESSVLISSDAETAMSTILIGT 253
           + YLHSL    I H D+K  NI+L D    K    + DF  +  I    E      + GT
Sbjct: 127 VYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGT 180
Query: 254 SGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
             ++ P  +N   L  ++D++S GV+   LL+G  P
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 69/156 (44%), Gaps = 13/156 (8%)
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
           ++ H NV+ +  +       +L+ E  + G L D +  + S    T +       +  + 
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESL---TEEEATEFLKQILNG 126
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAK----VADFESSVLISSDAETAMSTILIGT 253
           + YLHSL    I H D+K  NI+L D    K    + DF  +  I    E      + GT
Sbjct: 127 VYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGT 180
Query: 254 SGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
             ++ P  +N   L  ++D++S GV+   LL+G  P
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 69/156 (44%), Gaps = 13/156 (8%)
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
           ++ H NV+ +  +       +L+ E  + G L D +  + S    T +       +  + 
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESL---TEEEATEFLKQILNG 126
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAK----VADFESSVLISSDAETAMSTILIGT 253
           + YLHSL    I H D+K  NI+L D    K    + DF  +  I    E      + GT
Sbjct: 127 VYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGT 180
Query: 254 SGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
             ++ P  +N   L  ++D++S GV+   LL+G  P
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 69/156 (44%), Gaps = 13/156 (8%)
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
           ++ H NV+ +  +       +L+ E  + G L D +  + S    T +       +  + 
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESL---TEEEATEFLKQILNG 126
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAK----VADFESSVLISSDAETAMSTILIGT 253
           + YLHSL    I H D+K  NI+L D    K    + DF  +  I    E      + GT
Sbjct: 127 VYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGT 180
Query: 254 SGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
             ++ P  +N   L  ++D++S GV+   LL+G  P
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 69/156 (44%), Gaps = 13/156 (8%)
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
           ++ H NV+ +  +       +L+ E  + G L D +  + S    T +       +  + 
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESL---TEEEATEFLKQILNG 126
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAK----VADFESSVLISSDAETAMSTILIGT 253
           + YLHSL    I H D+K  NI+L D    K    + DF  +  I    E      + GT
Sbjct: 127 VYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGT 180
Query: 254 SGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
             ++ P  +N   L  ++D++S GV+   LL+G  P
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 69/156 (44%), Gaps = 13/156 (8%)
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
           ++ H NV+ +  +       +L+ E  + G L D +  + S    T +       +  + 
Sbjct: 69  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESL---TEEEATEFLKQILNG 125
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAK----VADFESSVLISSDAETAMSTILIGT 253
           + YLHSL    I H D+K  NI+L D    K    + DF  +  I    E      + GT
Sbjct: 126 VYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGT 179
Query: 254 SGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
             ++ P  +N   L  ++D++S GV+   LL+G  P
Sbjct: 180 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 69/156 (44%), Gaps = 13/156 (8%)
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
           ++ H NV+ +  +       +L+ E  + G L D +  + S    T +       +  + 
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESL---TEEEATEFLKQILNG 126
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAK----VADFESSVLISSDAETAMSTILIGT 253
           + YLHSL    I H D+K  NI+L D    K    + DF  +  I    E      + GT
Sbjct: 127 VYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGT 180
Query: 254 SGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
             ++ P  +N   L  ++D++S GV+   LL+G  P
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 69/156 (44%), Gaps = 13/156 (8%)
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
           ++ H NV+ +  +       +L+ E  + G L D +  + S    T +       +  + 
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESL---TEEEATEFLKQILNG 126
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAK----VADFESSVLISSDAETAMSTILIGT 253
           + YLHSL    I H D+K  NI+L D    K    + DF  +  I    E      + GT
Sbjct: 127 VYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGT 180
Query: 254 SGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
             ++ P  +N   L  ++D++S GV+   LL+G  P
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 35/154 (22%), Positives = 66/154 (42%), Gaps = 11/154 (7%)
Query: 139 VNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASAL 198
           + H N+V++     E     L+++  + G L + I             C++   +   A+
Sbjct: 67  LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQ---QILEAV 123
Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTA---KVADFESSVLISSDAETAMSTILIGTSG 255
            + H +    ++H ++K  N+LL         K+ADF  ++ +  + +        GT G
Sbjct: 124 LHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--FAGTPG 178
Query: 256 YLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           YL P  +      K  D+++ GV+L  LL G  P
Sbjct: 179 YLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 81/180 (45%), Gaps = 12/180 (6%)
Query: 139 VNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASAL 198
           VNHKN++ +L +    +    + EF     +++ +    SQV++      R++      L
Sbjct: 80  VNHKNIIGLLNVFTPQKS---LEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQML 136
Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLD 258
             +  L S  IIH D+K +NI++  + T K+ DF    L  +   + M T  + T  Y  
Sbjct: 137 VGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFG---LARTAGTSFMMTPYVVTRYYRA 193
Query: 259 PVCINTGKLTKKSDVYSFGVVLAELLTGKK--PGSCMTLASNKKISMV----PYFLNSIK 312
           P  I      +  D++S G ++ E++ G    PG+      NK I  +    P F+  ++
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQ 253

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 34/132 (25%), Positives = 62/132 (46%), Gaps = 13/132 (9%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETASALDYLHSLASPPIIHGDVKSA 217
           +V E+ + G +  H+R    ++ +  +   R  AA+     +YLHSL    +I+ D+K  
Sbjct: 118 MVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPE 170
Query: 218 NILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFG 277
           N++++     +V DF  +  +        +  L GT  YL P  I +    K  D ++ G
Sbjct: 171 NLIIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIIISKGYNKAVDWWALG 225
Query: 278 VVLAELLTGKKP 289
           V++ E+  G  P
Sbjct: 226 VLIYEMAAGYPP 237

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 68/157 (43%), Gaps = 17/157 (10%)
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHI--RCESSQVLKTWKTCLRIAAETA 195
           Q++H N++K+     +     LV E    G L D I  R + S+V         I  +  
Sbjct: 77  QLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEV-----DAAVIMKQVL 131
Query: 196 SALDYLHSLASPPIIHGDVKSANILLND---NYTAKVADFESSVLISSDAETAMSTILIG 252
           S   YLH      I+H D+K  N+LL     +   K+ DF  S       +       +G
Sbjct: 132 SGTTYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKER---LG 185
Query: 253 TSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           T+ Y+ P  +   K  +K DV+S GV+L  LL G  P
Sbjct: 186 TAYYIAPEVLRK-KYDEKCDVWSCGVILYILLCGYPP 221

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 68/157 (43%), Gaps = 17/157 (10%)
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHI--RCESSQVLKTWKTCLRIAAETA 195
           Q++H N++K+     +     LV E    G L D I  R + S+V         I  +  
Sbjct: 60  QLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEV-----DAAVIMKQVL 114
Query: 196 SALDYLHSLASPPIIHGDVKSANILLND---NYTAKVADFESSVLISSDAETAMSTILIG 252
           S   YLH      I+H D+K  N+LL     +   K+ DF  S       +       +G
Sbjct: 115 SGTTYLHK---HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKER---LG 168
Query: 253 TSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           T+ Y+ P  +   K  +K DV+S GV+L  LL G  P
Sbjct: 169 TAYYIAPEVLRK-KYDEKCDVWSCGVILYILLCGYPP 204

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 34/132 (25%), Positives = 62/132 (46%), Gaps = 13/132 (9%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETASALDYLHSLASPPIIHGDVKSA 217
           +V E+ + G +  H+R    ++ +  +   R  AA+     +YLHSL    +I+ D+K  
Sbjct: 118 MVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPE 170
Query: 218 NILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFG 277
           N+L++     +V DF  +  +        +  L GT  YL P  I +    K  D ++ G
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALG 225
Query: 278 VVLAELLTGKKP 289
           V++ ++  G  P
Sbjct: 226 VLIYQMAAGYPP 237

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 76/182 (41%), Gaps = 18/182 (9%)
Query: 114 VAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHI 173
           VAVK   R                 + H N+V+   + L      ++ E+AS G L + I
Sbjct: 48  VAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERI 107
Query: 174 RCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTA--KVAD 231
            C + +   +         +  S + Y HS+    I H D+K  N LL+ +     K+ D
Sbjct: 108 -CNAGRF--SEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICD 161
Query: 232 F---ESSVLISSDAETAMSTILIGTSGYLDP-VCINTGKLTKKSDVYSFGVVLAELLTGK 287
           F   +SSVL S    T      +GT  Y+ P V +      K +DV+S GV L  +L G 
Sbjct: 162 FGYSKSSVLHSQPKST------VGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGA 215
Query: 288 KP 289
            P
Sbjct: 216 YP 217

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 39/124 (31%), Positives = 57/124 (45%), Gaps = 25/124 (20%)
Query: 190 IAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADF---ESSVLI-------- 238
           +  +    + YLHS     ++H D+K +NILLN     KVADF    S V I        
Sbjct: 114 VVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIP 170
Query: 239 --------SSDAETAMSTILIGTSGYLDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK- 288
                   + D +  + T  + T  Y  P + + + K TK  D++S G +L E+L GK  
Sbjct: 171 LSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPI 230
Query: 289 -PGS 291
            PGS
Sbjct: 231 FPGS 234

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 95/226 (42%), Gaps = 17/226 (7%)
Query: 96  SQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXX---XSQVNHKNVVKILGLCL 152
           +QG   + Y  +L  N  VA+K   R  +                 VNHKN++ +L +  
Sbjct: 36  AQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFT 93
Query: 153 ETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHG 212
             +    + EF     +++ +    SQV++      R++      L  +  L S  IIH 
Sbjct: 94  PQKS---LEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHR 150
Query: 213 DVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSD 272
           D+K +NI++  + T K+ DF    L  +   + M T  + T  Y  P  I      +  D
Sbjct: 151 DLKPSNIVVKSDATLKILDFG---LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVD 207
Query: 273 VYSFGVVLAELLTGKK--PGSCMTLASNKKISMV----PYFLNSIK 312
           ++S G ++ E++ G    PG+      NK I  +    P F+  ++
Sbjct: 208 IWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQ 253

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 77/182 (42%), Gaps = 18/182 (9%)
Query: 114 VAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHI 173
           VAVK   R +K              + H N+V+   + L      +V E+AS G L + I
Sbjct: 47  VAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI 106
Query: 174 RCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTA--KVAD 231
            C + +   +         +  S + Y H++    + H D+K  N LL+ +     K+  
Sbjct: 107 -CNAGRF--SEDEARFFFQQLISGVSYCHAMQ---VCHRDLKLENTLLDGSPAPRLKICA 160
Query: 232 F---ESSVLISSDAETAMSTILIGTSGYLDP-VCINTGKLTKKSDVYSFGVVLAELLTGK 287
           F   +SSVL S    T      +GT  Y+ P V +      K +DV+S GV L  +L G 
Sbjct: 161 FGYSKSSVLHSQPKST------VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGA 214
Query: 288 KP 289
            P
Sbjct: 215 YP 216

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 69/156 (44%), Gaps = 13/156 (8%)
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
           ++ H NV+ +  +       +L+ E  + G L D +  + S    T +       +  + 
Sbjct: 70  EIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESL---TEEEATEFLKQILNG 126
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAK----VADFESSVLISSDAETAMSTILIGT 253
           + YLHSL    I H D+K  NI+L D    K    + DF  +  I    E      + GT
Sbjct: 127 VYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGT 180
Query: 254 SGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
             ++ P  +N   L  ++D++S GV+   LL+G  P
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 76/163 (46%), Gaps = 16/163 (9%)
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLK-----TWKTCLRIAA 192
              H N++ I  + L   VP    EF S   +LD +  +  Q++      T +       
Sbjct: 109 HFKHDNIIAIKDI-LRPTVPY--GEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLY 165
Query: 193 ETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFE-SSVLISSDAE-TAMSTIL 250
           +    L Y+HS     +IH D+K +N+L+N+N   K+ DF  +  L +S AE     T  
Sbjct: 166 QLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEY 222
Query: 251 IGTSGYLDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PG 290
           + T  Y  P + ++  + T+  D++S G +  E+L  ++  PG
Sbjct: 223 VATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPG 265

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 81/180 (45%), Gaps = 12/180 (6%)
Query: 139 VNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASAL 198
           VNHKN++ +L +    +    + EF     +++ +    SQV++      R++      L
Sbjct: 80  VNHKNIIGLLNVFTPQKS---LEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQML 136
Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLD 258
             +  L S  IIH D+K +NI++  + T K+ DF    L  +   + M T  + T  Y  
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFG---LARTAGTSFMMTPYVVTRYYRA 193
Query: 259 PVCINTGKLTKKSDVYSFGVVLAELLTGKK--PGSCMTLASNKKISMV----PYFLNSIK 312
           P  I      +  D++S G ++ E++ G    PG+      NK I  +    P F+  ++
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQ 253

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 50/105 (47%), Gaps = 11/105 (10%)
Query: 192 AETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILI 251
           AE   A+D +H L     +H D+K  NILL+     ++ADF S + + +D  T  S + +
Sbjct: 169 AEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG-TVRSLVAV 224
Query: 252 GTSGYLDPVCINT-------GKLTKKSDVYSFGVVLAELLTGKKP 289
           GT  YL P  +         G    + D ++ GV   E+  G+ P
Sbjct: 225 GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 93/226 (41%), Gaps = 17/226 (7%)
Query: 96  SQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXX---XSQVNHKNVVKILGLCL 152
           +QG   + Y  VL  N  VA+K   R  +                 VNHKN++ +L +  
Sbjct: 36  AQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFT 93
Query: 153 ETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHG 212
             +    + EF     +++ +     QV++      R++      L  +  L S  IIH 
Sbjct: 94  PQKT---LEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLHSAGIIHR 150
Query: 213 DVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSD 272
           D+K +NI++  + T K+ DF    L  +   + M T  + T  Y  P  I      +  D
Sbjct: 151 DLKPSNIVVKSDXTLKILDFG---LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVD 207
Query: 273 VYSFGVVLAELLTGK--KPGSCMTLASNKKISMV----PYFLNSIK 312
           ++S G ++ E++  K   PG       NK I  +    P F+  ++
Sbjct: 208 IWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 253

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 95/226 (42%), Gaps = 17/226 (7%)
Query: 96  SQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXX---XSQVNHKNVVKILGLCL 152
           +QG   + Y  +L  N  VA+K   R  +                 VNHKN++ +L +  
Sbjct: 36  AQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT 93
Query: 153 ETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHG 212
             +    + EF     +++ +    SQV++      R++      L  +  L S  IIH 
Sbjct: 94  PQKS---LEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHR 150
Query: 213 DVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSD 272
           D+K +NI++  + T K+ DF    L  +   + M T  + T  Y  P  I      +  D
Sbjct: 151 DLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVD 207
Query: 273 VYSFGVVLAELLTGKK--PGSCMTLASNKKISMV----PYFLNSIK 312
           ++S G ++ E++ G    PG+      NK I  +    P F+  ++
Sbjct: 208 IWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQ 253

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 76/163 (46%), Gaps = 16/163 (9%)
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLK-----TWKTCLRIAA 192
              H N++ I  + L   VP    EF S   +LD +  +  Q++      T +       
Sbjct: 110 HFKHDNIIAIKDI-LRPTVPY--GEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLY 166
Query: 193 ETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFE-SSVLISSDAE-TAMSTIL 250
           +    L Y+HS     +IH D+K +N+L+N+N   K+ DF  +  L +S AE     T  
Sbjct: 167 QLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEY 223
Query: 251 IGTSGYLDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PG 290
           + T  Y  P + ++  + T+  D++S G +  E+L  ++  PG
Sbjct: 224 VATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPG 266

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 11/98 (11%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            L Y+HS     IIH D+K +N+ +N++   K+ DF   +   +D E A     + T  Y
Sbjct: 137 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDF--GLARHTDDEMAG---FVATRWY 188
Query: 257 LDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PGS 291
             P + +N     +  D++S G ++AELLTG+   PG+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 11/98 (11%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            L Y+HS     IIH D+K +N+ +N++   K+ DF   +   +D E A     + T  Y
Sbjct: 137 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDF--GLARHTDDEMAG---FVATRWY 188
Query: 257 LDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PGS 291
             P + +N     +  D++S G ++AELLTG+   PG+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 11/98 (11%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            L Y+HS     IIH D+K +N+ +N++   K+ DF   +   +D E A     + T  Y
Sbjct: 133 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDF--GLARHTDDEMAG---FVATRWY 184
Query: 257 LDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PGS 291
             P + +N     +  D++S G ++AELLTG+   PG+
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 222

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 70/156 (44%), Gaps = 13/156 (8%)
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
           QV H NV+ +  +       +L+ E  S G L D +  + S   +   + ++   +    
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK---QILDG 127
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTA----KVADFESSVLISSDAETAMSTILIGT 253
           ++YLH+     I H D+K  NI+L D        K+ DF  +  I    E      + GT
Sbjct: 128 VNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFGT 181
Query: 254 SGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
             ++ P  +N   L  ++D++S GV+   LL+G  P
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 70/156 (44%), Gaps = 13/156 (8%)
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
           QV H NV+ +  +       +L+ E  S G L D +  + S   +   + ++   +    
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK---QILDG 127
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTA----KVADFESSVLISSDAETAMSTILIGT 253
           ++YLH+     I H D+K  NI+L D        K+ DF  +  I    E      + GT
Sbjct: 128 VNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFGT 181
Query: 254 SGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
             ++ P  +N   L  ++D++S GV+   LL+G  P
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 70/156 (44%), Gaps = 13/156 (8%)
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
           QV H NV+ +  +       +L+ E  S G L D +  + S   +   + ++   +    
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK---QILDG 127
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTA----KVADFESSVLISSDAETAMSTILIGT 253
           ++YLH+     I H D+K  NI+L D        K+ DF  +  I    E      + GT
Sbjct: 128 VNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFGT 181
Query: 254 SGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
             ++ P  +N   L  ++D++S GV+   LL+G  P
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 52/100 (52%), Gaps = 8/100 (8%)
Query: 191 AAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTIL 250
           AAE    L+++H+     +++ D+K ANILL+++   +++D    + ++ D         
Sbjct: 297 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISD----LGLACDFSKKKPHAS 349
Query: 251 IGTSGYLDPVCINTG-KLTKKSDVYSFGVVLAELLTGKKP 289
           +GT GY+ P  +  G      +D +S G +L +LL G  P
Sbjct: 350 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 389

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 11/98 (11%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            L Y+HS     IIH D+K +N+ +N++   K+ DF   +   +D E    T  + T  Y
Sbjct: 137 GLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDF--GLARHTDDEM---TGYVATRWY 188
Query: 257 LDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PGS 291
             P + +N     +  D++S G ++AELLTG+   PG+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 52/100 (52%), Gaps = 8/100 (8%)
Query: 191 AAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTIL 250
           AAE    L+++H+     +++ D+K ANILL+++   +++D    + ++ D         
Sbjct: 298 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISD----LGLACDFSKKKPHAS 350
Query: 251 IGTSGYLDPVCINTG-KLTKKSDVYSFGVVLAELLTGKKP 289
           +GT GY+ P  +  G      +D +S G +L +LL G  P
Sbjct: 351 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 70/156 (44%), Gaps = 13/156 (8%)
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
           QV H NV+ +  +       +L+ E  S G L D +  + S   +   + ++   +    
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK---QILDG 127
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTA----KVADFESSVLISSDAETAMSTILIGT 253
           ++YLH+     I H D+K  NI+L D        K+ DF  +  I    E      + GT
Sbjct: 128 VNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFGT 181
Query: 254 SGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
             ++ P  +N   L  ++D++S GV+   LL+G  P
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 11/98 (11%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            L Y+HS     IIH D+K +N+ +N++   K+ DF   +   +D E    T  + T  Y
Sbjct: 142 GLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDF--GLARHTDDEM---TGYVATRWY 193
Query: 257 LDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PGS 291
             P + +N     +  D++S G ++AELLTG+   PG+
Sbjct: 194 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 231

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 11/98 (11%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            L Y+HS     IIH D+K +N+ +N++   K+ DF   +   +D E    T  + T  Y
Sbjct: 142 GLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDF--GLARHTDDEM---TGYVATRWY 193
Query: 257 LDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PGS 291
             P + +N     +  D++S G ++AELLTG+   PG+
Sbjct: 194 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 231

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 55/106 (51%), Gaps = 11/106 (10%)
Query: 189 RIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFE-SSVLISSDAETAMS 247
           +I   T  AL++L       IIH D+K +NILL+ +   K+ DF  S  L+ S A+T  +
Sbjct: 129 KITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDA 186
Query: 248 TILIGTSGYLDPVCINTGKLTK----KSDVYSFGVVLAELLTGKKP 289
               G   Y+ P  I+     +    +SDV+S G+ L EL TG+ P
Sbjct: 187 ----GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 11/98 (11%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            L Y+HS     IIH D+K +N+ +N++   K+ DF   +   +D E    T  + T  Y
Sbjct: 148 GLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDF--GLARHTDDEM---TGYVATRWY 199
Query: 257 LDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PGS 291
             P + +N     +  D++S G ++AELLTG+   PG+
Sbjct: 200 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 237

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 52/100 (52%), Gaps = 8/100 (8%)
Query: 191 AAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTIL 250
           AAE    L+++H+     +++ D+K ANILL+++   +++D    + ++ D         
Sbjct: 298 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISD----LGLACDFSKKKPHAS 350
Query: 251 IGTSGYLDPVCINTG-KLTKKSDVYSFGVVLAELLTGKKP 289
           +GT GY+ P  +  G      +D +S G +L +LL G  P
Sbjct: 351 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 52/100 (52%), Gaps = 8/100 (8%)
Query: 191 AAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTIL 250
           AAE    L+++H+     +++ D+K ANILL+++   +++D    + ++ D         
Sbjct: 298 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISD----LGLACDFSKKKPHAS 350
Query: 251 IGTSGYLDPVCINTG-KLTKKSDVYSFGVVLAELLTGKKP 289
           +GT GY+ P  +  G      +D +S G +L +LL G  P
Sbjct: 351 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 70/156 (44%), Gaps = 13/156 (8%)
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
           QV H NV+ +  +       +L+ E  S G L D +  + S   +   + ++   +    
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK---QILDG 127
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTA----KVADFESSVLISSDAETAMSTILIGT 253
           ++YLH+     I H D+K  NI+L D        K+ DF  +  I    E      + GT
Sbjct: 128 VNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFGT 181
Query: 254 SGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
             ++ P  +N   L  ++D++S GV+   LL+G  P
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 95/226 (42%), Gaps = 30/226 (13%)
Query: 85  ATKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKXXXXXXXXXXXXSQV---- 139
           AT  ++    +  G + +VYK    H    VA+K+ R  +              +V    
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 140 -----NHKNVVKILGLCL------ETEVPLLVYEFASNG--TLLDHIRCESSQVLKTWKT 186
                 H NVV+++ +C       E +V  LV+E       T LD          +T K 
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKV-TLVFEHVDQDLRTYLDKAPPPGLPA-ETIKD 124
Query: 187 CLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAM 246
            +R   +    LD+LH+     I+H D+K  NIL+    T K+ADF  + + S   + A+
Sbjct: 125 LMR---QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY--QMAL 176
Query: 247 STILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSC 292
           + +++ T  Y  P  +         D++S G + AE+   +KP  C
Sbjct: 177 TPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLFC 220

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 11/98 (11%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            L Y+HS     IIH D+K +N+ +N++   K+ DF   +   +D E    T  + T  Y
Sbjct: 137 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDF--GLARHTDDEM---TGYVATRWY 188
Query: 257 LDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PGS 291
             P + +N     +  D++S G ++AELLTG+   PG+
Sbjct: 189 RAPEIMLNAMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 11/98 (11%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            L Y+HS     IIH D+K +N+ +N++   K+ DF   +   +D E    T  + T  Y
Sbjct: 143 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDF--GLARHTDDEM---TGYVATRWY 194
Query: 257 LDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PGS 291
             P + +N     +  D++S G ++AELLTG+   PG+
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 232

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 11/98 (11%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            L Y+HS     IIH D+K +N+ +N++   K+ DF   +   +D E    T  + T  Y
Sbjct: 143 GLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDF--GLARHTDDEM---TGYVATRWY 194
Query: 257 LDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PGS 291
             P + +N     +  D++S G ++AELLTG+   PG+
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 232

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 11/98 (11%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            L Y+HS     IIH D+K +N+ +N++   K+ DF   +   +D E    T  + T  Y
Sbjct: 143 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDF--GLARHTDDEM---TGYVATRWY 194
Query: 257 LDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PGS 291
             P + +N     +  D++S G ++AELLTG+   PG+
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 232

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 11/98 (11%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            L Y+HS     IIH D+K +N+ +N++   K+ DF   +   +D E    T  + T  Y
Sbjct: 139 GLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDF--GLARHTDDEM---TGYVATRWY 190
Query: 257 LDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PGS 291
             P + +N     +  D++S G ++AELLTG+   PG+
Sbjct: 191 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 228

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 11/98 (11%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            L Y+HS     IIH D+K +N+ +N++   K+ DF   +   +D E    T  + T  Y
Sbjct: 137 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDF--GLARHTDDEM---TGYVATRWY 188
Query: 257 LDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PGS 291
             P + +N     +  D++S G ++AELLTG+   PG+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 11/98 (11%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            L Y+HS     IIH D+K +N+ +N++   K+ DF   +   +D E    T  + T  Y
Sbjct: 137 GLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDF--GLCRHTDDEM---TGYVATRWY 188
Query: 257 LDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PGS 291
             P + +N     +  D++S G ++AELLTG+   PG+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 11/98 (11%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            L Y+HS     IIH D+K +N+ +N++   K+ DF   +   +D E    T  + T  Y
Sbjct: 137 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDF--GLARHTDDEM---TGYVATRWY 188
Query: 257 LDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PGS 291
             P + +N     +  D++S G ++AELLTG+   PG+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 93/226 (41%), Gaps = 17/226 (7%)
Query: 96  SQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXX---XSQVNHKNVVKILGLCL 152
           +QG   + Y  VL  N  VA+K   R  +                 VNHKN++ +L +  
Sbjct: 36  AQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFT 93
Query: 153 ETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHG 212
             +    + EF     +++ +     QV++      R++      L  +  L S  IIH 
Sbjct: 94  PQKT---LEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHR 150
Query: 213 DVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSD 272
           D+K +NI++  + T K+ DF    L  +   + M T  + T  Y  P  I      +  D
Sbjct: 151 DLKPSNIVVKSDXTLKILDFG---LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVD 207
Query: 273 VYSFGVVLAELLTGK--KPGSCMTLASNKKISMV----PYFLNSIK 312
           ++S G ++ E++  K   PG       NK I  +    P F+  ++
Sbjct: 208 IWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 253

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 93/226 (41%), Gaps = 17/226 (7%)
Query: 96  SQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXX---XSQVNHKNVVKILGLCL 152
           +QG   + Y  VL  N  VA+K   R  +                 VNHKN++ +L +  
Sbjct: 36  AQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFT 93
Query: 153 ETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHG 212
             +    + EF     +++ +     QV++      R++      L  +  L S  IIH 
Sbjct: 94  PQKT---LEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHR 150
Query: 213 DVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSD 272
           D+K +NI++  + T K+ DF    L  +   + M T  + T  Y  P  I      +  D
Sbjct: 151 DLKPSNIVVKSDXTLKILDFG---LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVD 207
Query: 273 VYSFGVVLAELLTGK--KPGSCMTLASNKKISMV----PYFLNSIK 312
           ++S G ++ E++  K   PG       NK I  +    P F+  ++
Sbjct: 208 IWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 253

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 52/98 (53%), Gaps = 11/98 (11%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            L Y+HS     IIH D+K +N+ +N++   K+ DF     ++   +  M T  + T  Y
Sbjct: 137 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDF----YLARHTDDEM-TGYVATRWY 188
Query: 257 LDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PGS 291
             P + +N     +  D++S G ++AELLTG+   PG+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 11/98 (11%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            L Y+HS     IIH D+K +N+ +N++   K+ DF   +   +D E    T  + T  Y
Sbjct: 147 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDF--GLARHTDDEM---TGYVATRWY 198
Query: 257 LDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PGS 291
             P + +N     +  D++S G ++AELLTG+   PG+
Sbjct: 199 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 236

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 11/98 (11%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            L Y+HS     IIH D+K +N+ +N++   K+ DF   +   +D E    T  + T  Y
Sbjct: 137 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDF--GLARHTDDEM---TGYVATRWY 188
Query: 257 LDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PGS 291
             P + +N     +  D++S G ++AELLTG+   PG+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 11/98 (11%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            L Y+HS     IIH D+K +N+ +N++   K+ DF   +   +D E    T  + T  Y
Sbjct: 149 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDF--GLARHTDDEM---TGYVATRWY 200
Query: 257 LDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PGS 291
             P + +N     +  D++S G ++AELLTG+   PG+
Sbjct: 201 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 238

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 11/98 (11%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            L Y+HS     IIH D+K +N+ +N++   K+ DF   +   +D E    T  + T  Y
Sbjct: 143 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDF--GLARHTDDEM---TGYVATRWY 194
Query: 257 LDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PGS 291
             P + +N     +  D++S G ++AELLTG+   PG+
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 232

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 11/98 (11%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            L Y+HS     IIH D+K +N+ +N++   K+ DF   +   +D E    T  + T  Y
Sbjct: 157 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDF--GLARHTDDEM---TGYVATRWY 208
Query: 257 LDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PGS 291
             P + +N     +  D++S G ++AELLTG+   PG+
Sbjct: 209 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 246

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 11/98 (11%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            L Y+HS     IIH D+K +N+ +N++   K+ DF   +   +D E    T  + T  Y
Sbjct: 149 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDF--GLARHTDDEM---TGYVATRWY 200
Query: 257 LDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PGS 291
             P + +N     +  D++S G ++AELLTG+   PG+
Sbjct: 201 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 238

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 79/180 (43%), Gaps = 12/180 (6%)
Query: 139 VNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASAL 198
           VNHKN++ +L +    +    + EF     +++ +     QV++      R++      L
Sbjct: 80  VNHKNIISLLNVFTPQKT---LEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQML 136
Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLD 258
             +  L S  IIH D+K +NI++  + T K+ DF    L  +   + M T  + T  Y  
Sbjct: 137 XGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFG---LARTAGTSFMMTPYVVTRYYRA 193
Query: 259 PVCINTGKLTKKSDVYSFGVVLAELLTGK--KPGSCMTLASNKKISMV----PYFLNSIK 312
           P  I      +  D++S G ++ E++  K   PG       NK I  +    P F+  ++
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 253

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 79/180 (43%), Gaps = 12/180 (6%)
Query: 139 VNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASAL 198
           VNHKN++ +L +    +    + EF     +++ +     QV++      R++      L
Sbjct: 73  VNHKNIISLLNVFTPQKT---LEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQML 129
Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLD 258
             +  L S  IIH D+K +NI++  + T K+ DF    L  +   + M T  + T  Y  
Sbjct: 130 XGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFG---LARTAGTSFMMTPYVVTRYYRA 186
Query: 259 PVCINTGKLTKKSDVYSFGVVLAELLTGK--KPGSCMTLASNKKISMV----PYFLNSIK 312
           P  I      +  D++S G ++ E++  K   PG       NK I  +    P F+  ++
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 11/98 (11%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            L Y+HS     IIH D+K +N+ +N++   K+ DF   +   +D E    T  + T  Y
Sbjct: 142 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDF--GLARHTDDEM---TGYVATRWY 193
Query: 257 LDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PGS 291
             P + +N     +  D++S G ++AELLTG+   PG+
Sbjct: 194 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 231

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 11/98 (11%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            L Y+HS     IIH D+K +N+ +N++   K+ DF   +   +D E    T  + T  Y
Sbjct: 137 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDF--GLARHTDDEM---TGYVATRWY 188
Query: 257 LDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PGS 291
             P + +N     +  D++S G ++AELLTG+   PG+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 11/98 (11%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            L Y+HS     IIH D+K +N+ +N++   K+ DF   +   +D E    T  + T  Y
Sbjct: 148 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDF--GLARHTDDEM---TGYVATRWY 199
Query: 257 LDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PGS 291
             P + +N     +  D++S G ++AELLTG+   PG+
Sbjct: 200 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 237

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 11/98 (11%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            L Y+HS     IIH D+K +N+ +N++   K+ DF   +   +D E    T  + T  Y
Sbjct: 136 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDF--GLARHTDDEM---TGYVATRWY 187
Query: 257 LDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PGS 291
             P + +N     +  D++S G ++AELLTG+   PG+
Sbjct: 188 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 225

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 11/98 (11%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            L Y+HS     IIH D+K +N+ +N++   K+ DF   +   +D E    T  + T  Y
Sbjct: 144 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDF--GLARHTDDEM---TGYVATRWY 195
Query: 257 LDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PGS 291
             P + +N     +  D++S G ++AELLTG+   PG+
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 233

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 71/161 (44%), Gaps = 23/161 (14%)
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
           QV H N++ +  +       +L+ E  S G L D +  + S           ++ E A++
Sbjct: 71  QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKES-----------LSEEEATS 119
Query: 198 -----LDYLHSLASPPIIHGDVKSANILLNDNYTA----KVADFESSVLISSDAETAMST 248
                LD ++ L +  I H D+K  NI+L D        K+ DF  +  I    E     
Sbjct: 120 FIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN-- 177
Query: 249 ILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
            + GT  ++ P  +N   L  ++D++S GV+   LL+G  P
Sbjct: 178 -IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 11/98 (11%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            L Y+HS     IIH D+K +N+ +N++   K+ DF   +   +D E    T  + T  Y
Sbjct: 149 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDF--GLARHTDDEM---TGYVATRWY 200
Query: 257 LDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PGS 291
             P + +N     +  D++S G ++AELLTG+   PG+
Sbjct: 201 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 238

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 11/98 (11%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            L Y+HS     IIH D+K +N+ +N++   K+ DF   +   +D E    T  + T  Y
Sbjct: 157 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDF--GLARHTDDEM---TGYVATRWY 208
Query: 257 LDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PGS 291
             P + +N     +  D++S G ++AELLTG+   PG+
Sbjct: 209 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 246

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 11/98 (11%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            L Y+HS     IIH D+K +N+ +N++   K+ DF   +   +D E    T  + T  Y
Sbjct: 137 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDF--GLARHTDDEM---TGYVATRWY 188
Query: 257 LDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PGS 291
             P + +N     +  D++S G ++AELLTG+   PG+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 39/144 (27%), Positives = 63/144 (43%), Gaps = 21/144 (14%)
Query: 192 AETASALDYLHSLASPPIIHGDVKSANILL-NDNYTAKVADFESSVLISSDA---ETAMS 247
            +    L+YLHS     I+HGDVK+ N+LL +D   A + DF  +V +  D    +    
Sbjct: 173 GQALEGLEYLHSRR---ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTG 229
Query: 248 TILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGS-------CMTLASNK- 299
             + GT  ++ P  +       K DV+S   ++  +L G  P +       C+ +AS   
Sbjct: 230 DYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPP 289
Query: 300 -----KISMVPYFLNSIKNNGLRQ 318
                  S  P    +I+  GLR+
Sbjct: 290 PVREIPPSCAPLTAQAIQ-EGLRK 312

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 11/98 (11%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            L Y+HS     IIH D+K +N+ +N++   K+ DF   +   +D E    T  + T  Y
Sbjct: 139 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDF--GLARHTDDEM---TGYVATRWY 190
Query: 257 LDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PGS 291
             P + +N     +  D++S G ++AELLTG+   PG+
Sbjct: 191 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 228

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 11/98 (11%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            L Y+HS     IIH D+K +N+ +N++   K+ DF   +   +D E    T  + T  Y
Sbjct: 137 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDF--GLARHTDDEM---TGYVATRWY 188
Query: 257 LDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PGS 291
             P + +N     +  D++S G ++AELLTG+   PG+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 11/98 (11%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            L Y+HS     IIH D+K +N+ +N++   K+ DF   +   +D E    T  + T  Y
Sbjct: 137 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDF--GLARHTDDEM---TGYVATRWY 188
Query: 257 LDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PGS 291
             P + +N     +  D++S G ++AELLTG+   PG+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 11/98 (11%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            L Y+HS     IIH D+K +N+ +N++   K+ DF   +   +D E    T  + T  Y
Sbjct: 139 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDF--GLARHTDDEM---TGYVATRWY 190
Query: 257 LDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PGS 291
             P + +N     +  D++S G ++AELLTG+   PG+
Sbjct: 191 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 228

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 11/98 (11%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            L Y+HS     IIH D+K +N+ +N++   K+ DF   +   +D E    T  + T  Y
Sbjct: 156 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDF--GLARHTDDEM---TGYVATRWY 207
Query: 257 LDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PGS 291
             P + +N     +  D++S G ++AELLTG+   PG+
Sbjct: 208 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 245

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 11/98 (11%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            L Y+HS     IIH D+K +N+ +N++   K+ DF   +   +D E    T  + T  Y
Sbjct: 139 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDF--GLARHTDDEM---TGYVATRWY 190
Query: 257 LDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PGS 291
             P + +N     +  D++S G ++AELLTG+   PG+
Sbjct: 191 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 228

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 11/98 (11%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            L Y+HS     IIH D+K +N+ +N++   K+ DF   +   +D E    T  + T  Y
Sbjct: 137 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDF--GLARHTDDEM---TGYVATRWY 188
Query: 257 LDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PGS 291
             P + +N     +  D++S G ++AELLTG+   PG+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 11/98 (11%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            L Y+HS     IIH D+K +N+ +N++   K+ DF   +   +D E    T  + T  Y
Sbjct: 160 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDF--GLARHTDDEM---TGYVATRWY 211
Query: 257 LDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PGS 291
             P + +N     +  D++S G ++AELLTG+   PG+
Sbjct: 212 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 249

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 11/98 (11%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            L Y+HS     IIH D+K +N+ +N++   K+ DF   +   +D E    T  + T  Y
Sbjct: 142 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDF--GLARHTDDEM---TGYVATRWY 193
Query: 257 LDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PGS 291
             P + +N     +  D++S G ++AELLTG+   PG+
Sbjct: 194 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 231

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 11/98 (11%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            L Y+HS     IIH D+K +N+ +N++   K+ DF   +   +D E    T  + T  Y
Sbjct: 134 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDF--GLARHTDDEM---TGYVATRWY 185
Query: 257 LDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PGS 291
             P + +N     +  D++S G ++AELLTG+   PG+
Sbjct: 186 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 223

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 11/98 (11%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            L Y+HS     IIH D+K +N+ +N++   K+ DF   +   +D E    T  + T  Y
Sbjct: 133 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDF--GLARHTDDEM---TGYVATRWY 184
Query: 257 LDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PGS 291
             P + +N     +  D++S G ++AELLTG+   PG+
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 222

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 11/98 (11%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            L Y+HS     IIH D+K +N+ +N++   K+ DF   +   +D E    T  + T  Y
Sbjct: 156 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDF--GLARHTDDEM---TGYVATRWY 207
Query: 257 LDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PGS 291
             P + +N     +  D++S G ++AELLTG+   PG+
Sbjct: 208 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 245

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 11/98 (11%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            L Y+HS     IIH D+K +N+ +N++   K+ DF   +   +D E    T  + T  Y
Sbjct: 137 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDF--GLARHTDDEM---TGYVATRWY 188
Query: 257 LDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PGS 291
             P + +N     +  D++S G ++AELLTG+   PG+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 11/98 (11%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            L Y+HS     IIH D+K +N+ +N++   K+ DF   +   +D E    T  + T  Y
Sbjct: 133 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDF--GLARHTDDEM---TGYVATRWY 184
Query: 257 LDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PGS 291
             P + +N     +  D++S G ++AELLTG+   PG+
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 222

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 95/219 (43%), Gaps = 17/219 (7%)
Query: 83  IRATKNFDRSRCLSQGGFVSVYKGVLHD-NIQVAVKTYR--RADKXXXXXXXXXXXXSQV 139
           + ++  F +   L  G + +VYKG+     + VA+K  +    +              ++
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL 60
Query: 140 NHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASAL 198
            H+N+V++  + + TE  L LV+EF  N    D  +   S+ +      L +        
Sbjct: 61  KHENIVRLYDV-IHTENKLTLVFEFMDN----DLKKYMDSRTVGNTPRGLELNLVKYFQW 115
Query: 199 DYLHSLA---SPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG 255
             L  LA      I+H D+K  N+L+N     K+ DF  +        T  S ++  T  
Sbjct: 116 QLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV--TLW 173
Query: 256 YLDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PGS 291
           Y  P V + +   +   D++S G +LAE++TGK   PG+
Sbjct: 174 YRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGT 212

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 11/98 (11%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            L Y+HS     IIH D+K +N+ +N++   K+ DF   +   +D E    T  + T  Y
Sbjct: 134 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDF--GLARHTDDEM---TGYVATRWY 185
Query: 257 LDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PGS 291
             P + +N     +  D++S G ++AELLTG+   PG+
Sbjct: 186 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 223

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 11/98 (11%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            L Y+HS     IIH D+K +N+ +N++   K+ DF   +   +D E    T  + T  Y
Sbjct: 135 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDF--GLARHTDDEM---TGYVATRWY 186
Query: 257 LDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PGS 291
             P + +N     +  D++S G ++AELLTG+   PG+
Sbjct: 187 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 224

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 11/98 (11%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            L Y+HS     IIH D+K +N+ +N++   K+ DF   +   +D E    T  + T  Y
Sbjct: 137 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDF--GLARHTDDEM---TGXVATRWY 188
Query: 257 LDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PGS 291
             P + +N     +  D++S G ++AELLTG+   PG+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 11/98 (11%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            L Y+HS     IIH D+K +N+ +N++   K+ DF   +   +D E    T  + T  Y
Sbjct: 133 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDF--GLARHTDDEM---TGYVATRWY 184
Query: 257 LDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PGS 291
             P + +N     +  D++S G ++AELLTG+   PG+
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 222

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 75/160 (46%), Gaps = 18/160 (11%)
Query: 140 NHKNVVKILGLC----LETEVPL-LVYEFASNG--TLLDHIRCESSQVLKTWKTCLRIAA 192
            H NVV+++ +C     + E+ + LV+E       T LD          +T K  +R   
Sbjct: 64  EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPA-ETIKDLMR--- 119
Query: 193 ETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIG 252
           +    LD+LH+     I+H D+K  NIL+    T K+ADF  + + S   + A++ +++ 
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY--QMALAPVVV- 173
Query: 253 TSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSC 292
           T  Y  P  +         D++S G + AE+   +KP  C
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLFC 212

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 47/93 (50%), Gaps = 11/93 (11%)
Query: 209 IIHGDVKSANILLNDNYTAKVADFESSVLISSDA--------ETAMSTILIGTSGYLDP- 259
           +IH D+K +N+L+N N   KV DF  + +I   A        + +  T  + T  Y  P 
Sbjct: 133 VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRAPE 192
Query: 260 VCINTGKLTKKSDVYSFGVVLAELLTGKK--PG 290
           V + + K ++  DV+S G +LAEL   +   PG
Sbjct: 193 VMLTSAKYSRAMDVWSCGCILAELFLRRPIFPG 225

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/226 (23%), Positives = 94/226 (41%), Gaps = 17/226 (7%)
Query: 96  SQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXX---XSQVNHKNVVKILGLCL 152
           +QG   + Y  +L  N  VA+K   R  +                 VNHKN++ +L +  
Sbjct: 36  AQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT 93
Query: 153 ETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHG 212
             +    + EF     +++ +     QV++      R++      L  +  L S  IIH 
Sbjct: 94  PQKS---LEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHR 150
Query: 213 DVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSD 272
           D+K +NI++  + T K+ DF    L  +   + M T  + T  Y  P  I      +  D
Sbjct: 151 DLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVD 207
Query: 273 VYSFGVVLAELLTGKK--PGSCMTLASNKKISMV----PYFLNSIK 312
           ++S G ++ E++ G    PG+      NK I  +    P F+  ++
Sbjct: 208 IWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQ 253

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/226 (23%), Positives = 94/226 (41%), Gaps = 17/226 (7%)
Query: 96  SQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXX---XSQVNHKNVVKILGLCL 152
           +QG   + Y  +L  N  VA+K   R  +                 VNHKN++ +L +  
Sbjct: 37  AQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT 94
Query: 153 ETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHG 212
             +    + EF     +++ +     QV++      R++      L  +  L S  IIH 
Sbjct: 95  PQKS---LEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHR 151
Query: 213 DVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSD 272
           D+K +NI++  + T K+ DF    L  +   + M T  + T  Y  P  I      +  D
Sbjct: 152 DLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVD 208
Query: 273 VYSFGVVLAELLTGKK--PGSCMTLASNKKISMV----PYFLNSIK 312
           ++S G ++ E++ G    PG+      NK I  +    P F+  ++
Sbjct: 209 IWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 47/93 (50%), Gaps = 11/93 (11%)
Query: 209 IIHGDVKSANILLNDNYTAKVADFESSVLISSDA--------ETAMSTILIGTSGYLDP- 259
           +IH D+K +N+L+N N   KV DF  + +I   A        + +  T  + T  Y  P 
Sbjct: 133 VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRAPE 192
Query: 260 VCINTGKLTKKSDVYSFGVVLAELLTGKK--PG 290
           V + + K ++  DV+S G +LAEL   +   PG
Sbjct: 193 VMLTSAKYSRAMDVWSCGCILAELFLRRPIFPG 225

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 53/226 (23%), Positives = 94/226 (41%), Gaps = 17/226 (7%)
Query: 96  SQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXX---XSQVNHKNVVKILGLCL 152
           +QG   + Y  +L  N  VA+K   R  +                 VNHKN++ +L +  
Sbjct: 36  AQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT 93
Query: 153 ETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHG 212
             +    + EF     +++ +     QV++      R++      L  +  L S  IIH 
Sbjct: 94  PQKS---LEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHR 150
Query: 213 DVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSD 272
           D+K +NI++  + T K+ DF    L  +   + M T  + T  Y  P  I      +  D
Sbjct: 151 DLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVD 207
Query: 273 VYSFGVVLAELLTGKK--PGSCMTLASNKKISMV----PYFLNSIK 312
           ++S G ++ E++ G    PG+      NK I  +    P F+  ++
Sbjct: 208 IWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 253

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 51/98 (52%), Gaps = 11/98 (11%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            L Y+HS     IIH D+K +N+ +N++   K+ DF   +   +D E    T  + T  Y
Sbjct: 166 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDF--GLARHTDDEM---TGYVATRWY 217
Query: 257 LDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PGS 291
             P + +N        D++S G ++AELLTG+   PG+
Sbjct: 218 RAPEIMLNWMHYNMTVDIWSVGCIMAELLTGRTLFPGT 255

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 34/132 (25%), Positives = 61/132 (46%), Gaps = 13/132 (9%)
Query: 159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETASALDYLHSLASPPIIHGDVKSA 217
           +V E+ + G +  H+R    ++ +  +   R  AA+     +YLHSL    +I+ D+K  
Sbjct: 118 MVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPE 170
Query: 218 NILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFG 277
           N+L++     +V DF  +  +        +  L GT   L P  I +    K  D ++ G
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVK-----GRTWXLCGTPEALAPEIILSKGYNKAVDWWALG 225
Query: 278 VVLAELLTGKKP 289
           V++ E+  G  P
Sbjct: 226 VLIYEMAAGYPP 237

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 39/144 (27%), Positives = 62/144 (43%), Gaps = 21/144 (14%)
Query: 192 AETASALDYLHSLASPPIIHGDVKSANILL-NDNYTAKVADFESSVLISSDA---ETAMS 247
            +    L+YLHS     I+HGDVK+ N+LL +D   A + DF  +V +  D         
Sbjct: 192 GQALEGLEYLHSRR---ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTG 248
Query: 248 TILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGS-------CMTLASNK- 299
             + GT  ++ P  +       K DV+S   ++  +L G  P +       C+ +AS   
Sbjct: 249 DYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPP 308
Query: 300 -----KISMVPYFLNSIKNNGLRQ 318
                  S  P    +I+  GLR+
Sbjct: 309 PVREIPPSCAPLTAQAIQ-EGLRK 331

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/228 (20%), Positives = 99/228 (43%), Gaps = 25/228 (10%)
Query: 140 NHKNVVKILGLCLETEV--PLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
           +H NV+ +LG C       P L+  +   G+L + +  E +  +      ++ A + A  
Sbjct: 65  SHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYN-VLHEGTNFVVDQSQAVKFALDMARG 123
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYL 257
           + +LH+L  P I    + S +++++++ TA+++  +      S         +   +   
Sbjct: 124 MAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYAPAWVAPEALQK 182
Query: 258 DPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLR 317
            P   N     + +D++SF V+L EL+T + P + +   SN +I M       +   GLR
Sbjct: 183 KPEDTN----RRSADMWSFAVLLWELVTREVPFADL---SNMEIGM------KVALEGLR 229
Query: 318 QILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLR 365
             +   ++          V++L   C+     +RP    +   L++++
Sbjct: 230 PTIPPGISPH--------VSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 37/155 (23%), Positives = 70/155 (45%), Gaps = 10/155 (6%)
Query: 137 SQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETAS 196
           +Q++H N++++          +LV E+   G L D I  ES  + +     +    +   
Sbjct: 141 NQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTEL--DTILFMKQICE 198
Query: 197 ALDYLHSLASPPIIHGDVKSANILL--NDNYTAKVADFESSVLISSDAETAMSTILIGTS 254
            + ++H +    I+H D+K  NIL    D    K+ DF  +       +  ++    GT 
Sbjct: 199 GIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN---FGTP 252
Query: 255 GYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
            +L P  +N   ++  +D++S GV+   LL+G  P
Sbjct: 253 EFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 74/160 (46%), Gaps = 18/160 (11%)
Query: 140 NHKNVVKILGLC----LETEVPL-LVYEFASNG--TLLDHIRCESSQVLKTWKTCLRIAA 192
            H NVV+++ +C     + E+ + LV+E       T LD          +T K  +R   
Sbjct: 64  EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPA-ETIKDLMR--- 119
Query: 193 ETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIG 252
           +    LD+LH+     I+H D+K  NIL+    T K+ADF  + + S   + A+  +++ 
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY--QMALDPVVV- 173
Query: 253 TSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSC 292
           T  Y  P  +         D++S G + AE+   +KP  C
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLFC 212

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 51/98 (52%), Gaps = 11/98 (11%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            L Y+HS     IIH D+K +N+ +N++   K+ DF  +   + +      T  + T  Y
Sbjct: 144 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEM-----TGYVATRWY 195
Query: 257 LDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PGS 291
             P + +N     +  D++S G ++AELLTG+   PG+
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 233

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 51/98 (52%), Gaps = 11/98 (11%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            L Y+HS     IIH D+K +N+ +N++   K+ DF  +   + +      T  + T  Y
Sbjct: 144 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEM-----TGYVATRWY 195
Query: 257 LDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PGS 291
             P + +N     +  D++S G ++AELLTG+   PG+
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 233

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 51/98 (52%), Gaps = 11/98 (11%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            L Y+HS     IIH D+K +N+ +N++   K+ DF  +   + +      T  + T  Y
Sbjct: 144 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEM-----TGYVATRWY 195
Query: 257 LDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PGS 291
             P + +N     +  D++S G ++AELLTG+   PG+
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 233

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 71/155 (45%), Gaps = 12/155 (7%)
Query: 140 NHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALD 199
           +H  +VK+LG         ++ EF   G + D I  E  + L T      +  +   AL+
Sbjct: 74  DHPYIVKLLGAYYHDGKLWIMIEFCPGGAV-DAIMLELDRGL-TEPQIQVVCRQMLEALN 131
Query: 200 YLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDP 259
           +LHS     IIH D+K+ N+L+      ++ADF  S       +   S   IGT  ++ P
Sbjct: 132 FLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAP 186
Query: 260 --VCINTGKLTK---KSDVYSFGVVLAELLTGKKP 289
             V   T K T    K+D++S G+ L E+   + P
Sbjct: 187 EVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 27/92 (29%), Positives = 50/92 (54%), Gaps = 9/92 (9%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            L Y+HS     ++H D+K  N+ +N++   K+ DF     ++  A+  M+  ++ T  Y
Sbjct: 156 GLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFG----LARHADAEMTGYVV-TRWY 207
Query: 257 LDP-VCINTGKLTKKSDVYSFGVVLAELLTGK 287
             P V ++     +  D++S G ++AE+LTGK
Sbjct: 208 RAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 52/98 (53%), Gaps = 11/98 (11%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            L Y+HS     IIH D+K +N+ +N++   K+ D+   +   +D E    T  + T  Y
Sbjct: 137 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDY--GLARHTDDEM---TGYVATRWY 188
Query: 257 LDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PGS 291
             P + +N     +  D++S G ++AELLTG+   PG+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 27/92 (29%), Positives = 50/92 (54%), Gaps = 9/92 (9%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            L Y+HS     ++H D+K  N+ +N++   K+ DF     ++  A+  M+  ++ T  Y
Sbjct: 138 GLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFG----LARHADAEMTGYVV-TRWY 189
Query: 257 LDP-VCINTGKLTKKSDVYSFGVVLAELLTGK 287
             P V ++     +  D++S G ++AE+LTGK
Sbjct: 190 RAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 53/226 (23%), Positives = 94/226 (41%), Gaps = 17/226 (7%)
Query: 96  SQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXX---XSQVNHKNVVKILGLCL 152
           +QG   + Y  +L  N  VA+K   R  +                 VNHKN++ +L +  
Sbjct: 36  AQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT 93
Query: 153 ETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHG 212
             +    + EF     +++ +     QV++      R++      L  +  L S  IIH 
Sbjct: 94  PQKS---LEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHR 150
Query: 213 DVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSD 272
           D+K +NI++  + T K+ DF    L  +   + M T  + T  Y  P  I      +  D
Sbjct: 151 DLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMTPEVVTRYYRAPEVILGMGYKENVD 207
Query: 273 VYSFGVVLAELLTGKK--PGSCMTLASNKKISMV----PYFLNSIK 312
           ++S G ++ E++ G    PG+      NK I  +    P F+  ++
Sbjct: 208 IWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 253

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 22/209 (10%)
Query: 87  KNFDRSRCLSQGGFVSVYKGVLHDNIQ-VAVKTYRRA------DKXXXXXXXXXXXXSQV 139
           K +++   L +G F +VYK    +  Q VA+K  +        D              ++
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 140 NHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAE---TAS 196
           +H N++ +L          LV++F    T L+ I  ++S VL    T   I A    T  
Sbjct: 70  SHPNIIGLLDAFGHKSNISLVFDFME--TDLEVIIKDNSLVL----TPSHIKAYMLMTLQ 123
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            L+YLH      I+H D+K  N+LL++N   K+ADF  +    S        ++  T  Y
Sbjct: 124 GLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV--TRWY 178
Query: 257 LDPVCINTGKLTKKS-DVYSFGVVLAELL 284
             P  +   ++     D+++ G +LAELL
Sbjct: 179 RAPELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 38/148 (25%), Positives = 67/148 (45%), Gaps = 6/148 (4%)
Query: 139 VNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASAL 198
           VNHKN++ +L +    +    + EF     +++ +     QV+       R++      L
Sbjct: 78  VNHKNIISLLNVFTPQKT---LEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQML 134
Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLD 258
             +  L S  IIH D+K +NI++  + T K+ DF    L  + +   M T  + T  Y  
Sbjct: 135 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG---LARTASTNFMMTPYVVTRYYRA 191
Query: 259 PVCINTGKLTKKSDVYSFGVVLAELLTG 286
           P  I      +  D++S G ++ EL+ G
Sbjct: 192 PEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 51/98 (52%), Gaps = 11/98 (11%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            L Y+HS     IIH D+K +N+ +N++   K+ DF   +   +D E       + T  Y
Sbjct: 157 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDF--GLARHTDDEMXGX---VATRWY 208
Query: 257 LDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PGS 291
             P + +N     +  D++S G ++AELLTG+   PG+
Sbjct: 209 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 246

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 74/160 (46%), Gaps = 18/160 (11%)
Query: 140 NHKNVVKILGLC----LETEVPL-LVYEFASNG--TLLDHIRCESSQVLKTWKTCLRIAA 192
            H NVV+++ +C     + E+ + LV+E       T LD          +T K  +R   
Sbjct: 64  EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPA-ETIKDLMR--- 119
Query: 193 ETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIG 252
           +    LD+LH+     I+H D+K  NIL+    T K+ADF  + + S   + A+  +++ 
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY--QMALFPVVV- 173
Query: 253 TSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSC 292
           T  Y  P  +         D++S G + AE+   +KP  C
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLFC 212

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 71/156 (45%), Gaps = 14/156 (8%)
Query: 138 QVNHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETAS 196
           +++H N++K L    ET   + LV E  + G L D I     +   + +       +   
Sbjct: 104 RLSHPNIIK-LKEIFETPTEISLVLELVTGGELFDRI---VEKGYYSERDAADAVKQILE 159
Query: 197 ALDYLHSLASPPIIHGDVKSANILLN---DNYTAKVADFESSVLISSDAETAMSTILIGT 253
           A+ YLH      I+H D+K  N+L      +   K+ADF  S ++  + +  M T+  GT
Sbjct: 160 AVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV--EHQVLMKTV-CGT 213
Query: 254 SGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
            GY  P  +       + D++S G++   LL G +P
Sbjct: 214 PGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEP 249

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 52/226 (23%), Positives = 93/226 (41%), Gaps = 17/226 (7%)
Query: 96  SQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXX---XSQVNHKNVVKILGLCL 152
           +QG   + Y  +L  N  VA+K   R  +                 VNHKN++ +L +  
Sbjct: 38  AQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT 95
Query: 153 ETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHG 212
             +    + EF     +++ +     QV++      R++      L  +  L S  IIH 
Sbjct: 96  PQKS---LEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHR 152
Query: 213 DVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSD 272
           D+K +NI++  + T K+ DF    L  +   + M    + T  Y  P  I      +  D
Sbjct: 153 DLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMVPFVVTRYYRAPEVILGMGYKENVD 209
Query: 273 VYSFGVVLAELLTGKK--PGSCMTLASNKKISMV----PYFLNSIK 312
           ++S G ++ E++ G    PG+      NK I  +    P F+  ++
Sbjct: 210 IWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 255

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 46/93 (49%), Gaps = 11/93 (11%)
Query: 209 IIHGDVKSANILLNDNYTAKVADFESSVLISSDA--------ETAMSTILIGTSGYLDP- 259
           +IH D+K +N+L+N N   KV DF  + +I   A        + +     + T  Y  P 
Sbjct: 133 VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPE 192
Query: 260 VCINTGKLTKKSDVYSFGVVLAELLTGKK--PG 290
           V + + K ++  DV+S G +LAEL   +   PG
Sbjct: 193 VMLTSAKYSRAMDVWSCGCILAELFLRRPIFPG 225

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 93/226 (41%), Gaps = 17/226 (7%)
Query: 96  SQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXX---XSQVNHKNVVKILGLCL 152
           +QG   + Y  VL  N  VA+K   R  +                 VNHKN++ +L +  
Sbjct: 35  AQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 92
Query: 153 ETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHG 212
             +    + EF     +++ +     QV++      R++      L  +  L S  IIH 
Sbjct: 93  PQKT---LEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHR 149
Query: 213 DVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSD 272
           D+K +NI++  + T K+ DF    L  +   + M T  + T  Y  P  I      +  D
Sbjct: 150 DLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVD 206
Query: 273 VYSFGVVLAELLTGK--KPGSCMTLASNKKISMV----PYFLNSIK 312
           ++S G ++ E++  K   PG       NK I  +    P F+  ++
Sbjct: 207 IWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 252

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 93/226 (41%), Gaps = 17/226 (7%)
Query: 96  SQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXX---XSQVNHKNVVKILGLCL 152
           +QG   + Y  VL  N  VA+K   R  +                 VNHKN++ +L +  
Sbjct: 36  AQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 93
Query: 153 ETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHG 212
             +    + EF     +++ +     QV++      R++      L  +  L S  IIH 
Sbjct: 94  PQKT---LEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHR 150
Query: 213 DVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSD 272
           D+K +NI++  + T K+ DF    L  +   + M T  + T  Y  P  I      +  D
Sbjct: 151 DLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVD 207
Query: 273 VYSFGVVLAELLTGK--KPGSCMTLASNKKISMV----PYFLNSIK 312
           ++S G ++ E++  K   PG       NK I  +    P F+  ++
Sbjct: 208 IWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 253

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 93/226 (41%), Gaps = 17/226 (7%)
Query: 96  SQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXX---XSQVNHKNVVKILGLCL 152
           +QG   + Y  VL  N  VA+K   R  +                 VNHKN++ +L +  
Sbjct: 30  AQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 87
Query: 153 ETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHG 212
             +    + EF     +++ +     QV++      R++      L  +  L S  IIH 
Sbjct: 88  PQKT---LEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHR 144
Query: 213 DVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSD 272
           D+K +NI++  + T K+ DF    L  +   + M T  + T  Y  P  I      +  D
Sbjct: 145 DLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVD 201
Query: 273 VYSFGVVLAELLTGK--KPGSCMTLASNKKISMV----PYFLNSIK 312
           ++S G ++ E++  K   PG       NK I  +    P F+  ++
Sbjct: 202 IWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 247

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 71/155 (45%), Gaps = 12/155 (7%)
Query: 140 NHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALD 199
           +H  +VK+LG         ++ EF   G + D I  E  + L T      +  +   AL+
Sbjct: 66  DHPYIVKLLGAYYHDGKLWIMIEFCPGGAV-DAIMLELDRGL-TEPQIQVVCRQMLEALN 123
Query: 200 YLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDP 259
           +LHS     IIH D+K+ N+L+      ++ADF  S       +   S   IGT  ++ P
Sbjct: 124 FLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAP 178
Query: 260 --VCINTGKLTK---KSDVYSFGVVLAELLTGKKP 289
             V   T K T    K+D++S G+ L E+   + P
Sbjct: 179 EVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 213

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 93/226 (41%), Gaps = 17/226 (7%)
Query: 96  SQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXX---XSQVNHKNVVKILGLCL 152
           +QG   + Y  VL  N  VA+K   R  +                 VNHKN++ +L +  
Sbjct: 36  AQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 93
Query: 153 ETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHG 212
             +    + EF     +++ +     QV++      R++      L  +  L S  IIH 
Sbjct: 94  PQKT---LEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHR 150
Query: 213 DVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSD 272
           D+K +NI++  + T K+ DF    L  +   + M T  + T  Y  P  I      +  D
Sbjct: 151 DLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVD 207
Query: 273 VYSFGVVLAELLTGK--KPGSCMTLASNKKISMV----PYFLNSIK 312
           ++S G ++ E++  K   PG       NK I  +    P F+  ++
Sbjct: 208 IWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 253

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 93/226 (41%), Gaps = 17/226 (7%)
Query: 96  SQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXX---XSQVNHKNVVKILGLCL 152
           +QG   + Y  VL  N  VA+K   R  +                 VNHKN++ +L +  
Sbjct: 29  AQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 86
Query: 153 ETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHG 212
             +    + EF     +++ +     QV++      R++      L  +  L S  IIH 
Sbjct: 87  PQKT---LEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHR 143
Query: 213 DVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSD 272
           D+K +NI++  + T K+ DF    L  +   + M T  + T  Y  P  I      +  D
Sbjct: 144 DLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVD 200
Query: 273 VYSFGVVLAELLTGK--KPGSCMTLASNKKISMV----PYFLNSIK 312
           ++S G ++ E++  K   PG       NK I  +    P F+  ++
Sbjct: 201 IWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 93/226 (41%), Gaps = 17/226 (7%)
Query: 96  SQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXX---XSQVNHKNVVKILGLCL 152
           +QG   + Y  VL  N  VA+K   R  +                 VNHKN++ +L +  
Sbjct: 37  AQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 94
Query: 153 ETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHG 212
             +    + EF     +++ +     QV++      R++      L  +  L S  IIH 
Sbjct: 95  PQKT---LEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHR 151
Query: 213 DVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSD 272
           D+K +NI++  + T K+ DF    L  +   + M T  + T  Y  P  I      +  D
Sbjct: 152 DLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVD 208
Query: 273 VYSFGVVLAELLTGK--KPGSCMTLASNKKISMV----PYFLNSIK 312
           ++S G ++ E++  K   PG       NK I  +    P F+  ++
Sbjct: 209 IWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 254

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 93/226 (41%), Gaps = 17/226 (7%)
Query: 96  SQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXX---XSQVNHKNVVKILGLCL 152
           +QG   + Y  VL  N  VA+K   R  +                 VNHKN++ +L +  
Sbjct: 30  AQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 87
Query: 153 ETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHG 212
             +    + EF     +++ +     QV++      R++      L  +  L S  IIH 
Sbjct: 88  PQKT---LEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHR 144
Query: 213 DVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSD 272
           D+K +NI++  + T K+ DF    L  +   + M T  + T  Y  P  I      +  D
Sbjct: 145 DLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVD 201
Query: 273 VYSFGVVLAELLTGK--KPGSCMTLASNKKISMV----PYFLNSIK 312
           ++S G ++ E++  K   PG       NK I  +    P F+  ++
Sbjct: 202 IWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 247

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 93/226 (41%), Gaps = 17/226 (7%)
Query: 96  SQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXX---XSQVNHKNVVKILGLCL 152
           +QG   + Y  VL  N  VA+K   R  +                 VNHKN++ +L +  
Sbjct: 37  AQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 94
Query: 153 ETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHG 212
             +    + EF     +++ +     QV++      R++      L  +  L S  IIH 
Sbjct: 95  PQKT---LEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHR 151
Query: 213 DVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSD 272
           D+K +NI++  + T K+ DF    L  +   + M T  + T  Y  P  I      +  D
Sbjct: 152 DLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVD 208
Query: 273 VYSFGVVLAELLTGK--KPGSCMTLASNKKISMV----PYFLNSIK 312
           ++S G ++ E++  K   PG       NK I  +    P F+  ++
Sbjct: 209 IWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 254

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/138 (28%), Positives = 60/138 (43%), Gaps = 21/138 (15%)
Query: 153 ETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHG 212
           E E P  +Y+   +   L+H+ C S QV K                  +  LAS   IH 
Sbjct: 176 EEEAPEDLYK---DFLTLEHLICYSFQVAKG-----------------MEFLASRKCIHR 215
Query: 213 DVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSD 272
           D+ + NILL++    K+ DF  +  I  D +            ++ P  I     T +SD
Sbjct: 216 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSD 275
Query: 273 VYSFGVVLAELLT-GKKP 289
           V+SFGV+L E+ + G  P
Sbjct: 276 VWSFGVLLWEIFSLGASP 293

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 51/98 (52%), Gaps = 11/98 (11%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            L Y+HS     IIH D+K +N+ +N++   K+ DF   +   +D E       + T  Y
Sbjct: 160 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDF--GLARHTDDEMXG---YVATRWY 211
Query: 257 LDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PGS 291
             P + +N     +  D++S G ++AELLTG+   PG+
Sbjct: 212 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 249

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/138 (28%), Positives = 60/138 (43%), Gaps = 21/138 (15%)
Query: 153 ETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHG 212
           E E P  +Y+   +   L+H+ C S QV K                  +  LAS   IH 
Sbjct: 178 EEEAPEDLYK---DFLTLEHLICYSFQVAKG-----------------MEFLASRKCIHR 217
Query: 213 DVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSD 272
           D+ + NILL++    K+ DF  +  I  D +            ++ P  I     T +SD
Sbjct: 218 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSD 277
Query: 273 VYSFGVVLAELLT-GKKP 289
           V+SFGV+L E+ + G  P
Sbjct: 278 VWSFGVLLWEIFSLGASP 295

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/138 (28%), Positives = 60/138 (43%), Gaps = 21/138 (15%)
Query: 153 ETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHG 212
           E E P  +Y+   +   L+H+ C S QV K                  +  LAS   IH 
Sbjct: 183 EEEAPEDLYK---DFLTLEHLICYSFQVAKG-----------------MEFLASRKCIHR 222
Query: 213 DVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSD 272
           D+ + NILL++    K+ DF  +  I  D +            ++ P  I     T +SD
Sbjct: 223 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSD 282
Query: 273 VYSFGVVLAELLT-GKKP 289
           V+SFGV+L E+ + G  P
Sbjct: 283 VWSFGVLLWEIFSLGASP 300

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 71/159 (44%), Gaps = 17/159 (10%)
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
           +++H N+V ++ +        LV+EF            +  +VL   KT L+ +      
Sbjct: 75  ELHHPNIVSLIDVIHSERCLTLVFEFMEK---------DLKKVLDENKTGLQDSQIKIYL 125
Query: 198 LDYLHSLA---SPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTS 254
              L  +A      I+H D+K  N+L+N +   K+ADF  +        +    ++  T 
Sbjct: 126 YQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV--TL 183
Query: 255 GYLDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PG 290
            Y  P V + + K +   D++S G + AE++TGK   PG
Sbjct: 184 WYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPG 222

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/134 (32%), Positives = 60/134 (44%), Gaps = 11/134 (8%)
Query: 162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILL 221
           E A NG++  H   ES   ++  K    I  +  SAL YLH+     I H D+K  N L 
Sbjct: 147 EEAINGSI--HGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLF 201
Query: 222 --NDNYTAKVADFESS--VLISSDAETAMSTILIGTSGYLDPVCINTGK--LTKKSDVYS 275
             N ++  K+ DF  S      ++ E    T   GT  ++ P  +NT       K D +S
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261
Query: 276 FGVVLAELLTGKKP 289
            GV+L  LL G  P
Sbjct: 262 AGVLLHLLLMGAVP 275

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/138 (28%), Positives = 60/138 (43%), Gaps = 21/138 (15%)
Query: 153 ETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHG 212
           E E P  +Y+   +   L+H+ C S QV K                  +  LAS   IH 
Sbjct: 185 EEEAPEDLYK---DFLTLEHLICYSFQVAKG-----------------MEFLASRKCIHR 224
Query: 213 DVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSD 272
           D+ + NILL++    K+ DF  +  I  D +            ++ P  I     T +SD
Sbjct: 225 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSD 284
Query: 273 VYSFGVVLAELLT-GKKP 289
           V+SFGV+L E+ + G  P
Sbjct: 285 VWSFGVLLWEIFSLGASP 302

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 87/210 (41%), Gaps = 25/210 (11%)
Query: 95  LSQGGFVSVYKG-VLHDNIQVAVKTYRR-----------ADKXXXXXXXXXXXXSQVNHK 142
           L +GGF +V+ G  L D +QVA+K   R           +              +   H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 143 NVVKILGLCLETEVPLLVYEFASNGT-LLDHIRCESSQVLKTWKTCLRIAAETASALDYL 201
            V+++L      E  +LV E       L D+I  E   + +    C     +  +A+ + 
Sbjct: 99  GVIRLLDWFETQEGFMLVLERPLPAQDLFDYIT-EKGPLGEGPSRCF--FGQVVAAIQHC 155
Query: 202 HSLASPPIIHGDVKSANILLN-DNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV 260
           HS     ++H D+K  NIL++     AK+ DF S  L+  +  T       GT  Y  P 
Sbjct: 156 HSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD----GTRVYSPPE 208
Query: 261 CINTGKLTK-KSDVYSFGVVLAELLTGKKP 289
            I+  +     + V+S G++L +++ G  P
Sbjct: 209 WISRHQYHALPATVWSLGILLYDMVCGDIP 238

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/148 (25%), Positives = 65/148 (43%), Gaps = 6/148 (4%)
Query: 139 VNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASAL 198
           VNHKN++ +L +    +    + EF     +++ +     QV+       R++      L
Sbjct: 80  VNHKNIISLLNVFTPQKT---LEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQML 136
Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLD 258
             +  L S  IIH D+K +NI++  + T K+ DF    L  +     M T  + T  Y  
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG---LARTACTNFMMTPYVVTRYYRA 193
Query: 259 PVCINTGKLTKKSDVYSFGVVLAELLTG 286
           P  I         D++S G ++ EL+ G
Sbjct: 194 PEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 52/98 (53%), Gaps = 11/98 (11%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            L Y+HS     IIH D+K +N+ +N++   K+ D  + +   +D E    T  + T  Y
Sbjct: 137 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILD--AGLARHTDDEM---TGYVATRWY 188
Query: 257 LDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PGS 291
             P + +N     +  D++S G ++AELLTG+   PG+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 71/159 (44%), Gaps = 17/159 (10%)
Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
           +++H N+V ++ +        LV+EF            +  +VL   KT L+ +      
Sbjct: 75  ELHHPNIVSLIDVIHSERCLTLVFEFMEK---------DLKKVLDENKTGLQDSQIKIYL 125
Query: 198 LDYLHSLA---SPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTS 254
              L  +A      I+H D+K  N+L+N +   K+ADF  +        +    ++  T 
Sbjct: 126 YQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV--TL 183
Query: 255 GYLDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PG 290
            Y  P V + + K +   D++S G + AE++TGK   PG
Sbjct: 184 WYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPG 222

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 82/195 (42%), Gaps = 11/195 (5%)
Query: 96  SQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXX---XSQVNHKNVVKILGLCL 152
           +QG   + Y  VL  N  VA+K   R  +                 VNHKN++ +L +  
Sbjct: 74  AQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 131
Query: 153 ETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHG 212
             +    + EF     +++ +     QV++      R++      L  +  L S  IIH 
Sbjct: 132 PQKT---LEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHR 188
Query: 213 DVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSD 272
           D+K +NI++  + T K+ DF    L  +   + M T  + T  Y  P  I      +  D
Sbjct: 189 DLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVD 245
Query: 273 VYSFGVVLAELLTGK 287
           ++S G ++ E++  K
Sbjct: 246 IWSVGCIMGEMVRHK 260

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 82/195 (42%), Gaps = 11/195 (5%)
Query: 96  SQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXX---XSQVNHKNVVKILGLCL 152
           +QG   + Y  VL  N  VA+K   R  +                 VNHKN++ +L +  
Sbjct: 74  AQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 131
Query: 153 ETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHG 212
             +    + EF     +++ +     QV++      R++      L  +  L S  IIH 
Sbjct: 132 PQKT---LEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHR 188
Query: 213 DVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSD 272
           D+K +NI++  + T K+ DF    L  +   + M T  + T  Y  P  I      +  D
Sbjct: 189 DLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVD 245
Query: 273 VYSFGVVLAELLTGK 287
           ++S G ++ E++  K
Sbjct: 246 IWSVGCIMGEMVRHK 260

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 51/98 (52%), Gaps = 11/98 (11%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            L Y+HS     IIH D+K +N+ +N++   K+ D    +   +D E    T  + T  Y
Sbjct: 137 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILD--GGLARHTDDEM---TGYVATRWY 188
Query: 257 LDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PGS 291
             P + +N     +  D++S G ++AELLTG+   PG+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/117 (25%), Positives = 53/117 (45%), Gaps = 14/117 (11%)
Query: 192 AETASALDYLHSLASPPIIHGDVKSANILL-NDNYTAKVADFESSVLISSDA---ETAMS 247
            +    L+YLH+     I+HGDVK+ N+LL +D   A + DF  ++ +  D         
Sbjct: 173 GQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTG 229
Query: 248 TILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGS-------CMTLAS 297
             + GT  ++ P  +       K D++S   ++  +L G  P +       C+ +AS
Sbjct: 230 DYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS 286

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/117 (25%), Positives = 53/117 (45%), Gaps = 14/117 (11%)
Query: 192 AETASALDYLHSLASPPIIHGDVKSANILL-NDNYTAKVADFESSVLISSDA---ETAMS 247
            +    L+YLH+     I+HGDVK+ N+LL +D   A + DF  ++ +  D         
Sbjct: 171 GQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTG 227
Query: 248 TILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGS-------CMTLAS 297
             + GT  ++ P  +       K D++S   ++  +L G  P +       C+ +AS
Sbjct: 228 DYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS 284

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/117 (25%), Positives = 53/117 (45%), Gaps = 14/117 (11%)
Query: 192 AETASALDYLHSLASPPIIHGDVKSANILL-NDNYTAKVADFESSVLISSDA---ETAMS 247
            +    L+YLH+     I+HGDVK+ N+LL +D   A + DF  ++ +  D         
Sbjct: 157 GQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTG 213
Query: 248 TILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGS-------CMTLAS 297
             + GT  ++ P  +       K D++S   ++  +L G  P +       C+ +AS
Sbjct: 214 DYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS 270

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/226 (23%), Positives = 93/226 (41%), Gaps = 17/226 (7%)
Query: 96  SQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXX---XSQVNHKNVVKILGLCL 152
           +QG   + Y  +L  N  VA+K   R  +                 VNHKN++ +L +  
Sbjct: 41  AQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT 98
Query: 153 ETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHG 212
             +    + EF     +++ +     QV++      R++      L  +  L S  IIH 
Sbjct: 99  PQKS---LEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHR 155
Query: 213 DVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSD 272
           D+K +NI++  + T K+ DF    L  +   + M T  + T  Y  P  I      +  D
Sbjct: 156 DLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVD 212
Query: 273 VYSFGVVLAELLTGK--KPGSCMTLASNKKISMV----PYFLNSIK 312
           ++S G ++ E++  K   PG       NK I  +    P F+  ++
Sbjct: 213 LWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 258

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 51/98 (52%), Gaps = 11/98 (11%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            L Y+HS     IIH D+K +N+ +N++   K+ D    +   +D E    T  + T  Y
Sbjct: 137 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILD--RGLARHTDDEM---TGYVATRWY 188
Query: 257 LDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PGS 291
             P + +N     +  D++S G ++AELLTG+   PG+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 51/98 (52%), Gaps = 11/98 (11%)
Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            L Y+HS     IIH D+K +N+ +N++   K+  F   +   +D E    T  + T  Y
Sbjct: 137 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILGF--GLARHTDDEM---TGYVATRWY 188
Query: 257 LDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PGS 291
             P + +N     +  D++S G ++AELLTG+   PG+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 84/204 (41%), Gaps = 30/204 (14%)
Query: 99  GFVSVYKGVLHD--NIQVAVKTYRRADKXXXXXXXXXXXXSQVNHKNVVKILGLCLETEV 156
           G  SV K  +H   N++ AVK   ++ +             Q  H N++ +  +  + + 
Sbjct: 33  GSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQ--HPNIITLKDVYDDGKY 90
Query: 157 PLLVYEFASNGTLLDHI-------RCESSQVLKTWKTCLRIAAETASALDYLHSLASPPI 209
             +V E    G LLD I         E+S VL T              ++YLH+     +
Sbjct: 91  VYVVTELMKGGELLDKILRQKFFSEREASAVLFT----------ITKTVEYLHAQG---V 137
Query: 210 IHGDVKSANILLNDNY----TAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTG 265
           +H D+K +NIL  D      + ++ DF  +  +   AE  +      T+ ++ P  +   
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLR--AENGLLMTPCYTANFVAPEVLERQ 195
Query: 266 KLTKKSDVYSFGVVLAELLTGKKP 289
                 D++S GV+L  +LTG  P
Sbjct: 196 GYDAACDIWSLGVLLYTMLTGYTP 219

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/226 (23%), Positives = 93/226 (41%), Gaps = 17/226 (7%)
Query: 96  SQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXX---XSQVNHKNVVKILGLCL 152
           +QG   + Y  +L  N  VA+K   R  +                 VNHKN++ +L +  
Sbjct: 30  AQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT 87
Query: 153 ETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHG 212
             +    + EF     +++ +     QV++      R++      L  +  L S  IIH 
Sbjct: 88  PQKS---LEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHR 144
Query: 213 DVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSD 272
           D+K +NI++  + T K+ DF    L  +   + M T  + T  Y  P  I      +  D
Sbjct: 145 DLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVD 201
Query: 273 VYSFGVVLAELLTGK--KPGSCMTLASNKKISMV----PYFLNSIK 312
           ++S G ++ E++  K   PG       NK I  +    P F+  ++
Sbjct: 202 LWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 247

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 75/158 (47%), Gaps = 20/158 (12%)
Query: 140 NHKNVVKILGLCL------ETEVPLLVYEFASNG--TLLDHIRCESSQVLKTWKTCLRIA 191
            H NVV++  +C       ET++  LV+E       T LD +  E     +T K  +   
Sbjct: 72  EHPNVVRLFDVCTVSRTDRETKL-TLVFEHVDQDLTTYLDKVP-EPGVPTETIKDMM--- 126
Query: 192 AETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILI 251
            +    LD+LHS     ++H D+K  NIL+  +   K+ADF  + + S   + A++++++
Sbjct: 127 FQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYS--FQMALTSVVV 181
Query: 252 GTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
            T  Y  P  +         D++S G + AE+   +KP
Sbjct: 182 -TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKP 217

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 75/158 (47%), Gaps = 20/158 (12%)
Query: 140 NHKNVVKILGLCL------ETEVPLLVYEFASNG--TLLDHIRCESSQVLKTWKTCLRIA 191
            H NVV++  +C       ET++  LV+E       T LD +  E     +T K  +   
Sbjct: 72  EHPNVVRLFDVCTVSRTDRETKL-TLVFEHVDQDLTTYLDKVP-EPGVPTETIKDMM--- 126
Query: 192 AETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILI 251
            +    LD+LHS     ++H D+K  NIL+  +   K+ADF  + + S   + A++++++
Sbjct: 127 FQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYS--FQMALTSVVV 181
Query: 252 GTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
            T  Y  P  +         D++S G + AE+   +KP
Sbjct: 182 -TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKP 217

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 75/158 (47%), Gaps = 20/158 (12%)
Query: 140 NHKNVVKILGLCL------ETEVPLLVYEFASNG--TLLDHIRCESSQVLKTWKTCLRIA 191
            H NVV++  +C       ET++  LV+E       T LD +  E     +T K  +   
Sbjct: 72  EHPNVVRLFDVCTVSRTDRETKL-TLVFEHVDQDLTTYLDKVP-EPGVPTETIKDMM--- 126
Query: 192 AETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILI 251
            +    LD+LHS     ++H D+K  NIL+  +   K+ADF  + + S   + A++++++
Sbjct: 127 FQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYS--FQMALTSVVV 181
Query: 252 GTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
            T  Y  P  +         D++S G + AE+   +KP
Sbjct: 182 -TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKP 217

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 26/98 (26%), Positives = 49/98 (50%), Gaps = 5/98 (5%)
Query: 192 AETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILI 251
           A+  S L++LH      II+ D+K  N+LL+D+   +++D   +V +   A    +    
Sbjct: 296 AQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK--AGQTKTKGYA 350
Query: 252 GTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           GT G++ P  +   +     D ++ GV L E++  + P
Sbjct: 351 GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 26/98 (26%), Positives = 49/98 (50%), Gaps = 5/98 (5%)
Query: 192 AETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILI 251
           A+  S L++LH      II+ D+K  N+LL+D+   +++D   +V +   A    +    
Sbjct: 296 AQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK--AGQTKTKGYA 350
Query: 252 GTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           GT G++ P  +   +     D ++ GV L E++  + P
Sbjct: 351 GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 26/98 (26%), Positives = 49/98 (50%), Gaps = 5/98 (5%)
Query: 192 AETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILI 251
           A+  S L++LH      II+ D+K  N+LL+D+   +++D   +V +   A    +    
Sbjct: 296 AQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK--AGQTKTKGYA 350
Query: 252 GTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           GT G++ P  +   +     D ++ GV L E++  + P
Sbjct: 351 GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 26/98 (26%), Positives = 49/98 (50%), Gaps = 5/98 (5%)
Query: 192 AETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILI 251
           A+  S L++LH      II+ D+K  N+LL+D+   +++D   +V +   A    +    
Sbjct: 296 AQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK--AGQTKTKGYA 350
Query: 252 GTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           GT G++ P  +   +     D ++ GV L E++  + P
Sbjct: 351 GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 37/155 (23%), Positives = 66/155 (42%), Gaps = 9/155 (5%)
Query: 139 VNHKNVVKILGLCLETEVPLLVYEFASNGTL-LDHIRCESSQVLKTWKTCLRIAAETASA 197
           + H ++V++L       +  +V+EF     L  + ++   +  + +         +   A
Sbjct: 83  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142
Query: 198 LDYLHSLASPPIIHGDVKSANILL---NDNYTAKVADFESSVLISSDAETAMSTILIGTS 254
           L Y H      IIH DVK  N+LL    ++   K+ DF  ++ +      A   +  GT 
Sbjct: 143 LRYCHDNN---IIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRV--GTP 197
Query: 255 GYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
            ++ P  +      K  DV+  GV+L  LL+G  P
Sbjct: 198 HFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 46/107 (42%), Gaps = 6/107 (5%)
Query: 201 LHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV 260
           LH L    ++H D+   NILL DN    + DF    L   D   A  T  +    Y  P 
Sbjct: 147 LHVLHEAGVVHRDLHPGNILLADNNDITICDFN---LAREDTADANKTHYVTHRWYRAPE 203
Query: 261 CINTGK-LTKKSDVYSFGVVLAELLTGKK--PGSCMTLASNKKISMV 304
            +   K  TK  D++S G V+AE+   K    GS      NK + +V
Sbjct: 204 LVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVV 250

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 27/103 (26%), Positives = 48/103 (46%), Gaps = 12/103 (11%)
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYL 257
           L+ +H++    I+H D+K AN L+ D    K+ DF  +  +  D  + +    +GT  Y+
Sbjct: 118 LEAVHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 176
Query: 258 DPVCINTGKLTKKS-----------DVYSFGVVLAELLTGKKP 289
            P  I     ++++           DV+S G +L  +  GK P
Sbjct: 177 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 43/100 (43%), Gaps = 10/100 (10%)
Query: 189 RIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTA--KVADFESSVLISSDAETAM 246
           + A      LD LH      IIH D+K  NILL     +  KV DF SS        T +
Sbjct: 204 KFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTXI 260
Query: 247 STILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTG 286
            +       Y  P  I   +     D++S G +LAELLTG
Sbjct: 261 QSRF-----YRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 27/103 (26%), Positives = 48/103 (46%), Gaps = 12/103 (11%)
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYL 257
           L+ +H++    I+H D+K AN L+ D    K+ DF  +  +  D  + +    +GT  Y+
Sbjct: 117 LEAVHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 175
Query: 258 DPVCINTGKLTKKS-----------DVYSFGVVLAELLTGKKP 289
            P  I     ++++           DV+S G +L  +  GK P
Sbjct: 176 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 218

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 46/107 (42%), Gaps = 6/107 (5%)
Query: 201 LHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV 260
           LH L    ++H D+   NILL DN    + DF    L   D   A  T  +    Y  P 
Sbjct: 147 LHVLHEAGVVHRDLHPGNILLADNNDITICDFN---LAREDTADANKTHYVTHRWYRAPE 203
Query: 261 CINTGK-LTKKSDVYSFGVVLAELLTGKK--PGSCMTLASNKKISMV 304
            +   K  TK  D++S G V+AE+   K    GS      NK + +V
Sbjct: 204 LVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVV 250

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 27/103 (26%), Positives = 48/103 (46%), Gaps = 12/103 (11%)
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYL 257
           L+ +H++    I+H D+K AN L+ D    K+ DF  +  +  D  + +    +GT  Y+
Sbjct: 137 LEAVHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 195
Query: 258 DPVCINTGKLTKKS-----------DVYSFGVVLAELLTGKKP 289
            P  I     ++++           DV+S G +L  +  GK P
Sbjct: 196 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 43/100 (43%), Gaps = 10/100 (10%)
Query: 189 RIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTA--KVADFESSVLISSDAETAM 246
           + A      LD LH      IIH D+K  NILL     +  KV DF SS        T +
Sbjct: 204 KFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTXI 260
Query: 247 STILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTG 286
            +       Y  P  I   +     D++S G +LAELLTG
Sbjct: 261 QSRF-----YRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 27/103 (26%), Positives = 48/103 (46%), Gaps = 12/103 (11%)
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYL 257
           L+ +H++    I+H D+K AN L+ D    K+ DF  +  +  D  + +    +GT  Y+
Sbjct: 121 LEAVHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 179
Query: 258 DPVCINTGKLTKKS-----------DVYSFGVVLAELLTGKKP 289
            P  I     ++++           DV+S G +L  +  GK P
Sbjct: 180 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 222

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 27/103 (26%), Positives = 48/103 (46%), Gaps = 12/103 (11%)
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYL 257
           L+ +H++    I+H D+K AN L+ D    K+ DF  +  +  D  + +    +GT  Y+
Sbjct: 165 LEAVHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 223
Query: 258 DPVCINTGKLTKKS-----------DVYSFGVVLAELLTGKKP 289
            P  I     ++++           DV+S G +L  +  GK P
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 27/103 (26%), Positives = 48/103 (46%), Gaps = 12/103 (11%)
Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYL 257
           L+ +H++    I+H D+K AN L+ D    K+ DF  +  +  D  + +    +GT  Y+
Sbjct: 165 LEAVHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 223
Query: 258 DPVCINTGKLTKKS-----------DVYSFGVVLAELLTGKKP 289
            P  I     ++++           DV+S G +L  +  GK P
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 43/100 (43%), Gaps = 10/100 (10%)
Query: 189 RIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTA--KVADFESSVLISSDAETAM 246
           + A      LD LH      IIH D+K  NILL     +  KV DF SS       E   
Sbjct: 204 KFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCY-----EHQR 255
Query: 247 STILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTG 286
               I +  Y  P  I   +     D++S G +LAELLTG
Sbjct: 256 VYXXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 27/105 (25%), Positives = 48/105 (45%), Gaps = 12/105 (11%)
Query: 196 SALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG 255
           + L+ +H++    I+H D+K AN L+ D    K+ DF  +  +  D    +    +GT  
Sbjct: 135 NMLEAVHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDXXXVVKDSQVGTVN 193
Query: 256 YLDPVCINTGKLTKKS-----------DVYSFGVVLAELLTGKKP 289
           Y+ P  I     ++++           DV+S G +L  +  GK P
Sbjct: 194 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 52/226 (23%), Positives = 92/226 (40%), Gaps = 17/226 (7%)
Query: 96  SQGGFVSVYKGVLHDNIQVAVKTYRRADKXXXXXXXXXXX---XSQVNHKNVVKILGLCL 152
           +QG   + Y  +L  N  VA+K   R  +                 VNHKN++ +L +  
Sbjct: 36  AQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT 93
Query: 153 ETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHG 212
             +    + EF     +++ +     QV++      R++      L  +  L S  IIH 
Sbjct: 94  PQKS---LEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHR 150
Query: 213 DVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSD 272
           D+K +NI++  + T K+ DF    L  +   + M    + T  Y  P  I      +  D
Sbjct: 151 DLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMEPEVVTRYYRAPEVILGMGYKENVD 207
Query: 273 VYSFGVVLAELLTGK--KPGSCMTLASNKKISMV----PYFLNSIK 312
           ++S G ++ E++  K   PG       NK I  +    P F+  ++
Sbjct: 208 IWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPAFMKKLQ 253

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	414
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	6e-92
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	4e-82
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	3e-80
3soc_A	322	Activin receptor type-2A; structural genomics cons	4e-59
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-53
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-52
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	4e-49
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	5e-49
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-48
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-48
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-48
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-48
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	8e-47
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-46
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-45
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	3e-45
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-44
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-44
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-37
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	8e-36
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	9e-36
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	3e-35
3pls_A	298	Macrophage-stimulating protein receptor; protein k	4e-35
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	6e-35
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	7e-35
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-34
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-34
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-34
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-34
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-34
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-34
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-34
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-34
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-34
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-34
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	4e-34
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	4e-34
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	6e-34
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	6e-34
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	9e-34
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	9e-34
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-33
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-33
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	4e-33
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	6e-33
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	8e-33
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	8e-33
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-32
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-32
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-32
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-32
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-32
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-32
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-32
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-31
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-31
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	4e-31
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	9e-31
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-30
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-30
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-30
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-30
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-29
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-29
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-29
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-29
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-29
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-29
4aoj_A	329	High affinity nerve growth factor receptor; transf	4e-29
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	6e-29
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-28
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-28
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-28
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-28
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	6e-28
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	8e-28
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-27
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-27
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-27
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	4e-27
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	6e-27
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	7e-27
3ork_A	311	Serine/threonine protein kinase; structural genomi	8e-27
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	3e-26
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-26
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	4e-26
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	7e-26
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	9e-25
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-24
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-24
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-24
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-24
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-24
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-24
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-24
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	4e-24
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	5e-24
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	8e-24
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-23
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-23
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	5e-23
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	7e-23
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	8e-23
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-22
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	7e-04
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-22
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-22
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	4e-22
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	4e-22
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	8e-22
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-21
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-21
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	5e-21
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-20
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	3e-20
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	4e-20
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	5e-20
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	7e-20
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-19
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-19
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-19
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-19
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-19
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-19
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	5e-19
3aln_A	327	Dual specificity mitogen-activated protein kinase;	7e-19
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	7e-19
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-18
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-18
3an0_A	340	Dual specificity mitogen-activated protein kinase;	4e-18
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-17
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	4e-17
3fme_A	290	Dual specificity mitogen-activated protein kinase;	4e-17
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	4e-17
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	8e-17
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	8e-17
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	9e-17
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-16
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-16
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-16
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-16
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-16
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-16
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-16
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	3e-16
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-16
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-16
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-16
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-16
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	4e-16
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	4e-16
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	5e-16
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	5e-16
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	7e-16
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	9e-16
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-15
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-15
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-15
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-15
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-15
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	3e-15
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-15
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-15
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	4e-15
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	5e-15
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	6e-15
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	7e-15
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	7e-15
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-14
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-14
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-14
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-14
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-14
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-14
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	7e-14
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	9e-14
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-13
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-13
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-13
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-13
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	3e-13
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	4e-13
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	4e-13
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	6e-13
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-12
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-12
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-12
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-12
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-12
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-12
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-12
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-12
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-06
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-12
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-12
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-12
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-12
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	3e-12
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	8e-12
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-11
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-11
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-11
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	4e-11
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	5e-11
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	6e-11
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	6e-11
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	7e-11
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-10
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-10
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-10
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-10
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-10
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-10
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-10
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-10
3o0g_A	292	Cell division protein kinase 5; kinase activator c	3e-10
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	4e-10
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	4e-10
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	5e-10
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	6e-10
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	6e-10
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	8e-10
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	9e-10
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-09
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-09
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	5e-09
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	5e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	5e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	7e-08
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	6e-09
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	3e-08
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	3e-08
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-08
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	6e-08
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-07
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	4e-07
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	6e-07
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	8e-07
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	3e-05
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	5e-05

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  279 bits (715), Expect = 6e-92
 Identities = 105/330 (31%), Positives = 161/330 (48%), Gaps = 16/330 (4%)

Query: 46  ISSAVRRGRGGRDPGPTIYSHPGLAFLRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYK 105
           + S   +     +      S   L           ++  AT NFD    +  G F  VYK
Sbjct: 1   MGSKYSKATNSINDAL---SSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYK 57

Query: 106 GVLHDNIQVAVKTYRRADK--IR--ITERELLRIISQVNHKNVVKILGLCLETEVPLLVY 161
           GVL D  +VA+K         I    TE E L   S   H ++V ++G C E    +L+Y
Sbjct: 58  GVLRDGAKVALKRRTPESSQGIEEFETEIETL---SFCRHPHLVSLIGFCDERNEMILIY 114

Query: 162 EFASNGTLLDHIRCESSQVLK-TWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANIL 220
           ++  NG L  H+       +  +W+  L I    A  L YLH+     IIH DVKS NIL
Sbjct: 115 KYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINIL 171

Query: 221 LNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVL 280
           L++N+  K+ DF  S   +   +T +ST++ GT GY+DP     G+LT+KSDVYSFGVVL
Sbjct: 172 LDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVL 231

Query: 281 AELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELA 340
            E+L  +     +     + +++  + + S  N  L QI++ ++AD+   + +    + A
Sbjct: 232 FEVLCARSA--IVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTA 289

Query: 341 SKCLRIRGTERPTMKQVSEELDRLRRLHEN 370
            KCL +   +RP+M  V  +L+   RL E+
Sbjct: 290 VKCLALSSEDRPSMGDVLWKLEYALRLQES 319

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  254 bits (650), Expect = 4e-82
 Identities = 94/296 (31%), Positives = 157/296 (53%), Gaps = 6/296 (2%)

Query: 66  HPGLAFLRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKI 125
            P +   ++K FS  E+  A+ NF     L +GGF  VYKG L D   VAVK  +     
Sbjct: 9   DPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ 68

Query: 126 RITERELLR---IISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLK 182
              E +      +IS   H+N++++ G C+     LLVY + +NG++   +R        
Sbjct: 69  G-GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPP 127

Query: 183 -TWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD 241
             W    RIA  +A  L YLH    P IIH DVK+ANILL++ + A V DF  + L+   
Sbjct: 128 LDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM-DY 186

Query: 242 AETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKI 301
            +T ++T + GT G++ P  ++TGK ++K+DV+ +GV+L EL+TG++      LA++  +
Sbjct: 187 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 246

Query: 302 SMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQV 357
            ++ +    +K   L  +++  +    + +E+E + ++A  C +    ERP M +V
Sbjct: 247 MLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEV 302

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  248 bits (636), Expect = 3e-80
 Identities = 89/311 (28%), Positives = 154/311 (49%), Gaps = 36/311 (11%)

Query: 73  RMKIFSKSEMIRATKNFDRSRC------LSQGGFVSVYKGVLHDNIQVAVKTYRRADKIR 126
           R   FS  E+   T NFD          + +GGF  VYKG + +N  VAVK       I 
Sbjct: 11  RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDIT 69

Query: 127 IT--ERELL---RIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVL 181
               +++     +++++  H+N+V++LG   + +   LVY +  NG+LLD + C      
Sbjct: 70  TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP 129

Query: 182 KTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD 241
            +W    +IA   A+ +++LH       IH D+KSANILL++ +TAK++DF  +      
Sbjct: 130 LSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKF 186

Query: 242 AETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKI 301
           A+T M++ ++GT+ Y+ P  +  G++T KSD+YSFGVVL E++TG            +  
Sbjct: 187 AQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVD----EHREPQ 241

Query: 302 SMV----PYFLNSIKNNGLRQILNFHVAD----ESEMKEIEIVAELASKCLRIRGTERPT 353
            ++               +         D    +++   +E +  +AS+CL  +  +RP 
Sbjct: 242 LLLDIKEEIEDE---EKTIEDY-----IDKKMNDADSTSVEAMYSVASQCLHEKKNKRPD 293

Query: 354 MKQVSEELDRL 364
           +K+V + L  +
Sbjct: 294 IKKVQQLLQEM 304

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  194 bits (495), Expect = 4e-59
 Identities = 68/316 (21%), Positives = 122/316 (38%), Gaps = 33/316 (10%)

Query: 77  FSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITEREL-LRI 135
                +   +         ++G F  V+K  L +   VAVK +   DK +  + E  +  
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNE-YVAVKIFPIQDK-QSWQNEYEVYS 71

Query: 136 ISQVNHKNVVKILGLCLETEVP----LLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIA 191
           +  + H+N+++ +G             L+  F   G+L D ++   + V+ +W     IA
Sbjct: 72  LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK---ANVV-SWNELCHIA 127

Query: 192 AETASALDYLHS-------LASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET 244
              A  L YLH           P I H D+KS N+LL +N TA +ADF  ++   +    
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187

Query: 245 AMSTILIGTSGYLDP-----VCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMT----L 295
             +   +GT  Y+ P               + D+Y+ G+VL EL +             L
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247

Query: 296 ASNKKISMVPYFLNSIK---NNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERP 352
              ++I   P   +  +   +   R +L  +    + M  +    E   +C       R 
Sbjct: 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAML---CETIEECWDHDAEARL 304

Query: 353 TMKQVSEELDRLRRLH 368
           +   V E + +++RL 
Sbjct: 305 SAGCVGERITQMQRLT 320

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  179 bits (457), Expect = 1e-53
 Identities = 72/273 (26%), Positives = 124/273 (45%), Gaps = 24/273 (8%)

Query: 97  QGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLR---IISQVNHKNVVKILGLCLE 153
            G F +V++   H    VAVK     D       E LR   I+ ++ H N+V  +G   +
Sbjct: 47  AGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ 105

Query: 154 TEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGD 213
                +V E+ S G+L   +    ++     +  L +A + A  ++YLH+  +PPI+H +
Sbjct: 106 PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRN 164

Query: 214 VKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDV 273
           +KS N+L++  YT KV DF  S L +S   ++ S    GT  ++ P  +      +KSDV
Sbjct: 165 LKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA--GTPEWMAPEVLRDEPSNEKSDV 222

Query: 274 YSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEI 333
           YSFGV+L EL T ++P   +     + ++ V            R  +  ++  +      
Sbjct: 223 YSFGVILWELATLQQPWGNLN--PAQVVAAVG-------FKCKRLEIPRNLNPQ------ 267

Query: 334 EIVAELASKCLRIRGTERPTMKQVSEELDRLRR 366
             VA +   C      +RP+   + + L  L +
Sbjct: 268 --VAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  177 bits (451), Expect = 1e-52
 Identities = 69/274 (25%), Positives = 125/274 (45%), Gaps = 28/274 (10%)

Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLET 154
           + +G F  V K        VA+K      + +    EL R +S+VNH N+VK+ G CL  
Sbjct: 16  VGRGAFGVVCKAKWR-AKDVAIKQIESESERKAFIVEL-RQLSRVNHPNIVKLYGACLN- 72

Query: 155 EVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGD 213
             P+ LV E+A  G+L + +         T    +    + +  + YLHS+    +IH D
Sbjct: 73  --PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130

Query: 214 VKSANILLNDNYT-AKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSD 272
           +K  N+LL    T  K+ DF ++  I +       T   G++ ++ P        ++K D
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTACDIQT-----HMTNNKGSAAWMAPEVFEGSNYSEKCD 185

Query: 273 VYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKE 332
           V+S+G++L E++T +KP          +I    + +    +NG R  L  ++        
Sbjct: 186 VFSWGIILWEVITRRKP--------FDEIGGPAFRIMWAVHNGTRPPLIKNLPKP----- 232

Query: 333 IEIVAELASKCLRIRGTERPTMKQVSEELDRLRR 366
              +  L ++C     ++RP+M+++ + +  L R
Sbjct: 233 ---IESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  167 bits (425), Expect = 4e-49
 Identities = 77/287 (26%), Positives = 127/287 (44%), Gaps = 43/287 (14%)

Query: 95  LSQGGFVSVYKGV-LHDNIQVAVKTYRR---------ADKIRITERELLRIISQVNHKNV 144
           + +GGF  V+KG  + D   VA+K+             +K +  +RE+  I+S +NH N+
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREV-FIMSNLNHPNI 85

Query: 145 VKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSL 204
           VK+ GL      P +V EF   G L   +  ++  +   W   LR+  + A  ++Y+ + 
Sbjct: 86  VKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHPI--KWSVKLRLMLDIALGIEYMQNQ 141

Query: 205 ASPPIIHGDVKSANILL-----NDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDP 259
            +PPI+H D++S NI L     N    AKVADF  S            + L+G   ++ P
Sbjct: 142 -NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----SVHSVSGLLGNFQWMAP 195

Query: 260 VCINTGKL--TKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLR 317
             I   +   T+K+D YSF ++L  +LTG+ P    +    K I+M+       +  GLR
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI-------REEGLR 248

Query: 318 QILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL 364
             +               +  +   C      +RP    + +EL  L
Sbjct: 249 PTIPEDCPPR--------LRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  167 bits (426), Expect = 5e-49
 Identities = 62/290 (21%), Positives = 107/290 (36%), Gaps = 42/290 (14%)

Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLR---IISQVNHKNVVKILGLC 151
           + +G F  VY G  H   +VA++            +   R      Q  H+NVV  +G C
Sbjct: 41  IGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98

Query: 152 LETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIH 211
           +      ++       TL   +R     +        +IA E    + YLH+     I+H
Sbjct: 99  MSPPHLAIITSLCKGRTLYSVVRDAKIVL--DVNKTRQIAQEIVKGMGYLHA---KGILH 153

Query: 212 GDVKSANILLNDNYTAKVADF----ESSVLISSDAETAMSTILIGTSGYLDPVCINTGKL 267
            D+KS N+   DN    + DF     S VL +   E  +  I  G   +L P  I     
Sbjct: 154 KDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKL-RIQNGWLCHLAPEIIRQLSP 211

Query: 268 ---------TKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQ 318
                    +K SDV++ G +  EL   + P       +   I  +          G++ 
Sbjct: 212 DTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA--IIWQM--------GTGMKP 261

Query: 319 ILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLH 368
            L+     +        ++++   C      ERPT  ++ + L++L + +
Sbjct: 262 NLSQIGMGKE-------ISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  165 bits (421), Expect = 1e-48
 Identities = 71/279 (25%), Positives = 127/279 (45%), Gaps = 29/279 (10%)

Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLR---IISQVNHKNVVKILGLC 151
           +  G F +VYKG  H    VAVK            +       ++ +  H N++  +G  
Sbjct: 32  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89

Query: 152 LETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPII 210
             T   L +V ++    +L  H+    ++     K  + IA +TA  +DYLH+     II
Sbjct: 90  --TAPQLAIVTQWCEGSSLYHHLHASETKF--EMKKLIDIARQTARGMDYLHA---KSII 142

Query: 211 HGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCI---NTGKL 267
           H D+KS NI L+++ T K+ DF  +   S  + +     L G+  ++ P  I   ++   
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202

Query: 268 TKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADE 327
           + +SDVY+FG+VL EL+TG+ P S +              +  +    L   L+   ++ 
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--------IIEMVGRGSLSPDLSKVRSNC 254

Query: 328 SEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR 366
            +      +  L ++CL+ +  ERP+  ++  E++ L R
Sbjct: 255 PKR-----MKRLMAECLKKKRDERPSFPRILAEIEELAR 288

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  165 bits (419), Expect = 2e-48
 Identities = 52/280 (18%), Positives = 115/280 (41%), Gaps = 35/280 (12%)

Query: 95  LSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLR---IISQVNHKNVVKILGLC 151
           L++     ++KG    N  + VK  +  D      R+       +   +H NV+ +LG C
Sbjct: 18  LNENHSGELWKGRWQGND-IVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76

Query: 152 LETEVPLL--VYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPI 209
                P    +  +   G+L + +   ++ V+      ++ A + A  + +LH+L  P I
Sbjct: 77  QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVV-DQSQAVKFALDMARGMAFLHTL-EPLI 134

Query: 210 IHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCIN---TGK 266
               + S +++++++ TA+++  +      S               ++ P  +       
Sbjct: 135 PRHALNSRSVMIDEDMTARISMADVKFSFQSPGRM-------YAPAWVAPEALQKKPEDT 187

Query: 267 LTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVAD 326
             + +D++SF V+L EL+T + P + +   SN +I M       +   GLR  +   ++ 
Sbjct: 188 NRRSADMWSFAVLLWELVTREVPFADL---SNMEIGM------KVALEGLRPTIPPGISP 238

Query: 327 ESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR 366
                    V++L   C+     +RP    +   L++++ 
Sbjct: 239 H--------VSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  167 bits (424), Expect = 2e-48
 Identities = 69/328 (21%), Positives = 123/328 (37%), Gaps = 42/328 (12%)

Query: 77  FSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIR-ITERELLRI 135
            + SE      N      + +G + +VYKG L +   VAVK +  A++   I E+ + R+
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDER-PVAVKVFSFANRQNFINEKNIYRV 61

Query: 136 ISQVNHKNVVKILGLCLETEVP-----LLVYEFASNGTLLDHIRCESSQVLKTWKTCLRI 190
              + H N+ + +              LLV E+  NG+L  ++   +S     W +  R+
Sbjct: 62  -PLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS----DWVSSCRL 116

Query: 191 AAETASALDYLHS------LASPPIIHGDVKSANILLNDNYTAKVADF------ESSVLI 238
           A      L YLH+         P I H D+ S N+L+ ++ T  ++DF        + L+
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176

Query: 239 SSDAETAMSTILIGTSGYLDP-------VCINTGKLTKKSDVYSFGVVLAELLTGKK--- 288
               E   +   +GT  Y+ P          +     K+ D+Y+ G++  E+        
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236

Query: 289 PGSCMT---LASNKKISMVPYFLNSIK---NNGLRQILNFHVADESEMKEIEIVAELASK 342
           PG  +    +A   ++   P F +          R        + S    +  + E    
Sbjct: 237 PGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLA--VRSLKETIED 294

Query: 343 CLRIRGTERPTMKQVSEELDRLRRLHEN 370
           C       R T +   E +  L  + E 
Sbjct: 295 CWDQDAEARLTAQXAEERMAELMMIWER 322

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  165 bits (419), Expect = 2e-48
 Identities = 71/290 (24%), Positives = 114/290 (39%), Gaps = 49/290 (16%)

Query: 93  RCLSQGGFVSVYKGVLHDNIQVAVKTYRRA--DKIRITERELLR---IISQVNHKNVVKI 147
             +  GGF  VY+       +VAVK  R    + I  T   + +   + + + H N++ +
Sbjct: 13  EIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71

Query: 148 LGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASP 207
            G+CL+     LV EFA  G L   +  +           +  A + A  ++YLH  A  
Sbjct: 72  RGVCLKEPNLCLVMEFARGGPLNRVLSGKR----IPPDILVNWAVQIARGMNYLHDEAIV 127

Query: 208 PIIHGDVKSANILLN--------DNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDP 259
           PIIH D+KS+NIL+          N   K+ DF  +       + +      G   ++ P
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA----AGAYAWMAP 183

Query: 260 VCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQI 319
             I     +K SDV+S+GV+L ELLTG+ P   +                         +
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL---------------------AV 222

Query: 320 LNFHVADESEMKEI-----EIVAELASKCLRIRGTERPTMKQVSEELDRL 364
             + VA       I     E  A+L   C       RP+   + ++L  +
Sbjct: 223 A-YGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  162 bits (413), Expect = 8e-47
 Identities = 64/301 (21%), Positives = 124/301 (41%), Gaps = 33/301 (10%)

Query: 93  RCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKI-RITERELLRIISQVNHKNVVKILGLC 151
           + + +G +  V+ G      +VAVK +   ++     E E+      + H+N++  +   
Sbjct: 43  KQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRETEIY-QTVLMRHENILGFIAAD 100

Query: 152 LETEVP----LLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLAS- 206
           ++         L+ ++  NG+L D+++   S  L   K+ L++A  + S L +LH+    
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYLK---STTL-DAKSMLKLAYSSVSGLCHLHTEIFS 156

Query: 207 ----PPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETA--MSTILIGTSGYLDP- 259
               P I H D+KS NIL+  N T  +AD   +V   SD           +GT  Y+ P 
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE 216

Query: 260 -----VCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPY------FL 308
                +  N  +    +D+YSFG++L E+      G  +         +VP         
Sbjct: 217 VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMR 276

Query: 309 NSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLH 368
             +    LR       + +  ++++    +L ++C       R T  +V + L ++    
Sbjct: 277 EIVCIKKLRPSFPNRWSSDECLRQM---GKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333

Query: 369 E 369
           +
Sbjct: 334 D 334

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  157 bits (400), Expect = 2e-45
 Identities = 61/302 (20%), Positives = 118/302 (39%), Gaps = 45/302 (14%)

Query: 93  RCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIR-ITERELLRIISQVNHKNVVKILGLC 151
            C+ +G +  V++G       VAVK +   D+     E EL      + H+N++  +   
Sbjct: 14  ECVGKGRYGEVWRGSWQGE-NVAVKIFSSRDEKSWFRETELY-NTVMLRHENILGFIASD 71

Query: 152 LETEVP----LLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLAS- 206
           + +        L+  +   G+L D+++      L    +CLRI    AS L +LH     
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQ---LTTL-DTVSCLRIVLSIASGLAHLHIEIFG 127

Query: 207 ----PPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET--AMSTILIGTSGYLDP- 259
               P I H D+KS NIL+  N    +AD   +V+ S         +   +GT  Y+ P 
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187

Query: 260 -----VCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYF------- 307
                + ++     K+ D+++FG+VL E+         +      +    P++       
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV------EDYKPPFYDVVPNDP 241

Query: 308 -----LNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELD 362
                   +  +  R  +      +  +  +   A+L  +C     + R T  ++ + L 
Sbjct: 242 SFEDMRKVVCVDQQRPNIPNRWFSDPTLTSL---AKLMKECWYQNPSARLTALRIKKTLT 298

Query: 363 RL 364
           ++
Sbjct: 299 KI 300

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  156 bits (395), Expect = 3e-44
 Identities = 64/297 (21%), Positives = 120/297 (40%), Gaps = 33/297 (11%)

Query: 94  CLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIR-ITERELLRIISQVNHKNVVKILGLCL 152
            + +G F  V++G      +VAVK +   ++     E E+      + H+N++  +    
Sbjct: 49  SIGKGRFGEVWRGKWRGE-EVAVKIFSSREERSWFREAEI-YQTVMLRHENILGFIAADN 106

Query: 153 ETEVP----LLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHS----- 203
           +         LV ++  +G+L D++   +     T +  +++A  TAS L +LH      
Sbjct: 107 KDNGTWTQLWLVSDYHEHGSLFDYLNRYTV----TVEGMIKLALSTASGLAHLHMEIVGT 162

Query: 204 LASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETA--MSTILIGTSGYLDP-- 259
              P I H D+KS NIL+  N T  +AD   +V   S  +T        +GT  Y+ P  
Sbjct: 163 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 222

Query: 260 ----VCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMT---LASNKKISMVPYFLNSIK 312
               + +   +  K++D+Y+ G+V  E+      G       L     +   P      K
Sbjct: 223 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 282

Query: 313 ---NNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR 366
                 LR  +         ++ +   A++  +C    G  R T  ++ + L +L +
Sbjct: 283 VVCEQKLRPNIPNRWQSCEALRVM---AKIMRECWYANGAARLTALRIKKTLSQLSQ 336

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  155 bits (393), Expect = 3e-44
 Identities = 63/288 (21%), Positives = 112/288 (38%), Gaps = 39/288 (13%)

Query: 95  LSQGGFVSVYKGVLHDNIQ-VAVKTYRRADKIRITERELLR---IISQVNHKNVVKILGL 150
           L +G F    K    +  + + +K   R D+   T+R  L+   ++  + H NV+K +G+
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEE--TQRTFLKEVKVMRCLEHPNVLKFIGV 75

Query: 151 CLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPII 210
             + +    + E+   GTL   I+   SQ    W   +  A + AS + YLHS+    II
Sbjct: 76  LYKDKRLNFITEYIKGGTLRGIIKSMDSQY--PWSQRVSFAKDIASGMAYLHSM---NII 130

Query: 211 HGDVKSANILLNDNYTAKVADFESSVLISSDAETA------------MSTILIGTSGYLD 258
           H D+ S N L+ +N    VADF  + L+  +                    ++G   ++ 
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190

Query: 259 PVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQ 318
           P  IN     +K DV+SFG+VL E++                  +            L +
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYL-PRTMDFGLN-------VRGFLDR 242

Query: 319 ILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR 366
               +               +  +C  +   +RP+  ++   L+ LR 
Sbjct: 243 YCPPNCPPS--------FFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  138 bits (351), Expect = 2e-37
 Identities = 71/292 (24%), Positives = 125/292 (42%), Gaps = 51/292 (17%)

Query: 93  RCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRITERELL---RIISQVNHKNVVKIL 148
             + +G F  V+ G L  DN  VAVK+ R        + + L   RI+ Q +H N+V+++
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCR-ETLPPDLKAKFLQEARILKQYSHPNIVRLI 178

Query: 149 GLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPP 208
           G+C + +   +V E    G  L  +R E +++    KT L++  + A+ ++YL S     
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGARL--RVKTLLQMVGDAAAGMEYLESK---C 233

Query: 209 IIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV------CI 262
            IH D+ + N L+ +    K++DF  S   +     A      G    + PV       +
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAAS-----GGLRQV-PVKWTAPEAL 287

Query: 263 NTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLAS-NKKISMVPYFLNSIKNNGLRQIL 320
           N G+ + +SDV+SFG++L E  + G  P   ++     + +             G R   
Sbjct: 288 NYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE-----------KGGR--- 333

Query: 321 NFHVADESEMKEIE----IVAELASKCLRIRGTERPTMKQVSEELDRLRRLH 368
                    +   E     V  L  +C      +RP+   + +EL  +R+ H
Sbjct: 334 ---------LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH 376

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  133 bits (336), Expect = 8e-36
 Identities = 67/293 (22%), Positives = 123/293 (41%), Gaps = 54/293 (18%)

Query: 93  RCLSQGGFVSVYKGVLHD-----NIQVAVKTYRRADKIRITERELLR---IISQVNHKNV 144
           + L  G F +VYKG+         I VA+K  R         +E+L    +++ V++ +V
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHV 79

Query: 145 VKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSL 204
            ++LG+CL + V  L+ +    G LLD++R     +    +  L    + A  ++YL   
Sbjct: 80  CRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNI--GSQYLLNWCVQIAKGMNYLEDR 136

Query: 205 ASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV---- 260
               ++H D+ + N+L+      K+ DF  + L+ ++ +           G   P+    
Sbjct: 137 R---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH------AEGGKVPIKWMA 187

Query: 261 --CINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLR 317
              I     T +SDV+S+GV + EL+T G KP   +      +I       + ++  G R
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI---PASEI------SSILE-KGER 237

Query: 318 QILNFHVADESEMKEIEI----VAELASKCLRIRGTERPTMKQVSEELDRLRR 366
                       + +  I    V  +  KC  I    RP  +++  E  ++ R
Sbjct: 238 ------------LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  133 bits (336), Expect = 9e-36
 Identities = 71/338 (21%), Positives = 138/338 (40%), Gaps = 56/338 (16%)

Query: 93  RCLSQGGFVSVYKGVLHD-----NIQVAVKTYRRADKIRITERELLR---IISQVNHKNV 144
           + L  G F +VYKG+         I VA+K  R         +E+L    +++ V++ +V
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHV 79

Query: 145 VKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSL 204
            ++LG+CL      L+ +    G LLD++R     +    +  L    + A  ++YL   
Sbjct: 80  CRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNI--GSQYLLNWCVQIAKGMNYLEDR 136

Query: 205 ASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV---- 260
               ++H D+ + N+L+      K+ DF  + L+ ++ +           G   P+    
Sbjct: 137 R---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH------AEGGKVPIKWMA 187

Query: 261 --CINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLR 317
              I     T +SDV+S+GV + EL+T G KP   +      +I       + ++  G R
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI---PASEI------SSILE-KGER 237

Query: 318 QILNFHVADESEMKEIEI----VAELASKCLRIRGTERPTMKQVSEELDRLRRLHENFWA 373
                       + +  I    V  +  KC  I    RP  +++  E  ++ R  + +  
Sbjct: 238 ------------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLV 285

Query: 374 QKKNKETEHLLGESSSYATAVIAQPDAQTVVSIDIENY 411
            + ++         S++  A++ + D      +D + Y
Sbjct: 286 IQGDERMHLPSPTDSNFYRALMDEEDMDD--VVDADEY 321

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  130 bits (328), Expect = 3e-35
 Identities = 51/207 (24%), Positives = 92/207 (44%), Gaps = 25/207 (12%)

Query: 93  RCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLR---IISQVNHKNVVKILG 149
           + L  G F  V  G       VAVK  +      ++E E  +    + +++H  +VK  G
Sbjct: 14  KELGSGQFGVVKLGKWKGQYDVAVKMIKEGS---MSEDEFFQEAQTMMKLSHPKLVKFYG 70

Query: 150 LCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPI 209
           +C +     +V E+ SNG LL+++R     +       L +  +    + +   L S   
Sbjct: 71  VCSKEYPIYIVTEYISNGCLLNYLRSHGKGL--EPSQLLEMCYDVCEGMAF---LESHQF 125

Query: 210 IHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV------CIN 263
           IH D+ + N L++ +   KV+DF  +  +  D   +       + G   PV        +
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS-------SVGTKFPVKWSAPEVFH 178

Query: 264 TGKLTKKSDVYSFGVVLAELLT-GKKP 289
             K + KSDV++FG+++ E+ + GK P
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFSLGKMP 205

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  130 bits (329), Expect = 4e-35
 Identities = 64/212 (30%), Positives = 102/212 (48%), Gaps = 25/212 (11%)

Query: 93  RCLSQGGFVSVYKGVLHD----NIQVAVKTYRRADKIRITERELLR---IISQVNHKNVV 145
           R + +G F  VY G   D     IQ A+K+  R  +++      LR   ++  +NH NV+
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQ-QVEAFLREGLLMRGLNHPNVL 85

Query: 146 KILGLCLETE-VPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSL 204
            ++G+ L  E +P ++  +  +G LL  IR        T K  +    + A  ++YL   
Sbjct: 86  ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNP--TVKDLISFGLQVARGMEYL--- 140

Query: 205 ASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV---- 260
           A    +H D+ + N +L++++T KVADF  +  I      ++          L PV    
Sbjct: 141 AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQ---HRHARL-PVKWTA 196

Query: 261 --CINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
              + T + T KSDV+SFGV+L ELLT G  P
Sbjct: 197 LESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  130 bits (328), Expect = 6e-35
 Identities = 63/307 (20%), Positives = 120/307 (39%), Gaps = 51/307 (16%)

Query: 89  FDRS-----RCLSQGGFVSVYKGVLH-----DNIQVAVKTYRRADKIRITERELLR---I 135
           F+       + L +G F SV               VAVK  + + +     R+  R   I
Sbjct: 7   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEI 64

Query: 136 ISQVNHKNVVKILGLCLET-EVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAE 193
           +  + H N+VK  G+C       L L+ E+   G+L D+++    ++       L+  ++
Sbjct: 65  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQ 122

Query: 194 TASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGT 253
               ++YL +      IH D+ + NIL+ +    K+ DF  + ++  D E          
Sbjct: 123 ICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVK----E 175

Query: 254 SGYLDPV------CINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYF 307
            G   P+       +   K +  SDV+SFGVVL EL T  +          + I      
Sbjct: 176 PGES-PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG 234

Query: 308 LNSIKNNGLRQILNFHVADESEMKEI--------EIVAELASKCLRIRGTERPTMKQVSE 359
                     Q++ FH+ +  +            + +  + ++C      +RP+ + ++ 
Sbjct: 235 ----------QMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284

Query: 360 ELDRLRR 366
            +D++R 
Sbjct: 285 RVDQIRD 291

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  133 bits (336), Expect = 7e-35
 Identities = 62/208 (29%), Positives = 108/208 (51%), Gaps = 15/208 (7%)

Query: 93  RCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELL---RIISQVNHKNVVKILG 149
             L QG F  V+ G  +   +VA+KT +      ++    L   +++ ++ H+ +V++  
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYA 246

Query: 150 LCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPP 208
           +   +E P+ +V E+ S G+LLD ++ E+ + L      + +AA+ AS + Y+  +    
Sbjct: 247 VV--SEEPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVERMN--- 300

Query: 209 IIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLT 268
            +H D+++ANIL+ +N   KVADF  + LI  +  TA          +  P     G+ T
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFT 359

Query: 269 KKSDVYSFGVVLAELLT-GKKPGSCMTL 295
            KSDV+SFG++L EL T G+ P   M  
Sbjct: 360 IKSDVWSFGILLTELTTKGRVPYPGMVN 387

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  129 bits (327), Expect = 1e-34
 Identities = 68/313 (21%), Positives = 121/313 (38%), Gaps = 63/313 (20%)

Query: 89  FDRS-----RCLSQGGFVSVYKGVLH-----DNIQVAVKTYRRADKIRITERELLR---I 135
           F++      R L +G F  V              QVAVK+ +  +       +L +   I
Sbjct: 18  FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK-PESGGNHIADLKKEIEI 76

Query: 136 ISQVNHKNVVKILGLCLETEV-PL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAE 193
           +  + H+N+VK  G+C E     + L+ EF  +G+L +++    +++    K  L+ A +
Sbjct: 77  LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKI--NLKQQLKYAVQ 134

Query: 194 TASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGT 253
               +DYL S      +H D+ + N+L+   +  K+ DF  +  I +D E          
Sbjct: 135 ICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVK----D 187

Query: 254 SGYLDPV------CINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPY 306
                PV      C+   K    SDV+SFGV L ELLT          +A   K+    +
Sbjct: 188 DRDS-PVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSD--SSPMALFLKMIGPTH 244

Query: 307 FLNSIKNNGLRQILNFHVADESEMKEIE-------------IVAELASKCLRIRGTERPT 353
                      Q+    +     +  ++              V +L  KC   + + R +
Sbjct: 245 ----------GQMTVTRL-----VNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTS 289

Query: 354 MKQVSEELDRLRR 366
            + + E  + L +
Sbjct: 290 FQNLIEGFEALLK 302

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  128 bits (324), Expect = 1e-34
 Identities = 55/207 (26%), Positives = 101/207 (48%), Gaps = 25/207 (12%)

Query: 93  RCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLR---IISQVNHKNVVKILG 149
           + +  G F  V+ G   +  +VA+KT R      ++E + +    ++ +++H  +V++ G
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYG 70

Query: 150 LCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPI 209
           +CLE     LV EF  +G L D++R +        +T L +  +    + Y   L    +
Sbjct: 71  VCLEQAPICLVTEFMEHGCLSDYLRTQRGLF--AAETLLGMCLDVCEGMAY---LEEACV 125

Query: 210 IHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV------CIN 263
           IH D+ + N L+ +N   KV+DF  +  +  D  T+       ++G   PV        +
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-------STGTKFPVKWASPEVFS 178

Query: 264 TGKLTKKSDVYSFGVVLAELLT-GKKP 289
             + + KSDV+SFGV++ E+ + GK P
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFSEGKIP 205

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  133 bits (337), Expect = 1e-34
 Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 27/214 (12%)

Query: 93  RCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELL---RIISQVNHKNVVKILG 149
             L QG F  V+ G  +   +VA+KT +      ++    L   +++ ++ H+ +V++  
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYA 329

Query: 150 LCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPP 208
           +   +E P+ +V E+ S G+LLD ++ E+ + L      + +AA+ AS + Y+  +    
Sbjct: 330 VV--SEEPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVERMN--- 383

Query: 209 IIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV------CI 262
            +H D+++ANIL+ +N   KVADF  + LI  +  TA             P+        
Sbjct: 384 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-------PIKWTAPEAA 436

Query: 263 NTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTL 295
             G+ T KSDV+SFG++L EL T G+ P   M  
Sbjct: 437 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 470

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  129 bits (327), Expect = 1e-34
 Identities = 68/335 (20%), Positives = 119/335 (35%), Gaps = 57/335 (17%)

Query: 89  FDRS-----RCLSQGGFVSVYKGVLH-----DNIQVAVKTYRRADKIRITERELLR---I 135
           F+         L +G F SV               VAVK  + +      +R+  R   I
Sbjct: 20  FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPD--QQRDFQREIQI 77

Query: 136 ISQVNHKNVVKILGLCLET-EVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAE 193
           +  ++   +VK  G+        L LV E+  +G L D ++   +++       L  +++
Sbjct: 78  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARL--DASRLLLYSSQ 135

Query: 194 TASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGT 253
               ++YL S      +H D+ + NIL+      K+ADF  + L+  D +  +       
Sbjct: 136 ICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVR----E 188

Query: 254 SGYLDPV------CINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPY 306
            G   P+       ++    +++SDV+SFGVVL EL T   K  S               
Sbjct: 189 PGQS-PIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERD- 246

Query: 307 FLNSIKNNGLRQILNFHVADESEMKEI--------EIVAELASKCLRIRGTERPTMKQVS 358
                            + +  E  +           V EL   C      +RP+   + 
Sbjct: 247 -----------VPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALG 295

Query: 359 EELDRLRRLHENFWAQKKNKETEHLLGESSSYATA 393
            +LD L          + +  T H  G+  S + +
Sbjct: 296 PQLDMLWSGSRG---CETHAFTAHPEGKHHSLSFS 327

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  132 bits (333), Expect = 2e-34
 Identities = 54/208 (25%), Positives = 100/208 (48%), Gaps = 27/208 (12%)

Query: 93  RCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLR---IISQVNHKNVVKILG 149
           + L  G F  V+    + + +VAVKT +      ++    L    ++  + H  +VK+  
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHA 250

Query: 150 LCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPP 208
           +   T+ P+ ++ EF + G+LLD ++ +           +  +A+ A  + ++       
Sbjct: 251 VV--TKEPIYIITEFMAKGSLLDFLKSDEGSKQ-PLPKLIDFSAQIAEGMAFI---EQRN 304

Query: 209 IIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV------CI 262
            IH D+++ANIL++ +   K+ADF  + +I  +  TA             P+       I
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF-------PIKWTAPEAI 357

Query: 263 NTGKLTKKSDVYSFGVVLAELLT-GKKP 289
           N G  T KSDV+SFG++L E++T G+ P
Sbjct: 358 NFGSFTIKSDVWSFGILLMEIVTYGRIP 385

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  129 bits (327), Expect = 2e-34
 Identities = 61/243 (25%), Positives = 107/243 (44%), Gaps = 31/243 (12%)

Query: 61  PTIYSHPGLAFLRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVL----HDNIQVAV 116
           P  Y  PG A      F++ E+          + +  G    V  G L      ++ VA+
Sbjct: 29  PHTYEEPGRAGRS---FTR-EIEA--SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAI 82

Query: 117 KTYRRADKIRITERELLR---IISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHI 173
           K  + A       R+ L    I+ Q +H N++++ G+     + ++V E+  NG+L   +
Sbjct: 83  KALK-AGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL 141

Query: 174 RCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFE 233
           R    Q   T    + +     + + YL  L     +H D+ + N+L++ N   KV+DF 
Sbjct: 142 RTHDGQF--TIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFG 196

Query: 234 SSVLISSDAETAMSTILIGTSGYLDPV------CINTGKLTKKSDVYSFGVVLAELLT-G 286
            S ++  D + A +     T+G   P+       I     +  SDV+SFGVV+ E+L  G
Sbjct: 197 LSRVLEDDPDAAYT-----TTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYG 251

Query: 287 KKP 289
           ++P
Sbjct: 252 ERP 254

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  129 bits (326), Expect = 2e-34
 Identities = 63/307 (20%), Positives = 120/307 (39%), Gaps = 51/307 (16%)

Query: 89  FDRS-----RCLSQGGFVSVYKGVLH-----DNIQVAVKTYRRADKIRITERELLR---I 135
           F+       + L +G F SV               VAVK  + + +     R+  R   I
Sbjct: 38  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEI 95

Query: 136 ISQVNHKNVVKILGLCLET-EVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAE 193
           +  + H N+VK  G+C       L L+ E+   G+L D+++    ++       L+  ++
Sbjct: 96  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQ 153

Query: 194 TASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGT 253
               ++YL +      IH D+ + NIL+ +    K+ DF  + ++  D E          
Sbjct: 154 ICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVK----E 206

Query: 254 SGYLDPV------CINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYF 307
            G   P+       +   K +  SDV+SFGVVL EL T  +          + I      
Sbjct: 207 PGES-PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG 265

Query: 308 LNSIKNNGLRQILNFHVADESEMKEI--------EIVAELASKCLRIRGTERPTMKQVSE 359
                     Q++ FH+ +  +            + +  + ++C      +RP+ + ++ 
Sbjct: 266 ----------QMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315

Query: 360 ELDRLRR 366
            +D++R 
Sbjct: 316 RVDQIRD 322

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  129 bits (325), Expect = 2e-34
 Identities = 59/301 (19%), Positives = 106/301 (35%), Gaps = 46/301 (15%)

Query: 87  KNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVK--TYRRADKIRITERELLRIISQVNHKN 143
           K++   + L +GGF  V     LHD    A+K             +RE   +    NH N
Sbjct: 29  KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREA-DMHRLFNHPN 87

Query: 144 VVKILGLCLETEVP----LLVYEFASNGTLLDHI-RCESSQVLKTWKTCLRIAAETASAL 198
           +++++  CL          L+  F   GTL + I R +      T    L +       L
Sbjct: 88  ILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGL 147

Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILI------- 251
           + +H+       H D+K  NILL D     + D  S        E +   + +       
Sbjct: 148 EAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR 204

Query: 252 GTSGYLDPVCINT---GKLTKKSDVYSFGVVLAELLTGKKP--GSCMTLASNKKISMVPY 306
            T  Y  P   +      + +++DV+S G VL  ++ G+ P         S         
Sbjct: 205 CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQL 264

Query: 307 FL--NSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL 364
            +  +   ++ L Q+L                    +  + +   +RP +  +  +L+ L
Sbjct: 265 SIPQSPRHSSALWQLL--------------------NSMMTVDPHQRPHIPLLLSQLEAL 304

Query: 365 R 365
           +
Sbjct: 305 Q 305

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  128 bits (323), Expect = 3e-34
 Identities = 68/212 (32%), Positives = 101/212 (47%), Gaps = 25/212 (11%)

Query: 93  RCLSQGGFVSVYKGVLHDN----IQVAVKTYRRADKIRITERELLR---IISQVNHKNVV 145
             + +G F  VY G L DN    I  AVK+  R   I     + L    I+   +H NV+
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGIIMKDFSHPNVL 89

Query: 146 KILGLCLETEVPLL-VYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSL 204
            +LG+CL +E   L V  +  +G L + IR E+     T K  +    + A  + YL   
Sbjct: 90  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP--TVKDLIGFGLQVAKGMKYL--- 144

Query: 205 ASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV---- 260
           AS   +H D+ + N +L++ +T KVADF  +  +      ++       +G   PV    
Sbjct: 145 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVH----NKTGAKLPVKWMA 200

Query: 261 --CINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
              + T K T KSDV+SFGV+L EL+T G  P
Sbjct: 201 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  127 bits (322), Expect = 3e-34
 Identities = 52/207 (25%), Positives = 98/207 (47%), Gaps = 25/207 (12%)

Query: 93  RCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLR---IISQVNHKNVVKILG 149
           + L  G F  V  G       VA+K  +      ++E E +    ++  ++H+ +V++ G
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS---MSEDEFIEEAKVMMNLSHEKLVQLYG 86

Query: 150 LCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPI 209
           +C +     ++ E+ +NG LL+++R    +     +  L +  +   A++Y   L S   
Sbjct: 87  VCTKQRPIFIITEYMANGCLLNYLREMRHRF--QTQQLLEMCKDVCEAMEY---LESKQF 141

Query: 210 IHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV------CIN 263
           +H D+ + N L+ND    KV+DF  S  +  D  T+       + G   PV       + 
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS-------SVGSKFPVRWSPPEVLM 194

Query: 264 TGKLTKKSDVYSFGVVLAELLT-GKKP 289
             K + KSD+++FGV++ E+ + GK P
Sbjct: 195 YSKFSSKSDIWAFGVLMWEIYSLGKMP 221

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  128 bits (323), Expect = 4e-34
 Identities = 66/312 (21%), Positives = 107/312 (34%), Gaps = 55/312 (17%)

Query: 89  FDRS-----RCLSQGGFVSVYKGVLHD-----NIQVAVKTYRRADKIRITERELLR---I 135
           F +      R L +G F  V               VAVK  + AD          +   I
Sbjct: 28  FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK-ADAGPQHRSGWKQEIDI 86

Query: 136 ISQVNHKNVVKILGLCLETEVP--LLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAE 193
           +  + H++++K  G C +       LV E+   G+L D++   S          L  A +
Sbjct: 87  LRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS----IGLAQLLLFAQQ 142

Query: 194 TASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGT 253
               + YLH+      IH D+ + N+LL+++   K+ DF  +  +    E          
Sbjct: 143 ICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVR----E 195

Query: 254 SGYLDPV------CINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPY 306
            G   PV      C+   K    SDV+SFGV L ELLT               ++  +  
Sbjct: 196 DGDS-PVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSS--QSPPTKFLELIGIAQ 252

Query: 307 FLNSIKNNGLRQILNFHVADESEMKEI--------EIVAELASKCLRIRGTERPTMKQVS 358
                      Q+    + +  E  E           V  L   C     + RPT + + 
Sbjct: 253 ----------GQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLI 302

Query: 359 EELDRLRRLHEN 370
             L  +   ++ 
Sbjct: 303 PILKTVHEKYQG 314

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  129 bits (326), Expect = 4e-34
 Identities = 67/212 (31%), Positives = 101/212 (47%), Gaps = 25/212 (11%)

Query: 93  RCLSQGGFVSVYKGVLHDN----IQVAVKTYRRADKIRITERELLR---IISQVNHKNVV 145
             + +G F  VY G L DN    I  AVK+  R   I     + L    I+   +H NV+
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGIIMKDFSHPNVL 153

Query: 146 KILGLCLETEVPLL-VYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSL 204
            +LG+CL +E   L V  +  +G L + IR E+     T K  +    + A  + +L   
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP--TVKDLIGFGLQVAKGMKFL--- 208

Query: 205 ASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV---- 260
           AS   +H D+ + N +L++ +T KVADF  +  +      ++       +G   PV    
Sbjct: 209 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN----KTGAKLPVKWMA 264

Query: 261 --CINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
              + T K T KSDV+SFGV+L EL+T G  P
Sbjct: 265 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  131 bits (331), Expect = 6e-34
 Identities = 63/209 (30%), Positives = 108/209 (51%), Gaps = 13/209 (6%)

Query: 93  RCLSQGGFVSVYKGVLHD-NIQVAVKTYRRADKIRITERELL---RIISQVNHKNVVKIL 148
             L  G +  VY+GV    ++ VAVKT +      +   E L    ++ ++ H N+V++L
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLL 282

Query: 149 GLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPP 208
           G+C       ++ EF + G LLD++R  + Q + +    L +A + +SA++YL       
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-SAVVLLYMATQISSAMEYLEKKN--- 338

Query: 209 IIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLT 268
            IH ++ + N L+ +N+  KVADF  S L++ D  TA +        +  P  +   K +
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-WTAPESLAYNKFS 397

Query: 269 KKSDVYSFGVVLAELLT-GKKPGSCMTLA 296
            KSDV++FGV+L E+ T G  P   + L+
Sbjct: 398 IKSDVWAFGVLLWEIATYGMSPYPGIDLS 426

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  129 bits (325), Expect = 6e-34
 Identities = 60/216 (27%), Positives = 103/216 (47%), Gaps = 25/216 (11%)

Query: 93  RCLSQGGFVSVYKGVLH----DNIQVAVKTYRRADKIRITERELLR---IISQVNHKNVV 145
           + +  G F  V  G L       I VA+KT +         R+ L    I+ Q +H N++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK-VGYTEKQRRDFLGEASIMGQFDHPNII 109

Query: 146 KILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLA 205
           ++ G+  +++  ++V E+  NG+L   +R   +Q   T    + +    AS + YL  + 
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF--TVIQLVGMLRGIASGMKYLSDMG 167

Query: 206 SPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV----- 260
               +H D+ + NIL+N N   KV+DF    ++  D E A +     T G   P+     
Sbjct: 168 ---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYT-----TRGGKIPIRWTSP 219

Query: 261 -CINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMT 294
             I   K T  SDV+S+G+VL E+++ G++P   M+
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  126 bits (319), Expect = 9e-34
 Identities = 55/211 (26%), Positives = 94/211 (44%), Gaps = 28/211 (13%)

Query: 93  RCLSQGGFVSVYKGVLHDN----IQVAVKTYRRADKIRITERELLR---IISQVNHKNVV 145
           R L +G F  VY+GV  ++    I VAVKT +  D     + + +    I+  ++H ++V
Sbjct: 18  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCK-KDCTLDNKEKFMSEAVIMKNLDHPHIV 76

Query: 146 KILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLA 205
           K++G+  E E   ++ E    G L  ++    + +     T +  + +   A+ YL S+ 
Sbjct: 77  KLIGIIEE-EPTWIIMELYPYGELGHYLERNKNSL--KVLTLVLYSLQICKAMAYLESIN 133

Query: 206 SPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV----- 260
               +H D+   NIL+      K+ DF  S  I  +            S    P+     
Sbjct: 134 ---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYK-------ASVTRLPIKWMSP 183

Query: 261 -CINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
             IN  + T  SDV+ F V + E+L+ GK+P
Sbjct: 184 ESINFRRFTTASDVWMFAVCMWEILSFGKQP 214

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  126 bits (318), Expect = 9e-34
 Identities = 60/208 (28%), Positives = 106/208 (50%), Gaps = 27/208 (12%)

Query: 93  RCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLR---IISQVNHKNVVKILG 149
             L  G F  V+ G  + + +VAVK+ ++     ++    L    ++ Q+ H+ +V++  
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYA 75

Query: 150 LCLETEVPLL-VYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPP 208
           +   T+ P+  + E+  NG+L+D ++  S   L T    L +AA+ A  + ++       
Sbjct: 76  VV--TQEPIYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFI---EERN 129

Query: 209 IIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV------CI 262
            IH D+++ANIL++D  + K+ADF  + LI  +  TA             P+       I
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF-------PIKWTAPEAI 182

Query: 263 NTGKLTKKSDVYSFGVVLAELLT-GKKP 289
           N G  T KSDV+SFG++L E++T G+ P
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIP 210

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  127 bits (320), Expect = 1e-33
 Identities = 75/312 (24%), Positives = 139/312 (44%), Gaps = 44/312 (14%)

Query: 93  RCLSQGGFVSVYKGVLHD-----NIQVAVKTYRRADKIRITERELLR---IISQVNHKNV 144
           + +  G F  VYKG+L        + VA+KT + A        + L    I+ Q +H N+
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK-AGYTEKQRVDFLGEAGIMGQFSHHNI 108

Query: 145 VKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSL 204
           +++ G+  + +  +++ E+  NG L   +R +  +   +    + +    A+ + YL ++
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDGEF--SVLQLVGMLRGIAAGMKYLANM 166

Query: 205 ASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV---- 260
                +H D+ + NIL+N N   KV+DF  S ++  D E   +     TSG   P+    
Sbjct: 167 N---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT-----TSGGKIPIRWTA 218

Query: 261 --CINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLR 317
              I+  K T  SDV+SFG+V+ E++T G++P   +   SN ++      + +I N+G R
Sbjct: 219 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL---SNHEV------MKAI-NDGFR 268

Query: 318 QILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLHENFWAQKKN 377
                     + M     + +L  +C +     RP    +   LD+L R  ++       
Sbjct: 269 L--------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLADF 320

Query: 378 KETEHLLGESSS 389
                +   S+S
Sbjct: 321 DPRVSIRLPSTS 332

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  125 bits (317), Expect = 2e-33
 Identities = 64/217 (29%), Positives = 109/217 (50%), Gaps = 30/217 (13%)

Query: 89  FDRS-----RCLSQGGFVSVYKGVLHD-NIQVAVKTYRRADKIRITERELLR---IISQV 139
            +R+       L  G +  VY+GV    ++ VAVKT +      +   E L+   ++ ++
Sbjct: 10  MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEI 66

Query: 140 NHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALD 199
            H N+V++LG+C       ++ EF + G LLD++R  + Q + +    L +A + +SA++
Sbjct: 67  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-SAVVLLYMATQISSAME 125

Query: 200 YLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDP 259
           Y   L     IH D+ + N L+ +N+  KVADF  S L++ D  TA +           P
Sbjct: 126 Y---LEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-------P 175

Query: 260 V------CINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
           +       +   K + KSDV++FGV+L E+ T G  P
Sbjct: 176 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  124 bits (314), Expect = 4e-33
 Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 25/208 (12%)

Query: 95  LSQGGFVSVYKGVLH---DNIQVAVKTYRRADKIRITERELLR---IISQVNHKNVVKIL 148
           L  G F SV +GV       I VA+K  +     +    E++R   I+ Q+++  +V+++
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLK-QGTEKADTEEMMREAQIMHQLDNPYIVRLI 76

Query: 149 GLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPP 208
           G+C    + +LV E A  G L   +  +  ++         +  + +  + YL       
Sbjct: 77  GVCQAEAL-MLVMEMAGGGPLHKFLVGKREEI--PVSNVAELLHQVSMGMKYLEEKN--- 130

Query: 209 IIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV------CI 262
            +H D+ + N+LL + + AK++DF  S  + +D     +      S    P+      CI
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR-----SAGKWPLKWYAPECI 185

Query: 263 NTGKLTKKSDVYSFGVVLAELLT-GKKP 289
           N  K + +SDV+S+GV + E L+ G+KP
Sbjct: 186 NFRKFSSRSDVWSYGVTMWEALSYGQKP 213

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  125 bits (315), Expect = 6e-33
 Identities = 61/229 (26%), Positives = 103/229 (44%), Gaps = 38/229 (16%)

Query: 89  FDRS-----RCLSQGGFVSVYKGVLHD----NIQVAVKTYRRADKIRITERELLR---II 136
            DR+     + L +G F SV +G L      +++VAVKT +  +  +    E L     +
Sbjct: 31  IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACM 90

Query: 137 SQVNHKNVVKILGLCLETE-----VPLLVYEFASNGTLLDHIRC---ESSQVLKTWKTCL 188
              +H NV+++LG+C+E        P+++  F   G L  ++     E+       +T L
Sbjct: 91  KDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLL 150

Query: 189 RIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFE-SSVLISSDAETAMS 247
           +   + A  ++YL   ++   +H D+ + N +L D+ T  VADF  S  + S D      
Sbjct: 151 KFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQ-- 205

Query: 248 TILIGTSGYLDPV------CINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
               G    + PV       +     T KSDV++FGV + E+ T G  P
Sbjct: 206 ----GRIAKM-PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  125 bits (315), Expect = 8e-33
 Identities = 59/231 (25%), Positives = 99/231 (42%), Gaps = 41/231 (17%)

Query: 89  FDRS-----RCLSQGGFVSVYKGVLHDN----IQVAVKTYRRADKIRITERELLR---II 136
                    R L +G F SV +  L       ++VAVK  +          E LR    +
Sbjct: 20  IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACM 79

Query: 137 SQVNHKNVVKILGLCLETE------VPLLVYEFASNGTLLDHIRC----ESSQVLKTWKT 186
            + +H +V K++G+ L +       +P+++  F  +G L   +      E+   L   +T
Sbjct: 80  KEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNL-PLQT 138

Query: 187 CLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFE-SSVLISSDAETA 245
            +R   + A  ++YL   +S   IH D+ + N +L ++ T  VADF  S  + S D    
Sbjct: 139 LVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQ 195

Query: 246 MSTILIGTSGYLDPV------CINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
                 G +  L PV       +     T  SDV++FGV + E++T G+ P
Sbjct: 196 ------GCASKL-PVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  125 bits (315), Expect = 8e-33
 Identities = 72/305 (23%), Positives = 129/305 (42%), Gaps = 59/305 (19%)

Query: 86  TKNFDRS-----RCLSQGGFVSVYKGVLHD-----NIQVAVKTYRRADKIRITERELLR- 134
            + F  +     + L  G F +V+KGV         I V +K        R + + +   
Sbjct: 7   ARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIE-DKSGRQSFQAVTDH 65

Query: 135 --IISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAA 192
              I  ++H ++V++LGLC       LV ++   G+LLDH+R     +    +  L    
Sbjct: 66  MLAIGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGAL--GPQLLLNWGV 122

Query: 193 ETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIG 252
           + A  + YL       ++H ++ + N+LL      +VADF  + L+  D +  +      
Sbjct: 123 QIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLL------ 173

Query: 253 TSGYLDPV------CINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVP 305
            S    P+       I+ GK T +SDV+S+GV + EL+T G +P + +      ++    
Sbjct: 174 YSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGL---RLAEV---- 226

Query: 306 YFLNSIKNNGLRQILNFHVADESEMKEIEI----VAELASKCLRIRGTERPTMKQVSEEL 361
              + ++  G R            + + +I    V  +  KC  I    RPT K+++ E 
Sbjct: 227 --PDLLE-KGER------------LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEF 271

Query: 362 DRLRR 366
            R+ R
Sbjct: 272 TRMAR 276

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  127 bits (320), Expect = 1e-32
 Identities = 55/208 (26%), Positives = 103/208 (49%), Gaps = 31/208 (14%)

Query: 93  RCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLR---IISQVNHKNVVKILG 149
           + + +G F  V  G      +VAVK      K   T +  L    +++Q+ H N+V++LG
Sbjct: 199 QTIGKGEFGDVMLGDYR-GNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQLLG 253

Query: 150 LCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPP 208
           + +E +  L +V E+ + G+L+D++R     VL      L+ + +   A++YL       
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL-GGDCLLKFSLDVCEAMEYLEGNN--- 309

Query: 209 IIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV------CI 262
            +H D+ + N+L++++  AKV+DF     ++ +A +              PV       +
Sbjct: 310 FVHRDLAARNVLVSEDNVAKVSDF----GLTKEASST-------QDTGKLPVKWTAPEAL 358

Query: 263 NTGKLTKKSDVYSFGVVLAELLT-GKKP 289
              K + KSDV+SFG++L E+ + G+ P
Sbjct: 359 REKKFSTKSDVWSFGILLWEIYSFGRVP 386

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  123 bits (310), Expect = 1e-32
 Identities = 51/211 (24%), Positives = 92/211 (43%), Gaps = 28/211 (13%)

Query: 93  RCLSQGGFVSVYKGVLHD----NIQVAVKTYRRADKIRITERELLR---IISQVNHKNVV 145
           RC+ +G F  V++G+        + VA+KT +          + L+    + Q +H ++V
Sbjct: 21  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHPHIV 79

Query: 146 KILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLA 205
           K++G+  E     ++ E  + G L   ++     +     + +  A + ++AL YL S  
Sbjct: 80  KLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSL--DLASLILYAYQLSTALAYLESKR 136

Query: 206 SPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV----- 260
               +H D+ + N+L++ N   K+ DF  S  +               S    P+     
Sbjct: 137 ---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK-------ASKGKLPIKWMAP 186

Query: 261 -CINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
             IN  + T  SDV+ FGV + E+L  G KP
Sbjct: 187 ESINFRRFTSASDVWMFGVCMWEILMHGVKP 217

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  123 bits (310), Expect = 2e-32
 Identities = 57/212 (26%), Positives = 99/212 (46%), Gaps = 25/212 (11%)

Query: 91  RSRCLSQGGFVSVYKGVLHDN---IQVAVKTYRRADKIRITERELLR---IISQVNHKNV 144
             + L  G F +V KG          VAVK  +        + ELL    ++ Q+++  +
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80

Query: 145 VKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSL 204
           V+++G+C   E  +LV E A  G L  +++ ++  V    K  + +  + +  + YL   
Sbjct: 81  VRMIGICEA-ESWMLVMEMAELGPLNKYLQ-QNRHV--KDKNIIELVHQVSMGMKYLEES 136

Query: 205 ASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV---- 260
                +H D+ + N+LL   + AK++DF  S  + +D     +      +    PV    
Sbjct: 137 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ-----THGKWPVKWYA 188

Query: 261 --CINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
             CIN  K + KSDV+SFGV++ E  + G+KP
Sbjct: 189 PECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  122 bits (308), Expect = 3e-32
 Identities = 55/217 (25%), Positives = 106/217 (48%), Gaps = 36/217 (16%)

Query: 89  FDRS-----RCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLR---IISQVN 140
            +       + + +G F  V  G      +VAVK  +       T +  L    +++Q+ 
Sbjct: 18  LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA----TAQAFLAEASVMTQLR 72

Query: 141 HKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALD 199
           H N+V++LG+ +E +  L +V E+ + G+L+D++R     VL      L+ + +   A++
Sbjct: 73  HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL-GGDCLLKFSLDVCEAME 131

Query: 200 YLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDP 259
           YL        +H D+ + N+L++++  AKV+DF     ++ +A +   T  +       P
Sbjct: 132 YL---EGNNFVHRDLAARNVLVSEDNVAKVSDFG----LTKEASSTQDTGKL-------P 177

Query: 260 V------CINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
           V       +   K + KSDV+SFG++L E+ + G+ P
Sbjct: 178 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 214

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  122 bits (309), Expect = 3e-32
 Identities = 62/293 (21%), Positives = 109/293 (37%), Gaps = 53/293 (18%)

Query: 93  RCLSQGGFVSVYKGVLH----DNIQVAVKTYRR-ADKIRITERELLR---IISQVNHKNV 144
             L  G F  V +G         + VAVK  +           + +R    +  ++H+N+
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83

Query: 145 VKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHS 203
           +++ G+ L    P+ +V E A  G+LLD +R           T  R A + A  + YL S
Sbjct: 84  IRLYGVVLTP--PMKMVTELAPLGSLLDRLRKHQGHF--LLGTLSRYAVQVAEGMGYLES 139

Query: 204 LASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV--- 260
                 IH D+ + N+LL      K+ DF     +  + +  +            P    
Sbjct: 140 KR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQ-----EHRKVPFAWC 191

Query: 261 ---CINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGL 316
               + T   +  SD + FGV L E+ T G++P   +   +  +I      L+ I   G 
Sbjct: 192 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL---NGSQI------LHKIDKEGE 242

Query: 317 RQILNFHVADESEMKEIEI----VAELASKCLRIRGTERPTMKQVSEELDRLR 365
           R            +   E     +  +  +C   +  +RPT   + + L   +
Sbjct: 243 R------------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  122 bits (308), Expect = 3e-32
 Identities = 63/319 (19%), Positives = 111/319 (34%), Gaps = 64/319 (20%)

Query: 84  RATKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRITERELLR---IISQV 139
           R   +F     +  GGF  V+K     D     +K      +++    +  R    ++++
Sbjct: 8   RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIK------RVKYNNEKAEREVKALAKL 61

Query: 140 NHKNVVKILGLCLETEVPL----------------LVYEFASNGTLLDHIRCESSQVLKT 183
           +H N+V   G     +                   +  EF   GTL   I     + L  
Sbjct: 62  DHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDK 121

Query: 184 WKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE 243
               L +  +    +DY+HS     +I+ D+K +NI L D    K+ DF     + +D +
Sbjct: 122 -VLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK 177

Query: 244 TAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISM 303
               T   GT  Y+ P  I++    K+ D+Y+ G++LAELL                   
Sbjct: 178 R---TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT-------------- 220

Query: 304 VPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDR 363
             +  +    +    I++     +           L  K L  +  +RP   ++      
Sbjct: 221 -AFETSKFFTDLRDGIISDIFDKK--------EKTLLQKLLSKKPEDRPNTSEI------ 265

Query: 364 LRRLHENFWAQKKNKETEH 382
           LR      W +   K   H
Sbjct: 266 LR--TLTVWKKSPEKNERH 282

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  122 bits (307), Expect = 4e-32
 Identities = 65/317 (20%), Positives = 126/317 (39%), Gaps = 68/317 (21%)

Query: 93  RCLSQGGFVSVYKGVLHD--------NIQVAVKTYRRADKIRITERELLR---IISQVNH 141
             L QG F  ++KGV  +          +V +K   +A   R           ++S+++H
Sbjct: 14  ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSH 71

Query: 142 KNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYL 201
           K++V   G+C+  +  +LV EF   G+L  +++   + +   WK  L +A + A+A+ + 
Sbjct: 72  KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWK--LEVAKQLAAAMHF- 128

Query: 202 HSLASPPIIHGDVKSANILLN--------DNYTAKVADFESSVLISSDAETAMSTILIGT 253
             L    +IHG+V + NILL         +    K++D              +S  ++  
Sbjct: 129 --LEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDP------------GISITVLPK 174

Query: 254 SGYLDPV------CINTGKL-TKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVP 305
               + +      CI   K     +D +SFG  L E+ + G KP S +    +++     
Sbjct: 175 DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL---DSQRK---- 227

Query: 306 YFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLR 365
                     L+   + H     +  E+   A L + C+      RP+ + +  +L+ L 
Sbjct: 228 ----------LQFYEDRHQLPAPKAAEL---ANLINNCMDYEPDHRPSFRAIIRDLNSL- 273

Query: 366 RLHENFWAQKKNKETEH 382
               +   +  +    H
Sbjct: 274 -FTPDLVPRGSHHHHHH 289

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  121 bits (306), Expect = 1e-31
 Identities = 60/230 (26%), Positives = 102/230 (44%), Gaps = 40/230 (17%)

Query: 89  FDRS-----RCLSQGGFVSVYKGVLHD------NIQVAVKTYRRADKIRITERELLR--- 134
             R      R L QG F  VY+GV           +VA+KT   A  +R    E L    
Sbjct: 22  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR-ERIEFLNEAS 80

Query: 135 IISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLK-------TWKTC 187
           ++ + N  +VV++LG+  + +  L++ E  + G L  ++R     +         +    
Sbjct: 81  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 140

Query: 188 LRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADF-ESSVLISSDAETAM 246
           +++A E A  + Y   L +   +H D+ + N ++ +++T K+ DF  +  +  +D     
Sbjct: 141 IQMAGEIADGMAY---LNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK- 196

Query: 247 STILIGTSGYLDPV------CINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
                G  G L PV       +  G  T  SDV+SFGVVL E+ T  ++P
Sbjct: 197 -----GGKGLL-PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  120 bits (303), Expect = 3e-31
 Identities = 74/305 (24%), Positives = 125/305 (40%), Gaps = 35/305 (11%)

Query: 87  KNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRITERELL----RIISQVNH 141
            NF   + + +G F  VY+   L D + VA+K  +  D +    R        ++ Q+NH
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 142 KNVVKILGLCLETEVPLLVYEFASNGTLLDHI-RCESSQVLKTWKTCLRIAAETASALDY 200
            NV+K     +E     +V E A  G L   I   +  + L   +T  +   +  SAL++
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151

Query: 201 LHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDP- 259
           +HS     ++H D+K AN+ +      K+ D       SS    A S  L+GT  Y+ P 
Sbjct: 152 MHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPE 206

Query: 260 VCINTGKLTKKSDVYSFGVVLAELLTGKKP--GSCMTLASNKKISMVPYFLNSIKNNGLR 317
                G    KSD++S G +L E+   + P  G  M L S             I+     
Sbjct: 207 RIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS---------LCKKIEQCDYP 256

Query: 318 QILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLHENFWAQKKN 377
            + + H ++E        + +L + C+     +RP +  V    D  +R+H    +  ++
Sbjct: 257 PLPSDHYSEE--------LRQLVNMCINPDPEKRPDVTYV---YDVAKRMHACTASSLEH 305

Query: 378 KETEH 382
               H
Sbjct: 306 HHHHH 310

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  124 bits (312), Expect = 4e-31
 Identities = 53/208 (25%), Positives = 98/208 (47%), Gaps = 25/208 (12%)

Query: 95  LSQGGFVSVYKGVLH---DNIQVAVKTYRRADKIRITERELLR---IISQVNHKNVVKIL 148
           L  G F SV +GV       I VA+K  +     +    E++R   I+ Q+++  +V+++
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLK-QGTEKADTEEMMREAQIMHQLDNPYIVRLI 402

Query: 149 GLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPP 208
           G+C    + +LV E A  G L   +  +  ++         +  + +  + YL       
Sbjct: 403 GVCQAEAL-MLVMEMAGGGPLHKFLVGKREEI--PVSNVAELLHQVSMGMKYLEEKN--- 456

Query: 209 IIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV------CI 262
            +H ++ + N+LL + + AK++DF  S  + +D     +      S    P+      CI
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR-----SAGKWPLKWYAPECI 511

Query: 263 NTGKLTKKSDVYSFGVVLAELLT-GKKP 289
           N  K + +SDV+S+GV + E L+ G+KP
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEALSYGQKP 539

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  118 bits (297), Expect = 9e-31
 Identities = 48/223 (21%), Positives = 89/223 (39%), Gaps = 21/223 (9%)

Query: 79  KSEMIRATKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRITEREL----- 132
            S      ++++    +  G +    K     D   +  K     D   +TE E      
Sbjct: 2   PSRA----EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWK---ELDYGSMTEAEKQMLVS 54

Query: 133 -LRIISQVNHKNVVKILGLCLETEVPLL--VYEFASNGTLLDHI-RCESSQVLKTWKTCL 188
            + ++ ++ H N+V+     ++     L  V E+   G L   I +    +     +  L
Sbjct: 55  EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL 114

Query: 189 RIAAETASALDYLHS--LASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAM 246
           R+  +   AL   H        ++H D+K AN+ L+     K+ DF  + +++ D   A 
Sbjct: 115 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK 174

Query: 247 STILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           +   +GT  Y+ P  +N     +KSD++S G +L EL     P
Sbjct: 175 T--FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  118 bits (298), Expect = 1e-30
 Identities = 61/299 (20%), Positives = 113/299 (37%), Gaps = 48/299 (16%)

Query: 84  RATKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRITEREL--LRIISQVN 140
           R   +F+  +CL +GGF  V++     D+   A+K  R  ++    E+ +  ++ ++++ 
Sbjct: 2   RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61

Query: 141 HKNVVKILGLCLE---------TEVPLLVY---EFASNGTLLDHIRCESSQVLKTWKTCL 188
           H  +V+     LE         +   + +Y   +      L D +    +   +    CL
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121

Query: 189 RIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADF----------ESSVLI 238
            I  + A A+++LHS     ++H D+K +NI    +   KV DF          E   ++
Sbjct: 122 HIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178

Query: 239 SSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASN 298
           +     A  T  +GT  Y+ P  I+    + K D++S G++L ELL              
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY------------- 225

Query: 299 KKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQV 357
                 P+     +   L  + N         K       +    L     ERP    +
Sbjct: 226 ------PFSTQMERVRTLTDVRNLKFPPLFTQKYPCE-YVMVQDMLSPSPMERPEAINI 277

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  118 bits (297), Expect = 1e-30
 Identities = 63/303 (20%), Positives = 114/303 (37%), Gaps = 53/303 (17%)

Query: 84  RATKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRA-DKIRITERELLRIISQVNH 141
           R   +F+    L QG F  V K     D+   A+K  R   +K+     E+  +++ +NH
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEV-MLLASLNH 61

Query: 142 KNVVKILGLCLETEVPL-------------LVYEFASNGTLLDHIRCESSQVLKTWKTCL 188
           + VV+     LE    +             +  E+  NGTL D I   S  + +      
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH--SENLNQQRDEYW 119

Query: 189 RIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADF-------------ESS 235
           R+  +   AL Y+HS     IIH D+K  NI ++++   K+ DF             +  
Sbjct: 120 RLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176

Query: 236 VLISSDAETAMSTILIGTSGYLDP-VCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMT 294
                 +   +++  IGT+ Y+   V   TG   +K D+YS G++  E++     G    
Sbjct: 177 SQNLPGSSDNLTS-AIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERV 235

Query: 295 LASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTM 354
                        L  +++  +    +F        K      ++    +     +RP  
Sbjct: 236 N-----------ILKKLRSVSIEFPPDFDDNKMKVEK------KIIRLLIDHDPNKRPGA 278

Query: 355 KQV 357
           + +
Sbjct: 279 RTL 281

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  123 bits (309), Expect = 2e-30
 Identities = 58/272 (21%), Positives = 108/272 (39%), Gaps = 33/272 (12%)

Query: 37  RKSRNVRGVISSAVRRGRGGRDPGPTIYSHPGLAFLRMKIFSKSEMIRATKNFDRS---- 92
              R +  +   A    +G R    ++      A +  +  + +          R     
Sbjct: 335 EGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERIEL 394

Query: 93  -RCLSQGGFVSVYKGVLHD----NIQVAVKTYRRADKIRITERELLR---IISQVNHKNV 144
            RC+ +G F  V++G+        + VA+KT +          + L+    + Q +H ++
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHPHI 453

Query: 145 VKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSL 204
           VK++G+  E  V  ++ E  + G L   ++     +     + +  A + ++AL YL S 
Sbjct: 454 VKLIGVITENPV-WIIMELCTLGELRSFLQVRKFSL--DLASLILYAYQLSTALAYLESK 510

Query: 205 ASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV---- 260
                +H D+ + N+L++ N   K+ DF  S  +               S    P+    
Sbjct: 511 R---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK-------ASKGKLPIKWMA 560

Query: 261 --CINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
              IN  + T  SDV+ FGV + E+L  G KP
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEILMHGVKP 592

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  118 bits (298), Expect = 2e-30
 Identities = 50/210 (23%), Positives = 89/210 (42%), Gaps = 16/210 (7%)

Query: 87  KNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRITEREL------LRIISQV 139
           + + R + + +G F          D  Q  +K     +  R++ +E       + +++ +
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIK---EINISRMSSKEREESRREVAVLANM 80

Query: 140 NHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALD 199
            H N+V+      E     +V ++   G L   I  +   + +     L    +   AL 
Sbjct: 81  KHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQE-DQILDWFVQICLALK 139

Query: 200 YLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDP 259
           ++H      I+H D+KS NI L  + T ++ DF  + +++S  E A +   IGT  YL P
Sbjct: 140 HVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSP 194

Query: 260 VCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
                     KSD+++ G VL EL T K  
Sbjct: 195 EICENKPYNNKSDIWALGCVLYELCTLKHA 224

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  116 bits (292), Expect = 1e-29
 Identities = 61/229 (26%), Positives = 92/229 (40%), Gaps = 38/229 (16%)

Query: 89  FDRS-----RCLSQGGFVSVYKGVLHD------NIQVAVKTYRRADKIRITERELLR--- 134
             R      R L  G F  VY+G +         +QVAVKT       +  E + L    
Sbjct: 27  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ-DELDFLMEAL 85

Query: 135 IISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLK----TWKTCLRI 190
           IIS+ NH+N+V+ +G+ L++    ++ E  + G L   +R    +  +         L +
Sbjct: 86  IISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 145

Query: 191 AAETASALDYLHSLASPPIIHGDVKSANILLN---DNYTAKVADFESSVLISSDAETAMS 247
           A + A    Y   L     IH D+ + N LL        AK+ DF  +  I   +     
Sbjct: 146 ARDIACGCQY---LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK- 201

Query: 248 TILIGTSGYLDPVC------INTGKLTKKSDVYSFGVVLAELLT-GKKP 289
               G    L PV          G  T K+D +SFGV+L E+ + G  P
Sbjct: 202 ----GGCAML-PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  115 bits (290), Expect = 1e-29
 Identities = 58/236 (24%), Positives = 101/236 (42%), Gaps = 47/236 (19%)

Query: 89  FDRS-----RCLSQGGFVSVYKGVLHD------NIQVAVKTYRRADKIRITERELLR--- 134
             R      R L +G F  V+    ++       + VAVK  +         ++  R   
Sbjct: 12  IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLA--ARKDFQREAE 69

Query: 135 IISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTC------- 187
           +++ + H+++VK  G+C + +  ++V+E+  +G L   +R      +             
Sbjct: 70  LLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE 129

Query: 188 ------LRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADF-ESSVLISS 240
                 L IA++ AS + Y   LAS   +H D+ + N L+  N   K+ DF  S  + S+
Sbjct: 130 LGLSQMLHIASQIASGMVY---LASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYST 186

Query: 241 DAETAMSTILIGTSGYLDPV------CINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
           D        ++       P+       I   K T +SDV+SFGV+L E+ T GK+P
Sbjct: 187 DYYRVGGHTML-------PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  115 bits (290), Expect = 1e-29
 Identities = 60/282 (21%), Positives = 109/282 (38%), Gaps = 48/282 (17%)

Query: 91  RSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRITERELLRII------SQVNHKN 143
               + +G F +VYKG+     ++VA          ++T+ E  R          + H N
Sbjct: 30  FDIEIGRGSFKTVYKGLDTETTVEVAWC---ELQDRKLTKSERQRFKEEAEMLKGLQHPN 86

Query: 144 VVKILGLCLETEVP----LLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALD 199
           +V+       T       +LV E  ++GTL  +++      +K  +       +    L 
Sbjct: 87  IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLR---SWCRQILKGLQ 143

Query: 200 YLHSLASPPIIHGDVKSANILLNDNY-TAKVADFESSVLISSDAETAMSTILIGTSGYLD 258
           +LH+  +PPIIH D+K  NI +     + K+ D   + L  +    A+    IGT  ++ 
Sbjct: 144 FLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV----IGTPEFMA 198

Query: 259 PVCINTGKLTKKSDVYSFGVVLAELLTGKKPGS-CMTLASNKKISM---VPYFLNSIKNN 314
           P         +  DVY+FG+ + E+ T + P S C   A   +       P   + +   
Sbjct: 199 PEMYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 257

Query: 315 GLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQ 356
            +++I+                      C+R    ER ++K 
Sbjct: 258 EVKEII--------------------EGCIRQNKDERYSIKD 279

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  114 bits (289), Expect = 2e-29
 Identities = 51/236 (21%), Positives = 97/236 (41%), Gaps = 46/236 (19%)

Query: 89  FDRS-----RCLSQGGFVSVYKGVLHD------NIQVAVKTYRRADKIRITERELLR--- 134
              S       L +  F  VYKG L           VA+KT +          E      
Sbjct: 6   ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK-DKAEGPLREEFRHEAM 64

Query: 135 IISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTC------- 187
           + +++ H NVV +LG+  + +   +++ + S+G L + +   S                 
Sbjct: 65  LRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSA 124

Query: 188 ------LRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADF-ESSVLISS 240
                 + + A+ A+ ++Y   L+S  ++H D+ + N+L+ D    K++D      + ++
Sbjct: 125 LEPPDFVHLVAQIAAGMEY---LSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAA 181

Query: 241 DAETAMSTILIGTSGYLDPV------CINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
           D    +   L+       P+       I  GK +  SD++S+GVVL E+ + G +P
Sbjct: 182 DYYKLLGNSLL-------PIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  115 bits (289), Expect = 2e-29
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 18/203 (8%)

Query: 95  LSQGGFVSVYKGVLHDNI---QVAVKTYR---RADKIRIT--ERELLRIISQVNHKNVVK 146
           L  GG  +VY     D I   +VA+K      R  +  +   ERE+    SQ++H+N+V 
Sbjct: 19  LGGGGMSTVYLA--EDTILNIKVAIKAIFIPPREKEETLKRFEREV-HNSSQLSHQNIVS 75

Query: 147 ILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLAS 206
           ++ +  E +   LV E+    TL ++I   S   L +  T +    +    + + H +  
Sbjct: 76  MIDVDEEDDCYYLVMEYIEGPTLSEYIE--SHGPL-SVDTAINFTNQILDGIKHAHDMR- 131

Query: 207 PPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGK 266
             I+H D+K  NIL++ N T K+ DF  +  +S  + T  + +L GT  Y  P       
Sbjct: 132 --IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVL-GTVQYFSPEQAKGEA 188

Query: 267 LTKKSDVYSFGVVLAELLTGKKP 289
             + +D+YS G+VL E+L G+ P
Sbjct: 189 TDECTDIYSIGIVLYEMLVGEPP 211

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  115 bits (290), Expect = 3e-29
 Identities = 51/349 (14%), Positives = 100/349 (28%), Gaps = 53/349 (15%)

Query: 58  DPGPTIYSHPGLAFLRMKIFSKSEMIR-ATKNFDRSRCLSQGGFVSVYKGV------LHD 110
               + Y +      ++         +  +K       L +G F  VY+          +
Sbjct: 35  SKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKN 94

Query: 111 NIQVAVKTYRRADKIRIT-ERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTL 169
             +  +K  + A+        +L+  +        +K     L     +LV E  S GTL
Sbjct: 95  KQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTL 154

Query: 170 LDHIRCESSQVLKTW--KTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTA 227
           L+ I    +   K       +  A      ++ +H      IIHGD+K  N +L + +  
Sbjct: 155 LNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLE 211

Query: 228 -----------KVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSF 276
                       + D   S+ +    +  + T    TSG+     ++      + D +  
Sbjct: 212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGV 271

Query: 277 GVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIV 336
              +  +L G                      N         +          +  +++ 
Sbjct: 272 AATVYCMLFGTY----------------MKVKNEGGECKPEGLF-------RRLPHLDMW 308

Query: 337 AELASKCLRIRGTERPTMKQVSEELDRLRRLHENFWAQKKNKETEHLLG 385
            E     L I              LD LR+  +  + Q    +   L  
Sbjct: 309 NEFFHVMLNIPDCHHLP------SLDLLRQKLKKVFQQHYTNKIRALRN 351

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  115 bits (289), Expect = 4e-29
 Identities = 57/235 (24%), Positives = 98/235 (41%), Gaps = 46/235 (19%)

Query: 89  FDRS-----RCLSQGGFVSVYKGVLHD------NIQVAVKTYRRADKIRITERELLR--- 134
             R        L +G F  V+    H+       + VAVK  + A +     ++  R   
Sbjct: 38  IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASES--ARQDFQREAE 95

Query: 135 IISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLK------------ 182
           +++ + H+++V+  G+C E    L+V+E+  +G L   +R                    
Sbjct: 96  LLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPL 155

Query: 183 TWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFE-SSVLISSD 241
                L +A++ A+ + YL  L     +H D+ + N L+      K+ DF  S  + S+D
Sbjct: 156 GLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 212

Query: 242 AETAMSTILIGTSGYLDPV------CINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
                   ++       P+       I   K T +SDV+SFGVVL E+ T GK+P
Sbjct: 213 YYRVGGRTML-------PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  113 bits (286), Expect = 6e-29
 Identities = 69/326 (21%), Positives = 115/326 (35%), Gaps = 91/326 (27%)

Query: 89  FDRS-----RCLSQGGFVSVYKGVLHD------NIQVAVKTYRRADKIRITEREL----- 132
           F R      + L +G F  V +              VAVK      K   T  E      
Sbjct: 24  FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML----KEGATHSEHRALMS 79

Query: 133 -LRIISQV-NHKNVVKILGLCLETEVPLLV-YEFASNGTLLDHIRCESSQVLKTWKTC-- 187
            L+I+  + +H NVV +LG C +   PL+V  EF   G L  ++R + ++ +        
Sbjct: 80  ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139

Query: 188 -----------LRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADF-ESS 235
                      +  + + A  +++L   AS   IH D+ + NILL++    K+ DF  + 
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196

Query: 236 VLISSDAETAMSTILIGTSGYLDPV------CINTGKLTKKSDVYSFGVVLAELLTGKKP 289
            +                   L P+       I     T +SDV+SFGV+L E+      
Sbjct: 197 DIYKDPDYVR------KGDARL-PLKWMAPETIFDRVYTIQSDVWSFGVLLWEI------ 243

Query: 290 GSCMTLASNKKISMVPYFLNSIKNNGLRQILNF-----------HVADESEMKEIEIVAE 338
               +L +       PY    +K +   +               +   E        + +
Sbjct: 244 ---FSLGA------SPYP--GVKID--EEFCRRLKEGTRMRAPDYTTPE--------MYQ 282

Query: 339 LASKCLRIRGTERPTMKQVSEELDRL 364
               C     ++RPT  ++ E L  L
Sbjct: 283 TMLDCWHGEPSQRPTFSELVEHLGNL 308

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  114 bits (287), Expect = 1e-28
 Identities = 61/229 (26%), Positives = 90/229 (39%), Gaps = 38/229 (16%)

Query: 89  FDRS-----RCLSQGGFVSVYKGVLHD------NIQVAVKTYRRADKIRITERELLR--- 134
             R      R L  G F  VY+G +         +QVAVKT          E + L    
Sbjct: 68  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP-EVCSEQDELDFLMEAL 126

Query: 135 IISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLK----TWKTCLRI 190
           IIS+ NH+N+V+ +G+ L++    ++ E  + G L   +R    +  +         L +
Sbjct: 127 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 186

Query: 191 AAETASALDYLHSLASPPIIHGDVKSANILLN---DNYTAKVADFESSVLISSDAETAMS 247
           A + A    Y   L     IH D+ + N LL        AK+ DF  +  I         
Sbjct: 187 ARDIACGCQY---LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRK- 242

Query: 248 TILIGTSGYLDPVC------INTGKLTKKSDVYSFGVVLAELLT-GKKP 289
               G    L PV          G  T K+D +SFGV+L E+ + G  P
Sbjct: 243 ----GGCAML-PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  113 bits (284), Expect = 1e-28
 Identities = 60/244 (24%), Positives = 97/244 (39%), Gaps = 54/244 (22%)

Query: 89  FDRS-----RCLSQGGFVSVYKGVLHD------NIQVAVKTYRRADKIRITERELLR--- 134
           F R      + L +G F  V K              VAVK   + +      R+LL    
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKM-LKENASPSELRDLLSEFN 78

Query: 135 IISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLK------------ 182
           ++ QVNH +V+K+ G C +    LL+ E+A  G+L   +R                    
Sbjct: 79  VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138

Query: 183 ---------TWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADF- 232
                    T    +  A + +  + Y   LA   ++H D+ + NIL+ +    K++DF 
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQY---LAEMKLVHRDLAARNILVAEGRKMKISDFG 195

Query: 233 ESSVLISSDAETAMSTILIGTSGYLDPV------CINTGKLTKKSDVYSFGVVLAELLT- 285
            S  +   D+          + G + PV       +     T +SDV+SFGV+L E++T 
Sbjct: 196 LSRDVYEEDSYVK------RSQGRI-PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTL 248

Query: 286 GKKP 289
           G  P
Sbjct: 249 GGNP 252

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  112 bits (282), Expect = 2e-28
 Identities = 53/247 (21%), Positives = 85/247 (34%), Gaps = 30/247 (12%)

Query: 52  RGRGGRDPGPTIYSHPGLAFLRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGV-LHD 110
           R    R         PG    R + F +         F R   L  G +  V+K     D
Sbjct: 29  RRVSFRGEASETLQSPGYDPSRPESFFQQS-------FQRLSRLGHGSYGEVFKVRSKED 81

Query: 111 NIQVAVKTYRRADKIRITERELLRIISQVN-------HKNVVKILGLCLETEVPLLVYEF 163
               AVK   R+       ++  R +++V        H   V++     E  +  L  E 
Sbjct: 82  GRLYAVK---RSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTEL 138

Query: 164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLND 223
               +L  H     + +            +T  AL +LHS     ++H DVK ANI L  
Sbjct: 139 CG-PSLQQHCEAWGASL--PEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGP 192

Query: 224 NYTAKVADFESSVLISSDAETAMSTILIGTSGYLDP-VCINTGKLTKKSDVYSFGVVLAE 282
               K+ DF   V + +        +  G   Y+ P +    G     +DV+S G+ + E
Sbjct: 193 RGRCKLGDFGLLVELGTAGAG---EVQEGDPRYMAPELL--QGSYGTAADVFSLGLTILE 247

Query: 283 LLTGKKP 289
           +    + 
Sbjct: 248 VACNMEL 254

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  112 bits (283), Expect = 3e-28
 Identities = 57/239 (23%), Positives = 98/239 (41%), Gaps = 49/239 (20%)

Query: 89  FDRS-----RCLSQGGFVSVYKGVLHD--------NIQVAVKTYRRADKIRITERELLR- 134
           F R      + L +G F  V                + VAVK  +     +    +L+  
Sbjct: 32  FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK-DLSDLVSE 90

Query: 135 --IISQV-NHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTC---- 187
             ++  +  HKN++ +LG C +     ++ E+AS G L +++R      ++         
Sbjct: 91  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 150

Query: 188 ---------LRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLI 238
                    +    + A  ++Y   LAS   IH D+ + N+L+ +N   K+ADF  +  I
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEY---LASQKCIHRDLAARNVLVTENNVMKIADFGLARDI 207

Query: 239 -SSDAETAMSTILIGTSGYLDPV------CINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
            + D           T+G L PV       +     T +SDV+SFGV++ E+ T G  P
Sbjct: 208 NNIDYYKK------TTNGRL-PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  112 bits (282), Expect = 6e-28
 Identities = 71/316 (22%), Positives = 124/316 (39%), Gaps = 71/316 (22%)

Query: 89  FDRS-----RCLSQGGFVSVYKGVLHD--------NIQVAVKTYRRADKIRITERELLR- 134
           F R      + L +G F  V                + VAVK  +     +    +L+  
Sbjct: 78  FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK-DLSDLVSE 136

Query: 135 --IISQV-NHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTC---- 187
             ++  +  HKN++ +LG C +     ++ E+AS G L +++R      ++         
Sbjct: 137 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 196

Query: 188 ---------LRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADF-ESSVL 237
                    +    + A  ++Y   LAS   IH D+ + N+L+ +N   K+ADF  +  +
Sbjct: 197 EEQMTFKDLVSCTYQLARGMEY---LASQKCIHRDLAARNVLVTENNVMKIADFGLARDI 253

Query: 238 ISSDAETAMSTILIGTSGYLDPV------CINTGKLTKKSDVYSFGVVLAELLTGKKPGS 291
            + D           T+G L PV       +     T +SDV+SFGV++ E+        
Sbjct: 254 NNIDYYKK------TTNGRL-PVKWMAPEALFDRVYTHQSDVWSFGVLMWEI-------- 298

Query: 292 CMTLASNKKISMVPYFLNSIKNNG-LRQILNFHVADESEM--KEIEIVAELASKCLRIRG 348
             TL  +      PY    I      + +   H  D+      E+     +   C     
Sbjct: 299 -FTLGGS------PYP--GIPVEELFKLLKEGHRMDKPANCTNELY---MMMRDCWHAVP 346

Query: 349 TERPTMKQVSEELDRL 364
           ++RPT KQ+ E+LDR+
Sbjct: 347 SQRPTFKQLVEDLDRI 362

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  110 bits (278), Expect = 8e-28
 Identities = 67/313 (21%), Positives = 117/313 (37%), Gaps = 64/313 (20%)

Query: 89  FDRS-----RCLSQGGFVSVYKGVLHD------NIQVAVKTYRRADKIRITERELLR--- 134
           F R+     + L  G F  V +   +        + VAVK  + +  +      L+    
Sbjct: 20  FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT-EREALMSELK 78

Query: 135 IISQV-NHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIR---------------CESS 178
           ++S + NH N+V +LG C      L++ E+   G LL+ +R                E  
Sbjct: 79  VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138

Query: 179 QVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFE-SSVL 237
           ++    +  L  + + A  + +   LAS   IH D+ + NILL      K+ DF  +  +
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAF---LASKNCIHRDLAARNILLTHGRITKICDFGLARDI 195

Query: 238 ISSDAETAMSTILIGTSGYLDPV------CINTGKLTKKSDVYSFGVVLAELLTGKKPGS 291
            +              +  L PV       I     T +SDV+S+G+ L EL        
Sbjct: 196 KNDSNYVV------KGNARL-PVKWMAPESIFNCVYTFESDVWSYGIFLWEL-------- 240

Query: 292 CMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTER 351
             +L S       PY    + +   + I         E    E+  ++   C      +R
Sbjct: 241 -FSLGS------SPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEM-YDIMKTCWDADPLKR 292

Query: 352 PTMKQVSEELDRL 364
           PT KQ+ + +++ 
Sbjct: 293 PTFKQIVQLIEKQ 305

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  112 bits (281), Expect = 2e-27
 Identities = 65/304 (21%), Positives = 116/304 (38%), Gaps = 45/304 (14%)

Query: 88  NFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERE--LLRIISQVNHKNVV 145
           +F     L  G   ++    + DN  VAVK     +     +RE  LLR   +  H NV+
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP-ECFSFADREVQLLRESDE--HPNVI 81

Query: 146 KILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLA 205
           +      + +   +  E  +  TL +++  E           + +  +T S L +LHSL 
Sbjct: 82  RYFCTEKDRQFQYIAIELCA-ATLQEYV--EQKDFAHLGLEPITLLQQTTSGLAHLHSLN 138

Query: 206 SPPIIHGDVKSANILL-----NDNYTAKVADF-ESSVLISSDAETAMSTILIGTSGYLDP 259
              I+H D+K  NIL+     +    A ++DF     L       +  + + GT G++ P
Sbjct: 139 ---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195

Query: 260 ---VCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGL 316
                      T   D++S G V   +++                   P F  S++    
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH---------------P-FGKSLQRQAN 239

Query: 317 RQILNFHVADESEMKEIEIVA-ELASKCLRIRGTERPTMKQVSEELDRLRRLHENFWAQK 375
             +    +      K  +++A EL  K + +   +RP+ K V      L+  H  FW+ +
Sbjct: 240 ILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHV------LK--HPFFWSLE 291

Query: 376 KNKE 379
           K  +
Sbjct: 292 KQLQ 295

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  110 bits (276), Expect = 2e-27
 Identities = 75/326 (23%), Positives = 124/326 (38%), Gaps = 82/326 (25%)

Query: 89  FDRS-----RCLSQGGFVSVYKGVLHD------NIQVAVKTYRRADKIRITEREL----- 132
           F R+     + L  G F  V +            ++VAVK      K      E      
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML----KSTAHADEKEALMS 98

Query: 133 -LRIISQV-NHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLK-------- 182
            L+I+S +  H+N+V +LG C      L++ E+   G LL+ +R +S  +          
Sbjct: 99  ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIAN 158

Query: 183 ---TWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFE-SSVLI 238
              + +  L  +++ A  + +   LAS   IH DV + N+LL + + AK+ DF  +  ++
Sbjct: 159 STASTRDLLHFSSQVAQGMAF---LASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIM 215

Query: 239 SSDAETAMSTILIGTSGYLDPV------CINTGKLTKKSDVYSFGVVLAELLTGKKPGSC 292
           +              +  L PV       I     T +SDV+S+G++L E+         
Sbjct: 216 NDSNYIV------KGNARL-PVKWMAPESIFDCVYTVQSDVWSYGILLWEI--------- 259

Query: 293 MTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEM-------KEIEIVAELASKCLR 345
            +L  N      PY    I  N   +     V D  +M       K I     +   C  
Sbjct: 260 FSLGLN------PYP--GILVN--SKFYKL-VKDGYQMAQPAFAPKNIY---SIMQACWA 305

Query: 346 IRGTERPTMKQVSEELDRLRRLHENF 371
           +  T RPT +Q+   L       E+ 
Sbjct: 306 LEPTHRPTFQQICSFLQEQ--AQEDR 329

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  110 bits (276), Expect = 2e-27
 Identities = 61/236 (25%), Positives = 101/236 (42%), Gaps = 51/236 (21%)

Query: 89  FDRS-----RCLSQGGFVSVYKGVLHDN---IQVAVKTYRRADKIRITEREL------LR 134
            D +       + +G F  V K  +  +   +  A+K      K   ++ +       L 
Sbjct: 22  LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM----KEYASKDDHRDFAGELE 77

Query: 135 IISQV-NHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLK----------- 182
           ++ ++ +H N++ +LG C       L  E+A +G LLD +R                   
Sbjct: 78  VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 137

Query: 183 --TWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISS 240
             + +  L  AA+ A  +DY   L+    IH D+ + NIL+ +NY AK+ADF     +S 
Sbjct: 138 TLSSQQLLHFAADVARGMDY---LSQKQFIHRDLAARNILVGENYVAKIADFG----LSR 190

Query: 241 DAETAMSTILIGTSGYLDPV------CINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
             E  +      T G L PV       +N    T  SDV+S+GV+L E+++ G  P
Sbjct: 191 GQEVYVKK----TMGRL-PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  110 bits (277), Expect = 4e-27
 Identities = 57/239 (23%), Positives = 97/239 (40%), Gaps = 49/239 (20%)

Query: 89  FDRS-----RCLSQGGFVSVYKGVLHD--------NIQVAVKTYRRADKIRITERELLR- 134
             R      + L +G F  V                 +VAVK  +     +    +L+  
Sbjct: 66  LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK-DLSDLISE 124

Query: 135 --IISQV-NHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTC---- 187
             ++  +  HKN++ +LG C +     ++ E+AS G L ++++      L+         
Sbjct: 125 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 184

Query: 188 ---------LRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLI 238
                    +  A + A  ++Y   LAS   IH D+ + N+L+ ++   K+ADF  +  I
Sbjct: 185 EEQLSSKDLVSCAYQVARGMEY---LASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 241

Query: 239 -SSDAETAMSTILIGTSGYLDPV------CINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
              D           T+G L PV       +     T +SDV+SFGV+L E+ T G  P
Sbjct: 242 HHIDYYKK------TTNGRL-PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  108 bits (273), Expect = 6e-27
 Identities = 64/331 (19%), Positives = 128/331 (38%), Gaps = 84/331 (25%)

Query: 89  FDRS-----RCLSQGGFVSVYKGVLHD------NIQVAVKTYRRADKIRITERELLR--- 134
           + R+     R + +G F  V++              VAVK   + +     + +  R   
Sbjct: 44  YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKM-LKEEASADMQADFQREAA 102

Query: 135 IISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTC------- 187
           ++++ ++ N+VK+LG+C   +   L++E+ + G L + +R  S   + +           
Sbjct: 103 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 162

Query: 188 --------------LRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADF- 232
                         L IA + A+ + Y   L+    +H D+ + N L+ +N   K+ADF 
Sbjct: 163 VSSPGPPPLSCAEQLCIARQVAAGMAY---LSERKFVHRDLATRNCLVGENMVVKIADFG 219

Query: 233 ESSVLISSDAETAMSTILIGTSGYLDPV------CINTGKLTKKSDVYSFGVVLAELLTG 286
            S  + S+D   A        +  + P+       I   + T +SDV+++GVVL E    
Sbjct: 220 LSRNIYSADYYKA------DGNDAI-PIRWMPPESIFYNRYTTESDVWAYGVVLWE---- 268

Query: 287 KKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEM-------KEIEIVAEL 339
                  +        + PY+   + +    +++ + V D + +        E+     L
Sbjct: 269 -----IFSYG------LQPYY--GMAH---EEVIYY-VRDGNILACPENCPLELY---NL 308

Query: 340 ASKCLRIRGTERPTMKQVSEELDRLRRLHEN 370
              C      +RP+   +   L R+    E 
Sbjct: 309 MRLCWSKLPADRPSFCSIHRILQRMCERAEG 339

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  112 bits (281), Expect = 7e-27
 Identities = 45/209 (21%), Positives = 77/209 (36%), Gaps = 31/209 (14%)

Query: 93  RCLSQGGFVSVYKGVLHDNI----QVAVKTYRRA---DKIRITERELLRIISQVNHKNVV 145
            C++ GG   +Y     D       V +K    +   +   +   E  + +++V H ++V
Sbjct: 86  GCIAHGGLGWIYLA--LDRNVNGRPVVLKGLVHSGDAEAQAMAMAER-QFLAEVVHPSIV 142

Query: 146 KIL-----GLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDY 200
           +I             V  +V E+    +L         Q L      +    E   AL Y
Sbjct: 143 QIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG----QKL-PVAEAIAYLLEILPALSY 197

Query: 201 LHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV 260
           LHS+    +++ D+K  NI+L +    K+ D        S    +   +  GT G+  P 
Sbjct: 198 LHSI---GLVYNDLKPENIMLTEE-QLKLIDLG----AVS-RINSFGYL-YGTPGFQAPE 247

Query: 261 CINTGKLTKKSDVYSFGVVLAELLTGKKP 289
            I     T  +D+Y+ G  LA L      
Sbjct: 248 -IVRTGPTVATDIYTVGRTLAALTLDLPT 275

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  108 bits (271), Expect = 8e-27
 Identities = 63/208 (30%), Positives = 90/208 (43%), Gaps = 22/208 (10%)

Query: 95  LSQGGFVSVYKGVLHDNI---QVAVKTYR---RADKIRIT--ERELLRIISQVNHKNVVK 146
           L  GG   V+     D      VAVK  R     D        RE  +  + +NH  +V 
Sbjct: 20  LGFGGMSEVHLA--RDLRDHRDVAVKVLRADLARDPSFYLRFRREA-QNAAALNHPAIVA 76

Query: 147 IL----GLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLH 202
           +            +P +V E+    TL D +  E      T K  + + A+   AL++ H
Sbjct: 77  VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM---TPKRAIEVIADACQALNFSH 133

Query: 203 SLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMST-ILIGTSGYLDPVC 261
                 IIH DVK ANI+++     KV DF  +  I+    +   T  +IGT+ YL P  
Sbjct: 134 QNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190

Query: 262 INTGKLTKKSDVYSFGVVLAELLTGKKP 289
                +  +SDVYS G VL E+LTG+ P
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  107 bits (268), Expect = 3e-26
 Identities = 60/296 (20%), Positives = 115/296 (38%), Gaps = 45/296 (15%)

Query: 93  RCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADK--IRITERELLRIISQVNHKNVVKILG 149
           R L++GGF  VY+   +    + A+K     ++   R   +E+  +     H N+V+   
Sbjct: 34  RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93

Query: 150 LCLETEVP-------LLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLH 202
                +          L+      G L++ ++   S+   +  T L+I  +T  A+ ++H
Sbjct: 94  AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH 153

Query: 203 SLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILI----------G 252
               PPIIH D+K  N+LL++  T K+ DF S+  IS   + + S               
Sbjct: 154 RQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212

Query: 253 TSGYLDP-VCINTGKL--TKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLN 309
           T  Y  P +          +K D+++ G +L  L   + P                 F  
Sbjct: 213 TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP-----------------F-- 253

Query: 310 SIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLR 365
             ++    +I+N   +      +  +   L    L++   ER ++ +V  +L  + 
Sbjct: 254 --EDGAKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA 307

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  107 bits (269), Expect = 3e-26
 Identities = 62/332 (18%), Positives = 115/332 (34%), Gaps = 97/332 (29%)

Query: 89  FDRS-----RCLSQGGFVSVYKGVLHD------NIQVAVKTYRRADKIRITEREL----- 132
           F R      + L  G F  V     +       +IQVAVK      K +    E      
Sbjct: 42  FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML----KEKADSSEREALMS 97

Query: 133 -LRIISQV-NHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTC--- 187
            L++++Q+ +H+N+V +LG C  +    L++E+   G LL+++R +  +  +        
Sbjct: 98  ELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQ 157

Query: 188 -----------------LRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVA 230
                            L  A + A  +++   L     +H D+ + N+L+      K+ 
Sbjct: 158 KRLEEEEDLNVLTFEDLLCFAYQVAKGMEF---LEFKSCVHRDLAARNVLVTHGKVVKIC 214

Query: 231 DFE-SSVLISSDAETAMSTILIGTSGYLDPV------CINTGKLTKKSDVYSFGVVLAEL 283
           DF  +  ++S              +  L PV       +  G  T KSDV+S+G++L E+
Sbjct: 215 DFGLARDIMSDSNYVV------RGNARL-PVKWMAPESLFEGIYTIKSDVWSYGILLWEI 267

Query: 284 LTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNF-----------HVADESEMKE 332
                     +L         PY    I  +                   +  +E     
Sbjct: 268 ---------FSLGV------NPYP--GIPVD--ANFYKLIQNGFKMDQPFYATEE----- 303

Query: 333 IEIVAELASKCLRIRGTERPTMKQVSEELDRL 364
              +  +   C      +RP+   ++  L   
Sbjct: 304 ---IYIIMQSCWAFDSRKRPSFPNLTSFLGCQ 332

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  106 bits (266), Expect = 4e-26
 Identities = 55/246 (22%), Positives = 89/246 (36%), Gaps = 24/246 (9%)

Query: 55  GGRDPGPTIYSHPGLAFLRMKIFSKSEMIRATKNFDR---SRCLSQGGFVSVYKGVLHDN 111
           G          H      R      +   R    F      R + +GG   VY+    D 
Sbjct: 2   GSSHHHH---HHSSGLVPRGSHMDGTAESREGTQFGPYRLRRLVGRGGMGDVYEA--EDT 56

Query: 112 I---QVAVKTYRR---ADKIRIT--ERELLRIISQVNHKNVVKILGLCLETEVPLLVYEF 163
           +    VA+K       +D +  T  +RE  R   ++   +VV I           +    
Sbjct: 57  VRERIVALKLMSETLSSDPVFRTRMQREA-RTAGRLQEPHVVPIHDFGEIDGQLYVDMRL 115

Query: 164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLND 223
            +   L   +R +           + I  +  SALD  H+       H DVK  NIL++ 
Sbjct: 116 INGVDLAAMLRRQGPL---APPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSA 169

Query: 224 NYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAEL 283
           +  A + DF  +   + +  T +    +GT  Y+ P   +    T ++D+Y+   VL E 
Sbjct: 170 DDFAYLVDFGIASATTDEKLTQLGNT-VGTLYYMAPERFSESHATYRADIYALTCVLYEC 228

Query: 284 LTGKKP 289
           LTG  P
Sbjct: 229 LTGSPP 234

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  104 bits (263), Expect = 7e-26
 Identities = 62/210 (29%), Positives = 95/210 (45%), Gaps = 19/210 (9%)

Query: 87  KNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRI-----TERELLRIISQVN 140
           ++F+  R L +G F +VY          +A+K   +A   +        RE+  I S + 
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV-EIQSHLR 67

Query: 141 HKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALD 199
           H N++++ G        + L+ E+A  GT+   ++          +T      E A+AL 
Sbjct: 68  HPNILRLYG-YFHDATRVYLILEYAPLGTVYRELQ--KLSKFDEQRTA-TYITELANALS 123

Query: 200 YLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDP 259
           Y HS     +IH D+K  N+LL      K+ADF  SV     A ++  T L GT  YL P
Sbjct: 124 YCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVH----APSSRRTDLCGTLDYLPP 176

Query: 260 VCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
             I      +K D++S GV+  E L GK P
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  101 bits (255), Expect = 9e-25
 Identities = 51/213 (23%), Positives = 92/213 (43%), Gaps = 22/213 (10%)

Query: 87  KNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKT--------YRRADKIRITERELLRIIS 137
           ++F     L +G F  VY+   +H  ++VA+K              +++    E+ +I  
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQ---NEV-KIHC 66

Query: 138 QVNHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETAS 196
           Q+ H +++++     E    + LV E   NG +  +++    +     +       +  +
Sbjct: 67  QLKHPSILELYN-YFEDSNYVYLVLEMCHNGEMNRYLK-NRVKPFSENEAR-HFMHQIIT 123

Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
            + YLHS     I+H D+  +N+LL  N   K+ADF  +  +    E    T L GT  Y
Sbjct: 124 GMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHY-T-LCGTPNY 178

Query: 257 LDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           + P          +SDV+S G +   LL G+ P
Sbjct: 179 ISPEIATRSAHGLESDVWSLGCMFYTLLIGRPP 211

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  102 bits (256), Expect = 1e-24
 Identities = 50/213 (23%), Positives = 88/213 (41%), Gaps = 23/213 (10%)

Query: 87  KNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRA--------DKIRITERELLRIIS 137
           + + R R L +GGF   ++          A K   ++        +K+     E+  I  
Sbjct: 41  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS---MEI-SIHR 96

Query: 138 QVNHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETAS 196
            + H++VV   G   E    + +V E     +LL+  +    + L   +       +   
Sbjct: 97  SLAHQHVVGFHG-FFEDNDFVFVVLELCRRRSLLELHK--RRKALTEPEAR-YYLRQIVL 152

Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
              YLH      +IH D+K  N+ LN++   K+ DF  +  +  D E     +L GT  Y
Sbjct: 153 GCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--RKKVLCGTPNY 207

Query: 257 LDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           + P  ++    + + DV+S G ++  LL GK P
Sbjct: 208 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  103 bits (257), Expect = 1e-24
 Identities = 38/316 (12%), Positives = 77/316 (24%), Gaps = 56/316 (17%)

Query: 79  KSEMIRATKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRITERELLR--- 134
            S + +  +       L  G    V+    +      A+K +    +   +E E L    
Sbjct: 54  DSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEAT 113

Query: 135 -IISQVNHKNVVKILGLCLETEVP--------------------------LLVYEFASNG 167
              +++  ++  +                                     LL+   AS  
Sbjct: 114 FAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-V 172

Query: 168 TLLDHI----RCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLND 223
            L             +  +       + A+       L S     ++HG     N+ +  
Sbjct: 173 DLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMP 229

Query: 224 NYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCI--NTGKLTKKSDVYSFGVVLA 281
           +    + D  +                     Y     +  +T   T   + +  G+ + 
Sbjct: 230 DGRLMLGDVSALW-----KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIY 284

Query: 282 ELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELAS 341
            +     P   +T          P    S K   LR      +A  S     + V  L  
Sbjct: 285 RVWCLFLPFGLVT----------PGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIG 334

Query: 342 KCLRIRGTERPTMKQV 357
           + L      R    + 
Sbjct: 335 RFLNFDRRRRLLPLEA 350

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  101 bits (253), Expect = 1e-24
 Identities = 55/209 (26%), Positives = 87/209 (41%), Gaps = 19/209 (9%)

Query: 88  NFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRI-----TERELLRIISQVNH 141
           +FD  R L +G F +VY      +   +A+K   ++   +        RE+  I S + H
Sbjct: 15  DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREI-EIQSHLRH 73

Query: 142 KNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDY 200
            N++++          + L+ EFA  G L   ++          ++      E A AL Y
Sbjct: 74  PNILRMYN-YFHDRKRIYLMLEFAPRGELYKELQ--KHGRFDEQRSA-TFMEELADALHY 129

Query: 201 LHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV 260
            H      +IH D+K  N+L+      K+ADF  SV     A +     + GT  YL P 
Sbjct: 130 CHERK---VIHRDIKPENLLMGYKGELKIADFGWSVH----APSLRRRTMCGTLDYLPPE 182

Query: 261 CINTGKLTKKSDVYSFGVVLAELLTGKKP 289
            I      +K D++  GV+  E L G  P
Sbjct: 183 MIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  101 bits (254), Expect = 2e-24
 Identities = 37/219 (16%), Positives = 79/219 (36%), Gaps = 24/219 (10%)

Query: 87  KNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLR---IISQVNHKN 143
           + +   + +  GG   V++ +       A+K     +    T          ++++   +
Sbjct: 28  RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87

Query: 144 --VVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYL 201
             ++++    +  +   +V E   N  L   ++    + +               A+  +
Sbjct: 88  DKIIRLYDYEITDQYIYMVMECG-NIDLNSWLK--KKKSI-DPWERKSYWKNMLEAVHTI 143

Query: 202 HSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGT-------- 253
           H      I+H D+K AN L+ D    K+ DF  +  +  D  + +    +GT        
Sbjct: 144 HQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 199

Query: 254 ---SGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
                       +  K++ KSDV+S G +L  +  GK P
Sbjct: 200 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  103 bits (257), Expect = 2e-24
 Identities = 48/393 (12%), Positives = 105/393 (26%), Gaps = 88/393 (22%)

Query: 17  ARLQDIASQIKQLDLRKKSGRKSRNVRGVISSAVRRGRGGRDPGPTIYSHPGLAFLRMKI 76
             ++++ ++I Q ++R  S         ++S+++                          
Sbjct: 27  VVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQ-------------------PF 67

Query: 77  FSKSEMIRATKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRR-----ADKIRITER 130
             +SE+    +   R   L Q    +  +           V          ++ I+  + 
Sbjct: 68  RVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKE 127

Query: 131 ELLRI---------------------ISQVNHKNVVKILGLCLETEVPLLVYEF----AS 165
           E+LR+                        V      K++ + L+     ++  F      
Sbjct: 128 EVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM 187

Query: 166 NGTLLDHIRCESSQVLK----TWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILL 221
              L        S             L++  +    L  LH      ++H  ++  +I+L
Sbjct: 188 QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVL 244

Query: 222 NDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCI-----NTGKLTKKSDVYSF 276
           +      +  FE  V   + A +                 +     +   +T   D ++ 
Sbjct: 245 DQRGGVFLTGFEHLVRDGASAVS-PIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTL 303

Query: 277 GVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIV 336
           G+ +  +     P                   +     G   I      +       + V
Sbjct: 304 GLAIYWIWCADLP-----------------NTDDAALGGSEWIFR-SCKNIP-----QPV 340

Query: 337 AELASKCLRIRGTERPTMKQVSE--ELDRLRRL 367
             L    LR    +R    Q  E  E ++LR  
Sbjct: 341 RALLEGFLRYPKEDRLLPLQAMETPEYEQLRTE 373

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  100 bits (252), Expect = 2e-24
 Identities = 50/213 (23%), Positives = 88/213 (41%), Gaps = 23/213 (10%)

Query: 87  KNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRA--------DKIRITERELLRIIS 137
           + + R R L +GGF   ++          A K   ++        +K+     E+  I  
Sbjct: 15  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS---MEI-SIHR 70

Query: 138 QVNHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETAS 196
            + H++VV   G   E    + +V E     +LL+  +    + L   +       +   
Sbjct: 71  SLAHQHVVGFHG-FFEDNDFVFVVLELCRRRSLLELHK--RRKALTEPEAR-YYLRQIVL 126

Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
              YLH      +IH D+K  N+ LN++   K+ DF  +  +  D E     +L GT  Y
Sbjct: 127 GCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--RKKVLCGTPNY 181

Query: 257 LDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           + P  ++    + + DV+S G ++  LL GK P
Sbjct: 182 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 214

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  100 bits (252), Expect = 3e-24
 Identities = 48/221 (21%), Positives = 86/221 (38%), Gaps = 25/221 (11%)

Query: 87  KNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRA---DKIRITERELLRIISQVNHK 142
             +  S  L QG   +V++G         A+K +        + +  RE   ++ ++NHK
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREF-EVLKKLNHK 67

Query: 143 NVVKILGL--CLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDY 200
           N+VK+  +     T   +L+ EF   G+L   +   S+         L +  +    +++
Sbjct: 68  NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127

Query: 201 LHSLASPPIIHGDVKSANILL----NDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
           L       I+H ++K  NI+     +     K+ DF ++  +  D      + L GT  Y
Sbjct: 128 LRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD--EQFVS-LYGTEEY 181

Query: 257 LDP--------VCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           L P           +  K     D++S GV      TG  P
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  102 bits (255), Expect = 4e-24
 Identities = 56/306 (18%), Positives = 105/306 (34%), Gaps = 35/306 (11%)

Query: 87  KNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRA---DKIRITERELLRIISQVNHK 142
             +  S  L QG   +V++G         A+K +        + +  RE   ++ ++NHK
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREF-EVLKKLNHK 67

Query: 143 NVVKILGL--CLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDY 200
           N+VK+  +     T   +L+ EF   G+L   +   S+         L +  +    +++
Sbjct: 68  NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127

Query: 201 LHSLASPPIIHGDVKSANILL----NDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
           L       I+H ++K  NI+     +     K+ DF ++  +  D      + L GT  Y
Sbjct: 128 LRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD--EQFVS-LYGTEEY 181

Query: 257 LDP--------VCINTGKLTKKSDVYSFGVVLAELLTGKKP----------GSCMTLASN 298
           L P           +  K     D++S GV      TG  P             M     
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241

Query: 299 KKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVS 358
            K S     +   +N  +    +  V+         ++  + +  L     +     Q  
Sbjct: 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFF 301

Query: 359 EELDRL 364
            E   +
Sbjct: 302 AETSDI 307

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  100 bits (252), Expect = 5e-24
 Identities = 49/266 (18%), Positives = 94/266 (35%), Gaps = 27/266 (10%)

Query: 35  SGRKSRNVRGVISSAVRRGRGGRDPGPTIYSHPGLAFLRMKIFSKSEMIRATKNFDRSRC 94
           S  ++ ++  +  +        +  GP    + G+           E             
Sbjct: 6   SSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPR 65

Query: 95  LSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRITEREL--LRIISQVNHKNVVKILGLC 151
           + +G F  V++        Q AVK      K+R+    +  L   + ++   +V + G  
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVK------KVRLEVFRVEELVACAGLSSPRIVPLYGAV 119

Query: 152 LETEVPLLVYEFASNG---TLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPP 208
            E     +  E    G    L+  + C                 +    L+YLH+     
Sbjct: 120 REGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALY------YLGQALEGLEYLHTRR--- 170

Query: 209 IIHGDVKSANILLNDN-YTAKVADFESSVLISSDAETAMSTI---LIGTSGYLDP-VCIN 263
           I+HGDVK+ N+LL+ +   A + DF  ++ +  D           + GT  ++ P V + 
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230

Query: 264 TGKLTKKSDVYSFGVVLAELLTGKKP 289
                 K D++S   ++  +L G  P
Sbjct: 231 KPC-DAKVDIWSSCCMMLHMLNGCHP 255

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  100 bits (251), Expect = 8e-24
 Identities = 45/288 (15%), Positives = 102/288 (35%), Gaps = 42/288 (14%)

Query: 87  KNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLR---IISQVNHKN 143
           + +   + +  GG   V++ +       A+K     +    T          ++++   +
Sbjct: 9   RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68

Query: 144 --VVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDY 200
             ++++      T+  + +V E   N  L   ++    + +  W            A+  
Sbjct: 69  DKIIRLYD-YEITDQYIYMVMECG-NIDLNSWLK--KKKSIDPW-ERKSYWKNMLEAVHT 123

Query: 201 LHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGT------- 253
           +H      I+H D+K AN L+ D    K+ DF  +  +  D  + +    +GT       
Sbjct: 124 IHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 179

Query: 254 ----SGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLN 309
                        +  K++ KSDV+S G +L  +  GK P   +    +K        L+
Sbjct: 180 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK--------LH 231

Query: 310 SIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQV 357
           +I +             +        + ++   CL+    +R ++ ++
Sbjct: 232 AIIDPNHEIEFPDIPEKD--------LQDVLKCCLKRDPKQRISIPEL 271

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 99.4 bits (248), Expect = 2e-23
 Identities = 59/327 (18%), Positives = 119/327 (36%), Gaps = 48/327 (14%)

Query: 88  NFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRIT------------------- 128
           ++   R L+QG F  +      DN   A+K Y ++   +                     
Sbjct: 32  DYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDF 90

Query: 129 ERELLRIISQVNHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRC-----ESSQVLK 182
           + EL +II+ + ++  +   G+ +     + ++YE+  N ++L          ++     
Sbjct: 91  KNEL-QIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148

Query: 183 TWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADF-ESSVLISSD 241
             +    I     ++  Y+H+  +  I H DVK +NIL++ N   K++DF ES  ++   
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK 206

Query: 242 AETAMSTILIGTSGYLDP-VCINTGKL-TKKSDVYSFGVVLAELLTGKKP--GSCMTLAS 297
            + +      GT  ++ P    N       K D++S G+ L  +     P       +  
Sbjct: 207 IKGSR-----GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL 261

Query: 298 NKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQV 357
              I          +N+ L  + N      +     E   +     LR    ER T +  
Sbjct: 262 FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNE-DIDFLKLFLRKNPAERITSEDA 320

Query: 358 SE-------ELDRLRRLHENFWAQKKN 377
            +        ++ LR   +  + ++K 
Sbjct: 321 LKHEWLADTNIEDLREFSKELYKKRKK 347

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 99.5 bits (248), Expect = 3e-23
 Identities = 37/219 (16%), Positives = 79/219 (36%), Gaps = 24/219 (10%)

Query: 87  KNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLR---IISQVNHKN 143
           + +   + +  GG   V++ +       A+K     +    T          ++++   +
Sbjct: 56  RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115

Query: 144 --VVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYL 201
             ++++    +  +   +V E   N  L   ++    + +  W            A+  +
Sbjct: 116 DKIIRLYDYEITDQYIYMVMECG-NIDLNSWLK--KKKSIDPW-ERKSYWKNMLEAVHTI 171

Query: 202 HSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGT-------- 253
           H      I+H D+K AN L+ D    K+ DF  +  +  D  + +    +G         
Sbjct: 172 HQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEA 227

Query: 254 ---SGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
                       +  K++ KSDV+S G +L  +  GK P
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 97.0 bits (242), Expect = 5e-23
 Identities = 47/236 (19%), Positives = 87/236 (36%), Gaps = 43/236 (18%)

Query: 84  RATKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRITERELLRIISQV--- 139
           R T  F     +  G F SV+K V   D    A+K   R+ K      +    + +V   
Sbjct: 8   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIK---RSKKPLAGSVDEQNALREVYAH 64

Query: 140 ----NHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWK--TCLRIAAE 193
                H +VV+      E +  L+  E+ + G+L D I  E+ +++  +K      +  +
Sbjct: 65  AVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAIS-ENYRIMSYFKEAELKDLLLQ 123

Query: 194 TASALDYLHSLASPPIIHGDVKSANILLNDN-------------------YTAKVADFES 234
               L Y+HS++   ++H D+K +NI ++                        K+ D   
Sbjct: 124 VGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH 180

Query: 235 SVLISSDAETAMSTILIGTSGYLDP-VCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
              ISS        +  G S +L   V         K+D+++  + +      +  
Sbjct: 181 VTRISS------PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  100 bits (249), Expect = 7e-23
 Identities = 55/219 (25%), Positives = 90/219 (41%), Gaps = 20/219 (9%)

Query: 84  RATKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRITE---RELLRIISQV 139
           +    ++    L  GGF  V + +      QVA+K  R+    +  E    E+ +I+ ++
Sbjct: 11  QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEI-QIMKKL 69

Query: 140 NHKNVVKIL------GLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAE 193
           NH NVV               ++PLL  E+   G L  ++    +           + ++
Sbjct: 70  NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSD 129

Query: 194 TASALDYLHSLASPPIIHGDVKSANILL---NDNYTAKVADFESSVLISSDAETAMSTIL 250
            +SAL YLH      IIH D+K  NI+L         K+ D   +  +        +   
Sbjct: 130 ISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG--ELCTE-F 183

Query: 251 IGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           +GT  YL P  +   K T   D +SFG +  E +TG +P
Sbjct: 184 VGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 222

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 96.6 bits (241), Expect = 8e-23
 Identities = 52/205 (25%), Positives = 91/205 (44%), Gaps = 12/205 (5%)

Query: 91  RSRCLSQGGFVSVYKGV-LHDNIQVAVK--TYRRADKIRITERELLRIISQVNHKNVVKI 147
               L +G +  VY G  L + +++A+K    R +   +    E+  +   + HKN+V+ 
Sbjct: 26  DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEI-ALHKHLKHKNIVQY 84

Query: 148 LGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASP 207
           LG   E     +  E    G+L   +R +   +    +T      +    L YLH     
Sbjct: 85  LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ-- 142

Query: 208 PIIHGDVKSANILLN-DNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGK 266
            I+H D+K  N+L+N  +   K++DF +S  ++       +    GT  Y+ P  I+ G 
Sbjct: 143 -IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKGP 199

Query: 267 L--TKKSDVYSFGVVLAELLTGKKP 289
               K +D++S G  + E+ TGK P
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGKPP 224

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 96.1 bits (239), Expect = 2e-22
 Identities = 47/246 (19%), Positives = 79/246 (32%), Gaps = 35/246 (14%)

Query: 123 DKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLK 182
                     +R +   + KN V  L          +  +      L D +    S   +
Sbjct: 102 PSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR 161

Query: 183 TWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADF---------- 232
               CL I  + A A+++LHS     ++H D+K +NI    +   KV DF          
Sbjct: 162 EHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE 218

Query: 233 ESSVLISSDAETAMSTILIGTSGYLDP-VCINTGKLTKKSDVYSFGVVLAELLTGKKPGS 291
           E   +++     A  T  +GT  Y+ P         + K D++S G++L ELL       
Sbjct: 219 EEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNN-YSHKVDIFSLGLILFELLYSFSTQM 277

Query: 292 CMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTER 351
                           +  ++N     +       E           +    L    TER
Sbjct: 278 ERVR-----------IITDVRNLKFPLLFTQKYPQE---------HMMVQDMLSPSPTER 317

Query: 352 PTMKQV 357
           P    +
Sbjct: 318 PEATDI 323

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 40.3 bits (94), Expect = 7e-04
 Identities = 19/108 (17%), Positives = 42/108 (38%), Gaps = 5/108 (4%)

Query: 84  RATKNFDRSRCLSQGGFVSVYKGVLH--DNIQVAVKTYRRADKIRITEREL--LRIISQV 139
           R   +F+  +C+ +GGF  V++   +  D+   A+K  R  ++    E+ +  ++ ++++
Sbjct: 3   RYLTDFEPIQCMGRGGFGVVFE-AKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL 61

Query: 140 NHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTC 187
            H  +V+     LET       E        +      S         
Sbjct: 62  EHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPS 109

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 95.5 bits (238), Expect = 2e-22
 Identities = 54/213 (25%), Positives = 101/213 (47%), Gaps = 25/213 (11%)

Query: 86  TKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVK--TYRRADKIRITERELLRIISQVNHK 142
            K + R   + QG   +VY  + +    +VA++    ++  K  +   E+L ++ +  + 
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEIL-VMRENKNP 77

Query: 143 NVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLR---IAA---ETAS 196
           N+V  L   L  +   +V E+ + G+L D +           +TC+    IAA   E   
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT----------ETCMDEGQIAAVCRECLQ 127

Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
           AL++LHS     +IH D+KS NILL  + + K+ DF     I+ +     +  ++GT  +
Sbjct: 128 ALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYW 182

Query: 257 LDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           + P  +       K D++S G++  E++ G+ P
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 97.2 bits (242), Expect = 3e-22
 Identities = 69/321 (21%), Positives = 114/321 (35%), Gaps = 62/321 (19%)

Query: 87  KNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERE--LLRIISQVNHKNV 144
                 + L  G   +V          VAVK     D   I   E  LL      +H NV
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI-DFCDIALMEIKLLTESD--DHPNV 71

Query: 145 VKILGLCLETEVPL-LVYEFASNGTLLDHI----RCESSQVLKTWKTCLRIAAETASALD 199
           ++       T+  L +  E   N  L D +      + +  L+     + +  + AS + 
Sbjct: 72  IRYYCSE-TTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129

Query: 200 YLHSLASPPIIHGDVKSANILL-------------NDNYTAKVADFESSVLISSDAETAM 246
           +LHSL    IIH D+K  NIL+              +N    ++DF     + S   +  
Sbjct: 130 HLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186

Query: 247 STI--LIGTSGYLDP-------VCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLAS 297
           + +    GTSG+  P             +LT+  D++S G V   +L+  K         
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH-------- 238

Query: 298 NKKISMVPYF-LNSIKNNGLRQILNFHVADESEMKEIEIVA-ELASKCLRIRGTERPTMK 355
                  P+    S ++N +R I +         + +   A +L S+ +     +RPT  
Sbjct: 239 -------PFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAM 291

Query: 356 QVSEELDRLRRLHENFWAQKK 376
           +V          H  FW + K
Sbjct: 292 KV--------LRHPLFWPKSK 304

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 95.1 bits (237), Expect = 4e-22
 Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 21/211 (9%)

Query: 86  TKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNV 144
            + FD    L +G + SVYK +       VA+K       ++   +E+  I+ Q +  +V
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEIS-IMQQCDSPHV 86

Query: 145 VKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLR---IAA---ETASAL 198
           VK  G   +     +V E+   G++ D        +++     L    IA     T   L
Sbjct: 87  VKYYGSYFKNTDLWIVMEYCGAGSVSD--------IIRLRNKTLTEDEIATILQSTLKGL 138

Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLD 258
           +YLH +     IH D+K+ NILLN    AK+ADF  +  ++     A    +IGT  ++ 
Sbjct: 139 EYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTD--TMAKRNTVIGTPFWMA 193

Query: 259 PVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           P  I        +D++S G+   E+  GK P
Sbjct: 194 PEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 95.8 bits (238), Expect = 4e-22
 Identities = 45/385 (11%), Positives = 106/385 (27%), Gaps = 85/385 (22%)

Query: 13  KEVNARLQDIASQIKQLDLRKKSGRKSRNVRGVISSAVRRGRGGRDPGPTIYSHPGLAFL 72
              +  ++++ ++I Q ++R  S         ++S+++                      
Sbjct: 18  GPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQ----------------- 60

Query: 73  RMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVK-----TYRRADKIR 126
                 +SE+    +   R   L Q    +  +           V          ++ I+
Sbjct: 61  --PFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIK 118

Query: 127 ITERELLR------------------------IISQVNHKNVVKILGLCLETEVP--LLV 160
             + E+LR                        ++     K ++++     +  V     +
Sbjct: 119 QMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFL 178

Query: 161 YEFA--SNGTLLDHI-RCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSA 217
           Y     +  T  + +    S+         L++  +    L  LH      ++H  ++  
Sbjct: 179 YPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPV 235

Query: 218 NILLNDNYTAKVADFESSVLISSDAETAMSTI-----LIGTSGYLDPVCINTGKLTKKSD 272
           +I+L+      +  FE  V   +   +++S       L      +         +T   D
Sbjct: 236 DIVLDQRGGVFLTGFEHLVRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFD 295

Query: 273 VYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKE 332
            ++ G+V+  +     P                         G   I      +  +   
Sbjct: 296 AWALGLVIYWIWCADLP-----------------ITKDAALGGSEWIFR-SCKNIPQP-- 335

Query: 333 IEIVAELASKCLRIRGTERPTMKQV 357
              V  L    LR    +R    Q 
Sbjct: 336 ---VRALLEGFLRYPKEDRLLPLQA 357

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 94.9 bits (236), Expect = 8e-22
 Identities = 71/350 (20%), Positives = 114/350 (32%), Gaps = 67/350 (19%)

Query: 89  FDRSRCLSQGGFVSVYKGVLH--DNIQVAVKTYRR---ADKIRITERELLRIISQVNHKN 143
           F++   L  G    V+K V H    + +A K               REL +++ + N   
Sbjct: 35  FEKISELGAGNGGVVFK-VSHKPSGLVMARKLIHLEIKPAIRNQIIREL-QVLHECNSPY 92

Query: 144 VVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCL-----RIAAETASAL 198
           +V   G         +  E    G+L          VLK           +++      L
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQ--------VLKKAGRIPEQILGKVSIAVIKGL 144

Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTAKVADFE-SSVLISSDAETAMSTILIGTSGYL 257
            YL       I+H DVK +NIL+N     K+ DF  S  LI S A +      +GT  Y+
Sbjct: 145 TYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-----FVGTRSYM 197

Query: 258 DPVCINTGKLTKKSDVYSFGVVLAELLTGKKP----GSCMTLASNKKISMVPYFLNSIKN 313
            P  +     + +SD++S G+ L E+  G+ P     +                    + 
Sbjct: 198 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 257

Query: 314 NGLRQILNFHVADESEMKEI-----EIVAELA----------------SKCLRIRGTERP 352
               + LN    D      I      IV E                  +KCL     ER 
Sbjct: 258 RTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERA 317

Query: 353 TMKQVSEELDRLRRLHENFWAQKKNKETEHLLGESSSYATAVIAQPDAQT 402
            +KQ          L  + + ++ + E        + +  + I      T
Sbjct: 318 DLKQ----------LMVHAFIKRSDAEEVDF----AGWLCSTIGLNQPST 353

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 95.1 bits (237), Expect = 2e-21
 Identities = 66/295 (22%), Positives = 117/295 (39%), Gaps = 35/295 (11%)

Query: 72  LRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRITER 130
               +F +      +  +   R L +G F  V          + AVK   +    + T++
Sbjct: 11  ATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDK 70

Query: 131 ELLR----IISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKT 186
           E L     ++ Q++H N++K+     +     LV E  + G L D I         +   
Sbjct: 71  ESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRF---SEVD 127

Query: 187 CLRIAAETASALDYLHSLASPPIIHGDVKSANILL---NDNYTAKVADFESSVLISSDAE 243
             RI  +  S + Y+H      I+H D+K  N+LL   + +   ++ DF  S    +  +
Sbjct: 128 AARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK 184

Query: 244 TAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISM 303
             M    IGT+ Y+ P  ++ G   +K DV+S GV+L  LL+G  P      A+   I  
Sbjct: 185 --MKDK-IGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPP---FNGANEYDI-- 235

Query: 304 VPYFLNSIKNNGLRQILNFHVADESEMKEIEIVA-ELASKCLRIRGTERPTMKQV 357
               L  +     +    F   +  + K++   A +L  K L    + R + +  
Sbjct: 236 ----LKKV----EKGKYTF---ELPQWKKVSESAKDLIRKMLTYVPSMRISARDA 279

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 92.4 bits (230), Expect = 3e-21
 Identities = 57/213 (26%), Positives = 91/213 (42%), Gaps = 25/213 (11%)

Query: 86  TKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKT--YRRADKIRITERELLRIISQVNHK 142
               D    + +G    V      H   QVAVK    R+  +  +   E++ I+    H 
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVV-IMRDYQHF 102

Query: 143 NVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLR---IAA---ETAS 196
           NVV++    L  E   ++ EF   G L D +           +  L    IA        
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVS----------QVRLNEEQIATVCEAVLQ 152

Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
           AL YLH+     +IH D+KS +ILL  +   K++DF     IS D     S  L+GT  +
Sbjct: 153 ALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYW 207

Query: 257 LDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           + P  I+      + D++S G+++ E++ G+ P
Sbjct: 208 MAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 94.0 bits (234), Expect = 5e-21
 Identities = 67/315 (21%), Positives = 116/315 (36%), Gaps = 36/315 (11%)

Query: 52  RGRGGRDPGPTIYSHPGLAFLRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGV-LHD 110
                   G       G       +F  S+    ++ + R + L  G +  V        
Sbjct: 2   HHHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVT 61

Query: 111 NIQVAVKTYRRADKIRITERELLR----IISQVNHKNVVKILGLCLETEVPLLVYEFASN 166
           +++ A+K  R+   +  +    L     ++  ++H N++K+     +     LV E    
Sbjct: 62  HVERAIKIIRKT-SVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKG 120

Query: 167 GTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILL---ND 223
           G L D I                I  +  S + YLH      I+H D+K  N+LL     
Sbjct: 121 GELFDEIIHRMKF---NEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEK 174

Query: 224 NYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAEL 283
           +   K+ DF  S +  +     M    +GT+ Y+ P  +   K  +K DV+S GV+L  L
Sbjct: 175 DALIKIVDFGLSAVFENQ--KKMKER-LGTAYYIAPEVLR-KKYDEKCDVWSIGVILFIL 230

Query: 284 LTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVA-ELASK 342
           L G  P    T   +++I      L  +     +    F   D  E K +   A +L  +
Sbjct: 231 LAGYPPFGGQT---DQEI------LRKV----EKGKYTF---DSPEWKNVSEGAKDLIKQ 274

Query: 343 CLRIRGTERPTMKQV 357
            L+     R + +Q 
Sbjct: 275 MLQFDSQRRISAQQA 289

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 90.1 bits (224), Expect = 2e-20
 Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 26/214 (12%)

Query: 86  TKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTY---RRADKIRITERELLRIISQVNH 141
            + F +   + +G F  V+KG+       VA+K        D+I   ++E+  ++SQ + 
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEIT-VLSQCDS 79

Query: 142 KNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLR---IAA---ETA 195
             V K  G  L+     ++ E+   G+ LD +              L    IA    E  
Sbjct: 80  PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE----------PGPLDETQIATILREIL 129

Query: 196 SALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG 255
             LDYLHS      IH D+K+AN+LL+++   K+ADF  +  ++       +   +GT  
Sbjct: 130 KGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPF 184

Query: 256 YLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           ++ P  I       K+D++S G+   EL  G+ P
Sbjct: 185 WMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 90.7 bits (225), Expect = 3e-20
 Identities = 42/221 (19%), Positives = 78/221 (35%), Gaps = 25/221 (11%)

Query: 86  TKNFDRSRCLSQG--GFVSVYKGV-LHDNIQVAVK----TYRRADKIRITERELLRIISQ 138
              ++    + +G    ++V           V V+         + +   + EL  +   
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGEL-HVSKL 82

Query: 139 VNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAA---ETA 195
            NH N+V      +      +V  F + G+  D I       +      L IA       
Sbjct: 83  FNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNE----LAIAYILQGVL 138

Query: 196 SALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD-----AETAMSTIL 250
            ALDY+H +     +H  VK+++IL++ +    ++   S++ + S               
Sbjct: 139 KALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYS 195

Query: 251 IGTSGYLDPVCINTGKL--TKKSDVYSFGVVLAELLTGKKP 289
           +    +L P  +         KSD+YS G+   EL  G  P
Sbjct: 196 VKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 88.9 bits (221), Expect = 4e-20
 Identities = 48/218 (22%), Positives = 86/218 (39%), Gaps = 28/218 (12%)

Query: 86  TKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKT--YRRADKIRITERELLRIISQVNHK 142
            + ++    L  G F  VYK          A K    +  +++     E+  I++  +H 
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIE-ILATCDHP 76

Query: 143 NVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLR---IAA---ETAS 196
            +VK+LG         ++ EF   G +          ++      L    I     +   
Sbjct: 77  YIVKLLGAYYHDGKLWIMIEFCPGGAVDA--------IMLELDRGLTEPQIQVVCRQMLE 128

Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
           AL++LHS     IIH D+K+ N+L+      ++ADF  S       +   S   IGT  +
Sbjct: 129 ALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYW 183

Query: 257 LDPVCINTGKLTK-----KSDVYSFGVVLAELLTGKKP 289
           + P  +    +       K+D++S G+ L E+   + P
Sbjct: 184 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 88.8 bits (221), Expect = 5e-20
 Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 19/212 (8%)

Query: 87  KNFDRSRCLSQGGFVSVYKGVLHDNIQV-AVKTYRRADKIR-------ITERELLRIISQ 138
           ++F   + L +G F +V         +  A+K   +   I+         ER    ++S+
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRER---DVMSR 86

Query: 139 VNHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
           ++H   VK+     + +  L     +A NG LL +IR           T     AE  SA
Sbjct: 87  LDHPFFVKLYF-TFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRF-YTAEIVSA 142

Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYL 257
           L+YLH      IIH D+K  NILLN++   ++ DF ++ ++S +++ A +   +GT+ Y+
Sbjct: 143 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 199

Query: 258 DPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
            P  +      K SD+++ G ++ +L+ G  P
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 90.5 bits (225), Expect = 7e-20
 Identities = 68/297 (22%), Positives = 113/297 (38%), Gaps = 46/297 (15%)

Query: 74  MKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRITEREL 132
            +           + ++    L +G F  V K        + AVK   +A   +  +   
Sbjct: 11  RENLYFQGTFA--ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKA-SAKNKDTST 67

Query: 133 LR----IISQVNHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTC 187
           +     ++ +++H N++K+  +  E      +V E  + G L D I         +    
Sbjct: 68  ILREVELLKKLDHPNIMKLFEIL-EDSSSFYIVGELYTGGELFDEIIKRKRF---SEHDA 123

Query: 188 LRIAAETASALDYLHSLASPPIIHGDVKSANILL---NDNYTAKVADFESSVLISSDAET 244
            RI  +  S + Y+H      I+H D+K  NILL     +   K+ DF  S     +  T
Sbjct: 124 ARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--T 178

Query: 245 AMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP--GSCMTLASNKKIS 302
            M    IGT+ Y+ P  +  G   +K DV+S GV+L  LL+G  P  G      +   I 
Sbjct: 179 KMKDR-IGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPPFYGK-----NEYDI- 230

Query: 303 MVPYFLNSIKNNGLRQILNFHVA-DESEMKEIEIVA-ELASKCLRIRGTERPTMKQV 357
                        L+++     A D  + + I   A +L  K L    + R T  Q 
Sbjct: 231 -------------LKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQC 274

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 87.7 bits (218), Expect = 1e-19
 Identities = 65/294 (22%), Positives = 110/294 (37%), Gaps = 38/294 (12%)

Query: 74  MKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKT---YRRADKIRITE 129
            +       I     F   R L  G F  V+        ++  +KT    R    +   E
Sbjct: 11  RENLYFQGTID--DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIE 68

Query: 130 RELLRIISQVNHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLK-TWKTC 187
            E+  ++  ++H N++KI  +  E    + +V E    G LL+ I    ++    +    
Sbjct: 69  AEI-EVLKSLDHPNIIKIFEVF-EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYV 126

Query: 188 LRIAAETASALDYLHSLASPPIIHGDVKSANILL---NDNYTAKVADFESSVLISSDAET 244
             +  +  +AL Y HS     ++H D+K  NIL    + +   K+ DF  + L  SD   
Sbjct: 127 AELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD--E 181

Query: 245 AMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMV 304
             +    GT+ Y+ P       +T K D++S GVV+  LLTG  P               
Sbjct: 182 HSTNA-AGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLP--------------- 224

Query: 305 PYFLNSIKNNGLRQILNFHVADESEMKEIEIVA-ELASKCLRIRGTERPTMKQV 357
             F  +      ++          E + +   A +L  + L      RP+  QV
Sbjct: 225 --FTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQV 276

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 87.5 bits (217), Expect = 1e-19
 Identities = 24/204 (11%), Positives = 54/204 (26%), Gaps = 46/204 (22%)

Query: 93  RCLSQGGFVSVYKGVLHDNI---QVAVKTYRRADKIRITERELL----RIISQVNHKNVV 145
                   +  ++    D     QVA+        +     +        +S+++   V 
Sbjct: 37  IFHGGVPPLQFWQA--LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94

Query: 146 KILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLA 205
           ++L +       L+V E+   G+L +                +R     A+A D  H   
Sbjct: 95  RVLDVVHTRAGGLVVAEWIRGGSLQEVAD----TSPSPVGA-IRAMQSLAAAADAAHRA- 148

Query: 206 SPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTG 265
              +       + + ++ +    +A                          +        
Sbjct: 149 --GVALSIDHPSRVRVSIDGDVVLAYP----------------------ATMPDA----- 179

Query: 266 KLTKKSDVYSFGVVLAELLTGKKP 289
               + D+   G  L  LL  + P
Sbjct: 180 --NPQDDIRGIGASLYALLVNRWP 201

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 86.9 bits (216), Expect = 2e-19
 Identities = 52/225 (23%), Positives = 91/225 (40%), Gaps = 21/225 (9%)

Query: 73  RMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRITERE 131
             +           + ++    L +G F  V K        + AVK   +A   +  +  
Sbjct: 10  GRENLYFQGTFA--ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKA-SAKNKDTS 66

Query: 132 LLR----IISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTC 187
            +     ++ +++H N++K+  +  ++    +V E  + G L D I              
Sbjct: 67  TILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI 126

Query: 188 LRIAAETASALDYLHSLASPPIIHGDVKSANILL---NDNYTAKVADFESSVLISSDAET 244
           ++      S + Y+H      I+H D+K  NILL     +   K+ DF  S     +  T
Sbjct: 127 IKQVF---SGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--T 178

Query: 245 AMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
            M    IGT+ Y+ P  +  G   +K DV+S GV+L  LL+G  P
Sbjct: 179 KMKDR-IGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPP 221

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 87.0 bits (216), Expect = 2e-19
 Identities = 51/216 (23%), Positives = 94/216 (43%), Gaps = 17/216 (7%)

Query: 87  KNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTY---RRADKIRITERELLRIISQVNHK 142
            +++    +  G    V          +VA+K     +    +    +E+   +SQ +H 
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQ-AMSQCHHP 73

Query: 143 NVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTC--LRIAA---ETASA 197
           N+V      +  +   LV +  S G++LD I+   ++            IA    E    
Sbjct: 74  NIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133

Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTI---LIGTS 254
           L+YLH       IH DVK+ NILL ++ + ++ADF  S  +++  +   + +    +GT 
Sbjct: 134 LEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190

Query: 255 GYLDPVCINTGKL-TKKSDVYSFGVVLAELLTGKKP 289
            ++ P  +   +    K+D++SFG+   EL TG  P
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 88.2 bits (219), Expect = 2e-19
 Identities = 58/221 (26%), Positives = 91/221 (41%), Gaps = 28/221 (12%)

Query: 86  TKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVK----------TYRRADKIRITERELLR 134
              +  S+ L  G    V          +VA++          + R AD     E E+  
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEI-E 192

Query: 135 IISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAET 194
           I+ ++NH  ++KI     + E   +V E    G L D +   + ++     TC     + 
Sbjct: 193 ILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKV-VGNKRL--KEATCKLYFYQM 248

Query: 195 ASALDYLHSLASPPIIHGDVKSANILL---NDNYTAKVADFESSVLISSDAETAMSTILI 251
             A+ YLH      IIH D+K  N+LL    ++   K+ DF  S ++     + M T L 
Sbjct: 249 LLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRT-LC 302

Query: 252 GTSGYLDP---VCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           GT  YL P   V + T    +  D +S GV+L   L+G  P
Sbjct: 303 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 89.0 bits (221), Expect = 3e-19
 Identities = 65/307 (21%), Positives = 122/307 (39%), Gaps = 49/307 (15%)

Query: 72  LRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRA-------- 122
           +   ++ + +  +  +++ + R L  G +  V      + + + A+K  +++        
Sbjct: 21  INPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYS 80

Query: 123 --DKIRITERELLR----IISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCE 176
             +K      E +     ++  ++H N++K+  +  + +   LV EF   G L + I   
Sbjct: 81  DDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR 140

Query: 177 SSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILL---NDNYTAKVADFE 233
                        I  +  S + YLH      I+H D+K  NILL   N     K+ DF 
Sbjct: 141 HKF---DECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFG 194

Query: 234 SSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP--GS 291
            S   S D +  +    +GT+ Y+ P  +   K  +K DV+S GV++  LL G  P  G 
Sbjct: 195 LSSFFSKDYK--LRDR-LGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQ 250

Query: 292 CMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVA-ELASKCLRIRGTE 350
                +++ I      +  +     +    F   D ++ K I   A EL    L     +
Sbjct: 251 -----NDQDI------IKKV----EKGKYYF---DFNDWKNISDEAKELIKLMLTYDYNK 292

Query: 351 RPTMKQV 357
           R T ++ 
Sbjct: 293 RCTAEEA 299

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 86.7 bits (215), Expect = 5e-19
 Identities = 59/219 (26%), Positives = 97/219 (44%), Gaps = 34/219 (15%)

Query: 86  TKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVK-----TYRRADKIRITERELLRIISQV 139
            K F   R +  G F +VY    + ++  VA+K       +  +K +   +E+   + ++
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVR-FLQKL 111

Query: 140 NHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLR---IAA---E 193
            H N ++  G  L      LV E+   G+  D        +L+  K  L+   IAA    
Sbjct: 112 RHPNTIQYRGCYLREHTAWLVMEYCL-GSASD--------LLEVHKKPLQEVEIAAVTHG 162

Query: 194 TASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGT 253
               L YLHS     +IH DVK+ NILL++    K+ DF S+      +  A +   +GT
Sbjct: 163 ALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSA------SIMAPANSFVGT 213

Query: 254 SGYLDP---VCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
             ++ P   + ++ G+   K DV+S G+   EL   K P
Sbjct: 214 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 85.8 bits (213), Expect = 7e-19
 Identities = 53/215 (24%), Positives = 91/215 (42%), Gaps = 22/215 (10%)

Query: 88  NFDRSRCLSQGGFVSVYKGVLH--DNIQVAVKTYRR---ADKIRITERELLRIISQVNHK 142
           +      + +G + SV K ++H      +AVK  R      + +    +L  ++   +  
Sbjct: 23  DLKDLGEIGRGAYGSVNK-MVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81

Query: 143 NVVKILGLCL-ETEVPLLVYEF--ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALD 199
            +V+  G    E +   +  E    S      ++      V+   +   +I   T  AL+
Sbjct: 82  YIVQFYGALFREGDC-WICMELMSTSFDKFYKYVYSVLDDVIPE-EILGKITLATVKALN 139

Query: 200 YLHSLASPPIIHGDVKSANILLNDNYTAKVADFE-SSVLISSDAETAMSTILIGTSGYLD 258
           +L       IIH D+K +NILL+ +   K+ DF  S  L+ S A+T       G   Y+ 
Sbjct: 140 HLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD----AGCRPYMA 193

Query: 259 PVCINTGKLTK----KSDVYSFGVVLAELLTGKKP 289
           P  I+     +    +SDV+S G+ L EL TG+ P
Sbjct: 194 PERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 85.9 bits (213), Expect = 7e-19
 Identities = 55/222 (24%), Positives = 90/222 (40%), Gaps = 29/222 (13%)

Query: 86  TKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYR-RADKIRITERELLRIISQV-NHK 142
              F+    +  G +  VYKG  +      A+K      D+    ++E+  ++ +  +H+
Sbjct: 23  AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEI-NMLKKYSHHR 81

Query: 143 NVVKILGLCLETEVPL------LVYEFASNGTLLDHIRCESSQVLK-TWKTCLRIAA--- 192
           N+    G  ++   P       LV EF   G++ D I+      LK  W     IA    
Sbjct: 82  NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW-----IAYICR 136

Query: 193 ETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIG 252
           E    L +LH      +IH D+K  N+LL +N   K+ DF  S  +        +   IG
Sbjct: 137 EILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIG 191

Query: 253 TSGYLDPVCINTGKLTK-----KSDVYSFGVVLAELLTGKKP 289
           T  ++ P  I   +        KSD++S G+   E+  G  P
Sbjct: 192 TPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 84.7 bits (210), Expect = 2e-18
 Identities = 50/216 (23%), Positives = 86/216 (39%), Gaps = 29/216 (13%)

Query: 89  FDRSRCLSQGGFVSVYKGVLH--DNIQVAVKTYRR---ADKIRITERELLRIISQVNHKN 143
            +    +  G    V+K +        +AVK  RR    ++ +    +L  ++   +   
Sbjct: 27  LENLGEMGSGTCGQVWK-MRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPY 85

Query: 144 VVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESS---QVLKTWKTCLRIAAETASALD 199
           +V+  G    T   + +  E           R +     ++L       ++      AL 
Sbjct: 86  IVQCFG-TFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILG------KMTVAIVKALY 138

Query: 200 YLHSLASPPIIHGDVKSANILLNDNYTAKVADFE-SSVLISSDAETAMSTILIGTSGYLD 258
           YL       +IH DVK +NILL++    K+ DF  S  L+   A+        G + Y+ 
Sbjct: 139 YLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK----DRSAGCAAYMA 192

Query: 259 PVCINTGKLTK-----KSDVYSFGVVLAELLTGKKP 289
           P  I+    TK     ++DV+S G+ L EL TG+ P
Sbjct: 193 PERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 83.9 bits (208), Expect = 3e-18
 Identities = 65/272 (23%), Positives = 122/272 (44%), Gaps = 31/272 (11%)

Query: 78  SKSEMIRATKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRR-----ADKIRITERE 131
           S ++      N+   + + +G F  V     +    +VA+K   +         ++  RE
Sbjct: 6   SCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKL-FRE 64

Query: 132 LLRIISQVNHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRI 190
           + RI+  +NH N+VK+    +ETE  L L+ E+AS G + D++   +   +K  K     
Sbjct: 65  V-RIMKILNHPNIVKLFE-VIETEKTLYLIMEYASGGEVFDYLV--AHGRMKE-KEARSK 119

Query: 191 AAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTIL 250
             +  SA+ Y H      I+H D+K+ N+LL+ +   K+ADF  S   +      +    
Sbjct: 120 FRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG--GKLDA-F 173

Query: 251 IGTSGYLDPVCINTGKL--TKKSDVYSFGVVLAELLTGKKP---GSCMTLASNKKIS--- 302
            G   Y  P     GK     + DV+S GV+L  L++G  P    +   L   +++    
Sbjct: 174 CGAPPYAAPELFQ-GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELR--ERVLRGK 230

Query: 303 -MVPYFLNSIKNNGLRQILNFHVADESEMKEI 333
             +P+++++   N L++ L  +      +++I
Sbjct: 231 YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQI 262

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 81.2 bits (201), Expect = 2e-17
 Identities = 54/222 (24%), Positives = 93/222 (41%), Gaps = 31/222 (13%)

Query: 74  MKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELL 133
           MK+ SK ++IR      R                     QV               +E+ 
Sbjct: 43  MKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQV--------------YQEI- 87

Query: 134 RIISQVNHKNVVKILG-LCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIA 191
            I+ +++H NVVK++  L    E  L +V+E  + G +++     + + L          
Sbjct: 88  AILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP---TLKPLSE-DQARFYF 143

Query: 192 AETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADF-ESSVLISSDAETAMSTIL 250
            +    ++YLH      IIH D+K +N+L+ ++   K+ADF  S+    SDA  + +   
Sbjct: 144 QDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTV-- 198

Query: 251 IGTSGYLDP-VCINTGKL--TKKSDVYSFGVVLAELLTGKKP 289
            GT  ++ P     T K+   K  DV++ GV L   + G+ P
Sbjct: 199 -GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 80.3 bits (199), Expect = 4e-17
 Identities = 56/218 (25%), Positives = 86/218 (39%), Gaps = 33/218 (15%)

Query: 86  TKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTY--RRADKIRITERELLRIISQVNHK 142
            K F     L  G F  V+           A+K      A +    E E+  ++ ++ H+
Sbjct: 8   RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEI-AVLKKIKHE 66

Query: 143 NVVKILGLCLETEVPL-LVYEFASNGTLLDHIR-------CESSQVLKTWKTCLRIAAET 194
           N+V +  +  E+     LV +  S G L D I         ++S V++            
Sbjct: 67  NIVTLEDIY-ESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQ----------V 115

Query: 195 ASALDYLHSLASPPIIHGDVKSANILL---NDNYTAKVADFESSVLISSDAETAMSTILI 251
            SA+ YLH      I+H D+K  N+L     +N    + DF  S +        MST   
Sbjct: 116 LSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ---NGIMSTA-C 168

Query: 252 GTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           GT GY+ P  +     +K  D +S GV+   LL G  P
Sbjct: 169 GTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 80.0 bits (198), Expect = 4e-17
 Identities = 55/207 (26%), Positives = 88/207 (42%), Gaps = 21/207 (10%)

Query: 95  LSQGGFVSVYKGVLH--DNIQVAVKTYRR---ADKIRITERELLRIISQVNHKNVVKILG 149
           L +G +  V K + H      +AVK  R    + + +    +L   +  V+    V   G
Sbjct: 15  LGRGAYGVVEK-MRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73

Query: 150 LCL-ETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCL-RIAAETASALDYLHSLASP 207
               E +V  +  E   + +L    +    +     +  L +IA     AL++LHS  S 
Sbjct: 74  ALFREGDV-WICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS- 130

Query: 208 PIIHGDVKSANILLNDNYTAKVADFE-SSVLISSDAETAMSTILIGTSGYLDPVCINTGK 266
            +IH DVK +N+L+N     K+ DF  S  L+   A+     I  G   Y+ P  IN   
Sbjct: 131 -VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK----DIDAGCKPYMAPERINPEL 185

Query: 267 LTK----KSDVYSFGVVLAELLTGKKP 289
             K    KSD++S G+ + EL   + P
Sbjct: 186 NQKGYSVKSDIWSLGITMIELAILRFP 212

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 80.8 bits (200), Expect = 4e-17
 Identities = 47/227 (20%), Positives = 83/227 (36%), Gaps = 20/227 (8%)

Query: 76  IFSKSEMIRATKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVK-------TYRRADKIRI 127
           +    + +     ++    + +G F  V + +      Q AVK       T         
Sbjct: 13  LDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTED 72

Query: 128 TERELLRIISQVNHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLK-TWK 185
            +RE   I   + H ++V++L     ++  L +V+EF     L   I   +      +  
Sbjct: 73  LKREA-SICHMLKHPHIVELLETY-SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEA 130

Query: 186 TCLRIAAETASALDYLHSLASPPIIHGDVKSANILL---NDNYTAKVADFESSVLISSDA 242
                  +   AL Y H      IIH DVK   +LL    ++   K+  F  ++ +    
Sbjct: 131 VASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG 187

Query: 243 ETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
                   +GT  ++ P  +      K  DV+  GV+L  LL+G  P
Sbjct: 188 LV-AGGR-VGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 80.5 bits (199), Expect = 8e-17
 Identities = 66/363 (18%), Positives = 133/363 (36%), Gaps = 43/363 (11%)

Query: 5   DDDVMSTVKEVNARLQDIASQIKQLDLRKKSGRKSRNVRGVISSAVRRGRGGRDPGPTIY 64
             D+ +      +         +      K    + ++   +    +R        P   
Sbjct: 11  GVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPA-- 68

Query: 65  SHPGLAFLRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRAD 123
             P   F    + +K   + +     ++  L  G F  V+K       +++A K  +   
Sbjct: 69  --PPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIK--- 123

Query: 124 KIRITERELLR----IISQVNHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESS 178
              + ++E ++    +++Q++H N++++     E++  + LV E+   G L D I  ES 
Sbjct: 124 TRGMKDKEEVKNEISVMNQLDHANLIQLYD-AFESKNDIVLVMEYVDGGELFDRIIDESY 182

Query: 179 QVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILL--NDNYTAKVADFESSV 236
            +  T    +    +    + ++H +    I+H D+K  NIL    D    K+ DF  + 
Sbjct: 183 NL--TELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLAR 237

Query: 237 LISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLA 296
                    +     GT  +L P  +N   ++  +D++S GV+   LL+G          
Sbjct: 238 RY--KPREKLKVNF-GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG---------- 284

Query: 297 SNKKISMVPYFLNSIKNNGLRQILNFHVA-DESEMKEIEIVA-ELASKCLRIRGTERPTM 354
                  +  FL       L  IL      ++ E ++I   A E  SK L    + R + 
Sbjct: 285 -------LSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISA 337

Query: 355 KQV 357
            + 
Sbjct: 338 SEA 340

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 79.6 bits (197), Expect = 8e-17
 Identities = 59/221 (26%), Positives = 91/221 (41%), Gaps = 28/221 (12%)

Query: 86  TKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVK----------TYRRADKIRITERELLR 134
              +  S+ L  G    V          +VA+K          + R AD     E E+  
Sbjct: 9   RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEI-E 67

Query: 135 IISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAET 194
           I+ ++NH  ++KI     + E   +V E    G L D +   + ++     TC     + 
Sbjct: 68  ILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKV-VGNKRL--KEATCKLYFYQM 123

Query: 195 ASALDYLHSLASPPIIHGDVKSANILL---NDNYTAKVADFESSVLISSDAETAMSTILI 251
             A+ YLH      IIH D+K  N+LL    ++   K+ DF  S ++     + M T L 
Sbjct: 124 LLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRT-LC 177

Query: 252 GTSGYLDP---VCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           GT  YL P   V + T    +  D +S GV+L   L+G  P
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 78.8 bits (195), Expect = 9e-17
 Identities = 45/218 (20%), Positives = 87/218 (39%), Gaps = 33/218 (15%)

Query: 86  TKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTY--RRADKIRITERELLRIISQVNHK 142
            + +     + +G +  V   V     I+ A K       + +   ++E+  I+  ++H 
Sbjct: 8   NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEI-EIMKSLDHP 66

Query: 143 NVVKILGLCLETEVPL-LVYEFASNGTLLDHIR-------CESSQVLKTWKTCLRIAAET 194
           N++++     E    + LV E  + G L + +         ++++++K            
Sbjct: 67  NIIRLYETF-EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKD----------V 115

Query: 195 ASALDYLHSLASPPIIHGDVKSANILL---NDNYTAKVADFESSVLISSDAETAMSTILI 251
            SA+ Y H L    + H D+K  N L    + +   K+ DF  +          M T  +
Sbjct: 116 LSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG--KMMRTK-V 169

Query: 252 GTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           GT  Y+ P  +  G    + D +S GV++  LL G  P
Sbjct: 170 GTPYYVSPQVLE-GLYGPECDEWSAGVMMYVLLCGYPP 206

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 79.9 bits (197), Expect = 1e-16
 Identities = 53/256 (20%), Positives = 83/256 (32%), Gaps = 57/256 (22%)

Query: 86  TKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRR-------ADKIRITERELLRIIS 137
            K +     + QG +  V   +        A+K   +          +   + E+ R++ 
Sbjct: 25  QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEV-RLMK 83

Query: 138 QVNHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETA- 195
           +++H N+ ++     E E  + LV E    G LLD +              +        
Sbjct: 84  KLHHPNIARLYE-VYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPC 142

Query: 196 ------------------------------------SALDYLHSLASPPIIHGDVKSANI 219
                                               SAL YLH+     I H D+K  N 
Sbjct: 143 PECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENF 199

Query: 220 LL--NDNYTAKVADFESSVLISSD--AETAMSTILIGTSGYLDP-VCINTGKL-TKKSDV 273
           L   N ++  K+ DF  S         E    T   GT  ++ P V   T +    K D 
Sbjct: 200 LFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA 259

Query: 274 YSFGVVLAELLTGKKP 289
           +S GV+L  LL G  P
Sbjct: 260 WSAGVLLHLLLMGAVP 275

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 80.7 bits (199), Expect = 1e-16
 Identities = 43/248 (17%), Positives = 88/248 (35%), Gaps = 18/248 (7%)

Query: 48  SAVRRGRGGRDPGPTIYSHPGLAFLRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGV 107
             VR                   +    +  K + +    ++D    L  G F  V++  
Sbjct: 120 KIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVL--DHYDIHEELGTGAFGVVHRVT 177

Query: 108 LHD-NIQVAVKT--YRRADKIRITERELLRIISQVNHKNVVKILGLCLETEVPL-LVYEF 163
                   A K              +E+ + +S + H  +V +     E +  + ++YEF
Sbjct: 178 ERATGNNFAAKFVMTPHESDKETVRKEI-QTMSVLRHPTLVNLHDAF-EDDNEMVMIYEF 235

Query: 164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLND 223
            S G L + +  E +++  +    +    +    L ++H       +H D+K  NI+   
Sbjct: 236 MSGGELFEKVADEHNKM--SEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTT 290

Query: 224 NYTA--KVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLA 281
             +   K+ DF  +  +          +  GT+ +  P       +   +D++S GV+  
Sbjct: 291 KRSNELKLIDFGLTAHLDPKQSV---KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSY 347

Query: 282 ELLTGKKP 289
            LL+G  P
Sbjct: 348 ILLSGLSP 355

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 80.6 bits (199), Expect = 1e-16
 Identities = 59/229 (25%), Positives = 97/229 (42%), Gaps = 21/229 (9%)

Query: 71  FLRMKIFSKSEMIRATKN-FDRSRCLSQGGFVSVYKGVLHDNIQV-AVKTYRRADKIR-- 126
           F R   +   E    TKN F + R L +GGF  V    +    ++ A K   +    +  
Sbjct: 167 FNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRK 226

Query: 127 -----ITERELLRIISQVNHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQV 180
                + E+   +I+ +VN + VV  L    ET+  L LV    + G L  HI       
Sbjct: 227 GEAMALNEK---QILEKVNSRFVVS-LAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAG 282

Query: 181 LKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISS 240
               +     AAE    L+ LH      I++ D+K  NILL+D+   +++D   +V +  
Sbjct: 283 FPEARAVF-YAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338

Query: 241 DAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
                     +GT GY+ P  +   + T   D ++ G +L E++ G+ P
Sbjct: 339 GQTI---KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 79.3 bits (196), Expect = 1e-16
 Identities = 52/207 (25%), Positives = 88/207 (42%), Gaps = 29/207 (14%)

Query: 95  LSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRI-TERELLRIISQVNHKNVVKILGLCL 152
           L +G F    K V    N   AVK   +  +     E   L++     H N+VK+  +  
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCE--GHPNIVKLHEVFH 76

Query: 153 ETEVPLLVYEFASNGTLLDHIR-------CESSQVLKTWKTCLRIAAETASALDYLHSLA 205
           +     LV E  + G L + I+        E+S +++             SA+ ++H + 
Sbjct: 77  DQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRK----------LVSAVSHMHDVG 126

Query: 206 SPPIIHGDVKSANILL---NDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCI 262
              ++H D+K  N+L    NDN   K+ DF  + L   D +  + T    T  Y  P  +
Sbjct: 127 ---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-LKTP-CFTLHYAAPELL 181

Query: 263 NTGKLTKKSDVYSFGVVLAELLTGKKP 289
           N     +  D++S GV+L  +L+G+ P
Sbjct: 182 NQNGYDESCDLWSLGVILYTMLSGQVP 208

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 78.5 bits (194), Expect = 2e-16
 Identities = 71/292 (24%), Positives = 114/292 (39%), Gaps = 48/292 (16%)

Query: 95  LSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRITERELLR----IISQV-NHKNVVKIL 148
           L +G    V   + L  + + AVK     +K     R  +     ++ Q   H+NV++++
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKI---IEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77

Query: 149 GLCLETEVPLLVYEFASNGTLLDHIR-------CESSQVLKTWKTCLRIAAETASALDYL 201
               E +   LV+E    G++L HI         E+S V++            ASALD+L
Sbjct: 78  EFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQD----------VASALDFL 127

Query: 202 HSLASPPIIHGDVKSANILL---NDNYTAKVADFESSVLIS-----SDAETAMSTILIGT 253
           H+     I H D+K  NIL    N     K+ DF+    I      S   T       G+
Sbjct: 128 HNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGS 184

Query: 254 SGY-----LDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP--GSCMTLASNKKISMVPY 306
           + Y     ++          K+ D++S GV+L  LL+G  P  G C +     +    P 
Sbjct: 185 AEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244

Query: 307 FLNSIKNNGLRQILNFHVADESEMKEIEIVA-ELASKCLRIRGTERPTMKQV 357
             N +  +       F    + +   I   A +L SK L     +R +  QV
Sbjct: 245 CQNMLFESIQEGKYEF---PDKDWAHISCAAKDLISKLLVRDAKQRLSAAQV 293

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 78.1 bits (193), Expect = 2e-16
 Identities = 52/249 (20%), Positives = 96/249 (38%), Gaps = 30/249 (12%)

Query: 93  RCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRITERELLRI---IS---QVNHKNVV 145
             L +G +  V + +      + AVK  ++  K+R        +   I    ++ HKNV+
Sbjct: 11  DLLGEGSYGKVKEVLDSETLCRRAVKILKK-KKLRRIPNGEANVKKEIQLLRRLRHKNVI 69

Query: 146 KILG-LCLETEVPL-LVYEFASNGT--LLDHIRCESSQVLKTWKTCLRIAAETASALDYL 201
           +++  L  E +  + +V E+   G   +LD +     +     +       +    L+YL
Sbjct: 70  QLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSV---PEKRFPVCQAH-GYFCQLIDGLEYL 125

Query: 202 HSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVC 261
           HS     I+H D+K  N+LL    T K++    +  +   A         G+  +  P  
Sbjct: 126 HSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEI 182

Query: 262 INTGKL--TKKSDVYSFGVVLAELLTGKKP---GSCMTLASNKKIS----MVPYFLNSIK 312
            N        K D++S GV L  + TG  P    +   L   + I      +P       
Sbjct: 183 ANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLF--ENIGKGSYAIPGDCGPPL 240

Query: 313 NNGLRQILN 321
           ++ L+ +L 
Sbjct: 241 SDLLKGMLE 249

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 78.0 bits (193), Expect = 2e-16
 Identities = 51/220 (23%), Positives = 91/220 (41%), Gaps = 34/220 (15%)

Query: 86  TKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRITERELLR----IISQVN 140
           + N+D    L +G F  V + V     ++ A K      K+   + + L     I  ++ 
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTK-KLSARDFQKLEREARICRKLQ 63

Query: 141 HKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIR-------CESSQVLKTWKTCLRIAA 192
           H N+V++     + E    LV++  + G L + I         ++S  ++          
Sbjct: 64  HPNIVRLHDSI-QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ--------- 113

Query: 193 ETASALDYLHSLASPPIIHGDVKSANILL---NDNYTAKVADFESSVLISSDAETAMSTI 249
               ++ Y HS     I+H ++K  N+LL         K+ADF  ++ +  +   A    
Sbjct: 114 -ILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDSEAWHGF 167

Query: 250 LIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
             GT GYL P  +     +K  D+++ GV+L  LL G  P
Sbjct: 168 -AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 79.8 bits (197), Expect = 3e-16
 Identities = 51/230 (22%), Positives = 97/230 (42%), Gaps = 20/230 (8%)

Query: 71  FLRMKIFSKSEMIRATKN-FDRSRCLSQGGFVSVYKGVLHDNIQV-AVKTYRRADKIR-- 126
           FLR   +   E     ++ F   R L +GGF  V+   +    ++ A K   +    +  
Sbjct: 168 FLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRK 227

Query: 127 -----ITERELLRIISQVNHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQV 180
                + E+   +I+++V+ + +V  L    ET+  L LV    + G +  HI       
Sbjct: 228 GYQGAMVEK---KILAKVHSRFIVS-LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDN 283

Query: 181 LKTWKTCLRI-AAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLIS 239
               +       A+  S L++LH      II+ D+K  N+LL+D+   +++D   +V + 
Sbjct: 284 PGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340

Query: 240 SDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           +           GT G++ P  +   +     D ++ GV L E++  + P
Sbjct: 341 AGQTKTKG--YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 78.2 bits (193), Expect = 3e-16
 Identities = 55/219 (25%), Positives = 89/219 (40%), Gaps = 29/219 (13%)

Query: 87  KNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVK-----------TYRRADKIRITERELLR 134
           + +     L  G F  V+  V    N +V VK                   ++T  E+  
Sbjct: 24  QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVT-LEI-A 81

Query: 135 IISQVNHKNVVKILGLCLETEVPL-LVYEFASNGT-LLDHIRCESSQVLKTWKTCLRIAA 192
           I+S+V H N++K+L +  E +    LV E   +G  L   I  +    L        I  
Sbjct: 82  ILSRVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFI--DRHPRLDE-PLASYIFR 137

Query: 193 ETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIG 252
           +  SA+ YL       IIH D+K  NI++ +++T K+ DF S+  +         T   G
Sbjct: 138 QLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG--KLFYT-FCG 191

Query: 253 TSGYLDPVCINTGKL--TKKSDVYSFGVVLAELLTGKKP 289
           T  Y  P  +  G      + +++S GV L  L+  + P
Sbjct: 192 TIEYCAPEVLM-GNPYRGPELEMWSLGVTLYTLVFEENP 229

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 78.5 bits (194), Expect = 3e-16
 Identities = 57/247 (23%), Positives = 100/247 (40%), Gaps = 35/247 (14%)

Query: 60  GPTIYSHP-GLAFLRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVK 117
           GP + S   G    R   F  +   + + N+D    L +G F  V + V     ++ A K
Sbjct: 1   GPHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK 60

Query: 118 TYRRADKIRITERELLR----IISQVNHKNVVKILGLCLETEVPL-LVYEFASNGTLLDH 172
                 K+   + + L     I  ++ H N+V++     + E    LV++  + G L + 
Sbjct: 61  IINTK-KLSARDFQKLEREARICRKLQHPNIVRLHDSI-QEESFHYLVFDLVTGGELFED 118

Query: 173 IR-------CESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILL---N 222
           I         ++S  ++              ++ Y HS     I+H ++K  N+LL    
Sbjct: 119 IVAREFYSEADASHCIQQ----------ILESIAYCHSNG---IVHRNLKPENLLLASKA 165

Query: 223 DNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAE 282
                K+ADF  ++ +  +   A      GT GYL P  +     +K  D+++ GV+L  
Sbjct: 166 KGAAVKLADFGLAIEV--NDSEAWHGF-AGTPGYLSPEVLKKDPYSKPVDIWACGVILYI 222

Query: 283 LLTGKKP 289
           LL G  P
Sbjct: 223 LLVGYPP 229

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 79.0 bits (195), Expect = 3e-16
 Identities = 52/220 (23%), Positives = 89/220 (40%), Gaps = 28/220 (12%)

Query: 87  KNFDRSRCLSQGGFVSVYKGVLHDNIQV-AVKTYRRADKIR-------ITERELLRIISQ 138
            +F+  + + +G F  V    +    QV A+K   + D ++         ER    ++  
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREER---DVLVN 117

Query: 139 VNHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETAS 196
            + + + + L    + E  L LV E+   G LL  +     ++        R   AE   
Sbjct: 118 GDRRWITQ-LHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEM---ARFYLAEIVM 173

Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
           A+D +H L     +H D+K  NILL+     ++ADF S + + +D         +GT  Y
Sbjct: 174 AIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLV-AVGTPDY 229

Query: 257 LDP-------VCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           L P           TG    + D ++ GV   E+  G+ P
Sbjct: 230 LSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 78.1 bits (193), Expect = 3e-16
 Identities = 53/231 (22%), Positives = 84/231 (36%), Gaps = 20/231 (8%)

Query: 67  PGLAFLRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKI 125
            GL  L      K   +       + + L  G    V +        + A+K    + K 
Sbjct: 10  SGLEVLFQGPEPKKYAVTDDYQLSK-QVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKA 68

Query: 126 RITERELLRIISQVNHKNVVKILGLCLETEVP----LLVYEFASNGTLLDHIRCESSQVL 181
           R  E +     S     ++V IL +           L++ E    G L   I  E     
Sbjct: 69  R-QEVDHHWQAS--GGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRI-QERGDQA 124

Query: 182 KTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILL---NDNYTAKVADFESSVLI 238
            T +    I  +  +A+ +LHS     I H DVK  N+L      +   K+ DF  +   
Sbjct: 125 FTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET 181

Query: 239 SSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           + +A   + T    T  Y+ P  +   K  K  D++S GV++  LL G  P
Sbjct: 182 TQNA---LQTP-CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 78.1 bits (193), Expect = 4e-16
 Identities = 65/330 (19%), Positives = 119/330 (36%), Gaps = 50/330 (15%)

Query: 43  RGVISSAVRRGRGGRDPGPTIYSHPGLAFLRMKIFSKSEMIRATKNFDRSRCLSQGGFVS 102
            GV                   +    + +       S     +  F+    L +G    
Sbjct: 9   SGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSI 68

Query: 103 VYKGV-LHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEVPL-LV 160
           VY+          A+K  ++    +I   E+  ++ +++H N++K+  +  ET   + LV
Sbjct: 69  VYRCKQKGTQKPYALKVLKKTVDKKIVRTEI-GVLLRLSHPNIIKLKEIF-ETPTEISLV 126

Query: 161 YEFASNGTLLDHI-------RCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGD 213
            E  + G L D I         +++  +K              A+ YLH      I+H D
Sbjct: 127 LELVTGGELFDRIVEKGYYSERDAADAVKQ----------ILEAVAYLHENG---IVHRD 173

Query: 214 VKSANILL---NDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKK 270
           +K  N+L      +   K+ADF  S ++  + +  M T+  GT GY  P  +       +
Sbjct: 174 LKPENLLYATPAPDAPLKIADFGLSKIV--EHQVLMKTV-CGTPGYCAPEILRGCAYGPE 230

Query: 271 SDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGL-RQILNFHVA-DES 328
            D++S G++   LL G                    F +   +  + R+ILN        
Sbjct: 231 VDMWSVGIITYILLCG-----------------FEPFYDERGDQFMFRRILNCEYYFISP 273

Query: 329 EMKEIEIVA-ELASKCLRIRGTERPTMKQV 357
              E+ + A +L  K + +   +R T  Q 
Sbjct: 274 WWDEVSLNAKDLVRKLIVLDPKKRLTTFQA 303

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 79.5 bits (196), Expect = 4e-16
 Identities = 50/213 (23%), Positives = 90/213 (42%), Gaps = 21/213 (9%)

Query: 87  KNFDRSRCLSQGGFVSVYKGVLHDNIQV-AVKTYRRADKIR-------ITERELLRIISQ 138
            +F   R + +GGF  VY     D  ++ A+K   +            + ER +L ++S 
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248

Query: 139 VNHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
            +   +V  +     T   L  + +  + G L  H+      V          AAE    
Sbjct: 249 GDCPFIVC-MSYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRF-YAAEIILG 304

Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYL 257
           L+++H+     +++ D+K ANILL+++   +++D   +   S     A     +GT GY+
Sbjct: 305 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYM 357

Query: 258 DPVCINTGKL-TKKSDVYSFGVVLAELLTGKKP 289
            P  +  G      +D +S G +L +LL G  P
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 78.1 bits (193), Expect = 5e-16
 Identities = 51/217 (23%), Positives = 93/217 (42%), Gaps = 31/217 (14%)

Query: 88  NFDRSRCLSQGGFVSVYKGVLHDNIQV-AVKTYRRADKIR-------ITERELLRIISQV 139
           +F+  R + +G F  V     +D  ++ A+K   +   +          E    +I+  +
Sbjct: 16  HFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKEL---QIMQGL 72

Query: 140 NHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCE---SSQVLKTWKTCLRIAAETA 195
            H  +V  L    + E  + +V +    G L  H++       + +K +        E  
Sbjct: 73  EHPFLVN-LWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLF------ICELV 125

Query: 196 SALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG 255
            ALDYL +     IIH D+K  NILL+++    + DF  + ++  + +    T + GT  
Sbjct: 126 MALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI---TTMAGTKP 179

Query: 256 YLDPVCINTGKL---TKKSDVYSFGVVLAELLTGKKP 289
           Y+ P   ++ K    +   D +S GV   ELL G++P
Sbjct: 180 YMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 78.5 bits (194), Expect = 5e-16
 Identities = 46/220 (20%), Positives = 87/220 (39%), Gaps = 33/220 (15%)

Query: 86  TKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRITERELLR----IISQVN 140
           T+ +     L +G F  V + V +    + A        K+   + + L     I   + 
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINT-KKLSARDHQKLEREARICRLLK 68

Query: 141 HKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIR-------CESSQVLKTWKTCLRIAA 192
           H N+V++       E    L+++  + G L + I         ++S  ++          
Sbjct: 69  HPNIVRLHDSI-SEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQ--------- 118

Query: 193 ETASALDYLHSLASPPIIHGDVKSANILL---NDNYTAKVADFESSVLISSDAETAMSTI 249
               A+ + H +    ++H ++K  N+LL         K+ADF  ++ +  + + A    
Sbjct: 119 -ILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ-AWFGF 173

Query: 250 LIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
             GT GYL P  +      K  D+++ GV+L  LL G  P
Sbjct: 174 -AGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 77.3 bits (191), Expect = 7e-16
 Identities = 57/306 (18%), Positives = 116/306 (37%), Gaps = 49/306 (16%)

Query: 67  PGLAFLRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKT-YRRADK 124
            G+  +  ++   S     T  ++    +  G +    + +    N++ AVK   +    
Sbjct: 4   VGVHSIVQQLHRNSIQF--TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD 61

Query: 125 IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIR-------CES 177
                 E+  ++    H N++ +  +  + +   +V E    G LLD I         E+
Sbjct: 62  PT---EEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREA 118

Query: 178 SQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILL----NDNYTAKVADFE 233
           S VL T              ++YLH+     ++H D+K +NIL      +  + ++ DF 
Sbjct: 119 SAVLFT----------ITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFG 165

Query: 234 SSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCM 293
            +  + ++    + T    T+ ++ P  +         D++S GV+L  +LTG  P +  
Sbjct: 166 FAKQLRAE-NGLLMTP-CYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANG 223

Query: 294 TLASNKKISMVPYFLNSIKNNGLRQILNFHVA-DESEMKEIEIVA-ELASKCLRIRGTER 351
              + ++I              L +I +   +        +   A +L SK L +   +R
Sbjct: 224 PDDTPEEI--------------LARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQR 269

Query: 352 PTMKQV 357
            T   V
Sbjct: 270 LTAALV 275

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 76.1 bits (188), Expect = 9e-16
 Identities = 53/230 (23%), Positives = 96/230 (41%), Gaps = 43/230 (18%)

Query: 86  TKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKT-------YRRADKIRITERELLR--- 134
            +N++    L +G    V + +      + AVK           A++++      L+   
Sbjct: 16  YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75

Query: 135 IISQVN-HKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIR-------CESSQVLKTWK 185
           I+ +V+ H N++++     ET     LV++    G L D++         E+ ++++   
Sbjct: 76  ILRKVSGHPNIIQLKDTY-ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA-- 132

Query: 186 TCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETA 245
                       +  LH L    I+H D+K  NILL+D+   K+ DF  S  +  D    
Sbjct: 133 --------LLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEK 179

Query: 246 MSTILIGTSGYLDP------VCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           +  +  GT  YL P      +  N     K+ D++S GV++  LL G  P
Sbjct: 180 LREV-CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 76.5 bits (189), Expect = 1e-15
 Identities = 56/313 (17%), Positives = 111/313 (35%), Gaps = 45/313 (14%)

Query: 86  TKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYR-RADKIRITERELLRIISQVNHKN 143
            + +  +  L +G F  V++ V          K  + +     + ++E+  I++   H+N
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEI-SILNIARHRN 62

Query: 144 VVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLH 202
           ++ +     E+   L +++EF S   + + I   S+  L   +  +    +   AL +LH
Sbjct: 63  ILHLHESF-ESMEELVMIFEFISGLDIFERI-NTSAFEL-NEREIVSYVHQVCEALQFLH 119

Query: 203 SLASPPIIHGDVKSANILLNDNYTA--KVADFESSVLISSDAETAMSTILIGTSGYLDPV 260
           S     I H D++  NI+     ++  K+ +F  +  +          +      Y  P 
Sbjct: 120 SHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQL--KPGDNFRLL-FTAPEYYAPE 173

Query: 261 CINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQIL 320
                 ++  +D++S G ++  LL+G  P                 FL       +  I+
Sbjct: 174 VHQHDVVSTATDMWSLGTLVYVLLSGINP-----------------FLAETNQQIIENIM 216

Query: 321 NFHVA-DESEMKEIEIVA-ELASKCLRIRGTERPTMKQV-----------SEELDRLRRL 367
           N     DE   KEI I A +   + L      R T  +                  +R L
Sbjct: 217 NAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTL 276

Query: 368 HENFWAQKKNKET 380
               +     K+ 
Sbjct: 277 KHRRYYHTLIKKD 289

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 76.6 bits (189), Expect = 1e-15
 Identities = 52/219 (23%), Positives = 88/219 (40%), Gaps = 27/219 (12%)

Query: 87  KNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVK--------TYRRADKIRITERE---LLR 134
             +     L +GGF +V+ G  L D +QVA+K         +           E   L +
Sbjct: 31  AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK 90

Query: 135 IISQVNHKNVVKILGLCLETEVPL-LVYEFASNGT-LLDHIRCESSQVLKTWKTCLRIAA 192
           + +   H  V+++L    ET+    LV E       L D+I       L           
Sbjct: 91  VGAGGGHPGVIRLLDW-FETQEGFMLVLERPLPAQDLFDYI--TEKGPLGE-GPSRCFFG 146

Query: 193 ETASALDYLHSLASPPIIHGDVKSANILLN-DNYTAKVADFESSVLISSDAETAMSTILI 251
           +  +A+ + HS     ++H D+K  NIL++     AK+ DF S  L+        +    
Sbjct: 147 QVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHD---EPYTD-FD 199

Query: 252 GTSGYLDPVCINTGKLT-KKSDVYSFGVVLAELLTGKKP 289
           GT  Y  P  I+  +     + V+S G++L +++ G  P
Sbjct: 200 GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP 238

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 77.5 bits (191), Expect = 1e-15
 Identities = 51/218 (23%), Positives = 95/218 (43%), Gaps = 26/218 (11%)

Query: 87  KNFDRSRCLSQGGFVSVYKGVLHDNIQV-AVKTYRRADKIR-------ITERELLRIISQ 138
           ++F+  + + +G F  V    L +  +V A+K   + + ++         ER    ++  
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREER---DVLVN 130

Query: 139 VNHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRI-AAETAS 196
            + K +   L    + +  L LV ++   G LL  +     ++ +      R   AE   
Sbjct: 131 GDSKWITT-LHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEM---ARFYLAEMVI 186

Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
           A+D +H L     +H D+K  NIL++ N   ++ADF S + +  D     S   +GT  Y
Sbjct: 187 AIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV-AVGTPDY 242

Query: 257 LDP-----VCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           + P     +    G+   + D +S GV + E+L G+ P
Sbjct: 243 ISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 75.8 bits (187), Expect = 2e-15
 Identities = 60/288 (20%), Positives = 109/288 (37%), Gaps = 36/288 (12%)

Query: 65  SHPGLAFLRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVK------ 117
             P       K+    E       +     L  GGF SVY G+ + DN+ VA+K      
Sbjct: 21  MAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDR 80

Query: 118 --TYRRADKIRITERELLRIISQVNHK--NVVKILGLCLETEVPL-LVYEFASN-GTLLD 171
              +           E+  ++ +V+     V+++L    E      L+ E       L D
Sbjct: 81  ISDWGELPNGTRVPMEV-VLLKKVSSGFSGVIRLLDW-FERPDSFVLILERPEPVQDLFD 138

Query: 172 HIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNY-TAKVA 230
            I       L+  +       +   A+ + H+     ++H D+K  NIL++ N    K+ 
Sbjct: 139 FI--TERGALQE-ELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLI 192

Query: 231 DFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLT-KKSDVYSFGVVLAELLTGKKP 289
           DF S  L+    +T  +    GT  Y  P  I   +   + + V+S G++L +++ G  P
Sbjct: 193 DFGSGALLK---DTVYTD-FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 248

Query: 290 GSCMTLASNKKIS----MVPYFLNSIKNNGLRQILNFHVADESEMKEI 333
                   +++I          ++S   + +R  L    +D    +EI
Sbjct: 249 -----FEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 291

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 76.3 bits (188), Expect = 2e-15
 Identities = 55/216 (25%), Positives = 87/216 (40%), Gaps = 38/216 (17%)

Query: 92  SRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGL 150
           S+ L  G    V +        + A+K  +   K R  E EL    SQ    ++V+I+ +
Sbjct: 67  SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR-REVELHWRASQ--CPHIVRIVDV 123

Query: 151 CLETEVP-----LLVYEFASNGTLLDHIR---------CESSQVLKTWKTCLRIAAETAS 196
             E         L+V E    G L   I+          E+S+++K+             
Sbjct: 124 Y-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS----------IGE 172

Query: 197 ALDYLHSLASPPIIHGDVKSANILL---NDNYTAKVADFESSVLISSDAETAMSTILIGT 253
           A+ YLHS+    I H DVK  N+L      N   K+ DF  +      +  +++T    T
Sbjct: 173 AIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET--TSHNSLTTP-CYT 226

Query: 254 SGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
             Y+ P  +   K  K  D++S GV++  LL G  P
Sbjct: 227 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 74.5 bits (184), Expect = 3e-15
 Identities = 68/248 (27%), Positives = 108/248 (43%), Gaps = 36/248 (14%)

Query: 93  RCLSQGGFVSVYKGV-LHDNIQVAVKTYRR------ADKIRITERELLRIISQVNHKNVV 145
             L  G F  V  G       +VAVK   R          +I +RE+ + +    H +++
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKI-KREI-QNLKLFRHPHII 74

Query: 146 KILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSL 204
           K+  + + T     +V E+ S G L D+I       ++      R+  +  SA+DY H  
Sbjct: 75  KLYQV-ISTPTDFFMVMEYVSGGELFDYI--CKHGRVEE-MEARRLFQQILSAVDYCHRH 130

Query: 205 ASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDA--ETAMSTILIGTSGYLDPVCI 262
               ++H D+K  N+LL+ +  AK+ADF  S ++S      T+      G+  Y  P  I
Sbjct: 131 M---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS-----CGSPNYAAPEVI 182

Query: 263 NTGKL--TKKSDVYSFGVVLAELLTGKKP---GSCMTLASNKKIS----MVPYFLNSIKN 313
           + G+L    + D++S GV+L  LL G  P       TL   KKI      +P +LN    
Sbjct: 183 S-GRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLF--KKIRGGVFYIPEYLNRSVA 239

Query: 314 NGLRQILN 321
             L  +L 
Sbjct: 240 TLLMHMLQ 247

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 75.9 bits (187), Expect = 3e-15
 Identities = 47/282 (16%), Positives = 99/282 (35%), Gaps = 39/282 (13%)

Query: 86  TKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRITERELLR----IISQVN 140
              +D    L  G F  V++ V          K           ++  ++    I++Q++
Sbjct: 50  YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFIN---TPYPLDKYTVKNEISIMNQLH 106

Query: 141 HKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALD 199
           H  ++ +     E +  + L+ EF S G L D I       + +    +    +    L 
Sbjct: 107 HPKLINLHDAF-EDKYEMVLILEFLSGGELFDRI-AAEDYKM-SEAEVINYMRQACEGLK 163

Query: 200 YLHSLASPPIIHGDVKSANILL--NDNYTAKVADFESSVLISSDAETAMSTILIGTSGYL 257
           ++H  +   I+H D+K  NI+       + K+ DF  +  +  + +  +      T+ + 
Sbjct: 164 HMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKL--NPDEIVKVTT-ATAEFA 217

Query: 258 DPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLR 317
            P  ++   +   +D+++ GV+   LL+G  P                 F        L+
Sbjct: 218 APEIVDREPVGFYTDMWAIGVLGYVLLSGLSP-----------------FAGEDDLETLQ 260

Query: 318 QILNFHVA-DESEMKEIEIVA-ELASKCLRIRGTERPTMKQV 357
            +       DE     +   A +     L+    +R T+   
Sbjct: 261 NVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDA 302

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 75.0 bits (185), Expect = 3e-15
 Identities = 55/229 (24%), Positives = 93/229 (40%), Gaps = 26/229 (11%)

Query: 74  MKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRA---DKIRITE 129
           M+ F + ++      +D    L  G F  V K       ++ A K  ++       R   
Sbjct: 2   MEPFKQQKV---EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVS 58

Query: 130 RELLR----IISQVNHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTW 184
           RE +     I+ QV H NV+ +  +  E    + L+ E  S G L D +  + S    + 
Sbjct: 59  REEIEREVSILRQVLHHNVITLHDVY-ENRTDVVLILELVSGGELFDFLAQKESL---SE 114

Query: 185 KTCLRIAAETASALDYLHSLASPPIIHGDVKSANILL----NDNYTAKVADFESSVLISS 240
           +       +    ++YLH+     I H D+K  NI+L          K+ DF  +  I  
Sbjct: 115 EEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-- 169

Query: 241 DAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           +       I  GT  ++ P  +N   L  ++D++S GV+   LL+G  P
Sbjct: 170 EDGVEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 74.2 bits (183), Expect = 4e-15
 Identities = 53/204 (25%), Positives = 86/204 (42%), Gaps = 16/204 (7%)

Query: 93  RCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRITE---RELLRIISQVNHKNVVKIL 148
           + L +G +  V   V       VAVK       +   E   +E+  I   +NH+NVVK  
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEI-CINKMLNHENVVKFY 71

Query: 149 GLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASP 207
           G          L  E+ S G L D I  E    +       R   +  + + YLH +   
Sbjct: 72  GH-RREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQ-RFFHQLMAGVVYLHGIG-- 125

Query: 208 PIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKL 267
            I H D+K  N+LL++    K++DF  + +   +    +   + GT  Y+ P  +   + 
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK-RRE 183

Query: 268 --TKKSDVYSFGVVLAELLTGKKP 289
              +  DV+S G+VL  +L G+ P
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELP 207

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 74.6 bits (184), Expect = 5e-15
 Identities = 49/229 (21%), Positives = 99/229 (43%), Gaps = 22/229 (9%)

Query: 75  KIFSKSEMIRATKNFD-----RSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRIT 128
            + +++   ++ +NF+      S+ L +G F  V + +      + A K  ++  + +  
Sbjct: 12  DLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDC 71

Query: 129 ERELLR---IISQVNH-KNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKT 183
             E+L    ++        V+ +  +  E    + L+ E+A+ G +      E ++++ +
Sbjct: 72  RAEILHEIAVLELAKSCPRVINLHEVY-ENTSEIILILEYAAGGEIFSLCLPELAEMV-S 129

Query: 184 WKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILL---NDNYTAKVADFESSVLISS 240
               +R+  +    + YLH      I+H D+K  NILL         K+ DF  S  I  
Sbjct: 130 ENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI-- 184

Query: 241 DAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
                +  I+ GT  YL P  +N   +T  +D+++ G++   LLT   P
Sbjct: 185 GHACELREIM-GTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 74.7 bits (184), Expect = 6e-15
 Identities = 52/217 (23%), Positives = 86/217 (39%), Gaps = 23/217 (10%)

Query: 86  TKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVK---TYRRADKIRITERELLR----IIS 137
              +D    L  G F  V K       ++ A K     +     R   RE +     I+ 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70

Query: 138 QVNHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETAS 196
           QV H N++ +  +  E    + L+ E  S G L D +  + S    + +       +   
Sbjct: 71  QVLHPNIITLHDVY-ENRTDVVLILELVSGGELFDFLAQKESL---SEEEATSFIKQILD 126

Query: 197 ALDYLHSLASPPIIHGDVKSANILL----NDNYTAKVADFESSVLISSDAETAMSTILIG 252
            ++YLH+     I H D+K  NI+L          K+ DF  +  I  +       I  G
Sbjct: 127 GVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIF-G 180

Query: 253 TSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           T  ++ P  +N   L  ++D++S GV+   LL+G  P
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 75.2 bits (185), Expect = 7e-15
 Identities = 53/211 (25%), Positives = 89/211 (42%), Gaps = 20/211 (9%)

Query: 88  NFDRSRCLSQGGFVSVYKGVLHDNIQV-AVKTYRRADKIR-------ITERELLRIISQV 139
            F+  + L +G F  V         +  A+K  ++   +        +TE    R++   
Sbjct: 149 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTEN---RVLQNS 205

Query: 140 NHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASAL 198
            H  +   L    +T   L  V E+A+ G L  H+  E  +V    +      AE  SAL
Sbjct: 206 RHPFLTA-LKYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARF-YGAEIVSAL 261

Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLD 258
           DYLHS  +  +++ D+K  N++L+ +   K+ DF        D  T  +    GT  YL 
Sbjct: 262 DYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLA 317

Query: 259 PVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           P  +      +  D +  GVV+ E++ G+ P
Sbjct: 318 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 74.4 bits (183), Expect = 7e-15
 Identities = 54/283 (19%), Positives = 108/283 (38%), Gaps = 46/283 (16%)

Query: 33  KKSGRKSRNVRGVISSAVRRGRGGRDPGPTIYSHPGLAFLRMKIFSKSEMIRATKNFDRS 92
           +           +++ A +           +Y         +  ++ ++     + +D  
Sbjct: 42  RSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFY--QKYDPK 99

Query: 93  RCLSQGGFVSVYKGV-LHDNIQVAVKTYRRA----------DKIRITERELLRIISQV-N 140
             + +G    V + V      + AVK               +    T RE   I+ QV  
Sbjct: 100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRET-HILRQVAG 158

Query: 141 HKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIR-------CESSQVLKTWKTCLRIAA 192
           H +++ ++    E+   + LV++    G L D++         E+  ++++         
Sbjct: 159 HPHIITLIDSY-ESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRS--------- 208

Query: 193 ETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIG 252
               A+ +LH+     I+H D+K  NILL+DN   +++DF  S  +  +    +  +  G
Sbjct: 209 -LLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHL--EPGEKLREL-CG 261

Query: 253 TSGYLDP------VCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           T GYL P      +        K+ D+++ GV+L  LL G  P
Sbjct: 262 TPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 73.0 bits (180), Expect = 1e-14
 Identities = 53/217 (24%), Positives = 89/217 (41%), Gaps = 23/217 (10%)

Query: 86  TKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRA---DKIRITERELLR----IIS 137
             +++    L  G F  V K        + A K  ++       R   RE +     I+ 
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 138 QVNHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETAS 196
           ++ H N++ +  +  E +  + L+ E  S G L D +  + S    T     +   +   
Sbjct: 64  EIRHPNIITLHDIF-ENKTDVVLILELVSGGELFDFLAEKESL---TEDEATQFLKQILD 119

Query: 197 ALDYLHSLASPPIIHGDVKSANILL----NDNYTAKVADFESSVLISSDAETAMSTILIG 252
            + YLHS     I H D+K  NI+L      N   K+ DF  +  I  +A      I  G
Sbjct: 120 GVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI--EAGNEFKNI-FG 173

Query: 253 TSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           T  ++ P  +N   L  ++D++S GV+   LL+G  P
Sbjct: 174 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 73.5 bits (181), Expect = 1e-14
 Identities = 53/204 (25%), Positives = 86/204 (42%), Gaps = 16/204 (7%)

Query: 93  RCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRITE---RELLRIISQVNHKNVVKIL 148
           + L +G +  V   V       VAVK       +   E   +E+  I   +NH+NVVK  
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEI-CINKMLNHENVVKFY 71

Query: 149 GLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASP 207
           G          L  E+ S G L D I  E    +       R   +  + + YLH +   
Sbjct: 72  GH-RREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQ-RFFHQLMAGVVYLHGIG-- 125

Query: 208 PIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKL 267
            I H D+K  N+LL++    K++DF  + +   +    +   + GT  Y+ P  +   + 
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK-RRE 183

Query: 268 --TKKSDVYSFGVVLAELLTGKKP 289
              +  DV+S G+VL  +L G+ P
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELP 207

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 73.5 bits (181), Expect = 2e-14
 Identities = 54/224 (24%), Positives = 94/224 (41%), Gaps = 67/224 (29%)

Query: 97  QGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLR---IISQVNHKNVVKIL----- 148
            G F  V++  L ++ +VA+K      K+   +R   R   I+  V H NVV +      
Sbjct: 50  NGSFGVVFQAKLVESDEVAIK------KVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYS 103

Query: 149 GLCLETEVPL-LVYEF-------------ASNGTL-LDHIRCESSQVLKTWKTCLRIAAE 193
               + EV L LV E+                 T+ +  I+    Q+L+           
Sbjct: 104 NGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLR----------- 152

Query: 194 TASALDYLHSLASPPIIHGDVKSANILLN-DNYTAKVADFESS-VLISSDAETA-MST-- 248
              +L Y+HS+    I H D+K  N+LL+  +   K+ DF S+ +LI+ +   + + +  
Sbjct: 153 ---SLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY 206

Query: 249 -----ILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGK 287
                ++ G + Y           T   D++S G V+AEL+ G+
Sbjct: 207 YRAPELIFGATNY-----------TTNIDIWSTGCVMAELMQGQ 239

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 73.1 bits (180), Expect = 2e-14
 Identities = 52/232 (22%), Positives = 83/232 (35%), Gaps = 51/232 (21%)

Query: 86  TKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRI-------------TEREL 132
              +   R +S G + +V  GV  + I VA+K                         RE+
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 133 LRIISQVNHKNVVKILGLCLETEVPL-----LVYEF---------ASNGTLL--DHIRCE 176
            R+++  +H N++ +  + +  E P      LV E               ++   HI+  
Sbjct: 81  -RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYF 139

Query: 177 SSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSV 236
              +L                L  LH  A   ++H D+   NILL DN    + DF    
Sbjct: 140 MYHILL--------------GLHVLHE-AG--VVHRDLHPGNILLADNNDITICDFN--- 179

Query: 237 LISSDAETAMSTILIGTSGYLDP-VCINTGKLTKKSDVYSFGVVLAELLTGK 287
           L   D   A  T  +    Y  P + +     TK  D++S G V+AE+   K
Sbjct: 180 LAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 72.2 bits (178), Expect = 3e-14
 Identities = 71/213 (33%), Positives = 103/213 (48%), Gaps = 23/213 (10%)

Query: 88  NFDRSRCLSQGGFVSVY---KGVLHDNIQV-AVKTYRRA-----DKIR-ITERELLRIIS 137
            F+  + L QG F  V+   K    D  Q+ A+K  ++A     D++R   ER    I+ 
Sbjct: 25  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMER---DILV 81

Query: 138 QVNHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETAS 196
           +VNH  +VK L    +TE  L L+ +F   G L   +  E   +           AE A 
Sbjct: 82  EVNHPFIVK-LHYAFQTEGKLYLILDFLRGGDLFTRLSKE--VMFTEEDVKF-YLAELAL 137

Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
           ALD+LHSL    II+ D+K  NILL++    K+ DF  S       + A S    GT  Y
Sbjct: 138 ALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEY 192

Query: 257 LDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           + P  +N    T+ +D +SFGV++ E+LTG  P
Sbjct: 193 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 71.9 bits (177), Expect = 3e-14
 Identities = 54/217 (24%), Positives = 88/217 (40%), Gaps = 23/217 (10%)

Query: 86  TKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRR---ADKIRITERELLR----IIS 137
              +D    L  G F  V K       +Q A K  ++       R   RE +     I+ 
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69

Query: 138 QVNHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETAS 196
           ++ H NV+ +  +  E +  + L+ E  + G L D +  + S    T +       +  +
Sbjct: 70  EIQHPNVITLHEVY-ENKTDVILILELVAGGELFDFLAEKESL---TEEEATEFLKQILN 125

Query: 197 ALDYLHSLASPPIIHGDVKSANILL----NDNYTAKVADFESSVLISSDAETAMSTILIG 252
            + YLHSL    I H D+K  NI+L          K+ DF  +  I          I  G
Sbjct: 126 GVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--NEFKNIF-G 179

Query: 253 TSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           T  ++ P  +N   L  ++D++S GV+   LL+G  P
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 71.7 bits (176), Expect = 7e-14
 Identities = 54/218 (24%), Positives = 97/218 (44%), Gaps = 29/218 (13%)

Query: 87  KNFDRSRCLSQGGFVSVYKGVLHDNIQV-AVKTYRRADKIR-------ITERELLRIISQ 138
           ++++  + + +G F  V         +V A+K   + + I+         ER    I++ 
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER---DIMAF 125

Query: 139 VNHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCE--SSQVLKTWKTCLRIAAETA 195
            N   VV+ L    + +  L +V E+   G L++ +       +  + +       AE  
Sbjct: 126 ANSPWVVQ-LFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFY------TAEVV 178

Query: 196 SALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG 255
            ALD +HS+     IH DVK  N+LL+ +   K+ADF + + ++ +      T  +GT  
Sbjct: 179 LALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPD 234

Query: 256 YLDP-VCINTGKL---TKKSDVYSFGVVLAELLTGKKP 289
           Y+ P V  + G      ++ D +S GV L E+L G  P
Sbjct: 235 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 71.7 bits (176), Expect = 9e-14
 Identities = 70/264 (26%), Positives = 115/264 (43%), Gaps = 44/264 (16%)

Query: 93  RCLSQGGFVSVYKGV-LHDNIQVAVKTYRR------ADKIRITERELLRIISQVNHKNVV 145
             L  G F  V  G       +VAVK   R          +I  RE+ + +    H +++
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKI-RREI-QNLKLFRHPHII 79

Query: 146 KILGLCLETEVPL-LVYEFASNGTLLDHI----RCESSQVLKTWKTCLRIAAETASALDY 200
           K+  + + T   + +V E+ S G L D+I    R +  +  + ++  L       S +DY
Sbjct: 80  KLYQV-ISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQIL-------SGVDY 131

Query: 201 LHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDA--ETAMSTILIGTSGYLD 258
            H      ++H D+K  N+LL+ +  AK+ADF  S ++S      T+      G+  Y  
Sbjct: 132 CHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS-----CGSPNYAA 183

Query: 259 PVCINTGKLTK--KSDVYSFGVVLAELLTGKKP---GSCMTLASNKKIS----MVPYFLN 309
           P  I+ G+L    + D++S GV+L  LL G  P       TL   KKI       P +LN
Sbjct: 184 PEVIS-GRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLF--KKICDGIFYTPQYLN 240

Query: 310 SIKNNGLRQILNFHVADESEMKEI 333
               + L+ +L       + +K+I
Sbjct: 241 PSVISLLKHMLQVDPMKRATIKDI 264

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 70.8 bits (174), Expect = 1e-13
 Identities = 47/236 (19%), Positives = 90/236 (38%), Gaps = 62/236 (26%)

Query: 86  TKNFDRSRCLSQGGFVSVYKGVL-HDNIQVAVKTYR--RADKIRITERELLRIISQVNHK 142
              F   R   QG F +V  G      + VA+K        + R  E ++++ ++ ++H 
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNR--ELQIMQDLAVLHHP 79

Query: 143 NVVKIL------GLCLETEVPL-LVYEF-------------ASNGTL-LDHIRCESSQVL 181
           N+V++       G     ++ L +V E+                       I+    Q++
Sbjct: 80  NIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLI 139

Query: 182 KTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLN-DNYTAKVADFESS-VLIS 239
           +              ++  LH   S  + H D+K  N+L+N  + T K+ DF S+  L  
Sbjct: 140 R--------------SIGCLHL-PSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSP 184

Query: 240 SDAETA-MST-------ILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGK 287
           S+   A + +       ++ G   Y           T   D++S G + AE++ G+
Sbjct: 185 SEPNVAYICSRYYRAPELIFGNQHY-----------TTAVDIWSVGCIFAEMMLGE 229

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 70.6 bits (174), Expect = 1e-13
 Identities = 60/219 (27%), Positives = 93/219 (42%), Gaps = 33/219 (15%)

Query: 88  NFDRSRCLSQGGFVSVY---KGVLHDNIQV-AVKTYRRADKIR--------ITERELLRI 135
            F+  R L +GG+  V+   K    +  ++ A+K  ++A  +R          ER    I
Sbjct: 18  CFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAER---NI 74

Query: 136 ISQVNHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAET 194
           + +V H  +V  L    +T   L L+ E+ S G L   +  E   +      C    AE 
Sbjct: 75  LEEVKHPFIVD-LIYAFQTGGKLYLILEYLSGGELFMQLERE--GIFMEDTACF-YLAEI 130

Query: 195 ASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADF----ESSVLISSDAETAMSTIL 250
           + AL +LH      II+ D+K  NI+LN     K+ DF    ES   I     T   T  
Sbjct: 131 SMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKES---IHDGTVT--HTFC 182

Query: 251 IGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
            GT  Y+ P  +      +  D +S G ++ ++LTG  P
Sbjct: 183 -GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 70.9 bits (174), Expect = 1e-13
 Identities = 55/236 (23%), Positives = 98/236 (41%), Gaps = 68/236 (28%)

Query: 86  TKNFDRSRCLSQGGFVSVYKGVLHD-NIQVAVKTYRRADKIRITERELLR---IISQVNH 141
             ++  ++ +  G F  VY+  L D    VA+K      K+   +R   R   I+ +++H
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK------KVLQDKRFKNRELQIMRKLDH 106

Query: 142 KNVVKILGLCLET-----EVPL-LVYEF-------------ASNGTL-LDHIRCESSQVL 181
            N+V++      +     EV L LV ++              +  TL + +++    Q+ 
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 166

Query: 182 KTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLN-DNYTAKVADFESS-VLIS 239
           +              +L Y+HS     I H D+K  N+LL+ D    K+ DF S+  L+ 
Sbjct: 167 R--------------SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 209

Query: 240 SDAETA-MST-------ILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGK 287
            +   + + +       ++ G + Y           T   DV+S G VLAELL G+
Sbjct: 210 GEPNVSYICSRYYRAPELIFGATDY-----------TSSIDVWSAGCVLAELLLGQ 254

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 69.2 bits (170), Expect = 3e-13
 Identities = 52/214 (24%), Positives = 89/214 (41%), Gaps = 30/214 (14%)

Query: 88  NFDRSRCLSQGGFVSVYKGVLHDNIQV-AVKTYRRADKIR-------ITERELLRIISQV 139
            FDR + L  G F  V      ++    A+K   +   ++       + E+   RI+  V
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK---RILQAV 98

Query: 140 NHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCE---SSQVLKTWKTCLRIAAETA 195
           N   +VK+     +    L +V E+ + G +  H+R     S    + +      AA+  
Sbjct: 99  NFPFLVKLEF-SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY------AAQIV 151

Query: 196 SALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG 255
              +YLHSL    +I+ D+K  N+L++     +V DF  +  +     T     L GT  
Sbjct: 152 LTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPE 203

Query: 256 YLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
            L P  I +    K  D ++ GV++ E+  G  P
Sbjct: 204 ALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 69.2 bits (170), Expect = 3e-13
 Identities = 50/228 (21%), Positives = 93/228 (40%), Gaps = 50/228 (21%)

Query: 86  TKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRI---------TERELLRI 135
              +     + +G +  V       + ++VA+K      KI           T RE+ +I
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK------KISPFEHQTYCQRTLREI-KI 78

Query: 136 ISQVNHKNVVKILGLCLETEVPL-----LVYEF---------ASNGTLLDHIRCESSQVL 181
           + +  H+N++ I  +     +       +V +           +     DHI     Q+L
Sbjct: 79  LLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 138

Query: 182 KTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD 241
           +               L Y+HS A+  ++H D+K +N+LLN     K+ DF  + +   D
Sbjct: 139 R--------------GLKYIHS-AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181

Query: 242 AETA-MSTILIGTSGYLDP-VCINTGKLTKKSDVYSFGVVLAELLTGK 287
            +     T  + T  Y  P + +N+   TK  D++S G +LAE+L+ +
Sbjct: 182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 69.4 bits (170), Expect = 4e-13
 Identities = 57/219 (26%), Positives = 82/219 (37%), Gaps = 53/219 (24%)

Query: 95  LSQGGFVSVYKGV-LHDNIQVAVK------TYRRADKIRITERELLRIISQ---VNHKNV 144
           + +G F  V K      +  VA+K       + R       E  +L  + +    N  NV
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAE---EIRILEHLRKQDKDNTMNV 161

Query: 145 VKILG-------LCLETEVPLL---VYEFASNGTL----LDHIRCESSQVLKTWKTCLRI 190
           + +L        +C+  E  LL   +YE           L  +R  +  +L+        
Sbjct: 162 IHMLENFTFRNHICMTFE--LLSMNLYELIKKNKFQGFSLPLVRKFAHSILQ-------- 211

Query: 191 AAETASALDYLHSLASPPIIHGDVKSANILLNDNYTA--KVADFESSVLISSDAETAMST 248
                  LD LH      IIH D+K  NILL     +  KV DF S    S      + T
Sbjct: 212 ------CLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGS----SCYEHQRVYT 258

Query: 249 ILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGK 287
             I +  Y  P  I   +     D++S G +LAELLTG 
Sbjct: 259 Y-IQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 68.6 bits (168), Expect = 6e-13
 Identities = 44/236 (18%), Positives = 84/236 (35%), Gaps = 73/236 (30%)

Query: 95  LSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIR---ITERELLRIISQV--------NHK 142
           L  G F +V+    + +N  VA+K  R           E +LL+ ++             
Sbjct: 27  LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGAN 86

Query: 143 NVVKILG-----------LCLETEVPLL---VYEFASN----GTLLDHIRCESSQVLKTW 184
           +++K+L            + +  E  +L   +          G  L +++  S Q+L   
Sbjct: 87  HILKLLDHFNHKGPNGVHVVMVFE--VLGENLLALIKKYEHRGIPLIYVKQISKQLLL-- 142

Query: 185 KTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLND------NYTAKVADFESSVLI 238
                        LDY+H      IIH D+K  N+L+            K+AD  ++   
Sbjct: 143 ------------GLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY 188

Query: 239 SSDAETAMST-------ILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGK 287
                 ++ T       +L+G + +              +D++S   ++ EL+TG 
Sbjct: 189 DEHYTNSIQTREYRSPEVLLG-APW-----------GCGADIWSTACLIFELITGD 232

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 67.7 bits (166), Expect = 1e-12
 Identities = 58/218 (26%), Positives = 97/218 (44%), Gaps = 27/218 (12%)

Query: 88  NFDRSRCLSQGGFVSVY---KGVLHDNIQV-AVKTYRRADKIR--------ITERELLRI 135
           NF+  + L  G +  V+   K   HD  ++ A+K  ++A  ++         TER   ++
Sbjct: 55  NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER---QV 111

Query: 136 ISQVNHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAET 194
           +  +     +  L    +TE  L L+ ++ + G L  H+     +     +  +    E 
Sbjct: 112 LEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQI-YVGEI 168

Query: 195 ASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFE-SSVLISSDAETAMSTILIGT 253
             AL++LH L    II+ D+K  NILL+ N    + DF  S   ++ + E A      GT
Sbjct: 169 VLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD--FCGT 223

Query: 254 SGYLDPVCINTGKL--TKKSDVYSFGVVLAELLTGKKP 289
             Y+ P  +  G     K  D +S GV++ ELLTG  P
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 67.3 bits (165), Expect = 1e-12
 Identities = 45/215 (20%), Positives = 91/215 (42%), Gaps = 44/215 (20%)

Query: 93  RCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRITERE--LLRIISQVNHKNVVKILG 149
           R L +G +  V++ + + +N +V VK  +   K +I +RE  +L  +      N++ +  
Sbjct: 42  RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKI-KREIKILENLR--GGPNIITLAD 98

Query: 150 LCL--ETEVPLLVYEFASNGTL--------LDHIRCESSQVLKTWKTCLRIAAETASALD 199
           +     +  P LV+E  +N              IR    ++LK              ALD
Sbjct: 99  IVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILK--------------ALD 144

Query: 200 YLHSLASPPIIHGDVKSANILLN-DNYTAKVADF---ESSVLISSDAETAMSTILIGTSG 255
           Y HS+    I+H DVK  N++++ ++   ++ D+   E               + + +  
Sbjct: 145 YCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY-----HPGQEY-NVRVASRY 195

Query: 256 YLDP-VCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           +  P + ++        D++S G +LA ++  K+P
Sbjct: 196 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 67.3 bits (165), Expect = 1e-12
 Identities = 51/247 (20%), Positives = 90/247 (36%), Gaps = 77/247 (31%)

Query: 84  RATKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRI-TERE-----LLRII 136
                +++   + QG F  V+K        +VA+K      K+ +  E+E      LR I
Sbjct: 14  DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALK------KVLMENEKEGFPITALREI 67

Query: 137 S---QVNHKNVVKILGLCLETEVPL--------LVYEFASN--GTLLD---------HIR 174
                + H+NVV ++ +C     P         LV++F  +    LL           I+
Sbjct: 68  KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK 127

Query: 175 CESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFES 234
                +L                L Y+H      I+H D+K+AN+L+  +   K+ADF  
Sbjct: 128 RVMQMLLN--------------GLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 170

Query: 235 SVLISSDAETAMST--------------ILIGTSGYLDPVCINTGKLTKKSDVYSFGVVL 280
           +   S    +  +               +L+G   Y  P+           D++  G ++
Sbjct: 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPI-----------DLWGAGCIM 219

Query: 281 AELLTGK 287
           AE+ T  
Sbjct: 220 AEMWTRS 226

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 67.3 bits (165), Expect = 2e-12
 Identities = 54/225 (24%), Positives = 91/225 (40%), Gaps = 49/225 (21%)

Query: 86  TKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRA-----DKIRITERELLRIISQV 139
            K +     +  G + SV   +      +VA+K   R         R   REL  ++  +
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKR-AYREL-LLLKHM 80

Query: 140 NHKNVVKILGLCLETEVPL------LVYEFASNGTLL----------DHIRCESSQVLKT 183
            H+NV+ +L +              LV  F    T L          + I+    Q+LK 
Sbjct: 81  QHENVIGLLDVFTPASSLRNFYDFYLVMPFM--QTDLQKIMGLKFSEEKIQYLVYQMLK- 137

Query: 184 WKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE 243
                         L Y+HS A   ++H D+K  N+ +N++   K+ DF     ++  A+
Sbjct: 138 -------------GLKYIHS-AG--VVHRDLKPGNLAVNEDCELKILDFG----LARHAD 177

Query: 244 TAMSTILIGTSGYLDP-VCINTGKLTKKSDVYSFGVVLAELLTGK 287
             M T  + T  Y  P V ++     +  D++S G ++AE+LTGK
Sbjct: 178 AEM-TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 67.3 bits (165), Expect = 2e-12
 Identities = 54/241 (22%), Positives = 90/241 (37%), Gaps = 59/241 (24%)

Query: 86  TKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRI---------TERELLRI 135
           + +F     L +G +  V           VA+K      KI           T RE+ +I
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIK------KIEPFDKPLFALRTLREI-KI 62

Query: 136 ISQVNHKNVVKILGLCLETEVPL-----LVYEFA--------SNGTLLD-HIRCESSQVL 181
           +    H+N++ I  +             ++ E          S   L D HI+    Q L
Sbjct: 63  LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTL 122

Query: 182 KTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADF--------E 233
           +              A+  LH  ++  +IH D+K +N+L+N N   KV DF         
Sbjct: 123 R--------------AVKVLHG-SN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165

Query: 234 SSVLISSDAETAMSTILIGTSGYLDP-VCINTGKLTKKSDVYSFGVVLAELLTGKK--PG 290
           ++       + +     + T  Y  P V + + K ++  DV+S G +LAEL   +   PG
Sbjct: 166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPG 225

Query: 291 S 291
            
Sbjct: 226 R 226

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 66.9 bits (164), Expect = 2e-12
 Identities = 56/211 (26%), Positives = 90/211 (42%), Gaps = 21/211 (9%)

Query: 88  NFDRSRCLSQGGFVSVYKGVLHDNIQV-AVKTYRRADKIR-------ITERELLRIISQV 139
           +FD  + L +G F  V         +  A+K  R+   I        +TE    R++   
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTES---RVLQNT 62

Query: 140 NHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASAL 198
            H  +   L    +T   L  V E+A+ G L  H+  E  +V    +      AE  SAL
Sbjct: 63  RHPFLTA-LKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARF-YGAEIVSAL 118

Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLD 258
           +YLHS     +++ D+K  N++L+ +   K+ DF       SD  T  +    GT  YL 
Sbjct: 119 EYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLA 173

Query: 259 PVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           P  +      +  D +  GVV+ E++ G+ P
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 67.4 bits (165), Expect = 2e-12
 Identities = 54/224 (24%), Positives = 90/224 (40%), Gaps = 46/224 (20%)

Query: 86  TKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRA-----DKIRITERELLRIISQV 139
            + +     +  G + SV         ++VAVK   R         R T REL R++  +
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYREL-RLLKHM 85

Query: 140 NHKNVVKILGLCLETEVPL------LVYEF---------ASNGTLLDHIRCESSQVLKTW 184
            H+NV+ +L +              LV                   DH++    Q+L+  
Sbjct: 86  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR-- 143

Query: 185 KTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET 244
                        L Y+HS A   IIH D+K +N+ +N++   K+ DF     ++     
Sbjct: 144 ------------GLKYIHS-AD--IIHRDLKPSNLAVNEDCELKILDFG----LARHTAD 184

Query: 245 AMSTILIGTSGYLDP-VCINTGKLTKKSDVYSFGVVLAELLTGK 287
            M T  + T  Y  P + +N     +  D++S G ++AELLTG+
Sbjct: 185 EM-TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 66.9 bits (163), Expect = 2e-12
 Identities = 32/114 (28%), Positives = 52/114 (45%), Gaps = 16/114 (14%)

Query: 183 TWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDA 242
           T +  +  + + A  +++L   AS   IH D+ + NILL++    K+ DF  +  I  D 
Sbjct: 191 TLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD- 246

Query: 243 ETAMSTILIGTSGYLDPV------CINTGKLTKKSDVYSFGVVLAELLT-GKKP 289
                  +      L P+       I     T +SDV+SFGV+L E+ + G  P
Sbjct: 247 ----PDYVRKGDARL-PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 48.4 bits (115), Expect = 2e-06
 Identities = 29/111 (26%), Positives = 45/111 (40%), Gaps = 15/111 (13%)

Query: 89  FDRS-----RCLSQGGFVSVYKGVLHD------NIQVAVKTYRR---ADKIRITERELLR 134
           F R      + L +G F  V +              VAVK  +      + R    EL  
Sbjct: 19  FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI 78

Query: 135 IISQVNHKNVVKILGLCLETEVPLLV-YEFASNGTLLDHIRCESSQVLKTW 184
           +I   +H NVV +LG C +   PL+V  EF   G L  ++R + ++ +   
Sbjct: 79  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 129

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 66.5 bits (163), Expect = 2e-12
 Identities = 67/260 (25%), Positives = 118/260 (45%), Gaps = 37/260 (14%)

Query: 93  RCLSQGGFVSVYKGV-LHDNIQVAVKTYRRA------DKIRITERELLRIISQVNHKNVV 145
             L +G F  V          +VA+K   R         +R+ ERE+   +  + H +++
Sbjct: 15  ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRV-EREI-SYLKLLRHPHII 72

Query: 146 KILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSL 204
           K+  + + T   + +V E+A  G L D+I     + +       R   +   A++Y H  
Sbjct: 73  KLYDV-ITTPTDIVMVIEYA-GGELFDYI--VEKKRMTE-DEGRRFFQQIICAIEYCHRH 127

Query: 205 ASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDA--ETAMSTILIGTSGYLDPVCI 262
               I+H D+K  N+LL+DN   K+ADF  S +++     +T+      G+  Y  P  I
Sbjct: 128 K---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS-----CGSPNYAAPEVI 179

Query: 263 NTGKLTK--KSDVYSFGVVLAELLTGKKP---GSCMTLASNKKIS----MVPYFLNSIKN 313
           N GKL    + DV+S G+VL  +L G+ P        L   KK++    ++P FL+    
Sbjct: 180 N-GKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF--KKVNSCVYVMPDFLSPGAQ 236

Query: 314 NGLRQILNFHVADESEMKEI 333
           + +R+++         ++EI
Sbjct: 237 SLIRRMIVADPMQRITIQEI 256

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 66.6 bits (163), Expect = 2e-12
 Identities = 49/224 (21%), Positives = 82/224 (36%), Gaps = 46/224 (20%)

Query: 86  TKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRA-----DKIRITERELLRIISQV 139
            K +   + +  G    V           VA+K   R         R   REL  ++  V
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKR-AYREL-VLMKCV 81

Query: 140 NHKNVVKILGLCLETEVPL------LVYEFASNGTLL----------DHIRCESSQVLKT 183
           NHKN++ +L +    +         +V E       L          + +     Q+L  
Sbjct: 82  NHKNIIGLLNVFTPQKSLEEFQDVYIVMELM--DANLCQVIQMELDHERMSYLLYQMLC- 138

Query: 184 WKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE 243
                         + +LHS A   IIH D+K +NI++  + T K+ DF    L  +   
Sbjct: 139 -------------GIKHLHS-AG--IIHRDLKPSNIVVKSDCTLKILDFG---LARTAGT 179

Query: 244 TAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGK 287
           + M T  + T  Y  P  I      +  D++S G ++ E++ G 
Sbjct: 180 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 66.6 bits (163), Expect = 2e-12
 Identities = 53/215 (24%), Positives = 85/215 (39%), Gaps = 41/215 (19%)

Query: 93  RCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILG 149
           + +  G F              VAVK   R   I   + +RE+      + H N+V+   
Sbjct: 26  KDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENV-QREI-INHRSLRHPNIVR-FK 82

Query: 150 LCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETA--------SALDY 200
             + T   L ++ E+AS G L + I C +           R + + A        S + Y
Sbjct: 83  EVILTPTHLAIIMEYASGGELYERI-CNAG----------RFSEDEARFFFQQLLSGVSY 131

Query: 201 LHSLASPPIIHGDVKSANILLNDNYTA--KVADFESSVLISSDA--ETAMSTILIGTSGY 256
            HS+    I H D+K  N LL+ +     K+ DF  S      +  ++      +GT  Y
Sbjct: 132 CHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-----VGTPAY 183

Query: 257 LDPVCINTGKL--TKKSDVYSFGVVLAELLTGKKP 289
           + P  +   +    K +DV+S GV L  +L G  P
Sbjct: 184 IAPEVLL-RQEYDGKIADVWSCGVTLYVMLVGAYP 217

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 66.4 bits (163), Expect = 3e-12
 Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 30/214 (14%)

Query: 88  NFDRSRCLSQGGFVSVYKGVLHDNIQV-AVKTYRRADKIR-------ITERELLRIISQV 139
           +F   R L  G F  V+      N +  A+K  ++   +R         ER    ++S V
Sbjct: 7   DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDER---LMLSIV 63

Query: 140 NHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCE---SSQVLKTWKTCLRIAAETA 195
            H  ++++ G   +    + ++ ++   G L   +R      + V K +      AAE  
Sbjct: 64  THPFIIRMWG-TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFY------AAEVC 116

Query: 196 SALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG 255
            AL+YLHS     II+ D+K  NILL+ N   K+ DF  +  +     T     L GT  
Sbjct: 117 LALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT-----LCGTPD 168

Query: 256 YLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           Y+ P  ++T    K  D +SFG+++ E+L G  P
Sbjct: 169 YIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 66.6 bits (163), Expect = 3e-12
 Identities = 53/200 (26%), Positives = 88/200 (44%), Gaps = 45/200 (22%)

Query: 109 HDNIQVAVKTYRRA-----DKIRITERELLRIISQVNHKNVVKILGLCLETEVPL----- 158
               +VA+K   R         R   REL R++  + H+NV+ +L +    E        
Sbjct: 48  RTGAKVAIKKLYRPFQSELFAKR-AYREL-RLLKHMRHENVIGLLDVFTPDETLDDFTDF 105

Query: 159 -LVYEFA--------SNGTLLD-HIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPP 208
            LV  F          +  L +  I+    Q+LK               L Y+H+ A   
Sbjct: 106 YLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLK--------------GLRYIHA-AG-- 148

Query: 209 IIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDP-VCINTGKL 267
           IIH D+K  N+ +N++   K+ DF     ++  A++ M T  + T  Y  P V +N  + 
Sbjct: 149 IIHRDLKPGNLAVNEDCELKILDFG----LARQADSEM-TGYVVTRWYRAPEVILNWMRY 203

Query: 268 TKKSDVYSFGVVLAELLTGK 287
           T+  D++S G ++AE++TGK
Sbjct: 204 TQTVDIWSVGCIMAEMITGK 223

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 65.6 bits (160), Expect = 8e-12
 Identities = 49/224 (21%), Positives = 82/224 (36%), Gaps = 46/224 (20%)

Query: 86  TKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRA-----DKIRITERELLRIISQV 139
            K +   + +  G    V        +  VA+K   R         R   REL  ++  V
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKR-AYREL-VLMKCV 118

Query: 140 NHKNVVKILGLCLETEVPL------LVYEFASNGTLL----------DHIRCESSQVLKT 183
           NHKN++ +L +    +         LV E       L          + +     Q+L  
Sbjct: 119 NHKNIISLLNVFTPQKTLEEFQDVYLVMELM--DANLCQVIQMELDHERMSYLLYQMLC- 175

Query: 184 WKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE 243
                         + +LHS     IIH D+K +NI++  + T K+ DF    L  +   
Sbjct: 176 -------------GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG---LARTAGT 216

Query: 244 TAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGK 287
           + M T  + T  Y  P  I      +  D++S G ++ E++  K
Sbjct: 217 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 65.1 bits (159), Expect = 1e-11
 Identities = 49/226 (21%), Positives = 83/226 (36%), Gaps = 65/226 (28%)

Query: 95  LSQGGFVSVYKGV-LHDNIQVAVK------TYRRADKIRITERELLRIISQ---VNHKNV 144
           + +G F  V K     +   VA+K       +    +I   E  LL ++++        +
Sbjct: 62  IGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQI---EVRLLELMNKHDTEMKYYI 118

Query: 145 VKILG-------LCLETEVPLL---VYEF----ASNGTLLDHIRCESSQVLKTWKTCLRI 190
           V +         LCL  E  +L   +Y+        G  L+  R  + Q+          
Sbjct: 119 VHLKRHFMFRNHLCLVFE--MLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCT-------- 168

Query: 191 AAETASALDYLHSLASPPIIHGDVKSANILLNDNYTA--KVADFESSVLISSDAETAMST 248
                 AL +L +     IIH D+K  NILL +   +  K+ DF SS  +       + +
Sbjct: 169 ------ALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQS 221

Query: 249 -------ILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGK 287
                  +L+G   Y               D++S G +L E+ TG+
Sbjct: 222 RFYRSPEVLLGM-PY-----------DLAIDMWSLGCILVEMHTGE 255

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 64.8 bits (158), Expect = 1e-11
 Identities = 58/291 (19%), Positives = 103/291 (35%), Gaps = 76/291 (26%)

Query: 86  TKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRA-----DKIRITERELLRIISQV 139
             N+     + +G +  VY     +    VA+K   R      D  R   RE+  I++++
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKR-ILREI-TILNRL 82

Query: 140 NHKNVVKILGLCLETEVPL-----LVYEFA---------SNGTLLD-HIRCESSQVLKTW 184
               ++++  L +  ++       +V E A         +   L + HI+     +L   
Sbjct: 83  KSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLL-- 140

Query: 185 KTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET 244
                         +++H  +   IIH D+K AN LLN + + KV DF  +  I+S+ +T
Sbjct: 141 ------------GENFIHE-SG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDT 185

Query: 245 AMSTILIGTSGYLDPVCINTGKLT---------------------KKSDVYSFGVVLAEL 283
            +   L               +LT                     K  D++S G + AEL
Sbjct: 186 NIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAEL 245

Query: 284 LTGKK-------------PGSCMTLASNKKISMVPYFLNSIKNNGLRQILN 321
           L   +             PGS     S  + S   +  ++   + L  I N
Sbjct: 246 LNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNR--DQLNIIFN 294

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 63.7 bits (156), Expect = 2e-11
 Identities = 54/224 (24%), Positives = 93/224 (41%), Gaps = 51/224 (22%)

Query: 88  NFDRSRCLSQGGFVSVYKGVLHDNIQ-VAVKTYRRADKIRITE----------RE--LLR 134
            +++   + +G +  V+K    D  Q VA+K      K   +E          RE  +L+
Sbjct: 4   KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK------KFLESEDDPVIKKIALREIRMLK 57

Query: 135 IISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAET 194
              Q+ H N+V +L +        LV+E+  + T+L  +  +  Q          I  +T
Sbjct: 58  ---QLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHEL--DRYQRGVPEHLVKSITWQT 111

Query: 195 ASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMST------ 248
             A+++ H       IH DVK  NIL+  +   K+ DF  + L++  ++           
Sbjct: 112 LQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY-YDDEVATRW 167

Query: 249 -----ILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGK 287
                +L+G + Y  PV           DV++ G V AELL+G 
Sbjct: 168 YRSPELLVGDTQYGPPV-----------DVWAIGCVFAELLSGV 200

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 63.0 bits (154), Expect = 4e-11
 Identities = 56/211 (26%), Positives = 88/211 (41%), Gaps = 20/211 (9%)

Query: 88  NFDRSRCLSQGGFVSVYKGVLHDNIQV-AVKTYRRADKIR-------ITERELLRIISQV 139
           +F   + + +G F  V            AVK  ++   ++       ++ER +L  +  V
Sbjct: 39  DFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVL--LKNV 96

Query: 140 NHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASAL 198
            H  +V  L    +T   L  V ++ + G L  H++ E  +     +     AAE ASAL
Sbjct: 97  KHPFLVG-LHFSFQTADKLYFVLDYINGGELFYHLQRE--RCFLEPRARF-YAAEIASAL 152

Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLD 258
            YLHSL    I++ D+K  NILL+      + DF           T  +    GT  YL 
Sbjct: 153 GYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST--FCGTPEYLA 207

Query: 259 PVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           P  ++     +  D +  G VL E+L G  P
Sbjct: 208 PEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 62.3 bits (152), Expect = 5e-11
 Identities = 51/231 (22%), Positives = 97/231 (41%), Gaps = 47/231 (20%)

Query: 86  TKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVK--TYRRADKIRITERELLRIISQVNHK 142
              +   + L  GG   V+  V    + +VA+K         ++   RE+ +II +++H 
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREI-KIIRRLDHD 68

Query: 143 NVVKILGLCLETEVPL--------------LVYEF---------ASNGTLLDHIRCESSQ 179
           N+VK+  +   +   L              +V E+              L +H R    Q
Sbjct: 69  NIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQ 128

Query: 180 VLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLN-DNYTAKVADFE-SSVL 237
           +L+               L Y+HS A+  ++H D+K AN+ +N ++   K+ DF  + ++
Sbjct: 129 LLR--------------GLKYIHS-AN--VLHRDLKPANLFINTEDLVLKIGDFGLARIM 171

Query: 238 ISSDAETAMSTILIGTSGYLDP-VCINTGKLTKKSDVYSFGVVLAELLTGK 287
               +     +  + T  Y  P + ++    TK  D+++ G + AE+LTGK
Sbjct: 172 DPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 62.6 bits (153), Expect = 6e-11
 Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 20/211 (9%)

Query: 88  NFDRSRCLSQGGFVSVYKGVLHDNIQV-AVKTYRRADKIR-------ITERELLRIISQV 139
           NF+  R L +G F  V    + +   + AVK  ++   ++       +TE+ +L +    
Sbjct: 24  NFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-- 81

Query: 140 NHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASAL 198
           NH  + + L  C +T   L  V EF + G L+ HI+    +     +     AAE  SAL
Sbjct: 82  NHPFLTQ-LFCCFQTPDRLFFVMEFVNGGDLMFHIQKS--RRFDEARARF-YAAEIISAL 137

Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLD 258
            +LH      II+ D+K  N+LL+     K+ADF        +  T  +    GT  Y+ 
Sbjct: 138 MFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT--FCGTPDYIA 192

Query: 259 PVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           P  +         D ++ GV+L E+L G  P
Sbjct: 193 PEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 63.1 bits (153), Expect = 6e-11
 Identities = 58/215 (26%), Positives = 91/215 (42%), Gaps = 28/215 (13%)

Query: 88  NFDRSRCLSQGGFVSVYKGVLHDNIQV-AVKTYRRADKIR-------ITERELLRIISQV 139
           +F+    L +G F  V         ++ AVK  ++   I+       + E+ +L +    
Sbjct: 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG-- 399

Query: 140 NHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASAL 198
               + + L  C +T   L  V E+ + G L+ HI+       K        AAE A  L
Sbjct: 400 KPPFLTQ-LHSCFQTMDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVF-YAAEIAIGL 455

Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTAKVADF----ESSVLISSDAETAMSTILIGTS 254
            +L S     II+ D+K  N++L+     K+ADF    E+   I     T   T   GT 
Sbjct: 456 FFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN---IWDGVTT--KT-FCGTP 506

Query: 255 GYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
            Y+ P  I      K  D ++FGV+L E+L G+ P
Sbjct: 507 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 61.8 bits (151), Expect = 7e-11
 Identities = 47/232 (20%), Positives = 89/232 (38%), Gaps = 66/232 (28%)

Query: 87  KNFDRSRCLSQGGFVSVYKGVLHDNIQ-VAVKTYRRADKIRITERE-----LLRIIS--- 137
           + + +   L +G + +VYKG        VA+K      +IR+   E      +R +S   
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALK------EIRLEHEEGAPCTAIREVSLLK 55

Query: 138 QVNHKNVVKILGLCLETEVPLLVYEF-----------ASNGTLLDHIRCESSQVLKTWKT 186
            + H N+V +  +    +   LV+E+             N   + +++    Q+L+    
Sbjct: 56  DLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLR---- 111

Query: 187 CLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAM 246
                      L Y H      ++H D+K  N+L+N+    K+ADF  +   S   +T  
Sbjct: 112 ----------GLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT-Y 157

Query: 247 ST-----------ILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGK 287
                        IL+G++ Y   +           D++  G +  E+ TG+
Sbjct: 158 DNEVVTLWYRPPDILLGSTDYSTQI-----------DMWGVGCIFYEMATGR 198

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 61.4 bits (150), Expect = 1e-10
 Identities = 52/254 (20%), Positives = 96/254 (37%), Gaps = 71/254 (27%)

Query: 65  SHPGLAFLRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADK 124
            H   +  R  ++ +  M    + + +   + +G +  VYK        VA+K      +
Sbjct: 4   HHHHSSG-RENLYFQGLM----EKYQKLEKVGEGTYGVVYKAKDSQGRIVALK------R 52

Query: 125 IRI-TERE-----LLRIIS---QVNHKNVVKILGLCLETEVPLLVYEF-----------A 164
           IR+  E E      +R IS   +++H N+V ++ +        LV+EF            
Sbjct: 53  IRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDEN 112

Query: 165 SNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDN 224
             G     I+    Q+L+               + + H      I+H D+K  N+L+N +
Sbjct: 113 KTGLQDSQIKIYLYQLLR--------------GVAHCHQHR---ILHRDLKPQNLLINSD 155

Query: 225 YTAKVADFESSVLISSDAETAMST-----------ILIGTSGYLDPVCINTGKLTKKSDV 273
              K+ADF  +        +  +            +L+G+  Y   V           D+
Sbjct: 156 GALKLADFGLARAFGIPVRS-YTHEVVTLWYRAPDVLMGSKKYSTSV-----------DI 203

Query: 274 YSFGVVLAELLTGK 287
           +S G + AE++TGK
Sbjct: 204 WSIGCIFAEMITGK 217

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 61.5 bits (150), Expect = 1e-10
 Identities = 56/239 (23%), Positives = 100/239 (41%), Gaps = 20/239 (8%)

Query: 88  NFDRSRCLSQGGFVSVYKGVLHDNIQV-AVKTYRRADKIR-------ITERELLRIISQV 139
           +FD  R + +G +  V    L    ++ A+K  ++             TE+ +    S  
Sbjct: 10  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS-- 67

Query: 140 NHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASAL 198
           NH  +V  L  C +TE  L  V E+ + G L+ H++ +  + L         +AE + AL
Sbjct: 68  NHPFLVG-LHSCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARF-YSAEISLAL 123

Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLD 258
           +YLH      II+ D+K  N+LL+     K+ D+          +T  +    GT  Y+ 
Sbjct: 124 NYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNYIA 178

Query: 259 PVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLR 317
           P  +         D ++ GV++ E++ G+ P   +  + N   +   Y    I    +R
Sbjct: 179 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR 237

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 61.6 bits (150), Expect = 1e-10
 Identities = 61/250 (24%), Positives = 95/250 (38%), Gaps = 89/250 (35%)

Query: 93  RCLSQGGFVSVYKGV-LHDNIQVAVK------TYRRADKIRITERELLRIISQ--VNHKN 143
           R +  G F  V     + +    AVK       Y R+ KI   E ++L+ I    +N+ N
Sbjct: 41  RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKI---EADILKKIQNDDINNNN 97

Query: 144 VVKILG-------LCLETEVPLL---VYEF----ASNGTLLDHIRCESSQVLKTWKTCLR 189
           +VK  G       +CL  E   L   +YE       NG  ++ I+    ++LK       
Sbjct: 98  IVKYHGKFMYYDHMCLIFE--PLGPSLYEIITRNNYNGFHIEDIKLYCIEILK------- 148

Query: 190 IAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTA---------------------- 227
                  AL+YL  ++   + H D+K  NILL+D Y                        
Sbjct: 149 -------ALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKS 198

Query: 228 ---KVADFESSVLISSDAETAMST-------ILIGTSGYLDPVCINTGKLTKKSDVYSFG 277
              K+ DF  +   S    + ++T       +++   G+              SD++SFG
Sbjct: 199 TGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNL-GW-----------DVSSDMWSFG 246

Query: 278 VVLAELLTGK 287
            VLAEL TG 
Sbjct: 247 CVLAELYTGS 256

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 61.1 bits (149), Expect = 2e-10
 Identities = 58/215 (26%), Positives = 91/215 (42%), Gaps = 28/215 (13%)

Query: 88  NFDRSRCLSQGGFVSVYKGVLHDNIQV-AVKTYRRADKIR-------ITERELLRIISQV 139
           +F+    L +G F  V         ++ AVK  ++   I+       + E+ +L +    
Sbjct: 21  DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG-- 78

Query: 140 NHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASAL 198
               + + L  C +T   L  V E+ + G L+ HI+       K        AAE A  L
Sbjct: 79  KPPFLTQ-LHSCFQTMDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVF-YAAEIAIGL 134

Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTAKVADF----ESSVLISSDAETAMSTILIGTS 254
            +L S     II+ D+K  N++L+     K+ADF    E+   I     T   T   GT 
Sbjct: 135 FFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN---IWDGVTT--KT-FCGTP 185

Query: 255 GYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
            Y+ P  I      K  D ++FGV+L E+L G+ P
Sbjct: 186 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 61.2 bits (149), Expect = 2e-10
 Identities = 55/239 (23%), Positives = 100/239 (41%), Gaps = 20/239 (8%)

Query: 88  NFDRSRCLSQGGFVSVYKGVLHDNIQV-AVKTYRRADKIR-------ITERELLRIISQV 139
           +FD  R + +G +  V    L    ++ A++  ++             TE+ +    S  
Sbjct: 53  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQAS-- 110

Query: 140 NHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASAL 198
           NH  +V  L  C +TE  L  V E+ + G L+ H++ +  + L         +AE + AL
Sbjct: 111 NHPFLVG-LHSCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARF-YSAEISLAL 166

Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLD 258
           +YLH      II+ D+K  N+LL+     K+ D+          +T  +    GT  Y+ 
Sbjct: 167 NYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNYIA 221

Query: 259 PVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLR 317
           P  +         D ++ GV++ E++ G+ P   +  + N   +   Y    I    +R
Sbjct: 222 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR 280

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 61.2 bits (149), Expect = 2e-10
 Identities = 53/246 (21%), Positives = 84/246 (34%), Gaps = 85/246 (34%)

Query: 93  RCLSQGGFVSVYKGVLH--DNIQVAVK------TYRRADKIRITERELLRIISQ---VNH 141
             L +G F  V + + H     QVA+K       YR A ++   E  +L+ I +    N 
Sbjct: 25  GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARL---EINVLKKIKEKDKENK 81

Query: 142 KNVVKILG-------LCLETEVPLL---VYEF----ASNGTLLDHIRCESSQVLKTWKTC 187
              V +         +C+  E  LL    +EF          L H+R  + Q+       
Sbjct: 82  FLCVLMSDWFNFHGHMCIAFE--LLGKNTFEFLKENNFQPYPLPHVRHMAYQLCH----- 134

Query: 188 LRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTA-------------------K 228
                    AL +LH      + H D+K  NIL  ++                      +
Sbjct: 135 ---------ALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIR 182

Query: 229 VADFESSVLISSDAETAMST-------ILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLA 281
           VADF S+        T ++T       +++   G+  P            DV+S G +L 
Sbjct: 183 VADFGSATFDHEHHTTIVATRHYRPPEVILEL-GWAQPC-----------DVWSIGCILF 230

Query: 282 ELLTGK 287
           E   G 
Sbjct: 231 EYYRGF 236

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 60.4 bits (147), Expect = 2e-10
 Identities = 54/246 (21%), Positives = 85/246 (34%), Gaps = 85/246 (34%)

Query: 93  RCLSQGGFVSVYKGVLH--DNIQVAVK------TYRRADKIRITERELLRIISQ---VNH 141
             L +G F  V + + H      VAVK       Y  A +    E ++L  ++     + 
Sbjct: 20  DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARS---EIQVLEHLNTTDPNST 76

Query: 142 KNVVKILG-------LCLETEVPLL---VYEF----ASNGTLLDHIRCESSQVLKTWKTC 187
              V++L        +C+  E  LL    Y+F          LDHIR  + Q+ K     
Sbjct: 77  FRCVQMLEWFEHHGHICIVFE--LLGLSTYDFIKENGFLPFRLDHIRKMAYQICK----- 129

Query: 188 LRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTA-------------------K 228
                    ++++LHS     + H D+K  NIL   +                      K
Sbjct: 130 ---------SVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIK 177

Query: 229 VADFESSVLISSDAETAMST-------ILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLA 281
           V DF S+        T +ST       +++   G+  P            DV+S G +L 
Sbjct: 178 VVDFGSATYDDEHHSTLVSTRHYRAPEVILAL-GWSQPC-----------DVWSIGCILI 225

Query: 282 ELLTGK 287
           E   G 
Sbjct: 226 EYYLGF 231

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 60.3 bits (147), Expect = 3e-10
 Identities = 52/211 (24%), Positives = 87/211 (41%), Gaps = 20/211 (9%)

Query: 88  NFDRSRCLSQGGFVSVYKGVLHDNIQV-AVKTYRRADKIR-------ITERELLRIISQV 139
           +F   + L +G F  V+        Q  A+K  ++   +        + E+ +L +    
Sbjct: 18  DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA--W 75

Query: 140 NHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASAL 198
            H  +   +    +T+  L  V E+ + G L+ HI+          +     AAE    L
Sbjct: 76  EHPFLTH-MFCTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATF-YAAEIILGL 131

Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLD 258
            +LHS     I++ D+K  NILL+ +   K+ADF              +    GT  Y+ 
Sbjct: 132 QFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIA 186

Query: 259 PVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           P  +   K     D +SFGV+L E+L G+ P
Sbjct: 187 PEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 59.5 bits (145), Expect = 3e-10
 Identities = 46/235 (19%), Positives = 89/235 (37%), Gaps = 67/235 (28%)

Query: 87  KNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRI-TERE-----LLRIIS-- 137
           + +++   + +G + +V+K      +  VA+K      ++R+  + E      LR I   
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALK------RVRLDDDDEGVPSSALREICLL 55

Query: 138 -QVNHKNVVKILGLCLETEVPLLVYEF-----------ASNGTLLDHIRCESSQVLKTWK 185
            ++ HKN+V++  +    +   LV+EF            +     + ++    Q+LK   
Sbjct: 56  KELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLK--- 112

Query: 186 TCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETA 245
                       L + HS     ++H D+K  N+L+N N   K+A+F  +          
Sbjct: 113 -----------GLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC- 157

Query: 246 MST-----------ILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
            S            +L G   Y   +           D++S G + AEL    +P
Sbjct: 158 YSAEVVTLWYRPPDVLFGAKLYSTSI-----------DMWSAGCIFAELANAGRP 201

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 60.1 bits (146), Expect = 4e-10
 Identities = 49/258 (18%), Positives = 90/258 (34%), Gaps = 102/258 (39%)

Query: 97  QGGFVSVYKGV-LHDNIQVAVKTYRRADKIRI----TERELLRIISQVNHKNVVKIL--- 148
            G F  V +   +    + A+K      K+        REL  I+  ++H N++K++   
Sbjct: 17  TGSFGIVCEVFDIESGKRFALK------KVLQDPRYKNREL-DIMKVLDHVNIIKLVDYF 69

Query: 149 ----------------------------------GLCLETEVPL-LVYEF---------- 163
                                              +       L ++ E+          
Sbjct: 70  YTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLK 129

Query: 164 ---ASNGTL-LDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANI 219
               S  ++ ++ I     Q+ +              A+ ++HSL    I H D+K  N+
Sbjct: 130 SFIRSGRSIPMNLISIYIYQLFR--------------AVGFIHSLG---ICHRDIKPQNL 172

Query: 220 LLN-DNYTAKVADFESS-VLISSDAETA-MST-------ILIGTSGYLDPVCINTGKLTK 269
           L+N  + T K+ DF S+  LI S+   A + +       +++G + Y           T 
Sbjct: 173 LVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEY-----------TP 221

Query: 270 KSDVYSFGVVLAELLTGK 287
             D++S G V  EL+ GK
Sbjct: 222 SIDLWSIGCVFGELILGK 239

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 59.9 bits (145), Expect = 4e-10
 Identities = 53/262 (20%), Positives = 86/262 (32%), Gaps = 85/262 (32%)

Query: 95  LSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIR---ITERELLRIISQVN-----HKNVV 145
           L  G F +V+    +     VA+K  + A+      + E  LL+ +   +      + VV
Sbjct: 45  LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVV 104

Query: 146 KILG-----------LCLETEV---PL--LVYEFASNGTLLDHIRCESSQVLKTWKTCLR 189
           ++L            +C+  EV    L   + +    G  L  ++    QVL+       
Sbjct: 105 QLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQ------- 157

Query: 190 IAAETASALDYLHSLASPPIIHGDVKSANILL--NDNYTAKVA----------------- 230
                   LDYLH+     IIH D+K  NILL  N+ Y  ++A                 
Sbjct: 158 -------GLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGS 208

Query: 231 --------------------DFESSVLISSDAETAMS-----TILIGTSGYLDPVCINTG 265
                               + E   +  +D   A       T  I T  Y     +   
Sbjct: 209 AVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGS 268

Query: 266 KLTKKSDVYSFGVVLAELLTGK 287
                +D++S   +  EL TG 
Sbjct: 269 GYNTPADIWSTACMAFELATGD 290

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 59.5 bits (145), Expect = 5e-10
 Identities = 47/232 (20%), Positives = 101/232 (43%), Gaps = 47/232 (20%)

Query: 78  SKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDNIQ-VAVKTYRRADKIRITE------- 129
           +++   ++ + ++    + +G +  V K    D  + VA+K      K   ++       
Sbjct: 16  TENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIK------KFLESDDDKMVKK 69

Query: 130 ---RELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKT 186
              RE+ +++ Q+ H+N+V +L +C + +   LV+EF  + T+LD +  E       ++ 
Sbjct: 70  IAMREI-KLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDL--ELFPNGLDYQV 125

Query: 187 CLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAM 246
             +   +  + + + HS     IIH D+K  NIL++ +   K+ DF  +  +++  E   
Sbjct: 126 VQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV-Y 181

Query: 247 ST-----------ILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGK 287
                        +L+G   Y   V           DV++ G ++ E+  G+
Sbjct: 182 DDEVATRWYRAPELLVGDVKYGKAV-----------DVWAIGCLVTEMFMGE 222

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 59.5 bits (145), Expect = 6e-10
 Identities = 57/244 (23%), Positives = 92/244 (37%), Gaps = 74/244 (30%)

Query: 81  EMIRATKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRITEREL------- 132
           ++    K +++   L +G F +VYK    + N  VA+K      KI++  R         
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIK------KIKLGHRSEAKDGINR 57

Query: 133 --LRIIS---QVNHKNVVKILGLCLETEVPLLVYEF---------ASNGTLLD--HIRCE 176
             LR I    +++H N++ +L          LV++F           N  +L   HI+  
Sbjct: 58  TALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAY 117

Query: 177 SSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSV 236
               L+               L+YLH      I+H D+K  N+LL++N   K+ADF    
Sbjct: 118 MLMTLQ--------------GLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADF---G 157

Query: 237 L--ISSDAETAMST-----------ILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAEL 283
           L         A +            +L G   Y   V           D+++ G +LAEL
Sbjct: 158 LAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGV-----------DMWAVGCILAEL 206

Query: 284 LTGK 287
           L   
Sbjct: 207 LLRV 210

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 59.1 bits (144), Expect = 6e-10
 Identities = 44/182 (24%), Positives = 68/182 (37%), Gaps = 56/182 (30%)

Query: 84  RATKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRITE------------- 129
            AT  ++    +  G + +VYK    H    VA+K       +R+               
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALK------SVRVPNGGGGGGGLPISTV 59

Query: 130 RE--LLRIISQVNHKNVVKILGLCLETEVPL-----LVYEF----------ASNGTLLD- 171
           RE  LLR +    H NVV+++ +C  +         LV+E            +    L  
Sbjct: 60  REVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPA 119

Query: 172 -HIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVA 230
             I+    Q L+               LD+LH+     I+H D+K  NIL+    T K+A
Sbjct: 120 ETIKDLMRQFLR--------------GLDFLHANC---IVHRDLKPENILVTSGGTVKLA 162

Query: 231 DF 232
           DF
Sbjct: 163 DF 164

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 58.8 bits (143), Expect = 8e-10
 Identities = 49/227 (21%), Positives = 92/227 (40%), Gaps = 43/227 (18%)

Query: 83  IRATKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRITERE-----LLRII 136
           + ++  F +   L  G + +VYKG+     + VA+K      ++++   E      +R I
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALK------EVKLDSEEGTPSTAIREI 54

Query: 137 S---QVNHKNVVKILGLCLETEVPLLVYEFASN--GTLLDHIRCESSQVLKTWKTCLRIA 191
           S   ++ H+N+V++  +        LV+EF  N     +D     ++             
Sbjct: 55  SLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQ 114

Query: 192 AETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMST--- 248
            +    L + H      I+H D+K  N+L+N     K+ DF  +        T  S+   
Sbjct: 115 WQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNT-FSSEVV 170

Query: 249 --------ILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGK 287
                   +L+G+  Y   +           D++S G +LAE++TGK
Sbjct: 171 TLWYRAPDVLMGSRTYSTSI-----------DIWSCGCILAEMITGK 206

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 58.8 bits (143), Expect = 9e-10
 Identities = 43/180 (23%), Positives = 72/180 (40%), Gaps = 54/180 (30%)

Query: 84  RATKNFDRSRCLSQGGFVSVYKG--VLHDNIQVAVKTYRRADKIRI-TERE--------- 131
           RA + ++    + +G +  V+K   + +    VA+K      ++R+ T  E         
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALK------RVRVQTGEEGMPLSTIRE 61

Query: 132 --LLRIISQVNHKNVVKIL----GLCLETEVPL-LVYEFASN--GTLLD----------H 172
             +LR +    H NVV++         + E  L LV+E       T LD           
Sbjct: 62  VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTET 121

Query: 173 IRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADF 232
           I+    Q+L+               LD+LHS     ++H D+K  NIL+  +   K+ADF
Sbjct: 122 IKDMMFQLLR--------------GLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 164

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 58.7 bits (142), Expect = 1e-09
 Identities = 67/297 (22%), Positives = 109/297 (36%), Gaps = 80/297 (26%)

Query: 86  TKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRA-----DKIRITERELLRIISQV 139
              ++    +  G +  V +     +   VA+K   R      D  R   RE+  I++++
Sbjct: 52  PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKR-ILREI-AILNRL 109

Query: 140 NHKNVVKILGLCLETEVPL-----LVYEFA---------SNGTLLD-HIRCESSQVLKTW 184
           NH +VVK+L + +  +V       +V E A         +   L + HI+     +L   
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLV-- 167

Query: 185 KTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADF-----------E 233
                        + Y+HS A   I+H D+K AN L+N + + KV DF            
Sbjct: 168 ------------GVKYVHS-AG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENG 212

Query: 234 SSVLISSDAETAMSTILIGTSGYLDP---------------VCINTGKLTKKSDVYSFGV 278
           +S L  S  E  M+ +    +  L                 + +     T+  DV+S G 
Sbjct: 213 NSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGC 272

Query: 279 VLAELLTGKK-------------PG-SCMTLASNKKISMVPYFLNSIKNNGLRQILN 321
           + AELL   K             PG SC  L+ ++K      F      + L  I N
Sbjct: 273 IFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFN 329

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 57.5 bits (140), Expect = 1e-09
 Identities = 45/232 (19%), Positives = 82/232 (35%), Gaps = 66/232 (28%)

Query: 87  KNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRI-TERE-----LLRIIS--- 137
           + +     + +G +  VYK   +     A+K      KIR+  E E      +R IS   
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALK------KIRLEKEDEGIPSTTIREISILK 55

Query: 138 QVNHKNVVKILGLCLETEVPLLVYEF-----------ASNGTLLDHIRCESSQVLKTWKT 186
           ++ H N+VK+  +    +  +LV+E               G      +    Q+L     
Sbjct: 56  ELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLN---- 111

Query: 187 CLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAM 246
                      + Y H      ++H D+K  N+L+N     K+ADF  +           
Sbjct: 112 ----------GIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK-Y 157

Query: 247 ST-----------ILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGK 287
           +            +L+G+  Y   +           D++S G + AE++ G 
Sbjct: 158 THEIVTLWYRAPDVLMGSKKYSTTI-----------DIWSVGCIFAEMVNGT 198

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 56.1 bits (136), Expect = 5e-09
 Identities = 39/149 (26%), Positives = 56/149 (37%), Gaps = 17/149 (11%)

Query: 93  RCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLC 151
           + L  G    V +        + A+K  +   K R  E EL    SQ    ++V+I+ + 
Sbjct: 24  QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR-REVELHWRASQ--CPHIVRIVDVY 80

Query: 152 LETEVP-----LLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLAS 206
            E         L+V E    G L   I  +      T +    I      A+ YLHS+  
Sbjct: 81  -ENLYAGRKCLLIVMECLDGGELFSRI-QDRGDQAFTEREASEIMKSIGEAIQYLHSIN- 137

Query: 207 PPIIHGDVKSANILL---NDNYTAKVADF 232
             I H DVK  N+L      N   K+ DF
Sbjct: 138 --IAHRDVKPENLLYTSKRPNAILKLTDF 164

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 56.5 bits (137), Expect = 5e-09
 Identities = 47/232 (20%), Positives = 93/232 (40%), Gaps = 55/232 (23%)

Query: 84  RATKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRI-TERE-----LLRII 136
            +   + R   L +G +  VYK +    N  VA+K      +IR+  E E      +R +
Sbjct: 31  TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIK------RIRLEHEEEGVPGTAIREV 84

Query: 137 S---QVNHKNVVKILGLCLETEVPLLVYEFASN--GTLLDHIRCESSQVLKTWKTCLRIA 191
           S   ++ H+N++++  +        L++E+A N     +D     S +V+K++       
Sbjct: 85  SLLKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSF------L 138

Query: 192 AETASALDYLHSLASPPIIHGDVKSANILLNDNYTA-----KVADFESSVLISSDAETAM 246
            +  + +++ HS      +H D+K  N+LL+ +  +     K+ DF  +           
Sbjct: 139 YQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQ-F 194

Query: 247 ST-----------ILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGK 287
           +            IL+G+  Y   V           D++S   + AE+L   
Sbjct: 195 THEIITLWYRPPEILLGSRHYSTSV-----------DIWSIACIWAEMLMKT 235

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 57.2 bits (137), Expect = 5e-09
 Identities = 60/475 (12%), Positives = 128/475 (26%), Gaps = 136/475 (28%)

Query: 3   LLDDDVMSTVKE-VNARLQD----IASQIKQLDLRKKSGRKSRNVRGVISSAVRRGRGGR 57
            L       V++ V   L+     + S I     + +  + S   R  I     R R   
Sbjct: 70  TLLSKQEEMVQKFVEEVLRINYKFLMSPI-----KTEQRQPSMMTRMYIEQ---RDRLYN 121

Query: 58  DPGPTIYSHPGLAFLRMKIFSKSEMIRATKNFDRSRCLSQ---GGFVSVY------KGVL 108
           D                ++F+K  + R        + L +      V +       K  +
Sbjct: 122 DN---------------QVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWV 166

Query: 109 HDNIQVAVKTYRRADKIRITERELLRI--ISQVNHKNVVKILGLCLETEVPL-----LVY 161
                 A+         ++  +   +I  ++          L  C   E  L     L+Y
Sbjct: 167 ------ALDVCL---SYKVQCKMDFKIFWLN----------LKNCNSPETVLEMLQKLLY 207

Query: 162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILL 221
           +   N T            + + +  LR       +  Y + L    ++  +V++A    
Sbjct: 208 QIDPNWTSRSDHSSNIKLRIHSIQAELR---RLLKSKPYENCL----LVLLNVQNAKAW- 259

Query: 222 NDNYTAKVADFESSVLI-SSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVL 280
                    +    +L+ +   +      L   +     +  ++  LT           L
Sbjct: 260 ------NAFNLSCKILLTTRFKQVT--DFLSAATTTHISLDHHSMTLTPDEVKSLLLKYL 311

Query: 281 --------AELLTG-----------KKPGSCM-----TLASNKKISMVPYFLNSIKNNGL 316
                    E+LT             + G         +  +K  +++   LN ++    
Sbjct: 312 DCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEY 371

Query: 317 RQ------ILNFHV-----------ADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE 359
           R+      +                 D  +   + +V +L    L          KQ  E
Sbjct: 372 RKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSL--------VEKQPKE 423

Query: 360 ELDRLRRLHENFWAQKKNKETEH--LLGESSSYATAVIAQPDAQTVVSIDIENYY 412
               +  ++     + +N+   H  ++     Y        D      +D   Y+
Sbjct: 424 STISIPSIYLELKVKLENEYALHRSIV---DHYNIPKTFDSDDLIPPYLD--QYF 473

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 53.7 bits (128), Expect = 7e-08
 Identities = 54/403 (13%), Positives = 109/403 (27%), Gaps = 139/403 (34%)

Query: 104 YKGVLHDNIQVAVKTYRRAD-----KIRITERELLRIISQVNHKNVVKILGLCLETEVPL 158
           YK +L       V  +   D     K  +++ E+  II   +  +    L   L ++   
Sbjct: 18  YKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEE 77

Query: 159 LVYEFASN------GTLLDHIRCESSQ--------------------------------- 179
           +V +F           L+  I+ E  Q                                 
Sbjct: 78  MVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPY 137

Query: 180 -VLKTW-------------------KTCLRIAAETASALDYLHSLASPPIIH----GDVK 215
             L+                     KT +  A +   +      +     I      +  
Sbjct: 138 LKLRQALLELRPAKNVLIDGVLGSGKTWV--ALDVCLSYKVQCKMDFK--IFWLNLKNCN 193

Query: 216 SANILL----------NDNYTAKVADFESSVLISSDAETAMSTILIGTSGY------LDP 259
           S   +L          + N+T++ +D  S++ +   +  A    L+ +  Y      L  
Sbjct: 194 SPETVLEMLQKLLYQIDPNWTSR-SDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLN 252

Query: 260 VCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQI 319
           V              +F +            SC  L + +    V  FL++     +   
Sbjct: 253 VQ-------NAKAWNAFNL------------SCKILLTTRFKQ-VTDFLSAATTTHISLD 292

Query: 320 LNFHVADESEMKEIEIVAELASKCLRIRGTERP---------TMKQVSEEL-DRLRRLHE 369
            +       E+K +     L  K L  R  + P          +  ++E + D L     
Sbjct: 293 HHSMTLTPDEVKSL-----LL-KYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATW-- 344

Query: 370 NFWAQKKNKETEHLLGESSSYATAVIAQPDAQTVVSIDIENYY 412
           + W      +   ++   SS     + +P        +    +
Sbjct: 345 DNWKHVNCDKLTTII--ESSLN---VLEPA-------EYRKMF 375

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 54.4 bits (131), Expect = 3e-08
 Identities = 49/247 (19%), Positives = 92/247 (37%), Gaps = 62/247 (25%)

Query: 83  IRATKNFDRSRC----------LSQGGFVSVYKGVLHDNI---QVAVKTYRRADKIRITE 129
            +   + +R R           + +G +  VYK    D       A+K            
Sbjct: 7   FKVKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC 66

Query: 130 RE--LLRIISQVNHKNVVKILGLCLE-TEVPL-LVYEFASN--GTLLDHIRCESSQVLKT 183
           RE  LLR   ++ H NV+ +  + L   +  + L++++A +    ++   R   +     
Sbjct: 67  REIALLR---ELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPV 123

Query: 184 W------KTCLRIAAETASALDYLHSLASPPIIHGDVKSANILL----NDNYTAKVADF- 232
                  K+ L    +    + YLH+     ++H D+K ANIL+     +    K+AD  
Sbjct: 124 QLPRGMVKSLLY---QILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMG 177

Query: 233 -----ESSVLISSDAETAMSTI-------LIGTSGYLDPVCINTGKLTKKSDVYSFGVVL 280
                 S +   +D +  + T        L+G   Y   +           D+++ G + 
Sbjct: 178 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAI-----------DIWAIGCIF 226

Query: 281 AELLTGK 287
           AELLT +
Sbjct: 227 AELLTSE 233

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 53.9 bits (130), Expect = 3e-08
 Identities = 52/212 (24%), Positives = 83/212 (39%), Gaps = 27/212 (12%)

Query: 93  RCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRITERE--LLRIISQVNHKNVVKILG 149
           R +  G F  +Y G  +    +VA+K      K      E  + +++       +  I  
Sbjct: 15  RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVG--IPTIRW 72

Query: 150 LCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPI 209
              E +  ++V E    G  L+ +    S+   + KT L +A +  S ++Y+HS      
Sbjct: 73  CGAEGDYNVMVMELL--GPSLEDLFNFCSRKF-SLKTVLLLADQMISRIEYIHSKN---F 126

Query: 210 IHGDVKSANILLNDNYTAK---VADFESSVLISSDAETAM------STILIGTSGYLDPV 260
           IH DVK  N L+          + DF  +     DA T        +  L GT+ Y    
Sbjct: 127 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY-RDARTHQHIPYRENKNLTGTARY---A 182

Query: 261 CINT--GK-LTKKSDVYSFGVVLAELLTGKKP 289
            INT  G   +++ D+ S G VL     G  P
Sbjct: 183 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 54.2 bits (130), Expect = 3e-08
 Identities = 51/212 (24%), Positives = 88/212 (41%), Gaps = 27/212 (12%)

Query: 93  RCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRITERE--LLRIISQVNHKNVVKILG 149
           R +  G F  +Y G  +  N +VA+K      K      E  + RI+       +  +  
Sbjct: 13  RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQ--GGTGIPNVRW 70

Query: 150 LCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPI 209
             +E +  +LV +    G  L+ +    S+ L + KT L +A +  + ++++HS +    
Sbjct: 71  FGVEGDYNVLVMDLL--GPSLEDLFNFCSRKL-SLKTVLMLADQMINRVEFVHSKS---F 124

Query: 210 IHGDVKSANILLNDNYTAK---VADFESSVLISSDAETAM------STILIGTSGYLDPV 260
           +H D+K  N L+     A    + DF  +     D  T        +  L GT+ Y    
Sbjct: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY-RDTSTHQHIPYRENKNLTGTARY---A 180

Query: 261 CINT--GK-LTKKSDVYSFGVVLAELLTGKKP 289
            +NT  G   +++ D+ S G VL   L G  P
Sbjct: 181 SVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 52.7 bits (127), Expect = 6e-08
 Identities = 44/214 (20%), Positives = 82/214 (38%), Gaps = 29/214 (13%)

Query: 93  RCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRITERE--LLRIISQVNHKNVVKILG 149
           R + +G F  +++G  L +N QVA+K   R         E    ++++      +  +  
Sbjct: 16  RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTG--IPNVYY 73

Query: 150 LCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPI 209
              E    +LV +    G  L+ +     +   + KT    A +  + +  +H  +   +
Sbjct: 74  FGQEGLHNVLVIDLL--GPSLEDLLDLCGRKF-SVKTVAMAAKQMLARVQSIHEKS---L 127

Query: 210 IHGDVKSANILLNDNYTAK-----VADFESSVLISSDAETAM------STILIGTSGYLD 258
           ++ D+K  N L+    +       V DF        D  T           L GT+ Y  
Sbjct: 128 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY-RDPVTKQHIPYREKKNLSGTARY-- 184

Query: 259 PVCINT--GK-LTKKSDVYSFGVVLAELLTGKKP 289
            + INT  G+  +++ D+ + G V    L G  P
Sbjct: 185 -MSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 50.8 bits (122), Expect = 3e-07
 Identities = 56/227 (24%), Positives = 86/227 (37%), Gaps = 82/227 (36%)

Query: 111 NIQVAVKTYRRA-----DKIRITERE--LLRIISQVNHKNVVKILGLCLE---TEVPLLV 160
              VAVK    A     D  R T RE  +L  +S   H+N+V +L +       +V  LV
Sbjct: 34  GEVVAVKKIFDAFQNSTDAQR-TFREIMILTELS--GHENIVNLLNVLRADNDRDV-YLV 89

Query: 161 YEFA---------SNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIH 211
           +++          +N     H +    Q++K               + YLHS     ++H
Sbjct: 90  FDYMETDLHAVIRANILEPVHKQYVVYQLIK--------------VIKYLHS-GG--LLH 132

Query: 212 GDVKSANILLNDNYTAKVADF-------------------ESSVLISSDAETAMST---- 248
            D+K +NILLN     KVADF                    +    + D +  + T    
Sbjct: 133 RDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVA 192

Query: 249 --------ILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGK 287
                   IL+G++ Y           TK  D++S G +L E+L GK
Sbjct: 193 TRWYRAPEILLGSTKY-----------TKGIDMWSLGCILGEILCGK 228

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 50.5 bits (121), Expect = 4e-07
 Identities = 50/227 (22%), Positives = 85/227 (37%), Gaps = 26/227 (11%)

Query: 78  SKSEMIRATKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRITERELLRII 136
           S   ++    NF   + +  G F  +  G  L+ N  VA+K      +      E     
Sbjct: 1   SMGVLMVG-PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYK 59

Query: 137 SQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETAS 196
              +   + ++       +   +V E    G  L+ +     +   + KT L IA +  S
Sbjct: 60  QLGSGDGIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTF-SLKTVLMIAIQLIS 116

Query: 197 ALDYLHSLASPPIIHGDVKSANILL-----NDNYTAKVADFESSVLISSDAETAM----- 246
            ++Y+HS     +I+ DVK  N L+            + DF  +     D ET       
Sbjct: 117 RMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY-IDPETKKHIPYR 172

Query: 247 -STILIGTSGYLDPVCINT--GK-LTKKSDVYSFGVVLAELLTGKKP 289
               L GT+ Y   + INT  GK  +++ D+ + G +    L G  P
Sbjct: 173 EHKSLTGTARY---MSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 50.2 bits (120), Expect = 6e-07
 Identities = 40/229 (17%), Positives = 78/229 (34%), Gaps = 45/229 (19%)

Query: 95  LSQGGFVSVYKGV------LHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKIL 148
           + QGGF  +Y         +  +    VK     +    TE +  +  ++          
Sbjct: 43  IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102

Query: 149 GLCLETEVPLLVY-------EFASN-------GTLLDHIRCESSQVLKTWKTCLRIAAET 194
                  VP             +         G+ L  I   +++   + KT L+++   
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRF-SRKTVLQLSLRI 161

Query: 195 ASALDYLHSLASPPIIHGDVKSANILLNDNYTAKV--ADF---------ESSVLISSDAE 243
              L+Y+H       +HGD+K++N+LLN     +V   D+               ++D +
Sbjct: 162 LDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPK 218

Query: 244 TAMSTILIGTSGYLDPVCINTGK---LTKKSDVYSFGVVLAELLTGKKP 289
                   GT  +     I+       +++ D+   G  + + LTG  P
Sbjct: 219 RC----HDGTIEF---TSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 49.5 bits (117), Expect = 8e-07
 Identities = 32/222 (14%), Positives = 61/222 (27%), Gaps = 66/222 (29%)

Query: 83  IRATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRIT-------------- 128
              T+   R   + +G F  V++ +  D+  VA+K         +               
Sbjct: 16  CLPTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEI 74

Query: 129 ----ERELLRIISQVNHKNVVKILGLCL----------------------ETEVPL---- 158
               E  LL        +  + +  +                          + P     
Sbjct: 75  IISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKD 134

Query: 159 ----LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDV 214
               +V EF   G  L+ +R +    L +  T   I  +  ++L    +  S    H D+
Sbjct: 135 DQLFIVLEFEFGGIDLEQMRTK----LSSLATAKSILHQLTASLAVAEA--SLRFEHRDL 188

Query: 215 KSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
              N+LL      K+    +             +  I + G 
Sbjct: 189 HWGNVLLKKTSLKKLHYTLNG-----------KSSTIPSCGL 219

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 44.7 bits (106), Expect = 3e-05
 Identities = 24/161 (14%), Positives = 58/161 (36%), Gaps = 28/161 (17%)

Query: 95  LSQGGFVSVYKGV---------LHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVV 145
            ++     +Y+                + ++K   +  ++   E+   +  ++    N  
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLF-NEQNFFQRAAKPLQVNKW 108

Query: 146 KILGLCLETEVPLLVYEFASN------------GTLLDHIRCESSQVLKTWKTCLRIAAE 193
           K L       +P  +  F  +            G  L      S + + + ++ L++A  
Sbjct: 109 KKLYSTPLLAIPTCMG-FGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACR 167

Query: 194 TASALDYLHSLASPPIIHGDVKSANILLNDNYTAKV--ADF 232
              AL++LH       +HG+V + NI ++    ++V  A +
Sbjct: 168 LLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGY 205

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 43.9 bits (104), Expect = 5e-05
 Identities = 41/227 (18%), Positives = 77/227 (33%), Gaps = 44/227 (19%)

Query: 95  LSQGGFVSVYKGV-LHDNIQVA---VKTYRRADKIRITERELLRIISQVNHKNVVKILGL 150
           +  GGF  +Y     +   + A   VK   + +    +E +  + +++ +          
Sbjct: 45  IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104

Query: 151 CLETEVPLLVY-------EFASN-------GTLLDHIRCESSQVLKTWKTCLRIAAETAS 196
                +PL            +         G  L  I  ++        T L++      
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTF--KKSTVLQLGIRMLD 162

Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKV--ADF---------ESSVLISSDAETA 245
            L+Y+H       +HGD+K+AN+LL      +V  AD+          +      +    
Sbjct: 163 VLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKG 219

Query: 246 MSTILIGTSGYLDPVCINT--GK-LTKKSDVYSFGVVLAELLTGKKP 289
                 GT  +     ++   G  L+++SDV   G  +   L GK P
Sbjct: 220 ----HNGTIEF---TSLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	414
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.92
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.83
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.76
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.4
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.3
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.18
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.07
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.75
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.54
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.52
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.47
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.46
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.4
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.35
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.22
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	98.06
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.01
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.81
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.8
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.74
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.74
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.65
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.56
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.54
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.47
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.35
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.33
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.25
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.54
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.99
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.97
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	92.24
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	88.47

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=4.7e-59  Score=436.47  Aligned_cols=260  Identities=27%  Similarity=0.382  Sum_probs=210.8

Q ss_pred             cCCCCCCccccCCceEEEEEEEc------CCcEEEEEEeecccc-hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH------DNIQVAVKTYRRADK-IRITERELLRIISQVNHKNVVKILGLCLETEVPLL  159 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~l  159 (414)
                      ++|.+.+.||+|+||+||+|.+.      ++..||||+++.... ....+.+|++++++++|||||+++|+|.+++..||
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            56788899999999999999863      477899999976543 23445778899999999999999999999999999


Q ss_pred             EEEeCCCCchhhhhhhcC----------CcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEE
Q 015027          160 VYEFASNGTLLDHIRCES----------SQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKV  229 (414)
Q Consensus       160 v~e~~~~gsL~~~l~~~~----------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl  229 (414)
                      |||||++|+|.++|...+          ....++|..++.++.||+.||+|||+++   |+||||||+|||+++++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence            999999999999997543          2346799999999999999999999977   999999999999999999999


Q ss_pred             eeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhh
Q 015027          230 ADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFL  308 (414)
Q Consensus       230 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~  308 (414)
                      +|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||...+...         ..
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~---------~~  240 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---------VI  240 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---------HH
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---------HH
Confidence            99999987655433333444579999999999999999999999999999999999 899997543211         11


Q ss_pred             hhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHh
Q 015027          309 NSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRL  367 (414)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~  367 (414)
                      ..+......         +.+...++.+.+|+.+||+.||++|||+.+|.+.|+.+.+.
T Consensus       241 ~~i~~~~~~---------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~  290 (299)
T 4asz_A          241 ECITQGRVL---------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA  290 (299)
T ss_dssp             HHHHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHcCCCC---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence            111111110         01111235699999999999999999999999999887654

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.8e-58  Score=438.32  Aligned_cols=261  Identities=25%  Similarity=0.374  Sum_probs=204.1

Q ss_pred             cCCCCCCccccCCceEEEEEEEc------CCcEEEEEEeecccch-hHhHHHHHHHHHccCCCceeeeeeeEecCCcceE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH------DNIQVAVKTYRRADKI-RITERELLRIISQVNHKNVVKILGLCLETEVPLL  159 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~l  159 (414)
                      ++|.+.++||+|+||+||+|.+.      +++.||||+++..... ...+.+|++++++++|||||+++|+|.+++..||
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            46777889999999999999864      4788999999765432 3455778899999999999999999999999999


Q ss_pred             EEEeCCCCchhhhhhhcCC------------cccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcE
Q 015027          160 VYEFASNGTLLDHIRCESS------------QVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTA  227 (414)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~  227 (414)
                      |||||++|+|.+++.....            ...++|..++.|+.||+.||+|||+.+   |+||||||+||||++++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence            9999999999999965432            245789999999999999999999977   9999999999999999999


Q ss_pred             EEeeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchh
Q 015027          228 KVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPY  306 (414)
Q Consensus       228 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~  306 (414)
                      ||+|||+|+...............||+.|||||++.+..|+.++|||||||+||||+| |+.||...+...         
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~---------  268 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE---------  268 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH---------
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH---------
Confidence            9999999987755444444456689999999999999999999999999999999999 899997543211         


Q ss_pred             hhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHhh
Q 015027          307 FLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLH  368 (414)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~~  368 (414)
                      ....+.... .    ...+    ...++.+.+|+.+||+.||++|||+.+|++.|+.+.+..
T Consensus       269 ~~~~i~~g~-~----~~~p----~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~p  321 (329)
T 4aoj_A          269 AIDCITQGR-E----LERP----RACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP  321 (329)
T ss_dssp             HHHHHHHTC-C----CCCC----TTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSC
T ss_pred             HHHHHHcCC-C----CCCc----ccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCC
Confidence            111111111 0    0111    112356999999999999999999999999999987653

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.2e-58  Score=435.59  Aligned_cols=257  Identities=23%  Similarity=0.338  Sum_probs=209.1

Q ss_pred             cCCCCCCccccCCceEEEEEEEc------CCcEEEEEEeecccc--hhHhHHHHHHHHHccCCCceeeeeeeEecCCcce
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH------DNIQVAVKTYRRADK--IRITERELLRIISQVNHKNVVKILGLCLETEVPL  158 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~  158 (414)
                      .++++.+.||+|+||+||+|.+.      +++.||||+++....  ....+.+|+.++++++|||||+++|+|.+++..+
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            34566788999999999999863      467899999975432  3355677889999999999999999999999999


Q ss_pred             EEEEeCCCCchhhhhhhcCC-------------cccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCC
Q 015027          159 LVYEFASNGTLLDHIRCESS-------------QVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNY  225 (414)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~  225 (414)
                      ||||||++|+|.++|.....             ...++|..++.++.||+.||+|||+.+   ||||||||+||||++++
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence            99999999999999965321             245789999999999999999999987   99999999999999999


Q ss_pred             cEEEeeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccc
Q 015027          226 TAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMV  304 (414)
Q Consensus       226 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~  304 (414)
                      .+||+|||+|+...............||+.|||||++.++.|+.++|||||||+||||+| |..||.+.+...       
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~-------  255 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD-------  255 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH-------
T ss_pred             CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH-------
Confidence            999999999987765444444556789999999999999999999999999999999998 899997544211       


Q ss_pred             hhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHH
Q 015027          305 PYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL  364 (414)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i  364 (414)
                        ....+......         +.+...+..+.+|+.+||+.||.+|||+.+|++.|+.+
T Consensus       256 --~~~~i~~~~~~---------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          256 --VVEMIRNRQVL---------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             --HHHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             --HHHHHHcCCCC---------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence              11112211111         11112235699999999999999999999999998764

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.6e-57  Score=426.44  Aligned_cols=260  Identities=25%  Similarity=0.385  Sum_probs=199.3

Q ss_pred             hcCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccc---hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADK---IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYE  162 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  162 (414)
                      .++|.+.++||+|+||+||+|++++  .||||+++....   ....+.+|+.++++++|||||+++|+|.+ +.+|||||
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE  111 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ  111 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence            3678889999999999999998743  599999875432   22345778899999999999999998865 56899999


Q ss_pred             eCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCc
Q 015027          163 FASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDA  242 (414)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  242 (414)
                      ||++|+|.+++....  ..+++..++.|+.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+|+......
T Consensus       112 y~~gGsL~~~l~~~~--~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~  186 (307)
T 3omv_A          112 WCEGSSLYKHLHVQE--TKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS  186 (307)
T ss_dssp             CCSSCBHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred             cCCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence            999999999996543  34589999999999999999999977   9999999999999999999999999998765443


Q ss_pred             cccceecccccccccchhhccc---CCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccc
Q 015027          243 ETAMSTILIGTSGYLDPVCINT---GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQI  319 (414)
Q Consensus       243 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (414)
                      ........+||+.|||||++.+   ..|+.++|||||||+||||+||+.||.......        ...........   
T Consensus       187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~--------~~~~~~~~~~~---  255 (307)
T 3omv_A          187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD--------QIIFMVGRGYA---  255 (307)
T ss_dssp             -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--------HHHHHHHTTCC---
T ss_pred             cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH--------HHHHHHhcCCC---
Confidence            3344456789999999999964   358999999999999999999999997433211        01111111111   


Q ss_pred             cccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHH
Q 015027          320 LNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR  366 (414)
Q Consensus       320 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~  366 (414)
                       .+... ..+...+..+.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus       256 -~p~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~  300 (307)
T 3omv_A          256 -SPDLS-KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH  300 (307)
T ss_dssp             -CCCST-TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred             -CCCcc-cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence             01000 0111223569999999999999999999999999988763

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2.2e-57  Score=424.66  Aligned_cols=248  Identities=24%  Similarity=0.335  Sum_probs=206.6

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeeccc----chhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRAD----KIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~  161 (414)
                      ++|++.+.||+|+||+||+|... +|+.||||++....    .......+|++++++++|||||+++++|.+++.+||||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            57999999999999999999975 58999999997543    22234567789999999999999999999999999999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCC
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD  241 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  241 (414)
                      |||+||+|.+++...+   .+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|+.+...
T Consensus       112 Ey~~gG~L~~~i~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence            9999999999997543   3588999999999999999999988   999999999999999999999999999987655


Q ss_pred             ccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccc
Q 015027          242 AETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILN  321 (414)
Q Consensus       242 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (414)
                      .........+||+.|||||++.+..|+.++|||||||++|||++|+.||...+...         ....+.....     
T Consensus       186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---------~~~~i~~~~~-----  251 (311)
T 4aw0_A          186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL---------IFAKIIKLEY-----  251 (311)
T ss_dssp             TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---------HHHHHHHTCC-----
T ss_pred             CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---------HHHHHHcCCC-----
Confidence            44445566799999999999999999999999999999999999999997433211         1111111111     


Q ss_pred             cccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          322 FHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       322 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                       .++.    ..++++.+|+.+||+.||++|||++|++.
T Consensus       252 -~~p~----~~s~~~~dli~~lL~~dp~~R~t~~e~~~  284 (311)
T 4aw0_A          252 -DFPE----KFFPKARDLVEKLLVLDATKRLGCEEMEG  284 (311)
T ss_dssp             -CCCT----TCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred             -CCCc----ccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence             1111    12356899999999999999999999743

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=4.8e-57  Score=429.12  Aligned_cols=249  Identities=23%  Similarity=0.324  Sum_probs=198.9

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc---hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK---IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYE  162 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  162 (414)
                      ++|++++.||+|+||+||+|++. +|+.||||++.....   ......+|++++++++|||||+++++|.+++.+|||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            68999999999999999999975 599999999976532   22344678899999999999999999999999999999


Q ss_pred             eCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCc
Q 015027          163 FASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDA  242 (414)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  242 (414)
                      ||+||+|.+++..... ..+++..++.++.||+.||+|||+++   |+||||||+||||+.+|.+||+|||+|+..... 
T Consensus       104 y~~gg~L~~~i~~~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-  178 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKG-VLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-  178 (350)
T ss_dssp             CCTTCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH-
T ss_pred             CCCCCcHHHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC-
Confidence            9999999999965432 34578899999999999999999988   999999999999999999999999999876532 


Q ss_pred             cccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccccc
Q 015027          243 ETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNF  322 (414)
Q Consensus       243 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (414)
                       .......+||+.|||||++.+..|+.++|||||||+||||++|+.||...+...         ....+......     
T Consensus       179 -~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~---------~~~~i~~~~~~-----  243 (350)
T 4b9d_A          179 -VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN---------LVLKIISGSFP-----  243 (350)
T ss_dssp             -HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---------HHHHHHHTCCC-----
T ss_pred             -cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---------HHHHHHcCCCC-----
Confidence             122345689999999999999999999999999999999999999997543211         11111111111     


Q ss_pred             ccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          323 HVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       323 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ..    +...+.++.+|+.+||+.||++|||+.++++
T Consensus       244 ~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          244 PV----SLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             CC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CC----CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            01    1112356999999999999999999999965

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.2e-56  Score=425.70  Aligned_cols=247  Identities=21%  Similarity=0.262  Sum_probs=202.9

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch-hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeC
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI-RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFA  164 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  164 (414)
                      ..|++.++||+|+||+||+|.+. +|+.||||++...... .....+|+++|++++|||||+++++|.+++.+|||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            56999999999999999999976 5999999999754332 334467789999999999999999999999999999999


Q ss_pred             CCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccc
Q 015027          165 SNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET  244 (414)
Q Consensus       165 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  244 (414)
                      +||+|.+++...    .+++..+..++.||+.||+|||+++   |+||||||+|||++.+|.+||+|||+|+.+....  
T Consensus       154 ~gg~L~~~l~~~----~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--  224 (346)
T 4fih_A          154 EGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--  224 (346)
T ss_dssp             TTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--
T ss_pred             CCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC--
Confidence            999999998642    3589999999999999999999988   9999999999999999999999999998775432  


Q ss_pred             cceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccccccc
Q 015027          245 AMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHV  324 (414)
Q Consensus       245 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (414)
                      ......+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.....         ....+....     .+..
T Consensus       225 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---------~~~~i~~~~-----~~~~  290 (346)
T 4fih_A          225 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---------AMKMIRDNL-----PPRL  290 (346)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---------HHHHHHHSS-----CCCC
T ss_pred             CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---------HHHHHHcCC-----CCCC
Confidence            23455789999999999999999999999999999999999999997433211         111111110     0000


Q ss_pred             CCcccHHHHHHHHHHHHHhhccCCCCCCChhHHH
Q 015027          325 ADESEMKEIEIVAELASKCLRIRGTERPTMKQVS  358 (414)
Q Consensus       325 ~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~  358 (414)
                        ......++.+.+|+.+||+.||++|||+.|++
T Consensus       291 --~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l  322 (346)
T 4fih_A          291 --KNLHKVSPSLKGFLDRLLVRDPAQRATAAELL  322 (346)
T ss_dssp             --SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred             --CccccCCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence              11112236699999999999999999999983

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2.1e-56  Score=422.78  Aligned_cols=254  Identities=20%  Similarity=0.235  Sum_probs=203.1

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCC
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFAS  165 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  165 (414)
                      +.|.+.++||+|+||+||+|++. +|+.||||+++.....    .+|+.+++.++|||||+++++|.+++.+|||||||+
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~----~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~  133 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLE  133 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC----THHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH----HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence            46778889999999999999976 5899999999765332    346789999999999999999999999999999999


Q ss_pred             CCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCC-cEEEeeccccccccCCccc
Q 015027          166 NGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNY-TAKVADFESSVLISSDAET  244 (414)
Q Consensus       166 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~DfGla~~~~~~~~~  244 (414)
                      ||+|.+++...+   .+++..++.++.||+.||+|||+++   |+||||||+||||+.+| .+||+|||+|+.+......
T Consensus       134 gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~  207 (336)
T 4g3f_A          134 GGSLGQLIKQMG---CLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG  207 (336)
T ss_dssp             TCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred             CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence            999999997544   3589999999999999999999988   99999999999999987 6999999999877543221


Q ss_pred             ---cceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccc
Q 015027          245 ---AMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILN  321 (414)
Q Consensus       245 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (414)
                         ......+||+.|||||++.+..|+.++|||||||++|||+||+.||.......     +.    ..+...... .  
T Consensus       208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~-----~~----~~i~~~~~~-~--  275 (336)
T 4g3f_A          208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP-----LC----LKIASEPPP-I--  275 (336)
T ss_dssp             ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC-----CH----HHHHHSCCG-G--
T ss_pred             cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-----HH----HHHHcCCCC-c--
Confidence               12234689999999999999999999999999999999999999997543221     11    111111000 0  


Q ss_pred             cccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHH
Q 015027          322 FHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR  366 (414)
Q Consensus       322 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~  366 (414)
                      ..+.    ...++.+.+|+.+||+.||.+|||+.|+++.|.....
T Consensus       276 ~~~~----~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~  316 (336)
T 4g3f_A          276 REIP----PSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQ  316 (336)
T ss_dssp             GGSC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hhcC----ccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence            0011    1123568999999999999999999999998877654

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.6e-56  Score=421.43  Aligned_cols=275  Identities=22%  Similarity=0.337  Sum_probs=203.5

Q ss_pred             cCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecCC----cceEEEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETE----VPLLVYE  162 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~----~~~lv~e  162 (414)
                      ++|.+.+.||+|+||+||+|++ +|+.||||++............++..+.+++|||||+++++|.+++    .+|||||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E   81 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD   81 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence            4577788999999999999998 6899999999765443333333455667889999999999998654    5799999


Q ss_pred             eCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCC-----CCCeeeCCCCCCceeeCCCCcEEEeecccccc
Q 015027          163 FASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLA-----SPPIIHGDVKSANILLNDNYTAKVADFESSVL  237 (414)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-----~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~  237 (414)
                      ||++|+|.+++...    .++|..+++++.|++.||+|||+.+     .++|+||||||+|||++.++++||+|||+|+.
T Consensus        82 y~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~  157 (303)
T 3hmm_A           82 YHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  157 (303)
T ss_dssp             CCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             CCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence            99999999999643    3589999999999999999999861     24599999999999999999999999999987


Q ss_pred             ccCCcccc--ceecccccccccchhhcccC------CCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchh--h
Q 015027          238 ISSDAETA--MSTILIGTSGYLDPVCINTG------KLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPY--F  307 (414)
Q Consensus       238 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~--~  307 (414)
                      ........  .....+||+.|||||++.+.      .++.++|||||||+||||+||.+||............+.+.  .
T Consensus       158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~  237 (303)
T 3hmm_A          158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS  237 (303)
T ss_dssp             EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred             ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence            65433221  23346899999999999764      47789999999999999999998876443322221111110  0


Q ss_pred             hhhhcccccccccccccCCc-ccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHH
Q 015027          308 LNSIKNNGLRQILNFHVADE-SEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR  366 (414)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~  366 (414)
                      ...+........+.+.++.. ...+.+..+.+|+.+||+.||++|||+.+|++.|+.+.+
T Consensus       238 ~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~  297 (303)
T 3hmm_A          238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             HHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence            00000000111112222211 223455679999999999999999999999999998875

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=3.1e-56  Score=414.66  Aligned_cols=244  Identities=24%  Similarity=0.366  Sum_probs=193.0

Q ss_pred             CCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch---hHhHHHHHHHHHccCCCceeeeeeeEec----CCcceEEE
Q 015027           90 DRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI---RITERELLRIISQVNHKNVVKILGLCLE----TEVPLLVY  161 (414)
Q Consensus        90 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~hpniv~l~~~~~~----~~~~~lv~  161 (414)
                      ++.+.||+|+||+||+|.+. ++..||+|.+......   ...+.+|++++++++|||||+++++|.+    ++.+||||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            45667999999999999976 5889999999764322   2345678899999999999999999865    34589999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCC-CCcEEEeeccccccccC
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLND-NYTAKVADFESSVLISS  240 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~DfGla~~~~~  240 (414)
                      |||+||+|.+++....   .+++..+..++.||+.||+|||+++ ++|+||||||+|||++. ++.+||+|||+|+....
T Consensus       109 Ey~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~  184 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence            9999999999997543   4588999999999999999999976 56999999999999984 89999999999986532


Q ss_pred             CccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccc
Q 015027          241 DAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQIL  320 (414)
Q Consensus       241 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (414)
                          ......+||+.|||||++.+ .|+.++|||||||++|||+||+.||.......        .....+........+
T Consensus       185 ----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~--------~~~~~i~~~~~~~~~  251 (290)
T 3fpq_A          185 ----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA--------QIYRRVTSGVKPASF  251 (290)
T ss_dssp             ----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--------HHHHHHTTTCCCGGG
T ss_pred             ----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH--------HHHHHHHcCCCCCCC
Confidence                23345689999999999875 69999999999999999999999996432111        011111111111111


Q ss_pred             ccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHH
Q 015027          321 NFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVS  358 (414)
Q Consensus       321 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~  358 (414)
                      +.        ..++++.+|+.+||+.||++|||+.+++
T Consensus       252 ~~--------~~~~~~~~li~~~L~~dP~~R~s~~e~l  281 (290)
T 3fpq_A          252 DK--------VAIPEVKEIIEGCIRQNKDERYSIKDLL  281 (290)
T ss_dssp             GG--------CCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             Cc--------cCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence            11        1124589999999999999999999984

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.4e-56  Score=428.65  Aligned_cols=270  Identities=24%  Similarity=0.334  Sum_probs=215.2

Q ss_pred             cHHHHHHHhcCCCCCCccccCCceEEEEEEEcC------CcEEEEEEeecccch--hHhHHHHHHHHHccCC-Cceeeee
Q 015027           78 SKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHD------NIQVAVKTYRRADKI--RITERELLRIISQVNH-KNVVKIL  148 (414)
Q Consensus        78 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~h-pniv~l~  148 (414)
                      ...+++...++|++.+.||+|+||+||+|.+..      ++.||||.+......  ...+..|++++.+++| ||||+++
T Consensus        55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~  134 (353)
T 4ase_A           55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL  134 (353)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence            444555556889999999999999999998643      357999999765432  2344667789999966 8999999


Q ss_pred             eeEecC-CcceEEEEeCCCCchhhhhhhcCC-------------cccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCC
Q 015027          149 GLCLET-EVPLLVYEFASNGTLLDHIRCESS-------------QVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDV  214 (414)
Q Consensus       149 ~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dl  214 (414)
                      |+|.+. +.++||||||++|+|.++|+....             ...+++..++.++.||+.||+|||+++   ||||||
T Consensus       135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDL  211 (353)
T 4ase_A          135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL  211 (353)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred             EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCcc
Confidence            999764 568999999999999999965432             344789999999999999999999987   999999


Q ss_pred             CCCceeeCCCCcEEEeeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCcc
Q 015027          215 KSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCM  293 (414)
Q Consensus       215 kp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~  293 (414)
                      ||+|||+++++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||+||||+| |+.||...
T Consensus       212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~  291 (353)
T 4ase_A          212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  291 (353)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999997765544444556789999999999999999999999999999999998 99999754


Q ss_pred             ccccccccccchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHh
Q 015027          294 TLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRL  367 (414)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~  367 (414)
                      ....        .+...+..+. .    ...+.    ..++++.+|+.+||+.||++|||+.+|++.|+.+.+.
T Consensus       292 ~~~~--------~~~~~i~~g~-~----~~~p~----~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~  348 (353)
T 4ase_A          292 KIDE--------EFCRRLKEGT-R----MRAPD----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  348 (353)
T ss_dssp             CCSH--------HHHHHHHHTC-C----CCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CHHH--------HHHHHHHcCC-C----CCCCc----cCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence            3211        1111111111 1    01111    1235699999999999999999999999999988654

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.1e-55  Score=427.25  Aligned_cols=247  Identities=21%  Similarity=0.259  Sum_probs=203.1

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc-hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeC
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK-IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFA  164 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  164 (414)
                      +.|++.+.||+|+||.||+|.+. +|+.||||++..... ......+|+.+|+.++|||||+++++|.+++.+|||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            56999999999999999999976 599999999975433 2344567889999999999999999999999999999999


Q ss_pred             CCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccc
Q 015027          165 SNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET  244 (414)
Q Consensus       165 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  244 (414)
                      +||+|.+++...    .+++..+..++.||+.||+|||+++   ||||||||+||||+.+|.+||+|||+|+.+....  
T Consensus       231 ~gG~L~~~i~~~----~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~--  301 (423)
T 4fie_A          231 EGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--  301 (423)
T ss_dssp             TTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC--
T ss_pred             CCCcHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC--
Confidence            999999998643    3588999999999999999999988   9999999999999999999999999998775432  


Q ss_pred             cceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccccccc
Q 015027          245 AMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHV  324 (414)
Q Consensus       245 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (414)
                      ......+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.....         ....+....     .+.+
T Consensus       302 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---------~~~~i~~~~-----~~~~  367 (423)
T 4fie_A          302 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---------AMKMIRDNL-----PPRL  367 (423)
T ss_dssp             CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---------HHHHHHHSC-----CCCC
T ss_pred             ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---------HHHHHHcCC-----CCCC
Confidence            23355789999999999999999999999999999999999999997433211         111111110     0000


Q ss_pred             CCcccHHHHHHHHHHHHHhhccCCCCCCChhHHH
Q 015027          325 ADESEMKEIEIVAELASKCLRIRGTERPTMKQVS  358 (414)
Q Consensus       325 ~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~  358 (414)
                      .  .....++.+.+|+.+||+.||++|||+.|++
T Consensus       368 ~--~~~~~s~~~~dli~~~L~~dP~~R~ta~ell  399 (423)
T 4fie_A          368 K--NLHKVSPSLKGFLDRLLVRDPAQRATAAELL  399 (423)
T ss_dssp             S--CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred             c--ccccCCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence            0  1111235699999999999999999999983

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=7.1e-55  Score=402.10  Aligned_cols=244  Identities=21%  Similarity=0.313  Sum_probs=186.8

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc----hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK----IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~  161 (414)
                      ++|++.+.||+|+||+||+|... +|+.||||++.....    ......+|++++++++|||||++++++.+++..|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            68999999999999999999965 699999999975432    2234567789999999999999999999999999999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCC
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD  241 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  241 (414)
                      ||| +|+|.+++...+   .+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|+.....
T Consensus        93 Ey~-~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  165 (275)
T 3hyh_A           93 EYA-GNELFDYIVQRD---KMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG  165 (275)
T ss_dssp             ECC-CEEHHHHHHHSC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred             eCC-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence            999 679999986543   4588999999999999999999988   999999999999999999999999999876532


Q ss_pred             ccccceecccccccccchhhcccCCC-CCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccc
Q 015027          242 AETAMSTILIGTSGYLDPVCINTGKL-TKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQIL  320 (414)
Q Consensus       242 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (414)
                         ......+||+.|||||++.+..+ +.++|||||||++|+|+||+.||...+...         ....+.....    
T Consensus       166 ---~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~---------~~~~i~~~~~----  229 (275)
T 3hyh_A          166 ---NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV---------LFKNISNGVY----  229 (275)
T ss_dssp             ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---------HHHHHHHTCC----
T ss_pred             ---CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH---------HHHHHHcCCC----
Confidence               22345689999999999998886 579999999999999999999997433111         1111111110    


Q ss_pred             ccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          321 NFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       321 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                        .++.    ..++.+.+|+.+||+.||++|||+.|+++
T Consensus       230 --~~p~----~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          230 --TLPK----FLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             --CCCT----TSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             --CCCC----CCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence              0111    12356899999999999999999999854

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2.8e-55  Score=410.20  Aligned_cols=241  Identities=27%  Similarity=0.288  Sum_probs=191.8

Q ss_pred             cCCCCCCccccCCceEEEEEEEc----CCcEEEEEEeecccc---hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH----DNIQVAVKTYRRADK---IRITERELLRIISQVNHKNVVKILGLCLETEVPLL  159 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~l  159 (414)
                      ++|++++.||+|+||+||+|+..    +++.||||++.....   .......|++++++++|||||++++++.+++.+||
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            57999999999999999999863    468899999975432   22234556788999999999999999999999999


Q ss_pred             EEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccccccc
Q 015027          160 VYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLIS  239 (414)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~  239 (414)
                      |||||+||+|.+++...+   .+++..+..++.||+.||+|||+++   |+||||||+|||++.+|.+||+|||+|+...
T Consensus       104 vmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  177 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI  177 (304)
T ss_dssp             EECCCTTCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred             EEEcCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence            999999999999997543   3588999999999999999999988   9999999999999999999999999998654


Q ss_pred             CCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccc
Q 015027          240 SDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQI  319 (414)
Q Consensus       240 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (414)
                      ...  ......+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+...         ....+.....   
T Consensus       178 ~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~---------~~~~i~~~~~---  243 (304)
T 3ubd_A          178 DHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE---------TMTMILKAKL---  243 (304)
T ss_dssp             -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---------HHHHHHHCCC---
T ss_pred             CCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH---------HHHHHHcCCC---
Confidence            322  22345689999999999999999999999999999999999999997543211         1111111110   


Q ss_pred             cccccCCcccHHHHHHHHHHHHHhhccCCCCCCCh
Q 015027          320 LNFHVADESEMKEIEIVAELASKCLRIRGTERPTM  354 (414)
Q Consensus       320 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~  354 (414)
                         ..+    ...++++.+|+.+||+.||++|||+
T Consensus       244 ---~~p----~~~s~~~~~li~~~L~~dP~~R~ta  271 (304)
T 3ubd_A          244 ---GMP----QFLSPEAQSLLRMLFKRNPANRLGA  271 (304)
T ss_dssp             ---CCC----TTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred             ---CCC----CcCCHHHHHHHHHHcccCHHHCCCC
Confidence               011    1123568999999999999999996

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.9e-54  Score=404.52  Aligned_cols=250  Identities=24%  Similarity=0.384  Sum_probs=188.2

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEecCC--------
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLETE--------  155 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~~~--------  155 (414)
                      ++|++++.||+|+||+||+|++. +|+.||||++......  .....+|++++++++|||||+++++|.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            46899999999999999999976 6899999999765432  234467789999999999999999987544        


Q ss_pred             ----cceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEee
Q 015027          156 ----VPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVAD  231 (414)
Q Consensus       156 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~D  231 (414)
                          ..|+|||||++|+|.+++.........++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence                36899999999999999987665555577788999999999999999988   99999999999999999999999


Q ss_pred             ccccccccCCcccc----------ceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCcccccccccc
Q 015027          232 FESSVLISSDAETA----------MSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKI  301 (414)
Q Consensus       232 fGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~  301 (414)
                      ||+|+.........          .....+||+.|||||++.+..|+.++|||||||++|||++   ||......     
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~-----  233 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMER-----  233 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHH-----
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHH-----
Confidence            99998765432211          1234589999999999999999999999999999999996   77521100     


Q ss_pred             ccchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          302 SMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                        .. ..........         .+.....++.+.+|+.+||+.||.+|||+.++++
T Consensus       234 --~~-~~~~~~~~~~---------p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          234 --VR-TLTDVRNLKF---------PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             --HH-HHHHHHTTCC---------CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --HH-HHHHHhcCCC---------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence              00 0001111111         0111222355789999999999999999999854

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=5.1e-51  Score=392.47  Aligned_cols=199  Identities=20%  Similarity=0.285  Sum_probs=167.3

Q ss_pred             HHhcCCCCCCccccCCceEEEEEEEc----CCcEEEEEEeecccchhHhHHHHHHHHHcc-CCCceeeeeeeEecCCcce
Q 015027           84 RATKNFDRSRCLSQGGFVSVYKGVLH----DNIQVAVKTYRRADKIRITERELLRIISQV-NHKNVVKILGLCLETEVPL  158 (414)
Q Consensus        84 ~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~l~~l-~hpniv~l~~~~~~~~~~~  158 (414)
                      ...++|++.+.||+|+||+||+|+.+    +++.||||.+...... ....++++++..+ +|||||+++++|.+.+..|
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~-~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~   96 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHP-IRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV   96 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCH-HHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCH-HHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence            45678999999999999999999864    3678999998765433 3345566888877 6999999999999999999


Q ss_pred             EEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCC-CcEEEeecccccc
Q 015027          159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDN-YTAKVADFESSVL  237 (414)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~DfGla~~  237 (414)
                      +|||||++|+|.+++.      .+++..+..++.||+.||+|||+++   |+||||||+|||++.+ +.+||+|||+|+.
T Consensus        97 lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~  167 (361)
T 4f9c_A           97 IAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQG  167 (361)
T ss_dssp             EEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence            9999999999999983      2578999999999999999999988   9999999999999876 8999999999976


Q ss_pred             ccCCcc--------------------------ccceecccccccccchhhcccC-CCCCcccchhHHHHHHHHHhCCCCC
Q 015027          238 ISSDAE--------------------------TAMSTILIGTSGYLDPVCINTG-KLTKKSDVYSFGVVLAELLTGKKPG  290 (414)
Q Consensus       238 ~~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~  290 (414)
                      ......                          .......+||+.|||||++.+. .|+.++||||+||++|||++|+.||
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf  247 (361)
T 4f9c_A          168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF  247 (361)
T ss_dssp             CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred             cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence            543211                          0112345799999999999775 5899999999999999999999999


Q ss_pred             Cc
Q 015027          291 SC  292 (414)
Q Consensus       291 ~~  292 (414)
                      ..
T Consensus       248 ~~  249 (361)
T 4f9c_A          248 YK  249 (361)
T ss_dssp             SC
T ss_pred             CC
Confidence            53

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.1e-51  Score=396.16  Aligned_cols=266  Identities=18%  Similarity=0.240  Sum_probs=195.1

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch---hHhHHHHHHHHHccCCCceeeeeeeEec------CC
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI---RITERELLRIISQVNHKNVVKILGLCLE------TE  155 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~hpniv~l~~~~~~------~~  155 (414)
                      .++|++++.||+|+||+||+|.+. +|+.||||++......   .....+|+++|+.++|||||++++++..      .+
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            367999999999999999999975 6999999999754322   2334567899999999999999998754      35


Q ss_pred             cceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccc
Q 015027          156 VPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESS  235 (414)
Q Consensus       156 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla  235 (414)
                      .+|||||||+ |+|.+++...   ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+|
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~~---~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla  205 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHSS---QPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA  205 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTSS---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEEeCCC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence            7899999996 6799888643   34689999999999999999999988   999999999999999999999999999


Q ss_pred             ccccCCc--cccceecccccccccchhhcccC-CCCCcccchhHHHHHHHHHhCCCCCCccccccccccc------cchh
Q 015027          236 VLISSDA--ETAMSTILIGTSGYLDPVCINTG-KLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKIS------MVPY  306 (414)
Q Consensus       236 ~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~------~~~~  306 (414)
                      +.+....  ........+||+.|||||++.+. .++.++||||+||++|||++|++||.+.+........      ....
T Consensus       206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~  285 (398)
T 4b99_A          206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA  285 (398)
T ss_dssp             BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGG
T ss_pred             eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence            8764321  22234567999999999998775 5699999999999999999999999754321100000      0000


Q ss_pred             hhhhhccccccc---ccccccCCccc---HHHHHHHHHHHHHhhccCCCCCCChhHHH
Q 015027          307 FLNSIKNNGLRQ---ILNFHVADESE---MKEIEIVAELASKCLRIRGTERPTMKQVS  358 (414)
Q Consensus       307 ~~~~~~~~~~~~---~~~~~~~~~~~---~~~~~~l~~Li~~cl~~dP~~Rps~~~v~  358 (414)
                      ............   .+.........   ...+..+.+|+.+||..||.+|||+.|++
T Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L  343 (398)
T 4b99_A          286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAAL  343 (398)
T ss_dssp             GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred             HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHh
Confidence            000000000000   00000000000   01125689999999999999999999983

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=9.2e-50  Score=404.65  Aligned_cols=242  Identities=19%  Similarity=0.231  Sum_probs=194.5

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch-------hHhHHHHHHHHHccCCCceeeeeeeEecCCcce
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI-------RITERELLRIISQVNHKNVVKILGLCLETEVPL  158 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~  158 (414)
                      ++|++++.||+|+||.||+|+.. +|+.||||++.+....       ...+..++.+++.++|||||+++++|.+.+.+|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            67999999999999999999976 5999999999754211       122344567788889999999999999999999


Q ss_pred             EEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccc
Q 015027          159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLI  238 (414)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~  238 (414)
                      ||||||+||+|.++|...+   .+++..+..++.||+.||.|||+++   ||||||||+||||+.+|++||+|||+|+..
T Consensus       269 lVmEy~~GGdL~~~l~~~~---~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~  342 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF  342 (689)
T ss_dssp             EEECCCCSCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeec
Confidence            9999999999999997543   3588999999999999999999988   999999999999999999999999999876


Q ss_pred             cCCccccceecccccccccchhhcc-cCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccc
Q 015027          239 SSDAETAMSTILIGTSGYLDPVCIN-TGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLR  317 (414)
Q Consensus       239 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (414)
                      ...    .....+||+.|||||++. +..|+.++|||||||++|||++|++||........     .. .........  
T Consensus       343 ~~~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~-----~~-i~~~i~~~~--  410 (689)
T 3v5w_A          343 SKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----HE-IDRMTLTMA--  410 (689)
T ss_dssp             SSC----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH-----HH-HHHHHHHCC--
T ss_pred             CCC----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-----HH-HHHhhcCCC--
Confidence            543    234568999999999996 46899999999999999999999999974332110     00 000000000  


Q ss_pred             cccccccCCcccHHHHHHHHHHHHHhhccCCCCCCCh
Q 015027          318 QILNFHVADESEMKEIEIVAELASKCLRIRGTERPTM  354 (414)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~  354 (414)
                          ...    +...++++.+||.+||+.||.+|++.
T Consensus       411 ----~~~----p~~~S~~a~dLI~~lL~~dP~~Rl~~  439 (689)
T 3v5w_A          411 ----VEL----PDSFSPELRSLLEGLLQRDVNRRLGC  439 (689)
T ss_dssp             ----CCC----CTTSCHHHHHHHHHHTCSCGGGCTTC
T ss_pred             ----CCC----CccCCHHHHHHHHHHccCCHhHCCCC
Confidence                011    11123568999999999999999983

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=8.7e-50  Score=379.96  Aligned_cols=293  Identities=32%  Similarity=0.538  Sum_probs=240.7

Q ss_pred             ccccccccHHHHHHHhcCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccch--hHhHHHHHHHHHccCCCceeeee
Q 015027           71 FLRMKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKIL  148 (414)
Q Consensus        71 ~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~  148 (414)
                      ......++..++....++|.+.+.||+|+||.||+|...+++.||||++......  ......++++++.++||||++++
T Consensus        14 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~   93 (326)
T 3uim_A           14 LGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR   93 (326)
T ss_dssp             -CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCC
T ss_pred             cCccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceE
Confidence            3445678889999999999999999999999999999878999999999765322  22346677899999999999999


Q ss_pred             eeEecCCcceEEEEeCCCCchhhhhhhcC-CcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcE
Q 015027          149 GLCLETEVPLLVYEFASNGTLLDHIRCES-SQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTA  227 (414)
Q Consensus       149 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~  227 (414)
                      +++...+..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+...++|+||||||+|||++.++.+
T Consensus        94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~  173 (326)
T 3uim_A           94 GFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA  173 (326)
T ss_dssp             EEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCE
T ss_pred             EEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCE
Confidence            99999999999999999999999997543 33447899999999999999999999822239999999999999999999


Q ss_pred             EEeeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhh
Q 015027          228 KVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYF  307 (414)
Q Consensus       228 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~  307 (414)
                      ||+|||++....... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||...............+.
T Consensus       174 kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  252 (326)
T 3uim_A          174 VVGDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV  252 (326)
T ss_dssp             EECCCSSCEECCSSS-SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHH
T ss_pred             EeccCccccccCccc-ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHH
Confidence            999999998765432 2233445699999999999999999999999999999999999999975443333333334444


Q ss_pred             hhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHH
Q 015027          308 LNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL  364 (414)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i  364 (414)
                      .............+...........+..+.+|+.+||+.||.+|||+.+|++.|+..
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          253 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             TTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             HHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence            444444555666666666777788889999999999999999999999999999863

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=2.2e-49  Score=376.51  Aligned_cols=282  Identities=34%  Similarity=0.528  Sum_probs=231.1

Q ss_pred             HHHHHhcCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccch-hHhHHHHHHHHHccCCCceeeeeeeEecCCcceE
Q 015027           81 EMIRATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKI-RITERELLRIISQVNHKNVVKILGLCLETEVPLL  159 (414)
Q Consensus        81 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~l  159 (414)
                      ++...+++|.+.+.||+|+||.||+|.+.+++.||||.+...... .....+++++++.++||||+++++++...+..++
T Consensus        33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  112 (321)
T 2qkw_B           33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL  112 (321)
T ss_dssp             CCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred             HHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence            444567899999999999999999999888999999998765432 3344677789999999999999999999999999


Q ss_pred             EEEeCCCCchhhhhhhcCC-cccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccc
Q 015027          160 VYEFASNGTLLDHIRCESS-QVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLI  238 (414)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~  238 (414)
                      ||||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  189 (321)
T 2qkw_B          113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKG  189 (321)
T ss_dssp             EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEEC
T ss_pred             EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccccccc
Confidence            9999999999999965432 234689999999999999999999987   999999999999999999999999999875


Q ss_pred             cCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccc
Q 015027          239 SSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQ  318 (414)
Q Consensus       239 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (414)
                      .............||+.|+|||++.+..++.++|||||||++|||++|+.||.......  ......+.........+..
T Consensus       190 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~  267 (321)
T 2qkw_B          190 TELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE--MVNLAEWAVESHNNGQLEQ  267 (321)
T ss_dssp             SSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSS--CCCHHHHTHHHHTTTCCCS
T ss_pred             ccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHH--HHHHHHHhhhccccccHHH
Confidence            54333333445578999999999999999999999999999999999999997433221  1222222222233344455


Q ss_pred             ccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHh
Q 015027          319 ILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRL  367 (414)
Q Consensus       319 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~  367 (414)
                      .+++..........+..+.+|+.+||+.||++|||+.++++.|+.+.+.
T Consensus       268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~  316 (321)
T 2qkw_B          268 IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL  316 (321)
T ss_dssp             SSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             hcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence            5566666666677888999999999999999999999999999988764

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2.3e-49  Score=402.98  Aligned_cols=251  Identities=20%  Similarity=0.249  Sum_probs=204.0

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch-hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEe
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI-RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  163 (414)
                      .++|++.+.||+|+||.||+|... +|+.||+|++...... .....+|+++|+.++|||||+++++|.+++.+||||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            368999999999999999999976 5999999999765433 33446778999999999999999999999999999999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCC--CCcEEEeeccccccccCC
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLND--NYTAKVADFESSVLISSD  241 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~--~~~~kl~DfGla~~~~~~  241 (414)
                      |+||+|.+++.....  .+++..+..++.||+.||.|||+++   |+||||||+|||++.  .+.+||+|||+|+.+...
T Consensus       236 ~~gg~L~~~i~~~~~--~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~  310 (573)
T 3uto_A          236 MSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  310 (573)
T ss_dssp             CCCCBHHHHHTCTTS--CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred             cCCCcHHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence            999999999864332  3578999999999999999999988   999999999999985  489999999999887543


Q ss_pred             ccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccc
Q 015027          242 AETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILN  321 (414)
Q Consensus       242 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (414)
                         ......+||+.|||||++.+..|+.++|||||||++|||++|..||.+.....         ....+.....     
T Consensus       311 ---~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~---------~~~~i~~~~~-----  373 (573)
T 3uto_A          311 ---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE---------TLRNVKSCDW-----  373 (573)
T ss_dssp             ---SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---------HHHHHHTTCC-----
T ss_pred             ---CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---------HHHHHHhCCC-----
Confidence               23345689999999999999999999999999999999999999997543211         1111111110     


Q ss_pred             cccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          322 FHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       322 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                       ..........+..+.+||.+||+.||.+|||+.|+++
T Consensus       374 -~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          374 -NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             -CCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             0011111122356899999999999999999999975

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=4.4e-48  Score=367.86  Aligned_cols=271  Identities=23%  Similarity=0.333  Sum_probs=209.1

Q ss_pred             hcCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecCCc----ceEEE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEV----PLLVY  161 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~----~~lv~  161 (414)
                      .++|++.+.||+|+||+||+|.+. ++.||||++............++.++.+++||||+++++++.....    .++||
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~  101 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT  101 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence            367999999999999999999874 7899999997765544444556788999999999999999987543    69999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhC----------CCCCeeeCCCCCCceeeCCCCcEEEee
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSL----------ASPPIIHGDVKSANILLNDNYTAKVAD  231 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~----------~~~~iiH~Dlkp~NIll~~~~~~kl~D  231 (414)
                      ||+++|+|.+++...    .+++..++.++.|++.||.|||+.          +   |+||||||+|||++.++.+||+|
T Consensus       102 e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~D  174 (322)
T 3soc_A          102 AFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIAD  174 (322)
T ss_dssp             ECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEECC
T ss_pred             ecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEcc
Confidence            999999999999653    358899999999999999999997          6   99999999999999999999999


Q ss_pred             ccccccccCCccccceecccccccccchhhccc-----CCCCCcccchhHHHHHHHHHhCCCCCCccccccccccc----
Q 015027          232 FESSVLISSDAETAMSTILIGTSGYLDPVCINT-----GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKIS----  302 (414)
Q Consensus       232 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~----  302 (414)
                      ||++................||+.|+|||++.+     ..++.++|||||||++|||++|+.||............    
T Consensus       175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  254 (322)
T 3soc_A          175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG  254 (322)
T ss_dssp             CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred             CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence            999987665433333444679999999999986     35677899999999999999999999753322110000    


Q ss_pred             ---cchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHh
Q 015027          303 ---MVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRL  367 (414)
Q Consensus       303 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~  367 (414)
                         .................+...+   .....+..+.+|+.+||+.||.+|||+.+|++.|+.+.+.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          255 QHPSLEDMQEVVVHKKKRPVLRDYW---QKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             SSCCHHHHHHHHTTSCCCCCCCGGG---GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cCCchhhhhhhhhcccCCCCccccc---cccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence               0000000001111111111111   1123446699999999999999999999999999999865

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.5e-47  Score=362.04  Aligned_cols=262  Identities=26%  Similarity=0.359  Sum_probs=202.1

Q ss_pred             HhcCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccchh---HhHHHHHHHHHccCCCceeeeeeeEecCCcceEEE
Q 015027           85 ATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIR---ITERELLRIISQVNHKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        85 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~  161 (414)
                      ..++|++.+.||+|+||+||+|.. +++.||||++.......   ....++++++++++||||+++++++...+..++||
T Consensus        35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  113 (309)
T 3p86_A           35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT  113 (309)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred             ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence            356899999999999999999987 68899999987654322   23456778999999999999999999999999999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCC
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD  241 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  241 (414)
                      ||+++|+|.+++........+++..++.++.||+.||+|||+.+ ++|+||||||+|||++.++.+||+|||++......
T Consensus       114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~  192 (309)
T 3p86_A          114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST  192 (309)
T ss_dssp             ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC--------
T ss_pred             ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccccc
Confidence            99999999999976554445689999999999999999999966 45999999999999999999999999999765432


Q ss_pred             ccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccc
Q 015027          242 AETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILN  321 (414)
Q Consensus       242 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (414)
                      .  .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......         ...........    
T Consensus       193 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~---------~~~~~~~~~~~----  257 (309)
T 3p86_A          193 F--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ---------VVAAVGFKCKR----  257 (309)
T ss_dssp             -----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH---------HHHHHHHSCCC----
T ss_pred             c--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---------HHHHHHhcCCC----
Confidence            1  22344579999999999999999999999999999999999999997443211         01111000000    


Q ss_pred             cccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHh
Q 015027          322 FHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRL  367 (414)
Q Consensus       322 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~  367 (414)
                      .....    ..+..+.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus       258 ~~~~~----~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          258 LEIPR----NLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             CCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             CCCCc----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            01111    1225589999999999999999999999999988754

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=2.7e-46  Score=352.69  Aligned_cols=283  Identities=31%  Similarity=0.548  Sum_probs=225.8

Q ss_pred             ccccccHHHHHHHhcCCCCC------CccccCCceEEEEEEEcCCcEEEEEEeeccc-----chhHhHHHHHHHHHccCC
Q 015027           73 RMKIFSKSEMIRATKNFDRS------RCLSQGGFVSVYKGVLHDNIQVAVKTYRRAD-----KIRITERELLRIISQVNH  141 (414)
Q Consensus        73 ~~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~~~l~~l~h  141 (414)
                      ....|+..++..++++|...      +.||+|+||.||+|.. +++.||||.+....     .......+++.++++++|
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   89 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH   89 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence            34668899999999999877      8999999999999987 68899999987532     123344667789999999


Q ss_pred             CceeeeeeeEecCCcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceee
Q 015027          142 KNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILL  221 (414)
Q Consensus       142 pniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll  221 (414)
                      |||+++++++.+.+..++||||+++++|.+++........+++..++.++.||+.||.|||+.+   |+||||||+||++
T Consensus        90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili  166 (307)
T 2nru_A           90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL  166 (307)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred             CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence            9999999999999999999999999999999976555556789999999999999999999988   9999999999999


Q ss_pred             CCCCcEEEeeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCcccccccccc
Q 015027          222 NDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKI  301 (414)
Q Consensus       222 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~  301 (414)
                      +.++.+||+|||++................||+.|+|||++.+ .++.++||||||+++|+|++|..||.......    
T Consensus       167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----  241 (307)
T 2nru_A          167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ----  241 (307)
T ss_dssp             CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS----
T ss_pred             cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH----
Confidence            9999999999999987654433333445679999999999875 58999999999999999999999997543221    


Q ss_pred             ccchhhhhhhc--ccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHH
Q 015027          302 SMVPYFLNSIK--NNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR  366 (414)
Q Consensus       302 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~  366 (414)
                       ..........  ...+...++... .......+..+.+|+.+||+.+|.+|||+.++++.|+.+..
T Consensus       242 -~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          242 -LLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             -BTTHHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             -HHHHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence             1111111111  111222222222 22345566789999999999999999999999999998753

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2.8e-47  Score=369.15  Aligned_cols=261  Identities=24%  Similarity=0.371  Sum_probs=209.2

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc--------CCcEEEEEEeecccchh--HhHHHHHHHHHcc-CCCceeeeeeeEecC
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH--------DNIQVAVKTYRRADKIR--ITERELLRIISQV-NHKNVVKILGLCLET  154 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~--~~~~~~~~~l~~l-~hpniv~l~~~~~~~  154 (414)
                      .++|.+.+.||+|+||.||+|.+.        ++..||||++.......  .....++.+++.+ +||||++++++|...
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            467889999999999999999863        34579999997654322  3346677899999 899999999999999


Q ss_pred             CcceEEEEeCCCCchhhhhhhcCC-------------cccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceee
Q 015027          155 EVPLLVYEFASNGTLLDHIRCESS-------------QVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILL  221 (414)
Q Consensus       155 ~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll  221 (414)
                      +..|+||||+++|+|.+++.....             ...+++..++.++.||+.||.|||+.+   |+||||||+|||+
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence            999999999999999999976432             234688999999999999999999988   9999999999999


Q ss_pred             CCCCcEEEeeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccc
Q 015027          222 NDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKK  300 (414)
Q Consensus       222 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~  300 (414)
                      +.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|||++ |..||.......   
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~---  313 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---  313 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---
Confidence            9999999999999987654433333344567889999999999999999999999999999999 999987433211   


Q ss_pred             cccchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHh
Q 015027          301 ISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRL  367 (414)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~  367 (414)
                            ..........         ...+...+..+.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus       314 ------~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~  365 (370)
T 2psq_A          314 ------LFKLLKEGHR---------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL  365 (370)
T ss_dssp             ------HHHHHHTTCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------HHHHHhcCCC---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence                  1111111110         001111225599999999999999999999999999998754

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2.4e-46  Score=353.80  Aligned_cols=262  Identities=24%  Similarity=0.346  Sum_probs=208.1

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc-hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEe
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK-IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  163 (414)
                      .++|.+.+.||+|+||+||+|.+. ++..||+|.+..... ......++++++++++||||+++++++.+++..++||||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            367888999999999999999976 589999998865432 334456778999999999999999999999999999999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcc
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE  243 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  243 (414)
                      +++|+|.+++.....  .+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++........
T Consensus        89 ~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  163 (310)
T 3s95_A           89 IKGGTLRGIIKSMDS--QYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT  163 (310)
T ss_dssp             CTTCBHHHHHHHCCT--TSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred             cCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence            999999999976433  3588999999999999999999988   99999999999999999999999999987654322


Q ss_pred             cc------------ceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhh
Q 015027          244 TA------------MSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSI  311 (414)
Q Consensus       244 ~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  311 (414)
                      ..            ......||+.|+|||++.+..++.++||||||+++|||++|..||.................    
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~----  239 (310)
T 3s95_A          164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGF----  239 (310)
T ss_dssp             ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHH----
T ss_pred             cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcc----
Confidence            11            11145799999999999999999999999999999999999999864332211111000000    


Q ss_pred             cccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHhh
Q 015027          312 KNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLH  368 (414)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~~  368 (414)
                          .........+        ..+.+|+.+||+.||.+|||+.++++.|+.+....
T Consensus       240 ----~~~~~~~~~~--------~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~  284 (310)
T 3s95_A          240 ----LDRYCPPNCP--------PSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL  284 (310)
T ss_dssp             ----HHHTCCTTCC--------TTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ----ccccCCCCCC--------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence                0011111111        33899999999999999999999999999987653

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=2.2e-47  Score=353.17  Aligned_cols=259  Identities=22%  Similarity=0.314  Sum_probs=210.8

Q ss_pred             hcCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCC
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFAS  165 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  165 (414)
                      .++|.+.+.||+|+||.||+|.+.++..||+|++...........++++++.+++||||+++++++.+....++||||++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYIS   86 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccC
Confidence            46789999999999999999999888899999998776656666777899999999999999999999999999999999


Q ss_pred             CCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcccc
Q 015027          166 NGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETA  245 (414)
Q Consensus       166 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  245 (414)
                      +++|.+++.....  .+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++........ .
T Consensus        87 ~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~  160 (268)
T 3sxs_A           87 NGCLLNYLRSHGK--GLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY-V  160 (268)
T ss_dssp             TCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE-E
T ss_pred             CCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhh-h
Confidence            9999999976433  3588999999999999999999988   99999999999999999999999999987654322 2


Q ss_pred             ceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhccccccccccccc
Q 015027          246 MSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHV  324 (414)
Q Consensus       246 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (414)
                      ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.......         ......... . ...+  
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---------~~~~~~~~~-~-~~~~--  227 (268)
T 3sxs_A          161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE---------VVLKVSQGH-R-LYRP--  227 (268)
T ss_dssp             ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH---------HHHHHHTTC-C-CCCC--
T ss_pred             cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH---------HHHHHHcCC-C-CCCC--
Confidence            2233456778999999999999999999999999999999 999997433211         111111100 0 0001  


Q ss_pred             CCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHhh
Q 015027          325 ADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLH  368 (414)
Q Consensus       325 ~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~~  368 (414)
                       .    ..+..+.+|+.+||+.||.+|||+.++++.|+.+....
T Consensus       228 -~----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~  266 (268)
T 3sxs_A          228 -H----LASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD  266 (268)
T ss_dssp             -T----TSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred             -C----cChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence             1    11245899999999999999999999999999886543

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.6e-47  Score=352.93  Aligned_cols=258  Identities=25%  Similarity=0.378  Sum_probs=211.6

Q ss_pred             hcCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCC
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFAS  165 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  165 (414)
                      .++|.+.+.||+|+||.||+|.+.+++.||+|++...........++++++++++||||+++++++.+.+..++||||++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   88 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence            36788999999999999999999888999999998776666666778899999999999999999999999999999999


Q ss_pred             CCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcccc
Q 015027          166 NGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETA  245 (414)
Q Consensus       166 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  245 (414)
                      +++|.+++.....  .+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++....... ..
T Consensus        89 ~~~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~  162 (269)
T 4hcu_A           89 HGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YT  162 (269)
T ss_dssp             TCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-HH
T ss_pred             CCcHHHHHHhcCc--ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccc-cc
Confidence            9999999965433  3588999999999999999999988   9999999999999999999999999998664332 11


Q ss_pred             ceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhccccccccccccc
Q 015027          246 MSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHV  324 (414)
Q Consensus       246 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (414)
                      ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.......         ........ .....    
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~---------~~~~~~~~-~~~~~----  228 (269)
T 4hcu_A          163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTG-FRLYK----  228 (269)
T ss_dssp             STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---------HHHHHHTT-CCCCC----
T ss_pred             cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH---------HHHHHhcC-ccCCC----
Confidence            2233456788999999999999999999999999999999 999997433211         11111111 00000    


Q ss_pred             CCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHh
Q 015027          325 ADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRL  367 (414)
Q Consensus       325 ~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~  367 (414)
                      .    ...+..+.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus       229 ~----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          229 P----RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             C----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             C----CcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence            1    11125589999999999999999999999999998753

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.7e-46  Score=352.81  Aligned_cols=249  Identities=22%  Similarity=0.347  Sum_probs=201.7

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch-hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEe
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI-RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  163 (414)
                      .++|.+.+.||+|+||+||+|.+. +++.||||++...... .....+++.+++.++||||+++++++..++..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            468999999999999999999964 6899999999765433 33446677899999999999999999999999999999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcc
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE  243 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  243 (414)
                      +++|+|.+++...    .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++........
T Consensus        99 ~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  171 (297)
T 3fxz_A           99 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (297)
T ss_dssp             CTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             CCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence            9999999998643    3578999999999999999999988   99999999999999999999999999987654322


Q ss_pred             ccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccc
Q 015027          244 TAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFH  323 (414)
Q Consensus       244 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (414)
                        ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......         .............    
T Consensus       172 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---------~~~~~~~~~~~~~----  236 (297)
T 3fxz_A          172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR---------ALYLIATNGTPEL----  236 (297)
T ss_dssp             --CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---------HHHHHHHHCSCCC----
T ss_pred             --ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---------HHHHHHhCCCCCC----
Confidence              2344689999999999999999999999999999999999999996433111         0000000000000    


Q ss_pred             cCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          324 VADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       324 ~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                         ..+...+..+.+|+.+||+.||.+|||+.++++
T Consensus       237 ---~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          237 ---QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             ---SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---CCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence               011122355899999999999999999999853

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2.2e-47  Score=370.93  Aligned_cols=259  Identities=25%  Similarity=0.418  Sum_probs=207.2

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYE  162 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  162 (414)
                      .++|.+.+.||+|+||.||+|.+. +++.||||.+......  ...+.++++++++++||||+++++++...+..++|||
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  192 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME  192 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence            467888999999999999999986 6899999998754322  2234567799999999999999999999999999999


Q ss_pred             eCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCc
Q 015027          163 FASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDA  242 (414)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  242 (414)
                      |+++|+|.+++.....  .+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus       193 ~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~  267 (377)
T 3cbl_A          193 LVQGGDFLTFLRTEGA--RLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGV  267 (377)
T ss_dssp             CCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred             cCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence            9999999999975433  3478999999999999999999988   9999999999999999999999999998654332


Q ss_pred             cccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhcccccccccc
Q 015027          243 ETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILN  321 (414)
Q Consensus       243 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (414)
                      .........+++.|+|||++.+..++.++|||||||++|||++ |..||.......         ......... ..   
T Consensus       268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~---------~~~~~~~~~-~~---  334 (377)
T 3cbl_A          268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ---------TREFVEKGG-RL---  334 (377)
T ss_dssp             EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH---------HHHHHHTTC-CC---
T ss_pred             eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---------HHHHHHcCC-CC---
Confidence            2222222345778999999999999999999999999999998 999997543211         111111110 00   


Q ss_pred             cccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHh
Q 015027          322 FHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRL  367 (414)
Q Consensus       322 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~  367 (414)
                           ..+...+..+.+|+.+||+.||.+|||+.+|++.|+.+.+.
T Consensus       335 -----~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          335 -----PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence                 01111225589999999999999999999999999998754

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=8.2e-47  Score=359.59  Aligned_cols=259  Identities=24%  Similarity=0.362  Sum_probs=205.1

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc----CCcEEEEEEeecccc--hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH----DNIQVAVKTYRRADK--IRITERELLRIISQVNHKNVVKILGLCLETEVPLL  159 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~l  159 (414)
                      .++|.+.+.||+|+||.||+|.+.    .+..||||.+.....  ......+++.+++.++||||+++++++.+++..++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            367889999999999999999975    345699999976432  23345677899999999999999999999999999


Q ss_pred             EEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccccccc
Q 015027          160 VYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLIS  239 (414)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~  239 (414)
                      ||||+++|+|.+++.....  .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus       128 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  202 (325)
T 3kul_A          128 VTEYMENGSLDTFLRTHDG--QFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE  202 (325)
T ss_dssp             EEECCTTCBHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             EeeCCCCCcHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence            9999999999999965432  3588999999999999999999988   9999999999999999999999999998765


Q ss_pred             CCcccc-ceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhcccccc
Q 015027          240 SDAETA-MSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLR  317 (414)
Q Consensus       240 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (414)
                      ...... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.......         ....+....  
T Consensus       203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---------~~~~~~~~~--  271 (325)
T 3kul_A          203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD---------VISSVEEGY--  271 (325)
T ss_dssp             ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH---------HHHHHHTTC--
T ss_pred             cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH---------HHHHHHcCC--
Confidence            432221 1223456788999999999999999999999999999999 999996433211         111111110  


Q ss_pred             cccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHh
Q 015027          318 QILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRL  367 (414)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~  367 (414)
                             ....+...+..+.+|+.+||+.||.+|||+.+|++.|+.+.+.
T Consensus       272 -------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~  314 (325)
T 3kul_A          272 -------RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS  314 (325)
T ss_dssp             -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             -------CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence                   0011111225699999999999999999999999999998764

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.6e-46  Score=356.35  Aligned_cols=246  Identities=23%  Similarity=0.311  Sum_probs=200.5

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch---hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI---RITERELLRIISQVNHKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~  161 (414)
                      .++|.+.+.||+|+||.||+|.+. +|+.||||++......   .....+++++++.++||||+++++++...+..|+||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            468999999999999999999974 6999999999765322   223456778999999999999999999999999999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCC
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD  241 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  241 (414)
                      ||+++|+|.+++...+   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        94 e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  167 (328)
T 3fe3_A           94 EYASGGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG  167 (328)
T ss_dssp             CCCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred             ECCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence            9999999999996543   3478999999999999999999988   999999999999999999999999999866533


Q ss_pred             ccccceecccccccccchhhcccCCCC-CcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccc
Q 015027          242 AETAMSTILIGTSGYLDPVCINTGKLT-KKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQIL  320 (414)
Q Consensus       242 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (414)
                      .   .....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.......         ....+.....    
T Consensus       168 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---------~~~~i~~~~~----  231 (328)
T 3fe3_A          168 G---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE---------LRERVLRGKY----  231 (328)
T ss_dssp             C---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---------HHHHHHHCCC----
T ss_pred             C---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH---------HHHHHHhCCC----
Confidence            2   23456899999999999888775 79999999999999999999997543211         1111111110    


Q ss_pred             ccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          321 NFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       321 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                        ..+.    ..+..+.+|+.+||+.||.+|||++++++
T Consensus       232 --~~p~----~~s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          232 --RIPF----YMSTDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             --CCCT----TSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             --CCCC----CCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence              0111    11255899999999999999999999843

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.5e-46  Score=350.42  Aligned_cols=257  Identities=24%  Similarity=0.344  Sum_probs=207.8

Q ss_pred             hcCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCC
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFAS  165 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  165 (414)
                      .++|.+.+.||+|+||.||+|.+.++..||||++...........++++++.+++||||+++++++.+.+..++||||++
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  102 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA  102 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCT
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccC
Confidence            46789999999999999999999888899999998776666666778899999999999999999999999999999999


Q ss_pred             CCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcccc
Q 015027          166 NGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETA  245 (414)
Q Consensus       166 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  245 (414)
                      +++|.+++.....  .+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++........ .
T Consensus       103 ~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~  176 (283)
T 3gen_A          103 NGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-T  176 (283)
T ss_dssp             TCBHHHHHHCGGG--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH-H
T ss_pred             CCcHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccccc-c
Confidence            9999999965332  3588999999999999999999988   99999999999999999999999999986643321 1


Q ss_pred             ceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhccccccccccccc
Q 015027          246 MSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHV  324 (414)
Q Consensus       246 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (414)
                      ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.......         ....+... .....    
T Consensus       177 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~---------~~~~~~~~-~~~~~----  242 (283)
T 3gen_A          177 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---------TAEHIAQG-LRLYR----  242 (283)
T ss_dssp             STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---------HHHHHHTT-CCCCC----
T ss_pred             cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH---------HHHHHhcc-cCCCC----
Confidence            2233456788999999999999999999999999999998 999997433211         11111110 00000    


Q ss_pred             CCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHH
Q 015027          325 ADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR  366 (414)
Q Consensus       325 ~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~  366 (414)
                      ..    ..+..+.+|+.+||+.+|.+|||+.++++.|+.+..
T Consensus       243 ~~----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~  280 (283)
T 3gen_A          243 PH----LASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD  280 (283)
T ss_dssp             CT----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CC----cCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence            11    112558999999999999999999999999998764

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=5.7e-47  Score=365.21  Aligned_cols=271  Identities=23%  Similarity=0.330  Sum_probs=212.8

Q ss_pred             ccHHHHHHHhcCCCCCCccccCCceEEEEEEEc------CCcEEEEEEeecccchh--HhHHHHHHHHHcc-CCCceeee
Q 015027           77 FSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLH------DNIQVAVKTYRRADKIR--ITERELLRIISQV-NHKNVVKI  147 (414)
Q Consensus        77 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~--~~~~~~~~~l~~l-~hpniv~l  147 (414)
                      +....+....++|.+.+.||+|+||.||+|.+.      +++.||||++.......  ....++++++.++ +||||+++
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence            445555666789999999999999999999842      35789999997654322  3346677888888 79999999


Q ss_pred             eeeEecCC-cceEEEEeCCCCchhhhhhhcCC------------------------------------------------
Q 015027          148 LGLCLETE-VPLLVYEFASNGTLLDHIRCESS------------------------------------------------  178 (414)
Q Consensus       148 ~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------  178 (414)
                      +++|.+.+ ..++||||+++|+|.+++.....                                                
T Consensus        92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (359)
T 3vhe_A           92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK  171 (359)
T ss_dssp             EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred             eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence            99998755 48999999999999999965432                                                


Q ss_pred             ---------------cccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcc
Q 015027          179 ---------------QVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE  243 (414)
Q Consensus       179 ---------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  243 (414)
                                     ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++........
T Consensus       172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  248 (359)
T 3vhe_A          172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD  248 (359)
T ss_dssp             ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred             ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence                           112688999999999999999999988   99999999999999999999999999987655434


Q ss_pred             ccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhccccccccccc
Q 015027          244 TAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNF  322 (414)
Q Consensus       244 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (414)
                      ........||+.|+|||++.+..++.++|||||||++|||++ |..||.......        ...........     .
T Consensus       249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--------~~~~~~~~~~~-----~  315 (359)
T 3vhe_A          249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--------EFCRRLKEGTR-----M  315 (359)
T ss_dssp             CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--------HHHHHHHHTCC-----C
T ss_pred             chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH--------HHHHHHHcCCC-----C
Confidence            344455678999999999999999999999999999999998 999997433211        01111111100     0


Q ss_pred             ccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHh
Q 015027          323 HVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRL  367 (414)
Q Consensus       323 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~  367 (414)
                      ....    ..+..+.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus       316 ~~~~----~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  356 (359)
T 3vhe_A          316 RAPD----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  356 (359)
T ss_dssp             CCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCC----CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence            0111    1125589999999999999999999999999988754

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2.1e-46  Score=356.51  Aligned_cols=251  Identities=24%  Similarity=0.344  Sum_probs=199.8

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYE  162 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  162 (414)
                      .++|++.+.||+|+||.||+|.+. +++.||||++......  .....+++.+++.++||||+++++++.+++..|+|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            468999999999999999999976 6899999998754332  2344667789999999999999999999999999999


Q ss_pred             eCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCc
Q 015027          163 FASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDA  242 (414)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  242 (414)
                      |+++|+|.+++...   ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.......
T Consensus        86 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  159 (323)
T 3tki_A           86 YCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (323)
T ss_dssp             CCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             cCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence            99999999998543   33588999999999999999999988   9999999999999999999999999998765443


Q ss_pred             cccceecccccccccchhhcccCCC-CCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccc
Q 015027          243 ETAMSTILIGTSGYLDPVCINTGKL-TKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILN  321 (414)
Q Consensus       243 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (414)
                      .........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.........       + ..+....  ....
T Consensus       160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-------~-~~~~~~~--~~~~  229 (323)
T 3tki_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-------Y-SDWKEKK--TYLN  229 (323)
T ss_dssp             EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-------H-HHHHTTC--TTST
T ss_pred             cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-------H-HHHhccc--ccCC
Confidence            3333455689999999999987775 78999999999999999999999743321100       0 0000000  0000


Q ss_pred             cccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHH
Q 015027          322 FHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVS  358 (414)
Q Consensus       322 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~  358 (414)
                      +      ....+..+.+|+.+||+.||.+|||+.+++
T Consensus       230 ~------~~~~~~~~~~li~~~L~~dP~~R~t~~eil  260 (323)
T 3tki_A          230 P------WKKIDSAPLALLHKILVENPSARITIPDIK  260 (323)
T ss_dssp             T------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred             c------cccCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence            0      011225589999999999999999999984

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=7e-47  Score=360.37  Aligned_cols=260  Identities=23%  Similarity=0.356  Sum_probs=199.6

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcE----EEEEEeeccc--chhHhHHHHHHHHHccCCCceeeeeeeEecCCcce
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQ----VAVKTYRRAD--KIRITERELLRIISQVNHKNVVKILGLCLETEVPL  158 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~~--~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~  158 (414)
                      .++|.+.+.||+|+||+||+|.+. +++.    ||+|.+....  .......+++.++++++||||++++++|..+. .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~   92 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence            367899999999999999999964 3443    6888876433  22344567789999999999999999998754 78


Q ss_pred             EEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccc
Q 015027          159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLI  238 (414)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~  238 (414)
                      +|+||+++|+|.+++.....  .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        93 ~v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  167 (327)
T 3poz_A           93 LITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEEECCTTCBHHHHHHHSTT--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred             EEEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence            99999999999999976443  3588999999999999999999987   999999999999999999999999999877


Q ss_pred             cCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhcccccc
Q 015027          239 SSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLR  317 (414)
Q Consensus       239 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (414)
                      .............+|+.|+|||++.+..++.++|||||||++|||++ |+.||.......         .........  
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---------~~~~~~~~~--  236 (327)
T 3poz_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---------ISSILEKGE--  236 (327)
T ss_dssp             TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---------HHHHHHTTC--
T ss_pred             cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH---------HHHHHHcCC--
Confidence            65444333444567889999999999999999999999999999999 999997433211         111111110  


Q ss_pred             cccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHhhh
Q 015027          318 QILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLHE  369 (414)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~~~  369 (414)
                             ....+...+..+.+|+.+||+.+|.+|||+.++++.|+.+.+...
T Consensus       237 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~  281 (327)
T 3poz_A          237 -------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ  281 (327)
T ss_dssp             -------CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSHH
T ss_pred             -------CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhhh
Confidence                   000111122458999999999999999999999999999876543

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.5e-46  Score=353.81  Aligned_cols=252  Identities=17%  Similarity=0.245  Sum_probs=204.1

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeC
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFA  164 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  164 (414)
                      .++|.+.+.||+|+||.||+|.+. +++.||+|.+...........+++.+++.++||||+++++++.+.+..++||||+
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~   83 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI   83 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence            468999999999999999999976 5889999999866555555567789999999999999999999999999999999


Q ss_pred             CCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCC--CCcEEEeeccccccccCCc
Q 015027          165 SNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLND--NYTAKVADFESSVLISSDA  242 (414)
Q Consensus       165 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~--~~~~kl~DfGla~~~~~~~  242 (414)
                      ++|+|.+++....  ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.  ++.+||+|||++...... 
T Consensus        84 ~g~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~-  157 (321)
T 1tki_A           84 SGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-  157 (321)
T ss_dssp             CCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred             CCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC-
Confidence            9999999996433  24588999999999999999999988   999999999999987  789999999999876543 


Q ss_pred             cccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccccc
Q 015027          243 ETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNF  322 (414)
Q Consensus       243 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (414)
                        .......||+.|+|||++.+..++.++|||||||++|+|++|..||.......         ....+......  .+.
T Consensus       158 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---------~~~~i~~~~~~--~~~  224 (321)
T 1tki_A          158 --DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ---------IIENIMNAEYT--FDE  224 (321)
T ss_dssp             --CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---------HHHHHHHTCCC--CCH
T ss_pred             --CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH---------HHHHHHcCCCC--CCh
Confidence              22345679999999999999889999999999999999999999997433211         11111111000  000


Q ss_pred             ccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHH
Q 015027          323 HVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEE  360 (414)
Q Consensus       323 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~  360 (414)
                          ......+..+.+|+.+||..||.+|||+.++++.
T Consensus       225 ----~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h  258 (321)
T 1tki_A          225 ----EAFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             ----HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ----hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                0000113568999999999999999999999763

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-46  Score=364.10  Aligned_cols=262  Identities=24%  Similarity=0.335  Sum_probs=207.7

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc------CCcEEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEecCCcc
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH------DNIQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLETEVP  157 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~  157 (414)
                      .++|.+.+.||+|+||.||+|.+.      ++..||||++......  ......++.++++++||||+++++++......
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            367899999999999999999943      3678999999754322  23345667899999999999999999999999


Q ss_pred             eEEEEeCCCCchhhhhhhcCC----cccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCC---cEEEe
Q 015027          158 LLVYEFASNGTLLDHIRCESS----QVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNY---TAKVA  230 (414)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~---~~kl~  230 (414)
                      ++||||+++|+|.+++.....    ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence            999999999999999976432    234688999999999999999999988   99999999999999554   59999


Q ss_pred             eccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhh
Q 015027          231 DFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLN  309 (414)
Q Consensus       231 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  309 (414)
                      |||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||.......         ...
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~---------~~~  297 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---------VLE  297 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---------HHH
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---------HHH
Confidence            9999986543323333445678999999999999999999999999999999998 999997433211         111


Q ss_pred             hhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHhh
Q 015027          310 SIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLH  368 (414)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~~  368 (414)
                      .+......         ..+...+..+.+|+.+||+.||.+|||+.+|++.|+.+....
T Consensus       298 ~i~~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~  347 (367)
T 3l9p_A          298 FVTSGGRM---------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  347 (367)
T ss_dssp             HHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             HHHcCCCC---------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence            11111100         001111245899999999999999999999999999887653

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2.5e-45  Score=348.71  Aligned_cols=260  Identities=22%  Similarity=0.291  Sum_probs=207.6

Q ss_pred             ccccHHHHHHHhcC----------CCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch-hHhHHHHHHHHHccCCC
Q 015027           75 KIFSKSEMIRATKN----------FDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI-RITERELLRIISQVNHK  142 (414)
Q Consensus        75 ~~~~~~~~~~~~~~----------~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~hp  142 (414)
                      ..++.+++..+++.          |...+.||+|+||.||+|... +|+.||||++...... .....+++.+++.++||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            45777787777764          667789999999999999976 6999999999765433 33446777999999999


Q ss_pred             ceeeeeeeEecCCcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeC
Q 015027          143 NVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLN  222 (414)
Q Consensus       143 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~  222 (414)
                      ||+++++++...+..++||||+++++|.+++..    ..+++..+..++.||+.||.|||+.+   |+||||||+|||++
T Consensus       103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~  175 (321)
T 2c30_A          103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLT  175 (321)
T ss_dssp             TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC
T ss_pred             CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEC
Confidence            999999999999999999999999999999853    24689999999999999999999987   99999999999999


Q ss_pred             CCCcEEEeeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccc
Q 015027          223 DNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKIS  302 (414)
Q Consensus       223 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~  302 (414)
                      .++.+||+|||++........  ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.......     
T Consensus       176 ~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~-----  248 (321)
T 2c30_A          176 LDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ-----  248 (321)
T ss_dssp             TTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-----
T ss_pred             CCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----
Confidence            999999999999987654322  2344579999999999999999999999999999999999999996432111     


Q ss_pred             cchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          303 MVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                          ..........     +...  .....+..+.+|+.+||+.||.+|||+.++++
T Consensus       249 ----~~~~~~~~~~-----~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          249 ----AMKRLRDSPP-----PKLK--NSHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             ----HHHHHHHSSC-----CCCT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ----HHHHHhcCCC-----CCcC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                0111111000     0000  01112255899999999999999999999854

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=4e-46  Score=352.43  Aligned_cols=260  Identities=23%  Similarity=0.343  Sum_probs=208.9

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc------CCcEEEEEEeecccchh--HhHHHHHHHHHccCCCceeeeeeeEecCCcc
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH------DNIQVAVKTYRRADKIR--ITERELLRIISQVNHKNVVKILGLCLETEVP  157 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~--~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~  157 (414)
                      .++|.+.+.||+|+||.||+|.+.      ++..||||++.......  ....+++++++.++||||+++++++.+.+..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  101 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL  101 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence            467899999999999999999862      35789999997653322  3346678999999999999999999999999


Q ss_pred             eEEEEeCCCCchhhhhhhcCC---------------------cccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCC
Q 015027          158 LLVYEFASNGTLLDHIRCESS---------------------QVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKS  216 (414)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~---------------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp  216 (414)
                      ++||||+++++|.+++.....                     ...+++..++.++.||+.||.|||+.+   |+||||||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp  178 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAA  178 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccch
Confidence            999999999999999975432                     123688999999999999999999988   99999999


Q ss_pred             CceeeCCCCcEEEeeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCcccc
Q 015027          217 ANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTL  295 (414)
Q Consensus       217 ~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~  295 (414)
                      +|||++.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus       179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  258 (314)
T 2ivs_A          179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP  258 (314)
T ss_dssp             GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999987654433333344567889999999999999999999999999999999 9999974332


Q ss_pred             ccccccccchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHH
Q 015027          296 ASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR  366 (414)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~  366 (414)
                      ..         ..........     ..    .+...+..+.+|+.+||+.||.+|||+.++++.|+.+..
T Consensus       259 ~~---------~~~~~~~~~~-----~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  311 (314)
T 2ivs_A          259 ER---------LFNLLKTGHR-----ME----RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV  311 (314)
T ss_dssp             GG---------HHHHHHTTCC-----CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HH---------HHHHhhcCCc-----CC----CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            11         1111111110     00    111122569999999999999999999999999998764

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.9e-45  Score=347.85  Aligned_cols=272  Identities=19%  Similarity=0.254  Sum_probs=209.4

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEecCC--cceEE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLETE--VPLLV  160 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~~~--~~~lv  160 (414)
                      .++|.+.+.||+|+||+||+|.+. +++.||||++......  .....++++++++++||||+++++++....  ..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            367899999999999999999976 4899999999764422  233456778999999999999999998655  77999


Q ss_pred             EEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceee----CCCCcEEEeeccccc
Q 015027          161 YEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILL----NDNYTAKVADFESSV  236 (414)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll----~~~~~~kl~DfGla~  236 (414)
                      |||+++++|.+++........+++..++.++.||+.||.|||+.+   |+||||||+|||+    +.++.+||+|||++.
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            999999999999977655555789999999999999999999988   9999999999999    888899999999998


Q ss_pred             cccCCccccceecccccccccchhhcc--------cCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhh
Q 015027          237 LISSDAETAMSTILIGTSGYLDPVCIN--------TGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFL  308 (414)
Q Consensus       237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~  308 (414)
                      ......   ......||+.|+|||++.        +..++.++|||||||++|||++|+.||............+.. ..
T Consensus       165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~-~~  240 (319)
T 4euu_A          165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK-II  240 (319)
T ss_dssp             ECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHH-HH
T ss_pred             ecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHH-Hh
Confidence            765432   223457999999999986        578999999999999999999999999643322111110000 00


Q ss_pred             hhhcccccc---c----c--c--ccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHH
Q 015027          309 NSIKNNGLR---Q----I--L--NFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL  364 (414)
Q Consensus       309 ~~~~~~~~~---~----~--~--~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i  364 (414)
                      .........   .    .  .  ...............+.+|+.+||+.||++|||+.++++....-
T Consensus       241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~  307 (319)
T 4euu_A          241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (319)
T ss_dssp             HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence            000000000   0    0  0  01112234456678899999999999999999999998877643

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.2e-46  Score=361.92  Aligned_cols=261  Identities=24%  Similarity=0.345  Sum_probs=209.9

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc--------CCcEEEEEEeecccchh--HhHHHHHHHHHcc-CCCceeeeeeeEecC
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH--------DNIQVAVKTYRRADKIR--ITERELLRIISQV-NHKNVVKILGLCLET  154 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~--~~~~~~~~~l~~l-~hpniv~l~~~~~~~  154 (414)
                      .++|.+.+.||+|+||.||+|.+.        .+..||||++.......  ....+++++++++ +||||++++++|..+
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            468899999999999999999863        23579999997654332  3345677889888 899999999999999


Q ss_pred             CcceEEEEeCCCCchhhhhhhcCC-------------cccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceee
Q 015027          155 EVPLLVYEFASNGTLLDHIRCESS-------------QVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILL  221 (414)
Q Consensus       155 ~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll  221 (414)
                      +..++||||+++|+|.+++.....             ...+++..++.++.||+.||.|||+.+   |+||||||+|||+
T Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll  224 (382)
T 3tt0_A          148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  224 (382)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred             CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEE
Confidence            999999999999999999976432             234689999999999999999999987   9999999999999


Q ss_pred             CCCCcEEEeeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccc
Q 015027          222 NDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKK  300 (414)
Q Consensus       222 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~  300 (414)
                      +.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||.......   
T Consensus       225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~---  301 (382)
T 3tt0_A          225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---  301 (382)
T ss_dssp             CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---
T ss_pred             cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---
Confidence            9999999999999987654433333445567889999999999999999999999999999999 999987433211   


Q ss_pred             cccchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHh
Q 015027          301 ISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRL  367 (414)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~  367 (414)
                            ....+.....     .....    ..+..+.+|+.+||+.||.+|||+.+|++.|+.+...
T Consensus       302 ------~~~~~~~~~~-----~~~~~----~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  353 (382)
T 3tt0_A          302 ------LFKLLKEGHR-----MDKPS----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL  353 (382)
T ss_dssp             ------HHHHHHTTCC-----CCCCS----SCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------HHHHHHcCCC-----CCCCc----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence                  1111111110     00011    1125599999999999999999999999999998754

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=8.7e-46  Score=348.00  Aligned_cols=262  Identities=22%  Similarity=0.324  Sum_probs=196.1

Q ss_pred             hcCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHH--ccCCCceeeeeeeEec----CCcceE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIIS--QVNHKNVVKILGLCLE----TEVPLL  159 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~--~l~hpniv~l~~~~~~----~~~~~l  159 (414)
                      .++|.+.+.||+|+||+||+|.. +++.||||++........  ..+.+++.  .++||||+++++++..    ....++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~--~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l   83 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSW--FRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL   83 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGGHHHH--HHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccccchhh--HHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence            47899999999999999999988 789999999976543222  22233443  4899999999998754    345799


Q ss_pred             EEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhh--------hCCCCCeeeCCCCCCceeeCCCCcEEEee
Q 015027          160 VYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLH--------SLASPPIIHGDVKSANILLNDNYTAKVAD  231 (414)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH--------~~~~~~iiH~Dlkp~NIll~~~~~~kl~D  231 (414)
                      ||||+++|+|.+++..    ..+++..++.++.||+.||+|||        +.+   |+||||||+|||++.++.+||+|
T Consensus        84 v~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~D  156 (301)
T 3q4u_A           84 ITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIAD  156 (301)
T ss_dssp             EECCCTTCBHHHHHTT----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECC
T ss_pred             ehhhccCCCHHHHHhh----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEee
Confidence            9999999999999943    34588999999999999999999        666   99999999999999999999999


Q ss_pred             ccccccccCCcccc--ceecccccccccchhhcccC------CCCCcccchhHHHHHHHHHhC----------CCCCCcc
Q 015027          232 FESSVLISSDAETA--MSTILIGTSGYLDPVCINTG------KLTKKSDVYSFGVVLAELLTG----------KKPGSCM  293 (414)
Q Consensus       232 fGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~SlGvil~el~tg----------~~p~~~~  293 (414)
                      ||++..........  ......||+.|+|||++.+.      .++.++|||||||++|||++|          ..||...
T Consensus       157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~  236 (301)
T 3q4u_A          157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV  236 (301)
T ss_dssp             CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence            99997665432211  12334799999999999876      566799999999999999999          6676532


Q ss_pred             ccccccccccchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHH
Q 015027          294 TLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL  364 (414)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i  364 (414)
                      .......    .................   ........+..+.+|+.+||+.||.+|||+.+|++.|+.+
T Consensus       237 ~~~~~~~----~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          237 VPNDPSF----EDMRKVVCVDQQRPNIP---NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             SCSSCCH----HHHHHHHTTSCCCCCCC---GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCcch----hhhhHHHhccCCCCCCC---hhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            2111100    00000010111000000   0112234557799999999999999999999999999876

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.2e-45  Score=351.05  Aligned_cols=247  Identities=23%  Similarity=0.269  Sum_probs=200.0

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc----hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK----IRITERELLRIISQVNHKNVVKILGLCLETEVPLLV  160 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv  160 (414)
                      .++|++.+.||+|+||.||+|... +|+.||+|++.....    .......+++++..++||||+++++++.+.+..|+|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            367899999999999999999976 589999999976421    223345667899999999999999999999999999


Q ss_pred             EEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccC
Q 015027          161 YEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISS  240 (414)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  240 (414)
                      |||+++|+|.+++....   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.+|.+||+|||+++....
T Consensus        84 ~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  157 (337)
T 1o6l_A           84 MEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             EECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence            99999999999986543   3478899999999999999999988   99999999999999999999999999976433


Q ss_pred             CccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccc
Q 015027          241 DAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQIL  320 (414)
Q Consensus       241 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (414)
                      ..  ......+||+.|+|||++.+..++.++|||||||++|||++|..||.......         ....+.....    
T Consensus       158 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---------~~~~i~~~~~----  222 (337)
T 1o6l_A          158 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---------LFELILMEEI----  222 (337)
T ss_dssp             TT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---------HHHHHHHCCC----
T ss_pred             CC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH---------HHHHHHcCCC----
Confidence            21  22345689999999999999999999999999999999999999997433111         1111111110    


Q ss_pred             ccccCCcccHHHHHHHHHHHHHhhccCCCCCC-----ChhHHHH
Q 015027          321 NFHVADESEMKEIEIVAELASKCLRIRGTERP-----TMKQVSE  359 (414)
Q Consensus       321 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rp-----s~~~v~~  359 (414)
                        ..+.    ..+..+.+|+.+||+.||.+||     ++.++++
T Consensus       223 --~~p~----~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          223 --RFPR----TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             --CCCT----TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             --CCCC----CCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence              0111    1225689999999999999999     7888854

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=3.2e-46  Score=362.10  Aligned_cols=260  Identities=26%  Similarity=0.389  Sum_probs=196.0

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc----CCcEEEEEEeecccc--hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH----DNIQVAVKTYRRADK--IRITERELLRIISQVNHKNVVKILGLCLETEVPLL  159 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~l  159 (414)
                      .++|.+.+.||+|+||.||+|.+.    ++..||||.+.....  ....+.+++.++.+++||||+++++++.+.+..++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            368999999999999999999865    467899999976432  22345677899999999999999999999999999


Q ss_pred             EEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccccccc
Q 015027          160 VYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLIS  239 (414)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~  239 (414)
                      ||||+++|+|.+++....  ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus       124 v~e~~~~~sL~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  198 (373)
T 2qol_A          124 VTEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE  198 (373)
T ss_dssp             EEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence            999999999999997543  23588999999999999999999987   9999999999999999999999999998765


Q ss_pred             CCcccc-ceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhcccccc
Q 015027          240 SDAETA-MSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLR  317 (414)
Q Consensus       240 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (414)
                      ...... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.......         ....+... ..
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~---------~~~~i~~~-~~  268 (373)
T 2qol_A          199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD---------VIKAVDEG-YR  268 (373)
T ss_dssp             ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH---------HHHHHHTT-EE
T ss_pred             cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---------HHHHHHcC-CC
Confidence            432211 1122345778999999999999999999999999999998 999986433211         11111111 00


Q ss_pred             cccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHhh
Q 015027          318 QILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLH  368 (414)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~~  368 (414)
                              ...+...+..+.+|+.+||+.||.+|||+.+|++.|+.+....
T Consensus       269 --------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~  311 (373)
T 2qol_A          269 --------LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP  311 (373)
T ss_dssp             --------CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred             --------CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence                    0011112256999999999999999999999999999987643

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2.1e-45  Score=357.96  Aligned_cols=251  Identities=20%  Similarity=0.257  Sum_probs=194.6

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchh----HhHHHHHHHHHcc-CCCceeeeeeeEecCCcceE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIR----ITERELLRIISQV-NHKNVVKILGLCLETEVPLL  159 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l-~hpniv~l~~~~~~~~~~~l  159 (414)
                      .++|++.+.||+|+||.||+|+.. +++.||+|+++......    .....+..++.++ +||||++++++|.+.+..|+
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            467999999999999999999976 48889999998653221    2234455666665 89999999999999999999


Q ss_pred             EEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccccccc
Q 015027          160 VYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLIS  239 (414)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~  239 (414)
                      ||||+++|+|.+++....   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       131 V~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~  204 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  204 (396)
T ss_dssp             EEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEcCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence            999999999999997543   3588999999999999999999988   9999999999999999999999999997633


Q ss_pred             CCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccc
Q 015027          240 SDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQI  319 (414)
Q Consensus       240 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (414)
                      ..  .......+||+.|+|||++.+..++.++|||||||++|||++|+.||....................+.....   
T Consensus       205 ~~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~---  279 (396)
T 4dc2_A          205 RP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---  279 (396)
T ss_dssp             CT--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC---
T ss_pred             cC--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc---
Confidence            22  1233456899999999999999999999999999999999999999964332211111111111111111110   


Q ss_pred             cccccCCcccHHHHHHHHHHHHHhhccCCCCCCCh
Q 015027          320 LNFHVADESEMKEIEIVAELASKCLRIRGTERPTM  354 (414)
Q Consensus       320 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~  354 (414)
                         ..+.    ..+..+.+|+.+||+.||.+||++
T Consensus       280 ---~~p~----~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          280 ---RIPR----SLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             ---CCCT----TSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             ---CCCC----cCCHHHHHHHHHHhcCCHhHcCCC
Confidence               1111    122568999999999999999996

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2.4e-45  Score=354.02  Aligned_cols=250  Identities=23%  Similarity=0.284  Sum_probs=201.6

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch-------hHhHHHHHHHHHccCCCceeeeeeeEecCCcc
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI-------RITERELLRIISQVNHKNVVKILGLCLETEVP  157 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~  157 (414)
                      .++|.+.+.||+|+||.||+|... +|+.||+|++......       ......++.++.+++||||+++++++.+....
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            467999999999999999999976 5899999999865432       23456778999999999999999999999999


Q ss_pred             eEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCC----cEEEeecc
Q 015027          158 LLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNY----TAKVADFE  233 (414)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~----~~kl~DfG  233 (414)
                      ++||||+++|+|.+++...   ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++    .+||+|||
T Consensus        91 ~lv~e~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG  164 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTC---SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred             EEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence            9999999999999999643   34588999999999999999999988   99999999999998876    79999999


Q ss_pred             ccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcc
Q 015027          234 SSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKN  313 (414)
Q Consensus       234 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  313 (414)
                      ++.......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......         ....+..
T Consensus       165 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~---------~~~~i~~  232 (361)
T 2yab_A          165 LAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---------TLANITA  232 (361)
T ss_dssp             SCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---------HHHHHHT
T ss_pred             CceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH---------HHHHHHh
Confidence            998765432   2344679999999999999999999999999999999999999997433111         1111111


Q ss_pred             cccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          314 NGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ....  ++.    ......+..+.+|+.+||..||.+|||+.++++
T Consensus       233 ~~~~--~~~----~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          233 VSYD--FDE----EFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             TCCC--CCH----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cCCC--CCc----hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            1000  000    000111256899999999999999999999874

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.7e-46  Score=373.35  Aligned_cols=259  Identities=24%  Similarity=0.375  Sum_probs=209.0

Q ss_pred             HHHhcCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEE
Q 015027           83 IRATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYE  162 (414)
Q Consensus        83 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  162 (414)
                      ....++|.+.+.||+|+||.||+|.+.++..||||++.........+.++++++++++||||+++++++. .+..++|||
T Consensus       184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e  262 (454)
T 1qcf_A          184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE  262 (454)
T ss_dssp             BCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred             eechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence            3445778899999999999999999988899999999876655666778889999999999999999986 667899999


Q ss_pred             eCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCc
Q 015027          163 FASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDA  242 (414)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  242 (414)
                      |+++|+|.+++..... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus       263 ~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~  338 (454)
T 1qcf_A          263 FMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE  338 (454)
T ss_dssp             CCTTCBHHHHHHSHHH-HTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred             ecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence            9999999999965432 23478889999999999999999987   9999999999999999999999999998764321


Q ss_pred             cccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhcccccccccc
Q 015027          243 ETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILN  321 (414)
Q Consensus       243 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (414)
                      . .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.......         ....+... ..    
T Consensus       339 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~---------~~~~i~~~-~~----  403 (454)
T 1qcf_A          339 Y-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---------VIRALERG-YR----  403 (454)
T ss_dssp             H-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---------HHHHHHHT-CC----
T ss_pred             e-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH---------HHHHHHcC-CC----
Confidence            1 11223356788999999999999999999999999999999 999997543211         11111111 00    


Q ss_pred             cccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHH
Q 015027          322 FHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLR  365 (414)
Q Consensus       322 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~  365 (414)
                          ...+...+..+.+|+.+||+.||.+|||+.+|++.|+.+.
T Consensus       404 ----~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~  443 (454)
T 1qcf_A          404 ----MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY  443 (454)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             ----CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence                0011112356999999999999999999999999988764

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.3e-46  Score=357.13  Aligned_cols=263  Identities=24%  Similarity=0.402  Sum_probs=207.2

Q ss_pred             HhcCCCCCCccccCCceEEEEEEEc------CCcEEEEEEeecccc--hhHhHHHHHHHHHcc-CCCceeeeeeeEecCC
Q 015027           85 ATKNFDRSRCLSQGGFVSVYKGVLH------DNIQVAVKTYRRADK--IRITERELLRIISQV-NHKNVVKILGLCLETE  155 (414)
Q Consensus        85 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~~~~~l~~l-~hpniv~l~~~~~~~~  155 (414)
                      ..++|.+.+.||+|+||.||+|.+.      ++..||||++.....  .......++.++.++ +||||+++++++...+
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            3578999999999999999999962      356799999975432  233446677899999 8999999999999999


Q ss_pred             cceEEEEeCCCCchhhhhhhcCCc--------------------ccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCC
Q 015027          156 VPLLVYEFASNGTLLDHIRCESSQ--------------------VLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVK  215 (414)
Q Consensus       156 ~~~lv~e~~~~gsL~~~l~~~~~~--------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlk  215 (414)
                      ..++||||+++|+|.+++......                    ..+++..++.++.||+.||.|||+.+   |+|||||
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik  199 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA  199 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence            999999999999999999764432                    23688999999999999999999988   9999999


Q ss_pred             CCceeeCCCCcEEEeeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccc
Q 015027          216 SANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMT  294 (414)
Q Consensus       216 p~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~  294 (414)
                      |+|||++.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus       200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  279 (344)
T 1rjb_A          200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  279 (344)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence            9999999999999999999987655433333445577889999999999999999999999999999998 999997443


Q ss_pred             cccccccccchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHh
Q 015027          295 LASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRL  367 (414)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~  367 (414)
                      ...        .+...... ....        ..+...+..+.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus       280 ~~~--------~~~~~~~~-~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  335 (344)
T 1rjb_A          280 VDA--------NFYKLIQN-GFKM--------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD  335 (344)
T ss_dssp             CSH--------HHHHHHHT-TCCC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             cHH--------HHHHHHhc-CCCC--------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence            211        01111111 1000        01111125699999999999999999999999999887543

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=4.4e-46  Score=356.67  Aligned_cols=262  Identities=23%  Similarity=0.332  Sum_probs=208.8

Q ss_pred             HhcCCCCCCccccCCceEEEEEEEcC------CcEEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEecCCc
Q 015027           85 ATKNFDRSRCLSQGGFVSVYKGVLHD------NIQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLETEV  156 (414)
Q Consensus        85 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~  156 (414)
                      ..++|.+.+.||+|+||.||+|.+.+      ++.||||++......  .....+++.++++++||||+++++++.+.+.
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  124 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP  124 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence            45789999999999999999999753      478999999765432  2344677899999999999999999999999


Q ss_pred             ceEEEEeCCCCchhhhhhhcCC---------------------cccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCC
Q 015027          157 PLLVYEFASNGTLLDHIRCESS---------------------QVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVK  215 (414)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~~---------------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlk  215 (414)
                      .++||||+++|+|.+++.....                     ...+++..++.++.||+.||.|||+.+   |+|||||
T Consensus       125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlk  201 (343)
T 1luf_A          125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA  201 (343)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred             eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence            9999999999999999975421                     145688999999999999999999988   9999999


Q ss_pred             CCceeeCCCCcEEEeeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccc
Q 015027          216 SANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMT  294 (414)
Q Consensus       216 p~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~  294 (414)
                      |+|||++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||....
T Consensus       202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  281 (343)
T 1luf_A          202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA  281 (343)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence            9999999999999999999987654333233345578899999999999999999999999999999999 999997433


Q ss_pred             cccccccccchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHh
Q 015027          295 LASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRL  367 (414)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~  367 (414)
                      ...         ....+......     ....    ..+..+.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus       282 ~~~---------~~~~~~~~~~~-----~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~  336 (343)
T 1luf_A          282 HEE---------VIYYVRDGNIL-----ACPE----NCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER  336 (343)
T ss_dssp             HHH---------HHHHHHTTCCC-----CCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred             hHH---------HHHHHhCCCcC-----CCCC----CCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence            211         11111111110     0011    1225599999999999999999999999999987643

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=6e-46  Score=351.06  Aligned_cols=262  Identities=25%  Similarity=0.393  Sum_probs=210.1

Q ss_pred             hcCCCCCCccccCCceEEEEEEE------cCCcEEEEEEeecccch--hHhHHHHHHHHHcc-CCCceeeeeeeEecCCc
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVL------HDNIQVAVKTYRRADKI--RITERELLRIISQV-NHKNVVKILGLCLETEV  156 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l-~hpniv~l~~~~~~~~~  156 (414)
                      .++|.+.+.||+|+||.||+|.+      .+++.||||++......  .....+++.++.++ +||||+++++++..++.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  101 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence            46789999999999999999985      24678999999865432  23446677889999 99999999999999999


Q ss_pred             ceEEEEeCCCCchhhhhhhcCCc---------------ccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceee
Q 015027          157 PLLVYEFASNGTLLDHIRCESSQ---------------VLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILL  221 (414)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll  221 (414)
                      .++||||+++|+|.+++......               ..+++..++.++.||+.||.|||+.+   |+||||||+|||+
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~  178 (313)
T 1t46_A          102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL  178 (313)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence            99999999999999999764421               24689999999999999999999987   9999999999999


Q ss_pred             CCCCcEEEeeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccc
Q 015027          222 NDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKK  300 (414)
Q Consensus       222 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~  300 (414)
                      +.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||........  
T Consensus       179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--  256 (313)
T 1t46_A          179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--  256 (313)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH--
T ss_pred             cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH--
Confidence            9999999999999987765433333344567889999999999999999999999999999999 9999874332110  


Q ss_pred             cccchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHh
Q 015027          301 ISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRL  367 (414)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~  367 (414)
                            ...... .......        +...+..+.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus       257 ------~~~~~~-~~~~~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  308 (313)
T 1t46_A          257 ------FYKMIK-EGFRMLS--------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (313)
T ss_dssp             ------HHHHHH-HTCCCCC--------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------HHHHhc-cCCCCCC--------cccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence                  111111 0111111        111225699999999999999999999999999987654

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2.1e-46  Score=351.56  Aligned_cols=275  Identities=21%  Similarity=0.272  Sum_probs=202.2

Q ss_pred             hcCCCCCCccccCCceEEEEEEE-----cCCcEEEEEEeecccchh-HhHHHHHHHHHccCCCceeeeeeeEec--CCcc
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVL-----HDNIQVAVKTYRRADKIR-ITERELLRIISQVNHKNVVKILGLCLE--TEVP  157 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~-~~~~~~~~~l~~l~hpniv~l~~~~~~--~~~~  157 (414)
                      .++|++.+.||+|+||+||+|.+     .+++.||||++....... ....++++++.+++||||+++++++..  ....
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            36789999999999999999984     258899999997654332 344667899999999999999999865  3568


Q ss_pred             eEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccccc
Q 015027          158 LLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVL  237 (414)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~  237 (414)
                      ++||||+++|+|.+++.....  .+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~  163 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV  163 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHCGG--GCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred             EEEEEeCCCCCHHHHHHhccc--ccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence            999999999999999976433  3588999999999999999999987   99999999999999999999999999987


Q ss_pred             ccCCccc-cceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccc
Q 015027          238 ISSDAET-AMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGL  316 (414)
Q Consensus       238 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (414)
                      ....... .......+|+.|+|||++.+..++.++||||||+++|+|++|..||..............+..  .......
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  241 (295)
T 3ugc_A          164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG--QMIVFHL  241 (295)
T ss_dssp             ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCT--HHHHHHH
T ss_pred             ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCcccc--chhHHHH
Confidence            6543221 122334577789999999999999999999999999999999999864321100000000000  0000000


Q ss_pred             ccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHh
Q 015027          317 RQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRL  367 (414)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~  367 (414)
                      ...+........+...+..+.+|+.+||+.||.+|||+.++++.|+.+.+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~  292 (295)
T 3ugc_A          242 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN  292 (295)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence            000000001111112235699999999999999999999999999998753

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5.7e-46  Score=343.20  Aligned_cols=257  Identities=25%  Similarity=0.375  Sum_probs=210.2

Q ss_pred             hcCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCC
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFAS  165 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  165 (414)
                      .++|.+.+.||+|+||.||+|.+.+++.||+|++...........++++++++++||||+++++++.+.+..++||||++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME   86 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred             hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence            36788899999999999999999888899999998776555666778899999999999999999999999999999999


Q ss_pred             CCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcccc
Q 015027          166 NGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETA  245 (414)
Q Consensus       166 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  245 (414)
                      +++|.+++.....  .+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++....... ..
T Consensus        87 ~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~  160 (267)
T 3t9t_A           87 HGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YT  160 (267)
T ss_dssp             TCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-HH
T ss_pred             CCcHHHHHhhCcc--cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccc-cc
Confidence            9999999965432  3478999999999999999999988   9999999999999999999999999998664321 11


Q ss_pred             ceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhccccccccccccc
Q 015027          246 MSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHV  324 (414)
Q Consensus       246 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (414)
                      ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.......         ....+... .....    
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---------~~~~i~~~-~~~~~----  226 (267)
T 3t9t_A          161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTG-FRLYK----  226 (267)
T ss_dssp             STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---------HHHHHHTT-CCCCC----
T ss_pred             ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH---------HHHHHhcC-CcCCC----
Confidence            2233457788999999998999999999999999999999 899987433111         11111111 00000    


Q ss_pred             CCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHH
Q 015027          325 ADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR  366 (414)
Q Consensus       325 ~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~  366 (414)
                      ..    ..+..+.+|+.+||+.||.+|||+.++++.|+.+..
T Consensus       227 ~~----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          227 PR----LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             CT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             Cc----cCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            11    112558999999999999999999999999999875

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=8.1e-46  Score=352.76  Aligned_cols=251  Identities=24%  Similarity=0.372  Sum_probs=198.2

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc--hhHhHHHHHHHHHccCCCceeeeeeeEecCC-------
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK--IRITERELLRIISQVNHKNVVKILGLCLETE-------  155 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~-------  155 (414)
                      .++|++.+.||+|+||.||+|.+. +++.||||++.....  ......++++++++++||||++++++|.+..       
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            467899999999999999999986 699999999975432  2344567789999999999999999986543       


Q ss_pred             --------------------------------------------------cceEEEEeCCCCchhhhhhhcCCcccCCHH
Q 015027          156 --------------------------------------------------VPLLVYEFASNGTLLDHIRCESSQVLKTWK  185 (414)
Q Consensus       156 --------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~  185 (414)
                                                                        ..++||||+++++|.+++.........++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                              279999999999999999877666666778


Q ss_pred             HHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccc----------cceeccccccc
Q 015027          186 TCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET----------AMSTILIGTSG  255 (414)
Q Consensus       186 ~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~----------~~~~~~~gt~~  255 (414)
                      .++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.........          .......||+.
T Consensus       165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            89999999999999999988   999999999999999999999999999876543211          12234579999


Q ss_pred             ccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccccCCcccHHHHHH
Q 015027          256 YLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEI  335 (414)
Q Consensus       256 y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (414)
                      |+|||++.+..++.++|||||||++|||++|..|+.....           .........         ........++.
T Consensus       242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~-----------~~~~~~~~~---------~~~~~~~~~~~  301 (332)
T 3qd2_B          242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR-----------IITDVRNLK---------FPLLFTQKYPQ  301 (332)
T ss_dssp             GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHH-----------HHHHHHTTC---------CCHHHHHHCHH
T ss_pred             ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHH-----------HHHHhhccC---------CCcccccCChh
Confidence            9999999999999999999999999999999877431100           000000000         01111223356


Q ss_pred             HHHHHHHhhccCCCCCCChhHHHH
Q 015027          336 VAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       336 l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      +.+|+.+||+.||.+|||+.++++
T Consensus       302 ~~~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          302 EHMMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHccCCCCcCCCHHHHhh
Confidence            899999999999999999999864

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=8.9e-46  Score=351.79  Aligned_cols=260  Identities=23%  Similarity=0.320  Sum_probs=190.8

Q ss_pred             hcCCCCCCccccCCceEEEEEEEcC-C---cEEEEEEeeccc---chhHhHHHHHHHHHccCCCceeeeeeeEecCCcc-
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLHD-N---IQVAVKTYRRAD---KIRITERELLRIISQVNHKNVVKILGLCLETEVP-  157 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~---~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~-  157 (414)
                      .++|.+.+.||+|+||.||+|.+.. +   ..||||++....   .......++++++++++||||+++++++...... 
T Consensus        22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  101 (323)
T 3qup_A           22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG  101 (323)
T ss_dssp             ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred             hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence            4689999999999999999999654 3   279999997642   2233446777999999999999999999877655 


Q ss_pred             -----eEEEEeCCCCchhhhhhhcCC---cccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEE
Q 015027          158 -----LLVYEFASNGTLLDHIRCESS---QVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKV  229 (414)
Q Consensus       158 -----~lv~e~~~~gsL~~~l~~~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl  229 (414)
                           ++||||+++|+|.+++.....   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||
T Consensus       102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~kl  178 (323)
T 3qup_A          102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCV  178 (323)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEE
T ss_pred             CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEEE
Confidence                 999999999999999864332   224688999999999999999999988   999999999999999999999


Q ss_pred             eeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhh
Q 015027          230 ADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFL  308 (414)
Q Consensus       230 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~  308 (414)
                      +|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||.......         ..
T Consensus       179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---------~~  249 (323)
T 3qup_A          179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE---------IY  249 (323)
T ss_dssp             CCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---------HH
T ss_pred             eeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH---------HH
Confidence            99999987654433333344567889999999999999999999999999999999 999997543211         11


Q ss_pred             hhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHH
Q 015027          309 NSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR  366 (414)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~  366 (414)
                      ........         ...+...+..+.+|+.+||+.||.+|||+.++++.|+.+..
T Consensus       250 ~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~  298 (323)
T 3qup_A          250 NYLIGGNR---------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG  298 (323)
T ss_dssp             HHHHTTCC---------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHhcCCC---------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            11111100         00011122569999999999999999999999999998875

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2e-45  Score=345.01  Aligned_cols=260  Identities=22%  Similarity=0.329  Sum_probs=200.8

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch----hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI----RITERELLRIISQVNHKNVVKILGLCLETEVPLLV  160 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv  160 (414)
                      .++|++.+.||+|+||.||+|.+. ++..||+|.+......    .....+++.++++++||||+++++++.+++..|+|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            467999999999999999999975 5899999998654322    23346677899999999999999999999999999


Q ss_pred             EEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccC
Q 015027          161 YEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISS  240 (414)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  240 (414)
                      |||+++++|.+++....   .+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus        90 ~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  163 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE  163 (294)
T ss_dssp             EECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred             EeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence            99999999999996543   3588999999999999999999988   99999999999999999999999999987653


Q ss_pred             CccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccc
Q 015027          241 DAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQIL  320 (414)
Q Consensus       241 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (414)
                      .. ........||+.|+|||++.+..++.++||||||+++|+|++|+.||........        ...... ...... 
T Consensus       164 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~--------~~~~~~-~~~~~~-  232 (294)
T 4eqm_A          164 TS-LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI--------AIKHIQ-DSVPNV-  232 (294)
T ss_dssp             ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH--------HHHHHS-SCCCCH-
T ss_pred             cc-ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH--------HHHHhh-ccCCCc-
Confidence            32 1223445799999999999999999999999999999999999999975432110        000000 000000 


Q ss_pred             ccccCCcccHHHHHHHHHHHHHhhccCCCCCC-ChhHHHHHHHHHHH
Q 015027          321 NFHVADESEMKEIEIVAELASKCLRIRGTERP-TMKQVSEELDRLRR  366 (414)
Q Consensus       321 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rp-s~~~v~~~L~~i~~  366 (414)
                      ......    ..+..+.+++.+||+.||.+|| +++++.+.|+.+..
T Consensus       233 ~~~~~~----~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~  275 (294)
T 4eqm_A          233 TTDVRK----DIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH  275 (294)
T ss_dssp             HHHSCT----TSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred             chhccc----CCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence            000111    1125599999999999999998 88999888876543

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=4.8e-46  Score=373.82  Aligned_cols=257  Identities=26%  Similarity=0.382  Sum_probs=210.0

Q ss_pred             hcCCCCCCccccCCceEEEEEEEcC-CcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeC
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLHD-NIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFA  164 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  164 (414)
                      ..+|.+.+.||+|+||.||+|.+.. +..||||.+.........+.+++.++++++||||++++++|...+..++||||+
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~  298 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM  298 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEcc
Confidence            4668888999999999999999875 889999999876655566677889999999999999999999999999999999


Q ss_pred             CCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccc
Q 015027          165 SNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET  244 (414)
Q Consensus       165 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  244 (414)
                      ++|+|.+++..... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++....... 
T Consensus       299 ~~g~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-  373 (495)
T 1opk_A          299 TYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY-  373 (495)
T ss_dssp             TTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE-
T ss_pred             CCCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCce-
Confidence            99999999975433 34588999999999999999999988   99999999999999999999999999987654321 


Q ss_pred             cceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhcccccccccccc
Q 015027          245 AMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFH  323 (414)
Q Consensus       245 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (414)
                      .......+++.|+|||++.+..++.++|||||||++|||++ |..||.......         ....+... .       
T Consensus       374 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~---------~~~~~~~~-~-------  436 (495)
T 1opk_A          374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---------VYELLEKD-Y-------  436 (495)
T ss_dssp             ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---------HHHHHHTT-C-------
T ss_pred             eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH---------HHHHHHcC-C-------
Confidence            12223456778999999999999999999999999999999 999997543211         11111111 0       


Q ss_pred             cCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHH
Q 015027          324 VADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLR  365 (414)
Q Consensus       324 ~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~  365 (414)
                       ....+...+..+.+|+.+||+.||.+|||+.+|++.|+.+.
T Consensus       437 -~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          437 -RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  477 (495)
T ss_dssp             -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             -CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence             00111112356899999999999999999999999998764

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.2e-45  Score=344.88  Aligned_cols=261  Identities=26%  Similarity=0.378  Sum_probs=213.5

Q ss_pred             HhcCCCCCCccccCCceEEEEEEEcC-CcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEe
Q 015027           85 ATKNFDRSRCLSQGGFVSVYKGVLHD-NIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        85 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  163 (414)
                      ..++|.+.+.||+|+||.||+|.+.. +..||+|.+............++.++++++||||+++++++.+++..++||||
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   90 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   90 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEc
Confidence            35778999999999999999999764 88999999987666556667778999999999999999999999999999999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcc
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE  243 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  243 (414)
                      +++++|.+++..... ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++........
T Consensus        91 ~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  166 (288)
T 3kfa_A           91 MTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  166 (288)
T ss_dssp             CTTEEHHHHHHHCCT-TTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS
T ss_pred             CCCCcHHHHHHhccc-CCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCcc
Confidence            999999999976443 34588999999999999999999988   99999999999999999999999999987654322


Q ss_pred             ccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhccccccccccc
Q 015027          244 TAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNF  322 (414)
Q Consensus       244 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (414)
                       .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.......         ........ .      
T Consensus       167 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~---------~~~~~~~~-~------  229 (288)
T 3kfa_A          167 -TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---------VYELLEKD-Y------  229 (288)
T ss_dssp             -EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---------HHHHHHTT-C------
T ss_pred             -ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---------HHHHHhcc-C------
Confidence             22334467889999999999999999999999999999999 999987433211         11111110 0      


Q ss_pred             ccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHhh
Q 015027          323 HVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLH  368 (414)
Q Consensus       323 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~~  368 (414)
                        ....+...+..+.+|+.+||+.||.+|||+.++++.|+.+....
T Consensus       230 --~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~  273 (288)
T 3kfa_A          230 --RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES  273 (288)
T ss_dssp             --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             --CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence              00111112256999999999999999999999999999887643

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=9.1e-46  Score=357.38  Aligned_cols=253  Identities=21%  Similarity=0.240  Sum_probs=192.8

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeC
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFA  164 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  164 (414)
                      .++|.+.+.||+|+||+||++... +++.||||++...........+++.+++.++||||+++++++.+.+..++||||+
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   98 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA   98 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence            468999999999999999999976 6899999999876665566677789999999999999999999999999999999


Q ss_pred             CCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCc--EEEeeccccccccCCc
Q 015027          165 SNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYT--AKVADFESSVLISSDA  242 (414)
Q Consensus       165 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~--~kl~DfGla~~~~~~~  242 (414)
                      ++|+|.+++....   .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.  +||+|||+++..... 
T Consensus        99 ~~~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~-  171 (361)
T 3uc3_A           99 SGGELYERICNAG---RFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-  171 (361)
T ss_dssp             CSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred             CCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc-
Confidence            9999999986543   3588999999999999999999988   999999999999987765  999999998754322 


Q ss_pred             cccceecccccccccchhhcccCCCCCc-ccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccc
Q 015027          243 ETAMSTILIGTSGYLDPVCINTGKLTKK-SDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILN  321 (414)
Q Consensus       243 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (414)
                        .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||........     ..........        
T Consensus       172 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-----~~~~~~~~~~--------  236 (361)
T 3uc3_A          172 --SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD-----YRKTIQRILS--------  236 (361)
T ss_dssp             -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC-----HHHHHHHHHT--------
T ss_pred             --CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH-----HHHHHHHHhc--------
Confidence              22334579999999999988887665 8999999999999999999974332111     0000000000        


Q ss_pred             cccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHH
Q 015027          322 FHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEE  360 (414)
Q Consensus       322 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~  360 (414)
                      .....+.....+..+.+|+.+||+.||.+|||+.++++.
T Consensus       237 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          237 VKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             TCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             CCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence            000001111112568999999999999999999999654

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.7e-45  Score=340.84  Aligned_cols=253  Identities=27%  Similarity=0.376  Sum_probs=191.5

Q ss_pred             hcCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccch-----hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKI-----RITERELLRIISQVNHKNVVKILGLCLETEVPLLV  160 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv  160 (414)
                      .++|.+.+.||+|+||.||+|.+ .+..||||++......     .....+++.+++.++||||+++++++..++..++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            36788999999999999999997 4889999998754322     23446677899999999999999999999999999


Q ss_pred             EEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCC--------CCcEEEeec
Q 015027          161 YEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLND--------NYTAKVADF  232 (414)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~--------~~~~kl~Df  232 (414)
                      |||+++++|.+++..    ..+++..++.++.|++.||.|||+.+..+|+||||||+|||++.        ++.+||+||
T Consensus        85 ~e~~~~~~L~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           85 MEFARGGPLNRVLSG----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             EECCTTEEHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EEcCCCCCHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            999999999999842    34588999999999999999999977445899999999999986        788999999


Q ss_pred             cccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhc
Q 015027          233 ESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIK  312 (414)
Q Consensus       233 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  312 (414)
                      |++.......    .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.......         ......
T Consensus       161 g~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---------~~~~~~  227 (271)
T 3dtc_A          161 GLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA---------VAYGVA  227 (271)
T ss_dssp             CC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH---------HHHHHH
T ss_pred             Cccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---------HHHhhh
Confidence            9998654322    224578999999999999999999999999999999999999997433211         000011


Q ss_pred             ccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHH
Q 015027          313 NNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL  364 (414)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i  364 (414)
                      ......        ..+...+..+.+|+.+||+.||.+|||+.++++.|+.+
T Consensus       228 ~~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          228 MNKLAL--------PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             TSCCCC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             cCCCCC--------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            111110        01111225599999999999999999999999998753

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2.6e-45  Score=364.42  Aligned_cols=252  Identities=24%  Similarity=0.402  Sum_probs=203.9

Q ss_pred             hcCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecCC-cceEEEEeC
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETE-VPLLVYEFA  164 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~-~~~lv~e~~  164 (414)
                      .++|.+.+.||+|+||.||+|.+ .++.||||+++... ....+.++++++++++||||+++++++...+ ..++||||+
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~  269 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM  269 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred             hHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence            46788899999999999999988 47899999998654 3445567789999999999999999987665 789999999


Q ss_pred             CCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccc
Q 015027          165 SNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET  244 (414)
Q Consensus       165 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  244 (414)
                      ++|+|.+++..... ..+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....   
T Consensus       270 ~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---  342 (450)
T 1k9a_A          270 AKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---  342 (450)
T ss_dssp             TTCBHHHHHHHHCT-TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             CCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc---
Confidence            99999999976543 23578899999999999999999988   999999999999999999999999999854322   


Q ss_pred             cceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhcccccccccccc
Q 015027          245 AMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFH  323 (414)
Q Consensus       245 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (414)
                        .....+++.|+|||++.+..++.++|||||||++|||++ |+.||.......         ....+... ...     
T Consensus       343 --~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---------~~~~i~~~-~~~-----  405 (450)
T 1k9a_A          343 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---------VVPRVEKG-YKM-----  405 (450)
T ss_dssp             ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---------HHHHHHTT-CCC-----
T ss_pred             --ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---------HHHHHHcC-CCC-----
Confidence              122357889999999999999999999999999999998 999997543221         11111111 000     


Q ss_pred             cCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHH
Q 015027          324 VADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR  366 (414)
Q Consensus       324 ~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~  366 (414)
                         ..+...+..+.+|+.+||+.||.+|||+.++++.|+.+..
T Consensus       406 ---~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~  445 (450)
T 1k9a_A          406 ---DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT  445 (450)
T ss_dssp             ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence               1111123569999999999999999999999999998874

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.6e-45  Score=347.04  Aligned_cols=263  Identities=18%  Similarity=0.187  Sum_probs=195.4

Q ss_pred             hcCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccch---hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKI---RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYE  162 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  162 (414)
                      .++|++.+.||+|+||+||+|.+.+++.||+|++......   .....++++++++++||||+++++++.++...++|||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   99 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE   99 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence            4789999999999999999999988999999999754322   2344667899999999999999999999999999999


Q ss_pred             eCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCc
Q 015027          163 FASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDA  242 (414)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  242 (414)
                      |+++ +|.+++....  ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.......
T Consensus       100 ~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  173 (311)
T 3niz_A          100 FMEK-DLKKVLDENK--TGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV  173 (311)
T ss_dssp             CCSE-EHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred             CCCC-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence            9985 7877775543  23588999999999999999999988   9999999999999999999999999998765332


Q ss_pred             cccceecccccccccchhhccc-CCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccch-------hhhhh----
Q 015027          243 ETAMSTILIGTSGYLDPVCINT-GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVP-------YFLNS----  310 (414)
Q Consensus       243 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~-------~~~~~----  310 (414)
                        .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........... +..       .....    
T Consensus       174 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~-i~~~~~~~~~~~~~~~~~~  250 (311)
T 3niz_A          174 --RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPK-IFSILGTPNPREWPQVQEL  250 (311)
T ss_dssp             --C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHH-HHHHHCCCCTTTSGGGTTS
T ss_pred             --ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHH-HHHHHCCCChHHhhhhhcc
Confidence              22334578999999999876 5689999999999999999999999975432211000 000       00000    


Q ss_pred             --hcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHH
Q 015027          311 --IKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVS  358 (414)
Q Consensus       311 --~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~  358 (414)
                        +...... ..............+.++.+|+.+||+.||.+|||+.+++
T Consensus       251 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell  299 (311)
T 3niz_A          251 PLWKQRTFQ-VFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAM  299 (311)
T ss_dssp             HHHHSCCCC-CCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred             chhhhcccc-cccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHh
Confidence              0000000 0000000000001125689999999999999999999985

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.8e-45  Score=353.89  Aligned_cols=242  Identities=24%  Similarity=0.253  Sum_probs=191.2

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc----hhHhHHHHHHHHHcc-CCCceeeeeeeEecCCcceE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK----IRITERELLRIISQV-NHKNVVKILGLCLETEVPLL  159 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~~~l~~l-~hpniv~l~~~~~~~~~~~l  159 (414)
                      .++|++.+.||+|+||.||+|... +++.||||++.....    .......+.+++..+ +||||+++++++.+.+..|+
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            478999999999999999999976 589999999986422    122234556777777 79999999999999999999


Q ss_pred             EEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccccccc
Q 015027          160 VYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLIS  239 (414)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~  239 (414)
                      ||||+++|+|.+++....   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       102 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~  175 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQKSR---RFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI  175 (353)
T ss_dssp             EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecc
Confidence            999999999999996543   3588999999999999999999988   9999999999999999999999999997543


Q ss_pred             CCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccc
Q 015027          240 SDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQI  319 (414)
Q Consensus       240 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (414)
                      ..  .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.......         ....+.....   
T Consensus       176 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---------~~~~i~~~~~---  241 (353)
T 3txo_A          176 CN--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD---------LFEAILNDEV---  241 (353)
T ss_dssp             C-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---------HHHHHHHCCC---
T ss_pred             cC--CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH---------HHHHHHcCCC---
Confidence            22  223345689999999999999999999999999999999999999997443211         1111111110   


Q ss_pred             cccccCCcccHHHHHHHHHHHHHhhccCCCCCCCh
Q 015027          320 LNFHVADESEMKEIEIVAELASKCLRIRGTERPTM  354 (414)
Q Consensus       320 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~  354 (414)
                         ..+.    ..+..+.+|+.+||+.||.+||++
T Consensus       242 ---~~p~----~~~~~~~~li~~lL~~dP~~R~~~  269 (353)
T 3txo_A          242 ---VYPT----WLHEDATGILKSFMTKNPTMRLGS  269 (353)
T ss_dssp             ---CCCT----TSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred             ---CCCC----CCCHHHHHHHHHHhhhCHHHccCC
Confidence               0011    122558999999999999999998

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2.8e-45  Score=358.84  Aligned_cols=254  Identities=21%  Similarity=0.263  Sum_probs=200.6

Q ss_pred             HHHhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc----hhHhHHHHHHHHHccCCCceeeeeeeEecCCcc
Q 015027           83 IRATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK----IRITERELLRIISQVNHKNVVKILGLCLETEVP  157 (414)
Q Consensus        83 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~  157 (414)
                      ....++|.+.+.||+|+||.||+|... +++.||+|++.....    ......++..++..++||||++++++|.+++..
T Consensus        65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~  144 (410)
T 3v8s_A           65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL  144 (410)
T ss_dssp             SCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence            344678999999999999999999976 588999999976322    222345677899999999999999999999999


Q ss_pred             eEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccccc
Q 015027          158 LLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVL  237 (414)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~  237 (414)
                      |+||||++||+|.+++...    .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus       145 ~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~~  217 (410)
T 3v8s_A          145 YMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMK  217 (410)
T ss_dssp             EEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeEe
Confidence            9999999999999998643    3578899999999999999999988   99999999999999999999999999987


Q ss_pred             ccCCccccceecccccccccchhhcccCC----CCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcc
Q 015027          238 ISSDAETAMSTILIGTSGYLDPVCINTGK----LTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKN  313 (414)
Q Consensus       238 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  313 (414)
                      ..... .......+||+.|+|||++.+..    ++.++|||||||++|||++|+.||...+...         ....+..
T Consensus       218 ~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---------~~~~i~~  287 (410)
T 3v8s_A          218 MNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG---------TYSKIMN  287 (410)
T ss_dssp             CCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH---------HHHHHHT
T ss_pred             eccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh---------HHHHHHh
Confidence            65432 12234568999999999998765    8899999999999999999999997433211         0111110


Q ss_pred             cccccccccccCCcccHHHHHHHHHHHHHhhccCCCC--CCChhHHHH
Q 015027          314 NGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTE--RPTMKQVSE  359 (414)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~--Rps~~~v~~  359 (414)
                      ......+.      .....+..+.+|+.+||..+|.+  ||++++|++
T Consensus       288 ~~~~~~~p------~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~  329 (410)
T 3v8s_A          288 HKNSLTFP------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR  329 (410)
T ss_dssp             HHHHCCCC------TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred             ccccccCC------CcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence            00000000      00011256899999999999988  999999854

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=2e-45  Score=349.98  Aligned_cols=259  Identities=26%  Similarity=0.378  Sum_probs=201.1

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcE----EEEEEeecccc--hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQ----VAVKTYRRADK--IRITERELLRIISQVNHKNVVKILGLCLETEVPLL  159 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~~~--~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~l  159 (414)
                      ++|++.+.||+|+||.||+|.+. ++..    ||+|.+.....  ....+.+++.+++.++||||+++++++. ++..++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            57889999999999999999965 3544    78887754322  1233355678899999999999999986 556899


Q ss_pred             EEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccccccc
Q 015027          160 VYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLIS  239 (414)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~  239 (414)
                      ||||+++|+|.+++....  ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus        92 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQHR--GALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             EEECCTTCBSHHHHHSSG--GGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             EEEeCCCCCHHHHHHHcc--ccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccC
Confidence            999999999999996543  24577889999999999999999988   9999999999999999999999999998876


Q ss_pred             CCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhccccccc
Q 015027          240 SDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQ  318 (414)
Q Consensus       240 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (414)
                      ............+|+.|+|||++.+..++.++|||||||++|+|++ |..||.......         ......... ..
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---------~~~~~~~~~-~~  236 (325)
T 3kex_A          167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE---------VPDLLEKGE-RL  236 (325)
T ss_dssp             CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH---------HHHHHHTTC-BC
T ss_pred             cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH---------HHHHHHcCC-CC
Confidence            5544444455678889999999999999999999999999999999 999997543211         111111110 00


Q ss_pred             ccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHhhh
Q 015027          319 ILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLHE  369 (414)
Q Consensus       319 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~~~  369 (414)
                      .......        ..+.+|+.+||+.||.+|||+.++++.|+.+.+...
T Consensus       237 ~~~~~~~--------~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~~  279 (325)
T 3kex_A          237 AQPQICT--------IDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPP  279 (325)
T ss_dssp             CCCTTBC--------TTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSHH
T ss_pred             CCCCcCc--------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence            1111111        237899999999999999999999999998865443

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.7e-45  Score=343.70  Aligned_cols=248  Identities=20%  Similarity=0.295  Sum_probs=192.8

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch---------------------------hHhHHHHHHHHH
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI---------------------------RITERELLRIIS  137 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---------------------------~~~~~~~~~~l~  137 (414)
                      .++|.+.+.||+|+||.||+|.+. +++.||||++......                           .....+++++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            367999999999999999999975 5889999999754321                           123466779999


Q ss_pred             ccCCCceeeeeeeEec--CCcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCC
Q 015027          138 QVNHKNVVKILGLCLE--TEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVK  215 (414)
Q Consensus       138 ~l~hpniv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlk  215 (414)
                      +++||||+++++++.+  ....++||||+++++|.+++.    ...+++..++.++.||+.||.|||+.+   |+|||||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk  164 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT----LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK  164 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence            9999999999999986  567899999999999988763    234688999999999999999999988   9999999


Q ss_pred             CCceeeCCCCcEEEeeccccccccCCccccceecccccccccchhhcccCC---CCCcccchhHHHHHHHHHhCCCCCCc
Q 015027          216 SANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGK---LTKKSDVYSFGVVLAELLTGKKPGSC  292 (414)
Q Consensus       216 p~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~SlGvil~el~tg~~p~~~  292 (414)
                      |+|||++.++.+||+|||++.......  .......||+.|+|||++.+..   ++.++|||||||++|+|++|+.||..
T Consensus       165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  242 (298)
T 2zv2_A          165 PSNLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD  242 (298)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             HHHEEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            999999999999999999998765432  2234457999999999997765   47889999999999999999999974


Q ss_pred             cccccccccccchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          293 MTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      .....         ............        ......+..+.+|+.+||+.||.+|||+.++++
T Consensus       243 ~~~~~---------~~~~~~~~~~~~--------~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          243 ERIMC---------LHSKIKSQALEF--------PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             SSHHH---------HHHHHHHCCCCC--------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ccHHH---------HHHHHhcccCCC--------CCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            32110         111111111000        000111255899999999999999999999853

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=8.1e-45  Score=359.32  Aligned_cols=252  Identities=20%  Similarity=0.262  Sum_probs=200.6

Q ss_pred             HhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch---hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEE
Q 015027           85 ATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI---RITERELLRIISQVNHKNVVKILGLCLETEVPLLV  160 (414)
Q Consensus        85 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv  160 (414)
                      ..++|.+.+.||+|+||.||+|... +|+.+|+|++......   .....+++++++.++||||+++++++.+++..|+|
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            4577999999999999999999975 6899999999765432   23346677999999999999999999999999999


Q ss_pred             EEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeC---CCCcEEEeecccccc
Q 015027          161 YEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLN---DNYTAKVADFESSVL  237 (414)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~---~~~~~kl~DfGla~~  237 (414)
                      |||+++|+|.+.+....   .+++..+..++.||+.||.|||+.+   |+||||||+|||++   .++.+||+|||++..
T Consensus        89 ~E~~~gg~L~~~i~~~~---~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~  162 (444)
T 3soa_A           89 FDLVTGGELFEDIVARE---YYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE  162 (444)
T ss_dssp             ECCCBCCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred             EEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence            99999999999986543   3588999999999999999999988   99999999999998   568899999999987


Q ss_pred             ccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccc
Q 015027          238 ISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLR  317 (414)
Q Consensus       238 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (414)
                      .....  .......||+.|+|||++.+..++.++|||||||++|+|++|..||.......         ....+......
T Consensus       163 ~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~---------~~~~i~~~~~~  231 (444)
T 3soa_A          163 VEGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR---------LYQQIKAGAYD  231 (444)
T ss_dssp             CCTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---------HHHHHHHTCCC
T ss_pred             ecCCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH---------HHHHHHhCCCC
Confidence            65432  22334689999999999999999999999999999999999999996433111         11111111110


Q ss_pred             cccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          318 QILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                       .     ........++.+.+|+.+||+.||.+|||+.++++
T Consensus       232 -~-----~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          232 -F-----PSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             -C-----CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             -C-----CccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence             0     00001112356899999999999999999999976

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=9.9e-45  Score=347.84  Aligned_cols=250  Identities=20%  Similarity=0.263  Sum_probs=194.6

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchh----HhHHHHHHHHHcc-CCCceeeeeeeEecCCcceEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIR----ITERELLRIISQV-NHKNVVKILGLCLETEVPLLV  160 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l-~hpniv~l~~~~~~~~~~~lv  160 (414)
                      ++|.+.+.||+|+||.||+|... +++.||+|++.......    .....+..++.++ +||||+++++++.+.+..|+|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            67899999999999999999976 58899999998653221    2234556777776 899999999999999999999


Q ss_pred             EEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccC
Q 015027          161 YEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISS  240 (414)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  240 (414)
                      |||+++|+|.+++....   .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        89 ~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~  162 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  162 (345)
T ss_dssp             ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred             EeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence            99999999999996543   3588999999999999999999988   99999999999999999999999999976432


Q ss_pred             CccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccc
Q 015027          241 DAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQIL  320 (414)
Q Consensus       241 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (414)
                      ..  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||....................+.....    
T Consensus       163 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~----  236 (345)
T 3a8x_A          163 PG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI----  236 (345)
T ss_dssp             TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC----
T ss_pred             CC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC----
Confidence            21  223456899999999999999999999999999999999999999964322111110111111111111110    


Q ss_pred             ccccCCcccHHHHHHHHHHHHHhhccCCCCCCCh
Q 015027          321 NFHVADESEMKEIEIVAELASKCLRIRGTERPTM  354 (414)
Q Consensus       321 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~  354 (414)
                        .++.    ..+..+.+|+.+||+.||.+||++
T Consensus       237 --~~p~----~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          237 --RIPR----SLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             --CCCT----TSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             --CCCC----CCCHHHHHHHHHHhcCCHhHCCCC
Confidence              0111    122558999999999999999996

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.9e-45  Score=346.01  Aligned_cols=250  Identities=23%  Similarity=0.294  Sum_probs=200.4

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc-------hhHhHHHHHHHHHccCCCceeeeeeeEecCCcc
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK-------IRITERELLRIISQVNHKNVVKILGLCLETEVP  157 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~  157 (414)
                      .++|.+.+.||+|+||.||+|... +++.||+|++.....       ......+++.+++.++||||+++++++.+....
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            356899999999999999999976 589999999976432       123456778999999999999999999999999


Q ss_pred             eEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCC----cEEEeecc
Q 015027          158 LLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNY----TAKVADFE  233 (414)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~----~~kl~DfG  233 (414)
                      ++||||+++++|.+++...   ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++    .+||+|||
T Consensus        90 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  163 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG  163 (326)
T ss_dssp             EEEEECCCSCBHHHHHTTS---SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEcCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence            9999999999999999643   34588999999999999999999988   99999999999999887    89999999


Q ss_pred             ccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcc
Q 015027          234 SSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKN  313 (414)
Q Consensus       234 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  313 (414)
                      ++.......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......         ....+..
T Consensus       164 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---------~~~~~~~  231 (326)
T 2y0a_A          164 LAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---------TLANVSA  231 (326)
T ss_dssp             TCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---------HHHHHHH
T ss_pred             CCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH---------HHHHHHh
Confidence            998765332   2234579999999999999999999999999999999999999996432111         1111100


Q ss_pred             cccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          314 NGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ...      ..........+..+.+|+.+||+.||.+|||+.++++
T Consensus       232 ~~~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          232 VNY------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             TCC------CCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             cCC------CcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            000      0000000011255899999999999999999999975

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.4e-45  Score=341.51  Aligned_cols=258  Identities=26%  Similarity=0.402  Sum_probs=208.1

Q ss_pred             hcCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCC
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFAS  165 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  165 (414)
                      .++|.+.+.||+|+||.||+|...++..||||.+............++++++.++||||+++++++. .+..++||||++
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   90 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYME   90 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred             HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCC
Confidence            4678899999999999999999888889999999876655556677789999999999999999986 456899999999


Q ss_pred             CCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcccc
Q 015027          166 NGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETA  245 (414)
Q Consensus       166 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  245 (414)
                      +++|.+++..... ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++........ .
T Consensus        91 ~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~  165 (279)
T 1qpc_A           91 NGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-T  165 (279)
T ss_dssp             TCBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-E
T ss_pred             CCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCccc-c
Confidence            9999999964321 24588999999999999999999988   99999999999999999999999999987654321 1


Q ss_pred             ceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhccccccccccccc
Q 015027          246 MSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHV  324 (414)
Q Consensus       246 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (414)
                      ......+++.|+|||++.+..++.++||||||+++|+|++ |+.||.......         ........ ....    .
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---------~~~~~~~~-~~~~----~  231 (279)
T 1qpc_A          166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---------VIQNLERG-YRMV----R  231 (279)
T ss_dssp             CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---------HHHHHHTT-CCCC----C
T ss_pred             cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH---------HHHHHhcc-cCCC----C
Confidence            2233456788999999998899999999999999999999 999987433211         11111111 0000    0


Q ss_pred             CCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHh
Q 015027          325 ADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRL  367 (414)
Q Consensus       325 ~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~  367 (414)
                      .    ...+..+.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus       232 ~----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  270 (279)
T 1qpc_A          232 P----DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (279)
T ss_dssp             C----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             c----ccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence            1    11225699999999999999999999999999988654

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=2.8e-45  Score=350.27  Aligned_cols=261  Identities=24%  Similarity=0.370  Sum_probs=207.4

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc--------CCcEEEEEEeecccch--hHhHHHHHHHHHcc-CCCceeeeeeeEecC
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH--------DNIQVAVKTYRRADKI--RITERELLRIISQV-NHKNVVKILGLCLET  154 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l-~hpniv~l~~~~~~~  154 (414)
                      .++|.+.+.||+|+||.||+|.+.        ++..||||++......  .....++++++.++ +||||+++++++...
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            468899999999999999999863        4678999999765432  23345667888888 899999999999999


Q ss_pred             CcceEEEEeCCCCchhhhhhhcCC-------------cccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceee
Q 015027          155 EVPLLVYEFASNGTLLDHIRCESS-------------QVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILL  221 (414)
Q Consensus       155 ~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll  221 (414)
                      +..++||||+++|+|.+++.....             ...+++..++.++.||+.||.|||+.+   |+||||||+|||+
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll  190 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV  190 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence            999999999999999999975432             123688999999999999999999988   9999999999999


Q ss_pred             CCCCcEEEeeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccc
Q 015027          222 NDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKK  300 (414)
Q Consensus       222 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~  300 (414)
                      +.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||.......   
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---  267 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---  267 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---
T ss_pred             cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH---
Confidence            9999999999999987654433233344567889999999999999999999999999999999 999987433111   


Q ss_pred             cccchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHh
Q 015027          301 ISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRL  367 (414)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~  367 (414)
                            ..........     .....    ..+..+.+|+.+||+.+|.+|||+.++++.|+.+...
T Consensus       268 ------~~~~~~~~~~-----~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~  319 (334)
T 2pvf_A          268 ------LFKLLKEGHR-----MDKPA----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL  319 (334)
T ss_dssp             ------HHHHHHHTCC-----CCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------HHHHHhcCCC-----CCCCc----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence                  1111111110     00111    1225589999999999999999999999999998764

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.4e-45  Score=351.40  Aligned_cols=263  Identities=23%  Similarity=0.359  Sum_probs=199.1

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcE----EEEEEeeccc--chhHhHHHHHHHHHccCCCceeeeeeeEecCCcce
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQ----VAVKTYRRAD--KIRITERELLRIISQVNHKNVVKILGLCLETEVPL  158 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~~--~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~  158 (414)
                      .++|++.+.||+|+||.||+|.+. +++.    ||+|.+....  .......+++.++++++||||+++++++..+. .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            367999999999999999999965 4544    5777765432  23344567789999999999999999998764 78


Q ss_pred             EEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccc
Q 015027          159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLI  238 (414)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~  238 (414)
                      +|++|+++|+|.+++.....  .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus        93 ~v~~~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~  167 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEECCCSSCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred             EEEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence            99999999999999976443  3578999999999999999999988   999999999999999999999999999877


Q ss_pred             cCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhcccccc
Q 015027          239 SSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLR  317 (414)
Q Consensus       239 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (414)
                      .............+|+.|+|||++.+..++.++|||||||++|+|++ |..||.......         .........  
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---------~~~~~~~~~--  236 (327)
T 3lzb_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---------ISSILEKGE--  236 (327)
T ss_dssp             ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---------HHHHHHTTC--
T ss_pred             cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---------HHHHHHcCC--
Confidence            55433333444567889999999999999999999999999999999 999997543211         111111110  


Q ss_pred             cccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHhhhhhh
Q 015027          318 QILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLHENFW  372 (414)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~~~~~~  372 (414)
                             ....+...+..+.+|+.+||+.||.+|||+.++++.|+.+......+.
T Consensus       237 -------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~  284 (327)
T 3lzb_A          237 -------RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYL  284 (327)
T ss_dssp             -------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSHHHHB
T ss_pred             -------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCcCceE
Confidence                   000111122458999999999999999999999999999987654443

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.1e-45  Score=353.07  Aligned_cols=276  Identities=21%  Similarity=0.314  Sum_probs=198.7

Q ss_pred             hcCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEec-----CCcceEE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLE-----TEVPLLV  160 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~-----~~~~~lv  160 (414)
                      .++|.+.+.||+|+||.||+|.. +++.||||++............++..+..++||||+++++++..     ...+++|
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv   90 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLV   90 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEE
Confidence            36789999999999999999977 78999999997654433333333344556899999999986542     2356899


Q ss_pred             EEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCC------CCCeeeCCCCCCceeeCCCCcEEEeeccc
Q 015027          161 YEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLA------SPPIIHGDVKSANILLNDNYTAKVADFES  234 (414)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~------~~~iiH~Dlkp~NIll~~~~~~kl~DfGl  234 (414)
                      |||+++|+|.+++.....    ++..++.++.||+.||.|||+..      .++|+||||||+|||++.++.+||+|||+
T Consensus        91 ~e~~~~g~L~~~l~~~~~----~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~  166 (336)
T 3g2f_A           91 MEYYPNGSLXKYLSLHTS----DWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGL  166 (336)
T ss_dssp             ECCCTTCBHHHHHHHCCB----CHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTT
T ss_pred             EecCCCCcHHHHHhhccc----chhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccc
Confidence            999999999999964332    78889999999999999999970      01399999999999999999999999999


Q ss_pred             cccccCCcc------ccceecccccccccchhhccc-------CCCCCcccchhHHHHHHHHHhCCCCCCcccccccccc
Q 015027          235 SVLISSDAE------TAMSTILIGTSGYLDPVCINT-------GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKI  301 (414)
Q Consensus       235 a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~  301 (414)
                      +........      ........||+.|+|||++.+       ..++.++|||||||++|||++|..||...........
T Consensus       167 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~  246 (336)
T 3g2f_A          167 SMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQM  246 (336)
T ss_dssp             CEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCC
T ss_pred             eeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHH
Confidence            987653211      122234579999999999987       4677899999999999999999777542221111110


Q ss_pred             ccch---------hhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHhh
Q 015027          302 SMVP---------YFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLH  368 (414)
Q Consensus       302 ~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~~  368 (414)
                      ....         ..............+....  ......+..+.+|+.+||+.||++|||+.++++.|+.+...+
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~  320 (336)
T 3g2f_A          247 AFQTEVGNHPTFEDMQVLVSREKQRPKFPEAW--KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIW  320 (336)
T ss_dssp             TTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTC--CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCC
T ss_pred             hhhcccCCCchHHHHHhhhcccccCCCCCccc--ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHH
Confidence            0000         0000001111111111111  112234567999999999999999999999999999987543

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.9e-45  Score=346.61  Aligned_cols=275  Identities=21%  Similarity=0.298  Sum_probs=198.8

Q ss_pred             HhcCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecC----CcceEE
Q 015027           85 ATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLET----EVPLLV  160 (414)
Q Consensus        85 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~----~~~~lv  160 (414)
                      ..++|++.+.||+|+||.||+|... ++.||||++............++.....++||||+++++++...    ...++|
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv  113 (337)
T 3mdy_A           35 IAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLI  113 (337)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEE
T ss_pred             cccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEE
Confidence            4578999999999999999999884 89999999976543322222222233335899999999999877    678999


Q ss_pred             EEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCC-----CCCeeeCCCCCCceeeCCCCcEEEeecccc
Q 015027          161 YEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLA-----SPPIIHGDVKSANILLNDNYTAKVADFESS  235 (414)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-----~~~iiH~Dlkp~NIll~~~~~~kl~DfGla  235 (414)
                      |||+++|+|.+++...    .+++..++.++.|++.||.|||+.+     .++|+||||||+|||++.++.+||+|||++
T Consensus       114 ~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a  189 (337)
T 3mdy_A          114 TDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  189 (337)
T ss_dssp             ECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCc
Confidence            9999999999999543    3588999999999999999999871     113999999999999999999999999999


Q ss_pred             ccccCCcccc--ceecccccccccchhhcccCCCCCc------ccchhHHHHHHHHHhCCCCCCccccccccccc-----
Q 015027          236 VLISSDAETA--MSTILIGTSGYLDPVCINTGKLTKK------SDVYSFGVVLAELLTGKKPGSCMTLASNKKIS-----  302 (414)
Q Consensus       236 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~-----  302 (414)
                      ..........  ......||+.|+|||++.+..++..      +|||||||++|||++|..|+............     
T Consensus       190 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~  269 (337)
T 3mdy_A          190 VKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSD  269 (337)
T ss_dssp             EECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             eeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCC
Confidence            7664432211  1224579999999999988777665      99999999999999994443221111100000     


Q ss_pred             -cchhhhhhhcccccccccccccCCc-ccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHhh
Q 015027          303 -MVPYFLNSIKNNGLRQILNFHVADE-SEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLH  368 (414)
Q Consensus       303 -~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~~  368 (414)
                       ..............    .+..... .....+..+.+|+.+||+.||.+|||+.+|++.|+.+.+..
T Consensus       270 ~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  333 (337)
T 3mdy_A          270 PSYEDMREIVCIKKL----RPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ  333 (337)
T ss_dssp             CCHHHHHHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             CchhhhHHHHhhhcc----CccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence             00000001111111    1111111 12245677999999999999999999999999999988653

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=7.3e-45  Score=349.78  Aligned_cols=253  Identities=21%  Similarity=0.259  Sum_probs=200.2

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc------hhHhHHHHHHHHHccCCCceeeeeeeEecCCcce
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK------IRITERELLRIISQVNHKNVVKILGLCLETEVPL  158 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~  158 (414)
                      .++|++.+.||+|+||.||+|... +++.||||++.....      ......+++.+++.++||||+++++++.+++..|
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            457999999999999999999975 589999999975321      2334567789999999999999999999999999


Q ss_pred             EEEEeCCCCchhhhhhhcC-CcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCc---EEEeeccc
Q 015027          159 LVYEFASNGTLLDHIRCES-SQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYT---AKVADFES  234 (414)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~---~kl~DfGl  234 (414)
                      +||||+++++|.+++.... ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            9999999999988875432 2334688999999999999999999988   999999999999986554   99999999


Q ss_pred             cccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccc
Q 015027          235 SVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNN  314 (414)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  314 (414)
                      +.......  .......||+.|+|||++.+..++.++|||||||++|+|++|..||.....          .....+...
T Consensus       180 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----------~~~~~i~~~  247 (351)
T 3c0i_A          180 AIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----------RLFEGIIKG  247 (351)
T ss_dssp             CEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----------HHHHHHHHT
T ss_pred             eeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----------HHHHHHHcC
Confidence            98765432  223445799999999999999999999999999999999999999974321          011111111


Q ss_pred             ccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          315 GLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ...  ..+.    .....+..+.+|+.+||+.||.+|||+.++++
T Consensus       248 ~~~--~~~~----~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          248 KYK--MNPR----QWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             CCC--CCHH----HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCC--CCcc----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            100  0000    00011256899999999999999999999975

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=2.7e-45  Score=341.64  Aligned_cols=257  Identities=22%  Similarity=0.342  Sum_probs=193.1

Q ss_pred             hcCCCCCCccccCCceEEEEEEEcC----CcEEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEecCCcceE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLHD----NIQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLETEVPLL  159 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~l  159 (414)
                      .++|++.+.||+|+||.||+|.+..    +..||+|.+......  .....+++.++++++||||+++++++. ++..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l   92 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   92 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence            4678899999999999999999643    456999998754322  234466778999999999999999984 567899


Q ss_pred             EEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccccccc
Q 015027          160 VYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLIS  239 (414)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~  239 (414)
                      ||||+++++|.+++....  ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus        93 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  167 (281)
T 1mp8_A           93 IMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME  167 (281)
T ss_dssp             EEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccC
Confidence            999999999999996543  23588999999999999999999988   9999999999999999999999999998765


Q ss_pred             CCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhccccccc
Q 015027          240 SDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQ  318 (414)
Q Consensus       240 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (414)
                      .... .......+|+.|+|||++.+..++.++||||||+++|||++ |..||.......         ....+...... 
T Consensus       168 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~---------~~~~i~~~~~~-  236 (281)
T 1mp8_A          168 DSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---------VIGRIENGERL-  236 (281)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---------HHHHHHTTCCC-
T ss_pred             cccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH---------HHHHHHcCCCC-
Confidence            4321 12233457789999999999999999999999999999997 999997433211         11111111100 


Q ss_pred             ccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHh
Q 015027          319 ILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRL  367 (414)
Q Consensus       319 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~  367 (414)
                          ...    ...+..+.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus       237 ----~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  277 (281)
T 1mp8_A          237 ----PMP----PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  277 (281)
T ss_dssp             ----CCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----CCC----CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence                011    11225689999999999999999999999999988754

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=4.9e-46  Score=353.33  Aligned_cols=264  Identities=25%  Similarity=0.376  Sum_probs=209.4

Q ss_pred             HHHHHhcCCCCCCccccCCceEEEEEEEc------CCcEEEEEEeecccchh--HhHHHHHHHHHccCCCceeeeeeeEe
Q 015027           81 EMIRATKNFDRSRCLSQGGFVSVYKGVLH------DNIQVAVKTYRRADKIR--ITERELLRIISQVNHKNVVKILGLCL  152 (414)
Q Consensus        81 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~--~~~~~~~~~l~~l~hpniv~l~~~~~  152 (414)
                      ++....++|.+.+.||+|+||.||+|.+.      ++..||||.+.......  ....+++.+++.++||||+++++++.
T Consensus        19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   98 (322)
T 1p4o_A           19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS   98 (322)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence            34445678999999999999999999864      36789999997654322  23456778999999999999999999


Q ss_pred             cCCcceEEEEeCCCCchhhhhhhcCC-------cccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCC
Q 015027          153 ETEVPLLVYEFASNGTLLDHIRCESS-------QVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNY  225 (414)
Q Consensus       153 ~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~  225 (414)
                      +.+..++||||+++|+|.+++.....       ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++
T Consensus        99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~  175 (322)
T 1p4o_A           99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDF  175 (322)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTC
T ss_pred             cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCC
Confidence            99999999999999999999865321       134578899999999999999999988   99999999999999999


Q ss_pred             cEEEeeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccc
Q 015027          226 TAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMV  304 (414)
Q Consensus       226 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~  304 (414)
                      .+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||.......       
T Consensus       176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------  248 (322)
T 1p4o_A          176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-------  248 (322)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH-------
T ss_pred             eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH-------
Confidence            999999999986654332233334567889999999999999999999999999999999 899987433211       


Q ss_pred             hhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHH
Q 015027          305 PYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLR  365 (414)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~  365 (414)
                        ............     ..    ...+..+.+|+.+||+.||.+|||+.++++.|+.+.
T Consensus       249 --~~~~~~~~~~~~-----~~----~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~  298 (322)
T 1p4o_A          249 --VLRFVMEGGLLD-----KP----DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM  298 (322)
T ss_dssp             --HHHHHHTTCCCC-----CC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             --HHHHHHcCCcCC-----CC----CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence              111111111100     01    112255899999999999999999999999988764

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=5e-45  Score=341.20  Aligned_cols=264  Identities=20%  Similarity=0.203  Sum_probs=194.2

Q ss_pred             cCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccch---hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEe
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKI---RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  163 (414)
                      ++|.+.+.||+|+||+||+|...+++.||+|++......   .....+++.++++++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            578899999999999999999978999999999754322   23446677999999999999999999999999999999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcc
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE  243 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  243 (414)
                      +++ +|.+++....  ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++....... 
T Consensus        82 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  154 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV-  154 (288)
T ss_dssp             CSE-EHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             cCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc-
Confidence            986 8888886543  23578899999999999999999987   9999999999999999999999999998664321 


Q ss_pred             ccceecccccccccchhhccc-CCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchh-------hhhhhc-cc
Q 015027          244 TAMSTILIGTSGYLDPVCINT-GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPY-------FLNSIK-NN  314 (414)
Q Consensus       244 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~-------~~~~~~-~~  314 (414)
                       .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||........... ....       .+.... ..
T Consensus       155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  232 (288)
T 1ob3_A          155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMR-IFRILGTPNSKNWPNVTELP  232 (288)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-HHHHHCCCCTTTSTTGGGST
T ss_pred             -cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHHHCCCChhhchhhhccc
Confidence             12234578999999999976 4589999999999999999999999975432110000 0000       000000 00


Q ss_pred             ccccccccccC---CcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          315 GLRQILNFHVA---DESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       315 ~~~~~~~~~~~---~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      .....+.....   .......+..+.+|+.+||+.||++|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            00000000000   0000112356899999999999999999999853

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=8.1e-45  Score=346.45  Aligned_cols=264  Identities=18%  Similarity=0.153  Sum_probs=206.5

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhHhHHHHHHHHHcc-CCCceeeeeeeEecCCcceEEEEe
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRITERELLRIISQV-NHKNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~  163 (414)
                      .++|.+.+.||+|+||.||+|... +++.||||++...... .....++++++++ +||||+++++++..++..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~   86 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL   86 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS-CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch-HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence            467999999999999999999964 6899999998765432 3345566888888 999999999999999999999999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCc-----EEEeeccccccc
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYT-----AKVADFESSVLI  238 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~-----~kl~DfGla~~~  238 (414)
                      + +++|.+++....  ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.     +||+|||++...
T Consensus        87 ~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~  160 (330)
T 2izr_A           87 L-GPSLEDLFDLCD--RTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY  160 (330)
T ss_dssp             C-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred             C-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence            9 999999997543  34589999999999999999999988   999999999999998887     999999999876


Q ss_pred             cCCcccc-----ceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcc
Q 015027          239 SSDAETA-----MSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKN  313 (414)
Q Consensus       239 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  313 (414)
                      .......     ......||+.|+|||++.+..++.++|||||||++|||++|+.||........     .. ....+..
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~-----~~-~~~~i~~  234 (330)
T 2izr_A          161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTL-----KE-RYQKIGD  234 (330)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSH-----HH-HHHHHHH
T ss_pred             ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccH-----HH-HHHHHHh
Confidence            5432211     12456899999999999999999999999999999999999999975432110     00 0000000


Q ss_pred             cccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHhh
Q 015027          314 NGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLH  368 (414)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~~  368 (414)
                      ...... .......    . +.+.+|+.+||+.+|.+||++.+|.+.|+.+....
T Consensus       235 ~~~~~~-~~~~~~~----~-p~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~  283 (330)
T 2izr_A          235 TKRATP-IEVLCEN----F-PEMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK  283 (330)
T ss_dssp             HHHHSC-HHHHTTT----C-HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             hhccCC-HHHHhcc----C-hHHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence            000000 0000000    1 25999999999999999999999999999876543

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=9.4e-46  Score=367.79  Aligned_cols=258  Identities=27%  Similarity=0.397  Sum_probs=202.9

Q ss_pred             HhcCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeC
Q 015027           85 ATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFA  164 (414)
Q Consensus        85 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  164 (414)
                      ..++|.+.+.||+|+||.||+|.+.++..||||++.........+.++++++++++||||+++++++.+ +..++||||+
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~  260 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM  260 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence            356788899999999999999999888889999998765555566778899999999999999999876 6789999999


Q ss_pred             CCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccc
Q 015027          165 SNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET  244 (414)
Q Consensus       165 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  244 (414)
                      ++|+|.+++..... ..+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++....... 
T Consensus       261 ~~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-  335 (452)
T 1fmk_A          261 SKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-  335 (452)
T ss_dssp             TTCBHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             cCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCce-
Confidence            99999999964322 23578999999999999999999988   99999999999999999999999999987653321 


Q ss_pred             cceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhcccccccccccc
Q 015027          245 AMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFH  323 (414)
Q Consensus       245 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (414)
                      .......+++.|+|||++.+..++.++|||||||++|||++ |+.||.......         ....+... ...     
T Consensus       336 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---------~~~~i~~~-~~~-----  400 (452)
T 1fmk_A          336 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERG-YRM-----  400 (452)
T ss_dssp             -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---------HHHHHHTT-CCC-----
T ss_pred             ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH---------HHHHHHcC-CCC-----
Confidence            12223456789999999999999999999999999999999 999997443211         11111111 000     


Q ss_pred             cCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHH
Q 015027          324 VADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR  366 (414)
Q Consensus       324 ~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~  366 (414)
                         ..+...+..+.+|+.+||+.||.+|||+.+|++.|+.+..
T Consensus       401 ---~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~  440 (452)
T 1fmk_A          401 ---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  440 (452)
T ss_dssp             ---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             ---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence               0111223568999999999999999999999999887653

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.5e-45  Score=351.72  Aligned_cols=262  Identities=25%  Similarity=0.395  Sum_probs=207.8

Q ss_pred             hcCCCCCCccccCCceEEEEEEEcC-C-----cEEEEEEeecccch--hHhHHHHHHHHHcc-CCCceeeeeeeEecCCc
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLHD-N-----IQVAVKTYRRADKI--RITERELLRIISQV-NHKNVVKILGLCLETEV  156 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~~--~~~~~~~~~~l~~l-~hpniv~l~~~~~~~~~  156 (414)
                      .++|.+.+.||+|+||.||+|.... +     ..||+|.+......  ......++.+++++ +||||+++++++...+.
T Consensus        45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  124 (333)
T 2i1m_A           45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP  124 (333)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence            4789999999999999999999653 3     47999999765432  23346677899999 89999999999999999


Q ss_pred             ceEEEEeCCCCchhhhhhhcCC-----------cccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCC
Q 015027          157 PLLVYEFASNGTLLDHIRCESS-----------QVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNY  225 (414)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~  225 (414)
                      .++||||+++|+|.+++.....           ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++
T Consensus       125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~  201 (333)
T 2i1m_A          125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGH  201 (333)
T ss_dssp             CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGGG
T ss_pred             eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCCC
Confidence            9999999999999999965431           234588999999999999999999987   99999999999999999


Q ss_pred             cEEEeeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccc
Q 015027          226 TAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMV  304 (414)
Q Consensus       226 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~  304 (414)
                      .+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||.......       
T Consensus       202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------  274 (333)
T 2i1m_A          202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS-------  274 (333)
T ss_dssp             EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH-------
T ss_pred             eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH-------
Confidence            999999999987654433333344567889999999999999999999999999999998 999987433211       


Q ss_pred             hhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHh
Q 015027          305 PYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRL  367 (414)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~  367 (414)
                       ....... .......    ..    ..+..+.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus       275 -~~~~~~~-~~~~~~~----~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  327 (333)
T 2i1m_A          275 -KFYKLVK-DGYQMAQ----PA----FAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE  327 (333)
T ss_dssp             -HHHHHHH-HTCCCCC----CT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -HHHHHHh-cCCCCCC----CC----CCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence             0101011 0110000    11    1125589999999999999999999999999987754

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=7.6e-45  Score=351.00  Aligned_cols=252  Identities=22%  Similarity=0.301  Sum_probs=200.8

Q ss_pred             HhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch---hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEE
Q 015027           85 ATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI---RITERELLRIISQVNHKNVVKILGLCLETEVPLLV  160 (414)
Q Consensus        85 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv  160 (414)
                      ..++|.+.+.||+|+||.||+|... +++.||+|++......   .....+++.+++.++||||+++++++.+.+..|+|
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            3567999999999999999999976 5899999999765322   23345677899999999999999999999999999


Q ss_pred             EEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCC---CcEEEeecccccc
Q 015027          161 YEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDN---YTAKVADFESSVL  237 (414)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~---~~~kl~DfGla~~  237 (414)
                      |||+++|+|.+++...   ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.+   +.+||+|||++..
T Consensus       107 ~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~  180 (362)
T 2bdw_A          107 FDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE  180 (362)
T ss_dssp             ECCCCSCBHHHHHTTC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred             EecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence            9999999999988643   34588999999999999999999988   9999999999999864   4599999999987


Q ss_pred             ccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccc
Q 015027          238 ISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLR  317 (414)
Q Consensus       238 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (414)
                      .....   ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......         ....+......
T Consensus       181 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~---------~~~~i~~~~~~  248 (362)
T 2bdw_A          181 VNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---------LYAQIKAGAYD  248 (362)
T ss_dssp             CTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---------HHHHHHHTCCC
T ss_pred             ecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---------HHHHHHhCCCC
Confidence            65321   2234679999999999999999999999999999999999999996433111         11111111100


Q ss_pred             cccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHH
Q 015027          318 QILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEE  360 (414)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~  360 (414)
                            .........+..+.+|+.+||+.||.+|||+.++++.
T Consensus       249 ------~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          249 ------YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             ------CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ------CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                  0000111123568999999999999999999998753

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-44  Score=343.25  Aligned_cols=243  Identities=25%  Similarity=0.302  Sum_probs=198.1

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc----hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK----IRITERELLRIISQVNHKNVVKILGLCLETEVPLLV  160 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv  160 (414)
                      .++|++.+.||+|+||.||+|... +|+.||+|++.....    ......++..+++.++||||+++++++.+....|+|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            367899999999999999999976 589999999976432    223345667889999999999999999999999999


Q ss_pred             EEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccC
Q 015027          161 YEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISS  240 (414)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  240 (414)
                      |||+++|+|.+++....   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.+|.+||+|||++.....
T Consensus        85 ~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~  158 (318)
T 1fot_A           85 MDYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD  158 (318)
T ss_dssp             ECCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             EeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence            99999999999997543   3578899999999999999999987   99999999999999999999999999987543


Q ss_pred             CccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccc
Q 015027          241 DAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQIL  320 (414)
Q Consensus       241 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (414)
                      .     ....+||+.|+|||++.+..++.++|||||||++|||++|..||.......         ....+.....    
T Consensus       159 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---------~~~~i~~~~~----  220 (318)
T 1fot_A          159 V-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK---------TYEKILNAEL----  220 (318)
T ss_dssp             C-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---------HHHHHHHCCC----
T ss_pred             c-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---------HHHHHHhCCC----
Confidence            2     234589999999999999999999999999999999999999997433111         0111111110    


Q ss_pred             ccccCCcccHHHHHHHHHHHHHhhccCCCCCC-----ChhHHH
Q 015027          321 NFHVADESEMKEIEIVAELASKCLRIRGTERP-----TMKQVS  358 (414)
Q Consensus       321 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rp-----s~~~v~  358 (414)
                        ..+.    ..+..+.+|+.+||+.||.+||     ++++++
T Consensus       221 --~~p~----~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~  257 (318)
T 1fot_A          221 --RFPP----FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVK  257 (318)
T ss_dssp             --CCCT----TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHH
T ss_pred             --CCCC----CCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHh
Confidence              0111    1125589999999999999999     777774

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2.4e-45  Score=354.89  Aligned_cols=268  Identities=16%  Similarity=0.186  Sum_probs=201.6

Q ss_pred             hcCCCCCCccccCCceEEEEEEEcC------CcEEEEEEeecccchhHhH------------HHHHHHHHccCCCceeee
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLHD------NIQVAVKTYRRADKIRITE------------RELLRIISQVNHKNVVKI  147 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~------------~~~~~~l~~l~hpniv~l  147 (414)
                      .++|.+.+.||+|+||.||+|.+..      ++.||||++.........+            ..++..+..++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            4689999999999999999999764      4789999987654322221            223345677899999999


Q ss_pred             eeeEecC----CcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeC-
Q 015027          148 LGLCLET----EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLN-  222 (414)
Q Consensus       148 ~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~-  222 (414)
                      ++++...    ...++||||+ +++|.+++....  ..+++..++.++.||+.||.|||+.+   |+||||||+|||++ 
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~  187 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA--KRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNY  187 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEES
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEec
Confidence            9998765    4589999999 999999997643  34589999999999999999999987   99999999999999 


Q ss_pred             -CCCcEEEeeccccccccCCcccc-----ceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccc
Q 015027          223 -DNYTAKVADFESSVLISSDAETA-----MSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLA  296 (414)
Q Consensus       223 -~~~~~kl~DfGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~  296 (414)
                       .++.+||+|||+++.........     ......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus       188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~  267 (364)
T 3op5_A          188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD  267 (364)
T ss_dssp             SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred             CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence             88999999999998765432111     113346999999999999999999999999999999999999999743211


Q ss_pred             cccccccchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHh
Q 015027          297 SNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRL  367 (414)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~  367 (414)
                      ..    ........ .......+++..+...   ..+..+.+|+..||+.+|.+||++.+|++.|+.+...
T Consensus       268 ~~----~~~~~~~~-~~~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  330 (364)
T 3op5_A          268 PK----YVRDSKIR-YRENIASLMDKCFPAA---NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKA  330 (364)
T ss_dssp             HH----HHHHHHHH-HHHCHHHHHHHHSCTT---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             HH----HHHHHHHH-hhhhHHHHHHHhcccc---cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Confidence            10    00000000 0011111222111100   1125599999999999999999999999999988764

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=4.2e-45  Score=341.26  Aligned_cols=254  Identities=30%  Similarity=0.455  Sum_probs=199.0

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchh--------HhHHHHHHHHHccCCCceeeeeeeEecCCc
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIR--------ITERELLRIISQVNHKNVVKILGLCLETEV  156 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------~~~~~~~~~l~~l~hpniv~l~~~~~~~~~  156 (414)
                      .++|.+.+.||+|+||.||+|.+. +++.||+|++.......        ....+++.++++++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            367899999999999999999975 68999999986543221        34466778999999999999999986654 


Q ss_pred             ceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCc-----EEEee
Q 015027          157 PLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYT-----AKVAD  231 (414)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~-----~kl~D  231 (414)
                       ++||||+++|+|.+++.....  .+++..++.++.|++.||.|||+.+ ++|+||||||+|||++.++.     +||+|
T Consensus        97 -~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             -eEEEEecCCCCHHHHHhcccC--CccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence             799999999999988865433  4588999999999999999999966 45999999999999988776     99999


Q ss_pred             ccccccccCCccccceecccccccccchhhc--ccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhh
Q 015027          232 FESSVLISSDAETAMSTILIGTSGYLDPVCI--NTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLN  309 (414)
Q Consensus       232 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~  309 (414)
                      ||++.....     ......||+.|+|||++  ....++.++|||||||++|+|++|+.||.........       ...
T Consensus       173 fg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-------~~~  240 (287)
T 4f0f_A          173 FGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK-------FIN  240 (287)
T ss_dssp             CTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH-------HHH
T ss_pred             CCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH-------HHH
Confidence            999975432     23446799999999998  4556889999999999999999999999743321100       011


Q ss_pred             hhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHH
Q 015027          310 SIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL  364 (414)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i  364 (414)
                      ..........+.        ...+..+.+|+.+||+.||.+|||+.++++.|+.+
T Consensus       241 ~~~~~~~~~~~~--------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          241 MIREEGLRPTIP--------EDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             HHHHSCCCCCCC--------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             HHhccCCCCCCC--------cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            111111111111        11225699999999999999999999999998753

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=4.9e-45  Score=349.69  Aligned_cols=247  Identities=23%  Similarity=0.277  Sum_probs=197.1

Q ss_pred             HhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc----hhHhHHHHHHHHHcc-CCCceeeeeeeEecCCcce
Q 015027           85 ATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK----IRITERELLRIISQV-NHKNVVKILGLCLETEVPL  158 (414)
Q Consensus        85 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~~~l~~l-~hpniv~l~~~~~~~~~~~  158 (414)
                      ..++|.+.+.||+|+||.||+|... +++.||||++.....    .......+..++..+ +||||+++++++.+.+..|
T Consensus        15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~   94 (345)
T 1xjd_A           15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF   94 (345)
T ss_dssp             -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence            4578999999999999999999976 589999999976431    122234445666655 8999999999999999999


Q ss_pred             EEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccc
Q 015027          159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLI  238 (414)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~  238 (414)
                      +||||+++|+|.+++....   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.+|.+||+|||+++..
T Consensus        95 lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  168 (345)
T 1xjd_A           95 FVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKEN  168 (345)
T ss_dssp             EEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence            9999999999999996543   3578999999999999999999988   999999999999999999999999999764


Q ss_pred             cCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccc
Q 015027          239 SSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQ  318 (414)
Q Consensus       239 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (414)
                      ....  ......+||+.|+|||++.+..++.++|||||||++|||++|..||.......         ....+....   
T Consensus       169 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---------~~~~i~~~~---  234 (345)
T 1xjd_A          169 MLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---------LFHSIRMDN---  234 (345)
T ss_dssp             CCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---------HHHHHHHCC---
T ss_pred             ccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH---------HHHHHHhCC---
Confidence            3221  22345689999999999999999999999999999999999999997433211         111111110   


Q ss_pred             ccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChh-HHH
Q 015027          319 ILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMK-QVS  358 (414)
Q Consensus       319 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~-~v~  358 (414)
                         ...+.    ..+..+.+|+.+||+.||.+||++. +|+
T Consensus       235 ---~~~p~----~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          235 ---PFYPR----WLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             ---CCCCT----TSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             ---CCCCc----ccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence               00111    1225689999999999999999997 653

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2.3e-45  Score=347.55  Aligned_cols=270  Identities=23%  Similarity=0.326  Sum_probs=211.4

Q ss_pred             cHHHHHHHhcCCCCCCccccCCceEEEEEEEc------CCcEEEEEEeecccchh--HhHHHHHHHHHcc-CCCceeeee
Q 015027           78 SKSEMIRATKNFDRSRCLSQGGFVSVYKGVLH------DNIQVAVKTYRRADKIR--ITERELLRIISQV-NHKNVVKIL  148 (414)
Q Consensus        78 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~--~~~~~~~~~l~~l-~hpniv~l~  148 (414)
                      ...++....++|.+.+.||+|+||.||+|.+.      +++.||||++.......  ....+++.++.++ +||||++++
T Consensus        18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~   97 (316)
T 2xir_A           18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   97 (316)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence            34444455688999999999999999999842      46789999997654322  2345667888888 799999999


Q ss_pred             eeEecCC-cceEEEEeCCCCchhhhhhhcCCc-------------ccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCC
Q 015027          149 GLCLETE-VPLLVYEFASNGTLLDHIRCESSQ-------------VLKTWKTCLRIAAETASALDYLHSLASPPIIHGDV  214 (414)
Q Consensus       149 ~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~-------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dl  214 (414)
                      +++...+ ..++||||+++++|.+++......             ..+++..++.++.||+.||.|||+.+   |+||||
T Consensus        98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~di  174 (316)
T 2xir_A           98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL  174 (316)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred             EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccC
Confidence            9987654 589999999999999999765431             12578899999999999999999987   999999


Q ss_pred             CCCceeeCCCCcEEEeeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCcc
Q 015027          215 KSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCM  293 (414)
Q Consensus       215 kp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~  293 (414)
                      ||+|||++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus       175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~  254 (316)
T 2xir_A          175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  254 (316)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence            99999999999999999999987655433333445678899999999999999999999999999999998 99998643


Q ss_pred             ccccccccccchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHh
Q 015027          294 TLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRL  367 (414)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~  367 (414)
                      ....        ...........     .....    ..+..+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus       255 ~~~~--------~~~~~~~~~~~-----~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  311 (316)
T 2xir_A          255 KIDE--------EFCRRLKEGTR-----MRAPD----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  311 (316)
T ss_dssp             CCSH--------HHHHHHHHTCC-----CCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             chhH--------HHHHHhccCcc-----CCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence            3211        01111111100     00011    1125589999999999999999999999999988754

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=6.1e-45  Score=347.74  Aligned_cols=245  Identities=22%  Similarity=0.309  Sum_probs=197.5

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc----hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK----IRITERELLRIISQVNHKNVVKILGLCLETEVPLLV  160 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv  160 (414)
                      .++|.+.+.||+|+||.||+|.+. +++.||||++.....    ......+++.+++.++||||+++++++...+..++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            367999999999999999999974 689999999975421    223446677999999999999999999999999999


Q ss_pred             EEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccC
Q 015027          161 YEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISS  240 (414)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  240 (414)
                      |||+ +|+|.+++....   .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus        88 ~E~~-~g~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~  160 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEKK---RMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD  160 (336)
T ss_dssp             ECCC-CEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred             EECC-CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence            9999 678988886543   3588999999999999999999988   99999999999999999999999999987654


Q ss_pred             CccccceecccccccccchhhcccCCC-CCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccc
Q 015027          241 DAETAMSTILIGTSGYLDPVCINTGKL-TKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQI  319 (414)
Q Consensus       241 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (414)
                      ..   .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||........         ........    
T Consensus       161 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~---------~~~i~~~~----  224 (336)
T 3h4j_B          161 GN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL---------FKKVNSCV----  224 (336)
T ss_dssp             SB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC---------BCCCCSSC----
T ss_pred             Cc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH---------HHHHHcCC----
Confidence            32   2344579999999999988876 6899999999999999999999964322110         00000000    


Q ss_pred             cccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          320 LNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       320 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                        ...+.    ..+..+.+|+.+||+.||.+|||+.++++
T Consensus       225 --~~~p~----~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          225 --YVMPD----FLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             --CCCCT----TSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             --CCCcc----cCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence              00111    11255899999999999999999999854

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=3.1e-44  Score=336.92  Aligned_cols=264  Identities=17%  Similarity=0.185  Sum_probs=206.3

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhHhHHHHHHHHHcc-CCCceeeeeeeEecCCcceEEEEe
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRITERELLRIISQV-NHKNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~  163 (414)
                      .++|.+.+.||+|+||.||+|... +++.||||++...... ....++++++..+ +|+|++++++++......++||||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~   87 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL   87 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc-HHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEe
Confidence            467999999999999999999964 6899999998755432 2345556778888 799999999999999999999999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCc-----EEEeeccccccc
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYT-----AKVADFESSVLI  238 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~-----~kl~DfGla~~~  238 (414)
                      + +++|.+++.....  .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.     +||+|||++...
T Consensus        88 ~-~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~  161 (298)
T 1csn_A           88 L-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  161 (298)
T ss_dssp             C-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             c-CCCHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence            9 9999999975433  3588999999999999999999987   999999999999987766     999999999876


Q ss_pred             cCCccc-----cceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcc
Q 015027          239 SSDAET-----AMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKN  313 (414)
Q Consensus       239 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  313 (414)
                      ......     .......||+.|+|||++.+..++.++|||||||++|||++|+.||..........      .......
T Consensus       162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~------~~~~~~~  235 (298)
T 1csn_A          162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ------KYERIGE  235 (298)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH------HHHHHHH
T ss_pred             ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHH------HHHHHHh
Confidence            543221     12345679999999999999999999999999999999999999997543211100      0000000


Q ss_pred             cccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHh
Q 015027          314 NGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRL  367 (414)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~  367 (414)
                      ....... +....    ..++.+.+|+.+||+.||.+|||+.+|++.|+.+...
T Consensus       236 ~~~~~~~-~~~~~----~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~  284 (298)
T 1csn_A          236 KKQSTPL-RELCA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER  284 (298)
T ss_dssp             HHHHSCH-HHHTT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             hccCccH-HHHHh----hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence            0000000 00000    1125699999999999999999999999999988754

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-44  Score=351.27  Aligned_cols=251  Identities=19%  Similarity=0.261  Sum_probs=201.5

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch-hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEe
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI-RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  163 (414)
                      .++|.+.+.||+|+||.||+|... +++.||+|++...... .....+++.+++.++||||+++++++.+....++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            467999999999999999999976 5889999999765432 23446778999999999999999999999999999999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCC--CCcEEEeeccccccccCC
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLND--NYTAKVADFESSVLISSD  241 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~--~~~~kl~DfGla~~~~~~  241 (414)
                      +++|+|.+++....  ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.  ++.+||+|||++......
T Consensus       130 ~~gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~  204 (387)
T 1kob_A          130 LSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  204 (387)
T ss_dssp             CCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence            99999999986543  23588999999999999999999988   999999999999974  578999999999876543


Q ss_pred             ccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccc
Q 015027          242 AETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILN  321 (414)
Q Consensus       242 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (414)
                         .......||+.|+|||++.+..++.++|||||||++|+|++|..||.......         ....+......  .+
T Consensus       205 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~---------~~~~i~~~~~~--~~  270 (387)
T 1kob_A          205 ---EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE---------TLQNVKRCDWE--FD  270 (387)
T ss_dssp             ---SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---------HHHHHHHCCCC--CC
T ss_pred             ---cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH---------HHHHHHhCCCC--CC
Confidence               22334579999999999999999999999999999999999999997433111         11111111000  00


Q ss_pred             cccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          322 FHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       322 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ..    .....+..+.+|+.+||+.||.+|||+.++++
T Consensus       271 ~~----~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          271 ED----AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             SS----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             cc----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence            00    01112356899999999999999999999965

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=3.9e-45  Score=360.46  Aligned_cols=259  Identities=22%  Similarity=0.294  Sum_probs=202.4

Q ss_pred             HHHHHhcCCCCCCccccCCceEEEEEEEcC-CcEEEEEEeecccch----hHhHHHHHHHHHccCCCceeeeeeeEecCC
Q 015027           81 EMIRATKNFDRSRCLSQGGFVSVYKGVLHD-NIQVAVKTYRRADKI----RITERELLRIISQVNHKNVVKILGLCLETE  155 (414)
Q Consensus        81 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~hpniv~l~~~~~~~~  155 (414)
                      ++....++|++.+.||+|+||+||+|.+.. ++.||+|++......    .....++..++..++||||++++++|.+.+
T Consensus        68 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~  147 (437)
T 4aw2_A           68 QMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDN  147 (437)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred             cccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC
Confidence            444456899999999999999999999764 788999999763321    222466778899999999999999999999


Q ss_pred             cceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccc
Q 015027          156 VPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESS  235 (414)
Q Consensus       156 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla  235 (414)
                      ..|+|||||++|+|.+++....  ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       148 ~~~lV~Ey~~gg~L~~~l~~~~--~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla  222 (437)
T 4aw2_A          148 NLYLVMDYYVGGDLLTLLSKFE--DRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSC  222 (437)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEEEecCCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhh
Confidence            9999999999999999996532  33588999999999999999999988   999999999999999999999999999


Q ss_pred             ccccCCccccceecccccccccchhhcc-----cCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhh
Q 015027          236 VLISSDAETAMSTILIGTSGYLDPVCIN-----TGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNS  310 (414)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  310 (414)
                      +...... .......+||+.|+|||++.     ...++.++|||||||++|||++|+.||...+...         ....
T Consensus       223 ~~~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~---------~~~~  292 (437)
T 4aw2_A          223 LKLMEDG-TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE---------TYGK  292 (437)
T ss_dssp             EECCTTS-CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---------HHHH
T ss_pred             hhcccCC-CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH---------HHHh
Confidence            7665432 22234468999999999987     5679999999999999999999999997433211         0001


Q ss_pred             hcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCC--CCChhHHHH
Q 015027          311 IKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTE--RPTMKQVSE  359 (414)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~--Rps~~~v~~  359 (414)
                      +........++... .    ..+..+.+|+.+||..+|++  ||+++++++
T Consensus       293 i~~~~~~~~~p~~~-~----~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          293 IMNHKERFQFPTQV-T----DVSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             HHTHHHHCCCCSSC-C----CSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             hhhccccccCCccc-c----cCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence            10000000001000 0    11255899999999988888  999999854

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.9e-45  Score=345.93  Aligned_cols=271  Identities=25%  Similarity=0.322  Sum_probs=202.2

Q ss_pred             cCCCCCCccccCCceEEEEEEE-----cCCcEEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEecC--Ccc
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVL-----HDNIQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLET--EVP  157 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~~--~~~  157 (414)
                      ++|++.+.||+|+||.||+|.+     .+++.||||++......  .....+++++++.++||||+++++++...  ...
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            4588899999999999999983     35889999999755322  23456678999999999999999999876  668


Q ss_pred             eEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccccc
Q 015027          158 LLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVL  237 (414)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~  237 (414)
                      ++||||+++++|.+++.....  .+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus       101 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  175 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKNKN--KINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA  175 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHHTT--TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEEeCCCCcHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence            999999999999999965443  3588999999999999999999988   99999999999999999999999999987


Q ss_pred             ccCCccc-cceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccc
Q 015027          238 ISSDAET-AMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGL  316 (414)
Q Consensus       238 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (414)
                      ....... .......||+.|+|||++.+..++.++||||||+++|+|++|..|+............  + ..........
T Consensus       176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--~-~~~~~~~~~~  252 (302)
T 4e5w_A          176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIG--P-THGQMTVTRL  252 (302)
T ss_dssp             CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHC--S-CCGGGHHHHH
T ss_pred             ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccC--C-cccccCHHHH
Confidence            6543221 2233456888899999999999999999999999999999999986432110000000  0 0000000000


Q ss_pred             ccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHH
Q 015027          317 RQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLR  365 (414)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~  365 (414)
                      ...+........+...+..+.+|+.+||+.||.+|||+.++++.|+.+.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          253 VNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            0000111111111122356999999999999999999999999998874

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.1e-44  Score=334.94  Aligned_cols=252  Identities=19%  Similarity=0.313  Sum_probs=200.8

Q ss_pred             cCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccch---hHhHHHHHHHHHccCCCceeeeeeeEecC--CcceEEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKI---RITERELLRIISQVNHKNVVKILGLCLET--EVPLLVY  161 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~hpniv~l~~~~~~~--~~~~lv~  161 (414)
                      ++|.+.+.||+|+||.||+|.+ +++.||||++......   .....+++.++++++||||+++++++.+.  ...++||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT   88 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence            6788999999999999999998 4889999999765322   23346677889999999999999999877  7889999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCC
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD  241 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  241 (414)
                      ||+++|+|.+++..... ..+++..++.++.||+.||.|||+.+ ++++||||||+|||++.++.++|+|||++..... 
T Consensus        89 e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~-  165 (271)
T 3kmu_A           89 HWMPYGSLYNVLHEGTN-FVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-  165 (271)
T ss_dssp             ECCTTCBHHHHHHSCSS-CCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-
T ss_pred             cccCCCcHHHHHhhccc-CCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc-
Confidence            99999999999975432 34689999999999999999999866 5699999999999999999999999988754322 


Q ss_pred             ccccceecccccccccchhhcccCCCCC---cccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccc
Q 015027          242 AETAMSTILIGTSGYLDPVCINTGKLTK---KSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQ  318 (414)
Q Consensus       242 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (414)
                            ....||+.|+|||++.+..++.   ++|||||||++|||++|+.||.......         ............
T Consensus       166 ------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---------~~~~~~~~~~~~  230 (271)
T 3kmu_A          166 ------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME---------IGMKVALEGLRP  230 (271)
T ss_dssp             ------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH---------HHHHHHHSCCCC
T ss_pred             ------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH---------HHHHHHhcCCCC
Confidence                  2346899999999998766555   7999999999999999999997433211         001111111111


Q ss_pred             ccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHH
Q 015027          319 ILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLR  365 (414)
Q Consensus       319 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~  365 (414)
                      .    ...    ..+..+.+|+.+||+.||.+|||+.++++.|+.+.
T Consensus       231 ~----~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~  269 (271)
T 3kmu_A          231 T----IPP----GISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ  269 (271)
T ss_dssp             C----CCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             C----CCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            1    111    12255999999999999999999999999998875

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.3e-44  Score=338.62  Aligned_cols=259  Identities=27%  Similarity=0.427  Sum_probs=190.6

Q ss_pred             hcCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccch---hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKI---RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYE  162 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  162 (414)
                      .++|.+.+.||+|+||.||+|.+..  .||||++......   .....+++.++++++||||+++++++ .....++|||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e   99 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ   99 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence            4679999999999999999998643  5999999754332   23346678999999999999999965 5567899999


Q ss_pred             eCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCc
Q 015027          163 FASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDA  242 (414)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  242 (414)
                      |+++++|.+++....  ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.......
T Consensus       100 ~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  174 (289)
T 3og7_A          100 WCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS  174 (289)
T ss_dssp             CCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred             ecCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccccc
Confidence            999999999986543  33588999999999999999999988   9999999999999999999999999998665433


Q ss_pred             cccceecccccccccchhhcc---cCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccc
Q 015027          243 ETAMSTILIGTSGYLDPVCIN---TGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQI  319 (414)
Q Consensus       243 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (414)
                      .........||+.|+|||++.   +..++.++||||||+++|+|++|+.||.......        ..............
T Consensus       175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~  246 (289)
T 3og7_A          175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--------QIIEMVGRGSLSPD  246 (289)
T ss_dssp             ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH--------HHHHHHHHTSCCCC
T ss_pred             ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH--------HHHHHhcccccCcc
Confidence            333344567999999999986   6678889999999999999999999997433211        01111111111100


Q ss_pred             cccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHH
Q 015027          320 LNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLR  365 (414)
Q Consensus       320 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~  365 (414)
                      .. ....    ..+..+.+|+.+||+.+|.+|||+.++++.|+.+.
T Consensus       247 ~~-~~~~----~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          247 LS-KVRS----NCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             TT-SSCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             hh-hccc----cCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence            00 0111    12256999999999999999999999999998864

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2e-44  Score=346.36  Aligned_cols=242  Identities=22%  Similarity=0.260  Sum_probs=198.5

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc----hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK----IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~  161 (414)
                      ++|.+.+.||+|+||.||+|... +|+.||||++.....    ......+++++++.++||||+++++++.+.+..|+||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            57899999999999999999976 589999999976432    2233456778999999999999999999999999999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCC
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD  241 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  241 (414)
                      ||+++|+|.+++....   .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus       121 e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~  194 (350)
T 1rdq_E          121 EYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC
Confidence            9999999999997543   3578999999999999999999988   999999999999999999999999999876432


Q ss_pred             ccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccc
Q 015027          242 AETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILN  321 (414)
Q Consensus       242 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (414)
                           ....+||+.|+|||++.+..++.++|||||||++|||++|..||.......         ....+.....     
T Consensus       195 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---------~~~~i~~~~~-----  255 (350)
T 1rdq_E          195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ---------IYEKIVSGKV-----  255 (350)
T ss_dssp             -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---------HHHHHHHCCC-----
T ss_pred             -----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH---------HHHHHHcCCC-----
Confidence                 234579999999999999999999999999999999999999997433111         1111111110     


Q ss_pred             cccCCcccHHHHHHHHHHHHHhhccCCCCCCC-----hhHHH
Q 015027          322 FHVADESEMKEIEIVAELASKCLRIRGTERPT-----MKQVS  358 (414)
Q Consensus       322 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps-----~~~v~  358 (414)
                       ..+.    ..+..+.+|+.+||+.||.+||+     +++|+
T Consensus       256 -~~p~----~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~  292 (350)
T 1rdq_E          256 -RFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIK  292 (350)
T ss_dssp             -CCCT----TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHH
T ss_pred             -CCCC----CCCHHHHHHHHHHhhcCHHhccCCccCCHHHHH
Confidence             0111    12255899999999999999998     67764

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.3e-44  Score=342.22  Aligned_cols=243  Identities=20%  Similarity=0.177  Sum_probs=188.0

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhH---hH-HHHHHHHHccCCCceeeeeeeEecCCcceEEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRI---TE-RELLRIISQVNHKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~---~~-~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~  161 (414)
                      ++|++.++||+|+||+||+|.+. +++.||||++........   .. .++..+....+||||++++++|.+++..++||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            57999999999999999999986 699999999865432221   12 33333344458999999999999999999999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCC
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD  241 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  241 (414)
                      ||+ +++|.+++.....  .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus       137 e~~-~~~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~  210 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAWGA--SLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA  210 (311)
T ss_dssp             ECC-CCBHHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred             ecc-CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence            999 6699888866543  4589999999999999999999987   999999999999999999999999998776432


Q ss_pred             ccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccc
Q 015027          242 AETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILN  321 (414)
Q Consensus       242 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (414)
                         .......||+.|+|||++.+ .++.++|||||||++|||++|..|+.....            ...+........+.
T Consensus       211 ---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~------------~~~~~~~~~~~~~~  274 (311)
T 3p1a_A          211 ---GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG------------WQQLRQGYLPPEFT  274 (311)
T ss_dssp             -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH------------HHHHTTTCCCHHHH
T ss_pred             ---CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH------------HHHHhccCCCcccc
Confidence               22344579999999999876 799999999999999999999766542211            11111111110011


Q ss_pred             cccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          322 FHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       322 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      .        ..+..+.+|+.+||+.||.+|||+.++++
T Consensus       275 ~--------~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          275 A--------GLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             T--------TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             c--------CCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            1        11256999999999999999999999854

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.9e-44  Score=351.62  Aligned_cols=270  Identities=18%  Similarity=0.217  Sum_probs=199.8

Q ss_pred             hcCCCCCCccccC--CceEEEEEEEc-CCcEEEEEEeecccchh---HhHHHHHHHHHccCCCceeeeeeeEecCCcceE
Q 015027           86 TKNFDRSRCLSQG--GFVSVYKGVLH-DNIQVAVKTYRRADKIR---ITERELLRIISQVNHKNVVKILGLCLETEVPLL  159 (414)
Q Consensus        86 ~~~~~~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~l  159 (414)
                      .++|++.+.||+|  +||.||+|.+. +++.||||++.......   ....+++.+++.++||||+++++++.+++..|+
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            4679999999999  99999999976 68999999998654222   334567899999999999999999999999999


Q ss_pred             EEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccccccc
Q 015027          160 VYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLIS  239 (414)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~  239 (414)
                      ||||+++|+|.+++..... ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||.+....
T Consensus       104 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~  179 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHFM-DGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI  179 (389)
T ss_dssp             EEECCTTCBHHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred             EEEccCCCCHHHHHhhhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence            9999999999999965432 23588999999999999999999988   9999999999999999999999999886543


Q ss_pred             CCcc-----ccceecccccccccchhhccc--CCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhh---hh
Q 015027          240 SDAE-----TAMSTILIGTSGYLDPVCINT--GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYF---LN  309 (414)
Q Consensus       240 ~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~---~~  309 (414)
                      ....     ........||+.|+|||++.+  ..++.++|||||||++|||++|+.||.................   ..
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  259 (389)
T 3gni_B          180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD  259 (389)
T ss_dssp             ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred             cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence            2211     111223478999999999987  6799999999999999999999999975332211100000000   00


Q ss_pred             hh--c-------------ccccccccc---------cccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          310 SI--K-------------NNGLRQILN---------FHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       310 ~~--~-------------~~~~~~~~~---------~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ..  .             .........         ...........+..+.+|+.+||+.||.+|||+.++++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~  333 (389)
T 3gni_B          260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN  333 (389)
T ss_dssp             ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            00  0             000000000         00000111222366999999999999999999999853

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=7e-45  Score=343.47  Aligned_cols=256  Identities=25%  Similarity=0.399  Sum_probs=196.9

Q ss_pred             cCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCCC
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASN  166 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  166 (414)
                      ++|++.+.||+|+||.||+|.. .++.||||.+.... ....+..+++++++++||||+++++++.+  ..++||||+++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~   83 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESES-ERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEG   83 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSSTT-HHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTT
T ss_pred             hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecChh-HHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCC
Confidence            5788899999999999999987 47889999987543 23445667799999999999999998874  48999999999


Q ss_pred             CchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCc-EEEeeccccccccCCcccc
Q 015027          167 GTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYT-AKVADFESSVLISSDAETA  245 (414)
Q Consensus       167 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~-~kl~DfGla~~~~~~~~~~  245 (414)
                      |+|.+++.........++..++.++.|++.||.|||+.+..+|+||||||+|||++.++. +||+|||++......    
T Consensus        84 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~----  159 (307)
T 2eva_A           84 GSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----  159 (307)
T ss_dssp             CBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----------
T ss_pred             CCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc----
Confidence            999999976655555688899999999999999999943334999999999999998876 799999999765422    


Q ss_pred             ceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccccC
Q 015027          246 MSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVA  325 (414)
Q Consensus       246 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (414)
                       .....||+.|+|||++.+..++.++||||||+++|||++|+.||........      . ..........     +...
T Consensus       160 -~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~-~~~~~~~~~~-----~~~~  226 (307)
T 2eva_A          160 -MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF------R-IMWAVHNGTR-----PPLI  226 (307)
T ss_dssp             ------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH------H-HHHHHHTTCC-----CCCB
T ss_pred             -cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH------H-HHHHHhcCCC-----CCcc
Confidence             2234689999999999999999999999999999999999999964321110      0 0000000000     0001


Q ss_pred             CcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHh
Q 015027          326 DESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRL  367 (414)
Q Consensus       326 ~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~  367 (414)
                      .    ..+..+.+|+.+||+.||.+|||+.++++.|+.+.+.
T Consensus       227 ~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  264 (307)
T 2eva_A          227 K----NLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY  264 (307)
T ss_dssp             T----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGG
T ss_pred             c----ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence            1    1124589999999999999999999999999988654

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.2e-44  Score=349.54  Aligned_cols=246  Identities=22%  Similarity=0.285  Sum_probs=196.6

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc----hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK----IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~  161 (414)
                      ++|.+.+.||+|+||.||+|... +++.||+|++.....    ......++++++..++||||++++++|.+.+..|+||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            67899999999999999999976 488999999976432    2233456779999999999999999999999999999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCC
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD  241 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  241 (414)
                      ||+++|+|.+++....   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        95 e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  168 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQNV---HFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE  168 (384)
T ss_dssp             CCCTTEEHHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence            9999999999996533   3588999999999999999999988   999999999999999999999999999876533


Q ss_pred             ccccceecccccccccchhhccc---CCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccc
Q 015027          242 AETAMSTILIGTSGYLDPVCINT---GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQ  318 (414)
Q Consensus       242 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (414)
                         ......+||+.|+|||++.+   ..++.++|||||||++|||++|+.||........      ...........   
T Consensus       169 ---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~------~~~~~~~~~~~---  236 (384)
T 4fr4_A          169 ---TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS------KEIVHTFETTV---  236 (384)
T ss_dssp             ---CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCH------HHHHHHHHHCC---
T ss_pred             ---CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccH------HHHHHHHhhcc---
Confidence               22345689999999999964   4689999999999999999999999964322110      00111111000   


Q ss_pred             ccccccCCcccHHHHHHHHHHHHHhhccCCCCCCC-hhHH
Q 015027          319 ILNFHVADESEMKEIEIVAELASKCLRIRGTERPT-MKQV  357 (414)
Q Consensus       319 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps-~~~v  357 (414)
                         ...+    ...+..+.+|+.+||+.||.+||+ ++++
T Consensus       237 ---~~~p----~~~s~~~~~li~~lL~~dP~~R~s~~~~l  269 (384)
T 4fr4_A          237 ---VTYP----SAWSQEMVSLLKKLLEPNPDQRFSQLSDV  269 (384)
T ss_dssp             ---CCCC----TTSCHHHHHHHHHHSCSSGGGSCCSHHHH
T ss_pred             ---cCCC----CcCCHHHHHHHHHHhcCCHhHhcccHHHH
Confidence               0011    112256899999999999999998 5555

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=5.8e-45  Score=345.71  Aligned_cols=271  Identities=23%  Similarity=0.286  Sum_probs=205.0

Q ss_pred             CCCCCccccCCceEEEEEEEc-----CCcEEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEecC--CcceE
Q 015027           89 FDRSRCLSQGGFVSVYKGVLH-----DNIQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLET--EVPLL  159 (414)
Q Consensus        89 ~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~~--~~~~l  159 (414)
                      |++.+.||+|+||+||++...     +++.||||++......  .....++++++++++||||+++++++.+.  ...++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            488899999999999988643     5788999999865432  23346778999999999999999999874  57799


Q ss_pred             EEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccccccc
Q 015027          160 VYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLIS  239 (414)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~  239 (414)
                      ||||+++|+|.+++....    +++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus       113 v~e~~~~~~L~~~l~~~~----~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  185 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  185 (318)
T ss_dssp             EECCCTTCBHHHHGGGSC----CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred             EEecccCCcHHHHHhhCC----CCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence            999999999999996432    588999999999999999999988   9999999999999999999999999998765


Q ss_pred             CCccc-cceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccc
Q 015027          240 SDAET-AMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQ  318 (414)
Q Consensus       240 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (414)
                      ..... .......+|+.|+|||++.+..++.++||||||+++|+|++|..||...............   ..........
T Consensus       186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~  262 (318)
T 3lxp_A          186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ---GQMTVLRLTE  262 (318)
T ss_dssp             TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCC---HHHHHHHHHH
T ss_pred             ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccc---cchhHHHHHH
Confidence            43221 1233456788899999999999999999999999999999999998643221100000000   0000000111


Q ss_pred             ccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHhhh
Q 015027          319 ILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLHE  369 (414)
Q Consensus       319 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~~~  369 (414)
                      .+........+...+..+.+|+.+||+.||.+|||+.++++.|+.+.....
T Consensus       263 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~  313 (318)
T 3lxp_A          263 LLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ  313 (318)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             HHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence            111111111112223569999999999999999999999999998876543

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.4e-44  Score=353.37  Aligned_cols=274  Identities=19%  Similarity=0.241  Sum_probs=210.7

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEecCC--cceEE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLETE--VPLLV  160 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~~~--~~~lv  160 (414)
                      .++|.+.+.||+|+||.||+|.+. +++.||||++......  .....++++++++++||||+++++++....  ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            367899999999999999999976 4899999999764432  233456778999999999999999998755  67999


Q ss_pred             EEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceee----CCCCcEEEeeccccc
Q 015027          161 YEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILL----NDNYTAKVADFESSV  236 (414)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll----~~~~~~kl~DfGla~  236 (414)
                      |||+++|+|.+++........+++..++.++.||+.||.|||+.+   |+||||||+|||+    +.++.+||+|||++.
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            999999999999976655545789999999999999999999988   9999999999999    788889999999998


Q ss_pred             cccCCccccceecccccccccchhhccc--------CCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhh
Q 015027          237 LISSDAETAMSTILIGTSGYLDPVCINT--------GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFL  308 (414)
Q Consensus       237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~  308 (414)
                      ......   ......||+.|+|||++.+        ..++.++|||||||++|||++|+.||............+.. ..
T Consensus       165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~-~~  240 (396)
T 4eut_A          165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK-II  240 (396)
T ss_dssp             ECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHH-HH
T ss_pred             EccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHH-Hh
Confidence            765432   2234579999999999865        56788999999999999999999999643221111100000 00


Q ss_pred             hhhcccc-----------cccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHH
Q 015027          309 NSIKNNG-----------LRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR  366 (414)
Q Consensus       309 ~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~  366 (414)
                      .......           ..-.-...............+.+|+.+||+.||++|||+.++++.++.+..
T Consensus       241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~  309 (396)
T 4eut_A          241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (396)
T ss_dssp             HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred             cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence            0000000           000000111222345667889999999999999999999999999988765

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.6e-45  Score=350.10  Aligned_cols=251  Identities=18%  Similarity=0.241  Sum_probs=190.8

Q ss_pred             hcCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccchh---HhHHHHHHHHHccCC--CceeeeeeeEecCCcceEE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIR---ITERELLRIISQVNH--KNVVKILGLCLETEVPLLV  160 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~l~~l~h--pniv~l~~~~~~~~~~~lv  160 (414)
                      .++|.+.+.||+|+||.||+|...+++.||||++.......   ....+++.++.+++|  |||+++++++..+...++|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            46789999999999999999998889999999997553322   334667788999976  9999999999999999999


Q ss_pred             EEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccC
Q 015027          161 YEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISS  240 (414)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  240 (414)
                      || +.+++|.+++....   .+++..+..++.||+.||.|||+.+   |+||||||+|||++ ++.+||+|||++.....
T Consensus        88 ~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~  159 (343)
T 3dbq_A           88 ME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  159 (343)
T ss_dssp             EC-CCSEEHHHHHHHSC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred             Ee-CCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence            99 55789999997543   3578899999999999999999988   99999999999997 67899999999987755


Q ss_pred             Cccccceecccccccccchhhccc-----------CCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhh
Q 015027          241 DAETAMSTILIGTSGYLDPVCINT-----------GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLN  309 (414)
Q Consensus       241 ~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~  309 (414)
                      ...........||+.|+|||++.+           ..++.++|||||||++|+|++|+.||.......       .... 
T Consensus       160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-------~~~~-  231 (343)
T 3dbq_A          160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-------SKLH-  231 (343)
T ss_dssp             ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-------HHHH-
T ss_pred             ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH-------HHHH-
Confidence            433333445689999999999865           678999999999999999999999996322110       0000 


Q ss_pred             hhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHH
Q 015027          310 SIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEE  360 (414)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~  360 (414)
                              ..++.......+...+..+.+|+.+||+.||.+|||+.++++.
T Consensus       232 --------~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          232 --------AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             --------HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             --------HHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence                    0011110111111112458999999999999999999999654

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=2.8e-44  Score=345.50  Aligned_cols=242  Identities=21%  Similarity=0.224  Sum_probs=195.0

Q ss_pred             hcCCCCCCccccCCceEEEEEEEcC-CcEEEEEEeecccc----hhHhHHHHHHHHHcc-CCCceeeeeeeEecCCcceE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLHD-NIQVAVKTYRRADK----IRITERELLRIISQV-NHKNVVKILGLCLETEVPLL  159 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~~~~~l~~l-~hpniv~l~~~~~~~~~~~l  159 (414)
                      .++|.+.+.||+|+||.||+|.... ++.||||++.....    .......+.+++..+ +||||+++++++.+.+..|+
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   98 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   98 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence            4789999999999999999999864 88999999986432    222334556778777 79999999999999999999


Q ss_pred             EEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccccccc
Q 015027          160 VYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLIS  239 (414)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~  239 (414)
                      ||||++||+|.+++...+   .+++..++.++.||+.||.|||+.+   |+||||||+|||++.+|.+||+|||++....
T Consensus        99 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  172 (353)
T 2i0e_A           99 VMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI  172 (353)
T ss_dssp             EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence            999999999999997543   3578999999999999999999988   9999999999999999999999999998643


Q ss_pred             CCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccc
Q 015027          240 SDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQI  319 (414)
Q Consensus       240 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (414)
                      ..  .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.......         ....+.....   
T Consensus       173 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---------~~~~i~~~~~---  238 (353)
T 2i0e_A          173 WD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---------LFQSIMEHNV---  238 (353)
T ss_dssp             CT--TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---------HHHHHHHCCC---
T ss_pred             cC--CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH---------HHHHHHhCCC---
Confidence            22  122345689999999999999999999999999999999999999997433211         1111111110   


Q ss_pred             cccccCCcccHHHHHHHHHHHHHhhccCCCCCCCh
Q 015027          320 LNFHVADESEMKEIEIVAELASKCLRIRGTERPTM  354 (414)
Q Consensus       320 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~  354 (414)
                         ..+.    ..+..+.+|+.+||+.||.+||++
T Consensus       239 ---~~p~----~~s~~~~~li~~lL~~dP~~R~~~  266 (353)
T 2i0e_A          239 ---AYPK----SMSKEAVAICKGLMTKHPGKRLGC  266 (353)
T ss_dssp             ---CCCT----TSCHHHHHHHHHHTCSCTTSCTTC
T ss_pred             ---CCCC----CCCHHHHHHHHHHhhcCHHHcCCC
Confidence               0111    122568999999999999999964

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=6.4e-44  Score=338.40  Aligned_cols=263  Identities=21%  Similarity=0.272  Sum_probs=185.3

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc--hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK--IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYE  162 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  162 (414)
                      .++|++.+.||+|+||.||+|... +++.||+|++.....  ......+++.++++++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            468999999999999999999975 589999999975432  22445667899999999999999999999999999999


Q ss_pred             eCCCCchhhhhhhcC---CcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccccccc
Q 015027          163 FASNGTLLDHIRCES---SQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLIS  239 (414)
Q Consensus       163 ~~~~gsL~~~l~~~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~  239 (414)
                      |++ |+|.+++....   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            998 59998885432   1234688899999999999999999987   9999999999999999999999999998764


Q ss_pred             CCccccceecccccccccchhhccc-CCCCCcccchhHHHHHHHHHhCCCCCCccccccccccc------cchhhhhhhc
Q 015027          240 SDAETAMSTILIGTSGYLDPVCINT-GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKIS------MVPYFLNSIK  312 (414)
Q Consensus       240 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~------~~~~~~~~~~  312 (414)
                      ...  .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||............      .....+....
T Consensus       160 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  237 (317)
T 2pmi_A          160 IPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT  237 (317)
T ss_dssp             SCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred             CCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence            322  12334578999999999976 46899999999999999999999999754321100000      0000000000


Q ss_pred             -------------ccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHH
Q 015027          313 -------------NNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVS  358 (414)
Q Consensus       313 -------------~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~  358 (414)
                                   ...+...+.+.....    .+..+.+|+.+||+.||.+|||+.+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~l~~li~~~L~~dP~~Rpt~~e~l  292 (317)
T 2pmi_A          238 KLPKYNPNIQQRPPRDLRQVLQPHTKEP----LDGNLMDFLHGLLQLNPDMRLSAKQAL  292 (317)
T ss_dssp             GCTTCCTTCCCCCCCCSHHHHGGGCSSC----CCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred             hhhhcccccccccchhHHHhhccccccc----CCHHHHHHHHHHCCCCcccCCCHHHHh
Confidence                         000000111111111    125689999999999999999999984

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.7e-44  Score=349.83  Aligned_cols=245  Identities=23%  Similarity=0.268  Sum_probs=191.2

Q ss_pred             CCccccCCceEEEEEEEc-CCcEEEEEEeecccc-hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCCCCch
Q 015027           92 SRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK-IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTL  169 (414)
Q Consensus        92 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL  169 (414)
                      .+.||+|+||.||+|... +|+.||+|++..... ......++++++++++||||+++++++.+.+..++||||+++++|
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L  173 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL  173 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence            567999999999999975 589999999987543 234456778999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceee--CCCCcEEEeeccccccccCCccccce
Q 015027          170 LDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILL--NDNYTAKVADFESSVLISSDAETAMS  247 (414)
Q Consensus       170 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll--~~~~~~kl~DfGla~~~~~~~~~~~~  247 (414)
                      .+++....  ..+++..++.++.||+.||.|||+.+   |+||||||+|||+  +.++.+||+|||++.......   ..
T Consensus       174 ~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~---~~  245 (373)
T 2x4f_A          174 FDRIIDES--YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KL  245 (373)
T ss_dssp             HHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---BC
T ss_pred             HHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---cc
Confidence            99886533  23588899999999999999999988   9999999999999  677899999999998765432   22


Q ss_pred             ecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccccCCc
Q 015027          248 TILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADE  327 (414)
Q Consensus       248 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (414)
                      ....||+.|+|||++.+..++.++|||||||++|||++|..||.......         ....+...... .     ...
T Consensus       246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---------~~~~i~~~~~~-~-----~~~  310 (373)
T 2x4f_A          246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE---------TLNNILACRWD-L-----EDE  310 (373)
T ss_dssp             CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---------HHHHHHHTCCC-S-----CSG
T ss_pred             ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH---------HHHHHHhccCC-C-----Chh
Confidence            34579999999999999999999999999999999999999997443211         11111110000 0     000


Q ss_pred             ccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          328 SEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       328 ~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      .....+..+.+|+.+||+.||.+|||+.++++
T Consensus       311 ~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          311 EFQDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            00112256899999999999999999999976

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=2.6e-44  Score=347.74  Aligned_cols=255  Identities=17%  Similarity=0.214  Sum_probs=201.8

Q ss_pred             HhcCCCCCCccccCCceEEEEEE------EcCCcEEEEEEeecccchhHhHHHHHHHHHccC---CCceeeeeeeEecCC
Q 015027           85 ATKNFDRSRCLSQGGFVSVYKGV------LHDNIQVAVKTYRRADKIRITERELLRIISQVN---HKNVVKILGLCLETE  155 (414)
Q Consensus        85 ~~~~~~~~~~lg~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~---hpniv~l~~~~~~~~  155 (414)
                      ..++|.+.+.||+|+||+||+|.      ..+++.||||++.....  .....+.+++..++   |+||+++++++...+
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~  140 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP--WEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN  140 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH--HHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh--hHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence            35779999999999999999994      34688999999976532  23334445555555   999999999999999


Q ss_pred             cceEEEEeCCCCchhhhhhhcC--CcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCC----------
Q 015027          156 VPLLVYEFASNGTLLDHIRCES--SQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLND----------  223 (414)
Q Consensus       156 ~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~----------  223 (414)
                      ..|+||||+++|+|.+++....  ....+++..++.++.||+.||+|||+.+   |+||||||+|||++.          
T Consensus       141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~~  217 (365)
T 3e7e_A          141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDD  217 (365)
T ss_dssp             CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC-----
T ss_pred             CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcccccc
Confidence            9999999999999999996432  2345689999999999999999999987   999999999999998          


Q ss_pred             -CCcEEEeeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccc
Q 015027          224 -NYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKIS  302 (414)
Q Consensus       224 -~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~  302 (414)
                       ++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||++|+.||........    
T Consensus       218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~----  293 (365)
T 3e7e_A          218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC----  293 (365)
T ss_dssp             -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE----
T ss_pred             ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce----
Confidence             899999999999766543334445567899999999999999999999999999999999999999853221110    


Q ss_pred             cchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCC-CChhHHHHHHHHHHHh
Q 015027          303 MVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTER-PTMKQVSEELDRLRRL  367 (414)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~R-ps~~~v~~~L~~i~~~  367 (414)
                               .   ....+    ....   ..+.+.+++..||+.+|.+| |+++++.+.|+.+...
T Consensus       294 ---------~---~~~~~----~~~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~  340 (365)
T 3e7e_A          294 ---------K---PEGLF----RRLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ  340 (365)
T ss_dssp             ---------E---ECSCC----TTCS---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             ---------e---echhc----cccC---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence                     0   00000    0001   12458899999999999999 6788888888876643

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=3.2e-44  Score=336.28  Aligned_cols=265  Identities=17%  Similarity=0.197  Sum_probs=194.1

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch---hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI---RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYE  162 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  162 (414)
                      ++|++.+.||+|+||+||+|.+. +++.||||++......   .....+++.++++++||||+++++++.+++..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            57889999999999999999976 5899999999755432   2344667899999999999999999999999999999


Q ss_pred             eCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCc
Q 015027          163 FASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDA  242 (414)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  242 (414)
                      |+++ +|.+.+....  ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.......
T Consensus        82 ~~~~-~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  155 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSE-EHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred             cCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence            9986 5555554322  33588999999999999999999988   9999999999999999999999999998765332


Q ss_pred             cccceecccccccccchhhcccCC-CCCcccchhHHHHHHHHHhCCCCCCccccccccccccchh-------hhhhhcc-
Q 015027          243 ETAMSTILIGTSGYLDPVCINTGK-LTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPY-------FLNSIKN-  313 (414)
Q Consensus       243 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~-------~~~~~~~-  313 (414)
                        .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||............+...       .+..... 
T Consensus       156 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  233 (292)
T 3o0g_A          156 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL  233 (292)
T ss_dssp             --SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred             --ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccc
Confidence              2234457899999999997765 8999999999999999999888853221111000000000       0000000 


Q ss_pred             cccccc--c-ccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          314 NGLRQI--L-NFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       314 ~~~~~~--~-~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ......  . ............+..+.+|+.+||+.||++|||++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            000000  0 000000001112356899999999999999999999853

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-44  Score=337.26  Aligned_cols=259  Identities=24%  Similarity=0.346  Sum_probs=204.1

Q ss_pred             cCCCCCC-ccccCCceEEEEEEEc---CCcEEEEEEeecccc--hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEE
Q 015027           87 KNFDRSR-CLSQGGFVSVYKGVLH---DNIQVAVKTYRRADK--IRITERELLRIISQVNHKNVVKILGLCLETEVPLLV  160 (414)
Q Consensus        87 ~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv  160 (414)
                      ++|.+.. .||+|+||.||+|.+.   ++..||||++.....  ......++++++.+++||||+++++++ ..+..++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            4566665 8999999999999853   578899999986532  233446677899999999999999999 45678999


Q ss_pred             EEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccC
Q 015027          161 YEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISS  240 (414)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  240 (414)
                      |||+++++|.+++....  ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++.....
T Consensus        88 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  162 (287)
T 1u59_A           88 MEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA  162 (287)
T ss_dssp             EECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEeCCCCCHHHHHHhCC--ccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence            99999999999986433  33588999999999999999999988   99999999999999999999999999987654


Q ss_pred             Cccc-cceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhccccccc
Q 015027          241 DAET-AMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQ  318 (414)
Q Consensus       241 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (414)
                      .... .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.......         ..........  
T Consensus       163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---------~~~~i~~~~~--  231 (287)
T 1u59_A          163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---------VMAFIEQGKR--  231 (287)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---------HHHHHHTTCC--
T ss_pred             CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH---------HHHHHhcCCc--
Confidence            3221 12233456889999999998999999999999999999998 999997433211         1111111110  


Q ss_pred             ccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHhhh
Q 015027          319 ILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLHE  369 (414)
Q Consensus       319 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~~~  369 (414)
                         ....    ...+..+.+|+.+||+.+|.+|||+.++++.|+.+.....
T Consensus       232 ---~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~  275 (287)
T 1u59_A          232 ---MECP----PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA  275 (287)
T ss_dssp             ---CCCC----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             ---CCCC----CCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence               0011    1122569999999999999999999999999999876543

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=2.1e-44  Score=335.57  Aligned_cols=259  Identities=23%  Similarity=0.347  Sum_probs=201.3

Q ss_pred             hcCCCCCCccccCCceEEEEEEEcC----CcEEEEEEeecccc--hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLHD----NIQVAVKTYRRADK--IRITERELLRIISQVNHKNVVKILGLCLETEVPLL  159 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~--~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~l  159 (414)
                      .++|.+.+.||+|+||.||+|.+..    +..||+|.+.....  ......+++.+++.++||||+++++++.+ +..++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence            4678899999999999999998643    34599999976532  22344667789999999999999999865 45789


Q ss_pred             EEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccccccc
Q 015027          160 VYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLIS  239 (414)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~  239 (414)
                      ||||+++++|.+++.....  .+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus        90 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  164 (281)
T 3cc6_A           90 IMELYPYGELGHYLERNKN--SLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIE  164 (281)
T ss_dssp             EEECCTTCBHHHHHHHHTT--TCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred             EEecCCCCCHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccc
Confidence            9999999999999965433  3478899999999999999999988   9999999999999999999999999998765


Q ss_pred             CCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhccccccc
Q 015027          240 SDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQ  318 (414)
Q Consensus       240 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (414)
                      .... .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.......         ..........  
T Consensus       165 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~---------~~~~~~~~~~--  232 (281)
T 3cc6_A          165 DEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---------VIGVLEKGDR--  232 (281)
T ss_dssp             ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG---------HHHHHHHTCC--
T ss_pred             cccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH---------HHHHHhcCCC--
Confidence            4321 12233467889999999999999999999999999999998 999986433211         1111111100  


Q ss_pred             ccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHhhh
Q 015027          319 ILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLHE  369 (414)
Q Consensus       319 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~~~  369 (414)
                         .....    ..++.+.+|+.+||+.||.+|||+.++++.|+.+.....
T Consensus       233 ---~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~  276 (281)
T 3cc6_A          233 ---LPKPD----LCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEK  276 (281)
T ss_dssp             ---CCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             ---CCCCC----CCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhhh
Confidence               00011    112558999999999999999999999999999876544

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=9.5e-45  Score=353.81  Aligned_cols=250  Identities=17%  Similarity=0.240  Sum_probs=191.2

Q ss_pred             cCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccch---hHhHHHHHHHHHccC--CCceeeeeeeEecCCcceEEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKI---RITERELLRIISQVN--HKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~--hpniv~l~~~~~~~~~~~lv~  161 (414)
                      .+|.+.+.||+|+||.||+|...+++.||||++......   .....+++.++.+++  ||||+++++++..++..|+||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            469999999999999999999888999999999764322   233466778888886  599999999999999999999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCC
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD  241 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  241 (414)
                      | +.+++|.+++....   .+++..+..++.||+.||.|||+.+   |+||||||+|||++ ++.+||+|||++......
T Consensus       136 E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~  207 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  207 (390)
T ss_dssp             E-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred             e-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence            9 56889999997543   4478889999999999999999987   99999999999996 579999999999876544


Q ss_pred             ccccceecccccccccchhhccc-----------CCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhh
Q 015027          242 AETAMSTILIGTSGYLDPVCINT-----------GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNS  310 (414)
Q Consensus       242 ~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  310 (414)
                      ..........||+.|+|||++.+           ..++.++|||||||++|||++|+.||.......       ... . 
T Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-------~~~-~-  278 (390)
T 2zmd_A          208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-------SKL-H-  278 (390)
T ss_dssp             ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-------HHH-H-
T ss_pred             CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH-------HHH-H-
Confidence            33333445689999999999865           468999999999999999999999996322110       000 0 


Q ss_pred             hcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHH
Q 015027          311 IKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEE  360 (414)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~  360 (414)
                             .+++.......+...+..+.+|+.+||+.||.+|||+.++++.
T Consensus       279 -------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          279 -------AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             -------HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             -------HHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence                   0111110000000112458999999999999999999999754

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=4e-45  Score=357.97  Aligned_cols=258  Identities=21%  Similarity=0.239  Sum_probs=200.4

Q ss_pred             HHHHHHhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc----hhHhHHHHHHHHHccCCCceeeeeeeEecC
Q 015027           80 SEMIRATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK----IRITERELLRIISQVNHKNVVKILGLCLET  154 (414)
Q Consensus        80 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~~~l~~l~hpniv~l~~~~~~~  154 (414)
                      .+.....++|++.+.||+|+||.||+|... +|+.||||++.....    ......++..++..++||||++++++|.+.
T Consensus        54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~  133 (412)
T 2vd5_A           54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDE  133 (412)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred             hhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence            344455689999999999999999999976 689999999976432    122345667889999999999999999999


Q ss_pred             CcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccc
Q 015027          155 EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFES  234 (414)
Q Consensus       155 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGl  234 (414)
                      +..|+||||+++|+|.+++...+.  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++++||+|||+
T Consensus       134 ~~~~lVmE~~~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGl  208 (412)
T 2vd5_A          134 NYLYLVMEYYVGGDLLTLLSKFGE--RIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGS  208 (412)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHSS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CEEEEEEcCCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechh
Confidence            999999999999999999975432  3578899999999999999999988   99999999999999999999999999


Q ss_pred             cccccCCccccceecccccccccchhhcc-------cCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhh
Q 015027          235 SVLISSDAETAMSTILIGTSGYLDPVCIN-------TGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYF  307 (414)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~  307 (414)
                      +........ ......+||+.|+|||++.       +..++.++|||||||++|||++|+.||...+...         .
T Consensus       209 a~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---------~  278 (412)
T 2vd5_A          209 CLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE---------T  278 (412)
T ss_dssp             CEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---------H
T ss_pred             heeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH---------H
Confidence            987654321 1223468999999999997       4578999999999999999999999997433211         0


Q ss_pred             hhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCC---CChhHHH
Q 015027          308 LNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTER---PTMKQVS  358 (414)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~R---ps~~~v~  358 (414)
                      ...+..... ....+..    ....+..+.+|+.+||. +|.+|   |++++++
T Consensus       279 ~~~i~~~~~-~~~~p~~----~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~  326 (412)
T 2vd5_A          279 YGKIVHYKE-HLSLPLV----DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFR  326 (412)
T ss_dssp             HHHHHTHHH-HCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHH
T ss_pred             HHHHHhccc-CcCCCcc----ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHh
Confidence            000000000 0000000    01122569999999999 99998   5788874

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=3.8e-44  Score=341.44  Aligned_cols=246  Identities=23%  Similarity=0.288  Sum_probs=190.1

Q ss_pred             hcCCCCCCccccCCceEEEEEEE----cCCcEEEEEEeecccc-----hhHhHHHHHHHHHccCCCceeeeeeeEecCCc
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVL----HDNIQVAVKTYRRADK-----IRITERELLRIISQVNHKNVVKILGLCLETEV  156 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~-----~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~  156 (414)
                      .++|++.+.||+|+||.||+|..    .+++.||+|++.....     ......+++.+++.++||||+++++++..++.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            36799999999999999999997    4689999999976432     12233556789999999999999999999999


Q ss_pred             ceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccc
Q 015027          157 PLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSV  236 (414)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~  236 (414)
                      .|+||||+++++|.+++....   .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  169 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLEREG---IFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK  169 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred             EEEEEeCCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence            999999999999999996543   3478889999999999999999988   9999999999999999999999999987


Q ss_pred             cccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccc
Q 015027          237 LISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGL  316 (414)
Q Consensus       237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (414)
                      .....  ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.......         ....+.....
T Consensus       170 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---------~~~~i~~~~~  238 (327)
T 3a62_A          170 ESIHD--GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK---------TIDKILKCKL  238 (327)
T ss_dssp             -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---------HHHHHHHTCC
T ss_pred             ccccC--CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH---------HHHHHHhCCC
Confidence            64332  122344679999999999999999999999999999999999999997433211         1111111100


Q ss_pred             ccccccccCCcccHHHHHHHHHHHHHhhccCCCCCC-----ChhHHH
Q 015027          317 RQILNFHVADESEMKEIEIVAELASKCLRIRGTERP-----TMKQVS  358 (414)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rp-----s~~~v~  358 (414)
                            ..+.    ..+..+.+|+.+||+.||.+||     ++.+++
T Consensus       239 ------~~p~----~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l  275 (327)
T 3a62_A          239 ------NLPP----YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQ  275 (327)
T ss_dssp             ------CCCT----TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHH
T ss_pred             ------CCCC----CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHH
Confidence                  0111    1125589999999999999999     555653

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4e-44  Score=343.47  Aligned_cols=260  Identities=23%  Similarity=0.279  Sum_probs=197.8

Q ss_pred             HHHHhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeeccc------chhHhHHHHHHHHHccCCCceeeeeeeEecC
Q 015027           82 MIRATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRAD------KIRITERELLRIISQVNHKNVVKILGLCLET  154 (414)
Q Consensus        82 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~  154 (414)
                      +....++|.+.+.||+|+||.||+|.+. ++..||+|++....      .......++++++++++||||+++++++.+.
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  100 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE  100 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence            3456788999999999999999999975 58899999997542      2223446678999999999999999999999


Q ss_pred             CcceEEEEeCCCCchhhhhhhcC-------------------------------------CcccCCHHHHHHHHHHHHHH
Q 015027          155 EVPLLVYEFASNGTLLDHIRCES-------------------------------------SQVLKTWKTCLRIAAETASA  197 (414)
Q Consensus       155 ~~~~lv~e~~~~gsL~~~l~~~~-------------------------------------~~~~~~~~~~~~i~~~i~~~  197 (414)
                      +..++||||+++|+|.+++....                                     ....+++..++.++.||+.|
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  180 (345)
T 3hko_A          101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA  180 (345)
T ss_dssp             SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            99999999999999999884210                                     01223567788899999999


Q ss_pred             HHHhhhCCCCCeeeCCCCCCceeeCCCC--cEEEeeccccccccCCccc--cceecccccccccchhhccc--CCCCCcc
Q 015027          198 LDYLHSLASPPIIHGDVKSANILLNDNY--TAKVADFESSVLISSDAET--AMSTILIGTSGYLDPVCINT--GKLTKKS  271 (414)
Q Consensus       198 l~~LH~~~~~~iiH~Dlkp~NIll~~~~--~~kl~DfGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~  271 (414)
                      |.|||+.+   |+||||||+|||++.++  .+||+|||++.........  .......||+.|+|||++.+  ..++.++
T Consensus       181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  257 (345)
T 3hko_A          181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC  257 (345)
T ss_dssp             HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred             HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence            99999988   99999999999998766  8999999999865432111  12345679999999999975  6789999


Q ss_pred             cchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCC
Q 015027          272 DVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTER  351 (414)
Q Consensus       272 Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~R  351 (414)
                      |||||||++|||++|+.||.......         ........... .     ........+..+.+|+.+||+.||.+|
T Consensus       258 DiwslG~il~el~~g~~pf~~~~~~~---------~~~~~~~~~~~-~-----~~~~~~~~~~~~~~li~~~l~~~p~~R  322 (345)
T 3hko_A          258 DAWSAGVLLHLLLMGAVPFPGVNDAD---------TISQVLNKKLC-F-----ENPNYNVLSPLARDLLSNLLNRNVDER  322 (345)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHH---------HHHHHHHCCCC-T-----TSGGGGGSCHHHHHHHHHHSCSCTTTS
T ss_pred             HHHHHHHHHHHHHHCCCCCCCCChHH---------HHHHHHhcccc-c-----CCcccccCCHHHHHHHHHHcCCChhHC
Confidence            99999999999999999997443211         00000000000 0     000001122568999999999999999


Q ss_pred             CChhHHHH
Q 015027          352 PTMKQVSE  359 (414)
Q Consensus       352 ps~~~v~~  359 (414)
                      ||+.++++
T Consensus       323 ps~~~~l~  330 (345)
T 3hko_A          323 FDAMRALQ  330 (345)
T ss_dssp             CCHHHHHH
T ss_pred             CCHHHHhc
Confidence            99999854

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=7.9e-45  Score=346.65  Aligned_cols=261  Identities=22%  Similarity=0.277  Sum_probs=187.3

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch-hHhHHHHHHHHHccC-CCceeeeeeeEe--------cC
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI-RITERELLRIISQVN-HKNVVKILGLCL--------ET  154 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~-hpniv~l~~~~~--------~~  154 (414)
                      ..+|++.+.||+|+||.||+|.+. +++.||||++...... .....+++.++.++. ||||+++++++.        ..
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            457999999999999999999975 6899999998665433 233456678888885 999999999984        33


Q ss_pred             CcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccc
Q 015027          155 EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFES  234 (414)
Q Consensus       155 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGl  234 (414)
                      ...++||||++ |+|.+++........+++..++.++.||+.||.|||+.+ ++|+||||||+|||++.++.+||+|||+
T Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~  184 (337)
T 3ll6_A          107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGS  184 (337)
T ss_dssp             EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred             ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCcc
Confidence            45799999996 699998866444455789999999999999999999865 4599999999999999999999999999


Q ss_pred             cccccCCcccc----------ceecccccccccchhhc---ccCCCCCcccchhHHHHHHHHHhCCCCCCcccccccccc
Q 015027          235 SVLISSDAETA----------MSTILIGTSGYLDPVCI---NTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKI  301 (414)
Q Consensus       235 a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~  301 (414)
                      +..........          ......||+.|+|||++   .+..++.++|||||||++|+|++|+.||........   
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~---  261 (337)
T 3ll6_A          185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI---  261 (337)
T ss_dssp             CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred             ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh---
Confidence            98765432211          11244689999999998   567789999999999999999999999964321110   


Q ss_pred             ccchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHhhh
Q 015027          302 SMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLHE  369 (414)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~~~  369 (414)
                                .............        +..+.+|+.+||+.||.+|||+.++++.|+.+.....
T Consensus       262 ----------~~~~~~~~~~~~~--------~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~  311 (337)
T 3ll6_A          262 ----------VNGKYSIPPHDTQ--------YTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN  311 (337)
T ss_dssp             --------------CCCCTTCCS--------SGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred             ----------hcCcccCCccccc--------chHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence                      0000000000000        1337899999999999999999999999999876543

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=2.1e-44  Score=340.79  Aligned_cols=262  Identities=24%  Similarity=0.343  Sum_probs=194.6

Q ss_pred             HhcCCCCCCccccCCceEEEEEEEc----CCcEEEEEEeecccch---hHhHHHHHHHHHccCCCceeeeeeeEecCC--
Q 015027           85 ATKNFDRSRCLSQGGFVSVYKGVLH----DNIQVAVKTYRRADKI---RITERELLRIISQVNHKNVVKILGLCLETE--  155 (414)
Q Consensus        85 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~hpniv~l~~~~~~~~--  155 (414)
                      ..++|.+.+.||+|+||.||+|.+.    ++..||+|.+......   .....+++.++++++||||+++++++....  
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  111 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ  111 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred             CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence            3567889999999999999999864    2457999998755322   233466778999999999999999998755  


Q ss_pred             ---cceEEEEeCCCCchhhhhhhc---CCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEE
Q 015027          156 ---VPLLVYEFASNGTLLDHIRCE---SSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKV  229 (414)
Q Consensus       156 ---~~~lv~e~~~~gsL~~~l~~~---~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl  229 (414)
                         ..++||||+++++|.+++...   .....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||
T Consensus       112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl  188 (313)
T 3brb_A          112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCV  188 (313)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEE
T ss_pred             CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEE
Confidence               359999999999999998432   23345689999999999999999999987   999999999999999999999


Q ss_pred             eeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhh
Q 015027          230 ADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFL  308 (414)
Q Consensus       230 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~  308 (414)
                      +|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||.......         ..
T Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---------~~  259 (313)
T 3brb_A          189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE---------MY  259 (313)
T ss_dssp             CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---------HH
T ss_pred             eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH---------HH
Confidence            99999987654433333344567889999999999999999999999999999999 899986433211         11


Q ss_pred             hhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHh
Q 015027          309 NSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRL  367 (414)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~  367 (414)
                      ........     ..    .+...+..+.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus       260 ~~~~~~~~-----~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~  309 (313)
T 3brb_A          260 DYLLHGHR-----LK----QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES  309 (313)
T ss_dssp             HHHHTTCC-----CC----CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHcCCC-----CC----CCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            11111100     00    0111225599999999999999999999999999988754

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=2.2e-44  Score=347.47  Aligned_cols=205  Identities=26%  Similarity=0.284  Sum_probs=175.2

Q ss_pred             HHHHHHhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhHhHHHHHHHHHccC-----CCceeeeeeeEec
Q 015027           80 SEMIRATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRITERELLRIISQVN-----HKNVVKILGLCLE  153 (414)
Q Consensus        80 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~-----hpniv~l~~~~~~  153 (414)
                      .+.....++|.+.+.||+|+||.||+|.+. +++.||||++............++.++..+.     ||||+++++++..
T Consensus        28 ~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~  107 (360)
T 3llt_A           28 KKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY  107 (360)
T ss_dssp             CTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE
T ss_pred             ecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE
Confidence            333445689999999999999999999975 5889999999765444444455667777776     9999999999999


Q ss_pred             CCcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCC----------
Q 015027          154 TEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLND----------  223 (414)
Q Consensus       154 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~----------  223 (414)
                      .+..++||||+ +++|.+++...... .+++..+..++.||+.||.|||+.+   |+||||||+|||++.          
T Consensus       108 ~~~~~lv~e~~-~~~L~~~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~~~~  182 (360)
T 3llt_A          108 YDHMCLIFEPL-GPSLYEIITRNNYN-GFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITV  182 (360)
T ss_dssp             TTEEEEEECCC-CCBHHHHHHHTTTC-CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEEEEEE
T ss_pred             CCeeEEEEcCC-CCCHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccccccch
Confidence            99999999999 88999999765432 3588999999999999999999988   999999999999975          


Q ss_pred             ---------------CCcEEEeeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCC
Q 015027          224 ---------------NYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKK  288 (414)
Q Consensus       224 ---------------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~  288 (414)
                                     ++.+||+|||++......     .....||+.|+|||++.+..++.++|||||||++|+|++|+.
T Consensus       183 ~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~  257 (360)
T 3llt_A          183 RRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSL  257 (360)
T ss_dssp             ECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred             hcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCC
Confidence                           789999999999865432     234578999999999999999999999999999999999999


Q ss_pred             CCCccc
Q 015027          289 PGSCMT  294 (414)
Q Consensus       289 p~~~~~  294 (414)
                      ||....
T Consensus       258 pf~~~~  263 (360)
T 3llt_A          258 LFRTHE  263 (360)
T ss_dssp             SCCCSS
T ss_pred             CCCCCc
Confidence            997533

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-44  Score=342.78  Aligned_cols=259  Identities=25%  Similarity=0.397  Sum_probs=198.4

Q ss_pred             cCCCCCCccccCCceEEEEEEEcC-----CcEEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEecCCcceE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLHD-----NIQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLETEVPLL  159 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~l  159 (414)
                      ++|.+.+.||+|+||.||+|.+..     +..||||.+......  .....+++.++.+++||||+++++++...+..++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            567778999999999999998653     235999999765332  2334667789999999999999999999999999


Q ss_pred             EEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccccccc
Q 015027          160 VYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLIS  239 (414)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~  239 (414)
                      ||||+++++|.+++....  ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus       124 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  198 (333)
T 1mqb_A          124 ITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  198 (333)
T ss_dssp             EEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence            999999999999996543  23588999999999999999999988   9999999999999999999999999998765


Q ss_pred             CCcccc-ceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhcccccc
Q 015027          240 SDAETA-MSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLR  317 (414)
Q Consensus       240 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (414)
                      ...... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.......         ....+.... .
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~---------~~~~~~~~~-~  268 (333)
T 1mqb_A          199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE---------VMKAINDGF-R  268 (333)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---------HHHHHHTTC-C
T ss_pred             cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH---------HHHHHHCCC-c
Confidence            432211 1223356788999999999999999999999999999999 999996433211         111111110 0


Q ss_pred             cccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHhh
Q 015027          318 QILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLH  368 (414)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~~  368 (414)
                              ...+...+..+.+|+.+||+.+|.+|||+.++++.|+.+....
T Consensus       269 --------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~  311 (333)
T 1mqb_A          269 --------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP  311 (333)
T ss_dssp             --------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             --------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence                    0001112255899999999999999999999999999887643

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=2.7e-44  Score=342.16  Aligned_cols=249  Identities=21%  Similarity=0.292  Sum_probs=175.0

Q ss_pred             CCccccCCceEEEEEEEc-CCcEEEEEEeecccchhHhHHHHHHHHHccC-CCceeeeeeeEecCCcceEEEEeCCCCch
Q 015027           92 SRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRITERELLRIISQVN-HKNVVKILGLCLETEVPLLVYEFASNGTL  169 (414)
Q Consensus        92 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~~~gsL  169 (414)
                      .+.||+|+||.||+|.+. +++.||||++....  .....+++.++..+. ||||+++++++.++...|+||||+++|+|
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L   93 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM--EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL   93 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG--HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChhh--hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence            478999999999999976 58999999997542  233455668888886 99999999999999999999999999999


Q ss_pred             hhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCC---cEEEeeccccccccCCccccc
Q 015027          170 LDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNY---TAKVADFESSVLISSDAETAM  246 (414)
Q Consensus       170 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~---~~kl~DfGla~~~~~~~~~~~  246 (414)
                      .+++....   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++   .+||+|||++.......  ..
T Consensus        94 ~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~~  165 (325)
T 3kn6_A           94 FERIKKKK---HFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QP  165 (325)
T ss_dssp             HHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred             HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCC--Cc
Confidence            99997543   4588999999999999999999988   99999999999997665   89999999998654332  22


Q ss_pred             eecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccccCC
Q 015027          247 STILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVAD  326 (414)
Q Consensus       247 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (414)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||........  ..........+.....      ....
T Consensus       166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~~~~~~~~i~~~~~------~~~~  237 (325)
T 3kn6_A          166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLT--CTSAVEIMKKIKKGDF------SFEG  237 (325)
T ss_dssp             ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC---------CCCHHHHHHHHTTTCC------CCCS
T ss_pred             ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccc--cccHHHHHHHHHcCCC------CCCc
Confidence            3445789999999999999999999999999999999999999975332110  0000011111111110      0011


Q ss_pred             cccHHHHHHHHHHHHHhhccCCCCCCChhHHH
Q 015027          327 ESEMKEIEIVAELASKCLRIRGTERPTMKQVS  358 (414)
Q Consensus       327 ~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~  358 (414)
                      ......+..+.+|+.+||+.||.+|||+.+++
T Consensus       238 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell  269 (325)
T 3kn6_A          238 EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLR  269 (325)
T ss_dssp             HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTST
T ss_pred             ccccCCCHHHHHHHHHHCCCChhHCCCHHHHh
Confidence            11112236699999999999999999999984

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=3.1e-44  Score=333.17  Aligned_cols=252  Identities=24%  Similarity=0.334  Sum_probs=200.7

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYE  162 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  162 (414)
                      .++|++.+.||+|+||.||+|... +++.||||++......  .....+++.+++.++||||+++++++.+++..++|||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            467999999999999999999976 6899999999755432  2344667789999999999999999999999999999


Q ss_pred             eCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCc
Q 015027          163 FASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDA  242 (414)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  242 (414)
                      |+++++|.+++...   ..+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++.......
T Consensus        86 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  159 (276)
T 2yex_A           86 YCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (276)
T ss_dssp             CCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             ecCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence            99999999998543   34588999999999999999999988   9999999999999999999999999998765433


Q ss_pred             cccceecccccccccchhhcccCCC-CCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccc
Q 015027          243 ETAMSTILIGTSGYLDPVCINTGKL-TKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILN  321 (414)
Q Consensus       243 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (414)
                      .........||+.|+|||++.+..+ +.++||||||+++|+|++|..||........        ....+.....  ...
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--------~~~~~~~~~~--~~~  229 (276)
T 2yex_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--------EYSDWKEKKT--YLN  229 (276)
T ss_dssp             EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH--------HHHHHHTTCT--TST
T ss_pred             chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH--------HHHHhhhccc--ccC
Confidence            3333445678999999999987765 7899999999999999999999974332110        0000000000  000


Q ss_pred             cccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          322 FHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       322 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                            .....+..+.+|+.+||+.||.+|||+.++++
T Consensus       230 ------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          230 ------PWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             ------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ------chhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence                  00111255899999999999999999999843

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=3.6e-44  Score=344.64  Aligned_cols=251  Identities=21%  Similarity=0.278  Sum_probs=187.2

Q ss_pred             HhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEe
Q 015027           85 ATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        85 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  163 (414)
                      ..++|.+.+.||+|+||.||+|.+. +++.||||++..... ......++.++.+++||||++++++|...+..++||||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  129 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD-KKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL  129 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchh-HHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence            4578999999999999999999986 488999999976542 23345567899999999999999999999999999999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCC---CCcEEEeeccccccccC
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLND---NYTAKVADFESSVLISS  240 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~DfGla~~~~~  240 (414)
                      +++++|.+++....   .+++..++.++.||+.||.|||+.+   |+||||||+|||++.   ++.+||+|||++.....
T Consensus       130 ~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~  203 (349)
T 2w4o_A          130 VTGGELFDRIVEKG---YYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH  203 (349)
T ss_dssp             CCSCBHHHHHTTCS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred             CCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence            99999999986533   3588999999999999999999988   999999999999975   89999999999987643


Q ss_pred             CccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccc
Q 015027          241 DAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQIL  320 (414)
Q Consensus       241 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (414)
                      .   .......||+.|+|||++.+..++.++|||||||++|||++|..||.......        .....+...... ..
T Consensus       204 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--------~~~~~i~~~~~~-~~  271 (349)
T 2w4o_A          204 Q---VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ--------FMFRRILNCEYY-FI  271 (349)
T ss_dssp             ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH--------HHHHHHHTTCCC-CC
T ss_pred             c---cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH--------HHHHHHHhCCCc-cC
Confidence            2   22344679999999999999999999999999999999999999986432111        011111111100 00


Q ss_pred             ccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          321 NFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       321 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      .+     .....+..+.+|+.+||+.||++|||+.++++
T Consensus       272 ~~-----~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          272 SP-----WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             TT-----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             Cc-----hhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00     11112356899999999999999999999865

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=4e-45  Score=370.45  Aligned_cols=257  Identities=27%  Similarity=0.400  Sum_probs=207.0

Q ss_pred             HhcCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeC
Q 015027           85 ATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFA  164 (414)
Q Consensus        85 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  164 (414)
                      ..++|.+.+.||+|+||.||+|.+.++..||||++.........+.++++++++++||||+++++++.+ +..++||||+
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~  343 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM  343 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence            346788899999999999999999888889999998766555566778899999999999999999876 6789999999


Q ss_pred             CCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccc
Q 015027          165 SNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET  244 (414)
Q Consensus       165 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  244 (414)
                      ++|+|.+++..... ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++...... .
T Consensus       344 ~~gsL~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~  418 (535)
T 2h8h_A          344 SKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE-Y  418 (535)
T ss_dssp             TTEEHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH-H
T ss_pred             cCCcHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCc-e
Confidence            99999999964322 23578999999999999999999988   9999999999999999999999999998764321 1


Q ss_pred             cceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhcccccccccccc
Q 015027          245 AMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFH  323 (414)
Q Consensus       245 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (414)
                      .......++..|+|||++.+..++.++|||||||++|||++ |+.||.......         ....+... ...     
T Consensus       419 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~---------~~~~i~~~-~~~-----  483 (535)
T 2h8h_A          419 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERG-YRM-----  483 (535)
T ss_dssp             HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH---------HHHHHHTT-CCC-----
T ss_pred             ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---------HHHHHHcC-CCC-----
Confidence            11223356788999999999999999999999999999999 999997543211         11111111 000     


Q ss_pred             cCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHH
Q 015027          324 VADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLR  365 (414)
Q Consensus       324 ~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~  365 (414)
                         ..+...+..+.+|+.+||+.||++|||+.+|++.|+.+.
T Consensus       484 ---~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~  522 (535)
T 2h8h_A          484 ---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  522 (535)
T ss_dssp             ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             ---CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence               011112256899999999999999999999999988764

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=7.3e-45  Score=348.96  Aligned_cols=265  Identities=17%  Similarity=0.148  Sum_probs=194.5

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc----CCcEEEEEEeecccchhH------------hHHHHHHHHHccCCCceeeeee
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH----DNIQVAVKTYRRADKIRI------------TERELLRIISQVNHKNVVKILG  149 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~------------~~~~~~~~l~~l~hpniv~l~~  149 (414)
                      .++|.+.+.||+|+||.||+|.+.    ++..+|||++........            ...+++..+..++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            367999999999999999999975    577899999876543211            1234456788899999999999


Q ss_pred             eEec----CCcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCC
Q 015027          150 LCLE----TEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNY  225 (414)
Q Consensus       150 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~  225 (414)
                      ++..    ....|+||||+ +++|.+++....   .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~  188 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN  188 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence            9987    67889999999 999999996544   5689999999999999999999987   99999999999998877


Q ss_pred             --cEEEeeccccccccCCccc-----cceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccc
Q 015027          226 --TAKVADFESSVLISSDAET-----AMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASN  298 (414)
Q Consensus       226 --~~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~  298 (414)
                        .+||+|||+++........     .......||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus       189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~  268 (345)
T 2v62_A          189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV  268 (345)
T ss_dssp             TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred             CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence              9999999999876432211     112345799999999999999999999999999999999999999953211110


Q ss_pred             cccccchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHH
Q 015027          299 KKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLR  365 (414)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~  365 (414)
                      ..    ........ ......+......   ...+..+.+|+.+||+.||.+|||+.+|++.|+.+.
T Consensus       269 ~~----~~~~~~~~-~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  327 (345)
T 2v62_A          269 AV----QTAKTNLL-DELPQSVLKWAPS---GSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG  327 (345)
T ss_dssp             HH----HHHHHHHH-HTTTHHHHHHSCT---TSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred             HH----HHHHHhhc-ccccHHHHhhccc---cccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence            00    00000000 0000000000000   011246999999999999999999999999887644

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=5.7e-44  Score=334.68  Aligned_cols=269  Identities=19%  Similarity=0.217  Sum_probs=201.3

Q ss_pred             HHhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeE-ecCCcceEEE
Q 015027           84 RATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLC-LETEVPLLVY  161 (414)
Q Consensus        84 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~-~~~~~~~lv~  161 (414)
                      ...++|.+.+.||+|+||.||+|.+. +++.||||++....... ....++.++..++|++++..+..+ ...+..++||
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP-QLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CC-CHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccch-HHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            34578999999999999999999974 68999999876554332 344556888889888877776665 5677789999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceee---CCCCcEEEeeccccccc
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILL---NDNYTAKVADFESSVLI  238 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~DfGla~~~  238 (414)
                      ||+ +++|.+++.....  .+++..++.++.||+.||.|||+.+   |+||||||+|||+   +.++.+||+|||++...
T Consensus        85 e~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~  158 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             ECC-CCBHHHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             Ecc-CCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence            999 9999999864433  3588999999999999999999988   9999999999999   78999999999999876


Q ss_pred             cCCccc-----cceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcc
Q 015027          239 SSDAET-----AMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKN  313 (414)
Q Consensus       239 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  313 (414)
                      ......     .......||+.|+|||++.+..++.++|||||||++|+|++|+.||..........  .....    ..
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~~~~~----~~  232 (296)
T 4hgt_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ--KYERI----SE  232 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSS--HHHHH----HH
T ss_pred             cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhh--hhhhh----hc
Confidence            543221     12235679999999999999999999999999999999999999997543221110  00000    00


Q ss_pred             cccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHhhhh
Q 015027          314 NGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLHEN  370 (414)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~~~~  370 (414)
                      ....... ......    .+..+.+|+.+||+.||.+|||+.++++.|+.+......
T Consensus       233 ~~~~~~~-~~~~~~----~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~  284 (296)
T 4hgt_A          233 KKMSTPI-EVLCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF  284 (296)
T ss_dssp             HHHHSCH-HHHTTT----SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred             ccccchh-hhhhcc----CCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCC
Confidence            0000000 000000    125599999999999999999999999999998765443

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.7e-44  Score=348.06  Aligned_cols=246  Identities=24%  Similarity=0.288  Sum_probs=192.4

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhH----hHHHHHHH-HHccCCCceeeeeeeEecCCcceE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRI----TERELLRI-ISQVNHKNVVKILGLCLETEVPLL  159 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~----~~~~~~~~-l~~l~hpniv~l~~~~~~~~~~~l  159 (414)
                      .++|++.+.||+|+||.||+|+.. ++..||||++........    ....+..+ ++.++||||++++++|.+.+..|+
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            467999999999999999999976 488999999986543221    11222233 567899999999999999999999


Q ss_pred             EEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccccccc
Q 015027          160 VYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLIS  239 (414)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~  239 (414)
                      ||||++||+|.+++....   .+++..++.++.||+.||.|||+++   |+||||||+|||++.+|.+||+|||+++...
T Consensus       117 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~  190 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRER---CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI  190 (373)
T ss_dssp             EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred             EEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence            999999999999996543   3478888999999999999999988   9999999999999999999999999998643


Q ss_pred             CCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccc
Q 015027          240 SDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQI  319 (414)
Q Consensus       240 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (414)
                      ..  .......+||+.|+|||++.+..++.++|||||||++|||++|..||.......         ....+.....   
T Consensus       191 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---------~~~~i~~~~~---  256 (373)
T 2r5t_A          191 EH--NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE---------MYDNILNKPL---  256 (373)
T ss_dssp             CC--CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH---------HHHHHHHSCC---
T ss_pred             cC--CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH---------HHHHHHhccc---
Confidence            22  122345689999999999999999999999999999999999999997433211         1111111100   


Q ss_pred             cccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHH
Q 015027          320 LNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVS  358 (414)
Q Consensus       320 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~  358 (414)
                         .+...    .+..+.+|+.+||+.||.+||++.+.+
T Consensus       257 ---~~~~~----~~~~~~~li~~lL~~dp~~R~~~~~~~  288 (373)
T 2r5t_A          257 ---QLKPN----ITNSARHLLEGLLQKDRTKRLGAKDDF  288 (373)
T ss_dssp             ---CCCSS----SCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred             ---CCCCC----CCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence               01111    125589999999999999999986443

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.7e-44  Score=343.79  Aligned_cols=262  Identities=24%  Similarity=0.335  Sum_probs=202.4

Q ss_pred             hcCCCCCCccccCCceEEEEEEE------cCCcEEEEEEeecccc--hhHhHHHHHHHHHccCCCceeeeeeeEecCCcc
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVL------HDNIQVAVKTYRRADK--IRITERELLRIISQVNHKNVVKILGLCLETEVP  157 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~--~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~  157 (414)
                      .++|.+.+.||+|+||.||+|.+      .++..||||.+.....  .......++.++++++||||+++++++......
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            46899999999999999999983      2477899999965432  223345677899999999999999999999999


Q ss_pred             eEEEEeCCCCchhhhhhhcCC----cccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCC---CCcEEEe
Q 015027          158 LLVYEFASNGTLLDHIRCESS----QVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLND---NYTAKVA  230 (414)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~  230 (414)
                      |+||||+++++|.+++.....    ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.   +..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence            999999999999999976532    134688899999999999999999988   999999999999984   4569999


Q ss_pred             eccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhh
Q 015027          231 DFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLN  309 (414)
Q Consensus       231 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~  309 (414)
                      |||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||.......         ...
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---------~~~  256 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---------VLE  256 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---------HHH
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH---------HHH
Confidence            9999986544333333445578999999999999999999999999999999998 999986432111         111


Q ss_pred             hhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHhh
Q 015027          310 SIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLH  368 (414)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~~  368 (414)
                      ........     ....    ..+..+.+|+.+||+.||.+|||+.++++.|+.+....
T Consensus       257 ~~~~~~~~-----~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~  306 (327)
T 2yfx_A          257 FVTSGGRM-----DPPK----NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  306 (327)
T ss_dssp             HHHTTCCC-----CCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             HHhcCCCC-----CCCC----CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence            11111100     0011    11245899999999999999999999999999887543

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.4e-43  Score=330.28  Aligned_cols=250  Identities=22%  Similarity=0.314  Sum_probs=199.3

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchh---HhHHHHHHHHHccCCCceeeeeeeEecCCcceEEE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIR---ITERELLRIISQVNHKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~  161 (414)
                      .++|.+.+.||+|+||.||+|.+. +++.||+|++.......   ....+++.++++++||||+++++++..++..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            478999999999999999999976 58999999997654322   33356778999999999999999999999999999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCc---EEEeeccccccc
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYT---AKVADFESSVLI  238 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~---~kl~DfGla~~~  238 (414)
                      ||+++++|.+++....   .+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.   +||+|||++...
T Consensus        85 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~  158 (284)
T 3kk8_A           85 DLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  158 (284)
T ss_dssp             CCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             ecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence            9999999998886543   3588999999999999999999988   999999999999986655   999999999776


Q ss_pred             cCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccc
Q 015027          239 SSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQ  318 (414)
Q Consensus       239 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (414)
                      ....   ......||+.|+|||++.+..++.++||||||+++|+|++|..||.......         ............
T Consensus       159 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---------~~~~~~~~~~~~  226 (284)
T 3kk8_A          159 NDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---------LYAQIKAGAYDY  226 (284)
T ss_dssp             CSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---------HHHHHHHTCCCC
T ss_pred             ccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH---------HHHHHHhccccC
Confidence            5432   2234579999999999999999999999999999999999999996433211         111111111100


Q ss_pred             ccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          319 ILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       319 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                            ........++.+.+|+.+||+.||.+|||+.++++
T Consensus       227 ------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          227 ------PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             ------CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ------CchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                  00000112255899999999999999999999954

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2.8e-44  Score=335.89  Aligned_cols=250  Identities=26%  Similarity=0.408  Sum_probs=197.8

Q ss_pred             hcCCCCCCccccCCceEEEEEEEcC-C-------cEEEEEEeecccc-hhHhHHHHHHHHHccCCCceeeeeeeEecCCc
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLHD-N-------IQVAVKTYRRADK-IRITERELLRIISQVNHKNVVKILGLCLETEV  156 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~-~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~  156 (414)
                      .++|.+.+.||+|+||.||+|.+.. +       ..||+|++..... ......+++.++++++||||+++++++.+++.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            3678899999999999999999653 4       4699999976543 33445677899999999999999999999999


Q ss_pred             ceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCc--------EE
Q 015027          157 PLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYT--------AK  228 (414)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~--------~k  228 (414)
                      .++||||+++|+|.+++.....  .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.        +|
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKNKN--CINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGG--GCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             CEEEEECCCCCCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence            9999999999999999976432  2588899999999999999999988   999999999999998877        99


Q ss_pred             EeeccccccccCCccccceecccccccccchhhccc-CCCCCcccchhHHHHHHHHHhCC-CCCCccccccccccccchh
Q 015027          229 VADFESSVLISSDAETAMSTILIGTSGYLDPVCINT-GKLTKKSDVYSFGVVLAELLTGK-KPGSCMTLASNKKISMVPY  306 (414)
Q Consensus       229 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~-~p~~~~~~~~~~~~~~~~~  306 (414)
                      |+|||++......      ....||+.|+|||++.+ ..++.++|||||||++|+|++|. +||.......         
T Consensus       162 l~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~---------  226 (289)
T 4fvq_A          162 LSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR---------  226 (289)
T ss_dssp             ECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---------
T ss_pred             eccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH---------
Confidence            9999998755321      23467899999999987 77999999999999999999954 5554222110         


Q ss_pred             hhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHH
Q 015027          307 FLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR  366 (414)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~  366 (414)
                      .......   ...+.....        ..+.+|+.+||+.||.+|||+.++++.|+.+..
T Consensus       227 ~~~~~~~---~~~~~~~~~--------~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~  275 (289)
T 4fvq_A          227 KLQFYED---RHQLPAPKA--------AELANLINNCMDYEPDHRPSFRAIIRDLNSLFT  275 (289)
T ss_dssp             HHHHHHT---TCCCCCCSS--------CTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred             HHHHhhc---cCCCCCCCC--------HHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            0000000   001111111        338999999999999999999999999887653

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=4.2e-44  Score=338.28  Aligned_cols=265  Identities=24%  Similarity=0.334  Sum_probs=197.1

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc----hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK----IRITERELLRIISQVNHKNVVKILGLCLETEVPLLV  160 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv  160 (414)
                      .++|.+.+.||+|+||.||+|... +|+.||||++.....    ......+++.++++++||||+++++++...+..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            367999999999999999999975 689999999975321    223346677899999999999999999999999999


Q ss_pred             EEeCCCCchhhhhhhcC-CcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccccccc
Q 015027          161 YEFASNGTLLDHIRCES-SQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLIS  239 (414)
Q Consensus       161 ~e~~~~gsL~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~  239 (414)
                      |||+++++|.+++.... ....+++..++.++.||+.||.|||+.+   ++|+||||+||+++.++.+||+|||++....
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            99999999999986422 2344588999999999999999999988   9999999999999999999999999987664


Q ss_pred             CCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccc
Q 015027          240 SDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQI  319 (414)
Q Consensus       240 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (414)
                      ...  .......||+.|+|||++.+..++.++||||||+++|+|++|..||.......      . ..............
T Consensus       188 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~-~~~~~~~~~~~~~~  258 (310)
T 2wqm_A          188 SKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL------Y-SLCKKIEQCDYPPL  258 (310)
T ss_dssp             -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH------H-HHHHHHHTTCSCCC
T ss_pred             CCC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH------H-HHHHHhhcccCCCC
Confidence            322  12234578999999999999999999999999999999999999986432110      0 00111111111111


Q ss_pred             cccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHhhhh
Q 015027          320 LNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLHEN  370 (414)
Q Consensus       320 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~~~~  370 (414)
                      .        ....+..+.+|+.+||+.||.+|||+.+|++.|+.+......
T Consensus       259 ~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~  301 (310)
T 2wqm_A          259 P--------SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS  301 (310)
T ss_dssp             C--------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred             c--------ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence            0        011125599999999999999999999999999999865443

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=7.9e-44  Score=354.64  Aligned_cols=245  Identities=24%  Similarity=0.323  Sum_probs=200.0

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc----hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK----IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~  161 (414)
                      ++|.+.+.||+|+||.||+|.+. +|+.||||++.....    ......+++.+++.++||||+++++++...+..|+||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            67899999999999999999976 699999999976432    1234466779999999999999999999999999999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCC
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD  241 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  241 (414)
                      ||+++|+|.+++...   ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        96 E~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~  169 (476)
T 2y94_A           96 EYVSGGELFDYICKN---GRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  169 (476)
T ss_dssp             ECCSSEEHHHHTTSS---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred             eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence            999999999999643   33588999999999999999999987   999999999999999999999999999876542


Q ss_pred             ccccceecccccccccchhhcccCCC-CCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccc
Q 015027          242 AETAMSTILIGTSGYLDPVCINTGKL-TKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQIL  320 (414)
Q Consensus       242 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (414)
                         ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.......         ....+.....    
T Consensus       170 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~---------~~~~i~~~~~----  233 (476)
T 2y94_A          170 ---EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT---------LFKKICDGIF----  233 (476)
T ss_dssp             ---CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH---------HHHHHHTTCC----
T ss_pred             ---ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH---------HHHHHhcCCc----
Confidence               22344589999999999988766 689999999999999999999997432111         1111111110    


Q ss_pred             ccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          321 NFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       321 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                        ..+.    ..+..+.+|+.+||+.||.+|||+.++++
T Consensus       234 --~~p~----~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          234 --YTPQ----YLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             --CCCT----TCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             --CCCc----cCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence              0001    11245899999999999999999999975

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=6.3e-44  Score=341.05  Aligned_cols=241  Identities=22%  Similarity=0.287  Sum_probs=197.5

Q ss_pred             HhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch---------hHhHHHHHHHHHccCCCceeeeeeeEecC
Q 015027           85 ATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI---------RITERELLRIISQVNHKNVVKILGLCLET  154 (414)
Q Consensus        85 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~~~~l~~l~hpniv~l~~~~~~~  154 (414)
                      ..++|.+.+.||+|+||.||+|.+. +++.||||++......         ......++.++++++||||++++++|.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            4578999999999999999999965 5889999999865321         11234567899999999999999999999


Q ss_pred             CcceEEEEeCCCC-chhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecc
Q 015027          155 EVPLLVYEFASNG-TLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFE  233 (414)
Q Consensus       155 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG  233 (414)
                      +..++||||+.+| +|.+++....   .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg  175 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRHP---RLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG  175 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTCC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred             CEEEEEEEeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence            9999999999777 9999886543   3588999999999999999999988   9999999999999999999999999


Q ss_pred             ccccccCCccccceecccccccccchhhcccCCC-CCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhc
Q 015027          234 SSVLISSDAETAMSTILIGTSGYLDPVCINTGKL-TKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIK  312 (414)
Q Consensus       234 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  312 (414)
                      ++.......   ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.......               
T Consensus       176 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---------------  237 (335)
T 3dls_A          176 SAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV---------------  237 (335)
T ss_dssp             TCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT---------------
T ss_pred             cceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH---------------
Confidence            998765432   2234579999999999988877 889999999999999999999996322110               


Q ss_pred             ccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          313 NNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ..    ....  ...    .+..+.+|+.+||+.||.+|||+.++++
T Consensus       238 ~~----~~~~--~~~----~~~~l~~li~~~L~~dP~~Rps~~ell~  274 (335)
T 3dls_A          238 EA----AIHP--PYL----VSKELMSLVSGLLQPVPERRTTLEKLVT  274 (335)
T ss_dssp             TT----CCCC--SSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hh----ccCC--Ccc----cCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00    0000  000    1255899999999999999999999965

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=8.5e-44  Score=335.97  Aligned_cols=265  Identities=22%  Similarity=0.248  Sum_probs=192.8

Q ss_pred             HhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc---------hhHhHHHHHHHHHccCCCceeeeeeeEecC
Q 015027           85 ATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK---------IRITERELLRIISQVNHKNVVKILGLCLET  154 (414)
Q Consensus        85 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~~~~l~~l~hpniv~l~~~~~~~  154 (414)
                      ..++|++.+.||+|+||+||+|.+. +++.||||++.....         ....+.+.++.+..++||||++++++|...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            4678999999999999999999964 689999999874321         112223334455556699999999999876


Q ss_pred             C-----cceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEE
Q 015027          155 E-----VPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKV  229 (414)
Q Consensus       155 ~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl  229 (414)
                      .     ..++||||++ ++|.+++..... ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl  161 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP-PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL  161 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence            5     4799999997 599999865443 23689999999999999999999988   999999999999999999999


Q ss_pred             eeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhh
Q 015027          230 ADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLN  309 (414)
Q Consensus       230 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~  309 (414)
                      +|||++......   .......||+.|+|||++.+..++.++|||||||++|+|++|+.||........... +... ..
T Consensus       162 ~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~-i~~~-~~  236 (308)
T 3g33_A          162 ADFGLARIYSYQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGK-IFDL-IG  236 (308)
T ss_dssp             CSCSCTTTSTTC---CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHH-HHHH-HC
T ss_pred             eeCccccccCCC---cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHH-hC
Confidence            999999876432   223456889999999999999999999999999999999999999975432110000 0000 00


Q ss_pred             hhccccc-------ccccccccCCc---ccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          310 SIKNNGL-------RQILNFHVADE---SEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       310 ~~~~~~~-------~~~~~~~~~~~---~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      .......       ...+.......   .....+..+.+|+.+||+.||.+|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          237 LPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             CCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            0000000       00000000000   00011256899999999999999999999853

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.9e-44  Score=340.99  Aligned_cols=258  Identities=25%  Similarity=0.319  Sum_probs=191.3

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchh----HhHHHHHHHHHccCCCceeeeeeeEecCCcc---
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIR----ITERELLRIISQVNHKNVVKILGLCLETEVP---  157 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~---  157 (414)
                      .++|.+.+.||+|+||.||+|.+. +++.||||++.......    ....+++.++.+++||||+++++++......   
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            468999999999999999999974 68999999997653222    2345667888999999999999998766544   


Q ss_pred             -eEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccc
Q 015027          158 -LLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSV  236 (414)
Q Consensus       158 -~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~  236 (414)
                       |+||||+++++|.+++....   .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  164 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR  164 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred             cEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence             99999999999999996543   3588999999999999999999988   9999999999999999999999999998


Q ss_pred             cccCCccc-cceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccc
Q 015027          237 LISSDAET-AMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNG  315 (414)
Q Consensus       237 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (414)
                      ........ .......||+.|+|||++.+..++.++|||||||++|+|++|+.||........        .........
T Consensus       165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~--------~~~~~~~~~  236 (311)
T 3ork_A          165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV--------AYQHVREDP  236 (311)
T ss_dssp             -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--------HHHHHHCCC
T ss_pred             cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH--------HHHHhcCCC
Confidence            76543221 223345789999999999999999999999999999999999999974332110        000011100


Q ss_pred             cccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHH-HHHHHH
Q 015027          316 LRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVS-EELDRL  364 (414)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~-~~L~~i  364 (414)
                      ...   .....    ..+..+.+|+.+||+.||.+||++.+++ ..+..+
T Consensus       237 ~~~---~~~~~----~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          237 IPP---SARHE----GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             CCH---HHHST----TCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             CCc---ccccC----CCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence            000   00000    1125589999999999999999766554 444443

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=2.1e-44  Score=335.06  Aligned_cols=253  Identities=23%  Similarity=0.391  Sum_probs=196.9

Q ss_pred             hcCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecC-CcceEEEEeC
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLET-EVPLLVYEFA  164 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~-~~~~lv~e~~  164 (414)
                      .++|++.+.||+|+||.||+|.. .|+.||||++..... .....++++++++++||||+++++++... +..++||||+
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~   97 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT-AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   97 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchhH-HHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence            46789999999999999999987 588999999976542 34456677999999999999999997654 4789999999


Q ss_pred             CCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccc
Q 015027          165 SNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET  244 (414)
Q Consensus       165 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  244 (414)
                      ++++|.+++..... ..+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++......   
T Consensus        98 ~~~~L~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~---  170 (278)
T 1byg_A           98 AKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---  170 (278)
T ss_dssp             TTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             CCCCHHHHHHhccc-ccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc---
Confidence            99999999965432 23578889999999999999999988   999999999999999999999999998765432   


Q ss_pred             cceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhcccccccccccc
Q 015027          245 AMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFH  323 (414)
Q Consensus       245 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (414)
                        .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.......         ........ ..    ..
T Consensus       171 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---------~~~~~~~~-~~----~~  234 (278)
T 1byg_A          171 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---------VVPRVEKG-YK----MD  234 (278)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---------HHHHHTTT-CC----CC
T ss_pred             --ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---------HHHHHhcC-CC----CC
Confidence              123367889999999999999999999999999999998 999987433211         11111111 00    01


Q ss_pred             cCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHh
Q 015027          324 VADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRL  367 (414)
Q Consensus       324 ~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~  367 (414)
                      ..    ...+..+.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus       235 ~~----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~  274 (278)
T 1byg_A          235 AP----DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  274 (278)
T ss_dssp             CC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             Cc----ccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence            11    11225699999999999999999999999999998753

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.7e-44  Score=335.13  Aligned_cols=257  Identities=24%  Similarity=0.326  Sum_probs=198.3

Q ss_pred             CCCCCCccccCCceEEEEEEEcC-C---cEEEEEEeecccchh--HhHHHHHHHHHccCCCceeeeeeeEecCCcc-eEE
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLHD-N---IQVAVKTYRRADKIR--ITERELLRIISQVNHKNVVKILGLCLETEVP-LLV  160 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~~~--~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~-~lv  160 (414)
                      .|...+.||+|+||+||+|.+.+ +   ..||+|.+.......  ....+++.+++.++||||+++++++.+.+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            45566889999999999998543 2   369999987644322  3346677899999999999999999876655 999


Q ss_pred             EEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccC
Q 015027          161 YEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISS  240 (414)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  240 (414)
                      |||+.+|+|.+++....  ..+++..++.++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++.....
T Consensus       102 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  176 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQ--RNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD  176 (298)
T ss_dssp             ECCCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred             EecccCCCHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence            99999999999996533  33478899999999999999999988   99999999999999999999999999986543


Q ss_pred             Ccc--ccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCC-CCccccccccccccchhhhhhhcccccc
Q 015027          241 DAE--TAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP-GSCMTLASNKKISMVPYFLNSIKNNGLR  317 (414)
Q Consensus       241 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (414)
                      ...  ........+|+.|+|||.+.+..++.++||||||+++|+|++|..| |.......         .........  
T Consensus       177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~---------~~~~~~~~~--  245 (298)
T 3pls_A          177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD---------LTHFLAQGR--  245 (298)
T ss_dssp             GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG---------HHHHHHTTC--
T ss_pred             CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH---------HHHHhhcCC--
Confidence            321  1222345678899999999999999999999999999999995554 44222111         001111100  


Q ss_pred             cccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHh
Q 015027          318 QILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRL  367 (414)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~  367 (414)
                             ....+...+..+.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus       246 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  288 (298)
T 3pls_A          246 -------RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA  288 (298)
T ss_dssp             -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -------CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence                   0000111125589999999999999999999999999988654

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=3e-44  Score=356.51  Aligned_cols=247  Identities=21%  Similarity=0.247  Sum_probs=193.4

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc----hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK----IRITERELLRIISQVNHKNVVKILGLCLETEVPLLV  160 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv  160 (414)
                      .++|++.+.||+|+||.||+|... +|+.||||++.....    .......++++++.++||||++++++|...+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            467999999999999999999975 589999999976422    112234566888899999999999999999999999


Q ss_pred             EEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhh-CCCCCeeeCCCCCCceeeCCCCcEEEeecccccccc
Q 015027          161 YEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHS-LASPPIIHGDVKSANILLNDNYTAKVADFESSVLIS  239 (414)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~  239 (414)
                      |||+++|+|.+++....   .+++..+..++.||+.||+|||+ .+   |+||||||+|||++.++.+||+|||++....
T Consensus       227 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  300 (446)
T 4ejn_A          227 MEYANGGELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI  300 (446)
T ss_dssp             ECCCSSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred             EeeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence            99999999999986543   35889999999999999999998 77   9999999999999999999999999997643


Q ss_pred             CCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccc
Q 015027          240 SDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQI  319 (414)
Q Consensus       240 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (414)
                      ..  .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.......         ....+.....   
T Consensus       301 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---------~~~~i~~~~~---  366 (446)
T 4ejn_A          301 KD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---------LFELILMEEI---  366 (446)
T ss_dssp             C-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---------HHHHHHHCCC---
T ss_pred             CC--CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH---------HHHHHHhCCC---
Confidence            32  122345689999999999999999999999999999999999999997433211         1111111110   


Q ss_pred             cccccCCcccHHHHHHHHHHHHHhhccCCCCCC-----ChhHHHH
Q 015027          320 LNFHVADESEMKEIEIVAELASKCLRIRGTERP-----TMKQVSE  359 (414)
Q Consensus       320 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rp-----s~~~v~~  359 (414)
                         ..+.    ..+..+.+|+.+||+.||.+||     |++++++
T Consensus       367 ---~~p~----~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          367 ---RFPR----TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             ---CCCT----TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ---CCCc----cCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence               0111    1125589999999999999999     8888853

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=3e-44  Score=341.99  Aligned_cols=258  Identities=27%  Similarity=0.414  Sum_probs=202.1

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcE--EEEEEeecccc--hhHhHHHHHHHHHcc-CCCceeeeeeeEecCCcceEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQ--VAVKTYRRADK--IRITERELLRIISQV-NHKNVVKILGLCLETEVPLLV  160 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~--vavK~~~~~~~--~~~~~~~~~~~l~~l-~hpniv~l~~~~~~~~~~~lv  160 (414)
                      ++|.+.+.||+|+||.||+|.+. ++..  +|+|.+.....  ......++++++.++ +||||+++++++.+.+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            67889999999999999999965 4654  49998875322  223346677899999 899999999999999999999


Q ss_pred             EEeCCCCchhhhhhhcC-------------CcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcE
Q 015027          161 YEFASNGTLLDHIRCES-------------SQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTA  227 (414)
Q Consensus       161 ~e~~~~gsL~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~  227 (414)
                      |||+++++|.+++....             ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence            99999999999996543             2235688999999999999999999988   9999999999999999999


Q ss_pred             EEeeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchh
Q 015027          228 KVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPY  306 (414)
Q Consensus       228 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~  306 (414)
                      ||+|||++......   .......+++.|+|||++.+..++.++|||||||++|+|++ |..||.......         
T Consensus       182 kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~---------  249 (327)
T 1fvr_A          182 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---------  249 (327)
T ss_dssp             EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---------
T ss_pred             EEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH---------
Confidence            99999998743321   12233467889999999999999999999999999999998 999997443211         


Q ss_pred             hhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHhh
Q 015027          307 FLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLH  368 (414)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~~  368 (414)
                      ........ ..    ....    ...+..+.+|+.+||+.||.+|||+.++++.|+.+....
T Consensus       250 ~~~~~~~~-~~----~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  302 (327)
T 1fvr_A          250 LYEKLPQG-YR----LEKP----LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  302 (327)
T ss_dssp             HHHHGGGT-CC----CCCC----TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             HHHHhhcC-CC----CCCC----CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence            11111111 00    0011    112255999999999999999999999999999887643

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=9.4e-44  Score=330.53  Aligned_cols=248  Identities=22%  Similarity=0.343  Sum_probs=179.1

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch----hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI----RITERELLRIISQVNHKNVVKILGLCLETEVPLLV  160 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv  160 (414)
                      .++|.+.+.||+|+||.||+|... +++.||||++......    .....+++.++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            367999999999999999999974 6899999999754321    23446677899999999999999999999999999


Q ss_pred             EEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccC
Q 015027          161 YEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISS  240 (414)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  240 (414)
                      |||+++++|.+++....  ..+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.....
T Consensus        90 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  164 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRV--KPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM  164 (278)
T ss_dssp             EECCTTEEHHHHHHTCS--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             EecCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence            99999999999986543  34588999999999999999999988   99999999999999999999999999987653


Q ss_pred             CccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccc
Q 015027          241 DAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQIL  320 (414)
Q Consensus       241 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (414)
                      ...  ......||+.|+|||++.+..++.++||||||+++|+|++|+.||........         .......      
T Consensus       165 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---------~~~~~~~------  227 (278)
T 3cok_A          165 PHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT---------LNKVVLA------  227 (278)
T ss_dssp             -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------CCSS------
T ss_pred             CCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH---------HHHHhhc------
Confidence            221  22345789999999999999999999999999999999999999974332110         0000000      


Q ss_pred             ccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          321 NFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       321 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      +...+.    ..+..+.+|+.+||+.||.+|||+.++++
T Consensus       228 ~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          228 DYEMPS----FLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             CCCCCT----TSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ccCCcc----ccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            000111    11245899999999999999999999853

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=9.5e-45  Score=345.47  Aligned_cols=273  Identities=21%  Similarity=0.245  Sum_probs=205.5

Q ss_pred             cCCCCCCccccCCceEEEEEEE-----cCCcEEEEEEeecccch-hHhHHHHHHHHHccCCCceeeeeeeEe--cCCcce
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVL-----HDNIQVAVKTYRRADKI-RITERELLRIISQVNHKNVVKILGLCL--ETEVPL  158 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~hpniv~l~~~~~--~~~~~~  158 (414)
                      ++|++.+.||+|+||.||+|.+     .+++.||||++...... .....++++++++++||||+++++++.  +....+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            6789999999999999999984     35889999999765433 233467789999999999999999987  456689


Q ss_pred             EEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccc
Q 015027          159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLI  238 (414)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~  238 (414)
                      +||||+++++|.+++.....  .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus       103 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  177 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLL  177 (327)
T ss_dssp             EEEECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred             EEEeecCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceec
Confidence            99999999999999975433  3588999999999999999999987   999999999999999999999999999876


Q ss_pred             cCCccc-cceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccc
Q 015027          239 SSDAET-AMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLR  317 (414)
Q Consensus       239 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (414)
                      ...... .......+|+.|+|||++.+..++.++||||||+++|+|++|..||.................   .......
T Consensus       178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~  254 (327)
T 3lxl_A          178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDV---PALSRLL  254 (327)
T ss_dssp             CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----C---CHHHHHH
T ss_pred             ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhccccccc---ccHHHHH
Confidence            543221 122345688889999999999999999999999999999999999864332110000000000   0000000


Q ss_pred             cccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHh
Q 015027          318 QILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRL  367 (414)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~  367 (414)
                      ..+........+...+..+.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus       255 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  304 (327)
T 3lxl_A          255 ELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG  304 (327)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred             HHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence            01111111111222235699999999999999999999999999987654

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=5.1e-44  Score=335.68  Aligned_cols=258  Identities=27%  Similarity=0.376  Sum_probs=198.3

Q ss_pred             hcCCCCCCccccCCceEEEEEEEcC----CcEEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEe-cCCcce
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLHD----NIQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCL-ETEVPL  158 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~-~~~~~~  158 (414)
                      ..+|.+.+.||+|+||.||+|.+.+    ...+|+|.+......  ......++.++++++||||+++++++. .++..+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            3568888999999999999998643    235899998764332  233466778999999999999999865 456789


Q ss_pred             EEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccc
Q 015027          159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLI  238 (414)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~  238 (414)
                      +||||+++|+|.+++....  ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus       104 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~  178 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM  178 (298)
T ss_dssp             EEEECCTTCBHHHHHHCTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred             EEEeCCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccc
Confidence            9999999999999996543  33478899999999999999999988   999999999999999999999999999866


Q ss_pred             cCCccc--cceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhcccc
Q 015027          239 SSDAET--AMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNG  315 (414)
Q Consensus       239 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (414)
                      ......  .......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||.......         ........ 
T Consensus       179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---------~~~~~~~~-  248 (298)
T 3f66_A          179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---------ITVYLLQG-  248 (298)
T ss_dssp             SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT---------HHHHHHTT-
T ss_pred             cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH---------HHHHHhcC-
Confidence            543211  12234567889999999999999999999999999999999 566665332111         00000000 


Q ss_pred             cccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHH
Q 015027          316 LRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR  366 (414)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~  366 (414)
                      ......    .    ..+..+.+|+.+||+.||.+|||+.++++.|+.+..
T Consensus       249 ~~~~~~----~----~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  291 (298)
T 3f66_A          249 RRLLQP----E----YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  291 (298)
T ss_dssp             CCCCCC----T----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCC----c----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            000001    1    112458999999999999999999999999998875

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=5.6e-44  Score=343.10  Aligned_cols=245  Identities=26%  Similarity=0.347  Sum_probs=195.1

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch----hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI----RITERELLRIISQVNHKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~  161 (414)
                      +.|...+.||+|+||.||+|... +++.||||++......    .....++++++++++||||+++++++..++..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            45888999999999999999964 6899999999754322    123466778999999999999999999999999999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCC
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD  241 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  241 (414)
                      ||++ |+|.+++....  ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus       134 e~~~-g~l~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~  207 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  207 (348)
T ss_dssp             ECCS-EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred             ecCC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence            9997 58888775433  34588999999999999999999988   999999999999999999999999999765432


Q ss_pred             ccccceecccccccccchhhcc---cCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccc
Q 015027          242 AETAMSTILIGTSGYLDPVCIN---TGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQ  318 (414)
Q Consensus       242 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (414)
                            ....||+.|+|||++.   +..++.++|||||||++|||++|+.||.......         ............
T Consensus       208 ------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~---------~~~~~~~~~~~~  272 (348)
T 1u5q_A          208 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---------ALYHIAQNESPA  272 (348)
T ss_dssp             ------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---------HHHHHHHSCCCC
T ss_pred             ------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---------HHHHHHhcCCCC
Confidence                  2357999999999984   5678999999999999999999999986433111         000111111111


Q ss_pred             ccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHH
Q 015027          319 ILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEE  360 (414)
Q Consensus       319 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~  360 (414)
                      ...        ...+..+.+|+.+||+.||.+|||+.++++.
T Consensus       273 ~~~--------~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          273 LQS--------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             CCC--------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             CCC--------CCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence            111        1112558999999999999999999999754

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=3.2e-43  Score=326.81  Aligned_cols=249  Identities=20%  Similarity=0.266  Sum_probs=198.7

Q ss_pred             hcCCCCCCccccCCceEEEEEEEcC-CcEEEEEEeecccch-hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEe
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLHD-NIQVAVKTYRRADKI-RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  163 (414)
                      .++|.+.+.||+|+||.||+|.+.. +..||+|.+...... .....++++++++++||||+++++++.+.+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL   87 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence            4679999999999999999999764 778999999765332 34456778999999999999999999999999999999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceee---CCCCcEEEeeccccccccC
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILL---NDNYTAKVADFESSVLISS  240 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~DfGla~~~~~  240 (414)
                      +++++|.+++....   .+++..++.++.|++.||.|||+.+   |+||||||+|||+   +.++.+||+|||++.....
T Consensus        88 ~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~  161 (277)
T 3f3z_A           88 CTGGELFERVVHKR---VFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP  161 (277)
T ss_dssp             CCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred             cCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence            99999999886543   3588999999999999999999988   9999999999999   7889999999999987653


Q ss_pred             CccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccc
Q 015027          241 DAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQIL  320 (414)
Q Consensus       241 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (414)
                      ..   ......||+.|+|||++.+. ++.++||||||+++|+|++|..||.......         ........... ..
T Consensus       162 ~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---------~~~~~~~~~~~-~~  227 (277)
T 3f3z_A          162 GK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE---------VMLKIREGTFT-FP  227 (277)
T ss_dssp             TS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---------HHHHHHHCCCC-CC
T ss_pred             cc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH---------HHHHHHhCCCC-CC
Confidence            32   23445799999999998754 9999999999999999999999997433211         11111111000 00


Q ss_pred             ccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          321 NFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       321 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ..     .....+..+.+|+.+||+.||.+|||+.++++
T Consensus       228 ~~-----~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          228 EK-----DWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             HH-----HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             ch-----hhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00     00011256899999999999999999999854

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=2.7e-44  Score=336.68  Aligned_cols=257  Identities=24%  Similarity=0.313  Sum_probs=200.1

Q ss_pred             hcCCCCCC-ccccCCceEEEEEEEc---CCcEEEEEEeecccch---hHhHHHHHHHHHccCCCceeeeeeeEecCCcce
Q 015027           86 TKNFDRSR-CLSQGGFVSVYKGVLH---DNIQVAVKTYRRADKI---RITERELLRIISQVNHKNVVKILGLCLETEVPL  158 (414)
Q Consensus        86 ~~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~  158 (414)
                      .++|.+.+ .||+|+||.||+|.+.   ++..||||++......   .....+++++++.++||||+++++++ ..+..+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence            46777777 9999999999999643   3688999999765322   33446678999999999999999999 566789


Q ss_pred             EEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccc
Q 015027          159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLI  238 (414)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~  238 (414)
                      +||||+++++|.+++....   .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus        94 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  167 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL  167 (291)
T ss_dssp             EEEECCTTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEeCCCCCHHHHHHhCc---CCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence            9999999999999997543   3578999999999999999999988   999999999999999999999999999876


Q ss_pred             cCCcccc-ceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhccccc
Q 015027          239 SSDAETA-MSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGL  316 (414)
Q Consensus       239 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (414)
                      ....... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.......         ..........
T Consensus       168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---------~~~~~~~~~~  238 (291)
T 1xbb_A          168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---------VTAMLEKGER  238 (291)
T ss_dssp             CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---------HHHHHHTTCC
T ss_pred             ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---------HHHHHHcCCC
Confidence            5432211 1223456788999999998899999999999999999999 999997433211         1111111110


Q ss_pred             ccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHh
Q 015027          317 RQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRL  367 (414)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~  367 (414)
                           ....    ...+..+.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus       239 -----~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  280 (291)
T 1xbb_A          239 -----MGCP----AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  280 (291)
T ss_dssp             -----CCCC----TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             -----CCCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence                 0011    11225699999999999999999999999999988654

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.5e-43  Score=336.30  Aligned_cols=250  Identities=23%  Similarity=0.286  Sum_probs=200.6

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch-------hHhHHHHHHHHHccCCCceeeeeeeEecCCcc
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI-------RITERELLRIISQVNHKNVVKILGLCLETEVP  157 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~  157 (414)
                      .++|.+.+.||+|+||.||+|... +|+.||+|++......       .....+++.++.+++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            467999999999999999999976 5899999999765321       23456677899999999999999999999999


Q ss_pred             eEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCC----cEEEeecc
Q 015027          158 LLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNY----TAKVADFE  233 (414)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~----~~kl~DfG  233 (414)
                      ++||||+++++|.+++....   .+++..++.++.|++.||.|||+.+   |+||||||+|||++.++    .+||+|||
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg  164 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTCS---CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred             EEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence            99999999999999996532   3578999999999999999999988   99999999999999887    79999999


Q ss_pred             ccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcc
Q 015027          234 SSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKN  313 (414)
Q Consensus       234 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  313 (414)
                      ++.......   ......||+.|+|||++.+..++.++||||||+++|+|++|..||.......         ....+..
T Consensus       165 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---------~~~~i~~  232 (321)
T 2a2a_A          165 LAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---------TLANITS  232 (321)
T ss_dssp             TCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---------HHHHHHT
T ss_pred             cceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH---------HHHHHHh
Confidence            998765432   2234579999999999999999999999999999999999999996433111         1111111


Q ss_pred             cccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          314 NGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ...  ..+....    ...+..+.+|+.+||+.||.+|||+.++++
T Consensus       233 ~~~--~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          233 VSY--DFDEEFF----SHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             TCC--CCCHHHH----TTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             ccc--ccChhhh----cccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            000  0000000    011255899999999999999999999975

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.4e-43  Score=329.61  Aligned_cols=245  Identities=30%  Similarity=0.392  Sum_probs=196.1

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc----hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK----IRITERELLRIISQVNHKNVVKILGLCLETEVPLLV  160 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv  160 (414)
                      .++|.+.+.||+|+||.||+|.+. ++..||||++.....    ......+++.++++++||||+++++++.+.+..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            467999999999999999999976 478899999975432    223346677899999999999999999999999999


Q ss_pred             EEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccC
Q 015027          161 YEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISS  240 (414)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  240 (414)
                      |||+++++|.+++....   .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus        88 ~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~  161 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS  161 (279)
T ss_dssp             ECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred             EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence            99999999999986543   3578999999999999999999987   99999999999999999999999999865433


Q ss_pred             CccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccc
Q 015027          241 DAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQIL  320 (414)
Q Consensus       241 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (414)
                      .    ......||+.|+|||++.+..++.++||||||+++|+|++|..||.......         .........     
T Consensus       162 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---------~~~~~~~~~-----  223 (279)
T 3fdn_A          162 S----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE---------TYKRISRVE-----  223 (279)
T ss_dssp             ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---------HHHHHHHTC-----
T ss_pred             c----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH---------HHHHHHhCC-----
Confidence            2    2234578999999999999999999999999999999999999997433111         111111000     


Q ss_pred             ccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          321 NFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       321 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                       .....    ..+..+.+|+.+||+.||.+|||+.++++
T Consensus       224 -~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~e~l~  257 (279)
T 3fdn_A          224 -FTFPD----FVTEGARDLISRLLKHNPSQRPMLREVLE  257 (279)
T ss_dssp             -CCCCT----TSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             -CCCCC----cCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence             00111    11255899999999999999999999965

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=3.8e-44  Score=333.85  Aligned_cols=250  Identities=23%  Similarity=0.354  Sum_probs=202.3

Q ss_pred             HhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEec----------
Q 015027           85 ATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLE----------  153 (414)
Q Consensus        85 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~----------  153 (414)
                      ...+|.+.+.||+|+||.||+|.+. +++.||+|.+.....   ...++++++++++||||+++++++..          
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   85 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE---KAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK   85 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSG---GGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccH---HHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence            3467999999999999999999986 689999999976542   33456788999999999999998854          


Q ss_pred             ------CCcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcE
Q 015027          154 ------TEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTA  227 (414)
Q Consensus       154 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~  227 (414)
                            ....++||||+++++|.+++..... ..+++..++.++.||+.||.|||+.+   |+|+||||+|||++.++.+
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~  161 (284)
T 2a19_B           86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG-EKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQV  161 (284)
T ss_dssp             ---CCEEEEEEEEECCCCSCBHHHHHHHGGG-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEE
T ss_pred             cccccCcceEEEEEeccCCCCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCE
Confidence                  3457999999999999999965432 34588999999999999999999987   9999999999999999999


Q ss_pred             EEeeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhh
Q 015027          228 KVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYF  307 (414)
Q Consensus       228 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~  307 (414)
                      ||+|||++.......   ......||+.|+|||++.+..++.++||||||+++|+|++|..|+....           ..
T Consensus       162 kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-----------~~  227 (284)
T 2a19_B          162 KIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS-----------KF  227 (284)
T ss_dssp             EECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH-----------HH
T ss_pred             EECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH-----------HH
Confidence            999999998765432   2234578999999999999999999999999999999999998864111           01


Q ss_pred             hhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHh
Q 015027          308 LNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRL  367 (414)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~  367 (414)
                      ........        .....    +..+.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus       228 ~~~~~~~~--------~~~~~----~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~  275 (284)
T 2a19_B          228 FTDLRDGI--------ISDIF----DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS  275 (284)
T ss_dssp             HHHHHTTC--------CCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred             HHHhhccc--------ccccC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence            11111111        11111    24589999999999999999999999999887654

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.3e-43  Score=331.14  Aligned_cols=251  Identities=24%  Similarity=0.296  Sum_probs=193.6

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYE  162 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  162 (414)
                      .++|.+.+.||+|+||.||+|... ++..||+|++......  ......+++++++++||||+++++++.+.+..++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            367899999999999999999975 5889999999765432  2444667799999999999999999999999999999


Q ss_pred             eCCCCchhhhhhhcC-CcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceee---CCCCcEEEeeccccccc
Q 015027          163 FASNGTLLDHIRCES-SQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILL---NDNYTAKVADFESSVLI  238 (414)
Q Consensus       163 ~~~~gsL~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~DfGla~~~  238 (414)
                      |+++|+|.+++.... ....+++..++.++.||+.||.|||+.+   |+||||||+|||+   +.++.+||+|||++...
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            999999999885432 2344688999999999999999999988   9999999999999   45688999999999866


Q ss_pred             cCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccc
Q 015027          239 SSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQ  318 (414)
Q Consensus       239 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (414)
                      ...   .......||+.|+|||++. ..++.++||||||+++|+|++|+.||.......         ........... 
T Consensus       178 ~~~---~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~---------~~~~~~~~~~~-  243 (285)
T 3is5_A          178 KSD---EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE---------VQQKATYKEPN-  243 (285)
T ss_dssp             ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---------HHHHHHHCCCC-
T ss_pred             CCc---ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH---------HHhhhccCCcc-
Confidence            533   2234457899999999986 578999999999999999999999997543211         10000000000 


Q ss_pred             ccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          319 ILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       319 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                       .... ...    .++.+.+|+.+||+.||.+|||+.++++
T Consensus       244 -~~~~-~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          244 -YAVE-CRP----LTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             -CCC---CC----CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             -cccc-cCc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             0000 000    1255899999999999999999999853

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.9e-44  Score=345.68  Aligned_cols=266  Identities=12%  Similarity=0.162  Sum_probs=202.0

Q ss_pred             hcCCCCCCccccCCceEEEEEEEcC---------CcEEEEEEeecccchhHhHHHHHHHHHccCCCceee----------
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLHD---------NIQVAVKTYRRADKIRITERELLRIISQVNHKNVVK----------  146 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~----------  146 (414)
                      .++|.+.+.||+|+||.||+|.+..         ++.||||++....    ...++++++.+++||||++          
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~~  116 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDG----RLFNEQNFFQRAAKPLQVNKWKKLYSTPL  116 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETTS----THHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEecccc----hHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence            3679999999999999999999763         7889999987652    3455668888899999987          


Q ss_pred             -----eeeeEec-CCcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCcee
Q 015027          147 -----ILGLCLE-TEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANIL  220 (414)
Q Consensus       147 -----l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIl  220 (414)
                           +++++.. +...++||||+ +++|.+++.... ...+++..++.++.||+.||.|||+.+   |+||||||+|||
T Consensus       117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl  191 (352)
T 2jii_A          117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIF  191 (352)
T ss_dssp             CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEE
T ss_pred             cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEE
Confidence                 5677765 67889999999 999999997542 234689999999999999999999987   999999999999


Q ss_pred             eCCCC--cEEEeeccccccccCCccc-----cceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCcc
Q 015027          221 LNDNY--TAKVADFESSVLISSDAET-----AMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCM  293 (414)
Q Consensus       221 l~~~~--~~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~  293 (414)
                      ++.++  .+||+|||++.........     .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  271 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC  271 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence            99998  9999999999876543211     1123457999999999999999999999999999999999999999743


Q ss_pred             ccccccccccchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHhh
Q 015027          294 TLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLH  368 (414)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~~  368 (414)
                      .........    ...... .....+......   ....+..+.+|+.+||+.||.+|||+.+|++.|+.+....
T Consensus       272 ~~~~~~~~~----~~~~~~-~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~  338 (352)
T 2jii_A          272 LPNTEDIMK----QKQKFV-DKPGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDL  338 (352)
T ss_dssp             TTCHHHHHH----HHHHHH-HSCCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             CcCHHHHHH----HHHhcc-CChhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhc
Confidence            311100000    000000 000111110000   0011255999999999999999999999999999887543

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.4e-43  Score=346.51  Aligned_cols=253  Identities=22%  Similarity=0.258  Sum_probs=187.0

Q ss_pred             hcCCCCC-CccccCCceEEEEEEEc-CCcEEEEEEeecccchhHhHHHHHHHH-HccCCCceeeeeeeEec----CCcce
Q 015027           86 TKNFDRS-RCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRITERELLRII-SQVNHKNVVKILGLCLE----TEVPL  158 (414)
Q Consensus        86 ~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~l-~~l~hpniv~l~~~~~~----~~~~~  158 (414)
                      .++|.+. +.||+|+||+||+|.+. +++.||||++....    ...+++.++ +..+||||++++++|..    ....|
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP----KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcch----hHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            3566666 68999999999999976 58899999996432    223333444 55689999999999875    56789


Q ss_pred             EEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCC---CCcEEEeecccc
Q 015027          159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLND---NYTAKVADFESS  235 (414)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~DfGla  235 (414)
                      +|||||++|+|.+++..... ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.   ++.+||+|||++
T Consensus       136 lv~E~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a  211 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA  211 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEeCCCCcHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccc
Confidence            99999999999999975432 34588999999999999999999988   999999999999997   789999999999


Q ss_pred             ccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccc
Q 015027          236 VLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNG  315 (414)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (414)
                      ......   ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||........     .......+....
T Consensus       212 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-----~~~~~~~i~~~~  283 (400)
T 1nxk_A          212 KETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----SPGMKTRIRMGQ  283 (400)
T ss_dssp             EECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSS-----CCSHHHHHHHTC
T ss_pred             cccCCC---CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccc-----cHHHHHHHHcCc
Confidence            865432   223456889999999999999999999999999999999999999974332110     000111111111


Q ss_pred             cccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHH
Q 015027          316 LRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEE  360 (414)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~  360 (414)
                      ..      .........+..+.+|+.+||+.||.+|||+.++++.
T Consensus       284 ~~------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          284 YE------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             CC------CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             cc------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            00      0000011123568999999999999999999999764

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.5e-44  Score=347.54  Aligned_cols=257  Identities=26%  Similarity=0.369  Sum_probs=189.7

Q ss_pred             CCCCCCccccCCceEEEEEEEcC--C--cEEEEEEeecccc--hhHhHHHHHHHHHccCCCceeeeeeeEec-CCcceEE
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLHD--N--IQVAVKTYRRADK--IRITERELLRIISQVNHKNVVKILGLCLE-TEVPLLV  160 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~--~~~~~~~~~~~l~~l~hpniv~l~~~~~~-~~~~~lv  160 (414)
                      .|.+.+.||+|+||.||+|.+.+  +  ..||||.+.....  ....+.+++.++++++||||+++++++.. ++..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            46667899999999999998642  2  4589999875432  22344667788999999999999998754 5678999


Q ss_pred             EEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccC
Q 015027          161 YEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISS  240 (414)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  240 (414)
                      |||+++|+|.+++.....  .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus       170 ~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~  244 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD  244 (373)
T ss_dssp             EECCTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EECCCCCCHHHHHhhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccc
Confidence            999999999999965433  3478889999999999999999988   99999999999999999999999999986643


Q ss_pred             Cccc--cceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhcccccc
Q 015027          241 DAET--AMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLR  317 (414)
Q Consensus       241 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (414)
                      ....  .......+|+.|+|||++.+..++.++|||||||++|||++ |.+||.......         ......... .
T Consensus       245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---------~~~~~~~~~-~  314 (373)
T 3c1x_A          245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---------ITVYLLQGR-R  314 (373)
T ss_dssp             -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---------HHHHHHTTC-C
T ss_pred             cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---------HHHHHHcCC-C
Confidence            2211  11233467889999999999999999999999999999999 678876433211         000011110 0


Q ss_pred             cccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHh
Q 015027          318 QILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRL  367 (414)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~  367 (414)
                      ....    .    ..+..+.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus       315 ~~~p----~----~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~  356 (373)
T 3c1x_A          315 LLQP----E----YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  356 (373)
T ss_dssp             CCCC----T----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCCC----C----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            0001    1    1124589999999999999999999999999988753

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=9.6e-44  Score=336.65  Aligned_cols=262  Identities=23%  Similarity=0.290  Sum_probs=191.4

Q ss_pred             hcCCCCC-CccccCCceEEEEEEEc-CCcEEEEEEeecccch-hHhHHHHHHHHHc-cCCCceeeeeeeEecCCcceEEE
Q 015027           86 TKNFDRS-RCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI-RITERELLRIISQ-VNHKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        86 ~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~~l~~-l~hpniv~l~~~~~~~~~~~lv~  161 (414)
                      .+.|.+. +.||+|+||.||+|... +++.||||++...... .....++++++.+ .+||||+++++++.+++..++||
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   90 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF   90 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            3567774 78999999999999965 6899999999765432 3344566677877 57999999999999999999999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCc---EEEeeccccccc
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYT---AKVADFESSVLI  238 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~---~kl~DfGla~~~  238 (414)
                      ||+++++|.+++....   .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.   +||+|||++...
T Consensus        91 e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~  164 (316)
T 2ac3_A           91 EKMRGGSILSHIHKRR---HFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI  164 (316)
T ss_dssp             ECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred             EcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence            9999999999996543   3578899999999999999999987   999999999999998766   999999998765


Q ss_pred             cCCcc-----ccceecccccccccchhhccc-----CCCCCcccchhHHHHHHHHHhCCCCCCcccccccccc--ccc--
Q 015027          239 SSDAE-----TAMSTILIGTSGYLDPVCINT-----GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKI--SMV--  304 (414)
Q Consensus       239 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~--~~~--  304 (414)
                      .....     ........||+.|+|||++.+     ..++.++|||||||++|+|++|+.||...........  ...  
T Consensus       165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  244 (316)
T 2ac3_A          165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA  244 (316)
T ss_dssp             -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred             ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence            42211     111234569999999999875     5689999999999999999999999975432211000  000  


Q ss_pred             --hhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          305 --PYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       305 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                        ......+.....      ..........+..+.+|+.+||+.||.+|||+.++++
T Consensus       245 ~~~~~~~~i~~~~~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          245 CQNMLFESIQEGKY------EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             HHHHHHHHHHHCCC------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHhccCc------ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence              000111111100      0000000012356899999999999999999999854

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.4e-43  Score=339.22  Aligned_cols=267  Identities=23%  Similarity=0.339  Sum_probs=202.4

Q ss_pred             HHhcCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHc--cCCCceeeeeeeEecCC----cc
Q 015027           84 RATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQ--VNHKNVVKILGLCLETE----VP  157 (414)
Q Consensus        84 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~--l~hpniv~l~~~~~~~~----~~  157 (414)
                      ...++|.+.+.||+|+||.||+|.+ +++.||||++.....  .....+.+++..  ++||||+++++++....    ..
T Consensus        39 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~--~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~  115 (342)
T 1b6c_B           39 TIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE--RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL  115 (342)
T ss_dssp             HHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGGH--HHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCE
T ss_pred             cccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchhH--HHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcccee
Confidence            4457899999999999999999998 589999999975432  223344456655  79999999999998776    78


Q ss_pred             eEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhh--------hCCCCCeeeCCCCCCceeeCCCCcEEE
Q 015027          158 LLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLH--------SLASPPIIHGDVKSANILLNDNYTAKV  229 (414)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH--------~~~~~~iiH~Dlkp~NIll~~~~~~kl  229 (414)
                      ++||||+++|+|.+++...    .+++..++.++.|++.||.|||        +.+   |+||||||+|||++.++.+||
T Consensus       116 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~kL  188 (342)
T 1b6c_B          116 WLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCCI  188 (342)
T ss_dssp             EEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCEEE
T ss_pred             EEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCEEE
Confidence            9999999999999999643    3588999999999999999999        656   999999999999999999999


Q ss_pred             eeccccccccCCcccc--ceecccccccccchhhcccC------CCCCcccchhHHHHHHHHHhC----------CCCCC
Q 015027          230 ADFESSVLISSDAETA--MSTILIGTSGYLDPVCINTG------KLTKKSDVYSFGVVLAELLTG----------KKPGS  291 (414)
Q Consensus       230 ~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~SlGvil~el~tg----------~~p~~  291 (414)
                      +|||++..........  ......||+.|+|||++.+.      .++.++|||||||++|||++|          ..||.
T Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~  268 (342)
T 1b6c_B          189 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY  268 (342)
T ss_dssp             CCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             EECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcc
Confidence            9999998765432211  22445799999999999765      344789999999999999999          66765


Q ss_pred             ccccccccccccchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHh
Q 015027          292 CMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRL  367 (414)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~  367 (414)
                      ........    ................+....   .....+..+.+|+.+||+.||.+|||+.+|++.|+.+...
T Consensus       269 ~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~  337 (342)
T 1b6c_B          269 DLVPSDPS----VEEMRKVVCEQKLRPNIPNRW---QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  337 (342)
T ss_dssp             TTSCSSCC----HHHHHHHHTTSCCCCCCCGGG---GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             ccCcCccc----HHHHHHHHHHHHhCCCCcccc---cchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence            32211100    011111111111111111111   1234556799999999999999999999999999998753

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1e-43  Score=346.51  Aligned_cols=202  Identities=26%  Similarity=0.334  Sum_probs=158.5

Q ss_pred             HhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc---hhHhHHHHHHHHHccC-CCceeeeeeeEecCC--cc
Q 015027           85 ATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK---IRITERELLRIISQVN-HKNVVKILGLCLETE--VP  157 (414)
Q Consensus        85 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~-hpniv~l~~~~~~~~--~~  157 (414)
                      ..++|.+.+.||+|+||.||+|.+. +|+.||||++.....   ......+++.++..+. ||||+++++++...+  ..
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~   86 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV   86 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence            4578999999999999999999975 589999999864322   2223355668888887 999999999997544  68


Q ss_pred             eEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccccc
Q 015027          158 LLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVL  237 (414)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~  237 (414)
                      |+|||||+ ++|.+++...    .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        87 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~  158 (388)
T 3oz6_A           87 YLVFDYME-TDLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRS  158 (388)
T ss_dssp             EEEEECCS-EEHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEecccC-cCHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence            99999997 5898888642    4578889999999999999999988   99999999999999999999999999986


Q ss_pred             ccCCc-------------------cccceecccccccccchhhccc-CCCCCcccchhHHHHHHHHHhCCCCCCccc
Q 015027          238 ISSDA-------------------ETAMSTILIGTSGYLDPVCINT-GKLTKKSDVYSFGVVLAELLTGKKPGSCMT  294 (414)
Q Consensus       238 ~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~  294 (414)
                      .....                   ........+||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  235 (388)
T 3oz6_A          159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS  235 (388)
T ss_dssp             SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            54311                   1112344689999999999976 679999999999999999999999997543

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.9e-43  Score=332.60  Aligned_cols=258  Identities=19%  Similarity=0.179  Sum_probs=195.5

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchh----HhHHHHHHHHHccCCCceeeeeeeEecCCcceEE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIR----ITERELLRIISQVNHKNVVKILGLCLETEVPLLV  160 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv  160 (414)
                      .++|.+.+.||+|+||.||+|.+. +++.||||++.......    ....+++.++.+++||||+++++++..++..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            478999999999999999999976 68899999997653322    3345677899999999999999999999999999


Q ss_pred             EEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccC
Q 015027          161 YEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISS  240 (414)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  240 (414)
                      |||+++++|.+++....   .+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus       113 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  186 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD  186 (309)
T ss_dssp             EECCCCEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred             EEecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence            99999999999997543   3588999999999999999999988   99999999999999999999999999876654


Q ss_pred             CccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccc-cccc
Q 015027          241 DAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNG-LRQI  319 (414)
Q Consensus       241 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  319 (414)
                      .. ........||+.|+|||++.+..++.++||||||+++|+|++|+.||.......         ......... ....
T Consensus       187 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---------~~~~~~~~~~~~~~  256 (309)
T 2h34_A          187 EK-LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV---------MGAHINQAIPRPST  256 (309)
T ss_dssp             -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH---------HHHHHHSCCCCGGG
T ss_pred             cc-cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH---------HHHHhccCCCCccc
Confidence            32 122334578999999999999999999999999999999999999997433210         001111000 0001


Q ss_pred             cccccCCcccHHHHHHHHHHHHHhhccCCCCCC-ChhHHHHHHHHHHHh
Q 015027          320 LNFHVADESEMKEIEIVAELASKCLRIRGTERP-TMKQVSEELDRLRRL  367 (414)
Q Consensus       320 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rp-s~~~v~~~L~~i~~~  367 (414)
                      ..+.+        +..+.+|+.+||+.||.+|| |++++++.|+.+...
T Consensus       257 ~~~~~--------~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~  297 (309)
T 2h34_A          257 VRPGI--------PVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT  297 (309)
T ss_dssp             TSTTC--------CTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred             cCCCC--------CHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence            11111        24489999999999999999 899999998876543

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=5.3e-43  Score=328.21  Aligned_cols=265  Identities=19%  Similarity=0.214  Sum_probs=203.7

Q ss_pred             hcCCCCCCccccCCceEEEEEEE-cCCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeE-ecCCcceEEEEe
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVL-HDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLC-LETEVPLLVYEF  163 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~-~~~~~~~lv~e~  163 (414)
                      .++|.+.+.||+|+||.||+|.+ .+++.||||++....... ....++.++..++|++++..+.++ ......++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~   86 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP-QLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   86 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCC-HHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchh-HHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEe
Confidence            57899999999999999999997 468999999987654433 345566888999988877666655 566778999999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceee---CCCCcEEEeeccccccccC
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILL---NDNYTAKVADFESSVLISS  240 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~DfGla~~~~~  240 (414)
                      + +++|.+++.....  .+++..++.++.||+.||.|||+.+   |+||||||+|||+   +.++.+||+|||++.....
T Consensus        87 ~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  160 (296)
T 3uzp_A           87 L-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             C-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             c-CCCHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence            9 8999999964332  3588999999999999999999988   9999999999999   4889999999999987654


Q ss_pred             Ccccc-----ceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccc
Q 015027          241 DAETA-----MSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNG  315 (414)
Q Consensus       241 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (414)
                      .....     ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..........  .....    ....
T Consensus       161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~~~~~----~~~~  234 (296)
T 3uzp_A          161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ--KYERI----SEKK  234 (296)
T ss_dssp             TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSS--HHHHH----HHHH
T ss_pred             cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhh--hhhhh----cccc
Confidence            32211     1245679999999999999999999999999999999999999997543221110  00000    0000


Q ss_pred             cccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHhh
Q 015027          316 LRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLH  368 (414)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~~  368 (414)
                      .... .+.....    .+..+.+|+.+||+.||.+|||+.+|++.|+.+....
T Consensus       235 ~~~~-~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  282 (296)
T 3uzp_A          235 MSTP-IEVLCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  282 (296)
T ss_dssp             HHSC-HHHHTTT----SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             cCCc-hHHHHhh----CCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence            0000 0000011    1255999999999999999999999999999887543

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=9e-44  Score=336.99  Aligned_cols=261  Identities=21%  Similarity=0.267  Sum_probs=199.1

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc-hhHhHHHHHHHHHccCCCceeeeeeeEe----cCCcceE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK-IRITERELLRIISQVNHKNVVKILGLCL----ETEVPLL  159 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~hpniv~l~~~~~----~~~~~~l  159 (414)
                      .++|.+.+.||+|+||.||+|... +++.||||++..... ......+++.+++.++||||+++++++.    .....++
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            468999999999999999999974 689999999865433 2334466778999999999999999987    3447899


Q ss_pred             EEEeCCCCchhhhhhhc-CCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccc
Q 015027          160 VYEFASNGTLLDHIRCE-SSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLI  238 (414)
Q Consensus       160 v~e~~~~gsL~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~  238 (414)
                      ||||+++|+|.+++... .....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~  184 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA  184 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence            99999999999998653 12345688999999999999999999987   999999999999999999999999998765


Q ss_pred             cCCcccc-------ceecccccccccchhhcccCC---CCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhh
Q 015027          239 SSDAETA-------MSTILIGTSGYLDPVCINTGK---LTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFL  308 (414)
Q Consensus       239 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~  308 (414)
                      .......       ......||+.|+|||++.+..   ++.++||||||+++|+|++|+.||........   .    ..
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~----~~  257 (317)
T 2buj_A          185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD---S----VA  257 (317)
T ss_dssp             CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS---C----HH
T ss_pred             ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc---h----hh
Confidence            3211110       112346799999999987654   78999999999999999999999853211100   0    00


Q ss_pred             hhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHH
Q 015027          309 NSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLR  365 (414)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~  365 (414)
                      ..... ..        ........+..+.+|+.+||+.||.+|||+.++++.|+.+.
T Consensus       258 ~~~~~-~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~  305 (317)
T 2buj_A          258 LAVQN-QL--------SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ  305 (317)
T ss_dssp             HHHHC-C----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred             HHhhc-cC--------CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence            00000 00        00001112256999999999999999999999999998765

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.8e-43  Score=352.05  Aligned_cols=262  Identities=21%  Similarity=0.235  Sum_probs=191.1

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc---hhHhHHHHHHHHHccCCCceeeeeeeEecCC------
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK---IRITERELLRIISQVNHKNVVKILGLCLETE------  155 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~------  155 (414)
                      .++|++.+.||+|+||.||+|.+. +++.||||++.....   ......+++.+++.++||||+++++++....      
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            478999999999999999999976 589999999976422   2233456778999999999999999996553      


Q ss_pred             cceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccc
Q 015027          156 VPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESS  235 (414)
Q Consensus       156 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla  235 (414)
                      ..|+||||++++ |.+.+..     .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       141 ~~~lv~E~~~~~-l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a  211 (464)
T 3ttj_A          141 DVYLVMELMDAN-LCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  211 (464)
T ss_dssp             EEEEEEECCSEE-HHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred             eEEEEEeCCCCC-HHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence            469999999864 5555532     2588899999999999999999988   999999999999999999999999999


Q ss_pred             ccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCcccccccccc------ccchhhhh
Q 015027          236 VLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKI------SMVPYFLN  309 (414)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~------~~~~~~~~  309 (414)
                      +.....   ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+......-..      ...+.+..
T Consensus       212 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~  288 (464)
T 3ttj_A          212 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK  288 (464)
T ss_dssp             -----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred             eecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            876532   223456899999999999999999999999999999999999999975432110000      00000000


Q ss_pred             hh--------cc------cccccccccccC---CcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          310 SI--------KN------NGLRQILNFHVA---DESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       310 ~~--------~~------~~~~~~~~~~~~---~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ..        ..      ..+...+.....   .......+..+.+|+.+||+.||.+|||+.++++
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            00        00      000011111100   0111222567999999999999999999999975

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.2e-43  Score=339.89  Aligned_cols=253  Identities=19%  Similarity=0.301  Sum_probs=196.1

Q ss_pred             HhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhHhHHHHHHHHHcc-CCCceeeeeeeEecCCcceEEEE
Q 015027           85 ATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRITERELLRIISQV-NHKNVVKILGLCLETEVPLLVYE  162 (414)
Q Consensus        85 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e  162 (414)
                      ..++|.+.+.||+|+||.||+|... +++.||||++........   ++++++.++ +||||+++++++.+++..|+|||
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~---~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E   96 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPT---EEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE   96 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCH---HHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChH---HHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence            3567999999999999999999976 588999999976543322   334555555 79999999999999999999999


Q ss_pred             eCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCC----CcEEEeeccccccc
Q 015027          163 FASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDN----YTAKVADFESSVLI  238 (414)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~----~~~kl~DfGla~~~  238 (414)
                      |+++|+|.+++....   .+++..+..++.||+.||.|||+.+   |+||||||+|||+.++    +.+||+|||++...
T Consensus        97 ~~~gg~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~  170 (342)
T 2qr7_A           97 LMKGGELLDKILRQK---FFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL  170 (342)
T ss_dssp             CCCSCBHHHHHHTCT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred             CCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence            999999999986543   3588999999999999999999988   9999999999998533    35999999999876


Q ss_pred             cCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccc
Q 015027          239 SSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQ  318 (414)
Q Consensus       239 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (414)
                      ....  ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.......      .......+...... 
T Consensus       171 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~------~~~~~~~i~~~~~~-  241 (342)
T 2qr7_A          171 RAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT------PEEILARIGSGKFS-  241 (342)
T ss_dssp             BCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC------HHHHHHHHHHCCCC-
T ss_pred             cCCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC------HHHHHHHHccCCcc-
Confidence            5432  22344688999999999998889999999999999999999999997422111      01111111111110 


Q ss_pred             ccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHH
Q 015027          319 ILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEE  360 (414)
Q Consensus       319 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~  360 (414)
                           .........+..+.+|+.+||..||.+|||+.++++.
T Consensus       242 -----~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  278 (342)
T 2qr7_A          242 -----LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH  278 (342)
T ss_dssp             -----CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             -----cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                 0011111223568999999999999999999998653

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=9e-44  Score=336.07  Aligned_cols=265  Identities=21%  Similarity=0.270  Sum_probs=193.5

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch---hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI---RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYE  162 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  162 (414)
                      ++|++.+.||+|+||.||+|.+. +++.||||++......   .....++++++++++||||+++++++...+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            67899999999999999999976 4899999998665432   2334567789999999999999999999999999999


Q ss_pred             eCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCc
Q 015027          163 FASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDA  242 (414)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  242 (414)
                      |+++++|.+++....   .+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++.......
T Consensus        83 ~~~~~~l~~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  156 (311)
T 4agu_A           83 YCDHTVLHELDRYQR---GVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS  156 (311)
T ss_dssp             CCSEEHHHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             eCCCchHHHHHhhhc---CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence            999999988875433   3588999999999999999999988   9999999999999999999999999998765332


Q ss_pred             cccceecccccccccchhhccc-CCCCCcccchhHHHHHHHHHhCCCCCCcccccccccc------ccchhhhhhhcccc
Q 015027          243 ETAMSTILIGTSGYLDPVCINT-GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKI------SMVPYFLNSIKNNG  315 (414)
Q Consensus       243 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~------~~~~~~~~~~~~~~  315 (414)
                        .......||+.|+|||++.+ ..++.++||||||+++|+|++|..||...........      ...+..........
T Consensus       157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (311)
T 4agu_A          157 --DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ  234 (311)
T ss_dssp             -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred             --cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence              22334578999999999976 6789999999999999999999999975432211000      00000000000000


Q ss_pred             cccccc-cccCCccc-----HHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          316 LRQILN-FHVADESE-----MKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       316 ~~~~~~-~~~~~~~~-----~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ...... +.......     ...+..+.+|+.+||+.||.+|||++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            000000 00000000     012355899999999999999999999853

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=4.1e-43  Score=353.60  Aligned_cols=250  Identities=22%  Similarity=0.296  Sum_probs=196.9

Q ss_pred             HhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc--------------hhHhHHHHHHHHHccCCCceeeeee
Q 015027           85 ATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK--------------IRITERELLRIISQVNHKNVVKILG  149 (414)
Q Consensus        85 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------------~~~~~~~~~~~l~~l~hpniv~l~~  149 (414)
                      ..++|.+.+.||+|+||+||+|... +++.||||++.....              .......++.++++++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            4578999999999999999999976 588999999976431              2234466789999999999999999


Q ss_pred             eEecCCcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCC---c
Q 015027          150 LCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNY---T  226 (414)
Q Consensus       150 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~---~  226 (414)
                      +|.+....|+|||||++|+|.+++....   .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++   .
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~  187 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINRH---KFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN  187 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence            9999999999999999999999886543   3588999999999999999999988   99999999999998775   6


Q ss_pred             EEEeeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchh
Q 015027          227 AKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPY  306 (414)
Q Consensus       227 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~  306 (414)
                      +||+|||++.......   ......||+.|+|||++. ..++.++|||||||++|+|++|..||.......         
T Consensus       188 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---------  254 (504)
T 3q5i_A          188 IKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD---------  254 (504)
T ss_dssp             EEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---------
T ss_pred             EEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---------
Confidence            9999999998765432   234457999999999987 469999999999999999999999997543211         


Q ss_pred             hhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          307 FLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ....+..........      .....+..+.+|+.+||+.||.+|||+.++++
T Consensus       255 ~~~~i~~~~~~~~~~------~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          255 IIKKVEKGKYYFDFN------DWKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             HHHHHHHCCCCCCHH------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHcCCCCCCcc------ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            111111111100000      00011256999999999999999999999865

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=6.4e-44  Score=360.56  Aligned_cols=251  Identities=22%  Similarity=0.246  Sum_probs=200.4

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc----hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK----IRITERELLRIISQVNHKNVVKILGLCLETEVPLLV  160 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv  160 (414)
                      .++|.+.+.||+|+||.||+|... +|+.||+|++.....    .......+++++..++||||+++++++.+.+..|+|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            467999999999999999999976 689999999976432    223345677899999999999999999999999999


Q ss_pred             EEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccC
Q 015027          161 YEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISS  240 (414)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  240 (414)
                      |||++||+|.+++..... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.+|.+||+|||++.....
T Consensus       263 mEy~~gg~L~~~l~~~~~-~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~  338 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMGQ-AGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE  338 (576)
T ss_dssp             ECCCCSCBHHHHHHSSSS-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEcCCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence            999999999999865442 33588999999999999999999988   99999999999999999999999999987653


Q ss_pred             CccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccc
Q 015027          241 DAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQIL  320 (414)
Q Consensus       241 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (414)
                      ..   .....+||+.|+|||++.+..++.++|||||||++|||++|+.||........     ...........      
T Consensus       339 ~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~-----~~~i~~~i~~~------  404 (576)
T 2acx_A          339 GQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-----REEVERLVKEV------  404 (576)
T ss_dssp             TC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC-----HHHHHHHHHHC------
T ss_pred             Cc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh-----HHHHHHHhhcc------
Confidence            32   23345899999999999999999999999999999999999999974331110     00000101000      


Q ss_pred             ccccCCcccHHHHHHHHHHHHHhhccCCCCCC-----ChhHHH
Q 015027          321 NFHVADESEMKEIEIVAELASKCLRIRGTERP-----TMKQVS  358 (414)
Q Consensus       321 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rp-----s~~~v~  358 (414)
                      .....    ...+..+.+|+.+||+.||.+||     ++.+|+
T Consensus       405 ~~~~p----~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil  443 (576)
T 2acx_A          405 PEEYS----ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVK  443 (576)
T ss_dssp             CCCCC----TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHH
T ss_pred             cccCC----ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHH
Confidence            00111    11225699999999999999999     567764

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.9e-44  Score=341.17  Aligned_cols=275  Identities=21%  Similarity=0.274  Sum_probs=204.7

Q ss_pred             hcCCCCCCccccCCceEEEEEEE-----cCCcEEEEEEeecccch-hHhHHHHHHHHHccCCCceeeeeeeEecCC--cc
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVL-----HDNIQVAVKTYRRADKI-RITERELLRIISQVNHKNVVKILGLCLETE--VP  157 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~hpniv~l~~~~~~~~--~~  157 (414)
                      .++|++.+.||+|+||.||+|..     .+++.||||++...... .....++++++++++||||+++++++...+  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            35688999999999999999984     25889999999765432 234567789999999999999999987644  78


Q ss_pred             eEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccccc
Q 015027          158 LLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVL  237 (414)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~  237 (414)
                      ++||||+++++|.+++.....  .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus       120 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~  194 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV  194 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHSTT--SSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEECCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence            999999999999999976432  3588999999999999999999987   99999999999999999999999999987


Q ss_pred             ccCCcccc-ceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccc
Q 015027          238 ISSDAETA-MSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGL  316 (414)
Q Consensus       238 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (414)
                      ........ ......++..|+|||++.+..++.++||||||+++|+|++|..||................  .......+
T Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  272 (326)
T 2w1i_A          195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ--GQMIVFHL  272 (326)
T ss_dssp             CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCC--THHHHHHH
T ss_pred             ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccc--hhhhHHHH
Confidence            65432211 1223457778999999999999999999999999999999999975321100000000000  00000000


Q ss_pred             ccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHh
Q 015027          317 RQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRL  367 (414)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~  367 (414)
                      ...+........+...+..+.+|+.+||+.||.+|||+.++++.|+.+.+.
T Consensus       273 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~  323 (326)
T 2w1i_A          273 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ  323 (326)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            000000000111112235699999999999999999999999999998764

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=5.1e-43  Score=338.71  Aligned_cols=255  Identities=24%  Similarity=0.325  Sum_probs=200.1

Q ss_pred             HHHHHhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch---------hHhHHHHHHHHHcc-CCCceeeeee
Q 015027           81 EMIRATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI---------RITERELLRIISQV-NHKNVVKILG  149 (414)
Q Consensus        81 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~~~~l~~l-~hpniv~l~~  149 (414)
                      ......++|.+.+.||+|+||.||+|.+. +|+.||||++......         ......++.++.++ +||||+++++
T Consensus        88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~  167 (365)
T 2y7j_A           88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID  167 (365)
T ss_dssp             HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred             hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence            34455678999999999999999999986 6999999999764311         22335566788888 7999999999


Q ss_pred             eEecCCcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEE
Q 015027          150 LCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKV  229 (414)
Q Consensus       150 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl  229 (414)
                      ++......++||||+++++|.+++....   .+++..+..++.||+.||.|||+.+   |+|+||||+|||++.++.+||
T Consensus       168 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl  241 (365)
T 2y7j_A          168 SYESSSFMFLVFDLMRKGELFDYLTEKV---ALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRL  241 (365)
T ss_dssp             EEEBSSEEEEEECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEE
T ss_pred             EEeeCCEEEEEEEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEE
Confidence            9999999999999999999999996532   3588999999999999999999988   999999999999999999999


Q ss_pred             eeccccccccCCccccceecccccccccchhhccc------CCCCCcccchhHHHHHHHHHhCCCCCCcccccccccccc
Q 015027          230 ADFESSVLISSDAETAMSTILIGTSGYLDPVCINT------GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISM  303 (414)
Q Consensus       230 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~  303 (414)
                      +|||++.......   ......||+.|+|||++.+      ..++.++|||||||++|+|++|..||.......      
T Consensus       242 ~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~------  312 (365)
T 2y7j_A          242 SDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL------  312 (365)
T ss_dssp             CCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH------
T ss_pred             EecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH------
Confidence            9999998765432   2344689999999999863      368899999999999999999999996432110      


Q ss_pred             chhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          304 VPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                         ....+...... ...+..     ...+..+.+|+.+||+.||.+|||+.++++
T Consensus       313 ---~~~~i~~~~~~-~~~~~~-----~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          313 ---MLRMIMEGQYQ-FSSPEW-----DDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             ---HHHHHHHTCCC-CCHHHH-----SSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ---HHHHHHhCCCC-CCCccc-----ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence               01111111000 000000     011255899999999999999999999854

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.1e-43  Score=365.01  Aligned_cols=250  Identities=24%  Similarity=0.357  Sum_probs=195.1

Q ss_pred             ccccCCceEEEEEEEc---CCcEEEEEEeecccc--hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCCCCc
Q 015027           94 CLSQGGFVSVYKGVLH---DNIQVAVKTYRRADK--IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGT  168 (414)
Q Consensus        94 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gs  168 (414)
                      .||+|+||.||+|.+.   ++..||||+++....  ....+.++++++++++||||++++++|.. +..++||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            7999999999999864   456799999976432  33455777899999999999999999976 56899999999999


Q ss_pred             hhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccc-cce
Q 015027          169 LLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET-AMS  247 (414)
Q Consensus       169 L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~  247 (414)
                      |.+++....  ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++........ ...
T Consensus       422 L~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~  496 (613)
T 2ozo_A          422 LHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR  496 (613)
T ss_dssp             HHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC---------
T ss_pred             HHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeec
Confidence            999996543  34588999999999999999999987   999999999999999999999999999876533211 112


Q ss_pred             ecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhcccccccccccccCC
Q 015027          248 TILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVAD  326 (414)
Q Consensus       248 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (414)
                      ....+|+.|+|||++.+..++.++|||||||++|||++ |+.||.......         ....+.... .        .
T Consensus       497 ~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---------~~~~i~~~~-~--------~  558 (613)
T 2ozo_A          497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---------VMAFIEQGK-R--------M  558 (613)
T ss_dssp             -----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH---------HHHHHHTTC-C--------C
T ss_pred             cCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---------HHHHHHcCC-C--------C
Confidence            23345689999999999999999999999999999998 999997543211         111111111 0        0


Q ss_pred             cccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHh
Q 015027          327 ESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRL  367 (414)
Q Consensus       327 ~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~  367 (414)
                      ..+...+..+.+|+.+||+.+|.+|||+.+|++.|+.+...
T Consensus       559 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~  599 (613)
T 2ozo_A          559 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  599 (613)
T ss_dssp             CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence            11111235699999999999999999999999999987654

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2.4e-43  Score=355.31  Aligned_cols=250  Identities=18%  Similarity=0.206  Sum_probs=199.0

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch----hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI----RITERELLRIISQVNHKNVVKILGLCLETEVPLLV  160 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv  160 (414)
                      .++|.+.+.||+|+||.||+|... +|+.||+|++......    ......+..++.+++||||+++++++.+.+..|+|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            367899999999999999999976 5899999999764322    23345667899999999999999999999999999


Q ss_pred             EEeCCCCchhhhhhhcCC-cccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccccccc
Q 015027          161 YEFASNGTLLDHIRCESS-QVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLIS  239 (414)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~  239 (414)
                      |||++||+|.+++..... ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.+|.+||+|||++....
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            999999999999865432 335688999999999999999999988   9999999999999999999999999998765


Q ss_pred             CCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccc
Q 015027          240 SDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQI  319 (414)
Q Consensus       240 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (414)
                      ...  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||........     .......+....    
T Consensus       341 ~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~-----~~~~~~~i~~~~----  409 (543)
T 3c4z_A          341 AGQ--TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-----NKELKQRVLEQA----  409 (543)
T ss_dssp             TTC--CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC-----HHHHHHHHHHCC----
T ss_pred             CCC--cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh-----HHHHHHHHhhcc----
Confidence            432  122345899999999999999999999999999999999999999974321110     000111111100    


Q ss_pred             cccccCCcccHHHHHHHHHHHHHhhccCCCCCCChh
Q 015027          320 LNFHVADESEMKEIEIVAELASKCLRIRGTERPTMK  355 (414)
Q Consensus       320 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~  355 (414)
                        ...+    ...+..+.+|+.+||+.||.+||++.
T Consensus       410 --~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~  439 (543)
T 3c4z_A          410 --VTYP----DKFSPASKDFCEALLQKDPEKRLGFR  439 (543)
T ss_dssp             --CCCC----TTSCHHHHHHHHHHSCSSGGGSCCCB
T ss_pred             --cCCC----cccCHHHHHHHHHhccCCHhHCCCCc
Confidence              0011    11235689999999999999999864

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=8.4e-44  Score=338.64  Aligned_cols=264  Identities=19%  Similarity=0.225  Sum_probs=188.6

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhH--hHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEe
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRI--TERELLRIISQVNHKNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  163 (414)
                      ++|.+.+.||+|+||+||+|... +++.||||++........  ...+++++++.++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            57889999999999999999976 689999999875432211  223456889999999999999999999999999999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcc
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE  243 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  243 (414)
                      ++ |+|.+++.....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++....... 
T Consensus        82 ~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-  154 (324)
T 3mtl_A           82 LD-KDLKQYLDDCGN--IINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT-  154 (324)
T ss_dssp             CS-EEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred             cc-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc-
Confidence            97 488888865433  3588999999999999999999988   9999999999999999999999999997654321 


Q ss_pred             ccceecccccccccchhhccc-CCCCCcccchhHHHHHHHHHhCCCCCCccccccccccc------cchhhhhh-hcccc
Q 015027          244 TAMSTILIGTSGYLDPVCINT-GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKIS------MVPYFLNS-IKNNG  315 (414)
Q Consensus       244 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~------~~~~~~~~-~~~~~  315 (414)
                       .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||............      ..+..+.. .....
T Consensus       155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  233 (324)
T 3mtl_A          155 -KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE  233 (324)
T ss_dssp             ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred             -cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchh
Confidence             22334578999999999876 57899999999999999999999999754321100000      00000000 00000


Q ss_pred             cccccccccCCcc----cHHHHHHHHHHHHHhhccCCCCCCChhHHH
Q 015027          316 LRQILNFHVADES----EMKEIEIVAELASKCLRIRGTERPTMKQVS  358 (414)
Q Consensus       316 ~~~~~~~~~~~~~----~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~  358 (414)
                      ......+......    ....+..+.+|+.+||+.||.+|||+.+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l  280 (324)
T 3mtl_A          234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAM  280 (324)
T ss_dssp             HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred             hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHh
Confidence            0000000000000    001125689999999999999999999984

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=4.9e-43  Score=352.18  Aligned_cols=250  Identities=23%  Similarity=0.310  Sum_probs=195.5

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeeccc---chhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRAD---KIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~  161 (414)
                      .++|.+.+.||+|+||+||+|... ++..||+|++....   .......+++.+++.++||||++++++|.+....|+||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            457999999999999999999976 58899999997643   22344567789999999999999999999999999999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCC---CCcEEEeeccccccc
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLND---NYTAKVADFESSVLI  238 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~DfGla~~~  238 (414)
                      |||++|+|.+++....   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.   ++.+||+|||++...
T Consensus       116 e~~~~g~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~  189 (494)
T 3lij_A          116 ECYKGGELFDEIIHRM---KFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF  189 (494)
T ss_dssp             ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence            9999999999886543   3578899999999999999999988   999999999999976   456999999999876


Q ss_pred             cCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccc
Q 015027          239 SSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQ  318 (414)
Q Consensus       239 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (414)
                      ....   ......||+.|+|||++. ..++.++|||||||++|+|++|..||.......         ....+...... 
T Consensus       190 ~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---------~~~~i~~~~~~-  255 (494)
T 3lij_A          190 ENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE---------ILRKVEKGKYT-  255 (494)
T ss_dssp             BTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---------HHHHHHHTCCC-
T ss_pred             CCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH---------HHHHHHhCCCC-
Confidence            5432   234457999999999986 569999999999999999999999997543211         11111111110 


Q ss_pred             ccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHH
Q 015027          319 ILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEE  360 (414)
Q Consensus       319 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~  360 (414)
                      ...+.     ....+..+.+|+.+||+.||.+|||+.++++.
T Consensus       256 ~~~~~-----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          256 FDSPE-----WKNVSEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             CCSGG-----GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             CCchh-----cccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence            00010     11122568999999999999999999999753

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.7e-44  Score=339.18  Aligned_cols=253  Identities=23%  Similarity=0.321  Sum_probs=194.1

Q ss_pred             HHhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhHhHHHHHHHHHcc-CCCceeeeeeeEec------CC
Q 015027           84 RATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRITERELLRIISQV-NHKNVVKILGLCLE------TE  155 (414)
Q Consensus        84 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~l~~l-~hpniv~l~~~~~~------~~  155 (414)
                      ...++|.+.+.||+|+||.||+|.+. +++.||||++............++.++.++ +||||+++++++..      ..
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~  100 (326)
T 2x7f_A           21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD  100 (326)
T ss_dssp             CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCC
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccc
Confidence            34678999999999999999999975 689999999987655555566677888888 79999999999976      46


Q ss_pred             cceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccc
Q 015027          156 VPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESS  235 (414)
Q Consensus       156 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla  235 (414)
                      ..++||||+++++|.+++.... ...+++..++.++.||+.||.|||+.+   |+|+||||+|||++.++.+||+|||++
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~  176 (326)
T 2x7f_A          101 QLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS  176 (326)
T ss_dssp             EEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCTTT
T ss_pred             eEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCcCc
Confidence            7899999999999999996543 234578899999999999999999988   999999999999999999999999998


Q ss_pred             ccccCCccccceecccccccccchhhcc-----cCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhh
Q 015027          236 VLISSDAETAMSTILIGTSGYLDPVCIN-----TGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNS  310 (414)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  310 (414)
                      .......  .......||+.|+|||++.     +..++.++|||||||++|+|++|..||.......         ....
T Consensus       177 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---------~~~~  245 (326)
T 2x7f_A          177 AQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR---------ALFL  245 (326)
T ss_dssp             C---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH---------HHHH
T ss_pred             eecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH---------HHHH
Confidence            7654321  1223457899999999987     5678999999999999999999999996433111         0000


Q ss_pred             hcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          311 IKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      .............        .+..+.+|+.+||+.||.+|||+.++++
T Consensus       246 ~~~~~~~~~~~~~--------~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          246 IPRNPAPRLKSKK--------WSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             HHHSCCCCCSCSC--------SCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             hhcCccccCCccc--------cCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            1111111111111        1245899999999999999999999976

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=4.9e-43  Score=326.45  Aligned_cols=249  Identities=22%  Similarity=0.283  Sum_probs=196.8

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc-------hhHhHHHHHHHHHccCCCceeeeeeeEecCCcce
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK-------IRITERELLRIISQVNHKNVVKILGLCLETEVPL  158 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~  158 (414)
                      ++|.+.+.||+|+||.||+|... +++.||+|++.....       ......+++.++++++||||+++++++.+....+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            56889999999999999999986 589999999976432       1334566778999999999999999999999999


Q ss_pred             EEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCC----cEEEeeccc
Q 015027          159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNY----TAKVADFES  234 (414)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~----~~kl~DfGl  234 (414)
                      +||||+++++|.+++....   .+++..++.++.||+.||.|||+.+   ++||||||+||+++.++    .+||+|||+
T Consensus        85 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~  158 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEKE---SLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI  158 (283)
T ss_dssp             EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEeecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence            9999999999999996533   3588999999999999999999987   99999999999998877    899999999


Q ss_pred             cccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccc
Q 015027          235 SVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNN  314 (414)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  314 (414)
                      +.......   ......||+.|+|||++.+..++.++||||||+++|+|++|..||.......         ....+...
T Consensus       159 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---------~~~~~~~~  226 (283)
T 3bhy_A          159 AHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE---------TLTNISAV  226 (283)
T ss_dssp             CEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---------HHHHHHTT
T ss_pred             ceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH---------HHHHhHhc
Confidence            98764322   2234578999999999999999999999999999999999999997433211         01111000


Q ss_pred             ccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          315 GLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ..  ......    ....+..+.+|+.+||+.||.+|||+.++++
T Consensus       227 ~~--~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          227 NY--DFDEEY----FSNTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             CC--CCCHHH----HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             cc--CCcchh----cccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence            00  000000    0011255899999999999999999999976

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2.9e-43  Score=329.37  Aligned_cols=248  Identities=23%  Similarity=0.363  Sum_probs=193.0

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch---hHhHHHHHHHHHccCCCceeeeeeeEec----CCcce
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI---RITERELLRIISQVNHKNVVKILGLCLE----TEVPL  158 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~hpniv~l~~~~~~----~~~~~  158 (414)
                      ..|.+.+.||+|+||.||+|.+. ++..||+|.+......   .....+++.+++.++||||+++++++..    ....+
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence            34677888999999999999975 5888999999764322   2334667789999999999999999875    35689


Q ss_pred             EEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeC-CCCcEEEeecccccc
Q 015027          159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLN-DNYTAKVADFESSVL  237 (414)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~-~~~~~kl~DfGla~~  237 (414)
                      +||||+++++|.+++....   .+++..++.++.||+.||.|||+.+ .+|+||||||+|||++ .++.+||+|||++..
T Consensus       106 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~  181 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EEEEecCCCCHHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence            9999999999999996543   3478999999999999999999966 4599999999999998 789999999999976


Q ss_pred             ccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccc
Q 015027          238 ISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLR  317 (414)
Q Consensus       238 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (414)
                      ....    ......||+.|+|||++. ..++.++||||||+++|+|++|+.||........        ...........
T Consensus       182 ~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--------~~~~~~~~~~~  248 (290)
T 1t4h_A          182 KRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--------IYRRVTSGVKP  248 (290)
T ss_dssp             CCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--------HHHHHTTTCCC
T ss_pred             cccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH--------HHHHHhccCCc
Confidence            5432    233457999999999887 4599999999999999999999999964321110        11111111111


Q ss_pred             cccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          318 QILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ...+..        .++.+.+|+.+||+.||.+|||+.++++
T Consensus       249 ~~~~~~--------~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          249 ASFDKV--------AIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             GGGGGC--------CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccCCC--------CCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            111111        1145899999999999999999999853

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=4.3e-43  Score=351.95  Aligned_cols=249  Identities=24%  Similarity=0.304  Sum_probs=198.0

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeeccc---chhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRAD---KIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~  161 (414)
                      .++|.+.+.||+|+||+||+|... +++.||||++....   .......+++.++++++||||+++++++.+....|+||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            467999999999999999999976 68999999996532   22344567789999999999999999999999999999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeC---CCCcEEEeeccccccc
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLN---DNYTAKVADFESSVLI  238 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~---~~~~~kl~DfGla~~~  238 (414)
                      ||+++|+|.+++....   .+++..+..++.||+.||.|||+.+   |+||||||+|||++   .++.+||+|||++...
T Consensus       101 e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  174 (486)
T 3mwu_A          101 ELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (486)
T ss_dssp             CCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred             EcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence            9999999999886543   3588999999999999999999988   99999999999995   4668999999999876


Q ss_pred             cCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccc
Q 015027          239 SSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQ  318 (414)
Q Consensus       239 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (414)
                      ...   .......||+.|+|||++.+ .++.++|||||||++|+|++|..||.......         ....+.......
T Consensus       175 ~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---------~~~~i~~~~~~~  241 (486)
T 3mwu_A          175 QQN---TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD---------ILKRVETGKYAF  241 (486)
T ss_dssp             CCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---------HHHHHHHTCCCS
T ss_pred             CCC---CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---------HHHHHHhCCCCC
Confidence            533   22344579999999999976 59999999999999999999999997433211         111111111100


Q ss_pred             ccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          319 ILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       319 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                            ..+.....+..+.+|+.+||+.||.+|||+.++++
T Consensus       242 ------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~  276 (486)
T 3mwu_A          242 ------DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (486)
T ss_dssp             ------CSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ------CCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                  00111122356899999999999999999999976

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.6e-43  Score=354.96  Aligned_cols=249  Identities=23%  Similarity=0.299  Sum_probs=200.1

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeeccc----chhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRAD----KIRITERELLRIISQVNHKNVVKILGLCLETEVPLLV  160 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv  160 (414)
                      .++|.+.+.||+|+||.||+|... +++.||||++....    .......+++.++++++||||+++++++.+.+..++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            467999999999999999999976 68999999997542    2234456778999999999999999999999999999


Q ss_pred             EEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceee---CCCCcEEEeecccccc
Q 015027          161 YEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILL---NDNYTAKVADFESSVL  237 (414)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~DfGla~~  237 (414)
                      |||+.+|+|.+++....   .+++..++.++.||+.||.|||+.+   |+||||||+|||+   +.++.+||+|||++..
T Consensus       105 ~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  178 (484)
T 3nyv_A          105 GEVYTGGELFDEIISRK---RFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH  178 (484)
T ss_dssp             ECCCCSCBHHHHHHTCS---CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred             EecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence            99999999999886543   3588999999999999999999988   9999999999999   5678999999999987


Q ss_pred             ccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccc
Q 015027          238 ISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLR  317 (414)
Q Consensus       238 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (414)
                      .....   ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.......         ....+......
T Consensus       179 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---------~~~~i~~~~~~  245 (484)
T 3nyv_A          179 FEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD---------ILKKVEKGKYT  245 (484)
T ss_dssp             BCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---------HHHHHHHCCCC
T ss_pred             ccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH---------HHHHHHcCCCC
Confidence            65432   2344579999999999876 69999999999999999999999997543211         11111111111


Q ss_pred             cccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          318 QILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      .      ..+.....++.+.+|+.+||+.||.+|||+.++++
T Consensus       246 ~------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          246 F------ELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             C------CSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             C------CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence            0      00111122356899999999999999999999865

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.8e-43  Score=341.18  Aligned_cols=264  Identities=22%  Similarity=0.266  Sum_probs=198.8

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYE  162 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  162 (414)
                      .++|.+.+.||+|+||.||+|.+. ++..||+|++......  .....+++.++..++||||+++++++..++..++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            357899999999999999999976 5899999999865322  2344667789999999999999999999999999999


Q ss_pred             eCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhC-CCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCC
Q 015027          163 FASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSL-ASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD  241 (414)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  241 (414)
                      |+++++|.+++....   .+++..+..++.+++.||.|||+. +   |+||||||+|||++.++.+||+|||++......
T Consensus       112 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  185 (360)
T 3eqc_A          112 HMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  185 (360)
T ss_dssp             CCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred             CCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence            999999999996543   347889999999999999999985 6   999999999999999999999999998765322


Q ss_pred             ccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccc---------h-------
Q 015027          242 AETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMV---------P-------  305 (414)
Q Consensus       242 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~---------~-------  305 (414)
                          ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..............         +       
T Consensus       186 ----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (360)
T 3eqc_A          186 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  261 (360)
T ss_dssp             ----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred             ----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence                23345799999999999999999999999999999999999999975332110000000         0       


Q ss_pred             ----hh-hhhhcccc----cccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          306 ----YF-LNSIKNNG----LRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       306 ----~~-~~~~~~~~----~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                          .+ ........    ...+.............+..+.+|+.+||+.||.+|||+.++++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             ------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                00 00000000    00000000011111112356999999999999999999999965

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=6.5e-44  Score=346.51  Aligned_cols=241  Identities=15%  Similarity=0.152  Sum_probs=184.5

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc----hhHhHHHHH---HHHHccCCCceeeee-------ee
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK----IRITERELL---RIISQVNHKNVVKIL-------GL  150 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~---~~l~~l~hpniv~l~-------~~  150 (414)
                      .++|.+.+.||+|+||.||+|.+. +|+.||||++.....    ......+++   ++++.++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            467888999999999999999964 699999999975322    223334555   566677899999998       55


Q ss_pred             EecCC-----------------cceEEEEeCCCCchhhhhhhcCCc----ccCCHHHHHHHHHHHHHHHHHhhhCCCCCe
Q 015027          151 CLETE-----------------VPLLVYEFASNGTLLDHIRCESSQ----VLKTWKTCLRIAAETASALDYLHSLASPPI  209 (414)
Q Consensus       151 ~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i  209 (414)
                      +...+                 ..|+||||+ +|+|.+++......    ..+++..++.++.||+.||+|||+.+   |
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            55443                 378999999 67999999754321    12335788889999999999999988   9


Q ss_pred             eeCCCCCCceeeCCCCcEEEeeccccccccCCccccceecccccccccchhhcccC-----------CCCCcccchhHHH
Q 015027          210 IHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTG-----------KLTKKSDVYSFGV  278 (414)
Q Consensus       210 iH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~SlGv  278 (414)
                      +||||||+|||++.++.+||+|||+++....     ......| +.|+|||++.+.           .++.++|||||||
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~  301 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL  301 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence            9999999999999999999999999986432     2344567 999999999887           8999999999999


Q ss_pred             HHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHH
Q 015027          279 VLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVS  358 (414)
Q Consensus       279 il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~  358 (414)
                      ++|||++|+.||........     .            ..+....  ...    +..+.+|+.+||+.||.+|||+.+++
T Consensus       302 il~elltg~~Pf~~~~~~~~-----~------------~~~~~~~--~~~----~~~~~~li~~~L~~dp~~Rpt~~e~l  358 (377)
T 3byv_A          302 VIYWIWCADLPITKDAALGG-----S------------EWIFRSC--KNI----PQPVRALLEGFLRYPKEDRLLPLQAM  358 (377)
T ss_dssp             HHHHHHHSSCCC------CC-----S------------GGGGSSC--CCC----CHHHHHHHHHHTCSSGGGCCCHHHHH
T ss_pred             HHHHHHHCCCCCcccccccc-----h------------hhhhhhc--cCC----CHHHHHHHHHHcCCCchhCCCHHHHh
Confidence            99999999999964332110     0            0000000  011    25589999999999999999999997


Q ss_pred             H
Q 015027          359 E  359 (414)
Q Consensus       359 ~  359 (414)
                      +
T Consensus       359 ~  359 (377)
T 3byv_A          359 E  359 (377)
T ss_dssp             T
T ss_pred             h
Confidence            5

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.3e-43  Score=330.63  Aligned_cols=244  Identities=19%  Similarity=0.256  Sum_probs=192.8

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc---hhHhHHHHHHHHHcc-CCCceeeeeeeEecCCcceEE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK---IRITERELLRIISQV-NHKNVVKILGLCLETEVPLLV  160 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l-~hpniv~l~~~~~~~~~~~lv  160 (414)
                      .++|.+.+.||+|+||.||+|.+. +++.||||++.....   .......++..+..+ +||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            467999999999999999999976 689999999986432   223334555677777 999999999999999999999


Q ss_pred             EEeCCCCchhhhhhhcCC-cccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCC----------------
Q 015027          161 YEFASNGTLLDHIRCESS-QVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLND----------------  223 (414)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~----------------  223 (414)
                      |||+++++|.+++..... ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.                
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------------
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            999999999999965432 234588999999999999999999988   999999999999984                


Q ss_pred             ---CCcEEEeeccccccccCCccccceecccccccccchhhcccC-CCCCcccchhHHHHHHHHHhCCCCCCcccccccc
Q 015027          224 ---NYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTG-KLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNK  299 (414)
Q Consensus       224 ---~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~  299 (414)
                         ...+||+|||++......      ....||+.|+|||++.+. .++.++|||||||++|+|++|.+|+.....    
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~----  236 (289)
T 1x8b_A          167 ASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ----  236 (289)
T ss_dssp             ---CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH----
T ss_pred             cCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH----
Confidence               448999999999876542      223589999999999766 667899999999999999999987642211    


Q ss_pred             ccccchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          300 KISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                              ..........     .....    .+..+.+|+.+||+.||.+|||+.++++
T Consensus       237 --------~~~~~~~~~~-----~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          237 --------WHEIRQGRLP-----RIPQV----LSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             --------HHHHHTTCCC-----CCSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --------HHHHHcCCCC-----CCCcc----cCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence                    1111111110     11111    1255899999999999999999999854

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=7.6e-43  Score=325.51  Aligned_cols=244  Identities=27%  Similarity=0.340  Sum_probs=198.9

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc----hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK----IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~  161 (414)
                      ++|.+.+.||+|+||.||+|... ++..||||++.....    ......+++.+++.++||||+++++++.+.+..++||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            67899999999999999999976 578899999975432    2234466778999999999999999999999999999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCC
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD  241 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  241 (414)
                      ||+++++|.+++....   .+++..++.++.||+.||.|||+.+   ++||||||+||+++.++.+||+|||++......
T Consensus        94 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  167 (284)
T 2vgo_A           94 EFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL  167 (284)
T ss_dssp             CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred             EeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence            9999999999996543   3578999999999999999999987   999999999999999999999999998765432


Q ss_pred             ccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccc
Q 015027          242 AETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILN  321 (414)
Q Consensus       242 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (414)
                          ......||+.|+|||++.+..++.++||||||+++|+|++|..||.......         .........      
T Consensus       168 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---------~~~~~~~~~------  228 (284)
T 2vgo_A          168 ----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE---------THRRIVNVD------  228 (284)
T ss_dssp             ----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---------HHHHHHTTC------
T ss_pred             ----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH---------HHHHHhccc------
Confidence                1234578999999999999999999999999999999999999997433211         001111000      


Q ss_pred             cccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          322 FHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       322 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      .....    ..+..+.+|+.+||+.||.+|||+.++++
T Consensus       229 ~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          229 LKFPP----FLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             CCCCT----TSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cCCCC----cCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence            00111    11255899999999999999999999854

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=4.7e-43  Score=345.03  Aligned_cols=252  Identities=23%  Similarity=0.295  Sum_probs=188.5

Q ss_pred             HHhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch---------hHhHHHHHHHHHccCCCceeeeeeeEec
Q 015027           84 RATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI---------RITERELLRIISQVNHKNVVKILGLCLE  153 (414)
Q Consensus        84 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~~~~l~~l~hpniv~l~~~~~~  153 (414)
                      ...++|.+.+.||+|+||.||+|.+. +++.||||++......         .....+++.++++++||||+++++++..
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  211 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA  211 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            34688999999999999999999976 5899999999764311         1123567799999999999999999754


Q ss_pred             CCcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCC---CcEEEe
Q 015027          154 TEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDN---YTAKVA  230 (414)
Q Consensus       154 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~---~~~kl~  230 (414)
                       +..|+||||+++|+|.+++...   ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.+   +.+||+
T Consensus       212 -~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~  284 (419)
T 3i6u_A          212 -EDYYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT  284 (419)
T ss_dssp             -SEEEEEEECCTTCBGGGGTSSS---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred             -CceEEEEEcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence             5579999999999999988643   34588999999999999999999988   9999999999999754   459999


Q ss_pred             eccccccccCCccccceecccccccccchhhccc---CCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhh
Q 015027          231 DFESSVLISSDAETAMSTILIGTSGYLDPVCINT---GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYF  307 (414)
Q Consensus       231 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~  307 (414)
                      |||++......   .......||+.|+|||++.+   ..++.++|||||||++|+|++|..||........        .
T Consensus       285 DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--------~  353 (419)
T 3i6u_A          285 DFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--------L  353 (419)
T ss_dssp             CSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--------H
T ss_pred             ecccceecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--------H
Confidence            99999876532   22345689999999999853   6788999999999999999999999974321110        0


Q ss_pred             hhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          308 LNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      .......... .....     ....+..+.+|+.+||+.||.+|||+.++++
T Consensus       354 ~~~i~~~~~~-~~~~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          354 KDQITSGKYN-FIPEV-----WAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             HHHHHTTCCC-CCHHH-----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHhcCCCC-CCchh-----hcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            0111111000 00000     0011256899999999999999999999864

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=2.5e-43  Score=331.85  Aligned_cols=249  Identities=25%  Similarity=0.354  Sum_probs=201.6

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc--hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK--IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYE  162 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  162 (414)
                      .+.|.+.+.||+|+||.||+|.+. +++.||||++.....  ......+++.++..++||||+++++++.+....++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            356899999999999999999975 589999999976542  23445667789999999999999999999999999999


Q ss_pred             eCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCc
Q 015027          163 FASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDA  242 (414)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  242 (414)
                      |+++++|.+++..    ..+++..++.++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||++.......
T Consensus       101 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~  173 (303)
T 3a7i_A          101 YLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  173 (303)
T ss_dssp             CCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred             eCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence            9999999999853    34588999999999999999999988   9999999999999999999999999998765432


Q ss_pred             cccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccccc
Q 015027          243 ETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNF  322 (414)
Q Consensus       243 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (414)
                        .......||+.|+|||++.+..++.++||||||+++|+|++|..||.......         .........     .+
T Consensus       174 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---------~~~~~~~~~-----~~  237 (303)
T 3a7i_A          174 --IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK---------VLFLIPKNN-----PP  237 (303)
T ss_dssp             --CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---------HHHHHHHSC-----CC
T ss_pred             --cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH---------HHHHhhcCC-----CC
Confidence              12234578999999999999999999999999999999999999987432111         000111110     01


Q ss_pred             ccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHH
Q 015027          323 HVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEEL  361 (414)
Q Consensus       323 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L  361 (414)
                      ......    +..+.+|+.+||+.||.+|||+.++++..
T Consensus       238 ~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~~  272 (303)
T 3a7i_A          238 TLEGNY----SKPLKEFVEACLNKEPSFRPTAKELLKHK  272 (303)
T ss_dssp             CCCSSC----CHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred             CCcccc----CHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence            111111    24589999999999999999999997643

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=7.1e-44  Score=345.49  Aligned_cols=251  Identities=13%  Similarity=0.033  Sum_probs=177.1

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch----hHhHHHH---HHHHHccCCCceeeee-------eeE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI----RITEREL---LRIISQVNHKNVVKIL-------GLC  151 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~---~~~l~~l~hpniv~l~-------~~~  151 (414)
                      .+|.+.+.||+|+||.||+|.+. +++.||||++......    .....++   ++.++. +||||++++       +++
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhe
Confidence            45888999999999999999976 6899999999875431    2222344   456666 799988755       444


Q ss_pred             ecC-----------------CcceEEEEeCCCCchhhhhhhcCCcccCCHHHH------HHHHHHHHHHHHHhhhCCCCC
Q 015027          152 LET-----------------EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTC------LRIAAETASALDYLHSLASPP  208 (414)
Q Consensus       152 ~~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~------~~i~~~i~~~l~~LH~~~~~~  208 (414)
                      ...                 ...|+||||++ |+|.+++.......  ++..+      ..++.||+.||+|||+++   
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~--~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---  214 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVY--VFRGDEGILALHILTAQLIRLAANLQSKG---  214 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSC--CCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcccc--chhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence            332                 23799999999 89999997643322  33444      677899999999999988   


Q ss_pred             eeeCCCCCCceeeCCCCcEEEeeccccccccCCccccceecccccccccchhhccc--CCCCCcccchhHHHHHHHHHhC
Q 015027          209 IIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINT--GKLTKKSDVYSFGVVLAELLTG  286 (414)
Q Consensus       209 iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGvil~el~tg  286 (414)
                      |+||||||+|||++.++.+||+|||++......     .....+|+.|+|||++.+  ..++.++|||||||++|||++|
T Consensus       215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg  289 (371)
T 3q60_A          215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL  289 (371)
T ss_dssp             EEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred             CccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence            999999999999999999999999999865422     224567799999999987  7899999999999999999999


Q ss_pred             CCCCCccccccccccccchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          287 KKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       287 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      +.||.............          ...................+..+.+|+.+||+.||++|||+.++++
T Consensus       290 ~~Pf~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          290 FLPFGLVTPGIKGSWKR----------PSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             SCSTTBCCTTCTTCCCB----------CCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCCCCCcCcccccchhh----------hhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            99997543221110000          0000000000000100112356999999999999999999999854

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=3.6e-43  Score=338.77  Aligned_cols=272  Identities=21%  Similarity=0.240  Sum_probs=189.1

Q ss_pred             HHHHHHhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecCCc--
Q 015027           80 SEMIRATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEV--  156 (414)
Q Consensus        80 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~--  156 (414)
                      .......++|.+.+.||+|+||.||+|.+. +++.||||++.........+.++++.+..++||||++++++|.....  
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~   95 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD   95 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence            345566789999999999999999999975 58999999997766555666777788888999999999999976433  


Q ss_pred             -----ceEEEEeCCCCchhhhh-hhcCCcccCCHHHHHHHHHHHHHHHHHhh--hCCCCCeeeCCCCCCceeeCC-CCcE
Q 015027          157 -----PLLVYEFASNGTLLDHI-RCESSQVLKTWKTCLRIAAETASALDYLH--SLASPPIIHGDVKSANILLND-NYTA  227 (414)
Q Consensus       157 -----~~lv~e~~~~gsL~~~l-~~~~~~~~~~~~~~~~i~~~i~~~l~~LH--~~~~~~iiH~Dlkp~NIll~~-~~~~  227 (414)
                           .++||||++++ |.+.+ ........+++..+..++.|++.||.|||  +.+   |+||||||+|||++. ++.+
T Consensus        96 ~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~  171 (360)
T 3e3p_A           96 RRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTL  171 (360)
T ss_dssp             TTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEE
T ss_pred             ccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcE
Confidence                 78999999874 44333 22233445588899999999999999999  766   999999999999996 8999


Q ss_pred             EEeeccccccccCCccccceecccccccccchhhcccC-CCCCcccchhHHHHHHHHHhCCCCCCcccccccccccc---
Q 015027          228 KVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTG-KLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISM---  303 (414)
Q Consensus       228 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~---  303 (414)
                      ||+|||++.......   ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.............   
T Consensus       172 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~  248 (360)
T 3e3p_A          172 KLCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVL  248 (360)
T ss_dssp             EECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred             EEeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHc
Confidence            999999998765432   22345789999999998655 48999999999999999999999997543211000000   


Q ss_pred             ---chhhhhhhccccc-ccccc------cccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHH
Q 015027          304 ---VPYFLNSIKNNGL-RQILN------FHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVS  358 (414)
Q Consensus       304 ---~~~~~~~~~~~~~-~~~~~------~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~  358 (414)
                         ............. .....      ...........+..+.+|+.+||+.||.+|||+.+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l  313 (360)
T 3e3p_A          249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEAL  313 (360)
T ss_dssp             CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred             CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHh
Confidence               0000000000000 00000      0000011111346799999999999999999999984

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=3.4e-43  Score=329.37  Aligned_cols=252  Identities=21%  Similarity=0.309  Sum_probs=195.9

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch-hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeC
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI-RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFA  164 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  164 (414)
                      ++|.....||+|+||.||+|.+. ++..||||.+...... .....+++.+++.++||||+++++++...+..++||||+
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  101 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV  101 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence            34555668999999999999975 5889999999765432 344567789999999999999999999999999999999


Q ss_pred             CCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCC-CCcEEEeeccccccccCCcc
Q 015027          165 SNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLND-NYTAKVADFESSVLISSDAE  243 (414)
Q Consensus       165 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~DfGla~~~~~~~~  243 (414)
                      ++++|.+++.........++..+..++.||+.||.|||+.+   ++|+||||+||+++. ++.+||+|||++....... 
T Consensus       102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-  177 (295)
T 2clq_A          102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-  177 (295)
T ss_dssp             SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred             CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC-
Confidence            99999999976655555678889999999999999999987   999999999999987 8999999999998764321 


Q ss_pred             ccceecccccccccchhhcccCC--CCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccc
Q 015027          244 TAMSTILIGTSGYLDPVCINTGK--LTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILN  321 (414)
Q Consensus       244 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (414)
                       .......||+.|+|||++.+..  ++.++||||||+++|+|++|+.||........        .........    ..
T Consensus       178 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--------~~~~~~~~~----~~  244 (295)
T 2clq_A          178 -PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA--------AMFKVGMFK----VH  244 (295)
T ss_dssp             ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH--------HHHHHHHHC----CC
T ss_pred             -CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH--------HHHhhcccc----cc
Confidence             1223457899999999997653  88999999999999999999999863221110        000000000    00


Q ss_pred             cccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          322 FHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       322 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      +....    ..+..+.+|+.+||+.||.+|||+.++++
T Consensus       245 ~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          245 PEIPE----SMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             CCCCT----TSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             ccccc----cCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            11111    12255899999999999999999999853

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=6.6e-43  Score=348.10  Aligned_cols=194  Identities=25%  Similarity=0.311  Sum_probs=150.6

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch---hHhHHHHHHHHHccCCCceeeeeeeEecC-----Cc
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI---RITERELLRIISQVNHKNVVKILGLCLET-----EV  156 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~hpniv~l~~~~~~~-----~~  156 (414)
                      .++|.+.+.||+|+||.||+|.+. +++.||||++......   .....+++++++.++||||+++++++...     ..
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            478999999999999999999976 6899999998654222   23345678999999999999999998543     56


Q ss_pred             ceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccc
Q 015027          157 PLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSV  236 (414)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~  236 (414)
                      .|+||||+. ++|.+++...   ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       132 ~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~  204 (458)
T 3rp9_A          132 LYVVLEIAD-SDFKKLFRTP---VYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR  204 (458)
T ss_dssp             EEEEECCCS-EEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEeccc-cchhhhcccC---CCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence            899999985 6898888543   34588999999999999999999988   9999999999999999999999999998


Q ss_pred             cccCCccc-------------------------cceecccccccccchhhc-ccCCCCCcccchhHHHHHHHHHhC
Q 015027          237 LISSDAET-------------------------AMSTILIGTSGYLDPVCI-NTGKLTKKSDVYSFGVVLAELLTG  286 (414)
Q Consensus       237 ~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~SlGvil~el~tg  286 (414)
                      ........                         ......+||++|+|||++ .+..++.++|||||||++|||++|
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            76532111                         123445789999999986 566799999999999999999994

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.2e-42  Score=328.69  Aligned_cols=251  Identities=25%  Similarity=0.333  Sum_probs=196.1

Q ss_pred             HhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEe
Q 015027           85 ATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        85 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  163 (414)
                      ..++|.+.+.||+|+||.||+|.+. +|+.||||.+...... ....+++.++..++||||+++++++...+..++||||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  105 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL-QEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEY  105 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCC-HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHH-HHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeec
Confidence            3578999999999999999999976 4899999999875433 3446667899999999999999999999999999999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcc
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE  243 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  243 (414)
                      +++++|.+++....  ..+++..++.++.+|+.||.|||+.+   ++|+||||+||+++.++.+||+|||++........
T Consensus       106 ~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  180 (314)
T 3com_A          106 CGAGSVSDIIRLRN--KTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA  180 (314)
T ss_dssp             CTTEEHHHHHHHHT--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred             CCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence            99999999986433  33588999999999999999999988   99999999999999999999999999977654321


Q ss_pred             ccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccc
Q 015027          244 TAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFH  323 (414)
Q Consensus       244 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (414)
                        ......||+.|+|||++.+..++.++||||||+++|+|++|..||........         ............    
T Consensus       181 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---------~~~~~~~~~~~~----  245 (314)
T 3com_A          181 --KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA---------IFMIPTNPPPTF----  245 (314)
T ss_dssp             --CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH---------HHHHHHSCCCCC----
T ss_pred             --ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH---------HHHHhcCCCccc----
Confidence              22345789999999999999999999999999999999999999974321110         000000000000    


Q ss_pred             cCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          324 VADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       324 ~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                         ..+...+..+.+|+.+||+.||.+|||+.++++
T Consensus       246 ---~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          246 ---RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             ---SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ---CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence               001111255899999999999999999999965

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-43  Score=340.43  Aligned_cols=252  Identities=22%  Similarity=0.264  Sum_probs=193.9

Q ss_pred             hcCCCCCCccccCCceEEEEEEE----cCCcEEEEEEeeccc-----chhHhHHHHHHHHHcc-CCCceeeeeeeEecCC
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVL----HDNIQVAVKTYRRAD-----KIRITERELLRIISQV-NHKNVVKILGLCLETE  155 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~-----~~~~~~~~~~~~l~~l-~hpniv~l~~~~~~~~  155 (414)
                      .++|.+.+.||+|+||.||+|..    .+++.||||++....     ........+++++..+ +||||+++++++...+
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            36799999999999999999997    368999999986532     1122234455777777 6999999999999999


Q ss_pred             cceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccc
Q 015027          156 VPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESS  235 (414)
Q Consensus       156 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla  235 (414)
                      ..++||||+++++|.+++....   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a  206 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS  206 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             eEEEEeecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence            9999999999999999996543   3578999999999999999999987   999999999999999999999999999


Q ss_pred             ccccCCccccceecccccccccchhhccc--CCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcc
Q 015027          236 VLISSDAETAMSTILIGTSGYLDPVCINT--GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKN  313 (414)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  313 (414)
                      +...... ........||+.|+|||++.+  ..++.++|||||||++|||++|+.||........     ..........
T Consensus       207 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-----~~~~~~~~~~  280 (355)
T 1vzo_A          207 KEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-----QAEISRRILK  280 (355)
T ss_dssp             EECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-----HHHHHHHHHH
T ss_pred             eecccCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch-----HHHHHHHHhc
Confidence            8654332 222345679999999999986  3578999999999999999999999964321110     0000000000


Q ss_pred             cccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCC-----ChhHHHH
Q 015027          314 NGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERP-----TMKQVSE  359 (414)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rp-----s~~~v~~  359 (414)
                      .      .+...    ...+..+.+|+.+||+.||.+||     |+.++++
T Consensus       281 ~------~~~~~----~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~  321 (355)
T 1vzo_A          281 S------EPPYP----QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  321 (355)
T ss_dssp             C------CCCCC----TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             c------CCCCC----cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHc
Confidence            0      00111    11225589999999999999999     8888754

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=9e-43  Score=326.67  Aligned_cols=247  Identities=24%  Similarity=0.349  Sum_probs=199.8

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc----hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK----IRITERELLRIISQVNHKNVVKILGLCLETEVPLLV  160 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv  160 (414)
                      .++|.+.+.||+|+||.||+|.+. +++.||+|++.....    ......+++.+++.++||||+++++++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            467889999999999999999976 488999999876532    223345677899999999999999999999999999


Q ss_pred             EEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccC
Q 015027          161 YEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISS  240 (414)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  240 (414)
                      |||+++++|.+++....   .+++..++.++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++.....
T Consensus        94 ~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  167 (294)
T 2rku_A           94 LELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  167 (294)
T ss_dssp             EECCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence            99999999999886543   3578999999999999999999988   99999999999999999999999999987643


Q ss_pred             CccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccc
Q 015027          241 DAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQIL  320 (414)
Q Consensus       241 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (414)
                      ...  ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.......         ..........    
T Consensus       168 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---------~~~~~~~~~~----  232 (294)
T 2rku_A          168 DGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE---------TYLRIKKNEY----  232 (294)
T ss_dssp             TTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---------HHHHHHTTCC----
T ss_pred             Ccc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---------HHHHHhhccC----
Confidence            221  2334578999999999999999999999999999999999999997433211         0011111100    


Q ss_pred             ccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          321 NFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       321 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                        ....    ..+..+.+|+.+||+.||.+|||+.++++
T Consensus       233 --~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          233 --SIPK----HINPVAASLIQKMLQTDPTARPTINELLN  265 (294)
T ss_dssp             --CCCT----TSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             --CCcc----ccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence              0111    11245899999999999999999999854

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=6.1e-43  Score=329.50  Aligned_cols=249  Identities=23%  Similarity=0.308  Sum_probs=198.3

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch-hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEe
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI-RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  163 (414)
                      .++|.+.+.||+|+||.||+|... +|+.||+|++...... .....+++.++..++||||+++++++.+.+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL   87 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence            467899999999999999999976 6899999999865432 23345677899999999999999999999999999999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceee---CCCCcEEEeeccccccccC
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILL---NDNYTAKVADFESSVLISS  240 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~DfGla~~~~~  240 (414)
                      +++++|.+++....   .+++..+..++.|++.||.|||+.+   |+||||||+||++   +.++.+||+|||++.....
T Consensus        88 ~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  161 (304)
T 2jam_A           88 VSGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN  161 (304)
T ss_dssp             CCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred             CCCccHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence            99999999986543   3578999999999999999999988   9999999999999   7889999999999876433


Q ss_pred             CccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccc
Q 015027          241 DAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQIL  320 (414)
Q Consensus       241 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (414)
                      .    ......||+.|+|||++.+..++.++||||||+++|+|++|..||.......         ....+...... . 
T Consensus       162 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---------~~~~i~~~~~~-~-  226 (304)
T 2jam_A          162 G----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK---------LFEKIKEGYYE-F-  226 (304)
T ss_dssp             B----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH---------HHHHHHHCCCC-C-
T ss_pred             C----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---------HHHHHHcCCCC-C-
Confidence            2    2234578999999999999999999999999999999999999996432111         11111111100 0 


Q ss_pred             ccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          321 NFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       321 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                          ........+..+.+|+.+||+.||.+|||+.++++
T Consensus       227 ----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          227 ----ESPFWDDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             ----CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             ----CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                00001112256899999999999999999999965

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.1e-43  Score=346.82  Aligned_cols=264  Identities=20%  Similarity=0.246  Sum_probs=191.5

Q ss_pred             hcCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecCCc------ceE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEV------PLL  159 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~------~~l  159 (414)
                      ..+|.+.+.||+|+||.||+|.+..+..||+|.+.......   .+++++++.++||||++++++|.....      .++
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~~---~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l  115 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFK---NRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL  115 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTSC---CHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcchH---HHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence            35789999999999999999998877779999887654332   245688999999999999999965433      789


Q ss_pred             EEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeC-CCCcEEEeeccccccc
Q 015027          160 VYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLN-DNYTAKVADFESSVLI  238 (414)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~-~~~~~kl~DfGla~~~  238 (414)
                      ||||++++.+............+++..+..++.||+.||.|||+.+   |+||||||+|||++ .++.+||+|||+++..
T Consensus       116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~  192 (394)
T 4e7w_A          116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL  192 (394)
T ss_dssp             EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence            9999987654443332333445688999999999999999999988   99999999999999 7999999999999876


Q ss_pred             cCCccccceecccccccccchhhcccC-CCCCcccchhHHHHHHHHHhCCCCCCccccccccccccch-------hhhhh
Q 015027          239 SSDAETAMSTILIGTSGYLDPVCINTG-KLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVP-------YFLNS  310 (414)
Q Consensus       239 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~-------~~~~~  310 (414)
                      ....   ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+........ .+..       .....
T Consensus       193 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~-~i~~~~g~p~~~~~~~  268 (394)
T 4e7w_A          193 IAGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLV-EIIKVLGTPSREQIKT  268 (394)
T ss_dssp             CTTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-HHHHHHCCCCHHHHHH
T ss_pred             cCCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHHhCCCCHHHHHh
Confidence            4332   22345789999999998764 59999999999999999999999997543211000 0000       00000


Q ss_pred             hc----ccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          311 IK----NNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       311 ~~----~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ..    ...........+........+..+.+|+.+||+.||.+|||+.++++
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence            00    00000000000000000112356999999999999999999999854

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=6.9e-43  Score=333.86  Aligned_cols=247  Identities=24%  Similarity=0.344  Sum_probs=200.1

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc----hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK----IRITERELLRIISQVNHKNVVKILGLCLETEVPLLV  160 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv  160 (414)
                      .++|.+.+.||+|+||.||++.+. +++.||+|++.....    .......++.+++.++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            468999999999999999999976 478999999976532    223345677899999999999999999999999999


Q ss_pred             EEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccC
Q 015027          161 YEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISS  240 (414)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  240 (414)
                      |||+++++|.+++....   .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus       120 ~e~~~~~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  193 (335)
T 2owb_A          120 LELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  193 (335)
T ss_dssp             ECCCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence            99999999999886543   3588999999999999999999988   99999999999999999999999999987643


Q ss_pred             CccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccc
Q 015027          241 DAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQIL  320 (414)
Q Consensus       241 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (414)
                      ..  .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.......         ..........    
T Consensus       194 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---------~~~~~~~~~~----  258 (335)
T 2owb_A          194 DG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE---------TYLRIKKNEY----  258 (335)
T ss_dssp             TT--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---------HHHHHHHTCC----
T ss_pred             Cc--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH---------HHHHHhcCCC----
Confidence            22  12334578999999999999999999999999999999999999997432111         0111111100    


Q ss_pred             ccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          321 NFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       321 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                        .....    ....+.+|+.+||+.||.+|||+.++++
T Consensus       259 --~~~~~----~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          259 --SIPKH----INPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             --CCCTT----SCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             --CCCcc----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              01111    1245899999999999999999999854

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2.4e-43  Score=363.48  Aligned_cols=249  Identities=24%  Similarity=0.319  Sum_probs=194.2

Q ss_pred             CccccCCceEEEEEEEc---CCcEEEEEEeecccch---hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCCC
Q 015027           93 RCLSQGGFVSVYKGVLH---DNIQVAVKTYRRADKI---RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASN  166 (414)
Q Consensus        93 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  166 (414)
                      +.||+|+||.||+|.+.   .++.||||+++.....   .....++++++.+++|||||++++++.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            46999999999999753   3678999999765332   2445677899999999999999999864 568899999999


Q ss_pred             CchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccc-c
Q 015027          167 GTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET-A  245 (414)
Q Consensus       167 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~-~  245 (414)
                      |+|.+++....   .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++........ .
T Consensus       454 g~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  527 (635)
T 4fl3_A          454 GPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  527 (635)
T ss_dssp             EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred             CCHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence            99999996432   3588999999999999999999988   999999999999999999999999999876543221 2


Q ss_pred             ceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhccccccccccccc
Q 015027          246 MSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHV  324 (414)
Q Consensus       246 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (414)
                      ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.......         ....+.....        
T Consensus       528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---------~~~~i~~~~~--------  590 (635)
T 4fl3_A          528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---------VTAMLEKGER--------  590 (635)
T ss_dssp             -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---------HHHHHHTTCC--------
T ss_pred             cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---------HHHHHHcCCC--------
Confidence            2233456789999999999999999999999999999998 999997543211         1111111110        


Q ss_pred             CCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHH
Q 015027          325 ADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR  366 (414)
Q Consensus       325 ~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~  366 (414)
                       ...+...+..+.+|+.+||+.||.+|||+.+|++.|+.+..
T Consensus       591 -~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~  631 (635)
T 4fl3_A          591 -MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  631 (635)
T ss_dssp             -CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             -CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence             00111123569999999999999999999999999998754

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1e-43  Score=332.08  Aligned_cols=251  Identities=23%  Similarity=0.254  Sum_probs=183.0

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhH---hHHHHHHHHHccCCCceeeeeeeEecCCcceEEE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRI---TERELLRIISQVNHKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~---~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~  161 (414)
                      .++|++.+.||+|+||.||+|... +++.||||++........   ...++...++.++||||+++++++.+++..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            467999999999999999999975 689999999976533222   2244445678889999999999999999999999


Q ss_pred             EeCCCCchhhhhhhc-CCcccCCHHHHHHHHHHHHHHHHHhhhC-CCCCeeeCCCCCCceeeCCCCcEEEeecccccccc
Q 015027          162 EFASNGTLLDHIRCE-SSQVLKTWKTCLRIAAETASALDYLHSL-ASPPIIHGDVKSANILLNDNYTAKVADFESSVLIS  239 (414)
Q Consensus       162 e~~~~gsL~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~-~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~  239 (414)
                      ||+++ +|.+++... .....+++..++.++.|++.||.|||+. +   |+||||||+|||++.++.+||+|||++....
T Consensus        86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            99975 887777432 2234568999999999999999999997 7   9999999999999999999999999998765


Q ss_pred             CCccccceecccccccccchhhc----ccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccc
Q 015027          240 SDAETAMSTILIGTSGYLDPVCI----NTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNG  315 (414)
Q Consensus       240 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (414)
                      ...   ......||+.|+|||++    .+..++.++|||||||++|+|++|+.||........       ....... ..
T Consensus       162 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~~-~~  230 (290)
T 3fme_A          162 DDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ-------QLKQVVE-EP  230 (290)
T ss_dssp             -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH-------HHHHHHH-SC
T ss_pred             ccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH-------HHHHHhc-cC
Confidence            432   22334799999999996    566789999999999999999999999964221110       0000000 00


Q ss_pred             cccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          316 LRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ....        .....+..+.+|+.+||+.||.+|||+.++++
T Consensus       231 ~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          231 SPQL--------PADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             CCCC--------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCc--------ccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence            0000        01112255899999999999999999999954

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=8.1e-44  Score=334.73  Aligned_cols=263  Identities=22%  Similarity=0.292  Sum_probs=184.1

Q ss_pred             HhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc--hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEE
Q 015027           85 ATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK--IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        85 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~  161 (414)
                      ..++|.+.+.||+|+||.||+|.+. +++.||||.+.....  ......+++.++.+++||||+++++++...+..++||
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   92 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM   92 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence            3578999999999999999999965 689999999865432  2233356678888999999999999999999999999


Q ss_pred             EeCCCCchhhhhhhc-----CCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccc
Q 015027          162 EFASNGTLLDHIRCE-----SSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSV  236 (414)
Q Consensus       162 e~~~~gsL~~~l~~~-----~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~  236 (414)
                      ||+++++|.+++...     .....+++..++.++.||+.||.|||+.+   ++||||||+||+++.++.+||+|||++.
T Consensus        93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~  169 (303)
T 2vwi_A           93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSA  169 (303)
T ss_dssp             ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred             hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchh
Confidence            999999999998642     12334688999999999999999999988   9999999999999999999999999987


Q ss_pred             cccCCcc---ccceecccccccccchhhccc-CCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhc
Q 015027          237 LISSDAE---TAMSTILIGTSGYLDPVCINT-GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIK  312 (414)
Q Consensus       237 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  312 (414)
                      .......   ........||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.........     ........
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-----~~~~~~~~  244 (303)
T 2vwi_A          170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL-----MLTLQNDP  244 (303)
T ss_dssp             HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH-----HHHHTSSC
T ss_pred             eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH-----HHHhccCC
Confidence            6543211   112234578999999999875 57899999999999999999999999743321100     00000000


Q ss_pred             ccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          313 NNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ........+.......    +..+.+|+.+||+.||.+|||+.++++
T Consensus       245 ~~~~~~~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          245 PSLETGVQDKEMLKKY----GKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             CCTTC-----CCCCCC----CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             Cccccccccchhhhhh----hHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            0000000011111111    245899999999999999999999854

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.8e-43  Score=337.04  Aligned_cols=264  Identities=17%  Similarity=0.204  Sum_probs=189.3

Q ss_pred             HhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchh---HhHHHHHHHHHccCCCceeeeeeeEecCCcceEE
Q 015027           85 ATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIR---ITERELLRIISQVNHKNVVKILGLCLETEVPLLV  160 (414)
Q Consensus        85 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv  160 (414)
                      ..++|.+.+.||+|+||+||+|.+. +++.||||++.......   ....+++.++++++||||+++++++.+++..++|
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  111 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI  111 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence            4578999999999999999999965 68999999997553322   2235677999999999999999999999999999


Q ss_pred             EEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceee-----CCCCcEEEeecccc
Q 015027          161 YEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILL-----NDNYTAKVADFESS  235 (414)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll-----~~~~~~kl~DfGla  235 (414)
                      |||+++ +|.+++....   .+++..++.++.||+.||.|||+.+   |+||||||+|||+     +.++.+||+|||++
T Consensus       112 ~e~~~~-~L~~~~~~~~---~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a  184 (329)
T 3gbz_A          112 FEYAEN-DLKKYMDKNP---DVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLA  184 (329)
T ss_dssp             EECCSE-EHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred             EecCCC-CHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence            999985 9999886543   3588999999999999999999988   9999999999999     45566999999999


Q ss_pred             ccccCCccccceecccccccccchhhcccC-CCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchh-------h
Q 015027          236 VLISSDAETAMSTILIGTSGYLDPVCINTG-KLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPY-------F  307 (414)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~-------~  307 (414)
                      .......  .......||+.|+|||++.+. .++.++|||||||++|+|++|..||........... ....       .
T Consensus       185 ~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~  261 (329)
T 3gbz_A          185 RAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFK-IFEVLGLPDDTT  261 (329)
T ss_dssp             HHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-HHHHHCCCCTTT
T ss_pred             cccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHH-HHHHhCCCchhh
Confidence            8764321  223445789999999999874 589999999999999999999999975432110000 0000       0


Q ss_pred             hhhhc-ccccccccccccCCcc-----cHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          308 LNSIK-NNGLRQILNFHVADES-----EMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       308 ~~~~~-~~~~~~~~~~~~~~~~-----~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ..... .......+. ......     ....+..+.+|+.+||+.||.+|||+.++++
T Consensus       262 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          262 WPGVTALPDWKQSFP-KFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             STTGGGSTTCCTTCC-CCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhhhhhhh-hhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            00000 000000000 000000     0001256899999999999999999999843

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2.8e-43  Score=329.29  Aligned_cols=258  Identities=23%  Similarity=0.323  Sum_probs=192.7

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc--CCc--EEEEEEeeccc----chhHhHHHHHHHHHccCCCceeeeeeeEecCCcc
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH--DNI--QVAVKTYRRAD----KIRITERELLRIISQVNHKNVVKILGLCLETEVP  157 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~~----~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~  157 (414)
                      .++|++.+.||+|+||.||+|.+.  ++.  .||||++....    .......++++++.+++||||+++++++.... .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            367999999999999999999854  233  68999987542    22234466778999999999999999998765 8


Q ss_pred             eEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccccc
Q 015027          158 LLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVL  237 (414)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~  237 (414)
                      ++||||+++++|.+++....  ..+++..+..++.|++.||.|||+.+   ++|+||||+|||++.++.+||+|||++..
T Consensus        96 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~  170 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA  170 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             eeeEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence            89999999999999997543  23578999999999999999999987   99999999999999999999999999987


Q ss_pred             ccCCccc-cceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhcccc
Q 015027          238 ISSDAET-AMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNG  315 (414)
Q Consensus       238 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (414)
                      ....... .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.......         .........
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---------~~~~~~~~~  241 (291)
T 1u46_A          171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---------ILHKIDKEG  241 (291)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---------HHHHHHTSC
T ss_pred             ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH---------HHHHHHccC
Confidence            6543221 12234567889999999999899999999999999999999 999997443211         111111111


Q ss_pred             cccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHH
Q 015027          316 LRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR  366 (414)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~  366 (414)
                      ...        ..+...+..+.+|+.+||+.||.+|||+.++++.|+.+..
T Consensus       242 ~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          242 ERL--------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             CCC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             CCC--------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence            000        0111122569999999999999999999999999887653

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=4.5e-43  Score=334.03  Aligned_cols=253  Identities=20%  Similarity=0.265  Sum_probs=195.0

Q ss_pred             HHhcCCCCC-CccccCCceEEEEEEEc-CCcEEEEEEeecccch---hHhHHHHHHHHHcc-CCCceeeeeeeEecCCcc
Q 015027           84 RATKNFDRS-RCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI---RITERELLRIISQV-NHKNVVKILGLCLETEVP  157 (414)
Q Consensus        84 ~~~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l-~hpniv~l~~~~~~~~~~  157 (414)
                      ...++|.+. +.||+|+||.||+|... +++.||+|++......   .....+++.++..+ .||||+++++++.+.+..
T Consensus        25 ~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~  104 (327)
T 3lm5_A           25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEI  104 (327)
T ss_dssp             HHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             hhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeE
Confidence            345667777 88999999999999976 5899999999764322   23445666778777 569999999999999999


Q ss_pred             eEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCC---CCcEEEeeccc
Q 015027          158 LLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLND---NYTAKVADFES  234 (414)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~DfGl  234 (414)
                      ++||||+++|+|.+++.... ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.   ++.+||+|||+
T Consensus       105 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~  180 (327)
T 3lm5_A          105 ILILEYAAGGEIFSLCLPEL-AEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGM  180 (327)
T ss_dssp             EEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCGGG
T ss_pred             EEEEEecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeCcc
Confidence            99999999999999985432 234588999999999999999999988   999999999999997   78999999999


Q ss_pred             cccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccc
Q 015027          235 SVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNN  314 (414)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  314 (414)
                      +.......   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......         ........
T Consensus       181 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---------~~~~i~~~  248 (327)
T 3lm5_A          181 SRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE---------TYLNISQV  248 (327)
T ss_dssp             CEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---------HHHHHHHT
T ss_pred             ccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH---------HHHHHHhc
Confidence            98765332   2234579999999999999999999999999999999999999996433211         00000000


Q ss_pred             ccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHH
Q 015027          315 GLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVS  358 (414)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~  358 (414)
                      ..      ..........+..+.+|+.+||+.||.+|||+.+++
T Consensus       249 ~~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll  286 (327)
T 3lm5_A          249 NV------DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICL  286 (327)
T ss_dssp             CC------CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred             cc------ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence            00      000011111225589999999999999999999984

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=2.7e-43  Score=336.07  Aligned_cols=266  Identities=21%  Similarity=0.314  Sum_probs=194.8

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchh---HhHHHHHHHHHccCCCceeeeeeeEecCCcceEEE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIR---ITERELLRIISQVNHKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~  161 (414)
                      .++|++.+.||+|+||.||+|.+. +++.||||++.......   ....+++.++++++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            367899999999999999999976 48999999987554322   23356778999999999999999999999999999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCC
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD  241 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  241 (414)
                      ||+++++|.+++....   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus       104 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  177 (331)
T 4aaa_A          104 EFVDHTILDDLELFPN---GLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  177 (331)
T ss_dssp             ECCSEEHHHHHHHSTT---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             ecCCcchHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence            9999999988764332   3588999999999999999999988   999999999999999999999999999766432


Q ss_pred             ccccceecccccccccchhhcccC-CCCCcccchhHHHHHHHHHhCCCCCCcccccccccc------ccchhhhhhhccc
Q 015027          242 AETAMSTILIGTSGYLDPVCINTG-KLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKI------SMVPYFLNSIKNN  314 (414)
Q Consensus       242 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~------~~~~~~~~~~~~~  314 (414)
                      .  .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........      ...+.....+...
T Consensus       178 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (331)
T 4aaa_A          178 G--EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN  255 (331)
T ss_dssp             --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred             c--cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence            2  223345789999999999875 789999999999999999999999975432110000      0000000000000


Q ss_pred             -ccccccccccCCcccH-----HHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          315 -GLRQILNFHVADESEM-----KEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       315 -~~~~~~~~~~~~~~~~-----~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                       .......+........     ..+..+.+|+.+||+.||.+|||+.++++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence             0000000000000000     12356999999999999999999999865

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=6.8e-43  Score=344.83  Aligned_cols=199  Identities=28%  Similarity=0.316  Sum_probs=169.2

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhHhHHHHHHHHHcc------CCCceeeeeeeEecCCcce
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRITERELLRIISQV------NHKNVVKILGLCLETEVPL  158 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~l~~l------~hpniv~l~~~~~~~~~~~  158 (414)
                      ..+|++.+.||+|+||.||+|.+. +++.||||++...........++++++..+      +|+||+++++++......+
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~  175 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC  175 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence            467999999999999999999976 489999999987654444444455555554      6889999999999999999


Q ss_pred             EEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCc--EEEeeccccc
Q 015027          159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYT--AKVADFESSV  236 (414)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~--~kl~DfGla~  236 (414)
                      +||||+. ++|.+++...... .+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.  +||+|||++.
T Consensus       176 lv~e~~~-~~L~~~l~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a~  250 (429)
T 3kvw_A          176 MTFELLS-MNLYELIKKNKFQ-GFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSC  250 (429)
T ss_dssp             EEECCCC-CBHHHHHHHTTTC-CCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred             EEEeccC-CCHHHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccce
Confidence            9999996 5899888664432 3588999999999999999999987   999999999999999887  9999999997


Q ss_pred             cccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccc
Q 015027          237 LISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMT  294 (414)
Q Consensus       237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~  294 (414)
                      .....     .....||+.|+|||++.+..++.++|||||||++|||++|.+||....
T Consensus       251 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~  303 (429)
T 3kvw_A          251 YEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED  303 (429)
T ss_dssp             ETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence            65432     234578999999999999999999999999999999999999997543

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=9.8e-44  Score=330.47  Aligned_cols=256  Identities=19%  Similarity=0.330  Sum_probs=197.8

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc---hhHhHHHHHHHHHccCCCceeeeeeeEe--cCCcceE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK---IRITERELLRIISQVNHKNVVKILGLCL--ETEVPLL  159 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~hpniv~l~~~~~--~~~~~~l  159 (414)
                      .++|++.+.||+|+||.||+|... +++.||+|.+.....   ......+++.++++++||||+++++++.  .....++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            468999999999999999999976 589999999976432   2233466778999999999999999885  4668899


Q ss_pred             EEEeCCCCchhhhhhhcC-CcccCCHHHHHHHHHHHHHHHHHhhhCC--CCCeeeCCCCCCceeeCCCCcEEEeeccccc
Q 015027          160 VYEFASNGTLLDHIRCES-SQVLKTWKTCLRIAAETASALDYLHSLA--SPPIIHGDVKSANILLNDNYTAKVADFESSV  236 (414)
Q Consensus       160 v~e~~~~gsL~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~--~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~  236 (414)
                      ||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+  ..+|+||||||+|||++.++.+||+|||++.
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~  164 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  164 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence            999999999999996543 2334688999999999999999999865  2349999999999999999999999999998


Q ss_pred             cccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccc
Q 015027          237 LISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGL  316 (414)
Q Consensus       237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (414)
                      ......  .......||+.|+|||++.+..++.++||||||+++|+|++|..||.......         ....+.....
T Consensus       165 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---------~~~~i~~~~~  233 (279)
T 2w5a_A          165 ILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---------LAGKIREGKF  233 (279)
T ss_dssp             HC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---------HHHHHHHTCC
T ss_pred             eecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH---------HHHHHhhccc
Confidence            764321  12234578999999999999999999999999999999999999997443111         1111111111


Q ss_pred             ccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHH
Q 015027          317 RQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEEL  361 (414)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L  361 (414)
                      .     ....    ..+..+.+|+.+||+.||.+|||+.+|++.+
T Consensus       234 ~-----~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~  269 (279)
T 2w5a_A          234 R-----RIPY----RYSDELNEIITRMLNLKDYHRPSVEEILENP  269 (279)
T ss_dssp             C-----CCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred             c-----cCCc----ccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence            1     0111    1125599999999999999999999997643

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=3e-42  Score=324.57  Aligned_cols=250  Identities=18%  Similarity=0.258  Sum_probs=194.2

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc-----hhHhHHHHHHHHHccCCCceeeeeeeEe--cCCcc
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK-----IRITERELLRIISQVNHKNVVKILGLCL--ETEVP  157 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~~~~l~~l~hpniv~l~~~~~--~~~~~  157 (414)
                      .++|.+.+.||+|+||.||+|.+. +++.||+|++.....     ......+++.++++++||||+++++++.  +....
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            478999999999999999999975 588999999976432     2234467789999999999999999984  45678


Q ss_pred             eEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccccc
Q 015027          158 LLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVL  237 (414)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~  237 (414)
                      ++||||++++ |.+++.... ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA  158 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEehhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence            9999999876 666665433 234588999999999999999999988   99999999999999999999999999987


Q ss_pred             ccCCccccceecccccccccchhhcccCC--CCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccc
Q 015027          238 ISSDAETAMSTILIGTSGYLDPVCINTGK--LTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNG  315 (414)
Q Consensus       238 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (414)
                      ..............||+.|+|||++.+..  ++.++||||||+++|+|++|..||.......         ....+....
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---------~~~~i~~~~  229 (305)
T 2wtk_C          159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK---------LFENIGKGS  229 (305)
T ss_dssp             CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---------HHHHHHHCC
T ss_pred             cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH---------HHHHHhcCC
Confidence            65433333344567999999999997654  4789999999999999999999997432111         111111111


Q ss_pred             cccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          316 LRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      .      .....    .+..+.+|+.+||+.||.+|||+.++++
T Consensus       230 ~------~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~  263 (305)
T 2wtk_C          230 Y------AIPGD----CGPPLSDLLKGMLEYEPAKRFSIRQIRQ  263 (305)
T ss_dssp             C------CCCSS----SCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             C------CCCCc----cCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            0      01111    1245899999999999999999999864

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=3.9e-43  Score=347.03  Aligned_cols=199  Identities=24%  Similarity=0.305  Sum_probs=164.1

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch---hHhHHHHHHHHHccCCCceeeeeeeEecC-----Cc
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI---RITERELLRIISQVNHKNVVKILGLCLET-----EV  156 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~hpniv~l~~~~~~~-----~~  156 (414)
                      .++|.+.+.||+|+||.||+|.+. +++.||||++......   .....+++++++.++||||+++++++...     ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            478999999999999999999976 5889999999754222   23346678999999999999999999766     56


Q ss_pred             ceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccc
Q 015027          157 PLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSV  236 (414)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~  236 (414)
                      .|+||||++ ++|.+++...   ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~  177 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTP---IFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR  177 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEecCC-cCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence            899999996 5999988643   34588999999999999999999988   9999999999999999999999999998


Q ss_pred             cccCCccc--------------------cceecccccccccchhhc-ccCCCCCcccchhHHHHHHHHHhCCCCCC
Q 015027          237 LISSDAET--------------------AMSTILIGTSGYLDPVCI-NTGKLTKKSDVYSFGVVLAELLTGKKPGS  291 (414)
Q Consensus       237 ~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~SlGvil~el~tg~~p~~  291 (414)
                      ........                    ......+||++|+|||++ .+..++.++|||||||++|||++|..||.
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            76543221                    123556899999999986 56679999999999999999999766654

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.3e-42  Score=360.50  Aligned_cols=243  Identities=21%  Similarity=0.222  Sum_probs=195.8

Q ss_pred             HhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc----hhHhHHHHHHHHHcc-CCCceeeeeeeEecCCcce
Q 015027           85 ATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK----IRITERELLRIISQV-NHKNVVKILGLCLETEVPL  158 (414)
Q Consensus        85 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~~~l~~l-~hpniv~l~~~~~~~~~~~  158 (414)
                      ..++|.+.+.||+|+||.||+|... +++.||||++.....    .......+..++..+ +||||+++++++.+.+.+|
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            3468999999999999999999976 588999999986421    222334555777776 7999999999999999999


Q ss_pred             EEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccc
Q 015027          159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLI  238 (414)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~  238 (414)
                      |||||+++|+|.+++...+   .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus       419 lV~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~  492 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN  492 (674)
T ss_dssp             EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred             EEEeCcCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence            9999999999999997643   3588999999999999999999988   999999999999999999999999999864


Q ss_pred             cCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccc
Q 015027          239 SSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQ  318 (414)
Q Consensus       239 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (414)
                      ....  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+...         ....+.....  
T Consensus       493 ~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~---------~~~~i~~~~~--  559 (674)
T 3pfq_A          493 IWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---------LFQSIMEHNV--  559 (674)
T ss_dssp             CCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---------HHHHHHSSCC--
T ss_pred             ccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH---------HHHHHHhCCC--
Confidence            3321  22345689999999999999999999999999999999999999997533211         1111111110  


Q ss_pred             ccccccCCcccHHHHHHHHHHHHHhhccCCCCCCCh
Q 015027          319 ILNFHVADESEMKEIEIVAELASKCLRIRGTERPTM  354 (414)
Q Consensus       319 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~  354 (414)
                          ..+    ...+..+.+|+.+||+.||.+||++
T Consensus       560 ----~~p----~~~s~~~~~li~~lL~~dP~~R~~~  587 (674)
T 3pfq_A          560 ----AYP----KSMSKEAVAICKGLMTKHPGKRLGC  587 (674)
T ss_dssp             ----CCC----TTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred             ----CCC----ccCCHHHHHHHHHHccCCHHHCCCC
Confidence                011    1123569999999999999999997

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.9e-43  Score=337.10  Aligned_cols=267  Identities=21%  Similarity=0.230  Sum_probs=191.7

Q ss_pred             HHhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch------hHhHHHHHHHHHccCCCceeeeeeeEecCCc
Q 015027           84 RATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI------RITERELLRIISQVNHKNVVKILGLCLETEV  156 (414)
Q Consensus        84 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~  156 (414)
                      ...++|.+.+.||+|+||.||+|.+. +|+.||||++......      .....+++.+++.++||||+++++++.+.+.
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence            34578999999999999999999975 5899999999753221      2234567789999999999999999999999


Q ss_pred             ceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccc
Q 015027          157 PLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSV  236 (414)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~  236 (414)
                      .++||||+++ +|.+++....  ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.
T Consensus        87 ~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK  160 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred             eEEEEEcCCC-CHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccce
Confidence            9999999986 8888886543  23467888999999999999999988   9999999999999999999999999998


Q ss_pred             cccCCccccceecccccccccchhhcccC-CCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhh----hhh
Q 015027          237 LISSDAETAMSTILIGTSGYLDPVCINTG-KLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFL----NSI  311 (414)
Q Consensus       237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~----~~~  311 (414)
                      ......  .......||+.|+|||++.+. .++.++|||||||++|+|++|.+||........... ......    ..+
T Consensus       161 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~-i~~~~~~~~~~~~  237 (346)
T 1ua2_A          161 SFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTR-IFETLGTPTEEQW  237 (346)
T ss_dssp             TTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-HHHHHCCCCTTTS
T ss_pred             eccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHH-HHHHcCCCChhhh
Confidence            764332  223445789999999999654 589999999999999999999999875432110000 000000    000


Q ss_pred             cc-cccccccccccCCccc-----HHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          312 KN-NGLRQILNFHVADESE-----MKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       312 ~~-~~~~~~~~~~~~~~~~-----~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      .. ......+........+     ...+..+.+|+.+||+.||.+|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  291 (346)
T 1ua2_A          238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  291 (346)
T ss_dssp             SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence            00 0000000000000000     111256999999999999999999999844

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=3.4e-43  Score=343.07  Aligned_cols=264  Identities=21%  Similarity=0.223  Sum_probs=196.4

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhHhHHHHHHHHHccC--------CCceeeeeeeEe----
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRITERELLRIISQVN--------HKNVVKILGLCL----  152 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~--------hpniv~l~~~~~----  152 (414)
                      .++|.+.+.||+|+||+||+|.+. +++.||||++...........+++++++.++        ||||+++++++.    
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~  115 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV  115 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence            368999999999999999999965 5889999999866544455566667777764        888999999987    


Q ss_pred             cCCcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhC-CCCCeeeCCCCCCceeeCCCC------
Q 015027          153 ETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSL-ASPPIIHGDVKSANILLNDNY------  225 (414)
Q Consensus       153 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-~~~~iiH~Dlkp~NIll~~~~------  225 (414)
                      .....++||||+ +++|.+.+..... ..+++..++.++.||+.||.|||+. +   |+||||||+|||++.++      
T Consensus       116 ~~~~~~lv~e~~-~~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~~  190 (397)
T 1wak_A          116 NGTHICMVFEVL-GHHLLKWIIKSNY-QGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRRL  190 (397)
T ss_dssp             TEEEEEEEECCC-CCBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHHH
T ss_pred             CCceEEEEEecc-CccHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhhh
Confidence            566889999999 5566666644322 3358899999999999999999997 7   99999999999999775      


Q ss_pred             -------------------------------------------cEEEeeccccccccCCccccceecccccccccchhhc
Q 015027          226 -------------------------------------------TAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCI  262 (414)
Q Consensus       226 -------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~  262 (414)
                                                                 .+||+|||++......     .....||+.|+|||++
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~  265 (397)
T 1wak_A          191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVL  265 (397)
T ss_dssp             HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHH
T ss_pred             hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChhh
Confidence                                                       7999999999876432     2345789999999999


Q ss_pred             ccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccc-cccchhhhhh------------------hcc-ccccccccc
Q 015027          263 NTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKK-ISMVPYFLNS------------------IKN-NGLRQILNF  322 (414)
Q Consensus       263 ~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~-~~~~~~~~~~------------------~~~-~~~~~~~~~  322 (414)
                      .+..++.++|||||||++|||++|+.||.......... ..........                  ... .....+...
T Consensus       266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (397)
T 1wak_A          266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL  345 (397)
T ss_dssp             HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred             cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence            99999999999999999999999999997543221100 0000000000                  000 000000000


Q ss_pred             c---------cCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          323 H---------VADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       323 ~---------~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      .         .....+...+..+.+|+.+||+.||.+|||+.++++
T Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence            0         011234556678999999999999999999999954

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=6.3e-43  Score=328.78  Aligned_cols=251  Identities=22%  Similarity=0.259  Sum_probs=193.0

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch-hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEe
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI-RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  163 (414)
                      .++|++.+.||+|+||.||+|.+. ++..||+|++...... ......+++++..++||||+++++++..++..++||||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   97 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF   97 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence            477999999999999999999986 4899999998765332 34446677899999999999999999999999999999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcc
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE  243 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  243 (414)
                      +++++|.+++.....  .+++..++.++.||+.||.|||+.+   ++||||||+||+++.++.+||+|||++......  
T Consensus        98 ~~~~~l~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  170 (302)
T 2j7t_A           98 CPGGAVDAIMLELDR--GLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT--  170 (302)
T ss_dssp             CTTEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH--
T ss_pred             CCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccc--
Confidence            999999998865433  3588999999999999999999987   999999999999999999999999987643221  


Q ss_pred             ccceecccccccccchhhc-----ccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccc
Q 015027          244 TAMSTILIGTSGYLDPVCI-----NTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQ  318 (414)
Q Consensus       244 ~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (414)
                      ........||+.|+|||++     .+..++.++||||||+++|+|++|..||.......         ............
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---------~~~~~~~~~~~~  241 (302)
T 2j7t_A          171 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR---------VLLKIAKSDPPT  241 (302)
T ss_dssp             HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---------HHHHHHHSCCCC
T ss_pred             ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH---------HHHHHhccCCcc
Confidence            1112345789999999998     46778999999999999999999999987433211         000011111000


Q ss_pred             ccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          319 ILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       319 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ..       .+...+..+.+|+.+||+.||.+|||+.++++
T Consensus       242 ~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          242 LL-------TPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             CS-------SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             cC-------CccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            00       01111255899999999999999999999854

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=3.3e-43  Score=337.50  Aligned_cols=257  Identities=21%  Similarity=0.273  Sum_probs=200.4

Q ss_pred             hcCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccchh------------------HhHHHHHHHHHccCCCceeee
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIR------------------ITERELLRIISQVNHKNVVKI  147 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~------------------~~~~~~~~~l~~l~hpniv~l  147 (414)
                      .++|.+.+.||+|+||.||+|.. +++.||||++.......                  ....+++.++.+++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            46899999999999999999999 99999999997643221                  455677899999999999999


Q ss_pred             eeeEecCCcceEEEEeCCCCchhhh------hhhcCCcccCCHHHHHHHHHHHHHHHHHhhh-CCCCCeeeCCCCCCcee
Q 015027          148 LGLCLETEVPLLVYEFASNGTLLDH------IRCESSQVLKTWKTCLRIAAETASALDYLHS-LASPPIIHGDVKSANIL  220 (414)
Q Consensus       148 ~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~iiH~Dlkp~NIl  220 (414)
                      ++++.+.+..++||||+++++|.++      +.... ...+++..++.++.||+.||.|||+ .+   ++||||||+|||
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil  184 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY-TCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL  184 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS-CCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc-ccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence            9999999999999999999999998      53321 3456899999999999999999998 77   999999999999


Q ss_pred             eCCCCcEEEeeccccccccCCccccceecccccccccchhhcccC-CCCC-cccchhHHHHHHHHHhCCCCCCccccccc
Q 015027          221 LNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTG-KLTK-KSDVYSFGVVLAELLTGKKPGSCMTLASN  298 (414)
Q Consensus       221 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~Dv~SlGvil~el~tg~~p~~~~~~~~~  298 (414)
                      ++.++.+||+|||++......    ......||+.|+|||++.+. .++. ++||||||+++|+|++|..||........
T Consensus       185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~  260 (348)
T 2pml_X          185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE  260 (348)
T ss_dssp             ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred             EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence            999999999999999876433    23445789999999999877 6766 99999999999999999999975432100


Q ss_pred             cccccchhhhhhhccccccc------cccccc---CCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          299 KKISMVPYFLNSIKNNGLRQ------ILNFHV---ADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~------~~~~~~---~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                              ....+.......      ...+..   ........+..+.+|+.+||+.||.+|||+.++++
T Consensus       261 --------~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          261 --------LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             --------HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             --------HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                    011111000000      000000   00000112356899999999999999999999965

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.7e-42  Score=321.59  Aligned_cols=246  Identities=24%  Similarity=0.338  Sum_probs=191.0

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc----hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK----IRITERELLRIISQVNHKNVVKILGLCLETEVPLLV  160 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv  160 (414)
                      .++|.+.+.||+|+||.||+|.+. +++.||||++.....    ......+++.+++.++||||+++++++...+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            367999999999999999999986 689999999976432    123345677899999999999999999999999999


Q ss_pred             EEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccC
Q 015027          161 YEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISS  240 (414)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  240 (414)
                      |||+++++|.+++....   .+++..+..++.||+.||.|||+.+   ++|+||||+||+++.++.+||+|||++.....
T Consensus        90 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  163 (276)
T 2h6d_A           90 MEYVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  163 (276)
T ss_dssp             EECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred             EeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence            99999999999996543   3578899999999999999999988   99999999999999999999999999987653


Q ss_pred             CccccceecccccccccchhhcccCCC-CCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccc
Q 015027          241 DAETAMSTILIGTSGYLDPVCINTGKL-TKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQI  319 (414)
Q Consensus       241 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (414)
                      ..   ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||.......         ..........   
T Consensus       164 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---------~~~~~~~~~~---  228 (276)
T 2h6d_A          164 GE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT---------LFKKIRGGVF---  228 (276)
T ss_dssp             ----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---------HHHHHHHCCC---
T ss_pred             Cc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH---------HHHHhhcCcc---
Confidence            21   2234578999999999987765 689999999999999999999996432111         1111111100   


Q ss_pred             cccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          320 LNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       320 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                         ..+..    .+..+.+|+.+||+.||.+|||+.++++
T Consensus       229 ---~~~~~----~~~~l~~li~~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          229 ---YIPEY----LNRSVATLLMHMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             ---CCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---cCchh----cCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence               01111    1245899999999999999999999965

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.8e-42  Score=344.15  Aligned_cols=265  Identities=19%  Similarity=0.228  Sum_probs=203.6

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhHhHHHHHHHHHccCC-CceeeeeeeEecCCcceEEEEe
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRITERELLRIISQVNH-KNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h-pniv~l~~~~~~~~~~~lv~e~  163 (414)
                      .++|.+.+.||+|+||.||+|.+. +++.||||++....... ....+++++..+.| +++..+..++...+..++||||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~-~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~   84 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP-QLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDL   84 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSC-CHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccH-HHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEEC
Confidence            478999999999999999999974 68999999887654433 34455678888877 5566666666778888999999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceee---CCCCcEEEeeccccccccC
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILL---NDNYTAKVADFESSVLISS  240 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~DfGla~~~~~  240 (414)
                      + +++|.+++.....  .+++..++.++.||+.||.|||+.+   |+||||||+|||+   +.++.+||+|||+++....
T Consensus        85 ~-g~sL~~ll~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~  158 (483)
T 3sv0_A           85 L-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD  158 (483)
T ss_dssp             C-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             C-CCCHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence            9 8999999965433  3589999999999999999999988   9999999999999   6889999999999987654


Q ss_pred             Cccc-----cceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccc
Q 015027          241 DAET-----AMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNG  315 (414)
Q Consensus       241 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (414)
                      ....     .......||+.|+|||++.+..++.++|||||||+||||++|+.||..........      ....+....
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~------~~~~i~~~~  232 (483)
T 3sv0_A          159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ------KYEKISEKK  232 (483)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHH------HHHHHHHHH
T ss_pred             CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHH------HHHHHhhcc
Confidence            3221     12235689999999999999999999999999999999999999997543221100      000000000


Q ss_pred             cccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHhh
Q 015027          316 LRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLH  368 (414)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~~  368 (414)
                      ....+.. +...    .+..+.+|+.+||+.+|.+||++.+|++.|+.+....
T Consensus       233 ~~~~~~~-l~~~----~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~  280 (483)
T 3sv0_A          233 VATSIEA-LCRG----YPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE  280 (483)
T ss_dssp             HHSCHHH-HHTT----SCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             ccccHHH-HhcC----CcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence            0000000 0001    1256999999999999999999999999999887643

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.9e-42  Score=332.80  Aligned_cols=268  Identities=21%  Similarity=0.263  Sum_probs=194.9

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch---hHhHHHHHHHHHccCCCceeeeeeeEec--------
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI---RITERELLRIISQVNHKNVVKILGLCLE--------  153 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~hpniv~l~~~~~~--------  153 (414)
                      .++|.+.+.||+|+||.||+|.+. +|+.||||++......   .....+++.+++.++||||+++++++..        
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            367999999999999999999975 6899999998654322   2344567799999999999999999976        


Q ss_pred             CCcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecc
Q 015027          154 TEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFE  233 (414)
Q Consensus       154 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG  233 (414)
                      .+..++||||+++ +|.+.+.....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg  169 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVLV--KFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG  169 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CceEEEEEeccCC-CHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence            3468999999986 77776654332  3588999999999999999999988   9999999999999999999999999


Q ss_pred             ccccccCCcc--ccceecccccccccchhhccc-CCCCCcccchhHHHHHHHHHhCCCCCCcccccccccc------ccc
Q 015027          234 SSVLISSDAE--TAMSTILIGTSGYLDPVCINT-GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKI------SMV  304 (414)
Q Consensus       234 la~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~------~~~  304 (414)
                      ++........  ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........      ...
T Consensus       170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  249 (351)
T 3mi9_A          170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  249 (351)
T ss_dssp             TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            9987653211  122345678999999999876 5689999999999999999999999975432110000      000


Q ss_pred             hhhhhhhcccccccccccccCCccc-HH------HHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          305 PYFLNSIKNNGLRQILNFHVADESE-MK------EIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~------~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      +..............+......... ..      ..+.+.+|+.+||+.||.+|||+.++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            0000000000000000000000000 00      1245889999999999999999999854

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=8.8e-43  Score=327.34  Aligned_cols=253  Identities=23%  Similarity=0.364  Sum_probs=189.7

Q ss_pred             HhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEec----------
Q 015027           85 ATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLE----------  153 (414)
Q Consensus        85 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~----------  153 (414)
                      ..++|++.+.||+|+||.||+|... +++.||||++...........+++.++++++||||+++++++.+          
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            3567999999999999999999975 68999999997655444555677899999999999999998865          


Q ss_pred             ---CCcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEe
Q 015027          154 ---TEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVA  230 (414)
Q Consensus       154 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~  230 (414)
                         ....++||||+++++|.+++....  ...++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~  158 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG  158 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred             cccCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence               356799999999999999997543  23477889999999999999999988   9999999999999999999999


Q ss_pred             eccccccccCCcc------------ccceecccccccccchhhcccC-CCCCcccchhHHHHHHHHHhCCCCCCcccccc
Q 015027          231 DFESSVLISSDAE------------TAMSTILIGTSGYLDPVCINTG-KLTKKSDVYSFGVVLAELLTGKKPGSCMTLAS  297 (414)
Q Consensus       231 DfGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~  297 (414)
                      |||++........            ........||+.|+|||++.+. .++.++|||||||++|+|++   ||.......
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~  235 (303)
T 1zy4_A          159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERV  235 (303)
T ss_dssp             CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH
T ss_pred             eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHH
Confidence            9999986543210            1122345789999999999764 78999999999999999998   543111000


Q ss_pred             ccccccchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          298 NKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                              .........      ....+.......+..+.+|+.+||+.||.+|||+.++++
T Consensus       236 --------~~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          236 --------NILKKLRSV------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             --------HHHHHHHST------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------HHHHhcccc------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence                    000111100      001111112222355899999999999999999999964

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=2.1e-42  Score=335.14  Aligned_cols=262  Identities=20%  Similarity=0.244  Sum_probs=188.1

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc---hhHhHHHHHHHHHccCCCceeeeeeeEecCC------
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK---IRITERELLRIISQVNHKNVVKILGLCLETE------  155 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~------  155 (414)
                      .++|.+.+.||+|+||.||+|.+. +++.||||++.....   ......+++.+++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            468999999999999999999975 588999999976432   2233456778999999999999999997654      


Q ss_pred             cceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccc
Q 015027          156 VPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESS  235 (414)
Q Consensus       156 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla  235 (414)
                      ..|+||||+++ +|.+.+..     .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  174 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  174 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred             ceEEEEEcCCC-CHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence            67999999975 78777742     3578899999999999999999988   999999999999999999999999999


Q ss_pred             ccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccc------cccchhhhh
Q 015027          236 VLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKK------ISMVPYFLN  309 (414)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~------~~~~~~~~~  309 (414)
                      ......   .......||+.|+|||++.+..++.++|||||||++|+|++|+.||..........      ....+.+..
T Consensus       175 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  251 (371)
T 2xrw_A          175 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK  251 (371)
T ss_dssp             ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHT
T ss_pred             cccccc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            865432   12334578999999999999999999999999999999999999997543211000      000000000


Q ss_pred             hh--------cc------ccccccccccc---CCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          310 SI--------KN------NGLRQILNFHV---ADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       310 ~~--------~~------~~~~~~~~~~~---~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ..        ..      ..+...+....   ........+..+.+|+.+||+.||.+|||+.++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence            00        00      00000000000   01112233567999999999999999999999965

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=8.9e-43  Score=336.45  Aligned_cols=271  Identities=21%  Similarity=0.242  Sum_probs=193.2

Q ss_pred             HHHHHHHhcCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccch------------hHhHHHHHHHHHccCCCceee
Q 015027           79 KSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKI------------RITERELLRIISQVNHKNVVK  146 (414)
Q Consensus        79 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------------~~~~~~~~~~l~~l~hpniv~  146 (414)
                      ..++....++|.+.+.||+|+||.||+|.+.+|..||||++......            .....++++++++++||||++
T Consensus        14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   93 (362)
T 3pg1_A           14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG   93 (362)
T ss_dssp             HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence            45777888999999999999999999999888999999998653221            134466779999999999999


Q ss_pred             eeeeEec-----CCcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceee
Q 015027          147 ILGLCLE-----TEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILL  221 (414)
Q Consensus       147 l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll  221 (414)
                      +++++..     ....|+||||++ |+|.+++....  ..+++..+..++.||+.||.|||+.+   |+||||||+|||+
T Consensus        94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~  167 (362)
T 3pg1_A           94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR--IVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILL  167 (362)
T ss_dssp             CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred             eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEE
Confidence            9999854     335799999998 58888776433  34588999999999999999999988   9999999999999


Q ss_pred             CCCCcEEEeeccccccccCCccccceecccccccccchhhccc-CCCCCcccchhHHHHHHHHHhCCCCCCccccccccc
Q 015027          222 NDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINT-GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKK  300 (414)
Q Consensus       222 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~  300 (414)
                      +.++.+||+|||++......   .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..........
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~  244 (362)
T 3pg1_A          168 ADNNDITICDFNLAREDTAD---ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLN  244 (362)
T ss_dssp             CTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             cCCCCEEEEecCcccccccc---cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            99999999999999754432   22344578999999999876 779999999999999999999999997543211000


Q ss_pred             cccchhh-------hhhhcccccccccccc---cCCcc----cHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          301 ISMVPYF-------LNSIKNNGLRQILNFH---VADES----EMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       301 ~~~~~~~-------~~~~~~~~~~~~~~~~---~~~~~----~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      . +....       ............+...   .....    ....++.+.+|+.+||+.||.+|||+.++++
T Consensus       245 ~-i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          245 K-IVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             H-HHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             H-HHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence            0 00000       0000000000000000   00000    0011256899999999999999999999843

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=4.2e-42  Score=322.55  Aligned_cols=251  Identities=23%  Similarity=0.309  Sum_probs=197.8

Q ss_pred             HhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc----------hhHhHHHHHHHHHccC-CCceeeeeeeEe
Q 015027           85 ATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK----------IRITERELLRIISQVN-HKNVVKILGLCL  152 (414)
Q Consensus        85 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----------~~~~~~~~~~~l~~l~-hpniv~l~~~~~  152 (414)
                      ..++|.+.+.||+|+||.||+|... +++.||||++.....          .......+++++.++. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            3578999999999999999999976 589999999975431          1223355678888885 999999999999


Q ss_pred             cCCcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeec
Q 015027          153 ETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADF  232 (414)
Q Consensus       153 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df  232 (414)
                      .....++||||+++++|.+++....   .+++..++.++.||+.||.|||+.+   ++|+||||+||+++.++.+||+||
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df  168 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF  168 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred             cCCeEEEEEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecc
Confidence            9999999999999999999996542   3588999999999999999999988   999999999999999999999999


Q ss_pred             cccccccCCccccceecccccccccchhhcc------cCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchh
Q 015027          233 ESSVLISSDAETAMSTILIGTSGYLDPVCIN------TGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPY  306 (414)
Q Consensus       233 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~  306 (414)
                      |++.......   ......||+.|+|||++.      ...++.++||||||+++|+|++|..||.......         
T Consensus       169 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---------  236 (298)
T 1phk_A          169 GFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML---------  236 (298)
T ss_dssp             TTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---------
T ss_pred             cchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH---------
Confidence            9998765332   223457899999999985      4568899999999999999999999986432111         


Q ss_pred             hhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          307 FLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ...........      .........+..+.+|+.+||+.||.+|||+.++++
T Consensus       237 ~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          237 MLRMIMSGNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             HHHHHHHTCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHHhcCCcc------cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            01111111100      000011112356999999999999999999999843

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=3.5e-43  Score=333.12  Aligned_cols=258  Identities=21%  Similarity=0.312  Sum_probs=194.5

Q ss_pred             hcCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccch---hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKI---RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYE  162 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  162 (414)
                      .++|.+.+.||+|+||.||+|.+..  .+|+|++......   .....+++.++++++||||+++++++.+.+..++|||
T Consensus        32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e  109 (319)
T 2y4i_B           32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS  109 (319)
T ss_dssp             CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred             HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence            5789999999999999999998754  4999998754321   1223455688899999999999999999999999999


Q ss_pred             eCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCc
Q 015027          163 FASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDA  242 (414)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  242 (414)
                      |+++++|.+++....  ..+++..++.++.||+.||.|||+.+   ++||||||+|||++ ++.+||+|||++.......
T Consensus       110 ~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~  183 (319)
T 2y4i_B          110 LCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ  183 (319)
T ss_dssp             CCCSEEHHHHTTSSC--CCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred             cccCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence            999999999996543  23578899999999999999999988   99999999999998 6799999999987653211


Q ss_pred             ---cccceecccccccccchhhccc---------CCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhh
Q 015027          243 ---ETAMSTILIGTSGYLDPVCINT---------GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNS  310 (414)
Q Consensus       243 ---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  310 (414)
                         .........||+.|+|||++.+         ..++.++||||||+++|+|++|+.||.......         ....
T Consensus       184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---------~~~~  254 (319)
T 2y4i_B          184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA---------IIWQ  254 (319)
T ss_dssp             ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH---------HHHH
T ss_pred             ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---------HHHH
Confidence               1122234468999999999864         457889999999999999999999997433211         1111


Q ss_pred             hcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHhh
Q 015027          311 IKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLH  368 (414)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~~  368 (414)
                      ...............        ..+.+|+.+||+.||.+|||+.++++.|+.+....
T Consensus       255 ~~~~~~~~~~~~~~~--------~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~  304 (319)
T 2y4i_B          255 MGTGMKPNLSQIGMG--------KEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN  304 (319)
T ss_dssp             HHTTCCCCCCCSSCC--------TTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred             hccCCCCCCCcCCCC--------HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence            111111111111111        33899999999999999999999999999887643

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-42  Score=334.76  Aligned_cols=260  Identities=21%  Similarity=0.260  Sum_probs=189.5

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch---hHhHHHHHHHHHccCCCceeeeeeeEecCC------
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI---RITERELLRIISQVNHKNVVKILGLCLETE------  155 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~hpniv~l~~~~~~~~------  155 (414)
                      .++|.+.+.||+|+||.||+|.+. +|+.||||++......   .....+++++++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            468999999999999999999975 6899999998653322   233466789999999999999999997653      


Q ss_pred             cceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccc
Q 015027          156 VPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESS  235 (414)
Q Consensus       156 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla  235 (414)
                      ..|+||||+ +++|.+++..    ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a  175 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA  175 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence            459999999 7899998864    23578899999999999999999988   999999999999999999999999999


Q ss_pred             ccccCCccccceecccccccccchhhccc-CCCCCcccchhHHHHHHHHHhCCCCCCcccccccccc------ccchhhh
Q 015027          236 VLISSDAETAMSTILIGTSGYLDPVCINT-GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKI------SMVPYFL  308 (414)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~------~~~~~~~  308 (414)
                      +.....     .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.........      .....+.
T Consensus       176 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~  250 (367)
T 1cm8_A          176 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV  250 (367)
T ss_dssp             EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             cccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            875432     234578999999999877 7899999999999999999999999975432110000      0000000


Q ss_pred             hhhcccccccc---c----ccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          309 NSIKNNGLRQI---L----NFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       309 ~~~~~~~~~~~---~----~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ..+........   +    ...+. ......+..+.+|+.+||+.||.+|||+.++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          251 QRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             HTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHhhhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence            00000000000   0    00000 000111256899999999999999999999864

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.1e-42  Score=331.50  Aligned_cols=260  Identities=18%  Similarity=0.277  Sum_probs=194.4

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhHhHHHHHHHHHccC-CCceeeeeeeEec--CCcceEEE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRITERELLRIISQVN-HKNVVKILGLCLE--TEVPLLVY  161 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~-hpniv~l~~~~~~--~~~~~lv~  161 (414)
                      .++|++.+.||+|+||.||+|.+. +++.||||++....  .....+++.++.+++ ||||+++++++.+  ....++||
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~  112 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  112 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC--HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc--hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence            367999999999999999999964 68999999987543  234456678888887 9999999999987  66789999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCC-cEEEeeccccccccC
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNY-TAKVADFESSVLISS  240 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~DfGla~~~~~  240 (414)
                      ||+++++|.+++..      +++..+..++.||+.||.|||+.+   |+||||||+|||++.++ .+||+|||++.....
T Consensus       113 e~~~~~~l~~~~~~------~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~  183 (330)
T 3nsz_A          113 EHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  183 (330)
T ss_dssp             ECCCCCCHHHHGGG------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             eccCchhHHHHHHh------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence            99999999988832      478889999999999999999988   99999999999999776 899999999987654


Q ss_pred             Cccccceecccccccccchhhccc-CCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccch-----hhhhhhcc-
Q 015027          241 DAETAMSTILIGTSGYLDPVCINT-GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVP-----YFLNSIKN-  313 (414)
Q Consensus       241 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~-----~~~~~~~~-  313 (414)
                      ..   ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||............+..     ........ 
T Consensus       184 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  260 (330)
T 3nsz_A          184 GQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY  260 (330)
T ss_dssp             TC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred             CC---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHh
Confidence            32   2334578999999999977 67999999999999999999999998432211000000000     00000000 


Q ss_pred             -------------cccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          314 -------------NGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       314 -------------~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                                   ...................+..+.+|+.+||+.||.+|||+.++++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             TCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             ccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                         0000000000111111112366999999999999999999999843

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.3e-43  Score=340.83  Aligned_cols=266  Identities=20%  Similarity=0.222  Sum_probs=191.8

Q ss_pred             HHHhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecC-------
Q 015027           83 IRATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLET-------  154 (414)
Q Consensus        83 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~-------  154 (414)
                      ....++|.+.+.||+|+||.||+|.+. +|+.||||++..+....   .+++++++.++||||++++++|...       
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~---~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~   79 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK---NRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP   79 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSC---CHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchH---HHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence            345678999999999999999999975 68999999987654332   2456889999999999999998543       


Q ss_pred             -------------------------------CcceEEEEeCCCCchhhhhhhc-CCcccCCHHHHHHHHHHHHHHHHHhh
Q 015027          155 -------------------------------EVPLLVYEFASNGTLLDHIRCE-SSQVLKTWKTCLRIAAETASALDYLH  202 (414)
Q Consensus       155 -------------------------------~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH  202 (414)
                                                     ...++||||+++ +|.+.+... .....+++..+..++.||+.||.|||
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH  158 (383)
T 3eb0_A           80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH  158 (383)
T ss_dssp             ------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence                                           347899999984 877776531 22345688999999999999999999


Q ss_pred             hCCCCCeeeCCCCCCceeeC-CCCcEEEeeccccccccCCccccceecccccccccchhhcccC-CCCCcccchhHHHHH
Q 015027          203 SLASPPIIHGDVKSANILLN-DNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTG-KLTKKSDVYSFGVVL  280 (414)
Q Consensus       203 ~~~~~~iiH~Dlkp~NIll~-~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil  280 (414)
                      +.+   |+||||||+|||++ .++.+||+|||++.......   ......||+.|+|||++.+. .++.++|||||||++
T Consensus       159 ~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il  232 (383)
T 3eb0_A          159 SLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF  232 (383)
T ss_dssp             TTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred             HCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence            987   99999999999998 68999999999998764332   23345789999999998765 599999999999999


Q ss_pred             HHHHhCCCCCCccccccccccccch-------hhhhhhc----ccccccccccccCCcccHHHHHHHHHHHHHhhccCCC
Q 015027          281 AELLTGKKPGSCMTLASNKKISMVP-------YFLNSIK----NNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGT  349 (414)
Q Consensus       281 ~el~tg~~p~~~~~~~~~~~~~~~~-------~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~  349 (414)
                      |||++|+.||.......... .+..       .......    ...........+....+...+..+.+|+.+||+.||.
T Consensus       233 ~ell~g~~pf~~~~~~~~~~-~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  311 (383)
T 3eb0_A          233 GELILGKPLFSGETSIDQLV-RIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD  311 (383)
T ss_dssp             HHHHHSSCSSCCSSHHHHHH-HHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred             HHHHhCCCCCCCCChHHHHH-HHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence            99999999997543211000 0000       0000000    0000000000000000111235589999999999999


Q ss_pred             CCCChhHHHH
Q 015027          350 ERPTMKQVSE  359 (414)
Q Consensus       350 ~Rps~~~v~~  359 (414)
                      +|||+.++++
T Consensus       312 ~R~t~~e~l~  321 (383)
T 3eb0_A          312 LRINPYEAMA  321 (383)
T ss_dssp             GSCCHHHHHT
T ss_pred             hCCCHHHHhc
Confidence            9999999964

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=4.4e-43  Score=345.35  Aligned_cols=261  Identities=21%  Similarity=0.261  Sum_probs=189.1

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecC------CcceE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLET------EVPLL  159 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~------~~~~l  159 (414)
                      .+|.+.+.||+|+||.||+|.+. +++.||||++.......   .+++++++.++||||++++++|...      ...++
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l  130 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL  130 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSC---CHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhH---HHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence            46888999999999999999986 58999999987653322   2456889999999999999998542      23679


Q ss_pred             EEEeCCCCchhhhhhh-cCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCC-CcEEEeecccccc
Q 015027          160 VYEFASNGTLLDHIRC-ESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDN-YTAKVADFESSVL  237 (414)
Q Consensus       160 v~e~~~~gsL~~~l~~-~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~DfGla~~  237 (414)
                      ||||+++ +|.+.+.. ......+++..+..++.||+.||.|||+.+   |+||||||+|||++.+ +.+||+|||+++.
T Consensus       131 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~~  206 (420)
T 1j1b_A          131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  206 (420)
T ss_dssp             EEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             ehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence            9999986 56555532 122345688999999999999999999987   9999999999999954 6789999999987


Q ss_pred             ccCCccccceecccccccccchhhcccC-CCCCcccchhHHHHHHHHHhCCCCCCccccccccccccch-------hhhh
Q 015027          238 ISSDAETAMSTILIGTSGYLDPVCINTG-KLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVP-------YFLN  309 (414)
Q Consensus       238 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~-------~~~~  309 (414)
                      .....   ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......... ..+..       ..+.
T Consensus       207 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l-~~i~~~lg~p~~~~~~  282 (420)
T 1j1b_A          207 LVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL-VEIIKVLGTPTREQIR  282 (420)
T ss_dssp             CCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHHHHCSCCHHHHH
T ss_pred             cccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhCCCCHHHHH
Confidence            64332   22345789999999999764 7999999999999999999999999754321100 00000       0000


Q ss_pred             hhcccccccccccccCCc-----ccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          310 SIKNNGLRQILNFHVADE-----SEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ... .....+..+.....     .....+..+.+|+.+||+.||.+|||+.++++
T Consensus       283 ~~~-~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          283 EMN-PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HHC-SCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhC-hhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence            000 00000000000000     00111356999999999999999999999864

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=2.9e-42  Score=327.59  Aligned_cols=250  Identities=24%  Similarity=0.314  Sum_probs=192.0

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc---------hhHhHHHHHHHHHccCCCceeeeeeeEecCC
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK---------IRITERELLRIISQVNHKNVVKILGLCLETE  155 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~  155 (414)
                      .++|.+.+.||+|+||.||+|.+. +++.||||++.....         ......++++++++++||||+++++++..+.
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            467999999999999999999976 588999999865421         1123456778999999999999999987655


Q ss_pred             cceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCc---EEEeec
Q 015027          156 VPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYT---AKVADF  232 (414)
Q Consensus       156 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~---~kl~Df  232 (414)
                       .|+||||+++++|.+++...   ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.   +||+||
T Consensus        89 -~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Df  161 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDF  161 (322)
T ss_dssp             -EEEEEECCTTEETHHHHSTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred             -eEEEEecCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccC
Confidence             89999999999999988643   34588999999999999999999988   999999999999987654   999999


Q ss_pred             cccccccCCccccceecccccccccchhhcc---cCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhh
Q 015027          233 ESSVLISSDAETAMSTILIGTSGYLDPVCIN---TGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLN  309 (414)
Q Consensus       233 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~  309 (414)
                      |++......   .......||+.|+|||++.   +..++.++|||||||++|+|++|..||........        ...
T Consensus       162 g~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--------~~~  230 (322)
T 2ycf_A          162 GHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--------LKD  230 (322)
T ss_dssp             TTCEECCCC---HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--------HHH
T ss_pred             ccceecccc---cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--------HHH
Confidence            999876432   1223457899999999974   56789999999999999999999999974322110        000


Q ss_pred             hhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          310 SIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      .+...... ... ..    ....+..+.+|+.+||+.||.+|||+.++++
T Consensus       231 ~~~~~~~~-~~~-~~----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          231 QITSGKYN-FIP-EV----WAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             HHHHTCCC-CCH-HH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHhCccc-cCc-hh----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            11111000 000 00    0011256899999999999999999999975

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=3.5e-42  Score=328.46  Aligned_cols=263  Identities=20%  Similarity=0.252  Sum_probs=197.4

Q ss_pred             hcCCCCCCccccCCceEEEEEEE-c-CCcEEEEEEeecccchhHhHHHHHHHHHccCCC------ceeeeeeeEecCCcc
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVL-H-DNIQVAVKTYRRADKIRITERELLRIISQVNHK------NVVKILGLCLETEVP  157 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hp------niv~l~~~~~~~~~~  157 (414)
                      .++|++.+.||+|+||.||+|.+ . +++.||||++............+++++..++|+      +++++++++...+..
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~   92 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI   92 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence            46899999999999999999997 3 588999999976554444455666777766555      599999999999999


Q ss_pred             eEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCC--------------
Q 015027          158 LLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLND--------------  223 (414)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~--------------  223 (414)
                      ++||||+ +++|.+++..... ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.              
T Consensus        93 ~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~  167 (339)
T 1z57_A           93 CIVFELL-GLSTYDFIKENGF-LPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRD  167 (339)
T ss_dssp             EEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred             EEEEcCC-CCCHHHHHHhcCC-CCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccccc
Confidence            9999999 8899999866543 34578999999999999999999988   999999999999987              


Q ss_pred             -----CCcEEEeeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccc
Q 015027          224 -----NYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASN  298 (414)
Q Consensus       224 -----~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~  298 (414)
                           ++.+||+|||++......     .....||+.|+|||++.+..++.++|||||||++|||++|..||........
T Consensus       168 ~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  242 (339)
T 1z57_A          168 ERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH  242 (339)
T ss_dssp             EEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred             cccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence                 678999999999865432     2345789999999999999999999999999999999999999975432110


Q ss_pred             ccc------ccchhhhhhhcccccc------------------ccccc-ccCCcccHHHHHHHHHHHHHhhccCCCCCCC
Q 015027          299 KKI------SMVPYFLNSIKNNGLR------------------QILNF-HVADESEMKEIEIVAELASKCLRIRGTERPT  353 (414)
Q Consensus       299 ~~~------~~~~~~~~~~~~~~~~------------------~~~~~-~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps  353 (414)
                      ...      ................                  ....+ ..........+..+.+|+.+||+.||.+|||
T Consensus       243 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt  322 (339)
T 1z57_A          243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT  322 (339)
T ss_dssp             HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred             HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence            000      0000000000000000                  00000 0001112234567999999999999999999


Q ss_pred             hhHHH
Q 015027          354 MKQVS  358 (414)
Q Consensus       354 ~~~v~  358 (414)
                      +.+++
T Consensus       323 ~~ell  327 (339)
T 1z57_A          323 LREAL  327 (339)
T ss_dssp             HHHHT
T ss_pred             HHHHh
Confidence            99984

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=9.6e-43  Score=329.51  Aligned_cols=251  Identities=18%  Similarity=0.252  Sum_probs=189.1

Q ss_pred             HhcCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccch---hHhHHHHHHHHHccC--CCceeeeeeeEecCCcceE
Q 015027           85 ATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKI---RITERELLRIISQVN--HKNVVKILGLCLETEVPLL  159 (414)
Q Consensus        85 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~--hpniv~l~~~~~~~~~~~l  159 (414)
                      ..++|.+.+.||+|+||.||+|.+.+++.||||++......   .....++++++.+++  ||||+++++++..++..++
T Consensus        26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l  105 (313)
T 3cek_A           26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM  105 (313)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred             ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence            35779999999999999999999888999999999754322   233456678888887  5999999999999999999


Q ss_pred             EEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccccccc
Q 015027          160 VYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLIS  239 (414)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~  239 (414)
                      ||| +.+++|.+++....   .+++..++.++.||+.||.|||+.+   |+||||||+|||+++ +.+||+|||++....
T Consensus       106 v~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~  177 (313)
T 3cek_A          106 VME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQMQ  177 (313)
T ss_dssp             EEC-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC--
T ss_pred             EEe-cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeecccccccc
Confidence            999 56789999997543   4578899999999999999999987   999999999999975 899999999998765


Q ss_pred             CCccccceecccccccccchhhccc-----------CCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhh
Q 015027          240 SDAETAMSTILIGTSGYLDPVCINT-----------GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFL  308 (414)
Q Consensus       240 ~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~  308 (414)
                      ............||+.|+|||++.+           ..++.++||||||+++|+|++|..||.......       ....
T Consensus       178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-------~~~~  250 (313)
T 3cek_A          178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-------SKLH  250 (313)
T ss_dssp             ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-------HHHH
T ss_pred             CccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH-------HHHH
Confidence            4433333345579999999999875           478889999999999999999999996332110       0000


Q ss_pred             hhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          309 NSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      . .......    .......    +..+.+|+.+||+.||.+|||+.++++
T Consensus       251 ~-~~~~~~~----~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          251 A-IIDPNHE----IEFPDIP----EKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             H-HHCTTSC----CCCCCCS----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             H-HHhcccc----cCCcccc----hHHHHHHHHHHccCCcccCcCHHHHhc
Confidence            0 0000000    0011111    245899999999999999999999854

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=2.4e-41  Score=321.49  Aligned_cols=265  Identities=21%  Similarity=0.253  Sum_probs=193.5

Q ss_pred             HhcCCCCCCccccCCceEEEEEEEc--CCcEEEEEEeecccch---hH---hHHHHHHHHHccCCCceeeeeeeEe----
Q 015027           85 ATKNFDRSRCLSQGGFVSVYKGVLH--DNIQVAVKTYRRADKI---RI---TERELLRIISQVNHKNVVKILGLCL----  152 (414)
Q Consensus        85 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~---~~---~~~~~~~~l~~l~hpniv~l~~~~~----  152 (414)
                      ..++|.+.+.||+|+||.||+|.+.  +++.||+|++......   ..   .+.+.++.+..++||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            4578999999999999999999973  5889999998754321   11   2233344455558999999999987    


Q ss_pred             -cCCcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEee
Q 015027          153 -ETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVAD  231 (414)
Q Consensus       153 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~D  231 (414)
                       .....++||||++ |+|.+++..... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D  163 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD  163 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence             5567899999998 599999865433 23588999999999999999999988   99999999999999999999999


Q ss_pred             ccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhh----
Q 015027          232 FESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYF----  307 (414)
Q Consensus       232 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~----  307 (414)
                      ||++......   .......||+.|+|||++.+..++.++|||||||++|+|++|+.||........... +....    
T Consensus       164 fg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-i~~~~~~~~  239 (326)
T 1blx_A          164 FGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK-ILDVIGLPG  239 (326)
T ss_dssp             CCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-HHHHHCCCC
T ss_pred             CcccccccCC---CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH-HHHHcCCCC
Confidence            9999866432   123345789999999999999999999999999999999999999975432110000 00000    


Q ss_pred             hhhhcccc-c-ccccccc---cCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHH
Q 015027          308 LNSIKNNG-L-RQILNFH---VADESEMKEIEIVAELASKCLRIRGTERPTMKQVS  358 (414)
Q Consensus       308 ~~~~~~~~-~-~~~~~~~---~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~  358 (414)
                      ...+.... . ...+...   .........+..+.+|+.+||+.||.+|||+.+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l  295 (326)
T 1blx_A          240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL  295 (326)
T ss_dssp             GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred             cccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence            00000000 0 0000000   00000011225589999999999999999999984

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2.8e-42  Score=333.46  Aligned_cols=265  Identities=19%  Similarity=0.256  Sum_probs=194.8

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEecC-----Ccc
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLET-----EVP  157 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~~-----~~~  157 (414)
                      .++|.+.+.||+|+||.||+|.+. ++..||||++......  .....++++++.+++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            468999999999999999999976 5888999999754322  23446678999999999999999999754     368


Q ss_pred             eEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccccc
Q 015027          158 LLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVL  237 (414)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~  237 (414)
                      |+||||+++ +|.+++...    .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus       106 ~iv~e~~~~-~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~  177 (364)
T 3qyz_A          106 YIVQDLMET-DLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV  177 (364)
T ss_dssp             EEEEECCSE-EHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEcccCc-CHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence            999999974 899888543    3588999999999999999999988   99999999999999999999999999987


Q ss_pred             ccCCccc-cceecccccccccchhhcc-cCCCCCcccchhHHHHHHHHHhCCCCCCcccccccccccc------chhhhh
Q 015027          238 ISSDAET-AMSTILIGTSGYLDPVCIN-TGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISM------VPYFLN  309 (414)
Q Consensus       238 ~~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~------~~~~~~  309 (414)
                      ....... .......||+.|+|||++. +..++.++|||||||++|+|++|+.||.............      ......
T Consensus       178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  257 (364)
T 3qyz_A          178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN  257 (364)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHH
T ss_pred             cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            6543221 1224458999999999865 4558999999999999999999999997543221100000      000000


Q ss_pred             hhccccccccc-ccccCCccc-----HHHHHHHHHHHHHhhccCCCCCCChhHHH
Q 015027          310 SIKNNGLRQIL-NFHVADESE-----MKEIEIVAELASKCLRIRGTERPTMKQVS  358 (414)
Q Consensus       310 ~~~~~~~~~~~-~~~~~~~~~-----~~~~~~l~~Li~~cl~~dP~~Rps~~~v~  358 (414)
                      ........... ........+     ...+..+.+|+.+||+.||.+|||+.+++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l  312 (364)
T 3qyz_A          258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL  312 (364)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred             HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence            00000000000 000000000     01125689999999999999999999984

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.8e-42  Score=358.33  Aligned_cols=258  Identities=22%  Similarity=0.344  Sum_probs=200.8

Q ss_pred             HhcCCCCCCccccCCceEEEEEEEcC----CcEEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEecCCcce
Q 015027           85 ATKNFDRSRCLSQGGFVSVYKGVLHD----NIQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLETEVPL  158 (414)
Q Consensus        85 ~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~  158 (414)
                      ..++|.+.+.||+|+||.||+|.+..    +..||||.+......  ...+.+++.++++++||||+++++++. ++..+
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~  466 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW  466 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence            34678899999999999999999642    467999998754322  244567788999999999999999985 45689


Q ss_pred             EEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccc
Q 015027          159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLI  238 (414)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~  238 (414)
                      +||||+++|+|.+++....  ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus       467 lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~  541 (656)
T 2j0j_A          467 IIMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM  541 (656)
T ss_dssp             EEEECCTTCBHHHHHHHTT--TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred             EEEEcCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeec
Confidence            9999999999999997543  23588999999999999999999988   999999999999999999999999999876


Q ss_pred             cCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhcccccc
Q 015027          239 SSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLR  317 (414)
Q Consensus       239 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (414)
                      ..... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.......         ....+......
T Consensus       542 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~---------~~~~i~~~~~~  611 (656)
T 2j0j_A          542 EDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---------VIGRIENGERL  611 (656)
T ss_dssp             CC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---------HHHHHHHTCCC
T ss_pred             CCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH---------HHHHHHcCCCC
Confidence            54321 22233467889999999999999999999999999999997 999997433211         11111111100


Q ss_pred             cccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHh
Q 015027          318 QILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRL  367 (414)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~  367 (414)
                       ..    ..    ..+..+.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus       612 -~~----~~----~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~  652 (656)
T 2j0j_A          612 -PM----PP----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  652 (656)
T ss_dssp             -CC----CT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -CC----Cc----cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence             01    11    1225689999999999999999999999999988643

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.3e-42  Score=340.49  Aligned_cols=203  Identities=23%  Similarity=0.333  Sum_probs=153.5

Q ss_pred             cCCCC-CCccccCCceEEEEEEEc---CCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEec--CCcceEE
Q 015027           87 KNFDR-SRCLSQGGFVSVYKGVLH---DNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLE--TEVPLLV  160 (414)
Q Consensus        87 ~~~~~-~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~--~~~~~lv  160 (414)
                      +.|.+ .++||+|+||.||+|...   ++..||||++..... .....+++.+++.++||||+++++++..  +...++|
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv   98 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL   98 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence            44665 458999999999999965   478899999975543 3345567799999999999999999954  6788999


Q ss_pred             EEeCCCCchhhhhhhcC------CcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceee----CCCCcEEEe
Q 015027          161 YEFASNGTLLDHIRCES------SQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILL----NDNYTAKVA  230 (414)
Q Consensus       161 ~e~~~~gsL~~~l~~~~------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll----~~~~~~kl~  230 (414)
                      |||+++ +|.+++....      ....+++..++.++.||+.||.|||+.+   |+||||||+|||+    +.++.+||+
T Consensus        99 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~  174 (405)
T 3rgf_A           99 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIA  174 (405)
T ss_dssp             EECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred             EeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEE
Confidence            999975 7877774322      1224688999999999999999999988   9999999999999    778999999


Q ss_pred             eccccccccCCccc-cceecccccccccchhhccc-CCCCCcccchhHHHHHHHHHhCCCCCCccc
Q 015027          231 DFESSVLISSDAET-AMSTILIGTSGYLDPVCINT-GKLTKKSDVYSFGVVLAELLTGKKPGSCMT  294 (414)
Q Consensus       231 DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~  294 (414)
                      |||++......... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus       175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  240 (405)
T 3rgf_A          175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  240 (405)
T ss_dssp             CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred             ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence            99999876543211 22345689999999999987 458999999999999999999999996543

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=3.3e-42  Score=327.81  Aligned_cols=255  Identities=21%  Similarity=0.251  Sum_probs=175.0

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchh--Hh-HHHHHHHHHccCCCceeeeeeeEecCCcceEEE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIR--IT-ERELLRIISQVNHKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~-~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~  161 (414)
                      .++|.+.+.||+|+||.||+|... +++.||||++.......  .. ..++..+++.++||||+++++++...+..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            368899999999999999999975 68999999997653222  12 233434778889999999999999999999999


Q ss_pred             EeCCCCchhhhhhhc--CCcccCCHHHHHHHHHHHHHHHHHhhhC-CCCCeeeCCCCCCceeeCCCCcEEEeeccccccc
Q 015027          162 EFASNGTLLDHIRCE--SSQVLKTWKTCLRIAAETASALDYLHSL-ASPPIIHGDVKSANILLNDNYTAKVADFESSVLI  238 (414)
Q Consensus       162 e~~~~gsL~~~l~~~--~~~~~~~~~~~~~i~~~i~~~l~~LH~~-~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~  238 (414)
                      ||+++ +|.+++...  .....+++..+..++.|++.||.|||+. +   |+||||||+|||++.++.+||+|||++...
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            99986 777776431  1234568899999999999999999997 7   999999999999999999999999999776


Q ss_pred             cCCccccceecccccccccchhhc----ccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccc
Q 015027          239 SSDAETAMSTILIGTSGYLDPVCI----NTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNN  314 (414)
Q Consensus       239 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  314 (414)
                      ....   ......||+.|+|||++    .+..++.++|||||||++|+|++|+.||...........        .....
T Consensus       177 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--------~~~~~  245 (327)
T 3aln_A          177 VDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLT--------QVVKG  245 (327)
T ss_dssp             --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------C--------CCCCS
T ss_pred             cccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHH--------HHhcC
Confidence            4321   22334789999999998    566789999999999999999999999974321110000        00000


Q ss_pred             ccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHH
Q 015027          315 GLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEE  360 (414)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~  360 (414)
                      ..     +.+........+..+.+|+.+||+.||.+|||+.++++.
T Consensus       246 ~~-----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  286 (327)
T 3aln_A          246 DP-----PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH  286 (327)
T ss_dssp             CC-----CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             CC-----CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence            00     001110001112559999999999999999999999653

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.1e-41  Score=318.30  Aligned_cols=250  Identities=24%  Similarity=0.300  Sum_probs=197.6

Q ss_pred             HhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc---hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEE
Q 015027           85 ATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK---IRITERELLRIISQVNHKNVVKILGLCLETEVPLLV  160 (414)
Q Consensus        85 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv  160 (414)
                      ..++|.+.+.||+|+||.||+|... +++.||||++.....   ......++++++++++||||+++++++...+..++|
T Consensus        20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   99 (287)
T 2wei_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (287)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence            3578999999999999999999976 689999999976432   233446677899999999999999999999999999


Q ss_pred             EEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCC---CcEEEeecccccc
Q 015027          161 YEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDN---YTAKVADFESSVL  237 (414)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~---~~~kl~DfGla~~  237 (414)
                      |||+++++|.+++....   .+++..++.++.||+.||.|||+.+   ++|+||||+||+++.+   +.+||+|||++..
T Consensus       100 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~  173 (287)
T 2wei_A          100 GELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (287)
T ss_dssp             ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred             EEccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCccee
Confidence            99999999999886543   3588999999999999999999988   9999999999999754   4799999999986


Q ss_pred             ccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccc
Q 015027          238 ISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLR  317 (414)
Q Consensus       238 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (414)
                      .....   ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.......         ....+......
T Consensus       174 ~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---------~~~~~~~~~~~  240 (287)
T 2wei_A          174 FQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD---------ILKRVETGKYA  240 (287)
T ss_dssp             BCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---------HHHHHHHCCCC
T ss_pred             ecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH---------HHHHHHcCCCC
Confidence            64332   1233468999999999875 48999999999999999999999997433211         11111111110


Q ss_pred             cccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          318 QILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ...      ......+..+.+|+.+||+.||.+|||+.++++
T Consensus       241 ~~~------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          241 FDL------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             CCS------GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCc------hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence            000      000111256899999999999999999999965

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=4.1e-42  Score=332.43  Aligned_cols=261  Identities=21%  Similarity=0.292  Sum_probs=177.8

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc---hhHhHHHHHHHHHccCCCceeeeeeeEecC------C
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK---IRITERELLRIISQVNHKNVVKILGLCLET------E  155 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~hpniv~l~~~~~~~------~  155 (414)
                      .++|.+.+.||+|+||.||+|.+. +|+.||||++.....   ......+++++++.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            478999999999999999999965 589999999865422   223345677999999999999999998654      5


Q ss_pred             cceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccc
Q 015027          156 VPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESS  235 (414)
Q Consensus       156 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla  235 (414)
                      ..|+||||+ +++|.+++..    ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a  179 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA  179 (367)
T ss_dssp             CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred             eEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence            679999999 6799988854    34588999999999999999999988   999999999999999999999999999


Q ss_pred             ccccCCccccceecccccccccchhhccc-CCCCCcccchhHHHHHHHHHhCCCCCCccccccccccc------cchhhh
Q 015027          236 VLISSDAETAMSTILIGTSGYLDPVCINT-GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKIS------MVPYFL  308 (414)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~------~~~~~~  308 (414)
                      +.....     .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+..........      ......
T Consensus       180 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~  254 (367)
T 2fst_X          180 RHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL  254 (367)
T ss_dssp             ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             cccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            865432     234578999999999977 68999999999999999999999999754321100000      000000


Q ss_pred             hhhccccccccccc--ccCCccc----HHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          309 NSIKNNGLRQILNF--HVADESE----MKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       309 ~~~~~~~~~~~~~~--~~~~~~~----~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ..+........+..  .......    ...++.+.+|+.+||+.||.+|||+.++++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence            00000000000000  0000000    011256899999999999999999999853

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=3e-42  Score=329.62  Aligned_cols=252  Identities=23%  Similarity=0.258  Sum_probs=172.9

Q ss_pred             hcCCCCCC-ccccCCceEEEEEEEc-CCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEec----CCcceE
Q 015027           86 TKNFDRSR-CLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLE----TEVPLL  159 (414)
Q Consensus        86 ~~~~~~~~-~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~----~~~~~l  159 (414)
                      .++|.+.+ .||+|+||.||+|.+. +++.||||++......   ..+....+..+.||||+++++++..    ....++
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l  103 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKA---RQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLI  103 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHH---HHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHH---HHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEE
Confidence            56788855 6999999999999976 5899999999764322   2333345677899999999999876    445899


Q ss_pred             EEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCC---CCcEEEeeccccc
Q 015027          160 VYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLND---NYTAKVADFESSV  236 (414)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~DfGla~  236 (414)
                      ||||+++|+|.+++..... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.   ++.+||+|||++.
T Consensus       104 v~e~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~  179 (336)
T 3fhr_A          104 IMECMEGGELFSRIQERGD-QAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAK  179 (336)
T ss_dssp             EEECCTTEEHHHHHHTC-C-CCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EEeccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccce
Confidence            9999999999999976543 34588999999999999999999988   999999999999976   4569999999998


Q ss_pred             cccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccc
Q 015027          237 LISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGL  316 (414)
Q Consensus       237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (414)
                      .....    ......||+.|+|||++.+..++.++|||||||++|+|++|..||.........     ........... 
T Consensus       180 ~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-----~~~~~~~~~~~-  249 (336)
T 3fhr_A          180 ETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAIS-----PGMKRRIRLGQ-  249 (336)
T ss_dssp             EC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------------
T ss_pred             ecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhh-----hhHHHhhhccc-
Confidence            65432    223457899999999999999999999999999999999999999643321100     00000000000 


Q ss_pred             ccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          317 RQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                           ...........+..+.+|+.+||+.||.+|||+.++++
T Consensus       250 -----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          250 -----YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             ------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             -----cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                 00011111112356899999999999999999999975

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.5e-41  Score=329.17  Aligned_cols=259  Identities=20%  Similarity=0.252  Sum_probs=190.1

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch---hHhHHHHHHHHHccCCCceeeeeeeEecCCcc----
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI---RITERELLRIISQVNHKNVVKILGLCLETEVP----  157 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~----  157 (414)
                      .++|.+.+.||+|+||.||+|.+. +|+.||||++......   .....+++.+++.++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            478999999999999999999976 5899999999764322   23445677899999999999999999877654    


Q ss_pred             --eEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccc
Q 015027          158 --LLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESS  235 (414)
Q Consensus       158 --~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla  235 (414)
                        ++||||++ ++|.+++..     .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       121 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a  191 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA  191 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred             eEEEEEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence              99999997 588877732     2588999999999999999999988   999999999999999999999999999


Q ss_pred             ccccCCccccceecccccccccchhhccc-CCCCCcccchhHHHHHHHHHhCCCCCCccccccccccc------cchhhh
Q 015027          236 VLISSDAETAMSTILIGTSGYLDPVCINT-GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKIS------MVPYFL  308 (414)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~------~~~~~~  308 (414)
                      ......     .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||............      ....+.
T Consensus       192 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  266 (371)
T 4exu_A          192 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV  266 (371)
T ss_dssp             -------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             cccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHH
Confidence            865432     234578999999999987 78999999999999999999999999754321100000      000000


Q ss_pred             hhhcccccccc---cccccCCcc---cHHHHHHHHHHHHHhhccCCCCCCChhHHH
Q 015027          309 NSIKNNGLRQI---LNFHVADES---EMKEIEIVAELASKCLRIRGTERPTMKQVS  358 (414)
Q Consensus       309 ~~~~~~~~~~~---~~~~~~~~~---~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~  358 (414)
                      ...........   +........   ....+..+.+|+.+||+.||.+|||+.+++
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell  322 (371)
T 4exu_A          267 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQAL  322 (371)
T ss_dssp             TTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred             HHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHh
Confidence            00000000000   000000000   001135699999999999999999999984

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.6e-41  Score=330.18  Aligned_cols=201  Identities=23%  Similarity=0.280  Sum_probs=166.7

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhHhHHHHHHHHHccC-CC-----ceeeeeeeEecCCcce
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRITERELLRIISQVN-HK-----NVVKILGLCLETEVPL  158 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~-hp-----niv~l~~~~~~~~~~~  158 (414)
                      .++|.+.+.||+|+||+||+|.+. +++.||||++............+++++..++ |+     +|+++++++...+..+
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~  132 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC  132 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEE
T ss_pred             eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceE
Confidence            578999999999999999999976 5889999999865443334444455655553 44     5999999999999999


Q ss_pred             EEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeC--CCCcEEEeeccccc
Q 015027          159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLN--DNYTAKVADFESSV  236 (414)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~--~~~~~kl~DfGla~  236 (414)
                      +||||+++ +|.+++..... ..+++..+..++.||+.||.|||++. .+|+||||||+|||++  .++.+||+|||++.
T Consensus       133 lv~e~~~~-~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~  209 (382)
T 2vx3_A          133 LVFEMLSY-NLYDLLRNTNF-RGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVDFGSSC  209 (382)
T ss_dssp             EEEECCCC-BHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred             EEEecCCC-CHHHHHhhcCc-CCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEEEeccCce
Confidence            99999964 99999865442 23588999999999999999999532 3499999999999994  57889999999998


Q ss_pred             cccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccc
Q 015027          237 LISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMT  294 (414)
Q Consensus       237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~  294 (414)
                      .....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       210 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~  262 (382)
T 2vx3_A          210 QLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN  262 (382)
T ss_dssp             ETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            76432     234578999999999999999999999999999999999999997543

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=3.9e-42  Score=333.01  Aligned_cols=263  Identities=21%  Similarity=0.259  Sum_probs=193.5

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhHhHHHHHHHHHccC-----------CCceeeeeeeEec
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRITERELLRIISQVN-----------HKNVVKILGLCLE  153 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~-----------hpniv~l~~~~~~  153 (414)
                      .++|.+.+.||+|+||.||+|.+. +++.||||++...........+++.++.+++           ||||+++++++..
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~   97 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   97 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence            367999999999999999999975 6899999999865544444455566666665           8999999999976


Q ss_pred             CC----cceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhC-CCCCeeeCCCCCCceeeC------
Q 015027          154 TE----VPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSL-ASPPIIHGDVKSANILLN------  222 (414)
Q Consensus       154 ~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-~~~~iiH~Dlkp~NIll~------  222 (414)
                      .+    ..++||||+ +++|.+++..... ..+++..+..++.||+.||.|||+. +   |+||||||+|||++      
T Consensus        98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~  172 (373)
T 1q8y_A           98 KGPNGVHVVMVFEVL-GENLLALIKKYEH-RGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPE  172 (373)
T ss_dssp             EETTEEEEEEEECCC-CEEHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTT
T ss_pred             cCCCCceEEEEEecC-CCCHHHHHHHhhc-cCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCc
Confidence            54    789999999 8899999865433 2358899999999999999999997 7   99999999999994      


Q ss_pred             CCCcEEEeeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCcccccccccc-
Q 015027          223 DNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKI-  301 (414)
Q Consensus       223 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~-  301 (414)
                      ..+.+||+|||++......     .....||+.|+|||++.+..++.++|||||||++|||++|+.||........... 
T Consensus       173 ~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  247 (373)
T 1q8y_A          173 NLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD  247 (373)
T ss_dssp             TEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred             CcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence            4558999999999876432     2334789999999999999999999999999999999999999974432110000 


Q ss_pred             c-----------cchhhhhh-------hccc-cccccccc---------ccCCcccHHHHHHHHHHHHHhhccCCCCCCC
Q 015027          302 S-----------MVPYFLNS-------IKNN-GLRQILNF---------HVADESEMKEIEIVAELASKCLRIRGTERPT  353 (414)
Q Consensus       302 ~-----------~~~~~~~~-------~~~~-~~~~~~~~---------~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps  353 (414)
                      .           ........       .... ....+...         ......+...+..+.+|+.+||+.||.+|||
T Consensus       248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt  327 (373)
T 1q8y_A          248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD  327 (373)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred             HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence            0           00000000       0000 00000000         0011233556678999999999999999999


Q ss_pred             hhHHH
Q 015027          354 MKQVS  358 (414)
Q Consensus       354 ~~~v~  358 (414)
                      +.+++
T Consensus       328 ~~ell  332 (373)
T 1q8y_A          328 AGGLV  332 (373)
T ss_dssp             HHHHH
T ss_pred             HHHHh
Confidence            99984

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2.7e-41  Score=324.51  Aligned_cols=263  Identities=19%  Similarity=0.224  Sum_probs=194.6

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CC-cEEEEEEeecccchhHhHHHHHHHHHccCCCc------eeeeeeeEecCCcc
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DN-IQVAVKTYRRADKIRITERELLRIISQVNHKN------VVKILGLCLETEVP  157 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpn------iv~l~~~~~~~~~~  157 (414)
                      .++|.+.+.||+|+||.||+|.+. ++ ..||||++............++.+++.++|++      ++.+++++...+..
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~   97 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM   97 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence            468999999999999999999975 34 68999999865544445556667777776655      99999999999999


Q ss_pred             eEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceee----------------
Q 015027          158 LLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILL----------------  221 (414)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll----------------  221 (414)
                      ++||||+ +++|.+++..... ..+++..++.++.||+.||.|||+.+   |+||||||+|||+                
T Consensus        98 ~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~~  172 (355)
T 2eu9_A           98 CIAFELL-GKNTFEFLKENNF-QPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCE  172 (355)
T ss_dssp             EEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred             EEEEecc-CCChHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccccccc
Confidence            9999999 5677677654432 24588999999999999999999987   9999999999999                


Q ss_pred             ---CCCCcEEEeeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccc
Q 015027          222 ---NDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASN  298 (414)
Q Consensus       222 ---~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~  298 (414)
                         +.++.+||+|||++......     .....||+.|+|||++.+..++.++|||||||++|||++|..||........
T Consensus       173 ~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  247 (355)
T 2eu9_A          173 EKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH  247 (355)
T ss_dssp             EEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             ccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence               56789999999999864432     2345799999999999999999999999999999999999999975432110


Q ss_pred             cc------cccchhhhhhhccccc------------------cccccc-ccCCcccHHHHHHHHHHHHHhhccCCCCCCC
Q 015027          299 KK------ISMVPYFLNSIKNNGL------------------RQILNF-HVADESEMKEIEIVAELASKCLRIRGTERPT  353 (414)
Q Consensus       299 ~~------~~~~~~~~~~~~~~~~------------------~~~~~~-~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps  353 (414)
                      ..      ................                  .....+ ..........+..+.+|+.+||+.||.+|||
T Consensus       248 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt  327 (355)
T 2eu9_A          248 LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT  327 (355)
T ss_dssp             HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred             HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcC
Confidence            00      0000000000000000                  000000 0000112233467999999999999999999


Q ss_pred             hhHHH
Q 015027          354 MKQVS  358 (414)
Q Consensus       354 ~~~v~  358 (414)
                      +.+++
T Consensus       328 ~~e~l  332 (355)
T 2eu9_A          328 LAEAL  332 (355)
T ss_dssp             HHHHT
T ss_pred             HHHHh
Confidence            99984

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.8e-41  Score=326.03  Aligned_cols=265  Identities=21%  Similarity=0.247  Sum_probs=192.6

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEecC-----Ccc
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLET-----EVP  157 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~~-----~~~  157 (414)
                      .++|.+.+.||+|+||.||+|.+. +|+.||||++......  .....+++.+++.++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            468999999999999999999976 5899999999754322  23345677899999999999999988654     678


Q ss_pred             eEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccccc
Q 015027          158 LLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVL  237 (414)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~  237 (414)
                      ++||||++ ++|.+++..    ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus        90 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI  161 (353)
T ss_dssp             EEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence            99999997 589888854    23588999999999999999999988   99999999999999999999999999987


Q ss_pred             ccCCcccc--------ceecccccccccchhhccc-CCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccch---
Q 015027          238 ISSDAETA--------MSTILIGTSGYLDPVCINT-GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVP---  305 (414)
Q Consensus       238 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~---  305 (414)
                      ........        ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......... .+..   
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~~  240 (353)
T 2b9h_A          162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLL-LIFGIIG  240 (353)
T ss_dssp             CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-HHHHHHC
T ss_pred             cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH-HHHHHhC
Confidence            65322111        1223478999999998754 779999999999999999999999997543211000 0000   


Q ss_pred             -----hhhhhhccccccccccc--ccCCc----ccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          306 -----YFLNSIKNNGLRQILNF--HVADE----SEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       306 -----~~~~~~~~~~~~~~~~~--~~~~~----~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                           .................  .....    .....+..+.+|+.+||+.||.+|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                 00000000000000000  00000    00012356899999999999999999999843

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=5.2e-42  Score=325.68  Aligned_cols=244  Identities=22%  Similarity=0.326  Sum_probs=193.9

Q ss_pred             HHHHHhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchh-------HhHHHHHHHHHccC--CCceeeeeee
Q 015027           81 EMIRATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIR-------ITERELLRIISQVN--HKNVVKILGL  150 (414)
Q Consensus        81 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~~~~l~~l~--hpniv~l~~~  150 (414)
                      +.....++|.+.+.||+|+||.||+|.+. +++.||||++.......       .....++.++.+++  ||||++++++
T Consensus        37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~  116 (320)
T 3a99_A           37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW  116 (320)
T ss_dssp             ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred             ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence            33445678999999999999999999965 68999999997653221       22234557777775  5999999999


Q ss_pred             EecCCcceEEEEeCCC-CchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeC-CCCcEE
Q 015027          151 CLETEVPLLVYEFASN-GTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLN-DNYTAK  228 (414)
Q Consensus       151 ~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~-~~~~~k  228 (414)
                      +...+..++||||+.+ ++|.+++....   .+++..++.++.||+.||.|||+.+   |+||||||+|||++ .++.+|
T Consensus       117 ~~~~~~~~lv~e~~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~k  190 (320)
T 3a99_A          117 FERPDSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELK  190 (320)
T ss_dssp             EECSSEEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEE
T ss_pred             EecCCcEEEEEEcCCCCccHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEE
Confidence            9999999999999976 89999986543   3578999999999999999999988   99999999999999 789999


Q ss_pred             EeeccccccccCCccccceecccccccccchhhcccCCC-CCcccchhHHHHHHHHHhCCCCCCccccccccccccchhh
Q 015027          229 VADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKL-TKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYF  307 (414)
Q Consensus       229 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~  307 (414)
                      |+|||++......    ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.......          
T Consensus       191 L~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~----------  256 (320)
T 3a99_A          191 LIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII----------  256 (320)
T ss_dssp             ECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH----------
T ss_pred             EeeCccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhh----------
Confidence            9999999876532    2234578999999999987766 688999999999999999999996322100          


Q ss_pred             hhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          308 LNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                           ...  ......        .+..+.+|+.+||+.||.+|||+.++++
T Consensus       257 -----~~~--~~~~~~--------~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          257 -----RGQ--VFFRQR--------VSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             -----HCC--CCCSSC--------CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -----ccc--cccccc--------CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                 000  001111        1245899999999999999999999854

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.2e-41  Score=336.54  Aligned_cols=252  Identities=21%  Similarity=0.205  Sum_probs=182.8

Q ss_pred             CCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHcc-CCCceeeeeeeEecCCcceEEEEeCCC
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQV-NHKNVVKILGLCLETEVPLLVYEFASN  166 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~  166 (414)
                      .|...+.||+|+||+||.+...+|+.||||++.....  .....+++++.++ +||||+++++++.+++..|+|||||+ 
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~~--~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-   92 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFC--DIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-   92 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGGH--HHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-
T ss_pred             eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHHH--HHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-
Confidence            4455688999999999877666899999999876432  2334556777765 89999999999999999999999996 


Q ss_pred             CchhhhhhhcCCccc----CCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCC-------------CcEEE
Q 015027          167 GTLLDHIRCESSQVL----KTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDN-------------YTAKV  229 (414)
Q Consensus       167 gsL~~~l~~~~~~~~----~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~-------------~~~kl  229 (414)
                      |+|.+++........    .++..++.++.||+.||+|||+.+   |+||||||+|||++.+             +.+||
T Consensus        93 gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL  169 (434)
T 2rio_A           93 LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILI  169 (434)
T ss_dssp             EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred             CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence            599999965433211    122345779999999999999988   9999999999999654             58999


Q ss_pred             eeccccccccCCcccc--ceecccccccccchhhccc-------CCCCCcccchhHHHHHHHHHh-CCCCCCcccccccc
Q 015027          230 ADFESSVLISSDAETA--MSTILIGTSGYLDPVCINT-------GKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNK  299 (414)
Q Consensus       230 ~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~  299 (414)
                      +|||++..........  ......||+.|+|||++.+       ..++.++|||||||++|||++ |..||.......  
T Consensus       170 ~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--  247 (434)
T 2rio_A          170 SDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--  247 (434)
T ss_dssp             CCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--
T ss_pred             cccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--
Confidence            9999998775432211  1234579999999999976       678999999999999999999 999996332110  


Q ss_pred             ccccchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          300 KISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                              .. +.....   ..+..........+..+.+|+.+||+.||.+|||+.+|++
T Consensus       248 --------~~-i~~~~~---~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          248 --------SN-IIRGIF---SLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             --------HH-HHHTCC---CCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --------HH-HhcCCC---CcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence                    00 000000   0001111223445677999999999999999999999975

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.1e-41  Score=319.40  Aligned_cols=265  Identities=18%  Similarity=0.225  Sum_probs=186.8

Q ss_pred             hcCCCCCCccccCCceEEEEEEEcC-CcEEEEEEeecccch-hHhHHHHHHHHHccCCCceeeeeeeEe-----------
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLHD-NIQVAVKTYRRADKI-RITERELLRIISQVNHKNVVKILGLCL-----------  152 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~hpniv~l~~~~~-----------  152 (414)
                      .++|.+.+.||+|+||.||+|.+.. ++.||||++...... .....++++++++++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            4689999999999999999999864 899999998765432 234466789999999999999999874           


Q ss_pred             ---cCCcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeC-CCCcEE
Q 015027          153 ---ETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLN-DNYTAK  228 (414)
Q Consensus       153 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~-~~~~~k  228 (414)
                         +....++||||++ |+|.+++..    ..+++..++.++.||+.||+|||+.+   |+||||||+|||++ .++.+|
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k  161 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK  161 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred             cccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence               3467899999998 599998853    34578899999999999999999988   99999999999997 577999


Q ss_pred             EeeccccccccCCcc-ccceecccccccccchhhccc-CCCCCcccchhHHHHHHHHHhCCCCCCcccccccccccc---
Q 015027          229 VADFESSVLISSDAE-TAMSTILIGTSGYLDPVCINT-GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISM---  303 (414)
Q Consensus       229 l~DfGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~---  303 (414)
                      |+|||++........ ........+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.............   
T Consensus       162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~  241 (320)
T 2i6l_A          162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI  241 (320)
T ss_dssp             ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHS
T ss_pred             EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            999999987643211 112334567999999998865 678999999999999999999999997543211000000   


Q ss_pred             ---chhhhhhhcccccccccccccC-Ccc-----cHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          304 ---VPYFLNSIKNNGLRQILNFHVA-DES-----EMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       304 ---~~~~~~~~~~~~~~~~~~~~~~-~~~-----~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                         ......... ......+..... ...     ....+..+.+|+.+||+.||.+|||+.++++
T Consensus       242 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          242 PVVHEEDRQELL-SVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             CCCCHHHHHHHH-TTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             CCCchhhhhhhh-hcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence               000000000 000000000000 000     0011356999999999999999999999954

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=7.2e-41  Score=322.11  Aligned_cols=258  Identities=21%  Similarity=0.255  Sum_probs=189.8

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch---hHhHHHHHHHHHccCCCceeeeeeeEecCCc-----
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI---RITERELLRIISQVNHKNVVKILGLCLETEV-----  156 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~-----  156 (414)
                      .++|.+.+.||+|+||.||+|.+. +|+.||||++......   .....+++.+++.++||||+++++++.....     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            467999999999999999999975 5899999999754322   2334567789999999999999999987654     


Q ss_pred             -ceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccc
Q 015027          157 -PLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESS  235 (414)
Q Consensus       157 -~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla  235 (414)
                       .|+||||++ ++|.+++..     .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~  173 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA  173 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred             eEEEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence             499999997 588887732     2588999999999999999999988   999999999999999999999999999


Q ss_pred             ccccCCccccceecccccccccchhhccc-CCCCCcccchhHHHHHHHHHhCCCCCCcccccccccc-----c-cchhhh
Q 015027          236 VLISSDAETAMSTILIGTSGYLDPVCINT-GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKI-----S-MVPYFL  308 (414)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~-----~-~~~~~~  308 (414)
                      ......     .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........     + ....+.
T Consensus       174 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  248 (353)
T 3coi_A          174 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV  248 (353)
T ss_dssp             TC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHH
T ss_pred             cCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            765432     234578999999999877 6889999999999999999999999975432110000     0 000000


Q ss_pred             hhhcccc-------cccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHH
Q 015027          309 NSIKNNG-------LRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVS  358 (414)
Q Consensus       309 ~~~~~~~-------~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~  358 (414)
                      .......       ........+. ......+..+.+|+.+||+.||.+|||+.+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l  304 (353)
T 3coi_A          249 QKLNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQAL  304 (353)
T ss_dssp             TTCSCHHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred             HHHhhHHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence            0000000       0000000000 00112235699999999999999999999984

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-41  Score=321.85  Aligned_cols=243  Identities=24%  Similarity=0.323  Sum_probs=185.7

Q ss_pred             HHHHhcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchh-------HhHHHHHHHHHcc----CCCceeeeee
Q 015027           82 MIRATKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIR-------ITERELLRIISQV----NHKNVVKILG  149 (414)
Q Consensus        82 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~~~~l~~l----~hpniv~l~~  149 (414)
                      .....++|.+.+.||+|+||.||+|.+. +++.||||++.......       .....++.++.++    +||||+++++
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~  105 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD  105 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence            3445688999999999999999999965 68899999997543211       1113345666666    8999999999


Q ss_pred             eEecCCcceEEEEe-CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeC-CCCcE
Q 015027          150 LCLETEVPLLVYEF-ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLN-DNYTA  227 (414)
Q Consensus       150 ~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~-~~~~~  227 (414)
                      ++...+..++|||| +.+++|.+++....   .+++..++.++.||+.||.|||+.+   |+||||||+||+++ .++.+
T Consensus       106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~  179 (312)
T 2iwi_A          106 WFETQEGFMLVLERPLPAQDLFDYITEKG---PLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCA  179 (312)
T ss_dssp             EC-----CEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEE
T ss_pred             EEecCCeEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeE
Confidence            99999999999999 78999999997543   3588999999999999999999988   99999999999999 89999


Q ss_pred             EEeeccccccccCCccccceecccccccccchhhcccCCCC-CcccchhHHHHHHHHHhCCCCCCccccccccccccchh
Q 015027          228 KVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLT-KKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPY  306 (414)
Q Consensus       228 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~  306 (414)
                      ||+|||++.......    .....||+.|+|||++.+..+. .++||||||+++|+|++|+.||......          
T Consensus       180 kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----------  245 (312)
T 2iwi_A          180 KLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEI----------  245 (312)
T ss_dssp             EECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH----------
T ss_pred             EEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHH----------
Confidence            999999998765432    2345789999999999876664 5899999999999999999999632210          


Q ss_pred             hhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          307 FLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                           .....      .....    .+..+.+|+.+||+.||.+|||+.++++
T Consensus       246 -----~~~~~------~~~~~----~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          246 -----LEAEL------HFPAH----VSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             -----HHTCC------CCCTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -----hhhcc------CCccc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                 00000      00111    1245899999999999999999999954

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=5e-41  Score=318.03  Aligned_cols=250  Identities=21%  Similarity=0.267  Sum_probs=176.5

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhH---hHHHHHHHHHccCCCceeeeeeeEecCCcceEEE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRI---TERELLRIISQVNHKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~---~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~  161 (414)
                      .++|.+.+.||+|+||.||+|.+. +++.||||++........   ...++..+++.++||||+++++++...+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            467889999999999999999976 689999999986543222   2244445788889999999999999999999999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhC-CCCCeeeCCCCCCceeeCCCCcEEEeeccccccccC
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSL-ASPPIIHGDVKSANILLNDNYTAKVADFESSVLISS  240 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  240 (414)
                      ||+ ++.+..+.....  ..+++..++.++.||+.||.|||+. +   ++|+||||+|||++.++.+||+|||++.....
T Consensus       104 e~~-~~~~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  177 (318)
T 2dyl_A          104 ELM-GTCAEKLKKRMQ--GPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVD  177 (318)
T ss_dssp             CCC-SEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             ecc-CCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence            999 445555443322  3358899999999999999999984 7   99999999999999999999999999976543


Q ss_pred             Cccccceecccccccccchhhcc-----cCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccc
Q 015027          241 DAETAMSTILIGTSGYLDPVCIN-----TGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNG  315 (414)
Q Consensus       241 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (414)
                      ..   ......||+.|+|||++.     +..++.++|||||||++|+|++|+.||.......        ..........
T Consensus       178 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--------~~~~~~~~~~  246 (318)
T 2dyl_A          178 DK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF--------EVLTKVLQEE  246 (318)
T ss_dssp             ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH--------HHHHHHHHSC
T ss_pred             Cc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH--------HHHHHHhccC
Confidence            21   223457899999999994     5678899999999999999999999997422110        0011111100


Q ss_pred             cccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          316 LRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      . ..+...      ...+..+.+|+.+||+.||.+|||+.++++
T Consensus       247 ~-~~~~~~------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          247 P-PLLPGH------MGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             C-CCCCSS------SCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             C-CCCCcc------CCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            0 000000      011255899999999999999999999975

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.4e-41  Score=332.66  Aligned_cols=249  Identities=22%  Similarity=0.272  Sum_probs=182.3

Q ss_pred             cCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHcc-CCCceeeeeeeEecCCcceEEEEeCC
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQV-NHKNVVKILGLCLETEVPLLVYEFAS  165 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~  165 (414)
                      .+|.+.+.||+|+||+||.....+++.||||++......  ...+++++++.+ +||||+++++++.+....|+|||||+
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~--~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~  101 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS--FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA  101 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE--ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH--HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC
Confidence            468888999999999976555568999999998754322  224456788888 79999999999999999999999996


Q ss_pred             CCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCC-----CCcEEEeeccccccccC
Q 015027          166 NGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLND-----NYTAKVADFESSVLISS  240 (414)
Q Consensus       166 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~-----~~~~kl~DfGla~~~~~  240 (414)
                       |+|.+++.......  .+..++.++.||+.||.|||+.+   |+||||||+|||++.     ...+||+|||++.....
T Consensus       102 -g~L~~~l~~~~~~~--~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~  175 (432)
T 3p23_A          102 -ATLQEYVEQKDFAH--LGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV  175 (432)
T ss_dssp             -EEHHHHHHSSSCCC--CSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred             -CCHHHHHHhcCCCc--cchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence             59999987554322  33456789999999999999988   999999999999953     34688999999987654


Q ss_pred             Cccc-cceecccccccccchhhcc---cCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhcccc
Q 015027          241 DAET-AMSTILIGTSGYLDPVCIN---TGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNG  315 (414)
Q Consensus       241 ~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (414)
                      .... .......||+.|+|||++.   +..++.++|||||||++|||++ |..||.......          ........
T Consensus       176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~----------~~~~~~~~  245 (432)
T 3p23_A          176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ----------ANILLGAC  245 (432)
T ss_dssp             ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH----------HHHHTTCC
T ss_pred             CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH----------HHHHhccC
Confidence            3211 2234467999999999997   4677889999999999999999 999985322110          00000000


Q ss_pred             cccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          316 LRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ...    ..  .........+.+|+.+||+.||.+|||+.+|++
T Consensus       246 ~~~----~~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          246 SLD----CL--HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             CCT----TS--CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             Ccc----cc--CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            000    00  011123355889999999999999999999974

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=6.5e-41  Score=342.11  Aligned_cols=274  Identities=23%  Similarity=0.228  Sum_probs=199.3

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEec------CCcc
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLE------TEVP  157 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~------~~~~  157 (414)
                      ++|.+.+.||+|+||.||+|.+. +|+.||||++......  ......+++++.+++||||+++++++..      ++..
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            68999999999999999999975 5899999998764322  2334667899999999999999998765      6778


Q ss_pred             eEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCc---EEEeeccc
Q 015027          158 LLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYT---AKVADFES  234 (414)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~---~kl~DfGl  234 (414)
                      ++||||+++|+|.+++........+++..++.++.+++.||.|||+.+   |+||||||+|||++.++.   +||+|||+
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~  170 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGY  170 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred             EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccccc
Confidence            999999999999999976555445678889999999999999999988   999999999999997664   99999999


Q ss_pred             cccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhh-hhhcc
Q 015027          235 SVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFL-NSIKN  313 (414)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~  313 (414)
                      +.......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||........-......... .....
T Consensus       171 a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~  247 (676)
T 3qa8_A          171 AKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY  247 (676)
T ss_dssp             CCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSC
T ss_pred             cccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhh
Confidence            98765432   234468999999999999999999999999999999999999999642111000000000000 00000


Q ss_pred             cccccc--ccc--ccCCcccHHHHHHHHHHHHHhhccCCCCCCChhH-----HHHHHHHHHH
Q 015027          314 NGLRQI--LNF--HVADESEMKEIEIVAELASKCLRIRGTERPTMKQ-----VSEELDRLRR  366 (414)
Q Consensus       314 ~~~~~~--~~~--~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~-----v~~~L~~i~~  366 (414)
                      ......  +..  ..........+..+.+|+.+||..||.+|||+.+     ..+.++.+..
T Consensus       248 ~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~  309 (676)
T 3qa8_A          248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS  309 (676)
T ss_dssp             CCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred             hhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence            000000  000  1111222334577999999999999999999988     4455555543

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=3.9e-40  Score=307.78  Aligned_cols=232  Identities=12%  Similarity=0.081  Sum_probs=180.5

Q ss_pred             hcCCCCCCccccCCceEEEEEEEcC-CcEEEEEEeecccchh----HhHHHHHHHHHccCCCceeeeeeeEecCCcceEE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLHD-NIQVAVKTYRRADKIR----ITERELLRIISQVNHKNVVKILGLCLETEVPLLV  160 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~----~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv  160 (414)
                      .++|.+.+.||+|+||.||+|.+.. ++.||||++.......    ....+++..+.+++||||+++++++.+++..|+|
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  109 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV  109 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence            3679999999999999999999864 8999999998654322    3446667889999999999999999999999999


Q ss_pred             EEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccC
Q 015027          161 YEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISS  240 (414)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  240 (414)
                      |||++|++|.+++...     .....+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+++|       
T Consensus       110 ~e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~-------  174 (286)
T 3uqc_A          110 AEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA-------  174 (286)
T ss_dssp             EECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred             EEecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-------
Confidence            9999999999998532     144568889999999999999988   9999999999999999999998443       


Q ss_pred             CccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccc
Q 015027          241 DAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQIL  320 (414)
Q Consensus       241 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (414)
                                     |++|       ++.++|||||||++|||++|+.||.............     .... .....  
T Consensus       175 ---------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~-----~~~~-~~~~~--  224 (286)
T 3uqc_A          175 ---------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE-----RDTA-GQPIE--  224 (286)
T ss_dssp             ---------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC-----BCTT-SCBCC--
T ss_pred             ---------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH-----HHhc-cCCCC--
Confidence                           3333       6889999999999999999999997544321100000     0000 00000  


Q ss_pred             ccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHh
Q 015027          321 NFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRL  367 (414)
Q Consensus       321 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~  367 (414)
                      ......    ..+..+.+|+.+||+.||.+| |+.++++.|+.+...
T Consensus       225 ~~~~~~----~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~  266 (286)
T 3uqc_A          225 PADIDR----DIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV  266 (286)
T ss_dssp             HHHHCT----TSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred             hhhccc----CCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence            000000    112559999999999999999 999999999988754

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=5.3e-40  Score=342.31  Aligned_cols=240  Identities=22%  Similarity=0.346  Sum_probs=191.3

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc--CCcEEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEecCCc-----
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH--DNIQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLETEV-----  156 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~-----  156 (414)
                      .++|.+.+.||+|+||.||+|.+.  +++.||||++......  ...+..+++++.+++||||++++++|...+.     
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            478999999999999999999975  5899999998754322  2334567789999999999999999987665     


Q ss_pred             ceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccc
Q 015027          157 PLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSV  236 (414)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~  236 (414)
                      .|+||||++|++|.+++..     .+++..++.++.||+.||.|||+.+   |+||||||+|||++.+ .+||+|||++.
T Consensus       159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~  229 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS  229 (681)
T ss_dssp             EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred             eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence            6999999999999987743     4689999999999999999999988   9999999999999986 99999999998


Q ss_pred             cccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccc
Q 015027          237 LISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGL  316 (414)
Q Consensus       237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (414)
                      .....      ....||+.|+|||++.+.. +.++|||||||++|+|++|..||.......             ..    
T Consensus       230 ~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-------------~~----  285 (681)
T 2pzi_A          230 RINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG-------------LP----  285 (681)
T ss_dssp             ETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS-------------CC----
T ss_pred             hcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc-------------cc----
Confidence            76432      3457999999999987654 889999999999999999998876321110             00    


Q ss_pred             ccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCC-hhHHHHHHHHHHH
Q 015027          317 RQILNFHVADESEMKEIEIVAELASKCLRIRGTERPT-MKQVSEELDRLRR  366 (414)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps-~~~v~~~L~~i~~  366 (414)
                              ........+..+.+|+.+||+.||.+||+ ++++...|..+.+
T Consensus       286 --------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  328 (681)
T 2pzi_A          286 --------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR  328 (681)
T ss_dssp             --------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred             --------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence                    00011122356899999999999999995 6677777776653

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1e-39  Score=320.65  Aligned_cols=241  Identities=15%  Similarity=0.153  Sum_probs=175.1

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch----hHhHHHHHHHHHccCC-Cceee-------------
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI----RITERELLRIISQVNH-KNVVK-------------  146 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~h-pniv~-------------  146 (414)
                      +.+|...+.||+|+||.||+|.+. +|+.||||++......    .....+++.++..++| +|...             
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            345777889999999999999965 6899999998743222    2334566677777776 22111             


Q ss_pred             --------eeeeEec-----CCcceEEEEeCCCCchhhhhhhc----CCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCe
Q 015027          147 --------ILGLCLE-----TEVPLLVYEFASNGTLLDHIRCE----SSQVLKTWKTCLRIAAETASALDYLHSLASPPI  209 (414)
Q Consensus       147 --------l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i  209 (414)
                              ++.++..     ....+++|+++ +++|.+++...    .....+++..++.++.||+.||.|||+.+   |
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i  232 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L  232 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence                    1111111     12356777765 67999888421    22344577888999999999999999988   9


Q ss_pred             eeCCCCCCceeeCCCCcEEEeeccccccccCCccccceecccccccccchhhc----------ccCCCCCcccchhHHHH
Q 015027          210 IHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCI----------NTGKLTKKSDVYSFGVV  279 (414)
Q Consensus       210 iH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Dv~SlGvi  279 (414)
                      +||||||+|||++.++.+||+|||+++.....     .....| +.|+|||++          .+..++.++|||||||+
T Consensus       233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi  306 (413)
T 3dzo_A          233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA  306 (413)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred             ccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence            99999999999999999999999998765432     344567 999999999          66678899999999999


Q ss_pred             HHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          280 LAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       280 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      +|||++|+.||........                 ...++....  ..    +..+.+|+.+||+.||.+|||+.++++
T Consensus       307 l~elltg~~Pf~~~~~~~~-----------------~~~~~~~~~--~~----~~~~~~li~~~l~~dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          307 IYWIWCADLPNTDDAALGG-----------------SEWIFRSCK--NI----PQPVRALLEGFLRYPKEDRLLPLQAME  363 (413)
T ss_dssp             HHHHHHSSCCCCTTGGGSC-----------------SGGGGSSCC--CC----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHHCCCCCCCcchhhh-----------------HHHHHhhcc--cC----CHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            9999999999974432110                 001111000  11    155999999999999999999988865

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=7.6e-39  Score=300.87  Aligned_cols=231  Identities=22%  Similarity=0.254  Sum_probs=173.2

Q ss_pred             hcCCCCC-CccccCCceEEEEEEEc-CCcEEEEEEeecccchhHhHHHHHHHH-HccCCCceeeeeeeEec----CCcce
Q 015027           86 TKNFDRS-RCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRITERELLRII-SQVNHKNVVKILGLCLE----TEVPL  158 (414)
Q Consensus        86 ~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~l-~~l~hpniv~l~~~~~~----~~~~~  158 (414)
                      .++|.+. +.||+|+||.||+|... +++.||+|++....    ...+++.++ +..+||||+++++++..    ....+
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   91 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP----KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   91 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecccH----HHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence            3567776 77999999999999975 68999999996532    223334444 66789999999999876    67789


Q ss_pred             EEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCC---CCcEEEeecccc
Q 015027          159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLND---NYTAKVADFESS  235 (414)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~DfGla  235 (414)
                      +||||+++|+|.+++..... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.   ++.+||+|||++
T Consensus        92 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a  167 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA  167 (299)
T ss_dssp             EEECCCCSCBHHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEeecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence            99999999999999976443 24588999999999999999999988   999999999999998   789999999998


Q ss_pred             ccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccc
Q 015027          236 VLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNG  315 (414)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (414)
                      ....                        +..++.++|||||||++|+|++|+.||...........     .........
T Consensus       168 ~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~-----~~~~~~~~~  218 (299)
T 3m2w_A          168 KETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-----MKTRIRMGQ  218 (299)
T ss_dssp             EECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CC-----SCCSSCTTC
T ss_pred             cccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHH-----HHHHHhhcc
Confidence            6432                        24567899999999999999999999964332110000     000000000


Q ss_pred             cccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          316 LRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      .      ..........+..+.+|+.+||+.||.+|||+.++++
T Consensus       219 ~------~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          219 Y------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             C------SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             c------cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            0      0000000112356999999999999999999999964

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=8.8e-40  Score=312.39  Aligned_cols=241  Identities=16%  Similarity=0.195  Sum_probs=177.3

Q ss_pred             hcCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccch---------hHhHHHHHHHHHccC---------CCceeee
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKI---------RITERELLRIISQVN---------HKNVVKI  147 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------~~~~~~~~~~l~~l~---------hpniv~l  147 (414)
                      .++|.+.+.||+|+||+||+|++ +|+.||||++......         .....+|+.+++.++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            46788999999999999999998 7899999999865321         133455556666664         5555555


Q ss_pred             eee-----------------Eec-------------CCcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHH
Q 015027          148 LGL-----------------CLE-------------TEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA  197 (414)
Q Consensus       148 ~~~-----------------~~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~  197 (414)
                      .+.                 |.+             .+..|+||||+++|++.+.+..    ..+++..+..++.||+.|
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence            554                 433             6789999999999987776633    335889999999999999


Q ss_pred             HHHhh-hCCCCCeeeCCCCCCceeeCCCC--------------------cEEEeeccccccccCCccccceecccccccc
Q 015027          198 LDYLH-SLASPPIIHGDVKSANILLNDNY--------------------TAKVADFESSVLISSDAETAMSTILIGTSGY  256 (414)
Q Consensus       198 l~~LH-~~~~~~iiH~Dlkp~NIll~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y  256 (414)
                      |.||| +.+   |+||||||+|||++.++                    .+||+|||+|+.....       ...||+.|
T Consensus       174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y  243 (336)
T 2vuw_A          174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVS  243 (336)
T ss_dssp             HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCT
T ss_pred             HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecc
Confidence            99999 887   99999999999999887                    9999999999876432       34799999


Q ss_pred             cchhhcccCCCCCcccchhHHHH-HHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccccCCcccHHHHHH
Q 015027          257 LDPVCINTGKLTKKSDVYSFGVV-LAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEI  335 (414)
Q Consensus       257 ~aPE~~~~~~~~~~~Dv~SlGvi-l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (414)
                      +|||++.+.. +.++||||||++ .+++++|..||.....        ...........   ...............++.
T Consensus       244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~--------~~~~~~~~~~~---~~~~~~~~~~~~~~~s~~  311 (336)
T 2vuw_A          244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLW--------LHYLTDKMLKQ---MTFKTKCNTPAMKQIKRK  311 (336)
T ss_dssp             TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHH--------HHHHHHHHHHT---CCCSSCCCSHHHHHHHHH
T ss_pred             cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhh--------hhHHHHhhhhh---hccCcccchhhhhhcCHH
Confidence            9999998776 889999998777 7778889999742100        00000000000   000111111223456678


Q ss_pred             HHHHHHHhhccCCCCCCChhHHH
Q 015027          336 VAELASKCLRIRGTERPTMKQVS  358 (414)
Q Consensus       336 l~~Li~~cl~~dP~~Rps~~~v~  358 (414)
                      +.+|+.+||+.|     |+.+++
T Consensus       312 ~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          312 IQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHHHHGGGSS-----SHHHHH
T ss_pred             HHHHHHHHhccC-----CHHHHH
Confidence            999999999976     888875

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=1.3e-32  Score=279.69  Aligned_cols=184  Identities=15%  Similarity=0.068  Sum_probs=128.1

Q ss_pred             ccccCCceEEEEEE-EcCCcEEEEEEeeccc-----------chhHhHHHHHHHHHcc-CCCceeeeeeeEecCCcceEE
Q 015027           94 CLSQGGFVSVYKGV-LHDNIQVAVKTYRRAD-----------KIRITERELLRIISQV-NHKNVVKILGLCLETEVPLLV  160 (414)
Q Consensus        94 ~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-----------~~~~~~~~~~~~l~~l-~hpniv~l~~~~~~~~~~~lv  160 (414)
                      ..+.|++|.+..++ ...|..+|+|++....           .....+.+|+++|+++ .|+||+++++++++++..|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            35677777777665 3358899999997542           1112346678999999 799999999999999999999


Q ss_pred             EEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccC
Q 015027          161 YEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISS  240 (414)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  240 (414)
                      |||++|++|.++|...+.   ++..   .|+.||+.||+|+|++|   ||||||||+|||++.+|.+||+|||+|+....
T Consensus       321 MEyv~G~~L~d~i~~~~~---l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~  391 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAGEE---IDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ  391 (569)
T ss_dssp             EECCCSEEHHHHHHTTCC---CCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred             EecCCCCcHHHHHHhCCC---CCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence            999999999999976543   2433   58899999999999988   99999999999999999999999999987654


Q ss_pred             CccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCC
Q 015027          241 DAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP  289 (414)
Q Consensus       241 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p  289 (414)
                      ..  ......+||+.|||||++.+ .+..++|+||+|+++++|.++..|
T Consensus       392 ~~--~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          392 DC--SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             ----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             CC--ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            32  23345689999999999976 467789999999998888766554

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=7.6e-29  Score=250.60  Aligned_cols=185  Identities=12%  Similarity=0.124  Sum_probs=144.6

Q ss_pred             CCCCccccCCceEEEEEEEcCCcEEEEEEeecccch---------hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEE
Q 015027           90 DRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKI---------RITERELLRIISQVNHKNVVKILGLCLETEVPLLV  160 (414)
Q Consensus        90 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv  160 (414)
                      ...+.||+|+||.||+|.. .+..+++|........         .....+|++++++++||||+++..++...+..|+|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            4456899999999999954 5788999986543211         12236677999999999999766666677888999


Q ss_pred             EEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccC
Q 015027          161 YEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISS  240 (414)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  240 (414)
                      |||+++++|.+++..           +..++.|++.||.|||+++   |+||||||+|||++.  .+||+|||+++....
T Consensus       418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~  481 (540)
T 3en9_A          418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL  481 (540)
T ss_dssp             EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred             EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence            999999999999854           4578999999999999988   999999999999998  999999999998754


Q ss_pred             Ccccc-----ceecccccccccchhhccc--CCCCCcccchhHHHHHHHHHhCCCCCC
Q 015027          241 DAETA-----MSTILIGTSGYLDPVCINT--GKLTKKSDVYSFGVVLAELLTGKKPGS  291 (414)
Q Consensus       241 ~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGvil~el~tg~~p~~  291 (414)
                      .....     ......||+.|||||++.+  ..|+..+|+||..+-..+-+.++.+|.
T Consensus       482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            32211     1245689999999999987  678889999999999999888887763

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.92  E-value=3e-25  Score=206.16  Aligned_cols=154  Identities=15%  Similarity=0.145  Sum_probs=120.6

Q ss_pred             cHHHHHHHhcCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccc-------------------hhHhHHHHHHHHHc
Q 015027           78 SKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADK-------------------IRITERELLRIISQ  138 (414)
Q Consensus        78 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------------------~~~~~~~~~~~l~~  138 (414)
                      ....+......|.+.+.||+|+||.||+|.+.+|+.||||+++....                   .......++.++++
T Consensus        81 ~l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~  160 (282)
T 1zar_A           81 SLHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQK  160 (282)
T ss_dssp             HHHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHh
Confidence            34455556677788899999999999999997799999999964321                   12334567788988


Q ss_pred             cCCCceeeeeeeEecCCcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCc
Q 015027          139 VNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSAN  218 (414)
Q Consensus       139 l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~N  218 (414)
                      ++  | +++.+++.. +..|+||||++|++|.+ +..         .....++.||+.||.|||+.+   |+||||||+|
T Consensus       161 l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~N  223 (282)
T 1zar_A          161 LQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYN  223 (282)
T ss_dssp             TT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTS
T ss_pred             cc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHH
Confidence            88  4 666665543 56799999999999988 421         123468999999999999988   9999999999


Q ss_pred             eeeCCCCcEEEeeccccccccCCccccceecccccccccchhhccc
Q 015027          219 ILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINT  264 (414)
Q Consensus       219 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  264 (414)
                      ||++ ++.+||+|||+|+.               +..++|||++..
T Consensus       224 ILl~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~r  253 (282)
T 1zar_A          224 VLVS-EEGIWIIDFPQSVE---------------VGEEGWREILER  253 (282)
T ss_dssp             EEEE-TTEEEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred             EEEE-CCcEEEEECCCCeE---------------CCCCCHHHHHHH
Confidence            9999 99999999999863               336789998753

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.83  E-value=5.4e-21  Score=175.25  Aligned_cols=137  Identities=20%  Similarity=0.180  Sum_probs=102.7

Q ss_pred             cCCCCCCccccCCceEEEEEEE-cCCcE--EEEEEeecccch-------------------------hHhHHHHHHHHHc
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVL-HDNIQ--VAVKTYRRADKI-------------------------RITERELLRIISQ  138 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~-------------------------~~~~~~~~~~l~~  138 (414)
                      .-|.+.+.||+|+||.||+|.+ .+|+.  ||||+++.....                         ......+++.+..
T Consensus        47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~  126 (258)
T 1zth_A           47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER  126 (258)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred             CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence            3467789999999999999997 67888  999987543211                         0133556678888


Q ss_pred             cCCCce--eeeeeeEecCCcceEEEEeCCC-C----chhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhh-hCCCCCee
Q 015027          139 VNHKNV--VKILGLCLETEVPLLVYEFASN-G----TLLDHIRCESSQVLKTWKTCLRIAAETASALDYLH-SLASPPII  210 (414)
Q Consensus       139 l~hpni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH-~~~~~~ii  210 (414)
                      +.|+++  +.++++    ...+|||||+.+ |    +|.+.....      ++..+..++.|++.||.||| +.+   |+
T Consensus       127 l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~~------~~~~~~~i~~qi~~~l~~lH~~~g---iv  193 (258)
T 1zth_A          127 AKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGREL------KELDVEGIFNDVVENVKRLYQEAE---LV  193 (258)
T ss_dssp             HHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGGG------GGSCHHHHHHHHHHHHHHHHHTSC---EE
T ss_pred             HHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhcc------ChHHHHHHHHHHHHHHHHHHHHCC---EE
Confidence            887754  334432    357899999942 4    565554221      23456778999999999999 877   99


Q ss_pred             eCCCCCCceeeCCCCcEEEeeccccccc
Q 015027          211 HGDVKSANILLNDNYTAKVADFESSVLI  238 (414)
Q Consensus       211 H~Dlkp~NIll~~~~~~kl~DfGla~~~  238 (414)
                      ||||||+|||++.  .++|+|||+|...
T Consensus       194 HrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          194 HADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             CSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             eCCCCHHHEEEcC--cEEEEECcccccC
Confidence            9999999999998  9999999999764

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.76  E-value=2.4e-19  Score=171.37  Aligned_cols=149  Identities=13%  Similarity=0.068  Sum_probs=101.9

Q ss_pred             HHHHHHHhcCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccch---------------hHhHHHHHHHHHccCCCc
Q 015027           79 KSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKI---------------RITERELLRIISQVNHKN  143 (414)
Q Consensus        79 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------~~~~~~~~~~l~~l~hpn  143 (414)
                      ...+.....-|.+.++||.|+||.||+|...+|+.||||+++.....               ......+.++.....|+|
T Consensus        87 L~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~n  166 (397)
T 4gyi_A           87 LHTHAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAF  166 (397)
T ss_dssp             HHHHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHH
Confidence            34444555569999999999999999999989999999997643110               001111112222223444


Q ss_pred             eeeeeeeEe------cCCcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCC
Q 015027          144 VVKILGLCL------ETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSA  217 (414)
Q Consensus       144 iv~l~~~~~------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~  217 (414)
                      +.+++....      .....+|||||++|++|..+...         .....++.||+.+|.+||+.|   ||||||||.
T Consensus       167 L~rL~~~gv~vp~p~~~~~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~  234 (397)
T 4gyi_A          167 MKALYEEGFPVPEPIAQSRHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAKHG---LIHGDFNEF  234 (397)
T ss_dssp             HHHHHHTTCSCCCEEEEETTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTT
T ss_pred             HHHHHhcCCCCCeeeeccCceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHH
Confidence            444332211      11234799999999988765421         123467899999999999988   999999999


Q ss_pred             ceeeCCCC----------cEEEeecccccccc
Q 015027          218 NILLNDNY----------TAKVADFESSVLIS  239 (414)
Q Consensus       218 NIll~~~~----------~~kl~DfGla~~~~  239 (414)
                      |||+++++          .+.|+||+-+....
T Consensus       235 NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          235 NILIREEKDAEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             SEEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred             HEEEeCCCCcccccccccceEEEEeCCcccCC
Confidence            99998776          38999999776543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.40  E-value=1.6e-12  Score=118.88  Aligned_cols=144  Identities=16%  Similarity=0.102  Sum_probs=107.6

Q ss_pred             HHhcCCCCCCccccCCceEEEEEEEcCCcEEEEEEeeccc-chhHhHHHHHHHHHccC-CCceeeeeeeEecCCcceEEE
Q 015027           84 RATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRAD-KIRITERELLRIISQVN-HKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        84 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~-hpniv~l~~~~~~~~~~~lv~  161 (414)
                      .....|.+...++.|+.+.||++.. +++.+++|+..... ........|.++++.+. +..++++++++...+..|+||
T Consensus        11 ~~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~   89 (263)
T 3tm0_A           11 KLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM   89 (263)
T ss_dssp             HHHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred             HHhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence            3446788888899999999999875 46899999987532 11223344456666653 677889999998888999999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCC------------------------------------
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLA------------------------------------  205 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~------------------------------------  205 (414)
                      ||++|.+|.+.+..        ......++.+++.+|..||+..                                    
T Consensus        90 e~i~G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (263)
T 3tm0_A           90 SEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED  161 (263)
T ss_dssp             ECCSSEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred             EecCCeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence            99999998775311        1122357888999999999811                                    


Q ss_pred             --------------------CCCeeeCCCCCCceeeCCCCcEEEeeccccc
Q 015027          206 --------------------SPPIIHGDVKSANILLNDNYTAKVADFESSV  236 (414)
Q Consensus       206 --------------------~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~  236 (414)
                                          ...++|+|++|.||+++++..+.|+||+.+.
T Consensus       162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                1348999999999999876667799999764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.30  E-value=3.9e-12  Score=115.74  Aligned_cols=136  Identities=16%  Similarity=0.110  Sum_probs=94.3

Q ss_pred             CCCCCccccCCceEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHccCCCc--eeeeeeeEecCCcceEEEEeCCC
Q 015027           89 FDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHKN--VVKILGLCLETEVPLLVYEFASN  166 (414)
Q Consensus        89 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpn--iv~l~~~~~~~~~~~lv~e~~~~  166 (414)
                      +.+....+.|..+.||++...+|..+++|+.....  ......+..+++.+.+.+  +.++++++..++..++||||++|
T Consensus        22 ~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~--~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G   99 (264)
T 1nd4_A           22 YDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA--LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG   99 (264)
T ss_dssp             CEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred             CceEecccCCCCceEEEEecCCCCeEEEEeCCccc--chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCC
Confidence            33333334666799999987678889999976541  122334445555554333  56688888887888999999999


Q ss_pred             CchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCC-----------------------------------------
Q 015027          167 GTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLA-----------------------------------------  205 (414)
Q Consensus       167 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-----------------------------------------  205 (414)
                      .+|.  ...   .   ..   ..++.+++..|..||+..                                         
T Consensus       100 ~~l~--~~~---~---~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (264)
T 1nd4_A          100 QDLL--SSH---L---AP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA  168 (264)
T ss_dssp             EETT--TSC---C---CH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred             cccC--cCc---C---CH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHH
Confidence            8884  211   0   11   245677778888888643                                         


Q ss_pred             --------------CCCeeeCCCCCCceeeCCCCcEEEeecccccc
Q 015027          206 --------------SPPIIHGDVKSANILLNDNYTAKVADFESSVL  237 (414)
Q Consensus       206 --------------~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~  237 (414)
                                    ...++|+|++|.||++++++.+.|+|||.+..
T Consensus       169 ~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          169 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                          12299999999999998876677999998643

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.18  E-value=1e-10  Score=111.93  Aligned_cols=142  Identities=18%  Similarity=0.229  Sum_probs=101.7

Q ss_pred             CCCCccccCCceEEEEEEEcCCcEEEEEEee--cccc--hhHhHHHHHHHHHccC--CCceeeeeeeEecC---CcceEE
Q 015027           90 DRSRCLSQGGFVSVYKGVLHDNIQVAVKTYR--RADK--IRITERELLRIISQVN--HKNVVKILGLCLET---EVPLLV  160 (414)
Q Consensus        90 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~~--~~~~~~~~~~~l~~l~--hpniv~l~~~~~~~---~~~~lv  160 (414)
                      ...+.|+.|.++.||+.... +..+++|+..  ....  ......+|.++++.+.  +..+++++.++.+.   +..|+|
T Consensus        41 ~~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v  119 (359)
T 3dxp_A           41 LSVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI  119 (359)
T ss_dssp             CEEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred             ceEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence            34677899999999998874 4678888876  3321  1223344556666665  45678899888766   458999


Q ss_pred             EEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCC-----------------------------------
Q 015027          161 YEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLA-----------------------------------  205 (414)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-----------------------------------  205 (414)
                      |||++|..+.+..     ...++......++.+++..|..||+..                                   
T Consensus       120 me~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (359)
T 3dxp_A          120 MEFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI  194 (359)
T ss_dssp             EECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred             EEecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence            9999998885422     112356777888999999999999731                                   


Q ss_pred             --------------------CCCeeeCCCCCCceeeCCCCc--EEEeecccccc
Q 015027          206 --------------------SPPIIHGDVKSANILLNDNYT--AKVADFESSVL  237 (414)
Q Consensus       206 --------------------~~~iiH~Dlkp~NIll~~~~~--~kl~DfGla~~  237 (414)
                                          ...++|+|+++.|||++.++.  +.|+||+.+..
T Consensus       195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                245999999999999997653  68999998764

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.07  E-value=9.3e-11  Score=109.52  Aligned_cols=187  Identities=16%  Similarity=0.157  Sum_probs=114.5

Q ss_pred             CCccccCCceEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHccC-CCc--eeeeeeeEecCC---cceEEEEeCC
Q 015027           92 SRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVN-HKN--VVKILGLCLETE---VPLLVYEFAS  165 (414)
Q Consensus        92 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~-hpn--iv~l~~~~~~~~---~~~lv~e~~~  165 (414)
                      ++.++.|.+..||+..    ..+++|+.... ........|.++++.+. +..  +.+++.......   ..|+||++++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~   99 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK   99 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence            4568999999999863    56899986543 12223344556666652 322  445555543333   4589999999


Q ss_pred             CCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCC----------------------------------------
Q 015027          166 NGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLA----------------------------------------  205 (414)
Q Consensus       166 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~----------------------------------------  205 (414)
                      |.+|.+...     ..++......++.+++..+..||+..                                        
T Consensus       100 G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  174 (304)
T 3sg8_A          100 GVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD  174 (304)
T ss_dssp             CEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred             CeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence            988865332     12245566677777777777777511                                        


Q ss_pred             ---------------CCCeeeCCCCCCceeeCC--CCcEEEeeccccccccCCccccceec------------ccccccc
Q 015027          206 ---------------SPPIIHGDVKSANILLND--NYTAKVADFESSVLISSDAETAMSTI------------LIGTSGY  256 (414)
Q Consensus       206 ---------------~~~iiH~Dlkp~NIll~~--~~~~kl~DfGla~~~~~~~~~~~~~~------------~~gt~~y  256 (414)
                                     ...++|+|++|.||++++  ...+.|+||+.+..-...........            .....+.
T Consensus       175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~  254 (304)
T 3sg8_A          175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKH  254 (304)
T ss_dssp             HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred             HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCC
Confidence                           134899999999999998  56688999998765322111000000            0000011


Q ss_pred             cc-hhhcccCCCCCcccchhHHHHHHHHHhCCCCC
Q 015027          257 LD-PVCINTGKLTKKSDVYSFGVVLAELLTGKKPG  290 (414)
Q Consensus       257 ~a-PE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~  290 (414)
                      .. |+....  .....+.|++|.++|.+.+|..+|
T Consensus       255 ~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          255 KDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             SCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence            11 222111  112358999999999999999875

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.54  E-value=6.2e-07  Score=83.52  Aligned_cols=136  Identities=15%  Similarity=0.132  Sum_probs=84.9

Q ss_pred             CCccccCCceEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHccCCC---ceeeeeeeEe-cCCcceEEEEeCCCC
Q 015027           92 SRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHK---NVVKILGLCL-ETEVPLLVYEFASNG  167 (414)
Q Consensus        92 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hp---niv~l~~~~~-~~~~~~lv~e~~~~g  167 (414)
                      .+.++.|....||+.    +..+++|+-... ........|.+++..+.+.   .+.+++.++. ..+..++||||++|.
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~~~-~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~   98 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPKSQ-QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ   98 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEESSH-HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecCCc-hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence            345788888999987    567888885322 2223334555677776542   3566676664 455678999999998


Q ss_pred             chhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhC-------------------------------------------
Q 015027          168 TLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSL-------------------------------------------  204 (414)
Q Consensus       168 sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-------------------------------------------  204 (414)
                      +|.+....     .++......++.++...|..||+.                                           
T Consensus        99 ~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~  173 (306)
T 3tdw_A           99 ILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT  173 (306)
T ss_dssp             ECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred             ECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence            88653110     012222333333333333333321                                           


Q ss_pred             --------------CCCCeeeCCCCCCceeeCC---CCc-EEEeecccccc
Q 015027          205 --------------ASPPIIHGDVKSANILLND---NYT-AKVADFESSVL  237 (414)
Q Consensus       205 --------------~~~~iiH~Dlkp~NIll~~---~~~-~kl~DfGla~~  237 (414)
                                    ....++|+|++|.||+++.   ++. +.|+||+.+..
T Consensus       174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                          2235799999999999987   355 58999997654

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.52  E-value=9.1e-07  Score=84.11  Aligned_cols=79  Identities=10%  Similarity=0.053  Sum_probs=50.1

Q ss_pred             Ccc-ccCCceEEEEEEEc-------CCcEEEEEEeeccc---c-hhHhHHHHHHHHHccC---CCceeeeeeeEecC---
Q 015027           93 RCL-SQGGFVSVYKGVLH-------DNIQVAVKTYRRAD---K-IRITERELLRIISQVN---HKNVVKILGLCLET---  154 (414)
Q Consensus        93 ~~l-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~-~~~~~~~~~~~l~~l~---hpniv~l~~~~~~~---  154 (414)
                      +.| +.|....+|+....       ++..+++|+.....   . .......|..+++.+.   .-.+.+++.++.+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            456 78889999988764       26788999876533   1 1122233334444332   23567788877655   


Q ss_pred             CcceEEEEeCCCCchhh
Q 015027          155 EVPLLVYEFASNGTLLD  171 (414)
Q Consensus       155 ~~~~lv~e~~~~gsL~~  171 (414)
                      +..|+||||++|..+.+
T Consensus       106 g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             SSCEEEEECCCCBCCCB
T ss_pred             CCceEEEEecCCCChhh
Confidence            35689999999877653

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.40  E-value=2.5e-06  Score=77.64  Aligned_cols=134  Identities=13%  Similarity=0.103  Sum_probs=88.0

Q ss_pred             cccCCce-EEEEEEEc-CCcEEEEEEeecccchhHhHHHHHHHHHccC-CCceeeeeeeEecCCcceEEEEeCCCCchhh
Q 015027           95 LSQGGFV-SVYKGVLH-DNIQVAVKTYRRADKIRITERELLRIISQVN-HKNVVKILGLCLETEVPLLVYEFASNGTLLD  171 (414)
Q Consensus        95 lg~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~  171 (414)
                      +..|..| .||+.... ++..+++|+-....  ......|...|+.+. +--+.++++++.+++..|+|||+++|.++.+
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~--~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~  109 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGSV--ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQ  109 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETHH--HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHH
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCCC--HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccc
Confidence            3445444 68988765 46789999876542  222233445555442 3346788899998899999999999988766


Q ss_pred             hhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCC----------------------------------------------
Q 015027          172 HIRCESSQVLKTWKTCLRIAAETASALDYLHSLA----------------------------------------------  205 (414)
Q Consensus       172 ~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~----------------------------------------------  205 (414)
                      ......       .....+..+++..|.-||...                                              
T Consensus       110 ~~~~~~-------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (272)
T 4gkh_A          110 VLEEYP-------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE  182 (272)
T ss_dssp             HHHHCG-------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred             cccCCH-------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence            542211       112234455555555555411                                              


Q ss_pred             ---------CCCeeeCCCCCCceeeCCCCcEEEeecccccc
Q 015027          206 ---------SPPIIHGDVKSANILLNDNYTAKVADFESSVL  237 (414)
Q Consensus       206 ---------~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~  237 (414)
                               ...++|+|+.+.|||+++++.+-|+||+.+..
T Consensus       183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                     12379999999999999887778999997653

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.35  E-value=1.8e-06  Score=81.28  Aligned_cols=143  Identities=17%  Similarity=0.221  Sum_probs=77.5

Q ss_pred             CccccCCceEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHcc--CCCceeeee-e--eEecCCcceEEEEeCCCC
Q 015027           93 RCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQV--NHKNVVKIL-G--LCLETEVPLLVYEFASNG  167 (414)
Q Consensus        93 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l--~hpniv~l~-~--~~~~~~~~~lv~e~~~~g  167 (414)
                      +.|+.|..+.||+....+| .+++|+..........+.+.++.|...  ..|.++... |  +....+..++||+|++|.
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i~G~  116 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRPEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWIEGR  116 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSCHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECCCCB
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCCHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEeecCc
Confidence            4466677899999887544 589999876322112223334444432  234444311 1  123456789999999986


Q ss_pred             chh-----------h---hhhhcCC----c-------ccCCHHHH-------------------------------HHHH
Q 015027          168 TLL-----------D---HIRCESS----Q-------VLKTWKTC-------------------------------LRIA  191 (414)
Q Consensus       168 sL~-----------~---~l~~~~~----~-------~~~~~~~~-------------------------------~~i~  191 (414)
                      .+.           .   .++....    .       ....|...                               ..+.
T Consensus       117 ~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (346)
T 2q83_A          117 PFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEIDGFI  196 (346)
T ss_dssp             CCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHHHHH
T ss_pred             cCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHHHHH
Confidence            542           0   1111000    0       01122211                               0111


Q ss_pred             HHHHHHHHHhhh----------CCCCCeeeCCCCCCceeeCCCCcEEEeeccccc
Q 015027          192 AETASALDYLHS----------LASPPIIHGDVKSANILLNDNYTAKVADFESSV  236 (414)
Q Consensus       192 ~~i~~~l~~LH~----------~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~  236 (414)
                      ..+..++.+|+.          .....++|+|+++.|||++.++.+.|+||+.+.
T Consensus       197 ~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          197 EDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            223345666653          013559999999999999888899999999764

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.22  E-value=1e-05  Score=78.09  Aligned_cols=74  Identities=15%  Similarity=0.060  Sum_probs=44.4

Q ss_pred             CCccccCCceEEEEEEEc-CCcEEEEEEeecccc--------hhHhHHHHHHHHHccC---CCceeeeeeeEecCCcceE
Q 015027           92 SRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK--------IRITERELLRIISQVN---HKNVVKILGLCLETEVPLL  159 (414)
Q Consensus        92 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~~~~l~~l~---hpniv~l~~~~~~~~~~~l  159 (414)
                      .+.||.|.++.||++... +++.++||.......        .......+.+++..+.   ...+.+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            467899999999999854 468899998653211        1112233334444442   2344556654  3456789


Q ss_pred             EEEeCCCC
Q 015027          160 VYEFASNG  167 (414)
Q Consensus       160 v~e~~~~g  167 (414)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999874

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=98.06  E-value=2.1e-05  Score=76.58  Aligned_cols=79  Identities=14%  Similarity=0.082  Sum_probs=47.0

Q ss_pred             CCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccccceecccccccccchhhcccC---CCCCcccchhHHHHHHHH
Q 015027          207 PPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTG---KLTKKSDVYSFGVVLAEL  283 (414)
Q Consensus       207 ~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~SlGvil~el  283 (414)
                      ..++|+|++|.|||++.++ ++++||+.+..-.........- ..-...|.+|+.....   ......++.+....+|+.
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYL-GNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL  309 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHH-HHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHH-HHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence            4599999999999999876 9999999876532111100000 0001245666544311   112234556778888887


Q ss_pred             HhCC
Q 015027          284 LTGK  287 (414)
Q Consensus       284 ~tg~  287 (414)
                      +++.
T Consensus       310 y~~~  313 (420)
T 2pyw_A          310 FNKR  313 (420)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            7653

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.01  E-value=4.5e-05  Score=70.93  Aligned_cols=138  Identities=19%  Similarity=0.194  Sum_probs=85.7

Q ss_pred             CCccccCCceEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHcc---CCCceeeeeeeEecCCcceEEEEeCCCCc
Q 015027           92 SRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQV---NHKNVVKILGLCLETEVPLLVYEFASNGT  168 (414)
Q Consensus        92 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l---~hpniv~l~~~~~~~~~~~lv~e~~~~gs  168 (414)
                      .+.|+.|.+..+|+... ++..+++|+.....  ......|...|+.+   ....++++++++...+..++||||+++..
T Consensus        41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~~--~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~  117 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND-EVQTVFVKINERSY--RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSK  117 (312)
T ss_dssp             EEEECCSSSSEEEEEES-SSCEEEEEEEEGGG--HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred             eEEeCCccceeeeEEEE-CCCeEEEEeCCccc--HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCC
Confidence            46689999999999876 56788999876542  22223333444443   34678888888887888999999999976


Q ss_pred             hhh-----------hhhhcCC-------------------cccCCHHHHH---HHH----------------HHHHHHH-
Q 015027          169 LLD-----------HIRCESS-------------------QVLKTWKTCL---RIA----------------AETASAL-  198 (414)
Q Consensus       169 L~~-----------~l~~~~~-------------------~~~~~~~~~~---~i~----------------~~i~~~l-  198 (414)
                      +..           .|+....                   ....+|....   ++.                ..++..+ 
T Consensus       118 ~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~  197 (312)
T 3jr1_A          118 NKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVA  197 (312)
T ss_dssp             CCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHH
T ss_pred             CCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHH
Confidence            521           1111111                   0012454321   111                1122122 


Q ss_pred             HHhhh-CCCCCeeeCCCCCCceeeCCCCcEEEeecc
Q 015027          199 DYLHS-LASPPIIHGDVKSANILLNDNYTAKVADFE  233 (414)
Q Consensus       199 ~~LH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG  233 (414)
                      ..|.. ...+.++|+|+.+.|++++.++ +.|.||.
T Consensus       198 ~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          198 DTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            23421 1236799999999999999887 8888874

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.81  E-value=0.00014  Score=67.64  Aligned_cols=158  Identities=15%  Similarity=0.160  Sum_probs=82.9

Q ss_pred             ccHHHHHHHhcCCCC-----CCccccCCceEEEEEEEcCCcEEEEEEeeccc--chhHhHHHHHHHHHccCCCceeeeee
Q 015027           77 FSKSEMIRATKNFDR-----SRCLSQGGFVSVYKGVLHDNIQVAVKTYRRAD--KIRITERELLRIISQVNHKNVVKILG  149 (414)
Q Consensus        77 ~~~~~~~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~l~~l~hpniv~l~~  149 (414)
                      ++.+++......|.+     .+.|+.|....+|+....+| .+++|+.....  .....+.+.++.+....- .+.+++.
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~-~vP~~~~   84 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGL-SCPLPLP   84 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC---CCHHHHHHHHHHHHHHTTC-CCCCBCC
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCCCHHHHHHHHHHHHHHHHCCC-CCCcccC
Confidence            455666666666765     23466788889999887555 68899887621  111222333344443211 1233332


Q ss_pred             e------EecCCcceEEEEeCCCCchhh--------------hhhhcC----Cc-----ccCCHHHHHH-----------
Q 015027          150 L------CLETEVPLLVYEFASNGTLLD--------------HIRCES----SQ-----VLKTWKTCLR-----------  189 (414)
Q Consensus       150 ~------~~~~~~~~lv~e~~~~gsL~~--------------~l~~~~----~~-----~~~~~~~~~~-----------  189 (414)
                      .      ....+..+++|+|++|..+..              .++...    ..     ....|.....           
T Consensus        85 ~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~  164 (322)
T 2ppq_A           85 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK  164 (322)
T ss_dssp             BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred             CCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhh
Confidence            1      122356789999999865421              011100    00     0001221100           


Q ss_pred             -HHHHHHHHHHHhhhC----CCCCeeeCCCCCCceeeCCCCcEEEeeccccc
Q 015027          190 -IAAETASALDYLHSL----ASPPIIHGDVKSANILLNDNYTAKVADFESSV  236 (414)
Q Consensus       190 -i~~~i~~~l~~LH~~----~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~  236 (414)
                       +...+...+..+...    ....++|+|+++.|||++.++.+.|+||+.+.
T Consensus       165 ~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          165 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence             001133445555431    12459999999999999987666899998764

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.80  E-value=0.00017  Score=67.61  Aligned_cols=31  Identities=26%  Similarity=0.375  Sum_probs=26.9

Q ss_pred             CCeeeCCCCCCceeeCCC----CcEEEeecccccc
Q 015027          207 PPIIHGDVKSANILLNDN----YTAKVADFESSVL  237 (414)
Q Consensus       207 ~~iiH~Dlkp~NIll~~~----~~~kl~DfGla~~  237 (414)
                      ..++|+|+.+.|||++.+    +.+.|+||+.+..
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            459999999999999874    6899999998764

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.74  E-value=0.00021  Score=65.49  Aligned_cols=78  Identities=13%  Similarity=0.006  Sum_probs=51.2

Q ss_pred             CCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccchh-HhHHHHHHHHHccC---CCceeeeeeeEecCCcceEEEEe
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIR-ITERELLRIISQVN---HKNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~l~~l~---hpniv~l~~~~~~~~~~~lv~e~  163 (414)
                      ...-++.+|.|..+.||+.+..+|+.|++|+........ ..+..|.+.|+.+.   ---+++++++.    ..++||||
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~   91 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW   91 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence            344467789999999999999999999999876543221 22333444454442   22345555542    34799999


Q ss_pred             CCCCch
Q 015027          164 ASNGTL  169 (414)
Q Consensus       164 ~~~gsL  169 (414)
                      ++++..
T Consensus        92 l~~~~~   97 (288)
T 3f7w_A           92 VDERPP   97 (288)
T ss_dssp             CCCCCC
T ss_pred             ecccCC
Confidence            987753

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.74  E-value=0.00016  Score=66.83  Aligned_cols=69  Identities=12%  Similarity=0.101  Sum_probs=41.9

Q ss_pred             CCccccCCceEEEEEEEcCCcEEEEEEeecccch---hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeC-CCC
Q 015027           92 SRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKI---RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFA-SNG  167 (414)
Q Consensus        92 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~-~~g  167 (414)
                      ++.|+.|....+|+.     ..+++|+.......   ...+.+.++.+....-+  .++++++  .+.-++|+||+ +|.
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~--P~~~~~~--~~~~~~v~e~i~~g~   93 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVS--PEVLHVD--PATGVMVTRYIAGAQ   93 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSS--CCEEEEC--TTTCCEEEECCTTCE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCC--CceEEEE--CCCCEEEEeecCCCc
Confidence            677889999999998     56888987653221   12333334445443322  4566543  33457899999 665


Q ss_pred             ch
Q 015027          168 TL  169 (414)
Q Consensus       168 sL  169 (414)
                      +|
T Consensus        94 ~l   95 (301)
T 3dxq_A           94 TM   95 (301)
T ss_dssp             EC
T ss_pred             cC
Confidence            55

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.65  E-value=0.00045  Score=64.44  Aligned_cols=92  Identities=14%  Similarity=0.022  Sum_probs=51.0

Q ss_pred             ccHHHHHHHhcCCCC-----CCccccCCceEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHccCC--Cceeeeee
Q 015027           77 FSKSEMIRATKNFDR-----SRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNH--KNVVKILG  149 (414)
Q Consensus        77 ~~~~~~~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h--pniv~l~~  149 (414)
                      ++.+.+......|.+     ...++ |....||+....+|+.+++|..............+..++..+..  -.+++++.
T Consensus        11 l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~   89 (328)
T 1zyl_A           11 LHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVA   89 (328)
T ss_dssp             CCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCC
T ss_pred             CCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceee
Confidence            444444444444432     23466 78889998877677789999987432222222233344433321  12344443


Q ss_pred             e-----EecCCcceEEEEeCCCCch
Q 015027          150 L-----CLETEVPLLVYEFASNGTL  169 (414)
Q Consensus       150 ~-----~~~~~~~~lv~e~~~~gsL  169 (414)
                      .     ...++..++||+|++|..+
T Consensus        90 ~~g~~~~~~~g~~~~l~~~i~G~~~  114 (328)
T 1zyl_A           90 FNGQTLLNHQGFYFAVFPSVGGRQF  114 (328)
T ss_dssp             BTTBSCEEETTEEEEEEECCCCEEC
T ss_pred             cCCcEEEEECCEEEEEEEecCCCCC
Confidence            3     1224456789999988654

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.56  E-value=0.00025  Score=69.54  Aligned_cols=74  Identities=16%  Similarity=0.088  Sum_probs=44.4

Q ss_pred             CCccccCCceEEEEEEEcC-CcEEEEEEeecccchhHhHHHHHHHHHccCCCce-eeeeeeEecCCcceEEEEeCCCCch
Q 015027           92 SRCLSQGGFVSVYKGVLHD-NIQVAVKTYRRADKIRITERELLRIISQVNHKNV-VKILGLCLETEVPLLVYEFASNGTL  169 (414)
Q Consensus        92 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpni-v~l~~~~~~~~~~~lv~e~~~~gsL  169 (414)
                      ++.|+.|-...+|+....+ +..+++|+.............|..++..+...++ +++++++..    .+||||++|.+|
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~l  188 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYAL  188 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEEC
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCccC
Confidence            4567788889999998755 5788999875432211111233455555543334 567777632    359999998655

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.54  E-value=0.00086  Score=63.06  Aligned_cols=71  Identities=8%  Similarity=0.077  Sum_probs=44.7

Q ss_pred             ccCCceEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeee------EecCCcceEEEEeCCCCch
Q 015027           96 SQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGL------CLETEVPLLVYEFASNGTL  169 (414)
Q Consensus        96 g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~------~~~~~~~~lv~e~~~~gsL  169 (414)
                      |.|....||+....+| .+++|+......  ..+.+.++.|..-.-|++++.+..      ....+..++||+|++|..+
T Consensus        32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~--~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G~~~  108 (339)
T 3i1a_A           32 GADTNAFAYQADSESK-SYFIKLKYGYHD--EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAPNG  108 (339)
T ss_dssp             TSCSSCEEEEEECSSC-EEEEEEEECSSC--CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCCCBT
T ss_pred             cCccccceEEEEeCCC-CEEEEEecCccc--hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCCCcC
Confidence            3344689999987667 899998766542  233344455544333334554432      2335677999999998765

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.47  E-value=0.00041  Score=66.24  Aligned_cols=142  Identities=15%  Similarity=0.116  Sum_probs=76.0

Q ss_pred             CCccccCCceEEEEEEEc--------CCcEEEEEEeecccchhHhHHHHHHHHHccC-CCceeeeeeeEecCCcceEEEE
Q 015027           92 SRCLSQGGFVSVYKGVLH--------DNIQVAVKTYRRADKIRITERELLRIISQVN-HKNVVKILGLCLETEVPLLVYE  162 (414)
Q Consensus        92 ~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e  162 (414)
                      .+.|..|-...+|+....        ++..+++|+............+|.++++.+. +.-..++++++.++    +|||
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e  130 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLEQ  130 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEE
Confidence            356777888899998864        2478999986442211222233334444442 22236677776542    8999


Q ss_pred             eCCCCchhhh--------------h---hhcCC--cccCC--HHHHHHHHHHHHH-------------------HHHH--
Q 015027          163 FASNGTLLDH--------------I---RCESS--QVLKT--WKTCLRIAAETAS-------------------ALDY--  200 (414)
Q Consensus       163 ~~~~gsL~~~--------------l---~~~~~--~~~~~--~~~~~~i~~~i~~-------------------~l~~--  200 (414)
                      |++|.+|..-              |   +....  .....  +.++.++..++..                   .+..  
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            9998765321              0   01100  01111  3444444433321                   1222  


Q ss_pred             --hhhC-CCCCeeeCCCCCCceeeCCC----CcEEEeecccccc
Q 015027          201 --LHSL-ASPPIIHGDVKSANILLNDN----YTAKVADFESSVL  237 (414)
Q Consensus       201 --LH~~-~~~~iiH~Dlkp~NIll~~~----~~~kl~DfGla~~  237 (414)
                        |... ....++|+|+.+.||+++.+    +.+.++||..+..
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence              2221 12458999999999999876    7899999987643

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.35  E-value=0.00075  Score=58.42  Aligned_cols=102  Identities=11%  Similarity=0.021  Sum_probs=66.3

Q ss_pred             chhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccccce
Q 015027          168 TLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMS  247 (414)
Q Consensus       168 sL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  247 (414)
                      ||.+.|...+.  ++++++++.++.|.+.+|.-+-... . -..+=+.|..|++..+|.|.+.+ +.+.           
T Consensus        34 SL~eIL~~~~~--PlsEEqaWALc~Qc~~~L~~~~~~~-~-~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------   97 (229)
T 2yle_A           34 SLEEILRLYNQ--PINEEQAWAVCYQCCGSLRAAARRR-Q-PRHRVRSAAQIRVWRDGAVTLAP-AADD-----------   97 (229)
T ss_dssp             EHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT-C-CCCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred             cHHHHHHHcCC--CcCHHHHHHHHHHHHHHHHhhhhcc-c-CCceecCCcceEEecCCceeccc-cccc-----------
Confidence            78999876654  4589999999999999987762211 1 12333457899999999988763 2110           


Q ss_pred             ecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCC
Q 015027          248 TILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP  289 (414)
Q Consensus       248 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p  289 (414)
                         .....+.+||... ...+.+.=|||||+++|.-+--..|
T Consensus        98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence               0122456787653 3556788899999999998875544

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.33  E-value=0.00056  Score=65.03  Aligned_cols=72  Identities=15%  Similarity=0.172  Sum_probs=40.3

Q ss_pred             CCccccCCceEEEEEEEcC---------CcEEEEEEeecccchh---HhHHHHHHHHHccCCCceeeeeeeEecCCcceE
Q 015027           92 SRCLSQGGFVSVYKGVLHD---------NIQVAVKTYRRADKIR---ITERELLRIISQVNHKNVVKILGLCLETEVPLL  159 (414)
Q Consensus        92 ~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~---~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~l  159 (414)
                      .+.++.|....+|+....+         +..+++|+........   ..+.+.++.+....  -..++++.+  .  -++
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g--~~P~~~~~~--~--~~~  111 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYK--IAPQLLNTF--N--GGR  111 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTT--SSCCEEEEE--T--TEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcC--CCCceEEec--C--CcE
Confidence            3457788888999988654         2688999876532221   22333344444322  144666554  2  378


Q ss_pred             EEEeCCCCch
Q 015027          160 VYEFASNGTL  169 (414)
Q Consensus       160 v~e~~~~gsL  169 (414)
                      ||||++|.++
T Consensus       112 v~e~i~G~~l  121 (369)
T 3c5i_A          112 IEEWLYGDPL  121 (369)
T ss_dssp             EEECCCSEEC
T ss_pred             EEEEecCCcC
Confidence            9999998654

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.25  E-value=0.00085  Score=65.25  Aligned_cols=73  Identities=12%  Similarity=0.112  Sum_probs=44.8

Q ss_pred             CCccccCCceEEEEEEEcC--------CcEEEEEEeecccchhHhHHHHHHHHHccCCCc-eeeeeeeEecCCcceEEEE
Q 015027           92 SRCLSQGGFVSVYKGVLHD--------NIQVAVKTYRRADKIRITERELLRIISQVNHKN-VVKILGLCLETEVPLLVYE  162 (414)
Q Consensus        92 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpn-iv~l~~~~~~~~~~~lv~e  162 (414)
                      .+.|+.|....+|++...+        +..+++|+...... ......|..++..+...+ .+++++.+.+    .+|+|
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e  152 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET-ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  152 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC-HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc-HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence            4567888899999998653        47899998844211 012223334444443222 3567776543    38999


Q ss_pred             eCCCCch
Q 015027          163 FASNGTL  169 (414)
Q Consensus       163 ~~~~gsL  169 (414)
                      |++|.+|
T Consensus       153 ~l~G~~l  159 (429)
T 1nw1_A          153 YIPSRPL  159 (429)
T ss_dssp             CCCEEEC
T ss_pred             EeCCccc
Confidence            9987554

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.99  E-value=0.026  Score=54.55  Aligned_cols=72  Identities=13%  Similarity=0.133  Sum_probs=44.1

Q ss_pred             CCccccCCceEEEEEEEcC--------CcEEEEEEeecccchh---HhHHHHHHHHHccCCCceeeeeeeEecCCcceEE
Q 015027           92 SRCLSQGGFVSVYKGVLHD--------NIQVAVKTYRRADKIR---ITERELLRIISQVNHKNVVKILGLCLETEVPLLV  160 (414)
Q Consensus        92 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~---~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv  160 (414)
                      ++.+..|-...+|+....+        +..+++|+........   ..+.+.++.+...  .-..++++.+.    -++|
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~--gi~P~l~~~~~----~~~I  148 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNI--NIAPNIIADFP----EGRI  148 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHT--TSSCCEEEEET----TEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhc--CCCCCEEEEcC----CCEE
Confidence            4567778889999998753        5789999875432211   2233333444432  22455665432    3789


Q ss_pred             EEeCCCCch
Q 015027          161 YEFASNGTL  169 (414)
Q Consensus       161 ~e~~~~gsL  169 (414)
                      |||++|..|
T Consensus       149 ~efI~G~~l  157 (424)
T 3mes_A          149 EEFIDGEPL  157 (424)
T ss_dssp             EECCCSEEC
T ss_pred             EEEeCCccC
Confidence            999998764

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=93.97  E-value=0.044  Score=52.52  Aligned_cols=29  Identities=34%  Similarity=0.516  Sum_probs=24.6

Q ss_pred             eeeCCCCCCceee------CCCCcEEEeecccccc
Q 015027          209 IIHGDVKSANILL------NDNYTAKVADFESSVL  237 (414)
Q Consensus       209 iiH~Dlkp~NIll------~~~~~~kl~DfGla~~  237 (414)
                      ++|+|+.+.|||+      +++..+.++||..|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            6799999999999      4567899999987653

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=92.24  E-value=0.39  Score=41.35  Aligned_cols=117  Identities=10%  Similarity=0.062  Sum_probs=77.1

Q ss_pred             cCCCceeeeeeeEecCCcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCc
Q 015027          139 VNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSAN  218 (414)
Q Consensus       139 l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~N  218 (414)
                      ..||+.+.. .+-.+++.+.+.++.-+.+.=...+      ...+....++++..|+....+++.     -+|--|+|+|
T Consensus        42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i------k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~N  109 (215)
T 4ann_A           42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI------KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDE  109 (215)
T ss_dssp             SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG------GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGG
T ss_pred             ccCCcccce-EEEEcccEEEEEEEcCcccCCHHHH------HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecce
Confidence            368988876 4555666655555544322111222      223667888999999988866654     4788999999


Q ss_pred             eeeCCCCcEEEeeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCC
Q 015027          219 ILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGS  291 (414)
Q Consensus       219 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~  291 (414)
                      |+++.++.+++.-.|+...+                   +|.     ..+...=.-.+=|++..+++++..|.
T Consensus       110 L~f~~~~~p~i~~RGik~~l-------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          110 LFFTRDGLPIAKTRGLQNVV-------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             EEECTTSCEEESCCEETTTB-------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             EEEcCCCCEEEEEccCccCC-------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            99999999999987764322                   111     11111223367788899999998875

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=88.47  E-value=1.3  Score=38.25  Aligned_cols=116  Identities=12%  Similarity=0.002  Sum_probs=74.5

Q ss_pred             cCCCceeeeeeeEecCCcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHH-HhhhCCCCCeeeCCCCCC
Q 015027          139 VNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALD-YLHSLASPPIIHGDVKSA  217 (414)
Q Consensus       139 l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~-~LH~~~~~~iiH~Dlkp~  217 (414)
                      ..||++  -..+-.+++.+.+.++.-+++.=...+      ...+....++++..|+.... +++.     -+|--|+|+
T Consensus        47 ~~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~  113 (219)
T 4ano_A           47 EVDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPE  113 (219)
T ss_dssp             GSCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGG
T ss_pred             ccCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCc
Confidence            358888  333335666666666655444222233      12266778888888888666 5554     578899999


Q ss_pred             ceeeCCCCcEEEeeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCC
Q 015027          218 NILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGS  291 (414)
Q Consensus       218 NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~  291 (414)
                      ||+++.++.+++.-.|+-..                   ++|.-     .+..-=.-.+=|++..++.++..|+
T Consensus       114 NL~f~~~~~p~i~hRGi~~~-------------------lpP~e-----~~ee~fl~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          114 NLMFNRALEPFFLHVGVKES-------------------LPPDE-----WDDERLLREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             GEEECTTCCEEESCCEETTT-------------------BSSCS-----CCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred             eEEEeCCCcEEEEEcCCccc-------------------CCCCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            99999999999998876332                   22211     1111112367788888888887764

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	414
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-61
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	4e-57
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	9e-57
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-54
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	4e-54
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-53
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-52
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-52
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	4e-52
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	6e-52
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	7e-52
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-50
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	7e-50
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-49
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-49
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	4e-49
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-48
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-48
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-48
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-48
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-48
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	7e-48
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	9e-48
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-47
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	5e-47
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	8e-47
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	9e-47
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-45
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	4e-45
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	4e-45
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-44
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	6e-43
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-42
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	5e-41
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	7e-41
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-40
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	5e-40
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-39
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-39
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	7e-39
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-38
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	8e-38
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-36
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-36
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-36
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-35
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-35
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	5e-35
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	6e-34
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	8e-34
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-33
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-33
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	3e-33
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	5e-33
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-32
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-31
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-30
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-28
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	6e-27
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	6e-26
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-25
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	9e-25
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-14

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (504), Expect = 2e-61
 Identities = 68/285 (23%), Positives = 125/285 (43%), Gaps = 27/285 (9%)

Query: 88  NFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLR---IISQVNHKNV 144
                + +  G F +VYKG  H    VAVK            +       ++ +  H N+
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 66

Query: 145 VKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSL 204
           +  +G     ++  +V ++    +L  H+    ++        + IA +TA  +DYLH+ 
Sbjct: 67  LLFMGYSTAPQL-AIVTQWCEGSSLYHHLHIIETKF--EMIKLIDIARQTAQGMDYLHA- 122

Query: 205 ASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCI-- 262
               IIH D+KS NI L+++ T K+ DF  + + S  + +     L G+  ++ P  I  
Sbjct: 123 --KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180

Query: 263 -NTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILN 321
            +    + +SDVY+FG+VL EL+TG+ P S +              +  +    L   L+
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--------IIFMVGRGYLSPDLS 232

Query: 322 FHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR 366
              ++  +      +  L ++CL+ +  ERP   Q+   ++ L R
Sbjct: 233 KVRSNCPKA-----MKRLMAECLKKKRDERPLFPQILASIELLAR 272

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 4e-57
 Identities = 67/284 (23%), Positives = 131/284 (46%), Gaps = 30/284 (10%)

Query: 87  KNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVK 146
           K     + + +G F  V  G  +   +VAVK  +     +    E   +++Q+ H N+V+
Sbjct: 7   KELKLLQTIGKGEFGDVMLGD-YRGNKVAVKCIKNDATAQAFLAEA-SVMTQLRHSNLVQ 64

Query: 147 ILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLA 205
           +LG+ +E +  L +V E+ + G+L+D++R     VL      L+ + +   A++YL    
Sbjct: 65  LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL-GGDCLLKFSLDVCEAMEYLE--- 120

Query: 206 SPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTG 265
               +H D+ + N+L++++  AKV+DF  +   SS  +T           +  P  +   
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK-----LPVKWTAPEALREK 175

Query: 266 KLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVA 325
           K + KSDV+SFG++L E+ +  +                PY    +K+  + ++   +  
Sbjct: 176 KFSTKSDVWSFGILLWEIYSFGRV---------------PYPRIPLKDV-VPRVEKGYKM 219

Query: 326 DESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLHE 369
           D  +      V E+   C  +    RP+  Q+ E+L+ ++  HE
Sbjct: 220 DAPD-GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT-HE 261

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (471), Expect = 9e-57
 Identities = 65/276 (23%), Positives = 121/276 (43%), Gaps = 23/276 (8%)

Query: 87  KNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVK 146
           +       L  G F  V+ G  + + +VAVK+ ++             ++ Q+ H+ +V+
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 72

Query: 147 ILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLAS 206
           +  +  +  +  ++ E+  NG+L+D ++  S   L T    L +AA+ A  + ++     
Sbjct: 73  LYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIE---E 127

Query: 207 PPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGK 266
              IH D+++ANIL++D  + K+ADF  + LI  + E            +  P  IN G 
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN-EYTAREGAKFPIKWTAPEAINYGT 186

Query: 267 LTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVAD 326
            T KSDV+SFG++L E++T  +              M    +      G R +   +  +
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPG---------MTNPEVIQNLERGYRMVRPDNCPE 237

Query: 327 ESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELD 362
           E        + +L   C + R  +RPT   +   L+
Sbjct: 238 E--------LYQLMRLCWKERPEDRPTFDYLRSVLE 265

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (454), Expect = 3e-54
 Identities = 59/279 (21%), Positives = 119/279 (42%), Gaps = 23/279 (8%)

Query: 87  KNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVK 146
                 + +  G F  V+ G   +  +VA+KT R          E   ++ +++H  +V+
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQ 64

Query: 147 ILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLAS 206
           + G+CLE     LV+EF  +G L D+    + + L   +T L +  +    + YL     
Sbjct: 65  LYGVCLEQAPICLVFEFMEHGCLSDY--LRTQRGLFAAETLLGMCLDVCEGMAYLE---E 119

Query: 207 PPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGK 266
             +IH D+ + N L+ +N   KV+DF  +  +  D  T+ +        +  P   +  +
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT-KFPVKWASPEVFSFSR 178

Query: 267 LTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVAD 326
            + KSDV+SFGV++ E+ +  K       ++++ +  +        + G R       + 
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKI-PYENRSNSEVVEDI--------STGFRLYKPRLAST 229

Query: 327 ESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLR 365
                    V ++ + C + R  +RP   ++  +L  + 
Sbjct: 230 H--------VYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (454), Expect = 4e-54
 Identities = 66/278 (23%), Positives = 121/278 (43%), Gaps = 23/278 (8%)

Query: 87  KNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVK 146
           ++      L QG F  V+ G  +   +VA+KT +          +  +++ ++ H+ +V+
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 76

Query: 147 ILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLAS 206
           +  +  E  +  +V E+ S G+LLD ++ E+ +        + +AA+ AS + Y+     
Sbjct: 77  LYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVE---R 131

Query: 207 PPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGK 266
              +H D+++ANIL+ +N   KVADF  + LI  +  TA          +  P     G+
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA-KFPIKWTAPEAALYGR 190

Query: 267 LTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVAD 326
            T KSDV+SFG++L EL T  +                      + N  +   +      
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRV-----------------PYPGMVNREVLDQVERGYRM 233

Query: 327 ESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL 364
               +  E + +L  +C R    ERPT + +   L+  
Sbjct: 234 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 1e-53
 Identities = 65/295 (22%), Positives = 127/295 (43%), Gaps = 27/295 (9%)

Query: 93  RCLSQGGFVSVYKGVLHDNIQVAVKTYR-RADKIRITERELLRIISQVNHKNVVKILGLC 151
             + +G F  V++G      +VAVK +  R ++    E E+      + H+N++  +   
Sbjct: 9   ESIGKGRFGEVWRGK-WRGEEVAVKIFSSREERSWFREAEIY-QTVMLRHENILGFIAAD 66

Query: 152 LETE----VPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHS---- 203
            +         LV ++  +G+L D++   +     T +  +++A  TAS L +LH     
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIVG 122

Query: 204 -LASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET--AMSTILIGTSGYLDPV 260
               P I H D+KS NIL+  N T  +AD   +V   S  +T        +GT  Y+ P 
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182

Query: 261 CINT------GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVP--YFLNSIK 312
            ++        +  K++D+Y+ G+V  E+      G            +VP    +  ++
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242

Query: 313 NNGLRQILNFHVADESEMKE-IEIVAELASKCLRIRGTERPTMKQVSEELDRLRR 366
                Q L  ++ +  +  E + ++A++  +C    G  R T  ++ + L +L +
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  175 bits (444), Expect = 2e-52
 Identities = 70/282 (24%), Positives = 129/282 (45%), Gaps = 25/282 (8%)

Query: 87  KNFDRSRCLSQGGFVSVYKGVLHD-NIQVAVKTYRR-ADKIRITERELLRIISQVNHKNV 144
            +      L  G +  VY+GV    ++ VAVKT +    ++    +E   ++ ++ H N+
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEA-AVMKEIKHPNL 75

Query: 145 VKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSL 204
           V++LG+C       ++ EF + G LLD++R  + Q + +    L +A + +SA++YL   
Sbjct: 76  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-SAVVLLYMATQISSAMEYLEK- 133

Query: 205 ASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINT 264
                IH D+ + N L+ +N+  KVADF  S L++ D  TA +        +  P  +  
Sbjct: 134 --KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA-KFPIKWTAPESLAY 190

Query: 265 GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHV 324
            K + KSDV++FGV+L E+ T                         I  + + ++L    
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKDY 233

Query: 325 ADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR 366
             E      E V EL   C +   ++RP+  ++ +  + + +
Sbjct: 234 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 2e-52
 Identities = 63/276 (22%), Positives = 115/276 (41%), Gaps = 25/276 (9%)

Query: 87  KNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVK 146
           K+    + L  G F  V  G       VA+K  +          E  +++  ++H+ +V+
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQ 63

Query: 147 ILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLAS 206
           + G+C +     ++ E+ +NG LL+++R    +     +  L +  +   A++YL    S
Sbjct: 64  LYGVCTKQRPIFIITEYMANGCLLNYLREMRHRF--QTQQLLEMCKDVCEAMEYLE---S 118

Query: 207 PPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGK 266
              +H D+ + N L+ND    KV+DF  S  +  D E   S        +  P  +   K
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-EYTSSVGSKFPVRWSPPEVLMYSK 177

Query: 267 LTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVA 325
            + KSD+++FGV++ E+ + GK P    T +              I   GLR       +
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---------TAEHIA-QGLRLYRPHLAS 227

Query: 326 DESEMKEIEIVAELASKCLRIRGTERPTMKQVSEEL 361
           ++        V  +   C   +  ERPT K +   +
Sbjct: 228 EK--------VYTIMYSCWHEKADERPTFKILLSNI 255

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (444), Expect = 4e-52
 Identities = 56/298 (18%), Positives = 107/298 (35%), Gaps = 37/298 (12%)

Query: 88  NFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRITEREL--LRIISQVNHKNV 144
           +F++   L  G    V+K       + +A K      K  I  + +  L+++ + N   +
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66

Query: 145 VKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSL 204
           V   G         +  E    G+L   ++          +   +++      L YL   
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLRE- 122

Query: 205 ASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINT 264
               I+H DVK +NIL+N     K+ DF  S  +       M+   +GT  Y+ P  +  
Sbjct: 123 -KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQG 177

Query: 265 GKLTKKSDVYSFGVVLAELLTGKKP---------------------GSCMTLASNKKISM 303
              + +SD++S G+ L E+  G+ P                                  +
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237

Query: 304 VPYFLNSIKNNGLRQILNFHVADESEMKEIEIV----AELASKCLRIRGTERPTMKQV 357
             Y ++S     + ++L++ V +        +      +  +KCL     ER  +KQ+
Sbjct: 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  174 bits (441), Expect = 6e-52
 Identities = 70/309 (22%), Positives = 121/309 (39%), Gaps = 42/309 (13%)

Query: 77  FSKSEMIRATKNFDRS---------RCLSQGGFVSVYKGVLHDN----IQVAVKTYRRA- 122
           F+  +   A + F +          + +  G F  V  G L       I VA+KT +   
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 123 --DKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQV 180
              + R    E   I+ Q +H NV+ + G+  ++   +++ EF  NG+L   +R    Q 
Sbjct: 67  TEKQRRDFLSEA-SIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQ- 124

Query: 181 LKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISS 240
             T    + +    A+ + YL        +H D+ + NIL+N N   KV+DF  S  +  
Sbjct: 125 -FTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180

Query: 241 DAETAMSTILIG---TSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLAS 297
           D      T  +G      +  P  I   K T  SDV+S+G+V+ E+++  +         
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER-------- 232

Query: 298 NKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQV 357
                  PY+   + N  +   +         M     + +L   C +     RP   Q+
Sbjct: 233 -------PYW--DMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQI 283

Query: 358 SEELDRLRR 366
              LD++ R
Sbjct: 284 VNTLDKMIR 292

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (442), Expect = 7e-52
 Identities = 71/341 (20%), Positives = 139/341 (40%), Gaps = 37/341 (10%)

Query: 74  MKIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGVLHDN-----IQVAVKTYRRADKIRIT 128
           ++I  ++E       F + + L  G F +VYKG+         I VA+K  R A   +  
Sbjct: 3   LRILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN 55

Query: 129 EREL--LRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKT 186
           +  L    +++ V++ +V ++LG+CL + V  L+ +    G LLD+      +     + 
Sbjct: 56  KEILDEAYVMASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDY--VREHKDNIGSQY 112

Query: 187 CLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAM 246
            L    + A  ++YL       ++H D+ + N+L+      K+ DF  + L+ ++ +   
Sbjct: 113 LLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 169

Query: 247 STILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPY 306
           +        ++    I     T +SDV+S+GV + EL+T                   PY
Sbjct: 170 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK---------------PY 214

Query: 307 FLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR 366
             + I  + +  IL               V  +  KC  I    RP  +++  E  ++ R
Sbjct: 215 --DGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272

Query: 367 LHENFWAQKKNKETEHLLGESSSYATAVIAQPDAQTVVSID 407
             + +   + ++         S++  A++ + D   VV  D
Sbjct: 273 DPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDAD 313

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (427), Expect = 3e-50
 Identities = 52/279 (18%), Positives = 112/279 (40%), Gaps = 29/279 (10%)

Query: 88  NFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRITERELLR---IISQVNHKN 143
           +++    +  G +    K     D   +  K           ++ L+    ++ ++ H N
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64

Query: 144 VVKILGLCLETE--VPLLVYEFASNGTLLDHI-RCESSQVLKTWKTCLRIAAETASALDY 200
           +V+     ++       +V E+   G L   I +    +     +  LR+  +   AL  
Sbjct: 65  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124

Query: 201 LHSL--ASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLD 258
            H        ++H D+K AN+ L+     K+ DF  + +++ D  T+ +   +GT  Y+ 
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD--TSFAKAFVGTPYYMS 182

Query: 259 PVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQ 318
           P  +N     +KSD++S G +L EL     P +  +                I+    R+
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---------LAGKIREGKFRR 233

Query: 319 ILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQV 357
           I  +  +DE        + E+ ++ L ++   RP+++++
Sbjct: 234 I-PYRYSDE--------LNEIITRMLNLKDYHRPSVEEI 263

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (427), Expect = 7e-50
 Identities = 63/301 (20%), Positives = 115/301 (38%), Gaps = 43/301 (14%)

Query: 88  NFDRSRCLSQGGFVSVYKGVLH------DNIQVAVKTYRRADKIRITEREL--LRIISQV 139
                + L  G F  V +   +        + VAVK  + +  +   E  +  L+++S +
Sbjct: 24  RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83

Query: 140 -NHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIR---------------CESSQVLKT 183
            NH N+V +LG C      L++ E+   G LL+ +R                E  ++   
Sbjct: 84  GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143

Query: 184 WKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE 243
            +  L  + + A  + +L S      IH D+ + NILL      K+ DF  +  I +D+ 
Sbjct: 144 LEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200

Query: 244 TAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISM 303
             +         ++ P  I     T +SDV+S+G+ L EL +            +K    
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK---- 256

Query: 304 VPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDR 363
                  +   G R +   H   E        + ++   C      +RPT KQ+ + +++
Sbjct: 257 ----FYKMIKEGFRMLSPEHAPAE--------MYDIMKTCWDADPLKRPTFKQIVQLIEK 304

Query: 364 L 364
            
Sbjct: 305 Q 305

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (423), Expect = 1e-49
 Identities = 66/292 (22%), Positives = 127/292 (43%), Gaps = 30/292 (10%)

Query: 88  NFDRSRCLSQGGFVSVYKGVLHDN-----IQVAVKTYRRA--DKIRITERELLRIISQVN 140
              R + +  G F  VYKG+L  +     + VA+KT +    +K R+       I+ Q +
Sbjct: 8   CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67

Query: 141 HKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDY 200
           H N++++ G+  + +  +++ E+  NG L   +R +  +   +    + +    A+ + Y
Sbjct: 68  HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEF--SVLQLVGMLRGIAAGMKY 125

Query: 201 LHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTI-LIGTSGYLDP 259
           L +      +H D+ + NIL+N N   KV+DF  S ++  D E   +T        +  P
Sbjct: 126 LAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182

Query: 260 VCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQI 319
             I+  K T  SDV+SFG+V+ E++T  +                      + N+ + + 
Sbjct: 183 EAISYRKFTSASDVWSFGIVMWEVMTYGER-----------------PYWELSNHEVMKA 225

Query: 320 LNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLHENF 371
           +N      + M     + +L  +C +     RP    +   LD+L R  ++ 
Sbjct: 226 INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSL 277

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (421), Expect = 2e-49
 Identities = 60/275 (21%), Positives = 101/275 (36%), Gaps = 26/275 (9%)

Query: 87  KNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRITEREL--LRIISQVNHKN 143
           +++D  + L +G +  V   V       VAVK       +   E     + I   +NH+N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 144 VVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHS 203
           VVK  G   E  +  L  E+ S G L D I  +            R   +  + + YLH 
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM---PEPDAQRFFHQLMAGVVYLHG 121

Query: 204 LASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCIN 263
           +    I H D+K  N+LL++    K++DF  + +   +    +   + GT  Y+ P  + 
Sbjct: 122 I---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178

Query: 264 TGKL-TKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNF 322
             +   +  DV+S G+VL  +L G+ P            S      +  K          
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQP--------SDSCQEYSDWKEKKTYLNPWK 230

Query: 323 HVADESEMKEIEIVAELASKCLRIRGTERPTMKQV 357
            +              L  K L    + R T+  +
Sbjct: 231 KIDSA--------PLALLHKILVENPSARITIPDI 257

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (424), Expect = 4e-49
 Identities = 63/305 (20%), Positives = 125/305 (40%), Gaps = 50/305 (16%)

Query: 88  NFDRSRCLSQGGFVSVYKGVLHD------NIQVAVKTYRRADKIRITEREL--LRIISQV 139
           N +  + L  G F  V     +       +IQVAVK  +        E  +  L++++Q+
Sbjct: 38  NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97

Query: 140 -NHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLK---------------- 182
            +H+N+V +LG C  +    L++E+   G LL+++R +  +  +                
Sbjct: 98  GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157

Query: 183 ----TWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLI 238
               T++  L  A + A  +++L        +H D+ + N+L+      K+ DF  +  I
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDI 214

Query: 239 SSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLAS 297
            SD+   +         ++ P  +  G  T KSDV+S+G++L E+ + G  P   + + +
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274

Query: 298 NKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQV 357
           N            +  NG +    F+  +E        +  +   C      +RP+   +
Sbjct: 275 N---------FYKLIQNGFKMDQPFYATEE--------IYIIMQSCWAFDSRKRPSFPNL 317

Query: 358 SEELD 362
           +  L 
Sbjct: 318 TSFLG 322

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  165 bits (419), Expect = 1e-48
 Identities = 59/306 (19%), Positives = 115/306 (37%), Gaps = 49/306 (16%)

Query: 88  NFDRSRCLSQGGFVSVYKGVL------HDNIQVAVKTYRRADKIRITEREL--LRIISQV 139
           N +  R + +G F  V++              VAVK  +      +         ++++ 
Sbjct: 14  NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 73

Query: 140 NHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLK----------------- 182
           ++ N+VK+LG+C   +   L++E+ + G L + +R  S   +                  
Sbjct: 74  DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 133

Query: 183 ----TWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLI 238
               +    L IA + A+ + YL        +H D+ + N L+ +N   K+ADF  S  I
Sbjct: 134 PPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNI 190

Query: 239 SSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASN 298
            S               ++ P  I   + T +SDV+++GVVL E+ +             
Sbjct: 191 YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ--------- 241

Query: 299 KKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVS 358
                 PY+  + +   +  + + ++    E      +  L   C      +RP+   + 
Sbjct: 242 ------PYYGMAHEEV-IYYVRDGNILACPE-NCPLELYNLMRLCWSKLPADRPSFCSIH 293

Query: 359 EELDRL 364
             L R+
Sbjct: 294 RILQRM 299

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (420), Expect = 1e-48
 Identities = 72/287 (25%), Positives = 124/287 (43%), Gaps = 33/287 (11%)

Query: 88  NFDRSRCLSQGGFVSVYKGVLHDN----IQVAVKTYRRADKIRITEREL--LRIISQVNH 141
           +F+    + +G F  VY G L DN    I  AVK+  R   I    + L    I+   +H
Sbjct: 30  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87

Query: 142 KNVVKILGLCLETE-VPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDY 200
            NV+ +LG+CL +E  PL+V  +  +G L + IR E+     T K  +    + A  + +
Sbjct: 88  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKF 145

Query: 201 LHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAM--STILIGTSGYLD 258
           L S      +H D+ + N +L++ +T KVADF  +  +      ++   T       ++ 
Sbjct: 146 LAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 202

Query: 259 PVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQ 318
              + T K T KSDV+SFGV+L EL+T   P               PY   +  +  +  
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP---------------PYPDVNTFDITVYL 247

Query: 319 ILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLR 365
           +    +         + + E+  KC   +   RP+  ++   +  + 
Sbjct: 248 LQGRRLLQPEYCP--DPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 292

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 1e-48
 Identities = 75/277 (27%), Positives = 115/277 (41%), Gaps = 36/277 (12%)

Query: 87  KNFDRSRCLSQGGFVSVYKGVL-HDNIQVAVKTYRRADKIRITERELLR----IISQVNH 141
           ++F+  R L +G F +VY          +A+K   +A   +      LR    I S + H
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 142 KNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYL 201
            N++++ G   +     L+ E+A  GT+   ++  S       +       E A+AL Y 
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF---DEQRTATYITELANALSYC 122

Query: 202 HSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVC 261
           HS     +IH D+K  N+LL      K+ADF  SV   S       T L GT  YL P  
Sbjct: 123 HSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEM 175

Query: 262 INTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASN-KKISMVPYFLNSIKNNGLRQIL 320
           I      +K D++S GV+  E L GK P    T     K+IS V +        G R   
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGAR--- 232

Query: 321 NFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQV 357
                            +L S+ L+   ++RP +++V
Sbjct: 233 -----------------DLISRLLKHNPSQRPMLREV 252

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 2e-48
 Identities = 68/295 (23%), Positives = 122/295 (41%), Gaps = 38/295 (12%)

Query: 95  LSQGGFVSVYKGVLH---DNIQVAVKTYRRADKIRITEREL--LRIISQVNHKNVVKILG 149
           L  G F SV +GV       I VA+K  ++  +   TE  +   +I+ Q+++  +V+++G
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76

Query: 150 LCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPI 209
           +C + E  +LV E A  G L   +  +  ++         +  + +  + YL        
Sbjct: 77  VC-QAEALMLVMEMAGGGPLHKFLVGKREEI--PVSNVAELLHQVSMGMKYLEE---KNF 130

Query: 210 IHGDVKSANILLNDNYTAKVADFE-SSVLISSDAETAMSTILIGTSGYLDPVCINTGKLT 268
           +H D+ + N+LL + + AK++DF  S  L + D+     +       +  P CIN  K +
Sbjct: 131 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 190

Query: 269 KKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVADE 327
            +SDV+S+GV + E L+ G+KP   M              +  I+  G R         E
Sbjct: 191 SRSDVWSYGVTMWEALSYGQKPYKKMKGPE---------VMAFIE-QGKRMECPPECPPE 240

Query: 328 SEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLHENFWAQKKNKETEH 382
                   +  L S C   +  +RP    V + +          +    +K   H
Sbjct: 241 --------LYALMSDCWIYKWEDRPDFLTVEQRM-------RACYYSLASKVEGH 280

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  164 bits (417), Expect = 3e-48
 Identities = 64/291 (21%), Positives = 110/291 (37%), Gaps = 40/291 (13%)

Query: 75  KIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRITERELL 133
           ++F K +     K F   R +  G F +VY    + ++  VA+K    + K    + + +
Sbjct: 6   ELFFKDD---PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDI 62

Query: 134 ----RIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLR 189
               R + ++ H N ++  G  L      LV E+            +             
Sbjct: 63  IKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAA 119

Query: 190 IAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTI 249
           +       L YLHS     +IH DVK+ NILL++    K+ DF S+ +++       +  
Sbjct: 120 VTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANS 170

Query: 250 LIGTSGYLDPVCI---NTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPY 306
            +GT  ++ P  I   + G+   K DV+S G+   EL   K P   M   S         
Sbjct: 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------- 221

Query: 307 FLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQV 357
            L  I  N    + + H ++                CL+    +RPT + +
Sbjct: 222 ALYHIAQNESPALQSGHWSEY--------FRNFVDSCLQKIPQDRPTSEVL 264

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 7e-48
 Identities = 57/276 (20%), Positives = 116/276 (42%), Gaps = 31/276 (11%)

Query: 86  TKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYR--RADKIRITERELLRIISQVNHK 142
            K + R   + QG   +VY  + +    +VA++     +  K  +   E+  ++ +  + 
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI-LVMRENKNP 77

Query: 143 NVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLH 202
           N+V  L   L  +   +V E+ + G+L D +                +  E   AL++LH
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLH 133

Query: 203 SLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCI 262
           S     +IH D+KS NILL  + + K+ DF     I+ +   +  + ++GT  ++ P  +
Sbjct: 134 SN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPYWMAPEVV 188

Query: 263 NTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNF 322
                  K D++S G++  E++ G+ P                 +LN      L  I   
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPP-----------------YLNENPLRALYLIATN 231

Query: 323 HVADESEMKEI-EIVAELASKCLRIRGTERPTMKQV 357
              +    +++  I  +  ++CL +   +R + K++
Sbjct: 232 GTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 9e-48
 Identities = 68/295 (23%), Positives = 117/295 (39%), Gaps = 40/295 (13%)

Query: 93  RCLSQGGFVSVYKGVLHD---NIQVAVKTYRRADKIRITERELLR---IISQVNHKNVVK 146
           + L  G F +V KG          VAVK  +        + ELL    ++ Q+++  +V+
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 147 ILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLAS 206
           ++G+C E E  +LV E A  G L  +++          K  + +  + +  + YL     
Sbjct: 73  MIGIC-EAESWMLVMEMAELGPLNKYLQQNRHV---KDKNIIELVHQVSMGMKYLEE--- 125

Query: 207 PPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTI-LIGTSGYLDPVCINTG 265
              +H D+ + N+LL   + AK++DF  S  + +D     +         +  P CIN  
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185

Query: 266 KLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHV 324
           K + KSDV+SFGV++ E  + G+KP   M  +              ++  G R       
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---------VTAMLE-KGERMGCPAGC 235

Query: 325 ADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLHENFWAQKKNKE 379
             E        + +L + C       RP    V   L        N++    N+ 
Sbjct: 236 PRE--------MYDLMNLCWTYDVENRPGFAAVELRL-------RNYYYDVVNEG 275

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (408), Expect = 2e-47
 Identities = 64/290 (22%), Positives = 110/290 (37%), Gaps = 35/290 (12%)

Query: 87  KNFDRSRCLSQGGFVSVYKGVLH----DNIQVAVKTYRR-----ADKIRITERELLRIIS 137
           K+      L  G F  V +G         + VAVK  +       + +    RE+   + 
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREV-NAMH 66

Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
            ++H+N++++ G+ L   +  +V E A  G+LLD +R           T  R A + A  
Sbjct: 67  SLDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGHF--LLGTLSRYAVQVAEG 123

Query: 198 LDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFE-SSVLISSDAETAMSTILIGTSGY 256
           + YL S      IH D+ + N+LL      K+ DF     L  +D    M         +
Sbjct: 124 MGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180

Query: 257 LDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNG 315
             P  + T   +  SD + FGV L E+ T G++P   +  +           L+ I   G
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---------ILHKIDKEG 231

Query: 316 LRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLR 365
            R         +        +  +  +C   +  +RPT   + + L   +
Sbjct: 232 ERLPRPEDCPQD--------IYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (407), Expect = 5e-47
 Identities = 62/287 (21%), Positives = 120/287 (41%), Gaps = 30/287 (10%)

Query: 84  RATKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRITERELL----RIISQ 138
           +  ++F   + L +G F +V     L  + + A+K   +   I+  +   +     ++S+
Sbjct: 5   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64

Query: 139 VNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASAL 198
           ++H   VK+     + E       +A NG LL +IR   S             AE  SAL
Sbjct: 65  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSAL 121

Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLD 258
           +YLH      IIH D+K  NILLN++   ++ DF ++ ++S +++ A +   +GT+ Y+ 
Sbjct: 122 EYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 178

Query: 259 PVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQ 318
           P  +      K SD+++ G ++ +L+ G  P                 F    +    ++
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGLPP-----------------FRAGNEYLIFQK 221

Query: 319 ILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLR 365
           I+        +        +L  K L +  T+R   +++        
Sbjct: 222 IIKLEYDFPEKF--FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKA 266

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (404), Expect = 8e-47
 Identities = 57/272 (20%), Positives = 108/272 (39%), Gaps = 34/272 (12%)

Query: 95  LSQGGFVSVYKGVLHD-NIQVAVKTYRRADKIRITERELLR---IISQVNHKNVVKILGL 150
           + +G F +VYKG+  +  ++VA    +     +   +       ++  + H N+V+    
Sbjct: 17  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76

Query: 151 CLET----EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLAS 206
              T    +  +LV E  ++GTL  +++          K       +    L +LH+  +
Sbjct: 77  WESTVKGKKCIVLVTELMTSGTLKTYLKRFKVM---KIKVLRSWCRQILKGLQFLHTR-T 132

Query: 207 PPIIHGDVKSANILLND-NYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTG 265
           PPIIH D+K  NI +     + K+ D   + L  +      +  +IGT  ++ P      
Sbjct: 133 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYE-E 187

Query: 266 KLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVA 325
           K  +  DVY+FG+ + E+ T +                 PY          R++ +    
Sbjct: 188 KYDESVDVYAFGMCMLEMATSEY----------------PYSECQNAAQIYRRVTSGVKP 231

Query: 326 DESEMKEIEIVAELASKCLRIRGTERPTMKQV 357
              +   I  V E+   C+R    ER ++K +
Sbjct: 232 ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDL 263

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 9e-47
 Identities = 71/304 (23%), Positives = 120/304 (39%), Gaps = 42/304 (13%)

Query: 87  KNFDRSRCLSQGGFVSVYKGVLHDN---IQVAVKTYRRA---DKIRITERELLRIISQVN 140
            +      + +G F  V K  +  +   +  A+K  +     D  R    EL  +    +
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 141 HKNVVKILGLCLETEVPLLVYEFASNGTLLDHIR-------------CESSQVLKTWKTC 187
           H N++ +LG C       L  E+A +G LLD +R               S+    + +  
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 188 LRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMS 247
           L  AA+ A  +DYL        IH D+ + NIL+ +NY AK+ADF  S       +  M 
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG 186

Query: 248 TILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYF 307
                   ++    +N    T  SDV+S+GV+L E+++                   PY 
Sbjct: 187 R---LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT---------------PYC 228

Query: 308 LNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRL 367
             +     L + L      E  +   + V +L  +C R +  ERP+  Q+   L+R+   
Sbjct: 229 GMTCAE--LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286

Query: 368 HENF 371
            + +
Sbjct: 287 RKTY 290

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 1e-45
 Identities = 64/301 (21%), Positives = 117/301 (38%), Gaps = 44/301 (14%)

Query: 88  NFDRSRCLSQGGFVSVYKGVL--------HDNIQVAVKTYRR---ADKIRITERELLRII 136
                + L +G F  V             +   +VAVK  +       +     E+  + 
Sbjct: 14  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73

Query: 137 SQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLK-------------T 183
               HKN++ +LG C +     ++ E+AS G L ++++      L+             +
Sbjct: 74  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133

Query: 184 WKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE 243
            K  +  A + A  ++YL S      IH D+ + N+L+ ++   K+ADF  +  I     
Sbjct: 134 SKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190

Query: 244 TAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISM 303
              +T       ++ P  +     T +SDV+SFGV+L E+ T                  
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS-------------- 236

Query: 304 VPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDR 363
            PY    ++   L ++L      +        +  +   C     ++RPT KQ+ E+LDR
Sbjct: 237 -PYPGVPVEE--LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 293

Query: 364 L 364
           +
Sbjct: 294 I 294

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (393), Expect = 4e-45
 Identities = 63/286 (22%), Positives = 118/286 (41%), Gaps = 32/286 (11%)

Query: 88  NFDRSRCLSQGGFVSVYKGVLHDN----IQVAVKTYRRADKIRITEREL--LRIISQVNH 141
             +  RC+ +G F  V++G+        + VA+KT +      + E+ L     + Q +H
Sbjct: 8   RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 67

Query: 142 KNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYL 201
            ++VK++G+  E  V  ++ E  + G L   ++     +     + +  A + ++AL YL
Sbjct: 68  PHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKYSL--DLASLILYAYQLSTALAYL 124

Query: 202 HSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVC 261
            S      +H D+ + N+L++ N   K+ DF  S  +        S        ++ P  
Sbjct: 125 ES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG-KLPIKWMAPES 180

Query: 262 INTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQIL 320
           IN  + T  SDV+ FGV + E+L  G KP   +              +  I+ NG R  +
Sbjct: 181 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---------VIGRIE-NGERLPM 230

Query: 321 NFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR 366
             +            +  L +KC     + RP   ++  +L  +  
Sbjct: 231 PPNCPPT--------LYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 4e-45
 Identities = 66/300 (22%), Positives = 125/300 (41%), Gaps = 37/300 (12%)

Query: 87  KNFDRSRCLSQGGFVSVYKGVLH------DNIQVAVKTYRRADKIRITEREL--LRIISQ 138
           +    SR L QG F  VY+GV           +VA+KT   A  +R     L    ++ +
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 139 VNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLK-------TWKTCLRIA 191
            N  +VV++LG+  + +  L++ E  + G L  ++R     +         +    +++A
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 192 AETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILI 251
            E A  + YL++      +H D+ + N ++ +++T K+ DF  +  I            +
Sbjct: 140 GEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 252 GTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSI 311
               ++ P  +  G  T  SDV+SFGVVL E+ T  +                PY   S 
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ---------------PYQGLSN 241

Query: 312 KNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLHENF 371
           +   LR ++   + D+ +    +++ EL   C +     RP+  ++   +     +   F
Sbjct: 242 EQV-LRFVMEGGLLDKPD-NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE--MEPGF 297

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 1e-44
 Identities = 67/309 (21%), Positives = 110/309 (35%), Gaps = 43/309 (13%)

Query: 88  NFDRSRCLSQGGFVSVYKGVLHD-NIQVAVKTYRRADK--IRITERELLRIISQVNHKNV 144
            ++    L  G F  VYK    + ++  A K      +  +     E+  I++  +H N+
Sbjct: 13  FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI-DILASCDHPNI 71

Query: 145 VKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSL 204
           VK+L          ++ EF + G +   +  E  + L T      +  +T  AL+YLH  
Sbjct: 72  VKLLDAFYYENNLWILIEFCAGGAVDAVM-LELERPL-TESQIQVVCKQTLDALNYLHDN 129

Query: 205 ASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCI-- 262
               IIH D+K+ NIL   +   K+ADF  S   +   +   S   IGT  ++ P  +  
Sbjct: 130 ---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMC 184

Query: 263 ---NTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQI 319
                     K+DV+S G+ L E+   + P                          L +I
Sbjct: 185 ETSKDRPYDYKADVWSLGITLIEMAEIEPP-----------------HHELNPMRVLLKI 227

Query: 320 LNFHVADESEMKEI-EIVAELASKCLRIRGTERPTMKQVSEELDRLRRLHENFWAQKKNK 378
                   ++         +   KCL      R T  Q+         L   F     NK
Sbjct: 228 AKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQL---------LQHPFVTVDSNK 278

Query: 379 ETEHLLGES 387
               L+ E+
Sbjct: 279 PIRELIAEA 287

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 6e-43
 Identities = 65/304 (21%), Positives = 114/304 (37%), Gaps = 42/304 (13%)

Query: 88  NFDRSRCLSQGGFVSVYKGVLH------DNIQVAVKTYRRA---DKIRITERELLRIISQ 138
                + L +G F  V +              VAVK  +      + R    EL  +I  
Sbjct: 14  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73

Query: 139 VNHKNVVKILGLCLETEVPL-LVYEFASNGTLLDHIRCESSQVLK-------------TW 184
            +H NVV +LG C +   PL ++ EF   G L  ++R + ++ +              T 
Sbjct: 74  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133

Query: 185 KTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET 244
           +  +  + + A  +++L S      IH D+ + NILL++    K+ DF  +  I  D + 
Sbjct: 134 EHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 190

Query: 245 AMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMV 304
                      ++ P  I     T +SDV+SFGV+L E+ +                   
Sbjct: 191 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS--------------- 235

Query: 305 PYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL 364
           PY    I +    + L       +       + +    C     ++RPT  ++ E L  L
Sbjct: 236 PYPGVKI-DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294

Query: 365 RRLH 368
            + +
Sbjct: 295 LQAN 298

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (378), Expect = 1e-42
 Identities = 62/309 (20%), Positives = 114/309 (36%), Gaps = 29/309 (9%)

Query: 84  RATKNFDRSRCLSQGGFVSVYKG--VLHDNIQVAVKTYRRADKIR------ITERELLRI 135
           RA + ++    + +G +  V+K   + +    VA+K  R            I E  +LR 
Sbjct: 4   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63

Query: 136 ISQVNHKNVVKILGLCL----ETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIA 191
           +    H NVV++  +C     + E  L +     +  L  ++       +   +T   + 
Sbjct: 64  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGV-PTETIKDMM 122

Query: 192 AETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILI 251
            +    LD+LHS     ++H D+K  NIL+  +   K+ADF    L    +     T ++
Sbjct: 123 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG---LARIYSFQMALTSVV 176

Query: 252 GTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMT----LASNKKISMVPYF 307
            T  Y  P  +         D++S G + AE+   K      +    L     +  +P  
Sbjct: 177 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 236

Query: 308 LNSIKNNGLRQILNFHVADESEMKEIEIVAELA----SKCLRIRGTERPTMKQVSEE--L 361
            +  ++  L +      + +   K +  + EL      KCL     +R +          
Sbjct: 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 296

Query: 362 DRLRRLHEN 370
             L R  EN
Sbjct: 297 QDLERCKEN 305

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (368), Expect = 5e-41
 Identities = 49/277 (17%), Positives = 103/277 (37%), Gaps = 33/277 (11%)

Query: 89  FDR---SRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNV 144
           +++   +  L +G F  V++ V          K  +     ++  ++ + I++   H+N+
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNI 63

Query: 145 VKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSL 204
           + +       E  ++++EF S   + + I   + ++    +  +    +   AL +LHS 
Sbjct: 64  LHLHESFESMEELVMIFEFISGLDIFERINTSAFEL--NEREIVSYVHQVCEALQFLHSH 121

Query: 205 ASPPIIHGDVKSANILL--NDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCI 262
               I H D++  NI+     + T K+ +F  +  +          +L     Y  P   
Sbjct: 122 ---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTAPEYYAPEVH 175

Query: 263 NTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNF 322
               ++  +D++S G ++  LL+G  P                 FL       +  I+N 
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINP-----------------FLAETNQQIIENIMNA 218

Query: 323 HVA-DESEMKEI-EIVAELASKCLRIRGTERPTMKQV 357
               DE   KEI     +   + L      R T  + 
Sbjct: 219 EYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEA 255

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  146 bits (369), Expect = 7e-41
 Identities = 52/277 (18%), Positives = 101/277 (36%), Gaps = 33/277 (11%)

Query: 88  NFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADK--IRITERELLRIISQVNHKNV 144
           ++D    L  G F  V++          A K      +       +E+ + +S + H  +
Sbjct: 27  HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEI-QTMSVLRHPTL 85

Query: 145 VKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSL 204
           V +     +    +++YEF S G L + +  E +++  +    +    +    L ++H  
Sbjct: 86  VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKM--SEDEAVEYMRQVCKGLCHMHEN 143

Query: 205 ASPPIIHGDVKSANILLN--DNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCI 262
                +H D+K  NI+     +   K+ DF  +  +       ++T   GT+ +  P   
Sbjct: 144 ---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVA 197

Query: 263 NTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNF 322
               +   +D++S GV+   LL+G  P                 F     +  LR + + 
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLSP-----------------FGGENDDETLRNVKSC 240

Query: 323 HVA-DESEMKEI-EIVAELASKCLRIRGTERPTMKQV 357
               D+S    I E   +   K L      R T+ Q 
Sbjct: 241 DWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQA 277

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  144 bits (363), Expect = 2e-40
 Identities = 56/287 (19%), Positives = 99/287 (34%), Gaps = 32/287 (11%)

Query: 77  FSKSEMIRATKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRA---DKIRITEREL 132
           + ++E IR    +D    L  G F  V           VA+K   +     K    E E+
Sbjct: 1   WKQAEDIR--DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEI 58

Query: 133 LRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAA 192
             ++ ++ H N+V +  +        L+ +  S G L D I     +   T +   R+  
Sbjct: 59  -AVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV---EKGFYTERDASRLIF 114

Query: 193 ETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIG 252
           +   A+ YLH L                L+++    ++DF  S +    +   + +   G
Sbjct: 115 QVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACG 171

Query: 253 TSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIK 312
           T GY+ P  +     +K  D +S GV+   LL G  P                 F +   
Sbjct: 172 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP-----------------FYDEND 214

Query: 313 NNGLRQILNFHVADESEMKEI--EIVAELASKCLRIRGTERPTMKQV 357
                QIL      +S   +   +   +     +     +R T +Q 
Sbjct: 215 AKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQA 261

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  141 bits (357), Expect = 5e-40
 Identities = 71/295 (24%), Positives = 111/295 (37%), Gaps = 38/295 (12%)

Query: 86  TKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRR-----ADKIRITERELLRIISQV 139
           +  ++    L  GG   V+    L  +  VAVK  R              RE  +  + +
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREA-QNAAAL 64

Query: 140 NHKNVVKILGLCLETE----VPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETA 195
           NH  +V +            +P +V E+    TL D +  E      T K  + + A+  
Sbjct: 65  NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADAC 121

Query: 196 SALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET-AMSTILIGTS 254
            AL++ H      IIH DVK ANI+++     KV DF  +  I+    +   +  +IGT+
Sbjct: 122 QALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178

Query: 255 GYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNN 314
            YL P       +  +SDVYS G VL E+LTG+ P                 F      +
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP-----------------FTGDSPVS 221

Query: 315 GLRQILNFHVADESEMKEI--EIVAELASKCLRIRGTERP-TMKQVSEELDRLRR 366
              Q +       S   E     +  +  K L      R  T  ++  +L R+  
Sbjct: 222 VAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  140 bits (355), Expect = 1e-39
 Identities = 61/290 (21%), Positives = 107/290 (36%), Gaps = 46/290 (15%)

Query: 88  NFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRITERELLRIISQV------- 139
           N++    L +G    V + +      + AVK          +  E+  +           
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 140 ----NHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETA 195
                H N++++           LV++    G L D++     +V  + K   +I     
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRALL 120

Query: 196 SALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSG 255
             +  LH L    I+H D+K  NILL+D+   K+ DF  S  +    +      + GT  
Sbjct: 121 EVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL---REVCGTPS 174

Query: 256 YLDPVCI------NTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLN 309
           YL P  I      N     K+ D++S GV++  LL G  P                 F +
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP-----------------FWH 217

Query: 310 SIKNNGLRQIL--NFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQV 357
             +   LR I+  N+           + V +L S+ L ++  +R T ++ 
Sbjct: 218 RKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  142 bits (360), Expect = 2e-39
 Identities = 47/277 (16%), Positives = 99/277 (35%), Gaps = 33/277 (11%)

Query: 88  NFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKI--RITERELLRIISQVNHKNV 144
            +D    L  G F  V++ V          K       +     + E+  I++Q++H  +
Sbjct: 30  YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEI-SIMNQLHHPKL 88

Query: 145 VKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSL 204
           + +     +    +L+ EF S G L D I  E  ++  +    +    +    L ++H  
Sbjct: 89  INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKM--SEAEVINYMRQACEGLKHMHEH 146

Query: 205 ASPPIIHGDVKSANILL--NDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCI 262
               I+H D+K  NI+       + K+ DF  +  ++ D    ++T    T+ +  P  +
Sbjct: 147 ---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEIV 200

Query: 263 NTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNF 322
           +   +   +D+++ GV+   LL+G  P                 F        L+ +   
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLSP-----------------FAGEDDLETLQNVKRC 243

Query: 323 HVADESEMKEI--EIVAELASKCLRIRGTERPTMKQV 357
               + +          +     L+    +R T+   
Sbjct: 244 DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDA 280

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  140 bits (353), Expect = 7e-39
 Identities = 70/301 (23%), Positives = 121/301 (40%), Gaps = 36/301 (11%)

Query: 87  KNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRITERELLR----IISQVNH 141
           ++F   R L  G F  V+     H+    A+K  ++   +R+ + E       ++S V H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 142 KNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYL 201
             ++++ G   + +   ++ ++   G L   +R                AAE   AL+YL
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF---PNPVAKFYAAEVCLALEYL 120

Query: 202 HSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVC 261
           HS     II+ D+K  NILL+ N   K+ DF  +  +     T     L GT  Y+ P  
Sbjct: 121 HS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT-----LCGTPDYIAPEV 172

Query: 262 INTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILN 321
           ++T    K  D +SFG+++ E+L G  P                 F +S       +ILN
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYTP-----------------FYDSNTMKTYEKILN 215

Query: 322 FHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVS-EELDRLRRLHENFWAQKKNKET 380
             +         E V +L S+ +    ++R    Q   E++       E  W +  ++  
Sbjct: 216 AELRFPPFFN--EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNI 273

Query: 381 E 381
           E
Sbjct: 274 E 274

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  140 bits (354), Expect = 1e-38
 Identities = 52/282 (18%), Positives = 103/282 (36%), Gaps = 35/282 (12%)

Query: 88  NFDRSRCLSQGGFVSVYKGVLHD-NIQVAVKTYRR-------ADKIRITERELLRIISQV 139
           +F   R + +GGF  VY     D     A+K   +        + + + ER +L ++S  
Sbjct: 5   DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64

Query: 140 NHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALD 199
           +   +V +       +    + +  + G L  H+       + +       AAE    L+
Sbjct: 65  DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLE 121

Query: 200 YLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDP 259
           ++H   +  +++ D+K ANILL+++   +++D      ++ D         +GT GY+ P
Sbjct: 122 HMH---NRFVVYRDLKPANILLDEHGHVRISDLG----LACDFSKKKPHASVGTHGYMAP 174

Query: 260 VCINTGK-LTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQ 318
             +  G      +D +S G +L +LL G  P                   + I    L  
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK----------TKDKHEIDRMTLTM 224

Query: 319 ILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEE 360
            +    +   E++       L    L+     R        +
Sbjct: 225 AVELPDSFSPELR------SLLEGLLQRDVNRRLGCLGRGAQ 260

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 8e-38
 Identities = 57/277 (20%), Positives = 94/277 (33%), Gaps = 37/277 (13%)

Query: 88  NFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRA-----DKIRITERELLRIISQVNH 141
           +F   + L +G F  V+       N   A+K  ++      D +  T  E   +     H
Sbjct: 3   DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62

Query: 142 KNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYL 201
             +  +       E    V E+ + G L+ HI+                AAE    L +L
Sbjct: 63  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFL 119

Query: 202 HSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVC 261
           HS     I++ D+K  NILL+ +   K+ADF            A +    GT  Y+ P  
Sbjct: 120 HS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG--DAKTNTFCGTPDYIAPEI 174

Query: 262 INTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILN 321
           +   K     D +SFGV+L E+L G+ P                            ++ +
Sbjct: 175 LLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---------------------ELFH 213

Query: 322 FHVADESEMKEI--EIVAELASKCLRIRGTERPTMKQ 356
               D         +   +L  K       +R  ++ 
Sbjct: 214 SIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRG 250

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 1e-36
 Identities = 62/274 (22%), Positives = 98/274 (35%), Gaps = 29/274 (10%)

Query: 92  SRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGL 150
           S+ L  G    V +        + A+K  +   K R   RE+          ++V+I+ +
Sbjct: 17  SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR---REVELHWRASQCPHIVRIVDV 73

Query: 151 C----LETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLAS 206
                   +  L+V E    G L   I+    Q   T +    I      A+ YLHS+  
Sbjct: 74  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF-TEREASEIMKSIGEAIQYLHSIN- 131

Query: 207 PPIIHGDVKSANILLN---DNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCIN 263
             I H DVK  N+L      N   K+ DF  +   +S            T  Y+ P  + 
Sbjct: 132 --IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVLG 186

Query: 264 TGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFH 323
             K  K  D++S GV++  LL G  P       SN  +++ P     I+           
Sbjct: 187 PEKYDKSCDMWSLGVIMYILLCGYPP-----FYSNHGLAISPGMKTRIRMGQYEFPNPEW 241

Query: 324 VADESEMKEIEIVAELASKCLRIRGTERPTMKQV 357
                E+K       L    L+   T+R T+ + 
Sbjct: 242 SEVSEEVK------MLIRNLLKTEPTQRMTITEF 269

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  132 bits (333), Expect = 2e-36
 Identities = 56/283 (19%), Positives = 105/283 (37%), Gaps = 20/283 (7%)

Query: 88  NFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLR---IISQVNHKNV 144
            +     + +G +  VYK   +     A+K  R   +        +R   I+ ++ H N+
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62

Query: 145 VKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSL 204
           VK+  +    +  +LV+E            CE         T      +  + + Y H  
Sbjct: 63  VKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG---LESVTAKSFLLQLLNGIAYCHD- 118

Query: 205 ASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINT 264
               ++H D+K  N+L+N     K+ADF  +             I +        V + +
Sbjct: 119 --RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEI-VTLWYRAPDVLMGS 175

Query: 265 GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASN-KKISMVPYFLNSIKNNGLRQI---- 319
            K +   D++S G + AE++ G      ++ A    +I  +    NS     + ++    
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235

Query: 320 LNFHVADESEMKEI-----EIVAELASKCLRIRGTERPTMKQV 357
            NF V +    +       E   +L SK L++   +R T KQ 
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (334), Expect = 2e-36
 Identities = 55/281 (19%), Positives = 100/281 (35%), Gaps = 27/281 (9%)

Query: 95  LSQGGFVSVYKGV-LHDNIQVAVKTYRRADKI-------RITERELLRIISQVNHKNVVK 146
           L +G F +VYK    + N  VA+K  +   +        R   RE+ +++ +++H N++ 
Sbjct: 6   LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI-KLLQELSHPNIIG 64

Query: 147 ILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLAS 206
           +L          LV++F      +            T          T   L+YLH    
Sbjct: 65  LLDAFGHKSNISLVFDFMETDLEVIIKDNSLVL---TPSHIKAYMLMTLQGLEYLHQ--- 118

Query: 207 PPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGK 266
             I+H D+K  N+LL++N   K+ADF  +    S       T  + T  Y  P  +   +
Sbjct: 119 HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA--YTHQVVTRWYRAPELLFGAR 176

Query: 267 L-TKKSDVYSFGVVLAELLTGKKPGSCMT-LASNKKISMVPYFLNSIKNNGLRQILNFHV 324
           +     D+++ G +LAELL         + L    +I          +   +  + ++  
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236

Query: 325 ADESEMKEIEIV--------AELASKCLRIRGTERPTMKQV 357
                   +  +         +L           R T  Q 
Sbjct: 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  131 bits (329), Expect = 1e-35
 Identities = 53/291 (18%), Positives = 97/291 (33%), Gaps = 26/291 (8%)

Query: 83  IRATKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRITERELLRIISQVNH 141
           +R    +   R +  G F  +Y G  +    +VA+K      K      E  +I   +  
Sbjct: 3   LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIES-KIYKMMQG 61

Query: 142 KNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYL 201
              +  +  C       ++       +L D     S +   + KT L +A +  S ++Y+
Sbjct: 62  GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKF--SLKTVLLLADQMISRIEYI 119

Query: 202 HSLASPPIIHGDVKSANILLND---NYTAKVADFESSVLISSDAETAM-----STILIGT 253
           HS      IH DVK  N L+          + DF  +                +  L GT
Sbjct: 120 HSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176

Query: 254 SGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKN 313
           + Y         + +++ D+ S G VL     G  P   +  A+ ++           K 
Sbjct: 177 ARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE---KKM 233

Query: 314 NGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL 364
           +   ++L      E         A   + C  +R  ++P    + +    L
Sbjct: 234 STPIEVLCKGYPSE--------FATYLNFCRSLRFDDKPDYSYLRQLFRNL 276

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (329), Expect = 3e-35
 Identities = 52/288 (18%), Positives = 97/288 (33%), Gaps = 26/288 (9%)

Query: 88  NFDRSRCLSQGGFVSVYKGVLHD-NIQVAVKTYRRADKIRITERELLRIISQVNHKNVVK 146
           ++  ++ +  G F  VY+  L D    VA+K   +  + +  E +++R   +++H N+V+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMR---KLDHCNIVR 77

Query: 147 ILGLCLETEVP------LLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDY 200
           +      +          LV ++              ++             +   +L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137

Query: 201 LHSLASPPIIHGDVKSANILLN-DNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDP 259
           +HS     I H D+K  N+LL+ D    K+ DF S+  +         + +         
Sbjct: 138 IHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSYICSRYYRAPE 192

Query: 260 VCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMT----------LASNKKISMVPYFLN 309
           +       T   DV+S G VLAELL G+      +          +        +     
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252

Query: 310 SIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQV 357
           +       QI           +       L S+ L    T R T  + 
Sbjct: 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (324), Expect = 5e-35
 Identities = 50/284 (17%), Positives = 104/284 (36%), Gaps = 20/284 (7%)

Query: 88  NFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRITERELLR---IISQVNHKN 143
           NF +   + +G +  VYK         VA+K  R   +        +R   ++ ++NH N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 144 VVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHS 203
           +VK+L +        LV+EF     L   +   +   +           +    L + HS
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGI-PLPLIKSYLFQLLQGLAFCHS 120

Query: 204 LASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCIN 263
                ++H D+K  N+L+N     K+ADF  +        T  +  ++        + + 
Sbjct: 121 ---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLG 176

Query: 264 TGKLTKKSDVYSFGVVLAELLTGKKPGSCMT-LASNKKISMVPYFLNSIKNNGLRQILNF 322
               +   D++S G + AE++T +      + +    +I       + +   G+  + ++
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236

Query: 323 HVADESEMKEI---------EIVAELASKCLRIRGTERPTMKQV 357
             +     ++          E    L S+ L     +R + K  
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (318), Expect = 6e-34
 Identities = 57/303 (18%), Positives = 107/303 (35%), Gaps = 34/303 (11%)

Query: 83  IRATKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRITERELLR---IISQ 138
                 +++   + QG F  V+K        +VA+K     ++        LR   I+  
Sbjct: 6   CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQL 65

Query: 139 VNHKNVVKILGLCLETEVP--------LLVYEFASNGTLLDHIRCESSQVLKTWKTCLRI 190
           + H+NVV ++ +C     P         LV++F  +                   T   I
Sbjct: 66  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV------LVKFTLSEI 119

Query: 191 AAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMS--T 248
                  L+ L+ +    I+H D+K+AN+L+  +   K+ADF  +   S    +  +  T
Sbjct: 120 KRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT 179

Query: 249 ILIGTSGYL-DPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMT------LASNKKI 301
             + T  Y    + +         D++  G ++AE+ T        T      L S    
Sbjct: 180 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG 239

Query: 302 SMVPYFLNSIKNNGLRQILNFHVADESEMKEI-------EIVAELASKCLRIRGTERPTM 354
           S+ P    ++ N  L + L      + ++K+            +L  K L +   +R   
Sbjct: 240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS 299

Query: 355 KQV 357
              
Sbjct: 300 DDA 302

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  125 bits (315), Expect = 8e-34
 Identities = 44/291 (15%), Positives = 88/291 (30%), Gaps = 28/291 (9%)

Query: 87  KNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVV 145
            ++   R + +G F  +++G  L +N QVA+K   R         E            + 
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIP 64

Query: 146 KILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLA 205
            +     E    +LV +            C       + KT    A +  + +  +H   
Sbjct: 65  NVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIHEK- 120

Query: 206 SPPIIHGDVKSANILLNDNYT-----AKVADFESSVLISSDAETA-----MSTILIGTSG 255
              +++ D+K  N L+    +       V DF                      L GT+ 
Sbjct: 121 --SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178

Query: 256 YLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNG 315
           Y+        + +++ D+ + G V    L G  P   +  A+NK+       +   K + 
Sbjct: 179 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER---IGEKKQST 235

Query: 316 LRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR 366
             + L     +E          +       +     P    +     ++  
Sbjct: 236 PLRELCAGFPEE--------FYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (314), Expect = 1e-33
 Identities = 46/286 (16%), Positives = 100/286 (34%), Gaps = 22/286 (7%)

Query: 87  KNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRITERELLR---IISQVNHK 142
           + +++   + +G + +V+K      +  VA+K  R  D         LR   ++ ++ HK
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 143 NVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLH 202
           N+V++  +    +   LV+EF           C         +       +    L + H
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL---DPEIVKSFLFQLLKGLGFCH 118

Query: 203 SLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCI 262
           S     ++H D+K  N+L+N N   K+A+F  +           S  ++        V  
Sbjct: 119 S---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC-YSAEVVTLWYRPPDVLF 174

Query: 263 NTGKLTKKSDVYSFGVVLAELLTGKKP--GSCMTLASNKKISMVPYFLNSIKNNGLRQIL 320
                +   D++S G + AEL    +P           K+I  +       +   + ++ 
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234

Query: 321 NFHVADESEMKEIEI---------VAELASKCLRIRGTERPTMKQV 357
           ++            +           +L    L+    +R + ++ 
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (311), Expect = 3e-33
 Identities = 56/282 (19%), Positives = 108/282 (38%), Gaps = 48/282 (17%)

Query: 89  FDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIR----------ITERELLRIIS 137
           +     L  GGF SVY G+ + DN+ VA+K   +                 E  LL+ +S
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65

Query: 138 QVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASA 197
                 V+++L      +  +L+ E       L     E   +    +       +   A
Sbjct: 66  S-GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGAL--QEELARSFFWQVLEA 122

Query: 198 LDYLHSLASPPIIHGDVKSANILLN-DNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
           + + H+     ++H D+K  NIL++ +    K+ DF S  L+       + T   GT  Y
Sbjct: 123 VRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVY 175

Query: 257 LDPVCINTGKL-TKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNG 315
             P  I   +   + + V+S G++L +++ G  P        +++I     F     ++ 
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP-----FEHDEEIIRGQVFFRQRVSSE 230

Query: 316 LRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQV 357
            + ++                      CL +R ++RPT +++
Sbjct: 231 CQHLI--------------------RWCLALRPSDRPTFEEI 252

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (314), Expect = 3e-33
 Identities = 52/209 (24%), Positives = 87/209 (41%), Gaps = 15/209 (7%)

Query: 87  KNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRA-----DKIRITERELLRIISQVN 140
            +FD  + L +G F  V            A+K  R+      D++  T  E  R++    
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTES-RVLQNTR 63

Query: 141 HKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDY 200
           H  +  +       +    V E+A+ G L  H+     + + T +      AE  SAL+Y
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEY 120

Query: 201 LHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPV 260
           LHS     +++ D+K  N++L+ +   K+ DF       SD  T       GT  YL P 
Sbjct: 121 LHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK--TFCGTPEYLAPE 175

Query: 261 CINTGKLTKKSDVYSFGVVLAELLTGKKP 289
            +      +  D +  GVV+ E++ G+ P
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 5e-33
 Identities = 64/297 (21%), Positives = 108/297 (36%), Gaps = 45/297 (15%)

Query: 76  IFSKSEMIRATKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYR--------RADKIR 126
           +F +  +      +D    L  G F  V K       +Q A K  +        R     
Sbjct: 2   VFRQENV---DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE 58

Query: 127 ITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKT 186
             ERE+  I+ ++ H NV+ +  +       +L+ E  + G L D +  + S    T + 
Sbjct: 59  DIEREV-SILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESL---TEEE 114

Query: 187 CLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDN----YTAKVADFESSVLISSDA 242
                 +  + + YLHS     I H D+K  NI+L D        K+ DF  +  I    
Sbjct: 115 ATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 171

Query: 243 ETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKIS 302
           E      + GT  ++ P  +N   L  ++D++S GV+   LL+G  P             
Sbjct: 172 EF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP------------- 215

Query: 303 MVPYFLNSIKNNGLRQILNFHVADESEMKEI--EIVAELASKCLRIRGTERPTMKQV 357
               FL   K   L  +   +   E E       +  +   + L     +R T++  
Sbjct: 216 ----FLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 268

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 1e-32
 Identities = 50/293 (17%), Positives = 106/293 (36%), Gaps = 28/293 (9%)

Query: 86  TKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRITEREL--LRIISQVNHK 142
              +     + +G +  V       + ++VA+K     +     +R L  ++I+ +  H+
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 143 NVVKILGLC----LETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASAL 198
           N++ I  +     +E    + +        L   ++ +      +         +    L
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH----LSNDHICYFLYQILRGL 122

Query: 199 DYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET-AMSTILIGTSGYL 257
            Y+HS     ++H D+K +N+LLN     K+ DF  + +   D +     T  + T  Y 
Sbjct: 123 KYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 179

Query: 258 DPVCINTGKL-TKKSDVYSFGVVLAELLTGKKP--GSCMTLASNKKISMVPYFLNSIKNN 314
            P  +   K  TK  D++S G +LAE+L+ +    G       N  + ++        N 
Sbjct: 180 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239

Query: 315 GLRQILNFHVADESEMKEI----------EIVAELASKCLRIRGTERPTMKQV 357
            +      ++       ++              +L  K L     +R  ++Q 
Sbjct: 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (301), Expect = 3e-31
 Identities = 54/302 (17%), Positives = 117/302 (38%), Gaps = 28/302 (9%)

Query: 77  FSKSEMIRAT----KNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRITERE 131
           F + E+ +        +   + +  G + +V   V      +VA+K   R  +  +  + 
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63

Query: 132 LLR---IISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLK-TWKTC 187
             R   ++  + H+NV+ +L +    E      +F      +     +  +  K      
Sbjct: 64  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123

Query: 188 LRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMS 247
             +  +    L Y+H+     IIH D+K  N+ +N++   K+ DF  +    S+    M+
Sbjct: 124 QFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MT 176

Query: 248 TILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMT-LASNKKISMVPY 306
             ++        V +N  + T+  D++S G ++AE++TGK        L   K+I  V  
Sbjct: 177 GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 236

Query: 307 -----FLNSIKNNGLRQIL-NFHVADESEMKEI-----EIVAELASKCLRIRGTERPTMK 355
                F+  ++++  +  +      ++ +   I      +   L  K L +   +R T  
Sbjct: 237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAG 296

Query: 356 QV 357
           + 
Sbjct: 297 EA 298

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  117 bits (293), Expect = 2e-30
 Identities = 52/295 (17%), Positives = 115/295 (38%), Gaps = 39/295 (13%)

Query: 88  NFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVK 146
           ++   R L +G +  V++ + + +N +V VK  +   K +I +RE+  + +     N++ 
Sbjct: 36  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKI-KREIKILENLRGGPNIIT 94

Query: 147 ILGLCLE--TEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSL 204
           +  +  +  +  P LV+E  +N       +        T         E   ALDY HS+
Sbjct: 95  LADIVKDPVSRTPALVFEHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCHSM 148

Query: 205 ASPPIIHGDVKSANILL-NDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDP-VCI 262
               I+H DVK  N+++ +++   ++ D+  +       E     + + +  +  P + +
Sbjct: 149 ---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPELLV 202

Query: 263 NTGKLTKKSDVYSFGVVLAELLTGKKP--------------------GSCMTLASNKKIS 302
           +        D++S G +LA ++  K+P                               I 
Sbjct: 203 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262

Query: 303 MVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQV 357
           + P F + +  +  ++   F  ++   +   E + +   K LR     R T ++ 
Sbjct: 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEAL-DFLDKLLRYDHQSRLTAREA 316

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  112 bits (281), Expect = 2e-28
 Identities = 52/220 (23%), Positives = 88/220 (40%), Gaps = 16/220 (7%)

Query: 75  KIFSKSEMIRATKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRITERELL 133
           K  + S+       FDR + L  G F  V            A+K   +   +++ + E  
Sbjct: 29  KWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT 88

Query: 134 ----RIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLR 189
               RI+  VN   +VK+     +     +V E+ + G +  H+R        +      
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARF 145

Query: 190 IAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTI 249
            AA+     +YLHSL    +I+ D+K  N+L++     +V DF  +  +     T     
Sbjct: 146 YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT----- 197

Query: 250 LIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP 289
           L GT   L P  I +    K  D ++ GV++ E+  G  P
Sbjct: 198 LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (269), Expect = 6e-27
 Identities = 54/306 (17%), Positives = 114/306 (37%), Gaps = 36/306 (11%)

Query: 77  FSKSEMIRA----TKNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRITERE 131
           F + E+ +      + +     +  G + SV         ++VAVK   R  +  I  + 
Sbjct: 4   FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63

Query: 132 LLR---IISQVNHKNVVKILGLC-----LETEVPLLVYEFASNGTLLDHIRCESSQVLKT 183
             R   ++  + H+NV+ +L +      LE    + +        L + ++C+       
Sbjct: 64  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT---- 119

Query: 184 WKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE 243
                 +  +    L Y+HS     IIH D+K +N+ +N++   K+ DF  +     +  
Sbjct: 120 DDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 176

Query: 244 TAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP--GSCMTLASNKKI 301
             ++T           + +N     +  D++S G ++AELLTG+    G+         +
Sbjct: 177 GYVAT----RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 232

Query: 302 SMVPYFLNSIKNNGLRQILNFHVADESEMKEIEI----------VAELASKCLRIRGTER 351
            +V      +      +    ++   ++M ++              +L  K L +   +R
Sbjct: 233 RLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR 292

Query: 352 PTMKQV 357
            T  Q 
Sbjct: 293 ITAAQA 298

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (262), Expect = 6e-26
 Identities = 57/298 (19%), Positives = 106/298 (35%), Gaps = 33/298 (11%)

Query: 87  KNFDRSRCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRITERELLR---IISQVNHK 142
           K +   + +  G    V        +  VA+K   R  + +   +   R   ++  VNHK
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 143 NVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLH 202
           N++ +L +    +      +      L+D   C+  Q+    +    +  +    + +LH
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 136

Query: 203 SLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCI 262
           S     IIH D+K +NI++  + T K+ DF    L  +   + M T  + T  Y  P  I
Sbjct: 137 S---AGIIHRDLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMTPYVVTRYYRAPEVI 190

Query: 263 NTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASN-KKI-------------SMVPYFL 308
                 +  D++S G ++ E++  K             K+              + P   
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250

Query: 309 NSIKNNGLRQILNFH---------VADESEMKEIEIVAELASKCLRIRGTERPTMKQV 357
           N ++N      L F             E    +     +L SK L I   +R ++   
Sbjct: 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (256), Expect = 2e-25
 Identities = 61/288 (21%), Positives = 104/288 (36%), Gaps = 38/288 (13%)

Query: 87  KNFDRSRCLSQGGFVSVYKGVL----HDNIQVAVKTYRRA---DKIRITEREL--LRIIS 137
           +NF+  + L  G +  V+              A+K  ++A    K + TE      +++ 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 138 QVNHK-NVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETAS 196
            +     +V +           L+ ++ + G L  H+     +   T         E   
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVL 140

Query: 197 ALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGY 256
           AL++LH L    II+ D+K  NILL+ N    + DF  S    +D ET  +    GT  Y
Sbjct: 141 ALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD-ETERAYDFCGTIEY 196

Query: 257 LDPVCINTGK--LTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNN 314
           + P  +  G     K  D +S GV++ ELLTG  P                 F    + N
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP-----------------FTVDGEKN 239

Query: 315 GLRQILNFHVADESEMKEI--EIVAELASKCLRIRGTERPTMKQVSEE 360
              +I    +  E    +    +  +L  + L     +R        +
Sbjct: 240 SQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDAD 287

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  102 bits (253), Expect = 9e-25
 Identities = 51/309 (16%), Positives = 100/309 (32%), Gaps = 46/309 (14%)

Query: 93  RCLSQGGFVSVYKGV-LHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLC 151
           R L  G F +V+    + +N  VA+K  R          + ++++ +VN  +  K   + 
Sbjct: 19  RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78

Query: 152 LETEVPLLVY-------------EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASAL 198
               + LL +              F   G  L  +  +            +I+ +    L
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 199 DYLHSLASPPIIHGDVKSANILLN-DNYTAKVADFESSVLISSDAETAMSTILIGTSGYL 257
           DY+H      IIH D+K  N+L+   +    +   + + L ++       T  I T  Y 
Sbjct: 139 DYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196

Query: 258 DPVCINTGKLTKKSDVYSFGVVLAELLTGKKP----GSCMTLASNKKISMVPYFLNSIKN 313
            P  +        +D++S   ++ EL+TG               +  I+ +   L  + +
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPS 256

Query: 314 NGLRQILNFHVADESEMKEIEI-------------------------VAELASKCLRIRG 348
             LR          S      I                         +++  S  L++  
Sbjct: 257 YLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 316

Query: 349 TERPTMKQV 357
            +R     +
Sbjct: 317 RKRADAGGL 325

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 69.0 bits (168), Expect = 2e-14
 Identities = 21/158 (13%), Positives = 51/158 (32%), Gaps = 21/158 (13%)

Query: 93  RCLSQGGFVSVYKGVLHDNIQVAVKTYRRA-----------DKIRITERELLRIISQVNH 141
           + + +G   +V+        +  VK ++             D   +    L    ++   
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 142 KNVVKILGLCLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYL 201
           + + K+ GL +        Y +     +L  +           +    +       +   
Sbjct: 66  RALQKLQGLAVPKV-----YAW-EGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKF 119

Query: 202 HSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLIS 239
           +      I+HGD+   N+L+++     + DF  SV + 
Sbjct: 120 Y---HRGIVHGDLSQYNVLVSE-EGIWIIDFPQSVEVG 153

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	414
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.91
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.55
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.22
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.95
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.52
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.11
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.01

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-56  Score=412.42  Aligned_cols=257  Identities=24%  Similarity=0.363  Sum_probs=201.4

Q ss_pred             cCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCCC
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASN  166 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  166 (414)
                      ++|++.+.||+|+||+||+|.+.+++.||||+++........+.+|++++++++|||||+++|+|..++..++||||+++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~   84 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH   84 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCC
Confidence            57888999999999999999998888999999987766666778888999999999999999999999999999999999


Q ss_pred             CchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccccc
Q 015027          167 GTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETAM  246 (414)
Q Consensus       167 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  246 (414)
                      |+|.+++....  ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++....... ..
T Consensus        85 g~L~~~l~~~~--~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~~  158 (263)
T d1sm2a_          85 GCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TS  158 (263)
T ss_dssp             CBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred             CcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCc-ee
Confidence            99999986543  34588999999999999999999987   99999999999999999999999999987654322 22


Q ss_pred             eecccccccccchhhcccCCCCCcccchhHHHHHHHHHhC-CCCCCccccccccccccchhhhhhhcccccccccccccC
Q 015027          247 STILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTG-KKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVA  325 (414)
Q Consensus       247 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (414)
                      .....||+.|+|||++.+..++.++|||||||++|||+|+ .+||.......         ....+... ....      
T Consensus       159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~---------~~~~i~~~-~~~~------  222 (263)
T d1sm2a_         159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTG-FRLY------  222 (263)
T ss_dssp             ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH---------HHHHHHHT-CCCC------
T ss_pred             ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHH---------HHHHHHhc-CCCC------
Confidence            3345789999999999999999999999999999999995 56654322111         11111111 0000      


Q ss_pred             CcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHh
Q 015027          326 DESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRL  367 (414)
Q Consensus       326 ~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~  367 (414)
                        .+...++.+.+|+.+||+.||++|||+++|++.|+++.+.
T Consensus       223 --~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es  262 (263)
T d1sm2a_         223 --KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES  262 (263)
T ss_dssp             --CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --CccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence              1111125689999999999999999999999999998753

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-56  Score=410.46  Aligned_cols=250  Identities=24%  Similarity=0.329  Sum_probs=201.1

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEe
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  163 (414)
                      ++|++.+.||+|+||+||+|.+. +|+.||||++......  .....+|+.++++++|||||++++++.+++..|+||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            57999999999999999999975 6899999999765322  23456778999999999999999999999999999999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcc
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE  243 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  243 (414)
                      |++|+|.+++...   ..+++..++.++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+|+.......
T Consensus        85 ~~gg~L~~~l~~~---~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~  158 (271)
T d1nvra_          85 CSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  158 (271)
T ss_dssp             CTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             cCCCcHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence            9999999999643   34588999999999999999999988   99999999999999999999999999988765444


Q ss_pred             ccceecccccccccchhhcccCCC-CCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccccc
Q 015027          244 TAMSTILIGTSGYLDPVCINTGKL-TKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNF  322 (414)
Q Consensus       244 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (414)
                      .......+||+.|||||++.+..+ +.++|||||||++|||++|+.||........       .. ........  .   
T Consensus       159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~-------~~-~~~~~~~~--~---  225 (271)
T d1nvra_         159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-------EY-SDWKEKKT--Y---  225 (271)
T ss_dssp             ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH-------HH-HHHHTTCT--T---
T ss_pred             cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH-------HH-HHHhcCCC--C---
Confidence            444556789999999999988876 5789999999999999999999964332110       00 00000000  0   


Q ss_pred             ccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHH
Q 015027          323 HVADESEMKEIEIVAELASKCLRIRGTERPTMKQVS  358 (414)
Q Consensus       323 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~  358 (414)
                         .......++.+.+|+.+||+.||++|||++|++
T Consensus       226 ---~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil  258 (271)
T d1nvra_         226 ---LNPWKKIDSAPLALLHKILVENPSARITIPDIK  258 (271)
T ss_dssp             ---STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred             ---CCccccCCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence               000111225688999999999999999999983

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-55  Score=407.31  Aligned_cols=261  Identities=26%  Similarity=0.397  Sum_probs=199.5

Q ss_pred             hcCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccc---hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADK---IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYE  162 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  162 (414)
                      .++|.+.+.||+|+||+||+|+.++  .||||+++....   ....+.+|+.++++++|||||++++++.+ +..++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            4679999999999999999998643  599999875432   22445677899999999999999998754 56899999


Q ss_pred             eCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCc
Q 015027          163 FASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDA  242 (414)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  242 (414)
                      ||++|+|.+++.....  .+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|+......
T Consensus        84 y~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~  158 (276)
T d1uwha_          84 WCEGSSLYHHLHIIET--KFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS  158 (276)
T ss_dssp             CCCEEEHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred             cCCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence            9999999999965433  3589999999999999999999987   9999999999999999999999999998776544


Q ss_pred             cccceecccccccccchhhcccC---CCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccc
Q 015027          243 ETAMSTILIGTSGYLDPVCINTG---KLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQI  319 (414)
Q Consensus       243 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (414)
                      .........||+.|||||++.+.   .|+.++|||||||++|||+||+.||........        .............
T Consensus       159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~--------~~~~~~~~~~~p~  230 (276)
T d1uwha_         159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--------IIFMVGRGYLSPD  230 (276)
T ss_dssp             -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH--------HHHHHHHTSCCCC
T ss_pred             CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH--------HHHHHhcCCCCCc
Confidence            44445567899999999999643   589999999999999999999999975332110        0011111111000


Q ss_pred             cccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHh
Q 015027          320 LNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRL  367 (414)
Q Consensus       320 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~  367 (414)
                      . .....    ..++.+.+|+.+||+.||.+|||+.+|++.|+.+.+.
T Consensus       231 ~-~~~~~----~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~  273 (276)
T d1uwha_         231 L-SKVRS----NCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS  273 (276)
T ss_dssp             G-GGSCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             c-hhccc----cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence            0 01111    1225699999999999999999999999999988753

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-55  Score=401.14  Aligned_cols=254  Identities=24%  Similarity=0.347  Sum_probs=211.7

Q ss_pred             hcCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCC
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFAS  165 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  165 (414)
                      .++|++.++||+|+||+||+|+.++++.||||+++........+.+++.++++++||||++++|+|.+++..++||||++
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            36899999999999999999999888899999998877666777888899999999999999999999999999999999


Q ss_pred             CCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcccc
Q 015027          166 NGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETA  245 (414)
Q Consensus       166 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  245 (414)
                      +|+|.+++.....  .+++..+++++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++....... .
T Consensus        83 ~g~l~~~~~~~~~--~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-~  156 (258)
T d1k2pa_          83 NGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-T  156 (258)
T ss_dssp             TEEHHHHHHSGGG--CCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-C
T ss_pred             CCcHHHhhhcccc--CCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCc-e
Confidence            9999998765443  3478899999999999999999987   99999999999999999999999999987654322 2


Q ss_pred             ceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhccccccccccccc
Q 015027          246 MSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHV  324 (414)
Q Consensus       246 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (414)
                      ......||+.|+|||++.+..++.++|||||||++|||+| |+.||.......         ....+... ....     
T Consensus       157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~---------~~~~i~~~-~~~~-----  221 (258)
T d1k2pa_         157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---------TAEHIAQG-LRLY-----  221 (258)
T ss_dssp             CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH---------HHHHHHTT-CCCC-----
T ss_pred             eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH---------HHHHHHhC-CCCC-----
Confidence            3334578999999999999999999999999999999998 899997554221         11111111 1111     


Q ss_pred             CCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHH
Q 015027          325 ADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDR  363 (414)
Q Consensus       325 ~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~  363 (414)
                         .+...++.+.+|+.+||+.||++|||+++|++.|..
T Consensus       222 ---~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         222 ---RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             ---CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             ---CcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence               111122569999999999999999999999988753

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-56  Score=407.81  Aligned_cols=256  Identities=25%  Similarity=0.392  Sum_probs=206.6

Q ss_pred             hcCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCC
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFAS  165 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  165 (414)
                      .++|++.+.||+|+||+||+|.+++++.||||++.........+.+++.++++++|||||+++|++.+ +..++||||++
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~   90 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME   90 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence            46788899999999999999999888999999998776666667888899999999999999998754 56799999999


Q ss_pred             CCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcccc
Q 015027          166 NGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETA  245 (414)
Q Consensus       166 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  245 (414)
                      +|+|.+++..... ..+++..++.++.||+.||.|||+.+   |+||||||+||||++++.+||+|||+|+..... ...
T Consensus        91 ~g~L~~~~~~~~~-~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~-~~~  165 (272)
T d1qpca_          91 NGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN-EYT  165 (272)
T ss_dssp             TCBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSS-CEE
T ss_pred             CCcHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCC-ccc
Confidence            9999998754432 23589999999999999999999987   999999999999999999999999999887543 222


Q ss_pred             ceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCC-CCccccccccccccchhhhhhhccccccccccccc
Q 015027          246 MSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKP-GSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHV  324 (414)
Q Consensus       246 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (414)
                      ......||+.|+|||++.+..++.++|||||||++|||+||..| |.......         ....+... .....    
T Consensus       166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~---------~~~~i~~~-~~~~~----  231 (272)
T d1qpca_         166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---------VIQNLERG-YRMVR----  231 (272)
T ss_dssp             CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---------HHHHHHTT-CCCCC----
T ss_pred             cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH---------HHHHHHhc-CCCCC----
Confidence            33445789999999999999999999999999999999996554 44222110         11111111 11111    


Q ss_pred             CCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHH
Q 015027          325 ADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLR  365 (414)
Q Consensus       325 ~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~  365 (414)
                          +...++.+.+|+.+||+.||++|||+.+|++.|+.+-
T Consensus       232 ----p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f  268 (272)
T d1qpca_         232 ----PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF  268 (272)
T ss_dssp             ----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----cccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence                1112256999999999999999999999999988764

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8.6e-56  Score=411.11  Aligned_cols=259  Identities=25%  Similarity=0.332  Sum_probs=210.0

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeC
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFA  164 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  164 (414)
                      .++|++.+.||+|+||+||+|.+. +++.||||+++.+......+.+|++++++++|||||+++++|.+++..++|||||
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~   95 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   95 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecc
Confidence            467888999999999999999976 5889999999877666666778889999999999999999999999999999999


Q ss_pred             CCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccc
Q 015027          165 SNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET  244 (414)
Q Consensus       165 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  244 (414)
                      ++|+|.+++..... ..+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|+....... 
T Consensus        96 ~~g~l~~~l~~~~~-~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~-  170 (287)
T d1opja_          96 TYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-  170 (287)
T ss_dssp             TTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS-
T ss_pred             cCcchHHHhhhccc-cchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCCc-
Confidence            99999999865433 35588999999999999999999987   99999999999999999999999999987765422 


Q ss_pred             cceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccccccc
Q 015027          245 AMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHV  324 (414)
Q Consensus       245 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (414)
                      .......||+.|+|||++.+..++.++|||||||++|||++|..||.......        .....+...         .
T Consensus       171 ~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~--------~~~~~i~~~---------~  233 (287)
T d1opja_         171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--------QVYELLEKD---------Y  233 (287)
T ss_dssp             EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--------HHHHHHHTT---------C
T ss_pred             eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH--------HHHHHHhcC---------C
Confidence            22334568899999999999999999999999999999999766653211100        011111111         1


Q ss_pred             CCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHH
Q 015027          325 ADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR  366 (414)
Q Consensus       325 ~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~  366 (414)
                      ..+.+...++.+.+|+.+||+.||.+|||+.+|++.|+.+..
T Consensus       234 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         234 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            111111223569999999999999999999999998887643

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-54  Score=402.81  Aligned_cols=247  Identities=23%  Similarity=0.339  Sum_probs=201.7

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc-hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeC
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK-IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFA  164 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  164 (414)
                      ++|++.+.||+|+||+||+|.+. +|+.||||++..... ......+|+.++++++|||||+++++|.+++..|+|||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            47999999999999999999965 699999999976543 2344567789999999999999999999999999999999


Q ss_pred             CCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccc
Q 015027          165 SNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET  244 (414)
Q Consensus       165 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  244 (414)
                      +||+|.+++...    .+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+|+......  
T Consensus       100 ~gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~--  170 (293)
T d1yhwa1         100 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--  170 (293)
T ss_dssp             TTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--
T ss_pred             CCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc--
Confidence            999999887542    3588999999999999999999988   9999999999999999999999999998765432  


Q ss_pred             cceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccccccc
Q 015027          245 AMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHV  324 (414)
Q Consensus       245 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (414)
                      ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.......         ............      
T Consensus       171 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~---------~~~~~~~~~~~~------  235 (293)
T d1yhwa1         171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR---------ALYLIATNGTPE------  235 (293)
T ss_dssp             CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---------HHHHHHHHCSCC------
T ss_pred             ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH---------HHHHHHhCCCCC------
Confidence            23345689999999999999999999999999999999999999997433211         000011110000      


Q ss_pred             CCcccHHHHHHHHHHHHHhhccCCCCCCChhHHH
Q 015027          325 ADESEMKEIEIVAELASKCLRIRGTERPTMKQVS  358 (414)
Q Consensus       325 ~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~  358 (414)
                       ...+...+..+.+|+.+||+.||.+|||+.|++
T Consensus       236 -~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil  268 (293)
T d1yhwa1         236 -LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELL  268 (293)
T ss_dssp             -CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred             -CCCcccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence             011112235699999999999999999999983

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-55  Score=398.48  Aligned_cols=244  Identities=30%  Similarity=0.395  Sum_probs=201.8

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeeccc----chhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRAD----KIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~  161 (414)
                      ++|++.+.||+|+||+||+|++. +++.||+|++....    .......+|++++++++|||||++++++.+++..|+||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            57999999999999999999986 58999999997542    22334466789999999999999999999999999999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCC
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD  241 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  241 (414)
                      |||++|+|.+++....   .+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|......
T Consensus        86 Ey~~~g~L~~~l~~~~---~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~  159 (263)
T d2j4za1          86 EYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  159 (263)
T ss_dssp             ECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred             eecCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence            9999999999996543   3588999999999999999999988   999999999999999999999999999876432


Q ss_pred             ccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccc
Q 015027          242 AETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILN  321 (414)
Q Consensus       242 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (414)
                          ......||+.|||||++.+..++.++|||||||++|||++|+.||...+...         ....+.....     
T Consensus       160 ----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---------~~~~i~~~~~-----  221 (263)
T d2j4za1         160 ----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE---------TYKRISRVEF-----  221 (263)
T ss_dssp             ----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---------HHHHHHTTCC-----
T ss_pred             ----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH---------HHHHHHcCCC-----
Confidence                2345689999999999999999999999999999999999999997543211         1111111110     


Q ss_pred             cccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          322 FHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       322 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                       ..+.    ..++.+.+|+.+||+.||.+|||++|+++
T Consensus       222 -~~p~----~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         222 -TFPD----FVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             -CCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -CCCc----cCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence             1111    12256899999999999999999999854

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8.8e-55  Score=406.61  Aligned_cols=258  Identities=26%  Similarity=0.361  Sum_probs=195.9

Q ss_pred             cCCCCCCccccCCceEEEEEEEcC-C---cEEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLHD-N---IQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLETEVPLLV  160 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv  160 (414)
                      ++|++.+.||+|+||+||+|.+.. +   ..||||.+......  ...+.+|++++++++|||||+++|+|.+++..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            456778899999999999999753 3   35899988654332  23456778999999999999999999999999999


Q ss_pred             EEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccC
Q 015027          161 YEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISS  240 (414)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  240 (414)
                      ||||++|+|.+++.....  .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+|+....
T Consensus       106 ~Ey~~~g~L~~~~~~~~~--~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  180 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED  180 (299)
T ss_dssp             EECCTTEEHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEecCCCcceeeeccccC--CCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence            999999999998865433  3589999999999999999999987   99999999999999999999999999987654


Q ss_pred             Cccccc---eecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhccccc
Q 015027          241 DAETAM---STILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGL  316 (414)
Q Consensus       241 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (414)
                      ......   .....||+.|||||++.+..++.++|||||||++|||+| |+.||.......         ....+.... 
T Consensus       181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~---------~~~~i~~~~-  250 (299)
T d1jpaa_         181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD---------VINAIEQDY-  250 (299)
T ss_dssp             ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---------HHHHHHTTC-
T ss_pred             CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH---------HHHHHHcCC-
Confidence            322211   122457899999999999999999999999999999998 899997543211         111111111 


Q ss_pred             ccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHh
Q 015027          317 RQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRL  367 (414)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~  367 (414)
                              ..+.+...+..+.+|+.+||+.||.+|||+.+|++.|+.+.+.
T Consensus       251 --------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~  293 (299)
T d1jpaa_         251 --------RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN  293 (299)
T ss_dssp             --------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             --------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence                    0111112235699999999999999999999999999988654

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-55  Score=403.34  Aligned_cols=254  Identities=19%  Similarity=0.342  Sum_probs=190.9

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch---hHhHHHHHHHHHccCCCceeeeeeeEec--CCcceE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI---RITERELLRIISQVNHKNVVKILGLCLE--TEVPLL  159 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~hpniv~l~~~~~~--~~~~~l  159 (414)
                      .++|++.+.||+|+||+||+|+.. +|+.||||++......   .....+|++++++++|||||++++++.+  ++.+|+
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence            367999999999999999999975 6899999999765432   2334667799999999999999999865  456899


Q ss_pred             EEEeCCCCchhhhhhhcC-CcccCCHHHHHHHHHHHHHHHHHhhhCC--CCCeeeCCCCCCceeeCCCCcEEEeeccccc
Q 015027          160 VYEFASNGTLLDHIRCES-SQVLKTWKTCLRIAAETASALDYLHSLA--SPPIIHGDVKSANILLNDNYTAKVADFESSV  236 (414)
Q Consensus       160 v~e~~~~gsL~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~--~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~  236 (414)
                      |||||++|+|.+++.... ....+++..++.++.||+.||.|||+.+  ..+|+||||||+|||++.++.+||+|||+|+
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence            999999999999986432 2345689999999999999999999854  2359999999999999999999999999998


Q ss_pred             cccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccc
Q 015027          237 LISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGL  316 (414)
Q Consensus       237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (414)
                      ......  .......||+.|||||++.+..++.++|||||||++|||+||+.||...+...         ....+.....
T Consensus       163 ~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~---------~~~~i~~~~~  231 (269)
T d2java1         163 ILNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---------LAGKIREGKF  231 (269)
T ss_dssp             HC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---------HHHHHHHTCC
T ss_pred             ecccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH---------HHHHHHcCCC
Confidence            875432  22345689999999999999999999999999999999999999997543211         1111111111


Q ss_pred             ccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          317 RQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ..     .+.    ..++++.+|+.+||+.||.+|||+.|+++
T Consensus       232 ~~-----~~~----~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         232 RR-----IPY----RYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             CC-----CCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CC-----CCc----ccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            11     111    12256999999999999999999999854

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-54  Score=399.30  Aligned_cols=249  Identities=23%  Similarity=0.264  Sum_probs=199.8

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch-hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeC
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI-RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFA  164 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  164 (414)
                      +.|++++.||+|+||+||+|.+. +++.||||++...... .....+|++++++++|||||++++++.+++..|+|||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            46899999999999999999976 5899999999765332 344567789999999999999999999999999999999


Q ss_pred             CCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccc
Q 015027          165 SNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET  244 (414)
Q Consensus       165 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  244 (414)
                      ++|+|.+++....  ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+|.......  
T Consensus        92 ~~g~L~~~~~~~~--~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--  164 (288)
T d2jfla1          92 AGGAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--  164 (288)
T ss_dssp             TTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--
T ss_pred             CCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc--
Confidence            9999999876543  23588999999999999999999988   9999999999999999999999999997654321  


Q ss_pred             cceecccccccccchhhcc-----cCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccc
Q 015027          245 AMSTILIGTSGYLDPVCIN-----TGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQI  319 (414)
Q Consensus       245 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (414)
                      .......||+.|+|||++.     +..|+.++|||||||++|||++|+.||.......         ....+.......+
T Consensus       165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~---------~~~~i~~~~~~~~  235 (288)
T d2jfla1         165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR---------VLLKIAKSEPPTL  235 (288)
T ss_dssp             HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---------HHHHHHHSCCCCC
T ss_pred             ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH---------HHHHHHcCCCCCC
Confidence            1233468999999999984     5568999999999999999999999997543211         1111111111000


Q ss_pred             cccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHH
Q 015027          320 LNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVS  358 (414)
Q Consensus       320 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~  358 (414)
                             ..+...++.+.+|+.+||+.||.+|||+.|++
T Consensus       236 -------~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell  267 (288)
T d2jfla1         236 -------AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLL  267 (288)
T ss_dssp             -------SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred             -------CccccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence                   11112235699999999999999999999984

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-54  Score=409.95  Aligned_cols=257  Identities=25%  Similarity=0.419  Sum_probs=203.6

Q ss_pred             cCCCCCCccccCCceEEEEEEEcC-C-----cEEEEEEeecccc--hhHhHHHHHHHHHcc-CCCceeeeeeeEecCCcc
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLHD-N-----IQVAVKTYRRADK--IRITERELLRIISQV-NHKNVVKILGLCLETEVP  157 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~--~~~~~~~~~~~l~~l-~hpniv~l~~~~~~~~~~  157 (414)
                      ++|++.+.||+|+||+||+|++.. +     ..||+|.+.....  ....+.+++.++.++ +|||||+++++|.+.+..
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~  116 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  116 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence            678999999999999999999653 2     3699999865432  233445667888887 899999999999999999


Q ss_pred             eEEEEeCCCCchhhhhhhcCC--------------------cccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCC
Q 015027          158 LLVYEFASNGTLLDHIRCESS--------------------QVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSA  217 (414)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~--------------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~  217 (414)
                      |+|||||++|+|.+++.....                    ...+++..++.++.||+.||+|||+++   |+||||||+
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~  193 (325)
T d1rjba_         117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAAR  193 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGG
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCchh
Confidence            999999999999999965432                    234688999999999999999999987   999999999


Q ss_pred             ceeeCCCCcEEEeeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccc
Q 015027          218 NILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLA  296 (414)
Q Consensus       218 NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~  296 (414)
                      |||++.++.+||+|||+|+...............||+.|||||++.+..++.++|||||||++|||+| |..||.+....
T Consensus       194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~  273 (325)
T d1rjba_         194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD  273 (325)
T ss_dssp             GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999987765544444456678999999999999999999999999999999998 89999743321


Q ss_pred             cccccccchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHH
Q 015027          297 SNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDR  363 (414)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~  363 (414)
                      .        .+..... ....        .+.+...++.+.+|+.+||+.||++|||+++|++.|..
T Consensus       274 ~--------~~~~~~~-~~~~--------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~  323 (325)
T d1rjba_         274 A--------NFYKLIQ-NGFK--------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC  323 (325)
T ss_dssp             H--------HHHHHHH-TTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             H--------HHHHHHh-cCCC--------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence            1        0111111 1111        11111123569999999999999999999999998853

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-54  Score=399.24  Aligned_cols=249  Identities=24%  Similarity=0.328  Sum_probs=200.6

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeeccc----chhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRAD----KIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~  161 (414)
                      ++|++.+.||+|+||+||+|.+. +|+.||||++....    .......+|++++++++||||++++++|.+++..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            57999999999999999999975 68999999997542    22234567789999999999999999999999999999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCC
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD  241 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  241 (414)
                      |||+||+|.+++...+   .+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+|+.+...
T Consensus        88 Ey~~gg~L~~~~~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  161 (288)
T ss_dssp             CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EccCCCCHHHhhhccC---CCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence            9999999999886544   3588999999999999999999988   999999999999999999999999999887654


Q ss_pred             ccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccc
Q 015027          242 AETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILN  321 (414)
Q Consensus       242 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (414)
                      .........+||+.|+|||++.+..++.++|||||||++|||++|+.||...+...         ....+.....     
T Consensus       162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---------~~~~i~~~~~-----  227 (288)
T d1uu3a_         162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL---------IFQKIIKLEY-----  227 (288)
T ss_dssp             --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---------HHHHHHTTCC-----
T ss_pred             CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH---------HHHHHHcCCC-----
Confidence            44444556789999999999999999999999999999999999999997433111         1111111110     


Q ss_pred             cccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHH
Q 015027          322 FHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEE  360 (414)
Q Consensus       322 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~  360 (414)
                       .++.    ..++.+.+|+.+||+.||++|||++|++..
T Consensus       228 -~~p~----~~s~~~~~li~~~L~~dP~~R~t~~e~~~~  261 (288)
T d1uu3a_         228 -DFPE----KFFPKARDLVEKLLVLDATKRLGCEEMEGY  261 (288)
T ss_dssp             -CCCT----TCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred             -CCCc----cCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence             0111    123568999999999999999999998654

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-54  Score=397.18  Aligned_cols=259  Identities=24%  Similarity=0.374  Sum_probs=197.5

Q ss_pred             cCCCCCCccccCCceEEEEEEEcCC-----cEEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEecCCcceE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLHDN-----IQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLETEVPLL  159 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~l  159 (414)
                      +.|.+.+.||+|+||+||+|.+.++     ..||||++......  ...+.+|++++++++|||||+++|++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            4678889999999999999997542     46999999754332  2334677899999999999999999999999999


Q ss_pred             EEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccccccc
Q 015027          160 VYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLIS  239 (414)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~  239 (414)
                      |||||.++++.+++.....  .+++..++.++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++...
T Consensus        87 v~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          87 ITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             EEECCTTEEHHHHHHHTTT--CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEEecccCcchhhhhcccc--cccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence            9999999999988765433  3588999999999999999999987   9999999999999999999999999998765


Q ss_pred             CCccc-cceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCC-ccccccccccccchhhhhhhcccccc
Q 015027          240 SDAET-AMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGS-CMTLASNKKISMVPYFLNSIKNNGLR  317 (414)
Q Consensus       240 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (414)
                      ..... .......||+.|||||++.+..++.++|||||||++|||++|..|+. ......         ....+...   
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~---------~~~~i~~~---  229 (283)
T d1mqba_         162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE---------VMKAINDG---  229 (283)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---------HHHHHHTT---
T ss_pred             CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH---------HHHHHhcc---
Confidence            43222 22334568999999999999999999999999999999999655543 221110         11111111   


Q ss_pred             cccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHhh
Q 015027          318 QILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLH  368 (414)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~~  368 (414)
                            ...+.+...+..+.+|+.+||+.||++|||+.+|++.|+.+.+..
T Consensus       230 ------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p  274 (283)
T d1mqba_         230 ------FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP  274 (283)
T ss_dssp             ------CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             ------CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence                  111111222356999999999999999999999999999887643

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-54  Score=407.45  Aligned_cols=264  Identities=21%  Similarity=0.241  Sum_probs=201.1

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYE  162 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  162 (414)
                      .++|++++.||+|+||+||+|.+. +|+.||+|+++.....  .....+|+.++++++|||||+++++|.+++..|+|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            578999999999999999999975 6899999999765322  3445677899999999999999999999999999999


Q ss_pred             eCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhh-CCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCC
Q 015027          163 FASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHS-LASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD  241 (414)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  241 (414)
                      ||++|+|.+++...+   .+++..+..++.|++.||.|||+ ++   |+||||||+|||++.++.+||+|||+|+.....
T Consensus        85 y~~gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  158 (322)
T d1s9ja_          85 HMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  158 (322)
T ss_dssp             CCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred             cCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence            999999999997543   35889999999999999999997 46   999999999999999999999999999876432


Q ss_pred             ccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccch----------h-----
Q 015027          242 AETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVP----------Y-----  306 (414)
Q Consensus       242 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~----------~-----  306 (414)
                          .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||...+...........          .     
T Consensus       159 ----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (322)
T d1s9ja_         159 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  234 (322)
T ss_dssp             ----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred             ----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence                234568999999999999999999999999999999999999999754321110000000          0     


Q ss_pred             ------hhhhhcccc----cccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          307 ------FLNSIKNNG----LRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       307 ------~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                            .........    .................+.++.+|+.+||+.||.+|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence                  000000000    00000000000011112356899999999999999999999965

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-53  Score=393.08  Aligned_cols=245  Identities=24%  Similarity=0.363  Sum_probs=192.5

Q ss_pred             CCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch---hHhHHHHHHHHHccCCCceeeeeeeEec----CCcceEEE
Q 015027           90 DRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI---RITERELLRIISQVNHKNVVKILGLCLE----TEVPLLVY  161 (414)
Q Consensus        90 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~hpniv~l~~~~~~----~~~~~lv~  161 (414)
                      ++.+.||+|+||+||+|.+. ++..||+|.+......   .....+|++++++++|||||+++++|.+    ...+|+||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            45668999999999999976 5889999998765322   2334677899999999999999999865    34579999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeC-CCCcEEEeeccccccccC
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLN-DNYTAKVADFESSVLISS  240 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~-~~~~~kl~DfGla~~~~~  240 (414)
                      |||++|+|.+++....   .+++..++.++.||+.||+|||+++ ++|+||||||+|||++ +++.+||+|||+|+....
T Consensus        92 E~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~  167 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  167 (270)
T ss_dssp             ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCcHHHHHhccc---cccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence            9999999999996543   3588999999999999999999976 5699999999999996 589999999999986543


Q ss_pred             CccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccc
Q 015027          241 DAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQIL  320 (414)
Q Consensus       241 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (414)
                      .    .....+||+.|||||++.+ .++.++|||||||++|||++|+.||.......        .....+........+
T Consensus       168 ~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~--------~~~~~i~~~~~~~~~  234 (270)
T d1t4ha_         168 S----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA--------QIYRRVTSGVKPASF  234 (270)
T ss_dssp             T----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--------HHHHHHTTTCCCGGG
T ss_pred             C----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH--------HHHHHHHcCCCCccc
Confidence            2    2345689999999999875 69999999999999999999999996432111        011111111111111


Q ss_pred             ccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          321 NFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       321 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      +.        ..++++.+|+.+||+.||++|||+.|+++
T Consensus       235 ~~--------~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         235 DK--------VAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             GG--------CCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             Cc--------cCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence            11        11245899999999999999999999854

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-53  Score=395.88  Aligned_cols=255  Identities=24%  Similarity=0.351  Sum_probs=201.7

Q ss_pred             cCCCCCC-ccccCCceEEEEEEEc---CCcEEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEE
Q 015027           87 KNFDRSR-CLSQGGFVSVYKGVLH---DNIQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLETEVPLLV  160 (414)
Q Consensus        87 ~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv  160 (414)
                      ++|.+.. +||+|+||+||+|.+.   ++..||||+++.....  ...+.+|++++++++|||||+++|+|.+ +..|+|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            4455666 4999999999999864   3567999999764332  2445677899999999999999999865 468999


Q ss_pred             EEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccC
Q 015027          161 YEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISS  240 (414)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  240 (414)
                      ||||++|+|.+++....  ..+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|+....
T Consensus        87 mE~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~  161 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA  161 (285)
T ss_dssp             EECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEeCCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence            99999999999875433  34588999999999999999999987   99999999999999999999999999987754


Q ss_pred             Cccc-cceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhccccccc
Q 015027          241 DAET-AMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQ  318 (414)
Q Consensus       241 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (414)
                      .... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||.......         ....+..+.. .
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~---------~~~~i~~~~~-~  231 (285)
T d1u59a_         162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---------VMAFIEQGKR-M  231 (285)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---------HHHHHHTTCC-C
T ss_pred             cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH---------HHHHHHcCCC-C
Confidence            3222 22334578999999999999999999999999999999998 999997543211         1111111111 0


Q ss_pred             ccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHH
Q 015027          319 ILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLR  365 (414)
Q Consensus       319 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~  365 (414)
                          .    .+...+..+.+|+.+||+.||++|||+.+|.+.|+.+.
T Consensus       232 ----~----~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~  270 (285)
T d1u59a_         232 ----E----CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  270 (285)
T ss_dssp             ----C----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----C----CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence                1    11112356899999999999999999999999888664

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-53  Score=392.70  Aligned_cols=248  Identities=24%  Similarity=0.331  Sum_probs=194.1

Q ss_pred             CccccCCceEEEEEEEcC---CcEEEEEEeecccc---hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCCC
Q 015027           93 RCLSQGGFVSVYKGVLHD---NIQVAVKTYRRADK---IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASN  166 (414)
Q Consensus        93 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~  166 (414)
                      ++||+|+||+||+|.+.+   ++.||||+++....   ....+.+|++++++++|||||+++++|.. +..++|||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            469999999999998643   56799999965432   22345677899999999999999999865 457899999999


Q ss_pred             CchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccc-c
Q 015027          167 GTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET-A  245 (414)
Q Consensus       167 gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~-~  245 (414)
                      |+|.+++....   .+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++........ .
T Consensus        92 g~L~~~l~~~~---~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~  165 (277)
T d1xbba_          92 GPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  165 (277)
T ss_dssp             EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred             CcHHHHHhhcc---CCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence            99999986533   3589999999999999999999987   999999999999999999999999999876543222 2


Q ss_pred             ceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhccccccccccccc
Q 015027          246 MSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHV  324 (414)
Q Consensus       246 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (414)
                      ......||+.|||||++.+..++.++|||||||++|||+| |+.||.......         ....+.....        
T Consensus       166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~---------~~~~i~~~~~--------  228 (277)
T d1xbba_         166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---------VTAMLEKGER--------  228 (277)
T ss_dssp             C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---------HHHHHHTTCC--------
T ss_pred             cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH---------HHHHHHcCCC--------
Confidence            2334578999999999999999999999999999999998 899997543211         1111111110        


Q ss_pred             CCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHH
Q 015027          325 ADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLR  365 (414)
Q Consensus       325 ~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~  365 (414)
                       .+.+...+..+.+|+.+||+.||++|||+.+|.+.|+...
T Consensus       229 -~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~  268 (277)
T d1xbba_         229 -MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  268 (277)
T ss_dssp             -CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             -CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence             0111112356899999999999999999999988887653

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.4e-53  Score=396.90  Aligned_cols=250  Identities=21%  Similarity=0.276  Sum_probs=187.5

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEE
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYE  162 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  162 (414)
                      .+.|++.+.||+|+||+||+|.+. +++.||||++......  .....+|+.++++++|||||++++++.+++..|+|||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            467999999999999999999976 5899999999765322  2233567799999999999999999999999999999


Q ss_pred             eCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeC---CCCcEEEeecccccccc
Q 015027          163 FASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLN---DNYTAKVADFESSVLIS  239 (414)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~---~~~~~kl~DfGla~~~~  239 (414)
                      ||+||+|.+++...   ..+++..+..++.||+.||+|||+.+   |+||||||+|||+.   +++.+||+|||+|+...
T Consensus        88 ~~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~  161 (307)
T d1a06a_          88 LVSGGELFDRIVEK---GFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED  161 (307)
T ss_dssp             CCCSCBHHHHHHTC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred             ccCCCcHHHhhhcc---cCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence            99999999999653   34589999999999999999999988   99999999999994   57899999999998764


Q ss_pred             CCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccc
Q 015027          240 SDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQI  319 (414)
Q Consensus       240 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (414)
                      ..   ......+||+.|||||++.+..|+.++|||||||++|||++|+.||.......         ....+......  
T Consensus       162 ~~---~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---------~~~~i~~~~~~--  227 (307)
T d1a06a_         162 PG---SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK---------LFEQILKAEYE--  227 (307)
T ss_dssp             --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---------HHHHHHTTCCC--
T ss_pred             CC---CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH---------HHHHHhccCCC--
Confidence            32   22345689999999999999999999999999999999999999997433211         11111111100  


Q ss_pred             cccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          320 LNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       320 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                          .........++.+.+|+.+||+.||.+|||+.|+++
T Consensus       228 ----~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         228 ----FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             ----CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ----CCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence                001111122356999999999999999999999865

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-54  Score=397.89  Aligned_cols=257  Identities=26%  Similarity=0.359  Sum_probs=200.3

Q ss_pred             hcCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCC
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFAS  165 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~  165 (414)
                      .++|++.+.||+|+||.||+|.+++++.||||++.........+.+++.++++++|||||+++++|.+ +..++||||++
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~   94 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS   94 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence            36799999999999999999999888899999998776666677888899999999999999999854 56799999999


Q ss_pred             CCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcccc
Q 015027          166 NGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETA  245 (414)
Q Consensus       166 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  245 (414)
                      +|+|.+++..... ..+++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++....... .
T Consensus        95 ~g~l~~~~~~~~~-~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-~  169 (285)
T d1fmka3          95 KGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-T  169 (285)
T ss_dssp             TCBHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             CCchhhhhhhccc-ccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCc-e
Confidence            9999988865432 23589999999999999999999987   99999999999999999999999999987654322 2


Q ss_pred             ceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccccccC
Q 015027          246 MSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHVA  325 (414)
Q Consensus       246 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (414)
                      ......||+.|+|||++.+..++.++|||||||++|||++|..|+......        ......+.... .        
T Consensus       170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~--------~~~~~~i~~~~-~--------  232 (285)
T d1fmka3         170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------REVLDQVERGY-R--------  232 (285)
T ss_dssp             ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHHHHHTTC-C--------
T ss_pred             eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH--------HHHHHHHHhcC-C--------
Confidence            334457899999999999999999999999999999999976554321111        00111111111 0        


Q ss_pred             CcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHH
Q 015027          326 DESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLR  365 (414)
Q Consensus       326 ~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~  365 (414)
                      .+.+...++.+.+|+.+||+.||++|||+++|++.|+.+.
T Consensus       233 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~  272 (285)
T d1fmka3         233 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  272 (285)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence            1111122356999999999999999999999988877644

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.6e-53  Score=396.15  Aligned_cols=244  Identities=25%  Similarity=0.316  Sum_probs=196.5

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchh----HhHHHHHHHHHccCCCceeeeeeeEecCCcceEEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIR----ITERELLRIISQVNHKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~  161 (414)
                      ..|+.++.||+|+||+||+|++. +++.||||++.......    .....|++++++++|||||++++++.+++..|+||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            34899999999999999999975 68899999997654322    23456789999999999999999999999999999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCC
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD  241 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  241 (414)
                      |||++|+|..++...   ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+|..... 
T Consensus        95 E~~~~g~l~~~~~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-  167 (309)
T d1u5ra_          95 EYCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-  167 (309)
T ss_dssp             ECCSEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred             EecCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence            999999997666443   34589999999999999999999988   99999999999999999999999999986543 


Q ss_pred             ccccceecccccccccchhhccc---CCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccc
Q 015027          242 AETAMSTILIGTSGYLDPVCINT---GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQ  318 (414)
Q Consensus       242 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (414)
                           .....||+.|||||++.+   ..|+.++|||||||++|||++|..||.......         ............
T Consensus       168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~---------~~~~i~~~~~~~  233 (309)
T d1u5ra_         168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---------ALYHIAQNESPA  233 (309)
T ss_dssp             -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---------HHHHHHHSCCCC
T ss_pred             -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH---------HHHHHHhCCCCC
Confidence                 234579999999999864   458999999999999999999999997433111         011111111111


Q ss_pred             ccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          319 ILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       319 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ..+        ...++.+.+|+.+||+.||.+|||+.++++
T Consensus       234 ~~~--------~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         234 LQS--------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             CSC--------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCC--------CCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence            111        112256999999999999999999999965

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.4e-52  Score=399.48  Aligned_cols=251  Identities=20%  Similarity=0.249  Sum_probs=203.1

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch-hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEe
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI-RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  163 (414)
                      -++|++.+.||+|+||.||+|.+. +|+.||||++...... .....+|+.++++++|||||++++++.+++..|+||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            358999999999999999999975 6899999999765433 23346678999999999999999999999999999999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeC--CCCcEEEeeccccccccCC
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLN--DNYTAKVADFESSVLISSD  241 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~--~~~~~kl~DfGla~~~~~~  241 (414)
                      |+||+|.+++.....  .+++..+..++.||+.||.|||+++   |+||||||+|||++  .++.+||+|||+|+.....
T Consensus       105 ~~gg~L~~~l~~~~~--~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~  179 (350)
T d1koaa2         105 MSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  179 (350)
T ss_dssp             CCSCBHHHHHTCTTS--CBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred             CCCCCHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence            999999999854332  3589999999999999999999988   99999999999995  4689999999999877543


Q ss_pred             ccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccc
Q 015027          242 AETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILN  321 (414)
Q Consensus       242 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (414)
                         .......||+.|||||++.+..++.++|||||||++|||++|+.||.+.+...         ....+.....     
T Consensus       180 ---~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---------~~~~i~~~~~-----  242 (350)
T d1koaa2         180 ---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE---------TLRNVKSCDW-----  242 (350)
T ss_dssp             ---SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---------HHHHHHHTCC-----
T ss_pred             ---cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH---------HHHHHHhCCC-----
Confidence               23345689999999999999999999999999999999999999997543211         1111111110     


Q ss_pred             cccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          322 FHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       322 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                       ..........++.+.+|+.+||+.||++|||+.|+++
T Consensus       243 -~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         243 -NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             -CSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             -CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             0011111112356899999999999999999999965

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-53  Score=399.19  Aligned_cols=258  Identities=24%  Similarity=0.357  Sum_probs=200.7

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCc----EEEEEEeeccc--chhHhHHHHHHHHHccCCCceeeeeeeEecCCcceE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNI----QVAVKTYRRAD--KIRITERELLRIISQVNHKNVVKILGLCLETEVPLL  159 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~--~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~l  159 (414)
                      .+|++++.||+|+||+||+|.+. +|+    .||+|.+....  .....+.+|+.++++++|||||+++|+|.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            46999999999999999999965 343    58999886543  2334557788999999999999999999865 5678


Q ss_pred             EEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccccccc
Q 015027          160 VYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLIS  239 (414)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~  239 (414)
                      +|||+.+|+|.+++....  ..+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|+...
T Consensus        88 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             EEECCTTCBHHHHHHHTS--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred             EEEeccCCcccccccccc--cCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence            899999999999886543  34588999999999999999999987   9999999999999999999999999999876


Q ss_pred             CCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhccccccc
Q 015027          240 SDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQ  318 (414)
Q Consensus       240 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (414)
                      ............||+.|+|||++.++.++.++|||||||++|||+| |.+||.......         ....+..+. . 
T Consensus       163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---------~~~~i~~~~-~-  231 (317)
T d1xkka_         163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---------ISSILEKGE-R-  231 (317)
T ss_dssp             TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---------HHHHHHHTC-C-
T ss_pred             cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---------HHHHHHcCC-C-
Confidence            5444444445678999999999999999999999999999999998 889987543211         111111111 0 


Q ss_pred             ccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHhh
Q 015027          319 ILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLH  368 (414)
Q Consensus       319 ~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~~  368 (414)
                             .+.+...++.+.+|+.+||+.||.+|||+.+|++.|+.+.+..
T Consensus       232 -------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~~  274 (317)
T d1xkka_         232 -------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  274 (317)
T ss_dssp             -------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSH
T ss_pred             -------CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhCh
Confidence                   0111112256899999999999999999999999998876543

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=3e-52  Score=397.40  Aligned_cols=251  Identities=19%  Similarity=0.268  Sum_probs=203.5

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch-hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEe
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI-RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  163 (414)
                      .++|++++.||+|+||.||+|... +|+.||||++...... .....+|++++++++|||||+++++|.+++..|+||||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            357999999999999999999975 6999999999765433 23345678999999999999999999999999999999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeC--CCCcEEEeeccccccccCC
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLN--DNYTAKVADFESSVLISSD  241 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~--~~~~~kl~DfGla~~~~~~  241 (414)
                      |+||+|.+++....  ..+++..++.++.||+.||.|||+++   |+||||||+|||++  .++.+||+|||+|......
T Consensus       108 ~~gg~L~~~~~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~  182 (352)
T d1koba_         108 LSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  182 (352)
T ss_dssp             CCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCCChHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC
Confidence            99999998875443  23588999999999999999999988   99999999999998  6789999999999887643


Q ss_pred             ccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccc
Q 015027          242 AETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILN  321 (414)
Q Consensus       242 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (414)
                         .......||+.|+|||++.+..++.++|||||||++|||+||+.||.+.+...         ....+.....     
T Consensus       183 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---------~~~~i~~~~~-----  245 (352)
T d1koba_         183 ---EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE---------TLQNVKRCDW-----  245 (352)
T ss_dssp             ---SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---------HHHHHHHCCC-----
T ss_pred             ---CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---------HHHHHHhCCC-----
Confidence               23445689999999999999999999999999999999999999997543211         1111111110     


Q ss_pred             cccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          322 FHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       322 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                       ..........++.+.+|+.+||+.||.+|||+.|+++
T Consensus       246 -~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         246 -EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             -CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             -CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             0011111122356899999999999999999999965

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-52  Score=384.35  Aligned_cols=251  Identities=24%  Similarity=0.393  Sum_probs=196.2

Q ss_pred             cCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEec-CCcceEEEEeCC
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLE-TEVPLLVYEFAS  165 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~-~~~~~lv~e~~~  165 (414)
                      ++|++.+.||+|+||.||+|.+ .|+.||||+++.+.. ...+.+|++++++++||||++++|+|.+ .+..|+||||++
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~~-~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~   84 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT-AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA   84 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred             HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHHH-HHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccC
Confidence            5688889999999999999998 578899999976543 3455677899999999999999999865 456899999999


Q ss_pred             CCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcccc
Q 015027          166 NGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAETA  245 (414)
Q Consensus       166 ~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  245 (414)
                      +|+|.+++..... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....    
T Consensus        85 ~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~----  156 (262)
T d1byga_          85 KGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----  156 (262)
T ss_dssp             TEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred             CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC----
Confidence            9999999965432 24589999999999999999999977   999999999999999999999999999875432    


Q ss_pred             ceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhccccccccccccc
Q 015027          246 MSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNFHV  324 (414)
Q Consensus       246 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (414)
                       .....+|+.|+|||++.+..++.++|||||||++|||+| |++||.......         ....+.... .    +..
T Consensus       157 -~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---------~~~~i~~~~-~----~~~  221 (262)
T d1byga_         157 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---------VVPRVEKGY-K----MDA  221 (262)
T ss_dssp             ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---------HHHHHTTTC-C----CCC
T ss_pred             -CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---------HHHHHHcCC-C----CCC
Confidence             233467889999999999999999999999999999998 788876433221         111111111 1    111


Q ss_pred             CCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHH
Q 015027          325 ADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR  366 (414)
Q Consensus       325 ~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~  366 (414)
                      .    ...++.+.+|+.+||+.||.+|||+.+|++.|+.++.
T Consensus       222 ~----~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         222 P----DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             C----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             C----ccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence            1    1122568999999999999999999999999998863

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-52  Score=385.31  Aligned_cols=249  Identities=23%  Similarity=0.296  Sum_probs=200.8

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc-------hhHhHHHHHHHHHccCCCceeeeeeeEecCCcc
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK-------IRITERELLRIISQVNHKNVVKILGLCLETEVP  157 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~  157 (414)
                      .++|++.+.||+|+||+||+|.+. +|+.||||++.....       ......+|+.++++++|||||+++++|.+++..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            467999999999999999999975 689999999975422       123456778999999999999999999999999


Q ss_pred             eEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCC----cEEEeecc
Q 015027          158 LLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNY----TAKVADFE  233 (414)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~----~~kl~DfG  233 (414)
                      |+|||||++|+|.+++....   .+++..++.++.||+.||+|||+.+   |+||||||+|||++.++    .+||+|||
T Consensus        89 ~iv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG  162 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG  162 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEcCCCccccchhcccc---ccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence            99999999999999996543   4588999999999999999999988   99999999999998776    59999999


Q ss_pred             ccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcc
Q 015027          234 SSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKN  313 (414)
Q Consensus       234 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  313 (414)
                      +|......   .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+...         ....+..
T Consensus       163 ~a~~~~~~---~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---------~~~~i~~  230 (293)
T d1jksa_         163 LAHKIDFG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---------TLANVSA  230 (293)
T ss_dssp             TCEECTTS---CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---------HHHHHHT
T ss_pred             hhhhcCCC---ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH---------HHHHHHh
Confidence            99876543   22344579999999999999999999999999999999999999997433211         1111111


Q ss_pred             cccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHH
Q 015027          314 NGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVS  358 (414)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~  358 (414)
                      ....      .........+..+.+|+.+||+.||.+|||+++++
T Consensus       231 ~~~~------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil  269 (293)
T d1jksa_         231 VNYE------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSL  269 (293)
T ss_dssp             TCCC------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred             cCCC------CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence            1000      00000011225689999999999999999999984

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-52  Score=385.59  Aligned_cols=256  Identities=22%  Similarity=0.343  Sum_probs=193.6

Q ss_pred             cCCCCCCccccCCceEEEEEEEcC----CcEEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLHD----NIQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLETEVPLLV  160 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv  160 (414)
                      ++|++.+.||+|+||.||+|.+..    +..||||.+......  ...+.+++.++++++|||||++++++. ++..|+|
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv   85 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII   85 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence            578899999999999999998643    356899988654322  344567889999999999999999986 4678999


Q ss_pred             EEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccC
Q 015027          161 YEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISS  240 (414)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  240 (414)
                      |||+++|+|.+++....  ..+++..++.++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||+|+....
T Consensus        86 ~E~~~~g~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~  160 (273)
T d1mp8a_          86 MELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  160 (273)
T ss_dssp             EECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             EEeccCCcHHhhhhccC--CCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheeccC
Confidence            99999999999876543  34588999999999999999999988   99999999999999999999999999987654


Q ss_pred             CccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhcccccccc
Q 015027          241 DAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQI  319 (414)
Q Consensus       241 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (414)
                      .. ........||+.|+|||++.+..++.++|||||||++|||++ |.+||.......         ....+...... .
T Consensus       161 ~~-~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---------~~~~i~~~~~~-~  229 (273)
T d1mp8a_         161 ST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---------VIGRIENGERL-P  229 (273)
T ss_dssp             -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---------HHHHHHTTCCC-C
T ss_pred             Cc-ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH---------HHHHHHcCCCC-C
Confidence            32 223345678999999999999999999999999999999998 899987543221         11111111110 0


Q ss_pred             cccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHh
Q 015027          320 LNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRL  367 (414)
Q Consensus       320 ~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~  367 (414)
                      .+        ...++.+.+|+.+||+.||.+|||+.+|++.|+.+.+.
T Consensus       230 ~~--------~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  269 (273)
T d1mp8a_         230 MP--------PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  269 (273)
T ss_dssp             CC--------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CC--------CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            11        11235699999999999999999999999999987643

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.6e-52  Score=392.17  Aligned_cols=260  Identities=22%  Similarity=0.317  Sum_probs=208.1

Q ss_pred             HhcCCCCCCccccCCceEEEEEEEc------CCcEEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEecCCc
Q 015027           85 ATKNFDRSRCLSQGGFVSVYKGVLH------DNIQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLETEV  156 (414)
Q Consensus        85 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~  156 (414)
                      ..++|++.+.||+|+||+||+|+..      +++.||||++......  ...+.+|+.++++++||||++++++|...+.
T Consensus        11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~   90 (301)
T d1lufa_          11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP   90 (301)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence            3568999999999999999999964      3578999999764433  3445777899999999999999999999999


Q ss_pred             ceEEEEeCCCCchhhhhhhcCC---------------------cccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCC
Q 015027          157 PLLVYEFASNGTLLDHIRCESS---------------------QVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVK  215 (414)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~~---------------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlk  215 (414)
                      .++||||+++|+|.+++.....                     ...+++..++.++.||+.||+|||+.+   |+|||||
T Consensus        91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlK  167 (301)
T d1lufa_          91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA  167 (301)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred             eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEc
Confidence            9999999999999999864321                     233688899999999999999999987   9999999


Q ss_pred             CCceeeCCCCcEEEeeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCC-CCCCccc
Q 015027          216 SANILLNDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGK-KPGSCMT  294 (414)
Q Consensus       216 p~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~-~p~~~~~  294 (414)
                      |+|||++.++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||++|. +||....
T Consensus       168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~  247 (301)
T d1lufa_         168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA  247 (301)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence            999999999999999999998765544444455668899999999999999999999999999999999985 6776433


Q ss_pred             cccccccccchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHH
Q 015027          295 LASNKKISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLR  365 (414)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~  365 (414)
                      ...         ....+......     ..    +...++++.+|+.+||+.+|++|||+.+|.+.|++|.
T Consensus       248 ~~e---------~~~~v~~~~~~-----~~----p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         248 HEE---------VIYYVRDGNIL-----AC----PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             HHH---------HHHHHHTTCCC-----CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             HHH---------HHHHHHcCCCC-----CC----CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            211         11112111111     01    1112256999999999999999999999999998864

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-51  Score=389.59  Aligned_cols=246  Identities=23%  Similarity=0.263  Sum_probs=200.9

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc----hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK----IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~  161 (414)
                      ++|++++.||+|+||.||+|+.. +|+.||||++.....    .......|+.++++++||||++++++|.+++..|+||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            67999999999999999999975 699999999976432    2233456778999999999999999999999999999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCC
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD  241 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  241 (414)
                      |||+||+|.+++.....   +++..++.++.||+.||+|||+++   |+||||||+|||++.+|.+||+|||+|+.....
T Consensus        85 ey~~gg~L~~~~~~~~~---~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~  158 (337)
T d1o6la_          85 EYANGGELFFHLSRERV---FTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             ECCTTCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             eccCCCchhhhhhcccC---CcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence            99999999999876443   478889999999999999999988   999999999999999999999999999876443


Q ss_pred             ccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccc
Q 015027          242 AETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILN  321 (414)
Q Consensus       242 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (414)
                      .  ......+||+.|+|||++.+..|+.++|||||||++|||++|++||...+...         ..........     
T Consensus       159 ~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~---------~~~~i~~~~~-----  222 (337)
T d1o6la_         159 G--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---------LFELILMEEI-----  222 (337)
T ss_dssp             T--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---------HHHHHHHCCC-----
T ss_pred             C--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH---------HHHHHhcCCC-----
Confidence            2  23345689999999999999999999999999999999999999997544211         1111111110     


Q ss_pred             cccCCcccHHHHHHHHHHHHHhhccCCCCCCC-----hhHHHH
Q 015027          322 FHVADESEMKEIEIVAELASKCLRIRGTERPT-----MKQVSE  359 (414)
Q Consensus       322 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps-----~~~v~~  359 (414)
                       ..+    ...++++.+||.+||+.||.+||+     ++++++
T Consensus       223 -~~p----~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         223 -RFP----RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             -CCC----TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             -CCC----ccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence             111    112356899999999999999995     666643

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-52  Score=390.57  Aligned_cols=263  Identities=23%  Similarity=0.326  Sum_probs=195.2

Q ss_pred             hcCCCCCCccccCCceEEEEEEEcC------CcEEEEEEeecccchh--HhHHHHHHHHHcc-CCCceeeeeeeEecC-C
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLHD------NIQVAVKTYRRADKIR--ITERELLRIISQV-NHKNVVKILGLCLET-E  155 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~--~~~~~~~~~l~~l-~hpniv~l~~~~~~~-~  155 (414)
                      .++|++.+.||+|+||.||+|.+..      ++.||||+++......  ..+..+...+.++ +||||+.+++++... .
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~   91 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   91 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence            4689999999999999999999642      4679999987543322  2233334455444 789999999998754 4


Q ss_pred             cceEEEEeCCCCchhhhhhhcCC-------------cccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeC
Q 015027          156 VPLLVYEFASNGTLLDHIRCESS-------------QVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLN  222 (414)
Q Consensus       156 ~~~lv~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~  222 (414)
                      ..++|||||++|+|.+++.....             ...+++..++.++.||+.||+|||+++   |+||||||+|||++
T Consensus        92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~  168 (299)
T d1ywna1          92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLS  168 (299)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC
T ss_pred             eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeEC
Confidence            68999999999999999965432             234688999999999999999999987   99999999999999


Q ss_pred             CCCcEEEeeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhC-CCCCCcccccccccc
Q 015027          223 DNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTG-KKPGSCMTLASNKKI  301 (414)
Q Consensus       223 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg-~~p~~~~~~~~~~~~  301 (414)
                      .++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||+|| .+||.......    
T Consensus       169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~----  244 (299)
T d1ywna1         169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE----  244 (299)
T ss_dssp             GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH----
T ss_pred             CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH----
Confidence            9999999999999876655444444566899999999999999999999999999999999997 56776432211    


Q ss_pred             ccchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHHhh
Q 015027          302 SMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRRLH  368 (414)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~~~  368 (414)
                          .+...+.....     +..+.    ..++.+.+|+.+||+.||++|||+.+|++.|+.+.+.+
T Consensus       245 ----~~~~~~~~~~~-----~~~~~----~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~n  298 (299)
T d1ywna1         245 ----EFCRRLKEGTR-----MRAPD----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  298 (299)
T ss_dssp             ----HHHHHHHHTCC-----CCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ----HHHHHHhcCCC-----CCCCc----cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCC
Confidence                11111111110     11111    12256899999999999999999999999999886543

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.9e-51  Score=385.30  Aligned_cols=243  Identities=25%  Similarity=0.301  Sum_probs=198.9

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc----hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK----IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~  161 (414)
                      ++|++++.||+|+||+||+|++. +|+.||||++.....    ......+|+.++++++|||||++++++.+++..|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            57999999999999999999975 589999999975422    2234466789999999999999999999999999999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCC
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD  241 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  241 (414)
                      |||+||+|..++.....   .++..+..++.||+.||+|||+++   |+||||||+|||++.+|.+||+|||+|+.....
T Consensus        84 E~~~gg~l~~~~~~~~~---~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~  157 (316)
T d1fota_          84 DYIEGGELFSLLRKSQR---FPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  157 (316)
T ss_dssp             CCCCSCBHHHHHHHTSS---CCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             eecCCcccccccccccc---ccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence            99999999988865443   367888889999999999999987   999999999999999999999999999876532


Q ss_pred             ccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccc
Q 015027          242 AETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILN  321 (414)
Q Consensus       242 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (414)
                           ....+||+.|||||++.+..|+.++|||||||++|||++|+.||...+...         ....+.....  .++
T Consensus       158 -----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~---------~~~~i~~~~~--~~p  221 (316)
T d1fota_         158 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK---------TYEKILNAEL--RFP  221 (316)
T ss_dssp             -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---------HHHHHHHCCC--CCC
T ss_pred             -----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH---------HHHHHHcCCC--CCC
Confidence                 234689999999999999999999999999999999999999997533211         1111111110  011


Q ss_pred             cccCCcccHHHHHHHHHHHHHhhccCCCCCC-----ChhHHHH
Q 015027          322 FHVADESEMKEIEIVAELASKCLRIRGTERP-----TMKQVSE  359 (414)
Q Consensus       322 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rp-----s~~~v~~  359 (414)
                      +        ..++.+.+++.+||..||.+||     |++++++
T Consensus       222 ~--------~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         222 P--------FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             T--------TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             C--------CCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence            1        1225589999999999999996     7888743

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-51  Score=386.55  Aligned_cols=275  Identities=22%  Similarity=0.334  Sum_probs=202.8

Q ss_pred             cCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecCC----cceEEEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETE----VPLLVYE  162 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~----~~~lv~e  162 (414)
                      .+|.+.+.||+|+||.||+|++ +|+.||||++............++..+.+++||||++++++|.+.+    ..|+|||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E   81 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD   81 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence            4577788999999999999997 6889999999765433222233344556789999999999998654    5789999


Q ss_pred             eCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhC-----CCCCeeeCCCCCCceeeCCCCcEEEeecccccc
Q 015027          163 FASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSL-----ASPPIIHGDVKSANILLNDNYTAKVADFESSVL  237 (414)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-----~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~  237 (414)
                      ||++|+|.+++...    .++|..++.++.|++.||+|||+.     ..++|+||||||+||||+.++.+||+|||++..
T Consensus        82 y~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~  157 (303)
T d1vjya_          82 YHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  157 (303)
T ss_dssp             CCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             cccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence            99999999999653    358999999999999999999974     124599999999999999999999999999987


Q ss_pred             ccCCcccc--ceecccccccccchhhcccCC------CCCcccchhHHHHHHHHHhCCCCCCccccccccccccchh--h
Q 015027          238 ISSDAETA--MSTILIGTSGYLDPVCINTGK------LTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPY--F  307 (414)
Q Consensus       238 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~--~  307 (414)
                      ........  ......||+.|+|||++.+..      ++.++|||||||+||||+||..||................  .
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~  237 (303)
T d1vjya_         158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS  237 (303)
T ss_dssp             EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred             ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence            75432221  234568999999999987643      6779999999999999999999886444332222211111  0


Q ss_pred             hhhhcccccccccccccCCc-ccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHH
Q 015027          308 LNSIKNNGLRQILNFHVADE-SEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR  366 (414)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~  366 (414)
                      ............+.+.+... ........+.+|+.+||+.||++|||+.||++.|+++.+
T Consensus       238 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  297 (303)
T d1vjya_         238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             HHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence            00011111111111222111 123345669999999999999999999999999998875

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-51  Score=385.74  Aligned_cols=260  Identities=24%  Similarity=0.337  Sum_probs=204.0

Q ss_pred             hcCCCCCCccccCCceEEEEEEEcC--------CcEEEEEEeecccchh--HhHHHHHHHHHcc-CCCceeeeeeeEecC
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLHD--------NIQVAVKTYRRADKIR--ITERELLRIISQV-NHKNVVKILGLCLET  154 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~--~~~~~~~~~l~~l-~hpniv~l~~~~~~~  154 (414)
                      .++|.+.+.||+|+||.||+|+...        +..||||+++.+....  ..+..+...+.++ +|||||+++++|.++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            3678889999999999999998542        2479999997654322  3334455666666 899999999999999


Q ss_pred             CcceEEEEeCCCCchhhhhhhcCC-------------cccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceee
Q 015027          155 EVPLLVYEFASNGTLLDHIRCESS-------------QVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILL  221 (414)
Q Consensus       155 ~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll  221 (414)
                      +..++|||||++|+|.+++.....             ...+++..++.++.||+.||+|||+.+   |+||||||+|||+
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence            999999999999999999965432             234689999999999999999999988   9999999999999


Q ss_pred             CCCCcEEEeeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccc
Q 015027          222 NDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKK  300 (414)
Q Consensus       222 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~  300 (414)
                      +.++.+||+|||+++...............||+.|+|||.+.++.|+.++|||||||++|||++ |.+||.......   
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~---  245 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---  245 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---
T ss_pred             cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH---
Confidence            9999999999999998776555445556789999999999999999999999999999999998 788886433211   


Q ss_pred             cccchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHH
Q 015027          301 ISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR  366 (414)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~  366 (414)
                            ....+... .....+        ...++.+.+|+.+||+.||++|||+.+|++.|+++..
T Consensus       246 ------~~~~i~~~-~~~~~p--------~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         246 ------LFKLLKEG-HRMDKP--------SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             ------HHHHHHTT-CCCCCC--------SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------HHHHHHcC-CCCCCC--------ccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence                  11111111 111111        1123569999999999999999999999999998864

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=5.3e-51  Score=377.40  Aligned_cols=258  Identities=26%  Similarity=0.330  Sum_probs=197.9

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch----hHhHHHHHHHHHccCCCceeeeeeeEecCC----c
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI----RITERELLRIISQVNHKNVVKILGLCLETE----V  156 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~hpniv~l~~~~~~~~----~  156 (414)
                      .++|++.+.||+|+||+||+|.+. +|+.||||+++.....    ...+.+|+++++.++||||+++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            467999999999999999999975 6999999999754322    233467789999999999999999997654    3


Q ss_pred             ceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccc
Q 015027          157 PLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSV  236 (414)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~  236 (414)
                      .|+||||++|++|.+++...+   .+++..++.++.||+.||+|||+++   |+||||||+|||++.++.++|+|||.+.
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR  159 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred             EEEEEECCCCCEehhhhcccC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence            789999999999999886543   3588999999999999999999988   9999999999999999999999999987


Q ss_pred             cccCCcc-ccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccc
Q 015027          237 LISSDAE-TAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNG  315 (414)
Q Consensus       237 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (414)
                      ....... ........||+.|+|||++.+..++.++|||||||++|||+||+.||...+...        ..........
T Consensus       160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~--------~~~~~~~~~~  231 (277)
T d1o6ya_         160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS--------VAYQHVREDP  231 (277)
T ss_dssp             ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------HHHHHHHCCC
T ss_pred             hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH--------HHHHHHhcCC
Confidence            6543322 223445689999999999999999999999999999999999999997433211        0111111111


Q ss_pred             cc-cccccccCCcccHHHHHHHHHHHHHhhccCCCCCC-ChhHHHHHHHHHH
Q 015027          316 LR-QILNFHVADESEMKEIEIVAELASKCLRIRGTERP-TMKQVSEELDRLR  365 (414)
Q Consensus       316 ~~-~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rp-s~~~v~~~L~~i~  365 (414)
                      .. ....+        ..++.+.+|+.+||+.||.+|| |++++++.|.++.
T Consensus       232 ~~~~~~~~--------~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         232 IPPSARHE--------GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             CCGGGTSS--------SCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             CCCchhcc--------CCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence            00 00111        1225699999999999999999 8999998888765

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-51  Score=379.93  Aligned_cols=255  Identities=24%  Similarity=0.331  Sum_probs=192.8

Q ss_pred             cCCCCCCccccCCceEEEEEEEcC--C--cEEEEEEeeccc----chhHhHHHHHHHHHccCCCceeeeeeeEecCCcce
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLHD--N--IQVAVKTYRRAD----KIRITERELLRIISQVNHKNVVKILGLCLETEVPL  158 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~----~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~  158 (414)
                      ++|++.+.||+|+||.||+|+...  +  ..||||++....    .....+.+|+.++++++||||++++|+|.+ +..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            568999999999999999998642  2  368999987542    222345677899999999999999999975 4678


Q ss_pred             EEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccc
Q 015027          159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLI  238 (414)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~  238 (414)
                      +||||+++|+|.+++.....  .+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        87 lv~e~~~~~~l~~~~~~~~~--~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~  161 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL  161 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHGG--GSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eeeeeecCcchhhhhhcccC--CCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence            99999999999998865433  3588999999999999999999977   999999999999999999999999999987


Q ss_pred             cCCcccc-ceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccccccchhhhhhhccccc
Q 015027          239 SSDAETA-MSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKKISMVPYFLNSIKNNGL  316 (414)
Q Consensus       239 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (414)
                      ....... ......|+..|+|||++.+..++.++|||||||++|||+| |..||...+...         ....+.....
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~---------~~~~i~~~~~  232 (273)
T d1u46a_         162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---------ILHKIDKEGE  232 (273)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---------HHHHHHTSCC
T ss_pred             ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH---------HHHHHHhCCC
Confidence            5543322 2334567889999999999999999999999999999998 899997543221         1111111111


Q ss_pred             ccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHH
Q 015027          317 RQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL  364 (414)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i  364 (414)
                      ..        +.+...+..+.+|+.+||+.||++|||+.+|.+.|++.
T Consensus       233 ~~--------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         233 RL--------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             CC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CC--------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            11        11111225699999999999999999999999888764

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-51  Score=386.71  Aligned_cols=261  Identities=25%  Similarity=0.380  Sum_probs=207.6

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc------CCcEEEEEEeecccchh--HhHHHHHHHHHcc-CCCceeeeeeeEecCCc
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH------DNIQVAVKTYRRADKIR--ITERELLRIISQV-NHKNVVKILGLCLETEV  156 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~--~~~~~~~~~l~~l-~hpniv~l~~~~~~~~~  156 (414)
                      .++|++.+.||+|+||.||+|++.      +++.||||+++......  ..+.+++.+++++ +|||||+++++|.+.+.
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~  101 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence            367888999999999999999852      35789999997654322  3345667888888 69999999999999999


Q ss_pred             ceEEEEeCCCCchhhhhhhcC---------------CcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceee
Q 015027          157 PLLVYEFASNGTLLDHIRCES---------------SQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILL  221 (414)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll  221 (414)
                      .++|||||++|+|.+++....               ....+++..+..++.||+.||+|||+++   ++||||||+|||+
T Consensus       102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~  178 (311)
T d1t46a_         102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL  178 (311)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence            999999999999999986543               2235688999999999999999999988   9999999999999


Q ss_pred             CCCCcEEEeeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHh-CCCCCCccccccccc
Q 015027          222 NDNYTAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLT-GKKPGSCMTLASNKK  300 (414)
Q Consensus       222 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~p~~~~~~~~~~~  300 (414)
                      +.++.+|++|||+++...............||+.|+|||++.+..++.++|||||||++|||+| |.+||.......   
T Consensus       179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~---  255 (311)
T d1t46a_         179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS---  255 (311)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH---
T ss_pred             cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH---
Confidence            9999999999999998765544444556789999999999999999999999999999999999 556654322111   


Q ss_pred             cccchhhhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHH
Q 015027          301 ISMVPYFLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR  366 (414)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~  366 (414)
                           .+...+ .....        ...+...+..+.+|+.+||+.||.+|||+.+|++.|+++..
T Consensus       256 -----~~~~~i-~~~~~--------~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~  307 (311)
T d1t46a_         256 -----KFYKMI-KEGFR--------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS  307 (311)
T ss_dssp             -----HHHHHH-HHTCC--------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----HHHHHH-hcCCC--------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence                 011111 11111        11111223569999999999999999999999999987643

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-51  Score=384.88  Aligned_cols=251  Identities=18%  Similarity=0.246  Sum_probs=203.9

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeC
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFA  164 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~  164 (414)
                      .++|.+.+.||+|+||+||+|.+. +++.||||+++..........+|+++|+.++|||||+++++|.+++.+|+|||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~   83 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI   83 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence            367999999999999999999976 5889999999876655555667789999999999999999999999999999999


Q ss_pred             CCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCC--CCcEEEeeccccccccCCc
Q 015027          165 SNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLND--NYTAKVADFESSVLISSDA  242 (414)
Q Consensus       165 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~--~~~~kl~DfGla~~~~~~~  242 (414)
                      +||+|.+++....  ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.  .+.+||+|||++...... 
T Consensus        84 ~gg~L~~~i~~~~--~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~-  157 (321)
T d1tkia_          84 SGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-  157 (321)
T ss_dssp             CCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred             CCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC-
Confidence            9999999996543  24589999999999999999999988   999999999999984  458999999999876532 


Q ss_pred             cccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccccc
Q 015027          243 ETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNF  322 (414)
Q Consensus       243 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (414)
                        .......+|+.|+|||.+.+..++.++|||||||++|+|++|..||.......         ....+......  ++.
T Consensus       158 --~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~---------~~~~i~~~~~~--~~~  224 (321)
T d1tkia_         158 --DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ---------IIENIMNAEYT--FDE  224 (321)
T ss_dssp             --CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---------HHHHHHHTCCC--CCH
T ss_pred             --CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH---------HHHHHHhCCCC--CCh
Confidence              23345689999999999999999999999999999999999999997543211         11111111100  000


Q ss_pred             ccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          323 HVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       323 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                          ......++.+.+|+.+||..||.+|||+.|+++
T Consensus       225 ----~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         225 ----EAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             ----HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ----hhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                000011356899999999999999999999975

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.3e-50  Score=387.98  Aligned_cols=246  Identities=20%  Similarity=0.245  Sum_probs=195.4

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch-------hHhHHHHHHHHHccCCCceeeeeeeEecCCcce
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI-------RITERELLRIISQVNHKNVVKILGLCLETEVPL  158 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~  158 (414)
                      ++|++.+.||+|+||.||+|... +|+.||||++......       ...+..++.+++.++|||||+++++|.+.+..|
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            67999999999999999999976 5899999998653211       122344567888889999999999999999999


Q ss_pred             EEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccc
Q 015027          159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLI  238 (414)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~  238 (414)
                      +|||||+||+|.+++....   .+++..++.++.||+.||.|||+.+   |+||||||+|||++.+|.+||+|||+|+..
T Consensus        84 ivmE~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~  157 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF  157 (364)
T ss_dssp             EEECCCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred             EEEEecCCCcHHHHHHhcc---cccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence            9999999999999996543   3478899999999999999999988   999999999999999999999999999876


Q ss_pred             cCCccccceecccccccccchhhcc-cCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccc
Q 015027          239 SSDAETAMSTILIGTSGYLDPVCIN-TGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLR  317 (414)
Q Consensus       239 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (414)
                      ...    ......||+.|+|||++. +..|+.++|||||||++|||+||+.||........     . .........   
T Consensus       158 ~~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-----~-~~~~~~~~~---  224 (364)
T d1omwa3         158 SKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----H-EIDRMTLTM---  224 (364)
T ss_dssp             SSS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH-----H-HHHHHSSSC---
T ss_pred             CCC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH-----H-HHHHhcccC---
Confidence            543    234458999999999996 45789999999999999999999999975332110     0 000000000   


Q ss_pred             cccccccCCcccHHHHHHHHHHHHHhhccCCCCCCC-----hhHHH
Q 015027          318 QILNFHVADESEMKEIEIVAELASKCLRIRGTERPT-----MKQVS  358 (414)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps-----~~~v~  358 (414)
                         ......    ..++.+.+||.+||+.||.+|||     +++++
T Consensus       225 ---~~~~~~----~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil  263 (364)
T d1omwa3         225 ---AVELPD----SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK  263 (364)
T ss_dssp             ---CCCCCS----SSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHH
T ss_pred             ---CCCCCC----CCCHHHHHHHHHHcccCHHHhCCCcccCHHHHH
Confidence               000111    12256999999999999999999     46664

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.5e-50  Score=373.44  Aligned_cols=248  Identities=23%  Similarity=0.308  Sum_probs=199.5

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch----------hHhHHHHHHHHHccC-CCceeeeeeeEecC
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI----------RITERELLRIISQVN-HKNVVKILGLCLET  154 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----------~~~~~~~~~~l~~l~-hpniv~l~~~~~~~  154 (414)
                      ++|++.+.||+|+||+||+|+.. +|+.||||++......          .....+|+.++++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            68999999999999999999975 6899999999765321          123456778999997 99999999999999


Q ss_pred             CcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccc
Q 015027          155 EVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFES  234 (414)
Q Consensus       155 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGl  234 (414)
                      +..|||||||++|+|.+++...+   .+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~  156 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF  156 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             cceEEEEEcCCCchHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence            99999999999999999997544   3589999999999999999999988   99999999999999999999999999


Q ss_pred             cccccCCccccceecccccccccchhhccc------CCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhh
Q 015027          235 SVLISSDAETAMSTILIGTSGYLDPVCINT------GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFL  308 (414)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~  308 (414)
                      +.......   ......||+.|+|||++.+      ..++.++||||+||++|||++|+.||.......         ..
T Consensus       157 a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~---------~~  224 (277)
T d1phka_         157 SCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML---------ML  224 (277)
T ss_dssp             CEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---------HH
T ss_pred             eeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH---------HH
Confidence            98765432   2344689999999999853      357889999999999999999999997543211         11


Q ss_pred             hhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHH
Q 015027          309 NSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVS  358 (414)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~  358 (414)
                      ..+......      .........++++.+|+.+||+.||++|||+.+|+
T Consensus       225 ~~i~~~~~~------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil  268 (277)
T d1phka_         225 RMIMSGNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEAL  268 (277)
T ss_dssp             HHHHHTCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHT
T ss_pred             HHHHhCCCC------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHH
Confidence            111111110      01111112235699999999999999999999983

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.7e-50  Score=385.21  Aligned_cols=243  Identities=22%  Similarity=0.258  Sum_probs=199.7

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc----hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK----IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVY  161 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~  161 (414)
                      ++|++++.||+|+||.||+|.+. +|+.||||++.....    .......++++++.++|||||++++++.+....++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            57999999999999999999975 699999999975432    2233466779999999999999999999999999999


Q ss_pred             EeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCC
Q 015027          162 EFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSD  241 (414)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  241 (414)
                      ||+.+|+|.+++....   .+++..+..++.||+.||.|||+++   |+||||||+|||++.+|.+||+|||+|+.....
T Consensus       121 e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             ccccccchhhhHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence            9999999999986544   3588999999999999999999988   999999999999999999999999999876532


Q ss_pred             ccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccccccccc
Q 015027          242 AETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILN  321 (414)
Q Consensus       242 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (414)
                           .....||+.|||||++.+..++.++|||||||++|||++|+.||...+...         ....+.....     
T Consensus       195 -----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~---------~~~~i~~~~~-----  255 (350)
T d1rdqe_         195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ---------IYEKIVSGKV-----  255 (350)
T ss_dssp             -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---------HHHHHHHCCC-----
T ss_pred             -----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH---------HHHHHhcCCC-----
Confidence                 234689999999999999999999999999999999999999997433211         1111111110     


Q ss_pred             cccCCcccHHHHHHHHHHHHHhhccCCCCCC-----ChhHHHH
Q 015027          322 FHVADESEMKEIEIVAELASKCLRIRGTERP-----TMKQVSE  359 (414)
Q Consensus       322 ~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rp-----s~~~v~~  359 (414)
                       ..+    ...++.+.+|+.+||+.||.+|+     |++++++
T Consensus       256 -~~p----~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         256 -RFP----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             -CCC----TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             -CCC----ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence             001    11235699999999999999994     7888753

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-51  Score=384.36  Aligned_cols=256  Identities=27%  Similarity=0.389  Sum_probs=201.3

Q ss_pred             cCCCCCCccccCCceEEEEEEEcC-Cc--EEEEEEeecccc--hhHhHHHHHHHHHcc-CCCceeeeeeeEecCCcceEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLHD-NI--QVAVKTYRRADK--IRITERELLRIISQV-NHKNVVKILGLCLETEVPLLV  160 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~--~~~~~~~~~~~l~~l-~hpniv~l~~~~~~~~~~~lv  160 (414)
                      ++|++.++||+|+||+||+|.+.+ |.  .||||.+.....  ....+.+|+++++++ +|||||+++++|.+++..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            678889999999999999999754 44  478888764322  233456777999998 799999999999999999999


Q ss_pred             EEeCCCCchhhhhhhc-------------CCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcE
Q 015027          161 YEFASNGTLLDHIRCE-------------SSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTA  227 (414)
Q Consensus       161 ~e~~~~gsL~~~l~~~-------------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~  227 (414)
                      |||+++|+|.+++...             .....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence            9999999999998643             22345689999999999999999999987   9999999999999999999


Q ss_pred             EEeeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCC-CCCCccccccccccccchh
Q 015027          228 KVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGK-KPGSCMTLASNKKISMVPY  306 (414)
Q Consensus       228 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~-~p~~~~~~~~~~~~~~~~~  306 (414)
                      ||+|||+++......   ......||+.|+|||.+.+..++.++|||||||++|||++|. +||.......         
T Consensus       167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~---------  234 (309)
T d1fvra_         167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---------  234 (309)
T ss_dssp             EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---------
T ss_pred             EEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH---------
Confidence            999999998654321   223456899999999999999999999999999999999975 5676433211         


Q ss_pred             hhhhhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHH
Q 015027          307 FLNSIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR  366 (414)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~  366 (414)
                      ....+....         ..+.+...++.+.+|+.+||+.||++|||+.+|++.|+++.+
T Consensus       235 ~~~~i~~~~---------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~  285 (309)
T d1fvra_         235 LYEKLPQGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  285 (309)
T ss_dssp             HHHHGGGTC---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHhcC---------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            111111110         011111223569999999999999999999999999998864

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-50  Score=381.83  Aligned_cols=245  Identities=23%  Similarity=0.285  Sum_probs=196.8

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc-----hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK-----IRITERELLRIISQVNHKNVVKILGLCLETEVPLLV  160 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv  160 (414)
                      ++|.+.+.||+|+||+||+|... +|+.||||++.....     ......++..+...++|||||++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            57899999999999999999976 589999999975421     112223443344578999999999999999999999


Q ss_pred             EEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccC
Q 015027          161 YEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISS  240 (414)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  240 (414)
                      ||||++|+|.+++.....   +++..+..++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+++....
T Consensus        82 mEy~~~g~L~~~i~~~~~---~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~  155 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML  155 (320)
T ss_dssp             EECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EeecCCCcHHHHhhccCC---CCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence            999999999999975443   478899999999999999999988   99999999999999999999999999986654


Q ss_pred             CccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccc
Q 015027          241 DAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQIL  320 (414)
Q Consensus       241 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (414)
                      ..  .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+...         ....+....     
T Consensus       156 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~---------~~~~i~~~~-----  219 (320)
T d1xjda_         156 GD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---------LFHSIRMDN-----  219 (320)
T ss_dssp             TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---------HHHHHHHCC-----
T ss_pred             cc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH---------HHHHHHcCC-----
Confidence            32  23345689999999999999999999999999999999999999997543211         111111111     


Q ss_pred             ccccCCcccHHHHHHHHHHHHHhhccCCCCCCChh-HHH
Q 015027          321 NFHVADESEMKEIEIVAELASKCLRIRGTERPTMK-QVS  358 (414)
Q Consensus       321 ~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~-~v~  358 (414)
                       +..+.    ..++.+.+|+.+||+.||.+|||+. +++
T Consensus       220 -~~~p~----~~s~~~~dli~~~L~~dP~~R~s~~~~l~  253 (320)
T d1xjda_         220 -PFYPR----WLEKEAKDLLVKLFVREPEKRLGVRGDIR  253 (320)
T ss_dssp             -CCCCT----TSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             -CCCCc----cCCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence             11111    1235699999999999999999996 664

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-50  Score=384.11  Aligned_cols=252  Identities=22%  Similarity=0.261  Sum_probs=194.5

Q ss_pred             hcCCCCCC-ccccCCceEEEEEEEc-CCcEEEEEEeecccchhHhHHHHHHHHH-ccCCCceeeeeeeEec----CCcce
Q 015027           86 TKNFDRSR-CLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRITERELLRIIS-QVNHKNVVKILGLCLE----TEVPL  158 (414)
Q Consensus        86 ~~~~~~~~-~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~l~-~l~hpniv~l~~~~~~----~~~~~  158 (414)
                      .++|.+.. .||+|+||+||+|.+. +++.||||+++...    ...+++.++. ..+|||||+++++|.+    +..+|
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~----~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~   85 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP----KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   85 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCcH----HHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence            36788875 5999999999999974 68999999987543    2334456544 4589999999999875    45689


Q ss_pred             EEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCC---CCcEEEeecccc
Q 015027          159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLND---NYTAKVADFESS  235 (414)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~DfGla  235 (414)
                      +|||||+||+|.+++...+. ..+++..++.++.||+.||+|||+.+   |+||||||+|||++.   ++.+||+|||+|
T Consensus        86 ivmEy~~gg~L~~~i~~~~~-~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a  161 (335)
T d2ozaa1          86 IVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA  161 (335)
T ss_dssp             EEEECCCSEEHHHHHHSCSC-CCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEECCCCCcHHHHHHhcCC-CCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccccccccee
Confidence            99999999999999975433 34688999999999999999999988   999999999999985   567999999999


Q ss_pred             ccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccc
Q 015027          236 VLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNG  315 (414)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (414)
                      +......   ......||+.|+|||++.+..|+.++|||||||++|+|+||+.||.+......     ........... 
T Consensus       162 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~-----~~~~~~~i~~~-  232 (335)
T d2ozaa1         162 KETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----SPGMKTRIRMG-  232 (335)
T ss_dssp             EECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------------CCCSC-
T ss_pred             eeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH-----HHHHHHHHhcC-
Confidence            8765432   23456899999999999999999999999999999999999999964332110     00000000000 


Q ss_pred             cccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          316 LRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                           ....+.......++++.+|+.+||+.||++|||+.++++
T Consensus       233 -----~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         233 -----QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             -----SSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             -----CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                 001111112233467999999999999999999999976

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-50  Score=376.63  Aligned_cols=253  Identities=27%  Similarity=0.381  Sum_probs=196.6

Q ss_pred             CCccccCCceEEEEEEEcC----CcEEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEec-CCcceEEEEeC
Q 015027           92 SRCLSQGGFVSVYKGVLHD----NIQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLE-TEVPLLVYEFA  164 (414)
Q Consensus        92 ~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~-~~~~~lv~e~~  164 (414)
                      .++||+|+||+||+|++..    ...||||.++.....  ...+.+|++++++++||||++++|++.. +...++|||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            4679999999999999653    235899999753332  2445778899999999999999999875 45789999999


Q ss_pred             CCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCccc
Q 015027          165 SNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAET  244 (414)
Q Consensus       165 ~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  244 (414)
                      ++|+|.+++.....  ..++..++.++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++........
T Consensus       112 ~~g~l~~~~~~~~~--~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         112 KHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             TTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred             ecCchhhhhccccc--cchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence            99999998865443  3367888999999999999999977   999999999999999999999999999876543222


Q ss_pred             --cceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccccccccccc
Q 015027          245 --AMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNGLRQILNF  322 (414)
Q Consensus       245 --~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (414)
                        .......||+.|+|||.+.+..++.++||||||+++|||+||..||.......    .....    +..+ .....+.
T Consensus       187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~----~~~~~----i~~g-~~~~~p~  257 (311)
T d1r0pa_         187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF----DITVY----LLQG-RRLLQPE  257 (311)
T ss_dssp             CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC----------CHHH----HHTT-CCCCCCT
T ss_pred             cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH----HHHHH----HHcC-CCCCCcc
Confidence              12233578999999999999999999999999999999999877765321110    01111    1111 1111111


Q ss_pred             ccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHH
Q 015027          323 HVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR  366 (414)
Q Consensus       323 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~  366 (414)
                              ..++.+.+|+.+||+.||++|||+.||++.|+.+..
T Consensus       258 --------~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~  293 (311)
T d1r0pa_         258 --------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  293 (311)
T ss_dssp             --------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --------cCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                    112559999999999999999999999999988864

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-50  Score=379.19  Aligned_cols=258  Identities=24%  Similarity=0.379  Sum_probs=207.0

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc------CCcEEEEEEeecccchh--HhHHHHHHHHHccCCCceeeeeeeEecCCcc
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH------DNIQVAVKTYRRADKIR--ITERELLRIISQVNHKNVVKILGLCLETEVP  157 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~--~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~  157 (414)
                      .++|.+.+.||+|+||+||+|.+.      +++.||||+++......  ..+.+++.++++++||||++++++|..++..
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~   98 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   98 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence            467889999999999999999864      25789999997654332  2346778999999999999999999999999


Q ss_pred             eEEEEeCCCCchhhhhhhcC-------CcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEe
Q 015027          158 LLVYEFASNGTLLDHIRCES-------SQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVA  230 (414)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~-------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~  230 (414)
                      ++|||||++|+|.+++....       ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++++||+
T Consensus        99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~  175 (308)
T d1p4oa_          99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG  175 (308)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred             eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence            99999999999999885432       2234588899999999999999999977   9999999999999999999999


Q ss_pred             eccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhC-CCCCCccccccccccccchhhhh
Q 015027          231 DFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTG-KKPGSCMTLASNKKISMVPYFLN  309 (414)
Q Consensus       231 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg-~~p~~~~~~~~~~~~~~~~~~~~  309 (414)
                      |||+|+...............||+.|+|||.+.+..++.++|||||||++|||+|| .+||.......         ...
T Consensus       176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~---------~~~  246 (308)
T d1p4oa_         176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ---------VLR  246 (308)
T ss_dssp             CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH---------HHH
T ss_pred             ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH---------HHH
Confidence            99999877655444444555789999999999999999999999999999999998 47776433211         111


Q ss_pred             hhcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHH
Q 015027          310 SIKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRL  364 (414)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i  364 (414)
                      .+.......         .+...++.+.+|+.+||+.+|.+|||+++|++.|+..
T Consensus       247 ~i~~~~~~~---------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~  292 (308)
T d1p4oa_         247 FVMEGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE  292 (308)
T ss_dssp             HHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred             HHHhCCCCC---------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            111111100         1111225699999999999999999999999887664

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-49  Score=371.21  Aligned_cols=259  Identities=20%  Similarity=0.189  Sum_probs=188.7

Q ss_pred             CCCccccCCceEEEEEEEc-CCcEEEEEEeecccch------hHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEe
Q 015027           91 RSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI------RITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        91 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  163 (414)
                      .+++||+|+||+||+|.+. +|+.||||+++.....      .....+|+.++++++|||||++++++.+++..|+||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            4578999999999999975 5899999998754322      22345678999999999999999999999999999999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcc
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE  243 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  243 (414)
                      ++++++..+....   ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|........
T Consensus        82 ~~~~~~~~~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~  155 (299)
T d1ua2a_          82 METDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR  155 (299)
T ss_dssp             CSEEHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred             hcchHHhhhhhcc---cCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc
Confidence            9998777665432   33467888999999999999999988   99999999999999999999999999987654322


Q ss_pred             ccceecccccccccchhhccc-CCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhh----hhhhc-ccccc
Q 015027          244 TAMSTILIGTSGYLDPVCINT-GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYF----LNSIK-NNGLR  317 (414)
Q Consensus       244 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~----~~~~~-~~~~~  317 (414)
                        .....+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||...+...... .+....    ...+. .....
T Consensus       156 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~-~i~~~~~~~~~~~~~~~~~~~  232 (299)
T d1ua2a_         156 --AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLT-RIFETLGTPTEEQWPDMCSLP  232 (299)
T ss_dssp             --CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-HHHHHHCCCCTTTSSSTTSST
T ss_pred             --cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHH-HHHHhcCCCChhhccchhccc
Confidence              2334579999999999864 468999999999999999999999997543211000 000000    00000 00000


Q ss_pred             cccc-cccCCccc----HHHHHHHHHHHHHhhccCCCCCCChhHHH
Q 015027          318 QILN-FHVADESE----MKEIEIVAELASKCLRIRGTERPTMKQVS  358 (414)
Q Consensus       318 ~~~~-~~~~~~~~----~~~~~~l~~Li~~cl~~dP~~Rps~~~v~  358 (414)
                      .... ........    ...++.+.+|+.+||+.||++|||++|++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L  278 (299)
T d1ua2a_         233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL  278 (299)
T ss_dssp             TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHH
T ss_pred             hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence            0000 00000000    01125689999999999999999999984

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-49  Score=372.41  Aligned_cols=266  Identities=19%  Similarity=0.200  Sum_probs=194.1

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc---hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK---IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYE  162 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  162 (414)
                      ++|++++.||+|+||+||+|.+. +|+.||||+++....   ......+|++++++++|||||+++++|.+++..|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            57999999999999999999975 689999999965432   23445677899999999999999999999999999999


Q ss_pred             eCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCc
Q 015027          163 FASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDA  242 (414)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  242 (414)
                      |+.++.+ +++.... ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+|+......
T Consensus        82 ~~~~~~~-~~~~~~~-~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~  156 (298)
T d1gz8a_          82 FLHQDLK-KFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  156 (298)
T ss_dssp             CCSEEHH-HHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred             ecCCchh-hhhhhhc-ccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence            9976544 4443222 233589999999999999999999988   9999999999999999999999999998765432


Q ss_pred             cccceecccccccccchhhcccCC-CCCcccchhHHHHHHHHHhCCCCCCcccccccccc------ccchhhhhhhc-cc
Q 015027          243 ETAMSTILIGTSGYLDPVCINTGK-LTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKI------SMVPYFLNSIK-NN  314 (414)
Q Consensus       243 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~------~~~~~~~~~~~-~~  314 (414)
                      .  ......||+.|+|||++.... ++.++|||||||++|+|++|+.||...+.......      ...+....... ..
T Consensus       157 ~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  234 (298)
T d1gz8a_         157 R--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP  234 (298)
T ss_dssp             B--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             c--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccc
Confidence            2  233458999999999887655 57899999999999999999999975432110000      00000000000 00


Q ss_pred             ccccccccccCCcc---cHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          315 GLRQILNFHVADES---EMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       315 ~~~~~~~~~~~~~~---~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ..............   ....++.+.+|+.+||+.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~  282 (298)
T d1gz8a_         235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA  282 (298)
T ss_dssp             TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            00000000000000   0011256899999999999999999999853

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-50  Score=369.25  Aligned_cols=238  Identities=22%  Similarity=0.327  Sum_probs=190.7

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchh-------HhHHHHHHHHHccC--CCceeeeeeeEecCC
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIR-------ITERELLRIISQVN--HKNVVKILGLCLETE  155 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~~~~l~~l~--hpniv~l~~~~~~~~  155 (414)
                      .++|++.+.||+|+||+||+|++. +|+.||||++.......       .....|+.++++++  |||||++++++.+++
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            367999999999999999999975 68999999997543211       11234567888776  899999999999999


Q ss_pred             cceEEEEeCCC-CchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCC-CCcEEEeecc
Q 015027          156 VPLLVYEFASN-GTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLND-NYTAKVADFE  233 (414)
Q Consensus       156 ~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~DfG  233 (414)
                      ..|+||||+.+ +++.+++....   .+++..++.++.||+.||+|||+.+   |+||||||+|||++. ++.+||+|||
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~~---~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG  156 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG  156 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             eEEEEEEeccCcchHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccc
Confidence            99999999976 57777775433   3588999999999999999999988   999999999999985 5799999999


Q ss_pred             ccccccCCccccceecccccccccchhhcccCCC-CCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhc
Q 015027          234 SSVLISSDAETAMSTILIGTSGYLDPVCINTGKL-TKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIK  312 (414)
Q Consensus       234 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  312 (414)
                      +|......    ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||......               .
T Consensus       157 ~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i---------------~  217 (273)
T d1xwsa_         157 SGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI---------------I  217 (273)
T ss_dssp             TCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH---------------H
T ss_pred             cceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHH---------------h
Confidence            99875432    2345689999999999987765 57799999999999999999999743210               0


Q ss_pred             ccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHH
Q 015027          313 NNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVS  358 (414)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~  358 (414)
                      ...  ..+...        .++++.+|+.+||+.||++|||++|++
T Consensus       218 ~~~--~~~~~~--------~s~~~~~li~~~L~~dp~~R~s~~eil  253 (273)
T d1xwsa_         218 RGQ--VFFRQR--------VSSECQHLIRWCLALRPSDRPTFEEIQ  253 (273)
T ss_dssp             HCC--CCCSSC--------CCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             hcc--cCCCCC--------CCHHHHHHHHHHccCCHhHCcCHHHHh
Confidence            000  011111        125589999999999999999999984

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-49  Score=368.73  Aligned_cols=264  Identities=20%  Similarity=0.252  Sum_probs=190.6

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-C-CcEEEEEEeecccch---hH---hHHHHHHHHHccCCCceeeeeeeEec----
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-D-NIQVAVKTYRRADKI---RI---TERELLRIISQVNHKNVVKILGLCLE----  153 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~---~~---~~~~~~~~l~~l~hpniv~l~~~~~~----  153 (414)
                      .++|++++.||+|+||+||+|.+. + ++.||||+++.....   ..   .+.++++.++..+||||++++++|..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            478999999999999999999974 4 667999998754221   11   22334455566689999999999853    


Q ss_pred             -CCcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeec
Q 015027          154 -TEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADF  232 (414)
Q Consensus       154 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df  232 (414)
                       ....+++|||++++++.......  ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df  160 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF  160 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred             cCceEEEEEEeccCCchhhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence             34679999999988775444332  234588899999999999999999988   999999999999999999999999


Q ss_pred             cccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhh----h
Q 015027          233 ESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYF----L  308 (414)
Q Consensus       233 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~----~  308 (414)
                      |++......   .......||+.|+|||++.+..|+.++|||||||++|||++|+.||...+...... .+....    .
T Consensus       161 g~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~-~i~~~~~~~~~  236 (305)
T d1blxa_         161 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG-KILDVIGLPGE  236 (305)
T ss_dssp             CSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-HHHHHHCCCCG
T ss_pred             hhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHH-HHHHhhCCCch
Confidence            998865432   23455689999999999999999999999999999999999999997543211000 000000    0


Q ss_pred             hhhccc-cc-ccccc---cccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHH
Q 015027          309 NSIKNN-GL-RQILN---FHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVS  358 (414)
Q Consensus       309 ~~~~~~-~~-~~~~~---~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~  358 (414)
                      ..+... .. .....   ...........++.+.+|+.+||+.||++|||+.|++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L  291 (305)
T d1blxa_         237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL  291 (305)
T ss_dssp             GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred             hcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHh
Confidence            000000 00 00000   0000000111225689999999999999999999984

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=4.8e-49  Score=365.97  Aligned_cols=264  Identities=21%  Similarity=0.196  Sum_probs=195.0

Q ss_pred             cCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccc---hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEe
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADK---IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~  163 (414)
                      ++|++++.||+|+||+||+|.+++|+.||||++.....   ....+.+|+.++++++|||||+++++|..++..+++|||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            58999999999999999999998899999999976432   234556778999999999999999999999999999999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCcc
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDAE  243 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  243 (414)
                      +.++.+..+....   ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++........
T Consensus        82 ~~~~~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~  155 (286)
T d1ob3a_          82 LDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (286)
T ss_dssp             CSEEHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             ehhhhHHHHHhhc---CCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence            9887776665432   34588999999999999999999987   99999999999999999999999999987654322


Q ss_pred             ccceecccccccccchhhcccC-CCCCcccchhHHHHHHHHHhCCCCCCccccccccccc-------cchhhhhhhcccc
Q 015027          244 TAMSTILIGTSGYLDPVCINTG-KLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKIS-------MVPYFLNSIKNNG  315 (414)
Q Consensus       244 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~-------~~~~~~~~~~~~~  315 (414)
                        ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||............       ....+........
T Consensus       156 --~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  233 (286)
T d1ob3a_         156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK  233 (286)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             --ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhh
Confidence              23344789999999998654 5689999999999999999999999754321100000       0000000000000


Q ss_pred             cccccc---cccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHH
Q 015027          316 LRQILN---FHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVS  358 (414)
Q Consensus       316 ~~~~~~---~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~  358 (414)
                      ......   ...........++.+.+|+.+||+.||++|||++|++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell  279 (286)
T d1ob3a_         234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL  279 (286)
T ss_dssp             CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred             cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence            000000   0000000011125689999999999999999999985

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-48  Score=370.78  Aligned_cols=263  Identities=21%  Similarity=0.222  Sum_probs=191.0

Q ss_pred             CCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhHhHHHHHHHHHccCCCceeeeeeeEecC------CcceEE
Q 015027           88 NFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVKILGLCLET------EVPLLV  160 (414)
Q Consensus        88 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~l~~~~~~~------~~~~lv  160 (414)
                      +|...++||+|+||+||+|++. +|+.||||++.......   .+|++++++++||||++++++|...      ...|+|
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~---~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv   97 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV   97 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSC---CHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHH---HHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence            5778899999999999999976 58999999997654332   2456889999999999999998543      346899


Q ss_pred             EEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCC-cEEEeecccccccc
Q 015027          161 YEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNY-TAKVADFESSVLIS  239 (414)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~DfGla~~~~  239 (414)
                      ||||+++.+............+++..+..++.||+.||+|||+++   |+||||||+|||++.++ .+||+|||++....
T Consensus        98 ~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~  174 (350)
T d1q5ka_          98 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV  174 (350)
T ss_dssp             EECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred             EeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhcc
Confidence            999987655544433334455689999999999999999999987   99999999999999765 89999999998765


Q ss_pred             CCccccceecccccccccchhhccc-CCCCCcccchhHHHHHHHHHhCCCCCCcccccccccc------ccchhhhhhhc
Q 015027          240 SDAETAMSTILIGTSGYLDPVCINT-GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKI------SMVPYFLNSIK  312 (414)
Q Consensus       240 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~------~~~~~~~~~~~  312 (414)
                      ..   .......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...+.......      ...........
T Consensus       175 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~  251 (350)
T d1q5ka_         175 RG---EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN  251 (350)
T ss_dssp             TT---SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred             CC---cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence            43   22344689999999998765 5789999999999999999999999975432110000      00000000000


Q ss_pred             c----cccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          313 N----NGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       313 ~----~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      .    ...................++.+.+|+.+||+.||.+|||+.|+++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0    0000000000000001112356899999999999999999999854

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-47  Score=356.45  Aligned_cols=267  Identities=21%  Similarity=0.256  Sum_probs=189.5

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc---hhHhHHHHHHHHHccCCCceeeeeeeEec--------
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK---IRITERELLRIISQVNHKNVVKILGLCLE--------  153 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~hpniv~l~~~~~~--------  153 (414)
                      .++|++++.||+|+||+||+|++. +|+.||||++.....   ......+|+.+|++++||||+++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            378999999999999999999975 699999999865432   23345667899999999999999999855        


Q ss_pred             CCcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecc
Q 015027          154 TEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFE  233 (414)
Q Consensus       154 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfG  233 (414)
                      ....|+||||+.++.+......   ....++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~---~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg  162 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG  162 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred             CceEEEEEeccCCCccchhhhc---ccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence            3457999999988776654432   223477888999999999999999988   9999999999999999999999999


Q ss_pred             ccccccCCccc--cceecccccccccchhhcccC-CCCCcccchhHHHHHHHHHhCCCCCCcccccccccc------ccc
Q 015027          234 SSVLISSDAET--AMSTILIGTSGYLDPVCINTG-KLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKI------SMV  304 (414)
Q Consensus       234 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~------~~~  304 (414)
                      ++.........  ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||...........      ...
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~  242 (318)
T d3blha1         163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  242 (318)
T ss_dssp             TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            99766543221  123345799999999998765 689999999999999999999999975332110000      000


Q ss_pred             hhhhhhhcccccccccccccCCccc-------HHHHHHHHHHHHHhhccCCCCCCChhHHH
Q 015027          305 PYFLNSIKNNGLRQILNFHVADESE-------MKEIEIVAELASKCLRIRGTERPTMKQVS  358 (414)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~l~~Li~~cl~~dP~~Rps~~~v~  358 (414)
                      +........................       ....+.+.+|+.+||+.||++|||++|++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL  303 (318)
T d3blha1         243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL  303 (318)
T ss_dssp             TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred             hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHH
Confidence            0000000000000000000000000       01124678999999999999999999984

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.6e-46  Score=348.72  Aligned_cols=263  Identities=20%  Similarity=0.194  Sum_probs=195.3

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhHhHHHHHHHHHccCCCceee-eeeeEecCCcceEEEEe
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRITERELLRIISQVNHKNVVK-ILGLCLETEVPLLVYEF  163 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpniv~-l~~~~~~~~~~~lv~e~  163 (414)
                      .++|++.+.||+|+||+||+|++. +|+.||||++...... .....+.++++.++|+|++. +.+++.+++..++||||
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            367999999999999999999975 5899999998765433 33455668899998776555 45556777888999999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeC---CCCcEEEeeccccccccC
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLN---DNYTAKVADFESSVLISS  240 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~---~~~~~kl~DfGla~~~~~  240 (414)
                      +. ++|.+.+....  ..+++..+..++.|++.||+|||+++   |+||||||+|||++   .+..+||+|||+|+....
T Consensus        85 ~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~  158 (299)
T d1ckia_          85 LG-PSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  158 (299)
T ss_dssp             CC-CBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred             cC-Cchhhhhhhcc--CCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence            94 56666654433  23588999999999999999999988   99999999999986   456799999999987654


Q ss_pred             Cccc-----cceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcccc
Q 015027          241 DAET-----AMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNNG  315 (414)
Q Consensus       241 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (414)
                      ....     .......||+.|||||++.+..++.++|||||||++|||++|+.||...........  .    .......
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~--~----~~~~~~~  232 (299)
T d1ckia_         159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK--Y----ERISEKK  232 (299)
T ss_dssp             TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC---------H----HHHHHHH
T ss_pred             cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHH--H----HHhhccc
Confidence            3221     223456899999999999999999999999999999999999999975432221110  0    0000000


Q ss_pred             cccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHH
Q 015027          316 LRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR  366 (414)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~  366 (414)
                      .. ...+.....    .++++.+|+.+||+.+|.+||++.++.+.|+.+..
T Consensus       233 ~~-~~~~~~~~~----~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~  278 (299)
T d1ckia_         233 MS-TPIEVLCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  278 (299)
T ss_dssp             HH-SCHHHHTTT----SCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred             CC-CChhHhccC----CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence            00 000000111    12558999999999999999999999888887643

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-47  Score=362.13  Aligned_cols=267  Identities=18%  Similarity=0.212  Sum_probs=191.7

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch--hHhHHHHHHHHHccCCCceeeeeeeEecCC----cce
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI--RITERELLRIISQVNHKNVVKILGLCLETE----VPL  158 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~hpniv~l~~~~~~~~----~~~  158 (414)
                      +.+|++++.||+|+||+||+|.+. +|+.||||++......  .....+|+.+|++++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            467999999999999999999975 6999999999754322  234467789999999999999999997653    235


Q ss_pred             EEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccc
Q 015027          159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLI  238 (414)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~  238 (414)
                      ++++|+.+|+|.+++...    .+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++...
T Consensus        87 ~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~  159 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA  159 (345)
T ss_dssp             EEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence            566777899999999643    3588999999999999999999988   999999999999999999999999999876


Q ss_pred             cCCccc-cceecccccccccchhhcc-cCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccc------hhhhhh
Q 015027          239 SSDAET-AMSTILIGTSGYLDPVCIN-TGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMV------PYFLNS  310 (414)
Q Consensus       239 ~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~------~~~~~~  310 (414)
                      ...... ......+||+.|+|||++. +..++.++||||+||++|+|++|+.||..............      ......
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (345)
T d1pmea_         160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC  239 (345)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred             cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence            543222 1234567999999999984 55678999999999999999999999975432111000000      000000


Q ss_pred             hc---ccccccccccccCCcc---cHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          311 IK---NNGLRQILNFHVADES---EMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       311 ~~---~~~~~~~~~~~~~~~~---~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ..   ................   ....+..+.+|+.+||+.||.+|||++++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~  294 (345)
T d1pmea_         240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  294 (345)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00   0000000000000000   0011245899999999999999999999953

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=4.5e-46  Score=346.71  Aligned_cols=263  Identities=17%  Similarity=0.177  Sum_probs=202.6

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhHhHHHHHHHHHccCC-CceeeeeeeEecCCcceEEEEe
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRITERELLRIISQVNH-KNVVKILGLCLETEVPLLVYEF  163 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h-pniv~l~~~~~~~~~~~lv~e~  163 (414)
                      .++|++.+.||+|+||+||+|++. +|+.||||++...... ....++++.+..+.| +|++.+++++..+...++||||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~   82 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL   82 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc-HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence            468999999999999999999976 5899999998654432 233455677777765 8999999999999999999999


Q ss_pred             CCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCC-----CCcEEEeeccccccc
Q 015027          164 ASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLND-----NYTAKVADFESSVLI  238 (414)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~-----~~~~kl~DfGla~~~  238 (414)
                      + +++|.+++.....  .+++..+..++.|++.||+|||+.+   |+||||||+|||++.     ++.+||+|||+|+..
T Consensus        83 ~-~~~l~~~~~~~~~--~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~  156 (293)
T d1csna_          83 L-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  156 (293)
T ss_dssp             C-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             c-CCCHHHHHHhhcc--chhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence            9 6799988865443  3488999999999999999999988   999999999999974     578999999999876


Q ss_pred             cCCccc-----cceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhcc
Q 015027          239 SSDAET-----AMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKN  313 (414)
Q Consensus       239 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  313 (414)
                      ......     .......||+.|||||++.+..++.++|||||||++|||++|..||..........      ....+..
T Consensus       157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~------~~~~i~~  230 (293)
T d1csna_         157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ------KYERIGE  230 (293)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH------HHHHHHH
T ss_pred             ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHH------HHHHHHh
Confidence            543221     12345689999999999999999999999999999999999999997543222110      0000000


Q ss_pred             cccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHH
Q 015027          314 NGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSEELDRLRR  366 (414)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~~L~~i~~  366 (414)
                      ... ......+...    .++++.+++..|+..+|.+||+++.+.+.|+.+.+
T Consensus       231 ~~~-~~~~~~l~~~----~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~  278 (293)
T d1csna_         231 KKQ-STPLRELCAG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE  278 (293)
T ss_dssp             HHH-HSCHHHHTTT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             ccC-CCChHHhcCC----CCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHH
Confidence            000 0000001111    12558999999999999999999999888887653

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2.8e-46  Score=354.02  Aligned_cols=258  Identities=18%  Similarity=0.278  Sum_probs=192.1

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhHhHHHHHHHHHccC-CCceeeeeeeEec--CCcceEEEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRITERELLRIISQVN-HKNVVKILGLCLE--TEVPLLVYE  162 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~-hpniv~l~~~~~~--~~~~~lv~e  162 (414)
                      ++|+++++||+|+||+||+|++. +|+.||||+++...  .....+|+.+|..++ ||||++++++|..  ....++|||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e  112 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE  112 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC--HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH--HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence            57999999999999999999975 68999999987543  234456678888885 9999999999974  456899999


Q ss_pred             eCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCC-CcEEEeeccccccccCC
Q 015027          163 FASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDN-YTAKVADFESSVLISSD  241 (414)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~DfGla~~~~~~  241 (414)
                      ||++++|..+..      .+++..+..++.||+.||.|||+++   |+||||||+|||++.+ +.+||+|||+|......
T Consensus       113 ~~~~~~L~~~~~------~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~  183 (328)
T d3bqca1         113 HVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  183 (328)
T ss_dssp             CCCSCBGGGTTT------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred             ecCCCcHHHHhc------CCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccCC
Confidence            999999987652      3588999999999999999999988   9999999999999865 46999999999876543


Q ss_pred             ccccceecccccccccchhhcccC-CCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchh--------hhhh--
Q 015027          242 AETAMSTILIGTSGYLDPVCINTG-KLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPY--------FLNS--  310 (414)
Q Consensus       242 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~--------~~~~--  310 (414)
                      .   ......+|+.|+|||.+.+. .++.++|||||||++|||++|+.||............+...        ....  
T Consensus       184 ~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  260 (328)
T d3bqca1         184 Q---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN  260 (328)
T ss_dssp             C---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred             C---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence            2   23456789999999998765 47999999999999999999999986433211100000000        0000  


Q ss_pred             ---------hcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHH
Q 015027          311 ---------IKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVS  358 (414)
Q Consensus       311 ---------~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~  358 (414)
                               ......................++++.+|+.+||..||++|||++|++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L  317 (328)
T d3bqca1         261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM  317 (328)
T ss_dssp             CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence                     000000000000111111122335689999999999999999999984

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-46  Score=357.33  Aligned_cols=260  Identities=22%  Similarity=0.269  Sum_probs=187.5

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch---hHhHHHHHHHHHccCCCceeeeeeeEecCC------
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI---RITERELLRIISQVNHKNVVKILGLCLETE------  155 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~hpniv~l~~~~~~~~------  155 (414)
                      .++|++++.||+|+||+||+|.+. +|+.||||+++.....   .....+|+++|++++|||||+++++|...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            468999999999999999999975 5999999999754322   233466789999999999999999997654      


Q ss_pred             cceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeecccc
Q 015027          156 VPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESS  235 (414)
Q Consensus       156 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla  235 (414)
                      .+|+||||+ +.+|..++..    ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+|++|||+|
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a  168 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA  168 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecc-cccHHHHHHh----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence            469999999 5577776643    23588999999999999999999988   999999999999999999999999999


Q ss_pred             ccccCCccccceecccccccccchhhccc-CCCCCcccchhHHHHHHHHHhCCCCCCcccccccccc------ccchhhh
Q 015027          236 VLISSDAETAMSTILIGTSGYLDPVCINT-GKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKI------SMVPYFL  308 (414)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~------~~~~~~~  308 (414)
                      +.....     .+...||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......      .....+.
T Consensus       169 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  243 (346)
T d1cm8a_         169 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV  243 (346)
T ss_dssp             EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             eccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence            876533     244679999999999876 4578999999999999999999999975432110000      0000000


Q ss_pred             hhhccc-------ccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHHH
Q 015027          309 NSIKNN-------GLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVSE  359 (414)
Q Consensus       309 ~~~~~~-------~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~~  359 (414)
                      ......       .........+. ......++.+.+|+.+||..||.+|||+.|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~  300 (346)
T d1cm8a_         244 QRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  300 (346)
T ss_dssp             HTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hhhcchhhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            000000       00000000000 000111245889999999999999999999954

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-46  Score=349.00  Aligned_cols=264  Identities=17%  Similarity=0.193  Sum_probs=196.9

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccc---hhHhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEE
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADK---IRITERELLRIISQVNHKNVVKILGLCLETEVPLLVYE  162 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  162 (414)
                      ++|++++.||+|+||+||+|++. +++.||||+++....   ......+|+.+++.++||||++++++|.+....++|++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            57999999999999999999975 688999999975532   23445677899999999999999999999999999999


Q ss_pred             eCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccccccCCc
Q 015027          163 FASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSVLISSDA  242 (414)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  242 (414)
                      ++.+++|..++....   ..++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||.+.......
T Consensus        82 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~  155 (292)
T d1unla_          82 FCDQDLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSEEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred             ecccccccccccccc---ccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence            999999888775433   3478899999999999999999988   9999999999999999999999999998765432


Q ss_pred             cccceecccccccccchhhcccCC-CCCcccchhHHHHHHHHHhCCCCCCccccccccccccch-----------hhhhh
Q 015027          243 ETAMSTILIGTSGYLDPVCINTGK-LTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVP-----------YFLNS  310 (414)
Q Consensus       243 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~-----------~~~~~  310 (414)
                      .  ......+++.|+|||.+.+.. ++.++|||||||++|||++|+.||............+..           .....
T Consensus       156 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (292)
T d1unla_         156 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL  233 (292)
T ss_dssp             S--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred             c--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhc
Confidence            2  233446788999999987655 689999999999999999999997432211110000000           00000


Q ss_pred             hcccccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHH
Q 015027          311 IKNNGLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPTMKQVS  358 (414)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~  358 (414)
                      ......................++.+.+|+.+||+.||.+|||++|++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L  281 (292)
T d1unla_         234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL  281 (292)
T ss_dssp             TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred             ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence            000000000000000011111235689999999999999999999983

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-46  Score=352.66  Aligned_cols=250  Identities=22%  Similarity=0.265  Sum_probs=193.8

Q ss_pred             cCCCCCCccccCCceEEEEEEEc----CCcEEEEEEeeccc-----chhHhHHHHHHHHHccCC-CceeeeeeeEecCCc
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH----DNIQVAVKTYRRAD-----KIRITERELLRIISQVNH-KNVVKILGLCLETEV  156 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-----~~~~~~~~~~~~l~~l~h-pniv~l~~~~~~~~~  156 (414)
                      ++|++++.||+|+||+||+|...    +|+.||||++....     ........|++++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            66999999999999999999852    47899999986432     122334556788899876 899999999999999


Q ss_pred             ceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccc
Q 015027          157 PLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSV  236 (414)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~  236 (414)
                      .++||||+.+|+|.+++......   ++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~~~---~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~  177 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRERF---TEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK  177 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSCC---CHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             eeeeeecccccHHHHHHHhcccc---cHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence            99999999999999999765533   67888889999999999999987   9999999999999999999999999998


Q ss_pred             cccCCccccceecccccccccchhhcccC--CCCCcccchhHHHHHHHHHhCCCCCCccccccccccccchhhhhhhccc
Q 015027          237 LISSDAETAMSTILIGTSGYLDPVCINTG--KLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKISMVPYFLNSIKNN  314 (414)
Q Consensus       237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  314 (414)
                      ....... .......|++.|+|||.+.+.  .++.++|||||||+||+|++|+.||........     ...........
T Consensus       178 ~~~~~~~-~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~-----~~~i~~~~~~~  251 (322)
T d1vzoa_         178 EFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-----QAEISRRILKS  251 (322)
T ss_dssp             ECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-----HHHHHHHHHHC
T ss_pred             hhccccc-ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHHhcccC
Confidence            7654322 234456899999999999754  478899999999999999999999975432221     00000000000


Q ss_pred             ccccccccccCCcccHHHHHHHHHHHHHhhccCCCCCCC-----hhHHH
Q 015027          315 GLRQILNFHVADESEMKEIEIVAELASKCLRIRGTERPT-----MKQVS  358 (414)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps-----~~~v~  358 (414)
                            .+..    +...+..+.+|+.+||++||.+|||     ++|++
T Consensus       252 ------~~~~----~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil  290 (322)
T d1vzoa_         252 ------EPPY----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIK  290 (322)
T ss_dssp             ------CCCC----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHH
T ss_pred             ------CCCC----cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHH
Confidence                  0001    1122356999999999999999995     56663

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-46  Score=354.34  Aligned_cols=260  Identities=20%  Similarity=0.224  Sum_probs=186.1

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch---hHhHHHHHHHHHccCCCceeeeeeeEec------CCc
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI---RITERELLRIISQVNHKNVVKILGLCLE------TEV  156 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~hpniv~l~~~~~~------~~~  156 (414)
                      ++|++++.||+|+||+||+|.+. +|+.||||++......   .....+++.++++++||||++++++|..      ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            68999999999999999999976 5999999999765322   2234677799999999999999999964      367


Q ss_pred             ceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccc
Q 015027          157 PLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSV  236 (414)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~  236 (414)
                      .|+|||||.++.+.. +.     ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+|++|||+++
T Consensus        97 ~~iv~Ey~~~~l~~~-~~-----~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~  167 (355)
T d2b1pa1          97 VYLVMELMDANLCQV-IQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_dssp             EEEEEECCSEEHHHH-HT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             eEEEEeccchHHHHh-hh-----cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence            899999997765543 32     23578999999999999999999988   9999999999999999999999999988


Q ss_pred             cccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCcccccccccc------ccchhhhh-
Q 015027          237 LISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKI------SMVPYFLN-  309 (414)
Q Consensus       237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~------~~~~~~~~-  309 (414)
                      .....   .......+|+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+.......      ...+.+.. 
T Consensus       168 ~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~  244 (355)
T d2b1pa1         168 TAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK  244 (355)
T ss_dssp             ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             ccccc---cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence            76533   233456799999999999999999999999999999999999999964432110000      00000000 


Q ss_pred             -------hhcc------cccccccccc---cCCcccHHHHHHHHHHHHHhhccCCCCCCChhHHH
Q 015027          310 -------SIKN------NGLRQILNFH---VADESEMKEIEIVAELASKCLRIRGTERPTMKQVS  358 (414)
Q Consensus       310 -------~~~~------~~~~~~~~~~---~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~  358 (414)
                             ....      ......+...   .........++.+.+|+.+||..||++|||++|++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL  309 (355)
T d2b1pa1         245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL  309 (355)
T ss_dssp             SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred             hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHh
Confidence                   0000      0000011111   11112334567899999999999999999999994

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-45  Score=347.54  Aligned_cols=261  Identities=21%  Similarity=0.283  Sum_probs=188.9

Q ss_pred             hcCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccch---hHhHHHHHHHHHccCCCceeeeeeeEecC-----Cc
Q 015027           86 TKNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKI---RITERELLRIISQVNHKNVVKILGLCLET-----EV  156 (414)
Q Consensus        86 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~hpniv~l~~~~~~~-----~~  156 (414)
                      +++|++++.||+|+||+||+|++. +|+.||||++......   .....+|++++++++|||||++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            568999999999999999999975 6999999999754322   22345678999999999999999998643     34


Q ss_pred             ceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEeeccccc
Q 015027          157 PLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVADFESSV  236 (414)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~  236 (414)
                      .+++|+|+.+|+|.+++...    .+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+|++|||++.
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~  169 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR  169 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred             eEEEEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence            56778888899999998532    3688999999999999999999988   9999999999999999999999999987


Q ss_pred             cccCCccccceecccccccccchhhcccC-CCCCcccchhHHHHHHHHHhCCCCCCccccccccccc------cchhhhh
Q 015027          237 LISSDAETAMSTILIGTSGYLDPVCINTG-KLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKIS------MVPYFLN  309 (414)
Q Consensus       237 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~~------~~~~~~~  309 (414)
                      .....     .....||+.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+........      .......
T Consensus       170 ~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~  244 (348)
T d2gfsa1         170 HTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK  244 (348)
T ss_dssp             CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred             ccCcc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence            65432     2345789999999987665 4689999999999999999999999754321100000      0000000


Q ss_pred             hhcccccccccc--cccCCcc----cHHHHHHHHHHHHHhhccCCCCCCChhHHH
Q 015027          310 SIKNNGLRQILN--FHVADES----EMKEIEIVAELASKCLRIRGTERPTMKQVS  358 (414)
Q Consensus       310 ~~~~~~~~~~~~--~~~~~~~----~~~~~~~l~~Li~~cl~~dP~~Rps~~~v~  358 (414)
                      ............  .......    ....++.+.+|+.+||..||.+|||+.|++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL  299 (348)
T d2gfsa1         245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL  299 (348)
T ss_dssp             TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHh
Confidence            000000000000  0000000    001125689999999999999999999984

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.2e-41  Score=324.63  Aligned_cols=264  Identities=20%  Similarity=0.233  Sum_probs=188.0

Q ss_pred             cCCCCCCccccCCceEEEEEEEc-CCcEEEEEEeecccchhHhHHHHHHHHHccC-----------CCceeeeeeeEec-
Q 015027           87 KNFDRSRCLSQGGFVSVYKGVLH-DNIQVAVKTYRRADKIRITERELLRIISQVN-----------HKNVVKILGLCLE-  153 (414)
Q Consensus        87 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~-----------hpniv~l~~~~~~-  153 (414)
                      .+|++++.||+|+||+||+|++. +|+.||||+++..........+++++++.++           |+||+++++++.. 
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~   92 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   92 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence            35999999999999999999975 6999999999876544444455556666554           6889999998864 


Q ss_pred             -CCcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhh-CCCCCeeeCCCCCCceeeCCCC------
Q 015027          154 -TEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHS-LASPPIIHGDVKSANILLNDNY------  225 (414)
Q Consensus       154 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~iiH~Dlkp~NIll~~~~------  225 (414)
                       ....+++|+++..+...............++..+..++.||+.||+|||+ .+   |+||||||+|||++.++      
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~~  169 (362)
T d1q8ya_          93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLI  169 (362)
T ss_dssp             ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEE
T ss_pred             cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccccc
Confidence             34567778877666554444444444556888999999999999999998 65   99999999999998654      


Q ss_pred             cEEEeeccccccccCCccccceecccccccccchhhcccCCCCCcccchhHHHHHHHHHhCCCCCCcccccccccc--cc
Q 015027          226 TAKVADFESSVLISSDAETAMSTILIGTSGYLDPVCINTGKLTKKSDVYSFGVVLAELLTGKKPGSCMTLASNKKI--SM  303 (414)
Q Consensus       226 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~p~~~~~~~~~~~~--~~  303 (414)
                      .++++|||.+......     .....||+.|+|||++.+..++.++||||+||++++|++|+.||...........  .+
T Consensus       170 ~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~  244 (362)
T d1q8ya_         170 QIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI  244 (362)
T ss_dssp             EEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred             eeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence            4999999998765432     2445799999999999999999999999999999999999999974332111000  00


Q ss_pred             c----------hhhhhh-------hcccccccccc----------cccCCcccHHHHHHHHHHHHHhhccCCCCCCChhH
Q 015027          304 V----------PYFLNS-------IKNNGLRQILN----------FHVADESEMKEIEIVAELASKCLRIRGTERPTMKQ  356 (414)
Q Consensus       304 ~----------~~~~~~-------~~~~~~~~~~~----------~~~~~~~~~~~~~~l~~Li~~cl~~dP~~Rps~~~  356 (414)
                      .          ......       ...........          ...........++.+.+|+.+||..||.+|||++|
T Consensus       245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e  324 (362)
T d1q8ya_         245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG  324 (362)
T ss_dssp             HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred             HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence            0          000000       00000000000          00112234556788999999999999999999999


Q ss_pred             HH
Q 015027          357 VS  358 (414)
Q Consensus       357 v~  358 (414)
                      ++
T Consensus       325 ~L  326 (362)
T d1q8ya_         325 LV  326 (362)
T ss_dssp             HH
T ss_pred             Hh
Confidence            83

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.91  E-value=3.1e-25  Score=192.09  Aligned_cols=162  Identities=14%  Similarity=0.143  Sum_probs=117.6

Q ss_pred             CCCCccccCCceEEEEEEEcCCcEEEEEEeecccch-------------------hHhHHHHHHHHHccCCCceeeeeee
Q 015027           90 DRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADKI-------------------RITERELLRIISQVNHKNVVKILGL  150 (414)
Q Consensus        90 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------------------~~~~~~~~~~l~~l~hpniv~l~~~  150 (414)
                      .+.++||+|+||+||+|.+.+|+.||||+++.....                   ......+...+.++.|++++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            356789999999999999988999999987532110                   0111334567888999999988766


Q ss_pred             EecCCcceEEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCCCCCeeeCCCCCCceeeCCCCcEEEe
Q 015027          151 CLETEVPLLVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLASPPIIHGDVKSANILLNDNYTAKVA  230 (414)
Q Consensus       151 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~  230 (414)
                      .    ..+++|||+++..+.+.          +......++.|++.+|.|||+.+   |+||||||+|||++++ .++|+
T Consensus        83 ~----~~~lvme~~~~~~~~~l----------~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~li  144 (191)
T d1zara2          83 E----GNAVLMELIDAKELYRV----------RVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWII  144 (191)
T ss_dssp             E----TTEEEEECCCCEEGGGC----------CCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEEC
T ss_pred             c----CCEEEEEeeccccccch----------hhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEE
Confidence            3    24799999988665432          22334578999999999999988   9999999999999965 58999


Q ss_pred             eccccccccCCccccceecccccccccch------hhcccCCCCCcccchhHHHHH
Q 015027          231 DFESSVLISSDAETAMSTILIGTSGYLDP------VCINTGKLTKKSDVYSFGVVL  280 (414)
Q Consensus       231 DfGla~~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~~~Dv~SlGvil  280 (414)
                      |||+|.....+...          .|...      +. ....|+.++|+||..--+
T Consensus       145 DFG~a~~~~~~~~~----------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         145 DFPQSVEVGEEGWR----------EILERDVRNIITY-FSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CCTTCEETTSTTHH----------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred             ECCCcccCCCCCcH----------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence            99999765432111          11111      11 236788899999986443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.55  E-value=2.8e-07  Score=81.37  Aligned_cols=148  Identities=18%  Similarity=0.129  Sum_probs=94.7

Q ss_pred             HHHHHhcCCCCCCccccCCceEEEEEEEcCCcEEEEEEeecccc-hhHhHHHHHHHHHccC-CCceeeeeeeEecCCcce
Q 015027           81 EMIRATKNFDRSRCLSQGGFVSVYKGVLHDNIQVAVKTYRRADK-IRITERELLRIISQVN-HKNVVKILGLCLETEVPL  158 (414)
Q Consensus        81 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~-hpniv~l~~~~~~~~~~~  158 (414)
                      ++......|+..+..+.++.+.||+... +++.++||+...... .......+...+..+. +--+.+++.++..++..+
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~   86 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence            5555667777777666666688998764 566778888765432 2222333444444442 334677888888888899


Q ss_pred             EEEEeCCCCchhhhhhhcCCcccCCHHHHHHHHHHHHHHHHHhhhCC---------------------------------
Q 015027          159 LVYEFASNGTLLDHIRCESSQVLKTWKTCLRIAAETASALDYLHSLA---------------------------------  205 (414)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~---------------------------------  205 (414)
                      +||++++|.++.+......     .   ...++.+++..+..||+..                                 
T Consensus        87 lv~~~l~G~~~~~~~~~~~-----~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (263)
T d1j7la_          87 LLMSEADGVLCSEEYEDEQ-----S---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW  158 (263)
T ss_dssp             EEEECCSSEEHHHHTTTCS-----C---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred             EEEEecccccccccccccc-----c---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence            9999999988755432111     1   1123344444444454311                                 


Q ss_pred             -----------------------CCCeeeCCCCCCceeeCCCCcEEEeecccccc
Q 015027          206 -----------------------SPPIIHGDVKSANILLNDNYTAKVADFESSVL  237 (414)
Q Consensus       206 -----------------------~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~~  237 (414)
                                             ...++|+|+.|.|||+++++.+-|.||+.+..
T Consensus       159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                   12379999999999999877677999997643

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.22  E-value=3.3e-06  Score=73.84  Aligned_cols=75  Identities=16%  Similarity=0.090  Sum_probs=50.4

Q ss_pred             ccCC-ceEEEEEEEcCCcEEEEEEeecccchh-HhHHHHHHHHHccCCCceeeeeeeEecCCcceEEEEeCCCCchhh
Q 015027           96 SQGG-FVSVYKGVLHDNIQVAVKTYRRADKIR-ITERELLRIISQVNHKNVVKILGLCLETEVPLLVYEFASNGTLLD  171 (414)
Q Consensus        96 g~G~-~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~  171 (414)
                      ..|. -+.||+....++..+++|......... ..+.+.++.+... .-.+.+++++..+++..++||++++|.++.+
T Consensus        19 ~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~-gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~   95 (255)
T d1nd4a_          19 TIGCSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATT-GVPCAAVLDVVTEAGRDWLLLGEVPGQDLLS   95 (255)
T ss_dssp             SCTTSSCEEEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTT-TCCBCCEEEEEECSSCEEEEEECCSSEETTT
T ss_pred             CCcccCCeEEEEEeCCCCEEEEEeCCccCHhHHHHHHHHHHHHHhc-CCCCCceeeecccccceEEEEEeeecccccc
Confidence            3444 367999988778889999876554322 2233344444432 3346778888888888999999999876643

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.95  E-value=3.2e-05  Score=72.16  Aligned_cols=76  Identities=14%  Similarity=0.069  Sum_probs=45.5

Q ss_pred             CCccccCCceEEEEEEEcC-CcEEEEEEeeccc-------c-hh---HhHHHHHHHHHccCCCceeeeeeeEecCCcceE
Q 015027           92 SRCLSQGGFVSVYKGVLHD-NIQVAVKTYRRAD-------K-IR---ITERELLRIISQVNHKNVVKILGLCLETEVPLL  159 (414)
Q Consensus        92 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-------~-~~---~~~~~~~~~l~~l~hpniv~l~~~~~~~~~~~l  159 (414)
                      .+.||.|....||+....+ ++.++||.-....       . ..   ..+.+.++.+...-...+++++.+  +.+..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            4568999999999998654 6789999754211       0 01   112333344444333456666655  4556789


Q ss_pred             EEEeCCCCch
Q 015027          160 VYEFASNGTL  169 (414)
Q Consensus       160 v~e~~~~gsL  169 (414)
                      |||++++..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999987543

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.52  E-value=0.00021  Score=64.58  Aligned_cols=68  Identities=19%  Similarity=0.077  Sum_probs=42.7

Q ss_pred             eEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHccCCCce-----eeee--eeEecCCcceEEEEeCCCCc
Q 015027          101 VSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNHKNV-----VKIL--GLCLETEVPLLVYEFASNGT  168 (414)
Q Consensus       101 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~hpni-----v~l~--~~~~~~~~~~lv~e~~~~gs  168 (414)
                      -.||++...+|..+++|+.+..........++...+..|....+     +..-  ..+..++..+.++++++|..
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~  110 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ  110 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence            57999999899999999987765444444445455544432211     1111  12234566789999998754

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.11  E-value=0.00061  Score=63.17  Aligned_cols=73  Identities=12%  Similarity=0.070  Sum_probs=45.4

Q ss_pred             CCccccCCceEEEEEEEcC--------CcEEEEEEeecccchhHhHHHHHHHHHccC-CCceeeeeeeEecCCcceEEEE
Q 015027           92 SRCLSQGGFVSVYKGVLHD--------NIQVAVKTYRRADKIRITERELLRIISQVN-HKNVVKILGLCLETEVPLLVYE  162 (414)
Q Consensus        92 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e  162 (414)
                      ++.|+.|-.-.+|++...+        ...|.+++....... .....|.++++.+. +.-..++++++.+    .+|+|
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~-idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e  121 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETE-SHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  121 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCH-HHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchh-hHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence            3568889999999998653        245777776533222 22223334444443 3334577887753    58999


Q ss_pred             eCCCCch
Q 015027          163 FASNGTL  169 (414)
Q Consensus       163 ~~~~gsL  169 (414)
                      |++|.+|
T Consensus       122 fi~g~~l  128 (395)
T d1nw1a_         122 YIPSRPL  128 (395)
T ss_dssp             CCCEEEC
T ss_pred             EeccccC
Confidence            9988655

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.01  E-value=0.0017  Score=57.92  Aligned_cols=158  Identities=12%  Similarity=0.064  Sum_probs=80.1

Q ss_pred             ccHHHHHHHhcCCCCCCcc-----ccCCceEEEEEEEcCCcEEEEEEeecccchhHhHHHHHHHHHccCC-----Cceee
Q 015027           77 FSKSEMIRATKNFDRSRCL-----SQGGFVSVYKGVLHDNIQVAVKTYRRADKIRITERELLRIISQVNH-----KNVVK  146 (414)
Q Consensus        77 ~~~~~~~~~~~~~~~~~~l-----g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h-----pniv~  146 (414)
                      ++.+++.....+|.+.+..     ..|---+.|+....+| .+++|++....... ....++.++..+..     |..+.
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~~~-~l~~~~~~l~~L~~~g~pvp~pi~   80 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVEKN-DLPFFLGLMQHLAAKGLSCPLPLP   80 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC---CC-HHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCCCHH-HHHHHHHHHHhhhhccccccccce
Confidence            4677888888889875544     3555577899887555 58999986532222 11222333433322     22222


Q ss_pred             ee-e--eEecCCcceEEEEeCCCCchhhh--------------hhhc----C--CcccC------------------CHH
Q 015027          147 IL-G--LCLETEVPLLVYEFASNGTLLDH--------------IRCE----S--SQVLK------------------TWK  185 (414)
Q Consensus       147 l~-~--~~~~~~~~~lv~e~~~~gsL~~~--------------l~~~----~--~~~~~------------------~~~  185 (414)
                      .. |  +.........++.++.+......              +...    .  .....                  ...
T Consensus        81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (316)
T d2ppqa1          81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK  160 (316)
T ss_dssp             BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred             ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence            11 1  11223455667777766432110              0000    0  00000                  000


Q ss_pred             HHHHHHHHHHHHHHHhhh-CCCCCeeeCCCCCCceeeCCCCcEEEeeccccc
Q 015027          186 TCLRIAAETASALDYLHS-LASPPIIHGDVKSANILLNDNYTAKVADFESSV  236 (414)
Q Consensus       186 ~~~~i~~~i~~~l~~LH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~DfGla~  236 (414)
                      .....+..+...+.-.+. .-+.++||+|+.++||+++.+...-|.||+.+.
T Consensus       161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            111222223333333322 123569999999999999988777899999764